FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kucharikova, S
   Gerits, E
   De Brucker, K
   Braem, A
   Ceh, K
   Majdic, G
   Spanic, T
   Pogorevc, E
   Verstraeten, N
   Tournu, H
   Delattin, N
   Impellizzeri, F
   Erdtmann, M
   Krona, A
   Lovenklev, M
   Knezevic, M
   Frohlich, M
   Vleugels, J
   Fauvart, M
   de Silva, WJ
   Vandamme, K
   Garcia-Forgas, J
   Cammue, BPA
   Michiels, J
   Van Dijck, P
   Thevissen, K
AF Kucharikova, Sona
   Gerits, Evelien
   De Brucker, Katrijn
   Braem, Annabel
   Ceh, Katerina
   Majdic, Gregor
   Spanic, Tanja
   Pogorevc, Estera
   Verstraeten, Natalie
   Tournu, Helene
   Delattin, Nicolas
   Impellizzeri, Frederic
   Erdtmann, Martin
   Krona, Annika
   Lovenklev, Maria
   Knezevic, Miomir
   Frohlich, Mirjam
   Vleugels, Jef
   Fauvart, Maarten
   de Silva, Wander Jose
   Vandamme, Katleen
   Garcia-Forgas, Jordi
   Cammue, Bruno P. A.
   Michiels, Jan
   Van Dijck, Patrick
   Thevissen, Karin
TI Covalent immobilization of antimicrobial agents on titanium prevents
   Staphylococcus aureus and Candida albicans colonization and biofilm
   formation
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID ORTHOPEDIC IMPLANTS; ESCHERICHIA-COLI; IN-VITRO; INFECTIONS;
   CASPOFUNGIN; EPIDERMIDIS; STRATEGIES; MANAGEMENT; DIAGNOSIS; SURFACES
AB Biofilm-associated implant infections represent a serious public health problem. Covalent immobilization of antimicrobial agents on titanium (Ti), thereby inhibiting biofilm formation of microbial pathogens, is a solution to this problem.
   Vancomycin (VAN) and caspofungin (CAS) were covalently bound on Ti substrates using an improved processing technique adapted to large-scale coating of implants. Resistance of the VAN-coated Ti (VAN-Ti) and CAS-coated Ti (CAS-Ti) substrates against in vitro biofilm formation of the bacterium Staphylococcus aureus and the fungal pathogen Candida albicans was determined by plate counting and visualized by confocal laser scanning microscopy. The efficacy of the coated Ti substrates was also tested in vivo using an adapted biomaterial-associated murine infection model in which control-Ti, VAN-Ti or CAS-Ti substrates were implanted subcutaneously and subsequently challenged with the respective pathogens. The osseointegration potential of VAN-Ti and CAS-Ti was examined in vitro using human bone marrow-derived stromal cells, and for VAN-Ti also in a rat osseointegration model.
   In vitro biofilm formation of S. aureus and C. albicans on VAN-Ti and CAS-Ti substrates, respectively, was significantly reduced compared with biofilm formation on control-Ti. In vivo, we observed over 99.9% reduction in biofilm formation of S. aureus on VAN-Ti substrates and 89% reduction in biofilm formation of C. albicans on CAS-Ti substrates, compared with control-Ti substrates. The coated substrates supported osseointegration in vitro and in vivo.
   These data demonstrate the clinical potential of covalently bound VAN and CAS on Ti to reduce microbial biofilm formation without jeopardizing osseointegration.
C1 [Kucharikova, Sona; Tournu, Helene; Van Dijck, Patrick] VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31,Box 2438, B-3001 Leuven, Belgium.
   [Kucharikova, Sona; Tournu, Helene; Van Dijck, Patrick] Katholieke Univ Leuven, Lab Mol Cell Biol, Kasteelpk Arenberg 31,Box 2438, B-3001 Leuven, Belgium.
   [Gerits, Evelien; De Brucker, Katrijn; Verstraeten, Natalie; Delattin, Nicolas; Fauvart, Maarten; Cammue, Bruno P. A.; Michiels, Jan; Thevissen, Karin] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium.
   [Braem, Annabel; Vleugels, Jef] Katholieke Univ Leuven, Dept Mat Engn MTM, Kasteelpk Arenberg 44,Box 2450, B-3001 Leuven, Belgium.
   [Ceh, Katerina; Majdic, Gregor; Spanic, Tanja; Pogorevc, Estera] Univ Ljubljana, Fac Vet, Ctr Anim Genom, Gerbiceva 60, Ljubljana 1000, Slovenia.
   [Impellizzeri, Frederic] Biotech Int, Allees Craponne 305, F-13300 Salon De Provence, France.
   [Erdtmann, Martin] Hemoteq AG, Adenauerstr 15, D-52146 Wurselen, Germany.
   [Krona, Annika; Lovenklev, Maria] SP Food & Biosci, Dept Struct & Mat Design, Box 5401, S-40229 Gothenburg, Sweden.
   [Knezevic, Miomir; Frohlich, Mirjam] Educell Doo, Prevale 9, Trzin 1236, Slovenia.
   [Frohlich, Mirjam] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova 39, Ljubljana 1000, Slovenia.
   [de Silva, Wander Jose; Vandamme, Katleen] Katholieke Univ Leuven, Dept Oral Hlth Sci Biomat BIOMAT, Kapucijnenvoer 33,Box 7001, B-3000 Leuven, Belgium.
   [de Silva, Wander Jose] FOP UNICAMP, Dept Prosthodont & Periodontol, Av Limeira 901, BR-13414903 Piracicaba, SP, Brazil.
   [Garcia-Forgas, Jordi] Alhenia AG, Tafernstr 39, CH-5405 Dattwil, Switzerland.
   [Cammue, Bruno P. A.] VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.
RP Thevissen, K (reprint author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium.
EM karin.thevissen@biw.kuleuven.be
RI Fauvart, Maarten/B-1612-2010; Braem, Annabel/A-4343-2017; Michiels,
   Jan/F-1601-2010; Thevissen, Karin/B-7003-2015; Vleugels,
   Jozef/C-8262-2017
OI Fauvart, Maarten/0000-0002-6256-9193; Braem,
   Annabel/0000-0002-4890-0177; Michiels, Jan/0000-0001-5829-0897;
   Thevissen, Karin/0000-0003-0275-9072; Vleugels,
   Jozef/0000-0003-4432-4675; Silva, Wander Jose da/0000-0002-5613-5081;
   Verstraeten, Natalie/0000-0002-9548-4647
FU European Commission [278425]; FWO [G0B2515N, G047112N, WO.026.11N];
   Interuniversity Attraction Poles Programme; Belgian Science Policy
   Office; 'Industrial Research Fund' of KU Leuven [IOFm/05/022];
   'Bijzonder Onderzoeks Fonds' of KU Leuven [PDMK 11/089, PDMK 14/149];
   FWO
FX This work was supported by the European Commission's Seventh Framework
   Programme (FP7/2007-2013) under the grant agreement COATIM (project no
   278425), by grants from the FWO (G0B2515N, G047112N, WO.026.11N), and
   the Interuniversity Attraction Poles Programme initiated by the Belgian
   Science Policy Office. K. T. acknowledges the receipt of a mandate of
   the 'Industrial Research Fund' of KU Leuven (IOFm/05/022). S. K. and N.
   D. acknowledge the receipt of postdoctoral grants of the 'Bijzonder
   Onderzoeks Fonds' of KU Leuven (grant PDMK 11/089 and 14/149,
   respectively) S. K. acknowledges the receipt of an FWO postdoctoral
   research grant.
CR Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344
   Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Aslam S, 2008, CURR INFECT DIS REP, V11, P7, DOI DOI 10.1007/S11908-009-0002-X
   Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002
   Botequim D, 2012, LANGMUIR, V28, P7646, DOI 10.1021/la300948n
   Burgers R, 2010, ACTA BIOMATER, V6, P2307, DOI 10.1016/j.actbio.2009.11.003
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   CARPINO LA, 1987, ACCOUNTS CHEM RES, V20, P401, DOI 10.1021/ar00143a003
   Cataldo MA, 2010, J INFECTION, V61, P443, DOI 10.1016/j.jinf.2010.09.033
   Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488
   Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111579
   Chu Vivian H, 2005, Am J Med, V118, P1416
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davidson H, 2015, J BIOMED MATER RES B, V103, P1381, DOI 10.1002/jbm.b.33310
   De Brucker K, 2015, ANTIMICROB AGENTS CH, V59, P3052, DOI 10.1128/AAC.04650-14
   Della Valle C, 2011, J BONE JOINT SURG AM, V93A, P1355, DOI 10.2106/JBJS.9314ebo
   Dettenkofer M, 2004, AM J INFECT CONTROL, V32, P84, DOI 10.1016/j.ajic.2003.07.006
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Dutronc H, 2010, SCAND J INFECT DIS, V42, P890, DOI 10.3109/00365548.2010.498023
   Falcone M, 2009, MEDICINE, V88, P160, DOI 10.1097/MD.0b013e3181a693f8
   Fernandes A, 2013, J CLIN DIAGN RES, V7, P219, DOI 10.7860/JCDR/2013/4533.2732
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Garcia-Oltra E, 2011, REV ESP QUIM, V24, P37
   GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721
   Hariott NN, 2009, CANDIDA ALBICANS STA, V53, P3914
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hoiby N, 2015, CLIN MICROBIOL INFEC, V21, pS1, DOI 10.1016/j.cmi.2014.10.024
   Jamsen E, 2010, ACTA ORTHOP, V81, P660, DOI 10.3109/17453674.2010.537805
   Johannsson B, 2009, DIAGN MICR INFEC DIS, V64, P76, DOI 10.1016/j.diagmicrobio.2009.01.005
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Juodzbalys G, 2003, STOMATOLOGIJA BALTIC, V5, P101
   Moraes MN, 2013, REV MED MINAS GERAIS, V23, P99
   Moyad TF, 2008, ORTHOPEDICS, V31, P581, DOI 10.3928/01477447-20080601-22
   O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x
   Ricicova M, 2010, MICROBIOL-SGM, V156, P909, DOI 10.1099/mic.0.033530-0
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   Sarkar S, 2014, ANTIMICROB AGENTS CH, V58, P1183, DOI 10.1128/AAC.01745-13
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   Stewart S, 2012, J BONE JOINT SURG AM, V94A, P1406, DOI 10.2106/JBJS.K.00886
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Uppuluri P, 2011, ANTIMICROB AGENTS CH, V55, P3591, DOI 10.1128/AAC.01701-10
NR 46
TC 18
Z9 18
U1 3
U2 17
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD APR
PY 2016
VL 71
IS 4
BP 936
EP 945
DI 10.1093/jac/dkv437
PG 10
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA DJ5FP
UT WOS:000374232500014
PM 26702917
OA Bronze
DA 2018-10-20
ER

PT J
AU McCreedy, DA
   Margul, DJ
   Seidlits, SK
   Antane, JT
   Thomas, RJ
   Sissman, GM
   Boehler, RM
   Smith, DR
   Goldsmith, SW
   Kukushliev, TV
   Lamano, JB
   Vedia, BH
   He, T
   Shea, LD
AF McCreedy, Dylan A.
   Margul, Daniel J.
   Seidlits, Stephanie K.
   Antane, Jennifer T.
   Thomas, Ryan J.
   Sissman, Gillian M.
   Boehler, Ryan M.
   Smith, Dominique R.
   Goldsmith, Sam W.
   Kukushliev, Todor V.
   Lamano, Jonathan B.
   Vedia, Bansi H.
   He, Ting
   Shea, Lonnie D.
TI Semi-automated counting of axon regeneration in poly(lactide
   co-glycolide) spinal cord bridges
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Spinal cord injury; Hessian filter; Myelination; Automated
   quantification
ID MULTIPLE-CHANNEL BRIDGES; NEURAL STEM-CELLS; RAT SCIATIC-NERVE;
   IMAGE-ANALYSIS; ADULT-RAT; INJURY; SCAFFOLDS; GROWTH; RECOVERY;
   MYELINATION
AB Background: Spinal cord injury (SCI) is a debilitating event with multiple mechanisms of degeneration leading to life-long paralysis. Biomaterial strategies, including bridges that span the injury and provide a pathway to reconnect severed regions of the spinal cord, can promote partial restoration of motor function following SO. Axon growth through the bridge is essential to characterizing regeneration, as recovery can occur via other mechanisms such as plasticity. Quantitative analysis of axons by manual counting of histological sections can be slow, which can limit the number of bridge designs evaluated. In this study, we report a semi-automated process to resolve axon numbers in histological sections, which allows for efficient analysis of large data sets.
   New method: Axon numbers were estimated in SCI cross-sections from animals implanted with poly(lactide co-glycolide) (PLG) bridges with multiple channels for guiding axons. Immunofluorescence images of histological sections were filtered using a Hessian-based approach prior to threshold detection to improve the signal-to-noise ratio and filter out background staining associated with PLG polymer.
   Results: Semi-automated counting successfully recapitulated average axon densities and myelination in a blinded PLG bridge implantation study.
   Comparison with existing methods: Axon counts obtained with the semi-automated technique correlated well with manual axon counts from blinded independent observers across sections with a wide range of total axons.
   Conclusions: This semi-automated detection of Hessian-filtered axons provides an accurate and significantly faster alternative to manual counting of axons for quantitative analysis of regeneration following SCI. (C) 2016 Elsevier B.V. All rights reserved.
C1 [McCreedy, Dylan A.; Margul, Daniel J.; Thomas, Ryan J.; Sissman, Gillian M.; Shea, Lonnie D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Seidlits, Stephanie K.; Antane, Jennifer T.; Boehler, Ryan M.; Smith, Dominique R.; Goldsmith, Sam W.; Kukushliev, Todor V.; Lamano, Jonathan B.; Vedia, Bansi H.; He, Ting] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.
   [Seidlits, Stephanie K.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA.
RP Shea, LD (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM ldshea@umich.edu
OI Margul, Daniel/0000-0002-0907-1839
FU National Institutes of Health [R01 EB005678]
FX The authors would like to acknowledge Dr. Bea Penalver for her expertise
   in data analysis and Dirk-Jan Kroon for online examples of Hessian-based
   filtering methods. The published work was funded by the National
   Institutes of Health (R01 EB005678).
CR AUER RN, 1994, J NEUROSCI METH, V51, P229, DOI 10.1016/0165-0270(94)90015-9
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178
   Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Gensel JC, 2010, J NEUROSCI METH, V190, P71, DOI 10.1016/j.jneumeth.2010.04.026
   Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Isaacs J, 2014, J NEUROSCI METH, V233, P45, DOI 10.1016/j.jneumeth.2014.05.032
   Kaplan S, 2010, J NEUROSCI METH, V187, P90, DOI 10.1016/j.jneumeth.2010.01.001
   Kim CY, 2015, VET OPHTHALMOL, V19, P29
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1
   McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P
   Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022
   Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Pawar K, 2015, BIOMATERIALS, V65, P1, DOI 10.1016/j.biomaterials.2015.05.032
   Sakiyama-Elbert S, 2012, Handb Clin Neurol, V109, P575, DOI 10.1016/B978-0-444-52137-8.00036-X
   Sathyanesan A, 2012, J NEUROSCI METH, V206, P165, DOI 10.1016/j.jneumeth.2012.02.019
   Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thomas AM, 2014, INTEGR BIOL-UK, V6, P694, DOI 10.1039/c4ib00009a
   Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tuinstra HM, 2014, TISSUE ENG PT A, V20, P1027, DOI [10.1089/ten.tea.2013.0111, 10.1089/ten.TEA.2013.0111]
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   WILSON DH, 1984, PARAPLEGIA, V22, P230, DOI 10.1038/sc.1984.39
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
NR 39
TC 1
Z9 2
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD APR 1
PY 2016
VL 263
BP 15
EP 22
DI 10.1016/j.jneumeth.2016.01.021
PG 8
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA DJ4SY
UT WOS:000374199500003
PM 26820904
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gharbi, A
   El Feki, H
   Oudadesse, H
AF Gharbi, Amina
   El Feki, Hafed
   Oudadesse, Hassane
TI Novel alkali borosilicate glasses: Preparation, structural investigation
   and thermal study
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Bioactive Glasses; Melting; Thermal Proprieties; Biomedical Applications
ID IN-VITRO EVALUATION; BIOACTIVE GLASSES; BORATE GLASSES;
   RAMAN-SPECTROSCOPY; IONIC TRANSPORT; SYSTEM; HYDROXYAPATITE; MECHANISMS;
   CONVERSION; ALUMINUM
AB Bioactive glasses are indicated for use as bone substitutes in orthopedic or dental surgery because of their high reactivity once in contact with the biological medium. Boron is known as a glass network former and an activator of the glasses bioactivity. In this work, bioactive glass was doped by 5, 10 and 20 wt% of B2O3 according to the melting process. Adding boron oxide with high content enhances glass materials' bioactivity. Likewise, thanks to their solubility, borate-containing bioactive glasses were fluently used as orthopedic implants. The aim of our study was to investigate of boron effect on the thermal characteristics of our bioactive glass to better understand their proprieties in order for use as bone biomaterial. The obtained results proved that the more the boron content in the glass network increases, the more the melting temperature decreases and the more the thermal stability increases.
C1 [Gharbi, Amina; Oudadesse, Hassane] Univ Rennes 1, ISCR, UMR CNRS 6226, 263 Av Gen Leclerc, F-35042 Rennes, France.
   [Gharbi, Amina; El Feki, Hafed] Fac Sci Sfax, Mat Sci & Environm Lab, Sfax 3018, Tunisia.
RP Oudadesse, H (reprint author), Univ Rennes 1, ISCR, UMR CNRS 6226, 263 Av Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Agathopoulos S, 2006, J NON-CRYST SOLIDS, V352, P322, DOI 10.1016/j.jnoncrysol.2005.12.003
   ASAI K, 1982, T JPN I MET, V23, P571, DOI 10.2320/matertrans1960.23.571
   Azooz MA, 2008, INDIAN J PURE AP PHY, V46, P880
   Bardez I., 2004, THESIS U P M CURIE P, P71
   Barton J, 2004, VERRE SCI TECHNOLOGI
   Bray P. J., 1997, P 2 INT C BOR GLASS, P1
   Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679
   Flower G. L., 2014, PHYS SCI, V62, P315
   Fu HL, 2009, MAT SCI ENG C-MATER, V29, P2275, DOI 10.1016/j.msec.2009.05.013
   FURUKAWA T, 1981, J AM CERAM SOC, V64, P443, DOI 10.1111/j.1151-2916.1981.tb09893.x
   Gadet M.D., 2002, BIOL TRACE ELEM RES, V85, P23
   Girot A. L., 2011, J NONCRSYT SOLIDS, V357, P3322
   Grandjean A, 2006, J NON-CRYST SOLIDS, V352, P2731, DOI 10.1016/j.jnoncrysol.2006.03.058
   Hakki SS, 2010, J TRACE ELEM MED BIO, V24, P243, DOI 10.1016/j.jtemb.2010.03.003
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   Jastrzebski W, 2011, SPECTROCHIM ACTA A, V79, P722, DOI 10.1016/j.saa.2010.08.044
   Jebahi Samira, 2013, Eur J Orthop Surg Traumatol, V23, P759, DOI 10.1007/s00590-012-1087-8
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   KAMITSOS EI, 1990, J NON-CRYST SOLIDS, V126, P52, DOI 10.1016/0022-3093(90)91023-K
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   KROGHMOE J, 1965, PHYS CHEM GLASSES, V6, P46
   Kumar V, 2010, SOLID STATE IONICS, V181, P79, DOI 10.1016/j.ssi.2009.12.005
   Lee JH, 2006, J BIOMED MATER RES A, V77A, P362, DOI 10.1002/jbm.a.30594
   Lee SK, 2002, GEOCHIM COSMOCHIM AC, V66, P303, DOI 10.1016/S0016-7037(01)00775-X
   Linati L, 2005, J PHYS CHEM B, V109, P4989, DOI 10.1021/jp046631n
   Miyoshi H, 2004, J NON-CRYST SOLIDS, V345, P99, DOI 10.1016/j.jnoncrysol.2004.08.003
   Mohini GJ, 2013, APPL SURF SCI, V287, P46, DOI 10.1016/j.apsusc.2013.09.055
   Raguenet B., 2011, THESIS U MONTPELLIER, P170
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rao K. J., 2002, STRUCTURAL CHEM GLAS
   Reddy MS, 2007, J ALLOY COMPD, V438, P41, DOI 10.1016/j.jallcom.2006.08.054
   Richet P, 2006, J NON-CRYST SOLIDS, V352, P3854, DOI 10.1016/j.jnoncrysol.2006.06.034
   Saranti A, 2006, J NON-CRYST SOLIDS, V352, P390, DOI 10.1016/j.jnoncrysol.2006.01.042
   Shelby J. E., 1997, ROYAL SOC CHEM, V91, P108
   Sitarz M, 2011, J NON-CRYST SOLIDS, V357, P1603, DOI 10.1016/j.jnoncrysol.2011.01.007
   Sitarz M, 2012, VIB SPECTROSC, V61, P72, DOI 10.1016/j.vibspec.2012.01.016
   Souquet JL, 1998, SOLID STATE IONICS, V105, P237, DOI 10.1016/S0167-2738(97)00470-0
   Torres FJ, 2004, J NON-CRYST SOLIDS, V347, P45, DOI 10.1016/j.jnoncrysol.2004.09.003
   Wers E, 2014, THERMOCHIM ACTA, V580, P79, DOI 10.1016/j.tca.2014.02.001
   Wers E, 2014, J THERM ANAL CALORIM, V115, P2137, DOI 10.1007/s10973-013-3280-3
   Yang XY, 2012, J NON-CRYST SOLIDS, V358, P1171, DOI 10.1016/j.jnoncrysol.2012.02.005
   Yano T, 2003, J NON-CRYST SOLIDS, V321, P137, DOI 10.1016/S0022-3093(03)00158-3
   Zhong J., 1986, J NONCRYST SOLIDS, V87, P226
NR 47
TC 3
Z9 3
U1 0
U2 18
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD APR
PY 2016
VL 33
IS 4
BP 1456
EP 1461
DI 10.1007/s11814-015-0287-4
PG 6
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DJ5RA
UT WOS:000374266300040
DA 2018-10-20
ER

PT J
AU Schacht, K
   Vogt, J
   Scheibel, T
AF Schacht, Kristin
   Vogt, Jessica
   Scheibel, Thomas
TI Foams Made of Engineered Recombinant Spider Silk Proteins as 3D
   Scaffolds for Cell Growth
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE recombinant spider silk proteins; salt leaching; foams; porous
   scaffolds; biomedical applications; tissue engineering
ID GLASS-CERAMIC SCAFFOLDS; FIBROIN SCAFFOLDS; IN-VITRO; ENZYMATIC
   DEGRADATION; MECHANICAL-PROPERTIES; STREPTOMYCES-GRISEUS; FILMS;
   BIOMATERIAL; PARTICLES; OPPORTUNITIES
AB Materials for tissue engineering have to be biocompatible and have to support cell adhesion, proliferation and differentiation. Additionally, in case of soft tissue engineering the mechanical properties have to accommodate that of the tissue with mechanical integrity until the artificial scaffold is replaced by natural extracellular matrix. In case of artificial 3D scaffolds, it is of critical importance to be able to tune the mechanical properties, the inner free volume (i.e., pore size) and degradation behavior of the employed biomaterial. Here, the potential of recombinant spider silk proteins was evaluated concerning their processing into and application as 3D scaffolds for soft tissue engineering. Highly porous foams made of the recombinant spider silk protein eADF4(C16) and a variant containing an RGD motif were fabricated by salt leaching yielding mechanically robust scaffolds. In contrast to other salt-leached silk scaffolds, the swelling behavior of these scaffolds was low, and the mechanical properties in the range of soft tissues. The pore size and porosity of the foams could be adjusted by the salt crystal size. Fibroblasts adhered and proliferated well in foams made of the spider silk RGD variant but not in the foams of the nonmodified one.
C1 [Schacht, Kristin; Vogt, Jessica; Scheibel, Thomas] Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, BZKG, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, Inst BioMakromol Biomac, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, BZMB, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, Bayreuther Mat Zentrum BayMAT, Univ Str 30, D-95447 Bayreuth, Germany.
   [Vogt, Jessica] RESORBA Med GmbH, Flachmoor 16, D-90475 Nurnberg, Germany.
RP Scheibel, T (reprint author), Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, BZKG, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, Inst BioMakromol Biomac, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, BZMB, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, Bayreuther Mat Zentrum BayMAT, Univ Str 30, D-95447 Bayreuth, Germany.
EM thomas.scheibel@bm.uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
FU Deutsche Forschungsgemeinschaft [SFB 840 TPA8]
FX We thank Dr. Hendrik Bargel for scanning electron microscopy, Prof. Dr.
   Gregor Lang for experimental help with tensile testing, Elena Doblhofer
   for experimental help with FTIR and FSD, and Aniela Heidebrecht for
   proof reading and discussions. The sintered 45S5 Bioglass (R) scaffolds,
   fabricated by the replication method, were produced at the Department of
   Biomaterials, University Erlangen-Nuremberg, supervised by Prof. Dr.
   Aldo R Boccaccini. The freeze-cast aluminum oxide
   (Al<INF>2</INF>O<INF>3</INF>) scaffolds were prepared at the Thayer
   School of Engineering at Dartmouth, supervised by Prof. Dr. Ulrike
   Wegst. This work was supported by the Deutsche Forschungsgemeinschaft
   (SFB 840 TPA8).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   BAUER CA, 1974, EUR J BIOCHEM, V41, P45, DOI 10.1111/j.1432-1033.1974.tb03242.x
   BAUER CA, 1974, EUR J BIOCHEM, V45, P469, DOI 10.1111/j.1432-1033.1974.tb03571.x
   Bauer F, 2013, BIOMATER SCI-UK, V1, P1244, DOI 10.1039/c3bm60114e
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chen QZ, 2008, J BIOMED MATER RES A, V84A, P1049, DOI 10.1002/jbm.a.31512
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2010, MATERIALS, V3, P1913, DOI 10.3390/ma3031913
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Lewicka M, 2012, BIOMATERIALS, V33, P7712, DOI 10.1016/j.biomaterials.2012.07.021
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   Muller-Herrmann S, 2015, ACS BIOMATER SCI ENG, V1, P247, DOI 10.1021/ab500147u
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Neubauer MP, 2013, BIOMATER SCI-UK, V1, P1160, DOI 10.1039/c3bm60108k
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Schacht K, 2015, ANGEW CHEM INT EDIT, V54, P2816, DOI 10.1002/anie.201409846
   Schacht K, 2011, BIOMACROMOLECULES, V12, P2488, DOI 10.1021/bm200154k
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wegst UGK, 2010, PHILOS T R SOC A, V368, P2099, DOI 10.1098/rsta.2010.0014
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Widhe M, 2013, BIOMATERIALS, V34, P8223, DOI 10.1016/j.biomaterials.2013.07.058
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   WOLTERS GHJ, 1995, DIABETES, V44, P227, DOI 10.2337/diabetes.44.2.227
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Yoon BH, 2008, SCRIPTA MATER, V58, P537, DOI 10.1016/j.scriptamat.2007.11.006
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2012, J MATER SCI-MATER M, V23, P315, DOI 10.1007/s10856-011-4476-3
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
NR 61
TC 9
Z9 9
U1 5
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2016
VL 2
IS 4
BP 517
EP 525
DI 10.1021/acsbiomaterials.5b00483
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DJ3CU
UT WOS:000374083200007
DA 2018-10-20
ER

PT J
AU Heiny, M
   Shastri, VP
AF Heiny, Markus
   Shastri, V. Prasad
TI Nanofibers of Elastin and Hydrophilic Segmented Polyurethane Solution
   Blends Show Enhanced Mechanical Properties through Intermolecular
   Protein-Polymer H Bonding
SO BIOMACROMOLECULES
LA English
DT Article
ID DRUG-DELIVERY VEHICLES; PEG BLOCK-COPOLYMERS; COLLAGEN NANOFIBERS;
   SECONDARY STRUCTURE; CIRCULAR-DICHROISM; FIBER FORMATION; SCAFFOLDS;
   SURFACES; BEHAVIOR; HELIX
AB Combining mechanical properties with enhanced cell interaction is highly desirable in a biomaterial. In this study, a new paradigm for enhancing the mechanical properties of segmented polyurethanes (SPUs) through solution blending with a biopolymer is presented. This noncovalent approach is based on the premise that molecular level blending of SPUs rich in hydrogen bonding (H bonding) domains with a biopolymer capable of H bonding will promote H-bond bridges between the components, leading to molecular annealing and modification of the physicochemical properties of the SPU. We demonstrate that by solution-blending solubilized elastin with a triblock copolymer-derived SPU, a 5-fold increase in tensile modulus of electrospun constructs of the SPU can be achieved, with concomitant enhancement in human endothelial cell attachment. Spectroscopic and calorimetric analysis confirm the role of H bonding in the enhancement, thus providing the impetus to further explore blending with biopolymers as a means of improving the property profiles of synthetic polymeric biomaterials.
C1 [Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus,Stefan Meier Str 31, D-79104 Freiburg, Germany.
   Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany.
RP Shastri, VP (reprint author), Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus,Stefan Meier Str 31, D-79104 Freiburg, Germany.
EM prasad.shastri@gmail.com
FU Excellence Initiative of the German Federal and State Governments [EXC
   294]; University of Freiburg
FX We thank Vincent Ahmadi for the acquisition of SEM images and Melika
   Sarem for technical help with circular dichroism. This work was funded
   by the Excellence Initiative of the German Federal and State Governments
   (Grant EXC 294, Centre for Biological Signalling Studies) and the
   University of Freiburg.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   [Anonymous], 2010, F284710 ASTM
   Beese AM, 2013, ACS NANO, V7, P3434, DOI 10.1021/nn400346r
   Chen HR, 2011, POLYMER, V52, P400, DOI 10.1016/j.polymer.2010.11.041
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   DEBELLE L, 1995, J BIOL CHEM, V270, P26099, DOI 10.1074/jbc.270.44.26099
   Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007
   Forget A, 2013, P NATL ACAD SCI USA, V110, P12887, DOI 10.1073/pnas.1222880110
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   He Y, 2004, PROG POLYM SCI, V29, P1021, DOI 10.1016/j.progpolymsci.2004.07.002
   Jaeger R, 1996, MACROMOLECULES, V29, P7634, DOI 10.1021/ma9610673
   Kaminski AM, 1997, J COATING TECHNOL, V69, P115
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Kim BS, 2008, ACS NANO, V2, P386, DOI 10.1021/nn700408z
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee PJ, 2003, PHARMACEUT RES, V20, P264, DOI 10.1023/A:1022283423116
   Ling XY, 2006, J POLYM SCI POL PHYS, V44, P3200, DOI 10.1002/polb.20972
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   MATSUO S, 1972, MAKROMOLEKUL CHEM, V152, P203
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Najafabadi AH, 2014, ADV MATER, V26, P5823, DOI 10.1002/adma.201401537
   Nisha SK, 2014, J MATER CHEM C, V2, P2051, DOI 10.1039/c3tc32241f
   Paulsson M, 2002, J COLLOID INTERF SCI, V248, P194, DOI 10.1006/jcis.2001.8182
   Pino CJ, 2012, P NATL ACAD SCI USA, V109, P21283, DOI 10.1073/pnas.1200942109
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Riley T, 2001, LANGMUIR, V17, P3168, DOI 10.1021/la001226i
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   ROBERT L, 1963, B SOC CHIM BIOL, V45, P1317
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Sarem M, 2015, MRS BULL, V40, P490, DOI 10.1557/mrs.2015.116
   Scelsi A, 2015, RSC ADV, V5, P95007, DOI 10.1039/c5ra21182d
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vasconcelos A, 2011, APPL MICROBIOL BIOT, V90, P445, DOI 10.1007/s00253-011-3135-4
   Walgers R, 1998, J AM CHEM SOC, V120, P5073, DOI 10.1021/ja973552z
   Wang P., 2010, PLOS ONE, V5
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yeo GC, 2015, ADV HEALTHC MATER, V4, P2530, DOI 10.1002/adhm.201400781
   Yilgor I, 2015, POLYMER, V58, pA1, DOI 10.1016/j.polymer.2014.12.014
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 47
TC 3
Z9 4
U1 3
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2016
VL 17
IS 4
BP 1312
EP 1320
DI 10.1021/acs.biomac.5b01681
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DJ3AL
UT WOS:000374076900008
PM 26940665
DA 2018-10-20
ER

PT J
AU Pichavant, L
   Carrie, H
   Nguyen, MN
   Plawinski, L
   Durrieu, MC
   Heroguez, V
AF Pichavant, Loic
   Carrie, Helene
   Minh Ngoc Nguyen
   Plawinski, Laurent
   Durrieu, Marie-Christine
   Heroguez, Valerie
TI Vancomycin Functionalized Nanoparticles for Bactericidal Biomaterial
   Surfaces
SO BIOMACROMOLECULES
LA English
DT Article
ID OPENING METATHESIS POLYMERIZATION; INFECTIONS; PARTICLES; DELIVERY;
   EPIDERMIDIS; IMPLANTS; BIOFILMS; TITANIUM; ADHESION; OXIDE)
AB In this paper, we describe a simple and powerful way to synthesize antibacterial biomaterials with applications as implants in orthopedic surgery. Such implants are obtained by covalently grafting onto the Ti90A16 V4 alloy surface with vancomycin-functionalized nanoparticles. Nanoparticles were produced by ring-opening metathesis polymerization of alpha-norbornenyl-omega-vancomycin poly(ethylene oxide) macromonomers. Vancomycin is an interesting candidate because of its use in the field of implant associated infection as it is a glycopeptide which acts on bacterial walls. As a consequence, vancomycin does not need to be released for it to be active. In the first part of this paper, the synthesis and the complete characterization of these materials are described. In a second part, the in vitro antibacterial behavior is analyzed and discussed.
C1 [Pichavant, Loic; Carrie, Helene; Minh Ngoc Nguyen; Heroguez, Valerie] Univ Bordeaux, CNRS UMR5629, Lab Chim Polymeres Organ, IPB ENSCBP, 16 Ave Pey Berland, F-33607 Pessac, France.
   [Pichavant, Loic; Carrie, Helene; Plawinski, Laurent; Durrieu, Marie-Christine] Univ Bordeaux, CNRS UMR5248, Inst Chim & Biol Membranes & Nanoobjets, INP Bordeaux, 2 Rue Robert Escarpit, F-33607 Pessac, France.
   [Minh Ngoc Nguyen] VNU Univ Sci, Fac Chem, 19 Le Thanh Tong, Hanoi, Vietnam.
RP Heroguez, V (reprint author), Univ Bordeaux, CNRS UMR5629, Lab Chim Polymeres Organ, IPB ENSCBP, 16 Ave Pey Berland, F-33607 Pessac, France.
EM heroguez@enscbp.fr
RI DURRIEU, Marie-Christine/I-4358-2016; Nguyen, Minh Ngoc/D-3459-2014
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; Nguyen, Minh
   Ngoc/0000-0002-1876-9761; Helene, Carrie/0000-0003-3352-2940
FU SATT of Region Aquitaine (Aquitaine Science Transfert); GIS AMA
   (Advanced Materials in Aquitaine)
FX The authors thank The SATT of Region Aquitaine (Aquitaine Science
   Transfert) and the GIS AMA (Advanced Materials in Aquitaine) for
   providing financial support to this project. The authors also want to
   thank Drs. G. Amador and J. Caillon from the University of Nantes for
   providing the bacterial strains. Microscopy was done in the Bordeaux
   Imaging Center, a service unit of the CNRS-INSERM and Bordeaux
   University, member of the national infrastructure France BioImaging.
   Finally, the authors would like to thank Dr. Edgar Cao from the
   University of Waterloo for his English assistance.
CR Arimoto H, 1999, CHEM COMMUN, P1361, DOI 10.1039/a903529j
   Arimoto H, 2001, TETRAHEDRON LETT, V42, P3347, DOI 10.1016/S0040-4039(01)00429-4
   Bernard L, 2004, J ANTIMICROB CHEMOTH, V53, P127, DOI 10.1093/jac/dkh033
   Chemtob A, 2002, MACROMOLECULES, V35, P9262, DOI 10.1021/ma020871o
   Cloutier M, 2015, TRENDS BIOTECHNOL, V33, P637, DOI 10.1016/j.tibtech.2015.09.002
   Collette F, 2013, J POLYM SCI POL CHEM, V51, P176, DOI 10.1002/pola.26357
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Denis I, 2014, BIOMACROMOLECULES, V15, P4534, DOI 10.1021/bm501338r
   Greenwald R. B., 2009, U.S. Patent, Patent No. [2009/0221471 Al, 20090221471]
   Gueugnon F, 2013, BIOMACROMOLECULES, V14, P2396, DOI 10.1021/bm400516b
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Heroguez V, 1996, MACROMOLECULES, V29, P4459, DOI 10.1021/ma951797v
   Lawson MC, 2007, CLIN ORTHOP RELAT R, P96, DOI 10.1097/BLO.0b013e3180986706
   Lawson MC, 2010, CLIN ORTHOP RELAT R, V468, P2081, DOI 10.1007/s11999-010-1266-z
   Lawson MC, 2009, BIOMACROMOLECULES, V10, P2221, DOI 10.1021/bm900410a
   Lu J, 2007, CHEM COMMUN, P251, DOI 10.1039/b613319c
   Nguyen MN, 2012, BIOMACROMOLECULES, V13, P896, DOI 10.1021/bm201812u
   Nitanai Y, 2009, J MOL BIOL, V385, P1422, DOI 10.1016/j.jmb.2008.10.026
   Ong KL, 2009, J ARTHROPLASTY, V24, P1137, DOI 10.1016/j.arth.2008.08.005
   Pearce C. M., 1995, J CHEM SOC P2, V1, P153
   Pedersen AB, 2010, ACTA ORTHOP, V81, P542, DOI 10.3109/17453674.2010.519908
   Pichavant L, 2012, J CONTROL RELEASE, V162, P373, DOI 10.1016/j.jconrel.2012.06.033
   Pichavant L, 2011, MACROMOLECULES, V44, P7879, DOI 10.1021/ma2015479
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Quemener D, 2005, POLYMER, V46, P1067, DOI 10.1016/j.polymer.2004.11.096
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Yoshida O, 2011, MEDCHEMCOMM, V2, P278, DOI 10.1039/c0md00230e
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
NR 29
TC 16
Z9 16
U1 3
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2016
VL 17
IS 4
BP 1339
EP 1346
DI 10.1021/acs.biomac.5b01727
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DJ3AL
UT WOS:000374076900011
PM 26938371
DA 2018-10-20
ER

PT J
AU Massey, CJ
   Suh, JD
   Tessema, B
   Gray, ST
   Singh, A
AF Massey, Conner J.
   Suh, Jeffrey D.
   Tessema, Belachew
   Gray, Stacey T.
   Singh, Ameet
TI Biomaterials in Rhinology
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Review
DE biomaterials; nasal packing; removable packing; absorbable packing;
   hemostasis; wound healing; drug-eluting stents; endoscopic sinus
   surgery; rhinology; chronic rhinosinusitis
ID ENDOSCOPIC SINUS SURGERY; RANDOMIZED CONTROLLED-TRIAL; MICROPOROUS
   POLYSACCHARIDE HEMOSPHERES; CARBOXY-METHYLATED CELLULOSE; MIDDLE MEATAL
   SPACER; NASAL PACKING; CHRONIC RHINOSINUSITIS; DOUBLE-BLIND; CHITOSAN
   GEL; FIBRIN GLUE
AB Introduction Many different kinds of rhinologic biomaterials, both nonabsorbable and absorbable, have been developed over the years to improve outcomes following endoscopic sinus surgery (ESS) for patients with chronic rhinosinusitis. In particular, these products have been designed to prevent postoperative bleeding, optimize the wound healing process, and reduce inflammation. This review evaluates the most recent evidence on biomaterials used in rhinology, focusing on these outcomes after ESS.
   Data Sources MEDLINE, Scopus, Google Scholar, and Clinicaltrials.gov.
   Review Methods A primary literature search based on the listed databases was performed with combinatorial search terms. Studies were considered for review if they met a set of inclusion and exclusion criteria.
   Conclusions Some products have performed better than others in clinical trials, although significant heterogeneity among studies does not allow for selection of a clearly superior biomaterial. While nonabsorbable biomaterials are still effective in achieving certain outcomes, newer, absorbable substances may be just as effective and avoid the morbidity associated with nasal packing removal. Steroid-eluting biomaterials have shown promising early results in reducing inflammation and promoting wound healing.
   Implications for Practice Certain absorbable biomaterials, such as chitosan gel and fibrin glue, have performed well with respect to postoperative hemostasis and wound healing, although they do not address mucosal inflammation. Steroid delivery systems may play an increasingly important role in reducing disease recurrence after ESS, although more studies are needed to assess long-term outcomes.
C1 [Massey, Conner J.; Singh, Ameet] George Washington Univ, Div Otolaryngol, 2300 M St NW,4th Floor, Washington, DC 20037 USA.
   [Suh, Jeffrey D.] Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA USA.
   [Tessema, Belachew] Univ Connecticut, Connecticut Sinus Ctr, Div Otolaryngol Head & Neck Surg, Farmington, CT USA.
   [Gray, Stacey T.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol,Dept Otolaryngol, Boston, MA 02115 USA.
RP Singh, A (reprint author), George Washington Univ, Div Otolaryngol, 2300 M St NW,4th Floor, Washington, DC 20037 USA.
EM ameetsingh@alum.mit.edu
CR Akbari E, 2012, RHINOLOGY, V50, P306, DOI 10.4193/Rhino11.215
   Akiyama K, 2014, AURIS NASUS LARYNX, V41, P264, DOI [10.1016/j.an1.2013.10.009, 10.1016/j.anl.2013.10.009]
   Al-Shaikh S, 2014, J LARYNGOL OTOL, V128, P709, DOI 10.1017/S0022215114001303
   Antisdel JL, 2011, AM J RHINOL ALLERGY, V25, P268, DOI 10.2500/ajra.2011.25.3619
   Antisdel JL, 2009, OTOLARYNG HEAD NECK, V141, P353, DOI 10.1016/j.otohns.2009.06.078
   Berlucchi M, 2009, EUR ARCH OTO-RHINO-L, V266, P839, DOI 10.1007/s00405-008-0841-3
   Beyea JA, 2011, ANN OTO RHINOL LARYN, V120, P495, DOI 10.1177/000348941112000801
   Chandra RK, 2003, AM J RHINOL, V17, P51, DOI 10.1177/194589240301700109
   Chang EH, 2011, J OTOLARYNGOL-HEAD N, V40, pS14, DOI 10.2310/7070.2011.100099
   Cho KS, 2015, EUR ARCH OTO-RHINO-L, V272, P1699, DOI 10.1007/s00405-014-3264-3
   Cho KS, 2013, LARYNGOSCOPE, V123, P564, DOI 10.1002/lary.23643
   Cote DWJ, 2010, LARYNGOSCOPE, V120, P1269, DOI 10.1002/lary.20905
   Cruise AS, 2006, CLIN OTOLARYNGOL, V31, P25, DOI 10.1111/j.1749-4486.2006.01122.x
   Dubin MG, 2007, AM J RHINOL, V21, P483, DOI 10.2500/ajr.2007.21.3047
   Eliashar R, 2006, OTOLARYNG HEAD NECK, V134, P276, DOI 10.1016/j.otohns.2005.10.012
   Erkan AN, 2007, LARYNGOSCOPE, V117, P491, DOI 10.1097/MLG.0b013e31802dc5bc
   Franklin JH, 2007, AM J RHINOL, V21, P214, DOI 10.2500/ajr.2007.21.3011
   Frenkiel Saul, 2002, J Otolaryngol, V31 Suppl 1, pS41, DOI 10.2310/7070.2002.21296
   Gall RM, 2002, J OTOLARYNGOL, V31, P271, DOI 10.2310/7070.2002.29810
   Hu KH, 2008, INT J PEDIATR OTORHI, V72, P1535, DOI 10.1016/j.ijporl.2008.07.006
   HUGGINS S, 1969, EYE EAR NOSE THROAT, V48, P420
   Jameson M, 2006, AM J OTOLARYNG, V27, P86, DOI 10.1016/j.amjoto.2005.07.011
   Kastl KG, 2009, AMJ RHINOL ALLERGY, V23, P80, DOI 10.2500/ajra.2009.23.3267
   Kastl KG, 2009, EUR ARCH OTO-RHINO-L, V266, P1239, DOI 10.1007/s00405-008-0881-8
   Kim DW, 2012, AM J RHINOL ALLERGY, V26, pE147, DOI 10.2500/ajra.2012.26.3813
   Kimmelman CP, 2001, OTOLARYNG HEAD NECK, V125, P603, DOI 10.1067/mhn.2001.120229
   Leung RM, 2011, AM J RHINOL ALLERGY, V25, P401, DOI 10.2500/ajra.2011.25.3672
   Lipworth BJ, 2000, DRUG SAFETY, V23, P11, DOI 10.2165/00002018-200023010-00002
   Marple BF, 2012, OTOLARYNG HEAD NECK, V146, P1004, DOI 10.1177/0194599811435968
   Melis A, 2015, LARYNGOSCOPE, V125, P1067, DOI 10.1002/lary.25105
   Miller RS, 2003, OTOLARYNG HEAD NECK, V128, P862, DOI 10.1016/S0194-5998(03)00460-1
   Murr AH, 2011, INT FORUM ALLERGY RH, V1, P23, DOI 10.1002/alr.20020
   Poetker DM, 2010, OTOLARYNG CLIN N AM, V43, P753, DOI 10.1016/j.otc.2010.04.003
   Ramadan HH, 1999, LARYNGOSCOPE, V109, P27, DOI 10.1097/00005537-199901000-00006
   Rudmik L, 2012, INT FORUM ALLERGY RH, V2, P248, DOI 10.1002/alr.21011
   Shaw CKL, 2000, J LARYNGOL OTOL, V114, P506
   Shi RJ, 2013, AM J RHINOL ALLERGY, V27, P71, DOI 10.2500/ajra.2013.27.3833
   Shoman N, 2009, J OTOLARYNGOL-HEAD N, V38, P112, DOI 10.2310/7070.2008.OA0217
   Song KJ, 2013, CLIN OTOLARYNGOL, V38, P225, DOI 10.1111/coa.12117
   Stankiewicz JA, 2011, LARYNGOSCOPE, V121, P2684, DOI 10.1002/lary.21446
   STEVENS RW, 1951, AMA ARCH OTOLARYNGOL, V54, P191
   Szczygielski K, 2010, EUR ARCH OTO-RHINO-L, V267, P537, DOI 10.1007/s00405-009-1117-2
   Ha TN, 2013, INT FORUM ALLERGY RH, V3, P573, DOI 10.1002/alr.21136
   Thornton RS, 1996, ARCH OTOLARYNGOL, V122, P869
   Tom LWC, 1997, AM J RHINOL, V11, P229, DOI 10.2500/105065897781751884
   Vaiman M, 2005, ANN OTO RHINOL LARYN, V114, P237, DOI 10.1177/000348940511400313
   Valentine R, 2010, AMJ RHINOL ALLERGY, V24, P70, DOI 10.2500/ajra.2010.24.3422
   Verim A, 2014, LARYNGOSCOPE, V124, P1529, DOI 10.1002/lary.24543
   Weber RK, 2009, HEAD NECK SURG, V8
   Wee JH, 2012, EUR ARCH OTO-RHINO-L, V269, P897, DOI 10.1007/s00405-011-1768-7
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4
   Wormald PJ, 2006, AM J RHINOL, V20, P7, DOI 10.1177/194589240602000102
   Yu MS, 2014, AM J RHINOL ALLERGY, V28, P335, DOI 10.2500/ajra.2014.28.4047
NR 53
TC 4
Z9 4
U1 2
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
EI 1097-6817
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD APR
PY 2016
VL 154
IS 4
BP 606
EP 617
DI 10.1177/0194599815627782
PG 12
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA DJ2FL
UT WOS:000374019100005
PM 26908551
DA 2018-10-20
ER

PT J
AU Zhou, X
   Chen, X
   Mao, TC
   Li, X
   Shi, XH
   Fan, DL
   Zhang, YM
AF Zhou, Xin
   Chen, Xing
   Mao, Tong-cun
   Li, Xiang
   Shi, Xiao-hua
   Fan, Dong-li
   Zhang, Yi-ming
TI Carbon Ion Implantation: A Good Method to Enhance the Biocompatibility
   of Silicone Rubber
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID LENS EPITHELIAL-CELLS; FOREIGN-BODY REACTION; SMOOTH MUSCLE ACTIN;
   BACTERIAL ADHESION; BREAST IMPLANTS; CAPSULAR CONTRACTURE; SURFACE
   MODIFICATION; INFECTION; ALPHA; RECONSTRUCTION
AB Background: Silicone rubber and silicone rubber-based materials have been used as medical tissue implants in the field of plastic surgery for many years, but there are still some reports of adverse reactions to long-term implants. Earlier studies have shown that ion implantation could enhance the biocompatibility of biomaterials. However, whether ion implantation has a good effect on silicone rubber is unknown. Methods: Three types of carbon ion silicone rubber were obtained by implanting three doses of carbon ions. Then, the antibacterial adhesion properties and the in vivo host responses were evaluated. The antibacterial adhesion properties were examined by plate colony counting, fluorescence staining, and scanning electron microscopic observation. The host responses were evaluated by surveying inflammation and fiber capsule formation that developed after subcutaneous implantation in Sprague-Dawley rats for 7, 30, 90, and 180 days. In addition, the possible mechanism by which ion implantation enhanced the biocompatibility of the biomaterial was investigated and discussed. Results: Carbon ion silicone rubber exhibits less bacterial adhesion, less collagen deposition, and thinner and weaker tissue capsules. Immunohistochemical staining results for CD4, tumor necrosis factor-alpha, alpha-smooth muscle actin, and elastin showed the possible mechanism enhancing the biocompatibility of silicone rubber. These data indicate that carbon ion silicone rubber exhibits good antibacterial adhesion properties and triggers thinner and weaker tissue capsules. In addition, high surface roughness and high zeta potential may be the main factors that induce the unique biocompatibility of carbon ion silicone rubber. Conclusion: Ion implantation should be considered for further investigation and application, and carbon ion silicone rubber could be a better biomaterial to decrease silicone rubber-initiated complications.
C1 [Zhou, Xin; Chen, Xing; Mao, Tong-cun; Li, Xiang; Shi, Xiao-hua; Fan, Dong-li; Zhang, Yi-ming] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China.
RP Fan, DL; Zhang, YM (reprint author), Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China.
EM fdltmmu@sina.com; zympla@sina.com
OI Fan, Dongli/0000-0003-4356-7181
FU National Natural Science Foundation of China [81372075, 81571918]; Third
   Military Medical University [2012XZH05]; grant for Scientific Personnel
   Innovation from Chongqing [cstc2013kjrc-qnrc10003]
FX This work was funded by grants from the National Natural Science
   Foundation of China (81372075 and 81571918), a grant for Transformation
   of Scientific and Technological Achievements from the Third Military
   Medical University (2012XZH05), and a grant for Scientific Personnel
   Innovation from Chongqing (cstc2013kjrc-qnrc10003).
CR Adams WP, 2006, PLAST RECONSTR SURG, V117, P30, DOI 10.1097/01.prs.0000185671.51993.7c
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Araco A, 2007, AESTHET PLAST SURG, V31, P325, DOI 10.1007/s00266-006-0156-y
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bergmann PA, 2014, J PLAST RECONSTR AES, V67, P1364, DOI 10.1016/j.bjps.2014.05.040
   Cazacu M, 2009, J COMPOS MATER, V43, P2045, DOI 10.1177/0021998309340447
   Eltze E, 2003, J BIOMED MATER RES A, V64A, P12, DOI 10.1002/jbm.a.10342
   Erlich Mark A, 2003, Facial Plast Surg, V19, P325
   Fundeanu I, 2010, ACTA BIOMATER, V6, P4271, DOI 10.1016/j.actbio.2010.06.010
   Garcia CM, 2006, EXP EYE RES, V83, P999, DOI 10.1016/j.exer.2006.04.009
   Grellner W, 2002, FORENSIC SCI INT, V130, P90, DOI 10.1016/S0379-0738(02)00342-0
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7
   Kaali P, 2010, POLYM DEGRAD STABIL, V95, P1456, DOI 10.1016/j.polymdegradstab.2010.06.024
   Knight MAF, 2004, PLAST RECONSTR SURG, V114, p26E, DOI 10.1097/01.PRS.0000132678.97041.53
   Lawrence EL, 2005, MED ENG PHYS, V27, P443, DOI 10.1016/j.medengphy.2004.12.013
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Ling T, 2013, J MATER SCI-MATER M, V24, P2709, DOI 10.1007/s10856-013-5028-9
   Liu PS, 2013, MAT SCI ENG C-MATER, V33, P3865, DOI 10.1016/j.msec.2013.05.025
   Lugowski SJ, 2000, J TRACE ELEM MED BIO, V14, P31, DOI 10.1016/S0946-672X(00)80021-8
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Macadam SA, 2004, ANN PLAS SURG, V53, P420, DOI 10.1097/01.sap.0000130705.19174.d4
   Meije Y, 2014, J INFECTION, V68, P548, DOI 10.1016/j.jinf.2014.01.001
   Meretoja VV, 2010, J BIOMED MATER RES A, V95A, P269, DOI 10.1002/jbm.a.32829
   Moyer HR, 2014, PLAST RECONSTR SURG, V133, P214, DOI 10.1097/01.prs.0000437255.01199.42
   Nagamoto T, 2000, INVEST OPHTH VIS SCI, V41, P1122
   National Research Council (US), COMM UPD GUID CAR US
   O'Horo JC, 2014, CRIT CARE MED, V42, P1334, DOI 10.1097/CCM.0000000000000166
   Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44
   Price C, 2002, J BIOMED MATER RES, V63, P122, DOI 10.1002/jbm.10094
   Rahman CV, 2014, J TISSUE ENG REGEN M, V8, P59, DOI 10.1002/term.1497
   Rohrich RJ, 2006, PLAST RECONSTR SURG, V118, p1S 2S
   Tsuji H, 2007, SURF COAT TECH, V201, P8123, DOI 10.1016/j.surfcoat.2006.01.074
   Tsuji H, 2004, APPL SURF SCI, V235, P182, DOI 10.1016/j.apsusc.2004.05.121
   Tsuji H, 2009, SURF COAT TECH, V203, P2562, DOI 10.1016/j.surfcoat.2009.02.076
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wang SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098320
   Wolfram Dolores, 2004, J Autoimmun, V23, P81
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
NR 41
TC 3
Z9 3
U1 3
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD APR
PY 2016
VL 137
IS 4
BP 690E
EP 699E
DI 10.1097/PRS.0000000000002022
PG 10
WC Surgery
SC Surgery
GA DI8VN
UT WOS:000373780400001
PM 27018697
DA 2018-10-20
ER

PT J
AU Nguyen, KV
   Holade, Y
   Minteer, SD
AF Khiem Van Nguyen
   Holade, Yaovi
   Minteer, Shelley D.
TI DNA Redox Hydrogels: Improving Mediated Enzymatic Bioelectrocatalysis
SO ACS CATALYSIS
LA English
DT Article
ID MODIFIED LINEAR POLY(ETHYLENIMINE); GLASSY-CARBON ELECTRODE;
   TOLUIDINE-BLUE; METHYLENE-BLUE; BIOFUEL CELLS; DEHYDROGENASE; GLUCOSE;
   FILM; ENZYMES; LIPIDS
AB We present the preparation of a redox DNA hydrogel for mediated bioelectrocatalysis of oxidoreductase enzymes for biosensor and biofuel cell applications. The noncovalent functionalization of DNA with redox molecules is achieved by intercalation of aromatic redox probes into the DNA double helix or electrostatic binding of redox-active tetraalkylammonium ions to phosphate groups on DNA. Prepared DNA redox hydrogels demonstrate the capability of mediating bioelectrocatalytic glucose oxidation by oxidoreductase enzymes. This is the first evidence that redox DNA hydrogels can replace redox polymer hydrogels for self-exchange based mediation for bioelectrocatalytic applications. This study contributes toward advances in the use of DNA, an emerging biomaterial, in enzymatic bioelectrocatalysis-based applications.
C1 [Khiem Van Nguyen; Holade, Yaovi; Minteer, Shelley D.] Univ Utah, Dept Chem, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
   [Khiem Van Nguyen; Holade, Yaovi; Minteer, Shelley D.] Univ Utah, Dept Mat Sci & Engn, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
   [Khiem Van Nguyen] Duy Tan Univ, Inst Res & Dev, Da Nan, Vietnam.
RP Minteer, SD (reprint author), Univ Utah, Dept Chem, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.; Minteer, SD (reprint author), Univ Utah, Dept Mat Sci & Engn, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
EM minteer@chem.utah.edu
RI Minteer, Shelley/C-4751-2014; HOLADE, Yaovi/K-8582-2015
OI Minteer, Shelley/0000-0002-5788-2249; HOLADE, Yaovi/0000-0002-8806-568X
FU Air Force Office of Scientific Research
FX Financial support from the Air Force Office of Scientific Research is
   greatly acknowledged.
CR Abbott NL, 2005, J AM CHEM SOC, V127, P11576, DOI 10.1021/ja054038t
   Aytar BS, 2013, J AM CHEM SOC, V135, P9111, DOI 10.1021/ja403546b
   Balazs DA, 2011, J DRUG DELIV, DOI 10.1155/2011/326497
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BOGUSLAVSKY LI, 1995, BIOSENS BIOELECTRON, V10, P693, DOI 10.1016/0956-5663(95)96960-7
   Chen W, 2015, J AM CHEM SOC, V137, P12884, DOI 10.1021/jacs.5b05432
   Chi ZX, 2010, J HAZARD MATER, V175, P274, DOI 10.1016/j.jhazmat.2009.09.160
   Cooney MJ, 2008, ENERG ENVIRON SCI, V1, P320, DOI 10.1039/b809009b
   Deng-Kai Y., 2011, NAN C INEC 2011 IEEE, P1
   GREGG BA, 1990, ANAL CHEM, V62, P258, DOI 10.1021/ac00202a007
   Gu JY, 2002, ELECTROANAL, V14, P949, DOI 10.1002/1521-4109(200207)14:13<949::AID-ELAN949>3.0.CO;2-O
   Gu TT, 2013, MATER SCI FORUM, V750, P84, DOI 10.4028/www.scientific.net/MSF.750.84
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   Jiao K, 2005, ELECTROANAL, V17, P997, DOI 10.1002/elan.200403208
   Kelley SO, 1997, BIOCONJUGATE CHEM, V8, P31, DOI 10.1021/bc960070o
   Nguyen KV, 2015, CHEM COMMUN, V51, P13071, DOI 10.1039/c5cc04810a
   Merchant SA, 2009, LANGMUIR, V25, P7736, DOI 10.1021/la9004938
   Meredith MT, 2012, ANNU REV ANAL CHEM, V5, P157, DOI 10.1146/annurev-anchem-062011-143049
   Meredith MT, 2011, J ELECTROCHEM SOC, V158, pB166, DOI 10.1149/1.3505950
   Moore CM, 2004, BIOMACROMOLECULES, V5, P1241, DOI 10.1021/bm0345256
   Nafisi S, 2007, J MOL STRUCT, V827, P35, DOI 10.1016/j.molstruc.2006.05.004
   Periasamy AP, 2011, TALANTA, V83, P930, DOI 10.1016/j.talanta.2010.10.058
   SAJI T, 1985, J AM CHEM SOC, V107, P6865, DOI 10.1021/ja00310a020
   Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081
   Yao YL, 2007, ELECTROCHIM ACTA, V53, P278, DOI 10.1016/j.electacta.2007.04.007
NR 25
TC 8
Z9 8
U1 1
U2 49
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2155-5435
J9 ACS CATAL
JI ACS Catal.
PD APR
PY 2016
VL 6
IS 4
BP 2603
EP 2607
DI 10.1021/acscatal.5b02699
PG 5
WC Chemistry, Physical
SC Chemistry
GA DI5FN
UT WOS:000373524400053
OA Bronze
DA 2018-10-20
ER

PT J
AU Liu, WQ
   Kang, N
   Dong, YL
   Guo, YC
   Zhao, D
   Zhang, SW
   Zhou, LY
   Seriwatanachai, D
   Liang, X
   Yuan, Q
AF Liu, Weiqing
   Kang, Ning
   Dong, Yuliang
   Guo, Yuchen
   Zhao, Dan
   Zhang, Shiwen
   Zhou, Liyan
   Seriwatanachai, Dutmanee
   Liang, Xing
   Yuan, Quan
TI Effect of Resorbable Collagen Plug on Bone Regeneration in Rat
   Critical-Size Defect Model
SO IMPLANT DENTISTRY
LA English
DT Article
DE animal model; bone substitute materials; bone defect repair
ID PARATHYROID-HORMONE 1-34; RICH PLASMA PREPARATION; MESENCHYMAL
   STEM-CELLS; CALVARIAL DEFECTS; MORPHOGENETIC PROTEIN-2; TISSUE
   REGENERATION; IN-VITRO; MATRIX; HYDROXYAPATITE; BIOMATERIAL
AB Objective: The purpose of this investigation was to examine the effect of resorbable collagen plug (RCP) on bone regeneration in rat calvarial critical-size defects. Methods: About 5-mm-diameter calvarial defects were created in forty 12-week-old male Sprague-Dawley rats and implanted with or without RCP. Animals were killed at 1, 2, 4, and 8 weeks postoperatively. After being killed, specimens were collected and subjected to micro-computed tomography (mu CT) and histological analysis. Results: The mu CT showed a significant increase of newly formed bone volume/tissue volume in RCP-implanted defect compared with controls at all designated time points. After 8 weeks, the defects implanted with RCP displayed almost complete closure. Hematoxylin and eosin staining of the decalcified sections confirmed these observations and evidenced active bone regeneration in the RCP group. In addition, Masson's trichrome staining demonstrated that RCP implantation accelerated the process of collagen maturation. Conclusions: The RCP enhances bone regeneration in rat critical-size cranial defects, which suggest it might be a desired material for bone defect repair.
C1 [Liu, Weiqing; Dong, Yuliang; Guo, Yuchen; Zhao, Dan; Zhang, Shiwen; Zhou, Liyan; Liang, Xing; Yuan, Quan] Sichuan Univ, West China Sch Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Kang, Ning; Liang, Xing; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, Dent Implant Ctr, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Peoples R China.
   [Seriwatanachai, Dutmanee] Mahidol Univ, Fac Dent, Dept Oral Biol, Bangkok, Thailand.
RP Liang, X; Yuan, Q (reprint author), Sichuan Univ, West China Hosp Stomatol, Dent Implant Ctr, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Peoples R China.
EM xingliangdent@vip.163.com; yuanquan@scu.edu.cn
FU National Natural Science Foundation of China [NSFC 81371173]; New
   Century Excellent Talents in University [NCET-120379]; Sichuan Province
   Youth Fund [2013JQ0017]; Science and Technology Supporting Program from
   Provincial Technology Department [2013SZ0070]
FX This work was supported by grants from the National Natural Science
   Foundation of China (NSFC 81371173), New Century Excellent Talents in
   University (NCET-120379) and Sichuan Province Youth Fund (2013JQ0017) to
   Q. Yuan, Science and Technology Supporting Program from Provincial
   Technology Department (2013SZ0070) to X. Liang. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Choi Jung-Yoo, 2010, J Periodontal Implant Sci, V40, P11, DOI 10.5051/jpis.2010.40.1.11
   CHOI SY, 1993, J PERIODONTOL, V64, P878, DOI 10.1902/jop.1993.64.9.878
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Giannoudis PV, 2005, INJURY, V36, pS2, DOI 10.1016/j.injury.2005.10.006
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Han DK, 2005, J PERIODONTOL, V76, P2216, DOI 10.1902/jop.2005.76.12.2216
   Herberg S, 2014, TISSUE ENG PT A, V20, P1444, DOI [10.1089/ten.TEA.2013.0442, 10.1089/ten.tea.2013.0442]
   Hong SJ, 2006, BIOMATERIALS, V27, P3810, DOI 10.1016/j.biomaterials.2006.02.045
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen SS, 2005, INT J ORAL MAX IMPL, V20, P703
   Jimi E, 2012, INT J DENT, V2012, DOI DOI 10.1155/2012/148261]
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Kigami R, 2013, IMPLANT DENT, V22, P422, DOI 10.1097/ID.0b013e31829d19f0
   Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071683
   Lee JH, 2014, TISSUE ENG PT A, V20, P2031, DOI 10.1089/ten.tea.2013.0282
   Levi B, 2011, STEM CELLS, V29, P1241, DOI 10.1002/stem.670
   Liu YH, 2013, BIOMATERIALS, V34, P9998, DOI 10.1016/j.biomaterials.2013.09.040
   Mardas N, 2008, CLIN ORAL IMPLAN RES, V19, P1010, DOI 10.1111/j.1600-0501.2008.01572.x
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Pang EK, 2005, J PERIODONTOL, V76, P1526, DOI 10.1902/jop.2005.76.9.1526
   Pelaez M, 2014, J CLIN PERIODONTOL, V41, P827, DOI 10.1111/jcpe.12270
   Peterson LJ, 1996, ORAL SURG ORAL MED O, V82, P365
   Petrungaro Paul S, 2005, Implant Dent, V14, P139, DOI 10.1097/01.id.0000163805.98577.ab
   Poehling S, 2006, J PERIODONTOL, V77, P1582, DOI 10.1902/jop.2006.050328
   Pryor ME, 2005, J PERIODONTOL, V76, P1287, DOI 10.1902/jop.2005.76.8.1287
   Pryor ME, 2005, J CLIN PERIODONTOL, V32, P966, DOI 10.1111/j.1600-051X.2005.00772.x
   RIPAMONTI U, 1991, J ORAL MAXIL SURG, V49, P817, DOI 10.1016/0278-2391(91)90010-J
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   Sohn Joo-Yeon, 2010, J Periodontal Implant Sci, V40, P180, DOI 10.5051/jpis.2010.40.4.180
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Stancoven BW, 2013, J PERIODONTAL RES, V48, P243, DOI 10.1111/jre.12001
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Vajgel A, 2014, CLIN ORAL IMPLAN RES, V25, P879, DOI 10.1111/clr.12194
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Yun JI, 2010, J CLIN PERIODONTOL, V37, P419, DOI 10.1111/j.1600-051X.2010.01547.x
   Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139
NR 47
TC 3
Z9 3
U1 4
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2016
VL 25
IS 2
BP 163
EP 170
DI 10.1097/ID.0000000000000396
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DI0YL
UT WOS:000373223100003
PM 26901636
DA 2018-10-20
ER

PT J
AU Wang, SF
   Ao, JF
   Lv, FJ
   Zhang, QR
   Jiao, TF
AF Wang, Sufeng
   Ao, Jingfen
   Lv, Fengjing
   Zhang, Qingrui
   Jiao, Tifeng
TI The enhanced antibacterial performance by the unique Artemia egg
   shell-supported nano-Ag composites
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Artemia egg shell; Ag; Composites; Antibacterial
ID WATER DISINFECTION; AQUEOUS-SOLUTION; WASTE-WATER; CHLORINE;
   INACTIVATION; NANOPARTICLES; BACTERIA; OZONE; LIGHT; RESIN
AB Sterilization in waters is a worldwide issue. Herein, we successfully fabricate a new composite biomaterial (denoted shell-Ag) by embedding Ag-0 nanoparticles onto the hierarchical porous structure of Artemia shell using the in-situ deposition method. The resultant shell-Ag exhibits effectively antibacterial activity for both gram-negative bacterium Escherichia coli and the gram-positive bacterium Staphylococcus aureus and the complete sterilization process can be well achieved within 240 min and 360 min, respectively. The bactericidal tests on E. coli and S. aureus show that the MIC (Minimum Inhibitory Concentration) value for both bacteria ranged from 0.32 to 0.62 g/L, and the MBC values (Minimum Bactericidal Concentration) is approximately between 2.5 and 5 g/L. Four cycles tests demonstrate that the shell-Ag also presents the satisfactory Ag slow-release capacity and lasting duration. All the results suggest that the composited shell-Ag is a promising candidate as antibacterial materials. (C) 2016 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Wang, Sufeng; Ao, Jingfen; Lv, Fengjing; Zhang, Qingrui; Jiao, Tifeng] Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
   [Wang, Sufeng; Jiao, Tifeng] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
RP Wang, SF; Zhang, QR (reprint author), Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.; Wang, SF (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
EM sfwang@ysu.edu.cn; zhangqr@ysu.edu.cn
OI Jiao, Tifeng/0000-0003-1238-0277
FU National Natural Science Foundation of China [40830746, 41271102,
   51578476, 21473153]; Key Laboratory of Reservoir Aquatic Environment,
   Chongqing Institute of Green and Intelligent Technology, Chinese Academy
   of Science [RAE2014CE03B]
FX We greatly acknowledge the financial support from the National Natural
   Science Foundation of China (Grant nos. 40830746, 41271102, 51578476 and
   21473153). Key Laboratory of Reservoir Aquatic Environment, Chongqing
   Institute of Green and Intelligent Technology, Chinese Academy of
   Science (Grant no. RAE2014CE03B).
CR Akhavan O, 2011, J MATER CHEM, V21, P387, DOI 10.1039/c0jm02395g
   Akhavan O, 2010, SURF COAT TECH, V204, P3676, DOI 10.1016/j.surfcoat.2010.04.048
   Akhavan O, 2009, CURR APPL PHYS, V9, P1381, DOI 10.1016/j.cap.2009.03.003
   Akhavan O, 2009, J COLLOID INTERF SCI, V336, P117, DOI 10.1016/j.jcis.2009.03.018
   Balamurugan A, 2008, DENT MATER, V24, P1343, DOI 10.1016/j.dental.2008.02.015
   Chord F, 2011, J HOSP INFECT, V78, P163
   Gayan E, 2013, INNOV FOOD SCI EMERG, V19, P140, DOI 10.1016/j.ifset.2013.04.007
   Hassen A, 2000, BIORESOURCE TECHNOL, V72, P85, DOI 10.1016/S0960-8524(99)00086-3
   Helbling DE, 2007, WATER RES, V41, P4424, DOI 10.1016/j.watres.2007.06.006
   Hua GH, 2007, WATER RES, V41, P1667, DOI 10.1016/j.watres.2007.01.032
   Huang L, 2014, MAT SCI ENG C-MATER, V39, P325, DOI 10.1016/j.msec.2014.03.017
   Jyoti KK, 2004, BIOCHEM ENG J, V18, P9, DOI 10.1016/S1369-703X(03)00116-5
   Kawashita M, 2003, J BIOMED MATER RES A, V66A, P266, DOI 10.1002/jbm.a.10547
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Kim BR, 2002, WATER RES, V36, P4433, DOI 10.1016/S0043-1354(02)00188-4
   Li D, 2013, J ENVIRON SCI-CHINA, V25, P1319, DOI 10.1016/S1001-0742(12)60176-4
   Liu Y, 2008, MICROPOR MESOPOR MAT, V114, P431, DOI 10.1016/j.micromeso.2008.01.032
   Mthombeni NH, 2012, J HAZARD MATER, V217, P133, DOI 10.1016/j.jhazmat.2012.03.004
   Nelson KY, 2013, ENVIRON SCI POLLUT R, V20, P5441, DOI 10.1007/s11356-013-1564-6
   Shang C, 2001, WATER RES, V35, P244, DOI 10.1016/S0043-1354(00)00248-7
   Silva GHR, 2010, BIORESOURCE TECHNOL, V101, P6981, DOI 10.1016/j.biortech.2010.04.022
   Tartanson MA, 2014, WATER RES, V63, P135, DOI 10.1016/j.watres.2014.06.019
   Wang SF, 2007, MICROSC RES TECHNIQ, V70, P663, DOI 10.1002/jemt.20451
   Wang SF, 2015, J NANOMATER, DOI 10.1155/2015/963012
   Xu ZW, 2014, ENVIRON SCI POLLUT R, V21, P6571, DOI 10.1007/s11356-014-2556-x
   Zhang QR, 2013, ENVIRON SCI TECHNOL, V47, P6536, DOI 10.1021/es400919t
NR 26
TC 0
Z9 0
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD APR
PY 2016
VL 61
BP 336
EP 341
DI 10.1016/j.jtice.2015.12.025
PG 6
WC Engineering, Chemical
SC Engineering
GA DI3RY
UT WOS:000373417400040
DA 2018-10-20
ER

PT J
AU Halgand, B
   Clouet, J
   Smith, A
   Colombier, P
   Lesoeur, J
   Weiss, P
   Hamel, O
   Gauthier, O
   Guicheux, J
   Fusellier, M
AF Halgand, B.
   Clouet, J.
   Smith, A.
   Colombier, P.
   Lesoeur, J.
   Weiss, P.
   Hamel, O.
   Gauthier, O.
   Guicheux, J.
   Fusellier, M.
TI REGENERATIVE MEDICINE OF NUCLEUS PULPOSUS NICHE THROUGH
   BIOMATERIAL-ASSISTED TRANSPLANTATION OF ADIPOSE STROMAL CELL-DERIVED
   NUCLEOPULPOCYTES: PRELIMINARY EXPERIMENTS IN SHEEP
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Meeting Abstract
CT World Congress of the Osteoarthritis-Research-Society-International
   (OARSI) on Osteoarthritis
CY MAR 31-APR 03, 2016
CL Amsterdam, NETHERLANDS
SP Osteoarthritis Res Soc Int
C1 [Halgand, B.; Clouet, J.; Smith, A.; Colombier, P.; Lesoeur, J.; Weiss, P.; Hamel, O.; Gauthier, O.; Guicheux, J.; Fusellier, M.] INSERM, UMRS791, LIOAD UFR Odontol Nantes, Nantes, France.
   [Clouet, J.] CHU Nantes, PHU11, Pharm Cent, UFR Sci Biol & Pharmaceut Nantes, F-44035 Nantes 01, France.
   [Gauthier, O.; Fusellier, M.] CRIP ONIRIS, Nantes, France.
RI Fusellier, Marion/P-1541-2014; HALGAND, Boris/P-1301-2014; Weiss,
   Pierre/P-1372-2014; guicheux, Jerome/F-7767-2013
OI HALGAND, Boris/0000-0003-2753-6123; Weiss, Pierre/0000-0002-6159-8590;
   guicheux, Jerome/0000-0003-2754-3024
NR 0
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2016
VL 24
SU S
MA 793
BP S464
EP S465
DI 10.1016/j.joca.2016.01.847
PG 2
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA DI5KW
UT WOS:000373538800823
OA Bronze
DA 2018-10-20
ER

PT J
AU Aamodt, JM
   Grainger, DW
AF Aamodt, Joseph M.
   Grainger, David W.
TI Extracellular matrix-based biomaterial scaffolds and the host response
SO BIOMATERIALS
LA English
DT Review
DE Decellularized; Implants; Integration; ECM; Protein scaffolds; Tissue
   engineering
ID FOREIGN-BODY REACTION; SMALL-INTESTINAL SUBMUCOSA; DECELLULARIZED
   ADIPOSE-TISSUE; STEM-CELL DIFFERENTIATION; DIAMETER VASCULAR GRAFTS;
   CROSS-LINKED COLLAGEN; PORCINE HEART-VALVES; CAGE IMPLANT SYSTEM;
   IN-VIVO; INJECTABLE COLLAGEN
AB Extracellular matrix (ECM) collectively represents a class of naturally derived proteinaceous biomaterials purified from harvested organs and tissues with increasing scientific focus and utility in tissue engineering and repair. This interest stems predominantly from the largely unproven concept that processed ECM biomaterials as natural tissue-derived matrices better integrate with host tissue than purely synthetic biomaterials. Nearly every tissue type has been decellularized and processed for re-use as tissue derived ECM protein implants and scaffolds. To date, however, little consensus exists for defining ECM compositions or sources that best constitute decellularized biomaterials that might better heal, integrate with host tissues and avoid the foreign body response (FBR). Metrics used to assess ECM performance in biomaterial implants are arbitrary and contextually specific by convention. Few comparisons for in vivo host responses to ECM implants from different sources are published. This review discusses current ECM derived biomaterials characterization methods including relationships between ECM material compositions from different sources, properties and host tissue response as implants. Relevant preclinical in vivo models are compared along with their associated advantages and limitations, and the current state of various metrics used to define material integration and biocompatibility are discussed. Commonly applied applications of these ECM-derived biomaterials as stand-alone implanted matrices and devices are compared with respect to host tissue responses. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Aamodt, Joseph M.; Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
RP Grainger, DW (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM david.grainger@utah.edu
OI Grainger, David/0000-0003-1506-7286
FU NIH [EB011879]
FX Authors acknowledge support from NIH grant EB011879.
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   ALBERTS A, 2008, MOL BIOL CELL
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056
   Ansaloni L, 2007, Hernia, V11, P321, DOI 10.1007/s10029-007-0225-4
   Ansaloni L, 2009, AM J SURG, V198, P303, DOI 10.1016/j.amjsurg.2008.09.021
   AUCHINCLOSS H, 1988, TRANSPLANTATION, V46, P1, DOI 10.1097/00007890-198807000-00001
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Avula MN, 2014, ACTA BIOMATER, V10, P1856, DOI 10.1016/j.actbio.2013.12.056
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bee YS, 2015, OPHTHAL PLAST RECONS, V31, P348, DOI 10.1097/IOP.0000000000000339
   BENICHOU G, 1992, J EXP MED, V175, P305, DOI 10.1084/jem.175.1.305
   Bernd O., 2008, ANAL CHIM ACTA, P71
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018
   Blit PH, 2010, J BIOMED MATER RES A, V94A, P1226, DOI 10.1002/jbm.a.32804
   Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015
   Bras LED, 2010, J BIOMED MATER RES B, V95B, P239, DOI 10.1002/jbm.b.31704
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   BREIER G, 1992, DEVELOPMENT, V114, P521
   BROOKS N, 1982, J DERMATOL SURG ONC, V8, P111, DOI 10.1111/j.1524-4725.1982.tb00247.x
   Brown BN, 2011, TISSUE ENG PART C-ME, V17, P411, DOI [10.1089/ten.tec.2010.0342, 10.1089/ten.TEC.2010.0342]
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chvapil M, 1968, J Biomed Mater Res, V2, P245, DOI 10.1002/jbm.820020208
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P638, DOI 10.1016/S0190-9622(84)80271-6
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Deeken CR, 2012, ANN SURG, V255, P595, DOI 10.1097/SLA.0b013e3182445341
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dunne LW, 2014, BIOMATERIALS, V35, P4940, DOI 10.1016/j.biomaterials.2014.03.003
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Elman JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089882
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Flynn L, 2007, BIOMATERIALS, V28, P3834, DOI 10.1016/j.biomaterials.2007.05.002
   Fortunati D, 2014, AMINO ACIDS, V46, P1751, DOI 10.1007/s00726-014-1732-0
   Franklin M E Jr, 2002, Hernia, V6, P171
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goh SK, 2013, BIOMATERIALS, V34, P6760, DOI 10.1016/j.biomaterials.2013.05.066
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gorgieva S, 2011, COLLAGEN VS GELATINE
   Gorham S., 1991, COLLAGEN BIOMATERIAL, P55
   Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Griffiths LG, 2008, BIOMATERIALS, V29, P3514, DOI 10.1016/j.biomaterials.2008.05.006
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902
   Haile LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125078
   HANKE CW, 1991, J AM ACAD DERMATOL, V25, P319, DOI 10.1016/0190-9622(91)70200-L
   Harbers DWG G. M., 2006, INTRO BIOMATERIALS
   Harbers G. M., 2005, CELL MAT INTERACTION
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   Hemmi H, 2000, NATURE, V408, P740
   Hernandez P, 2006, MASS SPECTROM REV, V25, P235, DOI 10.1002/mas.20068
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Himms-Hagen J, 1999, CRIT REV CL LAB SCI, V36, P575, DOI 10.1080/10408369991239259
   Ho KLV, 2004, J UROLOGY, V171, P268, DOI 10.1097/01.ju.0000098680.60020.32
   Hoganson DM, 2010, BIOMATERIALS, V31, P6730, DOI 10.1016/j.biomaterials.2010.05.019
   Holt DJ, 2012, ADV DRUG DELIVER REV, V64, P1123, DOI 10.1016/j.addr.2012.04.002
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005
   Jus S, 2011, MAT SCI ENG C-MATER, V31, P1068, DOI 10.1016/j.msec.2011.03.007
   KAMER FM, 1984, ARCH OTOLARYNGOL, V110, P93
   Karayel E, 2009, EUR J IMMUNOL, V39, P1929, DOI 10.1002/eji.200939344
   Karp G., 2010, CELL MOL BIOL CONCEP
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Khouw IMSL, 2000, J BIOMED MATER RES, V50, P259, DOI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Kim J, 2010, J BIOMED MATER RES A, V95A, P191, DOI 10.1002/jbm.a.32810
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Laschke M. W., 2011, EUR CELLS MATER, V22, P147
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   Lee CY, 2007, J AM CHEM SOC, V129, P9429, DOI 10.1021/ja071879m
   Li QY, 2016, BIOMATERIALS, V75, P37, DOI 10.1016/j.biomaterials.2015.10.011
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lopez-Soler RI, 2007, J SURG RES, V139, P1, DOI 10.1016/j.jss.2006.07.040
   Lu T.-Y., 2013, NAT COMMUN, P4
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCPHERSON IM, 1986, J BIOMED MATER RES, V20, P93
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   Medberry CJ, 2012, J SURG RES, V173, P38, DOI 10.1016/j.jss.2010.08.035
   MERGENHAGEN SE, 1960, BIOCHIM BIOPHYS ACTA, V43, P563, DOI 10.1016/0006-3002(60)90488-1
   Mermoud A, 1999, J CATARACT REFR SURG, V25, P323, DOI 10.1016/S0886-3350(99)80079-0
   Mescher A. L., 2010, JUNQUEIRAS BASIC HIS
   Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545
   Nalepka JL, 2004, BIOTECHNIQUES, V37, P413, DOI 10.2144/04373ST06
   Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009
   Nie X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135073
   Niu G., 2013, J SCI APPL BIOMED, V1, P1
   Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Petter-Puchner AH, 2006, SURG ENDOSC, V20, P942, DOI 10.1007/s00464-005-0568-9
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Pullinger BD, 1942, J PATHOL BACTERIOL, V54, P341, DOI 10.1002/path.1700540308
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Roch T, 2014, CLIN HEMORHEOL MICRO, V57, P203, DOI 10.3233/CH-141831
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Ronneberger B, 1996, J BIOMED MATER RES, V30, P31
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Rowland C. R., 2012, J LONG-TERM EFF MED, P22
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Salmi J, 2009, PROTEOMICS, V9, P848, DOI 10.1002/pmic.200800517
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x
   Schenke-Layland K, 2004, MATRIX BIOL, V23, P113, DOI 10.1016/j.matbio.2004.03.005
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Simon CG, 2015, J BIOMED MATER RES B, V103, P949, DOI 10.1002/jbm.b.33286
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Stacey KJ, 1996, J IMMUNOL, V157, P2116
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025
   Umashankar PR, 2011, J BIOMED MATER RES A, V97A, P311, DOI 10.1002/jbm.a.33061
   Ung DY, 1999, J BIOMED MATER RES, V46, P324, DOI 10.1002/(SICI)1097-4636(19990905)46:3<324::AID-JBM3>3.0.CO;2-5
   UNGAR H, 1953, AM J PATHOL, V29, P963
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   VAUGHAN HA, 1994, TRANSPLANTATION, V58, P879, DOI 10.1097/00007890-199410270-00003
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Welham NV, 2013, BIOMATERIALS, V34, P669, DOI 10.1016/j.biomaterials.2012.09.050
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028
   Wong V. W., 2010, BIOMED RES INT
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yu C, 2013, BIOMATERIALS, V34, P3290, DOI 10.1016/j.biomaterials.2013.01.056
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 197
TC 49
Z9 49
U1 14
U2 136
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2016
VL 86
BP 68
EP 82
DI 10.1016/j.biomaterials.2016.02.003
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG9FE
UT WOS:000372387400007
PM 26890039
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Montufar, EB
   Horynova, M
   Casas-Luna, M
   Diaz-De-La-Torre, S
   Celko, L
   Klakurkova, L
   Spotz, Z
   Dieguez-Trejo, G
   Fohlerova, Z
   Dvorak, K
   Zikmund, T
   Kaiser, J
AF Montufar, Edgar B.
   Horynova, Miroslava
   Casas-Luna, Mariano
   Diaz-De-La-Torre, Sebastian
   Celko, Ladislav
   Klakurkova, Lenka
   Spotz, Zdenek
   Dieguez-Trejo, Guillermo
   Fohlerova, Zdenka
   Dvorak, Karel
   Zikmund, Tomas
   Kaiser, Jozef
TI Spark Plasma Sintering of Load-Bearing Iron-Carbon Nanotube-Tricalcium
   Phosphate CerMets for Orthopaedic Applications
SO JOM
LA English
DT Article
ID FUNCTIONALLY GRADED BIOMATERIAL; POWDER-METALLURGY METHOD; HARD-TISSUE
   REPLACEMENT; IN-VITRO; COMPOSITES; HYDROXYAPATITE; CALCIUM; VIVO;
   OSTEOBLASTS; BIOACTIVITY
AB Recently, ceramic-metallic composite materials (CerMets) have been investigated for orthopaedic applications with promising results. This first generation of bio-CerMets combine the bioactivity of hydroxyapatite with the mechanical stability of titanium to fabricate bioactive, tough and biomechanically more biocompatible osteosynthetic devices. Nonetheless, these first CerMets are not biodegradable materials and a second surgery is required to remove the implant after bone healing. The present work aims to develop the next generation bio-CerMets, which are potential biodegradable materials. The process to produce the new biodegradable CerMet consisted of mixing powder of soluble and osteoconductive alpha tricalcium phosphate with biocompatible and biodegradable iron with consolidation through spark plasma sintering (SPS). The microstructure, composition and mechanical strength of the new CerMet were studied by metallography, x-ray diffraction and diametral tensile strength tests, respectively. The results show that SPS produces CerMet with higher mechanical performance (120 MPa) than the ceramic component alone (29 MPa) and similar mechanical strength to the pure metallic component (129 MPa). Nonetheless, although a short sintering time (10 min) was used, partial transformation of the alpha tricalcium phosphate into its allotropic and slightly less soluble beta phase was observed. Cell adhesion tests show that osteoblasts are able to attach to the CerMet surface, presenting spread morphology regardless of the component of the material with which they are in contact. However, the degradation process restricted to the small volume of the cell culture well quickly reduces the osteoblast viability.
C1 [Montufar, Edgar B.; Horynova, Miroslava; Casas-Luna, Mariano; Celko, Ladislav; Klakurkova, Lenka; Spotz, Zdenek; Fohlerova, Zdenka; Zikmund, Tomas; Kaiser, Jozef] Brno Univ Technol, CEITEC BUT, Cent European Inst Technol, CS-61090 Brno, Czech Republic.
   [Diaz-De-La-Torre, Sebastian; Dieguez-Trejo, Guillermo] Ctr Invest & Innovac Tecnol CIITEC, Inst Politecn Nacl, Mexico City, DF, Mexico.
   [Dvorak, Karel] Brno Univ Technol, Fac Civil Engn, CS-61090 Brno, Czech Republic.
RP Montufar, EB (reprint author), Brno Univ Technol, CEITEC BUT, Cent European Inst Technol, CS-61090 Brno, Czech Republic.
EM eb.montufar@ceitec.vutbr.cz
RI Montufar, Edgar/F-8040-2016; DvoAAk, Karel/K-2385-2014; Kaiser,
   Jozef/D-6800-2012; Zikmund, Tomas/G-9491-2014; Fohlerova,
   Zdenka/A-6893-2013; Celko, Ladislav/D-6870-2012; Casas Luna,
   Mariano/J-4074-2018; Horynova, Miroslava/E-4346-2012
OI Montufar, Edgar/0000-0002-8122-4000; DvoAAk, Karel/0000-0003-2111-3357;
   Kaiser, Jozef/0000-0002-7397-125X; Fohlerova,
   Zdenka/0000-0002-1232-2301; Celko, Ladislav/0000-0003-0264-3483;
   Horynova, Miroslava/0000-0003-3856-789X
FU European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Conacyt-SNI
   [P. 1777000]
FX The authors acknowledge the financial support provided in the frame of
   the Project "CEITEC-Central European Institute of Technology''
   (CZ.1.05/1.1.00/02.0068) by European Regional Development Fund. Part of
   the work was carried out with the support of core facilities of research
   infrastructure CEITEC Nano of CEITEC-Brno University of Technology. SDT
   acknowledges to Conacyt-SNI (P. 1777000). Special thanks to Dr. M.
   Rampichova from Czech Technical University in Prague for supplying the
   cells for this work.
CR [Anonymous], 2010, F108804A ASTM
   [Anonymous], 2010, E40707 ASTM
   Arifin A, 2014, MATER DESIGN, V55, P165, DOI 10.1016/j.matdes.2013.09.045
   Bakshi SR, 2010, INT MATER REV, V55, P41, DOI 10.1179/095066009X12572530170543
   BERENBAUM R, 1959, BRIT J APPL PHYS, V10, P281, DOI 10.1088/0508-3443/10/6/307
   BOHNER M, 2000, INJURY, V31, pD37, DOI DOI 10.1016/S0020-1383(00)80022-4
   Bresciani Eduardo, 2004, J. Appl. Oral Sci., V12, P344, DOI 10.1590/S1678-77572004000400017
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Cheng J, 2013, J BIOMED MATER RES B, V101B, P485, DOI 10.1002/jbm.b.32783
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chu CL, 2006, J MATER SCI-MATER M, V17, P245, DOI 10.1007/s10856-006-7310-6
   Chu CL, 2004, J MATER SCI-MATER M, V15, P665, DOI 10.1023/B:JMSM.0000030207.16887.f2
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Elliott JC, 1994, STRUCTURE CHEM APATI, V18, P1
   ETTMAYER P, 1995, INT J REFRACT MET H, V13, P343, DOI 10.1016/0263-4368(95)00027-G
   Francis A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5473-8
   Ginebra MP, 1999, J AM CERAM SOC, V82, P2808
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Jafari S, 2015, JOM-US, V67, P1143, DOI 10.1007/s11837-015-1366-z
   Karrholm J, 2008, CLIN ORTHOP RELAT R, V466, P380, DOI 10.1007/s11999-007-0039-9
   Kirkland N. T., 2014, MAGNESIUM BIOMATERIA, P73
   Kumar A, 2013, ACTA MATER, V61, P5198, DOI 10.1016/j.actamat.2013.05.013
   LeGeros RZ, 2003, KEY ENG MAT, V240-2, P3, DOI 10.4028/www.scientific.net/KEM.240-242.3
   Marie J.P., 2010, BONE, V46, P571, DOI DOI 10.1016/J.BONE.2009.07.082
   Montufar EB, 2013, ACTA BIOMATER, V9, P6188, DOI 10.1016/j.actbio.2012.11.028
   Mulukutla M, 2010, JOM-US, V62, P65, DOI 10.1007/s11837-010-0090-y
   Ning CQ, 2008, ACTA BIOMATER, V4, P1944, DOI 10.1016/j.actbio.2008.04.015
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Orru R, 2009, MAT SCI ENG R, V63, P127, DOI 10.1016/j.mser.2008.09.003
   Procopio AT, 2003, J MATER SCI, V38, P3629, DOI 10.1023/A:1025681432260
   Rajabi A, 2015, MATER DESIGN, V67, P95, DOI 10.1016/j.matdes.2014.10.081
   Reindl A, 2014, J MATER SCI, V49, P8234, DOI 10.1007/s10853-014-8532-5
   Santos L.A., 1999, BONE, V25, p99S
   Schmittenbecher PP, 2013, EUR J TRAUMA EMERG S, V39, P345, DOI 10.1007/s00068-013-0286-2
   Shepherd JH, 2011, JOM-US, V63, P83, DOI 10.1007/s11837-011-0063-9
   Ulum MF, 2014, MAT SCI ENG C-MATER, V36, P336, DOI 10.1016/j.msec.2013.12.022
   Wang LJ, 2013, INT J REFRACT MET H, V39, P103, DOI 10.1016/j.ijrmhm.2013.01.017
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
NR 39
TC 2
Z9 2
U1 4
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2016
VL 68
IS 4
BP 1134
EP 1142
DI 10.1007/s11837-015-1806-9
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA DH9QQ
UT WOS:000373131200012
DA 2018-10-20
ER

PT J
AU Back, JH
   Cho, WJ
   Kim, JH
   Park, IK
   Kwon, SW
AF Back, Ja Hoon
   Cho, Wan Jin
   Kim, Jun Ho
   Park, Il Kyu
   Kwon, Sung Won
TI Application of hyaluronic acid/sodium alginate-based microparticles to
   prevent tissue adhesion in a rabbit model
SO SURGERY TODAY
LA English
DT Article
DE Adhesion prevention; Microparticle; Hyaluronic acid/sodium alginate;
   Rabbit model
ID POSTOPERATIVE ABDOMINAL ADHESIONS; LAPAROSCOPIC MYOMECTOMY; ACID;
   SURGERY; CARBOXYMETHYLCELLULOSE; REDUCTION; MEMBRANE; EFFICACY; GEL
AB Purpose Postsurgical adhesion formation is a concern in every field of surgery. We evaluated the efficacy of hyaluronic acid/sodium alginate-based microparticle anti-adhesive agents (MP) for the prevention of postsurgical adhesion formation in a standardized rabbit model.
   Method To evaluate the anti-adhesion effect, a uterusabdominal wall abrasion model was created in rabbits. On the surface of the injured uterus, an anti-adhesive agent, Interceed (R) or MP, was applied (positive control and study groups, respectively; n = 10 each). In another group of 10 animals, neither agent was applied (negative control group). The adhesion levels were graded 3 weeks after surgery. Acute and chronic toxicity was also evaluated.
   Results The grade of adhesion was significantly lower in the MP group than in the negative control and positive control groups. No evidence of acute or chronic toxicity induced by this material was found in blood and tissue analysis.
   Conclusion MP shows potential as an effective novel type of resorbable biomaterial to reduce postoperative adhesion. The easy placement and handling of this material make the MP powder attractive as a tissue adhesion barrier.
C1 [Back, Ja Hoon; Kwon, Sung Won] CHA Univ, CHA Bundang Med Ctr, Dept Surg, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea.
   [Cho, Wan Jin; Kim, Jun Ho; Park, Il Kyu] Genewel Co Ltd, R&D Ctr, 37 Sagimakgol Ro 62 Beon Gil, Songnam 462738, Gyeonggi Do, South Korea.
RP Kwon, SW (reprint author), CHA Univ, CHA Bundang Med Ctr, Dept Surg, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea.
EM wizard95@cha.ac.kr
OI Kwon, Sung Won/0000-0002-1610-5726
FU SMBA [08-1-14]
FX We received a research grant from SMBA (08-1-14).
CR Almeida O D Jr, 1997, J Am Assoc Gynecol Laparosc, V4, P587, DOI 10.1016/S1074-3804(05)80093-3
   Attard JAP, 2007, CAN J SURG, V50, P291
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002
   Bowersock TL, 1997, CONTROLLED DRUG DELI, P281
   De Iaco PA, 1998, FERTIL STERIL, V69, P318
   Dijkstra FR, 2000, SCAND J GASTROENTE S, V232, P52
   Falk K, 2001, BRIT J SURG, V88, P286, DOI 10.1046/j.1365-2168.2001.01647.x
   FRASER JRE, 1984, CLIN EXP PHARMACOL P, V11, P17, DOI 10.1111/j.1440-1681.1984.tb00235.x
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Ishikawa K, 2013, SURG TODAY, V43, P412, DOI 10.1007/s00595-012-0249-y
   Kwon SW, 2006, J KOREAN SURG SOC, V71, P280
   Marana R, 2000, PERITONEAL SURG, P329
   MENZIES D, 1993, ANN ROY COLL SURG, V75, P147
   Miller RS, 2003, OTOLARYNG HEAD NECK, V128, P862, DOI 10.1016/S0194-5998(03)00460-1
   MOLL HD, 1992, AM J VET RES, V53, P1454
   Okabayashi K, 2014, SURG TODAY, V44, P405, DOI 10.1007/s00595-013-0591-8
   Parker MC, 2001, DIS COLON RECTUM, V44, P822, DOI 10.1007/BF02234701
   Pellicano M, 2003, FERTIL STERIL, V80, P441, DOI 10.1016/S0015-0282(03)00597-1
   Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0
   Rodgers KE, 1997, FERTIL STERIL, V67, P553, DOI 10.1016/S0015-0282(97)80085-4
   Shim HS, 2002, J KOREAN SURG SOC, V63, P179
   Shimizu A, 2014, SURG TODAY, V44, P314, DOI 10.1007/s00595-013-0530-8
   Takeuchi H, 2008, FERTIL STERIL, V89, P1247, DOI 10.1016/j.fertnstert.2007.05.021
   Tsujimoto H, 2014, SURG TODAY, V44, P391, DOI 10.1007/s00595-013-0608-3
   URMAN B, 1991, FERTIL STERIL, V56, P568
   Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006
   YAACOBI Y, 1993, J SURG RES, V55, P422, DOI 10.1006/jsre.1993.1163
   Yang HY, 1997, J KOREAN SURG SOC, V52, P335
NR 29
TC 4
Z9 5
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD APR
PY 2016
VL 46
IS 4
BP 501
EP 508
DI 10.1007/s00595-015-1186-3
PG 8
WC Surgery
SC Surgery
GA DI0BH
UT WOS:000373159300016
PM 25990765
DA 2018-10-20
ER

PT J
AU Rediguieri, CF
   Pinto, TDA
   Bou-Chacra, NA
   Galante, R
   de Araujo, GLB
   Pedrosa, TD
   Maria-Engler, SS
   De Bank, PA
AF Rediguieri, Carolina Fracalossi
   Andreoli Pinto, Terezinha de Jesus
   Bou-Chacra, Nadia Araci
   Galante, Raquel
   Barros de Araujo, Gabriel Lima
   Pedrosa, Tatiana do Nascimento
   Maria-Engler, Silvya Stuchi
   De Bank, Paul A.
TI Ozone Gas as a Benign Sterilization Treatment for PLGA Nanofiber
   Scaffolds
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID STEM-CELLS; POLY(LACTIDE-CO-GLYCOLIDE) PLGA; BIOMEDICAL APPLICATIONS;
   REGENERATIVE MEDICINE; POLY(L-LACTIDE) PLLA; GAMMA-IRRADIATION; POROUS
   SCAFFOLDS; ELECTROSPUN PLGA; DIFFERENTIATION; FABRICATION
AB The use of electrospun nanofibers for tissue engineering and regenerative medicine applications is a growing trend as they provide improved support for cell proliferation and survival due, in part, to their morphology mimicking that of the extracellular matrix. Sterilization is a critical step in the fabrication process of implantable biomaterial scaffolds for clinical use, but many of the existing methods used to date can negatively affect scaffold properties and performance. Poly(lactic-co-glycolic acid) (PLGA) has been widely used as a biodegradable polymer for 3D scaffolds and can be significantly affected by current sterilization techniques. The aim of this study was to investigate pulsed ozone gas as an alternative method for sterilizing PLGA nanofibers. The morphology, mechanical properties, physicochemical properties, and response of cells to PLGA nanofiber scaffolds were assessed following different degrees of ozone gas sterilization. This treatment killed Geobacillus stearothermophilus spores, the most common biological indicator used for validation of sterilization processes. In addition, the method preserved all of the characteristics of nonsterilized PLGA nanofibers at all degrees of sterilization tested. These findings suggest that ozone gas can be applied as an alternative method for sterilizing electrospun PLGA nanofiber scaffolds without detrimental effects.
C1 [Rediguieri, Carolina Fracalossi; Andreoli Pinto, Terezinha de Jesus; Bou-Chacra, Nadia Araci; Galante, Raquel; Barros de Araujo, Gabriel Lima] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farmacia, Sao Paulo, Brazil.
   [Rediguieri, Carolina Fracalossi] Agencia Nacl Vigilancia Santaria, Brasilia, DF, Brazil.
   [Galante, Raquel] Univ Lisbon, Inst Super Tecn, Ctr Quim Estrutural, P-1699 Lisbon, Portugal.
   [Pedrosa, Tatiana do Nascimento; Maria-Engler, Silvya Stuchi; De Bank, Paul A.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Analises Clin & Toxicol, Sao Paulo, Brazil.
   [De Bank, Paul A.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.
   [De Bank, Paul A.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.
RP De Bank, PA (reprint author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.; De Bank, PA (reprint author), Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.; Rediguieri, CF (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farmacia, Av Prof Lineu Prestes,580-B13 Cidade Univ, BR-05508000 Sao Paulo, Brazil.
EM carolina.rediguieri@usp.br; p.debank@bath.ac.uk
RI GALANTE, RAQUEL/K-2512-2014; Maria-Engler, Silvya/K-5936-2016; Pinto,
   Terezinha/C-4777-2012
OI GALANTE, RAQUEL/0000-0001-8616-4775; Maria-Engler,
   Silvya/0000-0003-4771-6041; Araujo, Gabriel/0000-0001-7590-3587; do
   Nascimento Pedrosa, Tatiana/0000-0003-0009-1013; De Bank,
   Paul/0000-0002-5717-7486; Pinto, Terezinha de Jesus
   Andreoli/0000-0002-0238-8227; Rediguieri, Carolina/0000-0002-3088-4535
FU National Council of Technological and Scientific Development of Brazil
   [CNPq-248814/2013-3]; University of Sao Paulo; University of Bath Global
   Partner Research Scholarship Scheme
FX The authors would like to thank the National Council of Technological
   and Scientific Development of Brazil (CNPq-248814/2013-3), the
   University of Sao Paulo, and the University of Bath Global Partner
   Research Scholarship Scheme for funding this research. They gratefully
   acknowledge Mrs. Tais Cecchi (Brasil Ozonio) for the use of the ozone
   sterilizer, Mr William Capelupi (TA Instruments, Sao Paulo) for access
   to their laboratory facility in Sao Paulo, Mr Nick Waywell (Department
   of Mechanical Engineering, University of Bath) for advice on mechanical
   testing, and Dr Ursula Potter and Dr John Mitchels (Microscopy and
   Analysis Suite, University of Bath) for their help and advice with
   electron microscopy.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Asti A, 2014, INT J ARTIF ORGANS, V37, P187, DOI [10.5301/ijao.5000307, 10.530/ijao.5000307]
   Bailey NA, 2002, J APPL POLYM SCI, V86, P1868, DOI 10.1002/app.11109
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Bilgin S, 2013, POLYMER, V54, P6665, DOI 10.1016/j.polymer.2013.10.019
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Bosworth LA, 2012, J POLYM SCI POL PHYS, V50, P870, DOI 10.1002/polb.23072
   Braghirolli DI, 2014, J BIOMED MATER RES B, V102, P700, DOI 10.1002/jbm.b.33049
   Cantara SI, 2012, BIOMATERIALS, V33, P8372, DOI 10.1016/j.biomaterials.2012.08.021
   Charpentier PA, 2006, APPL SURF SCI, V252, P6360, DOI 10.1016/j.apsusc.2005.09.064
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Danmark S, 2011, ACTA BIOMATER, V7, P2035, DOI 10.1016/j.actbio.2011.02.011
   Dong YX, 2008, TISSUE ENG PT A, V14, P1321, DOI 10.1089/ten.tea.2007.0395
   Dufresne S, 2008, AM J INFECT CONTROL, V36, P291, DOI 10.1016/j.ajic.2007.06.006
   Full SM, 2015, J BIOMED MATER RES B, V103, P39, DOI 10.1002/jbm.b.33153
   GURLEY B, 1985, Journal of Parenteral Science and Technology, V39, P256
   Ho MH, 2007, MACROMOL BIOSCI, V7, P467, DOI 10.1002/mabi.200600241
   ISO, 2009, 149372009 ISO
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Jia L, 2014, J BIOMATER APPL, V29, P364, DOI 10.1177/0885328214529002
   Jia L, 2013, MAT SCI ENG C-MATER, V33, P4640, DOI 10.1016/j.msec.2013.07.021
   Kai D, 2013, BIOTECHNOL J, V8, P59, DOI 10.1002/biot.201200249
   Kikkawa Y, 2013, J MATER CHEM A, V1, P4667, DOI 10.1039/c3ta01670f
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kwon JH, 2005, J BIOACT COMPAT POL, V20, P361, DOI 10.1177/0883911505055386
   Lee J. B., 2015, J NANOMATER, V2015
   Lee JJ, 2008, J BIOMAT SCI-POLYM E, V19, P1637, DOI 10.1163/156856208786440497
   Lee JB, 2010, MACROMOL RES, V18, P1195, DOI 10.1007/s13233-010-1206-5
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Loo SCJ, 2004, POLYM DEGRAD STABIL, V83, P259, DOI 10.1016/S0141-3910(03)00271-4
   Meng ZX, 2013, MAT SCI ENG C-MATER, V33, P699, DOI 10.1016/j.msec.2012.10.021
   Mitchell SA, 2004, BIOMATERIALS, V25, P4079, DOI 10.1016/j.biomaterials.2003.11.010
   Moat J, 2009, CAN J MICROBIOL, V55, P928, DOI [10.1139/W09-046, 10.1139/w09-046]
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Morris GE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035014
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Park J., 2013, INT J CONTROL AUTOM, V6, P73
   Pinto TJA, 2010, CONTROLE BIOL QUALID
   Prabhakaran MP, 2014, J BIOMED MATER RES B, V102, P447, DOI 10.1002/jbm.b.33022
   Pulikkot S, 2014, CELL PROLIFERAT, V47, P553, DOI 10.1111/cpr.12141
   Rouse JJ, 2007, INT J PHARM, V339, P112, DOI 10.1016/j.ijpharm.2007.02.026
   Sefat F, 2013, PROCEDIA ENGINEER, V59, P101, DOI 10.1016/j.proeng.2013.05.099
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Sousa CS, 2011, REV ESC ENFERM USP, V45, P1238
   Subramanian A, 2012, ANN BIOMED ENG, V40, P2098, DOI 10.1007/s10439-012-0592-6
   Subramanian A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025004
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Paragkumar NT, 2006, APPL SURF SCI, V253, P2758, DOI 10.1016/j.apsusc.2006.05.047
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   US Food and Drug Administration, 2004, GUID IND STER DRUG P
   US Pharmacopeial Convention Inc, 2012, US PHARM NAT FORM US
   WHO, 2011, WHO TECH REP SER, V961, P1
   World Health Organization, 2014, INT PHARM
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeatts AB, 2014, TISSUE ENG PT A, V20, P139, DOI [10.1089/ten.tea.2013.0168, 10.1089/ten.TEA.2013.0168]
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
NR 60
TC 6
Z9 6
U1 0
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2016
VL 22
IS 4
BP 338
EP 347
DI 10.1089/ten.tec.2015.0298
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DI1EA
UT WOS:000373237600005
PM 26757850
OA Green Published
DA 2018-10-20
ER

PT J
AU Thomas, D
   Thirumaran, A
   Mallard, B
   Chen, XZ
   Browne, S
   Wheatley, AM
   O'Brien, T
   Pandit, A
AF Thomas, Dilip
   Thirumaran, Arun
   Mallard, Beth
   Chen, Xizhe
   Browne, Shane
   Wheatley, Antony M.
   O'Brien, Timothy
   Pandit, Abhay
TI Variability in Endogenous Perfusion Recovery of Immunocompromised Mouse
   Models of Limb Ischemia
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID COLONY-FORMING CELLS; ENDOTHELIAL PROGENITOR CELLS; CIRCULATING
   ANGIOGENIC CELLS; FEMORAL-ARTERY OCCLUSION; MESENCHYMAL STEM-CELLS;
   ATHYMIC NUDE MICE; HINDLIMB ISCHEMIA; THERAPEUTIC ANGIOGENESIS;
   BLOOD-FLOW; MURINE MODEL
AB Immunocompromised hind limb ischemia (HLI) murine models are essential for preclinical evaluation of human cell-based therapy or biomaterial-based interventions. These models are used to generate proof of principle that the approach is effective and also regulatory preclinical data required for translation to the clinic. However, surgical variations in creation of HLI models reported in the literature introduce variability in the pathological manifestation of the model, in consequence affecting therapeutic endpoints. This study aims to compare the extent of vascular regeneration in HLI-induced immunocompromised murine models to obtain a stable and more reproducible injury model for testing. Athymic and Balb/C nude mice underwent HLI surgery with single and double ligation of femoral artery (FA). The recovery from surgery was observed over a period of 2 weeks with respect to ischemia reperfusion using laser Doppler and clinical signs of necrosis and ambulatory impairment. Double ligation of the FA results in a more severe response to ischemia in Balb/C with endogenous perfusion recovery up to 50% +/- 10% compared with 75% +/- 20% in athymic nude mice. Single iliac artery (IA) and FA lead to creation of mild ischemia compared with femoral artery-vein (FAV) pair ligation in Balb/C. Microcirculatory parameters indicate significantly lower capillary numbers (26 +/- 3/mm(2)) and functional capillary density (203 +/- 5 cm/cm(2)) in the FAV group. In this study, we demonstrate a reproducible, arterial double ligation in an immunocompromised Balb/C nude mouse model that exhibits characteristic pathological signs of ischemia with impaired endogenous recovery.
C1 [Thomas, Dilip; Thirumaran, Arun; Chen, Xizhe; O'Brien, Timothy] Natl Univ Ireland Galway, Regenerat Med Inst, Galway, Ireland.
   [Thomas, Dilip; Browne, Shane; O'Brien, Timothy; Pandit, Abhay] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Galway, Ireland.
   [Mallard, Beth; Wheatley, Antony M.] Natl Univ Ireland Galway, Dept Physiol, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Biomed Sci, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; O'Brien, Timothy/N-7112-2014; Mallard,
   Beth/Q-2137-2016
OI Pandit, Abhay/0000-0002-6292-4933; O'Brien, Timothy/0000-0001-9028-5481;
   Mallard, Beth/0000-0002-0634-7916; Thomas, Dilip/0000-0001-7427-5523
FU Science Foundation Ireland [09/SRC/B1794]
FX This material is based on works supported by the Science Foundation
   Ireland under Grant No. 09/SRC/B1794. The authors would also like to
   thank Mr. Maciej Doczyk for his help with the graphic illustrations.
CR Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70
   Aranguren XL, 2011, CELL TRANSPLANT, V20, P259, DOI 10.3727/096368910X516592
   Bhardwaj RS, 1997, J MATER SCI-MATER M, V8, P737, DOI 10.1023/A:1018552326808
   Bosevski M, 2006, Prilozi, V27, P89
   Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163
   Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010
   CHEERS C, 1975, J IMMUNOL, V115, P844
   Cho HH, 2009, CELL PHYSIOL BIOCHEM, V24, P511, DOI 10.1159/000257495
   Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643
   Fan WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045621
   Frey-Vasconcells J, 2012, STEM CELL TRANSL MED, V1, P353, DOI 10.5966/sctm.2012-0018
   GERSHWIN ME, 1975, CLIN IMMUNOL IMMUNOP, V4, P324, DOI 10.1016/0090-1229(75)90002-1
   Gottsater A, 2006, EUR J VASC ENDOVASC, V32, P478, DOI 10.1016/j.ejvs.2006.03.007
   Harada Y, 2013, BIOMED RES-TOKYO, V34, P23, DOI 10.2220/biomedres.34.23
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x
   Hellingman AA, 2011, EUR J VASC ENDOVASC, V41, P418, DOI 10.1016/j.ejvs.2010.11.017
   Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009
   Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578
   Herrler T, 2009, J VASC RES, V46, P333, DOI 10.1159/000189794
   Hoover-Plow JL, 2008, INFLAMM RES, V57, P457, DOI 10.1007/s00011-008-7062-5
   Ito WD, 1997, AM J PHYSIOL-HEART C, V273, pH1255
   Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019
   Kang Y, 2010, MICROVASC RES, V80, P310, DOI 10.1016/j.mvr.2010.05.006
   Kim JH, 2013, BIOMATERIALS, V34, P1657, DOI 10.1016/j.biomaterials.2012.11.008
   Kim MS, 2009, CIRCULATION, V120, P2240, DOI 10.1161/CIRCULATIONAHA.109.856815
   Kim MH, 2011, J MOL CELL CARDIOL, V51, P702, DOI 10.1016/j.yjmcc.2011.07.006
   Kochi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084047
   Koh YJ, 2011, ARTERIOSCL THROM VAS, V31, P1141, DOI 10.1161/ATVBAHA.110.218206
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Kwon YW, 2013, BBA-MOL BASIS DIS, V1832, P2136, DOI 10.1016/j.bbadis.2013.08.002
   Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656
   Lee E. J., 2013, REGEN MED, V8, P293
   Leifheit-Nestler M, 2010, ARTERIOSCL THROM VAS, V30, P1398, DOI 10.1161/ATVBAHA.110.206086
   Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185
   Mabuchi A, 2009, MICROCIRCULATION, V16, P364, DOI 10.1080/10739680902796917
   Moon SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075224
   Moon SH, 2011, BIOMATERIALS, V32, P6445, DOI 10.1016/j.biomaterials.2011.05.026
   Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618
   Patel AS, 2013, EMBO MOL MED, V5, P858, DOI 10.1002/emmm.201302752
   Rahnemai-Azar A, 2011, CYTOTHERAPY, V13, P179, DOI 10.3109/14653249.2010.515579
   RUSS JC, 2000, PRACTICAL STEREOLOGY
   Sarlon G, 2012, J THROMB HAEMOST, V10, P38, DOI 10.1111/j.1538-7836.2011.04554.x
   SCHMIDSCHOENBEIN GW, 1977, MICROVASC RES, V14, P303, DOI 10.1016/0026-2862(77)90028-0
   Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822
   Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013
   Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027
   Tang GL, 2005, J VASC SURG, V41, P312, DOI 10.1016/j.jvs.2004.11.012
   Tang ZCW, 2011, BIOMATERIALS, V32, P75, DOI 10.1016/j.biomaterials.2010.08.085
   Thomas D, 2014, BIOMATERIALS, V35, P8757, DOI 10.1016/j.biomaterials.2014.06.053
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   Westvik TS, 2009, J VASC SURG, V49, P464, DOI 10.1016/j.jvs.2008.08.077
   Yang HN, 2012, BIOMATERIALS, V33, P8670, DOI 10.1016/j.biomaterials.2012.08.012
   Yang YG, 2008, J VASC SURG, V48, P1546, DOI 10.1016/j.jvs.2008.07.063
   Yoshida T, 2010, ARTERIOSCL THROM VAS, V30, P1300, DOI 10.1161/ATVBAHA.109.198994
   Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049
   Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006
   Zhou B, 2007, J CELL BIOCHEM, V102, P183, DOI 10.1002/jcb.21290
NR 58
TC 3
Z9 3
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2016
VL 22
IS 4
BP 370
EP 381
DI 10.1089/ten.tec.2015.0441
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DI1EA
UT WOS:000373237600008
PM 26830861
DA 2018-10-20
ER

PT J
AU Jongedijk, E
   Cankar, K
   Buchhaupt, M
   Schrader, J
   Bouwmeester, H
   Beekwilder, J
AF Jongedijk, Esmer
   Cankar, Katarina
   Buchhaupt, Markus
   Schrader, Jens
   Bouwmeester, Harro
   Beekwilder, Jules
TI Biotechnological production of limonene in microorganisms
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Limonene; Biomaterial; Monoterpene; Microbial production; Metabolic
   engineering; Toxicity
ID GERANYL DIPHOSPHATE SYNTHASE; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   ESCHERICHIA-COLI; MONOTERPENE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE;
   TERPENOID BIOSYNTHESIS; GLANDULAR TRICHOMES; FUNCTIONAL-ANALYSIS; CDNA
   ISOLATION; ESSENTIAL OILS
AB This mini review describes novel, biotechnology-based, ways of producing the monoterpene limonene. Limonene is applied in relatively highly priced products, such as fragrances, and also has applications with lower value but large production volume, such as biomaterials. Limonene is currently produced as a side product from the citrus juice industry, but the availability and quality are fluctuating and may be insufficient for novel bulk applications. Therefore, complementary microbial production of limonene would be interesting. Since limonene can be derivatized to high-value compounds, microbial platforms also have a great potential beyond just producing limonene. In this review, we discuss the ins and outs of microbial limonene production in comparison with plant-based and chemical production. Achievements and specific challenges for microbial production of limonene are discussed, especially in the light of bulk applications such as biomaterials.
C1 [Jongedijk, Esmer; Bouwmeester, Harro] Wageningen Univ, Lab Plant Physiol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.
   [Cankar, Katarina; Beekwilder, Jules] Plant Res Int, POB 16, NL-6700 AA Wageningen, Netherlands.
   [Buchhaupt, Markus; Schrader, Jens] DECHEMA Res Inst, Biochem Engn, Theodor Heuss Allee 25, D-60486 Frankfurt, Germany.
RP Beekwilder, J (reprint author), Plant Res Int, POB 16, NL-6700 AA Wageningen, Netherlands.
EM jules.beekwilder@wur.nl
RI Beekwilder, Jules/A-6802-2011
OI Beekwilder, Jules/0000-0003-3238-4427; Buchhaupt,
   Markus/0000-0003-2720-5973; Bouwmeester, Harro/0000-0003-0907-2732
FU Dutch Ministry of Economic Affairs [KB-13-006-042]
FX This research was funded by the Dutch Ministry of Economic Affairs Grant
   KB-13-006-042.
CR Aharoni A, 2005, TRENDS PLANT SCI, V10, P594, DOI 10.1016/j.tplants.2005.10.005
   Aharoni Asaph, 2006, Phytochemistry Reviews, V5, P49, DOI 10.1007/s11101-005-3747-3
   Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004
   ANDREWS RE, 1980, APPL ENVIRON MICROB, V40, P301
   [Anonymous], 2015, DICTIONARY OF NATURA
   Banerjee A, 2014, NAT PROD REP, V31, P1043, DOI 10.1039/c3np70124g
   Barros MT, 2007, EUR J ORG CHEM, P1357, DOI 10.1002/ejoc.200600890
   Behrendorff JBYH, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-76
   Bouvier F, 2000, PLANT J, V24, P241, DOI 10.1046/j.1365-313x.2000.00875.x
   Bowen ER, 1975, FLORIDA STATE HORTIC, V7072, P304
   Brennan TCR, 2015, APPL ENVIRON MICROB, V81, P3316, DOI 10.1128/AEM.04144-14
   Brennan TCR, 2012, BIOTECHNOL BIOENG, V109, P2513, DOI 10.1002/bit.24536
   Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1
   Carter OA, 2003, PHYTOCHEMISTRY, V64, P425, DOI 10.1016/S0031-9422(03)00204-8
   Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738
   Chubukov V, 2015, APPL ENVIRON MICROB, V81, P4690, DOI 10.1128/AEM.01102-15
   Cimmino S, 1999, J POLYM SCI POL PHYS, V37, P867, DOI 10.1002/(SICI)1099-0488(19990501)37:9<867::AID-POLB1>3.3.CO;2-O
   Ciriminna R, 2014, CHEM COMMUN, V50, P15288, DOI 10.1039/c4cc06147k
   Colonna M, 2011, GREEN CHEM, V13, P2543, DOI 10.1039/c1gc15400a
   Davies F.K, 2014, SYNTH BIOL, V2, P21, DOI DOI 10.3389/FBI0E.2014.00021
   DOLENCE JM, 1995, P NATL ACAD SCI USA, V92, P5008, DOI 10.1073/pnas.92.11.5008
   Duetz WA, 2003, APPL MICROBIOL BIOT, V61, P269, DOI 10.1007/s00253-003-1221-y
   Duetz WA, 2001, APPL ENVIRON MICROB, V67, P2829, DOI 10.1128/AEM.67.6.2829-2832.2001
   Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21
   Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5
   Erhardt H, 2014, MICROBIOLOGYOPEN, V3, P316, DOI 10.1002/mbo3.163
   Firdaus M, 2011, MACROMOLECULES, V44, P7253, DOI 10.1021/ma201544e
   Fischer K, 2013, TERPENES REPLACING B
   Fischer MJC, 2011, BIOTECHNOL BIOENG, V108, P1883, DOI 10.1002/bit.23129
   FRIEDMAN L, 1971, SCIENCE, V172, P1044, DOI 10.1126/science.172.3987.1044
   FUJITA T, 1993, PHYTOCHEMISTRY, V34, P1545, DOI 10.1016/S0031-9422(00)90843-4
   George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P355, DOI 10.1007/10_2014_288
   Giglio S, 2011, ENVIRON SCI TECHNOL, V45, P992, DOI 10.1021/es102992p
   Griffin S, 1999, J CHROMATOGR A, V864, P221, DOI 10.1016/S0021-9673(99)01009-2
   Gruchattka E, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-84
   Hanson CD, 1999, US Patent US, Patent No. 005977421
   Heddergott C, 2014, EUKARYOT CELL, V13, P1014, DOI 10.1128/EC.00074-14
   Hodges A., 2012, FE903 U FLOR I FOOD
   Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005
   Ignea C, 2014, ACS SYNTH BIOL, V3, P298, DOI 10.1021/sb400115e
   Inouye S, 2001, J ANTIMICROB CHEMOTH, V47, P565, DOI 10.1093/jac/47.5.565
   Jongedijk E, 2015, YEAST, V32, P159, DOI 10.1002/yea.3038
   Kang JH, 2014, PLANT PHYSIOL, V164, P80, DOI 10.1104/pp.113.230466
   KARLBERG AT, 1994, ARCH DERMATOL RES, V286, P97, DOI 10.1007/BF00370734
   Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955
   Kiyota H, 2014, J BIOTECHNOL, V185, P1, DOI 10.1016/j.jbiotec.2014.05.025
   Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105
   Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011
   Lange BM, 2013, PLANT BIOTECHNOL J, V11, P2, DOI 10.1111/j.1467-7652.2012.00737.x
   Lange BM, 2015, ADV BIOCHEM ENG BIOT, V148, P319, DOI 10.1007/10_2014_289
   Langeveld JWA, 2010, CROP SCI, V50, pS142, DOI 10.2135/cropsci2009.09.0529
   Leng CB, 2013, J PHYS CHEM A, V117, P10359, DOI 10.1021/jp403603z
   Lerin L, 2010, CIENCIA TECNOL ALIME, V30, P399, DOI 10.1590/S0101-20612010000200017
   Lucker J, 2002, EUR J BIOCHEM, V269, P3160, DOI 10.1046/j.1432-1033.2002.02985.x
   Lucker J, 2001, PLANT J, V27, P315, DOI 10.1046/j.1365-313x.2001.01097.x
   Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833
   McCoy M, 2015, CONCENTRATES, V93, P17
   Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5
   Miller JA, 2011, ONCOL REV, V5, P31, DOI 10.1007/s12156-010-0066-8
   Mirata MA, 2009, PROCESS BIOCHEM, V44, P764, DOI 10.1016/j.procbio.2009.03.013
   Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028
   Narita K, 1999, J BIOCHEM-TOKYO, V126, P566, DOI 10.1093/oxfordjournals.jbchem.a022487
   Nichkova M, 2009, J AGR FOOD CHEM, V57, P5673, DOI 10.1021/jf900652a
   Ramos JL, 2015, FEMS MICROBIOL REV, V39, P555, DOI 10.1093/femsre/fuv006
   Reiling KK, 2004, BIOTECHNOL BIOENG, V87, P200, DOI 10.1002/bit.20128
   Renninger NS, 2008, US Patent, Patent No. [WO 2008133658, 2008133658]
   Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138
   Rumbold K, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-64
   Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106
   Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015
   Serra S, 2005, TRENDS BIOTECHNOL, V23, P193, DOI 10.1016/j.tibtech.2005.02.003
   SIKKEMA J, 1994, J BIOL CHEM, V269, P8022
   Sokovic M, 2010, MOLECULES, V15, P7532, DOI 10.3390/molecules15117532
   Stuart Clark IVG, 1998, PERFUMER FLAVORIST, V33
   Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002
   Takami T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049004
   Thorp N, 2010, DIPENTENE
   Tissier A, 2012, PLANT J, V70, P51, DOI 10.1111/j.1365-313X.2012.04913.x
   Tracy NI, 2009, FUEL, V88, P2238, DOI 10.1016/j.fuel.2009.02.002
   Tranchida PQ, 2013, J CHROMATOGR A, V1305, P276, DOI 10.1016/j.chroma.2013.07.042
   Tripathi A. K., 2009, J PHARMACOGNOSY PHYT, V1, P52
   Turner G, 1999, PLANT PHYSIOL, V120, P879, DOI 10.1104/pp.120.3.879
   Turner GW, 2015, INT J PLANT SCI, V176, P643, DOI 10.1086/682054
   Turner GW, 2004, PLANT PHYSIOL, V136, P4215, DOI 10.1104/pp.104.050229
   URIBE S, 1990, J CHEM ECOL, V16, P1399, DOI 10.1007/BF01021035
   van Schie CCN, 2007, PLANT J, V52, P752, DOI 10.1111/j.1365-313X.2007.03273.x
   Vararu F, 2015, NOTULAE SCI BIOL, V7, DOI 10.15835/nsb.7.1.9545
   Vickers CE, 2014, PLANT CELL ENVIRON, V37, P1753, DOI 10.1111/pce.12316
   Voirin B, 1996, PHYTOCHEMISTRY, V43, P573, DOI 10.1016/0031-9422(96)00285-3
   Voo SS, 2012, PLANT PHYSIOL, V159, P81, DOI 10.1104/pp.112.194233
   Wang X, 2015, PLANT BIOTECHNOL J, V13, P137, DOI 10.1111/pbi.12343
   Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063
   Weldon PJ, 2011, J CHEM ECOL, V37, P348, DOI 10.1007/s10886-011-9922-7
   Wilbon PA, 2013, MACROMOL RAPID COMM, V34, P8, DOI 10.1002/marc.201200513
   Willrodt C, 2014, BIOTECHNOL J, V9, P1000, DOI 10.1002/biot.201400023
   Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075972
NR 96
TC 19
Z9 20
U1 4
U2 51
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD APR
PY 2016
VL 100
IS 7
BP 2927
EP 2938
DI 10.1007/s00253-016-7337-7
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DG7RS
UT WOS:000372282000001
PM 26915992
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Park, JC
   Oh, SY
   Lee, JS
   Park, SY
   Choi, EY
   Cho, KS
   Kim, CS
AF Park, Jung-Chul
   Oh, Sang-Yeob
   Lee, Jung-Seok
   Park, So-Yon
   Choi, Eun-Young
   Cho, Kyoo-Sung
   Kim, Chang-Sung
TI In vivo bone formation by human alveolar-bone-derived mesenchymal stem
   cells obtained during implant osteotomy using biphasic calcium phosphate
   ceramics or Bio-Oss as carriers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biphasic calcium phosphate; mesenchymal stem cell; osteogenic
   differentiation; regeneration
ID SINUS FLOOR AUGMENTATION; PERIODONTAL-LIGAMENT; OSTEOBLAST
   DIFFERENTIATION; VITRO; REGENERATION; PARTICLES; COLLAGEN; CULTURE;
   MATRIX; RAT
AB ObjectivesThe aim of this study was to evaluate HA coated with different ratios of TCP as a carrier for hABMSCs obtained during implant osteotomy in comparison to slowly-resorbing biomaterial, Bio-Oss, as a negative control, using in vitro and in vivo experiments.
   Materials and MethodsHuman ABMSCs (hABMSCs) harvested during implant osteotomy were transplanted using HA/TCP or Bio-Oss as carriers in a murine ectopic transplantation model (n=12). Pore size and cell affinity were evaluated in vitro. The area of newly formed bone was analyzed histometrically, the number of osteocytes was counted, and immunohistochemical staining was conducted against several markers of osteogenesis, including alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX-2), osteocalcin (OCN), and osteopontin (OPN). Osteoclast formation was evaluated by tartrate-resistant acid phosphatase staining.
   ResultsThe carrier materials had comparable pore sizes. The cell affinity assay resulted in a high proportion of cell adhesion (>90%) in all experimental groups. Substantial new bone and osteocyte formation was observed on both HA/TCP carriers, whereas it was minimal with Bio-Oss. Positive immunostaining for ALP, RUNX-2, OCN, and OPN was observed with HA/TCP, but only limited expression of osteogenic markers with Bio-Oss. Conversely, there was a minimal osteoclast presence with Bio-Oss, but a significant presence of osteoclasts with both HA/TCP carriers.
   ConclusionsBoth types of scaffolds, BCP and Bio-Oss, showed high stem cell-carrying potential, but the in vivo healing patterns of their complexes with hABMSC could be affected by the microenvironment on the surfaces of the scaffolds. (c) 2015 Wiley Periodicals, Inc.
C1 [Park, Jung-Chul; Oh, Sang-Yeob; Lee, Jung-Seok; Park, So-Yon; Choi, Eun-Young; Cho, Kyoo-Sung; Kim, Chang-Sung] Yonsei Univ, Res Inst Periodontal Regenerat, Dept Periodontol, Coll Dent, Seoul 120749, South Korea.
   [Kim, Chang-Sung] Yonsei Univ, Dept Appl Life Sci, Coll Dent, BK PLUS Project 21, Seoul 120749, South Korea.
RP Kim, CS (reprint author), Yonsei Univ, Res Inst Periodontal Regenerat, Dept Periodontol, Coll Dent, Seoul 120749, South Korea.; Kim, CS (reprint author), Yonsei Univ, Dept Appl Life Sci, Coll Dent, BK PLUS Project 21, Seoul 120749, South Korea.
EM dentall@yuhs.ac
FU National Research Foundation of Korea (NRF) [2012R1A2A4A01007124]; Bio &
   Medical Technology Development Program of National Research Foundation
   (NRF) [2012M3A9B2052521]
FX Contract grant sponsor: National Research Foundation of Korea (NRF);
   contract grant number: 2012R1A2A4A01007124; Contract grant sponsor: Bio
   & Medical Technology Development Program of the National Research
   Foundation (NRF); contract grant number: 2012M3A9B2052521
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Bojic S, 2014, HISTOL HISTOPATHOL, V29, P699, DOI 10.14670/HH-29.699
   BUDKE H, 1994, MODERN PATHOL, V7, P860
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Clausen C, 2006, CLIN ORAL IMPLAN RES, V17, P533, DOI 10.1111/j.1600-0501.2006.01254.X
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Duncan RL, 1998, SEMIN NEPHROL, V18, P178
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Flanagan D, 2010, IMPLANT DENT, V19, P241, DOI 10.1097/ID.0b013e3181dc9852
   Han J, 2014, AUST DENT J, V59, P117, DOI 10.1111/adj.12100
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hofman S, 1999, BIOMATERIALS, V20, P1155, DOI 10.1016/S0142-9612(97)00082-3
   Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jung IH, 2012, TISSUE ENG PT A, V18, P643, DOI [10.1089/ten.tea.2011.0164, 10.1089/ten.TEA.2011.0164]
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Lee JS, 2015, CELL TRANSPLANT, V24, P1767, DOI 10.3727/096368914X684628
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Mladenovic Z, 2013, CLIN ORAL IMPLAN RES, V24, P329, DOI 10.1111/j.1600-0501.2011.02334.x
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Nishimura M, 2012, INT J DENT, V2012
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Paganelli C, 2006, J ORAL REHABIL, V33, P625, DOI 10.1111/j.1365-2842.2005.01594.x
   Park DS, 2015, STEM CELLS DEV, V24, P228, DOI 10.1089/scd.2014.0148
   Park JC, 2012, J CLIN PERIODONTOL, V39, P495, DOI 10.1111/j.1600-051X.2012.01865.x
   Park JC, 2011, J CLIN PERIODONTOL, V38, P721, DOI 10.1111/j.1600-051X.2011.01716.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   ROACH HI, 1994, CELL BIOL INT, V18, P617, DOI 10.1006/cbir.1994.1088
   Rossi F, 2015, J TISSUE ENG REGEN M, V9, P1093, DOI 10.1002/term.1827
   Saldana L, 2009, ACTA BIOMATER, V5, P1294, DOI 10.1016/j.actbio.2008.11.022
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Schwartz C, 1999, J MATER SCI-MATER M, V10, P821, DOI 10.1023/A:1008944227417
   Song DS, 2011, J PERIODONTAL RES, V46, P193, DOI 10.1111/j.1600-0765.2010.01328.x
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   Yu BH, 2014, J BIOMATER APPL, V29, P243, DOI 10.1177/0885328214521846
   Yu BH, 2014, J ORAL MAXIL SURG, V72, P1084, DOI 10.1016/j.joms.2013.12.024
NR 42
TC 2
Z9 2
U1 3
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2016
VL 104
IS 3
BP 515
EP 524
DI 10.1002/jbm.b.33416
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7XN
UT WOS:000372297100009
PM 25939881
DA 2018-10-20
ER

PT J
AU Weizbauer, A
   Kieke, M
   Rahim, MI
   Angrisani, GL
   Willbold, E
   Diekmann, J
   Florkemeier, T
   Windhagen, H
   Muller, PP
   Behrens, P
   Budde, S
AF Weizbauer, Andreas
   Kieke, Marc
   Rahim, Muhammad Imran
   Angrisani, Gian Luigi
   Willbold, Elmar
   Diekmann, Julia
   Floerkemeier, Thilo
   Windhagen, Henning
   Mueller, Peter Paul
   Behrens, Peter
   Budde, Stefan
TI Magnesium-containing layered double hydroxides as orthopaedic implant
   coating materials-An in vitro and in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial; layered double hydroxides; magnesium hydroxide; surface
   coating; orthopaedic implants; osteoconductivity
ID OSTEOBLAST ADHESION; LDH NANOHYBRID; DRUG-DELIVERY; UNITED-STATES;
   HYDROXYAPATITE; BONE; ARTHROPLASTY; REVISION; TITANIUM; ALLOYS
AB The total hip arthroplasty is one of the most common artificial joint replacement procedures. Several different surface coatings have been shown to improve implant fixation by facilitating bone ingrowth and consequently enhancing the longevity of uncemented orthopaedic hip prostheses. In the present study, two different layered double hydroxides (LDHs), Mg-Fe- and Mg-Al-LDH, were investigated as potential magnesium (Mg)-containing coating materials for orthopaedic applications in comparison to Mg hydroxide (Mg(OH)(2)). In vitro direct cell compatibility tests were carried out using the murine fibroblast cell line NIH 3T3 and the mouse osteosarcoma cell line MG 63. The host response of bone tissue was evaluated in in vivo experiments with nine rabbits. Two cylindrical pellets (3 x 3 mm) were implanted into each femoral condyle of the left hind leg. The samples were analyzed histologically and with -computed tomography (-CT) 6 weeks after surgery. An in vitro cytotoxicity test determined that more cells grew on the LDH pellets than on the Mg(OH)(2)-pellets. The pH value and the Mg2+ content of the cell culture media were increased after incubation of the cells on the degradable samples. The in vivo tests demonstrated the formation of fibrous capsules around Mg(OH)(2) and Mg-Fe-LDH. In contrast, the host response of the Mg-Al-LDH samples indicated that this Mg-containing biomaterial is a potential candidate for implant coating. (c) 2015 Wiley Periodicals, Inc.
C1 [Weizbauer, Andreas; Willbold, Elmar; Diekmann, Julia; Floerkemeier, Thilo; Windhagen, Henning; Budde, Stefan] Hannover Med Sch, Lab Biomech & Biomat, Dept Orthopaed Surg, Anna von Borries Str 1, D-30625 Hannover, Germany.
   [Weizbauer, Andreas; Willbold, Elmar; Diekmann, Julia] Hannover Med Sch, CrossBIT, Ctr Biocompatibil & Implant Immunol, Dept Orthopaed Surg, Feodor Lynen Str 31, D-30625 Hannover, Germany.
   [Kieke, Marc; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Callinstr 9, D-30167 Hannover, Germany.
   [Rahim, Muhammad Imran; Mueller, Peter Paul] Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38123 Braunschweig, Germany.
   [Angrisani, Gian Luigi] Univ Hannover, Inst Mat Sci, Univ 2, D-30823 Garbsen, Germany.
RP Weizbauer, A (reprint author), Hannover Med Sch, Lab Biomech & Biomat, Dept Orthopaed Surg, Anna von Borries Str 1, D-30625 Hannover, Germany.; Weizbauer, A (reprint author), Hannover Med Sch, CrossBIT, Ctr Biocompatibil & Implant Immunol, Dept Orthopaed Surg, Feodor Lynen Str 31, D-30625 Hannover, Germany.
EM weizbauer.andreas@mh-hannover.de
OI Mueller, Peter/0000-0002-1209-7546
FU German Research Foundation (DFG) [SFB 599]
FX Contract grant sponsor: German Research Foundation (DFG); contract grant
   number: SFB 599
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andia JBC, 1996, NEPHROL DIAL TRANSPL, V11, P69
   Badar M, 2015, J BIOMED MATER RES A, V103, P2141, DOI 10.1002/jbm.a.35358
   Bartsch I, 2014, ACTA BIOMATER, V10, P34, DOI 10.1016/j.actbio.2013.08.047
   Bosco R, 2012, COATINGS, V2, P95, DOI 10.3390/coatings2030095
   Choy JH, 2004, BIOMATERIALS, V25, P3059, DOI 10.1016/j.biomaterials.2003.09.083
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hesse D, 2013, J MATER SCI-MATER M, V24, P129, DOI 10.1007/s10856-012-4769-1
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Khan AI, 2001, CHEM COMMUN, P2342, DOI 10.1039/b106465g
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2009, J ARTHROPLASTY, V24, P195, DOI 10.1016/j.arth.2007.11.015
   Kwak SY, 2004, BIOMATERIALS, V25, P5995, DOI 10.1016/j.biomaterials.2004.01.056
   Kwak SY, 2002, SOLID STATE IONICS, V151, P229, DOI 10.1016/S0167-2738(02)00714-2
   Ladewig K, 2010, BIOMATERIALS, V31, P1821, DOI 10.1016/j.biomaterials.2009.10.058
   Ladewig K, 2009, EXPERT OPIN DRUG DEL, V6, P907, DOI 10.1517/17425240903130585
   Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5
   Lazarinis S, 2010, ACTA ORTHOP, V81, P53, DOI 10.3109/17453670903413178
   Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111
   Lin JK, 2011, J MATER CHEM, V21, P5011, DOI 10.1039/e0jm03764h
   Morscher EW, 1998, J BONE JOINT SURG BR, V80B, P267, DOI 10.1302/0301-620X.80B2.8316
   Oh JM, 2006, J PHYS CHEM SOLIDS, V67, P1024, DOI 10.1016/j.jpcs.2006.01.033
   OLAKANMI O, 1994, J IMMUNOL, V153, P2691
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Sjogren G, 2000, J PROSTHET DENT, V84, P229, DOI 10.1067/mpr.2000.107227
   Tonino AJ, 1999, J BONE JOINT SURG BR, V81B, P148, DOI 10.1302/0301-620X.81B1.8948
   Uan JY, 2010, J MATER CHEM, V20, P761, DOI 10.1039/b917177k
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Yang L, 2013, ACTA BIOMATER, V9, P8475, DOI 10.1016/j.actbio.2012.10.001
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 41
TC 6
Z9 6
U1 5
U2 57
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2016
VL 104
IS 3
BP 525
EP 531
DI 10.1002/jbm.b.33422
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7XN
UT WOS:000372297100010
PM 25939995
DA 2018-10-20
ER

PT J
AU Sun, B
   Liang, DD
   Li, XP
   Chen, P
AF Sun, Bai
   Liang, Dandan
   Li, Xiaoping
   Chen, Peng
TI Nonvolatile bio-memristor fabricated with natural bio-materials from
   spider silk
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID RESISTIVE SWITCHING MEMORY; FIELD-EFFECT TRANSISTORS;
   ELECTRON-TRANSPORT; PROTEIN; FILMS; DEVICES; BEHAVIOR; FIBROIN;
   NANOPARTICLES; INTERLAYERS
AB The employ of nontoxic biomaterials as the basic building blocks of electronic devices is of growing interest for biocompatible and environmentally friendly electronics. Herein the fabrication and characterization of natural biomaterials-based bio-memristors with Ag/Fibroin/Au/Si structure is demonstrated. We observed a significant bipolar resistive switching behavior in Ag/Fibroin/Au/Si structure at room temperature. The results suggested that the memory behavior originates from the formation and rupture of conductive filaments. This work reveals that fibroin from spider silk is a useful natural biomaterial for nonvolatile memory applications, suggesting that spider silk possesses the potential for sustainable electronics and data storage.
C1 [Sun, Bai; Liang, Dandan; Li, Xiaoping; Chen, Peng] Southwest Univ, Sch Phys Sci & Technol, Chongqing 400715, Peoples R China.
RP Chen, P (reprint author), Southwest Univ, Sch Phys Sci & Technol, Chongqing 400715, Peoples R China.
EM pchen@swu.edu.cn
RI Sun, Bai/P-7421-2018
OI Sun, Bai/0000-0002-5840-509X
FU National Nature Science Foundation of China [51372209]
FX This work was supported by the National Nature Science Foundation of
   China (Grant No. 51372209).
CR Ambrogio S, 2014, ADV MATER, V26, P3885, DOI 10.1002/adma.201306250
   Amdursky N, 2012, J AM CHEM SOC, V134, P18221, DOI 10.1021/ja308953q
   Breemen A., 2015, ADV FUNCT MATER, V25, P278
   Cao X, 2009, APPL PHYS A-MATER, V97, P883, DOI 10.1007/s00339-009-5351-7
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Chen Y. C., 2015, SCI REP, V5, P10022
   Chen YS, 2012, NAT NANOTECHNOL, V7, P197, DOI [10.1038/nnano.2012.7, 10.1038/NNANO.2012.7]
   Gogurla N, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/34/345202
   HIROSE Y, 1976, J APPL PHYS, V47, P2767, DOI 10.1063/1.322942
   Hosseini NR, 2015, ACS NANO, V9, P419, DOI 10.1021/nn5055909
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Hung YC, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671153
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Khan MA, 2014, ADV FUNCT MATER, V24, P1372, DOI 10.1002/adfm.201302056
   Kim CH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098071
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim DK, 2013, J APPL PHYS, V114, DOI 10.1063/1.4816794
   Ko Y, 2011, ACS NANO, V5, P9918, DOI 10.1021/nn2036939
   Lin DM, 2012, ADV MATER, V24, P6088, DOI 10.1002/adma.201201888
   Liu DQ, 2013, ACS APPL MATER INTER, V5, P11258, DOI 10.1021/am403497y
   Meng FB, 2014, SMALL, V10, P277, DOI 10.1002/smll.201300810
   Meng FB, 2011, SMALL, V7, P3016, DOI 10.1002/smll.201101494
   Mentovich ED, 2009, NANO LETT, V9, P1296, DOI 10.1021/nl802694k
   Mukherjee C, 2013, PHYS STATUS SOLIDI A, V210, P1797, DOI 10.1002/pssa.201329109
   Park J, 2013, ADV MATER, V25, P6423, DOI 10.1002/adma.201303017
   Rajachidambaram JS, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4767124
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ron I, 2010, J AM CHEM SOC, V132, P4131, DOI 10.1021/ja907328r
   Sun B, 2016, CHEM PHYS LETT, V643, P66, DOI 10.1016/j.cplett.2015.11.022
   Sun B, 2015, J MATER CHEM C, V3, P12149, DOI 10.1039/c5tc02732b
   Sun B, 2015, CHEM PHYS, V457, P28, DOI 10.1016/j.chemphys.2015.05.010
   Sun B, 2015, PHYS CHEM CHEM PHYS, V17, P6718, DOI 10.1039/c4cp04901b
   Sun B, 2014, CRYSTENGCOMM, V16, P9891, DOI 10.1039/c4ce01442a
   Sun B, 2014, CHEM PHYS LETT, V613, P100, DOI 10.1016/j.cplett.2014.08.071
   Sun YM, 2015, J PHYS CHEM C, V119, P19520, DOI 10.1021/acs.jpcc.5b05337
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Uenuma M, 2013, RSC ADV, V3, P18044, DOI 10.1039/c3ra42392a
   Vladu M.I., 2011, J MATER CHEM, V21, P1350
   Vladu M.I., 2012, MATER TODAY, V15, P340
   Wang H, 2015, ADV MATER, V27, P7670, DOI 10.1002/adma.201405728
   Wang H, 2015, ADV FUNCT MATER, V25, P3825, DOI 10.1002/adfm.201501389
   Wang H, 2013, ADV MATER, V25, P5498, DOI 10.1002/adma.201301983
   Wang L, 2015, J MATER SCI-MATER EL, V26, P4618, DOI 10.1007/s10854-015-2848-z
   Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375
   Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]
   Zalar P, 2011, J AM CHEM SOC, V133, P11010, DOI 10.1021/ja201868d
   Zhang Y, 2012, ADV MATER, V24, P4255, DOI 10.1002/adma.201201248
NR 47
TC 9
Z9 9
U1 9
U2 64
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD APR
PY 2016
VL 27
IS 4
BP 3957
EP 3962
DI 10.1007/s10854-015-4248-9
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA DG6BG
UT WOS:000372166600110
DA 2018-10-20
ER

PT J
AU Li, XS
   Yuan, ZW
   Wei, XW
   Li, H
   Zhao, GF
   Miao, JN
   Wu, D
   Liu, B
   Cao, SY
   An, D
   Ma, W
   Zhang, H
   Wang, WL
   Wang, QS
   Gu, H
AF Li, Xiaoshuai
   Yuan, Zhengwei
   Wei, Xiaowei
   Li, Hui
   Zhao, Guifeng
   Miao, Jiaoning
   Wu, Di
   Liu, Bo
   Cao, Songying
   An, Dong
   Ma, Wei
   Zhang, Henan
   Wang, Weilin
   Wang, Qiushi
   Gu, Hui
TI Application potential of bone marrow mesenchymal stem cell (BMSCs) based
   tissue-engineering for spinal cord defect repair in rat fetuses with
   spina bifida aperta
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NEURAL-TUBE DEFECTS; CHITOSAN-GELATIN SCAFFOLDS; IN-VITRO; STROMAL
   CELLS; FETAL RATS; NEURODEGENERATIVE DISEASES; MYELOMENINGOCELE REPAIR;
   ANORECTAL MALFORMATION; CLINICAL-EXPERIENCE; TRANSPLANTATION
AB Spina bifida aperta are complex congenital malformations resulting from failure of fusion in the spinal neural tube during embryogenesis. Despite surgical repair of the defect, most patients who survive with spina bifida aperta have a multiple system handicap due to neuron deficiency of the defective spinal cord. Tissue engineering has emerged as a novel treatment for replacement of lost tissue. This study evaluated the prenatal surgical approach of transplanting a chitosan-gelatin scaffold seeded with bone marrow mesenchymal stem cells (BMSCs) in the healing the defective spinal cord of rat fetuses with retinoic acid induced spina bifida aperta. Scaffold characterisation revealed the porous structure, organic and amorphous content. This biomaterial promoted the adhesion, spreading and in vitro viability of the BMSCs. After transplantation of the scaffold combined with BMSCs, the defective region of spinal cord in rat fetuses with spina bifida aperta at E20 decreased obviously under stereomicroscopy, and the skin defect almost closed in many fetuses. The transplanted BMSCs in chitosan-gelatin scaffold survived, grew and expressed markers of neural stem cells and neurons in the defective spinal cord. In addition, the biomaterial presented high biocompatibility and slow biodegradation in vivo. In conclusion, prenatal transplantation of the scaffold combined with BMSCs could treat spinal cord defect in fetuses with spina bifida aperta by the regeneration of neurons and repairmen of defective region.
C1 [Li, Xiaoshuai; Yuan, Zhengwei; Wei, Xiaowei; Li, Hui; Zhao, Guifeng; Miao, Jiaoning; Wu, Di; Liu, Bo; Cao, Songying; An, Dong; Ma, Wei; Zhang, Henan; Gu, Hui] China Med Univ, Shengjing Hosp, Key Lab, Hlth Minist Congenital Malformat, 36 Sanhao St, Shenyang 110004, Peoples R China.
   [Wang, Weilin] China Med Univ, Dept Pediat Surg, Shenyang 110001, Peoples R China.
   [Wang, Qiushi] China Med Univ, Shengjing Hosp, Dept Blood Transfus, Shenyang 110001, Peoples R China.
RP Yuan, ZW (reprint author), China Med Univ, Shengjing Hosp, Key Lab, Hlth Minist Congenital Malformat, 36 Sanhao St, Shenyang 110004, Peoples R China.
EM yuanzw@hotmail.com
FU National Natural Foundation of China [81370717, 81171072]; National
   Basic Research Program of China (973 Program) [2013CB945402]; Program
   for Liaoning Innovative Research Team in University [LT2013016]
FX This study was supported by the National Natural Foundation of China.
   (Grant Numbers: 81370717,81171072). National Basic Research Program of
   China (973 Program, No. 2013CB945402). Program for Liaoning Innovative
   Research Team in University (LT2013016).
CR Baniasadi H, 2015, INT J BIOL MACROMOL, V74, P360, DOI 10.1016/j.ijbiomac.2014.12.014
   Bhat S., 2012, BIOSCI BIOENG, DOI [10.1016/j.jbiosc.2012.07.005., DOI 10.1016/J.JBIOSC.2012.07.005]
   Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Chen X, 2006, MICROSURG, V26, P111, DOI 10.1002/micr.20184
   Cipriani P, 2007, ARTHRITIS RHEUM, V56, P1994, DOI 10.1002/art.22698
   Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643
   Danzer E, 2005, EXP NEUROL, V194, P467, DOI 10.1016/j.expneurol.2005.03.011
   Danzer E, 2009, J NEUROS-PEDIATR, V3, P141, DOI 10.3171/2008.10.PEDS08199
   Farmer DL, 2003, ARCH SURG-CHICAGO, V138, P872, DOI 10.1001/archsurg.138.8.872
   Fauza DO, 2008, SURGERY, V144, P367, DOI 10.1016/j.surg.2008.05.009
   Feng YP, 2014, NEURAL REGEN RES, V9, P1968, DOI 10.4103/1673-5374.145378
   George J., 2015, FRONT PHARMACOL, V10, P53
   Guan KP, 2009, BIRTH DEFECTS RES A, V85, P583, DOI 10.1002/bdra.20576
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Johnson MP, 2003, AM J OBSTET GYNECOL, V189, P482, DOI 10.1067/S0002-9378(03)00295-3
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kohl T, 2006, FETAL DIAGN THER, V21, P185, DOI 10.1159/000089301
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884
   Le Trong I, 2003, ACTA CRYSTALLOGR D, V59, P828, DOI 10.1107/S0907444903004153
   Li H, 2014, CYTOTHERAPY, V16, P319, DOI 10.1016/j.jcyt.2013.10.005
   Li H, 2012, J CELL MOL MED, V16, P1606, DOI 10.1111/j.1582-4934.2011.01470.x
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Merianos D, 2008, BIOL BLOOD MARROW TR, V14, P729, DOI 10.1016/j.bbmt.2008.02.012
   Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018
   Mohamed KR, 2014, J ADV RES, V5, P201, DOI 10.1016/j.jare.2013.02.004
   Muench MO, 2005, BONE MARROW TRANSPL, V35, P537, DOI 10.1038/sj.bmt.1704811
   Norambuena GA, 2012, PEDIATR RES, V71, P452, DOI 10.1038/pr.2011.68
   Pathak S, 2009, ARCH DIS CHILD-FETAL, V94, pF384, DOI 10.1136/adc.2008.137919
   Pezeshki-Modaress M, 2014, J BIOMED MATER RES A, V102, P3908, DOI 10.1002/jbm.a.35054
   Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443
   Poras JR, 2015, J IMMUNOL METHODS, V420, P38, DOI 10.1016/j.jim.2015.03.013
   Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Romosan G, 2009, ULTRASOUND OBST GYN, V34, P526, DOI 10.1002/uog.6446
   Roybal JL, 2010, SEMIN FETAL NEONAT M, V15, P46, DOI 10.1016/j.siny.2009.05.005
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Sutton LN, 2008, BEST PRACT RES CL OB, V22, P175, DOI 10.1016/j.bpobgyn.2007.07.004
   Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576
   Tseng HJ, 2013, J TISSUE ENG REGEN M, V7, P20, DOI 10.1002/term.492
   Tulipan N, 2003, PEDIATR NEUROSURG, V38, P27, DOI 10.1159/000067560
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Yuan ZW, 2003, J PEDIATR SURG, V38, P1383, DOI 10.1016/S0022-3468(03)00401-9
   Zambelli H, 2007, CHILD NERV SYST, V23, P39
   Zhu L, 2006, TISSUE ENG, V12, P423, DOI 10.1089/ten.2006.12.423
   Zhu L, 2008, FOOD NUTR BULL, V29, pS196, DOI 10.1177/15648265080292S123
NR 55
TC 6
Z9 6
U1 3
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2016
VL 27
IS 4
AR 77
DI 10.1007/s10856-016-5684-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7JA
UT WOS:000372259400014
PM 26894267
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, LG
AF Zhang, Lije Grace
TI Development of Biologically Inspired 3D Printed Biomaterial Scaffolds
   for Improved Stem Cell Differentiation
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Zhang, Lije Grace] George Washington Univ, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA 87.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FC
UT WOS:000406444004307
DA 2018-10-20
ER

PT J
AU Zhang, LG
AF Zhang, Lije Grace
TI Development of Biologically Inspired 3D Printed Biomaterial Scaffolds
   for Improved Stem Cell Differentiation
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Zhang, Lije Grace] George Washington Univ, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA 87.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FC
UT WOS:000406444001295
DA 2018-10-20
ER

PT J
AU Zhang, LG
AF Zhang, Lije Grace
TI Development of Biologically Inspired 3D Printed Biomaterial Scaffolds
   for Improved Stem Cell Differentiation
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Zhang, Lije Grace] George Washington Univ, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA 87.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FC
UT WOS:000406444000521
DA 2018-10-20
ER

PT J
AU Chen, RX
   Willcox, MDP
   Ho, KKK
   Smyth, D
   Kumar, N
AF Chen, Renxun
   Willcox, Mark D. P.
   Ho, Kitty Ka Kit
   Smyth, Daniel
   Kumar, Naresh
TI Antimicrobial peptide melimine coating for titanium and its in vivo
   antibacterial activity in rodent subcutaneous infection models
SO BIOMATERIALS
LA English
DT Article
DE Antimicrobial peptides; Biomaterial; In vivo infection model;
   Pseudomonas; Staphylococcus
ID CENTRAL VENOUS CATHETERS; RESIDUAL ETHYLENE-OXIDE; CATIONIC-PEPTIDE;
   CONTACT-LENSES; PSEUDOMONAS-AERUGINOSA; MEDICAL DEVICES; SILVER; VITRO;
   PREVENTION; SURFACES
AB Implant-associated infections represent a significant health problem and financial burden on healthcare systems. Current strategies for the treatment or prevention of such infections are still inadequate and new strategies are needed in this era of antibiotic resistance. Melimine, a synthetic antimicrobial peptide with broad spectrum activity against bacteria, fungi and protozoa, has been shown to be a promising candidate for development as antimicrobial coating for biomedical devices and implants. In this study, the in vitro and in vivo antimicrobial activity of melimine-coated titanium was tested. The titanium surface was amine-functionalised with 3-aminopropyltriethoxysilane (APTES) followed by reaction with a bifunctional linker 4-(N-maleimidomethyl)cyclohexane-1-carboxylic 3-sulfo-n-hydroxysuccinimide ester (Sulfo-SMCC) to yield a maleimide functionalised surface. Melimine was then tethered to the surface via a thioether linkage through a Michael addition reaction of the cysteine at its N-terminus with the maleimide moiety. Melimine coating significantly reduced in vitro adhesion and biofilm formation of Pseudomonas aeruginosa by up to 62% and Staphylococcus aureus by up to 84% on the titanium substrates compared to the blank (p < 0.05). The activity was maintained after ethylene oxide gas sterilisation. The coating was also challenged in both mouse and rat subcutaneous infection models and was able to reduce the bacterial load by up to 2 log(10) compared to the uncoated surface (p < 0.05). Melimine coating is a promising candidate for development as a surface antimicrobial that can withstand industrial sterilisation while showing good biocompatibility. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chen, Renxun; Ho, Kitty Ka Kit; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW, Australia.
   [Chen, Renxun; Willcox, Mark D. P.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.
   [Smyth, Daniel] Cochlear Ltd, Sydney, NSW, Australia.
RP Kumar, N (reprint author), Univ New S Wales, Sch Chem, Sydney, NSW, Australia.
EM n.kumar@unsw.edu.au
RI Chen, Renxun/G-7015-2014
OI Chen, Renxun/0000-0003-0828-9980
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06
   Belen Burcu, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208490
   BONDE M, 1992, ANAL BIOCHEM, V200, P195, DOI 10.1016/0003-2697(92)90298-L
   Bong JJ, 2003, J CLIN PATHOL, V56, P731, DOI 10.1136/jcp.56.10.731
   Chen L, 2015, J PHARM SCI-US, V104, P731, DOI 10.1002/jps.24257
   Chen RX, 2012, ACTA BIOMATER, V8, P4371, DOI 10.1016/j.actbio.2012.07.029
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Ciampi S, 2007, LANGMUIR, V23, P9320, DOI 10.1021/la701035g
   Cole N, 2010, INVEST OPHTH VIS SCI, V51, P390, DOI 10.1167/iovs.09-4068
   Darouiche R, 2007, INT J ARTIF ORGANS, V30, P820
   Darouiche RO, 2008, J ANTIMICROB CHEMOTH, V61, P651, DOI 10.1093/jac/dkn006
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dettin M, 2009, J BIOMED MATER RES A, V90A, P35, DOI 10.1002/jbm.a.32064
   Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05
   Dutta D, 2014, OPTOMETRY VISION SCI, V91, P570, DOI 10.1097/OPX.0000000000000232
   Dutta D, 2013, INVEST OPHTH VIS SCI, V54, P175, DOI 10.1167/iovs.12-10989
   Fraenkel D, 2006, CRIT CARE MED, V34, P668, DOI 10.1097/01.CCM.0000201404.05523.34
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Ho KKK, 2010, BIOFOULING, V26, P913, DOI 10.1080/08927014.2010.531463
   Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Lam PK, 2004, BRIT J BIOMED SCI, V61, P125, DOI 10.1080/09674845.2004.11732656
   Listyo A, 2014, A A CASE REP, V2, P3, DOI 10.1097/ACC.0b013e3182a08ff1
   Lucas AD, 2003, J BIOMED MATER RES B, V66B, P548, DOI 10.1002/jbm.b.10036
   Madkour AE, 2009, LANGMUIR, V25, P1060, DOI 10.1021/la802953v
   Mansouri MD, 2012, ANTIMICROB AGENTS CH, V56, P2201, DOI 10.1128/AAC.05521-11
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   O'Neill J., 2014, ANTIMICROBIAL RESIST, P1
   POOTHULLIL J, 1975, ANN INTERN MED, V82, P58, DOI 10.7326/0003-4819-82-1-58
   Ramritu P, 2008, AM J INFECT CONTROL, V36, P104, DOI 10.1016/i.ajic.2007.02.012
   Rasul R, 2010, INT J ANTIMICROB AG, V35, P566, DOI 10.1016/j.ijantimicag.2010.02.005
   Salwiczek M, 2014, TRENDS BIOTECHNOL, V32, P82, DOI 10.1016/j.tibtech.2013.09.008
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   SHERERTZ RJ, 1989, ANTIMICROB AGENTS CH, V33, P1174, DOI 10.1128/AAC.33.8.1174
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Tilmaciu CM, 2015, ACTA BIOMATER, V15, P266, DOI 10.1016/j.actbio.2014.12.020
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   WINDMUELLER HG, 1959, J BIOL CHEM, V234, P895
NR 41
TC 36
Z9 36
U1 21
U2 156
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2016
VL 85
BP 142
EP 151
DI 10.1016/j.biomaterials.2016.01.063
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG1QA
UT WOS:000371841400012
PM 26871890
DA 2018-10-20
ER

PT J
AU Lv, XG
   Li, Z
   Chen, SY
   Xie, MK
   Huang, JW
   Peng, XF
   Yang, RX
   Wang, HP
   Xu, YM
   Feng, C
AF Lv, XiangGuo
   Li, Zhe
   Chen, ShiYan
   Xie, MinKai
   Huang, JianWen
   Peng, XuFeng
   Yang, RanXing
   Wang, HuaPing
   Xu, YueMin
   Feng, Chao
TI Structural and functional evaluation of oxygenating keratin/silk fibroin
   scaffold and initial assessment of their potential for urethral tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Keratin; Oxygen generation; Urinary tract; Tissue
   Engineering
ID SILK FIBROIN; IN-VITRO; CALCIUM HYDROXIDE; STEM-CELLS; RECONSTRUCTION;
   REGENERATION; PROTEINS; MATRICES; REPAIR; REPLACEMENT
AB In this study, we report a new type of oxygen-generating scaffold, composed of human keratin, silk, gelatin and calcium peroxide (CPO). After mixing the silk/keratin (60:40) with 2% gelatin and 20% CPO, the film demonstrated excellent mechanical properties, non-cytotoxicity and oxygen-generative ability. The detailed structure of scaffold was revealed by confocal laser and electronic scanning microscopy. The gelatin formed the network structure, which mixed with silk fibroin and keratin. The CPOs were embedded into scaffold. A shell core structure was formed in the CPO particles, in which the CPO was located in the core and the gelatin was mainly wrapped around the CPO. Furthermore, the oxygen release test showed that scaffold was able to steadily release high level of oxygen over two weeks in vitro. In addition, the anti-bacterial function was also proved in the scaffold. Films with CPO enhanced the repair in dog urethral defect models, resulting in patent urethra. Improved organized muscle bundles and epithelial layer were observed in animals treated with CPO films compared with those treated with non-CPO films. This study suggests that this biomaterial could be suitable for tissue engineered urinary tract reconstruction. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Lv, XiangGuo; Xie, MinKai; Huang, JianWen; Peng, XuFeng; Yang, RanXing; Xu, YueMin; Feng, Chao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.
   [Li, Zhe; Chen, ShiYan; Wang, HuaPing] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.
   [Xu, YueMin] Shanghai Eastern Urol Reconstruct & Repair Inst, Shanghai, Peoples R China.
RP Feng, C (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.
EM fengchaomed@sina.com
FU National Natural Science Foundation of China [81170641, 81100488,
   81370795]; Department of Education for Post-graduate Event
   [20130073110021]
FX This study was supported by National Natural Science Foundation of China
   (81170641, 81100488 and 81370795). Fund from the Department of Education
   for Post-graduate Event (20130073110021).
CR Arlen AM, 2010, THESCIENTIFICWORLDJO, V10, P74, DOI 10.1100/tsw.2010.16
   Atala A, 2004, AM J TRANSPLANT, V4, P58, DOI 10.1111/j.1600-6135.2004.0346.x
   Atala A, 2003, CLIN PLAST SURG, V30, P649, DOI 10.1016/S0094-1298(03)00094-4
   Atala A, 2008, PEDIATR RES, V63, P569, DOI 10.1203/PDR.0b013e3181660639
   BAKER AM, 1987, PLANT SOIL, V99, P379, DOI 10.1007/BF02370883
   Bhardwaj N, 2015, INTEGR BIOL-UK, V7, P53, DOI 10.1039/c4ib00208c
   Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Ding J, 2014, UROL INT, V93, P454, DOI 10.1159/000360796
   Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6
   Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289
   Folin M., 1995, ANTHROPOL ANZ, P337
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   Fujii T, 2004, BIOL PHARM BULL, V27, P89, DOI 10.1248/bpb.27.89
   Fujii T, 2009, J BIOMED MATER RES B, V91B, P528, DOI 10.1002/jbm.b.31426
   Hanh DN, 2005, ENVIRON TECHNOL, V26, P581, DOI 10.1080/09593332608618543
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   HAYASHI A, 1983, AGR BIOL CHEM TOKYO, V47, P1711, DOI 10.1080/00021369.1983.10865852
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jetbumpenkul P, 2012, INT J BIOL MACROMOL, V50, P7, DOI 10.1016/j.ijbiomac.2011.08.028
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mangera A, 2013, ASIAN J ANDROL, V15, P89, DOI 10.1038/aja.2012.91
   Mohammadi Zahed, 2012, Iran Endod J, V7, P115
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Seino M, 2015, ANTICANCER RES, V35, P85
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102
   Shokraneh A, 2014, DENT MATER J, V33, P733, DOI 10.4012/dmj.2014-090
   Simaioforidis V, 2013, TISSUE ENG PART B-RE, V19, P413, DOI [10.1089/ten.teb.2012.0737, 10.1089/ten.TEB.2012.0737]
   Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Stark G, 2005, J MEMBRANE BIOL, V205, P1, DOI 10.1007/s00232-005-0753-8
   Urciuolo F, 2012, METHODS MOL BIOL, V811, P223, DOI 10.1007/978-1-61779-388-2_15
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   Ward CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072485
   Xie MK, 2014, J SURG RES, V188, P1, DOI 10.1016/j.jss.2013.11.1102
   Xie MK, 2013, J SURG RES, V184, P774, DOI 10.1016/j.jss.2013.04.016
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
NR 47
TC 9
Z9 11
U1 5
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2016
VL 84
BP 99
EP 110
DI 10.1016/j.biomaterials.2016.01.032
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF5BT
UT WOS:000371367500009
PM 26826299
DA 2018-10-20
ER

PT J
AU Michael, FM
   Khalid, M
   Ratnam, CT
   Chee, CY
   Rashmi, W
   Hoque, ME
AF Michael, Feven Mattews
   Khalid, M.
   Ratnam, C. T.
   Chee, Ching Yern
   Rashmi, W.
   Hoque, M. E.
TI Sono-synthesis of nanohydroxyapatite: Effects of process parameters
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Calcination; Nanohydroxyapatite; Precipitation; Ultrasonication; Thermal
   stability
ID HYDROXYAPATITE NANOPARTICLES; HYDROTHERMAL METHOD; NANOCRYSTALLINE
   HYDROXYAPATITE; NANOPHASE HYDROXYAPATITE; MECHANICAL-PROPERTIES;
   TEMPERATURE; PRECIPITATION; MORPHOLOGY; SCAFFOLDS; BIOMATERIAL
AB Hydroxyapatite (HA) [Ca-10(PO4)(6)(OH)(2)] is a bioactive ceramic with excellent osteoconductive properties. This characteristic helps HA to be integrated into the bone without provoking an immune reaction, thus making it a useful biocompatible material for load bearing bone implant. In this study, nanohydroxyapatite (NHA) was synthesised using a precipitation method assisted with ultrasonication. The process parameters such as ultrasonic time (t) (10-30 min), ultrasonic amplitude (A) (50-70%), solution temperature (T) (50-90 degrees C), and solution pH (7-9) were varied on the basis of single factor and their effects on NHA synthesis was investigated. Besides that, the effect of calcination on the NHA powder morphology was also studied by varying the calcination time (2, 4 and 6 h) and temperature (400, 800 and 1200 degrees C). The characterisations of the synthesised NHA powder were conducted using thermogravimetric analysis (TGA), field emission scanning electron microscope (FESEM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), Brunauer-Emmet-Teller (BET), transmission electron microscope (I EM), zeta-sizer and Fourier transform infrared spectroscopy (FTIR). It was found that nano-sized HA particles can be produced at optimum set of process parameters of t=25 min, T=90 degrees C, A=65%, and pH=8. Results revealed that the thermal stability, morphology and crystallinity of the NHA powder was further improved by calcinating the powder at optimum temperature and time of 800 degrees C and 2 h, respectively. (C) 2016 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Michael, Feven Mattews; Khalid, M.] Univ Nottingham, Fac Engn, Div Mfg & Ind Proc, Malaysia Campus, Semenyih 43500, Selangor, Malaysia.
   [Ratnam, C. T.] Agensi Nuklear Malaysia, Radiat Proc Technol Div, Bangi, Malaysia.
   [Chee, Ching Yern] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
   [Rashmi, W.] Taylors Univ, Sch Engn, Energy Res Grp, Subang Jaya 47500, Selangor, Malaysia.
   [Hoque, M. E.] King Faisal Univ, Dept Biomed Engn, Al Hufuf, Al Ahsa, Saudi Arabia.
RP Khalid, M (reprint author), Univ Nottingham, Fac Engn, Div Mfg & Ind Proc, Malaysia Campus, Semenyih 43500, Selangor, Malaysia.
EM khalid.siddiqui@nottingham.edu.my
RI CHING, CHEE/D-6881-2011; Engineering, Faculty/I-7935-2015; engineering,
   @UM-2016/I-9329-2016; RATNAM, CHANTARA THEVY/K-1275-2012
OI CHING, CHEE/0000-0002-1611-1341; Engineering,
   Faculty/0000-0002-4848-7052; RATNAM, CHANTARA THEVY/0000-0002-3683-8548;
   Hoque, Md Enamul/0000-0003-0393-6771; Khalid,
   Mohammad/0000-0002-0265-4820
FU University of Nottingham, Malaysia campus [UNR30005]; Ministry of
   Education Malaysia [UM.C/625/1/HIR/MoE/52]
FX The authors would like to acknowledge the financial support provided by
   the University of Nottingham, Malaysia campus, research Grant (UNR30005)
   and High Impact Research MoE Grant (UM.C/625/1/HIR/MoE/52) from the
   Ministry of Education Malaysia.
CR Aminzare M, 2013, CERAM INT, V39, P2197, DOI 10.1016/j.ceramint.2012.09.023
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Cengiz B, 2008, COLLOID SURFACE A, V322, P29, DOI 10.1016/j.colsurfa.2008.02.011
   Chandrasekar A., 2013, INT J PHYS SCI, V8, P1639
   Cox SC, 2014, J MATER SCI-MATER M, V25, P37, DOI 10.1007/s10856-013-5042-y
   Eslami H, 2010, MATER SCI-POLAND, V28, P5
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   Hogue M.E., 2013, J MAT SCI ENG, V2, P132
   Hoque M.E., 2014, INT J SCI ENG TECHNO, V3, P458
   Hutmacher DW, 2008, VIRTUAL PROTOTYPING & BIO MANUFACTURING IN MEDICAL APPLICATIONS, P261, DOI 10.1007/978-0-387-68831-2_12
   Lazic S, 2001, THERMOCHIM ACTA, V374, P13, DOI 10.1016/S0040-6031(01)00453-1
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Li XM, 2014, J BIOMED MATER RES A, V102, P1580, DOI 10.1002/jbm.a.34801
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Liu HS, 1997, CERAM INT, V23, P19, DOI 10.1016/0272-8842(95)00135-2
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Neira I. S., 2008, CRYSTAL GROWTH DESIG, V9, P466, DOI DOI 10.1021/CG800738A
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rhee SH, 2002, BIOMATERIALS, V23, P1147, DOI 10.1016/S0142-9612(01)00229-0
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Scalera F, 2013, CERAM INT, V39, P4839, DOI 10.1016/j.ceramint.2012.11.076
   Seema K, 2012, J MATER ENG PERFORM, V21, P1737, DOI 10.1007/s11665-011-0059-1
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Song QZ, 2011, MATER RES BULL, V46, P1398, DOI 10.1016/j.materresbull.2011.05.015
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
   Yousefi A., 2014, J BIOMED MATER RES A, V103, P2460
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
NR 32
TC 2
Z9 2
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD APR
PY 2016
VL 42
IS 5
BP 6263
EP 6272
DI 10.1016/j.ceramint.2016.01.009
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA DE8KI
UT WOS:000370884500079
DA 2018-10-20
ER

PT J
AU Cifuentes, SC
   Bensiamar, F
   Gallardo-Moreno, AM
   Osswald, TA
   Gonzalez-Carrasco, JL
   Benavente, R
   Gonzalez-Martin, ML
   Garcia-Rey, E
   Vilaboa, N
   Saldana, L
AF Cifuentes, Sandra C.
   Bensiamar, Fatima
   Gallardo-Moreno, Amparo M.
   Osswald, Tim A.
   Gonzalez-Carrasco, Jose L.
   Benavente, Rosario
   Gonzalez-Martin, Maria L.
   Garcia-Rey, Eduardo
   Vilaboa, Nuria
   Saldana, Laura
TI Incorporation of Mg particles into PDLLA regulates mesenchymal stem cell
   and macrophage responses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE magnesium; polymer; composite; mesenchymal stem cell; macrophage
ID MAGNESIUM DEGRADATION-PRODUCTS; IN-VIVO CORROSION; L-LACTIC ACID; BONE
   REGENERATION; ALLOYS; DIFFERENTIATION; FIXATION; IMPLANTS; VITRO;
   BIOCOMPATIBILITY
AB In this work, we investigated a new approach to incorporate Mg particles within a PDLLA matrix using a solvent-free commercially available process. PDLLA/Mg composites were manufactured by injection moulding and the effects of Mg incorporated into PDLLA on MSC and macrophage responses were evaluated. Small amounts of Mg particles (1 wt %) do not cause thermal degradation of PDLLA, which retains its mechanical properties. PDLLA/Mg composites release hydrogen, alkaline products and Mg2+ ions without changing pH of culture media. Mg-containing materials provide a noncytotoxic environment that enhances MSC viability. Concentration of Mg2+ ions in extracts of MSCs increases with the increment of Mg content in the composites. Incorporation of Mg particles into PDLLA stimulates FN production, ALP activity, and VEGF secretion in MSCs, an effect mediated by degradation products dissolved from the composites. Degradation products of PDLLA induce an increase in MCP-1, RANTES, and MIP-1 secretion in macrophages while products of composites have minimal effect on these chemokines. Regulation of MSC behavior at the biomaterial's interface and macrophage-mediated inflammatory response to the degradation products is related to the incorporation of Mg in the composites. These findings suggest that including small amounts of Mg particles into polymeric devices can be a valuable strategy to promote osseointegration and reduce host inflammatory response. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 866-878, 2016.
C1 [Cifuentes, Sandra C.; Gonzalez-Carrasco, Jose L.] CSIC, Ctr Nacl Invest Met CENIM, Dept Met Fis, Avda Gregorio Del Amo 8, Madrid 28040, Spain.
   [Bensiamar, Fatima; Garcia-Rey, Eduardo; Vilaboa, Nuria; Saldana, Laura] Hosp Univ La Paz IdiPAZ, Grp Fisiopatol Osea & Biomat, Paseo Castellana 261, Madrid 28046, Spain.
   [Bensiamar, Fatima; Gallardo-Moreno, Amparo M.; Gonzalez-Carrasco, Jose L.; Gonzalez-Martin, Maria L.; Vilaboa, Nuria; Saldana, Laura] CIBER Bioingn Biomat & Nanomed CIBER BBN, Madrid, Spain.
   [Gallardo-Moreno, Amparo M.; Gonzalez-Martin, Maria L.] Univ Extremadura, Dept Fis Aplicada, Avda De Elvas S-N, Badajoz 06006, Spain.
   [Osswald, Tim A.] Univ Wisconsin, PEC, Dept Mech Engn, Madison, WI USA.
   [Benavente, Rosario] ICTP CSIC, Dept Quim Fis, Madrid, Spain.
   [Garcia-Rey, Eduardo] Hosp Univ La Paz IdiPAZ, Dept Cirugia Ortoped & Traumatol, Paseo Castellana 261, Madrid 28046, Spain.
RP Saldana, L (reprint author), Hosp Univ La Paz IdiPAZ, Grp Fisiopatol Osea & Biomat, Paseo Castellana 261, Madrid 28046, Spain.; Saldana, L (reprint author), CIBER Bioingn Biomat & Nanomed CIBER BBN, Madrid, Spain.
EM laura.saldana@salud.madrid.org
RI Benavente, Rosario/F-5034-2016; Garcia-Rey, Eduardo/M-2094-2017
OI Benavente, Rosario/0000-0003-0416-0151; Garcia-Rey,
   Eduardo/0000-0002-8378-8096; CIFUENTES CUELLAR, SANDRA
   CAROLINA/0000-0001-9779-369X; Saldana, Laura/0000-0003-3057-4649
FU Ministerio de Economia y Competitividad (MINECO, Spain)
   [MAT2012-37736-CO5-01-03-05, MAT2013-47972-C2-1-P]; Fondo de
   Investigaciones Sanitarias (FIS, Spain) [PI12/01698]; Comunidad Autonoma
   de Madrid (CAM, Spain) [S2013/MIT-2862]; FIS [CP11/00022]
FX Contract grant sponsor: Ministerio de Economia y Competitividad (MINECO,
   Spain); contract grant numbers: MAT2012-37736-CO5-01-03-05;
   MAT2013-47972-C2-1-P.; Contract grant sponsor: Fondo de Investigaciones
   Sanitarias (FIS, Spain); contract grant number: PI12/01698.; Contract
   grant sponsor: Comunidad Autonoma de Madrid (CAM, Spain); contract grant
   number: S2013/MIT-2862; Program I2.; Contract grant sponsor: FIS;
   contract grant number: CP11/00022.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   BOSTMAN OM, 2000, CLIN ORTHOPAEDICS, V371, P216
   Brown A, 2015, ACTA BIOMATER, V11, P543, DOI 10.1016/j.actbio.2014.09.008
   Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022
   Cifuentes SC, 2012, MATER LETT, V74, P239, DOI 10.1016/j.matlet.2012.01.134
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   DesJong WH, 2005, BIOMATERIALS, V26, P1781
   Galli S, 2014, ACTA BIOMATER, V10, P5193, DOI 10.1016/j.actbio.2014.08.011
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Jiang X., 2010, POLYLACTIC ACID SYNT, P69
   Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008
   Leidi M, 2011, MAGNESIUM RES, V24, P1, DOI 10.1684/mrh.2011.0271
   Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111
   Marumo K, 2006, J ORTHOP SCI, V11, P154, DOI 10.1007/s00776-005-0989-2
   Mau LP, 2012, IMPLANT DENT, V21, P171, DOI 10.1097/ID.0b013e31824eece1
   Motoyama T, 2007, POLYM DEGRAD STABIL, V92, P1350, DOI 10.1016/j.polymdegradstab.2007.03.014
   Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105
   Park JW, 2012, CLIN ORAL IMPLAN RES, V23, P294, DOI 10.1111/j.1600-0501.2010.02144.x
   Razavi M, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5514-3
   Saldana L, 2006, J BIOMED MATER RES A, V77A, P220, DOI 10.1002/jbm.a.30599
   Seitz JM, 2014, J BIOMED MATER RES A, V102, P3744, DOI 10.1002/jbm.a.35023
   Sissi C, 2009, NUCLEIC ACIDS RES, V3, P702
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sugimoto J, 2012, J IMMUNOL, V188, P6338, DOI 10.4049/jimmunol.1101765
   Sun H, 2014, BONE JOINT J, V96B, P548, DOI 10.1302/0301-620X.96B4.32171
   Valles G, 2015, BIOMATERIALS, V37, P124, DOI 10.1016/j.biomaterials.2014.10.028
   Wan P, 2014, COMPOS SCI TECHNOL, V98, P36, DOI 10.1016/j.compscitech.2014.04.011
   Wang JL, 2015, ACTA BIOMATER, V21, P237, DOI 10.1016/j.actbio.2015.04.011
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wong HM, 2013, BIOMATERIALS, V34, P7016, DOI 10.1016/j.biomaterials.2013.05.062
   Yang CX, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045005
   Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002
   Zhai ZJ, 2014, BIOMATERIALS, V35, P6299, DOI 10.1016/j.biomaterials.2014.04.044
NR 37
TC 10
Z9 10
U1 1
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2016
VL 104
IS 4
BP 866
EP 878
DI 10.1002/jbm.a.35625
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF5XB
UT WOS:000371425000006
PM 26662548
DA 2018-10-20
ER

PT J
AU Bischel, LL
   Coneski, PN
   Lundin, JG
   Wu, PK
   Giller, CB
   Wynne, J
   Ringeisen, BR
   Pirlo, RK
AF Bischel, Lauren L.
   Coneski, Peter N.
   Lundin, Jeffrey G.
   Wu, Peter K.
   Giller, Carl B.
   Wynne, James
   Ringeisen, Brad R.
   Pirlo, Russell K.
TI Electrospun gelatin biopapers as substrate for in vitro bilayer models
   of blood-brain barrier tissue
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE blood-brain barrier; electrospinning; gelatin; tissue engineering;
   biomaterial
ID MICROVASCULAR ENDOTHELIAL-CELLS; CROSS-LINKING METHODS; ASTROCYTES;
   DIFFERENTIATION; PERMEABILITY; VIVO; MORPHOLOGY; SCAFFOLDS; MIGRATION;
   TRANSPORT
AB Gaining a greater understanding of the blood-brain barrier (BBB) is critical for improvement in drug delivery, understanding pathologies that compromise the BBB, and developing therapies to protect the BBB. In vitro human tissue models are valuable tools for studying these issues. The standard in vitro BBB models use commercially available cell culture inserts to generate bilayer co-cultures of astrocytes and endothelial cells (EC). Electrospinning can be used to produce customized cell culture substrates with optimized material composition and mechanical properties with advantages over off-the-shelf materials. Electrospun gelatin is an ideal cell culture substrate because it is a natural polymer that can aid cell attachment and be modified and degraded by cells. Here, we have developed a method to produce cell culture inserts with electrospun gelatin biopaper membranes. The electrospun fiber diameter and cross-linking method were optimized for the growth of primary human endothelial cell and primary human astrocyte bilayer co-cultures to model human BBB tissue. BBB co-cultures on biopaper were characterized via cell morphology, trans-endothelial electrical resistance (TEER), and permeability to FITC-labeled dextran and compared to BBB co-cultures on standard cell culture inserts. Over longer culture periods (up to 21 days), cultures on the optimized electrospun gelatin biopapers were found to have improved TEER, decreased permeability, and permitted a smaller separation between co-cultured cells when compared to standard PET inserts. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 901-909, 2016.
C1 [Bischel, Lauren L.; Coneski, Peter N.; Pirlo, Russell K.] US Naval Res Lab, Bldg 207,Rm 241,4555 Overlook Ave SW, Washington, DC USA.
   [Lundin, Jeffrey G.; Wynne, James; Ringeisen, Brad R.; Pirlo, Russell K.] US Naval Res Lab, Div Chem, Washington, DC USA.
   [Wu, Peter K.] Southern Oregon Univ, Dept Phys, Ashland, OR USA.
   [Giller, Carl B.] US Naval Res Lab, Leidos, Washington, DC USA.
RP Pirlo, RK (reprint author), US Naval Res Lab, Bldg 207,Rm 241,4555 Overlook Ave SW, Washington, DC USA.
EM russell.pirlo@nrl.navy.mil
FU Chemical Biological Technologies Directorate, Department of Defense
   Chemical and Biological Defense program through the Defense Threat
   Reduction Agency (DTRA); American Society for Engineering Education
   [CB10011]
FX Contract grant sponsor: Chemical Biological Technologies Directorate,
   Department of Defense Chemical and Biological Defense program through
   the Defense Threat Reduction Agency (DTRA) and the American Society for
   Engineering Education; contract grant number: CB10011.
CR ARTURSSON P, 1990, J PHARM SCI, V79, P476, DOI 10.1002/jps.2600790604
   Baiguera S, 2009, J MATER SCI-MATER M, V21, P1353
   Berezowski V, 2012, INT J CELL BIOL, V2012
   Carlson EC, 2003, ANAT REC PART A, V271A, P332, DOI 10.1002/ar.a.10038
   Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368
   Chang JC, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055002
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x
   Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8
   Demeuse P, 2002, J NEUROSCI METH, V121, P21, DOI 10.1016/S0165-0270(02)00225-X
   Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Fromm M, 2009, MOL STRUCTURE FUNCTI
   Gaillard PJ, 2000, EUR J PHARM SCI, V12, P95, DOI 10.1016/S0928-0987(00)00152-4
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Gnavi S, 2015, MAT SCI ENG C-MATER, V48, P620, DOI 10.1016/j.msec.2014.12.055
   Hajiali H, 2011, INT J NANOMED, P2133
   Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012
   Hawkins RA, 2006, J NUTR, V136, P218
   Hodgkinson T, 2014, J TISSUE ENG
   HURWITZ AA, 1993, BRAIN RES, V625, P238, DOI 10.1016/0006-8993(93)91064-Y
   Jalaja K, 2014, CARBOHYD POLYM, V114, P467, DOI 10.1016/j.carbpol.2014.08.023
   Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001
   Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112
   Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169
   Kuo YC, 2011, COLLOID SURFACE B, V86, P225, DOI 10.1016/j.colsurfb.2011.04.005
   Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5
   Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538
   Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   Megard I, 2002, BRAIN RES, V927, P153, DOI 10.1016/S0006-8993(01)03337-6
   Morris GE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035014
   Ozeki M, 2005, J BIOMAT SCI-POLYM E, V16, P549, DOI 10.1163/1568562053783731
   Panzavolta S, 2011, ACTA BIOMATER, V7, P1702, DOI 10.1016/j.actbio.2010.11.021
   Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551
   Ren YJ, 2013, ACTA BIOMATER, V9, P7727, DOI 10.1016/j.actbio.2013.04.034
   Schafer A, 2011, J VIROL, V85, P10682, DOI 10.1128/JVI.05032-11
   Sisson K, 2010, J BIOMED MATER RES A, V94A, P1312, DOI 10.1002/jbm.a.32756
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Soza G, 2005, INT J MED ROBOT COMP, V1, P87, DOI 10.1002/rcs.32
   Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065
   Whited BM, 2014, BIOTECHNOL BIOENG, V111, P184, DOI 10.1002/bit.24995
   Wolff A, 2015, J PHARM SCI, V1104, P2727
   Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016
   Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115
   Zhao L, 2008, J BIOMED MATER RES B, V87B, P26, DOI 10.1002/jbm.b.31060
NR 46
TC 5
Z9 5
U1 5
U2 47
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2016
VL 104
IS 4
BP 901
EP 909
DI 10.1002/jbm.a.35624
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF5XB
UT WOS:000371425000009
PM 26650896
DA 2018-10-20
ER

PT J
AU Ju, HW
   Lee, OJ
   Lee, JM
   Moon, BM
   Park, HJ
   Park, YR
   Lee, MC
   Kim, SH
   Chao, JR
   Ki, CS
   Park, CH
AF Ju, Hyung Woo
   Lee, Ok Joo
   Lee, Jung Min
   Moon, Bo Mi
   Park, Hyun Jung
   Park, Ye Ri
   Lee, Min Chae
   Kim, Soo Hyeon
   Chao, Janet Ren
   Ki, Chang Seok
   Park, Chan Hum
TI Wound healing effect of electrospun silk fibroin nanomatrix in
   burn-model
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Silk fibroin; Wound healing; Electrospinning
ID IN-VITRO; GROWTH-FACTOR; CELLS; RATS; SKIN; BIOMATERIALS; SCAFFOLDS;
   TISSUES; PROTEIN; FILMS
AB Silk fibroin has recently become an important biomaterial for tissue engineering application. In this study, silk fibroin nanomatrix was fabricated by electrospinning and evaluated as wound dressing material in a burn rat model. The wound size reduction, histological examination, and the quantification of transforming growth factor TGF-beta 1 and interleukin IL-1 alpha, 6, and 10 were measured to evaluate the healing effects. The silk fibroin nanomatrix treatment exhibited effective performance in decreasing the wound size and epithelialization. Histological finding also revealed that the deposition of collagen in the dermis was organized by covering the wound area in the silk fibroin nanomatrix treated group. The expression level of pro-inflammatory cytokine (IL-1 alpha) was significantly reduced in the injured skin following the silk fibroin nanomatrix treatment compared to the medical gauze (control) at 7 days after burn. Also, the expression level of TGF-beta 1 in the wound treated with silk fibroin nanomatrix peaked 21-days post-treatment whereas expression level of TGF-beta 1 was highest at day 7 in the gauze treated group. In conclusion, this data demonstrates that silk fibroin nanomatrix enhances the burn wound healing, suggesting it is a good candidate for burn wound treatment. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ju, Hyung Woo; Lee, Ok Joo; Lee, Jung Min; Moon, Bo Mi; Park, Hyun Jung; Park, Ye Ri; Lee, Min Chae; Kim, Soo Hyeon; Park, Chan Hum] Hallym Univ, Nanobio Regenerat Med Inst, 1 Hallymdaehak Gil, Chunchon 200702, Gangwon Do, South Korea.
   [Chao, Janet Ren] George Washington Univ, Sch Med, Washington, DC 20037 USA.
   [Ki, Chang Seok] Indiana Univ Purdue Univ, Purdue Sch Engn, Dept Biomed Engn, Indianapolis, IN 46202 USA.
   [Park, Chan Hum] Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 77 Sakju Ro, Chunchon 200704, Gangwon Do, South Korea.
RP Park, CH (reprint author), Hallym Univ, Nanobio Regenerat Med Inst, 1 Hallymdaehak Gil, Chunchon 200702, Gangwon Do, South Korea.
EM hlpch@paran.com
FU Hallym university research fund; National Research Foundation of
   Korea(NRF) - Korea government(MSIP), Republic of Korea.
   [NRF-2015R1A4A1041631]
FX This work was supported by Hallym university research fund and the
   National Research Foundation of Korea(NRF) grant funded by the Korea
   government(MSIP) (NRF-2015R1A4A1041631), Republic of Korea.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arturson G, 1996, BURNS, V22, P255, DOI 10.1016/0305-4179(95)00153-0
   Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Guang SY, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42503
   Gurfinkel R, 2010, ACAD EMERG MED, V17, P514, DOI 10.1111/j.1553-2712.2010.00736.x
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kim DW, 2011, J NEUROSURG, V114, P485, DOI 10.3171/2010.9.JNS091764
   Kim YS, 2010, J KOREAN MED SCI, V25, P589, DOI 10.3346/jkms.2010.25.4.589
   Lee JH, 2010, INT J TISSUE REGEN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0015394
   Lee OJ, 2014, J BIOMED NANOTECHNOL, V10, P1294, DOI 10.1166/jbn.2014.1818
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Molan Peter C, 2002, Ostomy Wound Manage, V48, P28
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Mori H, 2000, J Biotechnol, V74, P95
   Nall A. V., 1996, OTOLARYNGOLOGY, V122, P171
   PEJNOVIC N, 1995, ARCH SURG-CHICAGO, V130, P999
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Shan YH, 2015, INT J PHARMACEUT, V479, P291, DOI 10.1016/j.ijpharm.2014.12.067
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Sigal LH, 2004, JCR-J CLIN RHEUMATOL, V10, P353, DOI 10.1097/01.rhu.0000147138.11053.e4
   Singer AJ, 2007, ACAD EMERG MED, V14, P1125, DOI 10.1197/j.aem.2007.07.012
   Singer AJ, 2000, ACAD EMERG MED, V7, P1, DOI 10.1111/j.1553-2712.2000.tb01881.x
   Srivastava CM, 2015, FIBER POLYM, V16, P1020, DOI 10.1007/s12221-015-1020-y
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Upadhyay NK, 2009, FOOD CHEM TOXICOL, V47, P1146, DOI 10.1016/j.fct.2009.02.002
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang RJ, 2000, WOUND REPAIR REGEN, V8, P128, DOI 10.1046/j.1524-475x.2000.00128.x
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
   Zhang X, 2012, EXP THER MED, V3, P9, DOI 10.3892/etm.2011.367
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
NR 45
TC 27
Z9 27
U1 6
U2 93
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2016
VL 85
BP 29
EP 39
DI 10.1016/j.ijbiomac.2015.12.055
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DE8LF
UT WOS:000370886800005
PM 26718866
DA 2018-10-20
ER

PT J
AU Kim, SH
   Park, HS
   Lee, OJ
   Chao, JR
   Park, HJ
   Lee, JM
   Ju, HW
   Moon, BM
   Park, YR
   Song, JE
   Khang, G
   Park, CH
AF Kim, Soo Hyeon
   Park, Hae Sang
   Lee, Ok Joo
   Chao, Janet Ren
   Park, Hyun Jung
   Lee, Jung Min
   Ju, Hyung Woo
   Moon, Bo Mi
   Park, Ye Ri
   Song, Jeong Eun
   Khang, Gilson
   Park, Chan Hum
TI Fabrication of duck's feet collagen-silk hybrid biomaterial for tissue
   engineering
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Collagen; Duck's feet; Silk
ID FIBROIN; MEMBRANES; MATRIX
AB Collagen constituting the extracellular matrix has been widely used as biocompatible material for human use. In this study, we have selected duck's feet for extracting collagen. A simple method not utilizing harsh chemical had been employed to extract collagen from duck's feet. We fabricated duck's feet collagen/silk hybrid scaffold for the purpose of modifying the degradation rate of duck's feet collagen. This study suggests that extracted collagen from duck's feet is biocompatible and resembles collagen extracted from porcine which is commercially used. Duck's feet collagen is also economically feasible and it could therefore be a good candidate as a tissue engineering material. Further, addition of silk to fabricate a duck's feet collagen/silk hybrid scaffold could enhance the biostability of duck's feet collagen scaffold. Duck's feet collagen/silk scaffold increased the cell viability compared to silk alone. Animal studies also showed that duck's feet collagen/silk scaffold was more biocompatible than silk alone and more biostable than duck's feet or porcine collagen alone. Additionally, the results revealed that duck's feet collagen/silk hybrid scaffold had high porosity, cell infiltration and proliferation. We suggest that duck's feet collagen/silk hybrid scaffold could be used as a dermal substitution for full thickness skin defects. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kim, Soo Hyeon; Park, Hae Sang; Lee, Ok Joo; Park, Hyun Jung; Lee, Jung Min; Ju, Hyung Woo; Moon, Bo Mi; Park, Ye Ri; Park, Chan Hum] Hallym Univ, Sch Med, Nanobio Regenerat Med Inst, Chunchon 200702, Gangwon Do, South Korea.
   [Park, Hae Sang; Park, Chan Hum] Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 77 Sakju Ro, Chunchon 200704, Gangwon Do, South Korea.
   [Chao, Janet Ren] George Washington Univ, Sch Med, Washington, DC 20037 USA.
   [Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Technol, Dept Polymer Nano Sci &Technol, 567 Baekje Daero, Jeonju 561756, South Korea.
   [Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Polymer BIN Res Ctr, 567 Baekje Daero, Jeonju 561756, South Korea.
RP Park, CH (reprint author), Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 77 Sakju Ro, Chunchon 200704, Gangwon Do, South Korea.; Park, CH (reprint author), Hallym Univ, Nanobio Regenerat Med Inst, 1 Hallymdaehak Gil, Chunchon 200702, Gangwon Do, South Korea.
EM hlpch@paran.com
RI song, jeong eun/P-9106-2015; Park, Chan Hum/C-6848-2016
OI song, jeong eun/0000-0001-6879-7616; 
FU Hallym University Research Fund; Technology Commercialization Support
   Program, Ministry for Food, Agriculture, Forestry and Fisheries,
   Republic of Korea [814005-03-2-HD030]
FX This work was supported by a grant from Hallym University Research Fund
   and Technology Commercialization Support Program (814005-03-2-HD030),
   Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
   Korea.
CR Bi FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125900
   Bottcher-Haberzeth S, 2012, PEDIATR SURG INT, V28, P171, DOI 10.1007/s00383-011-2990-5
   Cha S.R., 2014, INT J TISSUE REGEN, V5, P84
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Hashim P., 2014, INT J BIOL FOOD VET, V8, P242
   Ko H.A., 2012, INT J TISSUE REGEN, V3, P103
   Lee OJ, 2014, J BIOMED NANOTECHNOL, V10, P1294, DOI 10.1166/jbn.2014.1818
   Lee OJ, 2012, J BIOMED MATER RES A, V100A, P2018, DOI 10.1002/jbm.a.33308
   Lee S.E., 2014, INT J TISSUE REGEN, V5, P103
   Liu DC, 2001, ASIAN AUSTRAL J ANIM, V14, P1638, DOI 10.5713/ajas.2001.1638
   Long K, 2015, J BIOMED MATER RES A, V103, P1159, DOI 10.1002/jbm.a.35268
   Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Silva TH, 2014, MAR DRUGS, V12, P5881, DOI 10.3390/md12125881
   Sun Kai, 2015, Eur J Orthop Surg Traumatol, V25, P243, DOI 10.1007/s00590-014-1515-z
   Tang J, 2015, INT J ARTIF ORGANS, V38, P105, DOI 10.5301/ijao.5000392
   Wei GJ, 2015, INT UROL NEPHROL, V47, P95, DOI 10.1007/s11255-014-0854-3
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 20
TC 15
Z9 17
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2016
VL 85
BP 442
EP 450
DI 10.1016/j.ijbiomac.2015.12.086
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DE8LF
UT WOS:000370886800052
PM 26748068
DA 2018-10-20
ER

PT J
AU Lalhmunsiama
   Lalchhingpuii
   Nautiyal, BP
   Tiwari, D
   Choi, SI
   Kong, SH
   Lee, SM
AF Lalhmunsiama
   Lalchhingpuii
   Nautiyal, B. P.
   Tiwari, Diwakar
   Choi, S. I.
   Kong, Sung-Ho
   Lee, Seung-Mok
TI Silane grafted chitosan for the efficient remediation of aquatic
   environment contaminated with arsenic(V)
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Hybrid biomaterials; Chitosan; Silane grafted chitosan; As(V); Column
   reactor
ID ACTIVATED CARBON; MESOPOROUS SILICA; AQUEOUS-SOLUTIONS; COPPER(II) IONS;
   HEAVY-METALS; WHEAT-STRAW; WASTE-WATER; DYE REMOVAL; ADSORPTION; BEADS
AB Hypothesis: Chitosan, naturally abundant biomaterial showed an insignificant affinity toward arsenate. The incorporation of organosilane could improve the physical and chemical properties of chitosan for the efficient removal of arsenate from aquatic environment.
   Experiment: The hybrid materials were obtained by grafting the natural biopolymer chitosan with 3mercaptopropyl trimethoxysilane (CHMS) and trimethoxy-octylsilane (CHTS). The hybrid materials along with bare chitosan were characterized with SEM EDX, FT-IR and BET specific surface area analyses and the solid materials were further employed in the efficient remediation of aqueous solutions contaminated with As(V) under batch and column reactor operations.
   Findings: The hybrid materials showed an extremely high percentage of As(V) removal compared to bare chitosan within a wide range of pH. As(V) was aggregated rapidly onto the solid surfaces and relatively high percent removal of As(V) was achieved in a wide range of As(V) initial concentrations. Moreover, As(V) was bound with, relatively, weaker forces and forming an 'outer sphere complexes' at the surface of solids. The presence of co-existing ions could not significantly affect the removal of As(V) from aqueous solutions. Furthermore, breakthrough data confirmed that these two hybrid materials possessed significantly high loading capacity of As(V) even under dynamic conditions. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Lalhmunsiama; Lee, Seung-Mok] Catholic Kwandong Univ, Dept Environm Engn, 522 Naegok Dong, Kangnung 210701, South Korea.
   [Lalchhingpuii; Tiwari, Diwakar] Mizoram Univ, Sch Phys Sci, Dept Chem, Aizawl 796004, India.
   [Nautiyal, B. P.] Mizoram Univ, Dept Hort Aromat & Med Plant, Aizawl 796004, India.
   [Choi, S. I.] Kwangwoon Univ, Dept Environm Engn, Seoul 139701, South Korea.
   [Kong, Sung-Ho] Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea.
RP Lee, SM (reprint author), Catholic Kwandong Univ, Dept Environm Engn, 522 Naegok Dong, Kangnung 210701, South Korea.; Kong, SH (reprint author), Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea.
EM shkong@hanyang.ac.kr; leesm@cku.ac.kr
FU Korea Ministry of Environment as "Converging technology project"
   [2013001450001]
FX This work was supported by the Korea Ministry of Environment as
   "Converging technology project" (Proposal No. 2013001450001).
CR Adak A, 2006, DYES PIGMENTS, V69, P245, DOI 10.1016/j.dyepig.2005.03.009
   BERTOLUZZA A, 1982, J NON-CRYST SOLIDS, V48, P117, DOI 10.1016/0022-3093(82)90250-2
   Boamah PO, 2015, ECOTOX ENVIRON SAFE, V116, P113, DOI 10.1016/j.ecoenv.2015.01.012
   Boddu VM, 2008, WATER RES, V42, P633, DOI 10.1016/j.watres.2007.08.014
   Cao CH, 2015, APPL SURF SCI, V333, P110, DOI 10.1016/j.apsusc.2015.02.002
   Chammui Y, 2014, CHEM ENG J, V240, P202, DOI 10.1016/j.cej.2013.11.083
   Chandra V, 2010, ACS NANO, V4, P3979, DOI 10.1021/nn1008897
   Chen CY, 2008, BIORESOURCE TECHNOL, V99, P7487, DOI 10.1016/j.biortech.2008.02.015
   Chuang CL, 2005, CHEMOSPHERE, V61, P478, DOI 10.1016/j.chemosphere.2005.03.012
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   Dambies L, 2000, COLLOID SURFACE A, V170, P19, DOI 10.1016/S0927-7757(00)00484-2
   Dang VBH, 2009, BIORESOURCE TECHNOL, V100, P211, DOI 10.1016/j.biortech.2008.05.031
   Dominguez-Gonzalez R, 2014, TALANTA, V118, P262, DOI 10.1016/j.talanta.2013.10.029
   Elwakeel K. Z., 2013, INT J ENVIRON SCI TE, V11, P1051
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Gong XJ, 2015, INT BIODETER BIODEGR, V102, P256, DOI 10.1016/j.ibiod.2015.01.007
   Gupta A, 2009, WATER RES, V43, P3862, DOI 10.1016/j.watres.2009.05.040
   HAYES KF, 1988, J COLLOID INTERF SCI, V125, P717, DOI 10.1016/0021-9797(88)90039-2
   Hossain MA, 2012, BIORESOURCE TECHNOL, V121, P386, DOI 10.1016/j.biortech.2012.06.119
   Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X
   Koonsom Titima, 2014, Environmental Engineering Research, V19, P241
   Lalhmunsiama, 2015, J ENVIRON RADIOACTIV, V147, P76
   Lalhmunsiama C. Lalhriatpuia, 2014, APPL SURF SCI, V321, P275
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lee MY, 2005, INT J BIOL MACROMOL, V36, P152, DOI 10.1016/j.ijbiomac.2005.05.004
   Lee SM, 2015, CHEM ENG J, V270, P496, DOI 10.1016/j.cej.2015.02.053
   Lee SM, 2014, ENVIRON SCI POLLUT R, V21, P3686, DOI 10.1007/s11356-013-2310-9
   Li GL, 2013, J COLLOID INTERF SCI, V405, P164, DOI 10.1016/j.jcis.2013.05.055
   Li YR, 2010, J HAZARD MATER, V177, P131, DOI 10.1016/j.jhazmat.2009.12.006
   Machida M, 2012, APPL SURF SCI, V258, P7389, DOI 10.1016/j.apsusc.2012.04.042
   Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006
   Pontoni L, 2012, CARBOHYD RES, V356, P86, DOI 10.1016/j.carres.2012.03.042
   Rivera-Utrilla J, 2001, J CHEM TECHNOL BIOT, V76, P1209, DOI 10.1002/jctb.506
   Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009
   Rusmin R, 2015, APPL SURF SCI, V353, P363, DOI 10.1016/j.apsusc.2015.06.124
   Silva SS, 2005, J MATER CHEM, V15, P3952, DOI 10.1039/b505875a
   Thanhmingliana, 2014, RSC ADV, V4, P43921
   Thomas HC, 1944, J AM CHEM SOC, V66, P1664, DOI 10.1021/ja01238a017
   Tian Y, 2011, J HAZARD MATER, V193, P10, DOI 10.1016/j.jhazmat.2011.04.093
   TINWELL H, 1991, ENVIRON HEALTH PERSP, V95, P205, DOI 10.2307/3431125
   Tiwari Diwakar, 2014, Environmental Engineering Research, V19, P107, DOI 10.4491/eer.2014.19.1.107
   Tiwari D, 2012, CHEM ENG J, V204, P23, DOI 10.1016/j.cej.2012.07.086
   Vakili M, 2014, CARBOHYD POLYM, V113, P115, DOI 10.1016/j.carbpol.2014.07.007
   Vipin AK, 2014, CARBOHYD POLYM, V111, P477, DOI 10.1016/j.carbpol.2014.04.037
   Wang JL, 2014, BIORESOURCE TECHNOL, V160, P129, DOI 10.1016/j.biortech.2013.12.110
   WanNgah W. S., 2011, CARBOHYD POLYM, V83, P1446, DOI DOI 10.1016/J.CARBPOL.2010.11.004
   Yamani JS, 2012, WATER RES, V46, P4427, DOI 10.1016/j.watres.2012.06.004
   Yang T, 2012, ENVIRON SCI TECHNOL, V46, P2251, DOI 10.1021/es204034z
   Yokohira M, 2010, TOXICOL APPL PHARM, V246, P1, DOI 10.1016/j.taap.2010.04.013
   Zavareh S, 2015, CHEM ENG J, V273, P610, DOI 10.1016/j.cej.2015.03.112
NR 50
TC 7
Z9 9
U1 4
U2 53
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 1
PY 2016
VL 467
BP 203
EP 212
DI 10.1016/j.jcis.2016.01.019
PG 10
WC Chemistry, Physical
SC Chemistry
GA DE7QP
UT WOS:000370832100024
PM 26802278
DA 2018-10-20
ER

PT J
AU Cabrejos-Azama, J
   Alkhraisat, MH
   Rueda, C
   Torres, J
   Pintado, C
   Blanco, L
   Lopez-Cabarcos, E
AF Cabrejos-Azama, Jatsue
   Hamdan Alkhraisat, Mohammad
   Rueda, Carmen
   Torres, Jesus
   Pintado, Concepcion
   Blanco, Luis
   Lopez-Cabarcos, Enrique
TI Magnesium substitution in brushite cements: Efficacy of a new
   biomaterial loaded with vancomycin for the treatment of Staphylococcus
   aureus infections
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Drug delivery; Magnesium; Newberyite; Calcium phosphate cement;
   Vancomycin; Staphylococcus aureus
ID CALCIUM-PHOSPHATE CEMENT; CEFUROXIME-IMPREGNATED CEMENT; VERTICAL BONE
   AUGMENTATION; TOTAL KNEE ARTHROPLASTY; IN-VITRO; TRICALCIUM PHOSPHATE;
   RELEASE; OSTEOMYELITIS; SYSTEM; APATITE
AB Staphylococcus aureus is the most relevant pathogen associated with bone infection that sometimes appears after implant surgery, thus compromising a successful treatment. The aim of this work was to assess the effectiveness of brushite cements, doped with magnesium, as a new vancomycin carrier system against S. aureus infections. We performed an "in vitro" study to evaluate vancomycin release from the cements by measuring its antimicrobial activity against a strain of S. aureus. We have used two methods to load the cements with vancomycin: i) adsorption from a solution and ii) incorporation of the antibiotic into the solid phase during the cement synthesis. Furthermore, the compression strength of the loaded samples was measured to detect changes in the mechanical properties of the system.
   The "in vitro" study showed that the sustained release of vancomycin depends on the concentration of magnesium in the cement matrix. In addition, the standardized antibacterial assay revealed that the release of vancomycin from the cements may be helpful to prevent infections in bone regeneration procedures. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Cabrejos-Azama, Jatsue; Hamdan Alkhraisat, Mohammad; Rueda, Carmen; Lopez-Cabarcos, Enrique] UCM, Fac Farm, Dept Quim Fis 2, Madrid, Spain.
   [Cabrejos-Azama, Jatsue; Torres, Jesus; Blanco, Luis] UCM, Fac Odontol, Dept Estomatol 3, Madrid, Spain.
   [Pintado, Concepcion] UCM, Fac Farm, Dept Microbiol 2, Madrid, Spain.
RP Cabrejos-Azama, J (reprint author), UCM, Fac Farm, Dept Quim Fis 2, Madrid, Spain.
EM jacaza@farm.ucm.es
OI Alkhraisat, Mohammad/0000-0003-4422-4527; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209
FU Spanish MINECO [MAT2014-55065R]; UCM-BSCH [911033]; EU COST Action
   [CM1101]
FX The authors acknowledge financial support from the Spanish MINECO grant
   (MAT2014-55065R), the UCM-BSCH grant to research group 911033, and the
   EU COST Action CM1101.
CR Alkhralsat MH, 2008, ACTA BIOMATER, V4, P664, DOI 10.1016/j.actbio.2007.12.001
   Barth RE, 2011, INT J ANTIMICROB AG, V38, P371, DOI 10.1016/j.ijantimicag.2011.03.008
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   Cabrejos-Azama J, 2014, MAT SCI ENG C-MATER, V43, P403, DOI 10.1016/j.msec.2014.06.036
   Chilukuri DM, 2005, PHARM RES, V22, P563, DOI 10.1007/s11095-005-2492-z
   Chiu FY, 2001, J BONE JOINT SURG BR, V83B, P691, DOI 10.1302/0301-620X.83B5.11737
   Chiu FY, 2002, J BONE JOINT SURG AM, V84A, P759, DOI 10.2106/00004623-200205000-00009
   CORNELL CN, 1993, J ORTHOPAED RES, V11, P619, DOI 10.1002/jor.1100110502
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Creedon A, 1999, BRIT J NUTR, V82, P63, DOI 10.1017/S0007114599001130
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   Esteban J, 2011, EXPERT OPIN PHARMACO, V12, P899, DOI 10.1517/14656566.2011.543676
   Ferraris S, 2010, J APPL BIOMATER BIOM, V8, P166, DOI 10.5301/JABB.2010.6068
   Gay E.C., 2003, TRATADO CIRUGIA BUCA
   Generosi A, 2008, MATER RES BULL, V43, P561, DOI 10.1016/j.materresbull.2007.04.016
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Grover LM, 2005, J AM CERAM SOC, V88, P3096, DOI [10.1111/j.1551-2916.2005.00558.x, 10.1111/j.1551-2916.2005.00566.x]
   Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R
   Alkhraisat MH, 2010, ACTA BIOMATER, V6, P1522, DOI 10.1016/j.actbio.2009.10.043
   Alkhraisat MH, 2013, MAT SCI ENG C-MATER, V33, P475, DOI 10.1016/j.msec.2012.09.017
   Hou CH, 2009, BIOMATERIALS, V30, P4700, DOI 10.1016/j.biomaterials.2009.05.018
   Ji C, 2010, J KOREAN NEUROSURG S, V47, P180, DOI 10.3340/jkns.2010.47.3.180
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Kannan S, 2005, J SOLID STATE CHEM, V178, P3190, DOI 10.1016/j.jssc.2005.08.003
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Lagier R, 2003, PATHOL RES PRACT, V199, P329, DOI 10.1078/0344-0338-00425
   Liu C, 2011, CLIN INFECT DIS, V52, pE18, DOI 10.1093/cid/ciq146
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Maenz S, 2014, J MECH BEHAV BIOMED, V39, P328, DOI 10.1016/j.jmbbm.2014.07.028
   Mayer I, 1997, J INORG BIOCHEM, V66, P1, DOI 10.1016/S0162-0134(96)00145-6
   Miclau T, 2010, J ORTHOP TRAUMA, V24, P583, DOI 10.1097/BOT.0b013e3181eebf12
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Mohamed W., 2014, EUR CELLS MATER, V23, P258
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   Obadia L, 2003, BIOMATERIALS, V24, P1265, DOI 10.1016/S0142-9612(02)00446-5
   Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749
   Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712
   Scott CP, 2003, J BIOMED MATER RES B, V64B, P94, DOI 10.1002/jbm.b.10515
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Soundrapandian C, 2007, CRIT REV THER DRUG, V24, P493, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i6.10
   Tamimi F, 2008, J BIOMED MATER RES A, V85A, P707, DOI 10.1002/jbm.a.31610
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Tamimi F, 2009, BIOMATERIALS, V30, P208, DOI 10.1016/j.biomaterials.2008.09.032
   Marinno FT, 2007, J BIOMED MATER RES A, V81A, P93, DOI 10.1002/jbm.a.31014
   Thomazeau H, 1997, Chirurgie, V121, P663
   Tran PA, 2009, J MATER CHEM, V19, P2653, DOI 10.1039/b814334j
   United States Pharmacopeial Convention Inc, 2001, US PHARM 25 NAT FORM
   Wen CY, 2009, J BIOMED MATER RES B, V89B, P466, DOI 10.1002/jbm.b.31236
NR 54
TC 3
Z9 3
U1 3
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 72
EP 78
DI 10.1016/j.msec.2015.10.092
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600011
PM 26838826
DA 2018-10-20
ER

PT J
AU Zhu, D
   Cheng, HH
   Li, JN
   Zhang, WW
   Shen, YY
   Chen, SJ
   Ge, ZC
   Chen, SG
AF Zhu, Dan
   Cheng, Honghao
   Li, Jianna
   Zhang, Wenwen
   Shen, Yuanyuan
   Chen, Shaojun
   Ge, Zaochuan
   Chen, Shiguo
TI Enhanced water-solubility and antibacterial activity of novel chitosan
   derivatives modified with quaternary phosphonium salt
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Chitosan; Quaternary phosphonium; Antibacterial; Water solubility
ID ANTIMICROBIAL ACTIVITY; DRUG-DELIVERY; GENE DELIVERY; NANOPARTICLES;
   NANOCOMPOSITES; SILVER
AB Chitosan (CS) has been widely recognized as an important biomaterial due to its good antimicrobial activity, biocompatibility and biodegradability. However, CS is insoluble in water in neutral and alkaline aqueous solution due to the linear aggregation of chain molecules and the formation of crystallinity. This is one of the key factors that limit its practical applications. Therefore, improving the solubility of CS in neutral and alkaline aqueous solution is a primary research direction for biomedical applications. In this paper, a reactive antibacterial compound (4-(2,5-Dioxo-pyrrolidin-1-yloxycarbonyl)-benzyl)-triphenyl-phosphonium bromide (NHS-QPS) was synthesized for chemical modification of CS, and a series of novel polymeric antimicrobial agents, N-quaternary phosphonium chitosan derivatives (N-QPCSxy, x = 1-2,y = 1-4) were obtained. The water solubilities and antibacterial activities of N-QPCSxy against Escherichia coli and Staphylococcus aureus were evaluated compare to CS. The water solubility of N-QPCSxy was all better than that of CS at neutral pH aqueous solution, particularly, N-QPCS14 can be soluble in water over the pH range of 3 to 12. The antibacterial activities of CS derivatives were improved by introducing quaternary phosphonium salt, and antibacterial activity of N-QPCSxy increases with degree of substitution. Overall, N-QPCS14 represents a novel antibacterial polymer material with good antibacterial activity, waters solubility and low cytotoxicity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhu, Dan; Cheng, Honghao; Chen, Shaojun; Ge, Zaochuan; Chen, Shiguo] Shenzhen Univ, Coll Mat Sci & Engn, Nanshan Dist Key Lab Biopolymers & Safety Evaluat, Shenzhen 518060, Peoples R China.
   [Li, Jianna; Shen, Yuanyuan] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.
   [Zhang, Wenwen] N Carolina State Univ, Raleigh, NC 27695 USA.
RP Chen, SG (reprint author), Shenzhen Univ, Coll Mat Sci & Engn, Nanshan Dist Key Lab Biopolymers & Safety Evaluat, Shenzhen 518060, Peoples R China.
EM csg@szu.edu.cn
RI chen, shiguo/J-3076-2014
OI chen, shiguo/0000-0002-5338-690X
FU Natural Science Foundation of China [51573097]; Natural Science
   Foundation of Guangdong Province [S2013010013056]; Science and
   Technology Project of Guangdong Province [2015A010105033]; Collaborative
   Innovation and Technology Project for Shenzhen-Hong Kong Innovation
   Circle of Shenzhen city [SGLH20120926161415782]; Science and Technology
   Project of Shenzhen City [JCYJ 20120613090936342]; Nanshan District Key
   lab for Biopolymers and safety evaluation [KC2014ZDZJ0001A]
FX We gratefully acknowledge financial support from the Natural Science
   Foundation of China (Grant 51573097), the Natural Science Foundation of
   Guangdong Province (Grant S2013010013056), the Science and Technology
   Project of Guangdong Province (Grant 2015A010105033), the Collaborative
   Innovation and Technology Project for Shenzhen-Hong Kong Innovation
   Circle of Shenzhen city (Grant SGLH20120926161415782), the Science and
   Technology Project of Shenzhen City (Grant JCYJ 20120613090936342), and
   Nanshan District Key lab for Biopolymers and safety evaluation (No.
   KC2014ZDZJ0001A).
CR Ambrogi V, 2014, J MATER CHEM B, V2, P6054, DOI 10.1039/c4tb00927d
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Cao CH, 2013, APPL SURF SCI, V271, P105, DOI 10.1016/j.apsusc.2013.01.135
   Casettari L, 2014, J CONTROL RELEASE, V190, P189, DOI 10.1016/j.jconrel.2014.05.003
   Chen SG, 2014, CHEM ENG J, V256, P238, DOI 10.1016/j.cej.2014.07.006
   Chen SG, 2012, J MATER CHEM, V22, P9092, DOI 10.1039/c2jm00063f
   Chen SG, 2011, ACS APPL MATER INTER, V3, P1154, DOI 10.1021/am101275d
   Chen SG, 2011, COLLOID SURFACE B, V85, P323, DOI 10.1016/j.colsurfb.2011.03.004
   Chen YZ, 2014, TETRAHEDRON, V70, P1748, DOI 10.1016/j.tet.2014.01.035
   Chivangkul T, 2014, CARBOHYD POLYM, V108, P224, DOI 10.1016/j.carbpol.2014.02.078
   Guo AJ, 2014, INT J BIOL MACROMOL, V67, P163, DOI 10.1016/j.ijbiomac.2014.03.024
   Hu LM, 2013, NANOSCALE, V5, P3103, DOI 10.1039/c3nr00338h
   Kuete V, 2008, J ETHNOPHARMACOL, V120, P17, DOI 10.1016/j.jep.2008.07.026
   Liang XF, 2013, LANGMUIR, V29, P8683, DOI 10.1021/la401166v
   Liong M, 2009, ADV MATER, V21, P1684, DOI 10.1002/adma.200802646
   Liu BJ, 2013, CHEM ENG J, V220, P412, DOI 10.1016/j.cej.2013.01.071
   Lu Y, 2014, BIOMATERIALS, V35, P1716, DOI 10.1016/j.biomaterials.2013.11.015
   Moura LIF, 2014, ACTA BIOMATER, V10, P843, DOI 10.1016/j.actbio.2013.09.040
   Regiel-Futyra A, 2015, ACS APPL MATER INTER, V7, P1087, DOI 10.1021/am508094e
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Sahariah P, 2015, BIOMACROMOLECULES, V16, P1449, DOI 10.1021/acs.biomac.5b00163
   Shi BY, 2013, POLYM CHEM-UK, V4, P840, DOI 10.1039/c2py20494k
   Torabi S, 2016, MAT SCI ENG C-MATER, V59, P1, DOI 10.1016/j.msec.2015.09.096
   Wang L, 2011, INT J BIOL MACROMOL, V48, P375, DOI 10.1016/j.ijbiomac.2010.12.006
   Wen Y, 2015, MAT SCI ENG C-MATER, V48, P220, DOI 10.1016/j.msec.2014.11.066
   Wiarachai O, 2012, COLLOID SURFACE B, V92, P121, DOI 10.1016/j.colsurfb.2011.11.034
   Xu JK, 2015, BIOMATERIALS, V37, P395, DOI 10.1016/j.biomaterials.2014.10.024
   Yao DD, 2013, POLYMER, V54, P3485, DOI 10.1016/j.polymer.2013.05.005
   Zhang W, 2008, J APPL POLYM SCI, V108, P2958, DOI 10.1002/app.27610
   Zhang WW, 2015, J POLYM SCI POL CHEM, V53, P1594, DOI 10.1002/pola.27592
   Zhou PY, 2014, BIOMATERIALS, V35, P10033, DOI 10.1016/j.biomaterials.2014.09.009
   Zhuang PY, 2012, INT J BIOL MACROMOL, V50, P658, DOI 10.1016/j.ijbiomac.2012.01.026
NR 32
TC 40
Z9 41
U1 12
U2 117
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 79
EP 84
DI 10.1016/j.msec.2015.12.024
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600012
PM 26838827
DA 2018-10-20
ER

PT J
AU Naleway, SE
   Fickas, KC
   Maker, YN
   Meyers, MA
   McKittrick, J
AF Naleway, Steven E.
   Fickas, Kate C.
   Maker, Yajur N.
   Meyers, Marc A.
   McKittrick, Joanna
TI Reproducibility of ZrO2-based freeze casting for biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Freeze casting; Bioinspired; Biomaterial; Statistical analysis;
   Reproducibility; Mechanical properties
ID POROUS ALUMINA; PRESSURELESS INFILTRATION; COMPOSITES; CERAMICS; TOUGH;
   FABRICATION; SCAFFOLDS
AB The processing technique of freeze casting has been intensely researched for its potential to create porous scaffold and infiltrated composite materials for biomedical implants and structural materials. However, in order for this technique to be employed medically or commercially, it must be able to reliably produce materials in great quantities with similar microstructures and properties. Here we investigate the reproducibility of the freeze casting process by independently fabricating three sets of eight ZrO2-epoxy composite scaffolds with the same processing conditions but varying solid loading (10, 15 and 20 vol.%). Statistical analyses (One-way ANOVA and Tukey's HSD tests) run upon measurements of the microstructural dimensions of these composite scaffold sets show that, while the majority of microstructures are similar, in all cases the composite scaffolds display statistically significant variability. In addition, composite scaffolds where mechanically compressed and statistically analyzed. Similar to the microstructures, almost all of their resultant properties displayed significant variability though most composite scaffolds were similar. These results suggest that additional research to improve control of the freeze casting technique is required before scaffolds and composite scaffolds can reliably be reproduced for commercial or medical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Naleway, Steven E.; Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Mat Sci & Engn Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Fickas, Kate C.] Oregon State Univ, Dept Forest Ecosyst & Soc, 321 Richardson Hall, Corvallis, OR 97331 USA.
   [Maker, Yajur N.] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Dept Mech & Aerosp Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Meyers, Marc A.] Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
RP Naleway, SE (reprint author), Univ Calif San Diego, Mat Sci & Engn Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM snaleway@eng.ucsd.edu; kate.fickas@oregonstate.edu; ymaker@eng.ucsd.edu;
   mameyers@eng.ucsd.edu; jmckittrick@eng.ucsd.edu
RI Naleway, Steven/K-3497-2016; Meyers, Marc/A-2970-2016
OI Naleway, Steven/0000-0001-9413-0399; Meyers, Marc/0000-0003-1698-5396;
   McKittrick, Joanna/0000-0002-1442-3472
FU Multi-University Research Initiative through the Air Force Office of
   Scientific Research of the United States [AFOSR-FA9550-15-1-0009]
FX This work is supported by a Multi-University Research Initiative through
   the Air Force Office of Scientific Research of the United States
   (AFOSR-FA9550-15-1-0009). The authors wish to acknowledge Dr. Antoni
   Tomsia for generously introducing us to the freeze casting process and
   Michael B. Frank, Christopher F. Yu, Rachel Hsiong and Michael Ix for
   their help with the freeze casting process.
CR Albakry M, 2003, J DENT, V31, P181, DOI 10.1016/S0300-5712(03)00025-3
   Binner J, 2009, J EUR CERAM SOC, V29, P837, DOI 10.1016/j.jeurceramsoc.2008.07.034
   Bouville F, 2014, NAT MATER, V13, P508, DOI [10.1038/NMAT3915, 10.1038/nmat3915]
   Chen HM, 2014, CERAM INT, V40, P6293, DOI 10.1016/j.ceramint.2013.11.088
   CHUN KJ, 2014, J DENT BIOMECH, V5, P1
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Deville S, 2013, J MATER RES, V28, P2202, DOI 10.1557/jmr.2013.105
   Deville S, 2010, MATERIALS, V3, P1913, DOI 10.3390/ma3031913
   Deville S, 2010, J AM CERAM SOC, V93, P2507, DOI 10.1111/j.1551-2916.2010.03840.x
   Deville S, 2009, J AM CERAM SOC, V92, P2489, DOI 10.1111/j.1551-2916.2009.03163.x
   Manhart J, 2000, J BIOMED MATER RES, V53, P353, DOI 10.1002/1097-4636(2000)53:4<353::AID-JBM9>3.0.CO;2-B
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Munch E, 2009, J AM CERAM SOC, V92, P1534, DOI 10.1111/j.1551-2916.2009.03087.x
   Naleway SE, 2015, MATER DESIGN, V71, P62, DOI 10.1016/j.matdes.2015.01.010
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Porter M.M., 2014, THESIS U CALIFORNIA
   Porter MM, 2015, COMPOS STRUCT, V119, P174, DOI 10.1016/j.compstruct.2014.08.033
   Porter MM, 2014, AM CERAM SOC BULL, V93, P18
   Porter MM, 2013, JOM-US, V65, P720, DOI 10.1007/s11837-013-0606-3
   Porter MM, 2012, MAT SCI ENG A-STRUCT, V556, P741, DOI 10.1016/j.msea.2012.07.058
   Porter MM, 2013, ADV FUNCT MATER, V24, P1978
   Rao BS, 2001, J MATER RES, V16, P2906, DOI 10.1557/JMR.2001.0399
   Tabachnick B. G., 2013, USING MULTIVARIATE S
   Tang YF, 2014, J EUR CERAM SOC, V34, P4077, DOI 10.1016/j.jeurceramsoc.2014.05.040
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]
   Wegst UGK, 2010, PHILOS T R SOC A, V368, P2099, DOI 10.1098/rsta.2010.0014
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
NR 30
TC 20
Z9 21
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 105
EP 112
DI 10.1016/j.msec.2015.12.012
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600015
PM 26838830
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wers, E
   Lefeuvre, B
   Pellen-Mussi, P
   Novella, A
   Oudadesse, H
AF Wers, E.
   Lefeuvre, B.
   Pellen-Mussi, P.
   Novella, A.
   Oudadesse, H.
TI New method of synthesis and in vitro studies of a porous biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biointerface; Surface; Bioglass; Hydroxyapatite; Porosity; Osteoblasts
ID DOPED BIOACTIVE GLASSES; THERMAL-BEHAVIOR; EXCESS ENTROPY; PART 1; BONE;
   SCAFFOLDS; CRYSTALLIZATION; CRYSTALS; DESIGN; MODEL
AB Biomaterials for bone reconstruction represent a widely studied area. In this paper, a new method of synthesis of a porous glass-ceramic obtained by thermal treatment is presented. The prepared biomaterial was characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), and induced couple plasma-optical emission spectroscopy (ICP-OES), mercury porosimetry and by the Archimedes method. In vitro evaluations in a simulated body fluid (SBF) and in contact with SaOS(2) human osteoblasts were also carried out. The porous glass-ceramic is composed of a total porous network of 60% suitable for body fluid and cell infiltration, with pore sizes varying from 60 nm to 143 mu m. The presence of two crystalline phases decreases the kinetic of bioactivity compared to an amorphous biomaterial (bioactive glass). A hydroxyapatite layer appears from 15 days of immersion on the surface and inside the pores, showing a biodegradation and a bioactivity in four steps. Cytotoxicity assessments present an increase of the cellular viability after 72 h proving the non-cytotoxic effect of the glass-ceramic. Thus, the results of these different studies indicate that the porous biomaterial may have a potential application for the bone regeneration. This paper also presents the novelty of this method. It is a rapid synthesis which combines simplicity and low cost. This represents an advantage for an eventual industrialization. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Wers, E.; Lefeuvre, B.; Oudadesse, H.] Univ Europeenne Bretagne, Univ Rennes 1, Equipe Chim Solide & Mat, UMR CNRS 6226,Sci Chim Rennes, 263 Ave Gen Leclerc, F-35042 Rennes, France.
   [Pellen-Mussi, P.; Novella, A.] Univ Europeenne Bretagne, Univ Rennes 1, Equipe Chim Solide & Mat, UMR CNRS 6226,Sci Chim Rennes, 2 Ave Prof Leon Bernard, F-35042 Rennes, France.
RP Wers, E (reprint author), Univ Europeenne Bretagne, Univ Rennes 1, Equipe Chim Solide & Mat, UMR CNRS 6226,Sci Chim Rennes, 263 Ave Gen Leclerc, F-35042 Rennes, France.
EM wers.eric@hotmail.com
CR Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   BROWN WE, 1983, J DENT RES, V62, P672
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Gosh S.K., 2008, J BIOMED MATER RES B, V86, P217
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang LC, 2007, MAT SCI ENG A-STRUCT, V452, P326, DOI 10.1016/j.msea.2006.10.136
   Jones R. J., 2013, ACTA BIOMATER, V9, P4457
   Kaito T., 2000, J BIOMED MATER RES B, V78, P378
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lefebvre L, 2007, ACTA MATER, V55, P3305, DOI 10.1016/j.actamat.2007.01.029
   Lefebvre L., 2007, THESIS INSA LYON
   Lin CC, 2005, J NON-CRYST SOLIDS, V351, P3195, DOI 10.1016/j.jnoncrysol.2005.08.020
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nandi SK, 2008, SMALL RUMINANT RES, V75, P144, DOI 10.1016/j.smallrumres.2007.09.006
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OHSATO H, 1986, ACTA CRYSTALLOGR C, V42, P934, DOI 10.1107/S0108270186093940
   Oudadesse H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035006
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roberts J.P., 1979, GLASS CERAM, P76
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   Wers E, 2014, J THERM ANAL CALORIM, V117, P579, DOI 10.1007/s10973-014-3731-5
   Wers E, 2014, THERMOCHIM ACTA, V580, P79, DOI 10.1016/j.tca.2014.02.001
   Wers E, 2014, J THERM ANAL CALORIM, V115, P2137, DOI 10.1007/s10973-013-3280-3
   Wucherer L, 2009, INT J APPL CERAM TEC, V6, P651, DOI 10.1111/j.1744-7402.2008.02303.x
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Yun HS, 2011, ACTA BIOMATER, V7, P2651, DOI 10.1016/j.actbio.2011.02.014
NR 36
TC 1
Z9 1
U1 1
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 133
EP 142
DI 10.1016/j.msec.2015.12.022
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600018
PM 26838833
DA 2018-10-20
ER

PT J
AU Przekora, A
   Ginalska, G
AF Przekora, Agata
   Ginalska, Grazyna
TI In vitro evaluation of the risk of inflammatory response after
   chitosan/HA and chitosan/beta-1,3-glucan/HA bone scaffold implantation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Reactive oxygen intermediates; Tumour necrosis factor-alpha; Protein
   adsorption; Fibrinogen; Biomaterial-induced inflammation; Bone tissue
   engineering
ID OSTEOBLAST ADHESION; THP-1 CELLS; DIFFERENTIATION; BIOMATERIALS;
   MACROPHAGES; COMPOSITES; RECOGNITION; ACTIVATION; CHEMISTRY; CURDLAN
AB The aim of the study was to evaluate in vitro the risk of inflammatory response induced by chitosan/hydroxyapatite (chit/HA) and novel chitosan/beta-1,3-glucan/hydroxyapatite (chit/glu/HA) bone scaffolds. The inflammatory response was assessed via measurement of proinflammatory cytokine and ROI production by human monocytes, macrophages, and osteoblasts stimulated with investigated scaffolds. Moreover, adsorption of human serum/plasma proteins to the tested materials was determined.
   Both biomaterials did not induce intracellular ROI generation by monocytes, macrophages, and osteoblasts and did not stimulate proinflammatory cytokine (IL-6 and TNF-alpha) production by inflammatory cells. Moreover, the chit/glu/HA material induced increased TNF-alpha production by osteoblasts that is believed to enhance osteogenic differentiation. Thus, it was demonstrated that chit/HA and chit/glu/HA scaffolds carry a low risk of biomaterial-induced inflammatory response and are promising materials as bone scaffolds for bone tissue engineering and regenerative medicine applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Przekora, Agata; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1, PL-20093 Lublin, Poland.
RP Przekora, A (reprint author), Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1, PL-20093 Lublin, Poland.
EM agata.przekora@umlub.pl
OI Przekora-Kusmierz, Agata/0000-0002-6076-1309; Ginalska,
   Grazyna/0000-0002-9961-4226
FU Ministry of Science and Higher Education in Poland within Medical
   University of Lublin [DS2/15]
FX Financial assistance was provided by the Ministry of Science and Higher
   Education in Poland within DS2/15 project of Medical University of
   Lublin. The paper was developed using the equipment purchased within the
   agreement No. POPW.01.03.00-06-010/09-00 Operational Programme
   Development of Eastern Poland 2007-2013, Priority Axis I, Modern
   Economy, Operations 1.3. Innovations Promotion.
CR Abbas S, 2003, CYTOKINE, V22, P33, DOI 10.1016/S1043-4666(03)00106-6
   [Anonymous], 2009, 1099352009E ISO
   Baldwin L, 2008, CYTOKINE, V41, P217, DOI 10.1016/j.cyto.2007.11.015
   Brevig T, 2005, BIOMATERIALS, V26, P3039, DOI 10.1016/j.biomaterials.2004.09.006
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108
   Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200
   Li GC, 2011, CYTOKINE, V56, P208, DOI 10.1016/j.cyto.2011.06.020
   Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589
   Przekora A., 2015, BIOMED MAT, V10
   Przekora A, 2016, MAT SCI ENG C-MATER, V58, P891, DOI 10.1016/j.msec.2015.09.046
   Przekora A, 2014, INT J BIOL MACROMOL, V70, P474, DOI 10.1016/j.ijbiomac.2014.07.035
   Przekora A, 2014, J BIOTECHNOL, V182, P46, DOI 10.1016/j.jbiotec.2014.04.022
   Przekora A, 2014, CENT EUR J BIOL, V9, P634, DOI 10.2478/s11535-014-0297-y
   Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sidney LE, 2015, TISSUE ENG PT A, V21, P362, DOI [10.1089/ten.tea.2014.0100, 10.1089/ten.TEA.2014.0100]
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   TANG L, 2000, BIOMATERIAL ENG DEVI, V1, P3
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tukulula M, 2015, PHARM RES-DORDR, V32, P2713, DOI 10.1007/s11095-015-1655-9
   Ueda M, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt420
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Zhang RR, 2014, BIOMACROMOLECULES, V15, P1079, DOI 10.1021/bm500038g
NR 27
TC 13
Z9 13
U1 2
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 355
EP 361
DI 10.1016/j.msec.2015.12.066
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600045
PM 26838861
DA 2018-10-20
ER

PT J
AU Gonzalez, M
   Merino, U
   Vargas, S
   Quintanilla, F
   Rodriguez, R
AF Gonzalez, Maykel
   Merino, Ulises
   Vargas, Susana
   Quintanilla, Francisco
   Rodriguez, Rogelio
TI Synthesis and characterization of a HAp-based biomarker with controlled
   drug release for breast cancer
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Breast cancer; Biomarkers; Drug controlled release; Implant; Cisplatin
ID CISPLATIN; HYDROXYAPATITE; CHEMOTHERAPY; ENHANCEMENT; SCAFFOLDS;
   DELIVERY; SPECTRA
AB A biocompatible hybrid porous polymer-ceramic material was synthesized to be used as a biomarker in the treatment of breast cancer. This device was equipped with the capacity to release medicaments locally in a controlled manner. The biomaterial was Hydroxyapatite(HAp)-based and had a controlled pore size and pore volume fraction. It was implemented externally using a sharp end and a pair of barbed rings placed opposite each other to prevent relative movement once implanted. The biomarker was impregnated with cis-diamine dichloride platinum (II) [Cl-2-Pt-(NH3)(2)]; the rate of release was obtained using inductively coupled plasma atomic emission spectroscopy (ICP-AES), and release occurred over the course of three months. Different release profiles were obtained as a function of the pore volume fraction. The biomaterial was characterized using scanning electron microscopy (SEM) and Raman spectroscopy. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Gonzalez, Maykel; Merino, Ulises; Vargas, Susana; Rodriguez, Rogelio] Univ Nacl Autonoma Mexico, Ctr Appl Phys & Adv Technol CFATA, Dept Mol Engn Mat, Blvd Juriquilla 3001, Santiago De Queretaro 76230, Queretaro, Mexico.
   [Merino, Ulises; Quintanilla, Francisco] UVM, Blvd Villas Meson 1000, Santiago De Queretaro 76320, Queretaro, Mexico.
RP Rodriguez, R (reprint author), Univ Nacl Autonoma Mexico, Ctr Appl Phys & Adv Technol CFATA, Dept Mol Engn Mat, Blvd Juriquilla 3001, Santiago De Queretaro 76230, Queretaro, Mexico.
EM rogelior@unam.mx
RI Rodriguez Talavera, Jose Rogelio/L-1709-2018
OI Rodriguez Talavera, Jose Rogelio/0000-0002-7455-2276; Gonzalez Torres,
   Maykel/0000-0003-3899-4410; VARGAS MUNOZ, SUSANA/0000-0001-9031-4182
FU DGAPA-CTIC (CONACYT-Mexico) [220224]
FX The authors wish to thank Carolina Munoz Tones and Alicia del Real Lopez
   for their technical assistance in the ICP-AES and SEM analysis. We are
   also indebted to Guillermo Vazquez Sanchez, Domingo Rangel, Blanca
   Huerta and Guadalupe Mendez for their technical assistance. This
   research was supported by DGAPA-CTIC (CONACYT-Mexico) (Grant # 220224).
CR Aebi Stefan, 2006, Breast, V15 Suppl 2, pS11, DOI 10.1016/S0960-9776(07)70010-3
   Arakawa Y, 2015, J INFECT CHEMOTHER, V21, P502, DOI 10.1016/j.jiac.2015.03.008
   Berners-Price S.J., 1992, J CHEM SOC CHEM COMM, P3
   Brostow W, 2008, J MATER RES, V23, P1587, DOI 10.1557/JMR.2008.0191
   Carr C, 2008, CURR ANAESTH CRIT CA, V19, P70, DOI DOI 10.1016/J.CACC2008.01.004
   Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006
   Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025
   Duncan R, 2013, ADV DRUG DELIVER REV, V65, P60, DOI 10.1016/j.addr.2012.08.012
   Karlsson KH, 2008, J NON-CRYST SOLIDS, V354, P717, DOI 10.1016/j.jnoncrysol.2007.06.100
   Kozelka J, 2009, INORG CHIM ACTA, V362, P651, DOI 10.1016/j.ica.2008.04.024
   Li P, 2014, INT J PHARMACEUT, V477, P390, DOI 10.1016/j.ijpharm.2014.10.039
   Lin KL, 2013, CHEM ENG J, V222, P49, DOI 10.1016/j.cej.2013.02.037
   Michalska D, 2005, CHEM PHYS LETT, V403, P211, DOI 10.1016/j.cplett.2004.12.096
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Peng JR, 2013, BIOMATERIALS, V34, P8726, DOI 10.1016/j.biomaterials.2013.07.092
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Truslow JG, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576926
   Verweij J, 2000, EUR J CANCER, V36, P1479, DOI 10.1016/S0959-8049(00)00133-7
   Villacampa AI, 2000, J CRYST GROWTH, V211, P111, DOI 10.1016/S0022-0248(99)00793-9
   Will J, 2008, J MATER SCI-MATER M, V19, P2781, DOI 10.1007/s10856-007-3346-5
   Wysokinski R, 2007, CHEM PHYS, V333, P37, DOI 10.1016/j.chemphys.2007.01.002
   Zhu YF, 2015, PHARMACOL RES, V93, P36, DOI 10.1016/j.phrs.2014.12.006
NR 24
TC 11
Z9 11
U1 2
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 801
EP 808
DI 10.1016/j.msec.2016.01.015
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600095
PM 26838911
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Du, XL
   Hu, D
   Zhang, J
   Zhou, Y
   Min, GQ
   Lang, MD
AF Zhang, Yan
   Du, Xiaolin
   Hu, Dan
   Zhang, Jing
   Zhou, Yan
   Min, Guoquan
   Lang, Meidong
TI Combined Chemical Groups and Topographical Nanopattern on the
   Poly(epsilon-Caprolactone) Surface for Regulating Human Foreskin
   Fibroblasts Behavior
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE poly(epsilon-caprolactone); surface chemistry; nanopattern;
   UV-nanoimprint; cell behaviors
ID MESENCHYMAL STEM-CELLS; LEAF-LIKE TOPOGRAPHY; SUBSTRATE TOPOGRAPHY;
   FUNCTIONAL-GROUPS; INTEGRIN BINDING; NANOWIRE ARRAYS; ADHESION;
   DIFFERENTIATION; CHEMISTRY; FABRICATION
AB Surface chemistry and substrate topography could contribute significantly to providing a biochemical and topographical cues for governing the fate of cells on the cell material interface. However, the synergies between these two properties have not been exploited extensively for biomaterial design. Herein, we achieved spatial-controlled patterning of chemical groups on the poly(epsilon-caprolactone) (PCL) surface by elegant UV-nanoimprint lithography (UN-NIL). The introduction of chemical groups on the PCL surface was developed by our newly 6-benzyloxycarbonylmethyl-epsilon-caprolactone (BCL) monomer, which not only solved the lack of functional groups along the PCL chain but also retained the original favorable properties of PCL materials. The synergetic effect of the chemical groups and nanopatterns on the human foreskin fibroblasts (HFFs) behaviors was evaluated in detail. The results revealed that the patterned functional PCL surfaces could induce enhanced cell adhesion and proliferation, further trigger changes in HFFs morphology, orientation and collagen secretion. Taken together, this study provided a method for straightforward fabrication of reactive PCL surfaces with topographic patterns by one-step process, and they would facilitate. PCL as potential candidate for cell cultivation and tissue engineering.
C1 [Zhang, Yan; Du, Xiaolin; Lang, Meidong] E China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, 130 Meilong Rd, Shanghai 200237, Peoples R China.
   [Hu, Dan; Zhou, Yan] E China Univ Sci & Technol, Sch Bioengn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
   [Zhang, Yan; Zhang, Jing; Min, Guoquan] Shanghai Nanotechnol Promot Ctr, Shanghai 200237, Peoples R China.
RP Zhang, Y; Lang, MD (reprint author), E China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, 130 Meilong Rd, Shanghai 200237, Peoples R China.; Zhang, Y (reprint author), Shanghai Nanotechnol Promot Ctr, Shanghai 200237, Peoples R China.
EM Zhang_yan@ecust.edu.cn; mdlang@ecust.edu.cn
OI Lang, Meidong/0000-0003-2053-9284
FU National Natural Science Foundation of China [21274039]; Shanghai
   Pujiang Program [14PJD014]; 111 Project [B14018]; Specialized Research
   Fund for the Doctoral Program of Higher Education [20130074110007]
FX Financial support from the National Natural Science Foundation of China
   (21274039), Shanghai Pujiang Program (14PJD014), 111 Project (B14018),
   and Specialized Research Fund for the Doctoral Program of Higher
   Education (20130074110007) are gratefully acknowledged.
CR Bi XP, 2014, ACTA BIOMATER, V10, P2814, DOI 10.1016/j.actbio.2014.02.018
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Broderick AH, 2011, BIOMACROMOLECULES, V12, P1998, DOI 10.1021/bm200296a
   Buck ME, 2009, BIOMACROMOLECULES, V10, P1564, DOI 10.1021/bm9001552
   Chapman CAR, 2015, ACS APPL MATER INTER, V7, P7093, DOI 10.1021/acsami.5b00410
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen M, 2015, COLLOID SURFACE B, V134, P322, DOI 10.1016/j.colsurfb.2015.07.018
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Di Cio S, 2016, ACTA BIOMATER, V30, P26, DOI 10.1016/j.actbio.2015.11.027
   Ding YH, 2015, ACTA BIOMATER, V15, P150, DOI 10.1016/j.actbio.2014.12.014
   Ebara M, 2014, POLYMER, V55, P5961, DOI 10.1016/j.polymer.2014.09.009
   Elsayed M, 2014, NANOMEDICINE-UK, V9, P349, DOI 10.2217/nnm.13.200
   Fox CB, 2015, NANO LETT, V15, P1540, DOI 10.1021/nl503872p
   Fredin NJ, 2009, BIOMACROMOLECULES, V10, P994, DOI 10.1021/bm900045c
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882
   Jeon H, 2015, ACS APPL MATER INTER, V7, P4525, DOI 10.1021/acsami.5b00554
   Juarez-Moreno JA, 2015, APPL SURF SCI, V349, P763, DOI 10.1016/j.apsusc.2015.05.063
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   LaPointe VLS, 2013, ADV HEALTHC MATER, V2, P1644, DOI 10.1002/adhm.201200382
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Li D, 2014, POLYM CHEM-UK, V5, P14, DOI 10.1039/c3py00739a
   Mahmud A, 2006, MACROMOLECULES, V39, P9419, DOI 10.1021/ma0613786
   Pinto LFV, 2011, LANGMUIR, V27, P6330, DOI 10.1021/la200422q
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434
   Shi XJ, 2012, LANGMUIR, V28, P17011, DOI 10.1021/la303042d
   Sreenivasan SV, 2011, COMPREHENSIVE NANOSCIENCE AND TECHNOLOGY, VOL 4: NANOFABRICATION AND DEVICES, P83
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tsai WB, 2009, ACTA BIOMATER, V5, P1442, DOI 10.1016/j.actbio.2009.01.002
   Wang HW, 2013, ACS APPL MATER INTER, V5, P1800, DOI 10.1021/am3031322
   Wang X, 2015, NANO LETT, V15, P1457, DOI 10.1021/nl5049862
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang YY, 2013, ACS APPL MATER INTER, V5, P3816, DOI 10.1021/am400469g
   Wu YN, 2014, NANOMED-NANOTECHNOL, V10, P1507, DOI 10.1016/j.nano.2014.04.002
   Yang HS, 2014, BIOMATERIALS, V35, P1478, DOI 10.1016/j.biomaterials.2013.10.067
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yuan L, 2011, MACROMOL BIOSCI, V11, P1031, DOI 10.1002/mabi.201000464
   Zhang Y, 2014, J POLYM SCI POL CHEM, V52, P188, DOI 10.1002/pola.26987
   Zhang Y, 2012, J COLLOID INTERF SCI, V368, P64, DOI 10.1016/j.jcis.2011.11.010
   Zhao SC, 2015, J MATER CHEM B, V3, P1612, DOI 10.1039/c4tb01287a
   Zheng J, 2013, ACS APPL MATER INTER, V5, P5882, DOI 10.1021/am4017329
   Zheng J, 2010, COLLOID SURFACE B, V77, P234, DOI 10.1016/j.colsurfb.2010.01.032
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 52
TC 2
Z9 2
U1 4
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 30
PY 2016
VL 8
IS 12
BP 7720
EP 7728
DI 10.1021/acsami.6b01361
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DI5DQ
UT WOS:000373519500013
PM 26950754
DA 2018-10-20
ER

PT J
AU de Viteria, VS
   Bayon, R
   Igartua, A
   Barandika, G
   Moreno, JE
   Peremarch, CPJ
   Perez, MM
AF Saenz de Viteria, V.
   Bayon, R.
   Igartua, A.
   Barandika, G.
   Esteban Moreno, J.
   Perez-Jorge Peremarch, C.
   Martinez Perez, M.
TI Structure, tribocorrosion and biocide characterization of Ca, P and I
   containing TiO2 coatings developed by plasma electrolytic oxidation
SO APPLIED SURFACE SCIENCE
LA English
DT Article
ID TITANIUM SURFACES; PURE TITANIUM; ALLOY; VITRO; BONE; ADHESION; TI6AL4V;
   OSSEOINTEGRATION; BIOMATERIALS; WETTABILITY
AB In hip joint implants, in particular in the stems, wear-corrosion effects can accelerate the degradation of the biomaterial. The lack of osseointegration and the risk of contracting implant-associated infections may be other reasons for a premature failure of the implant. In this work, TiO2 coatings have been developed by means of plasma electrolytic oxidation (PEO) technique in order to achieve wear-resistant hard coatings with osseointegration ability and biocide characteristics. During the PEO process, elements that favor cell growth, like Ca and P, were introduced into the coating. With the purpose of providing the coating with antibacterial properties iodine was added like biocide agent. The microstructure and chemical composition of the developed coatings were analyzed in order to see if the surface of the films was suitable for the cell attachment. The effect of wear-corrosion synergy was studied by means of tribocorrosion tests. Finally, the biocide capacity of iodine against Staphylococcus aureus and Staphylococcus epidermidis was analyzed through bacterial adhesion tests. High wear and corrosion resistance was shown in one of the developed coatings. The achieved surface microstructures seem to be appropriate to improve the osseointegration with proper pore size and porosity index. The antibacterial capacity of iodine was confirmed for S. epidermidis. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Saenz de Viteria, V.; Bayon, R.; Igartua, A.] IK4 Tekniker, Polo Tecnol Eibar, Calle Inaki Goenaga 5, Eibar 20600, Spain.
   [Barandika, G.] Univ Basque Country, UPV EHU, Fac Ciencia & Tecnol, Dept Quim Inorgan, Apartado 644, E-48080 Bilbao, Spain.
   [Esteban Moreno, J.; Perez-Jorge Peremarch, C.; Martinez Perez, M.] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Ave Reyes Catolicos 2, Madrid 28040, Spain.
RP de Viteria, VS (reprint author), IK4 Tekniker, Polo Tecnol Eibar, Calle Inaki Goenaga 5, Eibar 20600, Spain.
EM virginia.saenzdeviteri@tekniker.es
RI Barandika, Gotzone/N-2157-2014
OI Barandika, Gotzone/0000-0002-6771-6586
FU Basque Country; Spanish Ministry of Science and Innovation
   [CSD2008-0023]; Ministerio de Economia y Competitividad
   [MAT2013-42092-R]
FX The authors want to acknowledge to the Basque Country for the financial
   support, to the Spanish Ministry of Science and Innovation for the
   financial of FUNCOAT (CSD2008-0023), the EMAITEK Project, CONSOLIDER
   Project, and to the SGIker technical support (MEC, GV/EJ, European
   Social Found). This work has also been financially supported by the
   "Ministerio de Economia y Competitividad" (MAT2013-42092-R).
CR Aliasghari S, 2014, APPL SURF SCI, V316, P463, DOI 10.1016/j.apsusc.2014.08.037
   Alsaran A, 2011, SURF COAT TECH, V205, pS537, DOI 10.1016/j.surfcoat.2011.03.032
   [Anonymous], 2015, ASM MAT DAT SHEET
   Arenas MA, 2013, COLLOID SURFACE B, V105, P106, DOI 10.1016/j.colsurfb.2012.12.051
   Arrabal R, 2009, SURF COAT TECH, V203, P2207, DOI 10.1016/j.surfcoat.2009.02.011
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Chandra A, 2011, J MECH BEHAV BIOMED, V4, P1990, DOI 10.1016/j.jmbbm.2011.06.018
   Contu F, 2004, ELECTROCHIM ACTA, V50, P33, DOI 10.1016/j.electacta.2004.07.024
   Diomidis N, 2012, ACTA BIOMATER, V8, P852, DOI 10.1016/j.actbio.2011.09.034
   Diomidis N, 2011, TRIBOL INT, V44, P1452, DOI 10.1016/j.triboint.2011.02.013
   Durdu S, 2014, CERAM INT, V40, P3627, DOI 10.1016/j.ceramint.2013.09.062
   Fazel M, 2015, APPL SURF SCI, V324, P751, DOI 10.1016/j.apsusc.2014.11.030
   Goriainov V, 2014, ACTA BIOMATER, V10, P4043, DOI 10.1016/j.actbio.2014.06.004
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400
   Hussein R. O., 2010, J PHYS D, V43
   Jaspard-Mecuson F, 2007, SURF COAT TECH, V201, P8677, DOI 10.1016/j.surfcoat.2006.09.005
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Khorasanian M, 2011, SURF COAT TECH, V206, P1495, DOI 10.1016/j.surfcoat.2011.09.038
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Kotharu V, 2012, CERAM INT, V38, P731, DOI 10.1016/j.ceramint.2011.07.065
   Kulkarni M, 2015, COLLOID SURFACE B, V129, P47, DOI 10.1016/j.colsurfb.2015.03.024
   Kulkarni M, 2015, INT J NANOMED, V10, P1359, DOI 10.2147/IJN.S77492
   Kumar S, 2010, MAT SCI ENG C-MATER, V30, P921, DOI 10.1016/j.msec.2010.03.024
   Kuzyk PRT, 2011, INDIAN J ORTHOP, V45, P108, DOI 10.4103/0019-5413.77129
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Mabboux F, 2004, COLLOID SURFACE B, V39, P199, DOI 10.1016/j.colsurfb.2004.08.002
   Manhabosco TM, 2011, CORROS SCI, V53, P1786, DOI 10.1016/j.corsci.2011.01.057
   MAXIAN SH, 1994, J BIOMED MATER RES, V28, P1311, DOI 10.1002/jbm.820281109
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Neupane M. P., 2012, WORLD ACAD SCI ENG T, V6, P10
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Perez-Tanoira R., 2012, J BIOMED MATER RES A, V100, P4208
   Ravanetti F, 2010, ACTA BIOMATER, V6, P1014, DOI 10.1016/j.actbio.2009.09.022
   Segomotso B., 2012, APPL SURF SCI, V258, P3927
   Shin KR, 2014, APPL SURF SCI, V314, P221, DOI 10.1016/j.apsusc.2014.06.121
   Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036
   Sollazzo V, 2007, J CRANIOFAC SURG, V18, P806, DOI 10.1097/scs.0b013e3180a7728f
   Song HJ, 2009, J MATER PROCESS TECH, V209, P864, DOI 10.1016/j.jmatprotec.2008.02.055
   Temenoff J.S., 2008, BIOMATERIALS INTERSE
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wang HR, 2015, APPL SURF SCI, V356, P1234, DOI 10.1016/j.apsusc.2015.08.228
   Wang HY, 2014, MAT SCI ENG C-MATER, V42, P657, DOI 10.1016/j.msec.2014.06.005
   Williams S, 2003, P I MECH ENG H, V217, P147, DOI 10.1243/09544110360579367
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Zhang EL, 2013, MAT SCI ENG C-MATER, V33, P4280, DOI 10.1016/j.msec.2013.06.016
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 51
TC 9
Z9 9
U1 8
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 30
PY 2016
VL 367
BP 1
EP 10
DI 10.1016/j.apsusc.2016.01.145
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DH1BL
UT WOS:000372519300001
DA 2018-10-20
ER

PT J
AU Mosbahi, S
   Oudadesse, H
   Lefeuvre, B
   Barroug, A
   Elfeki, H
   Elfeki, A
   Roiland, C
   Keskes, H
AF Mosbahi, Siwar
   Oudadesse, Hassane
   Lefeuvre, Bertand
   Barroug, Allal
   Elfeki, Hafed
   Elfeki, Abdelfattah
   Roiland, Claire
   Keskes, Hassib
TI Risedronate adsorption on bioactive glass surface for applications as
   bone biomaterial
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Adsorption; Bisphosphonate; Bioactive glass; Risedronate; Spectroscopy
ID OSTEOPOROSIS; RAMAN; BISPHOSPHONATES; HYDROXYAPATITE; ALENDRONATE;
   DISORDERS; APATITE; WOMEN; ACID
AB The aim of the current work is to study the physicochemical interactions between bisphosphonates molecules, risedronate (RIS) and bioactive glass (46S6) after their association by adsorption phenomenon. To more understand the interaction processes of RIS with the 46S6 surface we have used complementary physicochemical techniques such as infrared (FTIR), Raman and nuclear magnetic resonance (NMR) spectroscopy. The obtained results suggest that risedronate adsorption corresponds to an ion substitution reaction with silicon ions occurring at the bioactive glass surface. Thus, a pure bioactive glass was synthesized and fully characterized comparing the solids after adsorption (46S6-XRIS obtained after the interaction of 46S6 and X% risedronate). Therefore, based on the spectroscopic results FTIR, Raman and MAS-NMR, it can be concluded that strong interactions have been established between RIS ions and 46S6 surface. In fact, FTIR and Raman spectroscopy illustrate the fixation of risedronate on the bioactive glass surface by the appearance of several bands characterizing risedronate. The P-31 MAS-NMR of the composite 46S6-XRIS show the presence of two species at a chemical shift of 15 and 19 ppm demonstrating thus the fixation of the RIS on 46S6 surface. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mosbahi, Siwar; Oudadesse, Hassane; Lefeuvre, Bertand; Roiland, Claire] Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
   [Mosbahi, Siwar; Keskes, Hassib] Sfax Fac Med, Orthopaed & Traumatol Lab, Sfax, Tunisia.
   [Elfeki, Hafed] Sfax Fac Sci, Sci Mat & Environm Lab, Sfax, Tunisia.
   [Elfeki, Abdelfattah] Sfax Fac Sci, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [Barroug, Allal] Univ Cadi Ayyad, Fac Sci Semlalia, Marrakech, Morocco.
   [Barroug, Allal] CNRST, Rabat, Morocco.
RP Oudadesse, H (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
OI roiland, claire/0000-0001-9587-1340
CR Barroug A, 1998, J COLLOID INTERF SCI, V208, P147, DOI 10.1006/jcis.1998.5759
   Benaziz L, 2001, J COLLOID INTERF SCI, V238, P48, DOI 10.1006/jcis.2001.7450
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Bui XV, 2010, J AUST CERAM SOC, V46, P24
   Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K
   Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2001.0210
   deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403
   Dietrich E., 2007, J BIOMED MAT, V10, P1002
   Errassifi F, 2014, J COLLOID INTERF SCI, V420, P101, DOI 10.1016/j.jcis.2014.01.017
   Ettinger B, 1998, AM J MANAG CARE, V4, P1377
   Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80
   Fleisch HA, 1997, ANN MED, V29, P55, DOI 10.3109/07853899708998743
   Gonzalez P, 2003, J NON-CRYST SOLIDS, V320, P92, DOI 10.1016/S0022-3093(03)00013-9
   Hammami K, 2015, APPL SURF SCI, V353, P165, DOI 10.1016/j.apsusc.2015.06.068
   Handke M, 2003, J MOL STRUCT, V651, P39, DOI 10.1016/S0022-2860(03)00099-1
   Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344
   HENCH LL, 1994, BIOCERAMICS, V7, P3
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hsi CS, 2007, J EUR CERAM SOC, V27, P3171, DOI 10.1016/j.jeurceramsoc.2006.11.081
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jebahi S., 2014, BIOTECHNOL LETT, V36, P2571
   JOHNSSON M, 1991, CALCIFIED TISSUE INT, V49, P134, DOI 10.1007/BF02565136
   Josse S, 2005, BIOMATERIALS, V26, P2073, DOI 10.1016/j.biomaterials.2004.05.019
   Juillard A, 2010, BONE, V47, P895, DOI 10.1016/j.bone.2010.07.018
   Karlsson KH, 1998, GLASTECH BER-GLASS, V71, P141
   Kos J, 2011, MOLECULES, V16, P3740, DOI 10.3390/molecules16053740
   MacDonald S. A., 2000, J NONCRYST SOLIDS, V275, P275
   Mosbahi S., 2014, IJET, V3, P2277
   Mostafa A. M., 2013, BIOCERAM DEV APPL, V4, P1
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Ouizat S., 2000, MAT RES B, V34, P2279, DOI DOI 10.1016/S0025-5408(00)00167-7
   Pascaud P., 2012, BIOMED MATER, V7, P1
   Redman-Furey N, 2005, J PHARM SCI-US, V94, P893, DOI 10.1002/jps.20308
   Reigstad O., 2011, J BIOMED MATER RES B, V19, P14
   Rosenqvist K, 2013, INT J PHARMACEUT, V452, P102, DOI 10.1016/j.ijpharm.2013.04.059
   Roussiere H, 2005, J MATER CHEM, V15, P3869, DOI 10.1039/b503680a
   Sitarz M., 1999, J MOL STRUCT, V511, P282
   Vallano PT, 2003, J CHROMATOGR B, V794, P23, DOI 10.1016/S1570-0232(03)00394-5
   Wers E, 2015, APPL SURF SCI, V353, P200, DOI 10.1016/j.apsusc.2015.06.146
   Xie XH, 2010, J MATER SCI-MATER M, V21, P2165, DOI 10.1007/s10856-010-4077-6
NR 40
TC 2
Z9 2
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 30
PY 2016
VL 367
BP 205
EP 213
DI 10.1016/j.apsusc.2016.01.184
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DH1BL
UT WOS:000372519300027
DA 2018-10-20
ER

PT J
AU Zhao, Q
   Mahmood, W
   Zhu, YY
AF Zhao, Qing
   Mahmood, Wacias
   Zhu, Yanying
TI Synthesis of dittmarite/Mg(OH)(2) composite coating on AZ31 using
   hydrothermal treatment
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Hydrothermal method; Cytotoxicity; Magnesium alloy; Biomaterial;
   Dittmarite/magnesium hydroxide composite (DMC) coating
ID MAGNESIUM ALLOY; ELECTROCHEMICAL METHOD; CORROSION-RESISTANCE;
   THIN-FILMS; BONE; TEMPERATURE; PROTECTION; IMPLANTS; GROWTH; STENTS
AB In this work, we have used hydrothermal method for the synthesis of dittmarite/Mg(OH)(2) composite (DMC) layer on AZ31 alloy of magnesium. The synthesized coating was characterized by X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM) and energy dispersive X-ray spectroscopy (EDS). In a test immersion into the Hank's mixture for 31 days, the synthesized coating inhibited corrosion of AZ31 significantly and the amorphous calcium apatite precursor deposited on the coating surface. In another tape test, we noticed strong adhesion between the coating and substrate that eventually concludes that the synthesized coating is hydrophilic and a promising candidate to be used in the absorbable implant materials. Besides, the cytotoxicity of the AZ31 alloy with DMC coating, grown under different conditions on L-929 cells in vitro was examined indirectly through the growth inhibition method (MTT assay). The cytotoxicity of the deposited coating lie between 0 similar to 1 that indicates it as a promising biomaterial. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhao, Qing; Mahmood, Wacias; Zhu, Yanying] Beijing Inst Technol, Sch Phys, Beijing 100081, Peoples R China.
RP Zhao, Q (reprint author), Beijing Inst Technol, Sch Phys, Beijing 100081, Peoples R China.
EM qzhaoyuping@bit.edu.cn
FU National Natural Science Foundation of China [11075077, 11275024];
   Ministry of Science and Technology, China [2013YQ03059503, 2014AA120101]
FX This work was supported by National Natural Science Foundation of China
   (11075077 and 11275024). Additional support was provided by the Ministry
   of Science and Technology, China (2013YQ03059503, 2014AA120101).
CR [Anonymous], 2004, G3172 ASTM
   Asl SKF, 2015, MATER CHEM PHYS, V161, P185, DOI 10.1016/j.matchemphys.2015.05.035
   Duygulu O, 2007, MATER SCI FORUM, V546-549, P421, DOI 10.4028/www.scientific.net/MSF.546-549.421
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guo XX, 2009, LANGMUIR, V25, P9894, DOI 10.1021/la901012w
   Hu Y, 2008, J PHYS CHEM C, V112, P13037, DOI 10.1021/jp803726c
   Huse E.C., 1878, CHICAGO MED J EXAMIN, V37, P171
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Jeong H, 2015, SURF COAT TECH, V284, P26, DOI 10.1016/j.surfcoat.2015.10.039
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Mario CD, 2004, J INTERV CARDIOL, V17, P391, DOI DOI 10.1111/J0IC.2004.17.ISSUE-6
   MOHAJIT K K B, 1989, Biological Wastes, V30, P133
   Optrajanov B. S., 2002, J MOL STRUCT, V613, P7
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   Ren YF, 2015, MAT SCI ENG C-MATER, V49, P364, DOI 10.1016/j.msec.2015.01.046
   Shaw B.A., 2003, ASM HDB A, V13, P692
   Song SW, 2000, J AM CERAM SOC, V83, P2839
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Sreekanth D, 2012, MATER LETT, V68, P439, DOI 10.1016/j.matlet.2011.11.025
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Suchanek WL, 1998, J AM CERAM SOC, V81, P2864, DOI 10.1111/j.1151-2916.1998.tb02707.x
   Sun K, 2011, CHEM COMMUN, V47, P7776, DOI 10.1039/c1cc11397f
   Tian P, 2015, COLLOID SURFACE B, V128, P44, DOI 10.1016/j.colsurfb.2015.02.011
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wu J, 2007, CHINESE J CHEM, V25, P72, DOI 10.1002/cjoc.200790020
   YOO SE, 1990, J AM CERAM SOC, V73, P2561, DOI 10.1111/j.1151-2916.1990.tb07637.x
   Yun H, 2008, APPL SURF SCI, V255, P2113, DOI 10.1016/j.apsusc.2008.06.194
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhu HL, 2007, SURF COAT TECH, V201, P5870, DOI 10.1016/j.surfcoat.2006.10.037
   Zhu YY, 2012, SURF COAT TECH, V206, P2961, DOI 10.1016/j.surfcoat.2011.12.029
   Zhu YY, 2011, APPL SURF SCI, V257, P6129, DOI 10.1016/j.apsusc.2011.02.017
   Zomorodian A, 2013, ACTA BIOMATER, V9, P8660, DOI 10.1016/j.actbio.2013.02.036
NR 37
TC 6
Z9 6
U1 4
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 30
PY 2016
VL 367
BP 249
EP 258
DI 10.1016/j.apsusc.2016.01.055
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DH1BL
UT WOS:000372519300032
DA 2018-10-20
ER

PT J
AU Miles, KB
   Ball, RL
   Matthew, HWT
AF Miles, Kevin Barrett
   Ball, Rebecca Lee
   Matthew, Howard William Trevor
TI Chitosan films with improved tensile strength and toughness from
   N-acetyl-cysteine mediated disulfide bonds
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE N-acetyl-cysteine chitosan; Cyclical tensile properties; Disulfide
   bonds; Biomaterial mechanical properties; Biomaterial crystallinitya
ID IN-VIVO DEGRADATION; MECHANICAL-PROPERTIES; CRYSTAL-STRUCTURE; HYDROGEL;
   CHITIN; VITRO; SCAFFOLDS; DEACETYLATION; BIOMATERIALS; CONJUGATE
AB To improve the mechanical properties of chitosan (Ct) materials without the use of cytotoxic crosslinkers, disulfide cross-linkable Ct was synthesized by grafting N-acetyl-cysteine (NAC) to Ct using carbodiimide chemistry. Cast films of NAC-Ct conjugates were prepared with degrees of substitution (DS) of 0%, 6%, 15%, and 20%, and the disulfide bond formation was induced by increasing the reaction media pH to 11. The tensile strength, breaking strain, elastic moduli and toughness of disulfide cross-linked polymers were analyzed by monotonic tensile testing of hydrated NAC-Ct films. Crystallinity was determined via XRD. Results demonstrated that NAC incorporation and crosslinking in chitosan produced tougher polymer films with 4-fold higher tensile strength (10 MPa) and 6-fold greater elongation (365%), but reduced crystallinity, compared to unmodified chitosan. The resilience of NAC-Ct films was evaluated by cyclic testing, and results demonstrate that increasing NAC content produced a more resilient material that dissipated less energy when deformed. These improved mechanical properties broaden chitosan's applicability towards the construction of mechanically robust implantable scaffolds for tissue regeneration. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Miles, Kevin Barrett; Ball, Rebecca Lee; Matthew, Howard William Trevor] Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
RP Matthew, HWT (reprint author), Wayne State Univ, Dept Chem Engn & Mat Sci, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA.
EM kbmiles@wayne.edu; rlball@andrew.cmu.edu; hmatthew@wayne.edu
OI Matthew, Howard/0000-0001-6033-9258
CR Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051
   Amin AFMS, 2006, INT J PLASTICITY, V22, P1610, DOI 10.1016/j.ijplas.2005.09.005
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bao DS, 2014, CARBOHYD POLYM, V110, P113, DOI 10.1016/j.carbpol.2014.03.095
   Cervera MF, 2004, CARBOHYD POLYM, V58, P401, DOI 10.1016/j.carbpol.2004.08.017
   Chang RJY, 2011, PROTEIN REV, V14, P1, DOI 10.1007/978-1-4419-7273-6
   Chen RH, 1996, CARBOHYD POLYM, V31, P141, DOI 10.1016/S0144-8617(96)00047-1
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Kim HJ, 2014, ACS NANO, V8, P2998, DOI 10.1021/nn5002968
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Lima IS, 2004, THERMOCHIM ACTA, V421, P133, DOI 10.1016/j.tca.2004.03.012
   Ma XX, 2014, J MATER CHEM B, V2, P2749, DOI 10.1039/c3tb21842b
   Ma ZW, 2011, BIOMACROMOLECULES, V12, P3265, DOI 10.1021/bm2007218
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mir S, 2011, CARBOHYD POLYM, V83, P414, DOI 10.1016/j.carbpol.2010.07.069
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Okuyama K, 1997, MACROMOLECULES, V30, P5849, DOI 10.1021/ma970509n
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Prabaharan M, 2007, J BIOMED MATER RES B, V81B, P427, DOI 10.1002/jbm.b.30680
   Ravindran S, 2012, TISSUE ENG PT A, V18, P295, DOI [10.1089/ten.tea.2011.0136, 10.1089/ten.TEA.2011.0136]
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schmitz T, 2008, INT J PHARMACEUT, V347, P79, DOI 10.1016/j.ijpharm.2007.06.040
   Shrestha A, 2012, ANTIMICROB AGENTS CH, V56, P4876, DOI 10.1128/AAC.00810-12
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Spada C, 2002, CLIN CHEM LAB MED, V40, P452, DOI 10.1515/CCLM.2002.077
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WALTON AG, 1973, BIOPOLYMERS
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   Wan Y, 2003, J APPL POLYM SCI, V89, P306, DOI 10.1002/app.12090
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   Wu ZM, 2009, EUR J PHARM SCI, V37, P198, DOI 10.1016/j.ejps.2009.01.010
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
   Zhang HW, 2011, BIOMACROMOLECULES, V12, P1428, DOI 10.1021/bm101192b
   Zhang YQ, 2005, CARBOHYD RES, V340, P1914, DOI 10.1016/j.carres.2005.05.005
   Zhang YF, 2007, BIOMATERIALS, V28, P1515, DOI 10.1016/j.biomaterials.2006.11.040
NR 40
TC 5
Z9 6
U1 6
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 30
PY 2016
VL 139
BP 1
EP 9
DI 10.1016/j.carbpol.2015.11.052
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DA8ZZ
UT WOS:000368097200001
PM 26794940
DA 2018-10-20
ER

PT J
AU Lin, KF
   He, S
   Song, Y
   Wang, CM
   Gao, Y
   Li, JQ
   Tang, P
   Wang, Z
   Bi, L
   Pei, GX
AF Lin, Kai-Feng
   He, Shu
   Song, Yue
   Wang, Chun-Mei
   Gao, Yi
   Li, Jun-Qin
   Tang, Peng
   Wang, Zheng
   Bi, Long
   Pei, Guo-Xian
TI Low-Temperature Additive Manufacturing of Biomimic Three-Dimensional
   Hydroxyapatite/Collagen Scaffolds for Bone Regeneration
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE three-dimensional printing; collagen; hydroxyapatite; bone substitutes;
   tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; CALCIUM-PHOSPHATE; BIOMATERIAL SCAFFOLDS;
   MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS; SUBSTITUTES; POROSITY;
   WETTABILITY; CARTILAGE; DELIVERY
AB Low-temperature additive manufacturing, (AM) holds promise for fabrication of-three-dimensional (3D) scaffolds containing bioactive molecules and/or drugs. Due to the strict technical limitations of current approaches, few materials are suitable for printing at low temperature. Here, a low-temperature robocasting method was employed to print: biomimic 3D scaffolds for bone regeneration using a routine collagen-hydroxyapatite (CHA) composite material, which is too viscous to be printed via normal 3D printing methods at low temperature. The CHA scaffolds had excellent 3D structure and maintained most raw material properties after printing. compared to nonprinted scaffolds, printed scaffolds promoted bone marrow stromal cell proliferation and improved osteogenic outcome in vitro. In a rabbit femoral condyle defect model, the interconnecting pores within the printed scaffolds facilitated cell penetration and mineralization before the scaffolds degraded and enhanced repair, compared-to nonprinted CHA scaffolds. Additionally, the optimal printing parameters for 3D CHA scaffolds were investigated; 600-mu m-diameter rods were optimal in terms of moderate mechanical strength and better repair outcome in vivo. This low-temperature robocasting method could enable-a variety of bioactive molecules to be incorporated into printed CHA materials and provides a method of bioprinting biomaterials without compromising their natural properties.
C1 [Lin, Kai-Feng; He, Shu; Song, Yue; Wang, Chun-Mei; Gao, Yi; Li, Jun-Qin; Tang, Peng; Wang, Zheng; Bi, Long; Pei, Guo-Xian] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.
RP Bi, L; Pei, GX (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.
EM bilong@fmmu.edu.cn; nfperry@163.com
FU National Natural Science Foundation of China [81371982]
FX National Natural Science Foundation of China, grant number 81371982.
CR An B, 2016, ADV DRUG DELIVER REV, V97, P69, DOI 10.1016/j.addr.2015.11.013
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Chen O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141201
   Forster Yvonne, 2012, Biomatter, V2, P149, DOI 10.4161/biom.21563
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Hao LJ, 2014, J MATER CHEM B, V2, P4794, DOI 10.1039/c4tb00597j
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Ishack S, 2017, J BIOMED MATER RES B, V105, P366, DOI 10.1002/jbm.b.33561
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kruger TE, 2013, SCI WORLD J, DOI 10.1155/2013/812718
   Kurien T, 2013, BONE JOINT J, V95B, P583, DOI 10.1302/0301-620X.95B5.30286
   Lee SB, 2005, BIOMATERIALS, V26, P1961, DOI 10.1016/j.biomaterials.2004.06.032
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587
   Molladavoodi S, 2013, J MECH BEHAV BIOMED, V17, P186, DOI 10.1016/j.jmbbm.2012.08.021
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Muzzarelli RAA, 2015, MAR DRUGS, V13, P7314, DOI 10.3390/md13127068
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Perez RA, 2013, J MATER SCI-MATER M, V24, P381, DOI 10.1007/s10856-012-4799-8
   Rupp F, 2014, ACTA BIOMATER, V10, P2894, DOI 10.1016/j.actbio.2014.02.040
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2008, ACTA BIOMATER, V4, P1322, DOI 10.1016/j.actbio.2008.03.016
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893
   Vorndran E, 2010, ADV FUNCT MATER, V20, P1585, DOI 10.1002/adfm.200901759
   Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang DX, 2013, INT J NANOMED, V8, P1855, DOI 10.2147/IJN.S43706
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus
   Zeng Q, 2014, China Patent, Patent No. [CN 104325644 A, 104325644]
   Zeng Q, 2015, China Patent, Patent No. [CN 104826171 A, 104826171]
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhu YL, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/5/055009
NR 49
TC 26
Z9 27
U1 11
U2 144
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 23
PY 2016
VL 8
IS 11
BP 6905
EP 6916
DI 10.1021/acsami.6b00815
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DH7BQ
UT WOS:000372946600016
PM 26930140
DA 2018-10-20
ER

PT J
AU Tarchala, M
   Harvey, EJ
   Barralet, J
AF Tarchala, Magdalena
   Harvey, Edward J.
   Barralet, Jake
TI Biomaterial-Stabilized Soft Tissue Healing for Healing of Critical-Sized
   Bone Defects: the Masquelet Technique
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
ID INDUCED MEMBRANE TECHNIQUE; POLYLACTIDE MEMBRANES; NERVE REGENERATION;
   SEGMENTAL DEFECTS; OPEN FRACTURES; LONG BONES; RECONSTRUCTION; FUTURE;
   REPAIR; SHEEP
AB Critical-sized bone defects present a signifi cant burden to the medical community due to their challenging treatment. However, a successful limb-salvaging technique, the Masquelet Technique (MT), has significantly improved the prognosis of many segmental bone defects in helping to restore form and function. Although the Masquelet Technique has proven to be clinically effective, the physiology of the healing it induces is not well understood. Multiple modifiable factors have been implicated by various surgical and research teams, but no single factor has been proven to be critical to the success of the Masquelet Technique. In this review the most recent clinical and experimental evidence that supports and helps to decipher the traditional Masquelet, as well as the modifiable factors and their effect on the success of the technique are discussed. In addition, future developments for the integration of the traditional Masquelet Technique with the use of alternative biomaterials to increase the effectiveness and expand the clinical applicability of the Masquelet Technique are reviewed.
C1 [Tarchala, Magdalena; Harvey, Edward J.] McGill Univ, Ctr Hlth, Div Orthopaed Surg, Montreal, PQ H3G 1A4, Canada.
   [Barralet, Jake] McGill Univ, Fac Dent, Montreal, PQ H3A 0G4, Canada.
RP Harvey, EJ (reprint author), McGill Univ, Ctr Hlth, Div Orthopaed Surg, Montreal, PQ H3G 1A4, Canada.
EM edward.harvey@mcgill.ca
OI Barralet, jake/0000-0003-3543-6042; harvey, edward/0000-0003-3934-8920
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Accadbled F, 2013, ORTHOP TRAUMATOL-SUR, V99, P479, DOI 10.1016/j.otsr.2013.01.008
   Aho OM, 2013, J BONE JOINT SURG AM, V95A, P597, DOI 10.2106/JBJS.L.00310
   Aronson J, 1997, J BONE JOINT SURG AM, V79A, P1243, DOI 10.2106/00004623-199708000-00019
   Auregan J.-C., 2014, INT ORTHOP, V38, P9
   Bauer T. W., 2005, CLIN ORTHOP RELAT R, V371, P10
   Biau D. J., 2009, CLIN ORTHOP RELAT R, V2, P572
   Blair C., 2015, CASE REP ORTHOP, V19, P1
   Boccaccini AR, 2012, EXPERT REV MED DEVIC, V9, P457, DOI [10.1586/ERD.12.49, 10.1586/erd.12.49]
   Bosemark P, 2015, J ORTHOP RES, V33, P488, DOI 10.1002/jor.22815
   Bouis D, 2006, PHARMACOL RES, V53, P89, DOI 10.1016/j.phrs.2005.10.006
   BOYNE PJ, 1969, J AM DENT ASSOC, V78, P767, DOI 10.1016/S0002-8177(69)84023-7
   Breitbart A. S., 2006, GRABB SMITHS PLASTIC, P1
   Cawcutt KA, 2014, MAYO CLIN PROC, V89, P1572, DOI 10.1016/j.mayocp.2014.07.009
   Childs SG, 2005, ORTHOP NURS, V24, P295
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Chotel F, 2012, ORTHOP TRAUMATOL-SUR, V98, P301, DOI 10.1016/j.otsr.2011.11.008
   Christou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114122
   Cross WW, 2008, INDIAN J ORTHOP, V42, P377, DOI 10.4103/0019-5413.43373
   de Gauzy JS, 2012, ORTHOP TRAUMATOL-SUR, V98, P220, DOI 10.1016/j.otsr.2012.01.001
   de Mones E, 2015, ACTA BIOMATER, V19, P119, DOI 10.1016/j.actbio.2015.03.005
   Dimitriou R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-81
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Dugan TR, 2013, INJURY, V44, P1826, DOI 10.1016/j.injury.2013.03.018
   Gardner MJ, 2008, J ORTHOP TRAUMA, V22, P451, DOI 10.1097/BOT.0b013e318176b8d9
   Gerber A, 2002, INJURY, V33, P43, DOI 10.1016/S0020-1383(02)00132-8
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Giannoudis PV, 2011, INJURY, V42, P591, DOI 10.1016/j.injury.2011.03.036
   Gottlow J., 2010, J JPN SOC PERIDONTOL, V35, P1
   Gouron R., 2013, ORTHOPAEDICA TRAUMAT, V7, P837
   Gouron R, 2017, J TISSUE ENG REGEN M, V11, P382, DOI 10.1002/term.1921
   Gugala Z, 2002, INJURY, V33, P71, DOI 10.1016/S0020-1383(02)00135-3
   Gugala Z, 2007, MACROMOL SYMP, V253, P147, DOI 10.1002/masy.200750722
   GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004
   Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008
   Henrich D, 2013, J TISSUE ENG REGENER
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Huffman LK, 2009, FOOT ANKLE INT, V30, P895, DOI 10.3113/FAI.2009.0895
   HURLEY LA, 1959, J BONE JOINT SURG AM, V41, P1243, DOI 10.2106/00004623-195941070-00007
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Javed A, 1999, J BONE MINER RES, V14, pS165
   Jung RE, 2011, CLIN ORAL IMPLAN RES, V22, P802, DOI 10.1111/j.1600-0501.2010.02068.x
   Kanczler J. M., 2008, EUR CELLS MATER, V29, P3105
   Karger C, 2012, ORTHOP TRAUMATOL-SUR, V98, P97, DOI 10.1016/j.otsr.2011.11.001
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Killion JA, 2013, MAT SCI ENG C-MATER, V33, P4203, DOI 10.1016/j.msec.2013.06.013
   Kinoshita Y., 2004, JMAJ, V47, P294
   Klaue K, 1995, REV CHIR ORTHOP S, V70, P109
   Klaue K, 2009, INJURY, V40, pS95, DOI 10.1016/j.injury.2009.10.043
   Kurobe H, 2012, STEM CELL TRANSL MED, V1, P566, DOI 10.5966/sctm.2012-0044
   Lasanianos NG, 2010, ORTHOP TRAUMA, V24, P149, DOI 10.1016/j.mporth.2009.10.003
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   Makridis KG, 2014, FOOT ANKLE SURG, V20, pE19, DOI 10.1016/j.fas.2013.11.006
   Marais LC, 2015, STRATEG TRAUMA LIMB, V10, P27, DOI 10.1007/s11751-015-0221-7
   Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346
   Masquelet AC, 2003, LANGENBECK ARCH SURG, V388, P344, DOI 10.1007/s00423-003-0379-1
   Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Meinig RP, 2010, ORTHOP CLIN N AM, V41, P39, DOI 10.1016/j.ocl.2009.07.012
   Mekhail O. A., 2004, J TRAUMA ACUTE CARE, V56, P368
   Micev AJ, 2015, J HAND SURG-AM, V40, P593, DOI 10.1016/j.jhsa.2014.12.007
   Motsitsi NS, 2012, E CENT AFR J SURG, V17, P1
   Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513
   Najafpour A, 2013, INT J SURG, V11, P1010, DOI 10.1016/j.ijsu.2013.05.034
   O'Malley NT, 2012, ARCH ORTHOP TRAUM SU, V132, P245, DOI 10.1007/s00402-011-1417-z
   OGISO B, 1991, J CELL PHYSIOL, V146, P442, DOI 10.1002/jcp.1041460315
   OSTERMANN PAW, 1995, J BONE JOINT SURG BR, V77B, P93
   PATZAKIS MJ, 1989, CLIN ORTHOP RELAT R, P36
   Pelissier P, 2002, BRIT J PLAST SURG, V55, P596, DOI 10.1054/bjps.2002.3936
   PELISSIER P.H, 2006, J ORTHOP RES, V22, P73
   Precheur Harry V, 2007, Dent Clin North Am, V51, P729
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Schenk R. K., 1994, HISTOLOGIC ULTRASTRU, P117
   SCHMID J, 1994, CLIN ORAL IMPLAN RES, V5, P125, DOI 10.1034/j.1600-0501.1994.050302.x
   Stevenson S, 1996, CLIN ORTHOP RELAT R, P66
   Suneelkumar C., 2008, J CONVERVATIVE DENT, V11, P1
   Toba T., 2004, JPN MED ASS J, V47, P282
   Uzel AP, 2010, ORTHOP TRAUMATOL-SUR, V96, P194, DOI [10.1016/j.rcot.2010.02.001, 10.1016/j.otsr.2009.10.017]
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   WEILAND AJ, 1984, PLAST RECONSTR SURG, V74, P368, DOI 10.1097/00006534-198409000-00006
   Wiese A, 2010, ORTHOP CLIN N AM, V41, P1, DOI 10.1016/j.ocl.2009.07.003
   Wong TM, 2014, SCI WORLD J, V2014
   Woon CYL, 2010, J BONE JOINT SURG AM, V92A, P196, DOI [10.2106/JBJS.1.00273, 10.2106/JBJS.I.00273]
   Zadegan SA, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00012
   Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d
   Zalavras CG, 2003, J AM ACAD ORTHOP SUR, V11, P212
   Zhou J., 2012, OSTEOGENESIS
NR 90
TC 6
Z9 6
U1 4
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR 23
PY 2016
VL 5
IS 6
BP 630
EP 640
DI 10.1002/adhm.201500793
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DH9LA
UT WOS:000373116400001
PM 26855349
DA 2018-10-20
ER

PT J
AU Amoako, KA
   Sundaram, HS
   Suhaib, A
   Jiang, SY
   Cook, KE
AF Amoako, Kagya A.
   Sundaram, Harihara S.
   Suhaib, Ahmed
   Jiang, Shaoyi
   Cook, Keith E.
TI Multimodal, Biomaterial-Focused Anticoagulation via Superlow Fouling
   Zwitterionic Functional Groups Coupled with Anti-Platelet Nitric Oxide
   Release
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
DE anti-fouling coatings; blood-contacting surfaces; nitric oxide; platelet
   adsorption; zwitterionic polycarboxybetaine
ID SURFACE-CHEMISTRY; EXTRACORPOREAL-CIRCULATION; PROTEIN ADSORPTION;
   POLYMER; PLATELET; SILICONE; ADHESION; MODEL; ACCUMULATION; RESISTANCE
AB The functions of anti-fouling, zwitterionic polycarboxybetaine (pCB) coating, and anti-platelet nitric oxide (NO) release replicate key anticoagulant properties of the endothelium. The two approaches, only tested separately thus far, are paired on gas permeable polydimethylsiloxane (PDMS) membranes and evaluated for fibrinogen (Fg) and platelet adsorption. Uncoated (control) and pCB-coated PDMS separate sheep plasma (10(8) platelets per milliliter) and gas flow chambers within bioreactors used in this study, and either 100 or 0 ppm of NO/N-2 flows through the gas chamber so PDMS transfers NO into flowing plasma. Surface-adsorbed platelets are quantified using a lactate dehydrogenase assay after 8h plasma recirculation. Fg and platelet adsorption on pCB-coated PDMS are 10.40% +/- 3.0% of control (p < 0.01) and 23.3% +/- 7.4% (p < 0.01) of control, respectively. NO flux alone limits platelet adsorption to 79.0% +/- 5.0% (p < 0.05) of control. Together, NO and pCB reduce platelet adsorption to 6.90% +/- 1.30% of control (p < 0.001). The data suggest that pCB coating and NO act in concert to reduce platelet fouling at significantly higher levels than either pCB coating or NO release alone.
C1 [Amoako, Kagya A.] Univ New Haven, Tagliatela Coll Engn Biomed Engn, West Haven, CT 06516 USA.
   [Sundaram, Harihara S.; Jiang, Shaoyi] Dept Chem Engn, Seattle, WA USA.
   [Suhaib, Ahmed] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Cook, Keith E.] Carnegie Mellon Univ, Dept Biomed Engn, 700 Technol Dr, Pittsburgh, PA 15219 USA.
RP Amoako, KA (reprint author), Univ New Haven, Tagliatela Coll Engn Biomed Engn, West Haven, CT 06516 USA.; Cook, KE (reprint author), Carnegie Mellon Univ, Dept Biomed Engn, 700 Technol Dr, Pittsburgh, PA 15219 USA.
EM Kamoako@newhaven.edu; keicook@andrew.cmu.edu
FU NIH [R01 HL089043, NIH 5T32HL007853-15]
FX This work was supported by NIH grants R01 HL089043 and NIH
   5T32HL007853-15. The authors thank Jiang lab at the University of
   Washington, Chemical Engineering Department, for assisting with surface
   coatings. The authors also thank Dr. Robert Bartlett's Extracorporeal
   Life Support Laboratory at the University of Michigan for their
   assistance.
CR Amoako K. A., 2011, THESIS U MICHIGAN
   Amoako KA, 2013, J BIOMED MATER RES A, V101, P3511, DOI 10.1002/jbm.a.34655
   Amoako KA, 2012, ASAIO J, V58, P238, DOI 10.1097/MAT.0b013e31824abed5
   Amoako KA, 2011, ASAIO J, V57, P539, DOI 10.1097/MAT.0b013e31823b9692
   Anderson TH, 2010, ADV FUNCT MATER, V20, P4196, DOI 10.1002/adfm.201000932
   Campbell E J, 1994, ASAIO J, V40, pM853, DOI 10.1097/00002480-199407000-00118
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Davidson D, 1998, PEDIATRICS, V101, P325, DOI 10.1542/peds.101.3.325
   Demirkilic U, 2004, J BIOACT COMPAT POL, V19, P395, DOI 10.1177/0883911504046690
   Gao CL, 2010, BIOMATERIALS, V31, P1486, DOI 10.1016/j.biomaterials.2009.11.025
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gupta S, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400012
   Howlett R, 1998, NATURE, V395, P625, DOI 10.1038/27019
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kang SM, 2010, ANGEW CHEM INT EDIT, V49, P9401, DOI 10.1002/anie.201004693
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Lantvit SM, 2013, J BIOMED MATER RES A, V101, P3201, DOI 10.1002/jbm.a.34627
   Larson DF, 2000, PERFUSION-UK, V15, P13, DOI 10.1177/026765910001500103
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Major TC, 2011, BIOMATERIALS, V32, P5957, DOI 10.1016/j.biomaterials.2011.03.036
   Major TC, 2010, BIOMATERIALS, V31, P2736, DOI 10.1016/j.biomaterials.2009.12.028
   Nakagawa TA, 1997, J PEDIATR-US, V131, P63, DOI 10.1016/S0022-3476(97)70125-2
   Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0
   Roman A, 2004, J PEDIATR SURG, V39, P48, DOI 10.1053/S0022-3468(03)00676-6
   Sundaram HS, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400071
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   Yang W, 2012, BIOMATERIALS, V33, P7945, DOI 10.1016/j.biomaterials.2012.07.035
   Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031
   Yoshinari N., 1999, ANESTH ANALG, V89, P573
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhang Z, 2008, BIOMACROMOLECULES, V9, P2686, DOI 10.1021/bm800407r
   Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200
   Zhu YH, 2014, BIOMACROMOLECULES, V15, P1845, DOI 10.1021/bm500209a
NR 42
TC 8
Z9 8
U1 7
U2 60
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD MAR 23
PY 2016
VL 3
IS 6
AR 1500646
DI 10.1002/admi.201500646
PG 9
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA DH9XN
UT WOS:000373149400008
DA 2018-10-20
ER

PT J
AU Asadi-Eydivand, M
   Solati-Hashjin, M
   Shafiei, SS
   Mohammadi, S
   Hafezi, M
   Abu Osman, NA
AF Asadi-Eydivand, Mitra
   Solati-Hashjin, Mehran
   Shafiei, Seyedeh Sara
   Mohammadi, Sepideh
   Hafezi, Masoud
   Abu Osman, Noor Azuan
TI Structure, Properties, and In Vitro Behavior of Heat-Treated Calcium
   Sulfate Scaffolds Fabricated by 3D Printing
SO PLOS ONE
LA English
DT Article
ID 3-DIMENSIONAL SCAFFOLDS; ENGINEERING SCAFFOLDS; REGENERATIVE MEDICINE;
   MECHANICAL-PROPERTIES; BONE SCAFFOLDS; FILL DEFECTS; TISSUE; DESIGN;
   PHOSPHATE; BIOMATERIALS
AB The ability of inkjet-based 3D printing (3DP) to fabricate biocompatible ceramics has made it one of the most favorable techniques to generate bone tissue engineering (BTE) scaffolds. Calcium sulfates exhibit various beneficial characteristics, and they can be used as a promising biomaterial in BTE. However, low mechanical performance caused by the brittle character of ceramic materials is the main weakness of 3DP calcium sulfate scaffolds. Moreover, the presence of certain organic matters in the starting powder and binder solution causes products to have high toxicity levels. A post-processing treatment is usually employed to improve the physical, chemical, and biological behaviors of the printed scaffolds. In this study, the effects of heat treatment on the structural, mechanical, and physical characteristics of 3DP calcium sulfate prototypes were investigated. Different microscopy and spectroscopy methods were employed to characterize the printed prototypes. The in vitro cytotoxicity of the specimens was also evaluated before and after heat treatment. Results showed that the as-printed scaffolds and specimens heat treated at 300 degrees C exhibited severe toxicity in vitro but had almost adequate strength. By contrast, the specimens heat treated in the 500 degrees C-1000 degrees C temperature range, although non-toxic, had insufficient mechanical strength, which was mainly attributed to the exit of the organic binder before 500 degrees C and the absence of sufficient densification below 1000 degrees C. The sintering process was accelerated at temperatures higher than 1000 degrees C, resulting in higher compressive strength and less cytotoxicity. An anhydrous form of calcium sulfate was the only crystalline phase existing in the samples heated at 500 degrees C-1150 degrees C. The formation of calcium oxide caused by partial decomposition of calcium sulfate was observed in the specimens heat treated at temperatures higher than 1200 degrees C. Although considerable improvements in cell viability of heat-treated scaffolds were observed in this study, the mechanical properties were not significantly improved, requiring further investigations. However, the findings of this study give a better insight into the complex nature of the problem in the fabrication of synthetic bone grafts and scaffolds via post-fabrication treatment of 3DP calcium sulfate prototypes.
C1 [Asadi-Eydivand, Mitra; Hafezi, Masoud; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Solati-Hashjin, Mehran; Mohammadi, Sepideh] Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran.
   [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran.
   [Shafiei, Seyedeh Sara] Natl Inst Genet Engn & Biotechnol, Stem Cell & Regenerat Med Grp, Tehran 14965161, Iran.
RP Abu Osman, NA (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.; Solati-Hashjin, M (reprint author), Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran.; Solati-Hashjin, M (reprint author), Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran.
EM solati@aut.ac.ir; azuan@um.edu.my
RI engineering, @UM-2016/I-9329-2016; Hafezi Ardakani, Masoud/K-3589-2013;
   Engineering, Faculty/I-7935-2015
OI Hafezi Ardakani, Masoud/0000-0002-7199-3180; Engineering,
   Faculty/0000-0002-4848-7052; Shafiei, Seyedeh Sara/0000-0002-4517-5969
FU University of Malaya [UM.C/HIR/MOHE/ENG/14 D000014-16001]
FX This study was supported by High Impact Research Grant
   UM.C/HIR/MOHE/ENG/14 D000014-16001 from the University of Malaya.
CR Aghajani F, 2004, DENT MATER J, V23, P373, DOI 10.4012/dmj.23.373
   Amini A. R., 2012, CRITICAL REV BIOMEDI, V40
   Asadi-Eydivand M, 2016, ROBOT CIM-INT MANUF, V37, P57, DOI 10.1016/j.rcim.2015.06.005
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833
   Bergmann C, 2010, J EUR CERAM SOC, V30, P2563, DOI 10.1016/j.jeurceramsoc.2010.04.037
   Blom A, 2007, CURR ORTHOPAED, V21, P280, DOI 10.1016/j.cuor.2007.06.005
   Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Brand RA, 2012, CLIN ORTHOP RELAT R, V470, P3628, DOI 10.1007/s11999-012-2571-5
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Chen AA, 2007, BIOMEMS BIOMEDICAL N, P23
   Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4
   Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7
   Farzadi A, 2014, EFFECT LAYER THICKNE, DOI [10.1371/journal.pone.0108252, DOI 10.1371/JOURNAL.PONE.0108252]
   Farzadi A, 2015, CERAM INT, V41, P8320, DOI 10.1016/j.ceramint.2015.03.004
   Fereshteh Z, 2015, MAT SCI ENG C-MATER, V54, P50, DOI 10.1016/j.msec.2015.05.011
   Frascati J., 2007, THESIS U CENTRAL FLO
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Guo BL, 2015, REGEN BIOMATER, V2, P47, DOI 10.1093/rb/rbu016
   Hollinger J. O., 2011, INTRO BIOMATERIALS
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Impens D., 2015, THESIS U WINDSOR
   Insights P., BONE REGENERATION CA
   Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kassim B, 2014, AUST DENT J, V59, P48, DOI 10.1111/adj.12098
   Khalyfa A, 2007, J MATER SCI-MATER M, V18, P909, DOI 10.1007/s10856-006-0073-2
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Mazzoli A, 2015, RAPID PROTOTYPING J, V21, P386, DOI 10.1108/RPJ-04-2013-0040
   Munch E, 2008, JOM-US, V60, P54, DOI 10.1007/s11837-008-0072-5
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184
   Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007
   Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021
   PELTIER LF, 1957, ANN SURG, V146, P61, DOI 10.1097/00000658-195707000-00007
   Pina S, 2015, ADV MATER, V27, P1143, DOI 10.1002/adma.201403354
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Rajzer I, 2014, MAT SCI ENG C-MATER, V44, P183, DOI 10.1016/j.msec.2014.08.017
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Rauschmann M, 2010, EUR SPINE J, V19, P887, DOI 10.1007/s00586-010-1279-z
   Razak SIA, 2012, INT J BASIC APPL SCI, V12, P31
   Sadeghpour S, 2014, CERAM INT, V40, P16107, DOI 10.1016/j.ceramint.2014.07.039
   Sadiasa A, 2014, J BIOMAT SCI-POLYM E, V25, P150, DOI 10.1080/09205063.2013.846633
   Shen Y, 2014, ACS APPL MATER INTER, V6, P12177, DOI 10.1021/am501448t
   Sottosanti J, 1992, Compendium, V13, P226
   Suwanprateeb J, 2010, J MATER SCI-MATER M, V21, P419, DOI 10.1007/s10856-009-3883-1
   Swift W. M., 1976, DECOMPOSITION CALCIU
   Technology NIoSa, 2011, 2 PYRR INFR SPECTR
   Technology NIoSa, 2011, WAT INFR SPECTR
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Thomas MV, 2005, J LONG TERM EFFECTS, V15
   Trdnost VPDNN, 2013, MATER TEHNOL, V47, P781
   Utela B, 2008, J MANUFACTURING PROC, V10, P96, DOI DOI 10.1016/J.JMAPRO.2009.03.002
   Vorndran E, 2011, ADV APPL CERAM, V110, P476, DOI 10.1179/1743676111Y.0000000030
   Vorndran E, 2015, MRS BULL, V40, P127, DOI 10.1557/mrs.2015.326
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Zhou Z, 2012, ISRN BIOMATERIALS, P2013
   Zhou ZX, 2014, MAT SCI ENG C-MATER, V38, P1, DOI 10.1016/j.msec.2014.01.027
NR 68
TC 10
Z9 10
U1 5
U2 69
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2016
VL 11
IS 3
AR e0151216
DI 10.1371/journal.pone.0151216
PG 29
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH3NW
UT WOS:000372694700027
PM 26999789
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cui, Y
   Han, J
   Xiao, ZF
   Chen, T
   Wang, B
   Chen, B
   Liu, SM
   Han, SF
   Fang, YX
   Wei, JS
   Wang, XJ
   Ma, X
   Dai, JW
AF Cui, Yi
   Han, Jin
   Xiao, Zhifeng
   Chen, Tong
   Wang, Bin
   Chen, Bing
   Liu, Sumei
   Han, Sufang
   Fang, Yongxiang
   Wei, Jianshu
   Wang, Xiujie
   Ma, Xu
   Dai, Jianwu
TI The miR-20-Rest-Wnt signaling axis regulates neural progenitor cell
   differentiation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; STEM-CELL; NEURONAL DIFFERENTIATION;
   SELF-RENEWAL; MICRORNAS; SCAFFOLDS; PATHWAY; FATE; REST; PROLIFERATION
AB Increasing evidence suggests that three dimensional (3-D) cell cultures are an improvement over traditional two dimensional (2-D) cell cultures. Current researches have extensively focused on the study of utilizing biomaterial-based 3-D culture systems to study and direct stem-cell fate both in vitro and in vivo. Here in our study, we screened the differential expression patterns of miRNAs between 2-D cultured and 3-D cultured NPCs using microarray analysis. Among these differentially expressed miRNAs, miR-20 was found to increase during differentiation of NPCs. Specifically, the facilitative effect on neural differentiation of miR-20 is mediated, at least in part by directly target the Rest gene, which is essential for preventing neural differentiation and maintaining NPCs self-renewal. Furthermore, the expression of miR-20 was decreased when the WNT pathway was inhibited by knock down of beta-catenin or by exogenous Dkk protein, whereas it increased when the WNT pathway was activated by exogenous Wnt3a protein. Overall, miR-20, Rest and Wnt signaling are suggested to be involved in a regulatory circuit that can modulate the neural differention of NPCs. This novel regulatory circuit provides additional insight into how microRNAs interact with signaling molecules during neural differentiation of NPCs, allowing for fine-tuning of intricate cellular processes.
C1 [Cui, Yi; Ma, Xu] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing 100081, Peoples R China.
   [Cui, Yi; Han, Jin; Xiao, Zhifeng; Wang, Bin; Chen, Bing; Liu, Sumei; Han, Sufang; Wei, Jianshu; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100190, Peoples R China.
   [Chen, Tong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Chen, Tong; Wang, Xiujie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.
   [Fang, Yongxiang] CAAS, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Publ Hlth,Minist Agr, Lanzhou 730046, Peoples R China.
RP Ma, X (reprint author), Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing 100081, Peoples R China.; Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100190, Peoples R China.
EM genetic88@126.com; jwdai@genentics.ac.cn
FU Ministry of Science and Technology of China [2011CB965001]; National
   Science Foundation of China [30930032, 31200813]
FX This work was supported by the Ministry of Science and Technology of
   China (2011CB965001) and the National Science Foundation of China
   (30930032 and 31200813).
CR Akerblom M, 2014, NEUROSCIENTIST, V20, P235, DOI 10.1177/1073858413497265
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Cui Y, 2014, STEM CELLS DEV, V23, P393, DOI 10.1089/scd.2013.0342
   Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116
   Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18
   Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621
   Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003
   Han J, 2013, BIOMATERIALS, V34, P1921, DOI 10.1016/j.biomaterials.2012.11.063
   Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165
   Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066
   Jo J, 2011, BRIEF FUNCT GENOMICS, V10, P175, DOI 10.1093/bfgp/elr012
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Lang MF, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00071
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mayer RP, 2005, J COLLOID INTERF SCI, V285, P781, DOI 10.1016/j.jcis.2004.11.067
   Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104
   Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334
   Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023
   Nishihara S, 2003, BIOCHEM BIOPH RES CO, V311, P55, DOI 10.1016/j.bbrc.2003.09.158
   Pham JT, 2012, AM J STEM CELLS, V1, P182
   Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973
   Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004
   Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004
   Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200
   Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174
   Threlfall RN, 2012, ORG BIOMOL CHEM, V10, P746, DOI 10.1039/c1ob06614e
   Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102
   Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8
NR 38
TC 15
Z9 16
U1 2
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 21
PY 2016
VL 6
AR 23300
DI 10.1038/srep23300
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0AK
UT WOS:000372444700001
PM 26996236
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Oh, DX
   Cha, YJ
   Nguyen, HL
   Je, HH
   Jho, YS
   Hwang, DS
   Yoon, DK
AF Oh, Dongyeop X.
   Cha, Yun Jeong
   Hoang-Linh Nguyen
   Je, Hwa Heon
   Jho, Yong Seok
   Hwang, Dong Soo
   Yoon, Dong Ki
TI Chiral nematic self-assembly of minimally surface damaged chitin
   nanofibrils and its load bearing functions
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESOPOROUS SILICA; COMPOSITES; FILMS; CHITOSAN; COMPLEX; CUTICLE
AB Chitin is one of the most abundant biomaterials in nature, with 1010 tons produced annually as hierarchically organized nanofibril fillers to reinforce the exoskeletons of arthropods. This green and cheap biomaterial has attracted great attention due to its potential application to reinforce biomedical materials. Despite that, its practical use is limited since the extraction of chitin nanofibrils requires surface modification involving harsh chemical treatments, leading to difficulties in reproducing their natural prototypal hierarchical structure, i.e. chiral nematic phase. Here, we develop a chemical etching-free approach using calcium ions, called "natural way", to disintegrate the chitin nanofibrils while keeping the essential moiety for the self-assembly, ultimately resulting in the reproduction of chitin's natural chiral structure in a polymeric matrix. This chiral chitin nanostructure exceptionally toughens the composite. Our resultant chiral nematic phase of chitin materials can contribute to the understanding and use of the reinforcing strategy in nature.
C1 [Oh, Dongyeop X.] Korea Res Inst Chem Technol, Res Ctr Ind Chem Biotechnol, Ulsan 44429, South Korea.
   [Cha, Yun Jeong; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.
   [Cha, Yun Jeong; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, KINC, Taejon 305701, South Korea.
   [Hoang-Linh Nguyen; Je, Hwa Heon; Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.
   [Jho, Yong Seok] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea.
   [Jho, Yong Seok] Asia Pacific Ctr Theoret Phys, Pohang 790784, South Korea.
   [Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea.
RP Yoon, DK (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.; Yoon, DK (reprint author), Korea Adv Inst Sci & Technol, KINC, Taejon 305701, South Korea.; Hwang, DS (reprint author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.; Hwang, DS (reprint author), Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea.
EM dshwang@postech.ac.kr; nandk@kaist.ac.kr
RI Yoon, Dong Ki/C-9670-2011
OI Yoon, Dong Ki/0000-0002-9383-8958; Oh, Dongyeop/0000-0003-3665-405X;
   Hwang, Dong Soo/0000-0002-2487-2255
FU National Research Foundation (NRF) - Korean Government (MSIP)
   [2014R1A2A2A01006724, C1ABA001-2011-0029960, 2015R1A1A1A05000986,
   2012M3A7B4049802]; Marine Biomaterials Research Centre - Ministry of
   Oceans and Fisheries, Korea [D11013214H480000110]
FX This work was supported by the grant from the National Research
   Foundation (NRF), funded by the Korean Government (MSIP)
   (2014R1A2A2A01006724, C1ABA001-2011-0029960, 2015R1A1A1A05000986 and
   2012M3A7B4049802). This work was also supported by the Marine
   Biomaterials Research Centre grant (D11013214H480000110) funded by the
   Ministry of Oceans and Fisheries, Korea.
CR Andersons J, 2004, COMPOS SCI TECHNOL, V64, P2139, DOI 10.1016/j.compscitech.2004.03.007
   Bar-On B., 2014, NAT COMMUN, V5, P1
   Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307
   COOK WJ, 1973, J AM CHEM SOC, V95, P6442, DOI 10.1021/ja00800a048
   Das P, 2012, BIOMACROMOLECULES, V13, P4205, DOI 10.1021/bm3014796
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822
   Fernandez JG, 2013, ADV FUNCT MATER, V23, P4454, DOI 10.1002/adfm.201300053
   Gordon LM, 2011, NATURE, V469, P194, DOI 10.1038/nature09686
   Grunenfelder LK, 2014, ACTA BIOMATER, V10, P3997, DOI 10.1016/j.actbio.2014.03.022
   Gyliene O, 2002, WATER RES, V36, P4128, DOI 10.1016/S0043-1354(02)00105-7
   HOICZYK E, 1995, J BACTERIOL, V177, P2387, DOI 10.1128/jb.177.9.2387-2395.1995
   Ifuku S, 2010, CARBOHYD POLYM, V81, P134, DOI 10.1016/j.carbpol.2010.02.006
   Kato Y, 2004, CARBOHYD POLYM, V58, P421, DOI 10.1016/j.carbpol.2004.08.011
   Liu Q, 2014, ADV MATER, V26, P7178, DOI 10.1002/adma.201402699
   Majtan J, 2007, INT J BIOL MACROMOL, V40, P237, DOI 10.1016/j.ijbiomac.2006.07.010
   Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117
   Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019
   Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H
   Park JH, 2014, CHEMPHYSCHEM, V15, P1477, DOI 10.1002/cphc.201400062
   Shopsowitz KE, 2010, NATURE, V468, P422, DOI 10.1038/nature09540
   Tamura H, 2006, CELLULOSE, V13, P357, DOI 10.1007/s10570-006-9058-z
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   TANIEWSKAOSINSKA S, 1984, J CHEM SOC FARAD T 1, V80, P1409, DOI 10.1039/f19848001409
   Nguyen TD, 2014, ADV OPT MATER, V2, P1031, DOI 10.1002/adom.201400279
   Nguyen TD, 2013, CHEM-EUR J, V19, P15148, DOI 10.1002/chem.201301929
   Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7
   Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764
   Zeng J. B., 2011, BIOMACROMOLECULES, V13, P1
   Zimmermann EA, 2013, NAT COMMUN, V4, P1
NR 30
TC 6
Z9 6
U1 2
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 18
PY 2016
VL 6
AR 23245
DI 10.1038/srep23245
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0IR
UT WOS:000372468200003
PM 26988392
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mozdzen, LC
   Rodgers, R
   Banks, JM
   Bailey, RC
   Harley, BAC
AF Mozdzen, Laura C.
   Rodgers, Ryan
   Banks, Jessica M.
   Bailey, Ryan C.
   Harley, Brendan A. C.
TI Increasing the strength and bioactivity of collagen scaffolds using
   customizable arrays of 3D-printed polymer fibers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Composite CG scaffolds; Tunable mechanics; Tendon tissue engineering;
   Three-dimensional printing
ID GROWTH-FACTOR SUPPLEMENTATION; TENDON MECHANICAL-PROPERTIES; BOVINE
   TRABECULAR BONE; GAG SCAFFOLDS; GLYCOSAMINOGLYCAN SCAFFOLDS; TENOCYTE
   BIOACTIVITY; COMPOSITE SCAFFOLDS; PLANT STEMS; REGENERATION; MATRIX
AB Tendon is a highly aligned connective tissue which transmits force from muscle to bone. Each year, people in the US sustain more than 32 million tendon injuries. To mitigate poor functional outcomes due to scar formation, current surgical techniques rely heavily on autografts. Biomaterial platforms and tissue engineering methods offer an alternative approach to address these injuries. Scaffolds incorporating aligned structural features can promote expansion of adult tenocytes and mesenchymal stem cells capable of tenogenic differentiation. However, appropriate balance between scaffold bioactivity and mechanical strength of these constructs remains challenging. The high porosity required to facilitate cell infiltration, nutrient and oxygen biotransport within three-dimensional constructs typically results in insufficient biomechanical strength. Here we describe the use of three-dimensional printing techniques to create customizable arrays of acrylonitrile butadiene styrene (ABS) fibers that can be incorporated into a collagen scaffold under development for tendon repair. Notably, mechanical performance of scaffold fiber composites (elastic modulus, peak stress, strain at peak stress, and toughness) can be selectively manipulated by varying fiber-reinforcement geometry without affecting the native bioactivity of the collagen scaffold. Further, we report an approach to functionalize ABS fibers with activity-inducing growth factors via sequential oxygen plasma and carbodiimide crosslinking treatments. Together, we report an adaptable approach to control both mechanical strength and presence of biomolecular cues in a manner orthogonal to the architecture of the collagen scaffold itself.
   Statement of Significance
   Tendon injuries account for more than 32 million injuries each year in the US alone. Current techniques use allografts to mitigate poor functional outcomes, but are not ideal platforms to induce functional regeneration following injury. Tissue engineering approaches using biomaterial substrates have significant potential for addressing these defects. However, the high porosity required to facilitate cell infiltration and nutrient transport often dictates that the resultant biomaterials has insufficient biomechanical strength. Here we describe the use of three-dimensional printing techniques to generate customizable fiber arrays from ABS polymer that can be incorporated into a collagen scaffold under development for tendon repair applications. Notably, the mechanical performance of the fiber-scaffold composite can be defined by the fiber array independent of the bioactivity of the collagen scaffold design. Further, the fiber array provides a substrate for growth factor delivery to aid healing. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mozdzen, Laura C.; Rodgers, Ryan; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Banks, Jessica M.; Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem & Biomol Engn, 110 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Bailey, Ryan/0000-0003-1021-4267; Harley, Brendan/0000-0001-5458-154X
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R21 AR063331]; National Science
   Foundation [0965918]; Support for Under-Represented Groups in
   Engineering (SURGE) Fellowship; DuPont Science and Engineering
   Fellowship; U.S. Department of Energy [DE-FG02-07ER46453,
   DE-FG02-07ER46471]
FX The authors would like to acknowledge Dr. Hyun Joon Kong (UIUC) for
   access to mechanical testing facilities, Dr. Sandra McMasters (SCS,
   UIUC) for preparation of culture media, Dr. Matthew Wheeler for
   providing pASCs, and Richard Graybill for assistance with oxygen plasma
   treatment. Research reported in this publication was supported by the
   National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health under Award Numbers R21 AR063331. LCM
   was partially funded via National Science Foundation Grant 0965918
   IGERT: Training the Next Generation of Researchers in Cellular &
   Molecular Mechanics and BioNanotechnology, as well as the Support for
   Under-Represented Groups in Engineering (SURGE) Fellowship and the
   DuPont Science and Engineering Fellowship. This research was carried out
   in part in the Frederick Seitz Materials Research Laboratory Central
   Facilities, University of Illinois, which are partially supported by the
   U.S. Department of Energy under Grants DE-FG02-07ER46453 and
   DE-FG02-07ER46471.
CR ABRAHAMS M, 1967, MED BIOL ENG, V5, P433, DOI 10.1007/BF02479137
   Alsop AT, 2014, ACTA BIOMATER, V10, P4715, DOI 10.1016/j.actbio.2014.07.002
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Banks JM, 2014, BIOMATERIALS, V35, P8951, DOI 10.1016/j.biomaterials.2014.07.012
   Caliari SR, 2015, ADV HEALTHC MATER, V4, P831, DOI 10.1002/adhm.201400809
   Caliari SR, 2014, J BIOMED MATER RES A, V102, P917, DOI 10.1002/jbm.a.35058
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Freyman TM, 2001, EXP CELL RES, V269, P140, DOI 10.1006/excr.2001.5302
   Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067
   Gibson L. J., 2010, CELLULAR MAT NATURE
   GIBSON LJ, 1995, P R SOC-MATH PHYS SC, V450, P141, DOI 10.1098/rspa.1995.0076
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Hortensius RA, 2015, BIOMATER SCI-UK, V3, P645, DOI [10.1039/c5bm00033e, 10.1039/C5BM00033E]
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Kanungo BP, 2008, ACTA BIOMATER, V4, P490, DOI 10.1016/j.actbio.2008.01.003
   KARAM GN, 1994, MAT SCI ENG C-BIOMIM, V2, P113, DOI 10.1016/0928-4931(94)90039-6
   Keays SL, 2007, AM J SPORT MED, V35, P729, DOI 10.1177/0363546506298277
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Maganaris CN, 2000, J BIOMECH, V33, P1453, DOI 10.1016/S0021-9290(00)00099-3
   Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Mathew A.P., 2012, MACROMOLECULAR BIOSC
   McCoy RJ, 2013, STEM CELLS, V31, P2420, DOI 10.1002/stem.1482
   MICHEL MC, 1993, J BIOMECH, V26, P453, DOI 10.1016/0021-9290(93)90009-4
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Monaco E, 2009, OPEN TISSUE ENG REGE, P20, DOI DOI 10.2174/1875043500902010020
   Moore TLA, 2001, J BIOMECH ENG-T ASME, V123, P613, DOI 10.1115/1.1407828
   Mullen LM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5325-y
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Quinlan E, 2015, BIOMATERIALS, V52, P358, DOI 10.1016/j.biomaterials.2015.02.006
   Serra T, 2013, ACTA BIOMATER, V9, P5521, DOI 10.1016/j.actbio.2012.10.041
   Speck T, 2011, ANNU REV MATER RES, V41, P169, DOI 10.1146/annurev-matsci-062910-100425
   Thorpe CT, 2010, EQUINE VET J, V42, P538, DOI 10.1111/j.2042-3306.2010.00175.x
   Thorpe CT, 2012, J R SOC INTERFACE, V9, P3108, DOI 10.1098/rsif.2012.0362
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Weisgerber DW, 2015, BIOMATER SCI-UK, V3, P533, DOI [10.1039/c4bm00397g, 10.1039/C4BM00397G]
   Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179
   Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 61
TC 16
Z9 16
U1 3
U2 109
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2016
VL 33
BP 25
EP 33
DI 10.1016/j.actbio.2016.02.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DH3LO
UT WOS:000372688700003
PM 26850145
OA Other Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Kuang, R
   Zhang, ZP
   Jin, XB
   Hu, J
   Shi, ST
   Ni, LX
   Ma, PX
AF Kuang, Rong
   Zhang, Zhanpeng
   Jin, Xiaobing
   Hu, Jiang
   Shi, Songtao
   Ni, Longxing
   Ma, Peter X.
TI Nanofibrous spongy microspheres for the delivery of hypoxia-primed human
   dental pulp stem cells to regenerate vascularized dental pulp
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Regeneration; Stem cell; Dental pulp; Hypoxic; Biomaterial; Microcarrier
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ODONTOGENIC DIFFERENTIATION;
   INDUCIBLE FACTOR-1; SCAFFOLDS; ANGIOGENESIS; TEETH; HIF-1-ALPHA;
   ACTIVATION; LIVER
AB Dental pulp infection and necrosis are widespread diseases. Conventional endodontic treatments result in a devitalized and weakened tooth. In this work, we synthesized novel star-shaped polymer to self assemble into unique nanofibrous spongy microspheres (NF-SMS), which were used to carry human dental pulp stem cells (hDPSCs) into the pulp cavity to regenerate living dental pulp tissues. It was found that NF-SMS significantly enhanced hDPSCs attachment, proliferation, odontogenic differentiation and angiogenesis, as compared to control cell carriers. Additionally, NF-SMS promoted vascular endothelial growth factor (VEGF) expression of hDPSCs in a 3D hypoxic culture. Hypoxia-primed hDPSCs/NF-SMS complexes were injected into the cleaned pulp cavities of rabbit molars for subcutaneous implantation in mice. After 4 weeks, the hypoxia group significantly enhanced angiogenesis inside the pulp chamber and promoted the formation of ondontoblast-like cells lining along the dentin pulp interface, as compared to the control groups (hDPSCs alone group, NF-SMS alone group, and hDPSCsiNF-SMS group pre-cultured under normoxic conditions). Furthermore, in an in situ dental pulp repair model in rats, hypoxia-primed hDPSCsiNF-SMS were injected to fully fill the pulp cavity and regenerate pulp-like tissues with a rich vasculature and a histological structure similar to the native pulp.
   Statement of Significance
   Vascularization is key to the regeneration of many vital tissues. However, it is challenging to create a suitable microenvironment for stem cells to regenerate vascularized tissue structure. This manuscript reports a novel star-shaped block copolymer that self-assembles into unique nanofibrous spongy microspheres, which as an injectable scaffold recapitulate the cell cell and cell matrix interactions in development. Using a clinically-relevant surgical procedure and a hypoxic treatment, the nanofibrous spongy micro spheres were used to deliver stem cells and successfully regenerate dental pulp with a rich vasculature and a complex histologic structure similar to that of the native dental pulp. The novel microspheres can likely be used to regenerate many other vascularized tissues. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kuang, Rong; Jin, Xiaobing; Hu, Jiang; Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.
   [Kuang, Rong; Ni, Longxing] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Zhang, Zhanpeng; Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Shi, Songtao] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, 240 S 40th St, Philadelphia, PA 19104 USA.
RP Ma, PX (reprint author), Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.; Ni, LX (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
EM nilx2007@gmail.com; mapx@umich.edu
RI Zhang, Zhanpeng/F-2272-2015
OI Zhang, Zhanpeng/0000-0002-6451-7004
FU NIH [NIDCR DE022327, DE015384, NHLBI HL114038]; DOD [W81XWH-12-2-0008];
   NSF [DMR-1206575]
FX The authors gratefully acknowledge financial support from the NIH (NIDCR
   DE022327, DE015384, and NHLBI HL114038: PXM), DOD (W81XWH-12-2-0008:
   PXM), and NSF (DMR-1206575: PXM).
CR Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944
   Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013
   Atari M, 2012, J CELL SCI, V125, P3343, DOI 10.1242/jcs.096537
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Chen FP, 2010, ACTA BIOMATER, V6, P3199, DOI 10.1016/j.actbio.2010.02.049
   CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45
   Dammaschke T, 2003, J ENDODONT, V29, P638, DOI 10.1097/00004770-200310000-00006
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   El-Backly RM, 2008, AUST ENDOD J, V34, P52, DOI 10.1111/j.1747-4477.2008.00139.x
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Huang AHC, 2009, J ENDODONT, V35, P673, DOI 10.1016/j.joen.2009.01.019
   Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kuang R, 2015, ADV HEALTHC MATER, V4, P1993, DOI 10.1002/adhm.201500308
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Ma DD, 2012, J ENDODONT, V38, P796, DOI 10.1016/j.joen.2012.02.014
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958
   Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012
   Perry BC, 2008, TISSUE ENG PT C-METH, V14, P149, DOI 10.1089/ten.tec.2008.0031
   Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677
   Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6
   Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408
   Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7
   Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008
   Yu CY, 2002, ARCH ORAL BIOL, V47, P529, DOI 10.1016/S0003-9969(02)00036-5
   Zhang Z., CELL CARRIERS MICROP
NR 41
TC 15
Z9 16
U1 4
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2016
VL 33
BP 225
EP 234
DI 10.1016/j.actbio.2016.01.032
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DH3LO
UT WOS:000372688700022
PM 26826529
OA Other Gold
DA 2018-10-20
ER

PT J
AU Torres, AM
   Matheny, JB
   Keaveny, TM
   Taylor, D
   Rimnac, CM
   Hernandez, CJ
AF Torres, Ashley M.
   Matheny, Jonathan B.
   Keaveny, Tony M.
   Taylor, David
   Rimnac, Clare M.
   Hernandez, Christopher J.
TI Material heterogeneity in cancellous bone promotes deformation recovery
   after mechanical failure
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; bone remodeling; fracture mechanics; advanced glycation end
   products; cellular solid
ID HUMAN CORTICAL BONE; AGE-RELATED-CHANGES; TRABECULAR BONE; NONENZYMATIC
   GLYCATION; FRACTURE CRITERIA; TOUGHNESS; MICRODAMAGE; STRENGTH; CRACKS;
   OSTEOPOROSIS
AB Many natural structures use a foam core and solid outer shell to achieve high strength and stiffness with relatively small amounts of mass. Biological foams, however, must also resist crack growth. The process of crack propagation within the struts of a foam is not well understood and is complicated by the foam microstructure. We demonstrate that in cancellous bone, the foam-like component of whole bones, damage propagation during cyclic loading is dictated not by local tissue stresses but by heterogeneity of material properties associated with increased ductility of strut surfaces. The increase in surface ductility is unexpected because it is the opposite pattern generated by surface treatments to increase fatigue life in man-made materials, which often result in reduced surface ductility. We show that the more ductile surfaces of cancellous bone are a result of reduced accumulation of advanced glycation end products compared with the strut interior. Damage is therefore likely to accumulate in strut centers making cancellous bone more tolerant of stress concentrations at strut surfaces. Hence, the structure is able to recover more deformation after failure and return to a closer approximation of its original shape. Increased recovery of deformation is a passive mechanism seen in biology for setting a broken bone that allows for a better approximation of initial shape during healing processes and is likely the most important mechanical function. Our findings suggest a previously unidentified biomimetic design strategy in which tissue level material heterogeneity in foams can be used to improve deformation recovery after failure.
C1 [Torres, Ashley M.; Matheny, Jonathan B.; Hernandez, Christopher J.] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
   [Torres, Ashley M.; Matheny, Jonathan B.; Hernandez, Christopher J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
   [Keaveny, Tony M.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
   [Taylor, David] Trinity Coll Dublin, Dept Mech & Mfg Engn, Dublin 2, Ireland.
   [Rimnac, Clare M.] Case Western Reserve Univ, Dept Mech Engn, Cleveland, OH 44106 USA.
   [Hernandez, Christopher J.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.
RP Hernandez, CJ (reprint author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.; Hernandez, CJ (reprint author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Hernandez, CJ (reprint author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.
EM cjh275@cornell.edu
RI Hernandez, Christopher/B-5290-2009
OI Hernandez, Christopher/0000-0002-0712-6533; Rimnac,
   Clare/0000-0001-9981-8723; Matheny, Jonathan/0000-0003-4046-9615
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health Award [AR057362]; National Institutes
   of Health (NIH) [8U42OD011158-22]; Cornell's National Science Foundation
   (NSF) [DGE-1144153]; NSF Graduate Research Fellowship Program (GRFP);
   NSF GRFP; Cornell Colman fellowship; NIH [S10RR025502]
FX We thank Christopher Chapa and Floor Lambers for assistance with
   specimen preparation. We thank Matthew Goff for assistance with finite
   element models. This work was supported by National Institute of
   Arthritis and Musculoskeletal and Skin Diseases of the National
   Institutes of Health Award AR057362 (principal investigator, C.J.H.). We
   acknowledge use of human vertebral bodies provided by the National
   Disease Research Interchange, with support from National Institutes of
   Health (NIH) Grant 8U42OD011158-22, Cornell's National Science
   Foundation (NSF) Grant DGE-1144153, NSF Graduate Research Fellowship
   Program (GRFP) (to A.M.T.), NSF GRFP (to J.B.M.), and a Cornell Colman
   fellowship (to A.M.T.). Imaging data were acquired in the Cornell
   Biotechnology Resource Center (BRC)-Imaging Facility using the shared,
   NIH-funded (S10RR025502) Zeiss LSM 710 Confocal.
CR Ager JW, 2006, J MATER RES, V21, P1878, DOI 10.1557/JMR.2006.0242
   Akkus O, 2000, J MATER SCI, V35, P6065, DOI 10.1023/A:1026719531300
   Akkus O, 2001, J ORTHOP RES, V19, P927, DOI 10.1016/S0736-0266(01)00004-3
   Bigley RF, 2008, BONE, V42, P212, DOI 10.1016/j.bone.2007.09.043
   Brennan O, 2009, J BIOMECH, V42, P498, DOI 10.1016/j.jbiomech.2008.11.032
   Burket JC, 2013, BONE, V52, P326, DOI 10.1016/j.bone.2012.10.018
   Busse B, 2013, SCI TRANSL MED, V5, P88
   Cook RB, 2009, J BIOMECH, V42, P2054, DOI 10.1016/j.jbiomech.2009.06.001
   Currey J.D., 2002, BONES STRUCTURE MECH
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Dempster DM, 2000, J BONE MINER RES, V15, P20, DOI 10.1359/jbmr.2000.15.1.20
   Dowling N., 2007, MECH BEHAV MAT
   Eswaran SK, 2006, J BONE MINER RES, V21, P307, DOI 10.1359/JBMR.051027
   FYHRIE DP, 1994, BONE, V15, P105, DOI 10.1016/8756-3282(94)90900-8
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Goff MG, 2014, J BIOMECH, V47, P3156, DOI 10.1016/j.jbiomech.2014.06.016
   Griffith JF, 2012, ENDOCRINE, V42, P39, DOI 10.1007/s12020-012-9691-2
   Hernandez CJ, 2008, BONE, V42, P1014, DOI 10.1016/j.bone.2008.02.001
   Hernandez CJ, 2014, BONE, V66, P205, DOI 10.1016/j.bone.2014.05.023
   Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116
   Keaveny TM, 1999, J ORTHOPAED RES, V17, P346, DOI 10.1002/jor.1100170308
   Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221
   Kruzic JJ, 2006, J BIOMECH, V39, P968, DOI 10.1016/j.jbiomech.2005.01.025
   Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI 10.1146/annurev-matsci-070909-10442
   McNamara LM, 2006, J BIOMECH, V39, P734, DOI 10.1016/j.jbiomech.2004.12.027
   Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854
   Meza LR, 2015, P NATL ACAD SCI USA, V112, P11502, DOI 10.1073/pnas.1509120112
   Nalla RK, 2005, J BIOMECH, V38, P1517, DOI 10.1016/j.jbiomech.2004.07.010
   Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832
   O'Brien FJ, 2002, J BIOMECH, V35, P523, DOI 10.1016/S0021-9290(01)00200-7
   Renders GAP, 2011, J BIOMECH, V44, P402, DOI 10.1016/j.jbiomech.2010.10.004
   Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332
   Slyfield CR, 2009, J MICROSC-OXFORD, V236, P52, DOI 10.1111/j.1365-2818.2009.03204.x
   Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003
   Taylor D, 2007, THEORY CRITICAL DIST
   Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866
   Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8
   Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]
   Willett TL, 2013, BONE, V52, P611, DOI 10.1016/j.bone.2012.11.014
   Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 42
TC 10
Z9 10
U1 1
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 15
PY 2016
VL 113
IS 11
BP 2892
EP 2897
DI 10.1073/pnas.1520539113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG4BF
UT WOS:000372014200044
PM 26929343
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Shakeri, H
   Arshadi, M
   Salvacion, JWL
AF Shakeri, H.
   Arshadi, M.
   Salvacion, J. W. L.
TI Removal of BTEX by using a surfactant - Bio originated composite
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Biomaterial; BTEX; Adsorption; Surfactant; Anzali lagoon water
ID AQUEOUS-SOLUTIONS; CARBON NANOTUBES; ACTIVATED CARBON; M-XYLENE;
   ADSORPTION; SORPTION; TOLUENE; ETHYLBENZENE; MONTMORILLONITE;
   CLINOPTILOLITE
AB The application of ostrich bone waste-loaded a cationic surfactant (OBW-OH-CTABr) bioadsorbent for benzene, toluene, ethylbenzene and p-xylene (BTEX) removal from the synthetic and real waters have been studied, and the prepared biomaterials were studied by Fourier transform infrared (FTIR), X-ray diffraction (XRD), surface area measurements (BET), scanning electron microscopy (SEM), Energy dispersive X-ray spectroscopy (EDX) and point of zero (pH(PZC)). The immobilization of CTABr molecules on the framework of modified OBW showed good tendency to adsorb BTEX from aqueous solution. The exposure time to obtain equilibrium for maximum removal of BTEX was observed to be 60 min. The removal kinetics of BTEX has been evaluated in terms of pseudo-first- and-second-order kinetics, and the Freundlich and Langmuir isotherm models have also been utilized to the equilibrium removal data. The removal process was spontaneous and endothermic in nature and followed pseudo-second-order kinetic model. The immobilized CTABr showed high reusability because of its high adsorption efficiency after 12th cycles. The proposed low-cost bioadsorbent could also be utilized to adsorb BTEX from the real water (Anzali lagoon water). The OBW-OH-CTABr composite is indeed an attractive biomaterial for drinking water-based pollutants and act as an adsorbent for BTEX and oil spills especially in third world due to its low-cost preparation and regeneration and clean processing of the biomaterial with no byproducts after utilize. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Shakeri, H.; Salvacion, J. W. L.] Mapua Inst Technol, Muralla St Intramuros, Manila 1002, Philippines.
   [Arshadi, M.] Islamic Azad Univ, Shiraz Branch, Dept Chem, POB 71955-149, Shiraz, Fars, Iran.
RP Arshadi, M (reprint author), Islamic Azad Univ, Shiraz Branch, Dept Chem, POB 71955-149, Shiraz, Fars, Iran.
EM m-arshadi@ch.iut.ac.ir
RI Magpantay, Ramil/C-9089-2016
CR Arshadi M, 2015, RSC ADV, V5, P43290, DOI 10.1039/c5ra03191e
   Bowman S.R., 2000, NATURAL ZEOLITES 3 M, P287
   Bundschuh J, 2004, APPL GEOCHEM, V19, P231, DOI 10.1016/j.apgeochem.2003.09.009
   CASON R, 1977, Proceedings of the Oklahoma Academy of Science, V57, P116
   Chen W, 2007, ENVIRON SCI TECHNOL, V41, P8295, DOI 10.1021/es071230h
   Chin CJM, 2007, CARBON, V45, P1254, DOI 10.1016/j.carbon.2007.01.015
   ECKENFELDER WW, 1989, IND WATER POLLUTION
   Faby J.-A., 1998, DOCUMENT TECHNIQUE F, V11
   Fan JL, 2011, DESALINATION, V267, P139, DOI 10.1016/j.desal.2010.09.016
   Ghiaci M, 2008, J CHEM ENG DATA, V53, P2707, DOI 10.1021/je800532p
   Institute A.P., 2002, PRED WAT SOL ORG WSO
   ISHIKAWA T, 1989, LANGMUIR, V5, P140, DOI 10.1021/la00085a025
   Khan FI, 2000, J LOSS PREVENT PROC, V13, P527, DOI 10.1016/S0950-4230(00)00007-3
   Kim Sang-Hyoun, 2013, J POROUS MAT, P9690
   Li ZH, 1998, ENVIRON SCI TECHNOL, V32, P2278, DOI 10.1021/es971118r
   Li ZH, 2003, CLAY CLAY MINER, V51, P445, DOI 10.1346/CCMN.2003.0510411
   Li ZH, 1999, LANGMUIR, V15, P6438, DOI 10.1021/la981535x
   Liu B, 2011, MATER CHEM PHYS, V130, P1220, DOI 10.1016/j.matchemphys.2011.08.064
   Lu C, 2008, APPL SURF SCI, V254, P7035, DOI 10.1016/j.apsusc.2008.05.282
   McBride M., 1994, ENV CHEM SOILS
   MING DW, 1987, CLAY CLAY MINER, V35, P463, DOI 10.1346/CCMN.1987.0350607
   Nourmoradi H, 2012, CHEM ENG J, V191, P341, DOI 10.1016/j.cej.2012.03.029
   Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2
   Ranganayaki M.D., 1999, SOUV CUM P NAT SEM P, P187
   Ribeiro TH, 2000, ENVIRON SCI TECHNOL, V34, P5201, DOI 10.1021/es991139g
   Royer B, 2010, J HAZARD MATER, V181, P366, DOI 10.1016/j.jhazmat.2010.05.019
   Su FS, 2010, COLLOID SURFACE A, V353, P83, DOI 10.1016/j.colsurfa.2009.10.025
   Tu A. T., 1986, SPECTROSCOPY BIOL SY, P47
   Wang XY, 2010, BIOMED ENVIRON SCI, V23, P473, DOI 10.1016/S0895-3988(11)60010-X
   WEBER WJ, 1991, WATER RES, V25, P499, DOI 10.1016/0043-1354(91)90125-A
   Wibowo N, 2007, J HAZARD MATER, V146, P237, DOI 10.1016/j.jhazmat.2006.12.011
   Yang R. T., 2003, ADSORBENTS FUNDAMENT
   Yu F, 2012, J AGR FOOD CHEM, V60, P12245, DOI 10.1021/jf304104z
   Yu F, 2011, J HAZARD MATER, V192, P1370, DOI 10.1016/j.jhazmat.2011.06.048
NR 34
TC 8
Z9 8
U1 0
U2 90
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAR 15
PY 2016
VL 466
BP 186
EP 197
DI 10.1016/j.jcis.2015.12.019
PG 12
WC Chemistry, Physical
SC Chemistry
GA DC3KV
UT WOS:000369119100021
PM 26724701
DA 2018-10-20
ER

PT J
AU Valouma, A
   Verganelaki, A
   Maravelaki-Kalaitzaki, P
   Gidarakos, E
AF Valouma, Aikaterini
   Verganelaki, Anastasia
   Maravelaki-Kalaitzaki, Pagona
   Gidarakos, Evangelos
TI Chrysotile asbestos detoxification with a combined treatment of oxalic
   acid and silicates producing amorphous silica and biomaterial
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Chrysotile asbestos; Oxalic acid; TEOS; Amorphous silica; Magnesium
   oxalate
ID THERMAL-DECOMPOSITION; TRADITIONAL CERAMICS; POWER ULTRASOUND; FIBERS;
   TEMPERATURE; WASTE
AB This study was primarily imposed by the ever increasing need for detoxification of asbestos and asbestos containing materials (ACM), with potential application onsite. The present work investigates potential detoxification of pure chrysotile (Chr) asbestos via a combined treatment of oxalic acid dihydrate (Oxac) (H2C2O4 center dot 2H(2)O) with silicates, such as tetraethoxysilane (TEOS) (SiH20C8O4) and pure water glass (WG) (potassium silicate) (K2SiO3). These reagents used in the experimental procedure, do not cause adverse effects on the environment and are cost effective. The results of FTIR, XRD, optical and scanning microscopy coupled with EDS analyses indicated that all of the applied treatments destructed the Chr structure and yielded silica of amorphous phase and the biomaterial glushinskite from the Oxac reacted with brucite [Mg(OH)(2)] layer. Each of the proposed formulations can be applied for the detoxification of asbestos, according to priorities related to the specific products of the recovery treatment. Therefore, Oxac acid leaching followed by the TEOS addition is preferred in cases of glushinskite recovery; TEOS treatment of asbestos with subsequent Oxac addition produced amorphous silica production; finally Oxac acid leaching followed by WG encapsulated the asbestos fibers and can be used in cases of onsite asbestos and ACM detoxification. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Valouma, Aikaterini; Gidarakos, Evangelos] Tech Univ Crete, Sch Environm Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.
   [Verganelaki, Anastasia; Maravelaki-Kalaitzaki, Pagona] Tech Univ Crete, Sch Architectural Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.
RP Gidarakos, E (reprint author), Tech Univ Crete, Sch Environm Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.; Maravelaki-Kalaitzaki, P (reprint author), Tech Univ Crete, Sch Architectural Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.
EM nmaravel@elci.tuc.gr; gidarako@mred.tuc.gr
CR Anastasiadou K, 2010, J HAZARD MATER, V179, P926, DOI 10.1016/j.jhazmat.2010.03.094
   Favero-Longo SE, 2005, J ENVIRON MONITOR, V7, P764, DOI 10.1039/b507569f
   Finley BL, 2012, CRIT REV TOXICOL, V42, P119, DOI 10.3109/10408444.2011.636028
   Fonseca MG, 2001, J COLLOID INTERF SCI, V240, P533, DOI 10.1006/jcis.2001.7663
   Gualtieri AF, 2000, J EUR CERAM SOC, V20, P1409, DOI 10.1016/S0955-2219(99)00290-3
   Gualtieri AF, 2000, J APPL POLYM SCI, V75, P713, DOI 10.1002/(SICI)1097-4628(20000131)75:5<713::AID-APP14>3.0.CO;2-D
   Gualtieri AF, 2008, J HAZARD MATER, V156, P260, DOI 10.1016/j.jhazmat.2007.12.016
   Gulumian M, 2005, J TOXICOL ENV HEAL B, V8, P453, DOI 10.1080/10937400590952547
   Habaue S, 2008, J APPL POLYM SCI, V110, P2891, DOI 10.1002/app.28899
   Jiang HM, 2006, IND ENG CHEM RES, V45, P8617, DOI 10.1021/ie0607550
   Kapridaki C, 2014, APPL CATAL B-ENVIRON, V156, P416, DOI 10.1016/j.apcatb.2014.03.042
   Koshi K., 2012, IND HLTH, V10, P16
   Lavkulich LM, 2014, J ENVIRON SCI HEAL A, V49, P617, DOI 10.1080/10934529.2014.865401
   Leonelli C, 2006, J HAZARD MATER, V135, P149, DOI 10.1016/j.jhazmat.2005.11.035
   MING DW, 1985, SOIL SCI SOC AM J, V49, P1303, DOI 10.2136/sssaj1985.03615995004900050046x
   Nam SN, 2014, J HAZARD MATER, V265, P151, DOI 10.1016/j.jhazmat.2013.11.004
   Norbet C, 2015, CURR PROBL DIAGN RAD, V44, P371, DOI 10.1067/j.cpradiol.2014.10.002
   Raloff J, 1998, SCI NEWS, V153, P5
   Rozalen M, 2013, CHEM GEOL, V352, P134, DOI 10.1016/j.chemgeo.2013.06.004
   Stanescu-Dumitru R., 2008, OALIB J, V4, P6
   Sugama T, 1998, IND ENG CHEM RES, V37, P79, DOI 10.1021/ie9702744
   Turci F, 2008, ULTRASON SONOCHEM, V15, P420, DOI 10.1016/j.ultsonch.2007.08.007
   Turci F, 2007, J ENVIRON MONITOR, V9, P1064, DOI 10.1039/b709571f
   Wypych F, 2003, J MATER CHEM, V13, P304, DOI 10.1039/b210370b
   Yamamoto T, 2014, WASTE MANAGE, V34, P536, DOI 10.1016/j.wasman.2013.11.008
NR 25
TC 8
Z9 8
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAR 15
PY 2016
VL 305
BP 164
EP 170
DI 10.1016/j.jhazmat.2015.11.036
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DC8DZ
UT WOS:000369451400019
PM 26685063
DA 2018-10-20
ER

PT J
AU Avula, M
   Jones, D
   Rao, AN
   McClain, D
   McGill, LD
   Grainger, DW
   Solzbacher, F
AF Avula, M.
   Jones, D.
   Rao, A. N.
   McClain, D.
   McGill, L. D.
   Grainger, D. W.
   Solzbacher, F.
TI Local release of masitinib alters in vivo implantable continuous glucose
   sensor performance
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Foreign body response (FBR); Encapsulation; Mast cells (MC); Tyrosine
   kinase inhibitor (TKI); Local drug delivery; Subcutaneous murine
   implants
ID FOREIGN-BODY RESPONSE; ACUTE INFLAMMATORY RESPONSES; TYROSINE KINASE
   INHIBITOR; MAST-CELLS; BIOMATERIAL IMPLANTS; TISSUE-RESPONSE; MEDICAL
   DEVICES; NITRIC-OXIDE; BIOSENSORS; DELIVERY
AB Continuous glucose monitoring (CGM) sensors are often advocated as a clinical solution to improve longterm glycemic control in the context of diabetes. Subcutaneous sensor inflammatory response, fouling and fibrous encapsulation resulting from the host foreign body response (FBR) reduce sensor sensitivity to glucose, eventually resulting in sensor performance compromise and device failure. Several combination device strategies load CGM sensors with drug payloads that release locally to tissue sites to mitigate FBR-mediated sensor failure. In this study, the mast cell-targeting tyrosine kinase inhibitor, masitinib, was released from degradable polymer microspheres delivered from the surfaces of FDA-approved human commercial CGM needle-type implanted sensors in a rodent subcutaneous test bed. By targeting the mast cell c-Kit receptor and inhibiting mast cell activation and degranulation, local masitinib penetration around the CGM to several hundred microns sought to reduce sensor fibrosis to extend CGM functional lifetimes in subcutaneous sites. Drug-releasing and control CGM implants were compared in murine percutaneous implant sites for 21 days using direct-wire continuous glucose reporting. Drug-releasing implants exhibited no significant difference in CGM fibrosis at implant sites but showed relatively stable continuous sensor responses over the study period compared to blank microsphere control CGM implants. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Avula, M.; Grainger, D. W.; Solzbacher, F.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Jones, D.; McClain, D.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.
   [Rao, A. N.; Grainger, D. W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [McGill, L. D.] Univ Utah, Associated Reg & Univ Pathologist Labs, Salt Lake City, UT 84112 USA.
   [Solzbacher, F.] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA.
RP Grainger, DW (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
EM david.grainger@utah.edu
OI McClain, Don/0000-0002-3310-2359; Avula, Mahender/0000-0001-5287-8972
FU University of Utah Research Foundation [SEED (51003520)]; Technology
   Commercialization [51003517]
FX The authors acknowledge support from the University of Utah Research
   Foundation (SEED (51003520) and Technology Commercialization (51003517)
   grants). D. Sze, R. Caldwell, and P. Hogrebe (all Utah) are thanked for
   support and technical assistance. Dr. B. Feldman and B. Cho, (Abbott
   Diabetes Care, Alameda, USA) are thanked for generously providing the
   CGM sensors used in this study. Author F. Solzbacher has a financial
   interest in the company Blackrock Microsystems (USA) that develops and
   produces implantable neural interfaces and electrophysiological
   equipment and software, none of which is used in this study.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Avula MN, 2014, ACTA BIOMATER, V10, P1856, DOI 10.1016/j.actbio.2013.12.056
   Avula M.N., 2015, DRUG DEVICE IN PRESS
   Avula MN, 2013, BIOMATERIALS, V34, P9737, DOI 10.1016/j.biomaterials.2013.08.090
   Bhardwaj Upkar, 2007, J Diabetes Sci Technol, V1, P8
   Bode BW, 1999, DIABETES RES CLIN PR, V46, P183, DOI 10.1016/S0168-8227(99)00113-8
   Chase HP, 2001, PEDIATRICS, V107, P222, DOI 10.1542/peds.107.2.222
   Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654
   Coster S, 2000, HEALTH TECHNOL ASSES, V12, P1
   Cunningham D. D., 2009, IN VIVO GLUCOSE SENS
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Daneshian M, 2006, J IMMUNOL METHODS, V313, P169, DOI 10.1016/j.jim.2006.04.009
   Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258
   Facchinetti Andrea, 2010, J Diabetes Sci Technol, V4, P4
   Feldman Ben, 2003, Diabetes Technol Ther, V5, P769, DOI 10.1089/152091503322526978
   Frost MC, 2002, CURR OPIN CHEM BIOL, V6, P633, DOI 10.1016/S1367-5931(02)00371-X
   Gerritsen M, 1999, NETH J MED, V54, P167, DOI 10.1016/S0300-2977(99)00006-6
   Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033
   Godek M.L., 2009, IN VIVO GLUCOSE SENS, P29
   Golub JS, 2010, AM J PHYSIOL-HEART C, V298, pH1959, DOI 10.1152/ajpheart.00199.2009
   Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P632
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Hickey T, 2002, J BIOMED MATER RES, V61, P180, DOI 10.1002/jbm.10016
   Ju YM, 2010, J BIOMED MATER RES A, V93A, P200, DOI 10.1002/jbm.a.32512
   Jungheim K, 2001, DIABETES CARE, V24, P1696, DOI 10.2337/diacare.24.9.1696
   Klueh U, 2005, BIOMATERIALS, V26, P1155, DOI 10.1016/j.biomaterials.2004.04.017
   Klueh U., 2013, J BIOMEDICAL MAT R A
   Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402
   Klueh U, 2010, BIOMATERIALS, V31, P4540, DOI 10.1016/j.biomaterials.2010.02.023
   Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034
   Krishnaswamy Guha, 2006, Methods Mol Biol, V315, P13
   Liao KC, 2008, BIOSENS BIOELECTRON, V23, P1458, DOI 10.1016/j.bios.2008.01.012
   Ludvigsson J, 2003, PEDIATRICS, V111, P933, DOI 10.1542/peds.111.5.933
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nablo BJ, 2005, BIOMATERIALS, V26, P6984, DOI 10.1016/j.biomaterials.2005.05.017
   Nichols SP, 2011, ANAL CHEM, V83, P1180, DOI 10.1021/ac103070t
   Nielsen JK, 2005, DIABETES, V54, P1635, DOI 10.2337/diabetes.54.6.1635
   Paul C, 2010, AM J HEMATOL, V85, P921, DOI 10.1002/ajh.21894
   Perez R, 2008, WOUNDS, V20, P3
   Reber L, 2006, EUR J PHARMACOL, V533, P327, DOI 10.1016/j.ejphar.2005.12.067
   Sung JY, 2009, BIOMATERIALS, V30, P622, DOI 10.1016/j.biomaterials.2008.09.052
   Tanenberg R, 2004, MAYO CLIN PROC, V79, P1521, DOI 10.4065/79.12.1521
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Ward W Kenneth, 2004, Diabetes Technol Ther, V6, P137, DOI 10.1089/152091504773731320
   Ward WK, 1999, ASAIO J, V45, P555, DOI 10.1097/00002480-199911000-00009
   Wilson G.S., 2010, IN VIVO GLUCOSE SENS, P1
   Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003
   Wilson GS, 2000, CHEM REV, V100, P2693, DOI 10.1021/cr990003y
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 55
TC 9
Z9 9
U1 3
U2 74
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAR 15
PY 2016
VL 77
BP 149
EP 156
DI 10.1016/j.bios.2015.08.059
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA CZ0AG
UT WOS:000366766900024
PM 26402593
DA 2018-10-20
ER

PT J
AU Fourel, L
   Valat, A
   Faurobert, E
   Guillot, R
   Bourrin-Reynard, I
   Ren, KF
   Lafanechere, L
   Planus, E
   Picart, C
   Albiges-Rizo, C
AF Fourel, Laure
   Valat, Anne
   Faurobert, Eva
   Guillot, Raphael
   Bourrin-Reynard, Ingrid
   Ren, Kefeng
   Lafanechere, Laurence
   Planus, Emmanuelle
   Picart, Catherine
   Albiges-Rizo, Corinne
TI beta 3 integrin-mediated spreading induced by matrix-bound BMP-2
   controls Smad signaling in a stiffness-independent manner
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID GROWTH-FACTOR RECEPTORS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   OSTEOBLAST LINEAGE; C2C12 MYOBLASTS; SKELETAL-MUSCLE; RHO-GTPASES;
   DIFFERENTIATION; ACTIN; MIGRATION
AB Understanding how cells integrate multiple signaling pathways to achieve specific cell differentiation is a challenging question in cell biology. We have explored the physiological presentation of BMP-2 by using a biomaterial that harbors tunable mechanical properties to promote localized BMP-2 signaling. We show that matrix-bound BMP-2 is sufficient to induce beta 3 integrin-dependent C2C12 cell spreading by overriding the soft signal of the biomaterial and impacting actin organization and adhesion site dynamics. In turn, alpha v beta 3 integrin is required to mediate BMP-2 induced Smad signaling through a Cdc42-Src-FAK-ILK pathway. beta 3 integrin regulates a multistep process to control first BMP-2 receptor activity and second the inhibitory role of GSK3 on Smad signaling. Overall, our results show that BMP receptors and beta 3 integrin work together to control Smad signaling and tensional homeostasis, thereby coupling cell adhesion and fate commitment, two fundamental aspects of developmental biology and regenerative medicine.
C1 [Fourel, Laure; Valat, Anne; Faurobert, Eva; Bourrin-Reynard, Ingrid; Lafanechere, Laurence; Planus, Emmanuelle; Albiges-Rizo, Corinne] INSERM, Inst Albert Bonniot, U823, F-38042 Grenoble, France.
   [Fourel, Laure; Valat, Anne; Faurobert, Eva; Bourrin-Reynard, Ingrid; Planus, Emmanuelle; Albiges-Rizo, Corinne] CNRS, Equipe Rech Labellisee 5284, F-38042 Grenoble, France.
   [Fourel, Laure; Valat, Anne; Faurobert, Eva; Bourrin-Reynard, Ingrid; Lafanechere, Laurence; Planus, Emmanuelle; Albiges-Rizo, Corinne] Univ Grenoble Alpes, F-38041 Grenoble, France.
   [Fourel, Laure; Valat, Anne; Guillot, Raphael; Ren, Kefeng; Picart, Catherine] CNRS, UMR 5628, Lab Mat & Genie Phys, Inst Technol, F-38016 Grenoble, France.
RP Albiges-Rizo, C (reprint author), INSERM, Inst Albert Bonniot, U823, F-38042 Grenoble, France.; Albiges-Rizo, C (reprint author), CNRS, Equipe Rech Labellisee 5284, F-38042 Grenoble, France.; Albiges-Rizo, C (reprint author), Univ Grenoble Alpes, F-38041 Grenoble, France.; Picart, C (reprint author), CNRS, UMR 5628, Lab Mat & Genie Phys, Inst Technol, F-38016 Grenoble, France.
EM catherine.picart@grenoble-inp.fr; corinne.albiges-rizo@ujf-grenoble.fr
RI Lafanechere, Laurence/N-7474-2013
OI Lafanechere, Laurence/0000-0002-7902-7630
FU European Commission, FP7, via a European Research Council starting grant
   [GA 239370]; Institut Universitaire de France; Fondation pour la
   Recherche Medical; Ligue Contre le Cancer for Equipe labelisee Ligue
FX This work was supported by the European Commission, FP7, via a European
   Research Council starting grant to C. Picart (BIOMIM, GA 239370), by the
   Institut Universitaire de France (C. Picart), by the Fondation pour la
   Recherche Medical (C. Albiges-Rizo), and by the Ligue Contre le Cancer
   for Equipe labelisee Ligue 2014 (C. Albiges-Rizo). The groups of C.
   Picart and C. Albiges-Rizo belong to the Centre National de la Recherche
   Scientifique consortium CellTiss.
CR Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704
   Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811
   Biver E, 2014, MOL CELL ENDOCRINOL, V382, P120, DOI 10.1016/j.mce.2013.09.018
   Boudou T, 2011, MACROMOL BIOSCI, V11, P77, DOI 10.1002/mabi.201000301
   Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245
   Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87
   Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g
   Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211
   Dingal PCDP, 2015, NAT MATER, V14, P951, DOI [10.1038/NMAT4350, 10.1038/nmat4350]
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dopie J, 2012, P NATL ACAD SCI USA, V109, pE544, DOI 10.1073/pnas.1118880109
   Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060
   Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027
   Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286
   Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534
   Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003
   Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009
   Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Kopf J, 2014, BIOFACTORS, V40, P171, DOI 10.1002/biof.1137
   Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107
   Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030
   Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276
   Martino M. M., 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3002614
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051
   Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667
   Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200
   Ozeki N, 2007, BIOCHEM BIOPH RES CO, V353, P54, DOI 10.1016/j.bbrc.2006.11.110
   Pelish Henry E, 2006, Nat Chem Biol, V2, P39, DOI 10.1038/nchembio751
   Plotnikov SV, 2013, CURR OPIN CELL BIOL, V25, P619, DOI 10.1016/j.ceb.2013.06.003
   Prudent R, 2012, CANCER RES, V72, P4429, DOI 10.1158/0008-5472.CAN-11-3342
   Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003
   Ren KF, 2010, ACTA BIOMATER, V6, P4238, DOI 10.1016/j.actbio.2010.06.014
   Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708
   Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006
   Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066
   Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090
   Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626
   Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007
   Song JF, 2014, P NATL ACAD SCI USA, V111, P7337, DOI 10.1073/pnas.1321764111
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003
   Tomar A, 2010, DEV CELL, V18, P170, DOI 10.1016/j.devcel.2010.01.013
   Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293
   Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325
   Yu PB, 2007, NAT CHEM BIOL, V4, P33, DOI DOI 10.1038/NCHEMBIO.2007.54
NR 70
TC 18
Z9 18
U1 6
U2 26
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAR 14
PY 2016
VL 212
IS 6
BP 693
EP 706
DI 10.1083/jcb.201508018
PG 14
WC Cell Biology
SC Cell Biology
GA DH3FC
UT WOS:000372671900011
PM 26953352
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Sudo, Y
   Nabae, Y
   Hayakawa, T
   Kakimoto, MA
AF Sudo, Yu
   Nabae, Yuta
   Hayakawa, Teruaki
   Kakimoto, Masa-Aki
TI Copolymer of hyperbranched polystyrene and poly(N-isopropylacrylamide)
   as a thermo-responsive biomaterial for cell sheet recovery
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Sudo, Yu; Nabae, Yuta; Hayakawa, Teruaki; Kakimoto, Masa-Aki] Tokyo Inst Technol, Organ & Polymer Mat, Meguro Ku, Tokyo, Japan.
EM sudo.y.ab@m.titech.ac.jp
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 13
PY 2016
VL 251
MA 57
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1WR
UT WOS:000431905706536
DA 2018-10-20
ER

PT J
AU Cartwright, JHE
AF Cartwright, Julyan H. E.
TI Directed self-assembly, genomic assembly complexity and the formation of
   biological structure, or, what are the genes for nacre?
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE complexity; DNA; information; self-assembly; self-organization
AB Biology uses dynamical mechanisms of self-organization and self-assembly of materials, but it also choreographs and directs these processes. The difference between abiotic self-assembly and a biological process is rather like the difference between setting up and running an experiment to make a material remotely compared with doing it in one's own laboratory: with a remote experiment-say on the International Space Station-everything must be set up beforehand to let the experiment run 'hands off', but in the laboratory one can intervene at any point in a 'hands-on' approach. It is clear that the latter process, of directed self-assembly, can allow much more complicated experiments and produce far more complex structures than self-assembly alone. This control over self-assembly in biology is exercised at certain key waypoints along a trajectory and the process may be quantified in terms of the genomic assembly complexity of a biomaterial.
C1 [Cartwright, Julyan H. E.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain.
   [Cartwright, Julyan H. E.] Univ Granada, Inst Carlos I de Fis Teor & Computac, E-18071 Granada, Spain.
RP Cartwright, JHE (reprint author), Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain.; Cartwright, JHE (reprint author), Univ Granada, Inst Carlos I de Fis Teor & Computac, E-18071 Granada, Spain.
EM julyan.cartwright@csic.es
RI Cartwright, Julyan/C-1387-2016
OI Cartwright, Julyan/0000-0001-7392-0957
FU Spanish Ministerio de Ciencia e Innovacion [FIS2013-48444-C2-2-P]
FX This research was funded by project FIS2013-48444-C2-2-P of the Spanish
   Ministerio de Ciencia e Innovacion.
CR Beebe CW, 1906, BIRD ITS FORM FUNCTI
   Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188
   Cartwright JHE, 2012, PHILOS T R SOC A, V370, P2807, DOI 10.1098/rsta.2012.0106
   Cartwright JHE, 2009, P NATL ACAD SCI USA, V106, P10499, DOI 10.1073/pnas.0900867106
   Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   MACKAY AL, 1986, COMPUT MATH APPL-B, V12, P803, DOI 10.1016/0898-1221(86)90426-8
   Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005
NR 8
TC 2
Z9 2
U1 1
U2 8
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
EI 1471-2962
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD MAR 13
PY 2016
VL 374
IS 2063
AR 20150449
DI 10.1098/rsta.2015.0449
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD1OE
UT WOS:000369690200021
PM 26857670
DA 2018-10-20
ER

PT J
AU Almaki, JH
   Nasiri, R
   Idris, A
   Majid, FAA
   Salouti, M
   Wong, TS
   Dabagh, S
   Marvibaigi, M
   Amini, N
AF Almaki, Javad Hamzehalipour
   Nasiri, Rozita
   Idris, Ani
   Majid, Fadzilah Adibah Abdul
   Salouti, Mojtaba
   Wong, Tet Soon
   Dabagh, Shadab
   Marvibaigi, Mohsen
   Amini, Neda
TI Synthesis, characterization and in vitro evaluation of exquisite
   targeting SPIONs-PEG-HER in HER2+human breast cancer cells
SO NANOTECHNOLOGY
LA English
DT Article
DE superparamagnetic; iron oxide nanoparticles; polyethylene glycol;
   herceptin; HER2+breast cancer
ID IRON-OXIDE NANOPARTICLES; BIOMEDICAL APPLICATIONS; MAGNETIC
   NANOPARTICLES; SUPERPARAMAGNETIC NANOPARTICLES; MAGHEMITE NANOPARTICLES;
   IMAGING AGENTS; HYPERTHERMIA; DELIVERY; THERAPY; DEXTRAN
AB A stable, biocompatible and exquisite SPIONs-PEG-HER targeting complex was developed. Initially synthesized superparamagnetic iron oxide nanoparticles (SPIONs) were silanized using 3-aminopropyltrimethoxysilane (APS) as the coupling agent in order to allow the covalent bonding of polyethylene glycol (PEG) to the SPIONs to improve the biocompatibility of the SPIONs. SPIONs-PEG were then conjugated with herceptin (HER) to permit the SPIONs-PEG-HER to target the specific receptors expressed over the surface of the HER2+ metastatic breast cancer cells. Each preparation step was physico-chemically analyzed and characterized by a number of analytical methods including AAS, FTIR spectroscopy, XRD, FESEM, TEM, DLS and VSM. The biocompatibility of SPIONs-PEG-HER was evaluated in vitro on HSF-1184 (human skin fibroblast cells), SK-BR-3 (human breast cancer cells, HER+), MDA-MB-231 (human breast cancer cells, HER-) and MDA-MB-468 (human breast cancer cells, HER-) cell lines by performing MTT and trypan blue assays. The hemolysis analysis results of the SPIONs-PEG-HER and SPIONs-PEG did not indicate any sign of lysis while in contact with erythrocytes. Additionally, there were no morphological changes seen in RBCs after incubation with SPIONs-PEG-HER and SPIONs-PEG under a light microscope. The qualitative and quantitative in vitro targeting studies confirmed the high level of SPION-PEG-HER binding to SK-BR-3 (HER2+ metastatic breast cancer cells). Thus, the results reflected that the SPIONs-PEG-HER can be chosen as a favorable biomaterial for biomedical applications, chiefly magnetic hyperthermia, in the future.
C1 [Almaki, Javad Hamzehalipour; Nasiri, Rozita; Idris, Ani; Majid, Fadzilah Adibah Abdul; Wong, Tet Soon] Univ Teknol Malaysia, Fac Chem Engn, Dept Bioproc Engn, Johor Baharu 81310, Johor, Malaysia.
   [Salouti, Mojtaba] Islamic Azad Univ, Zanjan Branch, Biol Res Ctr, Zanjan, Iran.
   [Dabagh, Shadab] Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Johor Baharu 81310, Johor, Malaysia.
   [Marvibaigi, Mohsen; Amini, Neda] Univ Teknol Malaysia, Fac Biomed Engn, Johor Baharu 81310, Johor, Malaysia.
RP Idris, A (reprint author), Univ Teknol Malaysia, Fac Chem Engn, Dept Bioproc Engn, Johor Baharu 81310, Johor, Malaysia.
EM ani@cheme.utm.my
FU Universiti Teknologi Malaysia [Q. J130000.2524.06H09]
FX The authors would like to thank the Universiti Teknologi Malaysia for
   the financial support through Geran Universiti Penyelidikan (GUP)
   funding number Q. J130000.2524.06H09.
CR Alexiou C, 2000, CANCER RES, V60, P6641
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Bean C.P., 1959, Journal of Applied Physics, V30, p120S, DOI 10.1063/1.2185850
   Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brusentsov NA, 2001, J MAGN MAGN MATER, V225, P113, DOI 10.1016/S0304-8853(00)01238-5
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Cheraghipour E, 2013, J MAGN MAGN MATER, V328, P91, DOI 10.1016/j.jmmm.2012.09.042
   Durgadas CV, 2012, BIOMATERIALS, V33, P6420, DOI 10.1016/j.biomaterials.2012.05.051
   Eghtedari M., 2008, NANO LETT, V9, P287
   Eghtedari M, 2009, NANO LETT, V9, P287, DOI 10.1021/nl802915q
   Flesch C, 2005, COLLOID SURFACE A, V262, P150, DOI 10.1016/j.colsurfa.2005.04.039
   Fura A, 2003, J PHARMACEUT BIOMED, V32, P513, DOI 10.1016/S0731-7085(03)00159-6
   Gokce G, 2004, RES VET SCI, V76, P121, DOI 10.1016/j.rvsc.2003.08.009
   Gref R, 2012, ADV DRUG DELIVER REV, V64, P316, DOI 10.1016/j.addr.2012.09.008
   Gruttner C, 2007, J MAGN MAGN MATER, V311, P181, DOI 10.1016/j.jmmm.2006.10.1151
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Habib AH, 2008, J APPL PHYS, V103, DOI 10.1063/1.2830975
   Hergt R, 2007, J MAGN MAGN MATER, V311, P187, DOI 10.1016/j.jmmm.2006.10.1156
   Herve K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/46/465608
   Hilger I, 2004, EUR RADIOL, V14, P1124, DOI 10.1007/s00330-004-2257-9
   Hu FQ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245604
   Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037
   Idris A, 2012, J IND ENG CHEM, V18, P1582, DOI 10.1016/j.jiec.2012.02.018
   Idris A, 2010, WATER RES, V44, P1683, DOI 10.1016/j.watres.2009.11.026
   Jayalekshmi AC, 2013, COLLOID SURFACE B, V101, P196, DOI 10.1016/j.colsurfb.2012.06.027
   Juang TY, 2014, MOLECULES, V19, P4997, DOI 10.3390/molecules19044997
   Lattuada M, 2007, J AM CHEM SOC, V129, P12878, DOI 10.1021/ja0740521
   de Freitas ERL, 2008, J NANOSCI NANOTECHNO, V8, P2385, DOI 10.1166/jnn.2008.275
   Liu C, 1999, SOIL SCI SOC AM J, V63, P65, DOI 10.2136/sssaj1999.03615995006300010011x
   Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Maiti D, 2013, CRYST GROWTH DES, V13, P3637, DOI 10.1021/cg400627c
   Mansour N, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/03/035701
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mukhopadhyay A., 2011, ACS APPL MATER INTER, V4, P142
   Munnier E, 2010, NANOPARTICLE RES, V13, P959
   Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064
   Nigam S., 2010, J MAGN MAGN MATER, V323, P237
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   Patil MP, 2011, BRAZ J PHARM SCI, V47, P161, DOI 10.1590/S1984-82502011000100020
   Quaglia F, 2006, INT J PHARM, V324, P56, DOI 10.1016/j.ijpharm.2006.07.020
   Racuciu M, 2006, EUR PHYS J E, V21, P117, DOI 10.1140/epje/i2006-10051-y
   Reis E. F., 2006, MAT RES, V9, P185, DOI DOI 10.1590/S1516-14392006000200014
   Rouhana LL, 2007, LANGMUIR, V23, P12799, DOI 10.1021/la702151q
   Sadjadi MS, 2013, J NANO RES-SW, V21, P37, DOI 10.4028/www.scientific.net/JNanoR.21.37
   Saraswathy A, 2014, CARBOHYD POLYM, V101, P760, DOI 10.1016/j.carbpol.2013.10.015
   Shukla SK, 2013, INT J ELECTROCHEM SC, V8, P11711
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Sun B, 2008, BIOMATERIALS, V29, P475, DOI 10.1016/j.biomaterials.2007.09.038
   Sun C, 2006, J BIOMED MATER RES A, V78A, P550, DOI 10.1002/jbm.a.30781
   Theivasanthi T., 2010, ARXIV10036068
   Tran T, 2007, BIOCONJUGATE CHEM, V18, P1956, DOI 10.1021/bc7002617
   Vayssieres L, 1998, J COLLOID INTERF SCI, V205, P205, DOI 10.1006/jcis.1998.5614
   Wang H, 2004, LANGMUIR, V20, P1877, DOI 10.1021/la035376f
   Wang TW, 2007, J BIOMED MATER RES A, V83A, P828, DOI 10.1002/jbm.a.31411
   Wilhelm C, 2008, SMALL, V4, P577, DOI 10.1002/smll.200700523
   Wu W, 2010, NANOSCALE RES LETT, V5, P1474, DOI 10.1007/s11671-010-9664-4
   Xie J, 2009, CURR MED CHEM, V16, P1278, DOI 10.2174/092986709787846604
   Xu CJ, 2004, J AM CHEM SOC, V126, P3392, DOI 10.1021/ja031776d
   Yu M, 2012, INT J MOL SCI, V13, P5554, DOI 10.3390/ijms13055554
   Zhang YF, 2008, CHEM RES CHINESE U, V24, P697
NR 64
TC 11
Z9 11
U1 2
U2 38
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD MAR 11
PY 2016
VL 27
IS 10
AR 105601
DI 10.1088/0957-4484/27/10/105601
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DD3US
UT WOS:000369849200010
PM 26861770
DA 2018-10-20
ER

PT J
AU Chen, JN
   Suenaga, H
   Hogg, M
   Li, W
   Swain, M
   Li, Q
AF Chen, Junning
   Suenaga, Hanako
   Hogg, Michael
   Li, Wei
   Swain, Michael
   Li, Qing
TI Determination of oral mucosal Poisson's ratio and coefficient of
   friction from in-vivo contact pressure measurements
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE oral mucosa; apparent Poisson's ratio; friction coefficient; in vivo
   contact pressure; hyperelastic finite element analysis; response surface
   method
ID 3-DIMENSIONAL FINITE-ELEMENT; RESIDUAL RIDGE RESORPTION;
   STRESS-ANALYSIS; PAIN THRESHOLD; DENTURE; BIOMECHANICS; TISSUE;
   OSSEOINTEGRATION; WETTABILITY; XEROSTOMIA
AB Despite their considerable importance to biomechanics, there are no existing methods available to directly measure apparent Poisson's ratio and friction coefficient of oral mucosa. This study aimed to develop an inverse procedure to determine these two biomechanical parameters by utilizing in vivo experiment of contact pressure between partial denture and beneath mucosa through nonlinear finite element (FE) analysis and surrogate response surface (RS) modelling technique. First, the in vivo denture-mucosa contact pressure was measured by a tactile electronic sensing sheet. Second, a 3D FE model was constructed based on the patient CT images. Third, a range of apparent Poisson's ratios and the coefficients of friction from literature was considered as the design variables in a series of FE runs for constructing a RS surrogate model. Finally, the discrepancy between computed in silico and measured in vivo results was minimized to identify the best matching Poisson's ratio and coefficient of friction. The established non-invasive methodology was demonstrated effective to identify such biomechanical parameters of oral mucosa and can be potentially used for determining the biomaterial properties of other soft biological tissues.
C1 [Chen, Junning; Hogg, Michael; Li, Wei; Li, Qing] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
   [Suenaga, Hanako] Tohoku Univ, Grad Sch Dent, Div Prevent Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Swain, Michael] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia.
RP Li, Q (reprint author), Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
EM qing.li@sydney.edu.au
RI Swain, Michael/J-7266-2017; Li, Qing/B-3422-2009; Chen,
   Junning/F-5287-2016; Chen, Junning/J-4864-2018
OI Li, Qing/0000-0002-7930-2145; Chen, Junning/0000-0001-7121-0994; Chen,
   Junning/0000-0001-7121-0994
FU Australian Research Council (ARC); Australian Postgraduate Award (APA)
FX This work was supported by Australian Research Council (ARC) through the
   Discovery and Fellowship schemes. The first author is a recipient of
   Australian Postgraduate Award (APA) in his Ph. D. study.
CR Ahmad R, 2013, CLIN ORAL IMPLAN RES, V24, P1273, DOI 10.1111/j.1600-0501.2012.02566.x
   Bergomi M, 2011, J BIOMECH, V44, P34, DOI 10.1016/j.jbiomech.2010.08.019
   Braga IU, 2013, COMPUT METHOD BIOMEC, V16, P954, DOI 10.1080/10255842.2011.645227
   Chen JN, 2015, J BIOMECH, V48, P512, DOI 10.1016/j.jbiomech.2014.11.043
   Chen JN, 2013, J MECH BEHAV BIOMED, V20, P387, DOI 10.1016/j.jmbbm.2012.08.019
   Clason Christian, 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P265, DOI 10.1080/10255840412331313590
   Field C, 2010, J BIOMECH, V43, P1771, DOI 10.1016/j.jbiomech.2010.02.016
   HART RT, 1992, J BIOMECH, V25, P261, DOI 10.1016/0021-9290(92)90025-V
   Igarashi Y, 1999, J ORAL REHABIL, V26, P111, DOI 10.1046/j.1365-2842.1999.00345.x
   Inoue K, 1985, Dent Mater J, V4, P47
   Isobe A, 2013, J PROSTHODONT RES, V57, P275, DOI 10.1016/j.jpor.2013.07.002
   Kanbara R, 2012, DENT MATER J, V31, P297, DOI 10.4012/dmj.2011-165
   Keenan KE, 2009, COMPUT METHOD BIOMEC, V12, P415, DOI 10.1080/10255840802654319
   Kishi M, 1972, SHIKWA GAKUHO, V72, P1043
   Klemetti E, 1996, J PROSTHET DENT, V75, P512, DOI 10.1016/S0022-3913(96)90455-2
   KORIOTH TWP, 1992, AM J PHYS ANTHROPOL, V88, P69, DOI 10.1002/ajpa.1330880107
   Kubo K, 2009, J PROSTHODONT RES, V53, P15, DOI 10.1016/j.jpor.2008.08.006
   KYDD WL, 1974, J PROSTHET DENT, V32, P493, DOI 10.1016/0022-3913(74)90003-1
   KYDD WL, 1982, J PROSTHET DENT, V47, P317, DOI 10.1016/0022-3913(82)90162-7
   Lacoste-Ferre MH, 2011, J MECH BEHAV BIOMED, V4, P269, DOI 10.1016/j.jmbbm.2010.10.005
   LESCH CA, 1989, J DENT RES, V68, P1345, DOI 10.1177/00220345890680091101
   Limbert Georges, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P337, DOI 10.1080/10255840310001637572
   Ogawa T, 2003, J ORAL REHABIL, V30, P1062, DOI 10.1046/j.1365-2842.2003.01183.x
   Prinz JF, 2007, FOOD HYDROCOLLOID, V21, P402, DOI 10.1016/j.foodhyd.2006.05.005
   Ranc H, 2006, COLLOID SURFACE A, V276, P155, DOI 10.1016/j.colsurfa.2005.10.033
   Rashmikant US, 2012, J PROSTHET DENT, V108, P332, DOI 10.1016/S0022-3913(12)60188-7
   Rungsiyakull C, 2010, BIOMATERIALS, V31, P7196, DOI 10.1016/j.biomaterials.2010.05.077
   Satoh Y, 2000, J ORAL REHABIL, V27, P660, DOI 10.1046/j.1365-2842.2000.00566.x
   Sawada A, 2011, J DENT RES, V90, P590, DOI 10.1177/0022034510396881
   SCAPINO RP, 1967, J MORPHOL, V122, P89, DOI 10.1002/jmor.1051220203
   Sonune SJ, 2013, INT J PROSTHODONT RE, V2, P34, DOI [10.5005/jp-journals-10019-1044, DOI 10.5005/JP-JOURNALS-10019-1044]
   SQUIER C A, 1991, Critical Reviews in Oral Biology and Medicine, V2, P13
   Squier C A, 2001, J Natl Cancer Inst Monogr, P7
   Suenaga H, 2015, J DENT RES, V94, P738, DOI 10.1177/0022034515573271
   Tadepalli SC, 2011, J BIOMECH, V44, P2337, DOI 10.1016/j.jbiomech.2011.05.006
   Thelin WR, 2008, ORAL DIS, V14, P683, DOI 10.1111/j.1601-0825.2008.01486.x
   Turner M, 2008, J AM DENT ASSOC, V139, P146, DOI 10.14219/jada.archive.2008.0129
   Wakabayashi Noriyuki, 2013, J Dent Biomech, V4, p1758736013483298, DOI 10.1177/1758736013483298
   Wang HY, 2011, J PROSTHET DENT, V105, P338, DOI 10.1016/S0022-3913(11)60066-8
   Wang YC, 2002, INT J SOLIDS STRUCT, V39, P4825, DOI 10.1016/S0020-7683(02)00379-7
   Waters MGJ, 1999, J PROSTHET DENT, V81, P439, DOI 10.1016/S0022-3913(99)80011-0
   Wood SA, 2011, J BIOMECH, V44, P1831, DOI 10.1016/j.jbiomech.2011.03.022
   Wright PS, 2002, CLIN ORAL IMPLAN RES, V13, P169, DOI 10.1034/j.1600-0501.2002.130207.x
   Zmudzki J, 2012, J MECH MED BIOL, V12, DOI 10.1142/S021951941250087X
   Zmudzki J, 2012, ACTA BIOENG BIOMECH, V14, P67, DOI 10.5277/abb120309
NR 45
TC 4
Z9 4
U1 1
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD MAR 11
PY 2016
VL 19
IS 4
BP 357
EP 365
DI 10.1080/10255842.2015.1028925
PG 9
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA CY8IA
UT WOS:000366650800002
PM 26024011
DA 2018-10-20
ER

PT J
AU Schulte, C
   Rodighiero, S
   Cappelluti, MA
   Puricelli, L
   Maffioli, E
   Borghi, F
   Negri, A
   Sogne, E
   Galluzzi, M
   Piazzoni, C
   Tamplenizza, M
   Podesta, A
   Tedeschi, G
   Lenardi, C
   Milani, P
AF Schulte, Carsten
   Rodighiero, Simona
   Cappelluti, Martino Alfredo
   Puricelli, Luca
   Maffioli, Elisa
   Borghi, Francesca
   Negri, Armando
   Sogne, Elisa
   Galluzzi, Massimiliano
   Piazzoni, Claudio
   Tamplenizza, Margherita
   Podesta, Alessandro
   Tedeschi, Gabriella
   Lenardi, Cristina
   Milani, Paolo
TI Conversion of nanoscale topographical information of cluster-assembled
   zirconia surfaces into mechanotransductive events promotes neuronal
   differentiation
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Mechanotransduction; Focal adhesion; Biomaterial; Integrin; Atomic force
   microscopy; Biophysics; Cell adhesion; Proteomics
ID NERVE GROWTH-FACTOR; REGULATES NEURITE OUTGROWTH; STRESS FIBER
   ORGANIZATION; FOCAL ADHESION PROTEIN; NEURAL STEM-CELLS; MYOSIN-II;
   EXTRACELLULAR-MATRIX; INTEGRIN ACTIVATION; SIGNALING PATHWAYS; ACIDIC
   CALPONIN
AB Background: Thanks to mechanotransductive components cells are competent to perceive nanoscale topographical features of their environment and to convert the immanent information into corresponding physiological responses. Due to its complex configuration, unraveling the role of the extracellular matrix is particularly challenging. Cell substrates with simplified topographical cues, fabricated by top-down micro- and nanofabrication approaches, have been useful in order to identify basic principles. However, the underlying molecular mechanisms of this conversion remain only partially understood.
   Results: Here we present the results of a broad, systematic and quantitative approach aimed at understanding how the surface nanoscale information is converted into cell response providing a profound causal link between mechanotransductive events, proceeding from the cell/nanostructure interface to the nucleus. We produced nanostructured ZrO2 substrates with disordered yet controlled topographic features by the bottom-up technique supersonic cluster beam deposition, i.e. the assembling of zirconia nanoparticles from the gas phase on a flat substrate through a supersonic expansion. We used PC12 cells, a well-established model in the context of neuronal differentiation. We found that the cell/nanotopography interaction enforces a nanoscopic architecture of the adhesion regions that affects the focal adhesion dynamics and the cytoskeletal organization, which thereby modulates the general biomechanical properties by decreasing the rigidity of the cell. The mechanotransduction impacts furthermore on transcription factors relevant for neuronal differentiation (e.g. CREB), and eventually the protein expression profile. Detailed proteomic data validated the observed differentiation. In particular, the abundance of proteins that are involved in adhesome and/or cytoskeletal organization is striking, and their up- or downregulation is in line with their demonstrated functions in neuronal differentiation processes.
   Conclusion: Our work provides a deep insight into the molecular mechanotransductive mechanisms that realize the conversion of the nanoscale topographical information of SCBD-fabricated surfaces into cellular responses, in this case neuronal differentiation. The results lay a profound cell biological foundation indicating the strong potential of these surfaces in promoting neuronal differentiation events which could be exploited for the development of prospective research and/or biomedical applications. These applications could be e.g. tools to study mechanotransductive processes, improved neural interfaces and circuits, or cell culture devices supporting neurogenic processes.
C1 [Schulte, Carsten; Puricelli, Luca; Borghi, Francesca; Galluzzi, Massimiliano; Piazzoni, Claudio; Podesta, Alessandro; Lenardi, Cristina; Milani, Paolo] Univ Milan, Dipartimento Fis, CIMAINA, Via Celoria 16, I-20133 Milan, Italy.
   [Cappelluti, Martino Alfredo; Sogne, Elisa] SEMM European Sch Mol Med, Via Adamello 16, I-20139 Milan, Italy.
   [Maffioli, Elisa; Negri, Armando; Tedeschi, Gabriella] Univ Milan, DIVET, Via Celoria 10, I-20133 Milan, Italy.
   [Rodighiero, Simona; Cappelluti, Martino Alfredo; Maffioli, Elisa; Negri, Armando; Sogne, Elisa; Tamplenizza, Margherita; Tedeschi, Gabriella] Fdn Filarete, Via Ortles 22-4, I-20139 Milan, Italy.
RP Schulte, C; Milani, P (reprint author), Univ Milan, Dipartimento Fis, CIMAINA, Via Celoria 16, I-20133 Milan, Italy.
EM carsten.schulte@unimi.it; paolo.milani@mi.infn.it
RI Tedeschi, Gabriella/I-6247-2017; Piazzoni, Claudio/V-9080-2017; Schulte,
   Carsten/R-2370-2016; Galluzzi, Massimiliano/M-8854-2016; Lenardi,
   Cristina/J-5872-2012; Maffioli, Elisa/U-5511-2017; Negri,
   Armando/H-7914-2017; Podesta, Alessandro/E-6568-2010
OI Tedeschi, Gabriella/0000-0003-2082-6443; Piazzoni,
   Claudio/0000-0002-8052-8053; Schulte, Carsten/0000-0002-7554-5342;
   Galluzzi, Massimiliano/0000-0003-0404-4783; Lenardi,
   Cristina/0000-0002-5522-6803; Maffioli, Elisa/0000-0002-5539-1825;
   Negri, Armando/0000-0002-8401-7437; Podesta,
   Alessandro/0000-0002-4169-6679
FU Italian Ministry of University and Research, MIUR, through the "National
   Funding for Basic Research" (FIRB) [FIRB RBA-P11AYN]; European project
   FutureNanoNeeds "Framework to respond to regulatory needs of future
   nanomaterials and markets" [FP7-NMP-2013-LARGE-7]
FX This work has been supported by the Italian Ministry of University and
   Research, MIUR, through the "National Funding for Basic Research" (FIRB)
   with a project entitled "Oxides at the nanoscale: functionalities and
   applications" (FIRB RBA-P11AYN) and by the European project
   FutureNanoNeeds "Framework to respond to regulatory needs of future
   nanomaterials and markets" (FP7-NMP-2013-LARGE-7). COST Action TD1002 is
   acknowledged for providing a stimulating scientific environment for the
   discussion of AFM-based nanomechanics of cells and soft matter. We are
   very grateful for the work of Andrea Notarnicola and Davide Alessandro
   Martella who provided a valuable contribution for some of the cell
   biological experiments and their quantifications. We are also thankful
   for the help of Massimiliano Garre from the Imaging Unit of IFOM (The
   FIRC Institute of Molecular Oncology) in the TIRF microscopy
   experiments.
CR Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002
   Argenzio E, 2014, J CELL SCI, V127, P5189, DOI 10.1242/jcs.150623
   Barabasi A.L., 1995, FRACTAL CONCEPTS SUR, DOI [10.1017/CBO9780511599798, DOI 10.1017/CB09780511599798, 10.1017/CB09780511599798]
   Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010
   Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002
   Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012
   Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Chua JS, 2014, BIOMATERIALS, V35, P7750, DOI 10.1016/j.biomaterials.2014.06.008
   Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009
   Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G
   Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Cramer H., 1945, MATH METHODS STAT
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Deerinck TJ, 2010, NCMIR METHODS FOR 3D
   Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006
   Elkhatib N, 2014, CURR BIOL, V24, P1492, DOI 10.1016/j.cub.2014.05.023
   Ferhat L, 2001, J CELL SCI, V114, P3899
   Ferraris GMS, 2014, EMBO J, V33, P2458, DOI 10.15252/embj.201387611
   Flynn Kevin C, 2013, Bioarchitecture, V3, P86
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   Franze K, 2013, ANNU REV BIOMED ENG, V15, P227, DOI 10.1146/annurev-bioeng-071811-150045
   Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036
   Gasiorowski JZ, 2013, ANNU REV BIOMED ENG, V15, P155, DOI 10.1146/annurev-bioeng-071811-150021
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004
   Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052
   Guo JY, 2010, CYTOSKELETON, V67, P431, DOI 10.1002/cm.20455
   Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018
   Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Humphries JD, 2015, TRENDS CELL BIOL, V25, P388, DOI 10.1016/j.tcb.2015.02.008
   Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551
   Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032
   Indrieri M, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3553499
   Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903
   Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574
   Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303
   Liu Y, 2014, NANO LETT, V14, P5539, DOI 10.1021/nl501912g
   Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Mendes PM, 2013, CHEM SOC REV, V42, P9207, DOI 10.1039/c3cs60198f
   Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x
   Meyer CJ, 2000, NAT CELL BIOL, V2, P666
   Migliorini E, 2011, BIOTECHNOL BIOENG, V108, P2736, DOI 10.1002/bit.23232
   Mingorance-Le Meur A, 2009, EMBO J, V28, P248, DOI 10.1038/emboj.2008.265
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931
   O'Toole M, 2015, BIOPHYS J, V108, P1027, DOI 10.1016/j.bpj.2015.01.021
   Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007
   Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473
   Plantier M, 1999, EUR J NEUROSCI, V11, P2801, DOI 10.1046/j.1460-9568.1999.00702.x
   Podesta A, 2015, J APPL PHYS, V118, DOI 10.1063/1.4937549
   Puricelli L, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4915896
   Rami G, 2006, HIPPOCAMPUS, V16, P183, DOI 10.1002/hipo.20145
   Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671
   Rocca DL, 2013, NEURON, V79, P293, DOI 10.1016/j.neuron.2013.05.003
   Sakurai M, 2006, J CELL SCI, V119, P162, DOI 10.1242/jcs.02716
   Santiago-Medina M, 2013, J CELL SCI, V126, P1122, DOI 10.1242/jcs.112607
   Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schlienger S, 2015, CELL SIGNAL, V27, P403, DOI 10.1016/j.cellsig.2014.11.032
   Schulte C, 2016, EUR J CELL BIOL, V95, P1, DOI 10.1016/j.ejcb.2015.10.002
   Schulte C, 2010, TRAFFIC, V11, P1304, DOI 10.1111/j.1600-0854.2010.01095.x
   Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Singh AV, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475101
   SPIEGELMAN BM, 1979, CELL, V16, P253, DOI 10.1016/0092-8674(79)90003-5
   Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050
   Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Tamplenizza M, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-35
   Tigyi G, 1996, J NEUROCHEM, V66, P537
   Tong ZX, 2015, EMBO J, V34, P987, DOI 10.15252/embj.201490756
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   van Kesteren RE, 2006, J NEUROSCI, V26, P152, DOI 10.1523/JNEUROSCI.4164-05.2006
   Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wegner K, 2006, J PHYS D APPL PHYS, V39, pR439, DOI 10.1088/0022-3727/39/22/R02
   Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x
   WINDER SJ, 1992, BIOCHEM J, V288, P733, DOI 10.1042/bj2880733
   Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769
   Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006
   Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200
   Yang K, 2014, ACS NANO, V8, P7809, DOI 10.1021/nn501182f
   Yim EKF, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt132
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289
   Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921
NR 103
TC 13
Z9 14
U1 0
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD MAR 9
PY 2016
VL 14
AR 18
DI 10.1186/s12951-016-0171-3
PG 24
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA DG9JH
UT WOS:000372398100002
PM 26955876
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wassenaar, JW
   Gaetani, R
   Garcia, JJ
   Braden, RL
   Luo, CG
   Huang, D
   DeMaria, AN
   Omens, JH
   Christman, KL
AF Wassenaar, Jean W.
   Gaetani, Roberto
   Garcia, Julian J.
   Braden, Rebecca L.
   Luo, Colin G.
   Huang, Diane
   DeMaria, Anthony N.
   Omens, Jeffrey H.
   Christman, Karen L.
TI Evidence for Mechanisms Underlying the Functional Benefits of a
   Myocardial Matrix Hydrogel for Post-MI Treatment
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE biomaterial; extracellular matrix; heart failure; infarction; microarray
ID CARDIAC STEM-CELLS; HEART REGENERATION; GENE-EXPRESSION; ADULT HEART;
   MAST-CELLS; IN-VIVO; INFARCTION; REPAIR; BIOMATERIALS; RESPONSES
AB BACKGROUND There is increasing need for better therapies to prevent the development of heart failure after myocardial infarction (MI). An injectable hydrogel derived from decellularized porcine ventricular myocardium has been shown to halt the post-infarction progression of negative left ventricular remodeling and decline in cardiac function in both small and large animal models.
   OBJECTIVES This study sought to elucidate the tissue-level mechanisms underlying the therapeutic benefits of myocardial matrix injection.
   METHODS Myocardial matrix or saline was injected into infarcted myocardium 1 week after ischemia-reperfusion in Sprague-Dawley rats. Cardiac function was evaluated by magnetic resonance imaging and hemodynamic measurements at 5 weeks after injection. Whole transcriptome microarrays were performed on RNA isolated from the infarct at 3 days and 1 week after injection. Quantitative polymerase chain reaction and histologic quantification confirmed expression of key genes and their activation in altered pathways.
   RESULTS Principal component analysis of the transcriptomes showed that samples collected from myocardial matrix-injected infarcts are distinct and cluster separately from saline-injected control subjects. Pathway analysis indicated that these differences are due to changes in several tissue processes that may contribute to improved cardiac healing after MI. Matrix-injected infarcted myocardium exhibits an altered inflammatory response, reduced cardiomyocyte apoptosis, enhanced infarct neovascularization, diminished cardiac hypertrophy and fibrosis, altered metabolic enzyme expression, increased cardiac transcription factor expression, and progenitor cell recruitment, along with improvements in global cardiac function and hemodynamics.
   CONCLUSIONS These results indicate that the myocardial matrix alters several key pathways after MI creating a pro-regenerative environment, further demonstrating its promise as a potential post-MI therapy. (C) 2016 by the American College of Cardiology Foundation.
C1 [Wassenaar, Jean W.; Gaetani, Roberto; Garcia, Julian J.; Braden, Rebecca L.; Omens, Jeffrey H.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.
   [Wassenaar, Jean W.; Gaetani, Roberto; Garcia, Julian J.; Braden, Rebecca L.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.
   [Luo, Colin G.; Huang, Diane; DeMaria, Anthony N.; Omens, Jeffrey H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU National Institutes of Health National Heart, Lung, and Blood Institute
   [1R01HL113468]; California Institute for Regenerative Medicine; American
   Heart Association; University of California, San Diego Medical Scientist
   Training Program [T32 GM007198-40]
FX This research was funded in part by the National Institutes of Health
   National Heart, Lung, and Blood Institute (1R01HL113468). Ms. Wassenaar
   was supported by predoctoral fellowships from the California Institute
   for Regenerative Medicine and the American Heart Association, as well as
   the University of California, San Diego Medical Scientist Training
   Program T32 GM007198-40. Dr. DeMaria is a scientific advisory board
   member of Ventrix, Inc. Dr. Christman is a co-founder, board member,
   consultant, and holds equity interest in Ventrix, Inc. All other authors
   have reported that they have no relationships relevant to the contents
   of this paper disclose.
CR Akhmedov AT, 2012, HEART FAIL REV, V18, P815
   Aminzadeh MA, 2015, EUR HEART J, V36, P751, DOI 10.1093/eurheartj/ehu196
   Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181
   Azakie A, 2006, J THORAC CARDIOV SUR, V132, P1262, DOI 10.1016/j.jtcvs.2006.08.005
   Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018
   Burt RK, 2012, CIRC RES, V111, P1286, DOI 10.1161/CIRCRESAHA.111.262584
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080
   Delewi R, 2013, HEART, V99, P225, DOI 10.1136/heartjnl-2012-302230
   Duncan J, 2012, TRANSLATIONAL CARDIO, P83
   Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039
   Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530
   Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106
   Jameel MN, 2010, AM J PHYSIOL-HEART C, V298, pH1348, DOI 10.1152/ajpheart.01100.2009
   Jin H, 2001, CIRCULATION, V103, P736
   Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255
   Lachtermacher S, 2012, STEM CELL REV REP, V8, P251, DOI 10.1007/s12015-011-9282-2
   Laurencin C.T., 2012, SCI TRANSL MED, V4, P160
   Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904
   Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154
   Marin-Garcia J, 2011, SIGNALING IN THE HEART, P155, DOI 10.1007/978-1-4419-9461-5_9
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213
   Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4
   Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726
   Pavo N, 2014, BIOMATERIALS, V35, P3541, DOI 10.1016/j.biomaterials.2013.12.071
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Somasundaram P, 2005, J PATHOL, V205, P102, DOI 10.1002/path.1690
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200
   Ungerleider JL, 2014, STEM CELL TRANSL MED, V3, P1090, DOI 10.5966/sctm.2014-0049
   van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309
   Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5
   Wang ZV, 2014, J CARDIOVASC PHARM, V63, P302, DOI 10.1097/FJC.0000000000000054
   Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619
NR 42
TC 20
Z9 21
U1 1
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD MAR 8
PY 2016
VL 67
IS 9
BP 1074
EP 1086
DI 10.1016/j.jacc.2015.12.035
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DE9DV
UT WOS:000370936800011
PM 26940929
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Costa, KD
AF Costa, Kevin D.
TI Decellularized Scaffold Hydrogel Materials for MI Treatment Could "The
   Matrix" Really Be the Future?
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Editorial Material
DE biomaterial; extracellular matrix; heart failure; infarction; tissue
   engineering
ID HEART; MYOCARDIUM; INFARCTION; DISEASE; IMPACT; MODEL
C1 [Costa, Kevin D.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.
RP Costa, KD (reprint author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.
EM kevin.costa@mssm.edu
CR Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372
   Johnson TD, 2016, PROTEOM CLIN APPL, V10, P75, DOI 10.1002/prca.201500048
   Lee RJ, 2015, INT J CARDIOL, V199, P18, DOI 10.1016/j.ijcard.2015.06.111
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Sanchez PL, 2015, BIOMATERIALS, V61, P279, DOI 10.1016/j.biomaterials.2015.04.056
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701
   Turnbull IC, 2014, FASEB J, V28, P644, DOI 10.1096/fj.13-228007
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wassenaar JW, 2016, J AM COLL CARDIOL, V67, P1074, DOI 10.1016/j.jacc.2015.12.035
   Wei K, 2015, NATURE, V525, P479, DOI 10.1038/nature15372
NR 13
TC 2
Z9 2
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD MAR 8
PY 2016
VL 67
IS 9
BP 1087
EP 1090
DI 10.1016/j.jacc.2016.01.006
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DE9DV
UT WOS:000370936800012
PM 26940930
OA Bronze
DA 2018-10-20
ER

PT J
AU Chen, H
   Ji, XR
   Zhang, Q
   Tian, XZ
   Zhang, BX
   Tang, PF
AF Chen, Hua
   Ji, Xin-Ran
   Zhang, Qun
   Tian, Xue-Zhong
   Zhang, Bo-Xun
   Tang, Pei-Fu
TI Effects of Calcium Sulfate Combined with Platelet-rich Plasma on
   Restoration of Long Bone Defect in Rabbits
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Bone Restoration; Calcium Sulfate; Long Bone Defect; Platelet-rich
   Plasma
ID MORPHOGENETIC PROTEIN-2; GRAFT; REGENERATION; ENHANCEMENT; BIOMATERIAL;
   SCAFFOLDS; REPAIR
AB +/- Background: The treatment for long bone defects has been a hot topic in the field of regenerative medicine. This study aimed to evaluate the therapeutic effects of calcium sulfate (CS) combined with platelet-rich plasma (PRP) on long bone defect restoration.
   Methods: A radial bone defect model was constructed through an osteotomy using New Zealand rabbits. The rabbits were randomly divided into four groups (n = 10 in each group): a CS combined with PRP (CS-PRP) group, a CS group, a PRP group, and a positive (recombinant human bone morphogenetic protein-2) control group. PRP was prepared from autologous blood using a two-step centrifugation process. CS-PRP was obtained by mixing hemihydrate CS with PRP. Radiographs and histologic micrographs were generated. The percentage of bone regenerated bone area in each rabbit was calculated at 10 weeks. One-way analysis of variance was performed in this study.
   Results: The radiographs and histologic micrographs showed bone restoration in the CS-PRP and positive control groups, while nonunion was observed in the CS and PRP groups. The percentages of bone regenerated bone area in the CS-PRP (84.60 +/- 2.87%) and positive control (52.21 +/- 4.53%) groups were significantly greater than those in the CS group (12.34 +/- 2.17%) and PRP group (16.52 +/- 4.22%) (P < 0.001). In addition, the bone strength of CS-PRP group (43.10 +/- 4.10%) was significantly greater than that of the CS group (20.10 +/- 3.70%) or PRP group (25.10 +/- 2.10%) (P < 0.001).
   Conclusion: CS-PRP functions as an effective treatment for long bone defects through stimulating bone regeneration and enhancing new bone strength.
C1 [Chen, Hua; Ji, Xin-Ran; Zhang, Qun; Zhang, Bo-Xun; Tang, Pei-Fu] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100038, Peoples R China.
   [Tian, Xue-Zhong] Peoples Hosp Tianjin, Dept Orthopaed, Tianjin 300131, Peoples R China.
RP Tang, PF (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100038, Peoples R China.
EM tangpf301@163.com
CR Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833
   Borrelli J, 2003, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000069893.31220.6f
   Chen TL, 2014, J CRANIOFAC SURG, V25, P215, DOI 10.1097/SCS.0000000000000420
   Cui X, 2008, J CRANIOFAC SURG, V19, P459, DOI 10.1097/SCS.0b013e31815ca034
   [崔旭 CUI Xu], 2009, [中华医学杂志, National Medical Journal of China], V89, P777
   Durmuslar MC, 2014, ACTA ODONTOL SCAND, V72, P948, DOI 10.3109/00016357.2014.926023
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Kutkut A, 2012, J PERIODONTOL, V83, P401, DOI 10.1902/jop.2011.110237
   Luca L, 2011, J BIOMED MATER RES A, V96A, P66, DOI 10.1002/jbm.a.32957
   Lyons F, 2012, J BONE JOINT SURG BR, V94, P162
   Marx R E, 2001, Implant Dent, V10, P225
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   Shanmugarajan S, 2007, J CHILD NEUROL, V22, P967, DOI 10.1177/0883073807305664
   Shi B, 2006, INT J ORAL MAXILLOF, V22, P656
   Simson J, 2013, J ORTHOP RES, V31, P392, DOI 10.1002/jor.22247
   Tadokoro M, 2012, J TISSUE ENG REGEN M, V6, P253, DOI 10.1002/term.427
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Wang ML, 2008, SPINE J, V8, P340, DOI 10.1016/j.spinee.2007.06.003
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Zhang M, 2014, ARTIF ORGANS, V38, P493, DOI 10.1111/aor.12208
NR 20
TC 3
Z9 4
U1 0
U2 12
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD MAR 5
PY 2016
VL 129
IS 5
BP 557
EP 561
DI 10.4103/0366-6999.176981
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG7WF
UT WOS:000372293700009
PM 26904990
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Li, RC
   Zhang, XT
   Zhang, QY
   Liu, HH
   Rong, JH
   Tu, M
   Zeng, R
   Zhao, JH
AF Li, Ruicong
   Zhang, Xiaoting
   Zhang, Qiuyu
   Liu, Huahua
   Rong, Jianhua
   Tu, Mei
   Zeng, Rong
   Zhao, Jianhao
TI beta-cyclodextrin-conjugated hyaluronan hydrogel as a potential drug
   sustained delivery carrier for wound healing
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterial; crosslinking; drug delivery systems; gels; polysaccharides
ID ACID HYDROGELS; CONTROLLED-RELEASE; NETWORKS; DEGRADATION; REGENERATION;
   MECHANISMS; BEHAVIORS; COMPLEXES; COMPOSITE; CELLULOSE
AB In order to develop a potential drug sustained delivery carrier suitable for wound healing, a series of beta-cyclodextrin conjugated hyaluronan hydrogels (beta-CD-HA) with adjustable crosslink densities were synthesized and characterized, meanwhile the delivery kinetics and mechanism of diclofenac as a model anti-inflammatory drug from these hydrogels were investigated. By controlling the feeding molar ratio of beta-CD/HA, a beta-CD substitution degree of 4.65% was obtained by H-1-NMR analysis. The incorporation of beta-CD modification had little effect on the internal porous structure, water swelling ratio, and rheological property of HA hydrogel, which however were influenced by the crosslink density. Although the crosslink density had an influence on the drug loading and release profile by altering the water swelling property, the interaction between beta-CD and drug was the primary factor for the high loading capacity and long-term sustained delivery of diclofenac. The semiempirical equation fit showed that the release of diclofenac from HA-based hydrogels followed a pseudo-Fickian diffusion mechanism. By the aid of beta-CD and controlled crosslink density, a beta-CD-HA hydrogel with a diclofenac sustained delivery period of over 28 days and desirable physicochemical properties was achieved, which will be a promising drug sustained delivery carrier for wound healing. (C) 2015 Wiley Periodicals, Inc.
C1 [Li, Ruicong; Zhang, Xiaoting; Zhang, Qiuyu; Liu, Huahua; Rong, Jianhua; Tu, Mei; Zeng, Rong; Zhao, Jianhao] Jinan Univ, Coll Sci & Technol, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Rong, Jianhua; Tu, Mei; Zeng, Rong; Zhao, Jianhao] Minist Educ, Engn Res Ctr Artificial Organs & Mat, Guangzhou 510632, Guangdong, Peoples R China.
RP Zhao, JH (reprint author), Jinan Univ, Coll Sci & Technol, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
EM jhzhao@jnu.edu.cn
FU National Natural Science Foundation of China [30900296, 51173070,
   21344001]; Science and Technology Planning Project of Guangdong Province
   of China [2015A010105017, 2015A020214014]; National Undergraduate
   Training Programs for Innovation and Entrepreneurship [201510559007,
   1055915021, CX15020, CX15028, 15123001]
FX The authors are thankful to the financial support from the National
   Natural Science Foundation of China (No. 30900296, 51173070, 21344001),
   Science and Technology Planning Project of Guangdong Province of China
   (No. 2015A010105017, 2015A020214014) and National Undergraduate Training
   Programs for Innovation and Entrepreneurship (No. 201510559007,
   1055915021, CX15020, CX15028, 15123001).
CR Antunes BP, 2015, CARBOHYD POLYM, V130, P104, DOI 10.1016/j.carbpol.2015.04.072
   Borzacchiello A., 2015, BIOMED RES INT, V2015
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Chen MC, 2009, BIOMATERIALS, V30, P2102, DOI 10.1016/j.biomaterials.2008.12.047
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dahlmann J, 2013, BIOMATERIALS, V34, P940, DOI 10.1016/j.biomaterials.2012.10.008
   Dang QF, 2011, CARBOHYD POLYM, V83, P171, DOI 10.1016/j.carbpol.2010.07.038
   Das S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40318
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Flynn TC, 2015, DERMATOL SURG, V41, pS143, DOI 10.1097/01.DSS.0000452647.14389.a7
   Gharib R, 2015, CARBOHYD POLYM, V129, P175, DOI 10.1016/j.carbpol.2015.04.048
   Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506
   Gupta A, 2013, J APPL POLYM SCI, V128, P4031, DOI 10.1002/app.38594
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Korhonen M, 2001, INT J PHARM, V221, P187, DOI 10.1016/S0378-5173(01)00675-5
   Li NN, 2014, MAT SCI ENG C-MATER, V36, P287, DOI 10.1016/j.msec.2013.12.025
   Liu YY, 2005, BIOMATERIALS, V26, P6367, DOI 10.1016/j.biomaterials.2005.04.011
   Loftsson T, 2007, INT J PHARM, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044
   Lou C. H., 2015, MAT SCI ENG C, V46, P316
   Lou Y., 2000, J CONTROL RELEASE, V69, P169
   Luo CH, 2014, MAT SCI ENG C-MATER, V36, P301, DOI 10.1016/j.msec.2013.12.021
   Marsano E, 2000, POLYMER, V41, P7691, DOI 10.1016/S0032-3861(00)00142-7
   Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005
   Metters A T, 1999, Biomed Sci Instrum, V35, P33
   Peng K, 2010, SOFT MATTER, V6, P85, DOI 10.1039/b914166a
   PETTER RC, 1990, J AM CHEM SOC, V112, P3860, DOI 10.1021/ja00166a021
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rodriguez-Tenreiro C, 2007, EUR J PHARM BIOPHARM, V66, P55, DOI 10.1016/j.ejpb.2006.09.003
   Rodriguez-Tenreiro C., 2006, J PHARM RES, V23, P121, DOI DOI 10.1007/S11095-005-8924-Y
   Rodriguez-Vita J, 2010, CYTOKINE GROWTH F R, V21, P61, DOI 10.1016/j.cytogfr.2009.11.006
   dos Santos JFR, 2009, BIOMATERIALS, V30, P1348, DOI [10.1016/j.biomaterials.2008.11.016, 10.1016/j.biomaterials.2008:11.016]
   Roy S., 2013, DISORDER LOCALIZED I, P173
   Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462
   Schneider HJ, 1998, CHEM REV, V98, P1755, DOI 10.1021/cr970019t
   Stella VJ, 1999, ADV DRUG DELIVER REV, V36, P3, DOI 10.1016/S0169-409X(98)00052-0
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tang WL, 2013, J APPL POLYM SCI, V127, P2803, DOI 10.1002/app.37607
   UEKAMA K, 1994, DRUG TARG D, V3, P411
   Zainuddin J. J., 2002, J BIOMAT SCI-POLYM E, V13, P1007
   Zhang YL, 2002, J BIOMED MATER RES, V59, P318, DOI 10.1002/jbm.1248
   Zhao JH, 2011, CARBOHYD POLYM, V86, P806, DOI 10.1016/j.carbpol.2011.05.026
NR 46
TC 1
Z9 1
U1 4
U2 84
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 5
PY 2016
VL 133
IS 9
AR 43072
DI 10.1002/app.43072
PG 8
WC Polymer Science
SC Polymer Science
GA DA5NQ
UT WOS:000367850200016
DA 2018-10-20
ER

PT J
AU Harvey, VL
   Egerton, VM
   Chamberlain, AT
   Manning, PL
   Buckley, M
AF Harvey, Virginia L.
   Egerton, Victoria M.
   Chamberlain, Andrew T.
   Manning, Phillip L.
   Buckley, Michael
TI Collagen Fingerprinting: A New Screening Technique for Radiocarbon
   Dating Ancient Bone
SO PLOS ONE
LA English
DT Article
ID ARCHAEOLOGICAL BONE; SPECIES IDENTIFICATION; PRESERVATION; PRETREATMENT;
   INDICATORS; SURVIVAL; SITES; AMS
AB Collagen is the dominant organic component of bone and is intimately locked within the hydroxyapatite structure of this ubiquitous biomaterial that dominates archaeological and palaeontological assemblages. Radiocarbon analysis of extracted collagen is one of the most common approaches to dating bone from late Pleistocene or Holocene deposits, but dating is relatively expensive compared to other biochemical techniques. Numerous analytical methods have previously been investigated for the purpose of screening out samples that are unlikely to yield reliable dates including histological analysis, UV-stimulated fluorescence and, most commonly, the measurement of percentage nitrogen (% N) and ratio of carbon to nitrogen (C:N). Here we propose the use of collagen fingerprinting (also known as Zooarchaeology by Mass Spectrometry, or ZooMS, when applied to species identification) as an alternative screening method for radiocarbon dating, due to its ability to provide information on collagen presence and quality, alongside species identification. The method was tested on a series of sub-fossil bone specimens from cave systems on Cayman Brac (Cayman Islands), chosen due to the observable range in diagenetic alteration, and in particular, the extent of mineralisation. Six C-14 dates, of 18 initial attempts, were obtained from remains of extinct hutia, Capromys sp. (Rodentia; Capromyidae), recovered from five distinct caves on Cayman Brac, and ranging from 393 +/- 25 to 1588 +/- 26 radiocarbon years before present (yr BP). All of the bone samples that yielded radiocarbon dates generated excellent collagen fingerprints, and conversely those that gave poor fingerprints also failed dating. Additionally, two successfully fingerprinted bone samples were screened out from a set of 81. Both subsequently generated C-14 dates, demonstrating successful utilisation of ZooMS as an alternative screening mechanism to identify bone samples that are suitable for C-14 analysis.
C1 [Harvey, Virginia L.; Egerton, Victoria M.; Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.
   [Egerton, Victoria M.; Manning, Phillip L.] Coll Charleston, Dept Geol & Environm Geosci, 66 George St, Charleston, SC 29424 USA.
   [Chamberlain, Andrew T.; Buckley, Michael] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England.
RP Buckley, M (reprint author), Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England.
EM m.buckley@manchester.ac.uk
RI Manning, Phillip/F-9966-2011; Chamberlain, Andrew/F-2118-2018
OI Manning, Phillip/0000-0002-7161-6246; Buckley,
   Michael/0000-0002-4166-8213; Harvey, Virginia/0000-0003-0796-8287
FU NERC New Investigator research grant [NE/K000799/1]; NERC fellowship
   [NE/H015132/1]; Royal Society [UF120473]; Science and Technology
   Facilities Council [ST/M001814/1]; Natural Environment Research Council;
   Science and Technology Facilities Council (STFC); Natural Environment
   Research Council [NE/H015132/1, NE/K000799/1]
FX This work was supported by NERC New Investigator research grant
   (NE/K000799/1), NERC fellowship (NE/H015132/1) and Royal Society
   (UF120473) fellowship funding to MB; Science and Technology Facilities
   Council (ST/M001814/1) fellowship funding to PM.; Sincere thanks go to
   Andrew Kitchener (National Museums Scotland) for help in the acquisition
   of the reference sample. Our many thanks also go to Oxford Radiocarbon
   Accelerator Unit (ORAU) and the University of Manchester's Faculty of
   Life Sciences Biomolecular Analysis core facility for access to
   instrumentation. We thank the editor and two anonymous reviewers for
   their useful comments on earlier versions of the manuscript. We also
   thank the Natural Environment Research Council, the Royal Society, and
   Science and Technology Facilities Council (STFC) for providing funding
   to make this research possible.
CR Aitken M. J., 2014, SCI BASED DATING ARC
   Brock F, 2013, RADIOCARBON, V55, P445, DOI 10.1017/S0033822200057581
   Brock F, 2007, EH RES DEP REP SER, V30, P2007
   Brock F, 2012, RADIOCARBON, V54, P879, DOI 10.1017/S0033822200047524
   Bronk Ramsey C., 2008, ARCHAEOMETRY, V50, P249, DOI DOI 10.1111/J.1475-4754.2008.00394.X)
   Bronk Ramsey C., 2002, ARCHAEOMETRY, V44, P1, DOI DOI 10.1111/J.1475-4754.2002.TB01101.X
   Buckley M, 2014, J ARCHAEOL SCI, V41, P631, DOI 10.1016/j.jas.2013.08.021
   Buckley M, 2016, RAPID COMMUNICATIONS, V30, P1
   Buckley M., 2011, ANTIQUA, V1, P1, DOI DOI 10.4081/ANTIQUA.2011.E1
   Buckley M, 2008, J ARCHAEOL SCI, V35, P1756, DOI 10.1016/j.jas.2007.11.022
   Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316
   Buckley M, 2011, ARCHAEOL ANTHROP SCI, V3, P271, DOI 10.1007/s12520-011-0066-z
   Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020
   Chiu TC, 2007, QUATERNARY SCI REV, V26, P18, DOI 10.1016/j.quascirev.2006.06.015
   Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071
   Davalos Liliana M., 2012, P157
   GOODFRIEND GA, 1983, GEOLOGY, V11, P575, DOI 10.1130/0091-7613(1983)11<575:LATPOR>2.0.CO;2
   Halcrow SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098462
   Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064
   HEDGES REM, 1992, RADIOCARBON, V34, P279
   Hoke N, 2011, PALAEOGEOGR PALAEOCL, V310, P23, DOI 10.1016/j.palaeo.2011.03.021
   Holmes KM, 2005, J ARCHAEOL SCI, V32, P157, DOI 10.1016/j.jas.2004.06.002
   Jans MME, 2002, ARCHAEOMETRY, V44, P343, DOI 10.1111/1475-4754.t01-1-00067
   Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109
   Morgan GS, 1994, MONOGRAPHIAE BIOL, P465
   Pestle WJ, 2012, J ARCHAEOL SCI, V39, P2079, DOI 10.1016/j.jas.2012.03.008
   Ramsey CB, 2013, RADIOCARBON, V55, P2021
   Ramsey CB, 2004, RADIOCARBON, V46, P17
   Ramsey CB, 2004, RADIOCARBON, V46, P155
   Rybczynski N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2516
   Steadman DW, 2005, P NATL ACAD SCI USA, V102, P11763, DOI 10.1073/pnas.0502777102
   STEADMAN DW, 1985, P BIOL SOC WASH, V98, P544
   Turner-Walker G, 2002, INT J OSTEOARCHAEOL, V12, P407, DOI 10.1002/oa.642
   van der Sluis LG, 2014, PALAEOGEOGR PALAEOCL, V416, P80, DOI 10.1016/j.palaeo.2014.06.003
   Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385
NR 35
TC 13
Z9 13
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 3
PY 2016
VL 11
IS 3
AR e0150650
DI 10.1371/journal.pone.0150650
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG0EB
UT WOS:000371735200128
PM 26938469
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Choudhury, M
   Talukdar, B
   Dass, NN
   Baruah, KC
   Devi, D
AF Choudhury, Manasee
   Talukdar, Bijit
   Dass, Narendra Nath
   Baruah, Kanak Chandra
   Devi, Dipali
TI Impact of BSA and casein on chemical modification of muga silk fiber
SO JOURNAL OF THE TEXTILE INSTITUTE
LA English
DT Article
DE graft copolymerization; muga silk fiber; BSA; casein; 2; 2'
   azobisisobutyronitrile (AIBN)
ID METHYL-METHACRYLATE MMA; GRAFT-COPOLYMERIZATION; PHYSICAL-PROPERTIES;
   VINYL MONOMERS; REDOX SYSTEM; FIBROIN; FILMS; ACID; METHYLMETHACRYLATE;
   POLYMERIZATION
AB The study reports on the effects of bovine serum albumin and casein on grafting of muga (Antheraea assamensis Helfer) silk fibers using initiator 2,2' azobisisobutyronitrile. FTIR studies confirm the chemical binding of the proteins onto muga fibers through shifting of the major amide bonds, accredited to grafting. Scanning electron microscopy imaging reveals rugged morphology of the grafted fibers, due to the imprints of granular proteins. Tensile strength of the fibers increases with the augmentation in grafting percent. The grafted fibers showed no loss in weight after chemical resistance measurement indicating stable bond formation between the proteins and the fibers. Moreover, the water retention capacity and dynamic contact angle study of grafted fibers suggest better hydrophobicity. Thus, the use of such eco-friendly grafting agents for enhancing the strength and stability of silk fiber proves to be more beneficial than to other chemical grafting agents in producing efficient and environment-friendly silk for various applications in textile and other biomaterial fields.
C1 [Choudhury, Manasee; Talukdar, Bijit; Devi, Dipali] Inst Adv Study Sci & Technol, Div Life Sci, Seribiotech Unit, Gauhati, India.
   [Dass, Narendra Nath] Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati, India.
   [Baruah, Kanak Chandra] Forens Sci Lab, Shillong, Meghalaya, India.
RP Devi, D (reprint author), Inst Adv Study Sci & Technol, Div Life Sci, Seribiotech Unit, Gauhati, India.
EM dipali.devi@gmail.com
FU Department of Science and Technology, Ministry of Science and Technology
   [IASST/PF/2012-13/2145-2153]
FX This work was supported by the Department of Science and Technology,
   Ministry of Science and Technology [grant number
   IASST/PF/2012-13/2145-2153].
CR Das A, 2001, J APPL POLYM SCI, V81, P2633, DOI 10.1002/app.1707
   Das A, 2000, BIORESOURCE TECHNOL, V74, P213, DOI 10.1016/S0960-8524(00)00020-1
   Das AM, 2010, INDIAN J FIBRE TEXT, V35, P107
   Deka H, 2012, J POLYM MATER, V29, P37
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Dong QZ, 2000, J APPL POLYM SCI, V77, P2543
   Dutta S., 2012, GLOBAL J BIOSCIENCE, V2, P229
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Freddi G, 1997, J POLYM SCI POL PHYS, V35, P841, DOI 10.1002/(SICI)1099-0488(19970415)35:5<841::AID-POLB13>3.0.CO;2-A
   Freddi G, 1996, J SOC DYERS COLOUR, V112, P191
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Freddi G., 1996, POLYM MAT ENCY, V10, P7734
   Gu F., 2009, FOOD CHEM, V120, P505
   HAFIZ SAA, 1995, J APPL POLYM SCI, V55, P997, DOI 10.1002/app.1995.070550704
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang P, 2010, J NANOMATER, V2010, P6
   Kawahara Y, 1999, J MACROMOL SCI PHYS, VB38, P471, DOI 10.1080/00222349908212445
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Liu X, 2012, ANALYST, V137, P4552, DOI 10.1039/c2an35700c
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   MISHRA MK, 1982, J APPL POLYM SCI, V27, P2403, DOI 10.1002/app.1982.070270710
   Nguyen T. T., 2010, J CHEM, V48, P637
   Ojah R, 2006, BIORESOURCE TECHNOL, V97, P1529, DOI 10.1016/j.biortech.2005.06.009
   Peng Q, 2006, J APPL POLYM SCI, V100, P1299, DOI 10.1002/app.23408
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Perez-Rigueiro J, 2002, J APPL POLYM SCI, V84, P1431, DOI 10.1002/app.10366
   Prachayawarakorn J., 2005, J SCI TECHNOL, V27, P1233
   SAMAL RK, 1983, J APPL POLYM SCI, V28, P1311, DOI 10.1002/app.1983.070280405
   SAMAL S, 1984, J APPL POLYM SCI, V29, P2007, DOI 10.1002/app.1984.070290609
   Sheikh M. R. K., 2006, J APPL SCI, V6, P1954
   Shimizu M., 2000, STRUCTURE SILK YARN, P7
   Song Y, 2006, POLYM INT, V55, P1350, DOI 10.1002/pi.2093
   Taghizadeh M. T., 2001, SCI ISLAMIC REPUBLIC, V12, P333
   TSUKADA M, 1988, J POLYM SCI POL PHYS, V26, P949, DOI 10.1002/polb.1988.090260418
   TSUKADA M, 1992, J APPL POLYM SCI, V44, P2203, DOI 10.1002/app.1992.070441217
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Zhao J., 2007, J MACROMOLECULAR SCI, V44, P299
NR 40
TC 1
Z9 1
U1 4
U2 27
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0040-5000
EI 1754-2340
J9 J TEXT I
JI J. Text. Inst.
PD MAR 3
PY 2016
VL 107
IS 3
BP 346
EP 354
DI 10.1080/00405000.2015.1034926
PG 9
WC Materials Science, Textiles
SC Materials Science
GA DA6FZ
UT WOS:000367899300008
DA 2018-10-20
ER

PT J
AU Jia, XT
   Wang, CY
   Zhao, C
   Ge, Y
   Wallace, GG
AF Jia, Xiaoteng
   Wang, Caiyun
   Zhao, Chen
   Ge, Yu
   Wallace, Gordon G.
TI Toward Biodegradable Mg-Air Bioelectric Batteries Composed of Silk
   Fibroin-Polypyrrole Film
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BOMBYX-MORI; BIOMEDICAL APPLICATIONS; CONDUCTING POLYMERS; DEVICES;
   BIOMATERIAL; ELECTRONICS; NANOPARTICLES; CYTOTOXICITY; STIMULATION;
   REDUCTION
AB Biodegradable active implantable devices can be used to diagnose and/or treat disease and eventually disappear without surgical removal. If an "external" energy source is required for effective operation then a biocompatible and biodegradable battery would be ideal. In this study, a partially biodegradable Mg-air bioelectric battery (biobattery) is demonstrated using a silk fibroin-polypyrrole (SF-PPy) film cathode coupled with bioresorbable Mg alloy anode in phosphate buffered saline (PBS) electrolyte. PPy is chemically coated onto one side of the silk substrate. SF-PPy film shows a conductivity of approximate to 1.1 S cm(-1) and a mild catalytic activity toward oxygen reduction. It degrades in a concentrated buffered protease XIV solution, with a weight loss of 82% after 15 d. The assembled Mg-air biobattery exhibits a discharge capacity up to 3.79 mA h cm(-2) at a current of 10 mu A cm(-2) at room temperature, offering a specific energy density of approximate to 4.70 mW h cm(-2). This novel partially biodegradable battery provides another step along the route to biodegradable batteries.
C1 [Jia, Xiaoteng; Wang, Caiyun; Zhao, Chen; Ge, Yu; Wallace, Gordon G.] Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, AIIM Facil, Innovat Campus, Wollongong, NSW 2522, Australia.
RP Wang, CY; Wallace, GG (reprint author), Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, AIIM Facil, Innovat Campus, Wollongong, NSW 2522, Australia.
EM caiyun@uow.edu.au; gwallace@uow.edu.au
RI Wallace, Gordon/H-1123-2011; Wang, Caiyun/A-2938-2013
OI Wallace, Gordon/0000-0002-0381-7273; Wang, Caiyun/0000-0001-9539-2155;
   Zhao, Chen/0000-0001-9848-4418
FU Australian Research Council Centre of Excellence [CE 140100012]; ARC
   [FL110100196]
FX Funding from the Australian Research Council Centre of Excellence Scheme
   (Project Number CE 140100012) is gratefully acknowledged. G.G.W. is
   grateful to the ARC for support under the Australian Laureate Fellowship
   scheme (FL110100196). The authors would like to thank the Australian
   National Nanofabrication Facility-Materials node (ANFF) and the UoW
   Electron Microscopy Centre for equipment use.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   DAVIDSON RG, 1995, SYNTHETIC MET, V72, P121, DOI 10.1016/0379-6779(94)02332-S
   Gordijo CR, 2010, ADV FUNCT MATER, V20, P1404, DOI 10.1002/adfm.200901581
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hwang SW, 2014, ADV MATER, V26, P1992, DOI 10.1002/adma.201304821
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d
   Jeong YS, 2011, BIOMATERIALS, V32, P7217, DOI 10.1016/j.biomaterials.2011.06.020
   Jia XT, 2014, ACS APPL MATER INTER, V6, P21110, DOI 10.1021/am505985z
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Khomenko VG, 2005, ELECTROCHIM ACTA, V50, P1675, DOI 10.1016/j.electacta.2004.10.024
   Kim DH, 2012, P NATL ACAD SCI USA, V109, P19910, DOI 10.1073/pnas.1205923109
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim S, 2011, BIOMATERIALS, V32, P2342, DOI 10.1016/j.biomaterials.2010.11.080
   Kim YJ, 2013, P NATL ACAD SCI USA, V110, P20912, DOI 10.1073/pnas.1314345110
   Kim YJ, 2013, J MATER CHEM B, V1, P3781, DOI 10.1039/c3tb20183j
   Kong Y, 2012, SYNTHETIC MET, V162, P584, DOI 10.1016/j.synthmet.2012.01.021
   Lee Y, 2013, IEEE J SOLID-ST CIRC, V48, P229, DOI 10.1109/JSSC.2012.2221233
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   LI YF, 1989, SYNTHETIC MET, V28, pC127
   Liu YC, 2000, SYNTHETIC MET, V113, P203, DOI 10.1016/S0379-6779(00)00188-0
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Macdonald JR, 2005, SOLID STATE IONICS, V176, P1961, DOI 10.1016/j.ssi.2004.05.035
   MILLER DL, 1992, J ELECTROCHEM SOC, V139, P967, DOI 10.1149/1.2069376
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Nguyen HT, 2014, J BIOMED MATER RES A, V102, P2554, DOI 10.1002/jbm.a.34925
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Romero IS, 2014, ADV FUNCT MATER, V24, P3866, DOI 10.1002/adfm.201303292
   Romero IS, 2013, ACS APPL MATER INTER, V5, P553, DOI 10.1021/am301844c
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072
   Sokolov A, 2012, J BIOMED MATER RES A, V100A, P1142, DOI 10.1002/jbm.a.34054
   Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Tsang M, 2014, J MICROELECTROMECH S, V23, P1281, DOI 10.1109/JMEMS.2014.2360201
   Vaitkuviene A, 2013, J HAZARD MATER, V250, P167, DOI 10.1016/j.jhazmat.2013.01.038
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CY, 2011, ADV MATER, V23, P3580, DOI 10.1002/adma.201101067
   Wei X, 2008, FRONT ENERGY POWER E, V2, P1, DOI DOI 10.1007/S11708-008-0016-3
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Wu A, 2007, SYNTHETIC MET, V157, P303, DOI 10.1016/j.synthmet.2007.03.008
   Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329
   Yang Y, 2012, ADV ENERGY MATER, V2, P266, DOI 10.1002/aenm.201100449
   Yin L, 2014, ADV MATER, V26, P3879, DOI 10.1002/adma.201306304
   Zhang TR, 2014, MATER HORIZONS, V1, P196, DOI 10.1039/c3mh00059a
NR 56
TC 21
Z9 21
U1 17
U2 133
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR 2
PY 2016
VL 26
IS 9
BP 1454
EP 1462
DI 10.1002/adfm.201503498
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DG6FR
UT WOS:000372179100017
OA Bronze
DA 2018-10-20
ER

PT J
AU Yazici, H
   O'Neill, MB
   Kacar, T
   Wilson, BR
   Oren, EE
   Sarikaya, M
   Tamerler, C
AF Yazici, Hilal
   O'Neill, Mary B.
   Kacar, Turgay
   Wilson, Brandon R.
   Oren, E. Emre
   Sarikaya, Mehmet
   Tamerler, Candan
TI Engineered Chimeric Peptides as Antimicrobial Surface Coating Agents
   toward Infection-Free Implants
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE chimeric peptides; antimicrobial peptide (AMP); titanium binding
   peptides (TiBP); surface functionalization; infection; modular peptides
   and peptide-based implant coatings
ID MESENCHYMAL STEM-CELLS; BINDING PEPTIDES; MOLECULAR BIOMIMETICS;
   ANTIBIOTIC-RESISTANCE; CATIONIC PEPTIDES; BIOFILM FORMATION; SENSING
   SYSTEM; TITANIUM; IMMOBILIZATION; BIOMATERIALS
AB Prevention of bacterial colonization and consequent biofilm formation remains a major challenge in implantable medical devices. Implant-associated infections are not only a major cause of implant failures but also their conventional treatment with antibiotics brings further complications due to the escalation in multidrug resistance to a variety of bacterial species. Owing to their unique properties, antimicrobial peptides (AMPs) have gained significant attention as effective agents to combat colonization of microorganisms. These peptides have been shown to exhibit a wide spectrum of activities with specificity to a target cell while having a low tendency for developing bacterial resistance. Engineering biomaterial surfaces that feature AMP properties, therefore, offer a promising approach to prevent implant infections. Here, we engineered a chimeric peptide with bifunctionality that both forms a robust solid-surface coating while presenting antimicrobial property. The individual domains of the chimeric peptides were evaluated for their solid-binding kinetics to titanium substrate as well as for their antimicrobial properties in solution. The antimicrobial efficacy of the chimeric peptide on the implant material was evaluated in vitro against infection by a variety of bacteria, including Streptococcus mutans, Staphylococcus. epidermidis, and Escherichia coli, which are commonly found in oral and orthopedic implant related surgeries. Our results demonstrate significant improvement in reducing bacterial colonization onto titanium surfaces below the detectable limit. Engineered chimeric peptides with freely displayed antimicrobial domains could be a potential solution for developing infection-free surfaces by engineering implant interfaces with highly reduced bacterial colonization property.
C1 [Yazici, Hilal; O'Neill, Mary B.; Kacar, Turgay; Wilson, Brandon R.; Oren, E. Emre; Sarikaya, Mehmet; Tamerler, Candan] Univ Washington, Genetically Engn Mat Sci & Engn Ctr, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
   [Yazici, Hilal; Kacar, Turgay] Istanbul Tech Univ, Dept Mol Biol & Genet, Mol Biol Biotechnol & Genet Ctr, TR-34469 Istanbul, Turkey.
   [Oren, E. Emre] TOBB Univ Econ & Technol, Dept Biomed Engn, TR-06560 Ankara, Turkey.
   [Tamerler, Candan] Univ Kansas, Bioengn Res Ctr, Dept Mech Engn, Lawrence, KS 66045 USA.
RP Tamerler, C (reprint author), Dept Mech Engn, Bioengn Res Ctr, 1530 W,15th St,Learned Hall, Lawrence, KS 66047 USA.
EM ctamerler@ku.edu
OI Tamerler, Candan/0000-0002-1960-2218; Oren, Ersin
   Emre/0000-0001-5902-083X
FU NIH-NIAMS [AR062249-03]; NIH- NIDCR through University of Kansas and
   University of Washington [R01DE025476-01]; NSF-MRSEC Program through the
   University of Washington GEMSEC [DMR-0520567]
FX This research was supported by NIH-NIAMS, AR062249-03, and NIH- NIDCR
   R01DE025476-01 through University of Kansas and University of Washington
   (C.T.) and by NSF-MRSEC Program, DMR-0520567, through the University of
   Washington GEMSEC (C.T., H.Y., M.B.O., T.K, B.R.W., E.E.O., and M.S.).
CR Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006
   Chen HB, 2008, LANGMUIR, V24, P6852, DOI 10.1021/la800314p
   Costa F, 2014, ACTA BIOMATER, V10, P3513, DOI 10.1016/j.actbio.2014.02.028
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donatan S, 2012, J R SOC INTERFACE, V9, P2688, DOI 10.1098/rsif.2012.0060
   Donatan S, 2009, MAT SCI ENG C-BIO S, V29, P14, DOI 10.1016/j.msec.2008.05.003
   Fang Y, 2008, J MATER CHEM, V18, P3871, DOI 10.1039/b806797j
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   Fukuta M, 2014, COLLOID SURFACE B, V118, P25, DOI 10.1016/j.colsurfb.2014.03.024
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hayashi T, 2009, LANGMUIR, V25, P10901, DOI 10.1021/la901242q
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kacar T, 2009, ADV MATER, V21, P295, DOI 10.1002/adma.200801877
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2012, J BIOMED MATER RES B, V100B, P1344, DOI 10.1002/jbm.b.32701
   Khatayevich D, 2010, ACTA BIOMATER, V6, P4634, DOI 10.1016/j.actbio.2010.06.004
   Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544
   Kraus D, 2012, J CELL PHYSIOL, V227, P994, DOI 10.1002/jcp.22808
   Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643
   Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x
   Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Ma MH, 2012, J BIOMED MATER RES A, V100A, P278, DOI 10.1002/jbm.a.33251
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Muszanska AK, 2014, BIOMACROMOLECULES, V15, P2019, DOI 10.1021/bm500168s
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Oren EE, 2005, NANO LETT, V5, P415, DOI 10.1021/nl048425x
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Seker UOS, 2007, LANGMUIR, V23, P7895, DOI 10.1021/la700446g
   So CR, 2012, ACS NANO, V6, P1648, DOI 10.1021/nn204631x
   Tamerler C, 2006, SMALL, V2, P1372, DOI 10.1002/smll.200600070
   Tamerler C, 2010, BIOPOLYMERS, V94, P78, DOI 10.1002/bip.21368
   Tamerler C, 2009, ACS NANO, V3, P1606, DOI 10.1021/nn900720g
   Tan XW, 2014, ANTIMICROB AGENTS CH, V58, P5229, DOI 10.1128/AAC.02859-14
   van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang L, 2014, ACS APPL MATER INTER, V6, P17323, DOI 10.1021/am5045604
   Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 59
TC 26
Z9 28
U1 9
U2 102
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 2
PY 2016
VL 8
IS 8
BP 5070
EP 5081
DI 10.1021/acsami.5b03697
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DF6GJ
UT WOS:000371453600004
PM 26795060
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Naves, AF
   Motay, M
   Merindol, R
   Davi, CP
   Felix, O
   Catalani, LH
   Decher, G
AF Naves, Alliny F.
   Motay, Marvin
   Merindol, Remi
   Davi, Christiane P.
   Felix, Olivier
   Catalani, Luiz H.
   Decher, Gero
TI Layer-by-Layer assembled growth factor reservoirs for steering the
   response of 3T3-cells
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Layer-by-layer assembly; Polyelectrolyte multilayers; Heparin; Chitosan;
   Acidic fibroblast growth factor (aFGF); Basic fibroblast growth factor
   (bFGF); Controlled release
ID CONTROLLED-RELEASE; MULTILAYER FILMS; FIBROBLAST; SURFACES; CHITOSAN
AB Layer-by-Layer (LbL) assemblies of heparin (Hep) and chitosan (Chi) were prepared for use as reservoirs for acidic and basic fibroblast growth factors (aFGFs and bFGFs, respectively). The effects of the architecture and composition of the reservoirs on the viability and proliferation of NIH-3T3 fibroblast cells were studied under starvation conditions. The reservoir stability was monitored by ellipsometry. The aFGF and bFGF loadings were determined using a dissipation-enhanced quartz crystal microbalance (QCM-D). Stability and release assays were performed in a phosphate buffer at physiological conditions. The results demonstrated that the amount of aFGF and bFGF loaded into and released from LbL reservoirs composed of 3 and 6 layer pairs could be controlled. Cell culture assays in low serum culture medium (LSCM) demonstrated that incorporating very small amounts of aFGF and bFGF into the (Hep/Chi)(n) multilayers significantly improved the proliferation of the NIH-3T3 fibroblasts. The cells did not proliferate on (Hep/Chi)(n) assemblies prepared in the absence of FGF under identical conditions. The LbL reservoirs were highly effective for the long-term storage (up to 9 months) of aFGF and bFGF. This work demonstrates the potential of LbL reservoirs for use as biomaterial coatings. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Naves, Alliny F.; Motay, Marvin; Merindol, Remi; Davi, Christiane P.; Felix, Olivier; Decher, Gero] CNRS, Inst Charles Sadron, 23 Rue Loess, F-67034 Strasbourg, France.
   [Naves, Alliny F.; Motay, Marvin; Merindol, Remi; Decher, Gero] Univ Strasbourg, Fac Chem, 1 Rue Blaise Pascal, F-67008 Strasbourg, France.
   [Davi, Christiane P.] Univ Fed ABC, CCNH, Rua Santa Adelia 166, BR-09210170 Santo Andre, Brazil.
   [Naves, Alliny F.; Catalani, Luiz H.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Av Prof Lineu Prestes 748,CP 26077, BR-05513970 Sao Paulo, Brazil.
   [Decher, Gero] Int Ctr Frontier Res Chem, 8 Allee Gaspard Monge, F-67083 Strasbourg, France.
RP Naves, AF (reprint author), CNRS, Inst Charles Sadron, 23 Rue Loess, F-67034 Strasbourg, France.; Decher, G (reprint author), Univ Strasbourg, Fac Chem, 1 Rue Blaise Pascal, F-67008 Strasbourg, France.; Naves, AF (reprint author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Av Prof Lineu Prestes 748,CP 26077, BR-05513970 Sao Paulo, Brazil.
EM alliny@iq.usp.br; decher@ics-cnrs.unistra.fr
RI Decher, Gero/E-7665-2011
OI Decher, Gero/0000-0002-7976-8818; Merindol, Remi/0000-0003-4193-7097
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Brazil [201407/2011-6]
FX This work was partly funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, grant for fellowship 201407/2011-6),
   Brazil. Facilities were provided by CNRS-ICS.
CR ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702
   BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   CLARKE MSF, 1993, J CELL SCI, V106, P121
   Cock L. J., 2010, BIOMACROMOLECULES, V11, P1002
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Decher G., 2002, MULTILAYER THIN FILM, V1
   Go DP, 2011, BIOMACROMOLECULES, V12, P1494, DOI 10.1021/bm1014574
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   GOSPODAROWICZ D, 1974, P NATL ACAD SCI USA, V71, P4584, DOI 10.1073/pnas.71.11.4584
   GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Hsu BB, 2014, BIOMACROMOLECULES, V15, P2049, DOI 10.1021/bm5001839
   Itoh Y, 2008, BIOMACROMOLECULES, V9, P2202, DOI 10.1021/bm800321w
   LEE K, 2011, R SOC INTERFACE, V8, P153, DOI DOI 10.1098/RSIF.2010.0223
   Lin Y, 2008, J APPL POLYM SCI, V109, P530, DOI 10.1002/app.28174
   Liu ZM, 2009, J MATER SCI-MATER M, V20, P2317, DOI 10.1007/s10856-009-3806-1
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   Nakahara T, 2003, TISSUE ENG, V9, P153, DOI 10.1089/107632703762687636
   Ornitz DM, 2001, GENOME BIOL, V2
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Volpato FZ, 2012, ACTA BIOMATER, V8, P1551, DOI 10.1016/j.actbio.2011.12.023
   YAMAGUCHI TP, 1995, CURR OPIN GENET DEV, V5, P485, DOI 10.1016/0959-437X(95)90053-J
   Zhu AP, 2005, BIOMACROMOLECULES, V6, P2607, DOI 10.1021/bm050328q
NR 30
TC 6
Z9 6
U1 2
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2016
VL 139
BP 79
EP 86
DI 10.1016/j.colsurfb.2015.11.019
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA EE5ZK
UT WOS:000389687900010
PM 26700236
DA 2018-10-20
ER

PT J
AU Lin, S
   Chen, MX
   Jiang, HY
   Fan, LP
   Sun, BB
   Yu, F
   Yang, XX
   Lou, XX
   He, CL
   Wang, HS
AF Lin, Si
   Chen, Mengxia
   Jiang, Huayue
   Fan, Linpeng
   Sun, Binbin
   Yu, Fan
   Yang, Xingxing
   Lou, Xiangxin
   He, Chuanglong
   Wang, Hongsheng
TI Green electrospun grape seed extract-loaded silk fibroin nanofibrous
   mats with excellent cytocompatibility and antioxidant effect
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Grape seed extract; Silk fibroin; Green electrospinning; Antioxidation
ID SKIN CARE APPLICATION; IN-VITRO; OXIDATIVE DAMAGE; CARCINOMA CELLS;
   SCAFFOLDS; PROANTHOCYANIDINS; BIOMATERIAL; PROTECTS; MATRICES; GROWTH
AB Silk fibroin (SF) from Bombyx mori has an excellent biocompatibility and thus be widely applied in the biomedical field. Recently, various SF-based composite nanofibers have been developed for more demanding applications. Additionally, grape seed extract (GSE) has been demonstrated to be powerful on antioxidation. In the present study, we dedicate to fabricate a GSE-loaded SF/polyethylene oxide (PEO) composite nanofiber by green electrospinning. Our results indicated the successful loading of GSE into the SF/PEO composite nanofibers. The introduction of GSE did not affect the morphology of the SF/PEO nanofibers and GSE can be released from the nanofibers with a sustained manner. Furthermore, comparing with the raw SF/PEO nanofibrous mats, the GSE-loaded SF/PEO nanofibrous mats significantly enhanced the proliferation of the skin fibroblasts and also protected them against the damage from tert-butyl hydroperoxide-induced oxidative stress. All these findings suggest a promising potential of this novel GSE-loaded SF/PEO composite nanofibrous mats applied in skin care, tissue regeneration and wound healing. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Lin, Si; Chen, Mengxia; Jiang, Huayue; Fan, Linpeng; Sun, Binbin; Yu, Fan; Yang, Xingxing; Lou, Xiangxin; He, Chuanglong; Wang, Hongsheng] Donghua Univ, Coll Chem Chem Engn & Biotechnol, 2999 North Renmin Rd, Shanghai 201620, Peoples R China.
   [Lou, Xiangxin; He, Chuanglong; Wang, Hongsheng] Donghua Univ, Minist Educ, Key Lab Text Sci & Technol, Shanghai 201620, Peoples R China.
RP Wang, HS (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, 2999 North Renmin Rd, Shanghai 201620, Peoples R China.
EM whs@dhu.edu.cn
RI He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
FU Natural Science Foundation of Shanghai [12ZR1400300]; Scientific
   Research Foundation for the Returned Overseas Chinese Scholars, State
   Education Ministry; 111 project [B07024]
FX This research was supported by the Natural Science Foundation of
   Shanghai (12ZR1400300), the Scientific Research Foundation for the
   Returned Overseas Chinese Scholars, State Education Ministry (To Dr.
   Hongsheng Wang) and 111 project (B07024).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7
   Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179
   Balu M, 2005, NEUROSCI LETT, V383, P295, DOI 10.1016/j.neulet.2005.04.042
   Cha BG, 2014, BIOPOLYMERS, V101, P307, DOI 10.1002/bip.22359
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Dailhankar A., 2005, INDIAN J BIOTECHNOL, V4, P115
   Draelos ZD, 2000, CURR PROBL DERM-US, V12, P235, DOI 10.1016/S1040-0486(00)80007-1
   Fan LP, 2014, COLLOID SURFACE B, V117, P14, DOI 10.1016/j.colsurfb.2013.12.030
   Fan LP, 2012, RSC ADV, V2, P4110, DOI 10.1039/c2ra20302b
   Fan LP, 2012, J BIOMAT SCI-POLYM E, V23, P497, DOI 10.1163/092050610X552771
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Guo HF, 2012, COLLOID SURFACE B, V96, P29, DOI 10.1016/j.colsurfb.2012.03.014
   Hu YY, 2015, MOLECULES, V20, P6443, DOI 10.3390/molecules20046443
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huh YS, 2004, BIOTECHNOL BIOPROC E, V9, P471, DOI 10.1007/BF02933488
   Jose RR, 2012, J MATER SCI-MATER M, V23, P2679, DOI 10.1007/s10856-012-4739-7
   Kaur M, 2006, CLIN CANCER RES, V12, P6194, DOI 10.1158/1078-0432.CCR-06-1465
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Mandic AI, 2008, INT J FOOD PROP, V11, P713, DOI 10.1080/10942910701584260
   Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030
   Mohansrinivasan V, 2015, BRAZ ARCH BIOL TECHN, V58, P540, DOI [10.1590/S1516-8913201500076, 10.1590/s1516-8913201500076]
   Ricci G, 2004, BRIT J DERMATOL, V150, P127, DOI 10.1111/j.1365-2133.2004.05705.x
   Rodriguez KJ, 2013, J DERMATOL SCI, V72, P304, DOI 10.1016/j.jdermsci.2013.08.004
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Saffari Y, 2004, LIFE SCI, V74, P1513, DOI 10.1016/j.lfs.2003.08.019
   Sheng XY, 2013, INT J BIOL MACROMOL, V56, P49, DOI 10.1016/j.ijbiomac.2013.01.029
   Sobajo C., 2008, OPEN ACCESS J PLASTI, V8, P438
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P127, DOI 10.1002/app.1990.070400111
   Zhang KH, 2011, POLYM DEGRAD STABIL, V96, P2266, DOI 10.1016/j.polymdegradstab.2011.08.011
   Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895
NR 37
TC 5
Z9 5
U1 11
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2016
VL 139
BP 156
EP 163
DI 10.1016/j.colsurfb.2015.12.001
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA EE5ZK
UT WOS:000389687900020
PM 26707696
DA 2018-10-20
ER

PT J
AU Cui, Z
   Yang, BF
   Li, RK
AF Cui, Zhi
   Yang, Baofeng
   Li, Ren-Ke
TI Application of Biomaterials in Cardiac Repair and Regeneration
SO ENGINEERING
LA English
DT Review
DE Myocardial infarction; Heart regeneration; Biomaterial; Tissue
   engineering; Stem cell
ID ACUTE MYOCARDIAL-INFARCTION; MESENCHYMAL STEM-CELLS; IMPLANTABLE
   CARDIOVERTER-DEFIBRILLATOR; RADIOFREQUENCY CATHETER ABLATION; ASSEMBLING
   PEPTIDE NANOFIBERS; PROMOTES ENDOGENOUS REPAIR;
   AMERICAN-HEART-ASSOCIATION; FREE-WALL RUPTURE; TEAM-BASED CARE;
   BIOMEDICAL APPLICATIONS
AB Cardiovascular disease is a leading cause of death throughout the world. The demand for new therapeutic interventions is increasing. Although pharmacological and surgical interventions dramatically improve the quality of life of cardiovascular disease patients, cheaper and less invasive approaches are always preferable. Biomaterials, both natural and synthetic, exhibit great potential in cardiac repair and regeneration, either as a carrier for drug delivery or as an extracellular matrix substitute scaffold. In this review, we discuss the current treatment options for several cardiovascular diseases, as well as types of biomaterials that have been investigated as potential therapeutic interventions for said diseases. We especially highlight investigations into the possible use of conductive polymers for correcting ischemic heart disease-induced conduction abnormalities, and the generation of biological pacemakers to improve the conduction pathway in heart block. (C) 2016 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Cui, Zhi; Li, Ren-Ke] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada.
   [Cui, Zhi; Li, Ren-Ke] Univ Toronto, Dept Surg, Div Cardiovasc Surg, Toronto, ON M5G 2M9, Canada.
   [Yang, Baofeng] Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin 150001, Peoples R China.
   [Cui, Zhi; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON M5G 1L7, Canada.
RP Li, RK (reprint author), Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada.; Li, RK (reprint author), Univ Toronto, Dept Surg, Div Cardiovasc Surg, Toronto, ON M5G 2M9, Canada.; Li, RK (reprint author), Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON M5G 1L7, Canada.
EM renkeli@uhnres.utoronto.ca
OI Li, Ren-Ke/0000-0002-2584-060X
CR Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   ALTEKIN RE, 2011, J CARDIOL CASES, V3, pE68
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Anker SD, 2015, EUR HEART J, V36, P2297, DOI 10.1093/eurheartj/ehv259
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Banypersad SM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000364
   Barold SS, 2006, J INTERV CARD ELECTR, V17, P139, DOI 10.1007/s10840-006-9065-x
   Barold SS, 2001, MAYO CLIN PROC, V76, P44, DOI 10.4065/76.1.44
   Belhassen B, 2011, EUROPACE, V13, P1009, DOI 10.1093/europace/eur056
   Benito B, 2012, REV ESP CARDIOL, V65, P939, DOI [10.1016/j.recesp.2012.03.027, 10.1016/j.rec.2012.03.022]
   Berul Charles I, 2003, Expert Rev Cardiovasc Ther, V1, P165, DOI 10.1586/14779072.1.2.165
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Boopathy AV, 2014, METHODS MOL BIOL, V1141, P159, DOI 10.1007/978-1-4939-0363-4_10
   Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Chen ZM, 2005, LANCET, V366, P1622
   Cheng K, 2012, J AM COLL CARDIOL, V59, P256, DOI 10.1016/j.jacc.2011.10.858
   Chi NH, 2013, CARBOHYD POLYM, V92, P591, DOI 10.1016/j.carbpol.2012.09.012
   Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936
   Cho Sung Woo, 2010, Korean Circ J, V40, P94, DOI 10.4070/kcj.2010.40.2.94
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Creaser JW, 2015, HEART FAIL CLIN, V11, P379, DOI 10.1016/j.hfc.2015.03.004
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   de Zwaan C, 2001, NETH HEART J, V9, P30
   Deng BY, 2015, J BIOMED MATER RES A, V103, P907, DOI 10.1002/jbm.a.35232
   Dorian P, 2010, CIRCULATION, V122, P2645, DOI 10.1161/CIRCULATIONAHA.109.924225
   Finsterer J, 2008, CAN J CARDIOL, V24, P786, DOI 10.1016/S0828-282X(08)70686-X
   Frederick JR, 2010, CIRCULATION, V122, pS107, DOI [10.1161/C1RCULATIONAHA.109.930404, 10.1161/CIRCULATIONAHA.109.930404]
   French KM, 2016, ADV DRUG DELIVER REV, V96, P40, DOI 10.1016/j.addr.2015.04.023
   Gelmi A, 2015, PROC SPIE, V9430, DOI 10.1117/12.2084165
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Ghuran AV, 2001, BRIT MED BULL, V59, P193, DOI 10.1093/bmb/59.1.193
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Goldenberg I, 2010, CIRCULATION, V122, P1265, DOI 10.1161/CIRCULATIONAHA.110.940148
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321
   Heidenreich P, 2015, HEART FAIL CLIN, V11, P349, DOI 10.1016/j.hfc.2015.03.001
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Hreybe H, 2009, CLIN CARDIOL, V32, P274, DOI 10.1002/clc.20357
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Iemura J, 2001, ANN THORAC SURG, V71, P201, DOI 10.1016/S0003-4975(00)02211-6
   Issa Z, 2008, CLIN ARRHYTHMOLOGY E, P127
   Ivashchenko CY, 2013, AM J PHYSIOL-HEART C, V305, pH913, DOI 10.1152/ajpheart.00819.2012
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Khan IA, 2002, AM J MED, V112, P58, DOI 10.1016/S0002-9343(01)01011-7
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lakshmanan R, 2013, MACROMOL BIOSCI, V13, P1119, DOI 10.1002/mabi.201300223
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   Lampert R, 2002, CIRCULATION, V106, P1800, DOI 10.1161/01.CIR.0000031733.51374.C1
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Larsen PM, 2015, HEART FAIL CLIN, V11, P359, DOI 10.1016/j.hfc.2015.03.002
   Laske TG, 2005, CURR CLIN ONCOL, P123
   Lee JC, 2009, CIRCULATION, V120, P1550, DOI 10.1161/CIRCULATIONAHA.109.872911
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Lundin V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018624
   Macia E, 2009, CIRCULATION, V119, P1814, DOI 10.1161/CIRCULATIONAHA.108.779900
   Mann DL, 2016, EUR J HEART FAIL, V18, P314, DOI 10.1002/ejhf.449
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Masumoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06716
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002
   Meng XL, 2013, J BIOMED MATER RES A, V101, P1095, DOI 10.1002/jbm.a.34400
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Miklas JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072956
   Miller JS, 2000, CHEMPHYSCHEM, V1, P229, DOI 10.1002/1439-7641(20001215)1:4<229::AID-CPHC229>3.0.CO;2-J
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Mukherjee S, 2011, ADV FUNCT MATER, V21, P2291, DOI 10.1002/adfm.201002434
   Munshi NV, 2014, SCIENCE, V345, P268, DOI 10.1126/science.1257976
   Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846
   Nakashima T, 2014, AM J PHYSIOL-HEART C, V306, pH1324, DOI 10.1152/ajpheart.00653.2013
   NOAKES TD, 1983, CIRCULATION, V67, P24, DOI 10.1161/01.CIR.67.1.24
   *NORW MULT STUD GR, 1981, NEW ENGL J MED, V304, P801
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84
   Okonogi Taichi, 2013, J Invasive Cardiol, V25, pE186
   Pascual-Gil S, 2015, J CONTROL RELEASE, V203, P23, DOI 10.1016/j.jconrel.2015.02.009
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Proulx MK, 2011, J BIOMED MATER RES A, V96A, P301, DOI 10.1002/jbm.a.32978
   Public Health Agency of Canada, 2014, EC BURD ILLN CAN 200
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   RARDON DP, 1995, CARDIAC ELECTROPHYSI, P485
   Reis LA, 2016, J TISSUE ENG REGEN M, V10, P11, DOI 10.1002/term.1944
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rosen AB, 2007, STEM CELLS, V25, P2128, DOI 10.1634/stemcells.2006-0722
   Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120
   Rosen MR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P54, DOI 10.1161/CIRCEP.108.764621
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Ruvinov E, 2016, ADV DRUG DELIVER REV, V96, P54, DOI 10.1016/j.addr.2015.04.021
   Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388
   Schaffer MS, 1996, CIRCULATION, V94, P3214, DOI 10.1161/01.CIR.94.12.3214
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Siminiak T, 2004, AM HEART J, V148, P531, DOI 10.1016/j.ahj.2004.03.043
   Singh SM, 2015, EUR HEART J, V36, P976, DOI 10.1093/eurheartj/ehu357
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Song KD, 2010, J MATER SCI-MATER M, V21, P2835, DOI 10.1007/s10856-010-4131-4
   Stevenson WG, 2011, CIRCULATION, V124, pE411, DOI 10.1161/CIRCULATIONAHA.111.064816
   Suarez SL, 2015, ACTA BIOMATER, V26, P13, DOI 10.1016/j.actbio.2015.08.004
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Terashima M, 2008, AM J CARDIOL, V101, P419, DOI 10.1016/j.amjcard.2007.09.086
   Tokunaga M, 2010, J MOL CELL CARDIOL, V49, P972, DOI 10.1016/j.yjmcc.2010.09.015
   Ungerleider JL, 2014, STEM CELL TRANSL MED, V3, P1090, DOI 10.5966/sctm.2014-0049
   Vogler J, 2012, REV ESP CARDIOL, V65, P656, DOI [10.1016/j.recesp.2012.01.025, 10.1016/j.rec.2012.01.027]
   Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110
   Witte KKA, 2006, J CARD FAIL, V12, P199, DOI 10.1016/j.cardfail.2005.12.003
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Yousuf O, 2015, CIRC RES, V116, P2020, DOI 10.1161/CIRCRESAHA.116.304555
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176
   Zhou J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03733
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 126
TC 10
Z9 10
U1 5
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2095-8099
EI 2096-0026
J9 ENGINEERING-PRC
JI Engineering
PD MAR
PY 2016
VL 2
IS 1
BP 141
EP 148
DI 10.1016/J.ENG.2016.01.028
PG 8
WC Engineering, Multidisciplinary
SC Engineering
GA EE1PV
UT WOS:000389355500032
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tamm, I
   Heinamaki, J
   Laidmae, I
   Rammo, L
   Paaver, U
   Ingebrigtsen, SG
   Skalko-Basnet, N
   Halenius, A
   Yliruusi, J
   Pitkanen, P
   Alakurtti, S
   Kogermann, K
AF Tamm, Ingrid
   Heinamaki, Jyrki
   Laidmae, Ivo
   Rammo, Liisi
   Paaver, Urve
   Ingebrigtsen, Sveinung G.
   Skalko-Basnet, Natasa
   Halenius, Anna
   Yliruusi, Jouko
   Pitkanen, Pauliina
   Alakurtti, Sami
   Kogermann, Karin
TI Development of Suberin Fatty Acids and Chloramphenicol-Loaded
   Antimicrobial Electrospun Nanofibrous Mats Intended for Wound Therapy
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE suberin fatty acids; electrospun nanofibers; nonwoven nanomats;
   antimicrobial agent/drug; nanotechnology; physical characterization;
   solvent evaporation; polymeric drug carrier; polymeric biomaterials;
   wound therapy
ID PHOTO-CROSS-LINKING; POLYMER NANOFIBERS; DELIVERY-SYSTEM;
   IMAGE-ANALYSIS; HYDROGELS; PVP; BIOSYNTHESIS; TECHNOLOGIES;
   BIOPOLYESTER; RELEASE
AB Suberin fatty acids (SFAs) isolated from outer birch bark were investigated as an antimicrobial agent and biomaterial in nanofibrous mats intended for wound treatment. Electrospinning (ES) was used in preparing the composite nonwoven nanomats containing chloramphenicol (CAM; as a primary antimicrobial drug), SFAs, and polyvinylpyrrolidone (as a carrier polymer for ES). The X-ray powder diffraction, differential scanning calorimetry, scanning electron microscopy, atomic force microscopy, and texture analysis were used for the physicochemical and mechanical characterization of the nanomats. ES produced nanofibrous mats with uniform structure and with an average fiber diameter ranging from 370 to 425 nm. Microcrystalline SFAs and crystalline CAM were found to undergo a solid-state transformation during ES processing. The ES process caused also the loss of CAM in the final nanofibers. In the texture analysis, the SFAs containing nanofibers exhibited significantly higher maximum detachment force to an isolated pig skin (p < 0.05) than that obtained with the reference nanofibers. CAM exists in an amorphous form in the nanofibers which needs to be taken into account in controlling the physical storage stability. In conclusion, homogeneous composite nanofibrous mats for wound healing can be electrospun from the ternary mixture(s) of CAM, SFAs, and polyvinylpyrrolidone. (C) 2016 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.
C1 [Tamm, Ingrid; Heinamaki, Jyrki; Laidmae, Ivo; Rammo, Liisi; Paaver, Urve; Kogermann, Karin] Univ Tartu, Inst Pharm, Fac Med, EE-50411 Tartu, Estonia.
   [Laidmae, Ivo] Univ Tartu, Fac Med, Dept Immunol, Inst Biomed & Translat Med, EE-50411 Tartu, Estonia.
   [Ingebrigtsen, Sveinung G.; Skalko-Basnet, Natasa] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Drug Transport & Delivery Res Grp,Dept Pharm, N-9037 Tromso, Norway.
   [Halenius, Anna; Yliruusi, Jouko] Univ Helsinki, Fac Pharm, Dept Pharmaceut Chem & Technol, Helsinki, Finland.
   [Pitkanen, Pauliina; Alakurtti, Sami] VTT Tech Res Ctr Finland Ltd, FI-02044 Espoo, Finland.
   [Kogermann, Karin] Univ Tartu, Fac Sci & Technol, Inst Technol, EE-50411 Tartu, Estonia.
RP Kogermann, K (reprint author), Univ Tartu, Inst Pharm, Fac Med, EE-50411 Tartu, Estonia.; Kogermann, K (reprint author), Univ Tartu, Fac Sci & Technol, Inst Technol, EE-50411 Tartu, Estonia.
EM karin.kogermann@ut.ee
RI Skalko-Basnet, Natasa/A-4117-2012
OI Skalko-Basnet, Natasa/0000-0002-4301-2840; Ingebrigtsen,
   Sveinung/0000-0002-3500-3055
FU European Social Fund's Doctoral Studies and Internationalization
   Programme DoRa and GREASE Woodwisdom-ERANET [40375/11]; ETF grant
   [ETF7980, IUT-34-18]
FX This study was supported by the European Social Fund's Doctoral Studies
   and Internationalization Programme DoRa and GREASE Woodwisdom-ERANET
   (Tekes decision 40375/11). The work is part of the ETF grant project no.
   ETF7980 and IUT-34-18 project. Mr. J. Aruvali is kindly acknowledged for
   performing the XRPD analysis. A. Meos and A. Simasko are thanked for
   conducting the HPLC and GC analyses and discussing the article.
CR Adediran GO, 2003, SCI FOCUS, V3, P112
   Andrady AL, 2008, SCI TECHNOLOGY POLYM, P146
   Arcangelo VP, 2013, PHARMACOTHERAPEUTICS
   Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034
   Bertoncelj V, 2014, EUR J PHARM BIOPHARM, V88, P64, DOI 10.1016/j.ejpb.2014.06.001
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Boateng JS, 2008, J PHARM SCI, V99, P4215
   Buhler V, 2005, POLYVINYLPYRROLIDONE, P254
   Cordeiro N, 2000, IND CROP PROD, V11, P63, DOI 10.1016/S0926-6690(99)00037-0
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   EKMAN R, 1983, HOLZFORSCHUNG, V37, P205, DOI 10.1515/hfsg.1983.37.4.205
   Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004
   Gordon V, 2015, INT J PHARMACEUT, V478, P172, DOI 10.1016/j.ijpharm.2014.11.038
   Graca J, 2007, MACROMOL BIOSCI, V7, P128, DOI 10.1002/mabi.200600218
   Heinamaki J, 2015, INT J PHARMACEUT, V489, P91, DOI 10.1016/j.ijpharm.2015.04.066
   Hofer R, 2008, J EXP BOT, V59, P2347, DOI 10.1093/jxb/ern101
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hurler J, 2012, BURNS PREVENTION CAU, P39
   Hurler J, 2013, BIOMED RES INT, V101, P3906
   Hurler J, 2012, J PHARM SCI-US, V101, P3906, DOI 10.1002/jps.23260
   Hurler Julia, 2012, J Funct Biomater, V3, P37, DOI 10.3390/jfb3010037
   Kalhapure RS, 2015, J PHARM SCI-US, V104, P872, DOI 10.1002/jps.24298
   Lacin NT, 2014, INT J BIOL MACROMOL, V67, P22, DOI 10.1016/j.ijbiomac.2014.03.003
   LEHR HA, 1992, ARTERIOSCLER THROMB, V12, P824, DOI 10.1161/01.ATV.12.7.824
   Leung V, 2011, POLYM ADVAN TECHNOL, V22, P350, DOI 10.1002/pat.1813
   Lopergolo LC, 2003, POLYMER, V44, P6217, DOI 10.1016/S0032-3861(03)00686-4
   Lu P, 2008, RECENT PAT NANOTECH, V2, P169, DOI 10.2174/187221008786369688
   Lulai EC, 1998, PHYSIOL MOL PLANT P, V53, P209, DOI 10.1006/pmpp.1998.0179
   Martin L, 2002, J CONTROL RELEASE, V80, P87, DOI 10.1016/S0168-3659(02)00005-6
   Martineau L, 2006, BURNS, V32, P172, DOI 10.1016/j.burns.2005.08.012
   Mayet N, 2014, J PHARM SCI-US, V103, P2211, DOI 10.1002/jps.24068
   Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016
   Nagy ZK, 2012, J PHARM SCI-US, V101, P322, DOI 10.1002/jps.22731
   Paaver U, 2014, BIOMED RES INT, DOI 10.1155/2014/789765
   Pelipenko J, 2015, INT J PHARMACEUT, V484, P57, DOI 10.1016/j.ijpharm.2015.02.043
   Pelipenko J, 2013, EUR J PHARM BIOPHARM, V84, P401, DOI 10.1016/j.ejpb.2012.09.009
   Pelipenko J, 2015, EUR J PHARM SCI, V66, P29, DOI 10.1016/j.ejps.2014.09.022
   Pillay V, 2013, J NANOMATER, DOI 10.1155/2013/789289
   Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003
   Rang H., 2012, RANG DALES PHARM, P237
   Rasekh M, 2014, INT J PHARMACEUT, V473, P95, DOI 10.1016/j.ijpharm.2014.06.059
   Rowe R.C., 2009, HDB PHARM EXCIPIENTS, p[581, 663, 685]
   Said SS, 2011, EUR J PHARM BIOPHARM, V79, P108, DOI 10.1016/j.ejpb.2011.03.002
   Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Self S, 2015, INT J PHARMACEUT, V478, P390, DOI 10.1016/j.ijpharm.2014.11.045
   Sionkowska A, 2008, POLYM DEGRAD STABIL, V88, P261
   Stalling SS, 2009, ACTA BIOMATER, V5, P1911, DOI 10.1016/j.actbio.2009.02.020
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Verreck G, 2003, PHARMACEUT RES, V20, P810, DOI 10.1023/A:1023450006281
   Wang YZ, 2010, J PHARM SCI-US, V99, P4805, DOI 10.1002/jps.22189
   Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030
   Xu XM, 2010, BIOMACROMOLECULES, V11, P2283, DOI 10.1021/bm1003509
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhou FL, 2008, POLYM INT, V57, P837, DOI 10.1002/pi.2395
NR 58
TC 6
Z9 6
U1 3
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD MAR
PY 2016
VL 105
IS 3
BP 1239
EP 1247
DI 10.1016/j.xphs.2015.12.025
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DT8TT
UT WOS:000381769100027
PM 26886306
DA 2018-10-20
ER

PT J
AU Sandomirsky, BP
   Repin, NV
   Mikhailova, IP
   Manchenko, AA
AF Sandomirsky, Boris P.
   Repin, Nikolay V.
   Mikhailova, Irina P.
   Manchenko, Anna A.
TI Application of cryoirradiation-modified xenopericardium for building
   bladder wall defect
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE beta(-)-radiation; Devitalization; Low temperatures; Porcine
   pericardium; Tissue grafts; Xenotransplantation
ID AORTIC-VALVE LEAFLETS; MECHANICAL-PROPERTIES; IMMUNE-RESPONSE;
   IRRADIATION; PERICARDIUM; XENOTRANSPLANTATION
AB Introduction: The project goal was to study special aspects of biointegration and the functional efficiency of the modified xenopericardium on the experimental model in vivo. Xenopericardium devitalization was performed using low temperatures and ionizing radiation (beta(-)-radiation) in an original manner.
   Methods: In rabbits, a urinary bladder (UB) wall defect was repaired through tissue replacement. Observation period: up to 1 year. After implantation, tissue reaction and biomaterial structure changes were studied using light and electron microscopy. Dynamic ultrasound diagnostics were performed.
   Results: After surgery all animals displayed normal physiological activity. No cases of material rejection or post-operative period complications were detected. At all stages the xenopericardium preserved structural integrity and served as a skeleton for forming an adequate UB wall. Small peripheral areas were exposed to lysis. After 3 months the collagen structure of the graft was rearranged and mucous membrane epithelization appeared. Folding was already formed and invasion of narrow SMC panniculi was registered within deeper layers. After 6 months the inner surface of the UB wall consisted of normal mucosa, lined by fully formed epithelium. By the 7th month an almost solid muscular sheet was formed in the lower layers.
   Conclusions: Modified pericardium tissue with the given physical and mechanical properties was sustainable and able to endure the work load in an aggressive environment. It causes minimal inflammatory response, has a potential for cellular repopulation in vivo, stimulates formation of fibrous tissue, and embedded and restored cellular integrity and UB storage function.
C1 [Sandomirsky, Boris P.; Mikhailova, Irina P.; Manchenko, Anna A.] NAS Ukraine, Inst Problems Cryobiol & Cryomed, Dept Expt Cryomed, 23 Pereyaslavskaya St, UA-61015 Kharkov, Ukraine.
   [Repin, Nikolay V.] NAS Ukraine, Inst Problems Cryobiol & Cryomed, Dept Cryomorphol, UA-61015 Kharkov, Ukraine.
RP Manchenko, AA (reprint author), NAS Ukraine, Inst Problems Cryobiol & Cryomed, Dept Expt Cryomed, 23 Pereyaslavskaya St, UA-61015 Kharkov, Ukraine.
EM anna.gorlenko@gmail.com
OI Sandomirsky, Boris/0000-0002-2440-1971
CR [Anonymous], 2002, TC198 INT ORG STAND
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Byzov DV, 2010, BIOTECHNOLOGIA ACTA, V3, P75
   Byzov DV, 2012, CURRENT PROBLEMS CRY, P623
   Byzov DV, 2011, PROBL CRYOBIOL CRYOM, V21, P137
   GRANT RA, 1970, J CELL SCI, V7, P387
   Hilkin AM, 1976, COLLAGEN ITS APPL ME
   Manchenko AA, 2015, CECRM 2015, P92
   Manchenko AA, 2014, FREEZ BIOL TIM 50 AN, P76
   McGregor CGA, 2011, J THORAC CARDIOV SUR, V141, P269, DOI 10.1016/j.jtcvs.2010.08.064
   Mikhailova IP, 2015, CRYO2015 ANN M SOC C, P48
   MIKHAILOVA IP, 2015, PROBL CRYOBIOL CRYOM, V25, P311
   Mikhailova I, 2014, PERIOD BIOL, V116, P105
   Ota T, 2007, ANN THORAC SURG, V83, P1501, DOI 10.1016/j.athoracsur.2006.11.083
   Platt JL, 1996, CURR OPIN IMMUNOL, V8, P721, DOI 10.1016/S0952-7915(96)80091-4
   REPIN NV, 2015, PROBL CRYOBIOL CRYOM, V25, P246
   Sandomirsky BP, Ukraine patent, Patent No. [68379 IPC A61L27/00 A01N1/02, 68379]
   Seto A, 2009, CLIN ORTHOP RELAT R, V467, P2994, DOI 10.1007/s11999-009-0934-3
   Sevastjanov VI, 2011, BIOCOMPATIBLE MAT
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Weakley B., 1975, ELECT MICROSCOPY BEG
NR 22
TC 0
Z9 0
U1 0
U2 2
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAR
PY 2016
VL 39
IS 3
BP 121
EP 127
DI 10.5301/ijao.5000491
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA DR3HE
UT WOS:000379792900004
PM 27102693
DA 2018-10-20
ER

PT J
AU Soardi, CM
   del Amo, FSL
   Galindo-Moreno, P
   Catena, A
   Zaffe, D
   Wang, HL
AF Soardi, Carlo Maria
   del Amo, Fernando Suarez-Lopez
   Galindo-Moreno, Pablo
   Catena, Andres
   Zaffe, Davide
   Wang, Hom-Lay
TI Reliability of Cone Beam Computed Tomography in Determining Mineralized
   Tissue in Augmented Sinuses
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone allograft; cone beam computed tomography; maxillary sinus
   augmentation; microradiographs
ID FLOOR AUGMENTATION; BONE ALLOGRAFT; MICRORADIOGRAPHY; HISTOMORPHOMETRY;
   DENSITY; SIZE
AB Purpose: The aim of this study was to analyze cone beam computed tomography (CBCT) densitometries of maxillary sinuses augmented with human bone allograft. In addition, previously obtained microradiographic specimens were used to verify the diagnostic potential of CBCT. Materials and Methods: A two-stage protocol was conducted in 21 consecutive patients, all with a crestal bone height < 2 mm. Mineralized human bone allograft particles were used to augment sinuses using a lateral window approach. A succession of CBCT scans of the maxilla were taken before surgery, immediately after sinus augmentation, and 6, 10, and 18 months after implant placement. Using virtual probes, CBCT images taken at 6, 8, and 10 mm from the crestal surface were processed with medical imaging software and expressed as gray level (GL). Results: A total of 24 sinus augmentation procedures were performed in 21 patients. The average values of CBCT-GL ranged from 571 to 654, presenting the maximum value at 8 mm immediately after implant placement and the minimum value at 6 mm after 10 months. Furthermore, it was found that the graft mineral content decreased over time, completely disappearing between 10 and 11 months. Conclusion: CBCT and the medical imaging software employed for imaging visualization are reliable tools to study biomaterial behavior after sinus augmentation procedures. In addition, results from this study demonstrate that a complete resorption of human bone allograft is possible. Due to the limited sample size, further clinical and morphometric studies are needed.
C1 [del Amo, Fernando Suarez-Lopez; Wang, Hom-Lay] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI USA.
   [Galindo-Moreno, Pablo] Univ Granada, Dept Oral Surg & Implantol, Granada, Spain.
   [Catena, Andres] Univ Granada, Sch Psychol, Dept Expt Psychol, Granada, Spain.
   [Zaffe, Davide] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Via Pozzo 71, I-41124 Modena, MO, Italy.
RP Zaffe, D (reprint author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Sez Morfol Umana, Via Pozzo 71, I-41124 Modena, MO, Italy.
EM davide.zaffe@unimore.it
RI Galindo-Moreno, Pablo/F-5567-2015; Catena, Andres/I-2159-2015
OI Galindo-Moreno, Pablo/0000-0002-6614-6470; Catena,
   Andres/0000-0002-0775-5751; Suarez Lopez del Amo,
   Fernando/0000-0002-0416-7380
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Arisan V, 2013, CLIN IMPLANT DENT R, V15, P893, DOI 10.1111/j.1708-8208.2011.00436.x
   Benavides E, 2012, IMPLANT DENT, V21, P78, DOI 10.1097/ID.0b013e31824885b5
   Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0
   Chan HL, 2010, IMPLANT DENT, V19, P288, DOI 10.1097/ID.0b013e3181e59ebd
   Ekfeldt A, 2001, CLIN ORAL IMPLAN RES, V12, P462, DOI 10.1034/j.1600-0501.2001.120505.x
   Froum SJ, 2006, INT J PERIODONT REST, V26, P543
   Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183, DOI 10.1111/j.1749-6632.2002.tb03079.x
   Gonzalez-Garcia R., 2012, CLIN ORAL IMPLAN RES, DOI [10.1111/j.1600-0501.2011.02390.x, DOI 10.1111/J.1600-0501.2011.02390.X]
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Misch C E, 1989, Dent Today, V8, P39
   Monje A, 2014, CLIN ORAL IMPLAN RES, V25, P723, DOI 10.1111/clr.12133
   Nolff MC, 2010, J CRANIO MAXILL SURG, V38, P38, DOI 10.1016/j.jcms.2009.07.010
   Puri KS, 2009, J POSTGRAD MED, V55, P131, DOI 10.4103/0022-3859.52846
   Rickert D, 2012, INT J ORAL MAX SURG, V41, P160, DOI 10.1016/j.ijom.2011.10.001
   Schultze-Mosgau S, 2001, BRIT J ORAL MAX SURG, V39, P439, DOI 10.1054/bjom.2001.0617
   SISSONS HA, 1960, XRAY MICROSCOPY XRAY, P199
   Soardi CM, 2014, CLIN IMPLANT DENT R, V16, P557, DOI 10.1111/cid.12016
   Soardi CM, 2011, CLIN ORAL IMPLAN RES, V22, P560, DOI 10.1111/j.1600-0501.2010.02034.x
   Todisco M, 2005, INT J ORAL MAX IMPL, V20, P898
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
NR 22
TC 2
Z9 2
U1 1
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2016
VL 31
IS 2
BP 352
EP 358
DI 10.11607/jomi.4111
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP8IT
UT WOS:000378742400015
PM 27004281
OA Bronze
DA 2018-10-20
ER

PT J
AU Di Stefano, DA
   Gastaldi, G
   Vinci, R
   Polizzi, EM
   Cinci, L
   Pieri, L
   Gherlone, E
AF Di Stefano, Danilo Alessio
   Gastaldi, Giorgio
   Vinci, Raffaele
   Polizzi, Elisabetta Maria
   Cinci, Lorenzo
   Pieri, Laura
   Gherlone, Enrico
TI Bone Formation Following Sinus Augmentation with an Equine-Derived Bone
   Graft: A Retrospective Histologic and Histomorphometric Study with
   36-Month Follow-up
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomaterial; bone remodeling; sinus augmentation; xenograft
ID BETA-TRICALCIUM PHOSPHATE; ANORGANIC BOVINE BONE; VERTICAL RIDGE
   AUGMENTATION; HUMAN OSTEOCLAST FORMATION; AUTOGENOUS BONE; BIO-OSS;
   MORPHOGENETIC PROTEIN; FLOOR AUGMENTATION; PORCINE BONE; CASE SERIES
AB Purpose: The aim of this study was to investigate bone formation over time following maxillary sinus augmentation with an enzyme-deantigenic, bone collagen-preserving equine bone graft by retrospective assessment of histomorphometric data. Materials and Methods: Records of patients with atrophic ridges who underwent maxillary sinus augmentation with the enzyme-deantigenic equine bone graft and two-step implant placement between 3 and 12 months after the sinus-augmentation surgery were assessed retrospectively. The histomorphometric data were clustered in three classes according to time of collection from the augmentation surgery and analyzed to assess newly formed bone deposition and residual biomaterial degradation rates. Data concerning the 36-month clinical follow-up were also assessed. Results: Records of 77 patients and 115 biopsy specimens were retrieved, and histomorphometric data were clustered (3 to 5 months, n = 33; 6 to 8 months, n = 57; 9 to 12 months, n = 25). Mean minimum atrophic ridge thickness was 4.9 +/- 0.5 mm (range, 4.0 to 7.1 mm). The amount of newly formed bone and residual biomaterial did not significantly differ among the three clusters. Qualitative analysis showed a denser trabecular structure in late (> 8 months) samples. At the 36-month clinical follow-up, no differences were found among the implant success rates in the three groups, according to the Albrektsson and Zarb criteria for success. The overall implant success rate was 98.3%. Conclusion: Based upon this retrospective human study of 77 patients with 4 to 7 mm of residual bone, when enzyme-deantigenic equine bone is used for sinus augmentation, new bone formation occurs at an early time (< 3 months) after the grafting, and implant placement can be safely carried out as soon as 3 to 5 months after the augmentation surgery.
C1 [Di Stefano, Danilo Alessio; Gastaldi, Giorgio; Vinci, Raffaele; Polizzi, Elisabetta Maria; Gherlone, Enrico] Univ Vita Salute San Raffaele, Sch Dent, Milan, Italy.
   [Di Stefano, Danilo Alessio; Gastaldi, Giorgio; Vinci, Raffaele; Polizzi, Elisabetta Maria; Gherlone, Enrico] IRCCS San Raffaele, Milan, Italy.
   [Cinci, Lorenzo] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth Neuro, Pharmacol & Toxicol Sect, Florence, Italy.
   [Pieri, Laura] Univ Florence, Interdept Forens Med Sect, Dept Hlth Sci, Florence, Italy.
RP Di Stefano, DA (reprint author), Via Matteo Civitali 40, I-20148 Milan, Italy.
EM distefano@centrocivitali.it
RI Gherlone, Enrico/M-7376-2016
OI vinci, raffaele/0000-0001-9541-9303
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Albrektsson T, 1998, INT J PROSTHODONT, V11, P517
   Artese L, 2011, IMPLANT DENT, V20, P383, DOI 10.1097/ID.0b013e3182310b3d
   Avila G, 2010, J PERIODONTOL, V81, P1041, DOI 10.1902/jop.2010.090686
   Baldini N, 2011, DENT MATER, V27, P61, DOI 10.1016/j.dental.2010.10.017
   Barone A, 2013, INT J PERIODONT REST, V33, P795, DOI 10.11607/prd.1690
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   Benlidayi ME, 2009, INT J ORAL MAX IMPL, V24, P704
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bou-Gharios G, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P285, DOI 10.1016/B978-0-12-373884-4.00034-3
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Busenlechner D, 2009, CLIN ORAL IMPLAN RES, V20, P1078, DOI 10.1111/j.1600-0501.2009.01733.x
   Buser D, 1994, Quintessence Int, V25, P679
   Buser D, 1999, PERIODONTOL 2000, V19, P151, DOI 10.1111/j.1600-0757.1999.tb00153.x
   Butz F, 2011, INT J ORAL MAX IMPL, V26, P1317
   De Angelis N, 2011, INT J PERIODONT REST, V31, P383
   Di Stefano D A, 2012, Minerva Stomatol, V61, P477
   Di Stefano DA, 2015, INT J ORAL MAX IMPL, V30, P1161, DOI 10.11607/jomi.4057
   Di Stefano DA, 2009, CLIN IMPLANT DENT R, V11, P90, DOI 10.1111/j.1708-8208.2008.00104.x
   Esposito M, 2014, COCHRANE DB SYST REV, V5
   Esposito M, 2009, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003607.PUB4
   Felice P, 2013, EUR J ORAL IMPLANTOL, V6, P153
   Felice P, 2013, INT J PERIODONT REST, V33, P159, DOI 10.11607/prd.1098
   Galindo-Moreno P, 2013, CLIN IMPLANT DENT R, V15, P858, DOI 10.1111/j.1708-8208.2012.00445.x
   Galindo-Moreno P, 2012, IMPLANT DENT, V21, P433, DOI 10.1097/ID.0b013e3182691959
   GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090
   Helfrich MH, 1996, BONE, V19, P317, DOI 10.1016/S8756-3282(96)00223-2
   Iezzi G, 2012, CLIN ORAL IMPLAN RES, V23, P1369, DOI 10.1111/j.1600-0501.2011.02308.x
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P902, DOI 10.1111/j.1600-0501.2011.02245.x
   Kolerman Roni, 2012, Int J Periodontics Restorative Dent, V32, pe21
   Lambert F, 2013, INT J ORAL MAX IMPL, V28, P393, DOI 10.11607/jomi.2332
   Lindgren C, 2012, INT J ORAL MAX IMPL, V27, P1151
   Liu Gang, 2004, Chin J Traumatol, V7, P358
   Ludovichetti M, 2011, INT J PERIODONT REST, V31, P401
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   MARINO AA, 1970, NATURE, V226, P652, DOI 10.1038/226652a0
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Misch CM, 2011, ORAL MAXIL SURG CLIN, V23, P229, DOI 10.1016/j.coms.2011.01.003
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Nevins M, 2013, INT J PERIODONT REST, V33, P483, DOI 10.11607/prd.1728
   Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   PARALKAR VM, 1990, J BIOL CHEM, V265, P17281
   Perrotti V, 2009, CLIN ORAL IMPLAN RES, V20, P17, DOI 10.1111/j.1600-0501.2008.01608.x
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Pistilli R, 2013, IMPLANT DENT, V22, P8, DOI 10.1097/ID.0b013e3182777239
   Regazzoni C, 2001, BIOCHEM BIOPH RES CO, V283, P316, DOI 10.1006/bbrc.2001.4813
   Rickert D, 2012, INT J ORAL MAX SURG, V41, P160, DOI 10.1016/j.ijom.2011.10.001
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   Santini S, 2011, MINERVA CHIR, V66, P63
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Schlegel KA, 2007, ORAL SURG ORAL MED O, V104, pE15, DOI 10.1016/j.tripleo.2007.04.021
   Shanbhag S, 2014, INT J ORAL MAX IMPL, V29, P881, DOI 10.11607/jomi.3472
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Stievano D, 2008, Minerva Chir, V63, P79
   Szabo G, 2001, INT J ORAL MAX IMPL, V16, P681
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tete S, 2013, EUR J HISTOCHEM, V57, P60, DOI 10.4081/ejh.2013.e10
   Tete S, 2014, J CRANIOFAC SURG, V25, P835, DOI 10.1097/SCS.0000000000000679
   Tosta M, 2013, CLIN ORAL IMPLAN RES, V24, P866, DOI 10.1111/j.1600-0501.2011.02384.x
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 66
TC 3
Z9 3
U1 0
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2016
VL 31
IS 2
BP 406
EP 412
DI 10.11607/jomi.4373
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP8IT
UT WOS:000378742400022
PM 27004287
OA Bronze
DA 2018-10-20
ER

PT J
AU Ghanaati, S
   Kovacs, A
   Barbeck, M
   Lorenz, J
   Teiler, A
   Sadeghi, N
   Kirkpatrick, CJ
   Sader, R
AF Ghanaati, Shahram
   Kovacs, Adorjan
   Barbeck, Mike
   Lorenz, Jonas
   Teiler, Anna
   Sadeghi, Nader
   Kirkpatrick, Charles James
   Sader, Robert
TI Bilayered, non-cross-linked collagen matrix for regeneration of facial
   defects after skin cancer removal: a new perspective for
   biomaterial-based tissue reconstruction
SO JOURNAL OF CELL COMMUNICATION AND SIGNALING
LA English
DT Article
DE Inflammation; BCC; Skin cancer; Flaps; Mucograft; Soft tissue
   regeneration; Facial plastic surgery
ID GINGIVAL RECESSION DEFECTS; CORONALLY ADVANCED FLAP; MATRICELLULAR
   PROTEINS; INFRABONY DEFECTS; CLINICAL-TRIAL; MODULATORS; GRAFT
AB Classically skin defects are covered by split thickness skin grafts or by means of local or regional skin flaps. In the presented case series for the first time a bilayered, noncrossed-linked collagen matrix has been used in an off-label fashion in order to reconstruct facial skin defects following different types of skin cancer resection. The material is of porcine origin and consists of a spongy and a compact layer. The ratio of the two layers is 1: 3 in favour of the spongy layer. The aim of the study was to investigate the potential of this matrix for skin regeneration as an alternative to the standard techniques of skin grafts or flaps. Six patients between 39 and 83 years old were included in the study based on a therapeutic trial. The collagen matrix was used in seven defects involving the nose, eyelid, forehead-and posterior scalp regions, and ranging from 1,2 to 6 cm in diameter. Two different head and neck surgeons at two different institutions performed the operations. Each used a different technique in covering the wound following surgery, i.e. with and without a latex-based sheet under the pressure dressing. In three cases cylindrical biopsies were taken after 14 days. In all cases the biomaterial application was performed without any complication and no adverse effects were observed. Clinically, the collagen matrix contributed to a tension-free skin regeneration, independent of the wound dressing used. The newly regenerated skin showed strong similarity to the adjacent normal tissue both in quality and colour. Histological analysis indicated that the spongy layer replaced the defective connective tissue, by providing stepwise integration into the surrounding implantation bed, while the compact layer was infiltrated by mononuclear cells and contributed to its epithelialization by means of a "conductive" process from the surrounding epithelial cells. The clinical and histological data demonstrate that the collagen bilayered matrix used in this series contributes to a "Guided-Integrative-Regeneration-Process", which still needs to be further understood. The biomimetic nature of this material seems to contribute to physiological matrix remodelling, which probably involves other matricellular proteins essential for soft tissue regeneration. A deeper understanding of the mechanism, involved in the tissue integration of this material and its contribution to soft tissue regeneration based on the direct and indirect effect of matricellular proteins could open new therapeutic avenues for biomaterial-based soft tissue regeneration as an alternative to traditional flap-based plastic surgery.
C1 [Ghanaati, Shahram; Barbeck, Mike; Lorenz, Jonas; Teiler, Anna; Kirkpatrick, Charles James; Sader, Robert] Goethe Univ Frankfurt, Med Ctr, Dept Oral Cranio Maxillofacial & Facial Plast Sur, FORM Lab, D-60054 Frankfurt, Germany.
   [Sadeghi, Nader] George Washington Univ, Head & Neck Surg Oncol, Washington, DC USA.
RP Ghanaati, S (reprint author), Goethe Univ Frankfurt, Med Ctr, Dept Oral Cranio Maxillofacial & Facial Plast Sur, FORM Lab, D-60054 Frankfurt, Germany.
EM shahram.ghanaati@kgu.de
OI Barbeck, Mike/0000-0002-3001-1347
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barbeck M, 2015, J ORAL IMPLANTOL, V41, pE267, DOI 10.1563/aaid-joi-D-14-00155
   Barbeck M, 2015, J ORAL IMPLANTOL, V41, pE238, DOI 10.1563/aaid-joi-D-14-00274
   Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7
   Cardaropoli D, 2012, J PERIODONTOL, V83, P321, DOI 10.1902/jop.2011.110215
   Eickholz P, 2007, J PERIODONTOL, V78, P37, DOI 10.1902/jop.2007.060097
   Emre Y, 2014, SEMIN IMMUNOPATHOL, V36, P253, DOI 10.1007/s00281-014-0420-1
   Ghanaati S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015010
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x
   Herford AS, 2010, J ORAL MAXIL SURG, V68, P1463, DOI 10.1016/j.joms.2010.02.054
   Jepsen K, 2013, J CLIN PERIODONTOL, V40, P82, DOI 10.1111/jcpe.12019
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Lorenz J, 2015, J ORAL IMPLANTOL, V41, pE257, DOI [10.1563/aaid-joi-D-14-00273, 10.1563/AAID-JOI-D-14-00273]
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Pretzl B, 2008, J PERIODONTOL, V79, P1491, DOI [10.1902/jop.2008.070571, 10.1902/jop.2008.070571 ]
   Rogers-Vizena CR, 2015, PLAST RECONSTR SURG, V135, p895E, DOI 10.1097/PRS.0000000000001146
   Sameem M, 2012, PLAST RECONSTR SURG, V130, p67E, DOI 10.1097/PRS.0b013e318254b19f
   Sandu K, 2012, EUR ARCH OTO-RHINO-L, V269, P1261, DOI 10.1007/s00405-011-1754-0
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   Schmitt C. M., 2015, CLIN ORAL IMPLAN RES, P1
   Schmitt CM, 2013, J PERIODONTOL, V84, P914, DOI 10.1902/jop.2012.120084
   Willershausen I, 2014, J APPL ORAL SCI, V22, P29, DOI 10.1590/1678-775720130316
   Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074
   Zhao MX, 2012, J PLAST RECONSTR AES, V65, P1634, DOI 10.1016/j.bjps.2012.07.017
NR 25
TC 2
Z9 2
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1873-9601
EI 1873-961X
J9 J CELL COMMUN SIGNAL
JI J. Cell Commun. Signal
PD MAR
PY 2016
VL 10
IS 1
BP 3
EP 15
DI 10.1007/s12079-015-0313-7
PG 13
WC Cell Biology
SC Cell Biology
GA DO3RO
UT WOS:000377699100002
PM 26660939
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Souza, MR
   Reyes, KM
   Oliveira, NTC
   Kuromoto, NK
   Marino, CEB
AF Souza, M. R.
   Reyes, K. M.
   Oliveira, N. T. C.
   Kuromoto, N. K.
   Marino, C. E. B.
TI Bioactivity of self-organized TiO2 nanotubes used as surface treatment
   on Ti biomaterials
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE TiO2 nanotubes; electrochemical stability; bioactivity; Brazilian MRS
ID BIOMEDICAL APPLICATIONS; TITANIUM NANOTUBES; METALLIC MATERIALS;
   BIOCOMPATIBILITY; COATINGS; IMPLANTS; BEHAVIOR; TI6AL4V; ALLOY
AB Titanium and its alloys are widely used as implants due to their excellent mechanical properties, corrosion resistance and biocompatibility. TiO2 nanotubes have been studied as surface treatment to increase the specific area and to improve osseointegration. However, the thermodynamic stability and bioactivity of these nanostructures must be evaluated. The objective of this research was to obtain nanotubes oxides on Ti6Al4V alloy and to analyze the electrochemical stability in physiological solution at 37 degrees C and the bioactive response of the biomaterial. The nanotubes were obtained by potentiostatic anodization. The morphology of the oxides was evaluated by scanning electron microscopy. The chemical characterization was analyzed by energy dispersive spectroscopy and x-ray photoelectron spectroscopy techniques. The electrochemical stability was analyzed by open circuit potential (OCP) and the bioactivity by biomimetic test in a simulated body fluid (SBF) solution. The OCP of the nanotubes oxides was shown to be more noble and stable than the compacted oxides. The biomaterial covered with theses oxides showed sealing by Ca and P after 30 d immersion in artificial blood. And after 15 d of immersion in SBF, the hydroxyapatite could be seen on the non-sealed nanotubes. TiO2 nanotube layers could improve the superficial chemical stability and also the osseointegration process.
C1 [Souza, M. R.; Reyes, K. M.; Kuromoto, N. K.; Marino, C. E. B.] Univ Fed Parana, Programa Posgrad Engn & Ciencia Mat PIPE, BR-80060000 Curitiba, Parana, Brazil.
   [Oliveira, N. T. C.] Univ Fed Sao Carlos, Dept Mat Engn, BR-13560 Sao Carlos, SP, Brazil.
   [Kuromoto, N. K.] Univ Fed Parana, Dept Fis, BR-80060000 Curitiba, Parana, Brazil.
   [Marino, C. E. B.] Univ Fed Parana, Dept Engn Mech, Lab Biomat & Eletroquim, BR-80060000 Curitiba, Parana, Brazil.
RP Reyes, KM (reprint author), Univ Fed Parana, Programa Posgrad Engn & Ciencia Mat PIPE, BR-80060000 Curitiba, Parana, Brazil.
EM mariana.rossi.souza@gmail.com; kareleiva@gmail.com; ntco@yahoo.com;
   kuromoto@fisica.ufpr.br; claudiamarino@ufpr.br
RI MARINO, CLAUDIA/H-8169-2017
OI MARINO, CLAUDIA/0000-0003-2660-4577
FU CAPES; CNPq [301434/2013-1]
FX The authors are grateful to CAPES for their financial support, to
   CCDM-UFSCAR and CME-UFPR for the SEM analyses and to LSI-UFPR for the
   XPS analysis. Finally, we thank the CNPq productivity fellowship from
   Claudia Eliana Bruno Marino (grant number 301434/2013-1).
CR Bauer S, 2006, ELECTROCHEM COMMUN, V8, P1321, DOI 10.1016/j.elecom.2006.05.030
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chiang CY, 2009, DENT MATER, V25, P1022, DOI 10.1016/j.dental.2009.03.001
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Karpagavalli R, 2007, J BIOMED MATER RES A, V83A, P1087, DOI 10.1002/jbm.a.31447
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Marino CEB, 2004, THIN SOLID FILMS, V468, P109, DOI 10.1016/j.tsf.2004.05.006
   Mohan L, 2015, ELECTROCHIM ACTA, V155, P411, DOI 10.1016/j.electacta.2014.12.032
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2007, MATER SCI FORUM, V539-543, P193, DOI 10.4028/www.scientific.net/MSF.539-543.193
   Parcharoen Y, 2014, APPL SURF SCI, V311, P54, DOI 10.1016/j.apsusc.2014.04.207
   Pisarek M, 2012, BIOMEDICAL ENG TECHN
   RATNER BD, 2004, INTRO MAT MED
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Shirdar MR, 2015, VACUUM, V122, P82, DOI 10.1016/j.vacuum.2015.09.008
   Souza M R, 2014, REV MAT, V19, P53
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Xie JH, 2008, J MATER RES, V23, P768, DOI 10.1557/JMR.2008.0089
   Yang SG, 2006, APPL CATAL A-GEN, V301, P284, DOI 10.1016/j.apcata.2005.12.016
   Yang WE, 2010, THIN SOLID FILMS, V518, P7545, DOI 10.1016/j.tsf.2010.05.045
   Zhang F, 2009, BIOMED MATER, V4
   Zhong ZY, 2015, MAT SCI ENG C-MATER, V49, P251, DOI 10.1016/j.msec.2015.01.020
NR 26
TC 3
Z9 3
U1 1
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD MAR
PY 2016
VL 3
IS 3
AR UNSP 035401
DI 10.1088/2053-1591/3/3/035401
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA DO5GH
UT WOS:000377811100023
DA 2018-10-20
ER

PT J
AU Feng, C
   Lv, XG
   Zhu, WD
   Lu, WL
   Peng, XF
   Zhang, XR
AF Feng, Chao
   Lv, Xiang-Guo
   Zhu, Wei-Dong
   Lu, Wen-Long
   Peng, Xu-Feng
   Zhang, Xin-Ru
TI VEGF-Loaded Nanoparticle-Modified Bacterial Cellulose Combined with
   Multiple Cells in Tissue-Engineered Bladder
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bladder Reconstruction; Vascularization; Nanoparticle; Bacterial
   Cellulose
ID SMALL-INTESTINAL SUBMUCOSA; ACELLULAR MATRIX; PORCINE MODEL;
   AUGMENTATION; REGENERATION; GROWTH; RECONSTRUCTION; CYSTOPLASTY;
   UROTHELIUM; CONSTRUCTS
AB The aim of this study is to assess the properties of a VEGF-loaded nanoparticle-modified bacterial cellulose scaffold and evaluate its feasibility for bladder reconstruction. The bacterial cellulose and the VEGF-nanoparticle was manufactured according to standard technique. After combining the BC with VEGF-nanoparticles, the scanning electronic microscopy, MTT assay, mechanical test, and controlled release test were performed. The keratinocytes and lingual muscle cells were seeded onto these scaffolds for bladder reconstruction (study group). Meanwhile, the cell seeded unmodified BC scaffolds were used as control group. The SEM showed the 3D network form in those scaffolds, which the VEGF nanoparticles attached to the surfaces of fibers. The biochemical and physical assessments showed excellent properties of scaffold. The ELISA test exhibited that VEGF loaded scaffold could release VEGF for at least 4 weeks. Three months after implantation, the study group showed an intact bladder, while mild defection was noticed in the control group. The urodynamic results suggested that the bladder capacity and compliance were better in the study group. In histological examination, thicker epithelial layers, better-organized muscle bundles and denser microvasculature existed in the study group. The VEGF-nanoparticle loaded BC scaffolds had excellent characters, which could be an alternative biomaterial for bladder reconstruction.
C1 [Feng, Chao; Lv, Xiang-Guo; Zhu, Wei-Dong; Lu, Wen-Long; Peng, Xu-Feng; Zhang, Xin-Ru] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
RP Zhang, XR (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ajalloueian F, 2014, BIOMATERIALS, V35, P5741, DOI 10.1016/j.biomaterials.2014.04.002
   Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Azzarello J, 2009, J TISSUE ENG REGEN M, V3, P579, DOI 10.1002/term.199
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   El-Taji OMS, 2015, ONCOL LETT, V10, P3, DOI 10.3892/ol.2015.3161
   Jiang XC, 2015, ANN BIOMED ENG, V43, P2577, DOI 10.1007/s10439-015-1284-9
   Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Li Z, 2015, CELLULOSE, V22, P373, DOI 10.1007/s10570-014-0487-9
   Lin HK, 2015, ADV DRUG DELIVER REV, V82-83, P47, DOI 10.1016/j.addr.2014.11.020
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Olyveira G. M., 2014, J BIOMATER TISS ENG, V24, P600
   Osborn SL, 2014, STEM CELL TRANSL MED, V3, P610, DOI 10.5966/sctm.2013-0131
   Polykandriotis E, 2007, J CELL MOL MED, V11, P6, DOI 10.1111/j.1582-4934.2007.00012.x
   Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74
   Reddy PP, 2000, J UROLOGY, V164, P936, DOI 10.1016/S0022-5347(05)67221-7
   Sanchavanakit N, 2006, BIOTECHNOL PROGR, V22, P1194, DOI 10.1021/bp060035o
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Xiong QW, 2015, TISSUE ENG PT A, V21, P45, DOI [10.1089/ten.tea.2013.0671, 10.1089/ten.TEA.2013.0671]
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Zhang F, 2014, J UROLOGY, V192, P544, DOI 10.1016/j.juro.2014.01.116
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhou L., 2015, PLOS ONE, V10
   Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2
NR 30
TC 0
Z9 0
U1 5
U2 17
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2016
VL 6
IS 3
BP 216
EP 223
DI 10.1166/jbt.2016.1434
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA DM5WG
UT WOS:000376420500006
DA 2018-10-20
ER

PT J
AU Vuong, BX
   Hiep, DT
AF Bui Xuan Vuong
   Dang Tan Hiep
TI In vitro studies of bioglass material by X-ray diffraction and
   solid-state MAS-NMR
SO GLASS PHYSICS AND CHEMISTRY
LA English
DT Article
DE bioactive glass; bioactivity; hydroxyapatite; P-31 MAS-NMR; Si-29
   MAS-NMR
ID NUCLEAR-MAGNETIC-RESONANCE; BIOACTIVE GLASSES; P-31; SPECTROSCOPY;
   PHOSPHATE; SI-29; NA-23
AB Bioactive glass 46S6 has been elaborated by melting method at high temperature. "In vitro" experiments of 46S6 glass were carried out by soaking in a simulated body fluid for different times. The kinetics of chemical reactivity and the bioactivity of this biomaterial was investigated by X-ray diffraction and elucidated by using an original structural analysis method based on solid-state MAS-NMR. After in vitro assays, X-ray diffraction confirmed the high bioactivity of bioglass 46S6. The Si-29 MAS-NMR spectra showed the emergence of two new species: Q (Si) (3) (OH) Q (Si) (4) and which are characteristic of the dissolution of vitreous network of 46S6 glass while the P-31 MAS-NMR spectra highlighted the formation of new component attributed to hydroxycarbonate apatite. The bioglass 46S6 have presented the rapid formation of a biological active hydroxycarbonate apatite layer after soaking in simulated body fluid fluid.
C1 [Bui Xuan Vuong] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.
   [Bui Xuan Vuong] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.
   [Dang Tan Hiep] Ho Chi Minh City Univ Food Ind, Fac Chem Engn, Ho Chi Minh City, Vietnam.
RP Vuong, BX (reprint author), Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.; Vuong, BX (reprint author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.
EM buixuanvuong@tdt.edu.vn
CR Angelopoulou A, 2008, J NON-CRYST SOLIDS, V354, P333, DOI 10.1016/j.jnoncrysol.2007.08.091
   AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   BELTON PS, 1988, J PHYS CHEM SOLIDS, V49, P21, DOI 10.1016/0022-3697(88)90129-1
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Dietrich E., 2008, J BIOMED MATER RES A, V88, P1087
   Elgayar I, 2005, J NON-CRYST SOLIDS, V351, P173, DOI 10.1016/j.jnoncrysol.2004.07.067
   Gunawidjaja PN, 2010, J PHYS CHEM C, V114, P19345, DOI 10.1021/jp105408c
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HINEDI ZR, 1992, J COLLOID INTERF SCI, V152, P141, DOI 10.1016/0021-9797(92)90015-E
   Karlsson K. H., 1991, J NONCRYST SOLIDS, V12, P129
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lin KSK, 2005, CHEM MATER, V17, P4493, DOI 10.1021/cm0505654c
   LOCKYER MWG, 1995, J NON-CRYST SOLIDS, V188, P207, DOI 10.1016/0022-3093(95)00188-3
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   OESTRIKE R, 1987, GEOCHIM COSMOCHIM AC, V51, P2199, DOI 10.1016/0016-7037(87)90269-9
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Smith M. E., 2002, MULTINUCLEAR SOLID S
NR 18
TC 0
Z9 0
U1 1
U2 11
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1087-6596
EI 1608-313X
J9 GLASS PHYS CHEM+
JI Glass Phys. Chem.
PD MAR
PY 2016
VL 42
IS 2
BP 188
EP 193
DI 10.1134/S108765961602005X
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA DM3OR
UT WOS:000376256300011
DA 2018-10-20
ER

PT J
AU Bita, AI
   Antoniac, A
   Cotrut, C
   Vasile, E
   Ciuca, I
   Niculescu, M
   Antoniac, I
AF Bita, A. I.
   Antoniac, A.
   Cotrut, C.
   Vasile, E.
   Ciuca, I.
   Niculescu, M.
   Antoniac, I.
TI In vitro Degradation and Corrosion Evaluation of Mg-Ca Alloys for
   Biomedical Applications
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Magnesium alloys; Corrosion rate; Biomedical; Degradation; Surface
ID MAGNESIUM ALLOYS; BONE
AB The ability to adjust degradation rate of magnesium alloys is critical for the successful development of new biodegradable trauma implants. The aim of this study was to evaluate the biodegradability of an Mg0.8Ca alloy in different simulated biological medium by immersion tests and corrosion resistance testing using electrochemical measurements. The degradation of the experimental magnesium alloy was investigated by immersion tests in two different simulated medium (Simulated Body Fluid-SBF and Dulbecco's Modified Eagle Medium-DMEM) for 3, 5, 7 and 10 days at 37 degrees C. The evaluation of corrosion resistance was performed using electrochemical measurements in the same simulated mediums for 1 hour, at 37 degrees C. The surface morphology of the experimental sample after both tests was investigated using scanning electron microscopy - SEM. The experimental results showed that the experimental magnesium alloy Mg0.8Ca appear to be a promising biomaterial for biodegradable trauma implants but their biodegradation rate must be improved using different techniques like coatings.
C1 [Bita, A. I.; Antoniac, A.; Cotrut, C.; Ciuca, I.; Antoniac, I.] Univ Politehn Bucuresti, Fac Mat Sci & Engn, St Splaiul Independentei 313,Sect 6, Bucharest, Romania.
   [Vasile, E.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, St Gh Polizu 1-7,Sect 1, Bucharest, Romania.
   [Niculescu, M.] Colentina Clin Hosp, Dept Orthopaed & Trauma 1, St Stefan Cel Mare 19-21,Sect 2, Bucharest, Romania.
RP Niculescu, M (reprint author), Colentina Clin Hosp, Dept Orthopaed & Trauma 1, St Stefan Cel Mare 19-21,Sect 2, Bucharest, Romania.
EM mariusniculescu1961@gmail.com
RI Cotrut, Mihai Cosmin/G-4505-2011; Antoniac, Iulian/D-4802-2014
OI Cotrut, Mihai Cosmin/0000-0002-8991-7485; Antoniac,
   Iulian/0000-0003-0112-3494
FU Sectoral Operational Programme Human Resources Development of the
   Ministry of European Funds [POSDRU/159/1.5/S/132397]; UEFISCDI - PN II -
   Partnerships in priority areas [271/2014]; EU [POSCCE-A2-O2.2.1-2013-1/,
   638/12.c03.2014, cod SMIS-CSrNR 48652]
FX The work has been funded by the Sectoral Operational Programme Human
   Resources Development 2007-2013 of the Ministry of European Funds
   through the Financial Agreement POSDRU/159/1.5/S/132397 and the UEFISCDI
   - PN II - Partnerships in priority areas, Contract No. 271/2014. The SEM
   analyses on samples were possible due to EU-funding grant
   POSCCE-A2-O2.2.1-2013-1/ Priority direction 2, Project
   No.638/12.c03.2014, cod SMIS-CSrNR 48652.
CR Bakhsheshi-Rad HR, 2015, VACUUM, V119, P95, DOI 10.1016/j.vacuum.2015.04.039
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Sanchez AHM, 2015, ACTA BIOMATER, V13, P16, DOI 10.1016/j.actbio.2014.11.048
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Waizy H, 2013, J MATER SCI, V48, P39, DOI 10.1007/s10853-012-6572-2
NR 10
TC 2
Z9 2
U1 1
U2 8
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAR-APR
PY 2016
VL 18
IS 3-4
BP 394
EP 398
PG 5
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA DL9LM
UT WOS:000375964800029
DA 2018-10-20
ER

PT J
AU Salehipour, M
   Mohammadian, R
   Malekahmadi, A
   Hosseinzadeh, M
   Yadollahi, M
   Natami, M
   Mohammadian, M
AF Salehipour, Mehdi
   Mohammadian, Reza
   Malekahmadi, Amir
   Hosseinzadeh, Massood
   Yadollahi, Mahnaz
   Natami, Mohammad
   Mohammadian, Mahsa
TI Renal capsule for augmentation cystoplasty in canine model: a favorable
   biomaterial?
SO INTERNATIONAL BRAZ J UROL
LA English
DT Article
DE Urinary Bladder; Dogs; Biocompatible Materials
ID SMALL-INTESTINAL SUBMUCOSA; BLADDER AUGMENTATION; CLINICAL-EXPERIENCE
AB Purpose: To evaluate effectiveness of canine renal capsule for augmentation cystoplasty.
   Materials and Methods: Ten adult dogs participated in this study. After induction of anesthesia each animal underwent bed side urodynamic study, bladder capacity and bladder pressure was recorded. Then via mid line incision abdominal cavity was entered, right kidney was identified and its capsule was dissected. Bladder augmentation was done by anastomosing the renal capsule to the bladder. After 6 months bed side urodynamic study was performed again and changes in bladder volume and pressure were recorded. Then the animals were sacrificed and the augmented bladders were sent for histopathology evaluation.
   Results: Mean maximum anatomic bladder capacity before cystoplasty was 334.00 +/- 11.40cc which increased to 488.00 +/- 14.83cc post-operatively (p=0.039). Mean anatomic bladder pressure before cystoplasty was 19.00 +/- 1.58cmH2O which decreased to 12.60 +/- 1.14cmH(2)O post-operatively (p=0.039). Histopathology evaluation revealed epithelialization of the renal capsule with urothelium without evidence of fibrosis, collagen deposits or contracture.
   Conclusions: Our data shows that renal capsule is a favorable biomaterial for bladder augmentation in a canine model.
C1 [Salehipour, Mehdi; Mohammadian, Reza; Malekahmadi, Amir; Natami, Mohammad; Mohammadian, Mahsa] Shiraz Univ Med Sci, Dept Urol, Shiraz, Iran.
   [Hosseinzadeh, Massood] Shiraz Univ Med Sci, Dept Pathol, Shiraz, Iran.
   [Yadollahi, Mahnaz] Shiraz Univ Med Sci, Trauma Res Ctr, Shiraz, Iran.
RP Salehipour, M (reprint author), Shiraz Univ Med Sci, Faghihi Hosp, Shiraz, Iran.
EM salehipour@sums.ac.ir
RI salehipour, mehdi/U-5423-2017; hosseinzadeh, massood/C-5216-2018
OI salehipour, mehdi/0000-0003-3882-0234; hosseinzadeh,
   massood/0000-0003-0531-0457
CR Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
   [Anonymous], 2009, WHEC PRACT B CLIN MA
   [Anonymous], 1996, GUIDE CARE USE LAB A
   Barrett D M, 1984, Semin Urol, V2, P167
   CARTWRIGHT PC, 1989, J UROLOGY, V142, P505, DOI 10.1016/S0022-5347(17)38798-0
   CHURCHILL BM, 1993, J UROLOGY, V150, P716, DOI 10.1016/S0022-5347(17)35596-9
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   Greenwell TJ, 2001, BJU INT, V88, P511, DOI 10.1046/j.1464-4096.2001.001206
   Greenwell TJ, 2001, UROLOGY, V58, P660, DOI 10.1016/S0090-4295(01)01363-2
   Higuchi TT, 2010, J UROLOGY, V84, P2492
   Hodjati H, 2013, UROLOGY, V81
   KHOURY JM, 1990, WORLD J UROL, V8, P203, DOI 10.1007/BF01580021
   Mikulicz V, 1889, ZENTRALBL CHIR, V20, P641
   NEUHOF H, 1917, SURG GYNECOL OBSTET, V24, P383
   Nurse DE, 1996, BRIT J UROL, V77, P684, DOI 10.1046/j.1464-410X.1996.97311.x
   Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF1254, DOI 10.1152/ajprenal.00406.2009
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Snow B W, 1992, Contemp Urol, V4, P41
   Swami KS, 1998, BRIT J UROL, V81, P68
   THOMPSON IM, 1969, J UROLOGY, V101, P487, DOI 10.1016/S0022-5347(17)62369-3
   Tizzoni G, 1888, CENTRALBL F CHIR, V15, P921
   Wang DS, 2007, BJU INT, V99, P628, DOI 10.1111/j.1464-410X.2006.06662.x
NR 22
TC 0
Z9 0
U1 0
U2 6
PU BRAZILIAN SOC UROL
PI RIO DE JANEIRO
PA RUA BAMBINA, 153, RIO DE JANEIRO, 2251-050, BRAZIL
SN 1677-5538
EI 1677-6119
J9 INT BRAZ J UROL
JI Int. Braz J Urol
PD MAR-APR
PY 2016
VL 42
IS 2
BP 383
EP 388
DI 10.1590/S1677-5538.IBJU.2014.0680
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA DL4KQ
UT WOS:000375604900029
PM 27256195
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dursun, CK
   Dursun, E
   Eratalay, K
   Orhan, K
   Tatar, I
   Baris, E
   Tozum, TF
AF Dursun, Ceyda Kanli
   Dursun, Erhan
   Eratalay, Kenan
   Orhan, Kaan
   Tatar, Ilkan
   Baris, Emre
   Toezuem, Tolga Fikret
TI Effect of Porous Titanium Granules on Bone Regeneration and Primary
   Stability in Maxillary Sinus: A Human Clinical, Histomorphometric, and
   Microcomputed Tomography Analyses
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Bone density; dental implant; maxillary sinus floor elevation;
   microcomputed tomography; stability
ID ANORGANIC BOVINE BONE; FLOOR AUGMENTATION; AUTOGENOUS BONE; DENTAL
   IMPLANTS; HISTOLOGIC EVALUATION; MINERAL DENSITY; BIO-OSS; GRAFT;
   BIOMATERIAL; PLACEMENT
AB The aim of this randomized controlled study was to comparatively analyze the new bone (NB), residual bone, and graft-bone association in bone biopsies retrieved from augmented maxillary sinus sites by histomorphometry and microcomputed tomography (MicroCT) in a split-mouth model to test the efficacy of porous titanium granules (PTG) in maxillary sinus augmentation. Fifteen patients were included in the study and each patient was treated with bilateral sinus augmentation procedure using xenograft (equine origine, granule size 1000-2000 mu m) and xenograft (1g) + PTG (granule size 700-1000 mu m, pore size >50 mu m) (1g), respectively. After a mean of 8.4 months, 30 bone biopsies were retrieved from the implant sites for three-dimensional MicroCT and two-dimensional histomorphometric analyses. Bone volume and vital NB percentages were calculated. Immediate after core biopsy, implants having standard dimensions were placed and implant stability quotient values were recorded at baseline and 3 months follow-up. There were no significant differences between groups according to residual bone height, residual bone width, implant dimensions, and implant stability quotient values (baseline and 3 months). According to MicroCT and two-dimensional histomorphometric analyses, the volume of newly formed bone was 57.05% and 52.67%, and 56.5% and 55.08% for xenograft + PTG and xenograft groups, respectively. No statistically significant differences found between groups according to NB percentages and higher Hounsfield unit values were found for xenograft + PTG group. The findings of the current study supports that PTG, which is a porous, permanent nonresorbable bone substitute, may have a beneficial osteoconductive effect on mechanical strength of NB in augmented maxillary sinus.
C1 [Dursun, Ceyda Kanli; Dursun, Erhan; Eratalay, Kenan] Hacettepe Univ, Fac Dent, Dept Periodontol, Ankara, Turkey.
   [Orhan, Kaan] Ankara Univ, Fac Dent, Dept Dentomaxillofacial Radiol, TR-06100 Ankara, Turkey.
   [Tatar, Ilkan] Hacettepe Univ, Fac Med, Dept Anat, Ankara, Turkey.
   [Baris, Emre] Gazi Univ, Fac Dent, Dept Oral Pathol, Ankara, Turkey.
   [Toezuem, Tolga Fikret] Univ Illinois, Coll Dent, Dept Dept Periodont, Chicago, IL USA.
RP Dursun, CK (reprint author), Univ Illinois, Dept Periodont, Coll Dent, Chicago, IL USA.
EM ttozum@uic.edu
RI Bayram, Cem/D-7403-2013
OI Bayram, Cem/0000-0001-8717-4668; Orhan, Kaan/0000-0001-6768-0176
FU Hacettepe University, Scientific Research Projects Coordination Unit,
   Ankara, Turkey [011D10201003]
FX This study is supported by Hacettepe University, Scientific Research
   Projects Coordination Unit, Grant Number: 011D10201003, Ankara, Turkey.
CR BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Butz F, 2011, INT J ORAL MAX IMPL, V26, P1317
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Chackartchi T, 2011, CLIN ORAL IMPLAN RES, V22, P473, DOI 10.1111/j.1600-0501.2010.02032.x
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Huang HL, 2012, CLIN ORAL IMPLAN RES, V23, P1098, DOI 10.1111/j.1600-0501.2011.02273.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Lambert F, 2013, CLIN IMPLANT DENT R, V15, P412, DOI 10.1111/j.1708-8208.2011.00374.x
   Lee CYS, 2011, IMPLANT DENT, V20, P202, DOI 10.1097/ID.0b013e318211f72e
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Ostman PO, 2008, INT J ORAL MAX IMPL, V23, P315
   Peleg M, 1998, J PERIODONTOL, V69, P1397, DOI 10.1902/jop.1998.69.12.1397
   Sabetrasekh R, 2011, J BIOMATER APPL, V25, P559, DOI 10.1177/0885328209354925
   Santagata M, 2010, J ORAL IMPLANTOL, V36, P485, DOI 10.1563/AAID-JOI-D-09-00105
   Sbordone L, 2009, INT J ORAL MAX SURG, V38, P1059, DOI 10.1016/j.ijom.2009.06.024
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schmitt CM, 2015, CLIN ORAL IMPLAN RES, V26, P1043, DOI 10.1111/clr.12396
   Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   SMILER D G, 1987, Journal of Oral Implantology, V13, P239
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tozum TF, 2010, J ORAL REHABIL, V37, P217, DOI 10.1111/j.1365-2842.2009.02038.x
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Velich N, 2004, J CRANIOFAC SURG, V15, P38, DOI 10.1097/00001665-200401000-00013
   Verket A, 2014, CLIN ORAL IMPLAN RES, V25, pE100, DOI 10.1111/clr.12070
   Verket A, 2013, INT J ORAL MAX IMPL, V28, P721, DOI 10.11607/jomi.2853
   Wallace SS, 2005, INT J PERIODONT REST, V25, P551
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wohlfahrt JC, 2010, CLIN ORAL IMPLAN RES, V21, P165, DOI 10.1111/j.1600-0501.2009.01813.x
   Xavier SP, 2015, CLIN ORAL IMPLAN RES, V26, P1080, DOI 10.1111/clr.12404
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 39
TC 9
Z9 9
U1 2
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2016
VL 27
IS 2
BP 391
EP 397
DI 10.1097/SCS.0000000000002421
PG 7
WC Surgery
SC Surgery
GA DK2RD
UT WOS:000374761200073
PM 26872278
DA 2018-10-20
ER

PT J
AU Ferreira, ACRD
   Munoz, XMJP
   Okamoto, R
   Pellizer, EP
   Garcia, IR
AF Rezende de Moraes Ferreira, Ana Carulina
   Johanna Palacio Munoz, Xiomara Monica
   Okamoto, Roberta
   Pellizer, Eduardo Piza
   Garcia, Idelmo Rangel, Jr.
TI Postoperative Complications in Craniomaxillofacial Reconstruction With
   Medpor
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Bone reconstruction; Medpor; postoperative complication
ID POROUS POLYETHYLENE IMPLANTS; FRACTURES; OUTCOMES; SURGERY
AB Bone reconstruction in craniofacial surgery is a challenge for surgeons, who most commonly adopt the autogenous bone grafting and alloplastic implants in such procedures. Among the alloplastic materials, the high-density porous polyethylene is highlighted-Medpor (Medpor, Porex Surgical Inc, Newman, GA), considered to be pure polyethylene, with only 1 manufacturing process and standard pore size. The purpose of the current study has been to present through a review of literature and the types of complications derived from the use of Medpor in craniomaxillo-facial bone surgery. A specific and sensitive database was initially created via PubMed, focusing on studies published in English peer-reviewed journals between 2004 and 2014, including case reports, experimental studies in humans, and prospective and retrospective studies. Forty articles were found at PubMed database. After analyzing their abstracts, 19 were selected, totaling 1453 patients and 121 complications, being the most commonly reported diplopia with 56 patients and infection with 6 patients. Most of the complications reported in the articles used for the development of the current review are not directly related to the use of the Medpor implant. The only complications directly related to the use of this biomaterial were cases of infection.
C1 [Rezende de Moraes Ferreira, Ana Carulina; Johanna Palacio Munoz, Xiomara Monica] Sao Paulo State Univ, Sao Paulo, Brazil.
   [Okamoto, Roberta] State Univ Sao Paulo UNESP, Coll Dent, Sao Paulo, Brazil.
   [Pellizer, Eduardo Piza; Garcia, Idelmo Rangel, Jr.] State Univ Sao Paulo UNESP, Coll Dent, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.
RP Ferreira, ACRD (reprint author), Sao Paulo State Univ, Rua Jose Bonifacio,1193 Vila Mendonca, BR-16015050 Aracatuba, SP, Brazil.
EM caru_moraes@hotmail.com
OI Okamoto, Roberta/0000-0002-6773-6966
CR Chambless LB, 2012, J CRANIO MAXILL SURG, V40, pE28, DOI 10.1016/j.jcms.2011.01.016
   Han DH, 2011, J CRANIOFAC SURG, V22, P1422, DOI 10.1097/SCS.0b013e31821cc2b5
   Heliotis M, 2007, PLAST RECONSTR SURG, V120, P1740, DOI 10.1097/01.prs.0000291404.03478.ff
   Hwang K, 2009, J CRANIOFAC SURG, V20, P1218, DOI 10.1097/SCS.0b013e3181acde01
   Kyung H, 2013, J CRANIOFAC SURG, V24, P1781, DOI 10.1097/SCS.0b013e3182a21076
   Lee S, 2005, ARCH OTOLARYNGOL, V131, P446, DOI 10.1001/archotol.131.5.446
   Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876
   Nahai FR, 2012, FACIAL PLAST SURG, V28, P34, DOI 10.1055/s-0032-1305788
   Naik MN, 2007, OPHTHAL PLAST RECONS, V23, P463, DOI 10.1097/IOP.0b013e318158ec8e
   Nocini PF, 2009, PLAST RECONSTR SURG, V123, P670, DOI 10.1097/PRS.0b013e318196b958
   Ozturk S, 2005, J CRANIOFAC SURG, V16, P973, DOI 10.1097/01.scs.0000179744.91165.3a
   Rapidis AD, 2006, J ORAL MAXIL SURG, V64, P12, DOI 10.1016/j.joms.2005.09.007
   Wajih WAS, 2011, J ORAL MAXIL SURG, V69, P1740, DOI 10.1016/j.joms.2010.07.053
   Wang JC, 2012, J CRANIOFAC SURG, V23, P1404, DOI 10.1097/SCS.0b013e31825e3aeb
   Wang M, 2012, J CRANIOFAC SURG, V23, P44, DOI 10.1097/SCS.0b013e318240c83e
   Wang ST, 2008, ORAL SURG ORAL MED O, V106, P324, DOI 10.1016/j.tripleo.2007.12.022
   Xiao Jin-gang, 2007, Hua Xi Kou Qiang Yi Xue Za Zhi, V25, P67
   Xu JJ, 2009, J CRANIOFAC SURG, V20, P918, DOI 10.1097/SCS.0b013e3181a2d728
   Ye J, 2006, INVEST OPHTH VIS SCI, V47, P509, DOI 10.1167/iovs.05-0816
NR 19
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2016
VL 27
IS 2
BP 425
EP 428
DI 10.1097/SCS.0000000000002325
PG 4
WC Surgery
SC Surgery
GA DK2RD
UT WOS:000374761200080
PM 26963299
DA 2018-10-20
ER

PT J
AU Pigache, P
   Anavekar, N
   Raoul, G
   Ferri, J
AF Pigache, Penelope
   Anavekar, Namrata
   Raoul, Gwenael
   Ferri, Joel
TI Maxillary Reconstruction for Sinus Lift Complications With Oro-Antral
   Fistula: The Le Fort I Approach
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Biomaterial; calvarial bone; maxillary reconstruction; oro-antral
   fistula; sinus lift complications
ID RETROSPECTIVE EVALUATION; ENDOSSEOUS IMPLANTS; OROANTRAL FISTULA;
   AUTOGENOUS BONE; CLOSURE; REPAIR
AB Although sinus lift procedures are reliable, some complications can lead to serious maxillary sequelae, including the development of oro-antral fistula (OAF). Maxillary reconstruction in such patients presents a challenge owing to sinus floor alterations, graft remnants, chronic infection, and morbidity from the original sinus lift approach. The current study describes our technique of maxillary reconstruction using a Le Fort 1 approach following major sinus lift complications with associated residual OAF. This technique provides excellent access for sinus curettage, OAF closure, and osseous reconstruction. It allowed a successful rehabilitation in our patients, with no implant loss and good functional and esthetic results.
C1 [Pigache, Penelope; Anavekar, Namrata; Raoul, Gwenael; Ferri, Joel] Lille Univ Hosp, Oral & Maxillofacial Dept, Lille, France.
RP Pigache, P (reprint author), Ctr Hosp Reg Univ Lille, Lille, France.
EM penelope.pigache@gmail.com
CR Abuabara A, 2006, INT J ORAL MAX SURG, V35, P155, DOI 10.1016/j.ijom.2005.04.024
   Ahmed MS, 2011, ORAL SURG ORAL MED O, V111, P8
   Anavi Y, 2003, ORAL SURG ORAL MED O, V96, P527, DOI 10.1016/S1079-2104(03)00470-0
   Anavi Y, 2008, ORAL SURG ORAL MED O, V106, P34, DOI 10.1016/j.tripleo.2007.09.021
   Anzalone JV, 2010, J ORAL IMPLANTOL, V36, P231, DOI 10.1563/AAID-JOI-D-09-00026
   Cawood JI, 2006, INT J ORAL MAX SURG, V35, P195, DOI 10.1016/j.ijom.2005.09.008
   Ferri J, 2010, REV STOMATOL CHIR, V111, P63, DOI 10.1016/j.stomax.2009.09.013
   Ferri J, 2008, HEAD FACE MED, V16, P4
   Goga D, 2000, Rev Stomatol Chir Maxillofac, V101, P303
   Lee BK, 2008, ORAL SURG ORAL MED O, V105, P707, DOI 10.1016/j.tripleo.2007.09.020
   Vazquez JCM, 2014, J ORAL MAXIL SURG, V72, P892, DOI 10.1016/j.joms.2013.11.023
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Nolan PJ, 2014, J ORAL MAXIL SURG, V72, P47, DOI 10.1016/j.joms.2013.07.020
   Papa F, 2005, BRIT J ORAL MAX SURG, V43, P309, DOI 10.1016/j.bjoms.2004.08.027
   PROCTOR B, 1969, LARYNGOSCOPE, V79, P822, DOI 10.1288/00005537-196905000-00005
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P279, DOI 10.1034/j.1600-0501.2001.012003279.x
   SAILER HF, 1989, J CRANIO MAXILL SURG, V17, P299, DOI 10.1016/S1010-5182(89)80057-5
   Soehardi A, 2015, INT J ORAL MAX SURG, V44, P97, DOI 10.1016/j.ijom.2014.06.002
   Watzak G, 2005, J ORAL MAXIL SURG, V63, P1288, DOI 10.1016/j.joms.2005.05.299
   Zijderveld SA, 2008, J ORAL MAXIL SURG, V66, P1426, DOI [10.1016/j.joms.2008.01.027, 10.1016/j.jams.2008.01.027]
NR 20
TC 1
Z9 1
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2016
VL 27
IS 2
BP 464
EP 468
DI 10.1097/SCS.0000000000002383
PG 5
WC Surgery
SC Surgery
GA DK2RD
UT WOS:000374761200089
PM 26825748
DA 2018-10-20
ER

PT J
AU Elangovan, S
   Prakasam, S
   Gajendrareddy, P
   Allareddy, V
AF Elangovan, Satheesh
   Prakasam, Sivaraman
   Gajendrareddy, Praveen
   Allareddy, Veerasathpurush
TI A RISK OF BIAS ASSESSMENT OF RANDOMIZED CONTROLLED TRIALS (RCTS) ON
   PERIODONTAL REGENERATION PUBLISHED IN 2013
SO JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE
LA English
DT Article
DE Randomized controlled trial; Evidence based dentistry; Bias
ID CONTROLLED CLINICAL-TRIAL; EVIDENCE-BASED DENTISTRY; LOCAL-DRUG
   DELIVERY; SYSTEMATIC REVIEWS; QUALITY ASSESSMENT; SURGERY; DEFECTS; GEL;
   SMOKERS
AB Objective
   The objective of this assessment isto evaluate the degree of risk of bias in randomized controlled trials published in 2013 and focusing on periodontal regeneration.
   Methods
   Three reviewers searched and selected the trials based on pre-defined inclusion criteria. Predictor variables [number of authors, primary objective of the study, biomaterial employed, follow-up time periods, split mouth study (yes/no), journal, year of publication, country, scale (single/multi-center) and nature of funding] were extracted and risk of bias assessment using Cochrane risk of bias tool were performed independently by the three reviewers.
   Results
   Seventeen RCTs were included in this assessment. The risk of bias in RCTs published in 2013 with a focus in periodontal regeneration varied significantly with only in less than 30% of the included trials, the overall risk of bias was found to be low, while 41% oftrials were designated to have a higherdegree of bias. Specifically, when looking at the domains assessed, 70% of the included trials reported an accepted method of sequence generation, blinding (whenever possible), completeness of outcome data or avoided selective outcome reporting. Meanwhile, only 47% of the included trials reported some form of allocation concealment.
   Conclusion
   In this assessment, of the included 17 trials, slightly more than 40% of them had a high risk of bias, underscoring the importance of careful appraisal of trials before implementing the study interventions in clinical practice and the need for more detailed analyses.
C1 [Prakasam, Sivaraman; Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA.
   [Elangovan, Satheesh] Oregon Hlth & Sci Univ, Sch Dent, Dept Periodont, Portland, OR 97239 USA.
   [Gajendrareddy, Praveen] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA.
RP Allareddy, V (reprint author), Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA.
EM Veerasathpurush-Allareddy@uiowa.edu
CR Cairo F, 2012, J CLIN PERIODONTOL, V39, P81, DOI 10.1111/j.1600-051X.2011.01839.x
   Chalmers TC, 1983, NEW ENGL J MED, V309, P1359
   Chambrone L, 2010, J CLIN PERIODONTOL, V37, P1110, DOI 10.1111/j.1600-051X.2010.01634.x
   Elangovan S, 2013, J PERIODONTOL, V84, P758, DOI 10.1902/jop.2012.120317
   Elangovan S, 2013, J PERIODONTOL, V84, P176, DOI 10.1902/jop.2012.120021
   Faggion CM, 2012, J PERIODONTOL, V83, P1251, DOI 10.1902/jop.2012.110609
   Farina R, 2013, CLIN ORAL INVEST, V17, P1573, DOI 10.1007/s00784-012-0838-6
   Forni F, 2013, BLOOD TRANSFUS-ITALY, V11, P102, DOI 10.2450/2012.0007-12
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Ismail AI, 2004, J AM DENT ASSOC, V135, P78, DOI 10.14219/jada.archive.2004.0024
   Kelly JT, 2013, J AM DENT ASSOC, V144, P371, DOI 10.14219/jada.archive.2013.0130
   Marshall TA, 2014, J DENT EDUC, V78, P359
   Pihlstrom BL, 2012, PERIODONTOL 2000, V59, P14, DOI 10.1111/j.1600-0757.2011.00439.x
   Pradeep AR, 2013, J PERIODONTOL, V84, P307, DOI 10.1902/jop.2012.110729
   Rao NS, 2013, AUST DENT J, V58, P156, DOI 10.1111/adj.12042
   Rao NS, 2013, J PERIODONTOL, V84, P1165, DOI 10.1902/jop.2012.120298
   Savovic Jelena, 2014, Syst Rev, V3, P37, DOI 10.1186/2046-4053-3-37
   Sjogren P, 2002, J CLIN PERIODONTOL, V29, P1112, DOI 10.1034/j.1600-051X.2002.291211.x
   Vere J, 2011, CLIN ORAL IMPLAN RES, V22, P1338, DOI 10.1111/j.1600-0501.2010.02124.x
NR 20
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-3382
EI 1532-3390
J9 J EVID-BASED DENT PR
JI J. Evid.-Based Dent. Pract.
PD MAR
PY 2016
VL 16
IS 1
BP 30
EP 40
DI 10.1016/j.jebdp.2015.03.016
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DL6FO
UT WOS:000375735300004
PM 27132553
DA 2018-10-20
ER

PT J
AU Valente, FL
   Reis, ECC
   Sepulveda, RV
   Ochoa, CCR
   Santos, LC
   Corsini, CM
   Borges, APB
AF Valente, F. L.
   Reis, E. C. C.
   Sepulveda, R. V.
   Ochoa, C. C. R.
   Santos, L. C.
   Corsini, C. M.
   Borges, A. P. B.
TI Hydroxyapatite, polycaprolactone and alendronate composites for bone
   regeneration in rabbits' olecranon: histological features
SO ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA
LA English
DT Article
DE bone regeneration; biocompatibility; biomaterial
ID IN-VIVO; DEFECT
C1 [Valente, F. L.; Reis, E. C. C.; Sepulveda, R. V.; Ochoa, C. C. R.; Santos, L. C.; Corsini, C. M.; Borges, A. P. B.] Univ Fed Vicosa, Vicosa, MG, Brazil.
RP Borges, APB (reprint author), Univ Fed Vicosa, Vicosa, MG, Brazil.
EM andrea@ufv.br
OI Borges, Andrea Pacheco Batista/0000-0002-7489-3847
FU FAPEMIG; CNPq; CAPES
FX The authors thank the agencies FAPEMIG, CNPq and CAPES for financial
   support and JHS Laboratorio Quimico Ltda. for providing the material for
   research.
CR Borges APB, 2000, ARQ BRAS MED VET ZOO, V52, P616, DOI 10.1590/S0102-09352000000600011
   Carlo EC, 2009, ARQ BRAS MED VET ZOO, V61, P844, DOI 10.1590/S0102-09352009000400011
   Fabbri P, 2010, J MATER SCI-MATER M, V21, P343, DOI 10.1007/s10856-009-3839-5
   FERNANDES R.G., 2004, REV ODONTOL UNESP, V33, P123
   Jakobsen T, 2007, J ORTHOP RES, V25, P432, DOI 10.1002/jor.20276
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Mitsak AG, 2011, TISSUE ENG PT A, V17, P1831, DOI [10.1089/ten.TEA.2010.0560, 10.1089/ten.tea.2010.0560]
   Perez-Lopez FR, 2004, MATURITAS, V48, P179, DOI 10.1016/j.maturitas.2003.12.006
   Somford MP, 2009, INT J RHEUMATOL, DOI 10.1155/2009/253432
   Vital CC, 2006, ARQ BRAS MED VET ZOO, V58, P175, DOI 10.1590/S0102-09352006000200005
   Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005
NR 12
TC 2
Z9 2
U1 3
U2 13
PU ARQUIVO BRASILEIRO MEDICINA VETERINARIA ZOOTECNIA
PI MINAS GERAIS
PA FEDERAL MINAS GERAIS CAIXA POSTAL 567-BELO HORIZ, MINAS GERAIS, BRAZIL
SN 0102-0935
EI 1678-4162
J9 ARQ BRAS MED VET ZOO
JI Arq. Bras. Med. Vet. Zootec.
PD MAR-APR
PY 2016
VL 68
IS 2
BP 543
EP 547
DI 10.1590/1678-4162-8343
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA DK3PZ
UT WOS:000374830900036
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Wang, P
   Deng, C
   Yuan, JG
   Yu, YY
   Cui, L
   Su, MT
   Wang, Q
   Fan, XR
AF Wang, Ping
   Deng, Chao
   Yuan, Jiugang
   Yu, Yuanyuan
   Cui, Li
   Su, Mengting
   Wang, Qiang
   Fan, Xuerong
TI Preparation of antibacterial silk fibroin membranes via
   tyrosinase-catalyzed coupling of epsilon-polylysine
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
DE epsilon-polylysine; enzymatic functionalization; silk fibroin membrane;
   TNBS; tyrosinase
ID CROSS-LINKING; PEPTIDES; PROTEINS; CHITOSAN; OXIDATION; TEXTILES
AB Silk fibroins have good biocompatibility and could be used to form a variety of regenerated functional biomaterials. In this study, enzymatic oxidization of silk fibroins with tyrosinase (TYR) was carried out, followed by coupling of epsilon-polylysine (epsilon-PLL) for improving antibacterial ability of the fibroin-based biomaterial. Trinitrobenzene sulfonic acid (TNBS) was selectively used to incubate with silk fibroins prior to TYR treatment, aiming at preventing the self-crosslinking of silk fibroins during enzymatic oxidation. The results indicated that tyrosine residues in silk fibroins could be converted to reactive dioxyphenylalanine and o-quinone residues TYR successively. TNBS pretreatment inhibited the self-crosslinks of silk fibroins and promoted the successive coupling of epsilon-PLL to fibroin proteins with high graft yield. The combined use of TNBS, TYR, and epsilon-PLL treatments endowed fibroin membrane with satisfactory antibacterial ability against Staphylococcus aureus, and the obtained durability was also acceptable. The changes in surface potential and amine acid composition for the fibroin membranes verified the favorable actions of the combined treatment. The present method could be potentially utilized for enzymatic functionalization of various fibroin-based biomaterials. (C) 2015 International Union of Biochemistry and Molecular Biology, Inc.
C1 [Wang, Ping; Yuan, Jiugang; Yu, Yuanyuan; Cui, Li; Su, Mengting; Wang, Qiang; Fan, Xuerong] Jiangnan Univ, Minist Educ, Key Lab Sci & Technol Ecotext, 1800 Lihu Ave, Wuxi 214122, Peoples R China.
   [Deng, Chao] Jiangnan Univ, Wuxi Med Sch, Wuxi 214122, Peoples R China.
RP Fan, XR (reprint author), Jiangnan Univ, Minist Educ, Key Lab Sci & Technol Ecotext, 1800 Lihu Ave, Wuxi 214122, Peoples R China.
EM wxfxr@163.com
FU National Natural Science Funds [51373071]; Program for New Century
   Excellent Talents in University [NCET-12-0883]; Fundamental Research
   Funds for the Central Universities [JUSRP51312B]
FX This work was financially supported by the National Natural Science
   Funds (51373071), the Program for New Century Excellent Talents in
   University (NCET-12-0883), and the Fundamental Research Funds for the
   Central Universities (JUSRP51312B). The authors have declared no
   conflict of interest.
CR Anghileri A, 2007, J BIOTECHNOL, V127, P508, DOI 10.1016/j.jbiotec.2006.07.021
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Chadeau E, 2010, FOOD CONTROL, V21, P505, DOI 10.1016/j.foodcont.2009.07.013
   Dehshahri A, 2009, BIOMATERIALS, V30, P4187, DOI 10.1016/j.biomaterials.2009.04.036
   Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003
   Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p
   Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332
   Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Jia SR, 2010, FOOD SCI BIOTECHNOL, V19, P361, DOI 10.1007/s10068-010-0051-9
   Jus S, 2008, ENZYME MICROB TECH, V42, P535, DOI 10.1016/j.enzmictec.2008.02.012
   Kang GD, 2004, FIBER POLYM, V5, P234, DOI 10.1007/BF02903006
   Kuboe Y, 2004, BIOMACROMOLECULES, V5, P348, DOI 10.1021/bm034363d
   Li GH, 2012, MAT SCI ENG C-MATER, V32, P627, DOI 10.1016/j.msec.2011.12.013
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Mattinen ML, 2008, J BIOTECHNOL, V133, P395, DOI 10.1016/j.biotec.2007.10.009
   Rodriguez C, 2014, CATAL TODAY, V230, P41, DOI 10.1016/j.cattod.2013.12.023
   Sampaio S, 2005, J BIOTECHNOL, V116, P21, DOI 10.1016/j.jbiotec.2004.10.003
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sionkowska A., 2011, POLYM DEGRAD STABIL, V96, P23
   Son K., CHEM ENG J, V239, P284
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Wang P, 2013, ENG LIFE SCI, V13, P102, DOI 10.1002/elsc.201200015
   Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9
NR 24
TC 4
Z9 4
U1 8
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD MAR-APR
PY 2016
VL 63
IS 2
BP 163
EP 169
DI 10.1002/bab.1365
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DK3VA
UT WOS:000374844300002
PM 25757371
DA 2018-10-20
ER

PT J
AU Aljawish, A
   Muniglia, L
   Chevalot, I
AF Aljawish, Abdulhadi
   Muniglia, Lionel
   Chevalot, Isabelle
TI Growth of human mesenchymal stem cells (MSCs) on films of enzymatically
   modified chitosan
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE enzymatic modification; chitosan films; ABTS; cell adhesion; mesenchymal
   stem cells
ID SELF-ASSEMBLED MONOLAYERS; IN-VITRO; FERULIC ACID; DYNAMIC COMPRESSION;
   PROTEIN ADSORPTION; CULTIVATION SYSTEM; EXPANSION; SCAFFOLDS;
   BIOCOMPATIBILITY; DIFFERENTIATION
AB Mesenchymal stem cells (MSCs) are known to be an attractive cell source for tissue engineering and regenerative medicine. One of the main limiting steps for clinical use or biotechnological purposes is the expansion step. The research of compatible biomaterials for MSCs expansion is recently regarded as an attractive topic. The aim of this study was to create new functional biomaterial for MSCs expansion by evaluating the impact of chitosan derivative films modified by enzymatic approach. First, chitosan particles were enzymatically modified with ferulic acid (FA) or ethyl ferulate (EF) under an eco-friendly procedure. Then, films of chitosan and its modified derivatives were prepared and evaluated by physicochemical and biological properties. Results showed that the enzymatic grafting of FA or EF onto chitosan significantly increased hydrophobic and antioxidant properties of chitosan films. The MSCs cell viability on chitosan derivative films also increased depending on the film thickness and the quantity of grafted phenols. Furthermore, the cytotoxicity test showed the absence of toxic effect of chitosan derivative films towards MSCs cells. Cell morphology showed a well attached and spread phenotype of MSCs cells on chitosan derivative films. On the other hand, due to the higher phenol content of FA-chitosan films, their hydrophobic, antioxidant properties and cell adhesion were improved in comparison with those of EF-chitosan films. Finally, this enzymatic process can be considered as a promising process to favor MSCs cell growth as well as to create useful biomaterials for biomedical applications especially for tissue engineering. (c) 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:491-500, 2016
C1 [Aljawish, Abdulhadi; Muniglia, Lionel] Univ Lorraine, Lab Ingn Biomol LIBio, TSA40602, F-54518 Vandoeuvre Les Nancy, France.
   [Chevalot, Isabelle] Univ Lorraine, Lab React & Genie Proc, TSA40602, LRGP,CNRS,UMR 7274, F-54518 Vandoeuvre Les Nancy, France.
RP Chevalot, I (reprint author), Univ Lorraine, Lab React & Genie Proc, TSA40602, LRGP,CNRS,UMR 7274, F-54518 Vandoeuvre Les Nancy, France.
EM isabelle.chevalot@univ-lorraine.fr
FU Forest Ecosystems, Agricultural Resources, Food and Bioprocess (EFABA)
   program, Lorraine University, France
FX The authors gratefully acknowledge financial support from Forest
   Ecosystems, Agricultural Resources, Food and Bioprocess (EFABA) program,
   Lorraine University, France.
CR Aljawish A, 2015, J MOL CATAL B-ENZYM, V112, P25, DOI 10.1016/j.molcatb.2014.10.014
   Aljawish A, 2014, PROCESS BIOCHEM, V49, P863, DOI 10.1016/j.procbio.2014.02.001
   Aljawish A, 2014, FOOD CHEM, V161, P279, DOI 10.1016/j.foodchem.2014.03.076
   Aljawish A, 2012, CARBOHYD POLYM, V87, P537, DOI 10.1016/j.carbpol.2011.08.016
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bettini R, 2008, EUR J PHARM BIOPHARM, V68, P74, DOI 10.1016/j.ejpb.2007.03.026
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Boo L, 2011, J MATER SCI-MATER M, V22, P1343, DOI 10.1007/s10856-011-4294-7
   Bozic M, 2012, CARBOHYD POLYM, V87, P2388, DOI 10.1016/j.carbpol.2011.11.006
   Breyner NM, 2010, CELLS TISSUES ORGANS, V191, P119, DOI 10.1159/000231472
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chang J, 2012, CELL PROLIFERAT, V45, P430, DOI 10.1111/j.1365-2184.2012.00836.x
   Chen CH, 2007, J APPL POLYM SCI, V105, P1086, DOI 10.1002/app.26257
   Chen XG, 2006, BIOCHEM ENG J, V27, P269, DOI 10.1016/j.bej.2005.08.021
   Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586
   Custodio C, 2014, J TISSUE ENG REGEN M, V8, P160
   Ebert R, 2006, STEM CELLS, V24, P1226, DOI 10.1634/stemcells.2005-0117
   Ferrari C, 2014, APPL BIOCHEM BIOTECH, V172, P1004, DOI 10.1007/s12010-013-0586-3
   Ferrari C, 2012, BIOTECHNOL PROGR, V28, P780, DOI 10.1002/btpr.1527
   Ferruti P, 1998, MACROMOL CHEM PHYSIC, V199, P2565, DOI 10.1002/(SICI)1521-3935(19981101)199:11<2565::AID-MACP2565>3.0.CO;2-G
   Fluri DA, 2012, NAT METHODS, V9, P509, DOI [10.1038/NMETH.1939, 10.1038/nmeth.1939]
   Fortier LA, 2005, VET SURG, V34, P415, DOI 10.1111/j.1532-950X.2005.00063.x
   Frauenschuh S, 2007, BIOTECHNOL PROGR, V23, P187, DOI 10.1021/bp060155w
   Gao J, 2007, P I MECH ENG H, V221, P441, DOI 10.1243/09544119JEIM257
   Godara P, 2008, J CHEM TECHNOL BIOT, V83, P408, DOI 10.1002/jctb.1918
   Helder MN, 2007, TISSUE ENG, V13, P1799, DOI 10.1089/ten.2006.0165
   Holmes C. A., 2011, J BIOMED MATER RES A, V100A, P518
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Kanatt SR, 2008, FOOD CHEM, V107, P845, DOI 10.1016/j.foodchem.2007.08.088
   Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Li JJ, 2010, J BIOMED MATER RES B, V95B, P308, DOI 10.1002/jbm.b.31715
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liu HN, 2008, ACTA BIOMATER, V4, P1472, DOI 10.1016/j.actbio.2008.02.025
   Liu JY, 2004, WOUND REPAIR REGEN, V12, P148, DOI 10.1111/j.1067-1927.2004.012205.x
   Maher S, 2006, BIOCHEM PHARMACOL, V71, P1289, DOI 10.1016/j.bcp.2006.01.012
   Malda J, 2003, BIOMATERIALS, V24, P5153, DOI 10.1016/S0142-9612(03)00428-9
   Maurstad G, 2007, BIOMACROMOLECULES, V8, P1124, DOI 10.1021/bm0610119
   Medrado GCB, 2006, BIOMED MATER, V1, P155, DOI 10.1088/1748-6041/1/3/010
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mustafa R, 2005, FOOD RES INT, V38, P995, DOI 10.1016/j.foodres.2005.02.019
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Neamnark A, 2007, CARBOHYD POLYM, V68, P166, DOI 10.1016/j.carbpol.2006.07.024
   Nenadis N, 2003, J AGR FOOD CHEM, V51, P1874, DOI 10.1021/jf0261452
   Phuc PV, 2012, CELL TISSUE BANK, V13, P341, DOI 10.1007/s10561-011-9262-4
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Ralph J, 1998, J AGR FOOD CHEM, V46, P2531, DOI 10.1021/jf980123r
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Sart S, 2009, J BIOTECHNOL, V139, P291, DOI 10.1016/j.jbiotec.2008.12.011
   Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Tsai WB, 2013, J TAIWAN INST CHEM E, V44, P1, DOI 10.1016/j.jtice.2012.09.003
   Tsai WB, 2012, CARBOHYD POLYM, V89, P379, DOI 10.1016/j.carbpol.2012.03.017
   Uygun BE, 2010, ACTA BIOMATER, V6, P2126, DOI 10.1016/j.actbio.2009.11.018
   VIENKEN J, 1995, ARTIF ORGANS, V19, P398, DOI 10.1111/j.1525-1594.1995.tb02349.x
   Wang PY, 2009, J BIOMED MATER RES B, V91B, P143, DOI 10.1002/jbm.b.31384
   Wang PY, 2009, J BIOMATER APPL, V23, P347, DOI 10.1177/0885328208093684
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   WESTERGREN I, 1993, ACTA PHYSIOL SCAND, V149, P99, DOI 10.1111/j.1748-1716.1993.tb09597.x
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yang JL, 2011, J BIOMAT SCI-POLYM E, V22, P919, DOI 10.1163/092050610X496396
   Yue JH, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0906-3
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhao GF, 2015, STEM CELL RES THER, V6, P31
   Zhuang PY, 2012, INT J BIOL MACROMOL, V50, P658, DOI 10.1016/j.ijbiomac.2012.01.026
NR 73
TC 5
Z9 5
U1 2
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
EI 1520-6033
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD MAR-APR
PY 2016
VL 32
IS 2
BP 491
EP 500
DI 10.1002/btpr.2216
PG 10
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA DK2VG
UT WOS:000374771900027
PM 26701830
DA 2018-10-20
ER

PT J
AU Naikoo, GA
   Thomas, M
   Ganaie, MA
   Sheikh, MUD
   Bano, M
   Hassan, IU
   Khan, F
AF Naikoo, Gowhar Ahmad
   Thomas, Molly
   Ganaie, Mohd. Anis
   Sheikh, Mehraj Ud Din
   Bano, Mustri
   Hassan, Israr Ul
   Khan, Farid
TI Hierarchically macroporous silver monoliths using Pluronic F127: Facile
   synthesis, characterization and its application as an efficient
   biomaterial for pathogens
SO JOURNAL OF SAUDI CHEMICAL SOCIETY
LA English
DT Article
DE Macroporous; Biomaterials; Pathogens; Pluronic F127
ID ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ESCHERICHIA-COLI;
   CATALYTIC PERFORMANCE; GOLD NANOPARTICLES; GREEN SYNTHESIS;
   NANOCOMPOSITES; IRRADIATION; PARTICLES; OXIDE
AB Herein we report the facile synthesis of three dimensional macroporous (MP) silver monoliths serving as intelligent biomaterials against Gram negative (Escherichia coli, Salmonella typhimurium) and Gram positive (Bacillus subtilis) bacteria with more efficacy against Gram negative bacteria. The macroporous silver monoliths were examined by Fourier transform infra red (FTIR) spectroscopy, thermogravimetric analysis (TGA), X-ray diffraction (XRD) study, field emission scanning electron microscopy (FESEM), energy dispersion X-ray spectroscopy analysis (EDX) and Brunauer-Emmet-Teller (BET) adsorption technique. From the antibacterial activity results, it was concluded that macroporous silver monoliths can serve as efficient disinfection agents. The enhanced antibacterial properties of macroporous silver monoliths was possibly due to high surface free energy of the surface Ag+ atoms leading to cell membrane damage followed by cell death. (C) 2015 King Saud University. Production and hosting by Elsevier B.V.
C1 [Naikoo, Gowhar Ahmad; Thomas, Molly; Sheikh, Mehraj Ud Din; Bano, Mustri; Khan, Farid] Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Nanomat Discovery Lab, Sagar 470003, MP, India.
   [Ganaie, Mohd. Anis] Univ Fed Sergipe, Lab Flavor & Chromatog Anal, BR-49000000 Sao Cristovao, Brazil.
   [Naikoo, Gowhar Ahmad; Hassan, Israr Ul] Dhofar Univ, Dept Math & Sci, Coll Arts & Appl Sci, Salalah, Oman.
RP Naikoo, GA (reprint author), Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Nanomat Discovery Lab, Sagar 470003, MP, India.
EM gowhar@du.edu.om; faridkhan58@yahoo.com
RI BANO, MUSTRI/R-1739-2017; THOMAS, MOLLY/C-9457-2017
OI BANO, MUSTRI/0000-0003-3993-9763; THOMAS, MOLLY/0000-0002-4723-5427;
   Naikoo, Gowhar/0000-0003-2276-6878; KHAN, FARID/0000-0002-6511-6050
FU UGC New Delhi through Central University Fellowship (CUF); UGC; National
   Council for Scientific and Technological Development, Brazil
FX GAN and MUDS acknowledge UGC New Delhi for financial assistance through
   Central University Fellowship (CUF) and MT acknowledges UGC for Rajiv
   Gandhi National Fellowship (RGNF). MAG is thankful to National Council
   for Scientific and Technological Development, Brazil for providing Post
   doctorate fellowship (Science without Border) and Department of Zoology,
   Dr. Hari Singh Gour University, Sagar, for antibacterial activities.
   Authors also acknowledge Head, Department of Chemistry, and
   Sophisticated Instrument Centre (SIC) Dr. Hari Singh Gour Central
   University, Sagar, for providing the necessary facilities to carry out
   this research work.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Aymonier C, 2002, CHEM COMMUN, P3018, DOI 10.1039/b208575e
   Banerjee M, 2011, NANOSCALE, V3, P5120, DOI 10.1039/c1nr10703h
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Cullity B.D., 1956, ELEMENTS XRAY DIFFRA
   Danilczuk M, 2006, SPECTROCHIM ACTA A, V63, P189, DOI 10.1016/j.saa.2005.05.002
   Dar RA, 2015, ELECTROCHIM ACTA, V163, P196, DOI 10.1016/j.electacta.2015.02.123
   Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542
   John R, 2009, CHALCOGENIDE LETT, V6, P535
   Khan F, 2007, SOLID STATE SCI, V9, P27, DOI 10.1016/j.solidstatesciences.2006.11.002
   Khan F, 2009, J PHYS CHEM C, V113, P19871, DOI 10.1021/jp9076068
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2
   Kumar VS, 2004, J MOL CATAL A-CHEM, V223, P313, DOI 10.1016/j.molcata.2003.09.047
   Liu YX, 2012, NANOSCALE, V4, P2317, DOI 10.1039/c2nr12046a
   Mallick K, 2004, J MATER SCI, V39, P4459, DOI 10.1023/B:JMSC.0000034138.80116.50
   Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6
   Melaiye A, 2005, J AM CHEM SOC, V127, P2285, DOI 10.1021/ja040226s
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Naiko GA, 2014, J MATER CHEM A, V2, P11792, DOI 10.1039/c3ta14977c
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Perelshtein I, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245705
   Petrochenko P.E., 2013, BIOMATTER, DOI e25528-1-e25528-7
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Rodriguez-Sanchez L, 2000, J PHYS CHEM B, V104, P9683, DOI 10.1021/jp001761r
   Shameli K, 2010, INT J NANOMED, V5, P1067, DOI 10.2147/IJN.S15033
   Shameli K, 2010, INT J NANOMED, V5, P875, DOI 10.2147/IJN.S13632
   Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Subhankari I., 2013, WORLD J NANOSCI TECH, V2, P10, DOI DOI 10.5829/ID0SI.WJNST.2013.2.1.21133
   Sun FQ, 2005, ADV MATER, V17, P2872, DOI 10.1002/adma.200500936
   Theivasanthi A. M., 2010, ARCH PHYS RES, V1, P112
   Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068
   Walsh D, 2003, NAT MATER, V2, P386, DOI 10.1038/nmat903
   Wei YC, 2012, J CATAL, V287, P13, DOI 10.1016/j.jcat.2011.11.006
   Wei YC, 2011, ENERG ENVIRON SCI, V4, P2959, DOI 10.1039/c0ee00813c
   Xia BY, 2012, ANGEW CHEM INT EDIT, V51, P7213, DOI 10.1002/anie.201201553
   Yan J, 2010, J POWER SOURCES, V195, P3041, DOI 10.1016/j.jpowsour.2009.11.028
   Yin HB, 2004, MATER CHEM PHYS, V83, P66, DOI 10.1016/j.matchemphys.2003.09.006
   Zhang C, 2013, CRYSTENGCOMM, V15, P3965, DOI 10.1039/c3ce00053b
   Zhang HL, 2012, J COLLOID INTERF SCI, V380, P16, DOI 10.1016/j.jcis.2012.04.059
   Zhou L, 2012, ANGEW CHEM INT EDIT, V51, P239, DOI 10.1002/anie.201106998
NR 42
TC 2
Z9 2
U1 3
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1319-6103
EI 2212-4640
J9 J SAUDI CHEM SOC
JI J. Saudi Chem. Soc.
PD MAR
PY 2016
VL 20
IS 2
BP 237
EP 244
DI 10.1016/j.jscs.2015.12.002
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DK4OT
UT WOS:000374898700015
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Ho, KN
   Salamanca, E
   Chang, KC
   Shih, TC
   Chang, YC
   Huang, HM
   Teng, NC
   Lin, CT
   Feng, SW
   Chang, WJ
AF Ho, Ko-Ning
   Salamanca, Eisner
   Chang, Kuo-Chi
   Shih, Tsai-Chin
   Chang, Yu-Chi
   Huang, Haw-Ming
   Teng, Nai-Chia
   Lin, Che-Tong
   Feng, Sheng-Wei
   Chang, Wei-Jen
TI A Novel HA/beta-TCP-Collagen Composite Enhanced New Bone Formation for
   Dental Extraction Socket Preservation in Beagle Dogs
SO MATERIALS
LA English
DT Article
DE hydroxyapatite; beta-tricalcium phosphate; composite; collagen;
   allograft; socket preservation; animal study
ID ALVEOLAR RIDGE PRESERVATION; TOOTH EXTRACTION; TRICALCIUM PHOSPHATE;
   CALCIUM-PHOSPHATE; BIOCERAMIC IMPLANTS; SCAFFOLDS; GROWTH; BIOMATERIALS;
   REGENERATION; METAANALYSIS
AB Past studies in humans have demonstrated horizontal and vertical bone loss after six months following tooth extraction. Many biomaterials have been developed to preserve bone volume after tooth extraction. Type I collagen serves as an excellent delivery system for growth factors and promotes angiogenesis. Calcium phosphate ceramics have also been investigated because their mineral chemistry resembles human bone. The aim of this study was to compare the performance of a novel bioresorbable purified fibrillar collagen and hydroxyapatite/-tricalcium phosphate (HA/-TCP) ceramic composite versus collagen alone and a bovine xenograft-collagen composite in beagles. Collagen plugs, bovine graft-collagen composite and HA/-TCP-collagen composite were implanted into the left and right first, second and third mandibular premolars, and the fourth molar was left empty for natural healing. In total, 20 male beagle dogs were used, and quantitative and histological analyses of the extraction ridge was done. The smallest width reduction was 19.09% +/- 8.81% with the HA/-TCP-collagen composite at Week 8, accompanied by new bone formation at Weeks 4 and 8. The HA/-TCP-collagen composite performed well, as a new osteoconductive and biomimetic composite biomaterial, for socket bone preservation after tooth extraction.
C1 [Ho, Ko-Ning; Salamanca, Eisner; Shih, Tsai-Chin; Chang, Yu-Chi; Teng, Nai-Chia; Lin, Che-Tong; Feng, Sheng-Wei; Chang, Wei-Jen] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan.
   [Chang, Kuo-Chi] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei 106, Taiwan.
   [Huang, Haw-Ming] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei 110, Taiwan.
   [Teng, Nai-Chia; Lin, Che-Tong] Taipei Med Univ Hosp, Dept Dent, Taipei 110, Taiwan.
   [Chang, Wei-Jen] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei 235, Taiwan.
RP Chang, WJ (reprint author), Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan.; Chang, WJ (reprint author), Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei 235, Taiwan.
EM d204097003@tmu.edu.tw; eisnergab@hotmail.com; hu2637@yahoo.com.tw;
   newdent.clinic@msa.hinet.net; ivytainan@hotmail.com; hhm@tmu.edu.tw;
   dianaten@tmu.edu.tw; chetong@tmu.edu.tw; b8702070@tmu.edu.tw;
   cweijen1@tmu.edu.tw
FU Taipei Medical University [99-TMU-IAC-021]
FX This study has been founded by the grant from Taipei Medical University
   99-TMU-IAC-021. Authors would like to thank Enago (www.enago.tw) for the
   English language review.
CR Albee FH, 1920, ANN SURG, V71, P32
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Avila-Ortiz G, 2014, J DENT RES, V93, P950, DOI 10.1177/0022034514541127
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Behnia H, 2013, OR SURG OR MED OR PA, V115, pE7, DOI 10.1016/j.oooo.2011.09.034
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   De Risi V, 2015, CLIN ORAL IMPLAN RES, V26, P50, DOI 10.1111/clr.12288
   Santis R, 2013, POLYM COMPOSITE, V34, P1413, DOI 10.1002/pc.22446
   De Santis R, 2015, J BIOMED NANOTECHNOL, V11, P1236, DOI 10.1166/jbn.2015.2065
   DENISSEN HW, 1979, J PROSTHET DENT, V42, P551, DOI 10.1016/0022-3913(79)90253-1
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Ebrahimi M, 2012, J BIOMED MATER RES A, V100A, P2260, DOI 10.1002/jbm.a.34160
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Han T, 1984, J West Soc Periodontol Periodontal Abstr, V32, P88
   Hoffmann O, 2008, J PERIODONTOL, V79, P1355, DOI 10.1902/jop.2008.070502 
   John A, 2003, J BIOMATER APPL, V18, P63, DOI 10.1177/088532803032826
   Khan SN, 2000, ORTHOP CLIN N AM, V31, P389, DOI 10.1016/S0030-5898(05)70158-9
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Li JF, 2010, MAT SCI ENG C-MATER, V30, P1272, DOI 10.1016/j.msec.2010.07.011
   Mahesh L, 2015, J ORAL IMPLANTOL, V41, P178, DOI 10.1563/AAID-JOI-D-13-00025
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Molly L, 2008, J PERIODONTOL, V79, P1108, DOI [10.1902/jop.2008.070476, 10.1902/jop.2008.070476 ]
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Patricio T, 2014, RAPID PROTOTYPING J, V20, P145, DOI 10.1108/RPJ-04-2012-0037
   Pietrokovski J, 2007, INT J ORAL MAXILLOF, V16, P141, DOI DOI 10.1111/J.1532-849X.2007.00165.X
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schropp L, 2003, INT J ORAL MAX IMPL, V18, P189
   Susin C, 2013, PERIODONTOL 2000, V62, P232, DOI 10.1111/prd.12003
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
NR 44
TC 1
Z9 1
U1 1
U2 15
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2016
VL 9
IS 3
AR 191
DI 10.3390/ma9030191
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA DI9ER
UT WOS:000373805400038
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cioata, R
   Balan, A
   Antohe, ME
   Savin, C
   Ignat, G
   Basno, A
AF Cioata, Radu
   Balan, Adriana
   Antohe, Magda Ecaterina
   Savin, Carmen
   Ignat, Gabriela
   Basno, Alexandru
TI Researches Regarding New Biomaterials Involved in Sports Mouthguard
SO MATERIALE PLASTICE
LA English
DT Article
DE sports mouthguard; siliconic biomaterials; mathematical analysis;
   antimicrobian effect
ID MECHANICAL-PROPERTIES; SILICA; ABSORPTION; COMPOSITE; BEHAVIOR
AB The aim of this study is to individualize from the structural point of view the silicon materials which lay at the basis of the manufacturing the oral mouth guards in full accordance to the features of the subject who is going to benefit from these devices, a highly important role belonging to the maxillary architecture and the occlusion type. Choosing the election biomaterial for the oral protection gear was done based on mathematical modelling using the Abaqus Standard system, with the aim of evaluating the tensions transmitted at the jaw level by different types of biomaterials which are embedded in the structure of these devices. The biomaterial represents an alternative favorable for the oral protection gear given the degree of elasticity and the possibility of including an antiseptic material, such as Eugenol, important features which individualize it.
C1 [Cioata, Radu; Balan, Adriana; Antohe, Magda Ecaterina; Savin, Carmen; Basno, Alexandru] Grigore T Popa Univ Med & Pharm, Fac Dent Med, 16 Piata Natiunii Str, Iasi 70015, Romania.
   [Ignat, Gabriela] Ion Ionescu de la Brad Univ Agr Sci & Vet Med Ias, 3 M Sadoveanu Alley, Iasi 700490, Romania.
RP Antohe, ME (reprint author), Grigore T Popa Univ Med & Pharm, Fac Dent Med, 16 Piata Natiunii Str, Iasi 70015, Romania.
EM magda.antohe@yahoo.com
CR Alexandru M, 2011, POLYM ENG SCI, V51, P78, DOI 10.1002/pen.21781
   Alexandru M, 2009, HIGH PERFORM POLYM, V21, P379, DOI 10.1177/0954008308094327
   ARANGUREN MI, 1994, RUBBER CHEM TECHNOL, V67, P820, DOI 10.5254/1.3538713
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   Cazacu M, 2008, POLYM INT, V57, P1067, DOI 10.1002/pi.2451
   Cazacu M, 2011, DYES PIGMENTS, V90, P106, DOI 10.1016/j.dyepig.2010.12.012
   Cazacu M, 2009, J COMPOS MATER, V43, P2045, DOI 10.1177/0021998309340447
   Chowdhury RU, 2014, DENT MATER J, V33, P551, DOI 10.4012/dmj.2014-061
   COOPER S.L., 2004, BIOMATERIALS SCIENCE
   FAZAL R., 2014, DENT TRAUMATOL, V30, P193
   GUIU A., 2001, POLYM SCI SER B, V39, P3843
   Hurduc N, 2008, SILICON BASED POLYMERS: ADVANCES IN SYNTHESIS AND SUPRAMOLECULAR ORGANIZATION, P65, DOI 10.1007/978-1-4020-8528-4_6
   Jandt KD, 2009, DENT MATER, V25, P1001, DOI 10.1016/j.dental.2009.02.009
   Moleavin I, 2011, CENT EUR J CHEM, V9, P1117, DOI 10.2478/s11532-011-0102-y
   Ona M, 2010, DENT MATER J, V29, P336, DOI 10.4012/dmj.2009-096
   Picu CR, 2012, MATER PLAST, V49, P133
   PLAZEK DJ, 1971, J POLYM SCI A2, V9, P209, DOI 10.1002/pol.1971.160090202
   Reza F, 2014, DENT TRAUMATOL, V30, P193, DOI 10.1111/edt.12068
   ROLAND CM, 1991, MACROMOLECULES, V24, P5315, DOI 10.1021/ma00019a016
   Stan F, 2011, MATER PLAST, V48, P1
   Vlad A, 2008, EUR POLYM J, V44, P2668, DOI 10.1016/j.eurpolymj.2008.05.014
NR 21
TC 13
Z9 13
U1 1
U2 9
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0025-5289
J9 MATER PLAST
JI Mater. Plast.
PD MAR
PY 2016
VL 53
IS 1
BP 147
EP 149
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA DJ1MI
UT WOS:000373966500034
DA 2018-10-20
ER

PT J
AU Cara-Fuentes, M
   Machuca-Ariza, J
   Ruiz-Martos, A
   Ramos-Robles, MC
   Martinez-Lara, I
AF Cara-Fuentes, Manuel
   Machuca-Ariza, Jesus
   Ruiz-Martos, Alberto
   Ramos-Robles, Ma-Carmen
   Martinez-Lara, Ildefonso
TI Long-term outcome of dental implants after maxillary augmentation with
   and without bone grafting
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Bone formation; sinus membrane elevation; maxillary sinus; bone grafting
ID SINUS MEMBRANE ELEVATION; POSTERIOR MAXILLA; FLOOR AUGMENTATION;
   CLINICAL REPORT; BOVINE BONE; PLACEMENT; INTEGRATION; IMMEDIATE;
   SURVIVAL; LIFT
AB Background: This study aims to evaluate the technique of sinus bone reformation, which consists of elevating the sinus membrane and placement the implant without bone graft, compared with the widely-used technique involving raising the maxillary sinus and grafting, using animal hydroxyapatite as the filler, while simultaneously fixing the implants.
   Material and Methods: This is a retrospective study on two groups of patients who underwent elevation of the sinus membrane and simultaneous placement of the implant. The grafting technique was applied to one group, while the other had no graft. An alveolar ridge height of 4 to 7 mm was necessary. Radiological control was undertaken at 6 months and one year post-prosthetic loading. In each group 38 implants were placed.
   Results: No significant behavioural differences were observed in the implants according to the Albrektsson success criteria. Implant failure was observed in 2 implants from the bone grafting group (success rate 93%) and in 1 implant from the reformation group (success rate 97%). In this group, bone formation was observed on both sides of each implant, the bone gain was measured using image management software (2.7 +/- 0.9mm mesial and 2.6 +/- 0.9mm distal). There was no correlation between mesial and distal bone gain and implant's length.
   Conclusions: The results indicate that bone reformation is a valid technique in cases involving atrophy of the posterior maxilla. Primary stability, maintenance of space by the implant, and the formation of a blood clot are crucial in this technique in order to achieve bone formation around the implant. It is an alternative to the conventional technique of sinus lift with filling material, and has several advantages over this procedure, including a lower infection risk, as it does not involve a biomaterial, reduced cost, a simpler technique, and better acceptance by the patient.
C1 [Ramos-Robles, Ma-Carmen] Sch Dent, Dept Oral Med, Granada, Spain.
   [Martinez-Lara, Ildefonso] Sch Dent, Hlth Sci, Granada, Spain.
RP Cara-Fuentes, M (reprint author), Avda Europa 177, La Mojonera, Almeria, Spain.
EM manolocaraf@gmail.com
CR Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Blomqvist J E, 1996, Int J Oral Maxillofac Implants, V11, P512
   Chen TW, 2007, J ORAL MAXIL SURG, V65, P2324, DOI 10.1016/j.joms.2007.06.649
   Cricchio G, 2014, CLIN IMPLANT DENT R, V16, P609, DOI 10.1111/cid.12035
   Cricchio G, 2011, CLIN ORAL IMPLAN RES, V22, P1200, DOI 10.1111/j.1600-0501.2010.02096.x
   Del Fabbro M, 2008, EUR J ORAL SCI, V116, P497, DOI 10.1111/j.1600-0722.2008.00571.x
   Gabbert O, 2009, J CLIN PERIODONTOL, V36, P177, DOI 10.1111/j.1600-051X.2008.01357.x
   Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.085405.095329
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hatano N, 2007, CLIN IMPLANT DENT R, V9, P150, DOI 10.1111/j.1708-8208.2007.00043.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jeong SM, 2009, ORAL SURG ORAL MED O, V107, P364, DOI 10.1016/j.tripleo.2008.05.032
   Johansson LA, 2012, CLIN IMPLANT DENT R, V14, P575, DOI 10.1111/j.1708-8208.2010.00293.x
   Lundgren S, 2008, PERIODONTOL 2000, V47, P193, DOI 10.1111/j.1600-0757.2008.00264.x
   Lundgren Stefan, 2003, Clin Implant Dent Relat Res, V5, P78, DOI 10.1111/j.1708-8208.2003.tb00187.x
   Lundgren Stefan, 2004, Clin Implant Dent Relat Res, V6, P165, DOI 10.1111/j.1708-8208.2004.tb00217.x
   Mardinger O, 2007, ORAL SURG ORAL MED O, V103, P180, DOI 10.1016/j.tripleo.2006.03.008
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Palma VC, 2006, CLIN IMPLANT DENT R, V8, P11, DOI 10.2310/6480.2005.00026
   SMILER D G, 1992, Dental Clinics of North America, V36, P151
   Sohn DS, 2008, IMPLANT DENT, V17, P321, DOI 10.1097/ID.0b013e318182f01b
   Sohn DS, 2011, IMPLANT DENT, V20, P389, DOI 10.1097/ID.0b013e31822f7a70
   Sohn DS, 2010, J ORAL MAXIL SURG, V68, P1327, DOI 10.1016/j.joms.2010.02.014
   Srouji S, 2009, CALCIFIED TISSUE INT, V84, P138, DOI 10.1007/s00223-008-9202-x
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P713
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Zitzmann NU, 1998, ORAL SURG ORAL MED O, V85, P8, DOI 10.1016/S1079-2104(98)90391-2
NR 29
TC 12
Z9 12
U1 0
U2 6
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD MAR
PY 2016
VL 21
IS 2
BP E229
EP E235
AR 21055
DI 10.4317/medoral.21055
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DJ1AM
UT WOS:000373935500015
PM 26827071
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Kim, K
   Wagner, WR
AF Kim, Kang
   Wagner, William R.
TI Non-invasive and Non-destructive Characterization of Tissue Engineered
   Constructs Using Ultrasound Imaging Technologies: A Review
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE Ultrasound imaging; Noninvasive; Nondestructive; Multi-modality; Tissue
   scaffolds; Regeneration
ID SCANNING ACOUSTIC MICROSCOPY; ORAL MUCOSAL TISSUES; IN-VIVO;
   PHOTOACOUSTIC MICROSCOPY; RADIATION FORCE; HEMODIALYSIS ACCESS; ELASTIC
   PROPERTIES; VIRTUAL HISTOLOGY; SPECKLE TRACKING; VASCULAR GRAFTS
AB With the rapid expansion of biomaterial development and coupled efforts to translate such advances toward the clinic, non-invasive and non-destructive imaging tools to evaluate implants in situ in a timely manner are critically needed. The required multi-level information is comprehensive, including structural, mechanical, and biological changes such as scaffold degradation, mechanical strength, cell infiltration, extracellular matrix formation and vascularization to name a few. With its inherent advantages of non-invasiveness and non-destructiveness, ultrasound imaging can be an ideal tool for both preclinical and clinical uses. In this review, currently available ultrasound imaging technologies that have been applied in vitro and in vivo for tissue engineering and regenerative medicine are discussed and some new emerging ultrasound technologies and multi-modality approaches utilizing ultrasound are introduced.
C1 [Kim, Kang] Univ Pittsburgh, Sch Med, Dept Med, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA.
   [Kim, Kang] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA 15213 USA.
   [Kim, Kang; Wagner, William R.] Univ Pittsburgh, Sch Engn, Dept Bioengn, Pittsburgh, PA 15213 USA.
   [Wagner, William R.] Univ Pittsburgh, Sch Engn, Dept Surg, Pittsburgh, PA 15213 USA.
   [Kim, Kang; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Kim, Kang; Wagner, William R.] UPMC, Pittsburgh, PA 15219 USA.
RP Kim, K (reprint author), Univ Pittsburgh, Sch Med, Dept Med, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA.
EM kangkim@upmc.edu
FU NIH [R21EB013353]
FX This work was supported by NIH R21EB013353.
CR Allen RA, 2014, BIOMATERIALS, V35, P165, DOI 10.1016/j.biomaterials.2013.09.081
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Assmann A, 2012, J SURG RES, V176, P367, DOI 10.1016/j.jss.2011.10.009
   Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425
   Bilgen M, 1996, J ACOUST SOC AM, V99, P3212, DOI 10.1121/1.414865
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2013, TISSUE ENG PART C-ME, V19, P196, DOI [10.1089/ten.tec.2012.0326, 10.1089/ten.TEC.2012.0326]
   Chung E, 2013, INT J NANOMED, V8, P325, DOI 10.2147/IJN.S36711
   Cicciu M, 2014, J CRANIOFAC SURG, V25, P860, DOI 10.1097/SCS.0000000000000830
   Cohn NA, 2000, IEEE T ULTRASON FERR, V47, P956, DOI 10.1109/58.852079
   Cox B, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061202
   Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426
   Deffieux T, 2009, IEEE T MED IMAGING, V28, P313, DOI 10.1109/TMI.2008.925077
   Dutta D, 2013, ULTRASOUND MED BIOL, V39, P2103, DOI 10.1016/j.ultrasmedbio.2013.04.023
   Emelianov SY, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3141939
   Fatemi M, 1999, P NATL ACAD SCI USA, V96, P6603, DOI 10.1073/pnas.96.12.6603
   Feleppa EJ, 2008, CANCER BIOMARK, V4, P201, DOI 10.3233/CBM-2008-44-504
   Fite BZ, 2011, TISSUE ENG PART C-ME, V17, P495, DOI 10.1089/ten.tec.2010.0368
   Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2
   Gessner RC, 2013, BIOMATERIALS, V34, P9341, DOI 10.1016/j.biomaterials.2013.08.033
   GOLUB RM, 1993, J ULTRAS MED, V12, P601
   Gudur MSR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085749
   Hall TJ, 2003, ULTRASOUND MED BIOL, V29, P427, DOI 10.1016/S0301-5629(02)00733-0
   Herford Alan S, 2007, J Calif Dent Assoc, V35, P335
   Herford AS, 2012, INT J ORAL MAX IMPL, V27, P1351
   Hibino N, 2012, J THORAC CARDIOV SUR, V143, P696, DOI 10.1016/j.jtcvs.2011.06.046
   Kang KT, 2011, BLOOD, V118, P6718, DOI 10.1182/blood-2011-08-375188
   Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim K, 2008, ULTRASOUND MED BIOL, V34, P902, DOI 10.1016/j.ultrasmedbio.2007.11.020
   Kim S, 2011, BIOMED OPT EXPRESS, V2, P2540, DOI 10.1364/BOE.2.002540
   Konofagou E, 1998, ULTRASOUND MED BIOL, V24, P1183, DOI 10.1016/S0301-5629(98)00109-4
   Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.tec.2010.0669, 10.1089/ten.TEC.2010.0669]
   Kumar VA, 2013, ACTA BIOMATER, V9, P8067, DOI 10.1016/j.actbio.2013.05.024
   Lee IS, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-25
   Lee WK, 2003, J BIOMED MATER RES A, V67A, P1087, DOI 10.1002/jbm.a.10570
   Lerner R. M., 1988, Acoustical Imaging. Vol.19. Proceedings of the 16th International Symposium, P317
   Lizzi FL, 1997, INT J IMAG SYST TECH, V8, P3, DOI 10.1002/(SICI)1098-1098(1997)8:1<3::AID-IMA2>3.0.CO;2-E
   Lubinski MA, 1999, IEEE T ULTRASON FERR, V46, P82, DOI 10.1109/58.741427
   Luke GP, 2012, ANN BIOMED ENG, V40, P422, DOI 10.1007/s10439-011-0449-4
   Lyshchik A, 2007, RADIOLOGY, V243, P258, DOI 10.1148/radiol.2431052032
   Martinez-Diaz S, 2010, AM J SPORT MED, V38, P509, DOI 10.1177/0363546509352448
   Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760
   Maurice RL, 2007, ULTRASOUND MED BIOL, V33, P1199, DOI 10.1016/j.ultrasmedbio.2007.01.018
   McAleavey S, 2009, ULTRASONIC IMAGING, V31, P217, DOI 10.1177/016173460903100401
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Mercado KP, 2014, ANN BIOMED ENG, V42, P1292, DOI 10.1007/s10439-014-0994-8
   Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E
   Nam SY, 2015, TISSUE ENG PART B-RE, V21, P88, DOI [10.1089/ten.TEB.2014.0180, 10.1089/ten.teb.2014.0180]
   Nam SY, 2012, OPT LETT, V37, P4708, DOI 10.1364/OL.37.004708
   Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267
   Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044
   Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093
   Nguyen MM, 2014, IEEE INT ULTRA SYM, P325, DOI 10.1109/ULTSYM.2014.0080
   Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008
   Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   ODONNELL M, 1994, IEEE T ULTRASON FERR, V41, P314, DOI 10.1109/58.285465
   OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W
   Pan D, 2011, FASEB J, V25, P875, DOI 10.1096/fj.10-171728
   Park DW, 2014, BIOMATERIALS, V35, P7851, DOI 10.1016/j.biomaterials.2014.05.088
   Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023
   Quint C, 2012, J VASC SURG, V55, P790, DOI 10.1016/j.jvs.2011.07.098
   Ribbers H, 2007, ULTRASOUND MED BIOL, V33, P530, DOI 10.1016/j.ultrasmedbio.2006.09.009
   Rice MA, 2009, ACTA BIOMATER, V5, P152, DOI 10.1016/j.actbio.2008.07.036
   Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354
   Rouze NC, 2010, IEEE T ULTRASON FERR, V57, P2662, DOI 10.1109/TUFFC.2010.1740
   Rubin JM, 2006, J ULTRAS MED, V25, P1179, DOI 10.7863/jum.2006.25.9.1179
   Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0
   SKOVORODA AR, 1994, IEEE T ULTRASON FERR, V41, P302, DOI 10.1109/58.285463
   Sun Y, 2012, TISSUE ENG PART C-ME, V18, P215, DOI [10.1089/ten.tec.2011.0343, 10.1089/ten.TEC.2011.0343]
   Talukdar Y, 2014, TISSUE ENG PART C-ME, V20, P440, DOI [10.1089/ten.tec.2013.0203, 10.1089/ten.TEC.2013.0203]
   Tanaka Y, 2012, J BIOSCI BIOENG, V113, P252, DOI 10.1016/j.jbiosc.2011.10.011
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tillman BW, 2012, J VASC SURG, V56, P783, DOI 10.1016/j.jvs.2012.02.030
   Tsuji W, 2013, J ARTIF ORGANS, V16, P110, DOI 10.1007/s10047-012-0670-4
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210
   Weber M, 2014, TISSUE ENG PART C-ME, V20, P265, DOI [10.1089/ten.TEC.2013.0258, 10.1089/ten.tec.2013.0258]
   Wells PNT, 2006, PHYS MED BIOL, V51, pR83, DOI 10.1088/0031-9155/51/13/R06
   Weyhe D, 2007, WORLD J SURG, V31, P234, DOI 10.1007/s00268-006-0123-4
   Winterroth F, 2013, TISSUE ENG PART C-ME, V19, P345, DOI [10.1089/ten.tec.2012.0467, 10.1089/ten.TEC.2012.0467]
   Winterroth F, 2011, ULTRASOUND MED BIOL, V37, P1734, DOI 10.1016/j.ultrasmedbio.2011.06.010
   Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821
   Wystrychowski W, 2014, J VASC SURG, V60, P1353, DOI 10.1016/j.jvs.2013.08.018
   Yoshikawa M, 2008, KEY ENG MATER, V361-363, P1185, DOI 10.4028/www.scientific.net/KEM.361-363.1185
   Yu J, 2013, BIOMATERIALS, V34, P2701, DOI 10.1016/j.biomaterials.2013.01.036
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V50, P7359, DOI 10.1002/anie.201101659
   Zhang Y, 2010, BIOMATERIALS, V31, P8651, DOI 10.1016/j.biomaterials.2010.07.089
   Zhang YS, 2014, ANGEW CHEM INT EDIT, V53, P184, DOI 10.1002/anie.201306282
NR 91
TC 3
Z9 3
U1 3
U2 32
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 621
EP 635
DI 10.1007/s10439-015-1495-0
PG 15
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900002
PM 26518412
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, YS
   Wang, LV
   Xia, YN
AF Zhang, Yu Shrike
   Wang, Lihong V.
   Xia, Younan
TI Seeing Through the Surface: Non-invasive Characterization of
   Biomaterial-Tissue Interactions Using Photoacoustic Microscopy
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Photoacoustic microscopy; Biomedical imaging; Tissue engineering;
   Regenerative medicine; Non-invasive
ID IN-VIVO; ENGINEERING SCAFFOLDS; REGENERATIVE MEDICINE; FLUORESCENT
   PROTEINS; OXYGEN-SATURATION; GOLD NANOCAGES; TOMOGRAPHY; RESOLUTION;
   VITRO; DEGRADATION
AB At the intersection of life sciences, materials science, engineering, and medicine, regenerative medicine stands out as a rapidly progressing field that aims at retaining, restoring, or augmenting tissue/organ functions to promote the human welfare. While the field has witnessed tremendous advancements over the past few decades, it still faces many challenges. For example, it has been difficult to visualize, monitor, and assess the functions of the engineered tissue/organ constructs, particularly when three-dimensional scaffolds are involved. Conventional approaches based on histology are invasive and therefore only convey end-point assays. The development of volumetric imaging techniques such as confocal and ultrasonic imaging has enabled direct observation of intact constructs without the need of sectioning. However, the capability of these techniques is often limited in terms of penetration depth and contrast. In comparison, the recently developed photoacoustic microscopy (PAM) has allowed us to address these issues by integrating optical and ultrasonic imaging to greatly reduce the effect of tissue scattering of photons with one-way ultrasound detection while retaining the high optical absorption contrast. PAM has been successfully applied to a number of studies, such as observation of cell distribution, monitoring of vascularization, and interrogation of biomaterial degradation. In this review article, we highlight recent progress in non-invasive and volumetric characterization of biomaterial-tissue interactions using PAM. We also discuss challenges ahead and envision future directions.
C1 [Zhang, Yu Shrike] Harvard Univ, Brigham & Womens Hosp, Sch Med, Biomat Innovat Res Ctr,Dept Med, Boston, MA 02115 USA.
   [Zhang, Yu Shrike] MIT, Harvard Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Zhang, Yu Shrike] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Wang, Lihong V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Xia, Younan] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Xia, Younan] Emory Univ, Atlanta, GA 30332 USA.
   [Xia, Younan] Georgia Inst Technol, Sch Chem & Biomol Engn, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Wang, LV (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Xia, YN (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Xia, YN (reprint author), Emory Univ, Atlanta, GA 30332 USA.
EM lhwang@wustl.edu; younan.xia@bme.gatech.edu
RI Xia, Younan/E-8499-2011
OI Wang, Lihong/0000-0001-9783-4383
FU Georgia Institute of Technology; NIH [DP1 OD000798, R01 AR060820]
FX This work was supported in part by startup funds from the Georgia
   Institute of Technology and NIH Grants DP1 OD000798 (NIH Director's
   Pioneer Award) and R01 AR060820. The authors would like to thank Dr. Yu
   Wang and Dr. Li Li for their assistance in OR-PAM-FCM and OR-PAM-OCT
   imaging of melanoma cell-scaffold interactions.
CR Allen TJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061209
   [Anonymous], 2005, DISC COL GUID MULT A
   Appel A, 2011, TISSUE ENG PART B-RE, V17, P321, DOI [10.1089/ten.teb.2011.0230, 10.1089/ten.TEB.2011.0230]
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688
   Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028
   Brunker J, 2012, J ACOUST SOC AM, V132, P1780, DOI 10.1121/1.4739458
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2013, TISSUE ENG PART C-ME, V19, P196, DOI [10.1089/ten.tec.2012.0326, 10.1089/ten.TEC.2012.0326]
   Cai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043999
   Cai X, 2012, TISSUE ENG PART C-ME, V18, P310, DOI [10.1089/ten.tec.2011.0519, 10.1089/ten.TEC.2011.0519]
   Chatni M. R., 2012, J BIOMED OPT, V17
   Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088
   Cho EC, 2009, J PHYS CHEM C, V113, P9023, DOI 10.1021/jp903343p
   Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107
   Del Guerra A, 2007, NUCL INSTRUM METH A, V583, P119, DOI 10.1016/j.nima.2007.08.187
   DURNIN J, 1988, OPT LETT, V13, P79, DOI 10.1364/OL.13.000079
   Favazza CP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528661
   Fernandez-Lopez C, 2015, ACS APPL MATER INTER, V7, P12530, DOI 10.1021/am5087209
   Filonov GS, 2012, ANGEW CHEM INT EDIT, V51, P1448, DOI 10.1002/anie.201107026
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gottschalk S, 2015, J CEREBR BLOOD F MET, V35, P531, DOI 10.1038/jcbfm.2014.249
   HORWITZ JP, 1964, J MED CHEM, V7, P574, DOI 10.1021/jm00334a044
   Hu S, 2011, OPT LETT, V36, P1134, DOI 10.1364/OL.36.001134
   Jansen K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.026006
   Jathoul AP, 2015, NAT PHOTONICS, V9, P239, DOI [10.1038/NPHOTON.2015.22, 10.1038/nphoton.2015.22]
   Kim C, 2010, CHEM REV, V110, P2756, DOI 10.1021/cr900266s
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464
   Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677
   Krumholz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03939
   Krumholz A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606568
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laufer J, 2013, BIOMED OPT EXPRESS, V4, P2477, DOI 10.1364/BOE.4.002477
   Li L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717531
   Li L, 2008, J INNOV OPT HEAL SCI, V1, P207, DOI 10.1142/S1793545808000212
   Li L, 2009, OPT EXPRESS, V17, P16450, DOI 10.1364/OE.17.016450
   Li ML, 2006, OPT LETT, V31, P474, DOI 10.1364/OL.31.000474
   Liao CK, 2004, OPT LETT, V29, P2506, DOI 10.1364/OL.29.002506
   Liu Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126014
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MANSOUR SL, 1990, P NATL ACAD SCI USA, V87, P7688, DOI 10.1073/pnas.87.19.7688
   Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/nmeth.1483, 10.1038/NMETH.1483]
   Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566
   O'Donnell M, 2013, ANN BIOMED ENG, V41, P2237, DOI 10.1007/s10439-013-0901-8
   Peptan IA, 2006, TISSUE ENG, V12, P843, DOI 10.1089/ten.2006.12.843
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Rajian JR, 2013, J PHYS CHEM LETT, V4, P3211, DOI 10.1021/jz401638e
   Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98
   SEIDLER E, 1991, PROG HISTOCHEM CYTOC, V24, P1
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Song KH, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818045
   Song Yi, 2013, J Pathol Inform, V4, pS7, DOI 10.4103/2153-3539.109864
   Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034
   Talukdar Y, 2014, TISSUE ENG PART C-ME, V20, P440, DOI [10.1089/ten.tec.2013.0203, 10.1089/ten.TEC.2013.0203]
   Taruttis A, 2015, NAT PHOTONICS, V9, P219, DOI 10.1038/nphoton.2015.29
   Wang B, 2012, OPT LETT, V37, P1244, DOI 10.1364/OL.37.001244
   WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F
   Wang LD, 2013, P NATL ACAD SCI USA, V110, P5759, DOI [10.1073/pnas.1215578110, 10.1073/pnas.121578110]
   Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210
   Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157
   Wang P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06889
   Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839
   Wang Y, 2011, OPT LETT, V36, P1029, DOI 10.1364/OL.36.001029
   Wang Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525643
   Xia YN, 2011, ACCOUNTS CHEM RES, V44, P914, DOI 10.1021/ar200061q
   Yao J., 2011, J BIOMED OPT, V16
   Yao JJ, 2013, LASER PHOTONICS REV, V7, P758, DOI 10.1002/lpor.201200060
   Yuste R, 2005, NAT METHODS, V2, P902, DOI 10.1038/nmeth1205-902
   Zhang C, 2010, OPT LETT, V35, P3195, DOI 10.1364/OL.35.003195
   Zhang HF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435697
   Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V50, P7359, DOI 10.1002/anie.201101659
   Zhang Y, 2010, BIOMATERIALS, V31, P8651, DOI 10.1016/j.biomaterials.2010.07.089
   Zhang YS, 2015, NANOMEDICINE-UK, V10, P689, DOI [10.2217/NNM.15.10, 10.2217/nnm.15.10]
   Zhang YS, 2014, ANGEW CHEM INT EDIT, V53, P8099, DOI 10.1002/anie.201403812
   Zhang YS, 2014, ANGEW CHEM INT EDIT, V53, P184, DOI 10.1002/anie.201306282
   Zhang YS, 2013, SOFT MATTER, V9, P9747, DOI 10.1039/c3sm52063c
   Zhang YS, 2013, THERANOSTICS, V3, P532, DOI 10.7150/thno.5369
NR 81
TC 5
Z9 5
U1 5
U2 40
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 649
EP 666
DI 10.1007/s10439-015-1485-2
PG 18
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900004
PM 26471785
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ozturk, MS
   Chen, CW
   Ji, R
   Zhao, LL
   Nguyen, BNB
   Fisher, JP
   Chen, Y
   Intes, X
AF Ozturk, Mehmet S.
   Chen, Chao-Wei
   Ji, Robin
   Zhao, Lingling
   Nguyen, Bao-Ngoc B.
   Fisher, John P.
   Chen, Yu
   Intes, Xavier
TI Mesoscopic Fluorescence Molecular Tomography for Evaluating Engineered
   Tissues
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Laminar optical tomography (LOT); Fluorescence laminar optical
   tomography (FLOT); Mesoscopic fluorescence molecular tomography (MFMT);
   Tissue engineering; Non-destructive imaging; Bioprinting; Optical
   imaging; In vivo imaging
ID LAMINAR OPTICAL TOMOGRAPHY; TUBULAR PERFUSION SYSTEM; MONTE-CARLO
   METHODS; COHERENCE TOMOGRAPHY; IMAGE-RECONSTRUCTION; TURBID MEDIA;
   PHOTON MIGRATION; SCAFFOLDS; ALGINATE; MICROSCOPY
AB Optimization of regenerative medicine strategies includes the design of biomaterials, development of cell-seeding methods, and control of cell-biomaterial interactions within the engineered tissues. Among these steps, one paramount challenge is to non-destructively image the engineered tissues in their entirety to assess structure, function, and molecular expression. It is especially important to be able to enable cell phenotyping and monitor the distribution andmigration of cells throughout the bulk scaffold. Advanced fluorescence microscopic techniques are commonly employed to perform such tasks; however, they are limited to superficial examination of tissue constructs. Therefore, the field of tissue engineering and regenerative medicine would greatly benefit from the development of molecular imaging techniques which are capable of non-destructive imaging of three-dimensional cellular distribution and maturation within a tissue-engineered scaffold beyond the limited depth of current microscopic techniques. In this review, we focus on an emerging depth-resolved optical mesoscopic imaging technique, termed laminar optical tomography (LOT) or mesoscopic fluorescence molecular tomography (MFMT), which enables longitudinal imaging of cellular distribution in thick tissue engineering constructs at depths of a fewmillimeters and with relatively high resolution. The physical principle, image formation, and instrumentation of LOT/MFMT systems are introduced. Representative applications in tissue engineering include imaging the distribution of human mesenchymal stemcells embedded in hydrogels, imaging of bioprinted tissues, and in vivo applications.
C1 [Ozturk, Mehmet S.; Ji, Robin; Zhao, Lingling; Intes, Xavier] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Chen, Chao-Wei; Nguyen, Bao-Ngoc B.; Fisher, John P.; Chen, Yu] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Chen, Y (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM yuchen@umd.edu; intesx@rpi.edu
FU NIH [R01 EB014946-01A1]; NSF [CBET-1263455]
FX This work is supported by the NIH R01 EB014946-01A1 (YC) and NSF
   CBET-1263455 (XI).
CR Abou-Elkacem L, 2012, EUR RADIOL, V22, P1955, DOI 10.1007/s00330-012-2462-x
   Alerstam E, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041496
   Arridge SR, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123010
   Arridge SR, 1997, PHILOS T R SOC B, V352, P717, DOI 10.1098/rstb.1997.0054
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bjorn S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3560631
   Bjorn S, 2010, OPT EXPRESS, V18, P8422, DOI 10.1364/OE.18.008422
   Burgess SA, 2008, OPT LETT, V33, P2710, DOI 10.1364/OL.33.002710
   Chartrand R, 2007, IEEE SIGNAL PROC LET, V14, P707, DOI 10.1109/LSP.2007.898300
   Chen CW, 2011, J INNOV OPT HEAL SCI, V4, P309, DOI 10.1142/S1793545811001435
   Chen J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106009
   Chen J, 2011, MED PHYS, V38, P5788, DOI 10.1118/1.3641827
   Chen J, 2011, BIOMED OPT EXPRESS, V2, P871, DOI 10.1364/BOE.2.000871
   Chen Y, 2010, IEEE J SEL TOP QUANT, V16, P755, DOI 10.1109/JSTQE.2009.2037723
   Crilly RJ, 1997, APPL OPTICS, V36, P6513, DOI 10.1364/AO.36.006513
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Dunn A, 2000, OPT LETT, V25, P1777, DOI 10.1364/OL.25.001777
   Endoh R, 2008, OPT REV, V15, P51, DOI 10.1007/s10043-008-0009-9
   Fang QQ, 2009, OPT EXPRESS, V17, P20178, DOI 10.1364/OE.17.020178
   Gardner AR, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.065003
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008
   Hayakawa CK, 2001, OPT LETT, V26, P1335, DOI 10.1364/OL.26.001335
   Hillman EMC, 2007, OPT EXPRESS, V15, P17827, DOI 10.1364/OE.15.017827
   Hillman EMC, 2007, NEUROIMAGE, V35, P89, DOI 10.1016/j.neuroimage.2006.11.032
   Hillman EMC, 2009, LASER PHOTONICS REV, V3, P159, DOI 10.1002/lpor.200810031
   Hillman EMC, 2004, OPT LETT, V29, P1650, DOI 10.1364/OL.29.001650
   Hoover EE, 2013, NAT PHOTONICS, V7, P93, DOI [10.1038/nphoton.2013.361, 10.1038/nphoton.2012.361]
   Intes X, 2002, PHYS MED BIOL, V47, pN1, DOI 10.1088/0031-9155/47/1/401
   Intes X, 2003, MED PHYS, V30, P1039, DOI 10.1118/1.1573791
   Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37
   Jaedicke V, 2013, BIOMED OPT EXPRESS, V4, P2945, DOI 10.1364/BOE.4.002945
   KELLER JB, 1976, AM MATH MON, V83, P107, DOI 10.2307/2976988
   Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Morgner U, 2000, OPT LETT, V25, P111, DOI 10.1364/OL.25.000111
   Muldoon TJ, 2012, BIOMED OPT EXPRESS, V3, P1701, DOI 10.1364/BOE.3.001701
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Ouakli N, 2010, OPT EXPRESS, V18, P10068, DOI 10.1364/OE.18.010068
   Ozturk MS, 2014, ACAD RADIOL, V21, P271, DOI 10.1016/j.acra.2013.11.009
   Ozturk MS, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.100501
   Pawley J.B., 2006, HDB BIOL CONFOCAL MI
   Pian Q., 2014, CURR MOL IMAGING, V3, P72
   Pogue BW, 1999, APPL OPTICS, V38, P2950, DOI 10.1364/AO.38.002950
   Pogue BW, 1999, OPT EXPRESS, V4, P270, DOI 10.1364/OE.4.000270
   Robles FE, 2011, NAT PHOTONICS, V5, P744, DOI 10.1038/nphoton.2011.257
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339
   Suzen M, 2010, OPT EXPRESS, V18, P23676, DOI 10.1364/OE.18.023676
   Tan W, 2004, TISSUE ENG, V10, P1747, DOI 10.1089/ten.2004.10.1747
   Tan W, 2007, MICROSC RES TECHNIQ, V70, P361, DOI 10.1002/jemt.20420
   Tan W, 2006, OPT EXPRESS, V14, P7159, DOI 10.1364/OE.14.007159
   Tanbakuchi AA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3194131
   Tay BCM, 2013, MICROW OPT TECHN LET, V55, P2587, DOI 10.1002/mop.27926
   Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221
   Tikhonov A. N., 1995, NUMERICAL METHODS SO
   Ueng SWN, 2007, J ORTHOP RES, V25, P62, DOI 10.1002/jor.20286
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Venugopal V, 2012, CURR MED IMAGING REV, V8, P244, DOI 10.2174/157340512803759884
   Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Wang LV, 2007, BIOMEDICAL OPTICS PR
   Yang FG, 2015, IEEE T BIO-MED ENG, V62, P248, DOI 10.1109/TBME.2014.2347284
   Yang Y, 2006, PHYS MED BIOL, V51, P1649, DOI 10.1088/0031-9155/51/7/001
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI 10.1089/ten.TEC.2010.0172
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P1171, DOI 10.1089/ten.tec.2011.0263
   YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445
   Yuan BH, 2009, J INNOV OPT HEAL SCI, V2, P149, DOI 10.1142/S1793545809000486
   Yuan BH, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117204
   Yuan SA, 2009, OPT LETT, V34, P1615, DOI 10.1364/OL.34.001615
   Zhao LL, 2014, OPT LETT, V39, P4156, DOI 10.1364/OL.39.004156
   Zhao LL, 2012, BIOMATERIALS, V33, P5325, DOI 10.1016/j.biomaterials.2012.04.004
   Zhu CG, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050902
   Zhu WW, 1997, J OPT SOC AM A, V14, P799, DOI 10.1364/JOSAA.14.000799
NR 76
TC 17
Z9 18
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 667
EP 679
DI 10.1007/s10439-015-1511-4
PG 13
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900005
PM 26645079
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhou, J
   Hu, WJ
   Tang, LP
AF Zhou, Jun
   Hu, Wenjing
   Tang, Liping
TI Non-invasive Characterization of Immune Responses to Biomedical Implants
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterials; Optical imaging probes; In vivo biocompatibility
ID BIORESORBABLE STENT MATERIALS; ACUTE INFLAMMATORY RESPONSES;
   FOREIGN-BODY REACTIONS; SMOOTH-MUSCLE-CELLS; RAT C6 GLIOMA; IN-VIVO;
   FLUORESCENT NANOSENSORS; ACTIVATED MACROPHAGES; RHEUMATOID-ARTHRITIS;
   CHEMOTACTIC PEPTIDE
AB Biomedical implants play an important role in today's clinical practice. Unfortunately, biomedical implant-mediated host responses may lead to implant failure. Thus, all implants are tested for tissue compatibility prior to clinical trials. For that, after implantation in animals for different periods of time, the implants and surrounding tissues are isolated for histological analyses. Unfortunately, histological evaluation methods are labor intensive, time consuming, expensive and do not produce quantitative outcomes. With the advent of in vivo imaging technology, many imaging methods have been developed for evaluating biomedical implant-associated immune responses. In this review, we summarize the recent progress in the use of in vivo real-time imaging techniques for assessing acute phase foreign body reactions, including fibrin deposition, inflammatory cell recruitment and responses surrounding biomaterial implants. These new technologies may serve as powerful tools to characterize tissue compatibility of medical implants.
C1 [Zhou, Jun; Tang, Liping] Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
   [Hu, Wenjing] Progenitec Inc, 1917 Parktree Dr, Arlington, TX 76001 USA.
   [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
CR Adams WP, 2006, PLAST RECONSTR SURG, V117, P1214, DOI 10.1097/01.prs.0000208306.79104.18
   Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104
   Babich JW, 1997, J NUCL MED, V38, P1316
   Baker DW, 2014, ACTA BIOMATER, V10, P2945, DOI 10.1016/j.actbio.2014.04.001
   Bartsch I, 2014, ACTA BIOMATER, V10, P34, DOI 10.1016/j.actbio.2013.08.047
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Botnar RM, 2004, CIRCULATION, V109, P2023, DOI 10.1161/01.CIR.000012703450006.C0
   Bouloux GF, 2009, J ORAL MAXIL SURG, V67, P2497, DOI 10.1016/j.joms.2009.04.103
   Brasuel M, 2001, ANAL CHEM, V73, P2221, DOI 10.1021/ac0012041
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Brown BN, 2012, ACTA BIOMATER, V8, P2871, DOI 10.1016/j.actbio.2012.03.005
   Cai T, 2012, NANOMED-NANOTECHNOL, V8, P1301, DOI 10.1016/j.nano.2012.02.002
   Carmoa VAS, 2008, NUCL MED COMMUN, V29, P33, DOI 10.1097/MNM.0b013e3282f1bc0d
   Chen Wei-Tsung, 2004, Mol Imaging, V3, P159, DOI 10.1162/1535350042380290
   Chen WT, 2005, ARTHRITIS RES THER, V7, pR310, DOI 10.1186/ar1483
   Chen ZW, 2015, BIOMATERIALS, V39, P15, DOI 10.1016/j.biomaterials.2014.10.066
   Chi C, 2014, THERANOSTICS, V4, P1072, DOI 10.7150/thno.9899
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041
   Daghighi S, 2014, EUR CELLS MATER, V27, P26, DOI 10.22203/eCM.v027a03
   De Backer D, 2003, Minerva Anestesiol, V69, P281
   de Chermont QL, 2007, P NATL ACAD SCI USA, V104, P9266, DOI 10.1073/pnas.0702427104
   Derian CK, 1996, BIOCHEMISTRY-US, V35, P1265, DOI 10.1021/bi952087k
   Dinjaski N, 2014, ACTA BIOMATER, V10, P2935, DOI 10.1016/j.actbio.2014.03.005
   Duo J, 2011, ANAL BIOANAL CHEM, V399, P783, DOI 10.1007/s00216-010-4333-0
   Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199
   FISCHMAN AJ, 1991, J NUCL MED, V32, P483
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Freeman TA, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-5
   Gerstner AOH, 2004, CYTOM PART A, V59A, P210, DOI 10.1002/cyto.a.20054
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2
   Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886
   Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776
   Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537
   Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457
   Hoemann CD, 2010, AM J SPORT MED, V38, P1845, DOI 10.1177/0363546510369547
   Ji J, 2000, ANAL CHEM, V72, P3497, DOI 10.1021/ac000080p
   JOSEFSSON E, 1992, CELL IMMUNOL, V142, P67, DOI 10.1016/0008-8749(92)90269-U
   LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y
   Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983
   Lee DW, 2008, INT J NANOMED, V3, P471
   Lefer AM, 1998, CIRCULATION, V98, P1322, DOI 10.1161/01.CIR.98.13.1322
   Lidgren L, 2008, J BONE JOINT SURG BR, V90B, P7, DOI 10.1302/0301-620X.90B1.19823
   Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Liu ZL, 2011, NUCL MED BIOL, V38, P795, DOI 10.1016/j.nucmedbio.2011.02.012
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815
   Lu YJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3304
   Mainnemare A, 2004, J DENT RES, V83, P823, DOI 10.1177/154405910408301101
   Marshall Milton V, 2010, Open Surg Oncol J, V2, P12
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Martinez-Pomares L, 2003, J LEUKOCYTE BIOL, V73, P604, DOI 10.1189/jlb.0902450
   McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163
   McNamara KP, 2001, ANAL CHEM, V73, P3240, DOI 10.1021/ac0102314
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Mou X, 2010, BIOMATERIALS, V31, P4530, DOI 10.1016/j.biomaterials.2010.02.016
   Nguyen KT, 2004, J BIOMED MATER RES A, V69A, P513, DOI 10.1002/jbm.a.30020
   Nguyen KT, 2004, BIOMATERIALS, V25, P5333, DOI 10.1016/j.biomaterials.2003.12.033
   Okusanya O. T., 2015, J THORAC CARDIOVASC, V150
   Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y
   Panizzi P, 2009, J AM CHEM SOC, V131, P15739, DOI 10.1021/ja903922u
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   Paulos CM, 2004, ADV DRUG DELIVER REV, V56, P1205, DOI 10.1016/j.addr.2004.01.012
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   Piemonti L, 2010, ADV EXP MED BIOL, V654, P725, DOI 10.1007/978-90-481-3271-3_32
   Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050
   Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7
   Requena L, 2011, J AM ACAD DERMATOL, V64, P1, DOI 10.1016/j.jaad.2010.02.064
   Roda A, 2005, ANAL CHIM ACTA, V541, P25, DOI 10.1016/j.aca.2004.11.083
   Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001
   Sailes FC, 2010, ANN PLAS SURG, V64, P696, DOI 10.1097/SAP.0b013e3181dc8409
   Santos E, 2010, ADV EXP MED BIOL, V670, P5
   Schreml S, 2012, EXP DERMATOL, V21, P951, DOI 10.1111/exd.12042
   Schreml S, 2011, P NATL ACAD SCI USA, V108, P2432, DOI 10.1073/pnas.1006945108
   Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   STEEN KH, 1995, J NEUROSCI, V15, P3982
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Suri S, 2015, J BIOMED MATER RES A, V103, P76, DOI 10.1002/jbm.a.35162
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Tan MQ, 2004, J MATER CHEM, V14, P2896, DOI 10.1039/b407535h
   Tang EN, 2014, J BIOMED NANOTECHNOL, V10, P856, DOI 10.1166/jbn.2014.1852
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   THAKUR ML, 1979, CIRCULATION, V60, P297, DOI 10.1161/01.CIR.60.2.297
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tsai YT, 2014, ADV HEALTHC MATER, V3, P221, DOI 10.1002/adhm.201200365
   Tsai YT, 2014, BIOMATERIALS, V35, P2089, DOI 10.1016/j.biomaterials.2013.11.040
   Turk MJ, 2002, ARTHRITIS RHEUM, V46, P1947, DOI 10.1002/art.10405
   Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028
   von Grote EC, 2011, MOL BIOSYST, V7, P150, DOI 10.1039/c0mb00059k
   Wang L, 2005, NANO LETT, V5, P37, DOI 10.1021/nl048417g
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Whiteman M, 2008, BIOCHEM BIOPH RES CO, V371, P50, DOI 10.1016/j.bbrc.2008.03.153
   Xiao L, 2010, BIOORG MED CHEM LETT, V20, P3515, DOI 10.1016/j.bmcl.2010.04.136
   Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718
   Yamamoto K, 1996, J CLIN INVEST, V97, P2440, DOI 10.1172/JCI118691
   Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049
   Yu DG, 2012, INT J NANOMED, V7, P5725, DOI [10.2147/IJN.S37455, 10.2147/IJN.S29961]
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhou J, 2008, BIOMACROMOLECULES, V9, P142, DOI 10.1021/bm700918d
   Zhou J, 2012, FREE RADICAL BIO MED, V52, P218, DOI 10.1016/j.freeradbiomed.2011.10.452
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
   Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278
NR 116
TC 2
Z9 2
U1 4
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 693
EP 704
DI 10.1007/s10439-015-1470-9
PG 12
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900007
PM 26438448
DA 2018-10-20
ER

PT J
AU Stukel, JM
   Goss, M
   Zhou, HY
   Zhou, WD
   Willits, RK
   Exner, AA
AF Stukel, Jessica M.
   Goss, Monika
   Zhou, Haoyan
   Zhou, Wenda
   Willits, Rebecca Kuntz
   Exner, Agata A.
TI Development of a High-Throughput Ultrasound Technique for the Analysis
   of Tissue Engineering Constructs
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Ultrasound; Imaging; Tissue engineering; Scaffold; Hydrogel;
   Poly(ethylene glycol); Collagen
ID RAY COMPUTED-TOMOGRAPHY; LOCAL-DRUG RELEASE; IN-VITRO; SCAFFOLD
   DEGRADATION; STEM-CELLS; COLLAGEN; VIVO; GELS; PROLIFERATION; EVOLUTION
AB Development of hydrogel-based tissue engineering constructs is growing at a rapid rate, yet translation to patient use has been sluggish. Years of costly preclinical tests are required to predict clinical performance and safety of these devices. The tests are invasive, destructive to the samples and, in many cases, are not representative of the ultimate in vivo scenario. Biomedical imaging has the potential to facilitate biomaterial development by enabling longitudinal noninvasive device characterization directly in situ. Among the various available imaging modalities, ultrasound stands out as an excellent candidate due to low cost, wide availability, and a favorable safety profile. The overall goal of this work was to demonstrate the utility of clinical ultrasound in longitudinal characterization of 3D hydrogel matrices supporting cell growth. Specifically, we developed a quantitative technique using clinical B-mode ultrasound to differentiate collagen content and fibroblast density within poly(ethylene glycol) (PEG) hydrogels and validated it in an in vitro phantom environment. By manipulating the hydrogel gelation, differences in ultrasound signal intensity were found between gels with collagen fibers and those with non-fiber forming collagen, indicating that the technique was sensitive to the configuration of the protein. At a collagen density of 2.5 mg/mL collagen, fiber forming collagen had a significantly increased signal intensity of 14.90 +/- 2.58 x 10(-5) a. u. compared to non-fiber forming intensity at 2.74 +/- 0.36 x 10(-5) a. u. Additionally, differences in intensity were found between living and fixed fibroblasts, with an increased signal intensity detected in living cells (5.00 +/- 0.80 x 10(-5) a. u. in 1 day live cells compared to 2.26 +/- 0.39 x 10(-5) a. u. in fixed cells at a concentration of 1 x 10(6) cells/mL in gels containing collagen). Overall, there was a linear correlation > 0.90 for ultrasound intensity with increasing cell density. Results demonstrate the feasibility of using clinical ultrasound for characterization of PEG-based hydrogels in a tissue-mimicking phantom. The approach is clinically-relevant and could, with further validation, be utilized to nondestructively monitor in vivo performance of implanted tissue engineering scaffolds over time in preclinical and clinical settings.
C1 [Stukel, Jessica M.; Zhou, Wenda; Willits, Rebecca Kuntz] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Goss, Monika; Zhou, Haoyan; Exner, Agata A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Exner, Agata A.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.
RP Willits, RK (reprint author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
EM js217@zips.uakron.edu; monika.goss@case.edu; haoyan.zhou@case.edu;
   wz20@zips.uakron.edu; willits@uakron.edu; agata.exner@case.edu
OI Exner, Agata/0000-0003-3913-7066; Willits, Rebecca/0000-0002-1866-6789
FU National Institute of Biomedical Imaging and Bioengineering of the
   National Institutes of Health [R01EB016960]; Margaret F. Donovan
   Endowment for Women in Engineering
FX This study was supported by the National Institute of Biomedical Imaging
   and Bioengineering of the National Institutes of Health (R01EB016960 to
   AAE) and the Margaret F. Donovan Endowment for Women in Engineering
   (RKW). The content is solely the responsibility of the authors and does
   not necessarily represent the official views of the National Institutes
   of Health.
CR Aldrich JE, 2007, CRIT CARE MED, V35, pS131, DOI 10.1097/OCM.000020624.99430.22
   Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48
   BERLINER LJ, 1985, SCIENCE, V227, P517
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   Bushberg J. T., 2002, ESSENTIAL PHYS MED I, P473
   Buxton AN, 2007, TISSUE ENG, V13, P2549, DOI 10.1089/ten.2007.0075
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Chen Y, 2012, J NANOMATER, DOI 10.1155/2012/939821
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Czarnota G. J., 2010, IMAG MED, V2, P17
   Czarnota GJ, 1999, BRIT J CANCER, V81, P520, DOI 10.1038/sj.bjc.6690724
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   du Toit LC, 2014, PHARM RES-DORDR, V31, P607, DOI 10.1007/s11095-013-1184-3
   Gudur MSR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085749
   Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018
   Han QQ, 2015, TISSUE ENG PT A, V21, P2156, DOI [10.1089/ten.tea.2014.0484, 10.1089/ten.TEA.2014.0484]
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Jensen T, 2015, BIOMATERIALS, V57, P133, DOI 10.1016/j.biomaterials.2015.04.004
   Kempe S, 2010, EUR J PHARM BIOPHARM, V74, P102, DOI 10.1016/j.ejpb.2009.06.008
   Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01198
   Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.tec.2010.0669, 10.1089/ten.TEC.2010.0669]
   Lysaght MJ, 1998, TISSUE ENG, V4, P231, DOI 10.1089/ten.1998.4.231
   Ma D, 2013, NATURE, V495, P187, DOI 10.1038/nature11971
   Mercado KP, 2015, TISSUE ENG PART C-ME, V21, P671, DOI [10.1089/ten.TEC.2014.0527, 10.1089/ten.tec.2014.0527]
   Mercado KP, 2014, ANN BIOMED ENG, V42, P1292, DOI 10.1007/s10439-014-0994-8
   Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a
   Ribeiro VP, 2016, J BIOMED MATER RES B, V104, P496, DOI 10.1002/jbm.b.33400
   Rice MA, 2009, ACTA BIOMATER, V5, P152, DOI 10.1016/j.actbio.2008.07.036
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Sancho-Tello M, 2015, INT J ARTIF ORGANS, V38, P210, DOI 10.5301/ijao.5000404
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   Skornia SL, 2007, J APPL BIOMATER BIOM, V5, P176
   Solorio L, 2010, J CONTROL RELEASE, V143, P183, DOI 10.1016/j.jconrel.2010.01.001
   Szymanski-Exner A, 2003, J PHARM SCI, V92, P289, DOI 10.1002/jps.10295
   Szymanski-Exner A, 2002, J CONTROL RELEASE, V83, P415, DOI 10.1016/S0168-3659(02)00216-X
   Uyanik I, 2013, LECT NOTES COMPUT SC, V7945, P466, DOI 10.1007/978-3-642-38899-6_55
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   You JO, 2015, BIOMATERIALS, V57, P22, DOI 10.1016/j.biomaterials.2015.04.011
   Zhou H., 2014, CURR DRUG TARGETS, V6, P672
NR 45
TC 1
Z9 1
U1 1
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 793
EP 802
DI 10.1007/s10439-015-1507-0
PG 10
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900014
PM 26577255
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hodde, J
   Hiles, M
AF Hodde, Jason
   Hiles, Michael
TI Transforming surgery through biomaterial template technology
SO BRITISH JOURNAL OF HOSPITAL MEDICINE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; OF-THE-LITERATURE; EXTRACELLULAR-MATRIX;
   ANTIGEN REMOVAL; HOST RESPONSE; SCAFFOLD; GRAFTS; MODULATION; REPAIR;
   MODEL
AB Templates inserted into surgical wounds strongly influence the healing responses in humans. The science of these templates, in the form of extracellular matrix biomaterials, is rapidly evolving and improving as the natural interactions with the body become better understood.
C1 [Hodde, Jason] Cook Biotech Inc, Med Sci, W Lafayette, IN USA.
   [Hiles, Michael] Cook Biotech Inc, Res & Dev, 1425 Innovat Pl, W Lafayette, IN 47906 USA.
   [Hiles, Michael] Purdue Univ, Biomed Engn, W Lafayette, IN 47907 USA.
RP Hiles, M (reprint author), Cook Biotech Inc, Res & Dev, 1425 Innovat Pl, W Lafayette, IN 47906 USA.; Hiles, M (reprint author), Purdue Univ, Biomed Engn, W Lafayette, IN 47907 USA.
EM mhiles@CookBiotech.com
CR Alberts B, 2002, MOL BIOL CELL
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Belcarz A, 2009, J BIOMED MATER RES B, V89B, P102, DOI 10.1002/jbm.b.31192
   Berlanga-Acosta J, 2013, BIOMED RES INT, DOI 10.1155/2013/256043
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Bryan N, 2012, CLIN BIOCHEM, V45, P672, DOI 10.1016/j.clinbiochem.2012.02.026
   Bryan N, 2015, J APPL BIOMATER FUNC, V13, P35, DOI 10.5301/jabfm.5000172
   Chan BP, 2008, EUR SPINE J, V4, P467
   Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304
   Chin LK, 2012, J BIOMED MATER RES A, V100A, P786, DOI 10.1002/jbm.a.34025
   Cintron JR, 2013, TECH COLOPROCTOL, V17, P187, DOI 10.1007/s10151-012-0897-3
   Cissell DD, 2014, J BIOMECH, V47, P1987, DOI 10.1016/j.jbiomech.2013.10.041
   Druecke D, 2004, WOUND REPAIR REGEN, V12, P518, DOI 10.1111/j.1067-1927.2004.012504.x
   Ebrecht M, 2004, PSYCHONEUROENDOCRINO, V29, P798, DOI 10.1016/S0306-4530(03)00144-6
   Engeland CG, 2009, BRAIN BEHAV IMMUN, V23, P629, DOI 10.1016/j.bbi.2008.12.001
   Gigliobianco G, 2015, BIOMED RES INT, DOI 10.1155/2015/968087
   Hiles M, 2005, INT SURG, V90, pS13
   Hiles M, 2006, INT UROGYNECOL J, V17, pS39, DOI 10.1007/s00192-006-0104-z
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hodde J, 2007, J MATER SCI-MATER M, V18, P545, DOI 10.1007/s10856-007-2301-9
   Holubec T, 2015, J CARDIAC SURG, V30, P145, DOI 10.1111/jocs.12494
   Jiang WW, 2016, J PEDIATR SURG, V51, P368, DOI 10.1016/j.jpedsurg.2015.08.005
   Jones C, 2011, ANN ROY COLL SURG, V93, P504, DOI 10.1308/147870811X13137608455136
   Jung MK, 2011, ALCOHOL CLIN EXP RES, V35, P392, DOI 10.1111/j.1530-0277.2010.01356.x
   Liang R, 2006, J ORTHOP RES, V24, P811, DOI 10.1002/jor.20080
   Mauney JR, 2015, ADV DRUG DELIVER REV, V82-83, P77, DOI 10.1016/j.addr.2014.10.016
   McDade JK, 2013, ACTA BIOMATER, V9, P7191, DOI 10.1016/j.actbio.2013.02.021
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   NALEBUFF EA, 1990, J HAND SURG-BRIT EUR, V15B, P395, DOI 10.1016/0266-7681(90)90078-I
   Nihsen Edith S, 2008, Adv Skin Wound Care, V21, P479, DOI 10.1097/01.ASW.0000323561.14144.19
   O'Donnell TF, 2006, J VASC SURG, V44, P1118, DOI 10.1016/j.jvs.2006.08.004
   Scully BB, 2016, J BIOMED MATER RES B, V104, P1713, DOI 10.1002/jbm.b.33484
   Seymour PE, 2008, ARCH FACIAL PLAST S, V10, P30, DOI 10.1001/archfacial.2007.17
   Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852
   Tam H, 2015, BIOMATERIALS, V66, P83, DOI 10.1016/j.biomaterials.2015.07.011
   Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001
   Trabuco EC, 2007, INT UROGYNECOL J, V18, P555, DOI 10.1007/s00192-006-0288-2
   Wang M, 2013, EMERGING TRENDS CELL, P485
   Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028
   Zhang J, 2011, BIOMATERIALS, V32, P7086, DOI 10.1016/j.biomaterials.2011.06.016
   Zhao HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111846
NR 43
TC 1
Z9 1
U1 0
U2 1
PU MA HEALTHCARE LTD
PI LONDON
PA ST JUDES CHURCH, DULWICH ROAD, LONDON SE24 0PB, ENGLAND
SN 1750-8460
EI 1759-7390
J9 BRIT J HOSP MED
JI Br. J. Hosp. Med.
PD MAR
PY 2016
VL 77
IS 3
BP 162
EP 166
DI 10.12968/hmed.2016.77.3.162
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI5QS
UT WOS:000373554300027
PM 26961446
DA 2018-10-20
ER

PT J
AU Deing, A
   Ebel, T
   Willumeit-Romer, R
   Luthringer, BJC
AF Deing, Axel
   Ebel, Thomas
   Willumeit-Roemer, Regine
   Luthringer, Berengere J. C.
TI Comparison of the Influence of Phospholipid-Coated Porous Ti-6Al-4V
   Material on the Osteosarcoma Cell Line Saos-2 and Primary Human Bone
   Derived Cells
SO METALS
LA English
DT Article
DE Ti-6Al-4V; biomaterial; phospholipid; implant; gene expression;
   immunocytochemistry; biomimetic coating; porous
ID HUMAN CORTICAL BONE; MECHANICAL-PROPERTIES; HUMAN OSTEOBLASTS; PCR DATA;
   IN-VIVO; TITANIUM; DIFFERENTIATION; SURFACE; ALLOYS; GROWTH
AB Biomaterial surface functionalization remains of great interest in the promotion of cell osteogenic induction. Previous studies highlighted the positive effects of porous Ti-6Al-4V and phospholipid coating on osteoblast differentiation and bone remodeling. Therefore, the first objective of this study was to evaluate the potential synergistic effects of material porosity and phospholipid coating. Primary human osteoblasts and Saos-2 cells were cultured on different Ti-6Al-4V specimens (mirror-like polished or porous specimens) and were coated or not with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) for three weeks or five weeks. Selected gene expressions (e.g., classical bone markers: alkaline phosphatase, osteocalcin, osteoprotegerin (OPG), receptor activator of nuclear factor kappa-beta ligand (RANKL) and runt-related transcription factor 2) were estimated in vitro. Furthermore, the expressions of osteocalcin and osteopontin were examined via fluorescent microscopy at five weeks (immunocytochemistry). Consequently, it was observed that phospholipid coating potentiates preferences for low and high porosities in Saos-2 and primary cells, respectively, at the gene and protein levels. Additionally, RANKL and OPG exhibited different gene expression patterns; primary cells showed dramatically increased RANKL expression, whereas OPG expression was decreased in the presence of POPE. A synergistic effect of increased porosity and phospholipid coating was observed in primary osteoblasts in bone remodeling. This study showed the advantage of primary cells over the standard bone cell model.
C1 [Deing, Axel; Ebel, Thomas; Willumeit-Roemer, Regine; Luthringer, Berengere J. C.] Helmholtz Zentrum Geesthacht, Inst Mat Res, Div Metall Biomat, D-21502 Geesthacht, Germany.
RP Luthringer, BJC (reprint author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Div Metall Biomat, D-21502 Geesthacht, Germany.
EM meseus@gmx.de; thomas.ebel@hzg.de; regine.willumeit@hzg.de;
   berengere.luthringer@hzg.de
RI Willumeit, Regine/I-8029-2013; Luthringer, Berengere/G-9039-2017
OI Willumeit, Regine/0000-0002-6004-6946; Luthringer,
   Berengere/0000-0002-8248-6715
CR Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   [Anonymous], 2014, ORTHOPEDIC DEVICES M
   Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Burmester Anna, 2014, Biomatter, V4, pe967616, DOI 10.4161/21592527.2014.967616
   Camolezi FL, 2002, INT J BIOCHEM CELL B, V34, P1091, DOI 10.1016/S1357-2725(02)00029-8
   Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032
   Da Silva Jorge H., 2008, THESIS U MINHO BRAGA
   Deing A., 2014, INT J BIOMATER, V2014
   EANES ED, 1992, BONE MINER, V17, P269, DOI 10.1016/0169-6009(92)90749-4
   Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200
   Faria P.E., 2008, CLIN IMPLANT DENT R, V12, P72
   Franceschi RT, 2009, CELLS TISSUES ORGANS, V189, P144, DOI 10.1159/000151747
   Gallagher JA, 2003, METH MOLEC MED, V80, P3
   Gartland A, 2012, METHODS MOL BIOL, V806, P337, DOI 10.1007/978-1-61779-367-7_22
   Golub M, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-21
   Gross TS, 2005, J BONE MINER RES, V20, P250, DOI 10.1359/JBMR.041004
   Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   Kawana F, 2003, J ELECTRON MICROSC, V52, P515, DOI 10.1093/jmicro/52.6.515
   Kemper A., 2007, P 20 INT TECHN C ENH
   Kitazawa R, 2008, J CELL BIOCHEM, V105, P1289, DOI 10.1002/jcb.21929
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Krishna OD, 2005, BIOMATERIALS, V26, P7115, DOI 10.1016/j.biomaterials.2005.05.023
   Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896
   Lee T, 2002, BIOMECH MODEL MECHAN, V1, P165, DOI 10.1007/s10237-002-0015-y
   Letellier SR, 1998, BBA-GEN SUBJECTS, V1380, P31, DOI 10.1016/S0304-4165(97)00121-9
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Lidington EA, 1999, TRANSPL IMMUNOL, V7, P239, DOI 10.1016/S0966-3274(99)80008-2
   Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376
   Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050378
   Luthringer BJC, 2014, J MATER SCI-MATER M, V25, P2561, DOI 10.1007/s10856-014-5263-8
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187
   Matassi F, 2013, CLIN CASES MINER BON, V10, P111, DOI 10.11138/ccmbm/2013.10.2.111
   Millan JL, 2006, DYNAMICS BONE CARTIL, P153
   Niinomi M, 2010, EXPERT REV MED DEVIC, V7, P481, DOI [10.1586/erd.10.16, 10.1586/ERD.10.16]
   NIYIBIZI C, 1989, CONNECT TISSUE RES, V20, P247, DOI 10.3109/03008208909023894
   Okulov IV, 2013, MAT SCI ENG C-MATER, V33, P4795, DOI 10.1016/j.msec.2013.07.042
   Pautke C, 2004, ANTICANCER RES, V24, P3743
   Pei XB, 2012, J MATER SCI-MATER M, V23, P2717, DOI 10.1007/s10856-012-4724-1
   Ponader S., 2009, J BIOMED MATER RES A, V92, P56
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Santin M, 2006, J R SOC INTERFACE, V3, P277, DOI 10.1098/rsif.2005.0088
   Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6
   Schulz M.C., 2013, J MATER SCI-MATER M, V25, P247
   Spoerke ED, 2005, ACTA BIOMATER, V1, P523, DOI 10.1016/j.actbio.2005.04.005
   Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Tan XW, 2012, J BIOMED MATER RES B, V100B, P2090, DOI 10.1002/jbm.b.32774
   Thorfve A, 2014, ACTA BIOMATER, V10, P1451, DOI 10.1016/j.actbio.2013.12.012
   Turner CH, 2001, CALCIFIED TISSUE INT, V69, P373, DOI 10.1007/s00223-001-1006-1
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   van Tuyl LHD, 2010, ANN RHEUM DIS, V69, P1623, DOI 10.1136/ard.2009.121764
   Wang XF, 2013, MOL MED REP, V7, P1169, DOI 10.3892/mmr.2013.1335
   Willumeit R, 2007, J MATER SCI-MATER M, V18, P367, DOI 10.1007/s10856-006-0702-9
   Willumeit R, 2007, EUR CELLS MATER, V13, P11, DOI 10.22203/eCM.v013a02
   Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202
   WUTHIER RE, 1975, BIOCHIM BIOPHYS ACTA, V409, P128, DOI 10.1016/0005-2760(75)90087-9
   YOON HS, 1976, J BIOMECH, V9, P459, DOI 10.1016/0021-9290(76)90089-0
   ZACHOWSKI A, 1993, BIOCHEM J, V294, P1
NR 63
TC 1
Z9 1
U1 0
U2 12
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2075-4701
J9 METALS-BASEL
JI Metals
PD MAR
PY 2016
VL 6
IS 3
DI 10.3390/met6030066
PG 16
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA DI6NR
UT WOS:000373616800019
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lee, SE
   Cha, SR
   Jang, NK
   Kim, SY
   Kim, EY
   Song, JE
   Park, CH
   Khang, G
AF Lee, Seon Eui
   Cha, Se Rom
   Jang, Na Keum
   Kim, Su Young
   Kim, Eun Young
   Song, Jeong Eun
   Park, Chan Hum
   Khang, Gilson
TI Effect of Degumming Time of Silk Films on Growth of Corneal Endothelial
   Cells for Tissue Engineered Endothelialized Neo-Corneas
SO POLYMER-KOREA
LA English
DT Article
DE silk; sericine; film; degumming time; corneal endothelial cells
ID INFLAMMATORY RESPONSES; FIBROIN MEMBRANE; IN-VIVO; BIOMATERIAL;
   KERATOPLASTY; SCAFFOLDS
AB Silk is a biodegradable natural polymer with low immunological rejection after transplantation. As well, silk can be manufactured in various forms and adjusted to the thickness of several micrometers depending on the manufacturing method. Silk shows high transparency in the form of film, high water and oxygen permeability. However, studies have cited some drawbacks of silk, such as inflammatory response due to presence of silk protein (sericin) and its another disadvantage of silk requires a long period of time to decomposition after transplantation. In this study, silk films with various degumming time (0, 20, 40 and 60 min) were fabricated in order to evaluate the effect of sericin in learns of biocompatibility, inflammatory responses, etc. The experiments such as the contact angle, cell viability and inflammatory factor expression using RT-PCR were performed. Corneal endothelial cells were seeded on silk films and examined to evaluate the degree of adhesion in films, cell's proliferation and specific mRNA expression. This study showed degumming time of silk film fabrication which is a factor for growth of corneal endothelial cells.
C1 [Lee, Seon Eui; Cha, Se Rom; Jang, Na Keum; Kim, Su Young; Kim, Eun Young; Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Tech, 567 Baekje Daero, Jeonju 54898, South Korea.
   [Lee, Seon Eui; Cha, Se Rom; Jang, Na Keum; Kim, Su Young; Kim, Eun Young; Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Dept PolymerNanoSci Tech, 567 Baekje Daero, Jeonju 54898, South Korea.
   [Park, Chan Hum] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 1-1 Okcheon, Chunchon 24253, Gangwon, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept BIN Fus Tech, 567 Baekje Daero, Jeonju 54898, South Korea.; Khang, G (reprint author), Chonbuk Natl Univ, Dept PolymerNanoSci Tech, 567 Baekje Daero, Jeonju 54898, South Korea.
EM gskang@jbnu.ac.kr
RI song, jeong eun/P-9106-2015
OI song, jeong eun/0000-0001-6879-7616
FU Brain Korea 21 PLUS Project, the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) - Korean government
   (MEST) [NRF-2012M3A9C6050204]
FX This research was supported by Brain Korea 21 PLUS Project, the Bio &
   Medical Technology Development Program of the National Research
   Foundation (NRF) funded by the Korean government (MEST)
   (NRF-2012M3A9C6050204).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   BARFORT P, 1974, EXP EYE RES, V19, P11, DOI 10.1016/0014-4835(74)90067-0
   Bhattacharjee M, 2013, BIOMATERIALS, V34, P8161, DOI 10.1016/j.biomaterials.2013.07.018
   Cho S. A., 2014, INT J TISSUE REG, V5, P46
   Ha YY, 2014, MACROMOL RES, V22, P1018, DOI 10.1007/s13233-014-2138-2
   Hatou S, 2009, CURR EYE RES, V34, P347, DOI 10.1080/02713680902829624
   Ho MP, 2012, APPL SURF SCI, V258, P3948, DOI 10.1016/j.apsusc.2011.12.068
   Hu E. P. X., 2013, MACROMOL BIOSCI, V13, P3
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   Kim E. Y., 2014, INT J TISSUE REG, V5, P3
   Kim EY, 2015, MACROMOL RES, V23, P189, DOI 10.1007/s13233-015-3027-z
   Kim HL, 2011, POLYM-KOREA, V35, P7
   Kim MK, 2014, POLYM-KOREA, V38, P98, DOI 10.7317/pk.2014.38.1.98
   Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee J. H., 2013, INT J TISSUE REG, V4, P2
   Lee M, 2014, MACROMOL RES, V22, P746, DOI 10.1007/s13233-014-2096-8
   Lee S.E., 2014, INT J TISSUE REGEN, V5, P103
   Lee S. J., 2014, POLYM-KOREA, V38, P3
   Lee Y, 2012, TISSUE ENG PT A, V18, P1967, DOI [10.1089/ten.tea.2012.0001, 10.1089/ten.TEA.2012.0001]
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Oh H, 2011, MACROMOL RES, V19, P266, DOI 10.1007/s13233-011-0301-6
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park S. W., 2015, INT J TISSUE REG, V6, P9
   Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   SLINGSBY JG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1041
   Terry MA, 2003, OPHTHALMOLOGY, V110, P755, DOI 10.1016/S0161-6420(02)01939-5
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang TJ, 2012, COLLOID SURFACE B, V90, P236, DOI 10.1016/j.colsurfb.2011.10.043
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wu WC, 2007, CURR EYE RES, V32, P199, DOI 10.1080/02713680601174165
   Yoon H, 2014, MACROMOL RES, V22, P297, DOI 10.1007/s13233-014-2037-6
NR 37
TC 1
Z9 1
U1 2
U2 12
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD MAR
PY 2016
VL 40
IS 2
BP 181
EP 187
DI 10.7317/pk.2016.40.2.181
PG 7
WC Polymer Science
SC Polymer Science
GA DI5QT
UT WOS:000373554400004
DA 2018-10-20
ER

PT J
AU Kuppusamy, S
   Thavamani, P
   Megharaj, M
   Venkateswarlu, K
   Lee, YB
   Naidu, R
AF Kuppusamy, Saranya
   Thavamani, Palanisami
   Megharaj, Mallavarapu
   Venkateswarlu, Kadiyala
   Lee, Yong Bok
   Naidu, Ravi
TI Potential of Melaleuca diosmifolia leaf as a low-cost adsorbent for
   hexavalent chromium removal from contaminated water bodies
SO PROCESS SAFETY AND ENVIRONMENTAL PROTECTION
LA English
DT Article
DE Melaleuca diosmifolia; Forest biomass; Biosorption; Chromium(VI)
   reduction; Kinetic model; Wastewater treatment
ID ADSORPTION-COUPLED REDUCTION; AQUEOUS-SOLUTIONS; WASTE-WATER; CR(VI)
   REMOVAL; BIOMASS; BIOSORPTION; INDUSTRIAL; EVIDENCES; PEEL
AB The present study describes for the first time the utilization of dried twigs of Melaleuca diosmifolia, fallen off from the plant, to detoxify and remove hexavalent chromium or Cr(VI) from aqueous systems. Initial characterization by gas chromatography revealed that the selected biomaterial is one of the natural sources of eucalyptol. It constituted high concentrations of reducing compounds (iron, phenols and flavonoids). Batch studies revealed that the biosorbent (5 g L-1) was able to remove 97-99.9% of 250 mg L-1 Cr(VI) at wide-ranging pH (2-10) and temperature (24-48 degrees C). Adsorption kinetics was well described using the pseudo second -order kinetic model, while the equilibrium adsorption data were interpreted in terms of the Langmuir isotherm model. The monolayer adsorption capacity was 62.5 mg g(-1). Both inductively coupled plasma optical emission spectrometry and liquid chromatography analyses of the aqueous and solid phases revealed that the mechanism of Cr(VI) removal was `adsorption-coupled reduction'. Scanning electron microscope, infrared spectroscopy and X-ray diffraction analyses of the biosorbent before and after adsorption also confirmed that both adsorption and reduction of Cr(VI) to Cr(III) followed by complexation onto functional groups of the active surface contributed to the removal of Cr(VI) from aqueous solution. The selected biomaterial effectively (99.9%) removed Cr(VI) in lake and sea water samples, highlighting its potential for remediating Cr(VI) in real environmental conditions. (C) 2016 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Kuppusamy, Saranya; Lee, Yong Bok] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
   [Kuppusamy, Saranya; Megharaj, Mallavarapu; Naidu, Ravi] Univ S Australia, CERAR, Mawson Lakes, SA 5095, Australia.
   [Kuppusamy, Saranya; Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] CRC CARE, POB 486, Salisbury South, SA 5106, Australia.
   [Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] Univ Newcastle, Fac Sci & Informat Technol, GCER, Callaghan, NSW 2308, Australia.
   [Venkateswarlu, Kadiyala] Sri Krishnadevaraya Univ, Dept Microbiol, Anantapur 515055, Andhra Pradesh, India.
RP Kuppusamy, S (reprint author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
EM saran.miles2go@gmail.com
RI Mallavarapu, Megharaj/D-3408-2011; Kuppusamy, Saranya/L-3912-2017
OI Mallavarapu, Megharaj/0000-0002-6230-518X; Kuppusamy,
   Saranya/0000-0002-6271-7475; Lee, Yong Bok/0000-0002-7651-4556
FU Australian Government; University of South Australia (UniSA);
   Cooperative Research Centre for Contamination Assessment and Remediation
   of the Environment (CRC CARE); CRC CARE
FX SK thanks the Australian Government, University of South Australia
   (UniSA) and Cooperative Research Centre for Contamination Assessment and
   Remediation of the Environment (CRC CARE) for the International
   Postgraduate Research Scholarship (IPRS), and CRC CARE for top-up
   fellowship during PhD.
CR Acharya J, 2009, CHEM ENG J, V150, P25, DOI 10.1016/j.cej.2008.11.035
   Atar N, 2012, CHEM ENG J, V192, P1, DOI 10.1016/j.cej.2012.03.067
   Augustin S., 2000, J NUTR, V130, P2073
   Babu BV, 2008, ADSORPTION, V14, P85, DOI 10.1007/s10450-007-9057-x
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Colak F, 2013, J IND ENG CHEM, V19, P863, DOI 10.1016/j.jiec.2012.11.001
   Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u
   El Nemr A, 2009, J HAZARD MATER, V161, P132, DOI 10.1016/j.jhazmat.2008.03.093
   Gao H, 2008, J HAZARD MATER, V150, P446, DOI 10.1016/j.jhazmat.2007.04.126
   Garg UK, 2009, DESALINATION, V249, P475, DOI 10.1016/j.desal.2008.10.025
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P332, DOI 10.1205/095758298529696
   Hu ZH, 2003, SEP PURIF TECHNOL, V31, P13, DOI 10.1016/S1383-5866(02)00149-1
   Jain M, 2009, J HAZARD MATER, V162, P365, DOI 10.1016/j.jhazmat.2008.05.048
   Khomdram S. D., 2011, Notulae Scientia Biologicae, V3, P108
   Kuppusamy S, 2015, ENVIRON TECHNOL INNO, V4, P17, DOI 10.1016/j.eti.2015.04.001
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P117, DOI 10.1007/978-3-319-20013-2_2
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P1, DOI 10.1007/978-3-319-20013-2_1
   Lopez-Garcia M, 2013, BIORESOURCE TECHNOL, V139, P181, DOI 10.1016/j.biortech.2013.04.044
   Luo P, 2011, IND ENG CHEM RES, V50, P10246, DOI 10.1021/ie200951n
   Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004
   Mallampati R, 2012, RSC ADV, V2, P9914, DOI 10.1039/c2ra21108d
   MASON B, 1949, J GEOL, V57, P62, DOI 10.1086/625575
   Memon JR, 2009, COLLOID SURFACE B, V70, P232, DOI 10.1016/j.colsurfb.2008.12.032
   Mohanty K, 2006, CHEM ENG J, V117, P71, DOI 10.1016/j.cej.2005.11.018
   Moulton MC, 2010, NANOSCALE, V2, P763, DOI 10.1039/c0nr00046a
   Moure A, 2001, FOOD CHEM, V72, P145, DOI 10.1016/S0308-8146(00)00223-5
   Nadagouda MN, 2010, GREEN CHEM, V12, P114, DOI 10.1039/b921203p
   Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029
   OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Rao RAK, 2010, J HAZARD MATER, V181, P405, DOI 10.1016/j.jhazmat.2010.05.025
   Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005
   Saha R, 2011, J COORD CHEM, V64, P1782, DOI 10.1080/00958972.2011.583646
   Sarkar B, 2010, J HAZARD MATER, V183, P87, DOI 10.1016/j.jhazmat.2010.06.110
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V47, P257, DOI 10.1016/0960-8524(94)90189-9
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Sreenivas KM, 2014, J ENVIRON CHEM ENG, V2, P455, DOI 10.1016/j.jece.2014.01.017
   Suksabye P, 2007, J HAZARD MATER, V141, P637, DOI 10.1016/j.jhazmat.2006.07.018
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Weng CH, 2008, J HAZARD MATER, V155, P65, DOI 10.1016/j.jhazmat.2007.11.029
   Xie AJ, 2014, NEW J CHEM, V38, P777, DOI 10.1039/c3nj01013a
   Yani S, 2014, FUEL, V133, P341, DOI 10.1016/j.fuel.2014.05.030
   Zhang YZ, 2011, MACROMOLECULES, V44, P683, DOI 10.1021/ma102492c
NR 43
TC 23
Z9 23
U1 4
U2 19
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0957-5820
EI 1744-3598
J9 PROCESS SAF ENVIRON
JI Process Saf. Environ. Protect.
PD MAR
PY 2016
VL 100
BP 173
EP 182
DI 10.1016/j.psep.2016.01.009
PG 10
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA DI5KV
UT WOS:000373538700016
DA 2018-10-20
ER

PT J
AU Lee, S
   Yun, S
   Park, KI
   Jang, JH
AF Lee, Slgirim
   Yun, Seokhwan
   Park, Kook In
   Jang, Jae-Hyung
TI Sliding Fibers: Slidable, Injectable, and Gel-like Electrospun
   Nanofibers as Versatile Cell Carriers
SO ACS NANO
LA English
DT Article
DE electrospun nanofibers; injectable nanofibers; minimally invasive cell
   delivery; ECM-like nanofibers; human neural stem cells; stroke
ID CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   CONTROLLED-RELEASE; SCAFFOLDS; DELIVERY; MODEL;
   POLY(EPSILON-CAPROLACTONE); NEUROPROTECTION; NANOPARTICLES
AB Designing biomaterial systems that can mimic fibrous, natural extracellular matrix is crucial for enhancing the efficacy of various therapeutic tools. Herein, a smart technology of three-dimensional electrospun fibers that can be injected in a minimally invasive manner was developed. Open surgery is currently the only route of administration of conventional electrospun fibers into the body. Coordinating electrospun fibers with a lubricating hydrogel produced fibrous constructs referred to as slidable, injectable, and gel-like (SLIDING) fibers. These SLIDING fibers could pass smoothly through a catheter and fill any cavity while maintaining their fibrous morphology. Their injectable features were derived from their distinctive theological characteristics, which were presumably caused by the combinatorial effects of mobile electrospun fibers and lubricating hydrogels. The resulting injectable fibers fostered a highly favorable environment for human neural stem cell (hNSC) proliferation and neurosphere formation within the fibrous structures without compromising hNSC viability. SLIDING fibers demonstrated superior performance as cell carriers in animal stroke models subjected to the middle cerebral artery occlusion (MCAO) stroke model. In this model, SLIDING fiber application extended the survival rate of administered hNSCs by blocking microglial infiltration at the early, acute inflammatory stage. The development of SLIDING fibers will increase the clinical significance of fiber-based scaffolds in many biomedical fields and will broaden their applicability.
C1 [Lee, Slgirim; Jang, Jae-Hyung] Yonsei Univ, Dept Chem & Biomol Engn, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Yun, Seokhwan; Park, Kook In] Yonsei Univ, Coll Med, Dept Pediat, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Jang, JH (reprint author), Yonsei Univ, Dept Chem & Biomol Engn, 50 Yonsei Ro, Seoul 03722, South Korea.; Park, KI (reprint author), Yonsei Univ, Coll Med, Dept Pediat, 50 Yonsei Ro, Seoul 03722, South Korea.
EM kipark@yuhs.ac; j-jang@yonsei.ac.kr
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [NRF-2015R1A2A2A03003553, NRF-2007-0056558]; Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI);
   Ministry of Health & Welfare, Republic of Korea [HI14C1564]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No.
   NRF-2015R1A2A2A03003553, and NRF-2007-0056558). This research was
   additionally supported by a grant of the Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI),
   funded by the Ministry of Health & Welfare, Republic of Korea (Grant
   Number: HI14C1564).
CR Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Bonino CA, 2012, SMALL, V8, P1928, DOI 10.1002/smll.201101791
   Chen ML, 2012, ACS NANO, V6, P4835, DOI 10.1021/nn300106t
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chin SJ, 2015, POLYMER, V58, P209, DOI 10.1016/j.polymer.2014.12.034
   Cirillo V, 2014, BIOMATERIALS, V35, P8970, DOI 10.1016/j.biomaterials.2014.07.010
   De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45
   Fedoseyeva EV, 2002, J IMMUNOL, V169, P1168, DOI 10.4049/jimmunol.169.3.1168
   Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016
   Gallego R, 2014, POLYMERS-BASEL, V6, P1929, DOI 10.3390/polym6071929
   Gullberg D, 1995, INT J DEV BIOL, V39, P845
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Gupta P, 2003, POLYMER, V44, P6353, DOI 10.1016/S0032-3861(03)00616-5
   Jiao YP, 2006, J APPL POLYM SCI, V101, P1515, DOI 10.1002/app.22291
   Jin G, 2015, ANGEW CHEM INT EDIT, V54, P7587, DOI 10.1002/anie.201502177
   Jin G, 2014, BIOMED MICRODEVICES, V16, P793, DOI 10.1007/s10544-014-9883-z
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015
   Kobsa S, 2013, BIOMATERIALS, V34, P3891, DOI 10.1016/j.biomaterials.2013.02.016
   Latchney Sarah E, 2012, Eur J Neurodegener Dis, V1, P335
   Lee S, 2013, NAT PROTOC, V8, P771, DOI 10.1038/nprot.2013.039
   Lee S, 2014, ACS APPL MATER INTER, V6, P1082, DOI 10.1021/am404627r
   Lee S, 2011, ACTA BIOMATER, V7, P3868, DOI 10.1016/j.actbio.2011.06.035
   Li XR, 2015, ADV HEALTHC MATER, V4, P1869, DOI 10.1002/adhm.201500271
   LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   Nakaya-Yaegashi K, 2008, J RHEOL, V52, P359, DOI 10.1122/1.2828645
   Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Ravichandran R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385102
   Schneider BL, 2003, MOL THER, V7, P506, DOI 10.1016/S1525-0016(03)00055-8
   Shah U, 2010, ACTA BIOMATER, V6, P3029, DOI 10.1016/j.actbio.2010.02.041
   Sollich P, 1998, PHYS REV E, V58, P738, DOI 10.1103/PhysRevE.58.738
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Subramanian G, 2015, MAT SCI ENG C-MATER, V51, P16, DOI 10.1016/j.msec.2015.02.030
   Taipale J, 1997, FASEB J, V11, P51
   Vag J, 2007, J CELL PHYSIOL, V212, P416, DOI 10.1002/jcp.21035
   Vaquette C, 2011, ACTA BIOMATER, V7, P2544, DOI 10.1016/j.actbio.2011.02.036
   Wallner EI, 1998, AM J PHYSIOL-RENAL, V275, pF467, DOI 10.1152/ajprenal.1998.275.4.F467
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Weightman AP, 2014, BIOMATERIALS, V35, P3756, DOI 10.1016/j.biomaterials.2014.01.022
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Zhang H, 2013, BIOMATERIALS, V34, P2202, DOI 10.1016/j.biomaterials.2012.12.005
   Zhang Z, 2014, SOFT MATTER, V10, P5965, DOI 10.1039/c4sm00716f
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
   Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705
NR 49
TC 9
Z9 9
U1 10
U2 70
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD MAR
PY 2016
VL 10
IS 3
BP 3282
EP 3294
DI 10.1021/acsnano.5b06605
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA DH5TR
UT WOS:000372855400029
PM 26885937
DA 2018-10-20
ER

PT J
AU Di Luca, A
   Longoni, A
   Criscenti, G
   Lorenzo-Moldero, I
   Klein-Gunnewiek, M
   Vancso, J
   van Blitterswijk, C
   Mota, C
   Moroni, L
AF Di Luca, Andrea
   Longoni, Alessia
   Criscenti, Giuseppe
   Lorenzo-Moldero, Ivan
   Klein-Gunnewiek, Michel
   Vancso, Julius
   van Blitterswijk, Clemens
   Mota, Carlos
   Moroni, Lorenzo
TI Surface energy and stiffness discrete gradients in additive manufactured
   scaffolds for osteochondral regeneration
SO BIOFABRICATION
LA English
DT Article
DE additive manufacturing; gradients; 3D scaffolds; stem cells;
   biomaterials
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; BONE-MARROW;
   IN-VITRO; SUBCHONDRAL BONE; GENE-EXPRESSION; DIFFERENTIATION; MATRIX;
   FATE; MECHANISMS
AB Swift progress in biofabrication technologies has enabled unprecedented advances in the application of developmental biology design criteria in three-dimensional scaffolds for regenerative medicine. Considering that tissues and organs in the human body develop following specific physico-chemical gradients, in this study, we hypothesized that additive manufacturing (AM) technologies would significantly aid in the construction of 3D scaffolds encompassing such gradients. Specifically, we considered surface energy and stiffness gradients and analyzed their effect on adult bone marrow derived mesenchymal stem cell differentiation into skeletal lineages. Discrete step-wise macroscopic gradients were obtained by sequentially depositing different biodegradable biomaterials in the AM process, namely poly(lactic acid) (PLA), polycaprolactone (PCL), and poly(ethylene oxide terephthalate)/poly(butylene terephthalate) (PEOT/PBT) copolymers. At the bulk level, PEOT/PBT homogeneous scaffolds supported a higher alkaline phosphatase (ALP) activity compared to PCL, PLA, and gradient scaffolds, respectively. All homogeneous biomaterial scaffolds supported also a significantly higher amount of glycosaminoglycans (GAGs) production compared to discrete gradient scaffolds. Interestingly, the analysis of the different material compartments revealed a specific contribution of PCL, PLA, and PEOT/PBT to surface energy gradients. Whereas PEOT/PBT regions were associated to significantly higher ALP activity, PLA regions correlated with significantly higher GAG production. These results show that cell activity could be influenced by the specific spatial distribution of different biomaterial chemistries in a 3D scaffold and that engineering surface energy discrete gradients could be considered as an appealing criterion to design scaffolds for osteochondral regeneration.
C1 [Di Luca, Andrea; Longoni, Alessia; Criscenti, Giuseppe; van Blitterswijk, Clemens; Moroni, Lorenzo] Univ Twente, Tissue Regenerat Dept, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
   [Criscenti, Giuseppe] Univ Pisa, Fac Engn, Res Ctr E Piaggio, Pisa, Italy.
   [Klein-Gunnewiek, Michel; Vancso, Julius] Univ Twente, Mat Sci & Technol Polymers Grp, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
   [Lorenzo-Moldero, Ivan; van Blitterswijk, Clemens; Mota, Carlos; Moroni, Lorenzo] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Complex Tissue Regenerat Grp, Univ Singel 40, NL-6229 ER Maastricht, Netherlands.
RP Moroni, L (reprint author), Univ Twente, Tissue Regenerat Dept, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.; Moroni, L (reprint author), Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Complex Tissue Regenerat Grp, Univ Singel 40, NL-6229 ER Maastricht, Netherlands.
EM l.moroni@maastrichtuniversity.nl
OI Mota, Carlos/0000-0001-5935-6245; Moroni, Lorenzo/0000-0003-1298-6025
FU Dutch Technology Foundation STW [11135]; Dutch Province of Limburg; NCRR
   of the NIH [P40RR017447]
FX This project was funded by the Dutch Technology Foundation STW (Grant
   number 11135). This project/research has been also made possible with
   the support of the Dutch Province of Limburg. Some of the materials used
   in this work were provided by the Texas A&M Health Science Center
   College of Medicine Institute for Regenerative Medicine at Scott & White
   through a grant from NCRR of the NIH (Grant #P40RR017447).
CR Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bartha Lajos, 2013, Eur J Orthop Surg Traumatol, V23, P81, DOI 10.1007/s00590-011-0907-6
   BRYNDA E, 1990, J COLLOID INTERF SCI, V139, P374, DOI 10.1016/0021-9797(90)90111-Z
   Buckwalter J.A., 1994, J AM ACAD ORTHOP SUR, V2, P192
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Claase MB, 2003, BIOMACROMOLECULES, V4, P57, DOI 10.1021/bm0256045
   de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Ding CM, 2013, BIOMATERIALS, V34, P6706, DOI 10.1016/j.biomaterials.2013.05.038
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Emans PJ, 2013, J TISSUE ENG REGEN M, V7, P751, DOI 10.1002/term.1477
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Eyre D, 2002, ARTHRITIS RES, P4
   Ferguson VL, 2003, J ANAT, V203, P191, DOI 10.1046/j.1469-7580.2003.00193.x
   Ge ZG, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/021001
   Ghazavi MT, 1997, J BONE JOINT SURG BR, V79B, P1008, DOI 10.1302/0301-620X.79B6.7534
   Grogan SP, 2013, ARTHRITIS RHEUM-US, V65, P418, DOI 10.1002/art.37760
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hendrikson WJ, 2015, RSC ADV, V5, P54510, DOI 10.1039/c5ra08048g
   Heymer A, 2009, J TISSUE ENG REGEN M, V3, P389, DOI 10.1002/term.175
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Knychala J, 2013, ANN BIOMED ENG, V41, P917, DOI 10.1007/s10439-013-0748-z
   Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/1757-6512-4-117
   Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Liu XD, 2014, J BIOMED MATER RES B, V102, P1407, DOI 10.1002/jbm.b.33119
   Lu HX, 2012, BIOMATERIALS, V33, P6140, DOI 10.1016/j.biomaterials.2012.05.038
   MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179
   Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MOW VC, 1991, J BIOMECH ENG-T ASME, V113, P198, DOI 10.1115/1.2891235
   Muller Sandra, 2010, Open Orthop J, V4, P111, DOI 10.2174/1874325001004020111
   Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720
   Richardson J B, 2008, BR MED B, P77
   Salerno A, 2012, MATER LETT, V82, P137, DOI 10.1016/j.matlet.2012.05.072
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Woodfield Cavb T B F, 2005, TISSUE ENG, V11, P1297
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110
NR 58
TC 5
Z9 7
U1 5
U2 61
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2016
VL 8
IS 1
AR 015014
DI 10.1088/1758-5090/8/1/015014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DI1WZ
UT WOS:000373289000018
PM 26924824
DA 2018-10-20
ER

PT J
AU Kusamori, K
   Katsumi, H
   Sakai, R
   Hayashi, R
   Hirai, Y
   Tanaka, Y
   Hitomi, K
   Quan, Y
   Kamiyama, F
   Yamada, K
   Sumida, S
   Kishi, K
   Hashiba, K
   Sakane, T
   Yamamoto, A
AF Kusamori, Kosuke
   Katsumi, Hidemasa
   Sakai, Ryota
   Hayashi, Rie
   Hirai, Yuka
   Tanaka, Yutaro
   Hitomi, Kaori
   Quan, Ying-shu
   Kamiyama, Fumio
   Yamada, Keigo
   Sumida, Shun-ichiro
   Kishi, Kazumasa
   Hashiba, Katsunori
   Sakane, Toshiyasu
   Yamamoto, Akira
TI Development of a drug-coated microneedle array and its application for
   transdermal delivery of interferon alpha
SO BIOFABRICATION
LA English
DT Article
DE antitumor effect; interferon alpha; microneedle arrays; transdermal drug
   delivery
ID HEPATITIS-C; CELL-PROLIFERATION; HYALURONIC-ACID; IN-VIVO; THERAPY;
   RESPONSES; SKIN; PHARMACOKINETICS; CARCINOMA; INNATE
AB Interferon alpha (IFN alpha) is one of the most famous drugs for the treatment of chronic hepatitis C and various types of human malignancy. Protein drugs, including IFN alpha, are generally administered by subcutaneous or intramuscular injection due to their poor permeability and low stability in the bloodstream or gastrointestinal tract. Therefore, in the present study, novel IFN alpha-coated polyvinyl alcohol-based microneedle arrays (IFN alpha-MNs) were fabricated for the transdermal delivery of IFN alpha without the painful injection. IFN alpha was rapidly released from MNs in phosphate buffered solution and these MNs presented piercing ability in the rat skin. Slight erythema and irritation were observed when MNs were applied to the rat skin, but these skin damages completely disappeared within 24 h after removing the IFN alpha-MNs. Furthermore, the pharmacokinetic parameters of IFN alpha-MNs were similar to those of IFN alpha subcutaneous administration. Finally, IFN alpha-MNs showed a significant antitumor effect in tumor bearing mice similar to that of IFN alpha subcutaneous administration. These results indicate that IFN alpha-MNs are a useful biomaterial tool for protein drug therapy and can improve the quality of life in patients by avoidance of painful injections.
C1 [Kusamori, Kosuke; Katsumi, Hidemasa; Sakai, Ryota; Hayashi, Rie; Hirai, Yuka; Tanaka, Yutaro; Hitomi, Kaori; Quan, Ying-shu; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan.
   [Quan, Ying-shu; Kamiyama, Fumio] CosMED Pharmaceut Co Ltd, Minami Ku, Kyoto 6018014, Japan.
   [Yamada, Keigo; Sumida, Shun-ichiro; Kishi, Kazumasa; Hashiba, Katsunori] Otsuka Pharmaceut Co Ltd, 224-18 Ebisuno Hiraishi, Kawaguchi, Tokushima 7710182, Japan.
RP Katsumi, H (reprint author), Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan.
EM hkatsumi@mb.kyoto-phu.ac.jp
FU Mochida Memorial Foundation for Medical and Pharmaceutical Research
FX This work was supported in part by a grant from the Mochida Memorial
   Foundation for Medical and Pharmaceutical Research.
CR Bariya SH, 2012, J PHARM PHARMACOL, V64, P11, DOI 10.1111/j.2042-7158.2011.01369.x
   Bashir SJ, 2001, SKIN RES TECHNOL, V7, P40, DOI 10.1034/j.1600-0846.2001.007001040.x
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x
   BRILLANTI S, 1994, GASTROENTEROLOGY, V107, P812, DOI 10.1016/0016-5085(94)90131-7
   Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159
   Gomaa YA, 2010, TOXICOL IN VITRO, V24, P1971, DOI 10.1016/j.tiv.2010.08.012
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439
   Imran M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-299
   Indermun S, 2014, J CONTROL RELEASE, V185, P130, DOI 10.1016/j.jconrel.2014.04.052
   Jain A, 2014, CRIT REV THER DRUG, V31, P219, DOI 10.1615/CritRevTherDrugCarrierSyst.2014008126
   JANIK P, 1975, CANCER RES, V35, P3698
   Kalia YN, 2000, PHARMACEUT RES, V17, P1148, DOI 10.1023/A:1026474200575
   Kalluri H, 2011, AAPS J, V13, P473, DOI 10.1208/s12248-011-9288-3
   Katsumi H, 2012, J PHARM SCI-US, V101, P3230, DOI 10.1002/jps.23136
   Krejcova D, 2009, GEN PHYSIOL BIOPHYS, V28, P294, DOI 10.4149/gpb_2009_03_294
   Kusamori K, 2010, J BONE MINER RES, V25, P2306, DOI 10.1002/jbmr.147
   Lim JYH, 2014, CANCER IMMUNOL IMMUN, V63, P259, DOI 10.1007/s00262-013-1506-7
   Liu S, 2014, EUR J PHARM BIOPHARM, V86, P267, DOI 10.1016/j.ejpb.2013.10.001
   Liu S, 2012, J CONTROL RELEASE, V161, P933, DOI 10.1016/j.jconrel.2012.05.030
   Liu X, 2012, CURR CANCER DRUG TAR, V12, P561, DOI 10.2174/156800912800673293
   Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029
   Naik A, 2000, PHARM SCI TECHNOL TO, V3, P318, DOI DOI 10.1016/S1461-5347(00)00295-9
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   RADWANSKI E, 1987, J CLIN PHARMACOL, V27, P432, DOI 10.1002/j.1552-4604.1987.tb03044.x
   Pierre MBR, 2014, CURR DRUG TARGETS, V15, P281
   Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x
   Thomas HC, 1999, HEPATOLOGY, V29, P1333, DOI 10.1002/hep.510290453
   Wu D, 2015, BIOL PHARM BULL, V38, P365, DOI 10.1248/bpb.b14-00502
   YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109
   YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879
   Yan GA, 2010, INT J PHARMACEUT, V391, P7, DOI 10.1016/j.ijpharm.2010.02.007
   Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06
NR 34
TC 7
Z9 9
U1 4
U2 45
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2016
VL 8
IS 1
AR 015006
DI 10.1088/1758-5090/8/1/015006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DI1WZ
UT WOS:000373289000010
PM 26756832
DA 2018-10-20
ER

PT J
AU Nagasawa, M
   Cooper, LF
   Ogino, Y
   Mendonca, D
   Liang, R
   Yang, S
   Mendonca, G
   Uoshima, K
AF Nagasawa, M.
   Cooper, L. F.
   Ogino, Y.
   Mendonca, D.
   Liang, R.
   Yang, S.
   Mendonca, G.
   Uoshima, K.
TI Topography Influences Adherent Cell Regulation of Osteoclastogenesis
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE biomaterial; dental implant; osteoblast; osteoclast; osseointegration;
   tissue engineering
ID TITANIUM IMPLANTS; BONE INTEGRATION; RAT MAXILLA; OSSEOINTEGRATION;
   NANOTOPOGRAPHY; OSTEOGENESIS; EXPRESSION; RESPONSES; SURFACES; MICRON
AB The importance of osteoclast-mediated bone resorption in the process of osseointegration has not been widely considered. In this study, cell culture was used to investigate the hypothesis that the function of implant-adherent bone marrow stromal cells (BMSCs) in osteoclastogenesis is influenced by surface topography. BMSCs isolated from femur and tibia of Sprague-Dawley rats were seeded onto 3 types of titanium surfaces (smooth, micro, and nano) and a control surface (tissue culture plastic) with or without osteogenic supplements. After 3 to 14 d, conditioned medium (CM) was collected. Subsequently, rat bone marrow-derived macrophages (BMMs) were cultured in media supplemented with soluble receptor activator of NF-kappa B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) as well as BMSC CM from each of the 4 surfaces. Gene expression levels of soluble RANKL, osteoprotegerin, tumor necrosis factor a, and M-CSF in cultured BMSCs at different time points were measured by real-time polymerase chain reaction. The number of differentiated osteoclastic cells was determined after tartrate-resistant acid phosphatase staining. Analysis of variance and t test were used for statistical analysis. The expression of prominent osteoclast-promoting factors tumor necrosis factor a and M-CSF was increased by BMSCs cultured on both micro-and nanoscale titanium topographies (P < 0.01). BMSC CM contained a heat-labile factor that increased BMMs osteoclastogenesis. CM from both micro-and nanoscale surface-adherent BMSCs increased the osteoclast number (P < 0.01). Difference in surface topography altered BMSC phenotype and influenced BMM osteoclastogenesis. Local signaling by implant-adherent cells at the implant-bone interface may indirectly control osteoclastogenesis and bone accrual around endosseous implants.
C1 [Nagasawa, M.; Cooper, L. F.; Liang, R.] Univ N Carolina, Sch Dent, Bone Biol & Implant Therapy Lab, 4610 Koury Oral Hlth Sci Bldg CB 7450, Chapel Hill, NC 27599 USA.
   [Nagasawa, M.; Uoshima, K.] Niigata Univ, Grad Sch Med & Dent Sci, Div Bioprosthodont, Niigata, Japan.
   [Ogino, Y.] Kyushu Univ, Dept Oral Rehabil, Fukuoka 812, Japan.
   [Mendonca, D.; Mendonca, G.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Div Prosthodont, Ann Arbor, MI 48109 USA.
   [Yang, S.] Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China.
RP Cooper, LF (reprint author), Univ N Carolina, Sch Dent, Bone Biol & Implant Therapy Lab, 4610 Koury Oral Hlth Sci Bldg CB 7450, Chapel Hill, NC 27599 USA.
EM Lyndon_Cooper@unc.edu
OI Cooper, Lyndon/0000-0002-6577-781X
FU UNC DENTSPLY PDPA
FX This work was financially supported by UNC DENTSPLY PDPA. The authors
   thank Dr. Yujin Aoyagi for his assistance with the titanium surface
   analysis. The authors declare no potential conflicts of interest with
   respect to the authorship and/or publication of this article.
CR Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023
   Bosshardt DD, 2011, CLIN ORAL IMPLAN RES, V22, P357, DOI 10.1111/j.1600-0501.2010.02107.x
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Fujii N, 1998, J PERIODONTOL, V69, P485, DOI 10.1902/jop.1998.69.4.485
   Futami T, 2000, J PERIODONTOL, V71, P287, DOI 10.1902/jop.2000.71.2.287
   Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x
   Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107
   Kitaura H, 2013, CLIN DEV IMMUNOL, V2013
   Klokkevold PR, 2007, INT J ORAL MAX IMPL, V22, P173
   Kupcova SH., 2013, BIOCHIMIE, V95, P2196, DOI DOI 10.1016/J.BIOCHI.2013.07.015
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Luo E, 2012, ACTA BIOMATER, V8, P734, DOI 10.1016/j.actbio.2011.10.029
   Masuda T, 1997, INT J ORAL MAX IMPL, V12, P472
   Matsubara R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047930
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mendonca G, 2010, J BIOMED MATER RES A, V94A, P169, DOI 10.1002/jbm.a.32701
   Minkin C, 1999, Adv Dent Res, V13, P49
   Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062
   Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200
   Ogino Y, 2016, J CELL PHYSIOL, V231, P568, DOI 10.1002/jcp.25100
   Ogle Orrett E, 2015, Dent Clin North Am, V59, P505, DOI 10.1016/j.cden.2014.12.003
   Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309
   Palmquist A, 2013, CLIN IMPLANT DENT R, V15, P96, DOI 10.1111/j.1708-8208.2011.00361.x
   Passeri G, 2010, CLIN ORAL IMPLAN RES, V21, P756, DOI 10.1111/j.1600-0501.2009.01906.x
   Schwartz Z, 2009, BIOMATERIALS, V30, P3390, DOI 10.1016/j.biomaterials.2009.03.047
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Shibata Y, 2015, J PROSTHODONT RES, V59, P20, DOI 10.1016/j.jpor.2014.11.007
   Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766
   Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102
   Thakral G. K., 2014, J CLIN DIAGN RES, V8, pZE07
   Thalji Ghadeer, 2014, Int J Oral Maxillofac Implants, V29, pe171, DOI 10.11607/jomi.te55
   Thalji G, 2013, INT J ORAL MAX IMPL, V28, pE521, DOI 10.11607/jomi.te33
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 34
TC 4
Z9 4
U1 2
U2 18
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2016
VL 95
IS 3
BP 319
EP 326
DI 10.1177/0022034515616760
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DH8YJ
UT WOS:000373082500010
PM 26553885
DA 2018-10-20
ER

PT J
AU Sheikh, FA
   Ju, HW
   Moon, BM
   Lee, OJ
   Kim, JH
   Park, HJ
   Kim, DW
   Kim, DK
   Jang, JE
   Khang, G
   Park, CH
AF Sheikh, Faheem A.
   Ju, Hyung Woo
   Moon, Bo Mi
   Lee, Ok Joo
   Kim, Jung-Ho
   Park, Hyun Jung
   Kim, Dong Wook
   Kim, Dong-Kyu
   Jang, Ji Eun
   Khang, Gilson
   Park, Chan Hum
TI Hybrid scaffolds based on PLGA and silk for bone tissue engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE silk; PLGA; osteoblasts; hard tissue; hydrophilic; cell viability
ID POLY(LACTIC-CO-GLYCOLIC ACID); HYDROXYAPATITE NANOPARTICLES;
   MECHANICAL-PROPERTIES; FIBROIN SCAFFOLDS; GROWTH-FACTOR; BIOMATERIALS;
   FABRICATION; COMPOSITES; NANOFIBERS; MORPHOLOGY
AB Porous silk scaffolds, which are considered to be natural polymers, cannot be used alone because they have a long degradation rate, which makes it difficult for them to be replaced by the surrounding tissue. Scaffolds composed of synthetic polymers, such as PLGA, have a short degradation rate, lack hydrophilicity and their release of toxic by-products makes them difficult to use. The present investigations aimed to study hybrid scaffolds fabricated from PLGA, silk and hydroxyapatite nanoparticles (Hap NPs) for optimized bone tissue engineering. The results from variable-pressure field emission scanning electron microscopy (VP-FE-SEM), equipped with EDS, confirmed that the fabricated scaffolds had a porous architecture, and the location of each component present in the scaffolds was examined. Contact angle measurements confirmed that the introduction of silk and HAp NPs helped to change the hydrophobic nature of PLGA to hydrophilic, which is the main constraint for PLGA used as a biomaterial. Thermo-gravimetric analysis (TGA) and FT-IR spectroscopy confirmed thermal decomposition and different vibrations caused in functional groups of compounds used to fabricate the scaffolds, which reflected improvement in their mechanical properties. After culturing osteoblasts for 1, 7 and 14 days in the presence of scaffolds, their viability was checked by MTT assay. The fluorescent microscopy results revealed that the introduction of silk and HAp NPs had a favourable impact on the infiltration of osteoblasts. In vivo experiments were conducted by implanting scaffolds in rat calvariae for 4 weeks. Histological examinations and micro-CT scans from these experiments revealed beneficial attributes offered by silk fibroin and HAp NPs to PLGA-based scaffolds for bone induction. Copyright (C) 2015 John Wiley & Sons, Ltd.
C1 [Sheikh, Faheem A.; Ju, Hyung Woo; Moon, Bo Mi; Lee, Ok Joo; Kim, Jung-Ho; Park, Hyun Jung; Kim, Dong Wook; Kim, Dong-Kyu; Park, Chan Hum] Hallym Univ, Coll Med, Nanobio Regenerat Med Inst, Chunchon, South Korea.
   [Kim, Dong-Kyu; Park, Chan Hum] Hallym Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chunchon 200704, South Korea.
   [Jang, Ji Eun; Khang, Gilson] Chonbuk Natl Univ, Polymer Fus Res Ctr, Jeonju 561756, South Korea.
RP Park, CH (reprint author), Hallym Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chunchon 200704, South Korea.
EM hlpch@paran.com
RI Park, Chan Hum/C-6848-2016; Sheikh, Faheem/Q-9166-2018
OI Sheikh, Faheem/0000-0003-0942-4398; Kim, Dong-Kyu/0000-0003-4917-0177
FU Hallym University Research Fund; Bio-industry Technology Development,
   Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
   Korea [112007-05-3-SB010]
FX This research was supported by Hallym University Research Fund and the
   Bio-industry Technology Development, Ministry for Food, Agriculture,
   Forestry and Fisheries, Republic of Korea (Grant Nos 112007-05-3-SB010).
   The authors are grateful to Dr Ju-Suk Nam at Hallym University for the
   gift of osteoblasts, and to Cell and Gene Biotechnology, Korea, for
   providing hydroxyapatite nanoparticles. The authors are grateful to the
   Korean Basic Science Institute, Chuncheon branch, for providing
   facilities to perform VP-FE-SEM investigations.
CR Arrington E D, 1996, Clin Orthop Relat Res, P300, DOI 10.1097/00003086-199608000-00037
   ASKEW MJ, 1990, J BIOMED MATER RES, V24, P573, DOI 10.1002/jbm.820240504
   Barakat NAM, 2008, MAT SCI ENG C-BIO S, V28, P1381, DOI 10.1016/j.msec.2008.03.003
   Baroli B, 2009, J PHARM SCI-US, V98, P1317, DOI 10.1002/jps.21528
   Choi JS, 2013, TISSUE ENG PT A, V19, P329, DOI [10.1089/ten.tea.2011.0738, 10.1089/ten.TEA.2011.0738]
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Cuddihy MJ, 2008, TISSUE ENG PT A, V14, P1639, DOI 10.1089/ten.tea.2007.0142
   Dang MH, 1996, J ENVIRON POLYM DEGR, V4, P197, DOI 10.1007/BF02067453
   Dimitriou R., 2011, BMC MED, V9, P1
   Ebrahimian-Hosseinabadi M, 2011, J MATER SCI TECHNOL, V27, P1105, DOI 10.1016/S1005-0302(12)60004-8
   Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Hsieh WC, 2007, COLLOID SURFACE B, V57, P250, DOI 10.1016/j.colsurfb.2007.02.004
   Ju HW, 2014, J BIOMED MATER RES A, V102, P2713, DOI 10.1002/jbm.a.34947
   Kim HY, 2017, J TISSUE ENG REGEN M, V11, P44, DOI 10.1002/term.1856
   Lanao RPF, 2013, TISSUE ENG PART B-RE, V19, P380, DOI [10.1089/ten.teb.2012.0443, 10.1089/ten.TEB.2012.0443]
   Li C, 2012, J BIOMAT SCI-POLYM E, V23, P405, DOI 10.1163/092050610X551970
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Magdalena S, 2008, BIOMED NANOTECHNOL, V4, P349
   Mura S, 2011, INT J NANOMED, V6, P2591, DOI 10.2147/IJN.S24552
   Ng KS, 2009, IFMBE PROC, V23, P1381
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Pommer A, 2002, J BONE JOINT SURG AM, V84A, P1162, DOI 10.2106/00004623-200207000-00011
   Popp JR, 2011, J TISSUE ENG REGEN M, V5, P780, DOI 10.1002/term.376
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Rubert M, 2012, BIOINTERPHASES, V18, P1253
   Saithna A, 2010, INJURY, V41, P128, DOI 10.1016/j.injury.2009.01.001
   SALAMA R, 1978, J BONE JOINT SURG BR, V60, P111
   Sheikh FA, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-303
   Sheikh FA, 2011, J BIOMATER TISS ENG, V1, P194, DOI 10.1166/jbt.2011.1017
   Sheikh FA, 2010, MACROMOL RES, V18, P59, DOI 10.1007/s13233-009-0111-2
   Shepperd JAN, 2005, J BONE JOINT SURG BR, V87B, P1046, DOI 10.1302/0301-620X.87B8.16692
   SOUCACOS PN, 2008, INJURY S2, V39, pS1
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Tigli RS, 2011, J BIOMED MATER RES A, V96A, P21, DOI 10.1002/jbm.a.32949
   Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 39
TC 15
Z9 15
U1 3
U2 42
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2016
VL 10
IS 3
BP 209
EP 221
DI 10.1002/term.1989
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DH6RV
UT WOS:000372920000011
PM 25628059
DA 2018-10-20
ER

PT J
AU Shin, HY
   Frechette, DM
   Rohner, N
   Zhang, XY
   Puleo, DA
   Bjursten, LM
AF Shin, Hainsworth Y.
   Frechette, Danielle M.
   Rohner, Nathan
   Zhang, Xiaoyan
   Puleo, David A.
   Bjursten, Lars M.
TI Dependence of macrophage superoxide release on the pulse amplitude of an
   applied pressure regime: a potential factor at the soft tissue-implant
   interface
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE mechanotransduction; macrophage; pressure; cell adhesion; superoxide;
   tissue-implant interface
ID PROMYELOCYTIC LEUKEMIA-CELLS; IN-VITRO; HUMAN MONOCYTE/MACROPHAGES;
   EXTRACELLULAR PRESSURE; HYDROSTATIC-PRESSURE; CYTOKINE PRODUCTION;
   CYCLIC PRESSURE; NADPH OXIDASE; PROPOSED ROLE; PHAGOCYTOSIS
AB Failure of soft tissue implants has been largely attributed to the influence of biomaterial surface properties on the foreign body response, but some implant complications, e.g. macrophage accumulation and necrosis, are still not effectively addressed with surface treatments to minimize deleterious biomaterial effects. We explored an alternative explanation for implant failure, linking biocompatibility with implant micromotion-induced pressure fluctuations at the tissue-biomaterial interface. For this purpose, we used a custom in vitro system to characterize the effects of pressure fluctuations on the activity of macrophages, the predominant cells at a healing implant site. Initially, we quantified superoxide production by HL60-derived macrophage-like cells under several different pressure regimes with means of 5-40mmHg, amplitudes of 0-15mmHg and frequencies of 0-1.5 Hz. All pressure regimes tested elicited significantly (p < 0.05) reduced superoxide production by macrophage-like cells relative to parallel controls. Notably, pressure-sensitive reductions in superoxide release correlated (r(2) = 0.74; p < 0.01) only with pulse pressures. Based on the connection between superoxide production and cell viability, we also explored the influence of cyclic pressure on macrophage numbers and death. Compared to controls, adherent macrophage-like cells exposed to 7.5/2.5 mmHg cyclic pressures for 6 h exhibited significantly (p < 0.01) reduced cell numbers, independent of cell death. A similar effect was observed for cells treated with 10 U/ml superoxide dismutase. Collectively, our results suggest that pressure pulses are a putative regulator of macrophage adhesion via a superoxide-related effect. Pressure fluctuations, e.g. due to implant micromotion, may, therefore, potentially modulate macrophage-dependent wound healing. Copyright (C) 2013 John Wiley & Sons, Ltd.
C1 [Shin, Hainsworth Y.; Frechette, Danielle M.; Rohner, Nathan; Zhang, Xiaoyan; Puleo, David A.] Univ Kentucky, Ctr Biomed Engn, Lexington, KY USA.
   [Bjursten, Lars M.] Lund Univ, Clin Sci, Malmo, Sweden.
RP Shin, HY (reprint author), Univ Kentucky, Ctr Biomed Engn, Wenner Gren Res Lab, Lexington, KY 40506 USA.
EM hy.shin@uky.edu
FU University of Kentucky Research Support Fund; National Science
   Foundation Research Experiences for Undergraduates; American Heart
   Association Beginning-Grant-Aid; NSF-Kentucky EPSCoR Bioengineering
   Initiative grant
FX This study was supported by the University of Kentucky Research Support
   Fund (to H.Y.S.), an American Heart Association Beginning-Grant-Aid (to
   H.Y.S.), a National Science Foundation Research Experiences for
   Undergraduates (to D.M.F. and N.R.; PI, K. W. Anderson) and an
   NSF-Kentucky EPSCoR Bioengineering Initiative grant (to X.Z.; PIs, J.
   Connelly and R. Andrews). We thank Dr S. Lai-Fook and Dr E. Bruce of the
   Center for Biomedical Engineering, University of Kentucky, for their
   technical and material assistance with setting up the pressure system.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Andrade J D, 1973, Med Instrum, V7, P110
   AUKLAND K, 1993, PHYSIOL REV, V73, P1
   Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126
   Bauer G, 2002, PROSTAG LEUKOTR ESS, V66, P41, DOI 10.1054/plef.2001.0332
   Beriault DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031320
   Bertram P, 1997, LANGENBECK ARCH CHIR, V382, P291, DOI 10.1007/s004230050069
   Bhalla S, 2009, AM J SURG, V198, P611, DOI 10.1016/j.amjsurg.2009.07.006
   Boutonnat J, 1999, CELL PROLIFERAT, V32, P203, DOI 10.1046/j.1365-2184.1999.3240203.x
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Cathcart MK, 2004, ARTERIOSCL THROM VAS, V24, P23, DOI 10.1161/01.ATV.0000097769.47306.12
   COLLINS SJ, 1987, BLOOD, V70, P1233
   Crowther JE, 2004, J IMMUNOL, V172, P6866, DOI 10.4049/jimmunol.172.11.6866
   Evans CE, 2008, ATHEROSCLEROSIS, V197, P596, DOI 10.1016/j.atherosclerosis.2007.08.027
   Ferrier GM, 2000, J BONE JOINT SURG BR, V82B, P755, DOI 10.1302/0301-620X.82B5.9561
   Fleming AJ, 2003, TISSUE ENG, V9, P1023, DOI 10.1089/107632703322495664
   Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189
   Fujishiro T, 2004, J BIOMED MATER RES A, V68A, P531, DOI 10.1002/jbm.a..20098
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   Guyton A.C., 1996, TXB MED PHYSL
   HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407
   Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P632
   HICKSTEIN DD, 1987, J IMMUNOL, V138, P513
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Ko JK, 2011, J BIOL CHEM, V286, P9038, DOI 10.1074/jbc.M110.198457
   Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786
   Matheson LA, 2006, J BIOMED MATER RES A, V76A, P52, DOI 10.1002/jbm.a.30448
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MCCARTHY KF, 1988, TOXICOL LETT, V43, P219, DOI 10.1016/0378-4274(88)90030-6
   McEvoy A, 2002, BONE, V30, P171
   Miguel L, 2011, J IMMUNOL, V186, P3505, DOI 10.4049/jimmunol.1002980
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Park JB, 2003, EXP MOL MED, V35, P325, DOI 10.1038/emm.2003.44
   Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5
   Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   Rosengren A, 1999, J BIOMED MATER RES, V46, P458, DOI 10.1002/(SICI)1097-4636(19990915)46:4<458::AID-JBM3>3.0.CO;2-I
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779
   Sakamoto H, 2001, CIRCULATION, V104, P109, DOI 10.1161/hc2701.091070
   Sampathkumar K, 2003, J BONE JOINT SURG BR, V85B, P288, DOI 10.1302/0301-620X.85B2.13211
   Schaser KD, 2003, LANGENBECK ARCH SURG, V388, P323, DOI 10.1007/s00423-003-0411-5
   Shin HY, 2012, TISSUE ENG PT A, V18, P2590, DOI [10.1089/ten.tea.2011.0588, 10.1089/ten.TEA.2011.0588]
   Shiratsuch H, 2005, AM J SURG, V190, P757, DOI 10.1016/j.amjsurg.2005.07.016
   Shiratsuchi H, 2005, AM J PHYSIOL-CELL PH, V288, pC1083, DOI 10.1152/ajpcell.00543.2004
   Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003
   Shiratsuchi H, 2007, J CELL BIOCHEM, V102, P353, DOI 10.1002/jcb.21295
   SKARLATOS S, 1994, J PHYSIOL-LONDON, V481, P743, DOI 10.1113/jphysiol.1994.sp020478
   Stromberg DD, 1977, MICROCIRCULATION
   Sven K, 2007, ADV PHYSIOL EDUC, V31, P116, DOI 10.1152/advan.00084.2006
   Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019
   Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629
   Victor VM, 1998, MOL CELL BIOCHEM, V189, P25, DOI 10.1023/A:1006891926301
   Yang PY, 2009, MOL CANCER THER, V8, P2319, DOI 10.1158/1535-7163.MCT-08-1085
   Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y
   Yokoyama Y, 2009, BLOOD, V113, P6584, DOI 10.1182/blood-2008-06-160838
NR 65
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2016
VL 10
IS 3
BP E227
EP E238
DI 10.1002/term.1789
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DH6RV
UT WOS:000372920000008
PM 23881832
DA 2018-10-20
ER

PT J
AU Viateau, V
   Manassero, M
   Sensebe, L
   Langonne, A
   Marchat, D
   Logeart-Avramoglou, D
   Petite, H
   Bensidhoum, M
AF Viateau, Veronique
   Manassero, Mathieu
   Sensebe, Luc
   Langonne, Alain
   Marchat, David
   Logeart-Avramoglou, Delphine
   Petite, Herve
   Bensidhoum, Morad
TI Comparative study of the osteogenic ability of four different ceramic
   constructs in an ectopic large animal model
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bone tissue engineering; bone formation; mesenchymal stem cells; ceramic
   scaffolds; osteogenesis; scaffold resorption; osteoconduction
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; LONG-BONE DEFECTS;
   STABILIZED TRICALCIUM PHOSPHATE; CRITICAL-SIZE DEFECTS; IN-VIVO; TISSUE;
   SHEEP; RECONSTRUCTION; REGENERATION
AB Tissue-engineered constructs combining bone marrow mesenchymal stem cells with biodegradable osteoconductive scaffolds are very promising for repairing large segmental bone defects. Synchronizing and controlling the balance between scaffold-material resorption and new bone tissue formation are crucial aspects for the success of bone tissue engineering. The purpose of the present study was to determine, and compare, the osteogenic potential of ceramic scaffolds with different resorbability. Four clinically relevant granular biomaterial scaffolds (specifically, Porites coral, Acropora coral, beta-tricalcium phosphate and banked bone) with or without autologous bone marrow stromal cells were implanted in the ectopic, subcutaneous-pouch sheep model. Scaffold material resorption and new bone formation were assessed eight weeks after implantation. New bone formation was only detected when the biomaterial constructs tested contained MSCs. New bone formation was higher in the Porites coral and Acropora coral than in either the beta-tricalcium phosphate or the banked bone constructs; furthermore, there was a direct correlation between scaffold resorption and bone formation. The results of the present study provide evidence that, among the biomaterials tested, coral scaffolds containing MSCs promoted the best new bone formation in the present study. Copyright (C) 2013 John Wiley & Sons, Ltd.
C1 [Viateau, Veronique; Manassero, Mathieu; Logeart-Avramoglou, Delphine; Petite, Herve; Bensidhoum, Morad] Univ Paris 07, PRES Paris Cite, UMR CNRS 7052 B2OA, Lab Bioengn & Biomech Bone Articulat, Paris, France.
   [Sensebe, Luc; Langonne, Alain] CNRS UPS EFS, UMR5273, Etablissement Francais Sang Ctr Atlantique, Tours, France.
   [Viateau, Veronique; Manassero, Mathieu] Ecole Natl Vet Alfort, Maisons Alfort, France.
   [Marchat, David] Ecole Natl Super Mines, CIS, F-42023 St Etienne, France.
RP Bensidhoum, M (reprint author), Univ Paris Diderot, UMR CNRS 7052, Lab Bioingn & Biomacan Osteo Articulaires B2OA, 10 Ave Verdun, F-75010 Paris, France.
EM morad.bensidhoum@paris7.jussieu.fr
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060; Bensidhoum,
   Morad/0000-0002-6621-6010; Manassero, Mathieu/0000-0003-1267-5120;
   Logeart-Avramoglou, Delphine/0000-0002-2052-9425
FU Delegation a la Recherche Clinique de l'Assistance Publique des Hopitaux
   de Paris; Centre National de Recherche Scientifique; ANR therabone
FX The authors thank Dr N. Guillemin (for her kind assistance with this
   study), Prof. R. Bizios (for her valuable comments on the manuscript),
   Biocoral, Inc., (for donating the coral scaffolds), Biobank, Inc., (for
   donating the banked bone) and Valentin Myrtil (for excellent technical
   support). We also acknowledge financial support from la Delegation a la
   Recherche Clinique de l'Assistance Publique des Hopitaux de Paris, from
   Centre National de Recherche Scientifique, and from ANR therabone.
CR Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Bensaid W, 2005, TISSUE ENG, V11, P814, DOI 10.1089/ten.2005.11.814
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Catros S, 2009, J ORTHOP RES, V27, P155, DOI 10.1002/jor.20738
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   DEBOER HH, 1989, J BONE JOINT SURG BR, V71, P374
   Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03
   Fouillard L, 2003, LEUKEMIA, V17, P474, DOI 10.1038/sj.leu.2402786
   Frayssinet P, 1998, BIOMATERIALS, V19, P2247, DOI 10.1016/S0142-9612(98)00124-0
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   FRIEDLAENDER GE, 1991, J BONE JOINT SURG AM, V73A, P1119, DOI 10.2106/00004623-199173080-00001
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HAN CS, 1992, J BONE JOINT SURG AM, V74A, P1441, DOI 10.2106/00004623-199274100-00002
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kitamura M, 2004, J MATER SCI-MATER M, V15, P1153, DOI 10.1023/B:JMSM.0000046399.40310.47
   Klaue K, 2009, INJURY, V40, pS95, DOI 10.1016/j.injury.2009.10.043
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kruyt MC, 2007, BIOMATERIALS, V28, P1798, DOI 10.1016/j.biomaterials.2006.11.038
   Liu GP, 2008, J MATER SCI-MATER M, V19, P2367, DOI 10.1007/s10856-007-3348-3
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   MAY JW, 1989, J BONE JOINT SURG AM, V71A, P1422, DOI 10.2106/00004623-198971090-00027
   Nair MB, 2010, TISSUE ENG PT A, V16, P385, DOI [10.1089/ten.tea.2009.0207, 10.1089/ten.TEA.2009.0207]
   Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   van der Pol U, 2010, ACTA BIOMATER, V6, P3755, DOI 10.1016/j.actbio.2010.03.028
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   Viateau V, 2010, ORTHOP CLIN N AM, V41, P49, DOI 10.1016/j.ocl.2009.07.010
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 43
TC 11
Z9 11
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2016
VL 10
IS 3
BP E177
EP E187
DI 10.1002/term.1782
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DH6RV
UT WOS:000372920000003
PM 23784976
DA 2018-10-20
ER

PT J
AU Liow, SS
   Dou, QQ
   Kai, D
   Karim, AA
   Zhang, KY
   Xu, FJ
   Loh, XJ
AF Liow, Sing Shy
   Dou, Qingqing
   Kai, Dan
   Karim, Anis Abdul
   Zhang, Kangyi
   Xu, Fujian
   Loh, Xian Jun
TI Thermogels: In Situ Gelling Biomaterial
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Review
DE injectable hydrogels; thermosensitive polymers; LCST; sol-gel transition
ID COPOLYMER AQUEOUS-SOLUTIONS; MESENCHYMAL STEM-CELLS; TRANSFER RADICAL
   POLYMERIZATION; PLGA-PEG-PLGA; PHYSIOLOGICALLY RELEVANT CONDITIONS;
   BIODEGRADABLE BLOCK-COPOLYMERS; CONTROLLED-RELEASE FORMULATION; LOW
   GELATION CONCENTRATIONS; PHASE-TRANSITION BEHAVIOR; THERMAL GEL DEPOT
AB In situ gel delivery systems are preferred over conventional systems due to sustained and prolonged release action of therapeutic payload onto the targeted site. Thermogel, a form of in situ gel-forming polymeric formulation, undergoes sol gel transition after administration into the body. At room temperature, the system is an aqueous polymer solution that easily entraps therapeutic payload by mixing. Upon injection, the higher physiological temperature causes gelation in situ because of the presence of thermosensitive polymers. The gel degrades gradually over time, allowing sustained release of therapeutics localized to the site of interest. This minimizes systemic toxicity and improved efficacy of drug release to the targeted site. Thermogel properties can be easily altered for specific applications via substitution and modification of components in diblock and triblock copolymer systems. The feasibility of fine-tuning allows modifications to biodegradability, biocompatibility, biological functionalization, mechanical properties, and drug release profile. This review summarized recent development in thermogel research with a focus on synthesis and self-assembly mechanisms, gel biodegradability, and applications for drug delivery, cell encapsulation and tissue engineering. This review also assessed inadequacy of material properties as a stand-alone factor on therapeutic action efficacy in human trials, with a focus on OncoGel, an experimental thermogel that demonstrated excellent individual or synergistic drug delivery system in preclinical trials but lacked therapeutic impact in human trials. Detailed analysis from all aspects must be considered during technology development for a successful thermogel platform in drug delivery and tissue engineering.
C1 [Liow, Sing Shy; Dou, Qingqing; Kai, Dan; Karim, Anis Abdul; Zhang, Kangyi; Loh, Xian Jun] Inst Mat Res & Engn, 2 Fusionopolis Way,08-03 Innovis, Singapore 138634, Singapore.
   [Xu, Fujian] Beijing Univ Chem Technol, Coll Mat Sci & Engn, Minist Educ, Key Lab Carbon Fiber & Funct Polymers, Beijing 100029, Peoples R China.
   [Xu, Fujian] Beijing Univ Chem Technol, Beijing Lab Biomed Mat, Beijing 100029, Peoples R China.
   [Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
   [Loh, Xian Jun] Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore.
RP Loh, XJ (reprint author), Inst Mat Res & Engn, 2 Fusionopolis Way,08-03 Innovis, Singapore 138634, Singapore.; Loh, XJ (reprint author), Natl Univ Singapore, Dept Mat Sci & Engn, 9 Engn Dr 1, Singapore 117576, Singapore.; Loh, XJ (reprint author), Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore.
EM lohxj@irnre.a-star.edu.sg
RI Xu, Fu-Jian/U-8024-2017; Zhang, Kangyi/R-3448-2017
OI Loh, Xian Jun/0000-0001-8118-6502
FU A*STAR Personal Care Grant [1325400026]
FX The authors express gratitude to the A*STAR Personal Care Grant (Project
   1325400026) for support of this project, Ms. Lally Owh for providing
   professional art work and proofreading, and Dr. Tan Mein Jin for
   proof-reading.
CR Abdul Karim Anis, 2015, Soft Matter, V11, P5425, DOI 10.1039/c5sm00665a
   Appel EA, 2012, CHEM COMMUN, V48, P9843, DOI 10.1039/c2cc35131e
   Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Bagley CA, 2007, J NEUROSURG-SPINE, V7, P194, DOI 10.3171/SPI-07/08/194
   Barreiro-Iglesias R, 2004, J CONTROL RELEASE, V97, P537, DOI 10.1016/j.jconrel.2004.04.007
   Boffito M, 2015, J BIOMED MATER RES A, V103, P1276, DOI 10.1002/jbm.a.35253
   Boustta M, 2014, J CONTROL RELEASE, V174, P1, DOI 10.1016/j.jconrel.2013.10.040
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Cha Y., 1997, US Patent, Patent No. 5702717
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chen CF, 2010, POLYM INT, V59, P1428, DOI 10.1002/pi.2886
   Chen L, 2015, MACROMOLECULES, V48, P3662, DOI 10.1021/acs.macromol.5b00168
   Chen L, 2014, MACROMOLECULES, V47, P5895, DOI 10.1021/ma501110p
   Chen YS, 2013, BIOMATERIALS, V34, P7328, DOI 10.1016/j.biomaterials.2013.06.017
   Cheng YH, 2013, CARBOHYD POLYM, V92, P1512, DOI 10.1016/j.carbpol.2012.10.074
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Choi B., 2015, SITU GELLING POLYM, P5
   Choi BG, 2011, SOFT MATTER, V7, P456, DOI 10.1039/c0sm00611d
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Choi S, 2004, PHARM RES, V21, P827, DOI 10.1023/B:PHAM.0000026435.27086.94
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Ci TY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05473
   Ci TY, 2013, BIOMATER SCI-UK, V1, P1235, DOI 10.1039/c3bm60152h
   Ci TY, 2013, POLYM CHEM-UK, V4, P3245, DOI 10.1039/c3py00118k
   Cui HT, 2014, BIOMACROMOLECULES, V15, P1115, DOI 10.1021/bm4018963
   DeWitt J. M., 2011, GASTROINTESTINAL E S, V73, pAB136
   Diao BS, 2014, RSC ADV, V4, P42996, DOI 10.1039/c4ra08673b
   Dou QQ, 2014, ADV HEALTHC MATER, V3, P977, DOI 10.1002/adhm.201300627
   DuValla GA, 2009, ANTI-CANCER DRUG, V20, P89, DOI 10.1097/CAD.0b013e3283222c12
   Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010
   EUSTACE DJ, 1988, J APPL POLYM SCI, V35, P707, DOI 10.1002/app.1988.070350311
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Garripelli VK, 2011, ACTA BIOMATER, V7, P1984, DOI 10.1016/j.actbio.2011.02.005
   Ge ZS, 2011, LANGMUIR, V27, P1143, DOI 10.1021/la1048166
   Gok B, 2009, NEUROSURGERY, V65, P193, DOI 10.1227/01.NEU.0000345948.54008.82
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   GOPFERICH A, 1993, MACROMOLECULES, V26, P4105, DOI 10.1021/ma00068a006
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Huang LF, 2014, NEURAL REGEN RES, V9, P1371, DOI 10.4103/1673-5374.137590
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Joo MK, 2007, MACROMOLECULES, V40, P5111, DOI 10.1021/ma070008u
   Ju CY, 2013, J PHARM SCI-US, V102, P2707, DOI 10.1002/jps.23649
   Kai D, 2015, ACS SUSTAIN CHEM ENG, V3, P2160, DOI 10.1021/acssuschemeng.5b00405
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kai D, 2013, J MATER CHEM B, V1, P2305, DOI 10.1039/c3tb00151b
   Kai D, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095705
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Kim DH, 2010, MACROMOL RES, V18, P387, DOI 10.1007/s13233-010-0405-4
   Kim SJ, 2014, ACS APPL MATER INTER, V6, P17034, DOI 10.1021/am504652y
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Ko DY, 2013, PROG POLYM SCI, V38, P672, DOI 10.1016/j.progpolymsci.2012.08.002
   Kwon JS, 2013, J MATER CHEM B, V1, P3314, DOI 10.1039/c3tb20105h
   Kwon JS, 2009, J CONTROL RELEASE, V138, P168, DOI 10.1016/j.jconrel.2009.05.023
   Lei KW, 2015, CHEM COMMUN, V51, P6080, DOI 10.1039/c5cc00049a
   Li CM, 2005, BIOMACROMOLECULES, V6, P994, DOI 10.1021/bm049331k
   Li J, 2003, MACROMOLECULES, V36, P2661, DOI 10.1021/ma025725x
   Li JJ, 2013, BIOMATERIALS, V34, P9071, DOI 10.1016/j.biomaterials.2013.08.031
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Li X., 2016, J SPINAL DISORDERS T, V1
   Li X, 2014, BIOMATERIALS, V35, P5679, DOI 10.1016/j.biomaterials.2014.03.067
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Li ZQ, 2012, BIOMACROMOLECULES, V13, P1956, DOI 10.1021/bm300574j
   Li ZQ, 2011, BIOMATERIALS, V32, P3220, DOI 10.1016/j.biomaterials.2011.01.050
   Lin YC, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024102
   Linghu E, 2005, ENDOSCOPY, V37, P1140, DOI 10.1055/s-870224
   Liu M, 2015, PROG POLYM SCI, V48, P111, DOI 10.1016/j.progpolymsci.2015.03.001
   Loh XJ, 2008, POLYMER, V49, P5084, DOI 10.1016/j.polymer.2008.08.061
   Loh XJ, 2008, BIOMATERIALS, V29, P3185, DOI 10.1016/j.biomaterials.2008.04.015
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Loh XJ, 2012, J MATER CHEM, V22, P21249, DOI 10.1039/c2jm33777k
   Loh XJ, 2010, MACROMOL SY, V296, P161, DOI 10.1002/masy.201051024
   Loh XJ, 2009, J PHYS CHEM B, V113, P11822, DOI 10.1021/jp903984r
   Loh XJ, 2009, MACROMOLECULES, V42, P194, DOI 10.1021/ma8019865
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   Low ZW, 2015, RSC ADV, V5, P57678, DOI 10.1039/c5ra09926a
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n
   Lutz JF, 2006, MACROMOLECULES, V39, P893, DOI 10.1021/ma0517042
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Martin BC, 2008, J NEURAL ENG, V5, P221, DOI 10.1088/1741-2560/5/2/013
   Martin L, 2015, POLYM CHEM-UK, V6, P4875, DOI 10.1039/c5py00478k
   Matthes K, 2007, GASTROINTEST ENDOSC, V65, P448, DOI 10.1016/j.gie.2006.06.030
   Matyjaszewski K, 2012, MACROMOLECULES, V45, P4015, DOI 10.1021/ma3001719
   Mei-Chun L., 2014, BIOMED MATER, V9
   Mekhail Tarek M, 2002, Expert Opin Pharmacother, V3, P755
   Mirahmadi F, 2013, MAT SCI ENG C-MATER, V33, P4786, DOI 10.1016/j.msec.2013.07.043
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Moon HJ, 2011, BIOMACROMOLECULES, V12, P1234, DOI 10.1021/bm101518c
   Moreno E, 2014, INT J PHARMACEUT, V459, P1, DOI 10.1016/j.ijpharm.2013.11.030
   Nguyen VPN, 2011, SOFT MATTER, V7, P2150, DOI 10.1039/c0sm00764a
   Ning JY, 2013, REACT FUNCT POLYM, V73, P969, DOI 10.1016/j.reactfunctpolym.2012.11.005
   Nisbet DR, 2010, TISSUE ENG PT A, V16, P2833, DOI 10.1089/ten.TEA.2009.0677
   Nsereko S, 2002, BIOMATERIALS, V23, P2723, DOI 10.1016/S0142-9612(02)00005-4
   Park KM, 2008, MACROMOL RES, V16, P517, DOI 10.1007/BF03218553
   Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040
   Park MH, 2014, ADV HEALTHC MATER, V3, P1782, DOI 10.1002/adhm.201400140
   Park MH, 2012, ADV FUNCT MATER, V22, P5118, DOI 10.1002/adfm.201201722
   Park MH, 2012, ACCOUNTS CHEM RES, V45, P424, DOI 10.1021/ar200162j
   Patel M., 2015, ADV HEALTHC MATER, V4, P1565
   Potta T, 2011, POLYM DEGRAD STABIL, V96, P1261, DOI 10.1016/j.polymdegradstab.2011.04.010
   Prasad A., 2015, IN SITU GELLING POLY, P215
   Rathi R. C., 2000, U.S. Patent, Patent No. [6004573 A, 6004573]
   Rothstein SN, 2009, BIOMATERIALS, V30, P1657, DOI 10.1016/j.biomaterials.2008.12.002
   ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1
   Roy D, 2013, CHEM SOC REV, V42, P7214, DOI 10.1039/c3cs35499g
   SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050
   Shen WJ, 2015, BIOMACROMOLECULES, V16, P105, DOI 10.1021/bm501220a
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   Shimada N, 2014, RSC ADV, V4, P52346, DOI 10.1039/c4ra10612a
   Shimada N, 2011, BIOMACROMOLECULES, V12, P3418, DOI 10.1021/bm2010752
   Soga O, 2004, BIOMACROMOLECULES, V5, P818, DOI 10.1021/bm049955q
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Sun KH, 2006, BIOMACROMOLECULES, V7, P2871, DOI 10.1021/bm060512r
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Thakur RRS, 2014, J CONTROL RELEASE, V176, P8, DOI 10.1016/j.jconrel.2013.12.020
   TISHLER RB, 1992, INT J RADIAT ONCOL, V22, P613, DOI 10.1016/0360-3016(92)90888-O
   TISHLER RB, 1992, CANCER RES, V52, P3495
   Torres AJ, 2011, BIOTECHNOL PROGR, V27, P1478, DOI 10.1002/btpr.665
   Tseng TC, 2015, ADV MATER, V27, P3518, DOI 10.1002/adma.201500762
   Tyler B, 2010, J NEUROSURG, V113, P210, DOI 10.3171/2009.11.JNS08162
   Tyler BM, 2012, J NEUROSURG-SPINE, V16, P93, DOI 10.3171/2011.9.SPINE11435
   Vancoillie G, 2014, PROG POLYM SCI, V39, P1074, DOI 10.1016/j.progpolymsci.2014.02.005
   Vellimana AK, 2013, J NEURO-ONCOL, V111, P229, DOI 10.1007/s11060-012-1014-1
   Vukelja SJ, 2007, ANTI-CANCER DRUG, V18, P283, DOI 10.1097/CAD.0b013e328011a51d
   Wan WB, 2015, J MATER CHEM B, V3, P1990, DOI 10.1039/c4tb01394h
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Wei G, 2002, J CONTROL RELEASE, V83, P65, DOI 10.1016/S0168-3659(02)00175-X
   Williams R, 2013, EXPERT OPIN INV DRUG, V22, P9, DOI 10.1517/13543784.2013.739605
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Wu WQ, 2014, MOL PHARMACEUT, V11, P3378, DOI 10.1021/mp500019p
   Xia Y, 2015, EXP BIOL MED, V240, P593, DOI 10.1177/1535370214560957
   Ye HY, 2015, RSC ADV, V5, P48720, DOI 10.1039/c5ra08222f
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2014, BIOMATER SCI-UK, V2, P1100, DOI 10.1039/c4bm00029c
   Yu L, 2013, J PHARM SCI-US, V102, P4140, DOI 10.1002/jps.23735
   Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d
   Yu L, 2012, MACROMOL RES, V20, P234, DOI 10.1007/s13233-012-0049-7
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Yun EJ, 2012, BIOMACROMOLECULES, V13, P1106, DOI 10.1021/bm2018596
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhang L, 2015, ACTA BIOMATER, V23, P271, DOI 10.1016/j.actbio.2015.05.005
   Zhang LS, 2007, J POLYM SCI POL CHEM, V45, P2617, DOI 10.1002/pola.22019
   Zhang Z, 2012, J BIOMED MATER RES B, V100B, P1599, DOI 10.1002/jbm.b.32728
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
   Zhou YM, 2007, LANGMUIR, V23, P13076, DOI 10.1021/la702548h
   Zhu WW, 2006, J BIOMED MATER RES B, V77B, P135, DOI 10.1002/jbm.b.30412
NR 171
TC 62
Z9 62
U1 39
U2 263
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2016
VL 2
IS 3
BP 295
EP 316
DI 10.1021/acsbiomaterials.5b00515
PG 22
WC Materials Science, Biomaterials
SC Materials Science
GA DG9IM
UT WOS:000372396000002
DA 2018-10-20
ER

PT J
AU Floros, MC
   Bortolatto, JF
   Oliveira, OB
   Salvador, SL
   Narine, SS
AF Floros, Michael C.
   Bortolatto, Janaina F.
   Oliveira, Osmir B.
   Salvador, Sergio L.
   Narine, Suresh S.
TI Antimicrobial Activity of Amphiphilic Triazole-Linked Polymers Derived
   from Renewable Sources
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biomimetic; antimicrobial polymer; amphiphilic; renewable; click
   chemistry; biomaterial
ID INDWELLING VASCULAR CATHETERS; ANTIBIOTIC-RESISTANCE;
   STAPHYLOCOCCUS-AUREUS; PATHOGENIC BACTERIA; ESCHERICHIA-COLI;
   MOLECULAR-WEIGHT; SATELLITE GROUPS; FATTY-ACIDS; IN-VITRO; SURFACES
AB Conventional engineered polymers are strong, stable, and can interact desirably within the human body in implants and medical devices. However, bacterial colonization of medical devices and implants constructed from these materials results in numerous hospital acquired infections (HAI) and deaths each year. Polytriazole based plastics containing triazole rings and fatty acid derivatives have been synthesized from biological sources without catalysts or solvents. In this study, three amphiphilic polytriazoles with varying triazole density and hydrophilic/hydrophobic segments demonstrated broad spectrum, contact antimicrobial properties against both Gram positive and negative bacteria. SEM analysis of bacteria killed by these polymers evidence membrane damage, indicating that these polymers act by direct contact with bacterial membranes. Surface hydrophobicity of these polymers increased with increasing triazole group density, which also improved the antimicrobial efficacy. This work demonstrates that amphiphilic polytriazoles have antimicrobial properties and that future utilization of triazole modified polymers may produce self-sterilizing materials which resist bacterial contamination and formation of antibiotic resistant organisms, ideal characteristics for medically relevant biomaterials.
C1 [Floros, Michael C.; Narine, Suresh S.] Trent Univ, Trent Ctr Biomat Res, Dept Phys & Astron, Peterborough, ON K9J 7B8, Canada.
   [Floros, Michael C.; Narine, Suresh S.] Trent Univ, Trent Ctr Biomat Res, Dept Chem, Peterborough, ON K9J 7B8, Canada.
   [Bortolatto, Janaina F.; Oliveira, Osmir B.] Univ Estadual Paulista, UNESP, Araraquara Sch Dent, Dept Restorat Dent, Araraquara, SP, Brazil.
   [Salvador, Sergio L.] Univ Sao Paulo, Dept Clin Anal, Sch Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil.
RP Narine, SS (reprint author), Trent Univ, Trent Ctr Biomat Res, Dept Phys & Astron, Peterborough, ON K9J 7B8, Canada.; Narine, SS (reprint author), Trent Univ, Trent Ctr Biomat Res, Dept Chem, Peterborough, ON K9J 7B8, Canada.
EM sureshnarine@trentu.ca
RI Oliveira Junior, Osmir/C-2693-2016; Floros, Michael/O-9198-2016
OI Oliveira Junior, Osmir/0000-0002-2153-9887; Floros,
   Michael/0000-0001-9539-0782; Salvador, Sergio Luiz/0000-0002-4867-7294
FU Elevance Renewable Sciences; NSERC; Grain Farmers of Ontario; GPA-EDC;
   CAPES/DFATD; Industry Canada; Trent University
FX We thank Marina Del Arco for her technical assistance with the
   preparation of microbiological samples. The financial support from
   Elevance Renewable Sciences, NSERC, Grain Farmers of Ontario, GPA-EDC,
   CAPES/DFATD, Industry Canada, and Trent University is gratefully
   acknowledged.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Afonin S, 2014, BBA-BIOMEMBRANES, V1838, P2260, DOI 10.1016/j.bbamem.2014.03.017
   Agalave SG, 2011, CHEM-ASIAN J, V6, P2696, DOI 10.1002/asia.201100432
   Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009
   Alexandridis P., 2000, AMPHIPHILIC BLOCK CO
   Bera S, 2012, MOLECULES, V17, P9129, DOI 10.3390/molecules17089129
   Bera S, 2010, BIOORG MED CHEM LETT, V20, P3031, DOI 10.1016/j.bmcl.2010.03.116
   Bossche H. V., 1984, PESTIC SCI, V15, P188
   Bouloussa O, 2008, CHEM COMMUN, P951, DOI 10.1039/b716026g
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   BUTCHER GW, 1976, J GEN MICROBIOL, V94, P290, DOI 10.1099/00221287-94-2-290
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11
   CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332
   Chen CZS, 2000, BIOMACROMOLECULES, V1, P473, DOI 10.1021/bm0055495
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Dallmann A, 2011, CHEM-EUR J, V17, P14714, DOI 10.1002/chem.201102979
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dennison SR, 2005, PROTEIN PEPTIDE LETT, V12, P31, DOI 10.2174/0929866053406084
   DYE ES, 1981, INFECT IMMUN, V32, P98
   El-Sagheer AH, 2011, P NATL ACAD SCI USA, V108, P11338, DOI 10.1073/pnas.1101519108
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Feng L., 2003, ANGEW CHEM, V115, P824, DOI DOI 10.1002/ANGE.200390181
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Floros MC, 2014, BIOMED RES INT, DOI 10.1155/2014/792901
   Fulmer PA, 2011, ACS APPL MATER INTER, V3, P2878, DOI 10.1021/am2005465
   GOODRICH MS, 1991, ENVIRON TOXICOL CHEM, V10, P509, DOI 10.1897/1552-8618(1991)10[509:AALTOW]2.0.CO;2
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Guggenbichler JP, 2011, GMS HYG INFECT CONTR, V6, DOI 10.3205/dgkh000175
   Haldar J, 2006, P NATL ACAD SCI USA, V103, P17667, DOI 10.1073/pnas.0608803103
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076
   KANAI K, 1979, JPN J MED SCI BIOL, V32, P135, DOI 10.7883/yoken1952.32.135
   KANAZAWA A, 1993, J POLYM SCI POL CHEM, V31, P1441, DOI 10.1002/pola.1993.080310611
   KATO K, 1978, INFECT IMMUN, V19, P12
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Kuroda K, 2005, J AM CHEM SOC, V127, P4128, DOI 10.1021/ja044205+
   Kurt P, 2007, LANGMUIR, V23, P4719, DOI 10.1021/la063718m
   Le Droumaguet C, 2010, CHEM SOC REV, V39, P1233, DOI 10.1039/b901975h
   Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   LINDSTEDT M, 1990, ANTIMICROB AGENTS CH, V34, P1949, DOI 10.1128/AAC.34.10.1949
   Liu XM, 2004, BIOMATERIALS, V25, P1929, DOI 10.1016/j.biomaterials.2003.08.023
   Lynch SV, 2007, ANTIMICROB AGENTS CH, V51, P3650, DOI 10.1128/AAC.00601-07
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159
   Miao SD, 2014, ACTA BIOMATER, V10, P1692, DOI 10.1016/j.actbio.2013.08.040
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Nathan C, 2014, NEW ENGL J MED, V371, P1761, DOI 10.1056/NEJMp1408040
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   RAAD II, 1992, CLIN INFECT DIS, V15, P197, DOI 10.1093/clinids/15.2.197
   Roberts DW, 2003, QSAR COMB SCI, V22, P220, DOI 10.1002/qsar.200390015
   Rostovtsev V. V., 2002, ANGEW CHEM, V114, P2708, DOI DOI 10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0
   Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997
   Sambhy V, 2008, LANGMUIR, V24, P7549, DOI 10.1021/la800858z
   Schlegel A, 2011, J CONTROL RELEASE, V152, P393, DOI 10.1016/j.jconrel.2011.03.031
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199
   Thiyagarajan D, 2014, CHEM COMMUN, V50, P7434, DOI 10.1039/c4cc02354d
   Tikhonov VE, 2006, CARBOHYD POLYM, V64, P66, DOI 10.1016/j.carbpol.2005.10.021
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9
   Trautner BW, 2004, ARCH INTERN MED, V164, P842, DOI 10.1001/archinte.164.8.842
   Vial F, 2007, SOFT MATTER, V3, P75, DOI 10.1039/b613003h
   Waschinski CJ, 2008, BIOMACROMOLECULES, V9, P1764, DOI 10.1021/bm7013944
   Waschinski CJ, 2004, MACROMOL BIOSCI, V5, P149, DOI 10.1002/mabi.200400169
   Weston DP, 2009, J ENVIRON QUAL, V38, P238, DOI 10.2134/jeq2008.0109
   Wilkins M C, 1993, Respir Care, V38, P1155
   Williams CK, 2008, POLYM REV, V48, P1, DOI 10.1080/15583720701834133
   Wiradharma N, 2011, BIOMATERIALS, V32, P2204, DOI 10.1016/j.biomaterials.2010.11.054
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 77
TC 8
Z9 8
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2016
VL 2
IS 3
BP 336
EP 343
DI 10.1021/acsbiomaterials.5b00412
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DG9IM
UT WOS:000372396000005
DA 2018-10-20
ER

PT J
AU Nickels, JD
   Atkinson, J
   Papp-Szabo, E
   Stanley, C
   Diallo, SO
   Perticaroli, S
   Baylis, B
   Mahon, P
   Ehlers, G
   Katsaras, J
   Dutcher, JR
AF Nickels, Jonathan D.
   Atkinson, John
   Papp-Szabo, Erzsebet
   Stanley, Christopher
   Diallo, Souleymane O.
   Perticaroli, Stefania
   Baylis, Benjamin
   Mahon, Perry
   Ehlers, Georg
   Katsaras, John
   Dutcher, John R.
TI Structure and Hydration of Highly-Branched, Monodisperse Phytoglycogen
   Nanoparticles
SO BIOMACROMOLECULES
LA English
DT Article
ID WATER-PROTEIN FLUCTUATIONS; NEUTRON-SCATTERING; AQUEOUS-SOLUTIONS;
   LIGHT-SCATTERING; DIELECTRIC-RELAXATION; BIOLOGICAL-MEMBRANES; PHYSICAL
   CONSTRAINTS; GLYCOGEN STRUCTURE; SUPERCOOLED WATER; TIME SCALES
AB Phytoglycogen is a naturally occurring polysaccharide nano particle made up of extensively branched glucose monomers. It has a number of unusual and advantageous properties, such as high water retention, low viscosity, and high stability in water, which make this biomaterial a promising candidate for a wide variety of applications. In this study, we have characterized the structure and hydration of aqueous dispersions of phytoglycogen nanoparticles using neutron scattering. Small angle neutron scattering results suggest that the phytoglycogen nanoparticles behave similar to hard sphere colloids and are hydrated by a large number of water molecules (each nanoparticle contains between 250% and 285% of its mass in water). This suggests that phytoglycogen is an ideal sample in which to study the dynamics of hydration water. To this end, we used quasielastic neutron scattering (QENS) to provide an independent and consistent measure of the hydration number, and to estimate the retardation factor (or degree of water slow-down) for hydration wafer translational motions. These data demonstrate a length-scale dependence in the measured retardation factors that clarifies the origin of discrepancies between retardation factor values reported for hydration water using different experimental techniques. The present approach can be generalized to other systems containing nanoconfined water.
C1 [Nickels, Jonathan D.; Katsaras, John] Oak Ridge Natl Lab, Joint Inst Neutron Sci, Oak Ridge, TN 37831 USA.
   [Nickels, Jonathan D.; Katsaras, John] Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA.
   [Atkinson, John; Papp-Szabo, Erzsebet; Perticaroli, Stefania; Baylis, Benjamin; Mahon, Perry; Dutcher, John R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada.
   [Nickels, Jonathan D.; Stanley, Christopher; Katsaras, John] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA.
   [Diallo, Souleymane O.] Oak Ridge Natl Lab, Chem & Engn Mat Div, Oak Ridge, TN 37831 USA.
   [Ehlers, Georg] Oak Ridge Natl Lab, Quantum Condensed Matter Div, POB 2008, Oak Ridge, TN 37831 USA.
RP Dutcher, JR (reprint author), Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada.
EM dutcher@uoguelph.ca
RI Ehlers, Georg/B-5412-2008; Nickels, Jonathan/I-1913-2012
OI Ehlers, Georg/0000-0003-3513-508X; Nickels,
   Jonathan/0000-0001-8351-7846; Stanley, Christopher/0000-0002-4226-7710;
   Katsaras, John/0000-0002-8937-4177
FU Ontario Ministry of Agriculture (OMAF); Natural Sciences and Engineering
   Research Council (NSERC) of Canada; Senior Canada Research Chair in Soft
   Matter and Biological Physics; U.S. DOE BES through EPSCoR
   [DE-FG02-08ER46528]; US DOE [DE-AC05-00OR22725]
FX The authors would like to thank Phil Whiting, Anton Korenevski, and
   Michael Grossutti for discussions that have greatly benefitted this
   work. Mirexus Biotechnologies, Inc. generously supplied the monodisperse
   phytoglycogen nano particles. This work was funded by grants from the
   Ontario Ministry of Agriculture (OMAF) and the Natural Sciences and
   Engineering Research Council (NSERC) of Canada (J.R.D.). J.R.D. is the
   recipient of a Senior Canada Research Chair in Soft Matter and
   Biological Physics. J.D.N. is partially supported by the U.S. DOE BES
   through EPSCoR Grant No. DE-FG02-08ER46528. J.K. is supported through
   the Scientific User Facilities Division of the DOE Office of Basic
   Energy Sciences under US DOE Contract No. DE-AC05-00OR22725. Facilities
   as the Spallation Neutron Source are managed by UT-Battelle, LLC under
   US DOE Contract No. DE-AC05-00OR22725.
CR Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029
   Azuah RT, 2009, J RES NATL INST STAN, V114, P341, DOI 10.6028/jres.114.025
   Ballauff M, 2004, ANGEW CHEM INT EDIT, V43, P2998, DOI 10.1002/anie.200300602
   BELLISSENTFUNEL MC, 1992, J PHYS I, V2, P995
   Ben Ishai P, 2013, J PHYS CHEM B, V117, P7724, DOI 10.1021/jp4030415
   Boris D, 1996, MACROMOLECULES, V29, P7251, DOI 10.1021/ma960397k
   Chiavazzo E., 2014, NAT COMMUN, V5, P1
   Denisov VP, 1996, FARADAY DISCUSS, V103, P227, DOI 10.1039/fd9960300227
   Ehlers G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626935
   Halle B, 2004, PHILOS T R SOC B, V359, P1207, DOI 10.1098/rstb.2004.1499
   Huang L, 2011, CARBOHYD POLYM, V83, P1665, DOI 10.1016/j.carbpol.2010.10.030
   Kajiura H, 2010, CARBOHYD RES, V345, P817, DOI 10.1016/j.carres.2010.01.013
   LESCANEC RL, 1990, MACROMOLECULES, V23, P2280, DOI 10.1021/ma00210a026
   Li TP, 2007, J AM CHEM SOC, V129, P3376, DOI 10.1021/ja0685957
   Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819
   Lupi L, 2012, J PHYS CHEM B, V116, P14760, DOI 10.1021/jp3079869
   Mamontov E, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626214
   MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J
   MANSFIELD ML, 1993, MACROMOLECULES, V26, P4262, DOI 10.1021/ma00068a029
   MASHIMO S, 1987, J PHYS CHEM-US, V91, P6337, DOI 10.1021/j100309a005
   Mattea C, 2008, BIOPHYS J, V95, P2951, DOI 10.1529/biophysj.108.135194
   Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249
   Melendez R, 1998, BIOPHYS J, V75, P106, DOI 10.1016/S0006-3495(98)77498-3
   Melendez R, 1999, BIOPHYS J, V77, P1327, DOI 10.1016/S0006-3495(99)76982-1
   NAGELE G, 1993, PHYS REV E, V47, P2562, DOI 10.1103/PhysRevE.47.2562
   Nickels JD, 2015, MEMBRANE HYDRATION, P45, DOI DOI 10.1007/978-3-319-19060-0_3
   Nickels JD, 2012, BIOPHYS J, V103, P1566, DOI 10.1016/j.bpj.2012.08.046
   Oleinikova A, 2005, J PHYS CHEM B, V109, P1988, DOI 10.1021/jp045903j
   Pal SK, 2002, J PHYS CHEM B, V106, P12376, DOI 10.1021/jp0213506
   Pal SK, 2002, P NATL ACAD SCI USA, V99, P1763, DOI 10.1073/pnas.042697899
   Paolantoni M, 2009, J PHYS CHEM B, V113, P7874, DOI 10.1021/jp9004983
   Paolantoni M., 2007, J CHEM PHYS, V127
   PEDERSEN JS, 1994, J APPL CRYSTALLOGR, V27, P595, DOI 10.1107/S0021889893013810
   PERCUS JK, 1958, PHYS REV, V110, P1, DOI 10.1103/PhysRev.110.1
   Perticaroli S, 2015, J PHYS CHEM LETT, V6, P4018, DOI 10.1021/acs.jpclett.5b01890
   Perticaroli S, 2013, J PHYS CHEM B, V117, P7729, DOI 10.1021/jp403665w
   Perticaroli S, 2010, J PHYS CHEM B, V114, P8262, DOI 10.1021/jp101896f
   Petrache HI, 1997, BIOPHYS J, V72, P2237, DOI 10.1016/S0006-3495(97)78867-2
   Powell PO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121337
   Putaux JL, 2006, BIOMACROMOLECULES, V7, P1720, DOI 10.1021/bm050988v
   Qvist J, 2008, J AM CHEM SOC, V130, P10345, DOI 10.1021/ja802668w
   Qvist J, 2009, FARADAY DISCUSS, V141, P131, DOI 10.1039/b806194g
   Santucci SC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.225701
   Sasisanker P, 2008, CHEMPHYSCHEM, V9, P2802, DOI 10.1002/cphc.200800508
   Sears V. F, 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]
   Suzuki T, 2003, J CHEM PHYS, V119, P10133, DOI 10.1063/1.1619953
   Takata H, 2009, CARBOHYD RES, V344, P654, DOI 10.1016/j.carres.2009.01.008
   Toppozini L., 2012, ISRN BIOPHYS, V2012, P1
   Toppozini L, 2015, SOFT MATTER, V11, P8354, DOI 10.1039/c5sm01713k
   Torre R, 2004, NATURE, V428, P296, DOI 10.1038/nature02409
   Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021
   VINEYARD GH, 1958, PHYS REV, V110, P999, DOI 10.1103/PhysRev.110.999
   Weik M, 2005, BIOPHYS J, V89, P3639, DOI 10.1529/biophysj.104.055749
   Wong KS, 2003, J CEREAL SCI, V37, P139, DOI 10.1006/jcrs.2002.0485
   Wood K, 2007, P NATL ACAD SCI USA, V104, P18049, DOI 10.1073/pnas.0706566104
   YUN SH, 1993, CARBOHYD RES, V243, P307, DOI 10.1016/0008-6215(93)87035-Q
   Zanotti JM, 1999, PHYS REV E, V59, P3084, DOI 10.1103/PhysRevE.59.3084
   Zhang LY, 2007, P NATL ACAD SCI USA, V104, P18461, DOI 10.1073/pnas.0707647104
   Zhang LY, 2009, J AM CHEM SOC, V131, P10677, DOI 10.1021/ja902918p
   Zhao JK, 2010, J APPL CRYSTALLOGR, V43, P1068, DOI 10.1107/S002188981002217X
   Zook TC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.015502
NR 61
TC 9
Z9 9
U1 8
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2016
VL 17
IS 3
BP 735
EP 743
DI 10.1021/acs.biomac.5b01393
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DG9GW
UT WOS:000372391800004
PM 26866896
DA 2018-10-20
ER

PT J
AU Xu, SJ
   Mu, JS
   Zhang, JQ
   Ping, B
AF Xu Shijun
   Mu Junsheng
   Zhang Jianqun
   Bo Ping
TI Invitro three-dimensional coculturing
   poly3-hydroxybutyrate-co-3-hydroxyhexanoate with mouse-induced
   pluripotent stem cells for myocardial patch application
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Vitamin C; mouse-induced pluripotent stem cells; cardiomyocytes; induced
   differentiation; poly3-hydroxybutyrate-co-3-hydroxyhexanoate film;
   myocardial patch
ID DIFFERENTIATION; SCAFFOLDS; REPAIR
AB Identifying a suitable polymeric biomaterial for myocardial patch repair following myocardial infarction, cerebral infarction, and cartilage injury is essential. This study aimed to investigate the effect of the novel polymer material, poly3-hydroxybutyrate-co-3-hydroxyhexanoate, on the adhesion, proliferation, and differentiation of mouse-induced pluripotent stem cells invitro. Mouse-induced pluripotent stem cells were isolated, expanded, and cultured on either two-dimensional or three-dimensional poly3-hydroxybutyrate-co-3-hydroxyhexanoate films (membranes were perforated to imitate three-dimensional space). Following attachment onto the films, mouse-induced pluripotent stem cell morphology was visualized using scanning electron microscopy. Cell vitality was detected using the Cell Counting Kit-8 assay and cell proliferation was observed using fluorescent 4',6-diamidino-2-phenylindole (DAPI) staining. Mouse-induced pluripotent stem cells were induced into cardiomyocytes by differentiation medium containing vitamin C. A control group in the absence of an inducer was included. Mouse-induced pluripotent stem cell survival and differentiation were observed using immunofluorescence and flow cytometry, respectively. Mouse-induced pluripotent stem cells growth, proliferation, and differentiation were observed on both two-dimensional and three-dimensional poly3-hydroxybutyrate-co-3-hydroxyhexanoate films. Vitamin C markedly improved the efficiency of mouse-induced pluripotent stem cells differentiation into cardiomyocytes on poly3-hydroxybutyrate-co-3-hydroxyhexanoate films. Three-dimensional culture was better at promoting mouse-induced pluripotent stem cell proliferation and differentiation compared with two-dimensional culture.
C1 [Xu Shijun; Mu Junsheng; Zhang Jianqun; Bo Ping] Capital Med Univ, Affiliated Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiac Surg, Beijing 100029, Peoples R China.
RP Mu, JS (reprint author), Capital Med Univ, Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China.
EM wesleymu@hotmail.com
FU Chaoyang District, Beijing Science and Technology Program [SF1417];
   Capital Medical University student technological innovation program
   [XSKY2015192]; Beijing Anzhen Hospital Science Research Fund [15P11]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: 2014
   Chaoyang District, Beijing Science and Technology Program (SF1417); 2015
   Capital Medical University student technological innovation program
   (XSKY2015192); 2015 Beijing Anzhen Hospital Science Research Fund
   (15P11).
CR Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066
   Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Jain K, 2014, METHODS MOL BIOL, V1194, P247, DOI 10.1007/978-1-4939-1215-5_13
   Li X, 2013, PLOS ONE, V8
   Li XL, 2015, J BIOMED MATER RES A, V103, P1169, DOI 10.1002/jbm.a.35265
   Lu Haixia, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P1216
   Matar AA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-440
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Wu Song, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P610, DOI 10.1016/S1872-2075(08)60030-8
   Yu Haiying, 2009, J Orthop Surg Res, V4, P5, DOI 10.1186/1749-799X-4-5
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 17
TC 1
Z9 2
U1 1
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2016
VL 30
IS 8
BP 1273
EP 1282
DI 10.1177/0885328215612115
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DH3WR
UT WOS:000372718000012
PM 26873635
DA 2018-10-20
ER

PT J
AU Zhang, XB
   Wang, Q
   Ba, ZX
   Wang, ZZ
   Xue, YJ
AF Zhang, Xiaobo
   Wang, Qian
   Ba, Zhixin
   Wang, Zhangzhong
   Xue, Yajun
TI Improved Corrosion Resistance of As-Extruded GZ51K Biomagnesium Alloy
   with High Mechanical Properties by Aging Treatment
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE aging treatment; biomaterial; corrosion; LPSO; magnesium alloy;
   mechanical property
ID ZN-ZR ALLOYS; MAGNESIUM ALLOYS; BIOMEDICAL APPLICATIONS; BIOCORROSION
   BEHAVIOR; MG; MICROSTRUCTURE; IMPLANTS; BIOMATERIALS; STENTS
AB Effects of aging treatment on microstructure, mechanical properties, and corrosion behavior of the as-extruded Mg-5Gd-1Zn-0.6Zr (GZ51K, wt.%) alloy were investigated. Microstructure was observed by optical microscopy and scanning electron microscopy, mechanical properties were tested on a tensile test machine and a microhardness tester, and corrosion behavior was evaluated by mass loss and polarization tests. It is found that most of equiaxed alpha-Mg grains have long-period stacking ordered (LPSO) structure, and some of them have no LPSO structure. Long-elongated grains are formed in the as-extruded alloy due to partial recrystallization and disappear after being aged at 200 and 220 A degrees C. The as-extruded alloy exhibits both high-yield strength and high ductility. The mechanical properties of the alloy are not apparently enhanced, but the corrosion resistance is significantly improved after aging treatment. Moreover, the alloy with LPSO structure presents uniform corrosion mode in simulated body fluid. The GZ51K alloy with high mechanical properties and uniform corrosion behavior is worthy to be further investigated for biomedical applications.
C1 [Zhang, Xiaobo; Wang, Qian; Ba, Zhixin; Wang, Zhangzhong; Xue, Yajun] Nanjing Inst Technol, Sch Mat Sci & Engn, Nanjing 211167, Jiangsu, Peoples R China.
   [Zhang, Xiaobo; Wang, Qian; Ba, Zhixin; Wang, Zhangzhong; Xue, Yajun] Jiangsu Key Lab Adv Struct Mat & Applicat Technol, Nanjing 211167, Jiangsu, Peoples R China.
RP Zhang, XB (reprint author), Nanjing Inst Technol, Sch Mat Sci & Engn, Nanjing 211167, Jiangsu, Peoples R China.; Zhang, XB (reprint author), Jiangsu Key Lab Adv Struct Mat & Applicat Technol, Nanjing 211167, Jiangsu, Peoples R China.
EM xbxbzhang2003@163.com
FU National Natural Science Foundation of China [51301089]; Natural Science
   Foundation of Jiangsu Province [BK20130745]; Jiangsu Key Laboratory of
   Advanced Structural Materials and Application Technology [ASMA201503];
   Qing Lan Project of Jiangsu Province
FX This project was supported by the National Natural Science Foundation of
   China (51301089), the Natural Science Foundation of Jiangsu Province
   (BK20130745), the Opening Project of Jiangsu Key Laboratory of Advanced
   Structural Materials and Application Technology (ASMA201503), and the
   Qing Lan Project of Jiangsu Province.
CR Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017
   Chen K, 2015, CORROS REV, V33, P101, DOI 10.1515/corrrev-2015-0007
   Chen YJ, 2014, ACTA BIOMATER, V10, P4561, DOI 10.1016/j.actbio.2014.07.005
   Du H, 2011, MATER CHEM PHYS, V125, P568, DOI 10.1016/j.matchemphys.2010.10.015
   Gao HY, 2015, MATER LETT, V146, P30, DOI 10.1016/j.matlet.2015.01.136
   Jeong YS, 2014, CORROS SCI, V82, P392, DOI 10.1016/j.corsci.2014.01.041
   Kirkland NT, 2012, CORROS ENG SCI TECHN, V47, P322, DOI 10.1179/1743278212Y.0000000034
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Li H, 2014, MATER DESIGN, V58, P43, DOI 10.1016/j.matdes.2014.01.031
   Li T, 2015, J MATER SCI TECHNOL, V31, P744, DOI 10.1016/j.jmst.2015.02.001
   Li X, 2015, BIOMATERIALS, V49, P135, DOI 10.1016/j.biomaterials.2015.01.060
   Liu F, 2015, MAT SCI ENG C-MATER, V48, P400, DOI 10.1016/j.msec.2014.12.024
   Liu K, 2010, MATER DESIGN, V31, P210, DOI 10.1016/j.matdes.2009.06.030
   Lu FM, 2014, MAT SCI ENG A-STRUCT, V594, P330, DOI 10.1016/j.msea.2013.11.081
   Manivannan S, 2015, J MATER ENG PERFORM, V24, P1649, DOI 10.1007/s11665-015-1432-2
   Manivasagam G, 2014, MATER SCI TECH-LOND, V30, P515, DOI 10.1179/1743284713Y.0000000500
   Qin H, 2015, BIOMATERIALS, V53, P211, DOI 10.1016/j.biomaterials.2015.02.096
   Shao XH, 2010, ACTA MATER, V58, P4760, DOI 10.1016/j.actamat.2010.05.012
   Wang ZH, 2014, PROG NAT SCI-MATER, V24, P423, DOI 10.1016/j.pnsc.2014.08.008
   Wu YJ, 2009, J MATER RES, V24, P3596, DOI 10.1557/JMR.2009.0425
   Zhang JS, 2013, MAT SCI ENG A-STRUCT, V585, P268, DOI 10.1016/j.msea.2013.07.049
   Zhang L., 2015, MAT SCI TECHNOL, V31, P1088
   Zhang XB, 2015, MATER SCI TECH-LOND, V31, P866, DOI 10.1179/1743284714Y.0000000661
   Zhang XB, 2014, MATER TECHNOL, V29, P179, DOI 10.1179/1753555714Y.0000000129
   Zhang XB, 2013, MATER TECHNOL, V28, P155, DOI 10.1179/1753555712Y.0000000048
   Zhang XB, 2014, T NONFERR METAL SOC, V24, P3797, DOI 10.1016/S1003-6326(14)63535-4
   Zhang XB, 2015, MATER LETT, V138, P212, DOI 10.1016/j.matlet.2014.09.133
   Zhang XB, 2014, CORROS SCI, V88, P1, DOI 10.1016/j.corsci.2014.07.004
   Zhang XB, 2014, ACTA METALL SIN, V50, P979
   Zhao CY, 2015, MATER DESIGN, V70, P60, DOI 10.1016/j.matdes.2014.12.041
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhou JC, 2014, J MATER ENG PERFORM, V23, P181, DOI 10.1007/s11665-013-0751-4
NR 32
TC 9
Z9 9
U1 2
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD MAR
PY 2016
VL 25
IS 3
BP 719
EP 725
DI 10.1007/s11665-016-1941-7
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA DG8CD
UT WOS:000372309100001
DA 2018-10-20
ER

PT J
AU Wise, SG
   Liu, HJ
   Yeo, GC
   Michael, PL
   Chan, AHP
   Ngo, AKY
   Bilek, MMM
   Bao, SS
   Weiss, AS
AF Wise, Steven G.
   Liu, Hongjuan
   Yeo, Giselle C.
   Michael, Praveesuda L.
   Chan, Alex H. P.
   Ngo, Alan K. Y.
   Bilek, Marcela M. M.
   Bao, Shisan
   Weiss, Anthony S.
TI Blended Polyurethane and Tropoelastin as a Novel Class of Biologically
   Interactive Elastomer
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; RECOMBINANT HUMAN TROPOELASTIN; IN-VIVO
   BIOSTABILITY; VASCULAR GRAFT; MECHANICAL-PROPERTIES; PORE-SIZE;
   SCAFFOLDS; ELASTIN; COLLAGEN; REGION
AB Polyurethanes are versatile elastomers but suffer from biological limitations such as poor control over cell attachment and the associated disadvantages of increased fibrosis. We address this problem by presenting a novel strategy that retains elasticity while modulating biological performance. We describe a new biomaterial that comprises a blend of synthetic and natural elastomers: the biostable polyurethane Elast-Eon and the recombinant human tropoelastin protein. We demonstrate that the hybrid constructs yield a class of coblended elastomers with unique physical properties. Hybrid constructs displayed higher elasticity and linear stress-strain responses over more than threefold strain. The hybrid materials showed increased overall porosity and swelling in comparison to polyurethane alone, facilitating enhanced cellular interactions. In vitro, human dermal fibroblasts showed enhanced proliferation, while in vivo, following subcutaneous implantation in mice, hybrid scaffolds displayed a reduced fibrotic response and tunable degradation rate. To our knowledge, this is the first example of a blend of synthetic and natural elastomers and is a promising approach for generating tailored bioactive scaffolds for tissue repair.
C1 [Wise, Steven G.; Michael, Praveesuda L.; Chan, Alex H. P.] Heart Res Inst, Sydney, NSW, Australia.
   [Wise, Steven G.; Liu, Hongjuan; Michael, Praveesuda L.; Chan, Alex H. P.; Bao, Shisan] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Wise, Steven G.; Yeo, Giselle C.; Ngo, Alan K. Y.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Bao, Shisan] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Bao, Shisan] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Yeo, Giselle C.; Bao, Shisan; Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Bao, Shisan; Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Bilek, Marcela M. M.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
RI Wise, Steven/G-2630-2018
OI Wise, Steven/0000-0001-7964-819X; Yeo, Giselle/0000-0001-6071-8899;
   Bilek, Marcela/0000-0003-3363-2664; Chan, Alex Ho
   Pang/0000-0002-1244-7673; WEISS, ANTHONY/0000-0002-8106-4836
FU Australian Research Council; National Institutes of Health [EB014283];
   Sydney Medical School, University of Sydney
FX The authors acknowledge funding from the Australian Research Council
   (M.M.M.B., A.S.W., and S.B.) and National Institutes of Health
   (EB014283; A.S.W.). A.S.W. is the Scientific Founder of Elastagen Pty
   Ltd. They also acknowledge a postgraduate scholarship from The Sydney
   Medical School, University of Sydney (H.L.). The authors declare no
   conflict of interest in this work. They also acknowledge the facilities
   as well as scientific and technical assistance at the Australian Centre
   for Microscopy and Microanalysis.
CR Ajalloueian F, 2014, BIOMATERIALS, V35, P5741, DOI 10.1016/j.biomaterials.2014.04.002
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Bax DV, 2014, BIOMATERIALS, V35, P6797, DOI 10.1016/j.biomaterials.2014.04.082
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bernacca GM, 2002, BIOMATERIALS, V23, P45, DOI 10.1016/S0142-9612(01)00077-1
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Detta N, 2010, J MATER SCI-MATER M, V21, P1761, DOI 10.1007/s10856-010-4006-8
   Gunatillake PA, 2000, J APPL POLYM SCI, V76, P2026, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2026::AID-APP5>3.0.CO;2-X
   Gunatillake PA, 2003, AUST J CHEM, V56, P545, DOI 10.1071/CH02168
   Heo DN, 2013, J BIOMED NANOTECHNOL, V9, P511, DOI 10.1166/jbn.2013.1509
   Jia L, 2014, J BIOMATER APPL, V29, P364, DOI 10.1177/0885328214529002
   Klumpp D, 2012, J BIOMED MATER RES A, V100A, P2302, DOI 10.1002/jbm.a.34172
   Lee BK, 2012, BIOMATERIALS, V33, P9027, DOI 10.1016/j.biomaterials.2012.09.008
   Lee P, 2014, J BIOL CHEM, V289, P1467, DOI 10.1074/jbc.M113.518381
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu HJ, 2014, BIOMATERIALS, V35, P5138, DOI 10.1016/j.biomaterials.2014.03.024
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   Machula H, 2014, ADV WOUND CARE, V3, P367, DOI 10.1089/wound.2013.0513
   McKenna KA, 2012, ACTA BIOMATER, V8, P225, DOI 10.1016/j.actbio.2011.08.001
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Padsalgikar A, 2015, J BIOMED MATER RES B, V103, P159, DOI 10.1002/jbm.b.33161
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Simmons A, 2004, BIOMATERIALS, V25, P4887, DOI 10.1016/j.biomaterials.2004.01.004
   Simmons A, 2008, BIOMATERIALS, V29, P2987, DOI 10.1016/j.biomaterials.2008.04.007
   Sridhar R, 2015, CHEM SOC REV, V44, P790, DOI 10.1039/c4cs00226a
   Stefanovic IS, 2015, J BIOMED MATER RES A, V103, P1459, DOI 10.1002/jbm.a.35285
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Tavakoli NN, 2012, INT J MOL MED, V30, P545, DOI 10.3892/ijmm.2012.1034
   Wakelin EA, 2015, ACS APPL MATER INTER, V7, P23029, DOI 10.1021/acsami.5b06395
   Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062
   Wise SG, 2014, ACTA BIOMATER, V10, P1532, DOI 10.1016/j.actbio.2013.08.003
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wong CS, 2013, J MATER SCI-MATER M, V24, P1865, DOI 10.1007/s10856-013-4937-y
   Yeo GC, 2014, J BIOL CHEM, V289, P34815, DOI 10.1074/jbc.M114.606772
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
   Yuan HH, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/045004
NR 41
TC 5
Z9 5
U1 4
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2016
VL 22
IS 5-6
BP 524
EP 533
DI 10.1089/ten.tea.2015.0409
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DH0FL
UT WOS:000372457800014
PM 26857114
OA Green Published
DA 2018-10-20
ER

PT J
AU Pereira, RC
   Carneiro, JDS
   Borges, SV
   Assis, OBG
   Alvarenga, GL
AF Pereira, Rafaela Correa
   Souza Carneiro, Joao de Deus
   Borges, Soraia Vilela
   Garrido Assis, Odilio Benedito
   Alvarenga, Gabriela Lara
TI Preparation and Characterization of Nanocomposites from Whey Protein
   Concentrate Activated with Lycopene
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE carotenoids; nanotechnology; packaging
ID IMPROVE BARRIER PROPERTIES; EDIBLE FILMS; SOLUBILITY; MODEL; PH
AB The production and characterization of nanocomposites based on whey protein concentrate (WPC) and montmorilonite (MMT) incorporated with lycopene as a functional substance is presented and discussed as an alternative biomaterial for potential uses in foodstuff applications. A full factorial design with varying levels of MMT (0% and 2% in w/w) and lycopene (0%, 6%, and 12% in w/w) was used. Color, light transmission, film transparency, moisture, density, solubility, water vapor permeability, and antioxidant activity of the resulting materials were evaluated. Results indicated that lycopene and MMT nanoparticles were successfully included in WPC films using the casting/evaporation method. Inclusion of 2% w/w of MMT in the polymeric matrix significantly improved barrier property against water vapor. Lycopene, besides its good red coloring ability, provided to the films antioxidant activity and UV-vis light protection. These findings open a new perspective for the use of materials for bioactive packaging applications.
C1 [Pereira, Rafaela Correa; Souza Carneiro, Joao de Deus; Borges, Soraia Vilela; Alvarenga, Gabriela Lara] Univ Fed Lavras, Dept Food Sci, Lavras, MG, Brazil.
   [Garrido Assis, Odilio Benedito] Embrapa Instrumentat CNPDIA, Sao Carlos, SP, Brazil.
RP Pereira, RC (reprint author), Univ Fed Lavras, Dept Food Sci, Lavras, MG, Brazil.
EM rafacpereira@gmail.com
RI AgroNano, Rede/F-5675-2017
OI Alvarenga, Gabriela/0000-0002-3061-1801
CR Akhtar MJ, 2012, CARBOHYD POLYM, V89, P1150, DOI 10.1016/j.carbpol.2012.03.088
   AMERICAN SOCIETY STANDARD TESTING AND MATERIALS (ASTM), 1994, D64494 ASTM
   [Anonymous], 2003, E39803 ASTM
   [Anonymous], 2000, D61800 ASTM
   Azevedo VM, 2015, FOOD HYDROCOLLOID, V48, P179, DOI 10.1016/j.foodhyd.2015.02.014
   Azevedo VM, 2014, REV I LAT CANDIDO TO, V69, P36
   Bourbon AI, 2011, J FOOD ENG, V106, P111, DOI 10.1016/j.jfoodeng.2011.03.024
   Cinelli P, 2014, POLYM DEGRAD STABIL, V108, P151, DOI 10.1016/j.polymdegradstab.2014.07.007
   Dias MV, 2014, FOOD CHEM, V165, P323, DOI 10.1016/j.foodchem.2014.05.120
   Domenek S, 2013, J POLYM ENVIRON, V21, P692, DOI 10.1007/s10924-013-0570-6
   Fu LJ, 2014, INTL ENDOCRINOL, V2014, P1
   Gajowik Aneta, 2014, Rocz Panstw Zakl Hig, V65, P263
   Garcia MA, 2000, J FOOD SCI, V65, P941, DOI 10.1111/j.1365-2621.2000.tb09397.x
   Giroux HJ, 2013, DAIRY SCI TECHNOL, V93, P241, DOI 10.1007/s13594-013-0119-4
   Gounga ME, 2007, J FOOD ENG, V83, P521, DOI 10.1016/j.jfoodeng.2007.04.008
   Gutierrez M, 2012, CARBOHYD POLYM, V87, P1495
   Li YX, 2011, FOOD HYDROCOLLOID, V25, P1098, DOI 10.1016/j.foodhyd.2010.10.006
   Lopez-Rubio A, 2006, TRENDS FOOD SCI TECH, V17, P567, DOI 10.1016/j.tifs.2006.04.012
   Mittal V, 2009, MATERIALS, V2, P992, DOI 10.3390/ma2030992
   Park SI, 2004, J AGR FOOD CHEM, V52, P1933, DOI 10.1021/jf034612p
   Perez LM, 2014, FOOD CONTROL, V37, P298
   Perez-Gago MB, 1999, J FOOD SCI, V64, P1034, DOI 10.1111/j.1365-2621.1999.tb12276.x
   Ramos OL, 2013, FOOD HYDROCOLLOID, V30, P110, DOI 10.1016/j.foodhyd.2012.05.001
   Rodrigues-Amaya DB, 2008, FONTES BRASILEIRAS C
   Sahin K, 2015, ARCH BIOCHEM BIOPHYS, V572, P36, DOI 10.1016/j.abb.2015.01.006
   Shiku Y, 2003, FISHERIES SCI, V69, P1026, DOI 10.1046/j.1444-2906.2003.00722.x
   Siripatrawan U, 2010, FOOD HYDROCOLLOID, V24, P770, DOI 10.1016/j.foodhyd.2010.04.003
   Sothornvit R, 2010, LWT-FOOD SCI TECHNOL, V43, P279, DOI 10.1016/j.lwt.2009.08.010
   Souza BWS, 2009, FOOD HYDROCOLLOID, V23, P2110, DOI 10.1016/j.foodhyd.2009.03.021
   Stice CP, 2015, ARCH BIOCHEM BIOPHYS, V572, P81, DOI 10.1016/j.abb.2015.01.004
   Wakai M, 2015, FOOD HYDROCOLLOID, V43, P612, DOI 10.1016/j.foodhyd.2014.07.022
NR 31
TC 4
Z9 4
U1 3
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD MAR
PY 2016
VL 81
IS 3
BP E637
EP E642
DI 10.1111/1750-3841.13234
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA DG5VW
UT WOS:000372148400011
PM 26814439
DA 2018-10-20
ER

PT J
AU Krawczyk, N
   Fehm, T
   Banys-Paluchowski, M
   Janni, W
   Schramm, A
AF Krawczyk, Natalia
   Fehm, Tanja
   Banys-Paluchowski, Malgorzata
   Janni, Wolfgang
   Schramm, Annelle
TI Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment
   Decisions
SO ONCOLOGY RESEARCH AND TREATMENT
LA English
DT Review
DE Circulating tumor cells; Circulating tumor DNA; Metastatic breast
   cancer; Liquid biopsy
ID CIRCULATING TUMOR-CELLS; POOLED ANALYSIS; ESR1 MUTATIONS; NUCLEIC-ACIDS;
   DNA; SURVIVAL; DISEASE; CHEMOTHERAPY; THERAPY; MARKERS
AB According to current guidelines, the additional biopsy of breast cancer metastases to analyze the receptor status for phenotype assessment is recommended. However, due to clinical difficulties in performing biopsies of metastatic lesions, the phenotype of the primary tumor most often determines the treatment decisions in metastatic breast cancer. Liquid biopsy allows the analysis of several circulating biomarkers like circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) in peripheral blood samples of cancer patients. Thus, it is an elegant and easily practicable technique that delivers information on the current disease status. Determination of the CTC phenotype regarding the hormone receptor and human epidermal growth factor receptor 2 (HER2) status might replace additional tissue biopsy for planning further therapy strategies. Liquid biopsy is a crucial step towards a more individualized cancer therapy. In contrast to the conventional concept of tissue biopsy, it offers an easy, less invasive acquisition of biomaterial. In addition, it allows multiple repetitions and real-time monitoring of metastasized disease in the clinical routine. However, the clinical utility of liquid biopsy still needs to be evaluated. (C) 2016 S. Karger GmbH, Freiburg
C1 [Krawczyk, Natalia; Fehm, Tanja; Banys-Paluchowski, Malgorzata] Univ Dusseldorf, Dept Obstet & Gynecol, Moorenstr 5, D-40225 Dusseldorf, Germany.
   [Janni, Wolfgang; Schramm, Annelle] Univ Ulm, Dept Obstet & Gynecol, D-89069 Ulm, Germany.
RP Krawczyk, N (reprint author), Univ Dusseldorf, Dept Obstet & Gynecol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM natalia_krawczyk@yahoo.de
CR Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006
   Babayan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075038
   Bernhard H, 2008, CANCER IMMUNOL IMMUN, V57, P271, DOI 10.1007/s00262-007-0355-7
   Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094
   Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5
   Bidard FC, 2013, CANCER METAST REV, V32, P179, DOI 10.1007/s10555-012-9398-0
   Bozionellou V, 2004, CLIN CANCER RES, V10, P8185, DOI 10.1158/1078-0432.CCR-03-0094
   Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769
   Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140
   Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766
   Dawson SJ, 2013, NEW ENGL J MED, V369, P93, DOI 10.1056/NEJMc1306040
   Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011
   Fasching PA, 2015, GEBURTSH FRAUENHEILK, V75, P41, DOI 10.1055/s-0034-1396215
   Fehm T, 2005, CYTOTHERAPY, V7, P171, DOI 10.1080/14653240510027082
   Fehm T, 2010, BREAST CANCER RES TR, V124, P403, DOI 10.1007/s10549-010-1163-x
   Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205
   Giordano A, 2012, ANN ONCOL, V23, P1144, DOI 10.1093/annonc/mdr434
   Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907
   Guttery DS, 2015, CLIN CHEM, V61, P974, DOI 10.1373/clinchem.2015.238717
   Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821
   Heidary M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0421-y
   Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140
   Hepp PG, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.541
   Kalinsky K, 2015, CLIN TRANSL ONCOL, V17, P539, DOI 10.1007/s12094-015-1275-1
   Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099
   Krawczyk N, 2014, BIOMED RES INT, DOI 10.1155/2014/415721
   Ma MW, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.29
   Madic J, 2015, INT J CANCER, V136, P2158, DOI 10.1002/ijc.29265
   Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065
   Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375
   Pantel K, 2013, CANCER RES, V73, P6384, DOI 10.1158/0008-5472.CAN-13-2030
   Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7
   Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030
   Rack B, 2012, ARCH GYNECOL OBSTET, V285, P485, DOI 10.1007/s00404-011-1954-2
   Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288
   Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066
   Sefrioui D, 2015, INT J CANCER, V137, P2513, DOI 10.1002/ijc.29612
   Singh N, 2015, CANCER INVEST, V33, P78, DOI 10.3109/07357907.2014.1001894
   Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561
   Spindler KLG, 2014, INT J CANCER, V135, P2984, DOI 10.1002/ijc.28946
   Wallwiener M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1423-6
   Wallwiener M, 2013, BREAST CANCER RES TR, V137, P503, DOI 10.1007/s10549-012-2382-0
   Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600
   Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670
NR 44
TC 3
Z9 3
U1 0
U2 10
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 2296-5270
EI 2296-5262
J9 ONCOL RES TREAT
JI Oncol. Res. Treat.
PD MAR
PY 2016
VL 39
IS 3
BP 112
EP 116
DI 10.1159/000444605
PG 5
WC Oncology
SC Oncology
GA DG3EO
UT WOS:000371952500003
PM 27031542
DA 2018-10-20
ER

PT J
AU Singh, C
   Ali, MA
   Sumana, G
AF Singh, Chandan
   Ali, Md Azahar
   Sumana, Gajjala
TI Green Synthesis of Graphene Based Biomaterial Using Fenugreek Seeds for
   Lipid Detection
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Green chemistry; Graphene oxide; Palladium nanoparticles; Biosensors;
   Lipid detection; Fenugreek seeds; Sustainability
ID GRAPHITE OXIDE; AMPEROMETRIC BIOSENSOR; CHEMICAL-REDUCTION;
   RAMAN-SPECTRA; NANOPARTICLES; SHEETS; FILMS; ELECTRON; TRANSPARENT;
   NANOSHEETS
AB A novel, green, and sustainable route has been introduced for biosynthesis of a palladium nanoparticles (PdNPs) anchored reduced graphene oxide (rGO) platform for protein conjugation and detection of triglycerides. Fenugreek seeds (FS) were utilized for the simultaneous green reduction of Pd salt and graphene oxide (GO), which also act as a stabilizing and decorating agent for in situ grown PdNPs on rGO sheets. The well dispersed, homogeneous, and biologically reduced PdNPs having an average size of 3.5 nm on the rGO sheets are electrophoretically deposited on an indium tin oxide (ITO) glass substrate. The biosynthesized Pd-rGO sheets were characterized using spectroscopic and electrochemical techniques and further utilized for co-immobilization of lipase and glycerol dehydrogenase (LIP-GLDH) enzymes using EDC-NHS coupling chemistry. The LIP-GLDH conjugated Pd-rGO platform was used for electrochemical detection of triglycerides. The green and nontoxic approach offers enhanced stability of the fabricated biosensor as phytochemical (present in FS extract) residues available on the surface of Pd-rGO nanocomposite might have prevented the loss in the structure of the immobilized biomolecules/enzymes by providing a biocompatible coating. The fabricated Pd-rGO-based biosensor shows a wide detection range of 25-400 mg dL(-1) with an excellent sensitivity of 1.3 mu A mg(-1) dLcm(-1).
C1 [Singh, Chandan; Ali, Md Azahar; Sumana, Gajjala] CSIR Natl Phys Lab, Biomed Instrumentat Sect, Dr KS Krishnan Marg, New Delhi 110012, India.
   [Singh, Chandan] CSIR Natl Phys Lab, Acad Sci & Innovat Res AcSIR, Dr KS Krisnan Marg, New Delhi 110012, India.
RP Sumana, G (reprint author), CSIR Natl Phys Lab, Biomed Instrumentat Sect, Dr KS Krishnan Marg, New Delhi 110012, India.
EM sumanagajjala@gmail.com
RI Ali, Md Azahar/B-5573-2017
OI Ali, Md Azahar/0000-0001-5752-8808; Ali, Md Azahar/0000-0002-4583-2818
FU CSIR [ESC-0103]
FX We thank Director CSIR-NPL, New Delhi, India, for the facilities. We are
   thankful to Dr. A. M. Biradar for his consistent support and
   encouragement. The authors are thankful to Prof. B. D. Malhotra from
   Delhi Technological University for his sincere guidance. C.S. and
   Md.A.A. are thankful to CSIR for the award of Senior Research
   Fellowships. The authors are thankful to Dr. Ved V. Agrawal, Dr. Bhanu
   Pratap Singh, and Dr. Vidyanand Singh for AFM, Raman, and HR-TEM
   studies, respectively. We acknowledge the financial support received
   from CSIR (ESC-0103).
CR Afonso CAM, 2005, GREEN SEPARATION PROCESSES: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1002/3527606602
   Albrecht MA, 2006, GREEN CHEM, V8, P417, DOI 10.1039/b517131h
   Ambrosi A, 2011, CHEM-EUR J, V17, P10763, DOI 10.1002/chem.201101117
   Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b
   Aswathy A. S., 2012, SPECTROCHIM ACTA A, V97, P1
   Becerril HA, 2008, ACS NANO, V2, P463, DOI 10.1021/nn700375n
   Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f
   Cancado LG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196057
   Chan KT, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235430
   Chua CK, 2014, CHEM SOC REV, V43, P291, DOI 10.1039/c3cs60303b
   Dhand C, 2009, ELECTROCHEM COMMUN, V11, P1482, DOI 10.1016/j.elecom.2009.05.034
   Djakovitch L., 2008, NANOPARTICLES CATALY
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Gilje S, 2007, NANO LETT, V7, P3394, DOI 10.1021/nl0717715
   Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c
   Goncalves G, 2009, CHEM MATER, V21, P4796, DOI 10.1021/cm901052s
   Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b
   Kang SJ, 2007, NAT NANOTECHNOL, V2, P230, DOI 10.1038/nnano.2007.77
   Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384
   Khomyakov PA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195425
   Kirchhoff MM, 2005, RESOUR CONSERV RECY, V44, P237, DOI 10.1016/j.resconrec.2005.01.003
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Kuila T, 2012, CARBON, V50, P914, DOI 10.1016/j.carbon.2011.09.053
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liao WY, 2008, ANALYST, V133, P1757, DOI 10.1039/b801703d
   Lu GH, 2009, NANO RES, V2, P192, DOI 10.1007/s12274-009-9017-8
   Mann D, 2003, NANO LETT, V3, P1541, DOI 10.1021/nl034700o
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Martins MVA, 2014, PHYS CHEM CHEM PHYS, V16, P17426, DOI 10.1039/c4cp00452c
   Mastalir A, 2008, CATAL LETT, V124, P34, DOI 10.1007/s10562-008-9503-8
   Minakshi CSP, 2008, SENSOR ACTUAT B-CHEM, V133, P251, DOI 10.1016/j.snb.2008.02.036
   Muszynski R, 2008, J PHYS CHEM C, V112, P5263, DOI 10.1021/jp800977b
   Narang J, 2011, INT J BIOL MACROMOL, V49, P707, DOI 10.1016/j.ijbiomac.2011.07.001
   Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Paredes JI, 2009, LANGMUIR, V25, P5957, DOI 10.1021/la804216z
   Pumera M, 2010, CHEM SOC REV, V39, P4146, DOI 10.1039/c002690p
   Pumera M, 2009, CHEM REC, V9, P211, DOI 10.1002/tcr.200900008
   Pundir CS, 2010, CLIN BIOCHEM, V43, P467, DOI 10.1016/j.clinbiochem.2009.12.003
   Ramamurthy C, 2013, BIOPROC BIOSYST ENG, V36, P1131, DOI 10.1007/s00449-012-0867-1
   Robinson JT, 2008, NANO LETT, V8, P3137, DOI 10.1021/nl8013007
   Sanderson K, 2011, NATURE, V469, P18, DOI 10.1038/469018a
   Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967
   Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f
   Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167
   Si YC, 2008, CHEM MATER, V20, P6792, DOI 10.1021/cm801356a
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Suganya T. R., 2014, INT J CHEMTECH RES, V6, P2156
   Tang LH, 2009, ADV FUNCT MATER, V19, P2782, DOI 10.1002/adfm.200900377
   Thakur S, 2012, CARBON, V50, P5331, DOI 10.1016/j.carbon.2012.07.023
   Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r
   Wang Y, 2011, ACS APPL MATER INTER, V3, P1127, DOI 10.1021/am1012613
   Watt-Smith M. J., 2008, J PHYS D, V41
   Wu ZS, 2009, ADV MATER, V21, P1756, DOI 10.1002/adma.200802560
   Xiang JL, 2011, ACS APPL MATER INTER, V3, P1325, DOI 10.1021/am200126x
   Yang X, 2010, J NANOPART RES, V12, P1589, DOI 10.1007/s11051-009-9675-1
   Yonezawa T, 2001, LANGMUIR, V17, P4701, DOI 10.1021/la0101954
   Zan R, 2011, NANO LETT, V11, P1087, DOI 10.1021/nl103980h
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
NR 62
TC 8
Z9 8
U1 5
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAR
PY 2016
VL 4
IS 3
BP 871
EP 880
DI 10.1021/acssuschemeng.5b00923
PG 10
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA DG0LD
UT WOS:000371755400031
DA 2018-10-20
ER

PT J
AU Panzella, L
   Cerruti, P
   Ambrogi, V
   Agustin-Salazar, S
   D'Errico, G
   Carfagna, C
   Goya, L
   Ramos, S
   Martin, MA
   Napolitano, A
   d'Ischia, M
AF Panzella, Lucia
   Cerruti, Pierfrancesco
   Ambrogi, Veronica
   Agustin-Salazar, Sarai
   D'Errico, Gerardino
   Carfagna, Cosimo
   Goya, Luis
   Ramos, Sonia
   Martin, Maria A.
   Napolitano, Alessandra
   d'Ischia, Marco
TI A Superior All-Natural Antioxidant Biomaterial from Spent Coffee Grounds
   for Polymer Stabilization, Cell Protection, and Food Lipid Preservation
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Spent coffee grounds; Polyethylene; Antioxidant; HepG2 cells; Lipid
   peroxidation inhibition
ID POLYUNSATURATED FATTY-ACIDS; SCAVENGING PROPERTIES; VALUABLE SOURCE;
   OXIDATION; FILMS; ASSAY; POLY(3-HYDROXYBUTYRATE); STABILITY; STRESS;
   HEALTH
AB Treatment with boiling 6 M HCl increases up to 30 times the intrinsic antioxidant potency of spent coffee grounds, leading to a versatile multifunctional material (hydrolyzed spent coffee grounds, HSCG). Spectral and morphological analyses suggest that the remarkable potentiation of the antioxidant activity is due to efficient removal of the hydrolyzable components, mainly carbohydrates, making the polyphenol-rich component available for interaction with free radicals and oxidizing species. HSCG efficiently protects hepatocarcinoma (HepG2) cells from oxidative stress-induced injury and delays lipid peroxidation in fish and soybean oils. Moreover, films made of polyethylene/2% HSCG blends display greater stability to thermal and photo-oxidative degradation. HSCG may thus represent an easily accessible and sustainable alternative to currently available biomaterials with intrinsic antioxidant properties for biomedical, industrial, and technological applications.
C1 [Panzella, Lucia; D'Errico, Gerardino; Napolitano, Alessandra; d'Ischia, Marco] Univ Naples Federico II, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy.
   [Cerruti, Pierfrancesco; Agustin-Salazar, Sarai; Carfagna, Cosimo] CNR, IPCB, Via Campi Flegrei 34, I-80078 Pozzuoli, Italy.
   [Ambrogi, Veronica; Carfagna, Cosimo] Univ Naples Federico II, Dept Chem Mat & Prod Engn, Piazzale Tecchio 80, I-80125 Naples, Italy.
   [D'Errico, Gerardino] CSGI Consorzio Sviluppo Sistemi Grande Interfase, Florence, Italy.
   [Goya, Luis; Ramos, Sonia; Martin, Maria A.] CSIC, ICTAN, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.
RP Panzella, L (reprint author), Univ Naples Federico II, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy.
EM panzella@unina.it
RI Martin, Maria Angeles/C-5768-2014; Napolitano, Alessandra/E-9761-2011;
   Ramos, Sonia/K-4594-2012
OI Martin, Maria Angeles/0000-0001-8173-4521; Ramos,
   Sonia/0000-0003-2649-2616; Cerruti, Pierfrancesco/0000-0003-0822-2866;
   AGUSTIN-SALAZAR, SARAI/0000-0002-8529-5965
FU Italian MIUR (PRIN PROxi project)
FX This work was partially supported by grants from Italian MIUR (PRIN
   2010-2011 PROxi project).
CR Agustin-Salazar S, 2014, ACS SUSTAIN CHEM ENG, V2, P1534, DOI 10.1021/sc5002337
   Ambrogi V, 2011, POLYM DEGRAD STABIL, V96, P2152, DOI 10.1016/j.polymdegradstab.2011.09.015
   Ambrogi V, 2014, BIOMACROMOLECULES, V15, P302, DOI 10.1021/bm4015478
   Angelini S, 2014, INT J BIOL MACROMOL, V71, P163, DOI 10.1016/j.ijbiomac.2014.07.038
   Auriemma M, 2015, EUR POLYM J, V63, P123, DOI 10.1016/j.eurpolymj.2014.12.021
   Ballesteros LF, 2014, FOOD BIOPROCESS TECH, V7, P3493, DOI 10.1007/s11947-014-1349-z
   Granado-Serrano AB, 2007, J AGR FOOD CHEM, V55, P2020, DOI 10.1021/jf062556x
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Cao SL, 2012, RSC ADV, V2, P10925, DOI 10.1039/c2ra22045h
   Lopez MDC, 2013, J AGR FOOD CHEM, V61, P8462, DOI 10.1021/jf402670a
   Cerruti P, 2009, POLYM DEGRAD STABIL, V94, P2095, DOI 10.1016/j.polymdegradstab.2009.07.023
   Cesareo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048849
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   Fan LH, 2014, CARBOHYD POLYM, V112, P32, DOI 10.1016/j.carbpol.2014.05.056
   FRANKEL EN, 1984, PROG LIPID RES, V23, P197, DOI 10.1016/0163-7827(84)90011-0
   Gokmen V, 2009, TRENDS FOOD SCI TECH, V20, P278, DOI 10.1016/j.tifs.2009.03.010
   Gonzalez-Centeno MR, 2013, J AGR FOOD CHEM, V61, P11579, DOI 10.1021/jf403168k
   Goupy P, 2003, J AGR FOOD CHEM, V51, P615, DOI 10.1021/jf025938l
   Goya L, 2007, MOL NUTR FOOD RES, V51, P536, DOI 10.1002/mnfr.200600228
   Huber GM, 2009, FOOD CHEM, V117, P290, DOI 10.1016/j.foodchem.2009.04.007
   Jimenez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Kaldstrom M, 2014, GREEN CHEM, V16, P2454, DOI 10.1039/c4gc00168k
   Kanner J, 2007, MOL NUTR FOOD RES, V51, P1094, DOI 10.1002/mnfr.200600303
   Kim E, 2011, BIOMACROMOLECULES, V12, P880, DOI 10.1021/bm101499a
   Kim E, 2010, ADV FUNCT MATER, V20, P2683, DOI 10.1002/adfm.200902428
   Li JB, 2007, BIORESOURCE TECHNOL, V98, P3061, DOI 10.1016/j.biortech.2006.10.018
   Liu QL, 2013, ACS APPL MATER INTER, V5, P11101, DOI 10.1021/am4033372
   Low JH, 2015, IND CROP PROD, V69, P456, DOI 10.1016/j.indcrop.2015.03.001
   Ma MG, 2012, BIORESOURCE TECHNOL, V114, P677, DOI 10.1016/j.biortech.2012.03.048
   MARCOCCI L, 1994, BIOCHEM BIOPH RES CO, V201, P748, DOI 10.1006/bbrc.1994.1764
   Monente C, 2015, J FUNCT FOODS, V12, P365, DOI 10.1016/j.jff.2014.12.006
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Mostert AB, 2013, J PHYS CHEM B, V117, P4965, DOI 10.1021/jp401615e
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Nand AV, 2013, J FOOD ENG, V116, P422, DOI 10.1016/j.jfoodeng.2012.11.023
   NOUROOZZADEH J, 1995, J AGR FOOD CHEM, V43, P17, DOI 10.1021/jf00049a005
   Olejar KJ, 2014, CELLULOSE, V21, P4545, DOI 10.1007/s10570-014-0447-4
   Panzella L, 2013, ANGEW CHEM INT EDIT, V52, P12684, DOI 10.1002/anie.201305747
   Panzella L, 2013, J AGR FOOD CHEM, V61, P1710, DOI 10.1021/jf302690c
   Panzella L, 2012, J AGR FOOD CHEM, V60, P8895, DOI 10.1021/jf2053096
   Persico P, 2012, INT J BIOL MACROMOL, V51, P1151, DOI 10.1016/j.ijbiomac.2012.08.036
   Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040
   Ribeiro JS, 2010, J FOOD QUALITY, V33, P212, DOI 10.1111/j.1745-4557.2010.00309.x
   Sadeghifar H, 2015, ACS SUSTAIN CHEM ENG, V3, P349, DOI 10.1021/sc500756n
   Serini S, 2011, CHEM RES TOXICOL, V24, P2093, DOI 10.1021/tx200314p
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Sturgeon MR, 2014, ACS SUSTAIN CHEM ENG, V2, P472, DOI 10.1021/sc400384w
   Vardon DR, 2013, ACS SUSTAIN CHEM ENG, V1, P1286, DOI 10.1021/sc400145w
   Wang H, 2008, FOOD CHEM, V106, P888, DOI 10.1016/j.foodchem.2007.05.068
   Wattamwar PP, 2012, ACTA BIOMATER, V8, P2529, DOI 10.1016/j.actbio.2012.03.022
   Williams SR, 2009, BIOMACROMOLECULES, V10, P155, DOI 10.1021/bm801058j
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
   Xu C, 2013, ANAL CHIM ACTA, V793, P53, DOI 10.1016/j.aca.2013.07.027
   Yang J, 2014, BIOMACROMOLECULES, V15, P3942, DOI 10.1021/bm5010004
   Yordanov ND, 1999, J RADIOANAL NUCL CH, V240, P619, DOI 10.1007/BF02349422
   Zuorro A, 2012, J CLEAN PROD, V34, P49, DOI 10.1016/j.jclepro.2011.12.003
NR 60
TC 10
Z9 10
U1 1
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAR
PY 2016
VL 4
IS 3
BP 1169
EP 1179
DI 10.1021/acssuschemeng.5b01234
PG 11
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA DG0LD
UT WOS:000371755400066
DA 2018-10-20
ER

PT J
AU Andorko, JI
   Hess, KL
   Pineault, KG
   Jewell, CM
AF Andorko, James I.
   Hess, Krystina L.
   Pineault, Kevin G.
   Jewell, Christopher M.
TI Intrinsic immunogenicity of rapidly-degradable polymers evolves during
   degradation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Poly(beta-amino esters); Dendritic cell; Vaccine; Microparticle and
   nanoparticie; Immune response and inflammation
ID DENDRITIC CELL MATURATION; GENE DELIVERY; POLY(BETA-AMINO ESTERS);
   CATIONIC POLYMER; VACCINE DELIVERY; PLASMID DNA; IN-VITRO;
   NANOPARTICLES; HYALURONAN; ACTIVATION
AB Recent studies reveal many biomaterial vaccine carriers are able to activate immunostimulatory pathways, even in the absence of other immune signals. How the changing properties of polymers during biodegradation impact this intrinsic immunogenicity is not well studied, yet this information could contribute to rational design of degradable vaccine carriers that help direct immune response. We use degradable poly(beta-amino esters) (PBAEs) to explore intrinsic immunogenicity as a function of the degree of polymer degradation and polymer form (e.g., soluble, particles). PBAE particles condensed by electrostatic interaction to mimic a common vaccine approach strongly activate dendritic cells, drive antigen presentation, and enhance T cell proliferation in the presence of antigen. Polymer molecular weight strongly influences these effects, with maximum stimulation at short degradation times - corresponding to high molecular weight - and waning levels as degradation continues. In contrast, free polymer is immunologically inert. In mice, PBAE particles increase the numbers and activation state of cells in lymph nodes. Mechanistic studies reveal that this evolving immunogenicity occurs as the physicochemical properties and concentration of particles change during polymer degradation. This work confirms the immunological profile of degradable, synthetic polymers can evolve over time and creates an opportunity to leverage this feature in new vaccines.
   Statement of Significance
   Degradable polymers are increasingly important in vaccination, but how the inherent immunogenicity of polymers changes during degradation is poorly understood. Using common rapidly-degradable vaccine carriers, we show that the activation of immune cells - even in the absence of other adjuvants - depends on polymer form (e.g., free, particulate) and the extent of degradation. These changing characteristics alter the physicochemical properties (e.g., charge, size, molecular weight) of polymer particles, driving changes in immunogenicity. Our results are important as many common biomaterials (e.g., PLGA) are now known to exhibit immune activity that alters how vaccines are processed. Thus, the results of this study could contribute to more rational design of biomaterial carriers that also actively direct the properties of responses generated by vaccines. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd.
C1 [Andorko, James I.; Hess, Krystina L.; Pineault, Kevin G.; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.
RP Jewell, CM (reprint author), Fischell Dept Bioengn, 2212 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
OI Jewell, Christopher/0000-0002-6668-6928
FU NSF CAREER Award [1351688]; NIH Grant [T32 AI089621]; American
   Association of Pharmaceutical Scientists; Department of Defense SMART
   Award; Damon Runyon Foundation [DRR3415]; Alliance for Cancer Gene
   Therapy [15051543]; Melanoma Research Alliance [348963]
FX This work was supported by NSF CAREER Award # 1351688. J.I. A. is a
   trainee on NIH Grant # T32 AI089621 and a Graduate Research Fellow
   supported by the American Association of Pharmaceutical Scientists.
   K.L.H. is a Graduate Research Fellow supported by a Department of
   Defense SMART Award. C.M.J. is a Damon Runyon-Rachleff Innovator
   supported by the Damon Runyon Foundation # DRR3415, a Young Investigator
   supported by the Alliance for Cancer Gene Therapy # 15051543, and a
   Young Investigator supported by the Melanoma Research Alliance # 348963.
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Akinc A, 2003, J AM CHEM SOC, V125, P5316, DOI 10.1021/ja034429c
   Andorko J. I., 2014, AAPS J, P1
   Andorko JI, 2014, JOVE-J VIS EXP, DOI 10.3791/50984
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Bechler SL, 2012, BIOMACROMOLECULES, V13, P1523, DOI 10.1021/bm300234q
   Bechler SL, 2012, BIOMACROMOLECULES, V13, P542, DOI 10.1021/bm2016338
   Bechler SL, 2011, J POLYM SCI POL CHEM, V49, P1572, DOI 10.1002/pola.24578
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   Gallorini S, 2007, J IMMUNOL, V179, P8208, DOI 10.4049/jimmunol.179.12.8208
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111
   Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x
   Guerrero-Cazares H, 2014, ACS NANO, V8, P5141, DOI 10.1021/nn501197v
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Jones CH, 2015, BIOMATERIALS, V37, P333, DOI 10.1016/j.biomaterials.2014.10.037
   Keeney M, 2013, ACS NANO, V7, P7241, DOI 10.1021/nn402657d
   Kozielski KL, 2014, ACS NANO, V8, P3232, DOI 10.1021/nn500704t
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Lynn DM, 2001, ANGEW CHEM INT EDIT, V40, P1707, DOI 10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.3.CO;2-6
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Swartz M. A., 2012, SCI TRANSL MED, V4
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x
   VanGool SW, 1996, IMMUNOL REV, V153, P47
   Zhang JT, 2007, LANGMUIR, V23, P11139, DOI 10.1021/la702021s
NR 50
TC 25
Z9 26
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 24
EP 34
DI 10.1016/j.actbio.2015.12.026
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100003
PM 26708710
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Zhang, JY
   Li, M
   Kang, ET
   Neoh, KG
AF Zhang, Jieyu
   Li, Min
   Kang, En-Tang
   Neoh, Koon Gee
TI Electrical stimulation of adipose-derived mesenchymal stem cells in
   conductive scaffolds and the roles of voltage-gated ion channels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Electrical stimulation; Polypyrrole; Adipose-derived mesenchymal stem
   cells; Polycaprolactone scaffold; Voltage-gated ion channels
ID IN-VITRO; OSTEOGENIC DIFFERENTIATION; BONE REGENERATION; BIOMATERIAL
   SCAFFOLDS; POLYPYRROLE FILMS; CALCIUM-CHANNEL; STROMAL CELLS; NA+
   CHANNELS; TISSUE; PROLIFERATION
AB Since electrical stimulation (ES) can significantly accelerate bone healing, a conductive scaffold that can deliver ES locally at the defect site is desirable for bone defect therapy. Herein, an electrically conductive scaffold was prepared via incorporation of polypyrrole (PPY) in a polycaprolactone (PCL) template scaffold. In vitro tests with mouse osteoblasts indicate that the PPY/PCL scaffold has good biocompatibility, and is suitable for use as an ES substrate. When human adipose-derived mesenchymal stem cells (AD-MSCs) were cultured in the PPY/PCL scaffold and subjected to 200 mu A of direct current for 4 h per day for 21 days, the amount of calcium deposited was 100% higher than that without ES. When these cells were subjected to ES together with blockers of voltage-gated calcium (Ca-v(2+)), sodium (Na-v(+)), potassium (K-v(+)), or chloride (Cl-v(-)) channels, the ES-induced enhancement of AD-MSCs' functions was reduced with Na-v(+), K-v(+), or Cl-v(-) blockers and completely nullified with Cev(2+) blocker. These results indicate that ion fluxes through these channels activated by ES induce different cascades of reactions in the cells, which subsequently regulate AD-MSCs' functions, and Cav(2+) plays a more critical role than the other three channels. Our results further the current understanding of the mechanisms by which ES regulates stem cells' behavior, and also showed that the conductive PPY/PCL scaffold with application of ES has good potential in bone defect therapy.
   Statement of Significance In this work, an electrically conductive and biocompatible scaffold was prepared by incorporating polypyrrole in a polycaprolactone template scaffold. Application of 200 A direct current for 4 h per day to human adipose derived-mesenchymal stem cells cultured on this scaffold promoted migration of these cells into the inner region of the scaffold and enhanced their osteogenic differentiation. The roles of voltage-gated ion channels (Ca-v(2+), Na-v(+), K-v(+), and Cl-v(-)) in osteogenic differentiation stimulated by the electric current were investigated. The results from these experiments further the current understanding of the mechanisms by which electrical stimulation regulates stem cells' behavior, and also show that the polypyr role-polycaprolactone scaffold with application of electrical stimulation has good potential in bone defect therapy. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Jieyu; Kang, En-Tang; Neoh, Koon Gee] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Kent Ridge 117576, Singapore.
   [Li, Min; Kang, En-Tang; Neoh, Koon Gee] Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge 117576, Singapore.
RP Neoh, KG (reprint author), Blk E5,4 Engn Dr 4,02-34, Singapore 117576, Singapore.
EM zhangjieyu@u.nus.edu; chelim@nus.edu.sg; cheket@nus.edu.sg;
   chenkg@nus.edu.sg
OI Neoh, Koon Gee/0000-0002-2700-1914; Kang, En-Tang/0000-0003-0599-7834
FU National Medical Research Council of Singapore [NMRC EDG09-nov024]
FX This work was financially supported by the National Medical Research
   Council of Singapore (Grant number NMRC EDG09-nov024). We thank Dr.
   Yaw-Chyn Lim from Department of Physiology, National University of
   Singapore, for providing us the cell culture facilities.
CR Aronin CEP, 2008, ACTA BIOMATER, V4, P1187, DOI 10.1016/j.actbio.2008.02.029
   Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007
   Banu SK, 2008, ENDOCRINOLOGY, V149, P219, DOI 10.1210/en.2007-1087
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319
   Bjorninen M, 2014, ANN BIOMED ENG, V42, P1889, DOI 10.1007/s10439-014-1023-7
   Boiko N, 2013, J BIOL CHEM, V288, P9418, DOI 10.1074/jbc.M112.449413
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Diykov D, 2013, INVERTEBR NEUROSCI, V13, P57, DOI 10.1007/s10158-012-0143-8
   Fassina L, 2010, J BIOMED MATER RES A, V93A, P1272, DOI 10.1002/jbm.a.32620
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Gabriel S, 2007, CHEM MATER, V19, P2364, DOI 10.1021/cm062450h
   Galar P, 2013, INT J ELECTROCHEM SC, V8, P57
   Goldstein C, 2010, J ORTHOP TRAUMA, V24, pS62, DOI 10.1097/BOT.0b013e3181cdde1b
   Hammerick KE, 2010, BIOCHEM BIOPH RES CO, V397, P12, DOI 10.1016/j.bbrc.2010.05.003
   Hardy JG, 2013, CURR OPIN BIOTECH, V24, P847, DOI 10.1016/j.copbio.2013.03.011
   Hess R, 2012, BIOMATERIALS, V33, P8975, DOI 10.1016/j.biomaterials.2012.08.056
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hong S, 2011, CARBOHYD POLYM, V83, P940, DOI 10.1016/j.carbpol.2010.09.002
   Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013
   Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019
   Isaacson BM, 2010, J BIOMED MATER RES A, V95A, P1270, DOI 10.1002/jbm.a.32905
   Jansen JHW, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-188
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawai T, 2014, TISSUE ENG PT A, V20, P1336, DOI [10.1089/ten.tea.2013.0508, 10.1089/ten.TEA.2013.0508]
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Koori K, 2014, CELL TISSUE RES, V357, P707, DOI 10.1007/s00441-014-1918-5
   Lefebvre M, 2006, APPL PROBABILITY STA
   Lian Kai, 2013, Biomatter, V3, DOI 10.4161/biom.27250
   Lin YH, 2011, LIFE SCI, V89, P886, DOI 10.1016/j.lfs.2011.09.011
   Liu AR, 2012, THIN SOLID FILMS, V520, P6307, DOI 10.1016/j.tsf.2012.06.039
   Meng SY, 2013, BIOELECTROMAGNETICS, V34, P189, DOI 10.1002/bem.21766
   Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125
   Olsen ML, 2003, J NEUROSCI, V23, P5572
   Pappalardo LW, 2014, GLIA, V62, P1162, DOI 10.1002/glia.22671
   Pelto J, 2013, TISSUE ENG PT A, V19, P882, DOI [10.1089/ten.tea.2012.0111, 10.1089/ten.TEA.2012.0111]
   Pereira C, 2015, BIOMATERIALS, V56, P36, DOI 10.1016/j.biomaterials.2015.03.054
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Radford R, 2012, AM J PHYSIOL-RENAL, V302, pF905, DOI 10.1152/ajprenal.00427.2011
   Russell TA, 2008, J BONE JOINT SURG AM, V90A, P2057, DOI 10.2106/JBJS.G.01191
   Saadoun S, 2011, J NEUROL NEUROSUR PS, V82, P3
   Shao SJ, 2011, BIOMATERIALS, V32, P2821, DOI 10.1016/j.biomaterials.2011.01.051
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480
   Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu WKK, 2008, MOL CELL BIOCHEM, V308, P219, DOI 10.1007/s11010-007-9631-2
   Xiao YH, 2012, J MATER CHEM, V22, P8076, DOI 10.1039/c2jm30601h
   Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200
   Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675
   Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796
   Zhang X, 2003, LANGMUIR, V19, P10703, DOI 10.1021/la034893v
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
   Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
   Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589
NR 59
TC 24
Z9 24
U1 7
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 46
EP 56
DI 10.1016/j.actbio.2015.12.024
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100005
PM 26703122
DA 2018-10-20
ER

PT J
AU Patel, A
   Mukundan, S
   Wang, WH
   Karumuri, A
   Sant, V
   Mukhopadhyay, SM
   Sant, S
AF Patel, Akhil
   Mukundan, Shilpaa
   Wang, Wenhu
   Karumuri, Anil
   Sant, Vinayak
   Mukhopadhyay, Sharmila M.
   Sant, Shilpa
TI Carbon-based hierarchical scaffolds for myoblast differentiation:
   Synergy between nano-functionalization and alignment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Carbon nanotubes; Multiscale hierarchy; Myogenesis; Carbon-based
   scaffolds; Alignment; Interconnected microporous structure; C2C12;
   Nano-roughness
ID SKELETAL-MUSCLE TISSUE; MESENCHYMAL STEM-CELLS; IN-VITRO; NANOTUBES;
   FABRICATION; COMPOSITE; CONSTRUCTS; SURFACES; ADHESION; CULTURE
AB While several scaffolds have been proposed for skeletal muscle regeneration, multiscale hierarchical scaffolds with the complexity of extracellular matrix (ECM) haven't been engineered successfully. By precise control over nano- and microscale features, comprehensive understanding of the effect of multiple factors on skeletal muscle regeneration can be derived. In this study, we engineered carbon-based scaffolds with hierarchical nano- and microscale architecture with controlled physico-chemical properties. More specifically, we built multiscale hierarchy by growing carbon nanotube (CNT) carpets on two types of scaffolds, namely, interconnected microporous carbon foams and aligned carbon fiber mats. Nanostructured CNT carpets offered fine control over nano-roughness and wettability facilitating myoblast adhesion, growth and differentiation into myocytes. However, microporous foam architecture failed to promote their fusion into multinucleated myotubes. On the other hand, aligned fibrous architecture stimulated formation of multinucleated myotubes. Most importantly, nanostructured CNT carpets interfaced with microscale aligned fibrous architecture significantly enhanced myocyte fusion into multinucleated mature myotubes highlighting synergy between nanoscale surface features and micro-/macroscale aligned fibrous architecture in the process of myogenesis.
   Statement of Significance
   Due to limited regenerative potential of skeletal muscle, strategies stimulating regeneration of functional muscles are important. These strategies are aimed at promoting differentiation of progenitor cells (myoblasts) into multinucleated myotubes, a key initial step in functional muscle regeneration. Recent tissue engineering approaches utilize various scaffolds ranging from decellularized matrices to aligned biomaterial scaffolds. Although, majority of them have focused on nano- or microscale organization, a systematic approach to build the multiscale hierarchy into these scaffolds is lacking. Here, we engineered multiscale hierarchy into carbon-based materials and demonstrated that the nanoscale features govern the differentiation of individual myoblasts into myocytes whereas microscale alignment cues orchestrate fusion of multiple myocytes into multinucleated myotubes underlining the importance of multiscale hierarchy in enhancing coordinated tissue regeneration. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Patel, Akhil; Mukundan, Shilpaa; Sant, Vinayak; Sant, Shilpa] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.
   [Mukundan, Shilpaa; Wang, Wenhu; Mukhopadhyay, Sharmila M.] Wright State Univ, Ctr Nanoscale Multifunct Mat, Mech & Mat Engn, Dayton, OH 45324 USA.
   [Sant, Shilpa] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Sant, Shilpa] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
RP Sant, S (reprint author), 3501 Terrace St,527 Salk Hall, Pittsburgh, PA 15261 USA.
EM shs149@pitt.edu
OI Patel, Akhil/0000-0001-8915-8995; Sant, Shilpa/0000-0002-2017-9584
FU Department of Pharmaceutical Sciences at University of Pittsburgh;
   NSF-CBET [1449582]; WSU PhD program; Ohio Board of Regents
FX The authors thank Dr. Donna B. Stolz, Center for Biologic Imaging (CBI),
   University of Pittsburgh for access to the electron microscopy facility.
   SS acknowledges funding support from start-up funds from the Department
   of Pharmaceutical Sciences at University of Pittsburgh. Mukhopadhyay
   group acknowledges financial support from NSF-CBET (1449582), WSU PhD
   program, and Ohio Board of Regents. We also thank Ultramet and Hexcel
   for generous supplies of carbon foam and fiber mats, respectively.
CR Ahadian S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04271
   [Anonymous], 2011, US BUR LAB STAT REP
   Bennett DB, 2014, J BONE JOINT SURG AM, V96A, P2062, DOI 10.2106/JBJS.M.01542
   Chen JY, 2008, J AM CHEM SOC, V130, P16778, DOI 10.1021/ja805570f
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Chinn J. A., 1995, BIOMEDICAL ENG HDB, P1597
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   Clark P, 2002, INT J BIOCHEM CELL B, V34, P816, DOI 10.1016/S1357-2725(01)00180-7
   Depan D, 2014, BIOMATER SCI-UK, V2, P1727, DOI 10.1039/c4bm00168k
   Duffy RM, 2014, WIRES NANOMED NANOBI, V6, P178, DOI 10.1002/wnan.1254
   El-Ayoubi R, 2008, TISSUE ENG PT A, V14, P1037, DOI [10.1089/ten.tea.2006.0418, 10.1089/tea.2006.0418]
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Evans DJR, 1999, DEV GENES EVOL, V209, P438, DOI 10.1007/s004270050275
   Ferlin KM, 2013, MICRO AND NANOTECHNOLOGIES IN ENGINEERING STEM CELLS AND TISSUES, P159
   Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Hall JE, 2011, GUYTON HALL TXB MED
   Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Karumuri AK, 2015, APPL SURF SCI, V327, P122, DOI [10.1016/j.apsusc.2014.11.154, 10.1016/j.apsusc.2014.10.154]
   Kerativitayanan P., 2015, ADV HEALTHCARE MAT
   Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015
   Lam MT, 2009, BIOMATERIALS, V30, P1150, DOI 10.1016/j.biomaterials.2008.11.014
   Li N., 2013, SCI REP, V3
   McKeon-Fischer KD, 2011, J BIOMED MATER RES A, V99A, P493, DOI 10.1002/jbm.a.33116
   Meng J, 2006, J BIOMED MATER RES A, V79A, P298, DOI 10.1002/jbm.a.30787
   Montesano S, 2013, ISRN TISSUE ENGINEER, V2013, P8
   Mukhopadhyay SM, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/36/365301
   Mukhopadhyay SM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/19/195503
   Mukundan S, 2015, EUR POLYM J, V68, P21, DOI 10.1016/j.eurpolymj.2015.04.026
   Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Sant S., 2012, TISSUE ANALOGS ASSEM, P471
   Sant S, 2013, ACTA BIOMATER, V9, P5963, DOI 10.1016/j.actbio.2012.11.014
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Sirivisoot S, 2011, INT J NANOMED, V6, P2483, DOI 10.2147/IJN.S24073
   Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.tea.2011.0219, 10.1089/ten.TEA.2011.0219]
   VANDERVEN PFM, 1992, CELL TISSUE RES, V270, P189, DOI 10.1007/BF00381893
   Vilquin J T, 2005, Acta Myol, V24, P119
   Wang H., 2015, ADV COLLOID INTERFAC
   Xu AX, 2015, MAT SCI ENG C-MATER, V48, P592, DOI 10.1016/j.msec.2014.12.061
   Zhang XY, 2012, TOXICOL RES-UK, V1, P62, DOI 10.1039/c2tx20006f
NR 48
TC 10
Z9 11
U1 7
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 77
EP 88
DI 10.1016/j.actbio.2016.01.004
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100008
PM 26768231
OA Other Gold
DA 2018-10-20
ER

PT J
AU Levingstone, TJ
   Thompson, E
   Matsiko, A
   Schepens, A
   Gleeson, JP
   O'Brien, FJ
AF Levingstone, Tanya J.
   Thompson, Emmet
   Matsiko, Amos
   Schepens, Alexander
   Gleeson, John P.
   O'Brien, Fergal J.
TI Multi-layered collagen-based scaffolds for osteochondral defect repair
   in rabbits
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cartilage; Osteochondral; Tissue engineering; Collagen; In vivo
ID ARTICULAR-CARTILAGE REPAIR; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   SIMULTANEOUS REGENERATION; TISSUE REGENERATION; BARRIER PRINCIPLE;
   TRABECULAR BONE; CELL-ADHESION; ANIMAL-MODELS; GAG SCAFFOLDS; II
   COLLAGEN
AB Introduction: Identification of a suitable treatment for osteochondral repair presents a major challenge due to existing limitations and an urgent clinical need remains for an off-the-shelf, low cost, one-step approach. A biomimetic approach, where the biomaterial itself encourages cellular infiltration from the underlying bone marrow and provides physical and chemical cues to direct these cells to regenerate the damaged tissue, provides a potential solution. To meet this need, a multi-layer collagen-based osteochondral defect repair scaffold has been developed in our group.
   Aim: The objective of this study was to assess the in vivo response to this scaffold and determine its ability to direct regenerative responses in each layer in order to repair osteochondral tissue in a critical-sized defect in a rabbit knee.
   Methods: Multi-layer scaffolds, consisting of a bone layer composed of type I collagen (bovine source) and hydroxyapatite (HA), an intermediate layer composed of type I and type II collagen and HA; and a superficial layer composed of type I and type II collagen (porcine source) and hyaluronic acid (HyA), were implanted into critical size (3 x 5 mm) osteochondral defects created in the medial femoral condyle of the knee joint of New Zealand white rabbits and compared to an empty control group. Repair was assessed macroscopically, histologically and using micro-CT analysis at 12 weeks post implantation.
   Results: Analysis of repair tissue demonstrated an enhanced macroscopic appearance in the multi-layer scaffold group compared to the empty group. In addition, diffuse host cellular infiltration in the scaffold group resulted in tissue regeneration with a zonal organisation, with repair of the subchondral bone, formation of an overlying cartilaginous layer and evidence of an intermediate tidemark.
   Conclusion: These results demonstrate the potential of this biomimetic multi-layered scaffold to support and guide the host reparative response in the treatment of osteochondral defects.
   Statement of Significance
   Osteochondral defects, involving cartilage and the underlying subchondral bone, frequently occur in young active patients due to disease or injury. While some treatment options are available, success is limited and patients often eventually require joint replacement. To address this clinical need, a multi-layer collagen-based osteochondral defect repair scaffold designed to direct host-stem cell mediated tissue formation within each region, has been developed in our group. The present study investigates the in vivo response to this scaffold in a critical-sized defect in a rabbit knee. Results shows the scaffolds ability to guide the host reparative response leading to tissue regeneration with a zonal organisation, repair of the subchondral bone, formation of an overlying cartilaginous layer and evidence of an intermediate tidemark. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Ireland.
   [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Trinity Coll Dublin, Trin Ctr Bioengn, Dublin 2, Ireland.
   [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.
   [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Trinity Coll Dublin, Dublin 2, Ireland.
   [Schepens, Alexander] AZ Sint Lucas Hosp, Dept Orthopaed Surg, Ghent, Belgium.
   [Gleeson, John P.] Dublin City Univ, Invent Ctr, SurgaColl Technol Ltd, Dublin 9, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surgeons Ireland, Dept Anat, 123 St Stephens Green, Dublin 2, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Levingstone,
   Tanya/0000-0002-9751-2314
FU Enterprise Ireland Proof of Concept Award [PC/2007/331];
   Commercialisation Fund Technology Development Award [CFTD/2009/0104];
   Science Foundation Ireland (SFI)/Health Research Board (HRB)
   Translational Research Award [TRA/2011/19]
FX The authors acknowledge Enterprise Ireland Proof of Concept Award
   (PC/2007/331) and Commercialisation Fund Technology Development Award
   (CFTD/2009/0104) and Science Foundation Ireland (SFI)/Health Research
   Board (HRB) Translational Research Award (TRA/2011/19) for funding.
CR Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912
   ASTM, 2010, STAND GUID IN VIV AS
   Benazzo F, 2008, J ORTHOP RES, V26, P631, DOI 10.1002/jor.20530
   Brittberg M., 2010, AM J SPORTS MED, V38, P259
   Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   Chang KY, 2010, J BIOMED MATER RES A, V92A, P712, DOI 10.1002/jbm.a.32198
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Chu CR, 1997, CLIN ORTHOP RELAT R, P220
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cook JL, 2014, BONE JOINT RES, V3, P89, DOI 10.1302/2046-3758.34.2000238
   De Franceschi L, 2005, J BIOMED MATER RES A, V75A, P612, DOI 10.1002/jbm.a.30471
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Getgood A, 2012, CARTILAGE, V3, P351, DOI 10.1177/1947603512444597
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Gleeson J. P., 2009, Patent, Patent No. [WO2010/084481, 2010084481]
   Gudas R, 2012, AM J SPORT MED, V40, P2499, DOI 10.1177/0363546512458763
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Henderson IJP, 2005, KNEE, V12, P435, DOI 10.1016/j.knee.2005.04.003
   Hunziker EB, 2003, OSTEOARTHR CARTILAGE, V11, P320, DOI 10.1016/S1063-4584(03)00031-1
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS182
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795
   Karamichos D, 2006, J BIOMED MATER RES A, V78A, P407, DOI 10.1002/jbm.a.30814
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Kon E, 2013, BONE JOINT RES, V2, P18, DOI 10.1302/2046-3758.22.2000092
   Lahm A, 2006, ARCH ORTHOP TRAUM SU, V126, P582, DOI 10.1007/s00402-005-0077-2
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Maehara H, 2010, J ORTHOP RES, V28, P677, DOI 10.1002/jor.21032
   Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068
   Matsiko A, 2012, J MECH BEHAV BIOMED, V11, P41, DOI 10.1016/j.jmbbm.2011.11.012
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Mrosek EH, 2006, OSTEOARTHR CARTILAGE, V14, P171, DOI 10.1016/j.joca.2005.08.004
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Panics G, 2012, CARTILAGE, V3, p25S, DOI 10.1177/1947603511408286
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Ragetly G, 2010, ACTA BIOMATER, V6, P3988, DOI 10.1016/j.actbio.2010.05.016
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Reyes R., 2014, J TISSUE ENG REGEN M, V6, P521
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Scotti C, 2010, BIOMATERIALS, V31, P2252, DOI 10.1016/j.biomaterials.2009.11.110
   Tassani S, 2014, J MICROSC-OXFORD, V256, P75, DOI 10.1111/jmi.12159
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Vines JB, 2012, ACTA BIOMATER, V8, P4053, DOI 10.1016/j.actbio.2012.07.024
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wang FY, 2009, J STRUCT BIOL, V168, P359, DOI 10.1016/j.jsb.2009.08.010
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
NR 53
TC 36
Z9 38
U1 8
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 149
EP 160
DI 10.1016/j.actbio.2015.12.034
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100015
PM 26724503
DA 2018-10-20
ER

PT J
AU Ferlin, KM
   Prendergast, ME
   Miller, ML
   Kaplan, DS
   Fisher, JP
AF Ferlin, Kimberly M.
   Prendergast, Margaret E.
   Miller, Makenzie L.
   Kaplan, David S.
   Fisher, John P.
TI Influence of 3D printed porous architecture on mesenchymal stem cell
   enrichment and differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE 3D printing; Biomaterial; Mesenchymal stem cell; Differentiation;
   Scaffold architecture
ID MARROW STROMAL CELLS; POLY(PROPYLENE FUMARATE); PORE-SIZE; SCAFFOLDS;
   BIOMATERIALS; REGENERATION; CULTURE; DESIGN; PERMEABILITY; LINEAGES
AB The interactions between cells and an underlying biomaterial are important for the promotion of cell adhesion, proliferation, and function. Mesenchymal stem cells (MSCs) have great clinical potential as they are an adult stem cell population capable of multilineage differentiation. The relationship between MSC behavior and several material properties including substrate stiffness and pore size are well investigated, but there has been little research on the influence of porous architecture in a three-dimensional scaffold with a well-controlled architecture. Here, we investigate the impact of two different three-dimensionally printed, pore geometries on the enrichment and differentiation of MSCs. 3D printed scaffolds with ordered cubic pore geometry were supportive of MSC enrichment from unprocessed bone marrow, resulting in cell surface marker expression that was comparable to typical adhesion to tissue culture polystyrene, the gold standard for MSC culture. Results also show that scaffolds fabricated with ordered cubic pores significantly increase the gene expression of MSCs undergoing adipogenesis and chondrogenesis, when compared to scaffolds with ordered cylindrical pores. However, at the protein expression level, these differences were modest. For MSCs undergoing osteogenesis, gene expression results suggest that cylindrical pores may initially increase early osteogenic marker expression, while protein level expression at later timepoints is increased for scaffolds with ordered cubic pores. Taken together, these results suggest that 3D printed scaffolds with ordered cubic pores could be a suitable culture system for single-step MSC enrichment and differentiation.
   Statement of Significance
   Mesenchymal stem cells (MSCs) have great therapeutic potential, as they are capable of multilineage differentiation. MSC behavior, including lineage commitment, may be influenced by biomaterial properties including substrate stiffness and pore size. With three-dimensional (3D) printing, we can investigate these relationships in 3D culture systems. Here, we fabricated scaffolds with two different well controlled pore geometries, and investigated the impact on MSC enrichment and differentiation. Results show that scaffolds with ordered cubic pore geometry were supportive of both MSC enrichment from unprocessed bone marrow as well as MSC differentiation, resulting in increased gene expression during adipogenesis and chondrogenesis. These results suggest that 3D printed scaffolds with ordered cubic pores could be a suitable culture system for single-step MSC enrichment and differentiation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ferlin, Kimberly M.; Prendergast, Margaret E.; Miller, Makenzie L.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
   [Kaplan, David S.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
OI Prendergast, Margaret/0000-0002-2534-5385
FU National Science Foundation/Food and Drug Administration
   Scholar-in-Residence Program [CBET 1238398]
FX Research reported in this publication was supported by the National
   Science Foundation/Food and Drug Administration Scholar-in-Residence
   Program (CBET 1238398). The authors wish to thank Dr. Srinidhi Nagaraja
   for his technical assistance obtaining and analyzing the results of mu
   CT and Dr. Girish Kumar for his technical assistance with the flow
   cytometry experiments.
CR Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649
   Bracaglia LG, 2014, TISSUE ENG PT A, V20, P2807, DOI [10.1089/ten.tea.2014.0516, 10.1089/ten.TEA.2014.0516]
   Campos DFD, 2015, TISSUE ENG PT A, V21, P740, DOI [10.1089/ten.TEA.2014.0231, 10.1089/ten.tea.2014.0231]
   Castro NJ, 2015, CELL MOL BIOENG, V8, P416, DOI 10.1007/s12195-015-0389-4
   Dean D, 2012, VIRTUAL PHYS PROTOTY, V7, P13, DOI 10.1080/17452759.2012.673152
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferlin KM, 2014, MOL PHARMACEUT, V11, P2172, DOI 10.1021/mp500062n
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Goh TKP, 2013, BIORESEARCH OPEN ACC, V2, P84, DOI 10.1089/biores.2013.0001
   Hervy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092120
   Huri PY, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045003
   Jeong CG, 2010, TISSUE ENG PT A, V16, P3759, DOI 10.1089/ten.TEA.2010.0103
   Jeong CG, 2011, ACTA BIOMATER, V7, P505, DOI 10.1016/j.actbio.2010.08.027
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016
   Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lipowiecki M, 2014, J BIOMED MATER RES A, V102, P4127, DOI 10.1002/jbm.a.35084
   Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681
   Mareschi K, 2012, STEM CELLS INT, DOI 10.1155/2012/920581
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Papadimitropoulos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102359
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Wang M.O., 2015, TISSUE ENG A
   Wang MO, 2015, ADV MATER, V27, P138, DOI 10.1002/adma.201403943
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang Z, 2011, METHODS MOL BIOL, V698, P353, DOI 10.1007/978-1-60761-999-4_26
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI 10.1089/ten.TEC.2010.0172
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
   Zhang WJ, 2015, MAT SCI ENG C-MATER, V46, P10, DOI 10.1016/j.msec.2014.09.042
NR 38
TC 13
Z9 14
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 161
EP 169
DI 10.1016/j.actbio.2016.01.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100016
PM 26773464
OA Other Gold
DA 2018-10-20
ER

PT J
AU Silva, SS
   Oliveira, NM
   Oliveira, MB
   da Costa, DPS
   Naskar, D
   Mano, JF
   Kundu, SC
   Reis, RL
AF Silva, Simone S.
   Oliveira, Nuno M.
   Oliveira, Mariana B.
   Soares da Costa, Diana P.
   Naskar, Deboki
   Mano, Joao F.
   Kundu, Subhas C.
   Reis, Rui L.
TI Fabrication and characterization of Eri silk fibers-based sponges for
   biomedical application
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Eri; Samia ricini; Ionic liquids; Genipin; Cartilage regeneration;
   Fibroin
ID CROSS-LINKING; VISCOELASTIC PROPERTIES; IONIC LIQUIDS; NON-MULBERRY;
   FIBROIN; GENIPIN; SCAFFOLDS; HYDROGELS; BIOMATERIAL; CRYSTALLINITY
AB Cocoon-derived semi-domesticated Ed silk fibers still lack exploitation for tissue engineering applications due to their poor solubility using conventional methods. The present work explores the ability to process cocoon fibers of non-mulberry Ed silk (Samia/Philosamia ricini) into sponges through a green approach using ionic liquid (IL) - 1-buthyl-imidazolium acetate as a solvent. The formation of beta-sheet structures during Eri silk/IL gelation was acquired by exposing the Ed silk/IL gels to a saturated atmosphere composed of two different solvents: (i) isopropanol/ethanol (physical stabilization) and (ii) genipin, a natural crosslinker, dissolved in ethanol (chemical crosslinking). The sponges were then obtained by freeze-drying. This approach promotes the formation of both stable and ordered non-crosslinked Eri silk fibroin matrices. Moreover, genipin-crosslinked silk fibroin sponges presenting high height recovery capacity after compression, high swelling degree and suitable mechanical properties for tissue engineering applications were produced. The incorporation of a model drug - ibuprofen - and the corresponding release study from the loaded sponges demonstrated the potential of using these matrices as effective drug delivery systems. The assessment of the biological performance of ATDC5 chondrocyte-like cells in contact with the developed sponges showed the promotion of cell adhesion and proliferation, as well as extracellular matrix production within 2 weeks of culture. Sponges' intrinsic properties and biological findings open up their potential use for biomedical applications.
   Statement of Significance
   This work addresses the preparation and characterization of non-mulberry cocoon-derived Ed silk sponges. The insolubility of cocoons-derived non-mulberry silkworms impairs their processability and applications in the healthcare field. We used a green approach with ionic liquids to overcome the lack solubility of such silk fibers. The formation of beta-sheet structures into Ed-based sponges was physically and chemically induced. The sponges were obtained by freeze-drying. The developed structures exhibited flexibility to adapt and recover their shapes upon application and subsequent removal of load, high swelling degree, ability to load an anti-inflammatory drug and to promote its sustained release. They promoted in vitro cellular adhesion, proliferation and extracellular matrix production of a chondrocyte-like cell line, opening up their potential application for biomedical applications. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Silva, Simone S.; Oliveira, Nuno M.; Oliveira, Mariana B.; Soares da Costa, Diana P.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk,Parque Ciencia & Tecnol, P-4806017 Barco Gmr, Portugal.
   [Silva, Simone S.; Oliveira, Nuno M.; Oliveira, Mariana B.; Soares da Costa, Diana P.; Mano, Joao F.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Naskar, Deboki; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Silva, SS (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk,Parque Ciencia & Tecnol, P-4806017 Barco Gmr, Portugal.; Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM simonesilva@dep.uminho.pt; Kundu@hijli.iitkgp.ernet.in
RI Mano, Joao/A-4418-2009; Reis, Rui L./A-8938-2008; Soares da Costa,
   Diana/C-3217-2011; Oliveira, Mariana/H-6933-2017; Group,
   3Bs/E-4374-2012; Oliveira, Nuno/K-8917-2016
OI Mano, Joao/0000-0002-2342-3765; Reis, Rui L./0000-0002-4295-6129; Soares
   da Costa, Diana/0000-0002-1870-6904; Oliveira,
   Mariana/0000-0002-6104-6075; Group, 3Bs/0000-0002-5195-3456; Oliveira,
   Nuno/0000-0002-2326-2404; Kundu, Subhas C./0000-0002-7170-2291; Silva,
   Simone/0000-0003-4268-9419
FU Portuguese Foundation for Science and Technology - FCT
   [SFRH/BPD/45307/2008, SFRH/BPD/85790/2012, SFRH/BD/71396/2010,
   SFRH/BD/73172/2010]; "Fundo Social Europeu" - FSE; Programa Diferencial
   de Potencial Humano POPH; European Union [REGPOT-CT2012-316331-POLARIS];
   Fundacao para a Ciencia e Tecnologia (FCT) [ENIGMA -
   PTDC/EQU-EPR/121491/2010]; Department of Biotechnology; Indian Council
   of Medical Research, Govt of India
FX The authors SSS, DSC, MBO, NMO acknowledge financial support from
   Portuguese Foundation for Science and Technology - FCT (Grants
   SFRH/BPD/45307/2008, SFRH/BPD/85790/2012, SFRH/BD/71396/2010 and
   SFRH/BD/73172/2010, respectively), "Fundo Social Europeu" - FSE, and
   "Programa Diferencial de Potencial Humano POPH". This work is also
   financially supported by the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no REGPOT-CT2012-316331-POLARIS
   and from Fundacao para a Ciencia e Tecnologia (FCT) through the project
   ENIGMA - PTDC/EQU-EPR/121491/2010. The laboratory work of SCK is
   supported by Department of Biotechnology and Indian Council of Medical
   Research, Govt of India. SCK and RLR acknowledge their short visits
   either Institutes. SCK is also grateful to 3 Bs Research Group-
   Biomaterials, Biodegradables and Biomimetics, University of Minho,
   Portugal for providing facilities during his short visit.
CR Almeida LR, 2013, ACTA BIOMATER, V9, P8167, DOI 10.1016/j.actbio.2013.05.019
   Andiyappan M, 2013, INT J MATER RES, V104, P498, DOI 10.3139/146.110888
   Anthony J. L., 2003, IONIC LIQUIDS SYNTHE, P41, DOI 10.1002/3527600701.ch3
   Aydin HM, 2009, J TISSUE ENG REGEN M, V3, P470, DOI 10.1002/term.187
   Babu KM, 2013, WOODHEAD PUBL SER TE, P56, DOI 10.1533/9781782421580.56
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   BRODT M, 1995, REV SCI INSTRUM, V66, P5292, DOI 10.1063/1.1146101
   Carballido A., 2004, INT J PHARMACEUT, V279, P33
   Costa AMS, 2014, LANGMUIR, V30, P4535, DOI 10.1021/la500286v
   Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115
   Dong YX, 2015, EUR J PHARM BIOPHARM, V91, P82, DOI 10.1016/j.ejpb.2015.01.018
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Elliott WH, 2015, ACS APPL MATER INTER, V7, P12099, DOI 10.1021/acsami.5b02308
   Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p
   Fulcher GR, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-61
   Goujon N, 2013, J APPL POLYM SCI, V128, P4411, DOI 10.1002/app.38666
   Goujon N, 2012, CHEM COMMUN, V48, P1278, DOI 10.1039/c2cc17143k
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Kafienah W, 2004, BIOPOLYMER METHODS T, P217
   Kar S, 2013, TISSUE ENG REGEN MED, V10, P200, DOI 10.1007/s13770-012-0008-6
   Kundu B., 2013, BIOMED MAT, V8
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mathew AP, 2013, MACROMOL BIOSCI, V13, P289, DOI 10.1002/mabi.201200317
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.3.CO;2-P
   Muthumanickkam A, 2013, IRAN POLYM J, V22, P143, DOI 10.1007/s13726-012-0113-3
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nakazawa Y, 2003, PROTEIN SCI, V12, P666, DOI 10.1110/ps.0239203
   Pal S, 2013, MACROMOL BIOSCI, V13, P1020, DOI 10.1002/mabi.201300013
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Popa EG, 2013, SOFT MATTER, V9, P875, DOI 10.1039/c2sm26846a
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P1339, DOI 10.1002/app.31981
   Rial-Hermida MI, 2014, ACTA BIOMATER, V10, P4314, DOI 10.1016/j.actbio.2014.06.009
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saha S., 2013, PLOS ONE, V8
   Silva M., 2010, TISSUE ENG PART B-RE, V16, P331
   Silva S. S., 2011, COMPREHENSIVE BIOMAT, P187
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Silva SS, 2013, GREEN CHEM, V15, P3252, DOI 10.1039/c3gc41060a
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   Silva SS, 2012, GREEN CHEM, V14, P1463, DOI 10.1039/c2gc16535j
   Silva SS, 2011, ACTA BIOMATER, V7, P1166, DOI 10.1016/j.actbio.2010.09.041
   Silva-Correia J, 2013, J BIOMED MATER RES A, V101, P3438, DOI 10.1002/jbm.a.34650
   Sosnowski S, 2006, MACROMOL BIOSCI, V6, P425, DOI 10.1002/mabi.200600003
   Sun W., 2014, J TISSUE ENG REGEN M
   Sung HW, 2000, J BIOMED MATER RES, V52, P77, DOI 10.1002/1097-4636(200010)52:1<77::AID-JBM10>3.0.CO;2-6
   Talukdar S, 2013, ADV FUNCT MATER, V23, P5249, DOI 10.1002/adfm.201300312
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   You RC, 2014, POLYM DEGRAD STABIL, V109, P226, DOI 10.1016/j.polymdegradstab.2014.07.029
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
NR 56
TC 13
Z9 13
U1 7
U2 90
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 178
EP 189
DI 10.1016/j.actbio.2016.01.003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100018
PM 26766632
DA 2018-10-20
ER

PT J
AU Kruppke, B
   Farack, J
   Wagner, AS
   Beckmann, S
   Heinemann, C
   Glenske, K
   Rossler, S
   Wiesmann, HP
   Wenisch, S
   Hanke, T
AF Kruppke, Benjamin
   Farack, Jana
   Wagner, Alena-Svenja
   Beckmann, Sarah
   Heinemann, Christiane
   Glenske, Kristina
   Roessler, Sina
   Wiesmann, Hans-Peter
   Wenisch, Sabine
   Hanke, Thomas
TI Gelatine modified monetite as a bone substitute material: An in vitro
   assessment of bone biocompatibility
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone; Biocompatibility; Gelatine; Bone marrow stromal cells; Osteoclast;
   Biomimetic material
ID EXTRACELLULAR CALCIUM; STROMAL CELLS; SCAFFOLDS; HYDROXYAPATITE;
   BRUSHITE; PROLIFERATION; MONOCYTES; GRANULES; CALVARIA; CEMENT
AB Calcium phosphate phases are increasingly used for bone tissue substitution, and the load bearing properties of these inherently brittle biomaterials are increased by inclusion of organic components. Monetite prepared using mineralization of gelatine pre-structured through phosphate leads to a significantly increased biaxial strength and indirect tensile strength compared to gelatine-free monetite. Besides the mechanical properties, degradation in physiological solutions and osteoblast and osteoclast cell response were investigated. Human bone marrow stromal cells (hBMSCs) showed considerably higher proliferation rates on the gelatine modified monetite than on polystyrene reference material in calcium-free as well as standard cell culture medium (alpha -MEM). Osteogenic differentiation on the material was comparable to polystyrene in both medium types. Osteoclast-like cells derived from monocytes were able to actively resorb the biomaterial. Osteoblastic differentiation and perhaps even more important the cellular resorption of the biomaterial indicate that it can be actively involved in the bone remodeling process. Thus the behavior of osteoblasts and osteoclasts as well as the adequate degradation and mechanical properties are strong indicators for bone biocompatibility, although in vivo studies are still required to prove this.
   Statement of Significance
   New and unique? A low temperature precipitationprocessforcalcium anhydrous hydrogen phosphateallows for the first time to produce monolithic compact composites of monetite and gelatine. The composite is degradable and resorbable. To prove that, the question arises: what is bone biocompatibility?
   The reaction of both mayor cell types of bone represents this biocompatibility. Therefore, human bone marrow stromal cells were seeded revealing the materials pro-osteogenic properties. Monocyte cultivation, becoming recently focus of interest, revealed the capability of the biomaterial to be actively resorbed by derived osteoclast-like cells.
   Not new but necessary ismechanical characterization, which is often only investigated as uniaxial property. Here, a biaxial method is applied, to characterize the materials properties closer to its application loads. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kruppke, Benjamin; Farack, Jana; Beckmann, Sarah; Heinemann, Christiane; Roessler, Sina; Wiesmann, Hans-Peter; Hanke, Thomas] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Kruppke, Benjamin; Farack, Jana; Beckmann, Sarah; Heinemann, Christiane; Roessler, Sina; Wiesmann, Hans-Peter; Hanke, Thomas] Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   [Wagner, Alena-Svenja; Glenske, Kristina; Wenisch, Sabine] Univ Giessen, Inst Vet Anat Histol & Embryol, Small Anim Clin, Dept Vet Clin Sci, D-35392 Giessen, Germany.
RP Kruppke, B (reprint author), Max Bergmann Zentrum Biomat, Budapester Str 27, D-01069 Dresden, Germany.
EM Benjamin.Kruppke@tu-dresden.de
OI Kruppke, Benjamin/0000-0002-0659-0238
FU Deutsche Forschungsgemeinschaft (DFG Collaborative Research Centre) [TRR
   79/SP M3]
FX The authors are grateful to Prof. Hartmut Worch<SUP>1</SUP> for giving
   the inspiring impulse for developing this material, to Axel
   Mensch<SUP>1</SUP> for XRD investigations and to Anne Hild<SUP>2</SUP>
   for her support in TEM sample preparation and for taking TEM images. We
   gratefully acknowledge the Deutsche Forschungsgemeinschaft (DFG
   Collaborative Research Centre TRR 79/SP M3) for financial support. We
   thank Prof. M. Bornhauser and co-workers (Medical Clinic I, University
   Hospital Carl Gustav Carus, Dresden) for providing hBMSC.
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605
   Borger A, 2002, J EUR CERAM SOC, V22, P1425, DOI 10.1016/S0955-2219(01)00458-7
   Da Silva MHP, 2001, SURF COAT TECH, V137, P270
   Detsch R., 2014, J TISSUE ENG REGEN M
   Dorozhkin SV, 2002, ANGEW CHEM, V114, P3260
   DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167
   Galea LG, 2008, BIOMATERIALS, V29, P3400, DOI 10.1016/j.biomaterials.2008.04.041
   Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   Gustavsson J, 2013, J TISSUE ENG REGEN M, V7, P609, DOI 10.1002/term.550
   Gustavsson J, 2012, J MATER SCI-MATER M, V23, P2509, DOI 10.1007/s10856-012-4705-4
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Habel B, 1998, EUR BIOPHYS J BIOPHY, V27, P411, DOI 10.1007/s002490050149
   Haema K, 2014, RADIAT PHYS CHEM, V103, P126, DOI 10.1016/j.radphyschem.2014.05.056
   Heinemann C., 2011, EUR CELL MAT
   Heinemann C, 2009, BIOMACROMOLECULES, V10, P1305, DOI 10.1021/bm900172m
   Heinemann S, 2013, ACTA BIOMATER, V9, P6199, DOI 10.1016/j.actbio.2012.12.017
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hoyer B, 2012, BIOMACROMOLECULES, V13, P1059, DOI 10.1021/bm201776r
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jones J. R., 2001, MAT SCI TECHNOL
   Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y
   Jung HJ, 2015, BONE, V76, P88, DOI 10.1016/j.bone.2015.03.014
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   Klammert U, 2009, ACTA BIOMATER, V5, P727, DOI 10.1016/j.actbio.2008.08.019
   Kollmann T, 2010, CHEM MATER, V22, P5137, DOI 10.1021/cm101755j
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P1831, DOI 10.1098/rsta.2010.0001
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   SCHILLING AF, 2006, EUR J TRAUMA, V32, P107
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014
   Sivakumar GR, 1998, CRYST RES TECHNOL, V33, P197, DOI 10.1002/(SICI)1521-4079(1998)33:2<197::AID-CRAT197>3.0.CO;2-K
   SUGIMOTO T, 1993, J BONE MINER RES, V8, P1445
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   Tas AC, 2009, J AM CERAM SOC, V92, P2907, DOI 10.1111/j.1551-2916.2009.03351.x
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Williams D, 2014, CAMB TEXT BIOMED ENG, P1
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 43
TC 10
Z9 10
U1 2
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 275
EP 285
DI 10.1016/j.actbio.2015.12.035
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100027
PM 26732518
DA 2018-10-20
ER

PT J
AU Biesiekierski, A
   Lin, JX
   Li, YC
   Ping, DH
   Yamabe-Mitarai, Y
   Wen, CE
AF Biesiekierski, Arne
   Lin, Jixing
   Li, Yuncang
   Ping, Dehai
   Yamabe-Mitarai, Yoko
   Wen, Cuie
TI Investigations into Ti-(Nb,Ta)-Fe alloys for biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Titanium; Orthopedic biomaterials; Admissible strain; Microstructure;
   High strength
ID CORROSION BEHAVIOR; TITANIUM-ALLOYS; MECHANICAL-PROPERTIES; IMPLANT
   MATERIALS; BONE TISSUE; TI; NB; MICROSTRUCTURE; DEFORMATION; ELEMENTS
AB In this study, a Ti-(Ta,Nb)-Fe system was investigated with aims toward the development of high strength, biocompatible titanium alloy suitable for the development of porous orthopedic biomaterials with minimal processing. Notable findings include yield strengths of 740, 1250 and 1360 MPa for the Ti-12Nb-5Fe, Ti-7Ta-5Fe and Ti-10Ta-4Fe alloys, respectively, with elastic moduli comparable to existing Ti-alloys, yielding admissible strains of 0.9 +/- 0.3, 12 +/- 0.2 and 1.13 +/- 0.02% for the Ti-12Nb-5Fe, Ti-7Ta-5Fe and Ti-10Ta-4Fe alloys, respectively; more than twice that of human bone. Observed microstructure varied significantly depending on alloy; near pure beta-phase was seen in Ti-12Nb-5Fe, beta with some omega precipitation in Ti-10Ta-4Fe, and a duplex alpha + beta structure was observed throughout the Ti-7Ta-5Fe. In addition to suitable mechanical parameters, all investigated alloys exhibited promising corrosion potentials on the order of -0.24 V SCE, equalling that seen for a C.P.-Ti control at -0.25 V SCE, and substantially more noble than that seen for Ti-6A1-4V. Electrochemical corrosion rates of 0.5-3 mu m/year were likewise seen to agree well with that measured for C.P.-Ti. Further, no statistically significant difference could be seen between any of the alloys relative to a C.P.-Ti control regards to cell proliferation, as investigated via MTS assay and confocal microscopy. As such, the combination of high admissible strain and low corrosion indicate all investigated alloys show significant promise as potential porous biomaterials while in the as-cast state, with the Ti-10Ta-4Fe alloy identified as the most promising composition investigated.
   Statement of Significance
   The findings of this paper are of significance to the field of metallic biomaterials as they detail the development of alloys of satisfactory biocompatibility and electrochemical behaviour, that furthermore display exceptional mechanical properties. Notably, both extremely high compressive yield strengths and admissible strains, up to 1.36 GPa and 1.2% respectively, are reported, exceeding or rivalling that seen in traditional alloys such as Ti-6A1-4V, which typically displays compressive yield strengths and admissible strains on the order of 895 MPa and 0.81% respectively, as well as modem alloys such as Gum Metal or TNZT. That this is achieved in the absence of thermomechanical processing represents a significant and novel outcome of substantial benefit for application as a porous biomaterial. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Biesiekierski, Arne; Wen, Cuie] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
   [Lin, Jixing] Zhejiang Ind & Trade Vocat Coll, Dept Mat Engn, Wenzhou 325003, Zhejiang, Peoples R China.
   [Lin, Jixing] Jilin Univ, Coll Mat Sci & Engn, Changchun 130025, Jilin, Peoples R China.
   [Li, Yuncang; Wen, Cuie] RMIT Univ, Dept Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
   [Ping, Dehai; Yamabe-Mitarai, Yoko] Natl Inst Mat Sci, Sengen 1-2-1, Tsukuba, Ibaraki 3050047, Japan.
RP Wen, CE (reprint author), RMIT Univ, Dept Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
EM cuie.wen@rmit.edu.au
RI Li, Yuncang/I-5832-2012
OI Li, Yuncang/0000-0003-4290-4772; Wen, Cuie/0000-0001-8008-3536
FU National Health and Medical Research Council (NHMRC) [GNT1087290]
FX The authors acknowledge financial support for this research by the
   National Health and Medical Research Council (NHMRC) through grant
   GNT1087290.
CR American Society for Testing Materials, 2014, G314 ASTM
   [Anonymous], 2010, G102892010 ASTM
   [Anonymous], 2009, E909 ASTM
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Bai Y, 2013, MAT SCI ENG C-MATER, V33, P2159, DOI 10.1016/j.msec.2013.01.036
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y
   Biesiekierski A, 2014, MATER DESIGN, V59, P303, DOI 10.1016/j.matdes.2014.02.058
   BOYER R, 1994, MAT PROPERTIES HDB T
   Choubey A, 2004, J ALLOY COMPD, V381, P288, DOI 10.1016/j.jallcom.2004.03.096
   Cremasco A, 2011, MATER DESIGN, V32, P2387, DOI 10.1016/j.matdes.2010.11.012
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DENTON AR, 1991, PHYS REV A, V43, P3161, DOI 10.1103/PhysRevA.43.3161
   Donachie M. J., 2000, TITANIUM TECHNICAL G
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Goodhew P., 2014, ELECT MICROSCOPY ANA
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Hinoshita K., 2006, SCRIPTA MATER, V55, P477
   Ikeda M, 2009, MATER TRANS, V50, P2737, DOI 10.2320/matertrans.MA200902
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Kent D, 2012, APPL PHYS A-MATER, V107, P835, DOI 10.1007/s00339-012-6778-9
   Kraus W, 1996, J APPL CRYSTALLOGR, V29, P301, DOI 10.1107/S0021889895014920
   Kuroda D, 2005, MATER TRANS, V46, P3015, DOI 10.2320/matertrans.46.3015
   Kuroda D, 2005, MAT SCI ENG C-BIO S, V25, P312, DOI 10.1016/j.msec.2005.04.004
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lavos-Valereto I. C., 2002, Journal of Biomedical Materials Research, V63, P664, DOI 10.1002/jbm.10351
   Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   Lima P., 2011, HUM EXP TOXICOL, P1435
   Lopes ESN, 2011, MATER CHARACT, V62, P673, DOI 10.1016/j.matchar.2011.04.015
   Mantani Y, 2004, MATER TRANS, V45, P1629, DOI 10.2320/matertrans.45.1629
   Narayan RJ, 2012, ASM HDB, V23
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Nunez M., 2007, TRENDS ELECTROCHEMIS
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   Ozan S, 2015, ACTA BIOMATER, V20, P176, DOI 10.1016/j.actbio.2015.03.023
   Ping DH, 2014, ACTA METALL SIN-ENGL, V27, P1, DOI 10.1007/s40195-013-0014-2
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   RODAN SB, 1987, CANCER RES, V47, P4961
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Wang J, 2014, INT J PLASTICITY, V61, P17, DOI 10.1016/j.ijplas.2014.05.005
   Wang K. K., 1996, MED APPL TITANIUM IT, P76
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Withey EA, 2010, ACTA MATER, V58, P2652, DOI 10.1016/j.actamat.2009.12.052
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   ZALUSKI L, 1993, J MATER RES, V8, P3059, DOI 10.1557/JMR.1993.3059
   Zywicki P, 2015, MET MATER INT, V21, P617, DOI 10.1007/s12540-015-4593-5
NR 53
TC 18
Z9 19
U1 7
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 336
EP 347
DI 10.1016/j.actbio.2015.12.010
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100032
PM 26689463
DA 2018-10-20
ER

PT J
AU Cheng, LY
   Sun, XM
   Zhao, X
   Wang, L
   Yu, J
   Pan, GQ
   Li, B
   Yang, HL
   Zhang, YG
   Cui, WG
AF Cheng, Liying
   Sun, Xiaoming
   Zhao, Xin
   Wang, Lan
   Yu, Jia
   Pan, Guoqing
   Li, Bin
   Yang, Huilin
   Zhang, Yuguang
   Cui, Wenguo
TI Surface biofunctional drug-loaded electrospun fibrous scaffolds for
   comprehensive repairing hypertrophic scars
SO BIOMATERIALS
LA English
DT Article
DE Electrospun scaffold; Poly (dopamine); Biofunctionalization;
   Drug-loading; Hypertrophic scar
ID INFLAMMATION RESPONSES; IMMOBILIZATION; POLYDOPAMINE; MEMBRANES; GROWTH;
   POLYMER; SKIN; CYTOCOMPATIBILITY; REGENERATION; FABRICATION
AB Incorporation of bioactive drugs and biofunctionalization of polyester fibrous scaffolds are essential means to improve their bio-functions and histocompatibility for regenerative medicine. However, it is still a challenge to biofunctionalize such drug carriers via traditional biochemical methods while maintaining their properties without changes in drug activity and loading ratio. Here, we demonstrated a facile approach for biofunctionalization of PLGA fibrous scaffolds with various molecules (i.e., PEG polymer, RGD peptide and bFGF growth factor for cell repellent, adhesion and proliferation, respectively) via mussel-Inspired poly(dopamine) (PDA) coating in aqueous solution. By virtue of the mild and efficient nature of this approach, the drug-loaded PLGA fibers could be easily biofunctionalized and showed negligible effects on the scaffold properties, especially drug activity and loading ratio. Further, in vivo study showed that, a ginsenoside-Rg3-loaded fibrous scaffold functionalized with bFGF growth factor could not only promote the early -stage wound healing in rabbit ear wounds (bio-signal from bFGF), but also inhibit later -stage hypertrophic scars formation (release of Rg3 drug). Therefore, the mussel -inspired method for bio-modification provides a facile and effective strategy to combine drug and bio-function in one system, thus facilitating a synergistic effect of drug -therapy and bio-signal when such biomaterial is used for regenerative medicine. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Cheng, Liying; Sun, Xiaoming; Zhang, Yuguang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.
   [Wang, Lan; Yu, Jia; Pan, Guoqing; Li, Bin; Yang, Huilin; Cui, Wenguo] Soochow Univ, Inst Orthoped, Affiliated Hosp 1, Dept Orthoped, 708 Renmin Rd, Suzhou 215006, Jiangsu, Peoples R China.
   [Zhao, Xin] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA.
RP Zhang, YG (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Cui, WG (reprint author), Soochow Univ, Inst Orthoped, Affiliated Hosp 1, Dept Orthoped, 708 Renmin Rd, Suzhou 215006, Jiangsu, Peoples R China.
EM zhangyg18@126.com; wgcui80@hotmail.com
RI Li, Bin/B-7802-2012; Zhao, Xin/P-2741-2017; Pan, Guoqing/E-1445-2014
OI Zhao, Xin/0000-0002-9521-7768; Pan, Guoqing/0000-0001-5187-796X
FU National Natural Science Foundation of China [51373112, 81372073];
   Jiangsu Provincial Special Program of Medical Science [BL2012004];
   Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This work was supported in part by National Natural Science Foundation
   of China (51373112 and 81372073), Jiangsu Provincial Special Program of
   Medical Science (BL2012004), Jiangsu Provincial Clinical Orthopedic
   Center, the Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD).
CR Alster TS, 2003, AM J CLIN DERMATOL, V4, P235, DOI 10.2165/00128071-200304040-00003
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cheng LY, 2013, ACTA BIOMATER, V9, P9461, DOI 10.1016/j.actbio.2013.07.040
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Cui WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068771
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lu L, 2012, J BIOMED MATER RES A, V100A, P2421, DOI 10.1002/jbm.a.34143
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pridgen EM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007049
   Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63
   Sankar D, 2014, TISSUE ENG PT A, V20, P1689, DOI [10.1089/ten.tea.2013.0569, 10.1089/ten.TEA.2013.0569]
   Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966
   Son SR, 2013, J BIOMED MATER RES B, V101B, P1095, DOI 10.1002/jbm.b.32923
   Sun XM, 2014, J MATER CHEM B, V2, P3636, DOI 10.1039/c3tb21814g
   Sun XM, 2014, COLLOID SURFACE B, V115, P61, DOI 10.1016/j.colsurfb.2013.11.030
   Swartjes JJTM, 2013, ADV FUNCT MATER, V23, P2843, DOI 10.1002/adfm.201202927
   Wu LL, 2010, J BIOMED MATER RES A, V92A, P563, DOI 10.1002/jbm.a.32393
   Xie DC, 2013, J BIOMED MATER RES A, V101, P2005, DOI 10.1002/jbm.a.34508
   Xu DW, 2013, COLLOID SURFACE B, V110, P225, DOI 10.1016/j.colsurfb.2013.04.050
   Xu WJ, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014104
   Yang SH, 2011, J AM CHEM SOC, V133, P2795, DOI 10.1021/ja1100189
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zhang M, 2014, ADV FUNCT MATER, V24, P978, DOI 10.1002/adfm.201302359
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
   Zhu LP, 2011, COLLOID SURFACE B, V86, P111, DOI 10.1016/j.colsurfb.2011.03.027
NR 38
TC 27
Z9 27
U1 14
U2 156
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 169
EP 181
DI 10.1016/j.biomaterials.2016.01.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700014
PM 26774564
DA 2018-10-20
ER

PT J
AU Yoshizumi, T
   Zhu, Y
   Jiang, HB
   D'Amore, A
   Sakaguchi, H
   Tchao, J
   Tobita, K
   Wagner, WR
AF Yoshizumi, Tomo
   Zhu, Yang
   Jiang, Hongbin
   D'Amore, Antonio
   Sakaguchi, Hirokazu
   Tchao, Jason
   Tobita, Kimimasa
   Wagner, William R.
TI Timing effect of intramyocardial hydrogel injection for positively
   impacting left ventricular remodeling after myocardial infarction
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Injectable materials; Myocardial infarction;
   Hydrogel; Intervention timing
ID BIODEGRADABLE CARDIAC PATCH; ASSOCIATION TASK-FORCE;
   EXTRACELLULAR-MATRIX; INJECTABLE HYDROGEL; PRACTICE GUIDELINES; CHITOSAN
   HYDROGEL; AMERICAN-COLLEGE; ANGIOTENSIN-II; HEART-FAILURE; THERAPY
AB Intramyocardial injection of various injectable hydrogel materials has shown benefit in positively impacting the course of left ventricular (LV) remodeling after myocardial infarction (MI). However, since LV remodeling is a complex, time dependent process, the most efficacious time of hydrogel injection is not clear. In this study, we injected a relatively stiff, thermoresponsive and bioabsorbable hydrogel in rat hearts at 3 different time points - immediately after MI (IM), 3 d post -MI (3D), and 2 w post -MI (2W), corresponding to the beginnings of the necrotic, fibrotic and chronic remodeling phases. The employed left anterior descending coronary artery ligation model showed expected infarction responses including functional loss, inflammation and fibrosis with distinct time dependent patterns. Changes in LV geometry and contractile function were followed by longitudinal echocardiography for 10 w post -MI. While all injection times positively affected LV function and wall thickness, the 3D group gave better functional outcomes than the other injection times and also exhibited more local vascularization and less inflammatory markers than the earlier injection time. The results indicate an important role for injection timing in the increasingly explored concept of post -MI biomaterial injection therapy and suggest that for hydrogels with mechanical support as primary function, injection at the beginning of the fibrotic phase may provide improved outcomes. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Yoshizumi, Tomo; Zhu, Yang; Jiang, Hongbin; D'Amore, Antonio; Sakaguchi, Hirokazu; Tobita, Kimimasa; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.
   [Zhu, Yang; Tobita, Kimimasa; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Tchao, Jason; Tobita, Kimimasa] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI D'Amore, Antonio/E-7111-2012
OI D'Amore, Antonio/0000-0002-3151-3170; Zhu, Yang/0000-0002-7384-607X
FU National Institutes of Health [R01 HL105911]
FX This study was supported by the National Institutes of Health (grant R01
   HL105911). The authors thank Deanna Rhoads and Lori Walton for their
   excellent help with tissue histological assessment and Neil Turner for
   technical assistance.
CR Akhmedov AT, 2013, HEART FAIL REV, V18, P815, DOI 10.1007/s10741-012-9348-5
   Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39
   Blackburn NJR, 2015, BIOMATERIALS, V39, P182, DOI 10.1016/j.biomaterials.2014.11.004
   Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dorsey SM, 2015, BIOMATERIALS, V69, P65, DOI 10.1016/j.biomaterials.2015.08.011
   Eckhouse SR, 2014, SCI TRANSL MED, V6, P223
   Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2012, J CARD FAIL, V18, P585, DOI 10.1016/j.cardfail.2012.05.006
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   GUPTA KB, 1994, CIRCULATION, V89, P2315, DOI 10.1161/01.CIR.89.5.2315
   Hashizume R, 2013, BIOMATERIALS, V34, P7353, DOI 10.1016/j.biomaterials.2013.06.020
   Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Jugdutt B.I., 2013, CARDIAC REMODELING M
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Lahera V, 2011, AM J HYPERTENS, V24, P1059, DOI 10.1038/ajh.2011.142
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Mallory GK, 1939, AM HEART J, V18, P647
   Nelson DM, 2014, BIOMACROMOLECULES, V15, P1, DOI 10.1021/bm4010639
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Ravi S, 2012, BIOMATERIALS, V33, P7736, DOI 10.1016/j.biomaterials.2012.07.010
   REIMER KA, 1979, CIRCULATION, V60, P866, DOI 10.1161/01.CIR.60.4.866
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Zhu Y, 2015, BIOMATERIALS, V53, P484, DOI 10.1016/j.biomaterials.2015.02.100
NR 46
TC 13
Z9 13
U1 4
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 182
EP 193
DI 10.1016/j.biomaterials.2015.12.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700015
PM 26774561
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, WA
   Lu, BY
   Gu, L
   Choi, Y
   Kim, J
   Mooney, DJ
AF Li, Weiwei Aileen
   Lu, Beverly Ying
   Gu, Luo
   Choi, Youngjin
   Kim, Jaeyun
   Mooney, David J.
TI The effect of surface modification of mesoporous silica micro-rod
   scaffold on immune cell activation and infiltration
SO BIOMATERIALS
LA English
DT Article
DE Mesoporous silica; Poly(ethylene glycol); RGD; Acute inflammation;
   Inflammasome
ID COMPLEMENT ACTIVATION; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; ADAPTIVE
   IMMUNITY; DENDRITIC CELLS; IN-VIVO; PROTEIN ADSORPTION;
   SUPPRESSOR-CELLS; NANOPARTICLES; HYDROGELS
AB Biomaterial scaffold based vaccines show significant potential in generating potent antigen -specific immunity. However, the role of the scaffold surface chemistry in initiating and modulating the immune response is not well understood. In this study, a mesoporous silica micro -rod (MSR) scaffold was modified with PEG, PEG-RGD and PEG-RDG groups. PEG modification significantly enhanced BMDC activation marker up-regulation and IL-113 production in vitro, and innate immune cell infiltration in vivo. PEG-RGD MSRs and PEG-RDG MSRs displayed decreased inflammation compared to PEG MSRs, and the effect was not RGD specific. Finally, the NIrp3 inflammasome was found to be necessary for MSR stimulated IL-113 production in vitro and played a key role in regulating immune cell infiltration in vivo. These findings suggest that simply modulating the surface chemistry of a scaffold can regulate its immune cell infiltration profile and have implications for the design and development of new material based vaccines. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Li, Weiwei Aileen; Lu, Beverly Ying; Gu, Luo; Mooney, David J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Li, Weiwei Aileen; Lu, Beverly Ying; Gu, Luo; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Choi, Youngjin; Kim, Jaeyun] Sungkyunkwan Univ, Sch Chem Engn, Suwon 440746, South Korea.
RP Mooney, DJ (reprint author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Gu, Luo/0000-0002-9813-7202; Li, Aileen/0000-0002-1056-5932
FU National Institute of Health [R01 EB015498]; Wyss Institute for
   Biologically Inspired Engineering; Found Animals Foundation [D1213-W13];
   National Science Foundation Graduate Research Fellowship
FX This work was funded by the National Institute of Health (R01 EB015498),
   the Wyss Institute for Biologically Inspired Engineering, the Found
   Animals Foundation (D1213-W13), and the National Science Foundation
   Graduate Research Fellowship. The authors would like to thank Kyle
   Vining for his help with the endotoxin assay, Dr. Kate Fitzgerald, Dr.
   Kenneth Rock and Dr. Jiann-Jyh Lai from the University of Massachusetts
   Medical School for helping with the Nlrp3<SUP>-/-</SUP> mice, and
   Professor Allan Hoffman at the University of Washington for his helpful
   discussions about the manuscript.
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Arima Y, 2008, BIOMATERIALS, V29, P551, DOI 10.1016/j.biomaterials.2007.10.015
   Arima Y, 2009, ACS APPL MATER INTER, V1, P2400, DOI 10.1021/am9005463
   Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739
   Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516
   Bradley AJ, 2001, TRANSFUSION, V41, P1225, DOI 10.1046/j.1537-2995.2001.41101225.x
   Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999
   Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113
   Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105
   Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1016/jem.20062602
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544
   Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014
   Garratty G, 2004, TRANSFUS MED REV, V18, P245, DOI 10.1016/j.tmrv.2004.06.005
   Godin B, 2010, J BIOMED MATER RES A, V94A, P1236, DOI 10.1002/jbm.a.32807
   Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720
   Hamada I, 2008, MOL IMMUNOL, V46, P225, DOI 10.1016/j.molimm.2008.08.276
   Hao NJ, 2012, J NANOSCI NANOTECHNO, V12, P6346, DOI 10.1166/jnn.2012.6199
   Hershfield MS, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4500
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Kidane A, 1999, J BIOMED MATER RES, V48, P640, DOI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kolla RV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001044
   Li WA, 2013, CURR OPIN IMMUNOL, V25, P238, DOI 10.1016/j.coi.2012.12.008
   Lin YS, 2011, J AM CHEM SOC, V133, P20444, DOI 10.1021/ja208567v
   Lynn AD, 2011, J BIOMED MATER RES A, V96A, P621, DOI 10.1002/jbm.a.33015
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   Moghimi SM, 2010, J CONTROL RELEASE, V146, P175, DOI 10.1016/j.jconrel.2010.04.003
   Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036
   Mosqueira VCF, 2001, BIOMATERIALS, V22, P2967, DOI 10.1016/S0142-9612(01)00043-6
   Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017
   Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309
   Salvador-Morales C, 2009, BIOMATERIALS, V30, P2231, DOI 10.1016/j.biomaterials.2009.01.005
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Sun BB, 2013, ACS NANO, V7, P10834, DOI 10.1021/nn404211j
   Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004
   Swartzlander MD, 2015, BIOMATERIALS, V41, P26, DOI 10.1016/j.biomaterials.2014.11.026
   Tobio M, 1998, PHARMACEUT RES, V15, P270, DOI 10.1023/A:1011922819926
   van der Eijk AA, 2006, NEW ENGL J MED, V354, P1323, DOI 10.1056/NEJMc052880
   van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350
   Zhang P, 2015, P NATL ACAD SCI USA, V112, P12046, DOI 10.1073/pnas.1512465112
NR 53
TC 20
Z9 21
U1 3
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 249
EP 256
DI 10.1016/j.biomaterials.2016.01.026
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700020
PM 26784009
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Crowley, C
   KlanritB, P
   Butler, CR
   Varanou, A
   Plate, M
   Hynds, RE
   Chambers, RC
   Seifalian, AM
   Birchall, MA
   Janes, SM
AF Crowley, Claire
   KlanritB, Poramate
   Butler, Colin R.
   Varanou, Aikaterini
   Plate, Manuela
   Hynds, Robert E.
   Chambers, Rachel C.
   Seifalian, Alexander M.
   Birchall, Martin A.
   Janes, Sam M.
TI Surface modification of a POSS-nanocomposite material to enhance
   cellular integration of a synthetic bioscaffold
SO BIOMATERIALS
LA English
DT Article
DE Tissue engineering; Biocompatible materials; Porosity; Nanocomposites;
   Re-epithelialization; Trachea
ID ENGINEERED TRACHEAL REPLACEMENT; BYPASS GRAFT; IN-VITRO; SCAFFOLDS;
   BIOMATERIALS; SIZE; ENDOTHELIALIZATION; HEMOCOMPATIBILITY;
   VASCULARIZATION; TRANSPLANTATION
AB Polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) is a versatile nano composite biomaterial with growing applications as a bioscaffold for tissue engineering. Integration of synthetic implants with host tissue can be problematic but could be improved by topographical modifications. We describe optimization of POSS-PCU by dispersion of porogens (sodium bicarbonate (NaHCO3), sodium chloride (NaCI) and sucrose) onto the material surface, with the principle aim of increasing surface porosity, thus providing additional opportunities for improved cellular and vascular ingrowth. We assess the effect of the porogens on the material's mechanical strength, surface chemistry, wettability and cytocompatibilty. Surface porosity was characterized by scanning electron microscopy (SEM). There was no alteration in surface chemistry and wettability and only modest changes in mechanical properties were detected. The size of porogens correlated well with the porosity of the construct produced and larger porogens improved interconnectivity of spaces within constructs. Using primary human bronchial epithelial cells (HBECs) we demonstrate moderate in vitro cytocompatibility for all surface modifications; however, larger pores resulted in cellular aggregation. These cells were able to differentiate on POSS-PCU scaffolds. Implantation of the scaffold in vivo demonstrated that'larger pore sizes favor cellular integration and vascular ingrowth. These experiments demonstrate that surface modification with large porogens can improve POSS-PCU nanocomposite scaffold integration and suggest the need to strike a balance between the non -porous surfaces required for epithelial coverage and the porous structure required for integration and vascularization of synthetic scaffolds in future construct design. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Crowley, Claire; Butler, Colin R.; Varanou, Aikaterini; Plate, Manuela; Hynds, Robert E.; Janes, Sam M.] UCL, UCL Resp, Lungs Living Res Ctr, 5 Univ St, London WC1E 6JF, England.
   [Crowley, Claire; KlanritB, Poramate; Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London, England.
   [Crowley, Claire; KlanritB, Poramate; Seifalian, Alexander M.; Birchall, Martin A.] UCL, London WC1E 6JF, England.
   [Plate, Manuela; Chambers, Rachel C.] UCL, Ctr Inflammat & Tissue Repair, UCL Resp, London WC1E 6JF, England.
   [Birchall, Martin A.] Royal Natl Throat Nose & Ear Hosp, UCL Ear Inst, Grays Inn Rd, London WC1X 8DA, England.
RP Janes, SM (reprint author), UCL, UCL Resp, Lungs Living Res Ctr, 5 Univ St, London WC1E 6JF, England.; Birchall, MA (reprint author), Royal Natl Throat Nose & Ear Hosp, 330 Grays Inn Rd, London WC1X 8DA, England.
EM m.birchall@ucl.ac.uk; s.janes@ucl.ac.uk
OI Klanrit, Poramate/0000-0003-0209-3901; Chambers,
   Rachel/0000-0003-1370-9417; Hynds, Robert/0000-0002-2170-8791; Plate,
   Manuela/0000-0002-9957-0681
FU Rosetrees Trust; UCLH Charitable foundation; Great Ormond Street
   Hospital Charity; Wellcome Clinical Training Fellowship; Department of
   Health's NIHR Biomedical Research Centre's funding scheme; UCL ECMC;
   GOSH Charity [V1202]; MRC Regenvox grant [G1001539]; Biotechnology and
   Biological Sciences Research Council [1179376]; Medical Research Council
   [MR/K026453/1, G1001539]; National Institute for Health Research
   [NF-SI-0513-10089]; Rosetrees Trust [M35-F1-CD1]
FX S.M.J. is a Wellcome Senior Fellow in Clinical Science (WT091730AIA;
   WT107963AIA) and is supported by the Rosetrees Trust and UCLH Charitable
   foundation. C.C. was funded by the Great Ormond Street Hospital Charity.
   C.R.B. received a Wellcome Clinical Training Fellowship. This work was
   partially undertaken at UCLH/UCL/GOSH who received a proportion of
   funding from the Department of Health's NIHR Biomedical Research
   Centre's funding scheme, the UCL ECMC (S.M.J.) and GOSH Charity (V1202).
   This work was supported by the MRC Regenvox grant (G1001539, S.M.J.,
   A.M.S., and M.A.B.).
CR Abouna GM, 2008, TRANSPL P, V40, P34, DOI 10.1016/j.transproceed.2007.11.067
   Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Ahmed M, 2013, J BIOMED MATER RES B, V101, P1182, DOI 10.1002/jbm.b.32928
   Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Ahmed M, 2010, IEEE ENG MED BIO, P251, DOI 10.1109/IEMBS.2010.5627472
   Anzlovar A, 2011, EXPRESS POLYM LETT, V5, P604, DOI 10.3144/expresspolymlett.2011.59
   Atala A., 2012, SCI TRANSL MED, V4
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Bland E, 2013, J TISSUE ENG REGEN M, V7, P505, DOI 10.1002/term.540
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Chawla R, 2014, J SURG RES, V188, P361, DOI 10.1016/j.jss.2014.01.006
   Chong DST, 2015, EUR J VASC ENDOVASC, V49, P335, DOI 10.1016/j.ejvs.2014.12.008
   Crowley C, 2015, J TISSUE ENG REGEN M, V9, P357, DOI 10.1002/term.1847
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Doss AE, 2007, ASAIO J, V53, P631, DOI 10.1097/MAT.0b013e318145ba13
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Forch R, 2007, CHEM VAPOR DEPOS, V13, P280, DOI 10.1002/cvde.200604035
   Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8
   Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318
   Hamilton N, 2014, LARYNGOSCOPE, V124, P961, DOI 10.1002/lary.24469
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Ker EDP, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Oseni A, 2012, J TISSUE ENG REGEN M, V6, P757, DOI 10.1002/term.487
   Pageau SC, 2011, BIOMATERIALS, V32, P7169, DOI 10.1016/j.biomaterials.2011.06.017
   Park JH, 2015, BIOMATERIALS, V62, P106, DOI 10.1016/j.biomaterials.2015.05.008
   Rahmani B, 2012, J BIOMECH, V45, P1205, DOI 10.1016/j.jbiomech.2012.01.046
   Ren X, 2014, PFLUG ARCH EUR J PHY, V466, P1847, DOI 10.1007/s00424-014-1504-4
   Solouk A, 2015, MAT SCI ENG C-MATER, V46, P400, DOI 10.1016/j.msec.2014.10.065
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Tan A., 2013, BIOINTERPHASES, P8
   Tan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077112
   Totonelli G, 2012, WORLD J GASTROENTERO, V18, P6900, DOI 10.3748/wjg.v18.i47.6900
   VOLLENBERG PHT, 1989, POLYMER, V30, P1663, DOI 10.1016/0032-3861(89)90327-3
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
NR 45
TC 15
Z9 15
U1 2
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 283
EP 293
DI 10.1016/j.biomaterials.2016.01.005
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700023
PM 26790147
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Mandal, A
   Farhan, MK
   Sastry, TP
AF Mandal, Abhishek
   Farhan, Md. Katheem
   Sastry, Thotapalli Parvathaleswara
TI Effect of reinforced Al2O3 nanoparticles on collagen nanobiocomposite
   from chrome-containing leather waste for biomedical applications
SO CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY
LA English
DT Article
DE Chrome leather waste; Al2O3; Collagen; Nanobiocomposite; Biomaterial
ID CAPPED SILVER NANOPARTICLES; SCAFFOLDS; CHITOSAN; ACID
AB The present study aims at developing nanobiocomposite from collagen extracted from solid biowaste, chrome-containing leather waste having aluminium oxide nanoparticles as reinforcement for value-added products. The extracted collagen was confirmed using sodium dodecyl sulphate-poly(acrylamide) gel electrophoresis technique, while Fourier-transform infrared spectroscopy and scanning electron microscopy were used to study the physicochemical and morphological properties of the prepared composites. Enhanced thermal stability and increase in denaturation temperature from 39 to 43 A degrees C with the increase in aluminium oxide content from 2 to 10 % in the composites were confirmed by differential scanning calorimetry and thermogravimetric analyses. Improved mechanical properties such as tensile, tear and flexural strength for the nanobiocomposites (NBCs) were also obtained. Moreover, decrease in water uptake from 475 to 285 % with the increase in aluminium oxide nanoparticles is attributed to the reduced porosity and their weak interaction with collagen that reduces the hydrophilicity of the NBCs. The above results indicate that the collagen-based NBCs present a simple, clean and easy route for effective recycling and recovery of biowaste that could find use in hip prosthesis and has the potential to be used in other biomedical applications.
C1 [Mandal, Abhishek] VIT Univ, Ctr Nanobiotechnol, Vellore 632014, Tamil Nadu, India.
   [Mandal, Abhishek; Farhan, Md. Katheem; Sastry, Thotapalli Parvathaleswara] Cent Leather Res Inst, Council Sci & Ind Res, Bioprod Lab, Chennai 600020, Tamil Nadu, India.
RP Sastry, TP (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Bioprod Lab, Chennai 600020, Tamil Nadu, India.
EM sastrytp@hotmail.com
CR Balaji S, 2012, POLYM ADVAN TECHNOL, V23, P500, DOI 10.1002/pat.1905
   Cao Y, 2004, ADV MATER, V16, P1189, DOI 10.1002/adma.200400028
   Cao Y, 2006, ADV MATER, V18, P1838, DOI 10.1002/adma.200600334
   Chen Z, 2014, INT J POLYM MATER, V63, P65
   CLESCERI LS, 1989, STANDARD METHODS EXA
   Geoprincy G, 2012, INT J PHARM PHARM SC, V4, P544
   GEORGE A, 1991, BIOCHEMISTRY-US, V30, P2372, DOI 10.1021/bi00223a011
   Gurusala NK, 2015, CLEAN TECHNOL ENVIR, V17, P681, DOI 10.1007/s10098-014-0825-5
   Hsieh WC, 2007, COLLOID SURFACE B, V57, P250, DOI 10.1016/j.colsurfb.2007.02.004
   Kalyanaraman C, 2013, CLEAN TECHNOL ENVIR, V15, P633, DOI 10.1007/s10098-012-0551-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mandal A, 2013, BBA-GEN SUBJECTS, V1830, P4628, DOI 10.1016/j.bbagen.2013.05.018
   Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021
   Mandal A., 2010, BIOL ENG, V2, P63
   Mandal A, 2015, J MATER CHEM B, V3, P3032, DOI 10.1039/c4tb02124j
   Mandal A, 2015, RSC ADV, V5, P15763, DOI 10.1039/c4ra09694k
   Mandal A, 2014, PHYS CHEM CHEM PHYS, V16, P20175, DOI 10.1039/c4cp02554g
   Marousek J, 2015, POLICY, DOI [10.1007/s10098-015-0941-x, DOI 10.1007/S10098-015-0941-X]
   Mitra T, 2013, INT J POLYM MATER PO, V62, P572, DOI 10.1080/00914037.2013.769161
   Rajeshwari A, 2014, J LUMIN, V145, P859, DOI 10.1016/j.jlumin.2013.08.073
   Ramamurthy G, 2014, CLEAN TECHNOL ENVIR, V16, P647, DOI 10.1007/s10098-013-0651-1
   Ramamurthy G, 2015, ACS SUSTAIN CHEM ENG, V3, P1348, DOI 10.1021/acssuschemeng.5b00071
   Rao J. R., 2004, Clean Technologies and Environmental Policy, V6, P243, DOI 10.1007/s10098-003-0240-9
   Sankar S, 2008, INT J BIOL MACROMOL, V42, P6, DOI 10.1016/j.ijbiomac.2007.08.003
   Seggiani M, 2014, CLEAN TECHNOL ENVIR, V16, P1795, DOI 10.1007/s10098-014-0722-y
   Senthil R, 2015, CLEAN TECHNOL ENVIR, V17, P1535, DOI 10.1007/s10098-014-0881-x
   Senthil R, 2015, CLEAN TECHNOL ENVIR, V17, P187, DOI 10.1007/s10098-014-0776-x
   Senthilvelan T, 2012, CLEAN TECHNOL ENVIR, V14, P889, DOI 10.1007/s10098-012-0458-5
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
NR 29
TC 1
Z9 1
U1 2
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1618-954X
EI 1618-9558
J9 CLEAN TECHNOL ENVIR
JI Clean Technol. Environ. Policy
PD MAR
PY 2016
VL 18
IS 3
BP 765
EP 773
DI 10.1007/s10098-015-1045-3
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA DF8TI
UT WOS:000371631800012
DA 2018-10-20
ER

PT J
AU Siddiqi, A
   Milne, T
   Cullinan, MP
   Seymour, GJ
AF Siddiqi, Allauddin
   Milne, Trudy
   Cullinan, Mary P.
   Seymour, Gregory J.
TI Analysis of P.gingivalis, T.forsythia and S.aureus levels in edentulous
   mouths prior to and 6months after placement of one-piece zirconia and
   titanium implants
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biofilm; edentulous patients; one-piece implant; Porphyromonas
   gingivalis; qRT-PCR; Staphylococcus aureus; Tannerella forsythia
ID ORAL MUCOUS-MEMBRANES; POLYMERASE-CHAIN-REACTION; PERIODONTAL PATHOGENS;
   IN-VITRO; BACTERIAL-COLONIZATION; STAPHYLOCOCCUS-AUREUS; SURFACES; PCR;
   EXTRACTION; MICROBIOTA
AB BackgroundIt has been suggested that completely edentulous patients harbour fewer periodontopathic bacteria compared with dentate patients, due to the removal of the subgingival periodontal environment. However, reappearance of certain microbes has been reported after the placement of implants in these patients.
   AimThe aim of this study was to determine whether the periodontopathic bacteria Porphyromonas gingivalis and Tannerella forsythia, as well as the non-periodontopathic bacterium, Staphylococcus aureus, emerged in edentulous patients 6months after placement of one-piece zirconia and titanium implants.
   Materials and methodsTwenty-six patients were included in the study (titanium=13, zirconia=13). Microbial samples were collected from the tongue prior to implant placement and 6months after implant placement from both the tongue and from around the implants. A qRT-PCR assay using SYBR green/ROX chemistry was used for the detection and quantification of rgp, nuc and karilysin single-copy gene of P.gingivalis, T.forsythia and S.aureus, respectively. Positive controls used in the study were pure bacterial gDNA purified from cultures of P.gingivalis and S.aureus, a cloned sequence of the karilysin gene for T.forsythia, a plaque sample positive for P.gingivalis and T.forsythia, and nasal gDNA for S.aureus.
   ResultsThe results show that prior to implant placement, all three bacterial species were below the lower limit of quantification in all edentulous patients. The samples collected from the tongue and around the implants remained below the lower limit of quantification for each of the three species. However, all positive controls used in the study were detectable in the samples. qPCR standard curves showed correlation coefficients >0.97 and efficiencies >94.5% (slope range -3.19 to -3.46) for each of the SYBR green PCR assays.
   ConclusionThe results of this study indicate that the tested organisms did not emerge 6months after implant placement irrespective of the nature of the implant biomaterial. A further follow-up of at least 2years post-implantation of these patients is suggested to determine whether there are any changes in the oral microbiota and whether such changes are associated with the development of peri-implant disease.
C1 [Siddiqi, Allauddin] Univ Otago, Oral Implantol Res Grp, Sir John Walsh Res Inst, Fac Dent, Dunedin 9054, New Zealand.
   [Milne, Trudy; Cullinan, Mary P.; Seymour, Gregory J.] Univ Otago, Fac Dent, Sir John Walsh Res Inst, POB 647, Dunedin 9054, New Zealand.
RP Siddiqi, A (reprint author), Univ Otago, Fac Dent, Sir John Walsh Res Inst, POB 647, Dunedin 9054, New Zealand.
EM siddiqidr@gmail.com
RI Milne, Trudy/G-2630-2011
OI SIDDIQI, ALLAUDDIN/0000-0001-5528-9153; Cullinan,
   Mary/0000-0002-0423-1581; Seymour, Gregory/0000-0001-7595-5651
CR Alarcon B, 2006, J APPL MICROBIOL, V100, P352, DOI 10.1111/j.1365-2672.2005.02768.x
   Albertini M., 2014, CLIN ORAL IMPLANTS R, V26, P937
   Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009
   BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654
   Carlen A, 2001, BIOMATERIALS, V22, P481, DOI 10.1016/S0142-9612(00)00204-0
   Cortelli JR, 2008, J PERIODONTOL, V79, P1962, DOI [10.1902/jop.2008.080092, 10.1902/jop.2008.080092 ]
   Danser MM, 1997, J PERIODONTOL, V68, P209, DOI 10.1902/jop.1997.68.3.209
   DANSER MM, 1994, J CLIN PERIODONTOL, V21, P484, DOI 10.1111/j.1600-051X.1994.tb00412.x
   DANSER MM, 1995, J CLIN PERIODONTOL, V22, P854, DOI 10.1111/j.1600-051X.1995.tb01784.x
   Devides SL, 2006, INT J ORAL MAX IMPL, V21, P262
   dosNascimento C., 2014, CLIN ORAL IMPLAN RES, V25, P337
   Egawa M, 2013, DENT MATER J, V32, P101, DOI 10.4012/dmj.2012-156
   Groessner-Schreiber B, 2004, EUR J ORAL SCI, V112, P516, DOI 10.1111/j.1600-0722.2004.00171.x
   Groner-Schreiber B., 2009, CLIN ORAL IMPLAN RES, V20, P817
   Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Heitz-Mayfield LJA, 2010, PERIODONTOL 2000, V53, P167, DOI 10.1111/j.1600-0757.2010.00348.x
   Karim AY, 2010, BIOL CHEM, V391, P105, DOI 10.1515/BC.2010.009
   Koar M., 2010, INT J ORAL MAXILLOF, V25, P690
   Leonhardt, 1999, CLIN ORAL IMPLAN RES, V10, P339
   Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x
   Mombelli A, 1993, Adv Dent Res, V7, P202
   Morillo JM, 2004, J CLIN PERIODONTOL, V31, P1054, DOI 10.1111/j.1600-051X.2004.00608.x
   Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257
   Quirynen M, 2005, CLIN ORAL IMPLAN RES, V16, P277, DOI 10.1111/j.1600-0501.2005.01127.x
   Quirynen M, 1992, Clin Oral Implants Res, V3, P104, DOI 10.1034/j.1600-0501.1992.030302.x
   Quirynen M, 2011, J CLIN PERIODONTOL, V38, P581, DOI 10.1111/j.1600-051X.2011.01728.x
   RAMS TE, 1990, ORAL MICROBIOL IMMUN, V5, P29, DOI 10.1111/j.1399-302X.1990.tb00222.x
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Sachdeo Amit, 2008, J Prosthodont, V17, P348, DOI 10.1111/j.1532-849X.2008.00301.x
   Salvi GE, 2008, CLIN ORAL IMPLAN RES, V19, P242, DOI 10.1111/j.1600-0501.2007.01470.x
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x
   Tesmer M, 2009, J PERIODONTOL, V80, P1991, DOI 10.1902/jop.2009.090178
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   VansAssche N., 2009, J CLIN PERIODONTOL, V36, P1043
   VansBrakel R., 2011, CLIN ORAL IMPLAN RES, V22, P571
   Yasui M, 2012, GERODONTOLOGY, V29, pE494, DOI 10.1111/j.1741-2358.2011.00506.x
NR 39
TC 2
Z9 2
U1 4
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAR
PY 2016
VL 27
IS 3
BP 288
EP 294
DI 10.1111/clr.12536
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DF6ST
UT WOS:000371487800004
PM 25529603
DA 2018-10-20
ER

PT J
AU Mustafa, A
   Lung, CYK
   Mustafa, NS
   Mustafa, BA
   Kashmoola, MA
   Zwahlen, RA
   Matinlinna, JP
AF Mustafa, Ammar
   Lung, Christie Y. K.
   Mustafa, Nazih S.
   Mustafa, Besma A.
   Kashmoola, Muhannad A.
   Zwahlen, Roger A.
   Matinlinna, Jukka P.
TI EPA-coated titanium implants promote osteoconduction in white New
   Zealand rabbits
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterials; dental implant; fatty acid; implant coatings; surface
   chemistry; titanium
ID POLYUNSATURATED FATTY-ACIDS; EICOSAPENTAENOIC ACID; DENTAL IMPLANTS;
   SURFACE; BONE; OSSEOINTEGRATION; COATINGS; BIOMATERIAL; HEALTH; SILANE
AB ObjectivesTo investigate the effect of eicosapentaenoic acid (EPA)-coated Ti implants on osteoconduction in white New Zealand rabbit mandibles.
   Material and methodsSandblasted and cleansed planar titanium specimens with a size of 5x5x1mm were coated on one side with 0.25 vol% eicosapentaenoic acid (EPA). The other side of the specimens was kept highly polished (the control side). These specimens were inserted in rabbit mandibles. Twelve rabbits were randomly assigned into three study groups (n=4). The rabbits were sacrificed at 4, 8, and 12weeks. The harvested specimens with the implants were assessed for new bone formation on both sides of the implant using CBCT, conventional radiographs, and the biaxial pullout test. The results were statistically analyzed by a nonparametric Kruskal-Wallis test and Friedman's test as multiple comparisons and by Brunner-Langer nonparametric mixed model approach (R Software).
   ResultsA significant osteoconductive bone formation was found on the EPA-coated Ti implant surface (P<0.05) at 8weeks when compared to the polished surface (control). Biaxial pullout test results showed a significant difference (P<0.05) after 8 and 12weeks with a maximum force of 243.8N, compared to 143.25N after 4week.
   ConclusionEPA implant coating promoted osteoconduction on the Ti implant surfaces, enhancing the anchorage of the implant to the surrounding bone in white New Zealand rabbits.
C1 [Mustafa, Ammar; Lung, Christie Y. K.; Matinlinna, Jukka P.] Univ Hong Kong, Fac Dent, Dent Mat Sci, Hong Kong, Hong Kong, Peoples R China.
   [Mustafa, Ammar; Lung, Christie Y. K.; Matinlinna, Jukka P.] Int Islamic Univ Malaysia, Dent Mat Sci, Kulliyyah Dent, Kuantan, Malaysia.
   [Mustafa, Ammar] ISF Med Unit, POB 12430, Doha, Qatar.
   [Mustafa, Nazih S.; Mustafa, Besma A.; Kashmoola, Muhannad A.] Int Islamic Univ Malaysia, Kulliyyah Dent, Kuantan, Malaysia.
   [Zwahlen, Roger A.] Univ Hong Kong, Fac Dent, Oral & Maxillofacial Surg, Hong Kong, Hong Kong, Peoples R China.
RP Mustafa, A (reprint author), Univ Hong Kong, Fac Dent, Dent Mat Sci, Hong Kong, Hong Kong, Peoples R China.; Mustafa, A (reprint author), ISF Med Unit, POB 12430, Doha, Qatar.
EM drammar71@gmail.com
FU Research Management Center, International Islamic University Malaysia
   (IIUM) [11-067-0545]
FX The authors would like to acknowledge the Research Management Center,
   International Islamic University Malaysia (IIUM) for the generous fund
   for this research project (EDW B, 11-067-0545), and The Faculty of
   Science (IIUM) for the animals experiment. The authors would also like
   to thank Dr. Zohaib Khorshid for his kind assistance in performing the
   statistical analyses.
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Babcock T, 2000, NUTRITION, V16, P1116, DOI 10.1016/S0899-9007(00)00392-0
   Barradas AMC, 2012, BIOMATERIALS, V33, P5696, DOI 10.1016/j.biomaterials.2012.04.021
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Ben-Nissan B, 2013, SURF COAT TECH, V233, P39, DOI 10.1016/j.surfcoat.2012.11.020
   Calder PC, 1997, ANN NUTR METAB, V41, P203, DOI 10.1159/000177997
   Cheng ZP, 2012, OR SURG OR MED OR PA, V113, pE48, DOI 10.1016/j.tripleo.2011.07.008
   Choi AH, 2013, J DENT RES, V92, P853, DOI 10.1177/0022034513497754
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   Damsgaard CT, 2012, PEDIATR RES, V71, P713, DOI 10.1038/pr.2012.28
   Guo CY, 2012, J ADHES SCI TECHNOL, V26, P189, DOI 10.1163/016942411X569390
   Hanisch O, 1997, J PERIODONTOL, V68, P59, DOI 10.1902/jop.1997.68.1.59
   Jaatinen JJP, 2011, ACTA ORTHOP, V82, P499, DOI 10.3109/17453674.2011.579522
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kelly O, 2003, BRIT J NUTR, V90, P743, DOI 10.1079/BJN2003951
   Khang W, 2001, J PERIODONTOL, V72, P1384, DOI 10.1902/jop.2001.72.10.1384
   Kruger MC, 2005, PROSTAG LEUKOTR ESS, V73, P327, DOI 10.1016/j.plefa.2005.08.001
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LIN H, 1992, J BIOMED MATER RES, V26, P7
   Lind M, 1998, ACTA ORTHOP SCAND, V69, P2
   Mallineni S. K., 2012, J INVESTIGATIVE CLIN, V4, P9
   Matinlinna JP, 2006, J DENT, V34, P740, DOI 10.1016/j.jdent.2006.01.008
   Matinlinna JP, 2013, CLIN ORAL IMPLAN RES, V24, P688, DOI 10.1111/j.1600-0501.2012.02504.x
   Murphy RA, 2011, BRIT J CANCER, V105, P1469, DOI 10.1038/bjc.2011.391
   National Research Council, 2011, GUID CAR US LAB AN
   NETTLETON JA, 1995, OMEGA 3 FATTY ACIDS
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Petzold C, 2008, J MATER CHEM, V18, P5502, DOI 10.1039/b811932e
   Petzold C, 2011, J BIOMED MATER RES A, V96A, P83, DOI 10.1002/jbm.a.32960
   Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P97, DOI 10.1111/j.1600-0501.2007.01439.x
   RAISZ LG, 1989, PROSTAG OTH LIPID M, V37, P615, DOI 10.1016/0090-6980(89)90076-2
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Sethi S, 1996, J LAB CLIN MED, V128, P27, DOI 10.1016/S0022-2143(96)90111-0
   Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Trisi P, 1999, INT J ORAL MAX IMPL, V14, P689
   Villard N, 2015, CLIN ORAL IMPLAN RES, V26, P332, DOI 10.1111/clr.12338
   Wagner W. C., 1992, J ORAL IMPLANTOL, V18, P31
   Watkins BA, 2001, EXP BIOL MED, V226, P485
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Zhao SF, 2013, CLIN ORAL IMPLAN RES, V24, P34, DOI 10.1111/j.1600-0501.2011.02362.x
NR 45
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAR
PY 2016
VL 27
IS 3
BP 303
EP 309
DI 10.1111/clr.12525
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DF6ST
UT WOS:000371487800006
PM 25393376
OA Green Published
DA 2018-10-20
ER

PT J
AU Papanas, N
   Demetzos, C
   Pippa, N
   Maltezos, E
   Tentolouris, N
AF Papanas, Nikolaos
   Demetzos, Costas
   Pippa, Natassa
   Maltezos, Efstratios
   Tentolouris, Nicholas
TI Efficacy of a New Heparan Sulfate Mimetic Dressing in the Healing of
   Foot and Lower Extremity Ulcerations in Type 2 Diabetes: A Case Series
SO INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS
LA English
DT Article
DE biomimetic scaffold; diabetic foot; dressing; hydration; tissue
   engineering; ulceration
ID ANKLE-BRACHIAL INDEX; SURGICAL-TREATMENT; GROWTH-FACTORS; INFECTIONS;
   ISCHEMIA; ULCERS; AMPUTATIONS; PREVALENCE; PRESSURE; OTR4120
AB A novel heparan sulfate glycosaminoglycan mimetic product for local application to promote wound healing (CACIPLIQ) has recently become available. It is a biophysical therapeutic product comprising a polysaccharide as an innovative biomaterial to accomplish mechanical tissue engineering and skin regeneration in the site of ulceration. We present a series of 12 patients with type 2 diabetes (4 men and 8 women; age 53-87 years; diabetes duration 8-25 years) having chronic resistance to therapy for foot and lower extremity ulcerations. CACIPLIQ was locally applied twice per week after careful debridement. Complete ulcer healing was accomplished in all patients after a mean treatment duration of 4.92 months (range = 2-12 months). The product was very well tolerated. In conclusion, these results, although preliminary, are encouraging and suggest adequate efficacy and safety of the new product in difficult-to-heal foot and lower extremity ulcerations in type 2 diabetes.
C1 [Papanas, Nikolaos; Maltezos, Efstratios] Democritus Univ Thrace, Alexandroupolis, Greece.
   [Demetzos, Costas; Pippa, Natassa; Tentolouris, Nicholas] Univ Athens, Athens 11528, Greece.
RP Papanas, N (reprint author), Ctr Diabet, Dept Internal Med 2, Diabet Foot Clin, G Kondyli 22c, Alexandroupolis 68132, Greece.
EM papanasnikos@yahoo.gr
OI DEMETZOS, COSTAS/0000-0001-9771-4314; Maltezos,
   Efstratios/0000-0002-5827-2661; Pippa, Natassa/0000-0002-1197-9010
FU Asta-Zeneca; GSK; Novo Nordisk; Novartis; Sanofi-Aventis; TrigoCare
   International; Eli-Lilly; Galenica; Pfizer; MSD; Astra-Zeneca; Wyeth;
   Bayer
FX The author(s) declared the following potential conflicts of interest
   with respect to the research, authorship, and/or publication of this
   article: Nikolaos Papanas has been an advisory board member of TrigoCare
   International, Astra-Zeneca, Boehringer Ingelheim, MSD, Novo Nordisk,
   and Pfizer; has participated in sponsored studies by Asta-Zeneca, GSK,
   Novo Nordisk, Novartis, and Sanofi-Aventis; has received honoraria as a
   speaker for Astra-Zeneca, Boehringer Ingelheim, Eli-Lilly, ELPEN, MSD,
   Mylan, Novo Nordisk, Pfizer, and Sanofi-Aventis; and attended
   conferences sponsored by TrigoCare International, Eli-Lilly, Galenica,
   Novo Nordisk, Pfizer, and Sanofi-Aventis. Nicholas Tentolouris has been
   an advisory board member of TrigoCare International; has participated in
   sponsored studies by Sanofi-Aventis, Eli-Lilly, MSD, Pfizer, Novo
   Nordisk, and Novartis; has received honoraria as a speaker for
   Astra-Zeneca, Eli-Lilly, Novo Nordisk, Novartis, and MSD; has received
   research support by Sanofi-Aventis and Novartis; and has attended
   conferences sponsored by Novo Nordisk, Sanofi-Aventis, Astra-Zeneca,
   MSD, and Novartis. Efstratios Maltezos has participated in sponsored
   studies by Asta-Zeneca, GSK, Novo Nordisk, Novartis and Sanofi-Aventis;
   and attended conferences sponsored by Wyeth, Pfizer, and Bayer. The
   other authors have no conflicts of interest to report.
CR Aragon-Sanchez J, 2013, INT J LOW EXTR WOUND, V12, P146, DOI 10.1177/1534734613486155
   Aragon-Sanchez J, 2011, INT J LOW EXTR WOUND, V10, P207, DOI 10.1177/1534734611426364
   Aragon-Sanchez J, 2011, INT J LOW EXTR WOUND, V10, P33, DOI 10.1177/1534734611400259
   Demetriou M, 2013, INT J LOW EXTR WOUND, V12, P87, DOI 10.1177/1534734613481975
   Demetzos C, 2015, AAPS PHARMSCITECH, V16, P491, DOI 10.1208/s12249-015-0321-1
   Desgranges P, 2011, J WOUND TECHNOL, V13, P1
   Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P62, DOI 10.1177/1534734609337930
   Franco D, 2013, BIOMATERIALS, V34, P1488, DOI 10.1016/j.biomaterials.2012.10.007
   Georgakarakos E, 2013, ANGIOLOGY, V64, P583, DOI 10.1177/0003319712465172
   Georgakarakos E, 2013, INT J LOW EXTR WOUND, V12, P138, DOI 10.1177/1534734613483769
   Georgakarakos E, 2013, INT J LOW EXTR WOUND, V12, P167, DOI 10.1177/1534734613483768
   Gouveri E, 2011, WORLD J DIABETES, V2, P59, DOI 10.4239/wjd.v2.i5.59
   Kakagia DD, 2007, J DIABETES COMPLICAT, V21, P387, DOI 10.1016/j.jdiacomp.2007.03.006
   Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091
   Mikroulis D, 2007, CURR VASC PHARMACOL, V5, P195
   Panagopoulos P, 2015, INT J LOW EXTR WOUND, V14, P87, DOI 10.1177/1534734614566937
   Papanas N, 2007, INT ANGIOL, V26, P253
   Papanas N, 2007, Int J Low Extrem Wounds, V6, P37, DOI 10.1177/1534734606298416
   Papanas N, 2015, INT J LOW EXTR WOUND, V14, P106, DOI 10.1177/1534734615592313
   Papanas N, 2012, CURR DIABETES REV, V8, P209, DOI 10.2174/157339912800563963
   Papanas N, 2011, VASA, V40, P267, DOI 10.1024/0301-1526/a000114
   Papanas N, 2011, INT J LOW EXTR WOUND, V10, P4, DOI 10.1177/1534734611400255
   Papanas N, 2013, INT J LOW EXTR WOUND, V12, P83, DOI 10.1177/1534734613490507
   Papanas N, 2010, DRUG SAFETY, V33, P455, DOI 10.2165/11534570-000000000-00000
   Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1
   Skoutas D, 2009, INT J LOW EXTR WOUND, V8, P69, DOI 10.1177/1534734609334808
   Tiaka EK, 2012, ANGIOLOGY, V63, P302, DOI 10.1177/0003319711416804
   Tong M, 2012, DIABETES, V61, P2633, DOI 10.2337/db11-1329
   Tong M, 2011, WOUND REPAIR REGEN, V19, P505, DOI 10.1111/j.1524-475X.2011.00704.x
   Tong M, 2009, WOUND REPAIR REGEN, V17, P840, DOI 10.1111/j.1524-475X.2009.00548.x
   YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697
NR 31
TC 6
Z9 6
U1 0
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1534-7346
EI 1552-6941
J9 INT J LOW EXTR WOUND
JI Int. J. Low. Extrem. Wounds
PD MAR
PY 2016
VL 15
IS 1
BP 63
EP 67
DI 10.1177/1534734616629302
PG 5
WC Dermatology; Surgery
SC Dermatology; Surgery
GA DF9QY
UT WOS:000371697400011
PM 26933115
DA 2018-10-20
ER

PT J
AU Zhang, Q
   Du, Y
   Jing, LJ
   Liang, XL
   Li, YQ
   Li, XF
   Dai, ZF
   Tian, J
AF Zhang, Qian
   Du, Yang
   Jing, Lijia
   Liang, Xiaolong
   Li, Yaqian
   Li, Xiaofeng
   Dai, Zhifei
   Tian, Jie
TI Infra Red Dye and Endostar Loaded Poly Lactic Acid Nano Particles as a
   Novel Theranostic Nanomedicine for Breast Cancer
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Endostar; Poly Lactic Acid (PLA); Zoledronic Acid (ZA); Breast Cancer;
   Nanoparticle; Molecular Imaging
ID TUMOR-ASSOCIATED MACROPHAGES; RECOMBINANT HUMAN ENDOSTATIN;
   BIODEGRADABLE NANOPARTICLES; DRUG-DELIVERY; PROGRESSION; METASTASIS;
   THERAPY; PHARMACOKINETICS; ANGIOGENESIS; CELLS
AB Endostar, a novel recombinant human endostatin, has been proven to inhibit tumor angiogenesis and is utilized as an anticancer drug. While free drugs can display limited efficacy, nanoscaled anticancer drugs have been fabricated and proven to possess superior therapeutic effects. Poly(lactic acid) (PLA) is a FDA-approved biomaterial displaying excellent biocompatibility and low toxicity. In this study, Endostar-loaded PLA nanoparticles (EPNPs) were first prepared, and a near-infrared (NIR) dye, IRDye 800CW, was conjugated to the surface for detecting nanoparticle biodistribution through fluorescence molecular imaging (FMI) using an orthotopic breast tumor mouse model. The antitumor efficacy of EPNPs was examined using bioluminescence imaging (BLI) and immunohistology. To further improve the antitumor effects, we combined EPNPs with zoledronic acid monohydrate (ZA), which is known to decrease the tumor-associated macrophages (TAM) and inhibit tumor progression. We found that EPNPs decreased human umbilical vein endothelial cell (HUVEC) viability by inhibiting tumor growth gene expression more significantly than free Endostar in vitro. In vivo, EPNPs displayed better tumor growth inhibitory effects compared with free Endostar, and the combination of EPNPs with ZA exhibited more significant antitumor effects. As confirmed by CD31 and CD11b immunohistochemistry, the combination of EPNPs and ZA showed synergistic effects in reducing tumor angiogenesis and TAM accumulation in tumor regions. Taken together, this study presents a novel and effective form of nanoscaled Endostar for the treatment of breast cancer that displays synergistic antitumor effects in combination with ZA.
C1 [Zhang, Qian; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China.
   [Zhang, Qian; Tian, Jie] Minist Educ, Engn Res Ctr Mol & Neuro Imaging, Beijing, Peoples R China.
   [Zhang, Qian; Du, Yang; Li, Yaqian; Tian, Jie] Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing 100190, Peoples R China.
   [Jing, Lijia] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.
   [Liang, Xiaolong; Dai, Zhifei] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
   [Li, Yaqian] Harbin Univ Sci & Technol, Harbin 150080, Peoples R China.
   [Li, Xiaofeng] Univ Louisville, Sch Med, Dept Diagnost Radiol, Louisville, KY 40208 USA.
   [Li, Xiaofeng] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA.
RP Tian, J (reprint author), Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China.; Tian, J (reprint author), Minist Educ, Engn Res Ctr Mol & Neuro Imaging, Beijing, Peoples R China.; Tian, J (reprint author), Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing 100190, Peoples R China.; Dai, ZF (reprint author), Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
EM zhifei.dai@pku.edu.cn; tian@ieee.org
RI Dai, Zhifei/B-1812-2012; Tian, Jie/H-1190-2011
FU Program of the National Basic Research and Development Program of China
   (973) [2011CB707702, 2014CB748600]; National Natural Science Foundation
   of China [81090272, 81227901]; National Key Technology Support Program
   [2012BAI23B06]; State Key laboratory of Management and Control for
   Complex Systems [Y3S9021F30]
FX This work was supported by the Program of the National Basic Research
   and Development Program of China (973) under Grant Nos. 2011CB707702 and
   2014CB748600, the National Natural Science Foundation of China under
   Grant Nos. 81090272 and 81227901 and the National Key Technology Support
   Program under Grant No. 2012BAI23B06. This work was also supported in
   part by the State Key laboratory of Management and Control for Complex
   Systems under Grant No. Y3S9021F30.
CR Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008
   Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154
   Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027
   Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007
   Coscia M, 2010, J CELL MOL MED, V14, P2803, DOI 10.1111/j.1582-4934.2009.00926.x
   DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134
   Fenlon D., 2012, EUR J ONCOL NURS, V17, P311
   Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015
   Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087
   Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3
   Jia Y, 2011, EUR J GYNAECOL ONCOL, V32, P316
   Kadam RS, 2012, DRUG METAB DISPOS, V40, P1380, DOI 10.1124/dmd.112.044925
   Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721
   Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155
   Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004
   Metcalf S, 2011, FUTURE ONCOL, V7, P1325, DOI [10.2217/FON.11.113, 10.2217/fon.11.113]
   O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004
   Ottewell PD, 2012, BREAST CANCER RES TR, V133, P523, DOI 10.1007/s10549-011-1782-x
   Panyam J, 2012, ADV DRUG DELIVER REV, V64, P61, DOI 10.1016/j.addr.2012.09.023
   Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256
   Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014
   Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007
   Vicioso L, 2006, AM J CLIN PATHOL, V125, P111, DOI 10.1309/0864AF2U3LGPCF3J
   WEIDNER N, 1992, J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875
   Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949
   Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917
   Wittig R, 2014, NANOMEDICINE-UK, V9, P971, DOI [10.2217/NNM.13.62, 10.2217/nnm.13.62]
   Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007
   Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904
   Zou P, 2013, MOL PHARMACEUT, V10, P1977, DOI 10.1021/mp4000019
   Zucker D, 2012, J CONTROL RELEASE, V160, P281, DOI 10.1016/j.jconrel.2011.10.003
NR 33
TC 5
Z9 6
U1 2
U2 41
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2016
VL 12
IS 3
BP 491
EP 502
DI 10.1166/jbn.2016.2022
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA DF6FJ
UT WOS:000371451000007
PM 27280247
DA 2018-10-20
ER

PT J
AU Schaller, B
   Saulacic, N
   Imwinkelried, T
   Beck, S
   Liu, EWY
   Gralla, J
   Nakahara, K
   Hofstetter, W
   Iizuka, T
AF Schaller, Benoit
   Saulacic, Nikola
   Imwinkelried, Thomas
   Beck, Stefan
   Liu, Edwin Wei Yang
   Gralla, Jan
   Nakahara, Ken
   Hofstetter, Willy
   Iizuka, Tateyuki
TI In vivo degradation of magnesium plate/screw osteosynthesis implant
   systems: Soft and hard tissue response in a calvarial model in miniature
   pigs
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Biomaterial; Magnesium; Osteosynthesis; Implant; Degradation
ID CRANIOMAXILLOFACIAL SURGERY; RABBIT MODEL; ALLOYS; CORROSION; BONE;
   VITRO; SCREWS; PLATES; BIOCOMPATIBILITY; BIOMATERIALS
AB Biodegradable magnesium plate/screw osteosynthesis systems were implanted on the frontal bone of adult miniature pigs. The chosen implant geometries were based on existing titanium systems used for the treatment of facial fractures. The aim of this study was to evaluate the in vivo degradation and tissue response of the magnesium alloy WE43 with and without a plasma electrolytic surface coating. Of 14 animals, 6 received magnesium implants with surface modification (coated), 6 without surface modification (uncoated), and 2 titanium implants. Radiological examination of the skull was performed at 1, 4, and 8 weeks post-implantation. After euthanasia at 12 and 24 weeks, X-ray, computed tomography, and microfocus computed tomography analyses and histological and histomorphological examinations of the bone/implant blocks were performed. The results showed a good tolerance of the plate/screw system without wound healing disturbance. In the radiological examination, gas pocket formation was found mainly around the uncoated plates 4 weeks after surgery. The micro-CT and histological analyses showed significantly lower corrosion rates and increased bone density and bone implant contact area around the coated screws compared to the uncoated screws at both endpoints. This study shows promising results for the further development of coated magnesium implants for the osteosynthesis of the facial skeleton. (C) 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Schaller, Benoit; Saulacic, Nikola; Nakahara, Ken; Iizuka, Tateyuki] Univ Hosp Bern, Inselspital, Dept Craniomaxillofacial Surg, CH-3010 Bern, Switzerland.
   [Schaller, Benoit; Saulacic, Nikola; Gralla, Jan; Nakahara, Ken; Iizuka, Tateyuki] Univ Bern, CH-3010 Bern, Switzerland.
   [Schaller, Benoit; Liu, Edwin Wei Yang] Natl Dent Ctr Singapore, Singapore 168938, Singapore.
   [Imwinkelried, Thomas] RMS Fdn, Bischmattstr 12, CH-2544 Bettlach, Switzerland.
   [Beck, Stefan] Synthes Biomat, Eimattstr 3, CH-4436 Oberdorf, Switzerland.
   [Gralla, Jan] Univ Hosp Bern, Dept Intervent & Diagnost Neuroradiol, CH-3010 Bern, Switzerland.
   [Hofstetter, Willy] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland.
RP Schaller, B (reprint author), Univ Hosp Bern, Inselspital, Dept Craniomaxillofacial Surg, CH-3010 Bern, Switzerland.; Schaller, B (reprint author), Univ Bern, CH-3010 Bern, Switzerland.; Schaller, B (reprint author), Natl Dent Ctr Singapore, Singapore 168938, Singapore.
EM benoit.schaller@ndcs.com.sg
OI Hofstetter, Wilhelm/0000-0003-0126-8423; Schaller,
   Benoit/0000-0002-6861-2340
CR Al-Samman T, 2011, MAT SCI ENG A-STRUCT, V528, P3809, DOI 10.1016/j.msea.2011.01.080
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Birbilis N, 2011, CORROS SCI, V53, P168, DOI 10.1016/j.corsci.2010.09.013
   Castellania C., 2010, ACTA BIOMATER, V7, P432
   Chaya A, 2015, ACTA BIOMATER, V18, P262, DOI 10.1016/j.actbio.2015.02.010
   Chaya A, 2015, J ORAL MAXIL SURG, V73, P295, DOI 10.1016/j.joms.2014.09.007
   Cui W, 2013, ACTA BIOMATER, V9, P8650, DOI 10.1016/j.actbio.2013.06.031
   Feyerabend F, 2015, ACTA BIOMATER, V25, P384, DOI 10.1016/j.actbio.2015.07.029
   Gephart MGH, 2013, CHILD NERV SYST, V29, P297, DOI 10.1007/s00381-012-1938-y
   Gunde P, 2010, J BIOMED MATER RES A, V92A, P409, DOI 10.1002/jbm.a.32350
   Guzman R, 2011, NEUROSURGERY, V68, P68, DOI 10.1227/NEU.0b013e31820780cd
   Han P, 2015, BIOMATERIALS, V64, P57, DOI 10.1016/j.biomaterials.2015.06.031
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Imwinkelried T, 2013, ACTA BIOMATER, V9, P8643, DOI 10.1016/j.actbio.2012.08.047
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Jung O, 2015, ACTA BIOMATER, V23, P354, DOI 10.1016/j.actbio.2015.06.005
   Keim S, 2011, J BIOMED MATER RES B, V96B, P84, DOI 10.1002/jbm.b.31742
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Marukawa E., 2015, J BIOMED MAT RES B
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rossig C, 2015, ACTA BIOMATER, V25, P369, DOI 10.1016/j.actbio.2015.07.025
   Sanchez MAH, 2015, ACTA BIOMATER, V13, P16
   Schumann P, 2013, PATHOBIOLOGY, V80, P211, DOI 10.1159/000348328
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Suuronen R, 2004, BIO-MED MATER ENG, V14, P517
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Thoren H, 2008, J ORAL MAXIL SURG, V66, P1901, DOI 10.1016/j.joms.2008.03.009
   Tschegg EK, 2011, J MECH BEHAV BIOMED, V4, P766, DOI 10.1016/j.jmbbm.2010.08.004
   Verbrugge J., 1934, PRESSE MED, V23, P460
   Waizy H, 2013, J BIOMATER APPL, V28, P667
   Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x
   Willumeit R, 2013, ACTA BIOMATER, V9, P8722, DOI 10.1016/j.actbio.2013.02.042
   Windhagen H, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-62
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 40
TC 14
Z9 14
U1 2
U2 28
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD MAR
PY 2016
VL 44
IS 3
BP 309
EP 317
DI 10.1016/j.jcms.2015.12.009
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA DF7PU
UT WOS:000371550900011
PM 26805919
DA 2018-10-20
ER

PT J
AU Tietsch, V
   Alencastre, J
   Witte, H
   Torres, FG
AF Tietsch, V.
   Alencastre, J.
   Witte, H.
   Torres, F. G.
TI Exploring the shock response of spider webs
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Spider silk; Spider orb-web; Vibration; Dynamic behavior
ID ORB-WEAVING SPIDERS; MECHANICAL-PROPERTIES; SILK; PREY; BIOMATERIAL;
   THREADS; INSECT; MODEL
AB Spider orb-webs are designed to allow for quick energy absorption as well as the constraint of drastic oscillations occurring upon prey impact. Studies on spider silk illustrate its impressive mechanical properties and its capacity to be used as technical fibers in composite materials. Models have previously been used to study the mechanical properties of different silk fibers, but not the behavior of the spider web as a whole. Full spider webs have been impacted by a projectile and the transverse displacement was measured by means of a laser interferometer. The damping and stiffness of the entire webs were quantified considering the orb-web as a single-degree-of-freedom (SDOF) system. The amplitude, the period duration, and the energy dissipation of the oscillations have also been reported from the experiments. The analysis of the energy dissipation confirmed that the webs of orb-web spiders are optimized for the capture of a single or few large prey, rather than several small prey. The experiments also confirmed that the overall stiffness of the web displayed a non-linear behavior. Such non-linearity was also observed in the damping characteristics of the webs studied. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Tietsch, V.; Witte, H.] Tech Univ Ilmenau, FachgebietBiomechatron, Max Planck Ring 12, D-98693 Ilmenau, Germany.
   [Alencastre, J.; Torres, F. G.] Pontificia Univ Catolica Peru, Dept Mech Engn, Av Univ 1801, Lima 32, Peru.
RP Alencastre, J; Torres, FG (reprint author), Pontificia Univ Catolica Peru, Dept Mech Engn, Av Univ 1801, Lima 32, Peru.
EM jalenca@pucp.edu.pe; fgtorres@pucp.pe
OI Torres, Fernando G./0000-0002-3123-266X
FU Pontificia Universidad Catolica del Peru [VRI-165]
FX F.T. and J.A. would like to acknowledge the Vice-Rectorate of Research
   of the Pontificia Universidad Catolica del Peru for financial support
   (VRI-165).
CR Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Bai JM, 2006, BIOMED MICRODEVICES, V8, P317, DOI 10.1007/s10544-006-9820-x
   Barrows WM, 1915, BIOL BULL-US, V29, P316, DOI 10.2307/1536407
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   Chen Q, 1996, J VIB ACOUST, V118, P252, DOI 10.1115/1.2889656
   CRAIG CL, 1985, J THEOR BIOL, V115, P201, DOI 10.1016/S0022-5193(85)80096-5
   DENNY M, 1976, J EXP BIOL, V65, P483
   Du N, 2011, ADV FUNCT MATER, V21, P772, DOI 10.1002/adfm.201001397
   Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Kelly SP, 2011, ZOOLOGY, V114, P233, DOI 10.1016/j.zool.2011.02.001
   LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0
   PARRY DA, 1965, J EXP BIOL, V43, P185
   Perez-Rigueiro J, 2010, INT J BIOL MACROMOL, V46, P555, DOI 10.1016/j.ijbiomac.2010.03.013
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Sensenig AT, 2013, J EXP BIOL, V216, P3388, DOI 10.1242/jeb.085571
   Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Torres FG, 2014, MAT SCI ENG C-MATER, V34, P341, DOI 10.1016/j.msec.2013.09.030
   Torres FG, 2013, MAT SCI ENG C-MATER, V33, P1432, DOI 10.1016/j.msec.2012.12.047
   Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114
NR 24
TC 4
Z9 4
U1 2
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2016
VL 56
BP 1
EP 5
DI 10.1016/j.jmbbm.2015.11.007
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF7RB
UT WOS:000371554200001
PM 26651062
DA 2018-10-20
ER

PT J
AU Rodriguez, AL
   Wang, TY
   Bruggeman, KF
   Li, R
   Williams, RJ
   Parish, CL
   Nisbet, DR
AF Rodriguez, Alexandra L.
   Wang, Ting-Yi
   Bruggeman, Kiara F.
   Li, Rui
   Williams, Richard J.
   Parish, Clare L.
   Nisbet, David R.
TI Tailoring minimalist self-assembling peptides for localized viral vector
   gene delivery
SO NANO RESEARCH
LA English
DT Article
DE viral vectors; gene therapy; self-assembling peptides; biomaterials
ID NEURAL PROGENITOR CELLS; STEM-CELLS; IN-VIVO; PARKINSONIAN MICE;
   SCAFFOLDS; THERAPY; HYDROGELS; DIFFERENTIATION; ADENOVIRUS; REPAIR
AB Viral vector gene delivery is a promising technique for the therapeutic administration of proteins to damaged tissue for the improvement of regeneration outcomes in various disease settings including brain and spinal cord injury, as well as autoimmune diseases. Though promising results have been demonstrated, limitations of viral vectors, including spread of the virus to distant sites, neutralization by the host immune system, and low transduction efficiencies have stimulated the investigation of biomaterials as gene delivery vehicles for improved protein expression at an injury site. Here, we show how Nfluorenylmethyloxycarbonyl (Fmoc) self-assembling peptide (SAP) hydrogels, designed for tissue-specific central nervous system (CNS) applications via incorporation of the laminin peptide sequence isoleucine-lysine-valine-alanine-valine (IKVAV), are effective as biocompatible, localized viral vector gene delivery vehicles in vivo. Through the addition of a C-terminal lysine (K) residue, we show that increased electrostatic interactions, provided by the additional amine side chain, allow effective immobilization of lentiviral vector particles, thereby limiting their activity exclusively to the site of injection and enabling focal gene delivery in vivo in a tissue-specific manner. When the C-terminal lysine was absent, no difference was observed between the number of transfected cells, the volume of tissue transfected, or the transfection efficiency with and without the Fmoc-SAP. Importantly, immobilization of the virus only affected transfection cell number and volume, with no impact observed on transfection efficiency. This hydrogel allows the sustained and targeted delivery of growth factors post injury. We have established Fmoc-SAPs as a versatile platform for enhanced biomaterial design for a range of tissue engineering applications.
C1 [Rodriguez, Alexandra L.; Bruggeman, Kiara F.; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Canberra, ACT 2601, Australia.
   [Wang, Ting-Yi; Parish, Clare L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.
   [Li, Rui] Deakin Univ, Ctr Chem & Biotechnol, Waurn Ponds, Vic 3217, Australia.
   [Williams, Richard J.] RMIT Univ, Res Inst, Sch Aerosp Mech & Mfg Engn & Hlth Innovat, Melbourne, Vic 3001, Australia.
RP Nisbet, DR (reprint author), Australian Natl Univ, Res Sch Engn, Canberra, ACT 2601, Australia.; Parish, CL (reprint author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.
EM clare.parish@florey.edu.au; david.nisbet@anu.edu.au
OI Nisbet, David/0000-0002-1343-0769; Wang, Ting-Yi/0000-0001-7722-8087;
   Parish, Clare/0000-0001-8212-9884
FU Centre for Advanced Microscopy (CAM) through the Australian Microscopy
   and Microanalysis Research Facility (AMMRF); National Health and Medical
   Research Council, Australia (NHMRC) [APP1050684]; Australian Research
   Council (ARC) [DP130103131]; Australian Postgraduate Award; Alfred
   Deakin Research Fellowship; Viertel charitable Foundation, Australia;
   ARC Australian Postdoctoral Fellowship; Victorian Government's
   Operational Infrastructure Support Grant
FX Access to the facilities of the Centre for Advanced Microscopy (CAM)
   with funding through the Australian Microscopy and Microanalysis
   Research Facility (AMMRF) is gratefully acknowledged. We acknowledge
   NanoScope-Scientific Graphics and Illustration for kindly designing the
   virus immobilization schematic in Fig. 3. We would also like to thank
   Conor Horgan, Francesca Maclean and Anitha Parnneerselvan for thorough
   proof reading. Funding for this research was obtained from the National
   Health and Medical Research Council, Australia (NHMRC, No. APP1050684),
   and the Australian Research Council (ARC, No. DP130103131). A. L. R. was
   supported by an Australian Postgraduate Award; R. J. W. was funded via
   an Alfred Deakin Research Fellowship; C. L. P. was supported by Senior
   Medical Research Fellowship provided by the Viertel charitable
   Foundation, Australia; D. R. N. was supported by an ARC Australian
   Postdoctoral Fellowship, followed by an NHMRC Career Development
   Fellowship. The Florey Institute of Neuroscience and Mental Health
   acknowledges the support from the Victorian Government's Operational
   Infrastructure Support Grant.
CR Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5
   Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004
   Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2
   Bye CR, 2012, EXP NEUROL, V236, P58, DOI 10.1016/j.expneurol.2012.04.002
   ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838
   Geral Claire, 2013, Pharmaceutics, V5, P127, DOI 10.3390/pharmaceutics5010127
   Gersbach CA, 2007, BIOMATERIALS, V28, P5121, DOI 10.1016/j.biomaterials.2007.07.047
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Jang JH, 2011, MOL THER, V19, P1407, DOI 10.1038/mt.2011.111
   Kauhausen J, 2013, J PHYSIOL-LONDON, V591, P77, DOI 10.1113/jphysiol.2012.243063
   Kidd ME, 2012, J CONTROL RELEASE, V157, P80, DOI 10.1016/j.jconrel.2011.08.036
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742
   Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321
   Lee GK, 2005, BIOTECHNOL BIOENG, V92, P24, DOI 10.1002/bit.20562
   Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Li R, 2015, RSC ADV, V5, P301, DOI 10.1039/c4ra13266a
   Matthews CB, 1999, GENE THER, V6, P1558, DOI 10.1038/sj.gt.3300978
   Modepalli VN, 2014, BIOPOLYMERS, V102, P197, DOI 10.1002/bip.22469
   Nisbet DR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0002-x
   Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Rey-Rico A, 2015, ACTA BIOMATER, V18, P118, DOI 10.1016/j.actbio.2015.02.013
   Rodriguez AL, 2014, J MATER CHEM B, V2, P7771, DOI 10.1039/c4tb01391c
   Rodriguez A. L., 2012, STEM CELLS CANC STEM, V4, P97
   Rodriguez AL, 2013, SOFT MATTER, V9, P3915, DOI 10.1039/c3sm27758e
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Turner P, 2007, BIOTECHNOL PROGR, V23, P423, DOI 10.1021/bp0600177
   Wang K, 2015, ADV FUNCT MATER, V25, P3380, DOI 10.1002/adfm.201403921
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Wu EC, 2012, ADV FUNCT MATER, V22, P456, DOI 10.1002/adfm.201101905
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 37
TC 11
Z9 12
U1 4
U2 31
PU TSINGHUA UNIV PRESS
PI BEIJING
PA TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA
SN 1998-0124
EI 1998-0000
J9 NANO RES
JI Nano Res.
PD MAR
PY 2016
VL 9
IS 3
BP 674
EP 684
DI 10.1007/s12274-015-0946-0
PG 11
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DG1AI
UT WOS:000371797000008
DA 2018-10-20
ER

PT J
AU Li, WY
   Zheng, YF
   Zhao, XH
   Ge, YJ
   Chen, T
   Liu, YS
   Zhou, YS
AF Li, Wenyue
   Zheng, Yunfei
   Zhao, Xianghui
   Ge, Yanjun
   Chen, Tong
   Liu, Yunsong
   Zhou, Yongsheng
TI Osteoinductive Effects of Free and Immobilized Bone Forming Peptide-1 on
   Human Adipose-Derived Stem Cells
SO PLOS ONE
LA English
DT Article
ID MORPHOGENETIC PROTEINS; IN-VITRO; TISSUE; REGENERATION; MARROW;
   DEGRADATION; INDUCTION; SCAFFOLDS; PRODOMAIN; ADHESION
AB Most synthetic polymeric materials currently used for bone tissue engineering lack specific signals through which cells can identify and interact with the surface, resulting in incompatibility and compromised osteogenic activity. Soluble inductive factors also have issues including a short half-live in vivo. Bone forming peptide-1 is a truncated peptide from the immature form of bone morphogenetic protein-7 (BMP-7) that displays higher osteogenic activity than full-length, mature BMP-7. In this study, we used a mussel-inspired immobilization strategy mediated by polymerization of dopamine to introduce recently discovered stimulators of bone forming peptide-1 (BFP-1) onto the surface of poly-lactic-co-glycolic acid (PLGA) substrate to form a biomaterial that overcomes these challenges. Human adipose-derived stem cells (hASCs), being abundant and easy accessible, were used to test the osteogenic activity of BFP-1 and the novel biomaterial. Under osteoinductive conditions, cells treated with both BFP-1 alone and BFP-1-coated biomaterials displayed elevated expression of the osteogenic markers alkaline phosphatase (ALP), osteocalcin (OC), and RUNX2. Furthermore, hASCs associated with poly-dopamine-assisted BFP-1-immobilized PLGA (pDA-BFP-1-PLGA) scaffolds promoted in vivo bone formation in nude mice. Our novel materials may hold great promise for future bone tissue engineering applications.
C1 [Li, Wenyue; Zhao, Xianghui; Ge, Yanjun; Chen, Tong; Liu, Yunsong; Zhou, Yongsheng] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
   [Zheng, Yunfei] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
   [Zhou, Yongsheng] Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
RP Liu, YS; Zhou, YS (reprint author), Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.; Zhou, YS (reprint author), Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
EM kqliuyunsong@163.com; kqzhouysh@hsc.pku.edu.cn
FU National Natural Science Foundation of China [2011/81170937,
   2013/81400484]; Ministry of Education of China [NCET-11-0026]
FX This work was supported by the National Natural Science Foundation of
   China (2011/81170937 to YZhou, 2013/81400484 to YG),
   (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Program for New
   Century Excellent Talents in University from Ministry of Education of
   China (NCET-11-0026 to YZhou),
   (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A16/index.html
   ). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8
   Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030
   Balmayor ER, 2015, ADV DRUG DELIVER REV, V94, P13, DOI 10.1016/j.addr.2015.04.022
   BANG G, 1967, ARCH SURG-CHICAGO, V94, P781
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chrastil J, 2013, SPINE, V38, pE1020, DOI 10.1097/BRS.0b013e3182982f8e
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Dick A, 2000, DEVELOPMENT, V127, P343
   Dormer NH, 2013, MAT SCI ENG C-MATER, V33, P4343, DOI 10.1016/j.msec.2013.06.026
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   Gao X, 2015, INT J NANOMED, V10, P7109, DOI 10.2147/IJN.S94045
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Kim HK, 2012, BIOMATERIALS, V33, P7057, DOI 10.1016/j.biomaterials.2012.06.036
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee JS, 2014, MACROMOL BIOSCI, V14, P1181, DOI 10.1002/mabi.201400052
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   Liu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056002
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lv LW, 2015, BIOMATERIALS, V39, P193, DOI 10.1016/j.biomaterials.2014.11.002
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Peroni D, 2008, EXP CELL RES, V314, P603, DOI 10.1016/j.yexcr.2007.10.007
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Ronziere MC, 2010, BIO-MED MATER ENG, V20, P145, DOI 10.3233/BME-2010-0626
   Sena P, 2012, HISTOL HISTOPATHOL, V27, P485, DOI 10.14670/HH-27.485
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687
   Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Yin WN, 2014, J MATER CHEM B, V2, P8434, DOI 10.1039/c4tb01548g
   Zhang H, 2014, BIOMATERIALS, V35, P711, DOI 10.1016/j.biomaterials.2013.10.017
NR 36
TC 5
Z9 5
U1 2
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 1
PY 2016
VL 11
IS 3
AR e0150294
DI 10.1371/journal.pone.0150294
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF5ZW
UT WOS:000371434500126
PM 26930062
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Peric, D
   Bartley, PA
   Davis, L
   Uzer, AU
   Gurer, C
AF Peric, Dunja
   Bartley, Paul A.
   Davis, Lawrence
   Uzer, Ali Ulvi
   Gurer, Cahit
TI Assessment of sand stabilization potential of a plant-derived biomass
SO SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS
LA English
DT Article
DE biomaterial; coproduct; sand; shear strength; stability; unpaved roads
AB Lignin is a coproduct of biofuel and paper industries, which exhibits binding qualities when mixed with water. Lignin is an ideal candidate for a sustainable stabilization of unpaved roads. To this end, an experimental program was devised and carried out to quantify effects of lignin on compaction and early age shear strength behaviors of sand. Samples were prepared by mixing a particular type of coproduct called calcium lignosulfonate (CaL) with sand and water. Based on the extensive analyses of six series of strength tests, it was found that a normalized cohesion increased with an increasing normalized areas ratio. Normalizations were carried out by dividing the cohesion and area ratio by gravimetric CaL content whereby the area ratio was obtained by dividing the portion of the cross-sectional area occupied with lignosulfonate-water (CaL-W) paste by the total cross-sectional area. While the increase in the normalized cohesion eventually leveled out, the cohesion peaked at 6% of CaL. Thus, sand-CaL-water (S-CaL-W) mixes sustained larger shear stresses than dry sand for a range of normal stresses below the limiting normal stress. Consequently, the early age behavior indicates that adding CaL-W to sand is clearly beneficial in the near-surface applications in dry sand.
C1 [Gurer, Cahit] Afyon Kocatepe Univ, Fac Engn, Dept Civil Engn, ANS Campus, TR-03200 Afyon, Turkey.
   [Peric, Dunja] Kansas State Univ, Coll Engn, Dept Civil Engn, Manhattan, KS 66506 USA.
   [Bartley, Paul A.] Union Pacific Railroad, Denver, CO 80221 USA.
   [Davis, Lawrence] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.
   [Uzer, Ali Ulvi] Selcuk Univ, Tech Sci Coll, Dept Construct, TR-42075 Konya, Turkey.
RP Gurer, C (reprint author), Afyon Kocatepe Univ, Fac Engn, Dept Civil Engn, ANS Campus, TR-03200 Afyon, Turkey.
EM cgurer@aku.edu.tr
RI Peric, Dunja/G-6411-2016
OI Peric, Dunja/0000-0002-8385-4487
CR Adams JW, 1988, ENV EFFECTS APPL LIG
   [Anonymous], D2487 ASTM
   [Anonymous], 2006, ANN BOOK ASTM STAND
   Bartley PA, 2009, THESIS KANSAS STATE
   Ceylan H, 2010, J T RES BOARD, V2186, P130
   DCN Digital Media, 2011, DAILY COMMERCIA 1018
   Fox C, 2006, THESIS U IDAHO
   Gopalakrishnan R, 2010, TR582 IHRB IOW STAT
   Kestler M. A., 2009, STABILIZATION SELECT
   Lignotech Borregaard, 2008, NORL POWD PROD DESCR
   Ragauskas A, 2011, BASICS KRAFT PULPING
   Santoni R. L., 2002, TRANSPORT RES REC, V1787, P61
   Stapanian M. A., 1986, INT J ENVIRON STUD, V27, P45
   Surdahl R, 2008, FEDERAL HIGHWAY ADM
   Surdahl R, 2005, FEDERAL HIGHWAY ADM
   Wang HJ, 2005, J ENVIRON SCI-CHINA, V17, P650
   Woll JH, 2008, FHWACFLTD08005
NR 17
TC 3
Z9 3
U1 0
U2 4
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0792-1233
EI 2191-0359
J9 SCI ENG COMPOS MATER
JI Sci. Eng. Compos. Mater.
PD MAR
PY 2016
VL 23
IS 2
BP 227
EP 236
DI 10.1515/secm-2014-0061
PG 10
WC Materials Science, Composites
SC Materials Science
GA DG2EH
UT WOS:000371878600011
DA 2018-10-20
ER

PT J
AU Jozala, AF
   de Lencastre-Novaes, LC
   Lopes, AM
   Santos-Ebinuma, VD
   Mazzola, PG
   Pessoa, A
   Grotto, D
   Gerenutti, M
   Chaud, MV
AF Jozala, Angela Faustino
   de Lencastre-Novaes, Leticia Celia
   Lopes, Andre Moreni
   Santos-Ebinuma, Valeria de Carvalho
   Mazzola, Priscila Gava
   Pessoa-, Adalberto, Jr.
   Grotto, Denise
   Gerenutti, Marli
   Chaud, Marco Vinicius
TI Bacterial nanocellulose production and application: a 10-year overview
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Bacterial nanocellulose; Biopolymers; Biomaterial; Bioprocess;
   Bioproducts; Fermentation process; Gluconacetobacter xylinus
ID DIFFERENT CARBON-SOURCES; GLUCONACETOBACTER-XYLINUS; CELLULOSE
   PRODUCTION; MICROBIAL CELLULOSE; ACETOBACTER-XYLINUM; AGITATED CULTURE;
   WASTE-WATER; COMPOSITES; DELIVERY; NANOPARTICLES
AB Production of bacterial nanocellulose (BNC) is becoming increasingly popular owing to its environmentally friendly properties. Based on this benefit of BNC production, researchers have also begun to examine the capacity for cellulose production through microbial hosts. Indeed, several research groups have developed processes for BNC production, and many studies have been published to date, with the goal of developing methods for large-scale production. During BNC bioproduction, the culture medium represents approximately 30 % of the total cost. Therefore, one important and challenging aspect of the fermentation process is identification of a new cost-effective culture medium that can facilitate the production of high yields within short periods of time, thereby improving BNC production and permitting application of BNC in the biotechnological, medical, pharmaceutical, and food industries. In this review, we addressed different aspects of BNC production, including types of fermentation processes and culture media, with the aim of demonstrating the importance of these parameters.
C1 [Jozala, Angela Faustino; Grotto, Denise; Gerenutti, Marli; Chaud, Marco Vinicius] Univ Sorocaba UNISO, Dept Technol & Environm Proc, Sorocaba, SP, Brazil.
   [de Lencastre-Novaes, Leticia Celia; Mazzola, Priscila Gava] Univ Campinas UNICAMP, Fac Pharmaceut Sci, Campinas, SP, Brazil.
   [Lopes, Andre Moreni; Pessoa-, Adalberto, Jr.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, Brazil.
   [Santos-Ebinuma, Valeria de Carvalho] Univ Estadual Paulista UNESP, Sch Pharmaceut Sci, Dept Bioproc & Biotechnol, Araraquara, SP, Brazil.
RP Jozala, AF (reprint author), Univ Sorocaba UNISO, Dept Technol & Environm Proc, Sorocaba, SP, Brazil.
EM angela.jozala@prof.uniso.br
RI C. Santos-Ebinuma, Valeria/J-3659-2014; Pessoa-Junior,
   Adalberto/B-7963-2012; Jozala, Angela/D-2373-2013; Lopes,
   Andre/E-9058-2013
OI Pessoa-Junior, Adalberto/0000-0002-5268-8690; Jozala,
   Angela/0000-0002-3763-5451; Lopes, Andre/0000-0002-3570-2470;
   Santos-Ebinuma, Valeria/0000-0002-6666-6695
FU Coordination for Higher Level Graduate Improvements (CAPES/Brazil);
   National Council for Scientific and Technological Development
   (CNPq/Brazil); State of Sao Paulo Research Foundation (FAPESP/Brazil)
   [2009/14897-7, 2013/08617-7]
FX The authors received grants from the Coordination for Higher Level
   Graduate Improvements (CAPES/Brazil), National Council for Scientific
   and Technological Development (CNPq/Brazil), and State of Sao Paulo
   Research Foundation (FAPESP/Brazil, process numbers 2009/14897-7 and
   2013/08617-7).
CR Akhlaghi SP, 2013, CELLULOSE, V20, P1747, DOI 10.1007/s10570-013-9954-y
   Almeida IF, 2014, EUR J PHARM BIOPHARM, V86, P332, DOI 10.1016/j.ejpb.2013.08.008
   Ashjaran A, 2013, J TEXT I, V104, P121, DOI 10.1080/00405000.2012.703796
   Backdahl H, 2011, MAT SCI ENG C-MATER, V31, P14, DOI 10.1016/j.msec.2010.07.010
   Basmaji P, 2014, J BIOMATER TISS ENG, V4, P59, DOI 10.1166/jbt.2014.1133
   Basta AH, 2009, J APPL MICROBIOL, V107, P2098, DOI 10.1111/j.1365-2672.2009.04467.x
   Cacicedo ML, 2015, J APPL BIOMED, V13, P239, DOI 10.1016/j.jab.2015.03.004
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Cakar F, 2014, CARBOHYD POLYM, V106, P7, DOI 10.1016/j.carbpol.2014.01.103
   Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107
   Conley K, 2016, CARBOHYD POLYM, V135, P285, DOI 10.1016/j.carbpol.2015.08.029
   Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   de Azeredo HMC, 2013, TRENDS FOOD SCI TECH, V30, P56, DOI 10.1016/j.tifs.2012.11.006
   de Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P227, DOI 10.1166/jbt.2013.1079
   Donini IAN, 2010, ECLET QUIM, V35, P165, DOI [DOI 10.1590/S0100-46702010000400021, 10.1590/50100-46702010000400021]
   Fu LN, 2013, CARBOHYD POLYM, V92, P1432, DOI 10.1016/j.carbpol.2012.10.071
   Gomes FP, 2013, BIOMASS BIOENERG, V55, P205, DOI 10.1016/j.biombioe.2013.02.004
   Hu WL, 2014, CARBOHYD POLYM, V101, P1043, DOI 10.1016/j.carbpol.2013.09.102
   Hu Y, 2010, LETT APPL MICROBIOL, V51, P109, DOI 10.1111/j.1472-765X.2010.02866.x
   Huang C, 2016, CARBOHYD POLYM, V136, P198, DOI 10.1016/j.carbpol.2015.09.043
   Jeon S, 2014, CURR APPL PHYS, V14, P1621, DOI 10.1016/j.cap.2014.07.010
   Jozala AF, 2015, APPL MICROBIOL BIOT, V99, P1181, DOI 10.1007/s00253-014-6232-3
   Jung HI, 2010, APPL BIOCHEM BIOTECH, V162, P486, DOI 10.1007/s12010-009-8759-9
   Keshk S, 2006, ENZYME MICROB TECH, V40, P4, DOI 10.1016/j.enzmictec.2006.07.037
   Keshk S.M., 2014, J BIOPROCESS BIOTECH, V4, P150, DOI DOI 10.4172/2155-9821.1000150
   Kim SS, 2017, SAUDI J BIOL SCI, V24, P314, DOI 10.1016/j.sjbs.2015.09.031
   Kiziltas EE, 2015, CARBOHYD POLYM, V129, P148, DOI 10.1016/j.carbpol.2015.04.039
   Kiziltas EE, 2015, CARBOHYD POLYM, V124, P131, DOI 10.1016/j.carbpol.2015.01.036
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kralisch D, 2010, BIOTECHNOL BIOENG, V105, P740, DOI 10.1002/bit.22579
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   Kuo CH, 2016, FOOD HYDROCOLLOID, V53, P98, DOI 10.1016/j.foodhyd.2014.12.034
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Lee KY, 2014, MACROMOL BIOSCI, V14, P10, DOI 10.1002/mabi.201300298
   Li Z, 2015, CARBOHYD POLYM, V120, P115, DOI 10.1016/j.carbpol.2014.11.061
   Lin DH, 2014, BIORESOURCE TECHNOL, V151, P113, DOI 10.1016/j.biortech.2013.10.052
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Lu ZG, 2011, WORLD J MICROB BIOT, V27, P2281, DOI 10.1007/s11274-011-0692-8
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   Martinez-Sanz M, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.42486
   Mautner A, 2015, REACT FUNCT POLYM, V86, P209, DOI 10.1016/j.reactfunctpolym.2014.09.014
   Mikkelsen D, 2009, J APPL MICROBIOL, V107, P576, DOI 10.1111/j.1365-2672.2009.04226.x
   Mohammadkazemi F, 2015, CARBOHYD POLYM, V117, P518, DOI 10.1016/j.carbpol.2014.10.008
   Muller A, 2013, J PHARM SCI-US, V102, P579, DOI 10.1002/jps.23385
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   Numata Y, 2015, INT J PHARMACEUT, V486, P217, DOI 10.1016/j.ijpharm.2015.03.068
   Numata Y, 2015, MAT SCI ENG C-MATER, V47, P57, DOI 10.1016/j.msec.2014.11.026
   Barud HGO, 2015, CARBOHYD POLYM, V128, P41, DOI 10.1016/j.carbpol.2015.04.007
   Padmanaban S, 2015, 3 BIOTECH, V5, P1067, DOI 10.1007/s13205-015-0308-3
   Rajwade JM, 2015, APPL MICROBIOL BIOT, V99, P2491, DOI 10.1007/s00253-015-6426-3
   Rehim SA, 2014, HAND CLIN, V30, P239, DOI 10.1016/j.hcl.2014.02.001
   Ruka DR, 2012, CARBOHYD POLYM, V89, P613, DOI 10.1016/j.carbpol.2012.03.059
   Santos-Ebinuma VC, 2013, BIOTECHNOL PROGR, V29, P778, DOI 10.1002/btpr.1720
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Shi ZJ, 2014, FOOD HYDROCOLLOID, V35, P539, DOI 10.1016/j.foodhyd.2013.07.012
   Tanskul S, 2013, CARBOHYD POLYM, V92, P421, DOI 10.1016/j.carbpol.2012.09.017
   Thompson DN, 2001, APPL BIOCHEM BIOTECH, V91-3, P503, DOI 10.1385/ABAB:91-93:1-9:503
   Trovatti E, 2011, CARBOHYD POLYM, V86, P1417, DOI 10.1016/j.carbpol.2011.06.046
   Tyagi N, 2016, J CLEAN PROD, V112, P71, DOI 10.1016/j.jclepro.2015.07.054
   Wu JM, 2012, CARBOHYD POLYM, V90, P116, DOI 10.1016/j.carbpol.2012.05.003
   Wu SC, 2015, J BIOSCI BIOENG, V120, P444, DOI 10.1016/j.jbiosc.2015.02.018
   Zhang S, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-62
NR 64
TC 35
Z9 36
U1 17
U2 157
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAR
PY 2016
VL 100
IS 5
BP 2063
EP 2072
DI 10.1007/s00253-015-7243-4
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DF3KT
UT WOS:000371243500003
PM 26743657
DA 2018-10-20
ER

PT J
AU Aminabadi, NA
   Huang, B
   Samiei, M
   Agheli, S
   Jamali, Z
   Shirazi, S
AF Aminabadi, N. A.
   Huang, B.
   Samiei, M.
   Agheli, S.
   Jamali, Z.
   Shirazi, Sajjad
TI A Randomized Trial Using 3Mixtatin Compared to MTA in Primary Molars
   with Inflammatory Root Resorption: A Novel Endodontic Biomaterial
SO JOURNAL OF CLINICAL PEDIATRIC DENTISTRY
LA English
DT Article
DE 3Mix; Primary teeth; Regenerative treatment; Root resorption
ID MINERAL TRIOXIDE AGGREGATE; FURCAL PERFORATION; PERMANENT TEETH;
   DENTAL-PULP; CASE SERIES; IN-VITRO; SIMVASTATIN; REPAIR; RATS;
   DIFFERENTIATION
AB Objectives: Novel methods for preserving prima?), teeth can help to maintain their developmental, esthetic, and functional capabilities. The aim of this study was to assess the success of the repair of bony defects, caused by pre-treatment perforations; with a mixture of three antibiotics combined with simvastatin (3Mixtatin) compared to MTA in hopeless primary molars. Study design: In this randomized clinical trial, 80 teeth from 65 healthy children aged 3-6 years with interradicular or periapical root resorption and/or perforation in primary molars were treated either with 3Mixtatin or MTA before conventional pulpectomy and restoration. The subjects were followed up clinically and radiographically for 4, 6, 12 and 24 months after pulp treatment to evaluate and compare the healing process. The data were compared using chi-square test at a significance level of 0.05. Results: By the end of 24 months in 3Mixtatin group, 31 (96.8%) teeth revealed no clinical signs or symptoms with arrested resorption progress in radiographs. In MTA group, clinical signs and symptoms including pain, mobility and sinus tract were observed in 18 (48.6%) teeth with cessation of root/interradicular radiolucency in 7 (18.9%) teeth without bone repair. Conclusions: Radiographic and clinical healing occurred more successfully following 3Mixtatin treatment compared to treatment with MTA, it may lead to a paradigm shift in the pulpal treatment of primary teeth in the future.
C1 [Aminabadi, N. A.] Tabriz Univ Med Sci, Dept Pediat Dent, Fac Dent, Daneshgah St,Golgasht St, Tabriz, Iran.
   [Huang, B.] Charles Sturt Univ, Dept Pediat Dent, Sch Dent & Hlth Sci, Bathurst, NSW 2795, Australia.
   [Samiei, M.] Tabriz Univ Med Sci, Fac Dent, Dept Endodont, Tabriz, Iran.
   [Agheli, S.] Tabriz Univ Med Sci, Fac Dent, Dept Paediat Dent, Tabriz, Iran.
   [Jamali, Z.] Tabriz Univ Med Sci, Fac Dent, Dept Oral Sci, Tabriz, Iran.
   [Shirazi, Sajjad] Tabriz Univ Med Sci, Dent & Periodontal Res Ctr, Fac Dent, Tabriz, Iran.
RP Aminabadi, NA (reprint author), Tabriz Univ Med Sci, Dept Pediat Dent, Fac Dent, Daneshgah St,Golgasht St, Tabriz, Iran.
EM aslaminabadi@Gmail.com
RI jamali, zahra/F-6325-2017; Asl Aminabadi, Naser/F-6669-2017; Shirazi,
   Sajjad/L-7133-2017; Huang, Boyen/I-7768-2014; aminabadi,
   naser/L-5731-2017
OI jamali, zahra/0000-0002-9214-0574; Asl Aminabadi,
   Naser/0000-0002-6624-4994; Shirazi, Sajjad/0000-0002-3996-6772; Huang,
   Boyen/0000-0002-1246-7447; aminabadi, naser/0000-0002-6624-4994
CR American Academy of Pediatric Dentistry, 2013, PEDIAT DENT, V35, P235
   ANDO N, 1990, INT ENDOD J, V23, P20, DOI 10.1111/j.1365-2591.1990.tb00798.x
   Ayukawa Y, 2004, CLIN ORAL IMPLAN RES, V15, P346, DOI 10.1111/j.1600-0501.2004.01015.x
   Ayukawa Y, 2009, ORAL SURG ORAL MED O, V107, P336, DOI 10.1016/j.tripleo.2008.07.013
   Barriesbi-Nusair KM, 2006, J ENDODONT, V32, P731, DOI 10.1016/j.joen.2005.12.008
   Bodem O, 2004, Int J Paediatr Dent, V14, P376, DOI 10.1111/j.1365-263X.2004.00547.x
   Cordeiro MMR, 2011, INT J PAEDIATR DENT, V21, P361, DOI 10.1111/j.1365-263X.2011.01132.x
   Dandashi Moutaz B., 1993, Pediatric Dentistry, V15, P254
   Dombrecht EJ, 2007, CLIN EXP RHEUMATOL, V25, P534
   FORD TRP, 1995, ORAL SURG ORAL MED O, V79, P756
   HOSHINO E, 1992, INT ENDOD J, V25, P2, DOI 10.1111/j.1365-2591.1992.tb00941.x
   Jepsen S, 1997, J ENDODONT, V23, P378, DOI 10.1016/S0099-2399(97)80187-2
   Jung IY, 2008, J ENDODONT, V34, P876, DOI 10.1016/j.joen.2008.03.023
   Kamada A, 2005, J ORAL TISSUE ENG, V3, P169
   Maciel-Oliveira N, 2011, ORAL SURG ORAL MED O, V112, P170, DOI 10.1016/j.tripleo.2010.08.027
   Maroto M, 2007, AM J DENT, V20, P283
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   NAKASHIMA M, 1989, ENDOD DENT TRAUMATOL, V5, P279
   Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5
   Nakornchai S, 2010, INT J PAEDIATR DENT, V20, P214, DOI 10.1111/j.1365-263X.2010.01044.x
   Ng FK, 2008, EUR ARCH PAEDIATR DE, V9, P58, DOI 10.1007/BF03262612
   Okamoto Y, 2009, J ENDODONT, V35, P367, DOI 10.1016/j.joen.2008.11.024
   Oliveira Thais M, 2008, J Dent Child (Chic), V75, P188
   Oxlund H, 2001, CALCIFIED TISSUE INT, V69, P299, DOI 10.1007/s00223-001-2027-5
   Pace R, 2008, J ENDODONT, V34, P1130, DOI 10.1016/i.joen.2008.05.019
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Roberts HW, 2008, DENT MATER, V24, P149, DOI 10.1016/j.dental.2007.04.007
   Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608
   SATO T, 1992, Microbial Ecology in Health and Disease, V5, P171
   Seto H, 2008, J PERIODONTAL RES, V43, P261, DOI 10.1111/j.1600-0765.2007.01024.x
   Silveira CMM, 2008, J CAN DENT ASSOC, V74, P729
   Takushige T, 2004, INT ENDOD J, V37, P132, DOI 10.1111/j.0143-2885.2004.00771.x
   Takushige T, 2009, J LSTR THER, V8, P3
   Tavassoli-Hojjati S, 2014, PEDIAT DENT, V36, P23
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Unal Gul Celik, 2010, Eur J Dent, V4, P475
   Yokoyama T, 2004, ATHEROSCLEROSIS, V174, P253, DOI 10.1016/j.atherosclerosis.2004.01.039
   Yoshinari M, 2006, BIOMED RES-TOKYO, V27, P29, DOI 10.2220/biomedres.27.29
NR 38
TC 5
Z9 5
U1 1
U2 18
PU JOURNAL PEDODONTICS INC
PI BIRMINGHAM
PA 5724 HIGHWAY 280 EAST, BIRMINGHAM, AL 35242 USA
SN 1053-4628
EI 1557-5268
J9 J CLIN PEDIATR DENT
JI J. Clin. Pediatr. Dent.
PD SPR
PY 2016
VL 40
IS 2
BP 95
EP 102
DI 10.17796/1053-4628-40.2.95
PG 8
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA DF6DJ
UT WOS:000371445800001
PM 26950808
DA 2018-10-20
ER

PT J
AU Tang, QZ
   Desai, TA
AF Tang, Qizhi
   Desai, Tejal A.
TI Approaching a cure for type 1 diabetes
SO NATURE MEDICINE
LA English
DT Editorial Material
ID EMBRYONIC STEM-CELLS; IN-VITRO; BETA-CELLS
AB A study has demonstrated that transplanting human embryonic stem cell derived, insulin-producing cells shielded in capsules made with an optimized biomaterial can achieve long-term cure of diabetes in mice without the need for any immunosuppression.
C1 [Tang, Qizhi] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.
   [Desai, Tejal A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.
RP Tang, QZ (reprint author), Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.
EM Qizhi.Tang@ucsf.edu
CR Andersson Trojer M., 2013, J CHEM, V2013
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259
   Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0
   Khosravi-Maharlooei M, 2015, EUR J ENDOCRINOL, V173, pR165, DOI 10.1530/EJE-15-0094
   Naujok O, 2011, MOL THER, V19, P1759, DOI 10.1038/mt.2011.165
   Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040
   Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033
   Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   Vegas A.J., 2016, NAT BIOTECHNOL, V34, P306
   Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030
NR 12
TC 1
Z9 1
U1 2
U2 14
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD MAR
PY 2016
VL 22
IS 3
BP 236
EP 237
DI 10.1038/nm.4060
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DF6DC
UT WOS:000371445100009
PM 26937617
DA 2018-10-20
ER

PT J
AU Trzeciak, T
   Richter, M
   Suchorska, W
   Augustyniak, E
   Lach, M
   Kaczmarek, M
   Kaczmarczyk, J
AF Trzeciak, Tomasz
   Richter, Magdalena
   Suchorska, Wiktoria
   Augustyniak, Ewelina
   Lach, Michal
   Kaczmarek, Malgorzata
   Kaczmarczyk, Jacek
TI Application of cell and biomaterial-based tissue engineering methods in
   the treatment of cartilage, menisci and ligament injuries
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Review
DE Biodegradation; Biocompatible; Cartilage tissue engineering; Collagen;
   Fibrin; Scaffold; Silk
ID MESENCHYMAL STEM-CELLS; ANTERIOR CRUCIATE LIGAMENT; AUTOLOGOUS
   CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; BONE-MARROW; IN-VIVO;
   OSTEOCHONDRAL DEFECTS; COLLAGEN MENISCUS; GENE-EXPRESSION; CHONDROGENIC
   DIFFERENTIATION
AB Over 20 years ago it was realized that the traditional methods of the treatment of injuries to joint components: cartilage, menisci and ligaments, did not give satisfactory results and so there is a need of employing novel, more effective therapeutic techniques. Recent advances in molecular biology, biotechnology and polymer science have led to both the experimental and clinical application of various cell types, adapting their culture conditions in order to ensure a directed differentiation of the cells into a desired cell type, and employing non-toxic and non-immunogenic biomaterial in the treatment of knee joint injuries. In the present review the current state of knowledge regarding novel cell sources, in vitro conditions of cell culture and major important biomaterials, both natural and synthetic, used in cartilage, meniscus and ligament repair by tissue engineering techniques are described, and the assets and drawbacks of their clinical application are critically evaluated.
C1 [Trzeciak, Tomasz; Richter, Magdalena; Kaczmarek, Malgorzata; Kaczmarczyk, Jacek] Poznan Univ Med Sci, Dept Orthoped & Traumatol, 28 Czerwca 1956,135-147, PL-61545 Poznan, Poland.
   [Suchorska, Wiktoria; Augustyniak, Ewelina; Lach, Michal] Greater Poland Canc Ctr, Radiobiol Lab, Garbary 15, PL-61688 Poznan, Poland.
   [Augustyniak, Ewelina; Lach, Michal] Med Univ Warsaw, Postgrad Sch Mol Med, Zwirki & Wigury 61, PL-02091 Warsaw, Poland.
RP Trzeciak, T (reprint author), Poznan Univ Med Sci, Dept Orthoped & Traumatol, 28 Czerwca 1956,135-147, PL-61545 Poznan, Poland.
EM doktortrzeciak@gmail.com
OI Lach, Michal/0000-0002-3615-3768; Suchorska,
   Wiktoria/0000-0003-4742-2465
FU National Science Centre [2012/07/E/NZ3/01819]
FX This work was supported by the National Science Centre [grant number
   2012/07/E/NZ3/01819].
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Akmal M, 2006, J BONE JOINT SURG BR, V88B, P544, DOI 10.1302/0301-620X.88B4.16498
   Alegre-Aguaron E, 2012, CELLS TISSUES ORGANS, V196, P231, DOI 10.1159/000334400
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Armentano I, 2013, PROG POLYM SCI, V38, P1720, DOI 10.1016/j.progpolymsci.2013.05.010
   Augustyniak E, 2015, INT ORTHOP, V39, P995, DOI 10.1007/s00264-014-2619-0
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febsict.2007.06.018
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324
   Cooper JA, 2006, BIOMATERIALS, V27, P2747, DOI 10.1016/j.biomaterials.2005.12.013
   Cui L, 2009, BIOMATERIALS, V30, P2683, DOI 10.1016/j.biomaterials.2009.01.045
   Deng J, 2013, J MATER SCI-MATER M, V24, P2037, DOI 10.1007/s10856-013-4944-z
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   Doppalapudi S, 2014, POLYM ADVAN TECHNOL, V25, P427, DOI 10.1002/pat.3305
   Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987
   Esposito AR, 2013, BIORESEARCH OPEN ACC, V2, P138, DOI 10.1089/biores.2012.0293
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Foldager CB, 2011, ACTA ORTHOP, V82, P234, DOI 10.3109/17453674.2011.566135
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Ge ZG, 2005, CELL TRANSPLANT, V14, P573, DOI 10.3727/000000005783982819
   Gierloff M, 2014, CLIN ORAL INVEST, V18, P247, DOI 10.1007/s00784-013-0956-9
   Gong GC, 2010, J CELL PHYSIOL, V224, P664, DOI 10.1002/jcp.22166
   Grassi A, 2014, INT ORTHOP, V38, P1945, DOI 10.1007/s00264-014-2408-9
   Grigolo B, 2005, BIOMATERIALS, V26, P5668, DOI 10.1016/j.biomaterials.2005.02.030
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024
   Hoffmann A, 2006, REGEN MED, V1, P563, DOI 10.2217/17460751.1.4.563
   Ikeda R, 2009, INT ORTHOP, V33, P821, DOI 10.1007/s00264-008-0532-0
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kang SW, 2006, J BIOMED MATER RES A, V77A, P659, DOI 10.1002/jbm.a.30579
   King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.tea.2011.0572, 10.1089/ten.TEA.2011.0572]
   Kreuz PC, 2011, AM J SPORT MED, V39, P1697, DOI 10.1177/0363546511403279
   LAURENT TC, 1992, FASEB J, V6, P2397
   Lebourg M, 2013, J BIOMED MATER RES A, V101, P518, DOI 10.1002/jbm.a.34349
   Legnani C, 2010, INT ORTHOP, V34, P465, DOI 10.1007/s00264-010-0963-2
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lien SM, 2009, MAT SCI ENG C-BIO S, V29, P315, DOI 10.1016/j.msec.2008.07.017
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mandal BB, 2011, TISSUE ENG PT A, V17, P2749, DOI [10.1089/ten.tea.2011.0031, 10.1089/ten.TEA.2011.0031]
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Meinel L, 2012, ADV DRUG DELIVER REV, V64, P1111, DOI 10.1016/j.addr.2012.03.016
   Moran CJ, 2014, INT ORTHOP, V38, P1937, DOI 10.1007/s00264-014-2426-7
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Nerurkar NL, 2011, BIOMATERIALS, V32, P461, DOI 10.1016/j.biomaterials.2010.09.015
   Niemeyer P, 2014, INT ORTHOP, V38, P2065, DOI 10.1007/s00264-014-2368-0
   Nishimoto H, 2012, INT ORTHOP, V36, P2379, DOI 10.1007/s00264-012-1660-0
   Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Pecina M, 2014, INT ORTHOP, V38, P1757, DOI 10.1007/s00264-014-2477-9
   Pei M, 2009, DIFFERENTIATION, V78, P260, DOI 10.1016/j.diff.2009.08.001
   Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790
   Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442
   Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281
   Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656
   Rodolfa K, 2007, DIFFERENTIATION, V75, P577, DOI 10.1111/j.1432-0436.2007.00213.x
   Rodrigues CAV, 2011, BIOTECHNOL ADV, V29, P815, DOI 10.1016/j.biotechadv.2011.06.009
   Saha S, 2013, CELL TISSUE RES, V352, P495, DOI 10.1007/s00441-013-1586-x
   Sarem M, 2013, MAT SCI ENG C-MATER, V33, P4777, DOI 10.1016/j.msec.2013.07.036
   Schop D, 2010, J TISSUE ENG REGEN M, V4, P131, DOI 10.1002/term.224
   Scotti C, 2009, KNEE SURG SPORT TR A, V17, P645, DOI 10.1007/s00167-009-0745-9
   Scotti C, 2013, EUR CELLS MATER, V26, P150, DOI 10.22203/eCM.v026a11
   Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015
   Setton LA, 1999, CLIN ORTHOP RELAT R, pS254, DOI 10.1097/00003086-199910001-00025
   Shafiee A, 2011, J BIOMED MATER RES A, V99A, P467, DOI 10.1002/jbm.a.33206
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   SOMMERLATH KG, 1991, INT ORTHOP, V15, P347
   Steck E, 2010, TISSUE ENG PT A, V16, P3697, DOI [10.1089/ten.tea.2009.0817, 10.1089/ten.TEA.2009.0817]
   Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461
   Stolzing A, 2006, FREE RADICAL BIO MED, V41, P326, DOI 10.1016/j.freeradbiomed.2006.04.018
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tarng YW, 2012, INT ORTHOP, V36, P863, DOI 10.1007/s00264-011-1291-x
   Tay LX, 2012, AM J SPORT MED, V40, P83, DOI 10.1177/0363546511420819
   Toh WS, 2011, STEM CELL REV REP, V7, P544, DOI 10.1007/s12015-010-9222-6
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vinardell T, 2012, TISSUE ENG PT A, V18, P1161, DOI [10.1089/ten.tea.2011.0544, 10.1089/ten.TEA.2011.0544]
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wang N, 2014, INT ORTHOP, V38, P1105, DOI 10.1007/s00264-013-2194-9
   Weinand C, 2006, AM J SPORT MED, V34, P1779, DOI 10.1177/0363546506290666
   Wu SC, 2013, J APPL PHYSIOL, V114, P1610, DOI 10.1152/japplphysiol.01132.2012
   Xing Q, 2010, ACTA BIOMATER, V6, P2132, DOI 10.1016/j.actbio.2009.12.036
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoo JJ, 2011, J BIOMED MATER RES A, V99A, P102, DOI 10.1002/jbm.a.33168
   Yuan T, 2014, J BIOMED MATER RES B, V102, P337, DOI 10.1002/jbm.b.33011
   Zaslav K, 2009, AM J SPORT MED, V37, P42, DOI 10.1177/0363546508322897
   Zellner J, 2013, J BIOMED MATER RES B, V101, P1133, DOI 10.1002/jbm.b.32922
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
   Zhao W, 2013, J CHEM TECHNOL BIOT, V88, P327, DOI 10.1002/jctb.3970
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 110
TC 12
Z9 14
U1 3
U2 66
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD MAR
PY 2016
VL 40
IS 3
BP 615
EP 624
DI 10.1007/s00264-015-3099-6
PG 10
WC Orthopedics
SC Orthopedics
GA DF1FM
UT WOS:000371084600027
PM 26762517
OA Other Gold
DA 2018-10-20
ER

PT J
AU Brix, M
   Kaipel, M
   Kellner, R
   Schreiner, M
   Apprich, S
   Boszotta, H
   Windhager, R
   Domayer, S
   Trattnig, S
AF Brix, Martin
   Kaipel, Martin
   Kellner, Richard
   Schreiner, Markus
   Apprich, Sebastian
   Boszotta, Harald
   Windhager, Reinhard
   Domayer, Stephan
   Trattnig, Siegfried
TI Successful osteoconduction but limited cartilage tissue quality
   following osteochondral repair by a cell-free multilayered
   nano-composite scaffold at the knee
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
DE Osteochondral lesions; Knee; Osteochondral repair; Scaffold
ID T2 RELAXATION-TIME; ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; REGENERATION;
   LESIONS; TRANSPLANTATION; BIOMATERIAL; MOCART; MRI
AB Introduction The treatment of larger osteochondral lesions in the knee is still a clinical challenge. One promising strategy to overcome this problem could be surgical repair by using a cell-free multilayered nano-composite scaffold.
   Method In this prospective cohort study eight consecutive patients which suffered from a single osteochondral lesion (>= 1.5 cm(2)) on the femoral condyle were enrolled. The repair potential of the implant was assessed by using MRI based biochemical MR sequences (T2 mapping) as well as semi-quantitative morphological analyses (MOCART score) at 18 months after the surgery. The clinical outcome was determined at six, 12, 18, and 24 month follow ups by using IKDC, Tegner-Lysholm, and Cincinnati knee scores.
   Results Seven out of eight patients showed a complete integration of the scaffold into the border zone and five out of eight patients excellent or good subchondral ossification of the implant at 18 months following implantation. The surface of the repair tissue was found to be intact in all eight patients. T2 mapping data and the zonal T2 index significantly differed in the repair tissue compared to the healthy control cartilage (P < 0.001) which indicates a limited quality of the repair cartilage. The clinical outcome scores consistently improved during the follow up period without reaching statistical significance.
   Conclusions Osteochondral repair by implanting the MaioRegenA (R) scaffold provides a successful osteoconduction and filling of the cartilage defect. However there is evidence for a limited repair cartilage tissue quality at 18 months after the surgery.
C1 [Brix, Martin; Schreiner, Markus; Domayer, Stephan; Trattnig, Siegfried] Med Univ Vienna, Ctr Excellence High Field Magnet Resonance MR, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
   [Kaipel, Martin; Kellner, Richard; Boszotta, Harald] Barmherzige Bruder Hosp, Dept Orthopaed & Trauma Surg, Johannes von Gott Pl 1, A-7000 Eisenstadt, Austria.
   [Apprich, Sebastian; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
RP Kaipel, M (reprint author), Barmherzige Bruder Hosp, Dept Orthopaed & Trauma Surg, Johannes von Gott Pl 1, A-7000 Eisenstadt, Austria.
EM martin.kaipel@ortho-sued.at
CR Baum T, 2013, OSTEOARTHR CARTILAGE, V21, P1474, DOI 10.1016/j.joca.2013.07.012
   Bentley G, 2013, INJURY, V44, pS3, DOI 10.1016/S0020-1383(13)70003-2
   Berruto M, 2014, AM J SPORT MED, V42, P1607, DOI 10.1177/0363546514530292
   Chahal J, 2013, ARTHROSCOPY, V29, P575, DOI 10.1016/j.arthro.2012.12.002
   Christensen BB, 2015, KNEE SURG SPORTS TRA, V18
   Filardo G, 2014, KNEE SURG SPORT TR A, V22, P1337, DOI 10.1007/s00167-013-2813-4
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Glaser C, 2005, RADIOL CLIN N AM, V43, P641, DOI 10.1016/j.rcl.2005.02.007
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lusse S, 2000, MAGN RESON IMAGING, V18, P423, DOI 10.1016/S0730-725X(99)00144-7
   Marcacci M, 2013, INJURY, V44, pS11, DOI 10.1016/S0020-1383(13)70004-4
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   McCormick F, 2014, ARTHROSCOPY, V30, P222, DOI 10.1016/j.arthro.2013.11.001
   McCoy B, 2012, J KNEE SURG, V25, P99, DOI 10.1055/s-0032-1322508
   Oussedik S, 2015, ARTHROSCOPY, V31, P732, DOI 10.1016/j.arthro.2014.11.023
   Recht MP, 2005, AM J ROENTGENOL, V185, P899, DOI 10.2214/AJR.05.0099
   Trattnig S, 2007, EUR RADIOL, V17, P103, DOI 10.1007/s00330-006-0333-z
   Trattnig S, 2015, OSTEOARTHR CARTILAGE, V23, P2224, DOI 10.1016/j.joca.2015.07.007
   Welsch GH, 2008, RADIOLOGY, V247, P154, DOI 10.1148/radiol.2471070688
NR 25
TC 10
Z9 10
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD MAR
PY 2016
VL 40
IS 3
BP 625
EP 632
DI 10.1007/s00264-016-3118-2
PG 8
WC Orthopedics
SC Orthopedics
GA DF1FM
UT WOS:000371084600028
PM 26803322
DA 2018-10-20
ER

PT J
AU Rath, A
   Mathesan, S
   Ghosh, P
AF Rath, Amrita
   Mathesan, Santhosh
   Ghosh, Pijush
TI Nanomechanical characterization and molecular mechanism study of
   nanoparticle reinforced and cross-linked chitosan biopolymer
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterials; Chitosan; Nanomechanical; Nanoindentation; NanoDMA;
   Nanoscratch
ID VISCOELASTIC PROPERTIES; NANOCOMPOSITE FILMS; ELASTIC-MODULUS;
   NANOINDENTATION; INDENTATION; SCAFFOLDS; DYNAMICS; BEHAVIOR; HARDNESS
AB Chitosan (CS) is a biomaterial that offers many sophisticated and innovative applications in the biomedical field owing to its excellent characteristics of biodegradability, biocompatibility and non-toxicity. However, very low mechanical properties of chitosan polymer impose restriction on its further development. Cross-linking and nanoparticle reinforcement are the two possible methods to improve the mechanical properties of chitosan films. In this research, these two methods are adopted individually by using tripolyphosphate as cross linker and nano-hydroxyapatite as particle reinforcement. The nanomechanical characterizations under static loading conditions are performed on these modified chitosan films. It is observed that nanoparticle reinforcement provided necessary mechanical properties such as ductility and modulus. The mechanisms involved in improvement of mechanical properties due to particle reinforcement are studied by molecular dynamics (MD). Further, improvement in mechanical properties due to combination of particle reinforcement and cross linking agent with chitosan is investigated. The stress relaxation behavior for all these types of films is characterized under dynamic loading conditions using dynamic mechanical analysis (nanoDMA) experiment. A viscoelastic solid like response is observed for all types of film with modulus relaxing by 3-6% of its initial value. A suitable generalized Maxwell model is fitted with the obtained viscoelastic response of these films. The response to nano-scratch behavior is also studied for particle reinforced composite films. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Rath, Amrita; Mathesan, Santhosh; Ghosh, Pijush] Indian Inst Technol, Dept Appl Mech, Madras 600036, Tamil Nadu, India.
RP Ghosh, P (reprint author), Indian Inst Technol, Dept Appl Mech, Madras 600036, Tamil Nadu, India.
EM pijush@iitm.ac.in
OI MATHESAN, SANTHOSH/0000-0001-6726-4033; ghosh,
   pijush/0000-0002-6077-6498
CR Albanna MZ, 2013, J MECH BEHAV BIOMED, V20, P217, DOI 10.1016/j.jmbbm.2012.09.012
   Aryaei A, 2012, J MECH BEHAV BIOMED, V5, P82, DOI 10.1016/j.jmbbm.2011.08.006
   Bassik N, 2010, J AM CHEM SOC, V132, P16314, DOI 10.1021/ja106218s
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Cunha R.A., 2012, COMPLEX WORLD POLYSA, P232
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Diez-Pascual AM, 2015, PROG MATER SCI, V67, P1, DOI 10.1016/j.pmatsci.2014.06.002
   Feng XM, 2014, COMPOS SCI TECHNOL, V93, P76, DOI 10.1016/j.compscitech.2013.11.016
   Fernandes R, 2009, MATER TODAY, V12, P14, DOI 10.1016/S1369-7021(09)70272-X
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jayasuriya A.G., 2009, BIOMED MATER, V4, P1
   Khanna R., 2007, ACTA BIOMATER, V7, P1173
   Kikuchi N, 2000, SURF COAT TECH, V126, P131, DOI 10.1016/S0257-8972(99)00670-2
   Lalov IG, 2000, WATER RES, V34, P1503, DOI 10.1016/S0043-1354(99)00291-2
   Lei C., 2002, COMPOS SCI TECHNOL, V62, P1327
   Magdalena G.D., 2011, PCACD, V16, P15
   Martinez-Camacho AP, 2010, CARBOHYD POLYM, V82, P305, DOI 10.1016/j.carbpol.2010.04.069
   Mathesan S., 2015, MAT SCI ENG C, V2015
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Odegard GM, 2005, EXP MECH, V45, P130, DOI 10.1177/0014485105052320
   Okuyama K, 2000, CARBOHYD POLYM, V41, P237, DOI 10.1016/S0144-8617(99)00142-3
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Randall CL, 2012, TRENDS BIOTECHNOL, V30, P138, DOI 10.1016/j.tibtech.2011.06.013
   Ratakonda S, 2012, ACTA BIOMATER, V8, P1566, DOI 10.1016/j.actbio.2011.12.013
   Rodrigues Susana, 2012, J Funct Biomater, V3, P615, DOI 10.3390/jfb3030615
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Silva J.A.L.D.A., 2006, J POLYM SCI B, V45, P1907
   Subramani S, 2007, COMPOS SCI TECHNOL, V67, P1561, DOI 10.1016/j.compscitech.2006.07.011
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Taylor P., 2011, CRIT REV FOOD SCI NU, V51, P872
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wu TF, 2014, J MECH BEHAV BIOMED, V32, P279, DOI 10.1016/j.jmbbm.2014.01.014
   Yahyaei H, 2013, TRIBOL INT, V57, P147, DOI 10.1016/j.triboint.2012.08.004
   Yao CK, 2012, APPL SURF SCI, V262, P218, DOI 10.1016/j.apsusc.2012.05.128
   Young R.J., 2011, INTRO POLYM, P255
NR 37
TC 6
Z9 6
U1 4
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2016
VL 55
BP 42
EP 52
DI 10.1016/j.jmbbm.2015.10.005
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DE8LD
UT WOS:000370886600005
PM 26540519
DA 2018-10-20
ER

PT J
AU de Viteri, VS
   Barandika, G
   Bayon, R
   Fernandez, X
   Ciarsolo, I
   Igartua, A
   Tanoira, RP
   Moreno, JE
   Conchita, JP
AF Saenz de Viteri, Virginia
   Barandika, Gotzone
   Bayon, Raquel
   Fernandez, Xana
   Ciarsolo, Inigo
   Igartua, Amaya
   Perez Tanoira, Ramon
   Esteban Moreno, Jaime
   Perez-Jorge Peremarch, Conchita
TI Development of Ti-C-N coatings with improved tribological behavior and
   antibacterial properties
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Ti-C-N; Tribocorrosion; Fretting; Silver; Bacterial adhesion
ID CARBON-FILMS; STAPHYLOCOCCUS-AUREUS; BIOMATERIAL SURFACES; BIOFILM
   DEVELOPMENT; BACTERIAL ADHESION; ION-IMPLANTATION; WOUND-INFECTION; DLC
   COATINGS; TRIBOCORROSION; TITANIUM
AB In artificial metallic joint implants, the failure is provoked by two effects in most of the cases: mass loss and wear debris removed due to tribological-corrosive effects on the implant alloy, and infections due to the presence of bacteria. In this work, several Ti-C-N corrosion and wear protective coatings were developed by Physical Vapour Deposition technology, and deposited on Ti6Al4V alloy. In order to provide the implant antibacterial properties, an additional silver top coating has been deposited. Tribological behavior was characterized through tribocorrosion and fretting tests. On the other hand, wettability tests were performed to study the grade of hydrophilicity/hydrophobia. Additionally, antibacterial properties were evaluated by means of bacterial adhesion tests. As a result of these characterization studies, the coating with the best performance was selected. The as coated material includes excellent protection against tribocorrosion and fretting effects (in relation to the uncoated one) and the silver layer has been confirmed to exhibit antibacterial properties. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Saenz de Viteri, Virginia; Bayon, Raquel; Fernandez, Xana; Ciarsolo, Inigo; Igartua, Amaya] IK4 Tekniker, Pk Teknol,C Inaki Goenaga 5, Eibar 20600, Gipuzkoa, Spain.
   [Barandika, Gotzone] Univ Basque Country, Dept Quim Inorgan, UPV EHU, Fac Ciencia & Tecnol, Apdo 644, Bilbao 48080, Spain.
   [Perez Tanoira, Ramon; Esteban Moreno, Jaime; Perez-Jorge Peremarch, Conchita] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Ave Reyes Catolicos 2, Madrid 28040, Spain.
RP de Viteri, VS (reprint author), IK4 Tekniker, Pk Teknol,C Inaki Goenaga 5, Eibar 20600, Gipuzkoa, Spain.
EM virginia.saenzdeviteri@tekniker.es
RI Barandika, Gotzone/N-2157-2014; Perez Tanoira, Ramon/K-4898-2014
OI Barandika, Gotzone/0000-0002-6771-6586; Perez Tanoira,
   Ramon/0000-0002-9816-3208
FU Spanish Government [CSD2008-00023]; Basque Country Government
FX The authors acknowledge FUNCOAT CONSOLIDER Project, financed by the
   Spanish Government, under contract CSD2008-00023 and to the Basque
   Country Government for the financing of EMAITEK project.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arslan E, 2012, PROG ORG COAT, V74, P768, DOI 10.1016/j.porgcoat.2011.10.023
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Baba K, 2013, VACUUM, V89, P179, DOI 10.1016/j.vacuum.2012.04.015
   Bayon R., 2011, THESIS U BASQUE COUN
   Bendavid A, 2007, DIAM RELAT MATER, V16, P1616, DOI 10.1016/j.diamond.2007.02.006
   Bhushan B, 1991, HDB TRIBOLOGY MAT CO
   Billi F, 2010, J BIOMECH, V43, P1310, DOI 10.1016/j.jbiomech.2010.01.015
   Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2
   Brodner W, 1997, J BONE JOINT SURG BR, V79B, P316, DOI 10.1302/0301-620X.79B2.7326
   Celis J.-P., 2012, TESTING TRIBOCORROSI
   Cheng Y, 2006, SURF COAT TECH, V200, P4543, DOI 10.1016/j.surfcoat.2005.03.039
   Cordero J, 1996, INJURY, V27, P34
   Cordero-Ampuero J, 2007, ACTA ORTHOP, V78, P511, DOI 10.1080/17453670710014167
   Currier JH, 2005, J BIOMECH, V38, P367, DOI 10.1016/j.jbiomech.2004.02.016
   Diomidis N, 2010, WEAR, V269, P93, DOI 10.1016/j.wear.2010.03.010
   Edwards C, 2008, J BONE JOINT SURG BR, V90B, P770, DOI 10.1302/0301-620X.90B6.20194
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Esteban J., 2014, MICROBIOLOGY SURG IN, P41
   Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07
   Esteban J, 2010, ACTA ORTHOP, V81, P674, DOI 10.3109/17453674.2010.537810
   GAMER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI DOI 10.1016/0196-6553(88)90053-3
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guggenbichler J. P., 2011, GMS KRANKENHHYG INTE, V6, P18, DOI DOI 10.3205/DGKH000175
   Hallab N, 2000, BIOMATERIALS, V21, P1301, DOI 10.1016/S0142-9612(99)00235-5
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Hodgson AWE, 2002, ELECTROCHIM ACTA, V47, P1913, DOI 10.1016/S0013-4686(02)00029-4
   Iwabuchi A, 2007, WEAR, V263, P492, DOI 10.1016/j.wear.2007.01.102
   Kaestner P, 2001, SURF COAT TECH, V142, P928, DOI 10.1016/S0257-8972(01)01214-2
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Landolt D, 2004, WEAR, V256, P517, DOI 10.1016/S0043-1648(03)00561-1
   Liu C., 2011, SURF COAT TECH, V414, P164
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Marciano FR, 2011, VACUUM, V85, P662, DOI 10.1016/j.vacuum.2010.07.017
   MARTINU L, 1992, THIN SOLID FILMS, V208, P42, DOI 10.1016/0040-6090(92)90945-8
   Medina O, 2012, DIAM RELAT MATER, V22, P77, DOI 10.1016/j.diamond.2011.12.022
   Mischler S, 2008, TRIBOL INT, V41, P573, DOI 10.1016/j.triboint.2007.11.003
   Mischler S, 2001, WEAR, V248, P211, DOI 10.1016/S0043-1648(00)00559-7
   Perez-Jorge C, 2012, J BIOMED MATER RES A, V100A, P1696, DOI 10.1002/jbm.a.34118
   Perez-Tanoira R, 2012, J BIOMED MATER RES A, V100A, P1521, DOI 10.1002/jbm.a.34090
   Perez-Tanoira R, 2014, SURG INFECT, V15, P90, DOI 10.1089/sur.2013.032
   Ponthiaux P, 2013, WOODH PUBL SER BIOM, V60, P372, DOI 10.1533/9780857098603.3.372
   RAVEH A, 1992, SURF COAT TECH, V53, P275, DOI 10.1016/0257-8972(92)90386-O
   Rochford ETJ, 2012, CLIN MICROBIOL INFEC, V18, P1162, DOI 10.1111/j.1469-0691.2012.04002.x
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   de Viteri VS, 2012, J INORG BIOCHEM, V117, P359, DOI 10.1016/j.jinorgbio.2012.09.012
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   Secinti KD, 2011, J CLIN NEUROSCI, V18, P391, DOI 10.1016/j.jocn.2010.06.022
   Sharkey P.F., 2001, CLIN ORTHOP RELAT R, V404, P7
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   Singhai M, 2012, J GLOB INFECT DIS, V4, P193, DOI 10.4103/0974-777X.103896
   Sinnett-Jones PE, 2005, WEAR, V259, P898, DOI 10.1016/j.wear.2005.02.045
   Snyders R, 2007, PLASMA PROCESS POLYM, V4, pS640, DOI 10.1002/ppap.200731601
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031
   Vitu T, 2014, SURF COAT TECH, V258, P734, DOI 10.1016/j.surfcoat.2014.08.003
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang PF, 2013, SURF COAT TECH, V221, P163, DOI 10.1016/j.surfcoat.2013.01.045
   Yildiz F, 2008, SURF COAT TECH, V202, P2471, DOI 10.1016/j.surfcoat.2007.08.004
   Zhecheva A, 2005, SURF COAT TECH, V200, P2192, DOI 10.1016/j.surfcoat.2004.07.115
   Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047
NR 63
TC 11
Z9 11
U1 3
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2016
VL 55
BP 75
EP 86
DI 10.1016/j.jmbbm.2015.10.020
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DE8LD
UT WOS:000370886600008
DA 2018-10-20
ER

PT J
AU Minuth, WW
   Denk, L
AF Minuth, Will W.
   Denk, Lucia
TI Bridging the gap between traditional cell cultures and bioreactors
   applied in regenerative medicine: practical experiences with the
   MINUSHEET perfusion culture system
SO CYTOTECHNOLOGY
LA English
DT Review
DE Cell culture; Perfusion culture; 3D culture; Tissue carrier; Bioreactor;
   Tissue engineering; Biomaterial testing; Biomedicine
ID DENTIN BARRIER TEST; IN-VITRO MODEL; TEXTILE CHITOSAN SCAFFOLDS; MARROW
   STROMAL CELLS; LONG-TERM CULTURE; ELECTROSPUN POLYMER SCAFFOLDS;
   DEPENDENT NEURONAL PLASTICITY; TISSUE-ENGINEERED CARTILAGE;
   RETINAL-PIGMENT EPITHELIUM; COLLECTING DUCT EPITHELIA
AB To meet specific requirements of developing tissues urgently needed in tissue engineering, biomaterial research and drug toxicity testing, a versatile perfusion culture system was developed. First an individual biomaterial is selected and then mounted in a MINUSHEETA (R) tissue carrier. After sterilization the assembly is transferred by fine forceps to a 24 well culture plate for seeding cells or mounting tissue on it. To support spatial (3D) development a carrier can be placed in various types of perfusion culture containers. In the basic version a constant flow of culture medium provides contained tissue with always fresh nutrition and respiratory gas. For example, epithelia can be transferred to a gradient container, where they are exposed to different fluids at the luminal and basal side. To observe development of tissue under the microscope, in a different type of container a transparent lid and base are integrated. Finally, stem/progenitor cells are incubated in a container filled by an artificial interstitium to support spatial development. In the past years the described system was applied in numerous own and external investigations. To present an actual overview of resulting experimental data, the present paper was written.
C1 [Minuth, Will W.; Denk, Lucia] Univ Regensburg, Mol & Cellular Anat, Univ St 31, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Mol & Cellular Anat, Univ St 31, D-93053 Regensburg, Germany.
EM will.minuth@vkl.uni-regensburg.de
FU Institute of Molecular and Cellular Anatomy, University of Regensburg
FX The authors thank the Institute of Molecular and Cellular Anatomy,
   University of Regensburg for financial support and technical assistance
   to write this article.
CR Aberle T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086740
   AIGNER J, 1994, EPITHELIAL CELL BIOL, V3, P70
   Aigner J, 1995, EPITHELIAL CELL BIOL, V4, P121
   Anders JO, 2009, J BONE JOINT SURG BR, V91B, P409, DOI 10.1302/0301-620X.91B3.20869
   Astasov-Frauenhoffer M, 2012, FEMS MICROBIOL LETT, V337, P31, DOI 10.1111/1574-6968.12007
   Bakowsky U, 2005, ADHESION CURRENT RES, P157
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Bernhardt A, 2011, J TISSUE ENG REGEN M, V5, P444, DOI 10.1002/term.331
   Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035
   Blattmann A, 2008, BIOMATERIALS, V29, P2749, DOI 10.1016/j.biomaterials.2008.03.019
   Blochl A, 1996, J BIOL CHEM, V271, P21100
   Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3
   Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446
   BUJIA J, 1994, LARYNGO RHINO OTOL, V73, P577, DOI 10.1055/s-2007-997199
   BUJIA J, 1995, ACTA OTO-LARYNGOL, V115, P307, DOI 10.3109/00016489509139316
   Campos Doris M, 2013, Biomatter, V3, DOI 10.4161/biom.24922
   Camps J, 2002, CONNECT TISSUE RES, V43, P396, DOI 10.1080/03008200290001069
   Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279
   Capitan Guarnizo A, 2002, ACTA OTORRINOLARINGO, V53, P631
   Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17
   da Silva HM, 2010, COLLOID SURFACE B, V75, P349, DOI 10.1016/j.colsurfb.2009.09.009
   da Silva JMF, 2014, CLIN ORAL INVEST, V18, P607, DOI 10.1007/s00784-013-1000-9
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146
   Demirci M, 2008, DENT MATER, V24, P362, DOI 10.1016/j.dental.2007.06.009
   Detsch R, 2008, J MATER SCI-MATER M, V19, P1491, DOI 10.1007/s10856-007-3297-x
   Dimova S, 2005, INT J PHARMACEUT, V292, P157, DOI 10.1016/j.ijpharm.2004.11.030
   Dithmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089150
   Dreesmann L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034119
   Du Y, 2008, BIOMATERIALS, V29, P290, DOI 10.1016/j.biomaterials.2007.09.016
   Duda GN, 2004, J BIOMED MATER RES B, V68B, P21, DOI 10.1002/jbm.b.10075
   Duda GN, 2000, J BIOMED MATER RES, V53, P673, DOI 10.1002/1097-4636(2000)53:6<673::AID-JBM9>3.0.CO;2-V
   Farack J, 2011, MATER SCI ENG B-ADV, V176, P1767, DOI 10.1016/j.mseb.2011.06.004
   Fiegel HC, 2004, TISSUE ENG, V10, P165, DOI 10.1089/107632704322791817
   Framme C, 2002, OPHTHALMOLOGICA, V216, P320, DOI 10.1159/000066184
   Frerich B, 2008, INT J ORAL MAX SURG, V37, P459, DOI 10.1016/j.ijom.2008.01.014
   Frerich Bernhard, 2006, Head Face Med, V2, P26, DOI 10.1186/1746-160X-2-26
   Fuss M, 2000, ANN ANAT, V182, P303
   Galler K, 2005, J ENDODONT, V31, P396, DOI 10.1097/01.don.0000145428.26880.e5
   Gelinsky M, 2004, MATERIALWISS WERKST, V35, P229, DOI 10.1002/mawe.200400732
   Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004
   Glashauser A, 2011, J TISSUE SCI ENG, V2, P105
   Glaum R, 2010, J BIOMED MATER RES A, V93A, P704, DOI 10.1002/jbm.a.32575
   Glaum Ricarda, 2013, Methods Mol Biol, V946, P423, DOI 10.1007/978-1-62703-128-8_27
   Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K
   Gueven N, 1996, EUR RESPIR J, V9, P968, DOI 10.1183/09031936.96.09050968
   Hagedorn GM, 2009, J PHYSIOL PHARMACOL, V60, P25
   Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1
   Hamilton RD, 2007, J ANAT, V211, P707, DOI 10.1111/j.1469-7580.2007.00812.x
   Hamilton RD, 2011, METHODS MOL BIOL, V686, P401, DOI 10.1007/978-1-60761-938-3_20
   Hammer M, 2008, GRAEF ARCH CLIN EXP, V246, P979, DOI 10.1007/s00417-008-0789-4
   Hayashi M, 2009, MOL CELL BIOCHEM, V322, P1, DOI 10.1007/s11010-008-9934-y
   Heber S, 2007, TISSUE ENG, V13, P281, DOI 10.1089/ten.2006.0199
   Heinemann C, 2010, EUR CELLS MATER, V19, P96, DOI 10.22203/eCM.v019a10
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Heinemann C, 2009, BIOMACROMOLECULES, V10, P1305, DOI 10.1021/bm900172m
   HERTER P, 1993, J MICROSC-OXFORD, V171, P107, DOI 10.1111/j.1365-2818.1993.tb03364.x
   Hoener MC, 2000, EUR J NEUROSCI, V12, P3096, DOI 10.1046/j.1460-9568.2000.00190.x
   Hu Kanghong, 2007, Biotechnology Journal, V2, P992, DOI 10.1002/biot.200700009
   Jian GE, 2007, FRONT MED-PRC, V1, P6
   Kalamarz-Kubiak H, 2011, J NEUROSCI METH, V199, P56, DOI 10.1016/j.jneumeth.2011.04.035
   Kim HS, 2013, INT J ORAL SCI, V5, P26, DOI 10.1038/ijos.2013.11
   Kim MJ, 2013, CLIN ORAL INVEST, V17, P1489, DOI 10.1007/s00784-012-0840-z
   Klettner A, 2014, GRAEF ARCH CLIN EXP, V252, P1593, DOI 10.1007/s00417-014-2719-y
   Klettner A, 2013, MOL VIS, V19, P281
   Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x
   Klettner AK, 2012, GRAEF ARCH CLIN EXP, V250, P33, DOI 10.1007/s00417-011-1776-8
   Klettner AK, 2009, GRAEF ARCH CLIN EXP, V247, P1601, DOI 10.1007/s00417-009-1136-0
   Kloth S, 1998, IN VITRO CELL DEV-AN, V34, P515
   KLOTH S, 1994, EUR J CELL BIOL, V63, P84
   Kloth S, 2000, TOXICOL IN VITRO, V14, P265, DOI 10.1016/S0887-2333(00)00010-2
   KLOTH S, 1995, FASEB J, V9, P963
   Kloth S, 1998, KIDNEY INT, V53, P970, DOI 10.1111/j.1523-1755.1998.00854.x
   Kloth S, 2000, MICROVASC RES, V59, P190, DOI 10.1006/mvre.1999.2214
   Kloth S, 1999, BIOFORUM INT, V3, P70
   Kobuch K, 2008, EXP EYE RES, V86, P661, DOI 10.1016/j.exer.2008.01.011
   Korsuwannawong Suwanna, 2012, Eur J Dent, V6, P408
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   Kremer M, 2001, LANGENBECK ARCH SURG, V386, P357, DOI 10.1007/s004230100227
   Lauer G, 2009, FUNDAMENTALS TISSUE, V27.6, P375
   Lehmann P, 1997, Mund Kiefer Gesichtschir, V1, P26
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Leukers B, 2005, MATERIALWISS WERKST, V36, P781, DOI 10.1002/mawe.200500968
   Maier KL, 2008, INHAL TOXICOL, V20, P319, DOI [10.1080/08958370701866313, 10.1080/08958370701866313 ]
   da Silva HM, 2010, COLLOID SURFACE B, V80, P138, DOI 10.1016/j.colsurfb.2010.05.040
   Masungi C, 2004, J PHARM SCI-US, V93, P2507, DOI 10.1002/jps.20149
   Masungi C, 2009, PHARMAZIE, V64, P36, DOI 10.1691/ph.2008.8592
   Mateescu Mihaela, 2012, Biomatter, V2, P103, DOI 10.4161/biom.21377
   Miess C, 2010, ANN BIOMED ENG, V38, P2197, DOI 10.1007/s10439-010-0006-6
   Minuth W.W., 2010, J TISSUE SCI ENG, V1, P101
   Minuth W.W., 2013, TRANSPLANT TECHNOL, V1, P2
   Minuth W.W., 2013, INT J STEM CELL RES, V1, P202
   Minuth WW, 2007, CENT EUR J BIOL, V2, P307, DOI 10.2478/s11535-007-0030-1
   Minuth WW, 2007, BIOMATERIALS, V28, P4418, DOI 10.1016/j.biomaterials.2007.06.031
   Minuth WW, 2014, INT J MOL SCI, V15, P23240, DOI 10.3390/ijms151223240
   Minuth WW, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-34
   Minuth WW, 2012, J BIOMED MATER RES A, V100A, P1115, DOI 10.1002/jbm.a.34039
   Minuth WW, 2010, MATERIALS, V3, P2369, DOI 10.3390/ma3042369
   Minuth WW, 2010, ADV DRUG DELIVER REV, V62, P841, DOI 10.1016/j.addr.2010.01.004
   Minuth WW, 2009, LANGMUIR, V25, P4621, DOI 10.1021/la803858q
   MINUTH WW, 1990, CYTOTECHNOLOGY, V4, P181, DOI 10.1007/BF00365099
   MINUTH WW, 1992, KIDNEY INT, V41, P215, DOI 10.1038/ki.1992.30
   Minuth WW, 2005, BIO-MED MATER ENG, V15, P51
   Minuth WW, 2005, BIOMATERIALS, V26, P6588, DOI 10.1016/j.biomaterials.2005.04.029
   Minuth WW, 2003, MED KLIN, V98, P31
   Minuth WW, 2004, CELL PHYSIOL BIOCHEM, V14, P387, DOI 10.1159/000080348
   Minuth WW, 2004, TISSUE ENG, V10, P285, DOI 10.1089/107632704322791925
   MINUTH WW, 1993, KIDNEY INT, V44, P537, DOI 10.1038/ki.1993.278
   MINUTH WW, 1992, EUR J CELL BIOL, V57, P132
   Minuth WW, 2001, J BIOMAT SCI-POLYM E, V12, P353, DOI 10.1163/156856201750180861
   Minuth WW, 1997, EXP NEPHROL, V5, P414
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   Minuth WW, 2008, J EPITHEL BIOL PHARM, V1, P24
   Minuth WW, 2010, STEM CELL ENG PRINCI, P321
   Minuth WW, 2009, J EPITHELIAL BIOL PH, V2, P1
   Minuth WW, 2008, TRANSPLANTATIONSMEDI, V20, P47
   Minuth WW, 1990, Patent No. [DE-PS 3923279, 3923279]
   Miura Y, 2013, INVEST OPHTH VIS SCI, V54, P3366, DOI 10.1167/iovs.13-11808
   Miura Y, 2010, OPHTHAL RES, V43, P122, DOI 10.1159/000252979
   Mollet BB, 2014, J MATER CHEM B, V2, P2483, DOI 10.1039/c3tb21516d
   Nandkumar MA, 2015, CELL BIOL INT, V39, P272, DOI 10.1002/cbin.10389
   Prem Caroline, 2000, Methods in Cell Science, V22, P125, DOI 10.1023/A:1009826424171
   Quadbeck P, 2010, PM2010 WORLD C PM BI, V4, P747
   Ramsauer M, 1998, J CEREBR BLOOD F MET, V18, P1270, DOI 10.1097/00004647-199811000-00014
   Rath SN, 2012, J CELL MOL MED, V16, P2350, DOI 10.1111/j.1582-4934.2012.01545.x
   Reischl J, 1999, CELL TISSUE RES, V296, P371, DOI 10.1007/s004410051297
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041
   Ropke E, 2007, LARYNGO RHINO OTOL, V86, P37
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Rotter N, 1999, J MATER SCI-MATER M, V10, P689, DOI 10.1023/A:1008912514271
   Ruder C, 2012, CLIN HEMORHEOL MICRO, V50, P101, DOI 10.3233/CH-2011-1447
   Saikia P, 2006, INVEST OPHTH VIS SCI, V47, P4998, DOI 10.1167/05-1665
   Schiessl IM, 2013, AM J PHYSIOL-RENAL, V305, pF1139, DOI 10.1152/ajprenal.00259.2013
   Schmalz G, 1996, J ENDODONT, V22, P249, DOI 10.1016/S0099-2399(06)80142-1
   Schmalz G, 1999, J ENDODONT, V25, P24, DOI 10.1016/S0099-2399(99)80394-X
   Schmalz G, 2002, J ENDODONT, V28, P188, DOI 10.1097/00004770-200203000-00011
   Schmalz G, 2001, J ENDODONT, V27, P96, DOI 10.1097/00004770-200102000-00009
   Schneider T, 2012, CLIN HEMORHEOL MICRO, V52, P325, DOI 10.3233/CH-2012-1608
   Schneider T, 2011, MACROMOL SYMP, V309-310, P28, DOI 10.1002/masy.201100057
   Schultz O, 1997, ARTHRITIS RHEUM, V40, P1420, DOI 10.1002/art.1780400809
   Schumacher K, 2002, CELL PHYSIOL BIOCHEM, V12, P63, DOI 10.1159/000063782
   Schumacher K, 2002, BIOMATERIALS, V23, P805, DOI 10.1016/S0142-9612(01)00186-7
   Schumacher K, 1999, IN VITRO CELL DEV-AN, V35, P465
   Schumacher K, 2007, TISSUE ENG, V13, P197, DOI 10.1089/ten.2006.0046
   Seitz S, 2007, TISSUE ENG, V13, P1059, DOI 10.1089/ten.2006.0334
   Sengun A, 2011, ORAL SURG ORAL MED O, V112, pE83, DOI 10.1016/j.tripleo.2011.02.023
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Spiegel D, 2002, GRAEF ARCH CLIN EXP, V240, P111, DOI 10.1007/s00417-001-0407-1
   Steiner P, 1997, DIFFERENTIATION, V62, P193
   Steinhagen J, 2010, TISSUE CELL, V42, P151, DOI 10.1016/j.tice.2010.03.003
   Sternberg K, 2004, UROLOGE A, V43, P1200, DOI 10.1007/s00120-004-0688-1
   Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925
   Steuer H, 2004, BRAIN RES PROTOC, V13, P26, DOI 10.1016/j.brainresprot.2003.12.002
   Strehl R, 2004, TISSUE ENG, V10, P1196, DOI 10.1089/1076327041887853
   Tiemann U, 2005, PROSTAG OTH LIPID M, V76, P35, DOI 10.1016/j.prostaglandins.2004.10.006
   Tippe A, 2002, J AEROSOL SCI, V33, P207, DOI 10.1016/S0021-8502(01)00158-6
   Treumer F, 2012, EXP EYE RES, V97, P63, DOI 10.1016/j.exer.2012.02.011
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   Ulker H, 2013, HUM EXP TOXICOL, V33, P949
   Ulker Hayriye Esra, 2009, Eur J Dent, V3, P120
   Ulker HE, 2013, BIOMED RES INT, V2013
   Vajrabhaya LO, 2009, ORAL SURG ORAL MED O, V107, pE86, DOI 10.1016/j.tripleo.2008.11.008
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   Volkmer E, 2012, J MATER SCI-MATER M, V23, P2793, DOI 10.1007/s10856-012-4725-0
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Wei FL, 2013, STEM CELLS DEV, V22, P1752, DOI 10.1089/scd.2012.0688
   Wu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093012
   Xia L, 2009, BIOMATERIALS, V30, P5927, DOI 10.1016/j.biomaterials.2009.07.022
   Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031
   Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138
   Yue S, 2011, ACTA BIOMATER, V7, P2637, DOI 10.1016/j.actbio.2011.02.009
   Zheng WM, 2007, BIOL REPROD, V76, P1091, DOI 10.1095/biolreprod.106.057877
NR 179
TC 1
Z9 1
U1 0
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD MAR
PY 2016
VL 68
IS 2
BP 179
EP 196
DI 10.1007/s10616-015-9873-x
PG 18
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA DE1AW
UT WOS:000370359200001
PM 25894791
OA Green Published
DA 2018-10-20
ER

PT J
AU Cui, GH
   Shao, SJ
   Yang, JJ
   Liu, JR
   Guo, HD
AF Cui, Guo-hong
   Shao, Shui-jin
   Yang, Jia-jun
   Liu, Jian-ren
   Guo, Hai-dong
TI Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of
   Neural Stem Cell Transplantation for Alzheimer's Disease via Enhancing
   Neuron Differentiation and Paracrine Action
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Alzheimer's disease; Neural stem cell; Transplantation; Self-assembling
   peptide; Differentiation
ID SPINAL-CORD-INJURY; AMYLOID BETA-PEPTIDE; PRECURSOR CELLS; GENE-THERAPY;
   MOUSE MODEL; RAT MODEL; NEUROGENESIS; MEMBRANE; ADHESION; PROLIFERATION
AB The neuropathological hallmarks of Alzheimer's disease (AD) include the presence of extracellular amyloid-beta peptide (A beta) in the form of amyloid plaques and neuronal loss. Neural stem cell (NSC) is being scrutinized as a promising cell replacement therapy for various neurodegenerative diseases. However, the unfavorable niche at the site of degenerative disease is hostile to the survival and differentiation of transplanted cells. Here, we undertook in vitro and in vivo works to examine whether a designer self-assemble peptide (DSP), which contains one functional domain Tyr-Ile-Gly-Ser-Arg (YIGSR) derived from laminin, promotes the survival and neuronal differentiation of NSC and behavioral improvement. We found that DSP could undergo spontaneous assembly into well-ordered nanofibers, and it not only facilitated the cell viability in normal culture condition, but also decreased the number of apoptotic cells induced by A beta in vitro. NSC seeded in DSP showed much more neuronal differentiation than that seeded in self-assemble peptide (SP) or alone. In the AD model, NSC transplantation in DSP-treated AD rats demonstrated much more obvious cognitive rescue with restoration of learning/memory function compared with NSC transplantation in SP, NSC alone, or DSP alone treated ones. Interestingly, DSP enhanced the survival and neuronal differentiation of transplanted NSC. Apoptosis levels in the CA1 region and A beta level in the hippocampus were significantly decreased in the group of NSC transplantation in DSP. Moreover, synaptic function, indicated by the expression of pre-synaptic protein synapsin-1, was restored and the secretion of anti-inflammatory and neurotrophic factors were increased, such as IL-10, brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), and insulin-like growth factor 1 (IGF-1), while the expression of pro-inflammatory factors were decreased, such as TNF-alpha and IL-1 beta. These data firstly unveiled that the biomaterial DSP can maximize the therapeutic benefits of NSC transplantation for AD through improving the survival and differentiation of transplanted stem cells and promoting the effects of neuroprotection, anti-neuroinflammatory and paracrine action. Our results may have important clinical implications for the design of future NSC-based strategies using the biomaterials for various neurodegenerative diseases including AD.
C1 [Cui, Guo-hong; Liu, Jian-ren] Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 9, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
   [Cui, Guo-hong; Yang, Jia-jun] Shanghai 6 Peoples Hosp, Dept Neurol, Sch Med, 639 Zhizaoju Rd, Shanghai 200233, Peoples R China.
   [Shao, Shui-jin; Guo, Hai-dong] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China.
RP Liu, JR (reprint author), Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 9, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Guo, HD (reprint author), Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China.
EM liujr021@vip.163.com; hdguo8@hotmail.com
FU National Natural Science Foundation of China [31400838, 81102670];
   Program of Shanghai No. 9 People's Hospital [2013A05]; Shanghai Jiaotong
   University Biomedical Engineering Crossover Project [YG2011MS12];
   Shanghai Municipal Natural Science Foundation [13ZR1431100]
FX This work was supported by grants from National Natural Science
   Foundation of China (31400838 and 81102670), Program of Shanghai No. 9
   People's Hospital (2013A05), Shanghai Jiaotong University Biomedical
   Engineering Crossover Project (YG2011MS12), and Shanghai Municipal
   Natural Science Foundation (13ZR1431100).
CR Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011
   Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x
   Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106
   Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8
   Burgos-Ramos E, 2008, NEUROSCIENCE, V154, P1458, DOI 10.1016/j.neuroscience.2008.04.036
   Carta MG, 2002, PSYCHOTHER PSYCHOSOM, V71, P233, DOI 10.1159/000063649
   Choi H, 2013, STEM CELLS DEV, V22, P2112, DOI 10.1089/scd.2012.0604
   Cigognini D, 2014, J BIOMED NANOTECHNOL, V10, P309, DOI 10.1166/jbn.2014.1759
   Ebert AD, 2008, EXP NEUROL, V209, P213, DOI 10.1016/j.expneurol.2007.09.022
   Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039
   Gelain F, 2012, NANOSCALE, V4, P2946, DOI 10.1039/c2nr30220a
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016
   Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x
   Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032
   Jackson Graham A, 2014, Nurs Times, V110, P24
   KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506
   Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280
   Li QQ, 2014, J BIOMED MATER RES A, V102, P1991, DOI 10.1002/jbm.a.34876
   Li YC, 2013, COLLOID SURFACE B, V102, P53, DOI 10.1016/j.colsurfb.2012.08.054
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Malinin NL, 2005, P NATL ACAD SCI USA, V102, P3058, DOI 10.1073/pnas.0408237102
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Musial A, 2007, CURR MED CHEM, V14, P2654, DOI 10.2174/092986707782023217
   Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y
   Park D, 2012, EXP NEUROL, V234, P521, DOI 10.1016/j.expneurol.2011.12.040
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Paxinos G, 1997, RAT BRAIN STEREOTAXI
   Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033
   Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328
   Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935
   Rozemuller Annemieke J. M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P223, DOI 10.2174/1568007054038229
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Stephan A, 2005, GENES BRAIN BEHAV, V4, P157, DOI 10.1111/j.1601-183X.2004.00113.x
   Stephan A, 2001, J NEUROSCI, V21, P5703
   Tian XQ, 2012, INT J NEUROSCI, V122, P563, DOI 10.3109/00207454.2012.690797
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239
   Wei Z, 2008, NEUROPHARMACOLOGY, V54, P721, DOI 10.1016/j.neuropharm.2007.12.006
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang W, 2014, J NEUROSCI RES, V92, P185, DOI 10.1002/jnr.23299
   Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018
NR 50
TC 7
Z9 9
U1 0
U2 32
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD MAR
PY 2016
VL 53
IS 2
BP 1108
EP 1123
DI 10.1007/s12035-014-9069-y
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA DD8OS
UT WOS:000370187100025
PM 25586060
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Usprech, J
   Chen, WLK
   Simmons, CA
AF Usprech, Jenna
   Chen, Wen Li Kelly
   Simmons, Craig A.
TI Heart valve regeneration: the need for systems approaches
SO WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; VALVULAR INTERSTITIAL-CELLS; AORTIC-VALVE;
   EXTRACELLULAR-MATRIX; IN-VITRO; GROWTH-FACTOR; PULSATILE BIOREACTOR;
   CURRENT CHALLENGES; PROGENITOR CELLS; 1ST EXPERIENCES
AB Tissue-engineered heart valves are promising alternatives to address the limitations of current valve replacements, particularly for growing children. Current heart valve tissue engineering strategies involve the selection of biomaterial scaffolds, cell types, and often in vitro culture conditions aimed at regenerating a valve for implantation and subsequent maturation in vivo. However, identifying optimal combinations of cell sources, biomaterials, and/or bioreactor conditions to produce functional, durable valve tissue remains a challenge. Despite some short-term success in animal models, attempts to recapitulate aspects of the native heart valve environment based on best guesses' of a limited number of regulatory factors have not proven effective. Better outcomes for valve tissue regeneration will likely require a systems-level understanding of the relationships between multiple interacting regulatory factors and their effects on cell function and tissue formation. Until recently, conventional culture methods have not allowed for multiple design parameters to be considered at once. Emerging microtechnologies are well suited to systematically probe multiple inputs, in combination, in high throughput and with great precision. When combined with statistical and network systems analyses, these microtechnologies have excellent potential to define multivariate signal-response relationships and reveal key regulatory pathways for robust functional tissue regeneration. WIREs Syst Biol Med 2016, 8:169-182. doi: 10.1002/wsbm.1329 For further resources related to this article, please visit the .
C1 [Usprech, Jenna; Chen, Wen Li Kelly; Simmons, Craig A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.
RP Simmons, CA (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.
EM c.simmons@utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772
CR Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Alavi SH, 2015, ANN THORAC SURG, V99, P2183, DOI 10.1016/j.athoracsur.2015.02.058
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Appleton AJE, 2009, TISSUE ENG PT A, V15, P3889, DOI [10.1089/ten.tea.2009.0031, 10.1089/ten.TEA.2009.0031]
   Balachandran K, 2009, AM J PHYSIOL-HEART C, V296, pH756, DOI 10.1152/ajpheart.00900.2008
   Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279
   Balguid A, 2009, CIRCULATION, V119, P290, DOI 10.1161/CIRCULATIONAHA.107.749853
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Bloch O, 2011, TISSUE ENG PT A, V17, P2399, DOI [10.1089/ten.tea.2011.0046, 10.1089/ten.TEA.2011.0046]
   Boerboom RA, 2008, ANN BIOMED ENG, V36, P244, DOI 10.1007/s10439-007-9413-8
   Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008
   Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750
   Chester AH, 2007, PHILOS T R SOC B, V362, P1437, DOI 10.1098/rstb.2007.2126
   Colazzo F, 2011, BIOMATERIALS, V32, P119, DOI 10.1016/j.biomaterials.2010.09.003
   Cosgrove BD, 2008, CELL MOL BIOENG, V1, P33, DOI 10.1007/s12195-008-0007-9
   Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627
   Cushing MC, 2007, BIOMATERIALS, V28, P3378, DOI 10.1016/j.biomaterials.2007.04.005
   Del Gaudio C, 2008, ANN I SUPER SANITA, V44, P178
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Dor Y, 2003, ANAT REC PART A, V271A, P202, DOI 10.1002/ar.a.10026
   Dreger SA, 2002, J HEART VALVE DIS, V11, P875
   Driessen-Mol A, 2014, J AM COLL CARDIOL, V63, P1320, DOI 10.1016/j.jacc.2013.09.082
   Duan B, 2014, ACTA BIOMATER, V10, P1836, DOI 10.1016/j.actbio.2013.12.005
   Duan B, 2015, TISSUE ENG PART C-ME, V21, P1
   Dube J, 2014, ACTA BIOMATER, V10, P3563, DOI 10.1016/j.actbio.2014.04.033
   Eckert CE, 2011, ANN BIOMED ENG, V39, P205, DOI 10.1007/s10439-010-0162-8
   El Oakley R, 2008, CIRCULATION, V117, P253, DOI 10.1161/CIRCULATIONAHA.107.736819
   Emmert MY, 2012, JACC-CARDIOVASC INTE, V5, P874, DOI 10.1016/j.jcin.2012.04.010
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Engelmayr GC, 2008, ANN BIOMED ENG, V36, P700, DOI 10.1007/s10439-008-9447-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539
   Eslami M, 2014, J BIOMATER APPL, V29, P399, DOI 10.1177/0885328214530589
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flanagan TC, 2006, BIOMATERIALS, V27, P2233, DOI 10.1016/j.biomaterials.2005.10.031
   Flanagan TC, 2009, TISSUE ENG PART A, V15, P2966
   Frank BS, 2012, J SURG RES, V174, P39, DOI 10.1016/j.jss.2010.11.911
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gould ST, 2013, CIRC RES, V113, P186, DOI 10.1161/CIRCRESAHA.112.300154
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Hoerstrup SP, 2002, CIRCULATION S1, V106
   Huang SD, 2007, HEART VESSELS, V22, P116, DOI 10.1007/s00380-006-0940-2
   Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   Kalfa D, 2010, BIOMATERIALS, V31, P4056, DOI 10.1016/j.biomaterials.2010.01.135
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   L'Heureux N, 1998, FASEB J, V12, P47
   Larouche Danielle, 2009, V482, P233, DOI 10.1007/978-1-59745-060-7_15
   Lau KS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001393
   Liu HJ, 2016, ACTA BIOMATER, V34, P113, DOI 10.1016/j.actbio.2015.11.054
   Lueders C, 2014, EUR J CARDIO-THORAC, V46, P593, DOI 10.1093/ejcts/ezt510
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI [10.1021/bp.128, 10.1002/btpr.128]
   Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6
   Masoumi N, 2014, BIOMATERIALS, V35, P7774, DOI 10.1016/j.biomaterials.2014.04.039
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2010, J BIOMED MATER RES A, V94, P1620
   Merryman WD, 2007, TISSUE ENG, V13, P2281, DOI 10.1089/ten.2006.0324
   Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4
   Mol A, 2009, EXPERT REV MED DEVIC, V6, P259, DOI [10.1586/erd.09.12, 10.1586/ERD.09.12]
   Moraes C, 2013, INTEGR BIOL-UK, V5, P673, DOI 10.1039/c3ib20254b
   Moraes C, 2010, LAB CHIP, V10, P227, DOI 10.1039/b914460a
   Morsi YS, 2007, J ARTIF ORGANS, V10, P109, DOI 10.1007/s10047-006-0369-5
   Myken PSU, 2009, J THORAC CARDIOV SUR, V137, P76, DOI 10.1016/j.jtcvs.2008.05.068
   Narine K, 2006, TISSUE ENG, V12, P2707, DOI 10.1089/ten.2006.12.2707
   Pho M, 2008, AM J PHYSIOL-HEART C, V294, pH1767, DOI 10.1152/ajpheart.01305.2007
   Rabkin-Aikawa E, 2005, ADV BIOCHEM ENG BIOT, V94, P141, DOI 10.1007/b100003
   Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767
   Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019
   Rodriguez KJ, 2009, J BIOMED MATER RES A, V90A, P1043, DOI 10.1002/jbm.a.32187
   Rothenburger M, 2002, ASAIO J, V48, P586, DOI 10.1097/01.MAT.0000033637.90113.1E
   Rubbens MP, 2009, TISSUE ENG PT A, V15, P999, DOI 10.1089/ten.tea.2007.0396
   Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sales VL, 2007, CIRCULATION, V116, pI55, DOI 10.1161/CIRCULATIONAHA.106.6806637
   Sant S, 2011, J TISSUE ENG REGEN M, V5, P283, DOI 10.1002/term.313
   Sarugaser R, 2009, PLOS ONE, V4, P1
   Schmidt D, 2007, PHILOS T R SOC B, V362, P1505, DOI 10.1098/rstb.2007.2131
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Shi YL, 2002, BIOMED SCI INSTRUM, V38, P35
   Sider K. L., 2011, INT J INFLAM, V2011, P18, DOI DOI 10.4061/2011/364310
   Simpson DL, 2014, ANN THORAC SURG, V98, P947, DOI 10.1016/j.athoracsur.2014.04.075
   Sodian R, 2006, ANN THORAC SURG, V81, P2207, DOI 10.1016/j.athoracsur.2005.12.073
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043
   Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378
   Syedain Z., 2011, CARDIOVASC ENG TECHN, V2, P101, DOI DOI 10.1007/S13239-011-0039-5>[ACCESSED
   Syedain ZH, 2013, TISSUE ENG PT A, V19, P759, DOI [10.1089/ten.tea.2012.0365, 10.1089/ten.TEA.2012.0365]
   Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027
   Taylor PM, 2007, PHILOS T R SOC B, V362, P1313, DOI 10.1098/rstb.2007.2117
   Tedder ME, 2009, TISSUE ENG PART A, V15, P1258
   Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035
   Tseng H, 2013, ANN BIOMED ENG, V41, P398, DOI 10.1007/s10439-012-0666-5
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   van Vlimmeren MAA, 2010, J APPL PHYSIOL, V109, P1483, DOI 10.1152/japplphysiol.00571.2010
   Vis PWR, 2011, EUR J CARDIO-THORAC, V39, P8, DOI 10.1016/j.ejcts.2010.05.032
   Waxman AS, 2012, J VET CARDIOL, V14, P211, DOI 10.1016/j.jvc.2012.02.006
   Weber B, 2011, EUR HEART J, V32, P2830, DOI 10.1093/eurheartj/ehr059
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 113
TC 9
Z9 9
U1 4
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-5094
EI 1939-005X
J9 WIRES SYST BIOL MED
JI Wiley Interdiscip. Rev.-Syst. Biol
PD MAR-APR
PY 2016
VL 8
IS 2
BP 169
EP 182
DI 10.1002/wsbm.1329
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DE5BB
UT WOS:000370644400005
PM 26862013
DA 2018-10-20
ER

PT J
AU Miron, RJ
   Bosshardt, DD
AF Miron, Richard J.
   Bosshardt, Dieter D.
TI OsteoMacs: Key players around bone biomaterials
SO BIOMATERIALS
LA English
DT Review
DE Macrophage; Bone regeneration; Osteoimmunology; Biomaterial integration;
   Tissue response; Multi-nucleated giant cells; OsteoMacs; Foreign body
   cells
ID BIPHASIC CALCIUM-PHOSPHATE; GIANT-CELL FORMATION; ALTERNATIVELY
   ACTIVATED MACROPHAGES; BETA-TRICALCIUM PHOSPHATE; FOREIGN-BODY REACTION;
   MONONUCLEAR PHAGOCYTE SYSTEM; TISSUE-RESIDENT MACROPHAGES; TITANIUM
   SURFACE-TOPOGRAPHY; TRANSFORMING-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA
AB Osteal macrophages (OsteoMacs) are a special subtype of macrophage residing in bony tissues. Interesting findings from basic research have pointed to their vast and substantial roles in bone biology by demonstrating their key function in bone formation and remodeling. Despite these essential findings, much less information is available concerning their response to a variety of biomaterials used for bone regeneration with the majority of investigation primarily focused on their role during the foreign body reaction. With respect to biomaterials, it is well known that cells derived from the monocyte/macrophage lineage are one of the first cell types in contact with implanted biomaterials. Here they demonstrate extremely plastic phenotypes with the ability to differentiate towards classical M1 or M2 macrophages, or subsequently fuse into osteoclasts or multinucleated giant cells (MNGCs). These MNGCs have previously been characterized as foreign body giant cells and associated with biomaterial rejection, however more recently their phenotypes have been implicated with wound healing and tissue regeneration by studies demonstrating their expression of key M2 markers around biomaterials. With such contrasting hypotheses, it becomes essential to better understand their roles to improve the development of osteo-compatible and osteo-promotive biomaterials. This review article expresses the necessity to further study OsteoMacs and MNGCs to understand their function in bone biomaterial tissue integration including dental/orthopedic implants and bone grafting materials. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Miron, Richard J.; Bosshardt, Dieter D.] Univ Bern, Dept Oral Surg & Stomatol, Dept Periodontol, Freiburgstrasse 7, CH-3010 Bern, Switzerland.
RP Miron, RJ (reprint author), Univ Bern, Oral Cell Biol, CH-3010 Bern, Switzerland.; Bosshardt, DD (reprint author), Univ Bern, Oral Histol, CH-3010 Bern, Switzerland.
EM richard.miron@zmk.unibe.ch; dieter.bosshardt@zmk.unibe.ch
RI Bosshardt, Dieter/C-9442-2012
CR Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142
   Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Alfarsi MA, 2014, J BIOMED MATER RES A, V102, P60, DOI 10.1002/jbm.a.34666
   Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013
   Anderson CF, 2002, J ENDOTOXIN RES, V8, P477, DOI 10.1179/096805102125001118
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Anderson JM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5423-5
   Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196
   ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020
   Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9
   Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Bonifer C, 2008, FRONT BIOSCI-LANDMRK, V13, P549, DOI 10.2741/2700
   BOURQUE WT, 1993, INT J DEV BIOL, V37, P573
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Brinkmann J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0034-x
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97
   Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442
   Buser D, 2013, J DENT RES, V92, p176S, DOI 10.1177/0022034513504949
   Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010
   CECCHINI MG, 1994, DEVELOPMENT, V120, P1357
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chappuis V, 2013, J DENT RES, V92, p195S, DOI 10.1177/0022034513506713
   Chappuis V., 2015, CLIN IMPLANT DENT RE
   Chehroudi B, 2010, J BIOMED MATER RES A, V93A, P724, DOI 10.1002/jbm.a.32587
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chen ZT, 2015, BIOMATERIALS, V61, P126, DOI 10.1016/j.biomaterials.2015.04.044
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Chen ZT, 2014, BIOMATERIALS, V35, P8553, DOI 10.1016/j.biomaterials.2014.06.038
   Chistiakov DA, 2015, J CELL MOL MED, V19, P1163, DOI 10.1111/jcmm.12591
   Chistiakov DA, 2015, INT J CARDIOL, V184, P436, DOI 10.1016/j.ijcard.2015.03.055
   Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111
   Curran JM, 2005, BIOMATERIALS, V26, P5313, DOI [10.1016/j.biomaterials.2005.01.065, 10.1016/.jbiomaterials.2005.01.065]
   Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877
   Davison NL, 2015, EUR CELLS MATER, V29, P314, DOI 10.22203/eCM.v029a24
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Davison N.L., 2014, EUR CELLS MATER, V27, P96
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Davison NL, 2014, BIOMATERIALS, V35, P5088, DOI 10.1016/j.biomaterials.2014.03.013
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Drake MT, 2015, CLIN THER, V37, P1837, DOI 10.1016/j.clinthera.2015.06.006
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Egli RJ, 2011, ADV ENG MATER, V13, pB102, DOI 10.1002/adem.201080037
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Favus M.J., 1996, PRIMER METABOLIC BON, V37, P553
   Fellah BH, 2007, J MATER SCI-MATER M, V18, P287, DOI 10.1007/s10856-006-0691-8
   Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663
   Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702
   Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Ghrebi S, 2013, J BIOMED MATER RES A, V101, P2118, DOI 10.1002/jbm.a.34509
   Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671
   Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553
   Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619
   Hamlet S, 2012, CLIN ORAL IMPLAN RES, V23, P584, DOI 10.1111/j.1600-0501.2011.02325.x
   Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004
   HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0
   Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623
   Haynes DR, 1997, J BONE JOINT SURG BR, V79B, P988, DOI 10.1302/0301-620X.79B6.7832
   Hefti T, 2010, BIOMATERIALS, V31, P7321, DOI 10.1016/j.biomaterials.2010.06.009
   Heinemann DEH, 2000, IMMUNOBIOLOGY, V202, P68, DOI 10.1016/S0171-2985(00)80054-6
   Heinemann DEH, 2000, J BONE JOINT SURG BR, V82B, P283, DOI 10.1302/0301-620X.82B2.9730
   Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005
   Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533
   Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307
   Hodge JM, 2004, J BONE MINER RES, V19, P190, DOI 10.1359/JBMR.0301232
   HUME DA, 1984, J CELL SCI, V66, P189
   Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008
   Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688
   James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084
   JANSEN A, 1992, KIDNEY INT, V42, P1107, DOI 10.1038/ki.1992.394
   Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jensen SS, 2014, J PERIODONTOL, V85, P1549, DOI 10.1902/jop.2014.140182
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518
   Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Jude EB, 1999, DIABETOLOGIA, V42, P748, DOI 10.1007/s001250051224
   Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004
   Kaneko M, 2001, RHEUMATOLOGY, V40, P247, DOI 10.1093/rheumatology/40.3.247
   Katsuyama E, 2015, J BIOL CHEM, V290, P716, DOI 10.1074/jbc.M114.568360
   Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574
   Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275
   Kong YY, 1999, NATURE, V397, P315
   Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990
   KREUTZ M, 1993, BLOOD, V82, P1300
   Kronstrom M, 2000, J CLIN PERIODONTOL, V27, P875, DOI 10.1034/j.1600-051x.2000.027012875.x
   Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170
   Kweon H, 2014, BIOMATERIALS, V35, P8576, DOI 10.1016/j.biomaterials.2014.06.050
   Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787
   Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253
   Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092
   Lean JM, 2000, BONE, V27, P29, DOI 10.1016/S8756-3282(00)00306-9
   Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257
   Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7
   Lipford GB, 1997, EUR J IMMUNOL, V27, P3420, DOI 10.1002/eji.1830271242
   Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540
   Louis CA, 1999, AM J PHYSIOL-REG I, V276, pR237
   Lu J, 2015, ACTA BIOMATER, V16, P223, DOI 10.1016/j.actbio.2015.01.036
   Ma QL, 2014, BIOMATERIALS, V35, P9853, DOI 10.1016/j.biomaterials.2014.08.025
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Makihira S, 2007, DENT MATER J, V26, P739, DOI 10.4012/dmj.26.739
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Maruyama K, 2006, J BONE MINER METAB, V24, P454, DOI 10.1007/s00774-006-0708-x
   Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280
   McNally AK, 2011, EXP MOL PATHOL, V91, P673, DOI 10.1016/j.yexmp.2011.06.012
   Menzies FM, 2010, CLIN EXP IMMUNOL, V160, P369, DOI 10.1111/j.1365-2249.2009.04086.x
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00059
   Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016
   MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436
   Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521
   Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409
   Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463
   Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599
   Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512
   Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673
   Olmsted-Davis EA, 2003, P NATL ACAD SCI USA, V100, P15877, DOI 10.1073/pnas.2632959100
   Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583
   PASSLICK B, 1989, BLOOD, V74, P2527
   Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128
   Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reyes-Botella C, 2000, J PERIODONTOL, V71, P614, DOI 10.1902/jop.2000.71.4.614
   Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150
   Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y
   Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258
   RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Roma-Lavisse C, 2015, DIABETES VASC DIS RE, V12, P279, DOI 10.1177/1479164115582351
   Ruiz C, 2003, CELL PHYSIOL BIOCHEM, V13, P309, DOI 10.1159/000074546
   Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173
   SANDBERG M, 1988, DEVELOPMENT, V102, P461
   Saulacic N, 2012, EUR CELLS MATER, V23, P273, DOI 10.22203/eCM.v023a21
   SAULACIC N, 2012, EUR CELLS MATER, V23, P86
   Saulacic N, 2014, CLIN IMPLANT DENT R, V16, P313, DOI 10.1111/cid.12070
   Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a
   Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702
   Scislowska-Czarnecka A, 2012, TISSUE CELL, V44, P391, DOI 10.1016/j.tice.2012.08.002
   Selander KS, 1996, MOL PHARMACOL, V50, P1127
   Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181
   Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2
   Shirey KA, 2014, MUCOSAL IMMUNOL, V7, P549, DOI 10.1038/mi.2013.71
   Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6
   Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159
   Shiwaku Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132903
   Silva SN, 2003, J BIOMED MATER RES A, V65A, P475, DOI 10.1002/jbm.a.10544
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712
   Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010
   Stacey KJ, 1996, J IMMUNOL, V157, P2116
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66
   Swier V. J., 2015, HISTOL HISTOPATHOL, P11652, DOI DOI 10.14670/HH-11-652
   Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103
   Takahashi F, 2004, LUNG, V182, P173
   Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816
   Teitelbaum SL, 2005, J CLIN ENDOCR METAB, V90, P2466, DOI 10.1210/jc.2005-0338
   Thalji Ghadeer, 2014, Int J Oral Maxillofac Implants, V29, pe171, DOI 10.11607/jomi.te55
   Thalji GN, 2014, CLIN ORAL IMPLAN RES, V25, P1273, DOI 10.1111/clr.12266
   Theurl I, 2005, BIOMETALS, V18, P359, DOI 10.1007/s10534-005-3710-1
   Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969
   Trindade R., 2014, CLIN IMPLANT DENT RE
   Trindade R, 2015, ORAL MAXIL SURG CLIN, V27, P175, DOI 10.1016/j.coms.2015.01.004
   Valles G, 2008, BIOMATERIALS, V29, P2326, DOI 10.1016/j.biomaterials.2008.02.011
   van Holten J, 2005, ANN RHEUM DIS, V64, P1780, DOI 10.1136/ard.2005.040477
   van Lent PLEM, 2004, ARTHRITIS RHEUM, V50, P103, DOI 10.1002/art.11422
   Van Wesenbeeck L, 2002, P NATL ACAD SCI USA, V99, P14303, DOI 10.1073/pnas.202332999
   VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415
   Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035
   Vi L, 2015, J BONE MINER RES, V30, P1090, DOI 10.1002/jbmr.2422
   Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123
   Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376
   Wehling-Henricks M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010763
   WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828
   WiktorJedrzejczak W, 1996, PHYSIOL REV, V76, P927
   Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Xia ZD, 2006, BIOMATERIALS, V27, P4557, DOI 10.1016/j.biomaterials.2006.04.030
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Yang SY, 2007, J ORTHOP RES, V25, P603, DOI 10.1002/jor.20342
   Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200
   Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200
   Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315
   Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012
   Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023
NR 238
TC 45
Z9 49
U1 14
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 82
BP 1
EP 19
DI 10.1016/j.biomaterials.2015.12.017
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7KS
UT WOS:000370103900001
PM 26735169
DA 2018-10-20
ER

PT J
AU Izadifar, Z
   Honaramooz, A
   Wiebe, S
   Belev, G
   Chen, XB
   Chapman, D
AF Izadifar, Zohreh
   Honaramooz, Ali
   Wiebe, Sheldon
   Belev, George
   Chen, Xiongbiao
   Chapman, Dean
TI Low-dose phase-based X-ray imaging techniques for in situ soft tissue
   engineering assessments
SO BIOMATERIALS
LA English
DT Article
DE Cartilage tissue engineering; Non-invasive imaging; Biomaterials
   characterization; Phase-based X-ray imaging; Synchrotron imaging;
   Imaging radiation dose; Biomaterial scaffolds
ID CONTRAST-COMPUTED-TOMOGRAPHY; SYNCHROTRON-RADIATION;
   ARTICULAR-CARTILAGE; CANINE MODEL; SCAFFOLDS; RETRIEVAL; VISUALIZATION;
   OPTIMIZATION; CELLS; CT
AB In tissue engineering, non-invasive imaging of biomaterial scaffolds and tissues in living systems is essential to longitudinal animal studies for assessments without interrupting the repair process. Conventional X-ray imaging is inadequate for use in soft tissue engineering due to the limited absorption difference between the soft tissue and biomaterial scaffolds. X-ray phase-based imaging techniques that derive contrast from refraction or phase effects rather than absorption can provide the necessary contrast to see low-density biomaterial scaffolds and tissues in large living systems. This paper explores and compares three synchrotron phase-based X-ray imaging techniques computed tomography (CT) diffraction enhanced imaging (DEI), -analyzer based imaging (ABI), and-phase contrast imaging (PCI)-for visualization and characterization of low-density biomaterial scaffolds and tissues in situ for non-invasive soft tissue engineering assessments. Intact pig joints implanted with polycaprolactone scaffolds were used as the model to assess and compare the imaging techniques in terms of different qualitative and quantitative criteria. For long-term in vivo live animal imaging, different strategies for reducing the imaging radiation dose and scan time reduced number of CT projections, region of interest, and low resolution imaging were examined with the presented phase-based imaging techniques. The results demonstrated promising capabilities of the phase-based techniques for visualization of biomaterial scaffolds and soft tissues in situ. The low-dose imaging strategies were illustrated effective for reducing the radiation dose to levels appropriate for live animal imaging. The comparison among the imaging techniques suggested that CT-DEI has the highest efficiency in retaining image contrast at considerably low radiation doses. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Izadifar, Zohreh; Chen, Xiongbiao; Chapman, Dean] Univ Saskatchewan, Coll Engn, Div Biomed Engn, Saskatoon, SK S7N 5A9, Canada.
   [Honaramooz, Ali] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK S7N 5B4, Canada.
   [Wiebe, Sheldon] Royal Univ Hosp, Dept Med Imaging, Saskatoon, SK S7N 0W8, Canada.
   [Belev, George; Chapman, Dean] Canadian Light Source, Saskatoon, SK S7N 2V3, Canada.
   [Chen, Xiongbiao] Univ Saskatchewan, Coll Engn, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada.
   [Chapman, Dean] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada.
RP Izadifar, Z (reprint author), Univ Saskatchewan, 57 Campus Dr, Saskatoon, SK S7N 5A9, Canada.
EM zohreh.izadifar@usask.ca
RI Chapman, Dean/I-6168-2013
OI Chapman, Dean/0000-0001-6590-4156
FU University of Saskatchewan (U of S) Dean's Scholarship; Saskatchewan
   Health Research Foundation [SHRF] [2784]; Natural Sciences and
   Engineering Research Council of Canada [NSERC] [RGPIN-2014-05648];
   Canada Foundation for Innovation; NSERC; U of S; Government of
   Saskatchewan; Western Economic Diversification Canada; National Research
   Council (NRC) Canada; Canadian Institutes of Health Research; Canadian
   Institutes of Health Research Training grant in Health Research Using
   Synchrotron Techniques (CIHR-THRUST)
FX The authors acknowledge the University of Saskatchewan (U of S) Dean's
   Scholarship and the funding for the present study from the Saskatchewan
   Health Research Foundation [SHRF Reference # 2784] and the Natural
   Sciences and Engineering Research Council of Canada [NSERC
   RGPIN-2014-05648]. Images presented in this paper were captured at the
   Canadian Light Source, which is supported by the Canada Foundation for
   Innovation, NSERC, U of S, Government of Saskatchewan, Western Economic
   Diversification Canada, National Research Council (NRC) Canada, and the
   Canadian Institutes of Health Research. Zohreh Izadifar is a Fellow in
   the Canadian Institutes of Health Research Training grant in Health
   Research Using Synchrotron Techniques (CIHR-THRUST).
CR Appel AA, 2015, BIOTECHNOL BIOENG, V112, P612, DOI 10.1002/bit.25467
   Appel AA, 2012, TISSUE ENG PART C-ME, V18, P859, DOI [10.1089/ten.tec.2012.0123, 10.1089/ten.TEC.2012.0123]
   BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X
   Bartels M., 2013, CONE BEAM XRAY PHASE
   Chang CH, 2005, BIOMED ENG-APP BAS C, V17, P61, DOI 10.4015/S101623720500010X
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   Chen RC, 2012, J SYNCHROTRON RADIAT, V19, P836, DOI 10.1107/S0909049512029731
   Chinga G, 2007, NORD PULP PAP RES J, V22, P441
   Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225
   Coan P, 2010, PHYS MED BIOL, V55, P7649, DOI 10.1088/0031-9155/55/24/017
   Diemoz PC, 2015, J SYNCHROTRON RADIAT, V22, P1072, DOI 10.1107/S1600577515008978
   Dreossi D, 2008, EUR J RADIOL, V68, pS58, DOI 10.1016/j.ejrad.2008.04.038
   EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y
   Grandl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097101
   Gureyev T. E., 2011, ADV COMPUTATIONAL ME, V8141
   Gureyev TE, 2004, APPL OPTICS, V43, P2418, DOI 10.1364/AO.43.002418
   Hagen CK, 2014, MED PHYS, V41, DOI 10.1118/1.4884297
   Hagen CK, 2014, OPT EXPRESS, V22, P7989, DOI 10.1364/OE.22.007989
   Herzen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083369
   Hetterich H, 2013, Z MED PHYS, V23, P194, DOI 10.1016/j.zemedi.2012.12.001
   Horng A, 2014, INVEST RADIOL, V49, P627, DOI 10.1097/RLI.0000000000000063
   Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09418
   International Commission on Radiological Protection, 2007, ANN ICRP, V37, P1, DOI [DOI 10.1016/J.ICRP.2007.10.003, 10.1016/j.icrp.2007.10.003]
   Izadifar Z, 2014, TISSUE ENG PART C-ME, V20, P140, DOI [10.1089/ten.tec.2013.0138, 10.1089/ten.TEC.2013.0138]
   Kotecha M, 2013, TISSUE ENG PART B-RE, V19, P470, DOI [10.1089/ten.TEB.2012.0755, 10.1089/ten.teb.2012.0755]
   Kwack KS, 2008, ACTA RADIOL, V49, P65, DOI 10.1080/02841850701552934
   Langer M, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P210, DOI 10.1109/ISBI.2012.6235521
   Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005
   Lewis RA, 2003, BRIT J RADIOL, V76, P301, DOI 10.1529/bjr/32889803
   Li J, 2009, OSTEOARTHR CARTILAGE, V17, P1193, DOI 10.1016/j.joca.2009.03.005
   Lin XJ, 2015, PHYS MED BIOL, V60, P1655, DOI 10.1088/0031-9155/60/4/1655
   Luan XJ, 2014, P NATL ACAD SCI USA, V111, P12930, DOI 10.1073/pnas.1406414111
   lzadifar Z., 2015, DATA BRIEF IN PRESS
   Mirone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114325
   Mollenhauer J, 2002, OSTEOARTHR CARTILAGE, V10, P163, DOI 10.1053/joca.2001.0496
   MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472
   Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473
   Muehleman C, 2006, OSTEOARTHR CARTILAGE, V14, P882, DOI 10.1016/j.joca.2006.02.011
   Muehleman C, 2004, OSTEOARTHR CARTILAGE, V12, P97, DOI 10.1016/j.joca.2003.10.001
   Muehleman C, 2002, ANN M ORTH RES SOC D
   Nesterets YI, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038107
   Noel PB, 2013, Z MED PHYS, V23, P204, DOI 10.1016/j.zemedi.2013.02.006
   Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961
   Olubamiji AD, 2014, TISSUE ENG PART B-RE, V20, P503, DOI [10.1089/ten.TEB.2013.0493, 10.1089/ten.teb.2013.0493]
   Pacile S, 2015, BIOMED OPT EXPRESS, V6, P3099, DOI 10.1364/BOE.6.003099
   Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x
   Pelliccia D, 2015, PHYS MED BIOL, V60, P3065, DOI 10.1088/0031-9155/60/8/3065
   Quai E, 2013, RADIOL MED, V118, P89, DOI 10.1007/s11547-012-0847-1
   Radiological Society of North America (RSNA), 2015, RAD DOS XRAY CT EX
   Ren YQ, 2011, OPT EXPRESS, V19, P4170, DOI 10.1364/OE.19.004170
   Rubin P., 1972, 6 ANN SAN FRANC CANC
   Sarapata A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898052
   Sarapata A, 2014, MED PHYS, V41, DOI 10.1118/1.4860275
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   STEEL GG, 1987, RADIOTHER ONCOL, V9, P299
   Suortti P, 2003, PHYS MED BIOL, V48, pR1, DOI 10.1088/0031-9155/48/13/201
   Szafraniec MB, 2014, PHYS MED BIOL, V59, DOI 10.1088/0031-9155/59/5/N1
   United States Nuclear Regulatory Commission (U. S. NRC), 2015, SHALL DOS EQ SDE
   Wang ZT, 2013, PHYS MED BIOL, V58, P6815, DOI 10.1088/0031-9155/58/19/6815
   Wrixon AD, 2008, J RADIOL PROT, V28, P161, DOI 10.1088/0952-4746/28/2/R02
   Wu XZ, 2005, OPT LETT, V30, P379, DOI 10.1364/OL.30.000379
   Wysokinski TW, 2007, NUCL INSTRUM METH A, V582, P73, DOI 10.1016/j.nima.2007.08.087
   Wysokinski TW, 2015, NUCL INSTRUM METH A, V775, P1, DOI 10.1016/j.nima.2014.11.088
   Zehbe R, 2010, ACTA BIOMATER, V6, P2097, DOI 10.1016/j.actbio.2009.11.020
   Zehbe R, 2007, INT J MATER RES, V98, P562, DOI 10.3139/146.101509
   Zehbe R, 2010, J R SOC INTERFACE, V7, P49, DOI 10.1098/rsif.2008.0539
   Zhang Lu, 2011, Open Med Inform J, V5, P19, DOI 10.2174/1874431101105010019
   Zhou T., 2013, J PHYS C SER IOP PUB
   Zhu N, 2011, TISSUE ENG PART C-ME, V17, P1071, DOI 10.1089/ten.tec.2011.0102
NR 69
TC 12
Z9 12
U1 0
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 82
BP 151
EP 167
DI 10.1016/j.biomaterials.2015.11.044
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7KS
UT WOS:000370103900012
PM 26761779
DA 2018-10-20
ER

PT J
AU Inzana, JA
   Schwarz, EM
   Kates, SL
   Awad, HA
AF Inzana, Jason A.
   Schwarz, Edward M.
   Kates, Stephen L.
   Awad, Hani A.
TI Biomaterials approaches to treating implant-associated osteomyelitis
SO BIOMATERIALS
LA English
DT Review
DE Biomaterials; Osteomyelitis; Staphylococcus aureus; Antibiotics; Drug
   delivery
ID RESISTANT STAPHYLOCOCCUS-AUREUS; GENTAMICIN-PMMA-BEADS; ACRYLIC
   BONE-CEMENT; POSITRON-EMISSION-TOMOGRAPHY; PROSTHETIC-JOINT INFECTIONS;
   ANTIBIOTIC DELIVERY-SYSTEM; FOREIGN-BODY INFECTION; IN-VITRO;
   DRUG-DELIVERY; CALCIUM-PHOSPHATE
AB Orthopaedic devices are the most common surgical devices associated with implant-related infections and Staphylococcus aureus (S. aureus) is the most common causative pathogen in chronic bone infections (osteomyelitis). Treatment of these chronic bone infections often involves combinations of antibiotics given systemically and locally to the affected site via a biomaterial spacer. The gold standard biomaterial for local antibiotic delivery against osteomyelitis, poly(methyl methacrylate) (PMMA) bone cement, bears many limitations. Such shortcomings include limited antibiotic release, incompatibility with many antimicrobial agents, and the need for follow-up surgeries to remove the non-biodegradable cement before surgical reconstruction of the lost bone. Therefore, extensive research pursuits are targeting alternative, biodegradable materials to replace PMMA in osteomyelitis applications.
   Herein, we provide an overview of the primary clinical treatment strategies and emerging biodegradable materials that may be employed for management of implant-related osteomyelitis. We performed a systematic review of experimental biomaterials systems that have been evaluated for treating established S. aureus osteomyelitis in an animal model. Many experimental biomaterials were not decisively more efficacious for infection management than PMMA when delivering the same antibiotic. However, alternative biomaterials have reduced the number of follow-up surgeries, enhanced the antimicrobial efficacy by delivering agents that are incompatible with PMMA, and regenerated bone in an infected defect. Understanding the advantages, limitations, and potential for clinical translation of each biomaterial, along with the conditions under which it was evaluated (e.g. animal model), is critical for surgeons and researchers to navigate the plethora of options for local antibiotic delivery. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Inzana, Jason A.] AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
   [Inzana, Jason A.; Schwarz, Edward M.; Kates, Stephen L.; Awad, Hani A.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, 601 Elmwood Ave,Box 665, Rochester, NY 14642 USA.
   [Inzana, Jason A.; Schwarz, Edward M.; Awad, Hani A.] Univ Rochester, Dept Biomed Engn, 207 Robert B Goergen Hall, Rochester, NY 14642 USA.
   [Schwarz, Edward M.; Kates, Stephen L.; Awad, Hani A.] Univ Rochester, Med Ctr, Dept Orthoped, 601 Elmwood Ave, Rochester, NY 14642 USA.
RP Inzana, JA (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM jason.inzana@aofoundation.org
FU AOTrauma Research- Clinical Priority Program on Bone Infection; National
   Institutes of Health (NIH) [P30 AR061307]; Whitaker International
   Program post-doctoral scholarship; National Science Foundation (NSF)
   [DGE-1419118]
FX This research was supported by the AOTrauma Research- Clinical Priority
   Program on Bone Infection and the National Institutes of Health (NIH P30
   AR061307). Jason Inzana was supported in part by a Whitaker
   International Program post-doctoral scholarship and a National Science
   Foundation graduate research fellowship (NSF Award DGE-1419118). The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of AOTrauma, NIH, NSF, or the
   Whitaker International Program.
CR Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   Ahola Niina, 2012, Biomatter, V2, P213, DOI 10.4161/biom.22793
   Alvarez H, 2008, J BIOMED MATER RES B, V85B, P93, DOI 10.1002/jbm.b.30921
   Amador G, 2010, ANTIMICROB AGENTS CH, V54, P950, DOI 10.1128/AAC.00434-09
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Amin TJ, 2012, J BONE JOINT SURG AM, V94A, P1946, DOI 10.2106/JBJS.L.00014
   Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035
   Basu S, 2009, SEMIN NUCL MED, V39, P36, DOI 10.1053/j.semnuclmed.2008.08.004
   BECKER PL, 1994, J ORTHOPAED RES, V12, P737, DOI 10.1002/jor.1100120517
   BEECHING NJ, 1986, J ANTIMICROB CHEMOTH, V17, P173, DOI 10.1093/jac/17.2.173
   Beenken KE, 2014, J BIOMATER APPL, V29, P514, DOI 10.1177/0885328214535452
   Bettin D, 2009, J BONE JOINT SURG BR, V91-B, P311
   Beuerlein MJS, 2010, J ORTHOP TRAUMA, V24, pS46, DOI 10.1097/BOT.0b013e3181cec48e
   Bosse MJ, 2005, J BONE JOINT SURG AM, V87A, P1343, DOI 10.2106/JBJS.D.02649
   Brin YS, 2008, J CONTROL RELEASE, V131, P121, DOI 10.1016/j.jconrel.2008.07.022
   Brown Kate V, 2010, J Surg Orthop Adv, V19, P18
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   Calhoun JH, 2005, INFECT DIS CLIN N AM, V19, P765, DOI 10.1016/j.idc.2005.07.009
   CALHOUN JH, 1993, CLIN ORTHOP RELAT R, P23
   Cevher E, 2007, J MICROENCAPSUL, V24, P577, DOI 10.1080/02652040701472584
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Chen LB, 2007, J BIOMED MATER RES B, V83B, P589, DOI 10.1002/jbm.b.30832
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479
   CORNELL CN, 1993, J ORTHOPAED RES, V11, P619, DOI 10.1002/jor.1100110502
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Ding H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085472
   Drago L, 2014, CLIN ORTHOP RELAT R, V472, P3311, DOI 10.1007/s11999-014-3558-1
   Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05
   EI-Kamel A. H., 2007, DRUG DELIV, V14, P349
   Ethell MT, 2000, VET SURG, V29, P375, DOI 10.1053/jvet.2000.7535
   Faber C, 2005, ANTIMICROB AGENTS CH, V49, P2438, DOI 10.1128/AAC.49.6.2438-2444.2005
   Ferguson JY, 2014, BONE JOINT J, V96B, P829, DOI 10.1302/0301-620X.96B6.32756
   Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x
   Fleiter N, 2014, BONE JOINT RES, V3, P223, DOI 10.1302/2046-3758.37.2000301
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000
   Garcia LG, 2013, J ANTIMICROB CHEMOTH, V68, P1455, DOI 10.1093/jac/dkt072
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   GARVIN KL, 1994, J BONE JOINT SURG AM, V76A, P1500, DOI 10.2106/00004623-199410000-00009
   Giavaresi G, 2012, J MATER SCI-MATER M, V23, P1247, DOI 10.1007/s10856-012-4585-7
   Giavaresi G, 2012, J ORTHOP RES, V30, P348, DOI 10.1002/jor.21531
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Gogia Jaspaul S, 2009, Semin Plast Surg, V23, P100, DOI 10.1055/s-0029-1214162
   GRISTINA AG, 1991, ORTHOP CLIN N AM, V22, P363
   Gu YX, 2012, ACTA BIOMATER, V8, P424, DOI 10.1016/j.actbio.2011.08.006
   Guelcher SA, 2011, J ORTHOP TRAUMA, V25, P477, DOI 10.1097/BOT.0b013e31821f624c
   Huntimer L, 2013, ADV HEALTHC MATER, V2, P369, DOI 10.1002/adhm.201200181
   Inzana JA, 2015, EUR CELLS MATER, V30, P232, DOI 10.22203/eCM.v030a16
   Inzana JA, 2015, BONE, V72, P128, DOI 10.1016/j.bone.2014.11.019
   Itokazu M, 1998, Bull Hosp Jt Dis, V57, P125
   Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006
   Jain JP, 2008, J BIOMED MATER RES A, V84A, P740, DOI 10.1002/jbm.a.31456
   Jain JP, 2005, J CONTROL RELEASE, V103, P541, DOI 10.1016/j.jconrel.2004.12.021
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Jiang JL, 2012, INFLAMM RES, V61, P207, DOI 10.1007/s00011-011-0402-x
   Joosten U, 2005, BIOMATERIALS, V26, P5251, DOI 10.1016/j.biomaterials.2005.01.001
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   KLEMM K, 1979, ZBL CHIR, V104, P934
   Knaepler H, 2012, INT J SURG, V10, pS15, DOI 10.1016/j.ijsu.2012.05.020
   Koort JK, 2005, ANTIMICROB AGENTS CH, V49, P1502, DOI 10.1128/AAC.49.4.1502-1508.2005
   Koort JK, 2004, J NUCL MED, V45, P1406
   KUBOTA R, 1992, J NUCL MED, V33, P1972
   Kundu B, 2011, J MATER SCI-MATER M, V22, P705, DOI 10.1007/s10856-010-4221-3
   Kurien T, 2013, BONE JOINT J, V95B, P583, DOI 10.1302/0301-620X.95B5.30286
   LAURENCIN CT, 1993, J ORTHOPAED RES, V11, P256, DOI 10.1002/jor.1100110213
   Le Ray AM, 2005, ANTIMICROB AGENTS CH, V49, P3025, DOI 10.1128/AAC.49.7.3025-3027.2005
   Letsch R, 1993, Aktuelle Traumatol, V23, P324
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Lora-Tamayo J, 2013, CLIN INFECT DIS, V56, P182, DOI 10.1093/cid/cis746
   Mader JT, 2002, CLIN ORTHOP RELAT R, P58, DOI 10.1097/01.blo.0000030070.92399.4d
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Mariconda M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-193
   Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011
   Mckee MD, 2010, J ORTHOP TRAUMA, V24, P483, DOI 10.1097/BOT.0b013e3181df91d9
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000143556.41472.2a
   McLaren AC, 2007, CLIN ORTHOP RELAT R, P60, DOI 10.1097/BLO.0b013e3181123e90
   Mendel V, 2005, ARCH ORTHOP TRAUM SU, V125, P363, DOI 10.1007/s00402-004-0774-2
   Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12
   Molina-Manso D, 2012, INT J ANTIMICROB AG, V40, P252, DOI 10.1016/j.ijantimicag.2012.05.013
   Moojen DJF, 2008, J ARTHROPLASTY, V23, P1152, DOI 10.1016/j.arth.2007.08.020
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Murray CK, 2008, J TRAUMA, V64, pS239, DOI 10.1097/TA.0b013e318163cd14
   Nelson CL, 1997, J ORTHOPAED RES, V15, P249, DOI 10.1002/jor.1100150214
   NELSON CL, 1993, CLIN ORTHOP RELAT R, P96
   Nishitani K, 2015, J ORTHOP RES, V33, P1311, DOI 10.1002/jor.22907
   NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410
   NORDEN CW, 1980, BRIT J EXP PATHOL, V61, P451
   O'Hara P, 2000, PHARMACEUT RES, V17, P955, DOI 10.1023/A:1007527204887
   Orhan Z, 2006, J BONE JOINT SURG BR, V88B, P270, DOI 10.1302/0301-620X.88B2.16328
   Orhan Z, 2010, ARCH ORTHOP TRAUM SU, V130, P135, DOI 10.1007/s00402-009-0886-9
   Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023
   Overstreet D, 2015, CLIN ORTHOP RELAT R, V473, P337, DOI 10.1007/s11999-014-3935-9
   PATZAKIS MJ, 1993, CLIN ORTHOP RELAT R, P112
   Pelissier P, 2004, J ORTHOPAED RES, V22, P73, DOI 10.1016/S0736-0266(03)00165-7
   Penner MJ, 1996, J ARTHROPLASTY, V11, P939, DOI 10.1016/S0883-5403(96)80135-5
   Perez R. A., 2012, J TISSUE ENG, V3, DOI DOI 10.1177/2041731412439555
   Perez RA, 2013, J MATER SCI-MATER M, V24, P381, DOI 10.1007/s10856-012-4799-8
   Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08
   Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07
   Rasyid HN, 2009, ACTA ORTHOP, V80, P508, DOI 10.3109/17453670903389782
   Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343
   Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15
   RISSING JP, 1985, INFECT IMMUN, V49, P141
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Scheman L, 1941, J AMER MED ASSOC, V117, P1525, DOI 10.1001/jama.1941.02820440033008
   Schmolders J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-144
   Shaikh AA, 2014, CLIN ORTHOP RELAT R, V472, P2201, DOI 10.1007/s11999-014-3545-6
   Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005
   Shi PJ, 2010, J BIOMED MATER RES A, V93A, P1020, DOI 10.1002/jbm.a.32598
   Shirtliff ME, 2002, CLIN ORTHOP RELAT R, P239
   Sia IG, 2006, BEST PRACT RES CL RH, V20, P1065, DOI 10.1016/j.berh.2006.08.014
   Smeltzer MS, 1997, J ORTHOPAED RES, V15, P414, DOI 10.1002/jor.1100150314
   Smith JK, 2013, CLIN ORTHOP RELAT R, V471, P3158, DOI 10.1007/s11999-013-2988-5
   Solberg BD, 1999, J ORTHOP TRAUMA, V13, P102, DOI 10.1097/00005131-199902000-00006
   Spellberg B, 2012, CLIN INFECT DIS, V54, P393, DOI 10.1093/cid/cir842
   Stinner DJ, 2010, J ORTHOP TRAUMA, V24, P592, DOI 10.1097/BOT.0b013e3181ed296c
   Sugawara Y, 1999, EUR J NUCL MED, V26, P333, DOI 10.1007/s002590050395
   Takigami I, 2010, ARCH ORTHOP TRAUM SU, V130, P1221, DOI 10.1007/s00402-009-0991-9
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tang HJ, 2013, ANTIMICROB AGENTS CH, V57, P5717, DOI 10.1128/AAC.01236-13
   ter Boo GJA, 2015, BIOMATERIALS, V52, P113, DOI 10.1016/j.biomaterials.2015.02.020
   Thein-Han W, 2011, TISSUE ENG PT A, V17, P2943, DOI 10.1089/ten.tea.2010.0674
   Tofuku K, 2012, EUR SPINE J, V21, P2027, DOI 10.1007/s00586-012-2435-4
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Tsiolis P, 2011, SURG INFECT, V12, P131, DOI 10.1089/sur.2010.050
   van de Belt H, 2000, ACTA ORTHOP SCAND, V71, P625, DOI 10.1080/000164700317362280
   Vergidis P, 2011, ANTIMICROB AGENTS CH, V55, P1182, DOI 10.1128/AAC.00740-10
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Waeiss RA, 2014, J ORAL MAXIL SURG, V72, P1310, DOI 10.1016/j.joms.2014.01.007
   Walenkamp GHIM, 1998, ACTA ORTHOP SCAND, V69, P518, DOI 10.3109/17453679808997790
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Winkler H, 2008, J BONE JOINT SURG BR, V90B, P1580, DOI 10.1302/0301-620X.90B12.20742
   Xing JC, 2013, TISSUE ENG PT A, V19, P255, DOI [10.1089/ten.TEA.2012.0262, 10.1089/ten.tea.2012.0262]
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   Yu BG, 1996, J CONTROL RELEASE, V39, P65, DOI 10.1016/0168-3659(95)00139-5
   Yun HC, 2008, J TRAUMA, V64, pS163, DOI 10.1097/TA.0b013e318160868c
   Zelken J, 2007, CLIN ORTHOP RELAT R, P190, DOI 10.1097/BLO.0b013e3180ca9521
   Zhang X, 2010, BIOMATERIALS, V31, P5865, DOI 10.1016/j.biomaterials.2010.04.005
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   Zuluaga AF, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-8
NR 148
TC 45
Z9 46
U1 6
U2 125
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 81
BP 58
EP 71
DI 10.1016/j.biomaterials.2015.12.012
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7KQ
UT WOS:000370103700006
PM 26724454
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rosato, A
   Catalano, A
   Carocci, A
   Carrieri, A
   Carone, A
   Caggiano, G
   Franchini, C
   Corbo, F
   Montagna, MT
AF Rosato, Antonio
   Catalano, Alessia
   Carocci, Alessia
   Carrieri, Antonio
   Carone, Addolorata
   Caggiano, Giuseppina
   Franchini, Carlo
   Corbo, Filomena
   Montagna, Maria Teresa
TI In vitro interactions between anidulafungin and nonsteroidal
   anti-inflammatory drugs on biofilms of Candida spp.
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article
DE Biofilm; Non-steroidal anti-inflammatory drugs (NSAIDs); Anidulafungin;
   XTT; Synergism; Candida species
ID ANTIFUNGAL AGENTS; ALBICANS BIOFILMS; FUNGAL-INFECTIONS; AMPHOTERICIN-B;
   RESISTANCE; ECHINOCANDINS; FLUCONAZOLE; SUSCEPTIBILITY; COMBINATION;
   PROSTAGLANDINS
AB Candida spp. are responsible for many biomaterial-related infections; they give rise to infective pathologies typically associated with biofilm formation. We recently reported that the echinocandin anidulafungin (ANF) showed a strong in vitro activity against both planktonic and biofilms cells. Herein, we report the antifungal activities of ANF alone and in association with some non-steroidal anti-inflammatory drugs (NSAIDs) against nine Candida strain biofilms: four Candida albicans, two Candida glabrata and three Candida guilliermondii. The activity of ANF was assessed using an in vitro microbiological model relevant for clinical practice. ANF proved oneself to be active against biofilms cells, and a clear-cut synergism was found against Candida species biofilms when ANF was used in combination with three NSAIDs: aspirin, diclofenac, ibuprofen. The positive synergism against Candida spp. of ANF in association with aspirin or the other NSAIDs proved to be a very effective antifungal treatment (FICI <0.5). These results may provide the starting point for new combination therapies of ANF with NSAIDs against Candida biofilm pathologies. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Rosato, Antonio; Catalano, Alessia; Carocci, Alessia; Carrieri, Antonio; Carone, Addolorata; Franchini, Carlo; Corbo, Filomena] Univ Bari, Dept Pharm Drug Sci, Bari, Italy.
   [Caggiano, Giuseppina; Montagna, Maria Teresa] Univ Bari, Hyg Sect, Dept Biomed Sci & Human Oncol, Bari, Italy.
   [Catalano, Alessia; Carocci, Alessia] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via E Orabona 4, I-70125 Bari, Italy.
RP Catalano, A; Carocci, A (reprint author), Univ Bari, Dept Pharm Drug Sci, Bari, Italy.; Catalano, A; Carocci, A (reprint author), Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via E Orabona 4, I-70125 Bari, Italy.
EM alessia.catalano@uniba.it; alessia.carocci@uniba.it
OI Carrieri, Antonio/0000-0002-7725-6667; Montagna, Maria
   Teresa/0000-0002-2958-5458
FU Pfizer s.r.l. Italy
FX This study was supported by an unrestricted grant from Pfizer s.r.l.
   Italy.
CR Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0
   Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004
   Ashraf A, 2015, AM J MICROBIOL RES, V3, P1
   Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002
   Bink A., 2011, The Open Mycology Journal, V5, P29, DOI 10.2174/1874437001105010029
   Bink A., 2012, J INFECT DIS, V1, P790
   Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7
   Cappelletty D, 2007, PHARMACOTHERAPY, V27, P369, DOI 10.1592/phco.27.3.369
   Catalano A, 2013, EUR J MED CHEM, V64, P357, DOI 10.1016/j.ejmech.2013.03.064
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Cocuaud C, 2005, J ANTIMICROB CHEMOTH, V56, P507, DOI 10.1093/jac/dki269
   COX GM, 1993, CURR OPIN INFECT DIS, V6, P422
   d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458
   de Quadros AU, 2011, FOLIA MICROBIOL, V56, P349, DOI 10.1007/s12223-011-0049-6
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07
   Ferreira J. A. G., 2004, ANTIMICROB AGENTS CH, V53, P4377
   Georgopapadakou NH, 2001, EXPERT OPIN INV DRUG, V10, P269, DOI 10.1517/13543784.10.2.269
   Ghalehnoo ZR, 2010, MICROB PATHOGENESIS, V48, P110, DOI 10.1016/j.micpath.2009.12.003
   Harriott M. M., 2011, THESIS
   Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450
   Jacobson MJ, 2008, ANTIMICROB AGENTS CH, V52, P2242, DOI 10.1128/AAC.00211-08
   Kim R, 2007, EXPERT OPIN PHARMACO, V8, P1479, DOI 10.1517/14656566.8.10.1479
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002
   Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186
   Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345
   Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009
   Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1
   Mukherjee PK, 2003, INFECT IMMUN, V71, P4333, DOI 10.1128/IAI.71.84333-4340.2003
   Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002
   Nett JE, 2014, EXPERT REV ANTI-INFE, V12, P375, DOI 10.1586/14787210.2014.885838
   Noverr MC, 2002, INFECT IMMUN, V70, P400, DOI 10.1128/IAI.70.1.400-402.2002
   Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001
   Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689
   PFALLER M, 1989, EUR J CLIN MICROBIOL, V8, P564, DOI 10.1007/BF01967483
   Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06
   Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10
   Pina-Vaz C, 2000, J MED MICROBIOL, V49, P831, DOI 10.1099/0022-1317-49-9-831
   Ramage G, 2001, Am Clin Lab, V20, P42
   Rosato A, 2013, J ANTIBIOT, V66, P701, DOI 10.1038/ja.2013.83
   Rosato A, 2012, MED CHEM, V8, P690, DOI 10.2174/157340612801216184
   Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x
   Simitsopoulou M, 2013, ANTIMICROB AGENTS CH, V57, P2562, DOI 10.1128/AAC.02541-12
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
NR 45
TC 6
Z9 7
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD MAR 1
PY 2016
VL 24
IS 5
BP 1002
EP 1005
DI 10.1016/j.bmc.2016.01.026
PG 4
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA DD5UH
UT WOS:000369989500009
PM 26833243
DA 2018-10-20
ER

PT J
AU Mosbahi, S
   Oudadesse, H
   Wers, E
   Trigui, M
   Lefeuvre, B
   Roiland, C
   Elfeki, H
   Elfeki, A
   Rebai, T
   Keskes, H
AF Mosbahi, Siwar
   Oudadesse, Hassane
   Wers, Eric
   Trigui, Moez
   Lefeuvre, Bertrand
   Roiland, Claire
   Elfeki, Hafed
   Elfeki, Abdelfatteh
   Rebai, Tareq
   Keskes, Hassib
TI Study of bioactive glass ceramic for use as bone biomaterial in vivo:
   Investigation by nuclear magnetic resonance and histology
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Porous glass ceramic; Nuclear magnetic resonance; Crystalline structure;
   Cells attachment
ID ALKALINE-PHOSPHATASE ACTIVITY; ZINC-DEFICIENCY; VITRO; IMPLANTS;
   APATITE; RATS; METABOLISM; BIOGLASS; CELLS; ZN
AB The performance of the porous glass ceramic doped with 10 wt% Zinc and 2 wt% TiN (46S6-10Zn), in the restoration of critical diaphyseal bone defect, was evaluated by several physicochemical methods and histological studies. The critical defect in rabbits was created and then filled with 46S6-10Zn. At different periods after implementation, animals were sacrificed. Samples were harvested for exploration. The nuclear magnetic resonance (MAS-NMR) of P-31 and Si-29 illustrates the progressive degradation of 46S6-10Zn in favor to of the formation and the development of biological apatite. Therefore, after one month of implementation, MAS-NMR Si-29 proves the presence of Q(2) (25%), Q(3) (73%) and Q(4) (2%). However, after six months, the disappearance of all these species was revealed and characterized by the 46S6-10Zn dissolution. Besides, MAS-NMR P-31 demonstrates the presence of Q(C)(0) (4%), Q(HA)(0) (55%) and Q(a)(0) (41%) after one month. Nevertheless, six months later, we observe the presence of Q(HA)(0) (80%) and Q(a)(0) (20%). Histological study demonstrates an intimate contact of 46S6-10Zn surrounding bone after one month of implantation. However, after four months, mature bone matrix became calcified and the implanted 46S6-10Zn began to be degraded. Moreover, nine months later, 46S6-10Zn was nearly resorbed and replaced by a calcified tissue in the periphery and an osteoid tissue in the middle of bone defects. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Mosbahi, Siwar; Oudadesse, Hassane; Wers, Eric; Lefeuvre, Bertrand; Roiland, Claire] Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
   [Mosbahi, Siwar; Trigui, Moez; Rebai, Tareq; Keskes, Hassib] Sfax Fac Med, Onhopaed & Traumatol Lab, Sfax, Tunisia.
   [Elfeki, Hafed] Sfax Fac Sci, Sci Mat & Environm Lab, Sfax, Tunisia.
   [Elfeki, Abdelfatteh] Sfax Fac Sci, Dept Life Sci, Anim Ecophys Lab, Sfax, Tunisia.
RP Oudadesse, H (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
OI roiland, claire/0000-0001-9587-1340
FU CNRST, Rabat, Morroco
FX The authors would like to acknowledge Francis GOUTTE-FANGEAS and Loic
   JOANNY(CMEBA, University of Rennes 1), for their help and their
   contribution during this work, and radiotherapy service in Sfax for
   their help for the sterilization of materials. Also, they would like to
   thank Professor A. Barroug from University of Cadi Ayyad, Marrakech,
   Morroco. This work concerns a part of our FINCOME program and
   collaboration supported by CNRST, Rabat, Morroco.
CR ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Bui XV, 2010, J AUST CERAM SOC, V46, P24
   Classen Hans-Georg, 2011, Med Monatsschr Pharm, V34, P87
   Dietrich E., 2009, BIOMED MAT RES A, V10, P1002
   Erol M, 2010, CHEM ENG TECHNOL, V33, P1066, DOI 10.1002/ceat.200900495
   Fetner A E, 1994, Compendium, V15, P935
   Garip S, 2010, J PHARMACEUT BIOMED, V52, P580, DOI 10.1016/j.jpba.2010.01.044
   Grussaute H, 2000, J NON-CRYST SOLIDS, V263, P312, DOI 10.1016/S0022-3093(99)00643-2
   Hall SL, 1999, CALCIFIED TISSUE INT, V64, P163, DOI 10.1007/s002239900597
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HSIEH HS, 1980, J NUTR, V110, P1581
   Ishikawa K, 2002, BIOMATERIALS, V23, P423, DOI 10.1016/S0142-9612(01)00121-1
   Kourkoumelis N, 2010, THESCIENTIFICWORLDJO, V10, P402, DOI 10.1100/tsw.2010.43
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   MCCARTHY TJ, 1992, J CLIN PHARM THER, V17, P51, DOI 10.1111/j.1365-2710.1992.tb01265.x
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Ohtsubo S, 2003, HISTOL HISTOPATHOL, V18, P153, DOI 10.14670/HH-18.153
   ONER G, 1984, ENDOCRINOLOGY, V114, P1860, DOI 10.1210/endo-114-5-1860
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Singh K, 2010, J MECH SCI TECHNOL, V24, P1661, DOI 10.1007/s12206-010-0524-z
   Solomons NW, 1998, NUTR REV, V56, P27
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Wers E. ., 2014, ELABORATION BIOMATER
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   YAMAGUCHI M, 1986, BIOCHEM PHARMACOL, V35, P773, DOI 10.1016/0006-2952(86)90245-5
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   YAMAGUCHI M, 1986, RES EXP MED, V186, P337, DOI 10.1007/BF01852099
NR 34
TC 1
Z9 1
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2016
VL 42
IS 4
BP 4827
EP 4836
DI 10.1016/j.ceramint.2015.11.168
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA DC8HM
UT WOS:000369460500025
DA 2018-10-20
ER

PT J
AU Brandes, C
   Tague, ACM
   Kroll, S
   Treccani, L
   Rezwan, K
AF Brandes, Christoph
   Tague, Armelle Cathy Megne
   Kroll, Stephen
   Treccani, Laura
   Rezwan, Kurosch
TI Gel casting of large area micro- and sub-micropatterned thin ceramic
   tapes
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Gel casting; Flexible ceramic tape; Micropatterning; High-precision
   pattern-contour; 3D-surface profilometry
ID FLEXURAL STRENGTH; SODIUM ALGINATE; SURFACES; ZIRCONIA; HYDROXYAPATITE;
   FABRICATION; GELATION; ALUMINA; ARRAYS; BIOCERAMICS
AB In this study an easy-to-use ceramic processing technique based on temperature-controlled ionotropic gelation of alginate is presented. This method is the breakthrough for simultaneously large scale tape casting and high quality patterning of thin ceramic tapes Alumina powder (d(50) = 205 nm) is used to cast flexible and on demand shapeable tapes. Compared to conventional ceramic micropatterning, ionotropic gelation combines complexity of the patterned structure over large-scale areas, a high pattern resolution down to sub-pm regime (similar to 400 nm) and tape thickness below 300 mu m. Obtained green and sintered (1350 degrees C) micro- and sub-micropatterns are characterized by SEM and quantitative 3D-profilometry focusing on both, pattern quality and pattern aspect ratio. The results show that reproducible thin ceramic tapes featuring positive and negative patterns maintain their aspect ratios after demolding, drying and sintering. This processing route represents a versatile tool for designing tailored ceramics for e.g. microelectromechanical engineered systems, biomaterial or microfluidic applications. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Brandes, Christoph; Tague, Armelle Cathy Megne; Kroll, Stephen; Treccani, Laura; Rezwan, Kurosch] Univ Bremen, Adv Ceram, Biologischen Garten 2, D-28359 Bremen, Germany.
   [Kroll, Stephen; Rezwan, Kurosch] Univ Bremen, MAPEX Ctr Mat & Proc, Biologischen Garten 2, D-28359 Bremen, Germany.
RP Treccani, L (reprint author), Univ Bremen, Adv Ceram, Biologischen Garten 2, D-28359 Bremen, Germany.
EM treccani@uni-bremen.de
RI Treccani, Laura/R-1725-2016; Rezwan, Kurosch/K-9451-2013
OI Treccani, Laura/0000-0001-5365-9827; Rezwan, Kurosch/0000-0002-7318-1119
FU European Research Council within the BiocerEng [205509]
FX We thank the European Research Council for financial support within the
   BiocerEng, Project No. 205509.
CR Abdulbari HA, 2013, J IND ENG CHEM, V19, P27, DOI 10.1016/j.jiec.2012.07.023
   [Anonymous], 2010, 4287 DIN EN ISO
   Berger J, 2011, APPL SURF SCI, V257, P3081, DOI 10.1016/j.apsusc.2010.10.120
   Bernardo E, 2014, CERAM INT, V40, P1029, DOI 10.1016/j.ceramint.2013.06.100
   Bertazzo S, 2010, LANGMUIR, V26, P3364, DOI 10.1021/la903140k
   Brandes C, 2014, J AM CERAM SOC, V97, P1393, DOI 10.1111/jace.12877
   Chen B, 2013, J AM CERAM SOC, V96, P73, DOI 10.1111/jace.12069
   Danzer R, 2014, J EUR CERAM SOC, V34, P3435, DOI 10.1016/j.jeurceramsoc.2014.04.026
   de Abajo FJG, 2007, REV MOD PHYS, V79, P1267, DOI 10.1103/RevModPhys.79.1267
   Diao CL, 2014, CERAM INT, V40, P13827, DOI 10.1016/j.ceramint.2014.05.099
   Donthu SK, 2005, J APPL PHYS, V98, DOI 10.1063/1.1949712
   Holthaus MG, 2012, J MATER PROCESS TECH, V212, P614, DOI 10.1016/j.jmatprotec.2011.06.007
   Holthaus MG, 2011, J EUR CERAM SOC, V31, P2809, DOI 10.1016/j.jeurceramsoc.2011.07.020
   Holthaus MG, 2010, J AM CERAM SOC, V93, P2574, DOI 10.1111/j.1551-2916.2010.03902.x
   HOTZA D, 1995, MAT SCI ENG A-STRUCT, V202, P206, DOI 10.1016/0921-5093(95)09785-6
   Hozumi A, 2011, MATER CHEM PHYS, V129, P464, DOI 10.1016/j.matchemphys.2011.04.048
   Nieto MI, 2014, ADV ENG MATER, V16, P637, DOI 10.1002/adem.201400076
   Jagdheesh R, 2014, LANGMUIR, V30, P12067, DOI 10.1021/la5033527
   Jimenez J, 2004, ANNU REV FLUID MECH, V36, P173, DOI 10.1146/annurev.fluid.36.050802.122103
   Kristoffersson A, 1997, J EUR CERAM SOC, V17, P289, DOI 10.1016/S0955-2219(96)00143-4
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lewis JA, 2000, J AM CERAM SOC, V83, P2341
   Li F, 2014, J ALLOY COMPD, V614, P394, DOI 10.1016/j.jallcom.2014.06.117
   Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213
   Liu YT, 2013, COLLOID SURFACE B, V106, P37, DOI 10.1016/j.colsurfb.2013.01.023
   Liu Y, 2014, J MEMBRANE SCI, V467, P100, DOI 10.1016/j.memsci.2014.05.020
   Nadeem D, 2013, J BIOMED MATER RES A, V101, P3247, DOI 10.1002/jbm.a.34622
   Ohashi N, 2007, J ELECTROCHEM SOC, V154, pD82, DOI 10.1149/1.2402991
   Ritzhaupt-Kleissl H.J., 2008, MICROENGINEERING MET, P421
   Roy T, 2014, CERAM INT, V40, P2381, DOI 10.1016/j.ceramint.2013.08.009
   Ruschel VC, 2014, J PROSTHET DENT, V112, P903, DOI 10.1016/j.prosdent.2014.04.003
   Santacruz I, 2002, MATER RES BULL, V37, P671, DOI 10.1016/S0025-5408(02)00686-4
   Selimovic A, 2014, ANALYST, V139, P5686, DOI 10.1039/c4an01062k
   Shan XC, 2009, MICROSYST TECHNOL, V15, P1319, DOI 10.1007/s00542-008-0739-4
   Souza ROA, 2013, J MECH BEHAV BIOMED, V26, P155, DOI 10.1016/j.jmbbm.2013.04.018
   Stefanic M, 2014, J MATER SCI-MATER M, V25, P2333, DOI 10.1007/s10856-014-5246-9
   Su B, 2012, J EUR CERAM SOC, V32, P3345, DOI 10.1016/j.jeurceramsoc.2012.04.009
   Su B, 2002, J MATER SCI, V37, P3123, DOI 10.1023/A:1016198009368
   Thampi VVA, 2014, CERAM INT, V40, P14355, DOI 10.1016/j.ceramint.2014.06.027
   Treccani L, 2009, ADV ENG MATER, V11, pB61, DOI 10.1002/adem.200800372
   Vasconcellos FD, 2014, ACS PHOTONICS, V1, P489, DOI 10.1021/ph400149m
   Wang X, 2002, CERAM INT, V28, P865, DOI 10.1016/S0272-8842(02)00066-4
   Xie ZP, 2001, J MATER SCI LETT, V20, P1255, DOI 10.1023/A:1010943427450
   Zapata-Solvas E, 2014, J EUR CERAM SOC, V34, P3535, DOI 10.1016/j.jeurceramsoc.2014.06.004
   Zhang X, 2013, APPL SURF SCI, V287, P329, DOI 10.1016/j.apsusc.2013.09.151
NR 45
TC 2
Z9 2
U1 6
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2016
VL 42
IS 4
BP 5036
EP 5044
DI 10.1016/j.ceramint.2015.12.015
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA DC8HM
UT WOS:000369460500049
DA 2018-10-20
ER

PT J
AU Ajioka, I
AF Ajioka, Itsuki
TI Biomaterial-engineering and neurobiological approaches for regenerating
   the injured cerebral cortex
SO REGENERATIVE THERAPY
LA English
DT Review
DE Cerebral cortex; Regeneration; Cell cycle; Biomaterials
ID NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; MARROW
   STROMAL CELLS; RETINOBLASTOMA PROTEIN; HORIZONTAL INTERNEURONS;
   ALZHEIMERS-DISEASE; CORTICAL-NEURONS; TRANSPLANTATION; NEUROGENESIS
AB The cerebral cortex is responsible for higher functions of the central nervous system (CNS), such as movement, sensation, and cognition. When the cerebral cortex is severely injured, these functions are irreversibly impaired. Although recent neurobiological studies reveal that the cortex has the potential for regeneration, therapies for functional recovery face some technological obstacles. Biomaterials have been used to evoke regenerative potential and promote regeneration in several tissues, including the CNS. This review presents a brief overview of new therapeutic strategies for cortical regeneration from the perspectives of neurobiology and biomaterial engineering, and discusses a promising technology for evoking the regenerative potential of the cerebral cortex. (c) 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
C1 [Ajioka, Itsuki] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Ajioka, Itsuki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.
RP Ajioka, I (reprint author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, 1-5-45 Yushima, Tokyo 1138510, Japan.
EM iajioka@ams.kuramae.ne.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT)
   [26106711]; Terumo Life Science Foundation
FX This work was supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology
   (MEXT) (26106711) and by the Terumo Life Science Foundation.
CR Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036
   Ajioka I, 2015, TISSUE ENG PT A, V21, P193, DOI [10.1089/ten.tea.2014.0080, 10.1089/ten.TEA.2014.0080]
   Ajioka I, 2014, DEV GROWTH DIFFER, V56, P324, DOI 10.1111/dgd.12127
   Ajioka I, 2011, BIOMATERIALS, V32, P5765, DOI 10.1016/j.biomaterials.2011.04.062
   Andrusiak MG, 2012, J NEUROSCI, V32, P14809, DOI 10.1523/JNEUROSCI.1912-12.2012
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007
   Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730
   Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399
   CAJAL SRY, 1913, ESTUDIOS DEGENERACIO
   Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   El-Khodor BF, 2003, EXP NEUROL, V179, P17, DOI 10.1006/exnr.2002.8047
   Elias PZ, 2012, J NEUROSCI METH, V209, P199, DOI 10.1016/j.jneumeth.2012.06.003
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002
   Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338
   Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124
   Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040
   Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008
   Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101
   Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618
   Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Le Magueresse C, 2012, CEREB CORTEX, V22, P2285, DOI 10.1093/cercor/bhr302
   LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   MACKLIS JD, 1993, J NEUROSCI, V13, P3848
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003
   MCCONNELL SK, 1988, J NEUROSCI, V8, P945
   McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005
   Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106
   Mohamad O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064160
   Nguyen MD, 2003, J NEUROSCI, V23, P2131
   Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384
   Oshikawa M, 2013, DEVELOPMENT, V140, P2310, DOI 10.1242/dev.095653
   Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197
   Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997
   Pittenger MF, 2011, SCIENCE, V143, P143
   Ratner B. D., 2012, BIOMATERIALS SCI INT
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006
   Silva ART, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099897
   Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   Williams D., 1986, P CONSC EUR SOC BIOM, V4, P414
   Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006
   Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001
   Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6
   Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
NR 68
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3204
J9 REGEN THER
JI Regen. Ther.
PD MAR
PY 2016
VL 3
SI SI
BP 63
EP 67
DI 10.1016/j.reth.2016.02.002
PG 5
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA FR1NM
UT WOS:000418834300010
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Abdal-hay, A
   Hussein, KH
   Casettari, L
   Khalil, KA
   Hamdy, AS
AF Abdal-hay, Abdalla
   Hussein, Kamal Hany
   Casettari, Luca
   Khalil, Khalil Abdelrazek
   Hamdy, Abdel Salam
TI Fabrication of novel high performance ductile poly(lactic acid)
   nanofiber scaffold coated with poly(vinyl alcohol) for tissue
   engineering applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly lactic acid; Poly vinyl alcohol; Tissue regeneration; Hydrothermal
   deposition; Nanofiber scaffolds; Cytocompatibility; Biodegradable
   synthetic polymers
ID ELECTROSPUN NYLON-6 NANOFIBERS; MECHANICAL-PROPERTIES; SURFACE
   MODIFICATION; BONE REGENERATION; BLENDS; PLA; HYDROXYAPATITE; MEMBRANE;
   POLYMERS; MATRIX
AB Poly(lactic acid) (PLA) nanofiber scaffold has received increasing interest as a promising material for potential application in the field of regenerative medicine. However, the low hydrophilicity and poor ductility restrict its practical application. Integration of hydrophilic elastic polymer onto the surface of the nanofiber scaffold may help to overcome the drawbacks of PLA material. Herein, we successfully optimized the parameters for in situ deposition of poly(vinyl alcohol), (PVA) onto post-electrospun PLA nanofibers using a simple hydrothermal approach. Our results showed that the average fiber diameter of coated nanofiber mat is about 1265 +/- 222 nm, which is remarkably higher than its pristine counterpart (650 +/- 180 nm). The hydrophilicity of PIA nanofiber scaffold coated with a PVA thin layer improved dramatically (36.11 +/- 1.5 degrees) compared to that of pristine PLA (119.7 +/- 1.5 degrees) scaffold. The mechanical testing showed that the PLA nanofiber scaffold could be converted from rigid to ductile with enhanced tensile strength, due to maximizing the hydrogen bond interaction during the heat treatment and in the presence of PVA. Cytocompatibility performance of the pristine and coated PLA fibers with PVA was observed through an in vitro experiment based on cell attachment and the MTT assay by EA.hy926 human endothelial cells. The cytocompatibility results showed that human cells induced more favorable attachment and proliferation behavior on hydrophilic PLA composite scaffold than that of pristine PLA. Hence, PVA coating resulted in an increase in initial human cell attachment and proliferation. We believe that the novel PVA-coated PLA nanofiber scaffold developed in this study, could be a promising high performance biomaterial in regeneration medicine. (C) 2015 Published by Elsevier B.V.
C1 [Abdal-hay, Abdalla] South Valley Univ, Fac Engn, Dept Engn Mat & Mech Design, Qena 83523, Egypt.
   [Hussein, Kamal Hany] Kangwon Natl Univ, Stem Cell Inst, Chunchon 200701, Gangwon, South Korea.
   [Hussein, Kamal Hany] Kangwon Natl Univ, Coll Vet Med, Chunchon 200701, Gangwon, South Korea.
   [Casettari, Luca] Univ Urbino, Dept Biomol Sci, Piazza Rinascimento 6, I-61029 Urbino, PU, Italy.
   [Khalil, Khalil Abdelrazek] King Saud Univ, Coll Engn, Dept Mech Engn, Riyadh 11421, Saudi Arabia.
   [Khalil, Khalil Abdelrazek] Aswan Univ, Fac Energy Engn, Dept Mech Engn, Aswan, Egypt.
   [Hamdy, Abdel Salam] Univ Texas Rio Grande Valley, Coll Engn & Comp Sci, Dept Mfg & Ind Engn, 1201 West Univ Dr, Edinburg, TX 78541 USA.
RP Abdal-hay, A (reprint author), South Valley Univ, Fac Engn, Dept Engn Mat & Mech Design, Qena 83523, Egypt.; Khalil, KA (reprint author), King Saud Univ, Coll Engn, Dept Mech Engn, POB 800, Riyadh 11421, Saudi Arabia.
EM abda_55@jbnu.ac.kr
RI Casettari, Luca/G-8518-2015
OI Casettari, Luca/0000-0001-6907-8904; Abdal-hay,
   Abdalla/0000-0001-6307-6027
FU Deanship of Scientific Research at King Saud University [RG 1435-001]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University for funding this
   Research Group NO. (RG 1435-001).
CR Abdal-hay A., 2013, COLLOID SURF A, P37
   Abdal-Hay A, 2014, MATER LETT, V137, P378, DOI 10.1016/j.matlet.2014.09.034
   Abdal-hay A, 2014, CERAM INT, V40, P4995, DOI 10.1016/j.ceramint.2013.08.057
   Abdal-hay A, 2013, CHEM ENG J, V228, P708, DOI 10.1016/j.cej.2013.05.022
   Abdal-hay A, 2013, EUR POLYM J, V49, P1314, DOI 10.1016/j.eurpolymj.2013.02.004
   Abdal-haya A, 2013, COLLOID SURFACE B, V102, P635, DOI 10.1016/j.colsurfb.2012.09.017
   Asran A., 2010, BIOMACROMOLECULES, P3413
   Chen BK, 2010, POLYMER, V51, P4667, DOI 10.1016/j.polymer.2010.08.028
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Cossement D, 2006, APPL SURF SCI, V252, P6636, DOI 10.1016/j.apsusc.2006.02.225
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Franco RA, 2014, POLYM ADVAN TECHNOL, V25, P55, DOI 10.1002/pat.3205
   Grumezescu V, 2014, APPL SURF SCI, V302, P262, DOI 10.1016/j.apsusc.2013.09.081
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Jorda-Vilaplana A, 2014, EUR POLYM J, V58, P23, DOI 10.1016/j.eurpolymj.2014.06.002
   Jung YH, 2005, MACROMOL RES, V13, P385, DOI 10.1007/BF03218470
   Kang S., 2001, MACROMOLECULES, P4542
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Leiggener CS, 2006, BIOMATERIALS, V27, P202, DOI 10.1016/j.biomaterials.2005.05.068
   Li J, 2008, APPL SURF SCI, V255, P494, DOI 10.1016/j.apsusc.2008.06.067
   Liu CB, 2007, COLLOID SURFACE A, V302, P430, DOI 10.1016/j.colsurfa.2007.03.006
   Liu X, 1997, J ENVIRON POLYM DEGR, V5, P225
   Ma GP, 2010, POLYM ADVAN TECHNOL, V21, P189, DOI 10.1002/pat.1415
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   Meneghello G, 2009, J MEMBRANE SCI, V344, P55, DOI 10.1016/j.memsci.2009.07.034
   MIKOS AG, 1989, POLYMER, V30, P84, DOI 10.1016/0032-3861(89)90387-X
   Nisbet DR, 2009, COLLOID SURFACE B, V71, pCP1, DOI 10.1016/j.colsurfb.2009.01.022
   Norton AB, 2014, FOOD HYDROCOLLOID, V42, P373, DOI 10.1016/j.foodhyd.2014.05.001
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Papkov D, 2013, ACS NANO, V7, P3324, DOI 10.1021/nn400028p
   Pi PH, 2013, APPL SURF SCI, V273, P184, DOI 10.1016/j.apsusc.2013.02.011
   Pitarresi G, 2012, J BIOMED MATER RES A, V100A, P1565, DOI 10.1002/jbm.a.34095
   Qazi TH, 2014, BIOMATERIALS, V35, P9068, DOI 10.1016/j.biomaterials.2014.07.020
   Ribeiro C, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/1/015001
   Rogina A, 2014, APPL SURF SCI, V296, P221, DOI 10.1016/j.apsusc.2014.01.098
   Sarapirom S, 2014, APPL SURF SCI, V310, P42, DOI 10.1016/j.apsusc.2014.03.141
   SCHMITT EA, 1994, MACROMOLECULES, V27, P743, DOI 10.1021/ma00081a019
   Shuai X, 2001, J APPL POLYM SCI, V81, P762, DOI 10.1002/app.1493
   Tsuji H, 2001, J APPL POLYM SCI, V81, P2151, DOI 10.1002/app.1651
   Yang DZ, 2007, CARBOHYD POLYM, V69, P538, DOI 10.1016/j.carbpol.2007.01.008
   You Y, 2006, MATER LETT, V60, P1331, DOI 10.1016/j.matlet.2005.11.022
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 43
TC 22
Z9 22
U1 8
U2 147
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 143
EP 150
DI 10.1016/j.msec.2015.11.024
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700018
PM 26706517
DA 2018-10-20
ER

PT J
AU Hedayati, R
   Sadighi, M
   Mohammadi-Aghdam, M
   Zadpoor, AA
AF Hedayati, R.
   Sadighi, M.
   Mohammadi-Aghdam, M.
   Zadpoor, A. A.
TI Mechanical properties of regular porous biomaterials made from truncated
   cube repeating unit cells: Analytical solutions and computational models
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Porous biomaterials; Mechanical behavior; Analytical; Lattice structure
ID LATTICE CELLULAR STRUCTURES; LINEAR ELASTIC BEHAVIOR; FINITE-ELEMENT;
   TISSUE-GROWTH; BONE TISSUE; TITANIUM; GEOMETRY; FOAMS; MICROSTRUCTURE;
   ARTHROPLASTY
AB Additive manufacturing (AM) has enabled fabrication of open-cell porous biomaterials based on repeating unit cells. The micro-architecture of the porous biomaterials and, thus, their physical properties could then be precisely controlled. Due to their many favorable properties, porous biomaterials manufactured using AM are considered as promising candidates for bone substitution as well as for several other applications in orthopedic surgery. The mechanical properties of such porous structures including static and fatigue properties are shown to be strongly dependent on the type of the repeating unit cell based on which the porous biomaterial is built. In this paper, we study the mechanical properties of porous biomaterials made from a relatively new unit cell, namely truncated cube. We present analytical solutions that relate the dimensions of the repeating unit cell to the elastic modulus, Poisson's ratio, yield stress, and buckling load of those porous structures. We also performed finite element modeling to predict the mechanical properties of the porous structures. The analytical solution and computational results were found to be in agreement with each other. The mechanical properties estimated using both the analytical and computational techniques were somewhat higher than the experimental data reported in one of our recent studies on selective laser melted Ti-6Al-4V porous biomaterials. In addition to porosity, the elastic modulus and Poisson's ratio of the porous structures were found to be strongly dependent on the ratio of the length of the inclined struts to that of the uninclined (i.e. vertical or horizontal) struts, a, in the truncated cube unit cell. The geometry of the truncated cube unit cell approaches the octahedral and cube unit cells when a respectively approaches zero and infinity. Consistent with those geometrical observations, the analytical solutions presented in this study approached those of the octahedral and cube unit cells when a approached respectively 0 and infinity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Hedayati, R.; Sadighi, M.; Mohammadi-Aghdam, M.] Amirkabir Univ Technol, Tehran Polytech, Dept Mech Engn, Hafez Ave, Tehran, Iran.
   [Hedayati, R.; Zadpoor, A. A.] Delft Univ Technol, Fac Mech Maritime & Mat Engn, Dept Biomech Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
RP Hedayati, R (reprint author), Amirkabir Univ Technol, Tehran Polytech, Dept Mech Engn, Hafez Ave, Tehran, Iran.
EM rezahedayati@gmail.com
RI Hedayati, Reza/F-8806-2014; Zadpoor, Amir A/A-8510-2008; Aghdam,
   M./I-5723-2018
OI Hedayati, Reza/0000-0002-4806-3970; Aghdam, M./0000-0003-3403-0307;
   Zadpoor, Amir Abbas/0000-0003-3234-2112
CR Ahmadi SM, 2014, J MECH BEHAV BIOMED, V34, P106, DOI 10.1016/j.jmbbm.2014.02.003
   Ahmadi SM, 2015, MATERIALS, V8, P1871, DOI 10.3390/ma8041871
   Babaee S, 2012, ACTA MATER, V60, P2873, DOI 10.1016/j.actamat.2012.01.052
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Bidan CM, 2013, ADV HEALTHC MATER, V2, P186, DOI 10.1002/adhm.201200159
   Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336
   Bitsche R, 2005, SPACE FILLING POLYHE
   Borleffs M.S., 2012, FINITE ELEMENT MODEL
   Buffel B, 2014, INT J SOLIDS STRUCT, V51, P3461, DOI 10.1016/j.ijsolstr.2014.06.017
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Cansizoglu O, 2008, MAT SCI ENG A-STRUCT, V492, P468, DOI 10.1016/j.msea.2008.04.002
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Hasan MA, 2010, ADV MAT SCI ENG, V2010
   Hedayati R, 2017, APPL MATH MODEL, V46, P408, DOI 10.1016/j.apm.2017.01.076
   Hedayati R, 2016, INT J MECH SCI, V106, P19, DOI 10.1016/j.ijmecsci.2015.11.033
   Hedayati R, 2016, INT J FATIGUE, V84, P67, DOI 10.1016/j.ijfatigue.2015.11.017
   Hedayati R, 2016, MATER DESIGN, V89, P9, DOI 10.1016/j.matdes.2015.09.052
   Hedayati R, 2016, J MECH BEHAV BIOMED, V53, P272, DOI 10.1016/j.jmbbm.2015.07.013
   Hedayati R., 2015, COMPARISON OF ELASTI
   Heinl P, 2008, ADV ENG MATER, V10, P882, DOI 10.1002/adem.200800137
   Hou C., 2013, NUMERICAL EXPT CRASH
   Joshi MG, 2000, J BIOMECH, V33, P1655, DOI 10.1016/S0021-9290(00)00110-X
   Karachalios T, 2004, J ARTHROPLASTY, V19, P469, DOI 10.1016/j.arth.2003.12.081
   Kim A, 2006, MODEL SIMUL MATER SC, V14, P933, DOI 10.1088/0965-0393/14/6/004
   Kraynik AM, 1996, J COLLOID INTERF SCI, V181, P511, DOI 10.1006/jcis.1996.0408
   Kuczynski K, 1967, INT J MECH SCI, V9, P609, DOI DOI 10.1016/0020-7403(67)90066-5
   Labeas GN, 2010, STRAIN, V46, P195
   Luxner MH, 2009, ACTA BIOMATER, V5, P381, DOI 10.1016/j.actbio.2008.07.025
   Mills NJ, 2009, INT J SOLIDS STRUCT, V46, P677, DOI 10.1016/j.ijsolstr.2008.09.012
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010
   Niendorf T, 2014, METALL MATER TRANS B, V45, P1181, DOI 10.1007/s11663-014-0086-z
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Ptochos E, 2012, STRAIN, V48, P415, DOI 10.1111/j.1475-1305.2012.00837.x
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Senthilkumar S., 2014, WALAILAK J SCI TECHN, V11, pi
   Shulmeister V, 1998, MECH MATER, V30, P125, DOI 10.1016/S0167-6636(98)00033-7
   Smith M, 2013, INT J MECH SCI, V67, P28, DOI 10.1016/j.ijmecsci.2012.12.004
   Sun J., 2012, ADV MECH ENG, V2012
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   Vigliotti A, 2012, COMPUT METHOD APPL M, V229, P27, DOI 10.1016/j.cma.2012.03.018
   Warren WE, 1997, J APPL MECH-T ASME, V64, P787, DOI 10.1115/1.2788983
   Yavari SA, 2014, J MECH BEHAV BIOMED, V36, P109, DOI 10.1016/j.jmbbm.2014.04.010
   Yavari SA, 2014, APPL SURF SCI, V290, P287, DOI 10.1016/j.apsusc.2013.11.069
   Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054
   Zadpoor AA, 2015, BIOMATER SCI-UK, V3, P231, DOI 10.1039/c4bm00291a
   Zadpoor AA, 2008, J MATER PROCESS TECH, V200, P288, DOI 10.1016/j.jmatprotec.2007,09.049
   Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 51
TC 29
Z9 29
U1 5
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 163
EP 183
DI 10.1016/j.msec.2015.11.001
PG 21
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700021
PM 26706520
DA 2018-10-20
ER

PT J
AU Kose, C
   Kacar, R
   Zorba, AP
   Bagirova, M
   Allahverdiyev, AM
AF Kose, Ceyhun
   Kacar, Ramazan
   Zorba, Asli Pinar
   Bagirova, Melahat
   Allahverdiyev, Adil M.
TI The effect of CO2 laser beam welded AISI 316L austenitic stainless steel
   on the viability of fibroblast cells, in vitro
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Laser beam welding; Austenitic stainless steel; L929 fibroblast cell;
   Viability; Tukey test
ID SIMULATED BODY-FLUIDS; MECHANICAL-PROPERTIES; CORROSION BEHAVIOR;
   ORTHOPEDIC IMPLANTS; LASER; SURFACE; NITROGEN; MICROSTRUCTURE;
   CYTOTOXICITY
AB It has been determined by the literature research that there is no clinical study on the in vivo and in vitro interaction of the cells with the laser beam welded joints of AISI 316L biomaterial. It is used as a prosthesis and implant material and that has adequate mechanical properties and corrosion resistance characteristics. Therefore, the interaction of the CO2 laser beam welded samples and samples of the base metal of AISI 316L austenitic stainless steel with L929 fibroblast cells as an element of connective tissue under in vitro conditions has been studied. To study the effect of the base metal and the laser welded test specimens on the viability of the fibroblast cells that act as an element of connective tissues in the body, they were kept in DMEMF-12 medium for 7, 14, 28 days and 18 months. The viability study was experimentally studied using the MTF method for 7, 14, 28 days. In addition, the direct interaction of the fibroblast cells seeded on 6 different plates with the samples was examined with an inverted microscope. The MIT cell viability experiment was repeated on the cells that were in contact with the samples. The statistical relationship was analyzed using a Tukey test for the variance with the GraphPad statistics software. The data regarding metallic ion release were identified with the ICP-MS method after the laser welded and main material samples were kept in cell culture medium for 18 months.
   The cell viability of the laser welded sample has been detected to be higher than that of the base metal and the control based on 7th day data. However, the laser welded sample's viability of the fibroblast cells has diminished by time during the test period of 14 and 28 days and base metal shows better viability when compared to the laser welded samples. On the other hand, the base metal and the laser welded sample show better cell viability effect when compared to the control group. According to the ICP-MS results of the main material and laser welded samples which were kept in the cell culture medium for 18 months, it was determined that the Fe, Ni and Cr ion concentration released to the cell culture medium from the laser welded test sample was less than that of the main material. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kose, Ceyhun] Gaziosmanpasa Univ, Dept Mech Engn, Fac Nat Sci & Engn, TR-60150 Tokat, Turkey.
   [Kacar, Ramazan] Karabuk Univ, Fac Technol, Dept Mfg Engn, TR-78050 Karabuk, Turkey.
   [Zorba, Asli Pinar] Yildiz Tekn Univ, Dept Bioengn Cell Culture & Tissue Engn, Grad Sch Nat & Appl Sci, Istanbul, Turkey.
   [Bagirova, Melahat; Allahverdiyev, Adil M.] Yildiz Tekn Univ, Dept Bioengn Cell Culture & Tissue Engn, Istanbul, Turkey.
RP Kose, C (reprint author), Gaziosmanpasa Univ, Dept Mech Engn, Fac Nat Sci & Engn, TR-60150 Tokat, Turkey.
EM ceyhun.kose@gop.edu.tr; rkacar@karabuk.edu.tr; aslipinarzorba@gmail.com;
   mbagir@yildiz.edu.tr; adil@yildiz.edu.tr
RI Zorba, Asli Pinar/L-6429-2018
OI KOSE, CEYHUN/0000-0002-3907-2226
CR Lopez DA, 2008, J MATER SCI-MATER M, V19, P2137, DOI 10.1007/s10856-007-3138-y
   Alexandra Moisa Bogdan, 2010, Advances in Control, Chemical Engineering, Civil Engineering and Mechanical Engineering. European Conference of Chemical Engineering (ECCE 2010). European Conference of Civil Engineering (ECCIE 2010) European Conference of Mechanical Engineering (ECME 2010). European Conference of Control (ECC 2010), P159
   Balasubramanian K R, 2008, Advances in Production Engineering & Management, V3, P93
   Balla VK, 2013, MAT SCI ENG C-MATER, V33, P4594, DOI 10.1016/j.msec.2013.07.015
   Beddoes J, 1999, INTRO STAINLESS STEE
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   CALLISTER WD, 1994, MAT SCI ENG INTRO
   Celik O., 2009, INT ADV TECHN S KAR
   Chukkan JR, 2015, J MATER PROCESS TECH, V219, P48, DOI 10.1016/j.jmatprotec.2014.12.008
   Dadfar M, 2007, MATER LETT, V61, P2343, DOI 10.1016/j.matlet.2006.09.008
   Davis J. R., 1994, ASM SPECIALITY HDB S
   Duley W. W., 1983, LASER PROCESSING ANA
   Eliades T, 2004, AM J ORTHOD DENTOFAC, V125, P24, DOI 10.1016/j.ajodo.2003.09.009
   Faghihi S, 2012, TISSUE CELL, V44, P365, DOI 10.1016/j.tice.2012.06.002
   Fan X, 2009, T NONFERR METAL SOC, V19, P347, DOI 10.1016/S1003-6326(08)60276-9
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Gopi D, 2014, COLLOID SURFACE B, V114, P234, DOI 10.1016/j.colsurfb.2013.10.011
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hansen D.C., 2008, METAL CORROSION HUMA, P31
   HI Y., 2006, J BIOMED MATER RES A, V76, P835
   Kenar H, 2013, COLLOID SURFACE B, V108, P305, DOI 10.1016/j.colsurfb.2013.02.039
   Kose C, 2015, J FAC ENG ARCHIT GAZ, V30, P225
   Kose C, 2014, MATER TEST, V56, P779, DOI 10.3139/120.110632
   Kose C, 2014, MATER DESIGN, V64, P221, DOI 10.1016/j.matdes.2014.07.044
   Kou S., 2003, WELDING METALLURGY
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Kuroda D., 2008, MAT T, V49, P2844
   Kwok CT, 2006, J MATER PROCESS TECH, V176, P168, DOI 10.1016/j.jmatprotec.2006.03.128
   Lee WS, 2003, MATER TRANS, V44, P2637, DOI 10.2320/matertrans.44.2637
   LIM IAL, 2004, MURJ, V11, P33
   Lippold J. C., 2005, WELDING METALLURGY W
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Ma TC, 2012, J MATER SCI TECHNOL, V28, P647, DOI 10.1016/S1005-0302(12)60111-X
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI [10.2174/1877610801002010040, DOI 10.2174/1877610801002010040]
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Murphy BP, 2003, ANN BIOMED ENG, V31, P686, DOI 10.1114/1.1569268
   Nie FL, 2011, DENT MATER, V27, P677, DOI 10.1016/j.dental.2011.03.009
   Oberringer M, 2013, MAT SCI ENG C-MATER, V33, P901, DOI 10.1016/j.msec.2012.11.018
   Oh KT, 2004, J BIOMED MATER RES B, V69B, P183, DOI 10.1002/jbm.b.30002
   Ozdemir KG, 2009, J BIOMED MATER RES B, V90B, P82, DOI 10.1002/jbm.b.31256
   Pan HA, 2013, BIOMATERIALS, V34, P841, DOI 10.1016/j.biomaterials.2012.09.078
   Reclaru L, 2010, TIMISOARA MED J, V60, P86
   Ruggiero A, 2011, OPT LASER TECHNOL, V43, P82, DOI 10.1016/j.optlastec.2010.05.008
   Salahinejad E., 2013, PLOS ONE, V8, P1
   Samanta SK, 2008, J MATER ENG PERFORM, V17, P908, DOI 10.1007/s11665-008-9235-3
   Sasaki M., 2012, SCI TECHNOL ADV MAT, V13, P1
   Tang YC, 2006, ACTA BIOMATER, V2, P709, DOI 10.1016/j.actbio.2006.06.003
   Terada Maysa, 2006, Mat. Res., V9, P281, DOI 10.1590/S1516-14392006000300007
   Turk R., 2007, MAT GEOENVIRON, V54, P471
   Ventrella A., 2010, J MATER PROCESS TECH, V2010, P1838
   Wan P, 2012, MAT SCI ENG C-MATER, V32, P510, DOI 10.1016/j.msec.2011.12.002
   Zambon A, 2006, MAT SCI ENG A-STRUCT, V424, P117, DOI 10.1016/j.msea.2006.03.003
NR 52
TC 5
Z9 5
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 211
EP 218
DI 10.1016/j.msec.2015.11.035
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700025
PM 26706524
DA 2018-10-20
ER

PT J
AU Huang, QL
   Liu, XJ
   Elkhooly, TA
   Zhang, RR
   Yang, X
   Shen, ZJ
   Feng, QL
AF Huang, Qianli
   Liu, Xujie
   Elkhooly, Tarek A.
   Zhang, Ranran
   Yang, Xing
   Shen, Zhijian
   Feng, Qingling
TI Preparation and characterization of TiO2/silicate hierarchical coating
   on titanium surface for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Micro-arc oxidation; Hydrothermal treatment; Titanium implant; Surface
   topography; Surface chemistry; Calcium silicate hydrate
ID CALCIUM SILICATE; IN-VITRO; HYDROXYAPATITE COATINGS; FORMING ABILITY;
   CELL RESPONSE; PURE TITANIUM; IMPLANTS; BONE; OXIDATION; MINERALIZATION
AB In the current work, TiO2/silicate hierarchical coatings with various nanostructure morphologies were successfully prepared on titanium substrates through micro-arc oxidation (MAO) and subsequent hydrothermal treatment (FIT). Moreover, the nucleation mechanism and growth behavior of the nanostructures, hydrophilicity, protein adsorption and apatite-inducing ability of various coatings were also explored. The novel TiO2/silicate hierarchical coatings comprised calcium silicate hydrate (CSH) as an outer-layer and TiO2 matrix as an inner-layer.According to the morphological features, the nanostructures were classified as nanorod, nanoplate and nanoleaf. The morphology, degree of crystallinity and crystalline phases of CSH nanostructures could be controlled by optimizing the HT conditions. The nucleation of CSH nanostructures is caused by release and re-precipitation mechanism. The TiO2/CSH hierarchical coatings exhibited some enhanced physical and biological performances compared to MAO-fabricated coating. The improvement of the hydrophilicity, fibronectin adsorption and apatite-inducing ability was found to be morphological dependent according to the following trend: nanoleaf coating > nanoplate coating > nanorod coating > MAO coating. The results indicate that the tuning of physical and morphological properties of nanostructures coated on biomaterial surface could significantly influence the hydrophilicity, protein adsorption and in vitro bioactivity of biomaterial. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Huang, Qianli; Liu, Xujie; Elkhooly, Tarek A.; Zhang, Ranran; Yang, Xing; Shen, Zhijian; Feng, Qingling] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
   [Liu, Xujie] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China.
   [Feng, Qingling] Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ China, Key Lab Adv Mat, Beijing 100084, Peoples R China.
   [Elkhooly, Tarek A.] Natl Res Ctr, Inorgan Chem Ind Div, Biomat Dept, Cairo 12622, Egypt.
RP Feng, QL (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
OI Liu, Xujie/0000-0001-8713-4287
FU National Natural Science Foundation of China [51361130032, 51472139];
   Doctor Subject Foundation of the Ministry of Education of China
   [20120002130002]
FX The authors are grateful for the financial support from the National
   Natural Science Foundation of China (51361130032, 51472139) and Doctor
   Subject Foundation of the Ministry of Education of China
   (20120002130002).
CR ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Della Valle C., 2012, J APPL BIOMATER FUNC, V11, pe106
   Diamanti MV, 2011, J APPL BIOMATER BIOM, V9, P55, DOI 10.5301/JABB.2011.7429
   Dou YD, 2012, ACTA BIOMATER, V8, P4139, DOI 10.1016/j.actbio.2012.07.009
   Gittens RA, 2014, ACTA BIOMATER
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002
   Guan JJ, 2015, BIOMATERIALS, V55, P1, DOI 10.1016/j.biomaterials.2015.03.029
   Han G, 2015, MAT SCI ENG C-MATER, V47, P376, DOI 10.1016/j.msec.2014.11.021
   Hu HJ, 2013, COLLOID SURFACE B, V101, P83, DOI 10.1016/j.colsurfb.2012.06.021
   Huang Q., 2015, COLLOIDS SURF B
   Huang QL, 2015, CERAM INT, V41, P4452, DOI 10.1016/j.ceramint.2014.11.137
   Jeon H, 2014, J BIOMED MATER RES B, V102, P1580, DOI 10.1002/jbm.b.33158
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kollath VO, 2013, J EUR CERAM SOC, V33, P2715, DOI 10.1016/j.jeurceramsoc.2013.04.030
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Kung KC, 2012, J ALLOY COMPD, V515, P68, DOI 10.1016/j.jallcom.2011.11.050
   Lakstein D, 2009, ACTA BIOMATER, V5, P2258, DOI 10.1016/j.actbio.2009.01.033
   Laurindo CAH, 2014, MAT SCI ENG C-MATER, V37, P223, DOI 10.1016/j.msec.2014.01.006
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Li HY, 2014, BIOMATERIALS, V35, P3803, DOI 10.1016/j.biomaterials.2014.01.039
   Lin KL, 2007, ACTA BIOMATER, V3, P271, DOI 10.1016/j.actbio.2006.11.003
   Liu PS, 2014, ACS APPL MATER INTER, V6, P7141, DOI 10.1021/am501967y
   Liu PS, 2013, BIOMATERIALS, V34, P2442, DOI 10.1016/j.biomaterials.2012.12.029
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Mansur AAP, 2010, MAT SCI ENG C-MATER, V30, P288, DOI 10.1016/j.msec.2009.11.004
   MIYAKE M, 1990, J AM CERAM SOC, V73, P3524, DOI 10.1111/j.1151-2916.1990.tb06491.x
   Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a
   Necula BS, 2013, APPL SURF SCI, V273, P310, DOI 10.1016/j.apsusc.2013.02.036
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Rani VVD, 2012, ACTA BIOMATER, V8, P1976, DOI 10.1016/j.actbio.2012.01.021
   Rani VVD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195101
   Roy M, 2011, SURF COAT TECH, V205, P2785, DOI 10.1016/j.surfcoat.2010.10.042
   STEVULA L, 1983, CEMENT CONCRETE RES, V13, P684, DOI 10.1016/0008-8846(83)90058-3
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Sun MC, 2014, COLLOID SURFACE B, V122, P134, DOI 10.1016/j.colsurfb.2014.06.041
   Surmeneva MA, 2013, RSC ADV, V3, P11240, DOI 10.1039/c3ra40446c
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang C., 2015, J MAT CHEM B
   Wang HY, 2014, APPL SURF SCI, V292, P204, DOI 10.1016/j.apsusc.2013.11.115
   Wang XH, 2015, COLLOID SURFACE B, V126, P358, DOI 10.1016/j.colsurfb.2014.11.044
   Wang YM, 2014, APPL SURF SCI, V299, P58, DOI 10.1016/j.apsusc.2014.01.185
   Wu J, 2013, SMALL, V9, P2911, DOI 10.1002/smll.201300097
   Zhang W, 2008, APPL SURF SCI, V254, P5216, DOI 10.1016/j.apsusc.2008.02.047
   Zhou JH, 2014, INT J NANOMED, V9, P1243, DOI 10.2147/IJN.S58236
   Zhou JH, 2013, APPL SURF SCI, V286, P384, DOI 10.1016/j.apsusc.2013.09.097
   Zhou R, 2014, ACS APPL MATER INTER, V6, P4797, DOI 10.1021/am405680d
NR 52
TC 12
Z9 12
U1 4
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 308
EP 316
DI 10.1016/j.msec.2015.11.056
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700036
PM 26706535
DA 2018-10-20
ER

PT J
AU Mareci, D
   Bolat, G
   Izquierdo, J
   Crimu, C
   Munteanu, C
   Antoniac, I
   Souto, RM
AF Mareci, D.
   Bolat, G.
   Izquierdo, J.
   Crimu, C.
   Munteanu, C.
   Antoniac, I.
   Souto, R. M.
TI Electrochemical characteristics of bioresorbable binary MgCa alloys in
   Ringer's solution: Revealing the impact of local pH distributions during
   in-vitro dissolution
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE MgCa alloys; Corrosion resistance; Electrochemical characterization;
   EIS; SECM; XRD; SEM; Local pH distributions
ID BIODEGRADABLE MAGNESIUM IMPLANTS; BIOMEDICAL APPLICATIONS; METALLIC
   BIOMATERIALS; CORROSION BEHAVIOR; SR ALLOYS; TI ALLOY; MICROSCOPY;
   CALCIUM; BONE; DEGRADATION
AB Biodegradable magnesium-calcium (MgCa) alloy is a very attractive biomaterial. Two MgCa alloys below the solid solubility of Ca were considered, as to solely investigate the effect of Ca content on the behavior of magnesium and the pH changes associated to metal dissolution. X-ray diffraction analysis and optical microscopy showed that both Mg-0.63Ca and Mg-0.89Ca alloys were solely composed of alpha(Mg) phase. Degradation characteristics and electro-chemical characterization of MgCa alloys were investigated during exposure to Ringer's solution at 37 degrees C by electro-chemical impedance spectroscopy and scanning electrochemical microscopy. The impedance behavior showed both capacitive and inductive features that are related to the alloy charge transfer reaction and the relaxation of the absorbed corrosion compounds, and can be described in terms of an equivalent circuit. Scanning electron microscopy (SEM) was employed to view the surface morphology of the MgCa samples after 1 week immersion in Ringer's solution showing extensive precipitation of corrosion products, whereas the substrate shows evidence of a non-uniform corrosion process. Energy dispersive analysis showed that the precipitates contained oxygen, calcium, magnesium and chlorine, and the Mg:Ca ratios were smaller than in the alloys. Scanning electrochemical microscopy (SECM) was used to visualize local pH changes associated to these physicochemical processes with high spatial resolution. The occurrence of pH variations in excess of 3 units between anodic and cathodic half-cell reactions was monitored in situ. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mareci, D.; Bolat, G.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Bd Mangeron 71, Iasi 700050, Romania.
   [Izquierdo, J.; Souto, R. M.] Univ La Laguna, Dept Chem, POB 456, E-38200 San Cristobal la Laguna, Tenerife, Spain.
   [Crimu, C.; Munteanu, C.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Iasi 700050, Romania.
   [Antoniac, I.; Souto, R. M.] Politehn Bucharest, Fac Mat Sci & Engn, Bucharest 060042, Romania.
RP Mareci, D (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Bd Mangeron 71, Iasi 700050, Romania.; Souto, RM (reprint author), Univ La Laguna, Dept Chem, E-38200 Tenerife, Canary Islands, Spain.
EM danmareci@yahoo.com; rsouto@ull.es
RI Antoniac, Iulian/D-4802-2014
OI Antoniac, Iulian/0000-0003-0112-3494; Mareci,
   Daniel/0000-0002-5859-1996; Souto, Ricardo M./0000-0001-9429-5513;
   Izquierdo Perez, Javier/0000-0003-3287-9403
FU Romanian National Authority for Scientific Research (CNCS-UEFISCDI)
   [PN-II-ID-PCE-2011-3-0218]; Spanish Ministry of Economy and
   Competitiveness; European Regional Development Fund [CTQ2012-36787]
FX The authors are grateful for the HPT deformed MgCa alloys supplied by
   Professor Koichi Tsuchiya, and PhD students Fanqiang Meng and Baozhen
   Jiang from the Graduate School of Pure and Applied Sciences, University
   of Tsukuba, Japan. The work was supported by grants from the Romanian
   National Authority for Scientific Research (CNCS-UEFISCDI, project
   number PN-II-ID-PCE-2011-3-0218), and from the Spanish Ministry of
   Economy and Competitiveness and the European Regional Development Fund
   (Project No. CTQ2012-36787).
CR [Anonymous], 1999, G190 ASTM
   Brar HS, 2012, J MECH BEHAV BIOMED, V7, P87, DOI 10.1016/j.jmbbm.2011.07.018
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Cheng J, 2013, J MATER SCI TECHNOL, V29, P619, DOI 10.1016/j.jmst.2013.03.019
   Ciurescu G, 2012, INT J ELECTROCHEM SC, V7, P7404
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Grobner J., 2001, MAT DESIGN APPROACHE
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   HOLLOSI M, 1994, P NATL ACAD SCI USA, V91, P4902, DOI 10.1073/pnas.91.11.4902
   Huang JJ, 2007, RARE METAL MAT ENG, V36, P1102
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Izquierdo J, 2014, APPL SURF SCI, V313, P259, DOI 10.1016/j.apsusc.2014.05.201
   Izquierdo J, 2013, ELECTROCHIM ACTA, V87, P283, DOI 10.1016/j.electacta.2012.09.029
   Izquierdo J, 2011, ELECTROCHIM ACTA, V56, P8846, DOI 10.1016/j.electacta.2011.07.076
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   lacoban S., 2015, METALL MATER TRANS B, V46, P1011
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Pust SE, 2007, J ELECTROCHEM SOC, V154, pC508, DOI 10.1149/1.2754080
   Pust SE, 2007, ADV MATER, V19, P878, DOI 10.1002/adma.200601446
   Rad HRB, 2012, MATER DESIGN, V33, P88, DOI 10.1016/j.matdes.2011.06.057
   Rao S, 1997, MAT SCI ENG C-BIO S, V4, P311, DOI 10.1016/S0928-4931(97)00016-7
   Rosalbino F, 2010, J MATER SCI-MATER M, V21, P1091, DOI 10.1007/s10856-009-3956-1
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Shaw B.A., 2003, ASM HDB A, V13, P692
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Souto R.M., 2012, CURRENT MICROSCOPY C, P1407
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Thomas S, 2015, CURR OPIN SOLID ST M, V19, P85, DOI 10.1016/j.cossms.2014.09.005
   Thomas S, 2015, CORROSION-US, V71, P171, DOI 10.5006/1483
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Von Der Hoh N., 2007, ADV ENG MATER, V11, pB47
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Xue DC, 2011, MAT SCI ENG C-MATER, V31, P215, DOI 10.1016/j.msec.2010.08.019
   Zakiyuddin A, 2015, J ALLOY COMPD, V629, P274, DOI 10.1016/j.jallcom.2014.12.181
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 52
TC 17
Z9 17
U1 3
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 402
EP 410
DI 10.1016/j.msec.2015.11.069
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700047
PM 26706546
DA 2018-10-20
ER

PT J
AU Baino, F
   Ferraris, S
   Miola, M
   Perero, S
   Verne, E
   Coggiola, A
   Dolcino, D
   Ferraris, M
AF Baino, Francesco
   Ferraris, Sara
   Miola, Marta
   Perero, Sergio
   Verne, Enrica
   Coggiola, Andrea
   Dolcino, Daniela
   Ferraris, Monica
TI Novel antibacterial ocular prostheses: Proof of concept and
   physico-chemical characterization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ophthalmic biomaterial; Coating; Silver; Sputtering; Antibacterial
ID POROUS ORBITAL IMPLANTS; ESCHERICHIA-COLI; IN-VITRO;
   STAPHYLOCOCCUS-AUREUS; SILVER RESISTANCE; BACTERIAL; BIOMATERIALS;
   ENUCLEATION; INFECTION; TOXICITY
AB Discouraging bacterial colonization of ocular biomaterials and implants is a significant challenge in ophthalmology as infections often lead to the need for secondary surgery, with associated risks and additional stress to patients. In this work we demonstrate for the first time the feasibility of an innovative antibacterial ocular prosthesis produced by depositing a silver nanocluster/silica composite layer on the poly(methyl methacrylate) implant surface via radio-frequency sputtering. Tape test performed according to relevant ASTM standard provided a preliminary evidence of the mechanical stability and good adhesion of the coating to the substrate (absence of macroscopic damage after tape removal). Coating integrity was maintained after prolonged soaking in aqueous medium (1 month). The antibacterial effect of the coating, associated to silver ion release upon contact with aqueous fluid, was confirmed by the in vitro formation of a 5-mm inhibition halo test against Staphylococcus aureus that is one of the most common bacteria involved in ocular infections. The approach proposed in the present study for facing implant-related ocular infections can have a significant impact in the field of ophthalmic biomaterials, suggesting a valuable alternative to the administration of antibiotics that may become ineffective due to bacterial resistance. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Baino, Francesco; Ferraris, Sara; Miola, Marta; Perero, Sergio; Verne, Enrica; Ferraris, Monica] Politecn Torino, Appl Sci & Technol Dept, Inst Mat Phys & Engn, Corso Duca Abruzzi 24, Turin, Italy.
   [Coggiola, Andrea; Dolcino, Daniela] St Antonio & Biagio & Cesare Arrigo Natl Hosp, Ophthalmol Ward, Via Venezia 16, Alessandria, Italy.
RP Baino, F (reprint author), Politecn Torino, Appl Sci & Technol Dept, Inst Mat Phys & Engn, Corso Duca Abruzzi 24, Turin, Italy.
EM francesco.baino@polito.it
OI Baino, Francesco/0000-0001-8860-0497; Verne, Enrica/0000-0002-8649-4739
FU Regione Piemonte (Italy) (Regional Project "NABLA" - Nanostructured
   Antibacterial Layers); EC [262209]
FX This work was partially supported by the Regione Piemonte (Italy)
   (Regional Project "NABLA" - Nanostructured Antibacterial Layers) and by
   the EC-funded Project NASLA-FP7-SME-2010-1 (Project no. 262209).
CR [Anonymous], 2006, M2A9 NCCLS
   ASTM-American Society for Testing and Materials, 2009, D3359 ASTM
   Badilla J, 2008, OPHTHAL PLAST RECONS, V24, P287, DOI 10.1097/IOP.0b013e318177ebc7
   Baino F., 2012, Rivestimenti e Trattamenti Superficiali per Impartire Proprieta Antibatteriche a Dispositivi per Oftalmoplastica, Patent No. [IT0001412705, 0001412705]
   Baino F, 2015, J BIOMED MATER RES A, V103, P1259, DOI 10.1002/jbm.a.35260
   Baino F, 2014, ACTA BIOMATER, V10, P3372, DOI 10.1016/j.actbio.2014.05.017
   Baino F, 2014, ACTA BIOMATER, V10, P1064, DOI 10.1016/j.actbio.2013.12.014
   Balagna C, 2013, ENG MATER, P225, DOI 10.1007/978-3-642-40322-4_10
   BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357
   Biederman H, 2000, VACUUM, V59, P594, DOI 10.1016/S0042-207X(00)00321-3
   Chalasani R, 2007, SURV OPHTHALMOL, V52, P145, DOI 10.1016/j.survophthal.2006.12.007
   Chuang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042437
   Chuo JY, 2009, OPHTHALMOLOGY, V116, P349, DOI 10.1016/j.ophtha.2008.09.022
   Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ferraris M, 2012, IOP CONF SER-MAT SCI, V40, DOI 10.1088/1757-899X/40/1/012037
   Ferraris M, 2010, MATER CHEM PHYS, V120, P123, DOI 10.1016/j.matchemphys.2009.10.034
   Ferraris S, 2014, APPL SURF SCI, V317, P131, DOI 10.1016/j.apsusc.2014.07.196
   Gupta A, 1998, APPL ENVIRON MICROB, V64, P5042
   Haase A., 2011, J PHYS C SER, V304, DOI DOI 10.1088/1742-6596/304/1/012030
   Hau SC, 2009, CORNEA, V28, P703, DOI 10.1097/ICO.0b013e31818f9724
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jordan DR, 2007, OPHTHAL PLAST RECONS, V23, P413, DOI 10.1097/IOP.0b013e318137a600
   Jordan DR, 2006, OPHTHAL PLAST RECONS, V22, P66, DOI 10.1097/01.iop.0000197018.44245.7e
   Jun M.S., 2008, US Patent, Patent No. [US2008/0262612A1, 20080262612]
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Karshoglu S, 2006, OPHTHAL PLAST RECONS, V22, P461, DOI 10.1097/01.iop.0000248156.41020.94
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Kelly PJ, 2000, VACUUM, V56, P159, DOI 10.1016/S0042-207X(99)00189-X
   Mawn LA, 2001, CAN J OPHTHALMOL, V36, P245, DOI 10.1016/S0008-4182(01)80017-X
   Miola M, 2014, APPL SURF SCI, V313, P107, DOI 10.1016/j.apsusc.2014.05.151
   Moshfeghi DM, 2000, SURV OPHTHALMOL, V44, P277, DOI 10.1016/S0039-6257(99)00112-5
   Muzio G., 2015, HERNIA IN PRESS
   Sandeman SR, 2003, BIOMATERIALS, V24, P4729, DOI 10.1016/S0142-9612(03)00370-3
   Sant SB, 2007, ACTA BIOMATER, V3, P341, DOI 10.1016/j.actbio.2006.10.008
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Stephens P., 2014, BBC NEWS HLTH   0430
   Tan XW, 2012, J MATER SCI-MATER M, V23, P1063, DOI 10.1007/s10856-012-4578-6
   Tan XW, 2011, INVEST OPHTH VIS SCI, V52, P21, DOI 10.1167/iovs.10-6186
   Wang HB, 2008, SURF ENG, V24, P70, DOI 10.1179/174329408X277493
   Yang JW, 2011, ORBIT, V30, P77, DOI 10.3109/01676830.2010.538123
   You JR, 2003, JPN J OPHTHALMOL, V47, P512, DOI 10.1016/S0021-5155(03)00137-0
   You SJ, 2002, J KOREAN OPHTHALMOL, V43, P1553
   Yun HS, 2011, ACTA BIOMATER, V7, P2651, DOI 10.1016/j.actbio.2011.02.014
NR 45
TC 5
Z9 5
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 467
EP 474
DI 10.1016/j.msec.2015.11.075
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700054
PM 26706553
DA 2018-10-20
ER

PT J
AU Choudhury, AJ
   Gogoi, D
   Kandimalla, R
   Kalita, S
   Chaudhari, YB
   Khan, MR
   Kotoky, J
   Chutia, J
AF Choudhury, Arup Jyoti
   Gogoi, Dolly
   Kandimalla, Raghuram
   Kalita, Sanjeeb
   Chaudhari, Yogesh B.
   Khan, Mojibur R.
   Kotoky, Jibon
   Chutia, Joyanti
TI Penicillin impregnation on oxygen plasma surface functionalized
   chitosan/Antheraea assama silk fibroin: Studies of antibacterial
   activity and antithrombogenic property
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Oxygen plasma; Chitosan; Antheraea assama silk fibroin; Antibiotic drug;
   Antithrombogenic property; Antimicrobial
ID DRUG-RELEASE; POLYMERS; NANOPARTICLES
AB Low temperature plasma can effectively tailor the surface properties of natural polymeric biomaterials according to the need for various biomedical applications. Non-mulberry silk, Antheraea assama silk fibroin (AASF) is a natural polymer having excellent biocompatibility and mechanical strength yet unlike mulberry silk, Bombyx mori silk fibroin, has drawn less interest in biomedical research. In the quest for developing as potential biomaterial, surface functionalization of plasma induced chitosan (Cs) grafted AASF ((AASF/O-2-C-S)(g)/O-2) yarn is carried out using oxygen (O-2) plasma. The (AASF/O-2-C-S)(g)/O-2 yarn exhibits enhanced antithrombogenic property as well as antimicrobial activity against Gram positive (Bacillus subtilis) and Gram negative (Escherichia coli) bacteria as compared to AASF yarn. Moreover, impregnation of antibiotic drug (penicillin G sodium salt, PEN) on (AASF/O-2-C-S)(g)/O-2 yarn further improves the observed properties. In-vitro hemolysis assay reveals that O-2 plasma treatment and subsequent impregnation of PEN do not affect the hemocompatibility of AASF yarn. The present research findings demonstrate that plasma induced grafting of Cs followed by penicillin impregnation could significantly improve the potential applicability of AASF in the field of surgical research. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Choudhury, Arup Jyoti] Tezpur Univ, Dept Phys, Sonitpur 784028, Assam, India.
   [Gogoi, Dolly; Chutia, Joyanti] Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati 781035, Assam, India.
   [Kandimalla, Raghuram; Kalita, Sanjeeb; Kotoky, Jibon] Inst Adv Study Sci & Technol, Drug Discovery Lab, Gauhati 781035, Assam, India.
   [Chaudhari, Yogesh B.; Khan, Mojibur R.] Inst Adv Study Sci & Technol, Mol Biol & Microbial Biotechnol Lab, Gauhati 781035, Assam, India.
RP Choudhury, AJ (reprint author), Tezpur Univ, Dept Phys, Sonitpur 784028, Assam, India.
EM arupjchoudhury@gmail.com
OI Kandimalla, Raghuram/0000-0002-9202-4071
FU Department of Science and Technology (DST), Government of India
   (DST/INSPIRE Faculty Award) [2014/DST/INSPIRE/04/2014/001621]
FX One of the authors, Arup Jyoti Choudhury would like to thank the
   Department of Science and Technology (DST), Government of India
   (DST/INSPIRE Faculty Award/2014/DST/INSPIRE/04/2014/001621) for
   providing the financial support through DST Inspire faculty scheme in
   carrying out this research work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amiji MM, 1998, COLLOID SURFACE B, V10, P263, DOI 10.1016/S0927-7765(98)00005-8
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Chang S. J., 2007, J MED BIOL ENG, V27, P41
   Choudhury AJ, 2016, SURGERY, V159, P539, DOI 10.1016/j.surg.2015.07.022
   Gogoi D, 2012, PLASMA CHEM PLASMA P, V32, P1293, DOI 10.1007/s11090-012-9410-z
   Gogoi D, 2014, BIOPOLYMERS, V101, P355, DOI 10.1002/bip.22369
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Kalita S, 2015, INT J NANOMED, V10, P2971, DOI 10.2147/IJN.S75023
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Maji TK, 1996, J APPL POLYM SCI, V62, P595
   Mohanty P. K., 1998, TROPICAL TASAR CULTU
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Oeveren W.V., 2002, ARTIF ORGANS, V26, P506
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pavia D. L., 2008, INTRO SPECTROSCOPY
   Peng Q., 2006, J APPL POLYM SCI, V1002, P1299
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   SAUER BB, 1990, LANGMUIR, V6, P1002, DOI 10.1021/la00095a020
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Snyder K.C., 2011, APPL SURG PHARM PHAR
   Wang H.S., 2005, BIODEGRADABLE SUSTAI, P391
   Wang Y., 2009, BIOMED MATER, V4
   WARWICKER JO, 1956, T FARADAY SOC, V52, P554, DOI 10.1039/tf9565200554
   Yoshida S, 2013, SURF COAT TECH, V233, P99, DOI 10.1016/j.surfcoat.2013.02.042
   Zhang DR, 2006, NANOTECHNOLOGY, V17, P5821, DOI 10.1088/0957-4484/17/23/018
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
NR 30
TC 13
Z9 13
U1 2
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 475
EP 484
DI 10.1016/j.msec.2015.11.070
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700055
PM 26706554
DA 2018-10-20
ER

PT J
AU Skolucka-Szary, K
   Ramiega, A
   Piaskowska, W
   Janicki, B
   Grala, M
   Rieske, P
   Bartczak, Z
   Piaskowski, S
AF Skolucka-Szary, Karolina
   Ramiega, Aleksandra
   Piaskowska, Wanda
   Janicki, Bartosz
   Grala, Magdalena
   Rieske, Piotr
   Bartczak, Zbigniew
   Piaskowski, Sylwester
TI Synthesis and physicochemical characterization of chitin dihexanoate - A
   new biocompatible chitin derivative - In comparison to chitin dibutyrate
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biopolymers; Polysaccharides; Chitin; Esterification; Biomaterial
ID DIFFERENTIAL SCANNING CALORIMETRY; CHITOSAN; WATER; DIBUTYRYLCHITIN;
   PART; IDENTIFICATION; SOLUBILITY; SPONGES
AB Chitin dihexanoate (DHCH) is the novel biocompatible and technologically friendly highly substituted chitin diester. Here we described optimization of DHCH and chitin dibutyrate (dibutyryl chitin, DBC) synthesis conditions (temperature and reaction time) to obtain desired polymers with high reaction yield, high substitution degree (close to 2) and appropriately high molecular weights. A two-step procedure, employing acidic anhydrides (hexanoic or butyric anhydride) as the acylation agent and methanesulfonic acid both as the catalyst and the reaction medium, was applied. Chemical structures of DBC and DHCH were confirmed by NMR (H-1 and C-13) and IR investigations. Mechanical properties, thermogravimetric analysis, differential scanning calorimetry and biocompatibility (Neutral red uptake assay, Skin Sensitization and Irritation Tests) were assessed. Both polymers proved highly biocompatible (non-cytotoxic in vitro, non-irritating and non-allergic to skin) and soluble in several organic solvents (dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, acetone, ethanol and others). It is worth emphasizing that DHCH and DBC can be easily processed by solvent casting method and the salt leaching method, what gives the opportunity to prepare highly porous structures, which can be further successfully applied as the material for wound dressings and scaffolds for tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Skolucka-Szary, Karolina; Ramiega, Aleksandra; Piaskowska, Wanda; Rieske, Piotr; Piaskowski, Sylwester] Celther Poland Sp Zoo, Dept Res & Dev, Ul Ostrzykowizna 14A, PL-05170 Zakroczym, Poland.
   [Janicki, Bartosz] Silesian Tech Univ, Dept Phys Chem & Technol Polymers, Fac Chem, Ul M Strzody 9, PL-44100 Gliwice, Poland.
   [Grala, Magdalena; Bartczak, Zbigniew] Polish Acad Sci, Ctr Mol & Macromol Studies, Sienkiewicza 112, PL-90363 Lodz, Poland.
RP Skolucka-Szary, K (reprint author), Celther Polska Sp Zoo, PL-05170 Zakroczym, Poland.
EM karolina.skolucka@celther.com
RI Rieske, Piotr/M-4821-2015
OI Rieske, Piotr/0000-0002-2970-0970; Bartczak,
   Zbigniew/0000-0003-0514-9106
FU Polish Agency for Enterprise Development Grant [POIG.01.04.00-10-020/10]
FX This Study was sponsored by Polish Agency for Enterprise Development
   Grant No. POIG.01.04.00-10-020/10.
CR Almond A, 2003, GLYCOBIOLOGY, V13, P255, DOI 10.1093/glycob/cwg031
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   [Anonymous], 2012, 10993102011 PNEN ISO
   AUSTIN PR, 1981, SCIENCE, V212, P749, DOI 10.1126/science.7221561
   Baxter A, 1992, J BIOL MACROMOL, V14, P166
   Bhatt LR, 2011, CARBOHYD RES, V346, P691, DOI 10.1016/j.carres.2011.01.033
   Blasinska A, 2004, FIBRES TEXT EAST EUR, V12, P51
   Bo M, 2012, INT J BIOL MACROMOL, V51, P129, DOI 10.1016/j.ijbiomac.2012.04.016
   Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028
   Capozza R. C., 1976, US Patent, Patent No. 3988411
   Capozza RC, 1976, US Patent, Patent No. [3989535, 3,989,535]
   Chen BQ, 2004, CARBOHYD POLYM, V58, P65, DOI 10.1016/j.carbpol.2004.06.030
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   Draczynski Z, 2011, J APPL POLYM SCI, V122, P175, DOI 10.1002/app.34031
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   EDWARD JT, 1955, CHEM IND-LONDON, P1102
   Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   Ehrlich H, 2013, J MATER CHEM B, V1, P5092, DOI 10.1039/c3tb20676a
   Ehrlich H, 2013, J STRUCT BIOL, V183, P474, DOI 10.1016/j.jsb.2013.06.015
   Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521
   Grzesiak E., 2011, Sposob otrzymywania estrow chityny, Patent No. [PL 389421(A1), 389421]
   Guinesi LS., 2006, THERMOCHIM ACTA, V444, P8128
   Hu XW, 2007, CARBOHYD POLYM, V70, P451, DOI 10.1016/j.carbpol.2007.05.002
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jindal D.K., 2013, INT J ADV PHARM SCI, V4, P1177
   KAIFU K, 1981, POLYM J, V13, P241, DOI 10.1295/polymj.13.241
   Kaya M., 2014, FOOD BIOPHYS
   Kaya M, 2014, INT J BIOL MACROMOL, V65, P553, DOI 10.1016/j.ijbiomac.2014.02.010
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kittur FS, 2002, CARBOHYD POLYM, V49, P185, DOI 10.1016/S0144-8617(01)00320-4
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709
   MUZZARELLI RAA, 1983, CARBOHYD POLYM, V3, P53
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Percot A, 2003, BIOMACROMOLECULES, V4, P12, DOI 10.1021/bm025602k
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   RATTO J, 1995, POLYMER, V36, P2915, DOI 10.1016/0032-3861(95)94340-Y
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rutherford III F. A., 1978, P 1 INT C CHIT CHIT, P182
   Rutkowska-Olma E., 2006, Sposob otrzymywania dibutyrylochityny, Patent No. [PL 370755, 370755]
   Saravanan D., 2011, ARCH APPL SCI RES, V3, P342
   SCHLEDE E, 1995, CONTACT DERMATITIS, V32, P1, DOI 10.1111/j.1600-0536.1995.tb00830.x
   Schoukens G, 2009, INT J CLOTH SCI TECH, V21, P93, DOI 10.1108/09556220910933817
   Skolucka-Szary K, 2015, MAT SCI ENG C-MATER, V55, P50, DOI 10.1016/j.msec.2015.05.051
   Szosland L, 1996, J BIOACT COMPAT POL, V11, P61, DOI 10.1177/088391159601100105
   Szosland L, 2001, FIBRES TEXT EAST EUR, V9, P54
   Szosland L., 2001, PROGR CHEM APPL CHIT, V7, P33
   Szosland L., 2003, FIBRES TEXT EAST EUR, V9, P49
   Szumielewicz J., 2003, PROGR CHEM APPL CHIT, VIX, P41
   Tamura H., 2004, ADV CHITIN SCI, P94
   TERBOJEVICH M, 1988, CARBOHYD RES, V180, P73, DOI 10.1016/0008-6215(88)80065-X
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Van de Velde K, 2004, CARBOHYD POLYM, V58, P409, DOI 10.1016/j.carbpol.2004.08.004
   Vikhoreva GA, 1999, FIBRE CHEM+, V31, P274, DOI 10.1007/BF02358332
   Vincendon M., 1985, CHITIN NATURE TECHNO, P343
   Wysokowski M, 2015, POLYMERS-BASEL, V7, P235, DOI 10.3390/polym7020235
   Yang BY, 2009, CARBOHYD RES, V344, P336, DOI 10.1016/j.carres.2008.11.006
NR 60
TC 4
Z9 4
U1 5
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 489
EP 502
DI 10.1016/j.msec.2015.11.078
PG 14
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700057
PM 26706556
DA 2018-10-20
ER

PT J
AU Li, HF
   Cong, Y
   Zheng, YF
   Cui, LS
AF Li, Huafang
   Cong, Ying
   Zheng, Yufeng
   Cui, Lishan
TI In vitro investigation of NiTiW shape memory alloy as potential
   biomaterial with enhanced radiopacity
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Metals and alloys; Shape memory alloys (SMAs); Phase transformation;
   Radiopacity; Corrosion behavior; Biomaterials
ID BIOMEDICAL APPLICATIONS; STENTS
AB In the present study, a novel kind of NiTiW shape memory alloy with chemical composition of Ni43.5Ti45.5W11 (at.%) has been successfully developed with excellent X-ray radiopacity by the introduction of pure W precipitates into the NiTi matrix phase. Its microstructure, X-ray radiopacity, mechanical properties, corrosion resistance in simulated body fluid, hemocompatibility and in vitro cytocompatibility were systematically investigated. The typical microstructural feature of NiTiW alloy at room temperature was tiny pure W particles randomly distributing in the NiTi matrix phase. The presence of W precipitates was found to result in enhanced radiopacity and microhardness of NiTiW alloy in comparison to that of NiTi binary alloy. NiTiW alloy exhibits excellent shape memory effect, and a maximum shape recovery ratio of about 30% was obtained with a total prestrain of 8% for the NiTiW alloy sample. In the electrochemical test, NiTiW alloy, presented an excellent corrosion resistance in simulated body fluid, comparable to that of NiTi alloy. Hemocompatibility tests indicated that the NiTiW alloy has quite low hemolysis (lower than 0.5%) and the adherent platelet showed round shape without pseudo pod. Besides, in vitro cell viability tests demonstrated that the cell viability is all above 90%, and the cells spread well on the NiTiW alloy, having polygon or spindle healthy morphology. The hemocompatibility tests, in vitro cell viability tests and morphology observation indicated that the NiTiW shape memory alloys have excellent bio-compatibility. The excellent X-ray radiopacity makes the NiTiW alloys show obvious advantages in orthopedic, stomatological, neurological and cardiovascular domains where radiopacity is quite important factor in order to guarantee successful implantation. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Li, Huafang; Zheng, Yufeng] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Li, Huafang; Zheng, Yufeng] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
   [Cong, Ying] Peking Univ, Phys Specialty YuanPei Coll, Beijing 100871, Peoples R China.
   [Cui, Lishan] China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
   [Cui, Lishan] China Univ Petr, Dept Mat Sci & Engn, Beijing 102249, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Li, Huafang/D-5486-2013
OI Zheng, Yufeng/0000-0002-7402-9979; 
FU National Basic Research Program of China (973 Program) [2012CB619102,
   2012CB619100]; National Science Fund for Distinguished Young Scholars
   [51225101]; National Natural Science Foundation of China [51431002,
   31170909]; NSFC/RGC Joint Research Scheme [51361165101]; Beijing
   Municipal Science and Technology Project [Z141100002814008]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (grant No. 2012CB619102 and 2012CB619100), the National
   Science Fund for Distinguished Young Scholars (grant No. 51225101), the
   National Natural Science Foundation of China (grant No. 51431002 and
   31170909), the NSFC/RGC Joint Research Scheme (grant No. 51361165101),
   and Beijing Municipal Science and Technology Project (grant No.
   Z141100002814008).
CR Ebrahimi N, 2007, AM J NEURORADIOL, V28, P823
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Goodman S., 1983, SCANNING ELECT MIC 1, P279
   Gu S, 2006, DENT MATER, V22, P765, DOI 10.1016/j.dental.2005.11.004
   Hsieh SF, 2005, J ALLOY COMPD, V387, P121, DOI 10.1016/j.jallcom.2004.06.026
   Kumari PNS, 2008, MATER LETT, V62, P305, DOI 10.1016/j.matlet.2007.05.013
   Pelton B.L, 2001, SMST 2000 P INT C SH, P109
   Peuster M, 2003, BIOMATERIALS, V24, P4057, DOI 10.1016/S0142-9612(03)00274-6
   Rossi P, 1996, EUR RADIOL, V6, P741
   Steegmuller R, 2008, SMST 2006: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MEMORY AND SUPERELASTIC TECHNOLOGIES, P227, DOI 10.1361/cp2006smst227
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
   Wang S., 2014, SCR MAT
   Yan XJ, 2011, MATER LETT, V65, P2934, DOI 10.1016/j.matlet.2011.06.040
   Zhu K, 2012, CLIN BIOCHEM, V45, P936, DOI 10.1016/j.clinbiochem.2012.05.006
NR 14
TC 4
Z9 4
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 554
EP 559
DI 10.1016/j.msec.2015.12.006
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700064
PM 26706563
DA 2018-10-20
ER

PT J
AU Schukur, L
   Geering, B
   Fussenegger, M
AF Schukur, Lina
   Geering, Barbara
   Fussenegger, Martin
TI Human whole-blood culture system for ex vivo characterization of
   designer-cell function
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE alginate; inflammatory disorder; personalized medicine; primary cells;
   synthetic biology; tumor necrosis factor
ID CYTOKINE PRODUCTION; MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; TNF-ALPHA;
   RESPONSES; ACTIVATION; APOPTOSIS; LIPOPOLYSACCHARIDE; STIMULATION;
   IMMUNOLOGY
AB Encapsulated designer cells implanted into mice are currently used to validate the efficacy of therapeutic gene networks for the diagnosis and treatment of various human diseases in preclinical research. Because many human conditions cannot be adequately replicated by animal models, complementary and alternative procedures to test future treatment strategies are required. Here we describe a novel approach utilizing an ex vivo human whole-blood culture system to validate synthetic biology-inspired designer cell-based treatment strategies. The viability and functionality of transgenic mammalian designer cells co-cultured with primary human immune cells were characterized. We demonstrated that transgenic mammalian designer cells required adequate insulation from the human blood microenvironment to maintain viability and functionality. The biomaterial alginate-(poly-l-lysine)-alginate used to encapsulate the transgenic designer cells did neither affect the viability of primary granulocytes and lymphocytes nor the functionality of lymphocytes. Additionally, alginate-encapsulated transgenic designer cells remained responsive to the release of the pro-inflammatory cytokine tumor necrosis factor (TNF) from the whole-blood culture upon exposure to bacterial lipopolysaccharide (LPS). TNF diffused into the alginate capsules, bound to the specific TNF receptors on the transgenic designer cells' surface and triggered the expression of the reporter gene SEAP (human placental secreted alkaline phosphatase) that was rewired to the TNF-specific signaling cascade. Human whole-blood culture systems can therefore be considered as valuable complementary assays to animal models for the validation of synthetic circuits in genetically modified mammalian cells and may speed up preclinical research in a world of personalized medicine. Biotechnol. Bioeng. 2016;113: 588-597. (c) 2015 Wiley Periodicals, Inc.
C1 [Schukur, Lina; Geering, Barbara; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.
   [Fussenegger, Martin] Univ Basel, Fac Sci, Basel, Switzerland.
RP Fussenegger, M (reprint author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.
EM fussenegger@bsse.ethz.ch
FU European Research Council (ERC) [321381]; National Center of Competence
   in Research (NCCR) Molecular Systems Engineering
FX We thank Katrin Roessger for providing plasmid pKR32, Sandra Leber and
   Samuel Huerlemann for technical support, Aizhan Tastanova for assistance
   in collecting blood samples and all of the blood donors who participated
   in this study. This work was supported by a European Research Council
   (ERC) advanced grant (No. 321381) and in part by the National Center of
   Competence in Research (NCCR) Molecular Systems Engineering.
CR Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007
   Auslander D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5408
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005
   Geering B, 2015, TRENDS BIOTECHNOL, V33, P65, DOI 10.1016/j.tibtech.2014.10.006
   Geering B, 2011, BLOOD, V117, P5953, DOI 10.1182/blood-2010-11-322206
   Godoy-Ramirez K, 2004, J IMMUNOL METHODS, V292, P1, DOI 10.1016/j.jim.204.04.028
   Hodge G, 2000, CYTOKINE, V12, P1763, DOI 10.1006/cyto.2000.0790
   Ingulli E, 2010, PEDIATR NEPHROL, V25, P61, DOI 10.1007/s00467-008-1020-x
   Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0
   Kaminska T, 2001, ARCH IMMUNOL THER EX, V49, P439
   Louis E, 1998, CLIN EXP IMMUNOL, V113, P401
   Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3
   Mak IWY, 2014, AM J TRANSL RES, V6, P114
   Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x
   McFarlane SM, 2002, FEBS LETT, V515, P119, DOI 10.1016/S0014-5793(02)02450-X
   McNamee JP, 2005, CYTOKINE, V31, P161, DOI 10.1016/j.cyto.2005.05.001
   Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x
   OLIVER JC, 1993, LYMPHOKINE CYTOK RES, V12, P115
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Paredes Juarez Genaro Alberto, 2014, Front Bioeng Biotechnol, V2, P26, DOI 10.3389/fbioe.2014.00026
   PAULY JL, 1973, J LAB CLIN MED, V82, P500
   Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825
   Rossger K, 2013, P NATL ACAD SCI USA, V110, P18150, DOI 10.1073/pnas.1312414110
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Sottong PR, 2000, CLIN DIAGN LAB IMMUN, V7, P307, DOI 10.1128/CDLI.7.2.307-311.2000
   Swaak AJG, 1997, ANN RHEUM DIS, V56, P693, DOI 10.1136/ard.56.11.693
   Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9
   Wallis RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030479
   Weir RE, 1999, CLIN EXP IMMUNOL, V116, P263
   WILSON BMG, 1991, J IMMUNOL METHODS, V139, P233, DOI 10.1016/0022-1759(91)90193-J
   YACHIE A, 1990, PEDIATR RES, V27, P227, DOI 10.1203/00006450-199003000-00005
   Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471
   Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535
   Zakharyan R, 2014, WORLD J BIOL PSYCHIA, V15, P174, DOI 10.3109/15622975.2013.830774
   ZANGERLE PF, 1992, CYTOKINE, V4, P568, DOI 10.1016/1043-4666(92)90021-I
NR 37
TC 6
Z9 6
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAR
PY 2016
VL 113
IS 3
BP 588
EP 597
DI 10.1002/bit.25828
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DC1YT
UT WOS:000369015100014
PM 26348251
DA 2018-10-20
ER

PT J
AU Ghimire, N
   Foss, BL
   Sun, YY
   Deng, Y
AF Ghimire, Niranjan
   Foss, Berit L.
   Sun, Yuyu
   Deng, Ying
TI Interactions among osteoblastic cells, Staphylococcus aureus, and
   chitosan-immobilized titanium implants in a postoperative coculture
   system: An in vitro study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bacteria-related infection (BRI); postoperative; sensitivity;
   osteogenic; antifouling
ID SURGICAL-SITE INFECTIONS; ORTHOPEDIC-SURGERY; ANTIBIOTIC-RESISTANCE;
   BIOFILM FORMATION; SURFACES; HIP; ARTHROPLASTY; EPIDERMIDIS; JOINT; BONE
AB Biomaterial-related infections (BRIs) have become a major challenge in the field of orthopedic implants. In this study, we delved into the problem of BRI and attempted to reduce the possibility of BRI incidence via surface modification of titanium (Ti) with chitosan (SA-CS-Ti). To comprehensively evaluate the anti-infection potential of SA-CS-Ti, we first constructed a postoperative infection (POI) model with varying concentrations of bacteria (10(2)CFU/sample and 10(4)CFU/sample) and a constant number of SaOS-2 cells (10(5)/sample). Then, we biologically characterized the interactions between the SaOS-2 cells, bacteria, and different Ti implants using the POI model. The results from the osteoblastic cell and bacterial attachment tests demonstrated that the SA-CS-Ti surfaces exhibit superior osteogenic behavior relative to other Ti surfaces studied while showing significant anti-infective activities in the POI model with a low infection ratio (bacteria: cell ratio of 0.001:1) 30min after infection. Additionally, the SA-CS-Ti surfaces showed significantly reduced (p<0.05) bacteria proliferation compared to the control Ti surfaces (UN-Ti), demonstrating their antifouling property. The significantly increased (p<0.05) sensitivity of Staphylococcus. aureus adhered to the SA-CS-Ti surfaces against cefazolin (1mg/L treatment) and gentamicin (10mg/L and 100mg/L treatment) in the coculture system augmented potential of SA-CS-Ti to be used as orthopedic implants. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 586-594, 2016.
C1 [Ghimire, Niranjan; Foss, Berit L.; Deng, Ying] Univ S Dakota, Dept Biomed Engn, 4800 North Career Ave, Sioux Falls, SD 57107 USA.
   [Sun, Yuyu] Univ Massachusetts, Dept Chem, One Univ Ave, Lowell, MA 01854 USA.
RP Deng, Y (reprint author), Univ S Dakota, Dept Biomed Engn, 4800 North Career Ave, Sioux Falls, SD 57107 USA.; Sun, YY (reprint author), Univ Massachusetts, Dept Chem, One Univ Ave, Lowell, MA 01854 USA.
EM Yuyu_sun@uml.edu; Ying.deng@usd.edu
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R21AR065625]
FX Contract grant sponsor: National Institute of Arthritis and
   Musculoskeletal and Skin Diseases of the National Institutes of Health;
   contract grant number: R21AR065625
CR Adachi K, 2007, J ORTHOP SCI, V12, P178, DOI 10.1007/s00776-006-1102-1
   American Academy of Orthopaedic Surgeons, 2004, REC US INTR ANT PROP, V2015
   Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Berbari EF, 2012, INFECT CONT HOSP EP, V33, P774, DOI 10.1086/666641
   Blomgren G, 1981, Acta Orthop Scand Suppl, V187, P1
   Bowler PG, 2013, J HOSP INFECT, V83, P232, DOI 10.1016/j.jhin.2012.11.018
   Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   Carlson RP, 2008, J BIOMAT SCI-POLYM E, V19, P1035, DOI 10.1163/156856208784909372
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902
   CRAIG WA, 1992, ANTIMICROB AGENTS CH, V36, P2577, DOI 10.1128/AAC.36.12.2577
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453
   Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001
   FIELDS MT, 1993, ANTIMICROB AGENTS CH, V37, P203, DOI 10.1128/AAC.37.2.203
   Ghimire N, 2014, COLLOID SURFACE B, V122, P126, DOI 10.1016/j.colsurfb.2014.06.060
   Greene AH, 2008, CLIN ORTHOP RELAT R, V466, P1699, DOI 10.1007/s11999-008-0269-5
   Greene LR, 2012, AM J INFECT CONTROL, V40, P384, DOI 10.1016/j.ajic.2011.05.011
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Hanberger H, 1990, Scand J Infect Dis Suppl, V74, P118
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Kasiakou SK, 2005, LANCET INFECT DIS, V5, P581, DOI 10.1016/S1473-3099(05)70218-8
   KIRBY WMM, 1973, J INFECT DIS, V128, pS341, DOI 10.1093/infdis/128.Supplement_2.S341
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   Knobben BAS, 2006, J HOSP INFECT, V62, P174, DOI 10.1016/j.jhin.2005.08.007
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   Phillips JE, 2006, J BONE JOINT SURG BR, V88B, P943, DOI 10.1302/0301-620X.88B7.17150
   Pier-Francesco A, 2006, CLIN ORAL IMPLAN RES, V17, P633, DOI 10.1111/j.1600-0501.2006.01274.x
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Sidhu P. K., 2014, Journal of Veterinary Science and Technology, V5, P199
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6
   Webb LXGE, 1993, T ORTHOP RES SOC, V18, P455
   Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Yao C, 2009, J BIOMED MATER RES B, V91B, P587, DOI 10.1002/jbm.b.31433
   Zeller V, 2009, ANTIMICROB AGENTS CH, V53, P883, DOI 10.1128/AAC.00389-08
NR 50
TC 2
Z9 2
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2016
VL 104
IS 3
BP 586
EP 594
DI 10.1002/jbm.a.35597
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DC4AB
UT WOS:000369160800002
PM 26488154
DA 2018-10-20
ER

PT J
AU Campoccia, D
   Testoni, F
   Ravaioli, S
   Cangini, I
   Maso, A
   Speziale, P
   Montanaro, L
   Visai, L
   Arciola, CR
AF Campoccia, Davide
   Testoni, Francesca
   Ravaioli, Stefano
   Cangini, Ilaria
   Maso, Alessandra
   Speziale, Pietro
   Montanaro, Lucio
   Visai, Livia
   Arciola, Carla Renata
TI Orthopedic implant infections: Incompetence of Staphylococcus
   epidermidis, Staphylococcus lugdunensis, and Enterococcus faecalis to
   invade osteoblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE implant infections; osteomyelitis; internalization; bone; osteoblasts;
   MG63 cells; Staphylococcus aureus; Staphylococcus epidermidis;
   Staphylococcus lugdunensis; Enterococcus faecalis; ribotyping; molecular
   epidemiology
ID MAMMARY EPITHELIAL-CELLS; EXTRACELLULAR ADHERENCE PROTEIN;
   ENDOTHELIAL-CELLS; BACTERIAL INTERNALIZATION; ANTIBIOTIC-RESISTANCE;
   BIOFILM FORMATION; ICA LOCUS; AUREUS; INVASION; EXPRESSION
AB Septic failure is still the major complication of prosthetic implants. Entering host cells, bacteria hide from host immune defenses, shelter from extracellular antibiotics, and cause chronic infection. Staphylococcus aureus, the leading etiologic agent of orthopedic implant infections, is able to enter bone cells and induce osteoblast apoptosis, osteoclast recruitment, and highly destructive osteomyelitis. Staphylococcus epidermidis, Staphylococcus lugdunensis, and Enterococcus faecalis are opportunistic pathogens causative of implant-related infections. This study investigated the ability to internalize into osteoblastic MG63 cells of 22 S. epidermidis, 9 S. lugdunensis, and 21 E. faecalis clinical isolates from orthopedic implant infections. Isolates were categorized in clusters by ribotyping. Internalization assay was carried out by means of a microtiter plate-based method. S. epidermidis, S. lugdunensis, and E. faecalis strains turned out incompetent to enter osteoblasts, exhibiting negligible internalization into MG63 cells, nearly three orders of magnitude lower than that of S. aureus. Osteoblast invasion does not appear as a pathogenetic mechanism utilized by S. epidermidis, S. lugdunensis, or E. faecalis for infecting orthopedic implants. Moreover, it can be inferred that intracellularly active antimicrobials should not be necessary against implant infections caused by the three bacterial species. Finally, implications with the uptake of biomaterial microparticles by nonphagocytic cells are enlightened. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 788-801, 2016.
C1 [Campoccia, Davide; Testoni, Francesca; Ravaioli, Stefano; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.
   [Testoni, Francesca; Ravaioli, Stefano; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
   [Maso, Alessandra] Rizzoli Orthoped Inst, Musculoskeletal Tissue Bank, Microbiol Anal Sect, Bologna, Italy.
   [Speziale, Pietro] Univ Pavia, Biochem Unit, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.
   [Visai, Livia] Univ Pavia, INSTM UdR Pavia, Ctr Tissue Engn CIT, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.
   [Visai, Livia] Salvatore Maugeri Fdn, Nanotechnol Lab, Dept Occupat Med Ergon & Disabil, Pavia, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.; Arciola, CR (reprint author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
FU "5 per mille" grants for Health Research to the Rizzoli Orthopedic
   Institute of Bologna
FX Contract grant sponsor: "5 per mille" grants for Health Research to the
   Rizzoli Orthopedic Institute of Bologna
CR Almeida RA, 2007, J VET PHARMACOL THER, V30, P151, DOI 10.1111/j.1365-2885.2007.00830.x
   Almeida RA, 2001, MICROB PATHOGENESIS, V31, P205, DOI 10.1006/mpat.2001.0465
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2007, BIOMATERIALS, V28, P3987, DOI 10.1016/j.biomaterials.2007.05.013
   Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Bartlett AH, 2010, PEDIATR INFECT DIS J, V29, P860, DOI 10.1097/INF.0b013e3181ef2477
   Bur S, 2013, J INVEST DERMATOL, V133, P2004, DOI 10.1038/jid.2013.87
   Carnpoccia D, 2009, J BIOMED MATER RES A, V88A, P664, DOI 10.1002/jbm.a.32090
   Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0
   Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003
   Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07
   Frank KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130187
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003
   Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x
   Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075
   Hussain M, 2015, INT J MED MICROBIOL, V305, P129, DOI 10.1016/j.ijmm.2014.11.010
   Hyvonen P, 2009, J DAIRY RES, V76, P144, DOI 10.1017/S0022029908003774
   Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091
   Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002
   Kuhbacher A, 2014, METHODS MOL BIOL, V1157, P167, DOI 10.1007/978-1-4939-0703-8_14
   Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y
   LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115
   Lione VOF, 2005, INT J MOL MED, V15, P153
   McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001
   Millan D, 2013, MICROB PATHOGENESIS, V57, P62, DOI 10.1016/j.micpath.2012.11.007
   Nagata E, 2011, MOL ORAL MICROBIOL, V26, P78, DOI 10.1111/j.2041-1014.2010.00597.x
   Osano E, 2003, TOXICOL IN VITRO, V17, P41, DOI 10.1016/S0887-2333(02)00127-3
   Oviedo-Boyso J, 2009, FEMS MICROBIOL LETT, V292, P92, DOI 10.1111/j.1574-6968.2008.01469.x
   Patino T, 2012, INT J NANOMED, V7, P5671, DOI 10.2147/IJN.S34635
   Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013
   Ravaioli S, 2012, INT J ARTIF ORGANS, V35, P742, DOI 10.5301/ijao.5000142
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   Solomon EB, 2005, J FOOD PROTECT, V68, P870, DOI 10.4315/0362-028X-68.4.870
   Soong G, 2011, J BIOL CHEM, V286, P35891, DOI 10.1074/jbc.M111.295386
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Szabados F, 2011, FEMS MICROBIOL LETT, V324, P48, DOI 10.1111/j.1574-6968.2011.02382.x
   Tang HJ, 2011, INT J ANTIMICROB AG, V38, P46, DOI 10.1016/j.ijantimicag.2011.02.013
   Testoni F, 2011, INT J ARTIF ORGANS, V34, P789, DOI 10.5301/ijao.5000058
   Valour F, 2015, ANTIMICROB AGENTS CH, V59, P2029, DOI 10.1128/AAC.04359-14
   Valour F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067240
   Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   Wang JH, 2013, J MICROBIOL, V51, P644, DOI 10.1007/s12275-013-3040-x
   Wells CL, 2000, INFECT IMMUN, V68, P7190, DOI 10.1128/IAI.68.12.7190-7194.2000
   WILSON CB, 1982, SEMIN PERINATOL, V6, P205
   YAO L, 1995, INFECT IMMUN, V63, P1835
   Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8
NR 51
TC 7
Z9 8
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2016
VL 104
IS 3
BP 788
EP 801
DI 10.1002/jbm.a.35564
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DC4AB
UT WOS:000369160800023
PM 26378773
DA 2018-10-20
ER

PT J
AU Aibibu, D
   Hild, M
   Woltje, M
   Cherif, C
AF Aibibu, Dilbar
   Hild, Martin
   Woeltje, Michael
   Cherif, Chokri
TI Textile cell-free scaffolds for in situ tissue engineering applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ACID-COLLAGEN TUBE; BIODEGRADABLE POLYMER SCAFFOLDS; PERIPHERAL-NERVE
   REGENERATION; ANTERIOR CRUCIATE LIGAMENT; ROTATOR CUFF REPAIR;
   3-DIMENSIONAL POROUS SCAFFOLDS; REINFORCED FASCIA PATCH; SPIDER SILK
   PROTEINS; POLYGLYCOLIC ACID; CROSS-LINKING
AB In this article, the benefits offered by micro-fibrous scaffold architectures fabricated by textile manufacturing techniques are discussed: How can established and novel fiber-processing techniques be exploited in order to generate templates matching the demands of the target cell niche? The problems related to the development of biomaterial fibers (especially from nature-derived materials) ready for textile manufacturing are addressed. Attention is also paid on how biological cues may be incorporated into micro-fibrous scaffold architectures by hybrid manufacturing approaches (e.g. nanofiber or hydrogel functionalization). After a critical review of exemplary recent research works on cell-free fiber based scaffolds for in situ TE, including clinical studies, we conclude that in order to make use of the whole range of favors which may be provided by engineered fibrous scaffold systems, there are four main issues which need to be addressed: (1) Logical combination of manufacturing techniques and materials. (2) Biomaterial fiber development. (3) Adaption of textile manufacturing techniques to the demands of scaffolds for regenerative medicine. (4) Incorporation of biological cues (e.g. stem cell homing factors).
C1 [Aibibu, Dilbar; Hild, Martin; Woeltje, Michael; Cherif, Chokri] Tech Univ Dresden, Fak Maschinenwesen, Inst Text Maschinen & Text Hochleistungswerkstoff, D-01062 Dresden, Germany.
RP Aibibu, D (reprint author), Tech Univ Dresden, Fak Maschinenwesen, Inst Text Maschinen & Text Hochleistungswerkstoff, D-01062 Dresden, Germany.
EM dilibaier.aibibu@tu-dresden.de
RI Cherif, Chokri/R-8818-2016
OI Cherif, Chokri/0000-0003-3835-0420
CR Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760
   Aberg M, 2009, J PLAST RECONSTR AES, V62, P1503, DOI 10.1016/j.bjps.2008.06.041
   Abounaim MD, 2012, TEXT RES J, V82, P288, DOI 10.1177/0040517511426609
   Ahn H, 2014, J MECH BEHAV BIOMED, V34, P37, DOI 10.1016/j.jmbbm.2014.01.004
   Akbarzadeh R, 2014, J BIOMED MATER RES B, V102, P1304, DOI 10.1002/jbm.b.33101
   Albanna MZ, 2013, J MECH BEHAV BIOMED, V20, P217, DOI 10.1016/j.jmbbm.2012.09.012
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Ansar M, 2011, COMPOS STRUCT, V93, P1947, DOI 10.1016/j.compstruct.2011.03.010
   Asti A, 2014, INT J ARTIF ORGANS, V37, P187, DOI [10.5301/ijao.5000307, 10.530/ijao.5000307]
   Aurora A, 2011, J BIOMED MATER RES A, V99A, P221, DOI 10.1002/jbm.a.33179
   Baker AR, 2012, CLIN ORTHOP RELAT R, V470, P2513, DOI 10.1007/s11999-012-2348-x
   Balasubramanian P, 2013, ADV POLYM SCI, V251, P173, DOI 10.1007/12_2012_176
   Behera BK, 2009, J IND TEXT, V38, P205, DOI 10.1177/1528083708091251
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Bettahalli NMS, 2011, ACTA BIOMATER, V7, P3312, DOI 10.1016/j.actbio.2011.06.012
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bilisik K, 2013, TEXT RES J, V83, P1414, DOI 10.1177/0040517512450766
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327
   Brunger JM, 2014, P NATL ACAD SCI USA, V111, pE798, DOI 10.1073/pnas.1321744111
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Burdick JA, 2011, BIOMATERIALS FOR TIS
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V44, P146, DOI 10.1002/bit.260440121
   Caves JM, 2010, J BIOMED MATER RES B, V93B, P24, DOI 10.1002/jbm.b.31555
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   Cherif C, 2011, TEXTILE WERKSTOFFE L
   Chung DE, 2014, FIBER POLYM, V15, P153, DOI 10.1007/s12221-014-0153-8
   Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Derwin KA, 2009, J BONE JOINT SURG AM, V91A, P1159, DOI 10.2106/JBJS.H.00775
   Desorme M, 2013, CARBOHYD POLYM, V98, P50, DOI 10.1016/j.carbpol.2013.04.070
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Efe T, 2012, KNEE SURG SPORT TR A, V20, P1911, DOI 10.1007/s00167-011-1777-5
   Elsabee MZ, 2012, MAT SCI ENG C-MATER, V32, P1711, DOI 10.1016/j.msec.2012.05.009
   Enea D, 2013, KNEE SURG SPORT TR A, V21, P1783, DOI 10.1007/s00167-012-2102-7
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Fioretta ES, 2012, MACROMOL BIOSCI, V12, P577, DOI 10.1002/mabi.201100315
   Funakoshi T, 2006, J SHOULDER ELB SURG, V15, P112, DOI 10.1016/j.jse.2005.05.012
   Gavenis K, 2010, ARTIF ORGANS, V34, P79, DOI 10.1111/j.1525-1594.2009.00776.x
   Giannitelli SM, 2014, ACTA BIOMATER, V10, P580, DOI 10.1016/j.actbio.2013.10.024
   Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073
   Gloy YS, 2013, ANN BIOMED ENG, V41, P1950, DOI 10.1007/s10439-013-0806-6
   Gokarneshan N, 2012, J IND TEXT, V42, P52, DOI 10.1177/1528083711426021
   Gomez G, 2006, J CRANIOFAC SURG, V17, P935
   Goonoo N, 2014, J BIOMED NANOTECHNOL, V10, P2173, DOI 10.1166/jbn.2014.1885
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Guan JJ, 2015, RSC ADV, V5, P36175, DOI 10.1039/c5ra01487e
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   He JX, 2014, POLYM INT, V63, P1288, DOI 10.1002/pi.4672
   He NF, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40404
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hild M, 2014, TEXT RES J, V84, P1084, DOI 10.1177/0040517513515315
   Hild M, 2014, COMPOS INTERFACE, V21, P301, DOI 10.1080/15685543.2014.852016
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Honkanen PB, 2010, J HAND SURG-EUR VOL, V35E, P746, DOI 10.1177/1753193410375777
   Honkanen PB, 2003, TISSUE ENG, V9, P957, DOI 10.1089/107632703322495600
   Hoogenkamp HR, 2014, TISSUE ENG PART C-ME, V20, P423, DOI [10.1089/ten.tec.2013.0485, 10.1089/ten.TEC.2013.0485]
   Hou QP, 2003, BIOMATERIALS, V24, P1937, DOI 10.1016/S0142-9612(02)00562-8
   Hsia Y, 2012, JOVE-J VIS EXP, DOI 10.3791/4191
   Hutmacher DW, 2007, J CELL MOL MED, V11, P654, DOI 10.1111/j.1582-4934.2007.00078.x
   Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508
   Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   Inada Yuji, 2007, Neurosurgery, V61, pE1105
   Ingavle GC, 2014, TISSUE ENG PART B-RE, V20, P277, DOI [10.1089/ten.TEB.2013.0276, 10.1089/ten.teb.2013.0276]
   Inui Atsuyuki, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P29, DOI 10.1186/1758-2555-3-29
   Inui A, 2010, INT ORTHOP, V34, P1327, DOI 10.1007/s00264-009-0917-8
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Iwai S, 2004, J THORAC CARDIOV SUR, V128, P472, DOI 10.1016/j.jtcvs.2004.04.013
   Iwasaki N, 2011, POLYMERS-BASEL, V3, P100, DOI 10.3390/polym3010100
   Jakob F, 2012, CELL TISSUE RES, V347, P725, DOI 10.1007/s00441-011-1237-z
   Janicki P, 2012, DEUT Z SPORTMED, V63, P30, DOI 10.5960/dzsm.2011.064
   Jassal M, 2013, TEXT RES J, V83, P1999, DOI 10.1177/0040517513481870
   Jayakumar R, 2011, CHITOSAN BIOMATERIAL
   Johannsen O, 1932, Z VER DTSCH ING, V76, P710
   Jun Y, 2014, LAB CHIP, V14, P2145, DOI 10.1039/c3lc51414e
   Kamiya R, 2000, COMPOS SCI TECHNOL, V60, P33, DOI 10.1016/S0266-3538(99)00093-7
   Kasahara Y, 2008, J BIOMED MATER RES A, V86A, P127, DOI 10.1002/jbm.a.31259
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Ki CS, 2007, J APPL POLYM SCI, V105, P1605, DOI 10.1002/app.26176
   Kimura Y, 2008, TISSUE ENG PT C-METH, V14, P47, DOI 10.1089/tec.2007.0286
   Kiyotani T, 1996, BRAIN RES, V740, P66, DOI 10.1016/S0006-8993(96)00848-7
   Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118
   Ko YG, 2013, COMPOS SCI TECHNOL, V79, P77, DOI 10.1016/j.compscitech.2013.02.016
   Koufaki N, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045004
   Koyanagi Ryo, 2010, Journal of Insect Biotechnology and Sericology, V79, P27
   Kumar RS, 2014, TEXTILES IND APPL
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lansman S, 2006, J CRANIOFAC SURG, V17, P1121
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee BR, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576903
   Leong NL, 2014, J BIOMED MATER RES A, V102, P1614, DOI 10.1002/jbm.a.34820
   Li L, 2012, J MATER CHEM, V22, P8585, DOI 10.1039/c2jm30555k
   Li S, 2014, WIRES SYST BIOL MED, V6, P61, DOI 10.1002/wsbm.1246
   Li XM, 2014, J BIOMED MATER RES A, V102, P1580, DOI 10.1002/jbm.a.34801
   Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774
   Li ZH, 2013, FRONT MATER SCI, V7, P237, DOI 10.1007/s11706-013-0214-8
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483
   Ling SJ, 2012, MATER LETT, V81, P13, DOI 10.1016/j.matlet.2012.04.136
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MacGillivray JD, 2006, J SHOULDER ELB SURG, V15, P639, DOI 10.1016/j.jse.2005.11.009
   Maleki H, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41388
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Matsumura G, 2013, BIOMATERIALS, V34, P6422, DOI 10.1016/j.biomaterials.2013.05.037
   Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760
   McCarron JA, 2010, J SHOULDER ELB SURG, V19, P688, DOI 10.1016/j.jse.2009.12.008
   McCullen SD, 2010, J MATER CHEM, V20, P8776, DOI 10.1039/c0jm01443e
   McNeil SE, 2011, CURR DRUG DELIV, V8, P448
   Meier C, 2011, BIOMACROMOLECULES, V12, P3453, DOI 10.1021/bm2005752
   Meyer M, 2010, MAT SCI ENG C-MATER, V30, P1266, DOI 10.1016/j.msec.2010.07.005
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mukherjee DP, 2009, J BIOMED MATER RES B, V88B, P92, DOI 10.1002/jbm.b.31155
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   Ogulata RT, 2012, J TEXT I, V103, P654, DOI 10.1080/00405000.2011.597567
   Oliveira JT, 2011, J BIOMAT SCI-POLYM E, V22, P773, DOI 10.1163/092050610X494604
   Ozipek B, 2014, WOODHEAD PUBL SER TE, P174, DOI 10.1533/9780857099174.2.174
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Pati F, 2012, J MATER SCI-MATER M, V23, P1085, DOI 10.1007/s10856-012-4559-9
   Peniston SJ, 2012, J BIOMED MATER RES B, V100B, P1922, DOI 10.1002/jbm.b.32759
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Piri N, 2013, E-POLYMERS, V13
   Pohl G, 2009, TEXTILES CONSTRUCTIO
   Puppi D, 2014, J BIOMED MATER RES B, V102, P1562, DOI 10.1002/jbm.b.33144
   Qian L, 2011, J CHEM TECHNOL BIOT, V86, P172, DOI 10.1002/jctb.2495
   Qiu WG, 2009, BIOMACROMOLECULES, V10, P602, DOI 10.1021/bm801296r
   Quigley AF, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016008
   Rampichova M, 2010, PHYSIOL RES, V59, P773
   Rawal A, 2014, WOODHEAD PUBL SER TE, P75, DOI 10.1533/9780857099174.2.75
   Ribba L, 2014, J BIOMED NANOTECHNOL, V10, P3508, DOI 10.1166/jbn.2014.2046
   Riva R, 2011, ADV POLYM SCI, V244, P19, DOI 10.1007/12_2011_137
   Salerno A, 2009, J MATER SCI-MATER M, V20, P2043, DOI 10.1007/s10856-009-3767-4
   Schacht K, 2014, CURR OPIN BIOTECH, V29, P62, DOI 10.1016/j.copbio.2014.02.015
   Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677
   Seib FP, 2013, ISR J CHEM, V53, P756, DOI 10.1002/ijch.201300083
   Sengupta D, 2014, ANN BIOMED ENG, V42, P1537, DOI 10.1007/s10439-014-1022-8
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Shepherd DV, 2015, APL MATER, V3, DOI 10.1063/1.4900887
   Shepherd JH, 2013, J BIOMED MATER RES A, V101, P176, DOI 10.1002/jbm.a.34317
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Starritt NE, 2011, LARYNGOSCOPE, V121, P1614, DOI 10.1002/lary.21868
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Tamayol A, 2013, BIOTECHNOL ADV, V31, P669, DOI 10.1016/j.biotechadv.2012.11.007
   Tian LL, 2015, REGEN BIOMATER, V2, P31, DOI 10.1093/rb/rbu017
   Tiihonen R, 2012, SCAND J SURG, V101, P265, DOI 10.1177/145749691210100408
   Tiihonen RP, 2012, J PLAST SURG HAND SU, V46, P113, DOI 10.3109/2000656X.2012.669202
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Torikai K, 2008, J THORAC CARDIOV SUR, V136, P37, DOI 10.1016/j.jtcvs.2007.06.039
   Toskas G, 2013, AUTEX RES J, V13, P134, DOI 10.2478/v10304-012-0041-5
   Trachtenberg JE, 2013, ISR J CHEM, V53, P646, DOI 10.1002/ijch.201300051
   Tuin SA, 2014, J BIOMED MATER RES A, V102, P3311, DOI 10.1002/jbm.a.35002
   Uquillas JA, 2012, J MECH BEHAV BIOMED, V15, P176, DOI 10.1016/j.jmbbm.2012.06.012
   Urita Y, 2008, PEDIATR SURG INT, V24, P1041, DOI 10.1007/s00383-008-2212-y
   Vleggeert-Lankamp CLAM, 2007, J BIOMED MATER RES A, V80A, P965, DOI 10.1002/jbm.a.30941
   Wan ACA, 2004, MACROMOLECULES, V37, P7019, DOI 10.1021/ma0498868
   Wang LM, 2009, TISSUE ENG PT A, V15, P1009, DOI 10.1089/ten.tea.2008.0012
   Wang XG, 2013, ACTA BIOMATER, V9, P7822, DOI 10.1016/j.actbio.2013.04.017
   Wang XG, 2012, J MECH BEHAV BIOMED, V8, P204, DOI 10.1016/j.jmbbm.2012.01.001
   Wang XG, 2011, J MECH BEHAV BIOMED, V4, P922, DOI 10.1016/j.jmbbm.2011.04.009
   Waris E, 2008, BIOMATERIALS, V29, P683, DOI 10.1016/j.biomaterials.2007.10.037
   Weber M, 2014, TISSUE ENG PART C-ME, V20, P265, DOI [10.1089/ten.TEC.2013.0258, 10.1089/ten.tec.2013.0258]
   Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Williams DF, 2014, TISSUE ENG PT A, V20, P1129, DOI 10.1089/ten.tea.2013.0769
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Wong CS, 2012, TEXT RES J, V82, P1371, DOI 10.1177/0040517512439915
   Woodruff MA, 2012, MATER TODAY, V15, P430, DOI 10.1016/S1369-7021(12)70194-3
   Wulfhorst B, 2006, TEXTILE TECHNOLOGY
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xu HL, 2014, LANGMUIR, V30, P8461, DOI 10.1021/la500768b
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
   Yan JP, 2010, BIOMACROMOLECULES, V11, P1, DOI 10.1021/bm900840h
   Yan WX, 2014, J APPL POLYM SCI, V131, DOI [10.1002/app.40852, 10.1002/APP.40852]
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yeoman MS, 2010, BIOMATERIALS, V31, P8484, DOI 10.1016/j.biomaterials.2010.07.033
   Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058
   Yokoya S, 2008, AM J SPORT MED, V36, P1298, DOI 10.1177/0363546508314416
   Yoshitani M, 2007, J THORAC CARDIOV SUR, V133, P726, DOI 10.1016/j.jtcvs.2006.08.089
   You CG, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-125
   Younesi M, 2014, ADV FUNCT MATER, V24, P5762, DOI 10.1002/adfm.201400828
   Yudin VE, 2014, CARBOHYD POLYM, V108, P176, DOI 10.1016/j.carbpol.2014.02.090
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
   Zeugolis DI, 2008, J APPL POLYM SCI, V108, P2886, DOI 10.1002/app.27208
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang CC, 2012, BIOMACROMOLECULES, V13, P2148, DOI 10.1021/bm300541g
   Zhou H, 2014, CHINESE J POLYM SCI, V32, P29, DOI 10.1007/s10118-014-1368-2
   Zhu MF, 2015, BIOMATERIALS, V61, P85, DOI 10.1016/j.biomaterials.2015.05.024
NR 213
TC 5
Z9 6
U1 2
U2 74
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2016
VL 27
IS 3
AR 63
DI 10.1007/s10856-015-5656-3
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB7WQ
UT WOS:000368728100021
PM 26800694
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Lotfi, M
   Bagherzadeh, R
   Naderi-Meshkin, H
   Mahdipour, E
   Mafinezhad, A
   Sadeghnia, HR
   Esmaily, H
   Maleki, M
   Hasssanzadeh, H
   Ghayaour-Mobarhan, M
   Bidkhori, HR
   Bahrami, AR
AF Lotfi, Marzieh
   Bagherzadeh, Roohollah
   Naderi-Meshkin, Hojjat
   Mahdipour, Elahe
   Mafinezhad, Asghar
   Sadeghnia, Hamid Reza
   Esmaily, Habibollah
   Maleki, Masoud
   Hasssanzadeh, Halimeh
   Ghayaour-Mobarhan, Majid
   Bidkhori, Hamid Reza
   Bahrami, Ahmad Reza
TI Hybrid Chitosan-beta-Glycerol Phosphate-Gelatin Nano-/Micro Fibrous
   Scaffolds with Suitable Mechanical and Biological Properties for Tissue
   Engineering
SO BIOPOLYMERS
LA English
DT Article
DE regenerative medicine; chitosan; gelatin; tissue engineering;
   biocompatible scaffold
ID MESENCHYMAL STEM-CELLS; NORMAL HUMAN KERATINOCYTES; PORE
   STRUCTURE-ANALYSIS; CROSS-LINKING; NANOFIBERS; SKIN; DIFFERENTIATION;
   PREDICTION; REPAIR
AB Scaffold-based tissue engineering is considered as a promising approach in the regenerative medicine. Graft instability of collagen, by causing poor mechanical properties and rapid degradation, and their hard handling remains major challenges to be addressed. In this research, a composite structured nano-/microfibrous scaffold, made from a mixture of chitosan-beta-glycerol phosphate-gelatin (chitosan-GP-gelatin) using a standard electrospinning setup was developed. Gelatin-acid acetic and chitosan beta-glycerol phosphate-HCL solutions were prepared at ratios of 30/70, 50/50, 70/30 (w/w) and their mechanical and biological properties were engineered. Furthermore, the pore structure of the fabricated nanofibrous scaffolds was investigated and predicted using a theoretical model. Higher gelatin concentrations in the polymer blend resulted in significant increase in mean pore size and its distribution. Interaction between the scaffold and the contained cells was also monitored and compared in the test and control groups. Scaffolds with higher chitosan concentrations showed higher rate of cell attachment with better proliferation property, compared with gelatin-only scaffolds. The fabricated scaffolds, unlike many other natural polymers, also exhibit non-toxic and biodegradable properties in the grafted tissues. In conclusion, the data clearly showed that the fabricated biomaterial is a biologically compatible scaffold with potential to serve as a proper platform for retaining the cultured cells for further application in cell-based tissue engineering, especially in wound healing practices. These results suggested the potential of using mesoporous composite chitosan-GP-gelatin fibrous scaffolds for engineering three-dimensional tissues with different inherent cell characteristics. (C) 2015 Wiley Periodicals, Inc.
C1 [Lotfi, Marzieh] Mashhad Univ Med Sci, Dept Modern Sci, Mashhad, Iran.
   [Lotfi, Marzieh] Mashhad Univ Med Sci, Technol Sch Med, Mashhad, Iran.
   [Bagherzadeh, Roohollah] Amirkabir Univ Technol, Adv Text Mat & Technol Res Inst ATMT, Text Engn Dept, Tehran, Iran.
   [Naderi-Meshkin, Hojjat; Hasssanzadeh, Halimeh; Bidkhori, Hamid Reza; Bahrami, Ahmad Reza] Iranian Acad Ctr Educ Culture & Res ACECR, Stem Cell & Regenerat Med Res Grp, Khorasan Razavi Branch, Mashhad, Iran.
   [Mahdipour, Elahe] Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, Mashhad, Iran.
   [Mafinezhad, Asghar] Mashhad Univ Med Sci, Dept Pathol, Shahid Kamyab Emdadi Hosp, Mashhad, Iran.
   [Sadeghnia, Hamid Reza] Mashhad Univ Med Sci, Sch Med, Neurocognit Res Ctr, Mashhad, Iran.
   [Esmaily, Habibollah] Mashhad Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Mashhad, Iran.
   [Maleki, Masoud] Mashhad Univ Med Sci, Sch Med, Cutaneous Leishmaniasis Res Ctr, Mashhad, Iran.
   [Ghayaour-Mobarhan, Majid] Mashhad Univ Med, Sch Med, Biochem Nutr Res Ctr, Mashhad, Iran.
   [Bahrami, Ahmad Reza] Ferdowsi Univ Mashhad, Inst Biotechnol, Cell & Mol Biotechnol Res Grp, Mashhad, Iran.
RP Bahrami, AR (reprint author), Iranian Acad Ctr Educ Culture & Res ACECR, Stem Cell & Regenerat Med Res Grp, Khorasan Razavi Branch, Mashhad, Iran.
EM ghayourm@mums.ac.ir; Ar-Bahrami@um.ac.ir
RI Bagherzadeh, Roohollah/B-7077-2014
OI Bagherzadeh, Roohollah/0000-0001-8297-5343; Esmaily,
   Habibollah/0000-0003-4139-546X
FU Mashhad University of Medical Sciences; Iranian Academic Center for
   Education, Culture and Research (ACECR), Khorasan Razavi Branch, Mashhad
FX The results described in this paper were part of a Ph.D. student
   (Marzieh Loth) thesis (thesis # A-543). This research project was
   supported by Mashhad University of Medical Sciences and Iranian Academic
   Center for Education, Culture and Research (ACECR), Khorasan Razavi
   Branch, Mashhad.
CR Alli A, 2006, EUR POLYM J, V42, P3024, DOI 10.1016/j.eurpolymj.2006.07.012
   Bagherzadeh R, 2014, J IND TEXT, V43, P483, DOI 10.1177/1528083712463400
   Bagherzadeh R, 2014, J IND TEXT, V43, P496, DOI 10.1177/1528083712463414
   Bagherzadeh R, 2014, J BIOMED MATER RES A, V102, P903, DOI 10.1002/jbm.a.34736
   Bagherzadeh R, 2013, J BIOMED MATER RES A, V101, P2107, DOI 10.1002/jbm.a.34487
   Bagherzadeh R, 2013, J BIOMED MATER RES A, V101, P765, DOI 10.1002/jbm.a.34379
   Bagherzadeh R, 2012, TEXT RES J, V82, P70, DOI 10.1177/0040517511420766
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7
   Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Jana S., 2012, DESIGNING CHITOSAN B
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   Knaul JZ, 1999, J POLYM SCI POL PHYS, V37, P1079, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1079::AID-POLB4>3.0.CO;2-O
   Ko FK, 2014, INTRODUCTION TO NANOFIBER MATERIALS, P1, DOI 10.1017/CBO9781139021333
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lao LH, 2011, J MATER SCI-MATER M, V22, P1873, DOI 10.1007/s10856-011-4374-8
   Lee F, 2013, ACTA BIOMATER, V9, P5143, DOI 10.1016/j.actbio.2012.08.036
   Liu P, 2008, ARTIF ORGANS, V32, P925, DOI 10.1111/j.1525-1594.2008.00654.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maharlooei MK, 2011, DIABETES RES CLIN PR, V93, P228, DOI 10.1016/j.diabres.2011.04.018
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   Min BM, 2004, CARBOHYD POLYM, V57, P285, DOI 10.1016/j.carbpol.2004.05.007
   Nalwa H. S., 2005, HDB NANOSTRUCTURED B
   Nguyen TBL, 2012, J BIOMATER APPL, V27, P255, DOI 10.1177/0885328211401932
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Qian YF, 2011, J BIOMAT SCI-POLYM E, V22, P1099, DOI 10.1163/092050610X499447
   Quint C., 2009, TISSUE ENG REGEN MED, P950
   Ratanavaraporn J, 2006, J METALS MAT MINERAL, V16, P31
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Tchemtchoua VT, 2011, BIOMACROMOLECULES, V12, P3194, DOI 10.1021/bm200680q
   Telci D., 2013, STEM CELLS WOUND HEA, P1751
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Xiumei M., 1997, ACTA POLYM SIN, V1, P222
   Zhan J., 2013, J RES UPDATE POLITIC, V1, P59
NR 39
TC 8
Z9 8
U1 2
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD MAR
PY 2016
VL 105
IS 3
BP 163
EP 175
DI 10.1002/bip.22764
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DB0GZ
UT WOS:000368187900004
PM 26566174
DA 2018-10-20
ER

PT J
AU Ribeiro, AM
   Flores-Sahagun, THS
   Paredes, RC
AF Ribeiro, Andreza M.
   Flores-Sahagun, Thais H. S.
   Paredes, Ramon C.
TI A perspective on molybdenum biocompatibility and antimicrobial activity
   for applications in implants
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID TI-MO ALLOYS; TI-10MO EXPERIMENTAL ALLOY; POROUS TI-7.5MO ALLOY;
   SHAPE-MEMORY ALLOY; IN-VIVO EFFICACY; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; CORROSION-RESISTANCE; SURFACE MODIFICATION;
   TITANIUM-ALLOYS
AB The use of biomaterials has become routine in dentistry, reconstructive surgery of the locomotor system, treatment of congenital, traumatic and tumor situations, and knee or hip arthroplasty. The main issue related to metal biomaterials is the systemic release of metal ions and the related biological risks. When placed in contact with a living organism, they must meet a set of criteria: they must be biocompatible and biofunctional, as well as have the ability to produce a specific biological response at the surface, leading to the formation of a bond between the material and the receiving tissue and a surface texture which allows cell adhesion and bone growth; they must also provide adequate structure and mechanical strength, without causing adverse reactions in the surrounding physiological environment; they must not cause oncogenic effects; they must be easy to manipulate during surgery; and they must be amenable to visible imaging and sterilization. The ability to use biomaterials is linked to the degree of biocompatibility and biofunctionality which in turn, are dependent on their physicochemical and mechanical properties, macroscopic and microscopic configuration, and the biological environment where they are deployed. Metal alloys, particularly stainless steel, cobalt, molybdenum, chromium alloys, and titanium-based alloys find wide application in orthopedics for making joint replacement prostheses, systems for external or internal fixation of bone fractures, surgical correction of degenerative conditions, or in the composition of staples, screws, and wires. Any synthetic biomaterial can replace or restore the function of body tissues while maintaining a continuous or intermittent contact with the fluid. When in contact with the fluid, it is essential that materials be biocompatible, so they do not produce adverse biological responses or induce systemic effects. Thus, they must not be toxic, carcinogenic, mutagenic, or antigenic. Bioactive materials with antibacterial properties are also of significant medical interest. Materials exhibiting good antimicrobial activity that minimize the formation of biofilm without the risk of promoting the development of resistant microorganisms are desirable. In this respect, this review briefly summarizes the recent successes of this metal as a biocompatible material with antibacterial activity for biomedical applications.
C1 [Ribeiro, Andreza M.; Flores-Sahagun, Thais H. S.; Paredes, Ramon C.] Univ Fed Parana, Engn & Mat Sci, BR-80060000 Curitiba, Parana, Brazil.
RP Ribeiro, AM (reprint author), Univ Fed Parana, Engn & Mat Sci, BR-80060000 Curitiba, Parana, Brazil.
EM ribeiroandreza@yahoo.com.br
RI Ribeiro, Andreza/I-8400-2012
OI Ribeiro, Andreza/0000-0003-3002-7362
FU National Council for Scientific and Technological Research (CNPq)
   [310272/2014-92]
FX We thank the National Council for Scientific and Technological Research
   for the research Grant (CNPq, process 310272/2014-92).
CR Akiyama H, 2013, J ORTHOP SCI, V18, P29, DOI 10.1007/s00776-012-0298-5
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   Almeida Filho Ed, 2007, QUIM NOVA, V30, P1129, DOI [10.1590/S0100-40422007000500034, DOI 10.1590/S0100-40422007000500034]
   Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   Rezende MCRA, 2007, J MATER SCI-MATER M, V18, P149, DOI 10.1007/s10856-006-0674-9
   Anderson JM, 2006, BIOMATERIALS SILVER
   [Anonymous], 2013, F181313A ASTM INT
   [Anonymous], 2013, F56200A ASTM INT
   [Anonymous], 2000, F56300A ASTM INT
   [Anonymous], 2008, F105808 ASTM INT
   [Anonymous], 2014, F96114A ASTM INT
   [Anonymous], 2012, F7512A ASTM INT
   [Anonymous], 2011, F153711A
   [Anonymous], 2011, F79911A ASTM INT
   [Anonymous], 2008, F961A ASTM INT
   [Anonymous], F68814A ASTM INT
   [Anonymous], F74507A ASTM INT
   [Anonymous], 2014, F96108A ASTM INT
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arruebo M, 2010, EXPERT OPIN DRUG DEL, V7, P589, DOI 10.1517/17425241003671544
   Bago JR, 2013, TISSUE ENG PT A, V19, P593, DOI [10.1089/ten.tea.2012.0073, 10.1089/ten.TEA.2012.0073]
   Balas F, 2007, J MATER SCI-MATER M, V18, P1167, DOI 10.1007/s10856-007-0130-5
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   Bitar M, 2012, EUR CELLS MATER, V23, P333
   Borcard F, 2012, J MED CHEM, V55, P7988, DOI 10.1021/jm301092r
   BUNDY KJ, 1980, J BIOMED MATER RES, V14, P653, DOI 10.1002/jbm.820140511
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chai YW, 2009, ACTA MATER, V57, P4054, DOI 10.1016/j.actamat.2009.04.051
   Chang YY, 2014, SURF COAT TECH, V259, P193, DOI 10.1016/j.surfcoat.2014.03.061
   Cheng CH, 2009, J ALLOY COMPD, V484, P524, DOI 10.1016/j.jallcom.2009.04.148
   Chu CL, 2005, J BIOMED MATER RES A, V75A, P595, DOI 10.1002/jbm.a.30465
   Chu PK, 2006, NUCL INSTRUM METH B, V242, P1, DOI 10.1016/j.nimb.2005.08.015
   Coraca DC, 2008, J MATER SCI-MATER M, V19, P2699, DOI 10.1007/s10856-008-3397-2
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   DeHoff PH, 1998, J BIOMED MATER RES, V41, P614, DOI 10.1002/(SICI)1097-4636(19980915)41:4<614::AID-JBM14>3.0.CO;2-E
   EVANS EJ, 1986, BIOMATERIALS, V7, P25, DOI 10.1016/0142-9612(86)90084-0
   Fisher L, 2014, BIOFOULING, V30, P911, DOI 10.1080/08927014.2014.939959
   Flores-Sahagun JH, 2011, Patent No. [1107210- 5, 11072105]
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gonzalez-Chomon C, 2012, EUR J PHARM BIOPHARM, V82, P383, DOI 10.1016/j.ejpb.2012.07.007
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   Gordin DM, 2004, J MATER SCI-MATER M, V15, P885, DOI 10.1023/B:JMSM.0000036276.32211.31
   Guggenbichler J. P., 2011, GMS KRANKENHHYG INTE, V6, P18, DOI DOI 10.3205/DGKH000175
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hacking SA, 2012, J NEUROSCI METH, V211, P237, DOI 10.1016/j.jneumeth.2012.09.002
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004
   He FP, 2012, J BIOMED MATER RES A, V100A, P3239, DOI 10.1002/jbm.a.34265
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Ho WF, 2012, MAT SCI ENG C-MATER, V32, P517, DOI 10.1016/j.msec.2011.12.003
   Ho WF, 2010, MAT SCI ENG C-MATER, V30, P904, DOI 10.1016/j.msec.2010.04.006
   Ho WF, 2009, SURF COAT TECH, V203, P3142, DOI 10.1016/j.surfcoat.2009.03.042
   Ho WF, 2008, J MED BIOL ENG, V28, P47
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hsu HC, 2013, MAT SCI ENG A-STRUCT, V568, P1, DOI 10.1016/j.msea.2013.01.002
   Hsu HC, 2013, MATER DESIGN, V47, P21, DOI 10.1016/j.matdes.2012.12.043
   Hsu HC, 2013, J MATER SCI-MATER M, V24, P645, DOI 10.1007/s10856-012-4843-8
   Iijima D, 2003, BIOMATERIALS, V24, P1519, DOI 10.1016/S0142-9612(02)00533-1
   Jeong KJ, 2011, THER DELIV, V2, P737, DOI 10.4155/TDE.11.54
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Joyce TJ, 2011, TRIBOL INT, V44, P513, DOI 10.1016/j.triboint.2010.04.007
   Kent D, 2010, MAT SCI ENG A-STRUCT, V527, P2246, DOI 10.1016/j.msea.2009.11.059
   Khalid A. Q., 2014, AFR J MICROBIOL RES, V8, P1080, DOI [10.5897/AJMR2013.5893, DOI 10.5897/AJMR2013.5893]
   Kokubo T, 2004, Med J Malaysia, V59 Suppl B, P91
   Krishnamoorthy K, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/31/315101
   Krishnamoorthy K, 2013, COLLOID SURFACE B, V112, P521, DOI 10.1016/j.colsurfb.2013.08.026
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   Lemons J. E., 1996, MED APPL TITANIUM IT
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Li YH, 2009, J ALLOY COMPD, V485, P215, DOI 10.1016/j.jallcom.2009.06.003
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mansouri MD, 2008, CLIN MICROBIOL INFEC, V14, P190, DOI 10.1111/j.1469-0691.2007.01894.x
   MARCUS P, 1994, CORROS SCI, V36, P2155, DOI 10.1016/0010-938X(94)90013-2
   Mardare CC, 2014, ACS COMB SCI, V16, P631, DOI 10.1021/co5000536
   Marti A, 2000, INJURY, V31, P18, DOI [10.1016/S0020-1383(00)80018-2), DOI 10.1016/S0020-1383(00)80018-2]
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   MERRITT K, 1992, J BIOMED MATER RES, V26, P1503, DOI 10.1002/jbm.820261109
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Murphy SV, 2013, BIOESSAYS, V35, P163, DOI 10.1002/bies.201200062
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Nadim James H, 2003, BIOMATERIALS ORTHOPE
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Nordberg GF, 2015, HDB TOXICOLOGY METAL
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Oliveira A, 2015, REV BRASILEIRA APLIC, V34, P66, DOI 10.17563/rbav.v34i2.994
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2013, ELECTROCHEM COMMUN, V35, P139, DOI 10.1016/j.elecom.2013.08.019
   Oudadesse H, 2008, APPL SURF SCI, V255, P593, DOI 10.1016/j.apsusc.2008.06.086
   Page JM, 2012, ACTA BIOMATER, V8, P4405, DOI 10.1016/j.actbio.2012.07.037
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Patterson JT, 2012, REGEN MED, V7, P409, DOI [10.2217/RME.12.12, 10.2217/rme.12.12]
   Peckitt NS, 1999, BRIT J ORAL MAX SURG, V37, P353, DOI 10.1054/bjom.1999.0070
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Qureshi N, 2015, APPL NANOSCI, V5, P331, DOI 10.1007/s13204-014-0322-5
   Randelli F, 2012, J ARTHROPLASTY, V27, P186, DOI 10.1016/j.arth.2011.04.015
   Ratner B. D., 2012, BIOMATERIALS SCI INT
   Ravaioli S, 2012, INT J ARTIF ORGANS, V35, P742, DOI 10.5301/ijao.5000142
   Ribeiro A, 2012, J R SOC INTERFACE, V9, P2059, DOI 10.1098/rsif.2012.0102
   Ribeiro A, 2012, CARBOHYD POLYM, V88, P977, DOI 10.1016/j.carbpol.2012.01.053
   Ribeiro A, 2011, J MEMBRANE SCI, V383, P60, DOI 10.1016/j.memsci.2011.08.030
   RIEU J, 1992, MATER SCI TECH-LOND, V8, P589, DOI 10.1179/mst.1992.8.7.589
   Rondelli G, 2002, BIOMATERIALS, V23, P639, DOI 10.1016/S0142-9612(01)00142-9
   Ross R.B., 1992, METALLIC MAT SPECIFI
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   San Roman J, 2004, BIODEGRADABLE SYSTEM
   Shafaei S, 2013, SURF INNOV, V1, P202, DOI 10.1680/si.13.00021
   Shalabi MM, 2007, J MATER SCI-MATER M, V18, P2033, DOI 10.1007/s10856-007-3160-0
   Shields J, 2013, INT MOLYBDENUM ASS
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Temenoff J.S., 2008, BIOMATERIALS INTERSE
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Torricelli P, 2004, INT J ARTIF ORGANS, V27, P658
   Torricelli Paola, 2000, Artificial Cells Blood Substitutes and Immobilization Biotechnology, V28, P181, DOI 10.3109/10731190009118580
   Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6
   Turnlund JR, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P731, DOI 10.1016/B978-012369413-3/50089-6
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Wan YZ, 2007, VACUUM, V81, P1114, DOI 10.1016/j.vacuum.2006.12.011
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Whitcombe MJ, 2011, CHEM SOC REV, V40, P1547, DOI 10.1039/c0cs00049c
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yasuyuki M, 2010, BIOFOULING, V26, P851, DOI 10.1080/08927014.2010.527000
   Yeo A, 2010, J BIOMED MATER RES A, V92A, P311, DOI 10.1002/jbm.a.32366
   Young S, 2008, TISSUE ENG PT B-REV, V14, P295, DOI 10.1089/ten.teb.2008.0153
   Yu S, 2011, COLLOID SURFACE B, V85, P103, DOI 10.1016/j.colsurfb.2011.02.025
   Yu Z, 2009, MAT SCI ENG A-STRUCT, V513-14, P233, DOI 10.1016/j.msea.2009.01.077
   Yu ZT, 2009, T TECH PUBL
   Zaffe D, 2005, MICRON, V36, P583, DOI 10.1016/j.micron.2005.05.008
   Zardiackas LD, 1996, MED APPL TITANIUM IT, V60
   Zhao X, 2011, WOODHEAD PUBL MATER, P1, DOI 10.1533/9780857092939
   Zhentao Y., 2006, MAT SCI ENG A-STRUCT, V438-440, P391, DOI DOI 10.1016/J.MSEA.2005.12.079
   Zhou SF, 2014, J TISSUE ENG REGEN M, V8, P620, DOI 10.1002/term.1558
   Zhou YL, 2011, J ALLOY COMPD, V509, P6267, DOI 10.1016/j.jallcom.2011.03.045
   Zollfrank C, 2012, MAT SCI ENG C-MATER, V32, P47, DOI 10.1016/j.msec.2011.09.010
NR 143
TC 13
Z9 13
U1 2
U2 79
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2016
VL 51
IS 6
BP 2806
EP 2816
DI 10.1007/s10853-015-9664-y
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DA3FE
UT WOS:000367681300003
DA 2018-10-20
ER

PT J
AU Li, G
   Li, F
   Zheng, ZZ
   Luo, TT
   Liu, J
   Wu, JB
   Wang, XQ
   Kaplan, DL
AF Li, Gang
   Li, Fei
   Zheng, Zhaozhu
   Luo, Tingting
   Liu, Jian
   Wu, Jianbing
   Wang, Xiaoqin
   Kaplan, David L.
TI Silk microfiber-reinforced silk composite scaffolds: fabrication,
   mechanical properties, and cytocompatibility
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID SPIDER SILK; FIBROIN; FIBERS; BIOMATERIALS; HYDROGEL; REPAIR; FILMS
AB Mechanical reinforcement of silk membranes by embedding silk microfibers was studied. Silk microfibers of 10-600 mu m long were prepared by hydrolyzing degummed silk fibers in alkali solution. The silk microfibers were mixed with silk fibroin solution (continuous phase) at various ratios to fabricate silk microfiber-reinforced composite scaffolds (SMCSs). The morphology, mechanical properties, structural characteristics, biodegradation, and cytotoxicity of the composites were investigated. Silk microfiber-reinforced membranes with 1 wt% of microfibers displayed the most homogeneous distribution of microfibers in the membrane matrix. The tensile strength and elongation at break were 10.5 +/- A 2.7 MPa and 56.7 +/- A 7.8 %, respectively, comparable to human meniscus tissue. The presence of silk microfibers did not significantly impact the secondary structure and crystallization of SMCSs. Proteolytic degradation in vitro using protease XIV showed that the 1 % silk microfiber-reinforced membranes lost 90 % weight after 5 days, a longer time frame than plain silk membrane controls. The viability of human fibroblasts (Hs 865.Sk) on the SMCSs demonstrated no cytotoxicity. SMCSs may be useful as biomaterial systems as tissue substitutes where mechanical strength is critical for functional performance.
C1 [Li, Gang; Li, Fei; Zheng, Zhaozhu; Luo, Tingting; Liu, Jian; Wu, Jianbing; Wang, Xiaoqin; Kaplan, David L.] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Wang, Xiaoqin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Wang, XQ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM wangxiaoqin@suda.edu.cn; david.kaplan@tufts.edu
FU National Natural Science Foundation of China (NSFC) [51273138]; National
   Institutes of Health [P41 EB002520]; State Key Laboratory for
   Modification of Chemical Fibers and Polymer Materials, Donghua
   University [LK1421]; Natural Science Foundation of Jiangsu Province
   [BK20150372]
FX This work was funded by the National Natural Science Foundation of China
   (NSFC, 51273138) and the National Institutes of Health (P41 EB002520).
   We would like to thank the support of State Key Laboratory for
   Modification of Chemical Fibers and Polymer Materials, Donghua
   University (LK1421) and Natural Science Foundation of Jiangsu Province
   (BK20150372).
CR Asha S, 2012, FIBER POLYM, V13, P224
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Eli Nnaemeka, 2011, Ortop Traumatol Rehabil, V13, P319
   Gloria A, 2010, J APPL BIOMATER BIOM, V9, P151
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Li CM, 2015, ACTA BIOMATER, V11, P222, DOI 10.1016/j.actbio.2014.08.009
   Li G, 2015, MACROMOL BIOSCI, V15, P1125, DOI 10.1002/mabi.201400502
   Li G, 2015, ADV HEALTHC MATER, V4, P1134, DOI 10.1002/adhm.201500002
   Li G, 2013, BIOMATERIALS, V34, P9451, DOI 10.1016/j.biomaterials.2013.08.055
   Li G, 2014, J BIOMED MATER RES A, V102, P982, DOI 10.1002/jbm.a.34759
   Li JS, 2015, ACS APPL MATER INTER, V7, P3871, DOI 10.1021/am508498u
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lu S, 2009, BIOMACROMOLECULES, V11, P143
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Pendleton M, 2006, GRANA, V45, P71, DOI 10.1080/00173130500520479
   Rizvi GM, 2008, J VINYL ADDIT TECHN, V14, P39, DOI 10.1002/vnl.20135
   Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677
   Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Thwe MM, 2002, COMPOS PART A-APPL S, V33, P43, DOI 10.1016/S1359-835X(01)00071-9
   TISSAKHT M, 1995, J BIOMECH, V28, P411, DOI 10.1016/0021-9290(94)00081-E
   Tungjitpornkull S, 2007, J THERMOPLAST COMPOS, V20, P535, DOI 10.1177/0892705707084541
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Xie RJ, 2013, ADV MATER RES-SWITZ, V796, P126, DOI 10.4028/www.scientific.net/AMR.796.126
   Xu X, 2008, J MATER PROCESS TECH, V198, P168, DOI 10.1016/j.jmatprotec.2007.06.087
   Yang G, 2002, J MEMBRANE SCI, V210, P379, DOI 10.1016/S0376-7388(02)00419-2
   Yang MY, 2014, ACS APPL MATER INTER, V6, P13782, DOI 10.1021/am503214g
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   Yuan QQ, 2010, POLYMER, V51, P4843, DOI 10.1016/j.polymer.2010.08.042
   Zhao Z, 2014, POWDER TECHNOL, V268, P118, DOI 10.1016/j.powtec.2014.07.029
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 40
TC 10
Z9 11
U1 10
U2 120
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2016
VL 51
IS 6
BP 3025
EP 3035
DI 10.1007/s10853-015-9613-9
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DA3FE
UT WOS:000367681300024
DA 2018-10-20
ER

PT J
AU Kang, MO
   Tang, LP
   Gao, J
AF Kang, Mingon
   Tang, Liping
   Gao, Jean
TI Computational modeling of phagocyte transmigration for foreign body
   responses to subcutaneous biomaterial implants in mice
SO BMC BIOINFORMATICS
LA English
DT Article
DE Computational modeling; Foreign body responses; Phagocyte
   transmigration; Parameter estimation
ID ACUTE INFLAMMATORY RESPONSES; FIBRINOGEN ADSORPTION; TISSUE RESPONSES;
   MAST-CELLS
AB Background: Computational modeling and simulation play an important role in analyzing the behavior of complex biological systems in response to the implantation of biomedical devices. Quantitative computational modeling discloses the nature of foreign body responses. Such understanding will shed insight on the cause of foreign body responses, which will lead to improved biomaterial design and will reduce foreign body reactions. One of the major obstacles in computational modeling is to build a mathematical model that represents the biological system and to quantitatively define the model parameters.
   Results: In this paper, we considered quantitative inter connections and logical relationships among diverse proteins and cells, which have been reported in biological experiments and literature. Based on the established biological discovery, we have built a mathematical model while unveiling the key components that contribute to biomaterial-mediated inflammatory responses. For the parameter estimation of the mathematical model, we proposed a global optimization algorithm, called Discrete Selection Levenberg-Marquardt (DSLM). This is an extension of Levenberg-Marquardt (LM) algorithm which is a gradient-based local optimization algorithm. The proposed DSLM suggests a new approach for the selection of optimal parameters in the discrete space with fast computational convergence.
   Conclusions: The computational modeling not only provides critical clues to recognize current knowledge of fibrosis development but also enables the prediction of yet-to-be observed biological phenomena.
C1 [Kang, Mingon; Gao, Jean] Univ Texas Arlington, Dept Comp Sci & Engn, 500 UTA Blvd, Arlington, TX 76019 USA.
   [Tang, Liping] Univ Texas Arlington, Dept Bioengn, 500 UTA Blvd, Arlington, TX 76019 USA.
RP Gao, J (reprint author), Univ Texas Arlington, Dept Comp Sci & Engn, 500 UTA Blvd, Arlington, TX 76019 USA.
EM gao@uta.edu
FU NIH [R01EB00727]
FX This research was supported by NIH under grant R01EB00727.
CR Arfken G., 1985, MATH METHODS PHYS, P428
   Bonnans JF, 2006, NUMERICAL OPTIMIZATI
   Carlos D, 2006, EUR J IMMUNOL, V36, P1494, DOI 10.1002/eji.200535464
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   Goldberg D. E., 1989, OPTIMIZATION MACHINE
   Kang M, 2010, BIOINF BIOM BIBM 201, P609
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Levenberg K., 1944, Quarterly of Applied Mathematics, V2, P164
   MADSEN K, 2004, TECHNICAL REPORT
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   Nielsen HB, 1999, TECHNICAL REPORT
   Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530
   Pinter J, 2002, HDB GLOBAL OPTIMIZAT, V62
   Rolfe B., 2011, REGENERATIVE MED TIS
   Su Jianzhong, 2011, Open Access Bioinformatics, V2011, P19
   Su JZ, 2011, INT J COMPUT MATH, V88, P610, DOI 10.1080/00207161003640035
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Tang LP, 2002, J BIOMED MATER RES, V62, P471, DOI 10.1002/jbm.10271
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Xue J, 2008, BIOINFORMATICS BIOEN, P1
   Yamasaki S, 2005, CHEM IMMUNOL ALLERGY, V87, P22
   Yang JC, 2013, J IMMUNOL METHODS, V397, P37, DOI 10.1016/j.jim.2013.08.013
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 26
TC 3
Z9 3
U1 2
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD FEB 29
PY 2016
VL 17
AR 111
DI 10.1186/s12859-016-0947-3
PG 13
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA DE9ID
UT WOS:000370949300003
PM 26927968
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Maattanen, A
   Ihalainen, P
   Torngren, B
   Rosqvist, E
   Pesonen, M
   Peltonen, J
AF Maattanen, Anni
   Ihalainen, Petri
   Torngren, Bjorn
   Rosqvist, Emil
   Pesonen, Markus
   Peltonen, Jouko
TI Hierarchically structured self-supported latex films for flexible and
   semi-transparent electronics
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Transparent conducting electrodes; Thin film; 3D surface topography;
   Latex; Evaporated gold
ID CELL-CULTURE; PROTEIN ADSORPTION; GOLD-FILMS; ALIGNMENT; SURFACES;
   TITANIUM; PAPER; TOPOGRAPHY; SUBSTRATE; STIFFNESS
AB Different length scale alterations in topography, surface texture, and symmetry are known to evoke diverse cell behavior, including adhesion, orientation, motility, cytoskeletal condensation, and modulation of intracellular signaling pathways. In this work, self-supported latex films with well-defined isotropic/anisotropic surface features and hierarchical morphologies were fabricated by a peel-off process from different template surfaces. In addition, the latex films were used as substrates for evaporated ultrathin gold films with nominal thicknesses of 10 and 20 nm. Optical properties and topography of the samples were characterized using UV-vis spectroscopy and Atomic Force Microscopy (AFM) measurements, respectively. The latex films showed high-level transmittance of visible light, enabling the fabrication of semi-transparent gold electrodes. Electrochemical impedance spectroscopy (EIS) measurements were carried out for a number of days to investigate the long-term stability of the electrodes. The effect of 1-octadecanethiol (ODT) and HS(CH2)(11)OH (MuOH) thiolation and protein (human serum albumin, HSA) adsorption on the impedance and capacitance was studied. In addition, cyclic voltammetry ( CV) measurements were carried out to determine active medicinal components, i.e., caffeic acid with interesting biological activities and poorly water-soluble anti-inflammatory drug, piroxicam. The results show that the fabrication procedure presented in this study enables the formation of platforms with hierarchical morphologies for multimodal (optical and electrical) real-time monitoring of length-scale-dependent biomaterial-surface interactions. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Maattanen, Anni; Ihalainen, Petri; Torngren, Bjorn; Rosqvist, Emil; Peltonen, Jouko] Abo Akad Univ, Ctr Funct Mat, Fac Sci & Engn, Phys Chem Lab, Porthaninkatu 3, SF-20500 Turku, Finland.
   [Pesonen, Markus] Abo Akad Univ, Ctr Funct Mat, Fac Sci & Engn, Phys, Porthaninkatu 3, SF-20500 Turku, Finland.
RP Maattanen, A (reprint author), Abo Akad Univ, Ctr Funct Mat, Fac Sci & Engn, Phys Chem Lab, Porthaninkatu 3, SF-20500 Turku, Finland.
EM anni.maattanen@abo.fi; petri.ihalainen@abo.fi; bjorn.torngren@abo.fi;
   emil.rosqvist@abo.fi; markus.pesonen@abo.fi; jouko.peltonen@abo.fi
FU Abo Akademi University Endowment; Graduate School at Abo Akademi
   University
FX The author M. P. thankfully acknowledges the financial support from the
   Abo Akademi University Endowment. The author A. M. thankfully
   acknowledges the Graduate School at Abo Akademi University for the
   granted research scholarship.
CR Asadpour-Zeynali K, 2010, CENT EUR J CHEM, V8, P155, DOI 10.2478/s11532-009-0122-z
   Bao LR, 2002, J VAC SCI TECHNOL B, V20, P2881, DOI 10.1116/1.1526355
   Beier JP, 2010, HANDCHIR MIKROCHIR P, V42, P342, DOI 10.1055/s-0030-1252044
   Catheline A, 2015, J MATER RES, V30, P2009, DOI 10.1557/jmr.2015.166
   Choi CK, 2008, SENSORS-BASEL, V8, P3257, DOI 10.3390/s8053257
   Choi JS, 2014, BIOTECHNOL BIOPROC E, V19, P269, DOI 10.1007/s12257-013-0740-3
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Deppe H, 2005, LASER MED SCI, V19, P229, DOI 10.1007/s10103-005-0327-0
   DeRosa ME, 2014, J APPL POLYM SCI, V131, DOI [10.1002/APP.40181, 10.1002/app.40181]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fernandez JG, 2008, J BIOMED MATER RES A, V85A, P242, DOI 10.1002/jbm.a.31561
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Galli C, 2001, SURF SCI, V474, pL180, DOI 10.1016/S0039-6028(00)01054-2
   Giacomelli C, 2002, J BRAZIL CHEM SOC, V13, P332, DOI 10.1590/S0103-50532002000300007
   Greiner AM, 2012, MACROMOL BIOSCI, V12, P1301, DOI 10.1002/mabi.201200132
   Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400
   Harms J, 2001, BIOSENS BIOELECTRON, V16, P169, DOI 10.1016/S0956-5663(00)00145-7
   Hassanin H, 2012, LAB CHIP, V12, P4160, DOI 10.1039/c2lc40512a
   Ihalainen P, 2015, APPL SURF SCI, V329, P321, DOI 10.1016/j.apsusc.2014.12.156
   Ihalainen P, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/9/094009
   Ihalainen P, 2013, BBA-GEN SUBJECTS, V1830, P4391, DOI 10.1016/j.bbagen.2012.09.007
   Ihalainen P, 2013, BIOSENSORS-BASEL, V3, P1, DOI 10.3390/bios3010001
   Juvonen H, 2015, COLLOID SURFACE B, V136, P527, DOI 10.1016/j.colsurfb.2015.09.061
   Juvonen H, 2014, COLLOID SURFACE B, V118, P261, DOI 10.1016/j.colsurfb.2014.03.050
   Juvonen H, 2013, ACTA BIOMATER, V9, P6704, DOI 10.1016/j.actbio.2013.01.033
   Kalyuzhny G, 2000, J PHYS CHEM B, V104, P8238, DOI 10.1021/jp0010785
   Le X, 2013, INT J BIOMATER, DOI 10.1155/2013/782549
   Leach R., 2013, CHARACTERISATION ARE
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Li JM, 2008, J BIOMED MATER RES A, V87A, P392, DOI 10.1002/jbm.a.31814
   Li YH, 2014, BIOTECHNOL ADV, V32, P347, DOI 10.1016/j.biotechadv.2013.11.007
   Liu RM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-79
   Lukaski Henry C, 2012, J Diabetes Sci Technol, V6, P209
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maattanen A, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0032-0
   Morariu MD, 2003, NAT MATER, V2, P48, DOI 10.1038/nmat789
   NORRMAN S, 1978, PHYS REV B, V18, P674, DOI 10.1103/PhysRevB.18.674
   Ortiz R, 2014, MAT SCI ENG C-MATER, V37, P241, DOI 10.1016/j.msec.2013.12.039
   Pfleging W, 2007, APPL SURF SCI, V253, P9177, DOI 10.1016/j.apsusc.2007.05.047
   Sarfraz J., 2014, SENSOR ACTUAT B-CHEM, V173, P868
   Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108
   Strakosas X, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41735
   Sun JY, 2013, RSC ADV, V3, P14862, DOI 10.1039/c3ra41096j
   Vieira MJ, 2003, BIOFOULING, V19, P215, DOI 10.1080/08927010310000100800
   Wang XZ, 2010, IEEE J SEL TOP QUANT, V16, P1685, DOI 10.1109/JSTQE.2010.2049004
   Wanunu M, 2004, J AM CHEM SOC, V126, P5569, DOI 10.1021/ja0396448
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Xie L, 2012, IEEE ENG MED BIO, P5026, DOI 10.1109/EMBC.2012.6347122
   Yoshinari M, 2002, METALL MATER TRANS A, V33, P511, DOI 10.1007/s11661-002-0113-6
   Zhang JF, 2011, OPT EXPRESS, V19, P23279, DOI 10.1364/OE.19.023279
NR 51
TC 1
Z9 1
U1 5
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2016
VL 364
BP 37
EP 44
DI 10.1016/j.apsusc.2015.12.088
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DD5IW
UT WOS:000369957800006
DA 2018-10-20
ER

PT J
AU Jenkins, SI
   Weinberg, D
   al-Shakli, AF
   Fernandes, AR
   Yiu, HHP
   Telling, ND
   Roach, P
   Chari, DM
AF Jenkins, Stuart I.
   Weinberg, Daniel
   al-Shakli, Arwa F.
   Fernandes, Alinda R.
   Yiu, Humphrey H. P.
   Telling, Neil D.
   Roach, Paul
   Chari, Divya M.
TI 'Stealth' nanoparticles evade neural immune cells but also evade major
   brain cell populations: Implications for PEG-based neurotherapeutics
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Astrocytes; Microglia; Oligodendrocyte precursor cells; Neural stem
   cells; Targeting; Corona
ID IRON-OXIDE NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; PEGYLATED
   POLYCYANOACRYLATE NANOPARTICLES; POLYETHYLENE-GLYCOL; DRUG-DELIVERY;
   PROTEIN CORONA; MAGNETIC NANOPARTICLES; CARBOXYMETHYL DEXTRAN;
   THERAPEUTIC AGENTS; GOLD NANOPARTICLES
AB Surface engineering to control cell behavior is of high interest across the chemical engineering, drug delivery and biomaterial communities. Defined chemical strategies are necessary to tailor nanoscale protein interactions/adsorption, enabling control of cell behaviors for development of novel therapeutic strategies. Nanoparticle-based therapies benefit from such strategies but particle targeting to sites of neurological injury remains challenging due to circulatory immune clearance. As a strategy to overcome this barrier, the use of stealth coatings can reduce immune clearance and prolong circulatory times, thereby enhancing therapeutic capacity. Polyethylene glycol (PEG) is the most widely-used stealth coating and facilitates particle accumulation in the brain. However, once within the brain, the mode of handling of PEGylated particles by the resident immune cells of the brain itself (the 'microglia') is unknown. This is a critical question as it is well established that microglia avidly sequester nanoparticles, limiting their bioavailability and posing a major translational barrier. If PEGylation can be proved to promote evasion of microglia, then this information will be of high value in developing tailored nanoparticle-based therapies for neurological applications. Here, we have conducted the first comparative study of uptake of PEGylated particles by all the major (immune and non-immune) brain cell types. We prove for the first time that PEGylated nanoparticles evade major brain cell populations - a phenomenon which will enhance extracellular bioavailability. We demonstrate changes in protein coronas around these particles within biological media, and discuss how surface chemistry presentation may affect this process and subsequent cellular interactions. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Jenkins, Stuart I.; Weinberg, Daniel; al-Shakli, Arwa F.; Fernandes, Alinda R.; Telling, Neil D.; Roach, Paul; Chari, Divya M.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England.
   [Yiu, Humphrey H. P.] Heriot Watt Univ, Chem Engn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Chari, DM (reprint author), Keele Univ, Inst Sci & Technol Med, Sch Med, David Weatherall Bldg, Keele ST5 5BG, Staffs, England.
EM s.i.jenkins@keele.ac.uk; weinberg@hotmail.co.uk;
   a.f.j.al-shakli@keele.ac.uk; a.fernandes@keele.ac.uk; H.H.Yiu@hw.ac.uk;
   n.d.telling@keele.ac.uk; p.roach@keele.ac.uk; d.chari@keele.ac.uk
OI Jenkins, Stuart/0000-0002-9857-957X
FU Engineering and Physical Sciences Research Council (EPSRC; UK)
   Engineering Tissue Engineering and Regenerative Medicine (E-TERM)
   Landscape Fellowship [EP/I017801/1]; Biotechnology and Biological
   Sciences Research Council [BB/J017590/1, BB/F013884/1]; Engineering and
   Physical Sciences Research Council [EP/I017801/1, 1119377]
FX We thank R Fricker and M Gates for access to z stack microscopy
   facilities (Keele University). SJ is funded by an Engineering and
   Physical Sciences Research Council (EPSRC; UK) Engineering Tissue
   Engineering and Regenerative Medicine (E-TERM) Landscape Fellowship
   (EP/I017801/1).
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   Adams CF, 2013, NANOMED-NANOTECHNOL, V9, P737, DOI 10.1016/j.nano.2013.05.014
   Arora Wahajuddin S., 2012, INT J NANOMED, V7, P3445, DOI DOI 10.2147/IJN.S30320
   Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001
   Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528
   Brigger I, 2002, J PHARMACOL EXP THER, V303, P928, DOI 10.1124/jpet.102.039669
   Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745
   Calvo P, 2002, EUR J NEUROSCI, V15, P1317, DOI 10.1046/j.1460-9568.2002.01967.x
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Cheng Y, 2014, ADV DRUG DELIVER REV, V66, P42, DOI 10.1016/j.addr.2013.09.006
   Cole AJ, 2011, BIOMATERIALS, V32, P6291, DOI 10.1016/j.biomaterials.2011.05.024
   De Bock M, 2014, FEBS LETT, V588, P1259, DOI 10.1016/j.febslet.2014.02.060
   Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f
   Dobrovolskaia MA, 2014, NANOMED-NANOTECHNOL, V10, P1453, DOI 10.1016/j.nano.2014.01.009
   Fernandes AR, 2014, INTEGR BIOL-UK, V6, P855, DOI 10.1039/c4ib00085d
   Fleige G, 2001, NEOPLASIA, V3, P489, DOI 10.1038/sj.neo.7900176
   Gao XH, 2013, PHARM RES-DORDR, V30, P2538, DOI 10.1007/s11095-013-1004-9
   Garcia KP, 2014, SMALL, V10, P2516, DOI 10.1002/smll.201303540
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Guo HY, 2015, CARBOHYD POLYM, V118, P209, DOI 10.1016/j.carbpol.2014.10.076
   Hirsch V, 2013, NANOSCALE, V5, P3723, DOI 10.1039/c2nr33134a
   Hong RL, 1999, CLIN CANCER RES, V5, P3645
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Jarjour AA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002107
   Jenkins S.I., 2014, NANOMED-NANOTECHNOL, V11, P77
   Jenkins Stuart I, 2014, Mol Cell Ther, V2, P23, DOI 10.1186/2052-8426-2-23
   Jenkins SI, 2013, NANOMEDICINE-UK, V8, P951, DOI [10.2217/NNM.12.145, 10.2217/nnm.12.145]
   Jenkins SI, 2011, ACS NANO, V5, P6527, DOI 10.1021/nn2018717
   Kang JS, 2009, EXPERT OPIN EMERG DR, V14, P363, DOI 10.1517/14728210902907847
   Kim HR, 2007, BIOMACROMOLECULES, V8, P793, DOI 10.1021/bm060711a
   Koyama T, 2012, J CONTROL RELEASE, V159, P413, DOI 10.1016/j.jconrel.2012.01.023
   Krol S, 2012, J CONTROL RELEASE, V164, P145, DOI 10.1016/j.jconrel.2012.04.044
   Lee S, 2006, DIABETOLOGIA, V49, P1608, DOI 10.1007/s00125-006-0234-3
   Lehner R, 2013, NANOMED-NANOTECHNOL, V9, P742, DOI 10.1016/j.nano.2013.01.012
   Barran-Berdon AL, 2013, LANGMUIR, V29, P6485, DOI 10.1021/la401192x
   Lu CC, 2012, J MATER CHEM, V22, P19806, DOI 10.1039/c2jm34327d
   Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g
   Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021
   Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0
   Mahon E, 2012, J CONTROL RELEASE, V161, P164, DOI 10.1016/j.jconrel.2012.04.009
   Maldiney T, 2011, ACS NANO, V5, P854, DOI 10.1021/nn101937h
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Misra A, 2003, J PHARM PHARM SCI, V6, P252
   Nance E.A., 2013, SCI TRANSL MED, V4
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Nielsen PA, 2011, DRUG DISCOV TODAY, V16, P472, DOI 10.1016/j.drudis.2011.04.004
   Ning SH, 2011, SOFT MATTER, V7, P9394, DOI 10.1039/c1sm05814b
   Pickard MR, 2011, TISSUE ENG PART C-ME, V17, P89, DOI [10.1089/ten.tec.2010.0170, 10.1089/ten.TEC.2010.0170]
   Pickard MR, 2010, INT J MOL SCI, V11, P967, DOI 10.3390/ijms11030967
   Pires LR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1224
   Pozzi D, 2014, NANOSCALE, V6, P2782, DOI 10.1039/c3nr05559k
   Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722
   Rittchen S, 2015, BIOMATERIALS, V56, P78, DOI 10.1016/j.biomaterials.2015.03.044
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Rogers M.-L., 2014, FRONT MOL NEUROSCI, V7, P1
   Safi M, 2011, BIOMATERIALS, V32, P9353, DOI 10.1016/j.biomaterials.2011.08.048
   Santi DV, 2012, P NATL ACAD SCI USA, V109, P6211, DOI 10.1073/pnas.1117147109
   Schroeder U, 1998, PEPTIDES, V19, P777, DOI 10.1016/S0196-9781(97)00474-9
   Serrano-Perez MC, 2015, GLIA, V63, P987, DOI 10.1002/glia.22797
   Sosnovik DE, 2012, CIRC-CARDIOVASC IMAG, V5, P551, DOI 10.1161/CIRCIMAGING.112.978932
   Struckhoff AP, 2013, METHODS MOL BIOL, V1078, P119, DOI 10.1007/978-1-62703-640-5_10
   Sun ZZ, 2013, INT J NANOMED, V8, P961, DOI 10.2147/IJN.S39048
   Vllasaliu D, 2014, EXPERT OPIN DRUG DEL, V11, P139, DOI 10.1517/17425247.2014.866651
   Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5
   Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v
   Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e
   Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110
   Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017
   Yiu HHP, 2012, PHARM RES-DORDR, V29, P1328, DOI 10.1007/s11095-011-0632-1
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
NR 71
TC 11
Z9 11
U1 2
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD FEB 28
PY 2016
VL 224
BP 136
EP 145
DI 10.1016/j.jconrel.2016.01.013
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA DD1NT
UT WOS:000369689100013
PM 26780172
DA 2018-10-20
ER

PT J
AU Staufer, O
   Weber, S
   Bengtson, CP
   Bading, H
   Spatz, JP
   Rustom, A
AF Staufer, Oskar
   Weber, Sebastian
   Bengtson, C. Peter
   Bading, Hilmar
   Spatz, Joachim P.
   Rustom, Amin
TI Functional fusion of living systems with synthetic electrode interfaces
SO BEILSTEIN JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
DE biointerface; biosensor; energy harvesting; nanoelectrodes; Physarum
   polycephalum
ID NANOWIRE CELL PENETRATION; PHYSARUM-POLYCEPHALUM; MICROPLASMODIA;
   MEMBRANE
AB The functional fusion of "living" biomaterial (such as cells) with synthetic systems has developed into a principal ambition for various scientific disciplines. In particular, emerging fields such as bionics and nanomedicine integrate advanced nanomaterials with biomolecules, cells and organisms in order to develop novel strategies for applications, including energy production or real-time diagnostics utilizing biomolecular machineries "perfected" during billion years of evolution. To date, hardware-wetware interfaces that sample or modulate bioelectric potentials, such as neuroprostheses or implantable energy harvesters, are mostly based on microelectrodes brought into the closest possible contact with the targeted cells. Recently, the possibility of using electrochemical gradients of the inner ear for technical applications was demonstrated using implanted electrodes, where 1.12 nW of electrical power was harvested from the guinea pig endocochlear potential for up to 5 h (Mercier, P.; Lysaght, A.; Bandyopadhyay, S.; Chandrakasan, A.; Stankovic, K. Nat. Biotech. 2012, 30, 1240-1243). More recent approaches employ nanowires (NWs) able to penetrate the cellular membrane and to record extra-and intracellular electrical signals, in some cases with subcellular resolution (Spira, M.; Hai, A. Nat. Nano. 2013, 8, 83-94). Such techniques include nanoelectric scaffolds containing free-standing silicon NWs (Robinson, J. T.; Jorgolli, M.; Shalek, A. K.; Yoon, M. H.; Gertner, R. S.; Park, H. Nat Nanotechnol. 2012, 10, 180-184) or NW field-effect transistors (Qing, Q.; Jiang, Z.; Xu, L.; Gao, R.; Mai, L.; Lieber, C. Nat. Nano. 2013, 9, 142-147), vertically aligned gallium phosphide NWs (Hallstrom, W.; Martensson, T.; Prinz, C.; Gustavsson, P.; Montelius, L.; Samuelson, L.; Kanje, M. Nano Lett. 2007, 7, 2960-2965) or individually contacted, electrically active carbon nanofibers. The latter of these approaches is capable of recording electrical responses from oxidative events occurring in intercellular regions of neuronal cultures (Zhang, D.; Rand, E.; Marsh, M.; Andrews, R.; Lee, K.; Meyyappan, M.; Koehne, J. Mol. Neurobiol. 2013, 48, 380-385). Employing monocrystalline gold, nanoelectrode interfaces, we have now achieved stable, functional access to the electrochemical machinery of individual Physarum polycephalum slime mold cells. We demonstrate the "symbionic" union, allowing for electrophysiological measurements, functioning as autonomous sensors and capable of producing nanowatts of electric power. This represents a further step towards the future development of groundbreaking, cell-based technologies, such as bionic sensory systems or miniaturized energy sources to power various devices, or even "intelligent implants", constantly refueled by their surrounding nutrients.
C1 [Staufer, Oskar; Weber, Sebastian; Spatz, Joachim P.; Rustom, Amin] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Heisenbergstr 3, D-70569 Stuttgart, Germany.
   [Staufer, Oskar] German Canc Res Ctr, DKFZ Life Sci Lab, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.
   [Staufer, Oskar] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Bachelor Program Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Bengtson, C. Peter; Bading, Hilmar] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Spatz, Joachim P.; Rustom, Amin] Heidelberg Univ, Dept Biophys Chem, Neuenheimer Feld 253, D-69120 Heidelberg, Germany.
RP Rustom, A (reprint author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Heisenbergstr 3, D-70569 Stuttgart, Germany.; Rustom, A (reprint author), Heidelberg Univ, Dept Biophys Chem, Neuenheimer Feld 253, D-69120 Heidelberg, Germany.
EM amin.rustom@urz.uni-heidelberg.de
RI Spatz, Joachim/A-1107-2017
OI Spatz, Joachim/0000-0003-3419-9807; Bengtson, C
   Peter/0000-0002-8245-3323
FU Max-Planck Society; Baden-Wurttemberg Stiftung ("Funktionelle
   Nanostrukturen IV")
FX We would like to thank It4ip Belgium for providing us with track-etched
   PC filter membranes with custom parameters, Sigrid Riese for cell
   culture and experimental support, Andrea Hellwig for support with SEM
   and TEM measurements, and Gunther Meinusch for help with electronics.
   This study was supported by the Max-Planck Society and the
   Baden-Wurttemberg Stiftung ("Funktionelle Nanostrukturen IV").
CR BAR-ZEEV MICHA, 1960, ENT EXPTL ET APPL, V3, P251
   Fendyur Anna, 2012, Front Neuroeng, V5, P21, DOI 10.3389/fneng.2012.00021
   FINGERLE J, 1982, J MEMBRANE BIOL, V68, P67, DOI 10.1007/BF01872255
   KURODA H, 1989, BIOCHIM BIOPHYS ACTA, V987, P154, DOI 10.1016/0005-2736(89)90538-5
   Latty T, 2015, J EXP BIOL, V218, P1175, DOI 10.1242/jeb.116533
   MEYER R, 1979, CELL BIOL INT REP, V3, P321, DOI 10.1016/S0309-1651(79)80002-8
   Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159
   Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101
   Schneckenburger M, 2012, SMALL, V8, P3396, DOI 10.1002/smll.201200963
   Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4
   Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/nnano.2012.265, 10.1038/NNANO.2012.265]
   Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894
   Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009
   UEDA T, 1975, J GEN PHYSIOL, V65, P223, DOI 10.1085/jgp.65.2.223
   Xie X, 2015, ACS NANO, V9, P11667, DOI 10.1021/acsnano.5b05498
   Xie X, 2013, NANO LETT, V13, P6002, DOI 10.1021/nl403201a
   Xu AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4613
NR 17
TC 1
Z9 1
U1 3
U2 34
PU BEILSTEIN-INSTITUT
PI FRANKFURT AM MAIN
PA TRAKEHNER STRASSE 7-9, FRANKFURT AM MAIN, 60487, GERMANY
SN 2190-4286
J9 BEILSTEIN J NANOTECH
JI Beilstein J. Nanotechnol.
PD FEB 26
PY 2016
VL 7
BP 296
EP 301
DI 10.3762/bjnano.7.27
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DF3AZ
UT WOS:000371217400001
PM 26977386
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sato, YT
   Umezaki, K
   Sawada, S
   Mukai, S
   Sasaki, Y
   Harada, N
   Shiku, H
   Akiyoshi, K
AF Sato, Yuko T.
   Umezaki, Kaori
   Sawada, Shinichi
   Mukai, Sada-atsu
   Sasaki, Yoshihiro
   Harada, Naozumi
   Shiku, Hiroshi
   Akiyoshi, Kazunari
TI Engineering hybrid exosomes by membrane fusion with liposomes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; ENERGY-TRANSFER; EXTRACELLULAR VESICLES;
   UNILAMELLAR VESICLES; IN-VITRO; CELLS; SIRNA; CRYOPRESERVATION;
   EFFICIENCY; INJECTION
AB Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze- thaw method. Exosomes embedded with a specific membrane protein isolated from genetically modified cells were fused with various liposomes, confirming that membrane engineering methods can be combined with genetic modification techniques. Cellular uptake studies performed using the hybrid exosomes revealed that the interactions between the developed exosomes and cells could be modified by changing the lipid composition or the properties of the exogenous lipids. These results suggest that the membraneengineering approach reported here offers a new strategy for developing rationally designed exosomes as hybrid nanocarriers for use in advanced drug delivery systems.
C1 [Sato, Yuko T.; Umezaki, Kaori; Sawada, Shinichi; Mukai, Sada-atsu; Akiyoshi, Kazunari] Kyoto Univ Katsura, JST ERATO, Akiyoshi Bionanotransporter Project, Nishikyo Ku, Kyoto 6158510, Japan.
   [Sawada, Shinichi; Mukai, Sada-atsu; Sasaki, Yoshihiro; Akiyoshi, Kazunari] Kyoto Univ Katsura, Dept Polymer Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.
   [Harada, Naozumi; Shiku, Hiroshi] Mie Univ, Dept Immunogene Therapy, Grad Sch Med, Tsu, Mie 5148507, Japan.
RP Akiyoshi, K (reprint author), Kyoto Univ Katsura, JST ERATO, Akiyoshi Bionanotransporter Project, Nishikyo Ku, Kyoto 6158510, Japan.; Akiyoshi, K (reprint author), Kyoto Univ Katsura, Dept Polymer Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.
EM akiyoshi@bio.polym.kyoto-u.ac.jp
FU Exploratory Research for Advanced Technology division of the Japan
   Science and Technology Agency (JSTERATO)
FX We wish to thank S. Ikeda of Kyoto University for preparing the
   exosomes. This work was supported by the Exploratory Research for
   Advanced Technology division of the Japan Science and Technology Agency
   (JSTERATO).
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Banizs AB, 2014, INT J NANOMED, V9, P4223, DOI 10.2147/IJN.S64267
   BLUME G, 1990, BIOCHIM BIOPHYS ACTA, V1029, P91, DOI 10.1016/0005-2736(90)90440-Y
   Cooper JM, 2014, MOVEMENT DISORD, V29, P1476, DOI 10.1002/mds.25978
   Costa AP, 2014, PHARM RES-DORDR, V31, P97, DOI 10.1007/s11095-013-1135-z
   Duzgunes N, 2003, METHOD ENZYMOL, V372, P260
   Jia SD, 2014, EXPERT REV MOL DIAGN, V14, P307, DOI 10.1586/14737159.2014.893828
   Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005
   Kanada M., 2015, P NATL ACAD SCI USA, pE1433
   Kooijmans SAA, 2013, J CONTROL RELEASE, V172, P229, DOI 10.1016/j.jconrel.2013.08.014
   Lee JK, 1997, BIOCHEMISTRY-US, V36, P421, DOI 10.1021/bi9622332
   Lee J, 2015, NANO LETT, V15, P2938, DOI 10.1021/nl5047494
   MACDONALD RC, 1994, BBA-BIOMEMBRANES, V1191, P362, DOI 10.1016/0005-2736(94)90187-2
   MACDONALD RI, 1987, J BIOL CHEM, V262, P10392
   MACDONALD RI, 1983, BIOCHIM BIOPHYS ACTA, V735, P243, DOI 10.1016/0005-2736(83)90299-7
   Matsuoka T, 2015, WORLD J CLIN CASES, V3, P42, DOI 10.12998/wjcc.v3.i1.42
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1
   Montecalvo A., 2011, BLOOD, V119, P756
   Moritani Y, 2010, FEBS J, V277, P3343, DOI 10.1111/j.1742-4658.2010.07736.x
   Mukai K, 2002, GENE THER, V9, P879, DOI 10.1038/sj.gt.3301707
   Mulcahy L. A., 2014, J EXTRACELL VESICLES, V3, P1, DOI DOI 10.3402/JEV.V3.24641
   Nagata Y, 1997, J IMMUNOL, V159, P1336
   Ohno S-I, 2012, MOL THER, DOI [10.1038/mt.2012.180, DOI 10.1038/MT.2012.180]
   OKU N, 1983, BIOCHEMISTRY-US, V22, P855, DOI 10.1021/bi00273a023
   Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152
   PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1
   Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63
   RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1
   Shtam TA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-88
   Siow LF, 2007, CRYOBIOLOGY, V55, P210, DOI 10.1016/j.cryobiol.2007.08.002
   STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023
   Takahashi Y, 2013, J BIOTECHNOL, V165, P77, DOI 10.1016/j.jbiotec.2013.03.013
   TALSMA H, 1991, INT J PHARM, V77, P119, DOI 10.1016/0378-5173(91)90309-C
   Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046
   Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304
   Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083
   Trier S, 2011, SOFT MATTER, V7, P9027, DOI 10.1039/c1sm05818e
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van der Meel R, 2014, J CONTROL RELEASE, V195, P72, DOI 10.1016/j.jconrel.2014.07.049
   Wahlgren J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks463
NR 43
TC 39
Z9 41
U1 4
U2 50
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 25
PY 2016
VL 6
AR 21933
DI 10.1038/srep21933
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE7DA
UT WOS:000370793200001
PM 26911358
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ricapito, NG
   Ghobril, C
   Zhang, H
   Grinstaff, MW
   Putnam, D
AF Ricapito, Nicole G.
   Ghobril, Cynthia
   Zhang, Heng
   Grinstaff, Mark W.
   Putnam, David
TI Synthetic Biomaterials from Metabolically Derived Synthons
SO CHEMICAL REVIEWS
LA English
DT Review
ID RING-OPENING POLYMERIZATION; KETAL-PROTECTED DIHYDROXYACETONE;
   CONTROLLED DRUG-DELIVERY; NUCLEIC-ACID DELIVERY; CELL LUNG-CANCER;
   CARBOHYDRATE-CONTAINING POLYCATIONS; TISSUE ENGINEERING APPLICATIONS;
   5-MEMBERED CYCLIC CARBONATE; POLY-AMIDO-SACCHARIDES; ONE-STEP SYNTHESIS
AB The utility of metabolic synthons as the building blocks for new biomaterials is based on the early application and success of hydroxy acid based polyesters as degradable sutures and controlled drug delivery matrices. The sheer number of potential monomers derived from the metabolome (e.g., lactic acid, dihydroxyacetone, glycerol, fumarate) gives rise to almost limitless biomaterial structural possibilities, functionality, and performance characteristics, as well as opportunities for the synthesis of new polymers. This review describes recent advances in new chemistries, as well as the inventive use of traditional chemistries, toward the design and synthesis of new polymers. Specific polymeric biomaterials can be prepared for use in varied medical applications (e.g., drug delivery, tissue engineering, wound repair, etc.) through judicious selection of the monomer and backbone linkage.
C1 [Ricapito, Nicole G.; Putnam, David] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
   [Ghobril, Cynthia; Zhang, Heng; Grinstaff, Mark W.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.
   [Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Grinstaff, Mark W.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   [Putnam, David] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
RP Putnam, D (reprint author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.; Grinstaff, MW (reprint author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.; Grinstaff, MW (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Grinstaff, MW (reprint author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.; Putnam, D (reprint author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
EM mgrin@bu.edu; dap43@cornell.edu
RI Zhang, Heng/L-9010-2015
FU Cornell Center for Materials Research; Cornell Center for Advanced
   Technology, Boston University; Coulter Foundation; Pew Foundation;
   National Science Foundation; National Institutes of Health
FX The authors would like to thank the Cornell Center for Materials
   Research, the Cornell Center for Advanced Technology, Boston University,
   the Coulter Foundation, the Pew Foundation, the National Science
   Foundation, and National Institutes of Health (R01, R21, R56, and T32
   mechanisms) for support of our research and educational programs.
CR Abele S, 1998, HELV CHIM ACTA, V81, P2141, DOI 10.1002/(SICI)1522-2675(19981216)81:12<2141::AID-HLCA2141>3.0.CO;2-5
   AJIOKA M, 1995, J ENVIRON POLYM DEGR, V3, P225, DOI 10.1007/BF02068677
   AKAR A, 1989, MAKROMOL CHEM-RAPID, V10, P127
   ALDER RW, 1994, POLYMER, V35, P5765, DOI 10.1016/S0032-3861(05)80054-0
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Appelhans D, 2015, CHEM SOC REV, V44, P3968, DOI 10.1039/c4cs00339j
   Arima Y, 2007, J MATER CHEM, V17, P4079, DOI 10.1039/b708099a
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Avseenko NV, 2001, ANAL CHEM, V73, P6047, DOI 10.1021/ac010460q
   Azechi M, 2013, J POLYM SCI POL CHEM, V51, P1651, DOI 10.1002/pola.26538
   Bajpai AK, 2008, PROG POLYM SCI, V33, P1088, DOI 10.1016/j.progpolymsci.2008.07.005
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Bao HM, 2012, MICROCHIM ACTA, V179, P291, DOI 10.1007/s00604-012-0896-0
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Bonvalot S, 2009, J CLIN ONCOL, V27, P31, DOI 10.1200/JCO.2008.18.0802
   Bouten PJM, 2014, PROG POLYM SCI, V39, P1375, DOI 10.1016/j.progpolymsci.2014.02.001
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Bugnicourt E, 2014, EXPRESS POLYM LETT, V8, P791, DOI 10.3144/expresspolymlett.2014.82
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144
   Carnahan MA, 2006, MACROMOLECULES, V39, P609, DOI 10.1021/ma0518407
   Carnahan MA, 2002, J AM CHEM SOC, V124, P5291, DOI 10.1021/ja025576y
   Carnahan MA, 2001, MACROMOLECULES, V34, P7648, DOI 10.1021/ma010848n
   Carnahan MA, 2001, J AM CHEM SOC, V123, P2905, DOI 10.1021/ja005726+
   Carnali JO, 2012, IND ENG CHEM RES, V51, P15573, DOI 10.1021/ie301929w
   CESAROTTI E, 1993, HELV CHIM ACTA, V76, P2344, DOI 10.1002/hlca.19930760620
   Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023
   Chen LG, 2005, POLYMER, V46, P6274, DOI 10.1016/j.polymer.2005.05.041
   Cheng JJ, 2001, MACROMOLECULES, V34, P5169, DOI 10.1021/ma010386d
   Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c
   Choi JS, 2000, J AM CHEM SOC, V122, P474, DOI 10.1021/ja9931473
   Choi JS, 1999, BIOCONJUGATE CHEM, V10, P62, DOI 10.1021/bc9800668
   Cohen CT, 2005, J AM CHEM SOC, V127, P10869, DOI 10.1021/ja051744l
   Cui W, 2012, CHEM-ASIAN J, V7, P127, DOI 10.1002/asia.201100425
   Dandu R, 2009, POLYMER, V50, P366, DOI 10.1016/j.polymer.2008.11.047
   Dane EL, 2014, CHEM SCI, V5, P551, DOI [10.1039/c3sc52777h, 10.1039/C3SC52777H]
   Dane EL, 2013, ACS MACRO LETT, V2, P887, DOI 10.1021/mz400394r
   Dane EL, 2012, J AM CHEM SOC, V134, P16255, DOI 10.1021/ja305900r
   Darensbourg DJ, 2007, CHEM REV, V107, P2388, DOI 10.1021/cr068363q
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   DAVIS L, 1973, BIOORG CHEM, V2, P197, DOI 10.1016/0045-2068(73)90023-0
   Degoricija L, 2007, INVEST OPHTH VIS SCI, V48, P2037, DOI 10.1167/iovs.06-0957
   Deming TJ, 2007, PROG POLYM SCI, V32, P858, DOI 10.1016/j.progpolymsci.2007.05.010
   Deming TJ, 2016, CHEM REV, V116, P786, DOI 10.1021/acs.chemrev.5b00292
   Deming TJ, 2013, ADV POLYM SCI, V262, P1, DOI 10.1007/12_2013_234
   Deming TJ, 1997, J AM CHEM SOC, V119, P2759, DOI 10.1021/ja962625w
   Deming TJ, 1999, MACROMOLECULES, V32, P4500, DOI 10.1021/ma9902899
   Denkewalter R. G., 1981, US Patent No, Patent No. [4(289):872, 4289872, 4, 289, 872]
   Denyer SP, 1995, INT BIODETER BIODEGR, V36, P227, DOI 10.1016/0964-8305(96)00015-7
   Do JY, 2005, POLYM ADVAN TECHNOL, V16, P221, DOI 10.1002/pat.554
   Do JY, 2005, MACROMOL CHEM PHYSIC, V206, P1326, DOI 10.1002/macp.200400547
   Dorgan JR, 2001, MACROMOL SYMP, V175, P55, DOI 10.1002/1521-3900(200110)175:1<55::AID-MASY55>3.0.CO;2-K
   Duan L, 2007, BIOCHEM BIOPH RES CO, V354, P357, DOI 10.1016/j.bbrc.2006.12.223
   Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9
   Erni B, 2006, CELL MOL LIFE SCI, V63, P890, DOI 10.1007/s00018-005-5518-0
   Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Fang X, 2015, CHEM COMMUN, V51, P1185, DOI 10.1039/c4cc07909d
   Feng J, 2012, PROG POLYM SCI, V37, P211, DOI 10.1016/j.progpolymsci.2011.07.008
   Ferroni EL, 1999, J ORG CHEM, V64, P4943, DOI 10.1021/jo9823902
   Fesq H, 2001, DERMATOLOGY, V203, P241, DOI 10.1159/000051757
   FLORY PJ, 1952, J AM CHEM SOC, V74, P2718, DOI 10.1021/ja01131a008
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Frechet JMJ, 1995, REACT FUNCT POLYM, V26, P127, DOI 10.1016/1381-5148(95)00010-D
   Fu JM, 2004, J AM ACAD DERMATOL, V50, P706, DOI 10.1016/j.jaad.2003.12.006
   Gao C, 2004, PROG POLYM SCI, V29, P183, DOI 10.1016/j.progpolymsci.2003.12.002
   GARSON LR, 1969, CAN J CHEMISTRY, V47, P1249, DOI 10.1139/v69-205
   Geschwind J, 2013, MACROMOLECULES, V46, P3280, DOI 10.1021/ma400090m
   Ghobril C, 2015, CHEM SOC REV, V44, P1820, DOI 10.1039/c4cs00332b
   Ghobril C, 2014, ACS MACRO LETT, V3, P359, DOI 10.1021/mz5000703
   Ghobril C, 2013, ANGEW CHEM INT EDIT, V52, P14070, DOI 10.1002/anie.201308007
   Girelli AM, 2007, SENSOR ACTUAT B-CHEM, V121, P515, DOI 10.1016/j.snb.2006.04.076
   Godula K, 2009, ANGEW CHEM INT EDIT, V48, P4973, DOI 10.1002/anie.200805756
   GOLDMAN L, 1960, J INVEST DERMATOL, V35, P161, DOI 10.1038/jid.1960.100
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003
   Grayson SM, 2001, CHEM REV, V101, P3819, DOI 10.1021/cr990116h
   GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9
   Greenberg James A, 2009, Rev Obstet Gynecol, V2, P146
   Grinstaff MW, 2008, J POLYM SCI POL CHEM, V46, P383, DOI 10.1002/pola.22525
   Grinstaff MW, 2007, BIOMATERIALS, V28, P5205, DOI 10.1016/j.biomaterials.2007.08.041
   Grinstaff MW, 2002, CHEM-EUR J, V8, P2838, DOI 10.1002/1521-3765(20020703)8:13<2838::AID-CHEM2838>3.0.CO;2-I
   Groot W., 2010, POLYLACTIC ACID SYNT, P1
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Guerin W, 2014, POLYM CHEM-UK, V5, P1229, DOI 10.1039/c3py00955f
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Haag R, 2000, J AM CHEM SOC, V122, P2954, DOI 10.1021/ja994363e
   Haba O, 2005, MACROMOLECULES, V38, P3562, DOI 10.1021/ma0476745
   Haddleton DM, 1996, J CHEM SOC PERK T 1, P649, DOI 10.1039/p19960000649
   HARPOLE DH, 1995, CANCER-AM CANCER SOC, V76, P787, DOI 10.1002/1097-0142(19950901)76:5<787::AID-CNCR2820760512>3.0.CO;2-Q
   HAWKER CJ, 1991, J AM CHEM SOC, V113, P4583, DOI 10.1021/ja00012a030
   Hawker CJ, 1996, MACROMOLECULES, V29, P3831, DOI 10.1021/ma951909i
   HAWKER CJ, 1992, J CHEM SOC PERK T 1, P2459, DOI 10.1039/p19920002459
   HAWKER CJ, 1992, J AM CHEM SOC, V114, P8405, DOI 10.1021/ja00048a009
   Helou M, 2011, POLYM CHEM-UK, V2, P2789, DOI 10.1039/c1py00405k
   Helou M, 2010, CHEM-EUR J, V16, P13805, DOI 10.1002/chem.201001111
   Henderson PW, 2010, J BIOMED MATER RES A, V93A, P776, DOI 10.1002/jbm.a.32586
   Hilf J, 2014, POLYM CHEM-UK, V5, P814, DOI 10.1039/c3py00977g
   HODGE JE, 1953, J AGR FOOD CHEM, V1, P928, DOI 10.1021/jf60015a004
   Hu J, 2006, MACROMOLECULES, V39, P6789, DOI 10.1021/ma0612834
   Ingle NP, 2011, TRENDS BIOTECHNOL, V29, P443, DOI 10.1016/j.tibtech.2011.04.012
   James HP, 2014, ACTA PHARM SIN B, V4, P120, DOI 10.1016/j.apsb.2014.02.005
   Jia J, 1997, PROTEIN SCI, V6, P119
   Jia Y, 2015, CHEM REV, V115, P1597, DOI 10.1021/cr400559g
   Jia Y, 2011, CHEM COMMUN, V47, P1175, DOI 10.1039/c0cc03578e
   Jiang T, 2013, COLLOID SURFACE B, V111, P542, DOI 10.1016/j.colsurfb.2013.06.054
   Jin HB, 2012, CHEM SOC REV, V41, P5986, DOI 10.1039/c2cs35130g
   Johnson J. A., 1994, MAILLARD REACTIONS C, P114
   Jung K, 2008, SPECTROCHIM ACTA A, V69, P1423, DOI 10.1016/j.saa.2007.09.029
   JUNG SH, 1994, J ORG CHEM, V59, P7182, DOI 10.1021/jo00102a060
   Kang PC, 2005, J CATARACT REFR SURG, V31, P1208, DOI 10.1016/j.jcrs.2004.10.067
   Karakousis CP, 1996, ANN SURG ONCOL, V3, P150, DOI 10.1007/BF02305794
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   Ke XY, 2014, POLYM CHEM-UK, V5, P2621, DOI 10.1039/c3py01784b
   Kiessling LL, 2013, CHEM SOC REV, V42, P4476, DOI 10.1039/c3cs60097a
   Kim JG, 2012, MACROMOLECULES, V45, P7878, DOI 10.1021/ma301137q
   Kim JG, 2011, MACROMOLECULES, V44, P1110, DOI 10.1021/ma102585a
   Kim J, 2012, TISSUE ENG PT A, V18, P1132, DOI [10.1089/ten.tea.2011.0582, 10.1089/ten.TEA.2011.0582]
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   KOST J, 1991, ADV DRUG DELIVER REV, V6, P19
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kricheldorf HR, 2006, ANGEW CHEM INT EDIT, V45, P5752, DOI 10.1002/anie.200600693
   KRICHELDORF HR, 1995, MACROMOLECULES, V28, P2118, DOI 10.1021/ma00111a003
   Krsko P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)71223-2
   Kumar A, 2003, MACROMOLECULES, V36, P8219, DOI 10.1021/ma0351827
   Kumar A, 1996, MACROMOLECULES, V29, P2524, DOI 10.1021/ma950948r
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumar MNVR, 2001, DRUG DEV IND PHARM, V27, P1
   Kumar R, 2002, IND CROP PROD, V16, P155, DOI 10.1016/S0926-6690(02)00007-9
   Kumar R, 2002, MACROMOLECULES, V35, P6835, DOI 10.1021/ma020041a
   Kwon D. Y., 2012, J BIOMED SCI ENG, V05, P208
   Kwon Y, 2012, ACS CATAL, V2, P759, DOI 10.1021/cs200599g
   Ladmiral V, 2004, EUR POLYM J, V40, P431, DOI 10.1016/j.eurpolymj.2003.10.019
   Langowska K, 2014, J MATER CHEM B, V2, P4684, DOI 10.1039/c4tb00277f
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Lee ALZ, 2015, BIOMACROMOLECULES, V16, P465, DOI 10.1021/bm5015206
   Lee ALZ, 2014, ADV FUNCT MATER, V24, P1538, DOI 10.1002/adfm.201301307
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lehnert T, 2009, EJSO-EUR J SURG ONC, V35, P986, DOI 10.1016/j.ejso.2008.11.003
   Lentini P. J, 1999, U.S. Patent, Patent No. [5,885,557, 5885557]
   Leuchs H, 1906, BER DTSCH CHEM GES, V39, P857, DOI 10.1002/cber.190603901133
   Lewitus D, 2011, ACTA BIOMATER, V7, P2483, DOI 10.1016/j.actbio.2011.02.027
   LINDE F, 1992, J BIOMECH, V25, P359, DOI 10.1016/0021-9290(92)90255-Y
   Liu R, 2012, ANN SURG ONCOL, V19, P199, DOI 10.1245/s10434-011-1871-4
   Liu R, 2010, ANN SURG ONCOL, V17, P1203, DOI 10.1245/s10434-009-0856-z
   Liu YM, 2010, BIOMACROMOLECULES, V11, P316, DOI 10.1021/bm9008233
   Liu YM, 2005, J AM CHEM SOC, V127, P3004, DOI 10.1021/ja0436446
   Liu YM, 2004, J AM CHEM SOC, V126, P7422, DOI 10.1021/ja049831l
   Lo CT, 2010, BIOMATERIALS, V31, P3631, DOI 10.1016/j.biomaterials.2010.01.048
   Lo MC, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9927-z
   Lu H, 2007, J AM CHEM SOC, V129, P14114, DOI 10.1021/ja074961q
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   Lu XB, 2004, ANGEW CHEM INT EDIT, V43, P3574, DOI 10.1002/anie.200453998
   Lu XB, 2012, CHEM SOC REV, V41, P1462, DOI 10.1039/c1cs15142h
   Lukaszczyk J, 2000, MACROMOL RAPID COMM, V21, P754, DOI 10.1002/1521-3927(20000701)21:11<754::AID-MARC754>3.0.CO;2-O
   Lukaszczyk J, 2001, MACROMOL BIOSCI, V1, P282
   Luman NR, 2004, PURE APPL CHEM, V76, P1375, DOI 10.1351/pac200476071375
   Luman NR, 2003, CHEM-EUR J, V9, P5618, DOI 10.1002/chem.2003051
   Lv L, 2015, METAB ENG, V29, P160, DOI 10.1016/j.ymben.2015.03.013
   MacBeath G, 2000, SCIENCE, V289, P1760
   Macdermot H E, 1925, Can Med Assoc J, V15, P412
   Magno MHR, 2010, J MATER CHEM, V20, P8885, DOI 10.1039/c0jm00868k
   Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66
   Majoral JP, 1999, CHEM REV, V99, P845, DOI 10.1021/cr970414j
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Marques ME, 2013, APPL SURF SCI, V275, P347, DOI 10.1016/j.apsusc.2012.12.099
   MARTINI N, 1992, ANN THORAC SURG, V54, P460, DOI 10.1016/0003-4975(92)90435-7
   Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X
   Masood F, 2013, J MATER SCI-MATER M, V24, P1927, DOI 10.1007/s10856-013-4946-x
   Mccoy CP, 2007, BIOCONJUGATE CHEM, V18, P209, DOI 10.1021/bc060238y
   Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j
   Meyers SR, 2008, J AM CHEM SOC, V130, P14444, DOI 10.1021/ja806912a
   Mikami K, 2013, J AM CHEM SOC, V135, P6826, DOI 10.1021/ja402319m
   Mintzer MA, 2011, CHEM SOC REV, V40, P173, DOI 10.1039/b901839p
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Miura Y, 2007, J POLYM SCI POL CHEM, V45, P5031, DOI 10.1002/pola.22369
   Miura Y, 2016, CHEM REV, V116, P1673, DOI 10.1021/acs.chemrev.5b00247
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   Moon SI, 2000, J POLYM SCI POL CHEM, V38, P1673, DOI 10.1002/(SICI)1099-0518(20000501)38:9<1673::AID-POLA33>3.0.CO;2-T
   Morgan MT, 2006, CANCER RES, V66, P11913, DOI 10.1158/0008-5472.CAN-06-2066
   Morgan MT, 2005, CHEM COMMUN, P4309, DOI 10.1039/b502411k
   Morgan MT, 2003, J AM CHEM SOC, V125, P15485, DOI 10.1021/ja0347383
   Mowery P, 2004, CHEM BIOL, V11, P725, DOI 10.1016/j.chembiol.2004.03.027
   Mulhaupt R, 2013, MACROMOL CHEM PHYS, V214, P159, DOI 10.1002/macp.201200439
   Nakano K, 2006, ANGEW CHEM INT EDIT, V45, P7274, DOI 10.1002/anie.200603132
   Namazi H, 2005, BIOMATERIALS, V26, P1175, DOI 10.1016/j.biomaterials.2004.04.014
   Namazi H, 2003, EUR POLYM J, V39, P1491, DOI 10.1016/S0014-3057(02)00385-3
   Newkome GR, 1999, CHEM REV, V99, P1689, DOI 10.1021/cr9800659
   Nguyen BC, 2003, J INVEST DERMATOL, V120, P655, DOI 10.1046/j.1523-1747.2003.12089.x
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Niknahad H, 2002, TOXICOL LETT, V132, P95, DOI 10.1016/S0378-4274(02)00016-4
   Nuyken O, 2013, POLYMERS-BASEL, V5, P361, DOI 10.3390/polym5020361
   O'Leary RE, 2014, J AM ACAD DERMATOL, V70, P562, DOI 10.1016/j.jaad.2013.11.004
   Oelker AM, 2008, J MATER CHEM, V18, P2521, DOI 10.1039/b719791h
   Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010
   Ohsaki M, 2002, BIOCONJUGATE CHEM, V13, P510, DOI 10.1021/bc015525a
   Owen RM, 2002, ORG LETT, V4, P2293, DOI 10.1021/ol0259239
   Pagoto S, 2012, SHEDDING LIGHT INDOO, P165
   Painter RM, 2010, ANGEW CHEM INT EDIT, V49, P9456, DOI 10.1002/anie.201004063
   Parzuchowski PG, 2008, MACROMOLECULES, V41, P3859, DOI 10.1021/ma8000912
   Parzuchowski PG, 2006, MACROMOLECULES, V39, P7181, DOI 10.1021/ma061488c
   Pearson DM, 2011, ADV SYNTH CATAL, V353, P3007, DOI 10.1002/adsc.201100240
   Peng YL, 2008, MACROMOLECULES, V41, P3455, DOI 10.1021/ma7025836
   Peng YF, 2014, BIOMACROMOLECULES, V15, P4214, DOI 10.1021/bm501255j
   Petersen AB, 2004, MUTAT RES-GEN TOX EN, V560, P173, DOI 10.1016/j.mrgentox.2004.03.002
   Pratt C. W., 2008, FUNDAMENTALS BIOCH L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Putnam D., 2008, U.S. Patent, Patent No. [WO2008101173, 02008101173]
   Putnam D. A., 2010, <IT>US Patent</IT>, Patent No. 7659420
   QUINTANA RP, 1970, J ECON ENTOMOL, V63, P1128, DOI 10.1093/jee/63.4.1128
   QUINTANA RP, 1969, CAN J CHEMISTRY, V47, P853, DOI 10.1139/v69-135
   Rabinowitch IM, 1925, CAN MED ASSOC J, V15, P374
   Rabinowitch IM, 1925, CAN MED ASSOC J, V15, P520
   Rabinowitch IM, 1925, J BIOL CHEM, V65, P55
   Rajatanavin N, 2008, INT J DERMATOL, V47, P402, DOI 10.1111/j.1365-4632.2008.03356.x
   Ranganathan D, 1997, TETRAHEDRON LETT, V38, P1265, DOI 10.1016/S0040-4039(97)00054-3
   Ranganathan D, 2000, BIOPOLYMERS, V54, P289, DOI 10.1002/1097-0282(20001005)54:4<289::AID-BIP60>3.0.CO;2-7
   Ray WC, 2003, MACROMOLECULES, V36, P3557, DOI 10.1021/ma025872v
   Reineke TM, 2005, MRS BULL, V30, P635, DOI 10.1557/mrs2005.189
   Reineke TM, 2003, BIOCONJUGATE CHEM, V14, P255, DOI 10.1021/bc025593c
   Ren KF, 2006, BIOCONJUGATE CHEM, V17, P77, DOI 10.1021/bc050264g
   Reul R, 2009, BIOMATERIALS, V30, P5815, DOI 10.1016/j.biomaterials.2009.06.057
   REYNOLDS SJ, 1971, BIOCHEM J, V122, P285, DOI 10.1042/bj1220285
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Ringer AI, 1914, J BIOL CHEM, V18, P233
   Rojas R, 2009, J POLYM SCI POL CHEM, V47, P49, DOI 10.1002/pola.23119
   Rokicki G, 2000, PROG POLYM SCI, V25, P259, DOI 10.1016/S0079-6700(00)00006-X
   Rokicki G, 2005, GREEN CHEM, V7, P529, DOI 10.1039/b501597a
   Sahoo B, 2005, ORG LETT, V7, P3857, DOI 10.1021/ol050942e
   Saito H, 2007, J BIOACT COMPAT POL, V22, P589, DOI 10.1177/0883911507084653
   Sakthivel T, 1998, PHARMACEUT RES, V15, P776, DOI 10.1023/A:1011935406664
   Sanner T., 2010, SCCS134710, P1
   Schmitt E. E., 1967, U. S. Patent, Patent No. [3,297,033, 3297033]
   Scholl M, 2009, PROG POLYM SCI, V34, P24, DOI 10.1016/j.progpolymsci.2008.09.001
   Schweizer D, 2013, BIOMACROMOLECULES, V14, P75, DOI 10.1021/bm301352x
   Seebach D, 1996, ANGEW CHEM INT EDIT, V35, P2795, DOI 10.1002/anie.199627951
   Seebach D, 1996, HELV CHIM ACTA, V79, P913, DOI 10.1002/hlca.19960790402
   Shinno K, 1997, MACROMOLECULES, V30, P6438, DOI 10.1021/ma9704323
   Simon J, 2012, MACROMOLECULES, V45, P9275, DOI 10.1021/ma302311h
   Singer JW, 2005, J CONTROL RELEASE, V109, P120, DOI 10.1016/j.jconrel.2005.09.033
   Sisson AL, 2010, SOFT MATTER, V6, P4968, DOI 10.1039/c0sm00149j
   Slepokura K, 2004, CARBOHYD RES, V339, P1995, DOI 10.1016/j.carres.2004.05.020
   Snell KD, 2015, CURR OPIN BIOTECH, V32, P68, DOI 10.1016/j.copbio.2014.11.005
   Sontjens SHM, 2006, BIOMACROMOLECULES, V7, P310, DOI 10.1021/bm050663e
   Spain SG, 2011, POLYM CHEM-UK, V2, P60, DOI 10.1039/c0py00149j
   Srinivasachari S, 2006, J AM CHEM SOC, V128, P8176, DOI 10.1021/ja0585580
   STANKO RT, 1990, J APPL PHYSIOL, V69, P1651
   Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l
   Stevens DM, 2015, POLYM CHEM-UK, V6, P1096, DOI 10.1039/c4py00986j
   Stidham SE, 2014, J AM CHEM SOC, V136, P9544, DOI 10.1021/ja5036804
   Strain HH, 1934, J AM CHEM SOC, V56, P2649, DOI 10.1021/ja01327a034
   Sudesh K, 2008, CLEAN-SOIL AIR WATER, V36, P433, DOI 10.1002/clen.200700183
   Sugimura H, 2007, ANN THORAC SURG, V83, P409, DOI 10.1016/j.athoracsur.2006.08.046
   Sun JW, 2004, J ORG CHEM, V69, P8932, DOI 10.1021/jo0486239
   Sun LL, 2014, J BIOMED MATER RES A, V102, P3446, DOI 10.1002/jbm.a.35008
   Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w
   Tang SZ, 2006, TETRAHEDRON LETT, V47, P7671, DOI 10.1016/j.tetlet.2006.08.110
   Taori VP, 2011, BIOMACROMOLECULES, V12, P2055, DOI 10.1021/bm101537f
   Taylor CR, 1999, ARCH DERMATOL, V135, P540, DOI 10.1001/archderm.135.5.540
   Teles H, 2010, J CONTROL RELEASE, V147, P298, DOI 10.1016/j.jconrel.2010.07.098
   Tian Y, 2006, BIOMACROMOLECULES, V7, P2539, DOI 10.1021/bm0604121
   Ting SRS, 2010, POLYM CHEM-UK, V1, P1392, DOI 10.1039/c0py00141d
   Treiser MD, 2007, BIOTECHNIQUES, V43, P361, DOI 10.2144/000112533
   Turner BB, 1933, J PHARMACOL EXP THER, V48, P445
   TURNER SR, 1993, MACROMOLECULES, V26, P4617, DOI 10.1021/ma00069a031
   Twibanire JDK, 2014, POLYMERS-BASEL, V6, P179, DOI 10.3390/polym6010179
   Twibanire JDK, 2012, POLYMERS-BASEL, V4, P794, DOI 10.3390/polym4010794
   Twyman LJ, 1998, J CHEM RES-S, P758, DOI 10.1039/a805918g
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   van Boekel MAJS, 2001, NAHRUNG, V45, P150, DOI 10.1002/1521-3803(20010601)45:3<150::AID-FOOD150>3.0.CO;2-9
   Vazquez-Dorbatt V, 2012, CHEMBIOCHEM, V13, P2478, DOI 10.1002/cbic.201200480
   Velazquez AJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P867, DOI 10.1001/archopht.122.6.867
   Wang DL, 2015, CHEM SOC REV, V44, P4023, DOI 10.1039/c4cs00229f
   Wang LS, 2014, POLYM BULL, V71, P47, DOI 10.1007/s00289-013-1044-7
   Wang LS, 2013, POLYM SCI SER B+, V55, P604, DOI 10.1134/S1560090413080101
   Wang LS, 2013, POLYM-PLAST TECHNOL, V52, P1063, DOI 10.1080/03602559.2013.769582
   Wang LS, 2013, MACROMOL CHEM PHYS, V214, P458, DOI 10.1002/macp.201200525
   Wang LS, 2005, CHINESE CHEM LETT, V16, P572
   Wang LS, 2004, MACROMOL RAPID COMM, V25, P959, DOI 10.1002/marc.200300319
   Wang XL, 2002, J POLYM SCI POL CHEM, V40, P70, DOI 10.1002/pola.10088
   Wathier M, 2004, J AM CHEM SOC, V126, P12744, DOI 10.1021/ja045870l
   Weiser JR, 2013, ACTA BIOMATER, V9, P8245, DOI 10.1016/j.actbio.2013.05.020
   Weiser JR, 2012, ANAL BIOCHEM, V430, P116, DOI 10.1016/j.ab.2012.08.009
   Weiser JR, 2011, BIOMACROMOLECULES, V12, P977, DOI 10.1021/bm101342p
   Weldon CB, 2012, J CONTROL RELEASE, V161, P903, DOI 10.1016/j.jconrel.2012.05.021
   Wilms D, 2010, ACCOUNTS CHEM RES, V43, P129, DOI 10.1021/ar900158p
   WITTGENSTEIN E, 1960, SCIENCE, V132, P894, DOI 10.1126/science.132.3431.894
   WITTGENSTEIN E, 1961, J INVEST DERMATOL, V36, P283, DOI 10.1038/jid.1961.46
   Wolinsky JB, 2008, ADV DRUG DELIVER REV, V60, P1037, DOI 10.1016/j.addr.2008.02.012
   Wolinsky JB, 2007, MACROMOLECULES, V40, P7065, DOI 10.1021/ma071276v
   Wolinsky JB, 2012, BIOMACROMOLECULES, V13, P406, DOI 10.1021/bm201443m
   Wolinsky JB, 2010, J CONTROL RELEASE, V144, P280, DOI 10.1016/j.jconrel.2010.02.022
   WOOLEY KL, 1994, POLYM J, V26, P187, DOI 10.1295/polymj.26.187
   Wright JC, 2012, ADV DEL SCI TECHNOL, P11, DOI 10.1007/978-1-4614-0554-2_2
   Wu GP, 2011, J AM CHEM SOC, V133, P15191, DOI 10.1021/ja206425j
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Wu X, 2014, MACROMOLECULES, V47, P492, DOI 10.1021/ma401899h
   Wu XM, 2014, ACS NANO, V8, P153, DOI 10.1021/nn4054107
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Xu JW, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39822
   Xu JW, 2011, CHEM-ASIAN J, V6, P2730, DOI 10.1002/asia.201100411
   Xue L, 2013, BIOMACROMOLECULES, V14, P3903, DOI 10.1021/bm401026n
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu XH, 2005, MACROMOLECULES, V38, P6244, DOI 10.1021/ma048839c
   Zagar E, 2011, PROG POLYM SCI, V36, P53, DOI 10.1016/j.progpolymsci.2010.08.004
   Zawaneh PN, 2006, BIOMACROMOLECULES, V7, P3245, DOI 10.1021/bm0605457
   Zawaneh PN, 2010, P NATL ACAD SCI USA, V107, P11014, DOI 10.1073/pnas.0811529107
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P3239, DOI 10.1021/bm060544e
   Zelikin AN, 2005, MACROMOLECULES, V38, P5532, DOI 10.1021/ma050049v
   Zhang H, 2014, MACROMOL RAPID COMM, V35, P1906, DOI 10.1002/marc.201400389
   Zhang H, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39893
   Zhang H, 2013, J AM CHEM SOC, V135, P6806, DOI 10.1021/ja402558m
   Zhang XL, 2010, PROG ORG COAT, V69, P295, DOI 10.1016/j.porgcoat.2010.08.007
   Zhang XL, 2011, POLYM INT, V60, P153, DOI 10.1002/pi.2930
   Zhang XQ, 2011, ACS NANO, V5, P6962, DOI 10.1021/nn201446c
   Zhou CHC, 2008, CHEM SOC REV, V37, P527, DOI 10.1039/b707343g
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zhu Q, 2013, RSC ADV, V3, P2071, DOI 10.1039/c2ra22210h
NR 329
TC 29
Z9 29
U1 8
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2665
EI 1520-6890
J9 CHEM REV
JI Chem. Rev.
PD FEB 24
PY 2016
VL 116
IS 4
SI SI
BP 2664
EP 2704
DI 10.1021/acs.chemrev.5b00465
PG 41
WC Chemistry, Multidisciplinary
SC Chemistry
GA DF1NH
UT WOS:000371106000020
PM 26821863
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hazra, S
   Nandi, S
   Naskar, D
   Guha, R
   Chowdhury, S
   Pradhan, N
   Kundu, SC
   Konar, A
AF Hazra, Sarbani
   Nandi, Sudip
   Naskar, Deboki
   Guha, Rajdeep
   Chowdhury, Sushovan
   Pradhan, Nirparaj
   Kundu, Subhas C.
   Konar, Aditya
TI Non-mulberry Silk Fibroin Biomaterial for Corneal Regeneration
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POSTERIOR CAPSULAR OPACIFICATION; EXPANDED EX-VIVO; STEM-CELLS;
   EPITHELIAL-CELLS; AMNIOTIC MEMBRANE; LIMBAL EPITHELIUM; PROTEIN FIBROIN;
   OCULAR SURFACE; RAT MODEL; TRANSPLANTATION
AB Purpose: Successful repair of a damaged corneal surface is a great challenge and may require the use of a scaffold that supports cell growth and differentiation. Amniotic membrane is currently used for this purpose, in spite of its limitations. A thin transparent silk fibroin film from non-mulberry Antheraea mylitta (Am) has been developed which offers to be a promising alternative. The silk scaffolds provide sufficient rigidity for easy handling, the scaffolds support the sprouting, migration, attachment and growth of epithelial cells and keratocytes from rat corneal explants; the cells form a cell sheet, preserve their phenotypes, express cytokeratin3 and vimentin respectively. The films also support growth of limbal stem cell evidenced by expression of ABCG2. The cell growth on the silk film and the amniotic membrane is comparable. The implanted film within the rabbit cornea remains transparent, stable. The clinical examination as well as histology shows absence of any inflammatory response or neovascularization. The corneal surface integrity is maintained; tear formation, intraocular pressure and electroretinography of implanted eyes show no adverse changes. The silk fibroin film from non-mulberry silk worms may be a worthy candidate for use as a corneal scaffold.
C1 [Hazra, Sarbani; Pradhan, Nirparaj] West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata 700037, W Bengal, India.
   [Nandi, Sudip; Guha, Rajdeep; Chowdhury, Sushovan; Konar, Aditya] CSIR Indian Inst Chem Biol, Kolkata 700032, W Bengal, India.
   [Naskar, Deboki; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Hazra, S (reprint author), West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata 700037, W Bengal, India.; Konar, A (reprint author), CSIR Indian Inst Chem Biol, Kolkata 700032, W Bengal, India.
EM shazrakon@yahoo.co.in; adityakonar@yahoo.com
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology, Govt. of India [BT/PR12304/TDS/121/2/2014];
   CSIR, Govt. of India
FX This work is supported by Department of Biotechnology, Govt. of India
   BT/PR12304/TDS/121/2/2014 and CSIR, Govt. of India. We acknowledge West
   Bengal University of Animal & Fishery Sciences, CSIR-Indian Institute of
   Chemical Biology and IIT, Kharagpur for providing facilities.
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   CHEN JJY, 1991, INVEST OPHTH VIS SCI, V32, P2219
   Chung YG, 2014, BIOMATERIALS, V35, P7452, DOI 10.1016/j.biomaterials.2014.05.044
   Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Ge Z, 2012, INT J ORAL MAX SURG, V41, P673, DOI 10.1016/j.ijom.2011.11.016
   George KA, 2013, MAT SCI ENG C-MATER, V33, P668, DOI 10.1016/j.msec.2012.10.016
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gruchenberg K, 2015, KNEE SURG SPORT TR A, V23, P2218, DOI 10.1007/s00167-014-3009-2
   Guha R, 2013, NANOMEDICINE-UK, V8, P1415, DOI [10.2217/NNM.12.175, 10.2217/nnm.12.175]
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hazra S, 2012, MOL VIS, V18, P1701
   Higa K, 2010, J BIOMAT SCI-POLYM E, V22, P2261
   Hogerheyde TA, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025016
   Ke QC, 2011, J TISSUE ENG REGEN M, V5, P138, DOI 10.1002/term.298
   Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015
   Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Omoto M, 2009, INVEST OPHTH VIS SCI, V50, P2109, DOI 10.1167/iovs.08-2262
   Paranthan RR, 2011, MOL VIS, V17, P1901
   Parker S. T., 2009, ADV MATER, V21, P1
   PATEL S, 1995, J REFRACT SURG, V11, P100
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632
   Shang K, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.3.2
   Shen Y, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015015
   Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8
   Talukdar S, 2013, ADV FUNCT MATER, V23, P5249, DOI 10.1002/adfm.201300312
   Talukdar S, 2012, ADV FUNCT MATER, V22, P4778, DOI 10.1002/adfm.201200375
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng Scheffer C G, 2004, Ocul Surf, V2, P177
   Uebersax L, 2013, EUR J PHARM BIOPHARM, V85, P107, DOI 10.1016/j.ejpb.2013.05.008
   van Essen TH, 2013, INVEST OPHTH VIS SCI, V54, P3224, DOI 10.1167/iovs.13-11799
   Wang LQ, 2015, J BIOMED MATER RES B, V103, P204, DOI 10.1002/jbm.b.33192
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Zhou Y., 2011, CORNEA, V3, P73
NR 49
TC 10
Z9 11
U1 1
U2 25
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 24
PY 2016
VL 6
AR 21840
DI 10.1038/srep21840
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE5PE
UT WOS:000370682700001
PM 26908015
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ma, HS
   Jiang, CA
   Zhai, D
   Luo, YX
   Chen, Y
   Lv, F
   Yi, ZF
   Deng, Y
   Wang, JW
   Chang, J
   Wu, CT
AF Ma, Hongshi
   Jiang, Chuan
   Zhai, Dong
   Luo, Yongxiang
   Chen, Yu
   Lv, Fang
   Yi, Zhengfang
   Deng, Yuan
   Wang, Jinwu
   Chang, Jiang
   Wu, Chengtie
TI A Bifunctional Biomaterial with Photothermal Effect forTumor Therapy and
   Bone Regeneration
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE 3D printing; bifunctional; bone regeneration; scaffolds; photothermal
   therapy
ID NANO-GRAPHENE OXIDE; CARBON NANOTUBES; CANCER-THERAPY; IN-VITRO;
   BIOMEDICAL APPLICATIONS; MOS2 NANOSHEETS; STEM-CELLS; NANOPARTICLES;
   DIFFERENTIATION; CHALLENGES
AB Malignant bone tumor is one of the major bone diseases. The treatment of such a bone disease typically requires the removal of bone tumor and regeneration of tumor-initiated bone defects simultaneously. To address this issue, it is required that implanted biomaterials should combine the bifunctions of both therapy and regeneration. In this work, a bifunctional graphene oxide (GO)-modified -tricalcium phosphate (GO-TCP) composite scaffold combining a high photothermal effect with significantly improved bone-forming ability is prepared by 3D-printing and surface-modification strategies. The prepared GO-TCP scaffolds exhibit excellent photothermal effects under the irradiation of 808 nm near infrared laser (NIR) even at an ultralow power density of 0.36 W cm(-2), while no photothermal effects are observed for pure -TCP scaffolds. The photothermal temperature of GO-TCP scaffolds can be effectively modulated in the range of 40-90 degrees C by controlling the used GO concentrations, surface-modification times, and power densities of NIR. The distinct photothermal effect of GO-TCP scaffolds induces more than 90% of cell death for osteosarcoma cells (MG-63) in vitro, and further effectively inhibits tumor growth in mice. Meanwhile, the prepared GO-TCP scaffolds possess the improved capability to stimulate the osteogenic differentiation of rabbit bone mesenchymal stem cells (rBMSCs) by upregulating bone-related gene expression, and significantly promote new bone formation in the bone defects of rabbits as compared to pure -TCP scaffolds. These results successfully demonstrate that the prepared GO-TCP scaffolds have bifunctional properties of photothermal therapy and bone regeneration, which is believed to pave the way to design and fabricate novel implanting biomaterials in combination of therapy and regeneration functions.
C1 [Ma, Hongshi; Zhai, Dong; Luo, Yongxiang; Chen, Yu; Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Wang, Jinwu; Chang, Jiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Affiated 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200011, Peoples R China.
   [Lv, Fang; Yi, Zhengfang] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.
   [Lv, Fang; Yi, Zhengfang] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.
   [Deng, Yuan; Wang, Jinwu] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.
RP Chang, J; Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Chang, J (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Affiated 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200011, Peoples R China.
EM jchang@mail.sic.ac.cn; chengtiewu@mail.sic.ac.cn
RI Chen, Yu/N-8463-2015
OI Chen, Yu/0000-0002-8206-3325
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Natural Science Foundation of China [31370963,
   81190132, 81171707]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]; Key Research Program of Chinese Academy of Sciences
   [KGZD-EW-T06]; joint research project for Shanghai Municipal Significant
   Diseases [2013ZYJB0501]
FX This study was funded by the Recruitment Program of Global Young Talent,
   China (Dr. Wu), the National High Technology Research and Development
   Program of China (863 Program, Grant No. SS2015AA020302), Natural
   Science Foundation of China (Grant Nos. 31370963, 81190132, and
   81171707), Program of Shanghai Outstanding Academic Leaders (Grant No.
   15XD1503900), Key Research Program of Chinese Academy of Sciences (Grant
   No. KGZD-EW-T06), and joint research project for Shanghai Municipal
   Significant Diseases (Grant No. 2013ZYJB0501).
CR Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017
   Andronescu E, 2010, J MATER SCI-MATER M, V21, P2237, DOI 10.1007/s10856-010-4076-7
   Bai J, 2014, BIOMATERIALS, V35, P5805, DOI 10.1016/j.biomaterials.2014.04.008
   Bernhardt A, 2009, J TISSUE ENG REGEN M, V3, P54, DOI 10.1002/term.134
   Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chen JY, 2007, NANO LETT, V7, P1318, DOI 10.1021/nl070345g
   Chen SC, 2013, WORLD J PEDIATR, V9, P9, DOI 10.1007/s12519-013-0404-6
   Cheng L, 2014, CHEM REV, V114, P10869, DOI 10.1021/cr400532z
   [程亮 Cheng Liang], 2014, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V41, P18
   Cheng L, 2013, ADV FUNCT MATER, V23, P5893, DOI 10.1002/adfm.201301045
   Coleman R. E., 1997, CANCER, V80, P8
   Dong JJ, 2013, INT J NANOMED, V8, P1317, DOI 10.2147/IJN.S42862
   Du L, 2012, CHINESE MED J-PEKING, V125, P4022, DOI 10.3760/cma.j.issn.0366-6999.2012.22.021
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Goncalves G, 2013, ADV HEALTHC MATER, V2, P1072, DOI 10.1002/adhm.201300023
   Hong J, 2012, ACS NANO, V6, P81, DOI 10.1021/nn202607r
   Huang Xiaohua, 2006, J AM CHEM SOC, V128, P2115
   Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200
   Jaque D, 2014, NANOSCALE, V6, P9494, DOI 10.1039/c4nr00708e
   Kim J, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035010
   Kirui DK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105105
   La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571
   Lee C, 2010, PHOTOCHEM PHOTOBIOL, V86, P981, DOI 10.1111/j.1751-1097.2010.00731.x
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180
   Li JL, 2008, ADV MATER, V20, P3866, DOI 10.1002/adma.200800941
   Liu T, 2015, ACS NANO, V9, P950, DOI 10.1021/nn506757x
   Liu T, 2014, ADV MATER, V26, P3433, DOI 10.1002/adma.201305256
   Liu XW, 2011, BIOMATERIALS, V32, P144, DOI 10.1016/j.biomaterials.2010.08.096
   Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006
   Markovic ZM, 2011, BIOMATERIALS, V32, P1121, DOI 10.1016/j.biomaterials.2010.10.030
   Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858
   Moon HK, 2009, ACS NANO, V3, P3707, DOI 10.1021/nn900904h
   Nikfarjam M, 2005, ANTICANCER RES, V25, P1413
   Orecchioni M, 2015, THERANOSTICS, V5, P710, DOI 10.7150/thno.11387
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Prosecka E, 2015, J BIOMED MATER RES A, V103, P671, DOI 10.1002/jbm.a.35216
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Sahu A, 2013, BIOMATERIALS, V34, P6239, DOI 10.1016/j.biomaterials.2013.04.066
   Saito K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.115409
   Shi XZ, 2013, BIOMATERIALS, V34, P4786, DOI 10.1016/j.biomaterials.2013.03.023
   Su SS, 2013, BIOMATERIALS, V34, P3523, DOI 10.1016/j.biomaterials.2013.01.083
   Thakor AS, 2013, CA-CANCER J CLIN, V63, P395, DOI 10.3322/caac.21199
   Verron E, 2014, DRUG DISCOV TODAY, V19, P1419, DOI 10.1016/j.drudis.2014.04.004
   Wang C, 2014, ADV MATER, V26, P8154, DOI 10.1002/adma.201402996
   Wang SG, 2015, BIOMATERIALS, V39, P206, DOI 10.1016/j.biomaterials.2014.11.009
   Wang YH, 2013, BIOMATERIALS, V34, P7715, DOI 10.1016/j.biomaterials.2013.06.045
   Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145
   Yang K, 2013, BIOMATERIALS, V34, P2787, DOI 10.1016/j.biomaterials.2013.01.001
   Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c
   Yang K, 2012, ADV MATER, V24, P5586, DOI 10.1002/adma.201202625
   Yang K, 2012, ADV MATER, V24, P1868, DOI 10.1002/adma.201104964
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Young JK, 2012, ANN BIOMED ENG, V40, P438, DOI 10.1007/s10439-011-0472-5
   Zha ZB, 2013, ADV MATER, V25, P777, DOI 10.1002/adma.201202211
   Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f
NR 57
TC 47
Z9 48
U1 48
U2 398
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD FEB 23
PY 2016
VL 26
IS 8
BP 1197
EP 1208
DI 10.1002/adfm.201504142
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DF1DG
UT WOS:000371078100006
DA 2018-10-20
ER

PT J
AU Kawabe, S
   Seki, M
   Tabata, H
AF Kawabe, Shunsuke
   Seki, Munetoshi
   Tabata, Hitoshi
TI Evaluation of hydration in a water-soluble polymer by terahertz
   spectroscopy
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID TOTAL-REFLECTION SPECTROSCOPY; RELAXATION; BIOCOMPATIBILITY; ABSORPTION;
   DYNAMICS; STATE
AB In this study, we have evaluated the hydration properties of water-soluble polymers by terahertz spectroscopy. In particular, we focused on polyvinylpyrrolidone which has potential use for a wide range of applications as a biomaterial. The dielectric loss of samples obtained by the terahertz spectroscopy was found to strongly depend on the molecular weight of the polymers and the density of the solution. We revealed that the hydration number per monomer depends on the molecular weight of the polymer. It is also deduced that the hydration number is affected by the conformation of the polymer in the solution. (C) 2016 AIP Publishing LLC.
C1 [Kawabe, Shunsuke; Seki, Munetoshi; Tabata, Hitoshi] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
RP Seki, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM m-seki@ee.t.u-tokyo.ac.jp
FU JSPS Core-to-Core Program, A. Advanced Research Networks
FX We would like to acknowledge Advantest Co. for the opportunity to use
   the TAS7500 system in this work. This work was supported by the JSPS
   Core-to-Core Program, A. Advanced Research Networks.
CR Arikawa T, 2008, CHEM PHYS LETT, V457, P12, DOI 10.1016/j.cplett.2008.03.062
   Born B, 2009, J INFRARED MILLIM TE, V30, P1245, DOI 10.1007/s10762-009-9514-6
   Bye JW, 2014, J PHYS CHEM A, V118, P83, DOI 10.1021/jp407410g
   Choi DH, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764304
   Elashmawi IS, 2012, CURR APPL PHYS, V12, P141, DOI 10.1016/j.cap.2011.05.011
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Hishida M, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/28/284113
   Hishida M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.158102
   Jones DS, 2005, BIOMATERIALS, V26, P2013, DOI 10.1016/j.biomaterials.2004.06.001
   Kawabe S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870954
   Kawaguchi S, 2010, PHYS CHEM CHEM PHYS, V12, P10255, DOI 10.1039/b927397b
   Matvejev V, 2012, J PHYS CHEM B, V116, P14071, DOI 10.1021/jp305356d
   Moller U, 2009, J OPT SOC AM B, V26, pA113, DOI 10.1364/JOSAB.26.00A113
   Murakami H, 2012, CHEM PHYS LETT, V519-20, P105, DOI 10.1016/j.cplett.2011.11.029
   Nagai M, 2006, INT J INFRARED MILLI, V27, P505, DOI 10.1007/s10762-006-9098-3
   Nibali VC, 2014, J AM CHEM SOC, V136, P12800, DOI 10.1021/ja504441h
   Ronne C, 1999, PHYS REV LETT, V82, P2888, DOI 10.1103/PhysRevLett.82.2888
   Shiraga K, 2013, FOOD CHEM, V140, P315, DOI 10.1016/j.foodchem.2013.02.066
   Tielrooij KJ, 2010, SCIENCE, V328, P1006, DOI 10.1126/science.1183512
   Tielrooij KJ, 2009, BIOPHYS J, V97, P2484, DOI 10.1016/j.bpj.2009.08.024
   Yada H, 2008, CHEM PHYS LETT, V464, P166, DOI 10.1016/j.cplett.2008.09.015
   Yada H, 2009, CHEM PHYS LETT, V473, P279, DOI 10.1016/j.cplett.2009.03.075
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
NR 23
TC 1
Z9 1
U1 2
U2 22
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD FEB 22
PY 2016
VL 108
IS 8
AR 081103
DI 10.1063/1.4942411
PG 3
WC Physics, Applied
SC Physics
GA DH8PO
UT WOS:000373057000003
DA 2018-10-20
ER

PT J
AU Cao, HL
   Qin, H
   Zhao, YC
   Jin, GD
   Lu, T
   Meng, FH
   Zhang, XL
   Liu, XY
AF Cao, Huiliang
   Qin, Hui
   Zhao, Yaochao
   Jin, Guodong
   Lu, Tao
   Meng, Fanhao
   Zhang, Xianlong
   Liu, Xuanyong
TI Nano-thick calcium oxide armed titanium: boosts bone cells against
   methicillin-resistant Staphylococcus aureus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FOREIGN-BODY INFECTION; ION-IMPLANTATION; MODEL; PATHOGENESIS;
   MECHANISMS; ADHESION
AB Since the use of systemic antibiotics for preventing acute biomaterial-associated infections (BAIs) may build up bacterial resistance and result in huge medical costs and unpredictable mortality, new precaution strategies are required. Here, it demonstrated that titanium armed with a nano-thick calcium oxide layer was effective on averting methicillin-resistant Staphylococcus aureus (MRSA) infections in rabbits. The calcium oxide layer was constructed by, firstly, injecting of metallic calcium into titanium via a plasma immersion ion implantation process, and then transforming the outer most surface into oxide by exposing to the atmosphere. Although the calcium oxide armed titanium had a relative low reduction rate (similar to 74%) in growth of MRSA in vitro, it could markedly promote the osteogenic differentiation of bone marrow stem cells (BMSCs), restore local bone integration against the challenge of MRSA, and decrease the incidence of MRSA infection with a rate of 100% (compared to the titanium control). This study demonstrated for the first time that calcium, as one of the major elements in a human body, could be engineered to avert MRSA infections, which is promising as a safe precaution of disinfection for implantable biomedical devices.
C1 [Cao, Huiliang; Jin, Guodong; Lu, Tao; Meng, Fanhao; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Qin, Hui; Zhao, Yaochao; Zhang, Xianlong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China.
RP Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Zhang, XL (reprint author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China.
EM zhangxianl197826@163.com; xyliu@mail.sic.ac.cn
RI Liu, Xuanyong/J-2609-2018; Cao, Huiliang/V-1999-2017
OI Cao, Huiliang/0000-0002-5209-4497
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [31370962]; Shanghai
   Committee of Science and Technology [14XD1403900]; Shanghai Rising-Star
   Program [15QA1404100]; Youth Innovation Promotion Association CAS
   [2015204]; Open Research Fund of State Key Laboratory of Bioelectronics,
   Southeast University
FX This work was supported by the National Basic Research Program of China
   (973 Program, 2012CB933600), National Natural Science Foundation of
   China (31370962), Shanghai Committee of Science and Technology
   (14XD1403900), Shanghai Rising-Star Program (15QA1404100), Youth
   Innovation Promotion Association CAS (2015204), and the Open Research
   Fund of State Key Laboratory of Bioelectronics, Southeast University.
CR Akiyama H, 1999, J DERMATOL SCI, V22, P62, DOI 10.1016/S0923-1811(99)00064-X
   Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244
   Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3
   Bourre L, 2002, J PHOTOCH PHOTOBIO B, V67, P23, DOI 10.1016/S1011-1344(02)00279-8
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032
   Jinno T, 2004, J ARTHROPLASTY, V19, P102, DOI 10.1016/j.arth.2003.10.001
   Kang SN, 2014, TISSUE ENG REGEN MED, V11, P39, DOI 10.1007/s13770-013-1104-y
   Kiernan J. A., 2008, HISTOLOGICAL HISTOCH
   Krupa D, 2001, BIOMATERIALS, V22, P2139, DOI 10.1016/S0142-9612(00)00405-1
   Mohammadi Z, 2012, Chonnam Med J, V48, P133, DOI 10.4068/cmj.2012.48.3.133
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133
   Naseem R, 2009, J MOL BIOL, V391, P42, DOI 10.1016/j.jmb.2009.05.064
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Nayab SN, 2007, BIOMATERIALS, V28, P38, DOI 10.1016/j.biomaterials.2006.08.032
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   RAMACHANDRAN VS, 1964, NATURE, V201, P288, DOI 10.1038/201288a0
   Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058
   Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x
   Shen H, 2014, CHINESE MED J-PEKING, V127, P2748, DOI 10.3760/cma.j.issn.0366-6999.20140423
   Shen YH, 2012, J MATER CHEM, V22, P8662, DOI 10.1039/c2jm16141a
   Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   van Oosten M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3584
   Vianna Morgana Eli, 2009, Braz. Dent. J., V20, P382, DOI 10.1590/S0103-64402009000500005
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 43
TC 6
Z9 6
U1 2
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 22
PY 2016
VL 6
AR 21761
DI 10.1038/srep21761
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE3FR
UT WOS:000370513300001
PM 26899567
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Burkhardt, MA
   Waser, J
   Milleret, V
   Gerber, I
   Emmert, MY
   Foolen, J
   Hoerstrup, SP
   Schlottig, F
   Vogel, V
AF Burkhardt, Melanie A.
   Waser, Jasmin
   Milleret, Vincent
   Gerber, Isabel
   Emmert, Maximilian Y.
   Foolen, Jasper
   Hoerstrup, Simon P.
   Schlottig, Falko
   Vogel, Viola
TI Synergistic interactions of blood-borne immune cells, fibroblasts and
   extracellular matrix drive repair in an in vitro peri-implant wound
   healing model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESENCHYMAL STROMAL CELLS; FIBRONECTIN-FIBRIN MATRIX; COLD-INSOLUBLE
   GLOBULIN; MYOFIBROBLAST DIFFERENTIATION; MACROPHAGE PHENOTYPE; DENTAL
   IMPLANTS; CROSS-LINKING; BONE REPAIR; TITANIUM; SURFACE
AB Low correlations of cell culture data with clinical outcomes pose major medical challenges with costly consequences. While the majority of biomaterials are tested using in vitro cell monocultures, the importance of synergistic interactions between different cell types on paracrine signalling has recently been highlighted. In this proof-of-concept study, we asked whether the first contact of surfaces with whole human blood could steer the tissue healing response. This hypothesis was tested using alkali-treatment of rough titanium (Ti) surfaces since they have clinically been shown to improve early implant integration and stability, yet blood-free in vitro cell cultures poorly correlated with in vivo tissue healing. We show that alkali-treatment, compared to native Ti surfaces, increased blood clot thickness, including platelet adhesion. Strikingly, blood clots with entrapped blood cells in synergistic interactions with fibroblasts, but not fibroblasts alone, upregulated the secretion of major factors associated with fast healing. This includes matrix metalloproteinases (MMPs) to break down extracellular matrix and the growth factor VEGF, known for its angiogenic potential. Consequently, in vitro test platforms, which consider whole blood-implant interactions, might be superior in predicting wound healing in response to biomaterial properties.
C1 [Burkhardt, Melanie A.; Gerber, Isabel; Foolen, Jasper; Vogel, Viola] Swiss Fed Inst Technol, Lab Appl Mechanobiol, Dept Hlth Sci & Technol, CH-8093 Zurich, Switzerland.
   [Waser, Jasmin; Schlottig, Falko] Thommen Med AG, CH-2540 Grenchen, Switzerland.
   [Milleret, Vincent] Univ Zurich Hosp, Lab Cell & Tissue Engn, Dept Obstet, CH-8091 Zurich, Switzerland.
   [Emmert, Maximilian Y.; Hoerstrup, Simon P.] Swiss Ctr Regenerat Med, CH-8091 Zurich, Switzerland.
   [Schlottig, Falko] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland.
RP Vogel, V (reprint author), Swiss Fed Inst Technol, Lab Appl Mechanobiol, Dept Hlth Sci & Technol, CH-8093 Zurich, Switzerland.
EM viola.vogel@hest.ethz.ch
RI Vogel, Viola/O-8025-2015
OI Vogel, Viola/0000-0003-2898-7671
FU Scientific Center for Optical and Electron Microscopy ScopeM of ETH
   Zurich; ERC Advanced Grant of the European Research Council [233157];
   Swiss National Science Foundation (SNF) [310030B-133122]; SwissTransMed
   [33/2013]; European Union Seventh Framework Programme (FP7)
   [PIEF-GA-2013-628585]
FX The authors gratefully acknowledge Thommen Medical AG for providing SBA
   Ti surfaces and the Scientific Center for Optical and Electron
   Microscopy ScopeM of ETH Zurich for support. We thank Chantel Spencer
   for helping with ELISA assays, Dr. Thomas Hefti for giving input on
   experimental plans and Daniela Ortiz Franyuti for drawing Figure 7. The
   authors acknowledge funding from the ERC Advanced Grant of the European
   Research Council, Contract No. 233157 (V.V.), the Swiss National Science
   Foundation (SNF, Contract No. 310030B-133122) (V.V.), the SwissTransMed
   33/2013 (LifeMatrix) (V.V.). The research leading to these results has
   received funding from the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no. PIEF-GA-2013-628585 (J.F.).
CR Al Mustafa M, 2015, CLIN ORAL IMPLAN RES, V26, P15, DOI 10.1111/clr.12294
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217
   Bae SE, 2012, BIOMACROMOLECULES, V13, P2811, DOI 10.1021/bm300791h
   Ballotta V, 2014, BIOMATERIALS, V35, P9100, DOI 10.1016/j.biomaterials.2014.07.042
   Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Calvo-Guirado JL, 2010, CLIN ORAL IMPLAN RES, V21, P308, DOI 10.1111/j.1600-0501.2009.01841.x
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   Corbett SA, 1996, BLOOD, V88, P158
   Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999
   Daley JM, 2005, J IMMUNOL, V174, P2265, DOI 10.4049/jimmunol.174.4.2265
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Held U, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-37
   Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x
   Herter JM, 2014, THROMB HAEMOSTASIS, V12, P1764, DOI DOI 10.1111/JTH.12730
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kopf BS, 2015, ACTA BIOMATER, V19, P180, DOI 10.1016/j.actbio.2015.03.022
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Lichtnekert J, 2013, CURR OPIN PHARMACOL, V13, P555, DOI 10.1016/j.coph.2013.05.013
   Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35
   Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336
   Milleret V, 2012, ACTA BIOMATER, V8, P4349, DOI 10.1016/j.actbio.2012.07.032
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Mirastschijski U, 2010, WOUND REPAIR REGEN, V18, P223, DOI 10.1111/j.1524-475X.2010.00574.x
   MOSHER DF, 1975, J BIOL CHEM, V250, P6614
   Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418
   Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Saran U, 2014, ARCH BIOCHEM BIOPHYS, V561, P109, DOI 10.1016/j.abb.2014.07.006
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Shiu HT, 2014, TISSUE ENG PART B-RE, V20, P697, DOI [10.1089/ten.teb.2013.0709, 10.1089/ten.TEB.2013.0709]
   Stadlinger B, 2012, BRIT J ORAL MAX SURG, V50, P74, DOI 10.1016/j.bjoms.2010.11.013
   Stadlinger B, 2009, J CLIN PERIODONTOL, V36, P882, DOI 10.1111/j.1600-051X.2009.01466.x
   Stanford CM, 2010, INT J MOL SCI, V11, P354, DOI 10.3390/ijms11010354
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Tugulu S, 2010, J MATER SCI-MATER M, V21, P2751, DOI 10.1007/s10856-010-4138-x
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   Vasak C, 2014, CLIN ORAL IMPLAN RES, V25, P1378, DOI 10.1111/clr.12277
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001
   Zhang Y, 2014, MATRIX BIOL, V40, P62, DOI 10.1016/j.matbio.2014.09.001
NR 60
TC 5
Z9 5
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 17
PY 2016
VL 6
AR 21071
DI 10.1038/srep21071
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE1HW
UT WOS:000370378800001
PM 26883175
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chiatti, F
   Delle Piane, M
   Ugliengo, P
   Corno, M
AF Chiatti, Fabio
   Delle Piane, Massimo
   Ugliengo, Piero
   Corno, Marta
TI Water at hydroxyapatite surfaces: the effect of coverage and surface
   termination as investigated by all-electron B3LYP-D* simulations
SO THEORETICAL CHEMISTRY ACCOUNTS
LA English
DT Article
DE Hydroxyapatite; Periodic modeling; Biomaterial; Water adsorption;
   B3LYP-D*; CRYSTAL14; Surface properties
ID DIFFERENTIAL SCANNING CALORIMETER; MOLECULAR-DYNAMICS; PHASE-TRANSITION;
   GLYCINE ADSORPTION; CATIONIC SITES; CRYSTAL-GROWTH; CITRIC-ACID;
   AB-INITIO; DENSITY; B3LYP
AB Hydroxyapatite [HA, Ca-10(PO4)(6)(OH)(2)], the main constituent of bones and teeth enamels, is a widely studied and employed biomaterial. Its applications span from dental to orthopedic implants, including bone tissue engineering scaffolds, coating, filler and many others. Previous theoretical and experimental studies have already characterized the physical-chemical foundations of water adsorption on a number of HA surfaces, an essential step in the mechanism of biomaterial integration. Here, we extend such knowledge by simulating, at a hybrid DFT level of theory, different HA surface terminations, both stoichiometric and non-stoichiometric, as free and in interaction with water. Such a goal is achieved at an unprecedented accuracy, with a large all-electron basis set and including dispersion forces contributions. The calculated results are then compared with experimental micro-calorimetric data, showing a good agreement in the loading trend of the (010) surfaces. More generally, this theoretical approach is confirmed to be an efficient tool to analyze these biomaterials, giving the possibility to investigate the HA behavior toward more complex molecules, from amino acids to collagen, at the here-presented level of theory, to shed some light on the complex biomineralization process of human bones and teeth.
C1 [Chiatti, Fabio; Delle Piane, Massimo; Ugliengo, Piero; Corno, Marta] Univ Turin, Dipartimento Chim, Via P Giuria 7, I-10125 Turin, Italy.
   [Chiatti, Fabio; Delle Piane, Massimo; Ugliengo, Piero; Corno, Marta] NIS Nanostruct Interfaces & Surfaces Ctr, Via P Giuria 7, I-10125 Turin, Italy.
RP Corno, M (reprint author), Univ Turin, Dipartimento Chim, Via P Giuria 7, I-10125 Turin, Italy.; Corno, M (reprint author), NIS Nanostruct Interfaces & Surfaces Ctr, Via P Giuria 7, I-10125 Turin, Italy.
EM marta.corno@unito.it
RI Corno, Marta/I-4310-2012; Delle Piane, Massimo/K-5153-2012; ugliengo,
   piero/H-6373-2015
OI Corno, Marta/0000-0001-7248-2705; Delle Piane,
   Massimo/0000-0001-8522-9047; ugliengo, piero/0000-0001-8886-9832
CR Almora-Barrios N, 2012, CRYST GROWTH DES, V12, P756, DOI 10.1021/cg201092s
   Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bertinetti L, 2007, J PHYS CHEM C, V111, P4027, DOI 10.1021/jp066040s
   Bolis V, 2012, PHILOS T R SOC A, V370, P1313, DOI 10.1098/rsta.2011.0273
   BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561
   Bystrov VS, 2013, FERROELECTRICS, V449, P94, DOI 10.1080/00150193.2013.822774
   Canepa P, 2011, PHYS CHEM CHEM PHYS, V13, P1099, DOI 10.1039/c0cp01143f
   CATTI M, 1991, J PHYS-CONDENS MAT, V3, P4151, DOI 10.1088/0953-8984/3/23/004
   Chiatti F, 2013, J PHYS CHEM C, V117, P25526, DOI 10.1021/jp4086574
   Chiatti F, 2012, J PHYS CHEM C, V116, P6108, DOI 10.1021/jp212595d
   Civalleri B, 2008, CRYSTENGCOMM, V10, P405, DOI 10.1039/b715018k
   Cora F, 2004, STRUCT BOND, V113, P171, DOI 10.1007/b97944
   Corno M, 2014, ENCY NANOTECHNOL, P1
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Corno M, 2011, BIOMATERIALS - PHYSICS AND CHEMISTRY, P275
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Currey JD, 2005, SCIENCE, V309, P253, DOI 10.1126/science.1113954
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   Dovesi IL, 2014, CRYSTAL14 USERS MANU
   Dovesi R, 2014, INT J QUANTUM CHEM, V114, P1287, DOI 10.1002/qua.24658
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317
   Hernandez SER, 2015, PHYS CHEM CHEM PHYS, V17, P22377, DOI 10.1039/c5cp02630j
   Hochrein O, 2005, CHEM MATER, V17, P1978, DOI 10.1021/cm0401903
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Kato K, 2015, CHEM PHYS LETT, V629, P58, DOI 10.1016/j.cplett.2015.03.057
   Katti DR, 2015, MAT SCI ENG C-MATER, V46, P207, DOI 10.1016/j.msec.2014.07.057
   KUKURA M, 1972, J PHYS CHEM-US, V76, P900, DOI 10.1021/j100650a019
   Lang SB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02215
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lemaire T, 2015, J BIOMECH, V48, P3066, DOI 10.1016/j.jbiomech.2015.07.025
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Mugnaioli E, 2014, CHEM-EUR J, V20, P6849, DOI 10.1002/chem.201402275
   Ospina CA, 2012, COLLOID SURFACE B, V89, P15, DOI 10.1016/j.colsurfb.2011.08.016
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Peccati F, 2014, J PHYS CHEM C, V118, P1364, DOI 10.1021/jp4108415
   Ratner B. D., 2013, BIOMATERIALS SCI
   Rimola A, 2011, J PHYS CHEM LETT, V2, P1390, DOI 10.1021/jz200457x
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Roosen AR, 1998, COMP MATER SCI, V11, P16, DOI 10.1016/S0927-0256(97)00167-5
   Rulis P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245410
   Sakhno Y, 2015, J PHYS CHEM C, V119, P5928, DOI 10.1021/jp510492m
   Sakhno Y, 2010, J PHYS CHEM C, V114, P16640, DOI 10.1021/jp105971s
   Sato K, 2002, J AM CERAM SOC, V85, P3054
   SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096
   SHANNO DF, 1970, MATH COMPUT, V24, P657, DOI 10.2307/2004841
   Slepko A, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813828
   SUDA H, 1995, J PHYS CHEM-US, V99, P6752, DOI 10.1021/j100017a068
   Suetsugu Y, 2002, J MATER SCI-MATER M, V13, P767, DOI 10.1023/A:1016170924138
   Takahashi H, 2001, THERMOCHIM ACTA, V371, P53, DOI 10.1016/S0040-6031(01)00431-2
   Tao JH, 2015, LANGMUIR, V31, P10451, DOI 10.1021/acs.langmuir.5b02549
   Tao JH, 2015, P NATL ACAD SCI USA, V112, P326, DOI 10.1073/pnas.1404481112
   Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115
   UGLIENGO P, 1993, Z KRISTALLOGR, V207, P9, DOI 10.1524/zkri.1993.207.Part-1.9
   Wang ZQ, 2015, J MATER CHEM B, V3, P9157, DOI 10.1039/c5tb01036e
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wierzbicki A, 2000, J MOL STRUC-THEOCHEM, V529, P73, DOI 10.1016/S0166-1280(00)00534-0
   Wu F, 2015, CRYST GROWTH DES, V15, P2452, DOI 10.1021/acs.cgd.5b00231
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
   Zeglinski J, 2014, SURF SCI, V623, P55, DOI 10.1016/j.susc.2014.01.008
   Zhao WL, 2014, LANGMUIR, V30, P13283, DOI 10.1021/la503158p
NR 65
TC 12
Z9 12
U1 4
U2 58
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1432-881X
EI 1432-2234
J9 THEOR CHEM ACC
JI Theor. Chem. Acc.
PD FEB 16
PY 2016
VL 135
IS 3
AR 54
DI 10.1007/s00214-016-1818-8
PG 15
WC Chemistry, Physical
SC Chemistry
GA DH2TT
UT WOS:000372640100001
DA 2018-10-20
ER

PT J
AU Lawrence, H
   Mawdesley, AE
   Holland, JP
   Kirby, JA
   Deehan, DJ
   Tyson-Capper, AJ
AF Lawrence, Helen
   Mawdesley, Amy Elizabeth
   Holland, James Patrick
   Kirby, John Andrew
   Deehan, David John
   Tyson-Capper, Alison Jane
TI Targeting Toll-like receptor 4 prevents cobalt-mediated inflammation
SO ONCOTARGET
LA English
DT Article
DE cobalt; metal-on-metal; antibody; TLR4; inflammation; Immunology and
   Microbiology Section; Immune response; Immunity
ID HIP-ARTHROPLASTY; REPLACEMENT
AB Cobalt-chrome alloy is a widely used biomaterial in joint replacements, dental implants and spinal rods. Although it is an effective and biocompatible material, adverse reactions to metal debris (ARMD) have arisen in a minority of patients, particularly in those with metal-on-metal bearing hip replacements. There is currently no treatment for ARMD and once progressive, early revision surgery of the implant is necessary. Therapeutic agents to prevent, halt or reverse ARMD would therefore be advantageous.
   Cobalt ions activate Toll-like receptor 4 (TLR4), an innate immune receptor responsible for inflammatory responses to bacterial lipopolysaccharide (LPS) resulting in the production of pro-inflammatory cytokines and chemokines. We hypothesised that anti-TLR4 neutralising antibodies, reported to inhibit TLR4-mediated inflammation, could prevent the inflammatory response to cobalt ions in an in vitro macrophage cell culture model.
   This study shows that a monoclonal anti-TLR4 antibody inhibited cobalt-mediated increases in pro-inflammatory IL8, CCL20 and IL1A expression, as well as IL-8 secretion. In contrast, a polyclonal antibody did not prevent the effect of cobalt ions on either IL-8 or IL1A expression, although it did have a small effect on the CCL20 response. Interestingly, both antibodies inhibited cobalt-mediated neutrophil migration although the greater effect was observed with the monoclonal antibody.
   In summary our data shows that a monoclonal anti-TLR4 antibody can inhibit cobalt-mediated inflammatory responses while a polyclonal antibody only inhibits the effect of specific cytokines. Anti-TLR4 antibodies have therapeutic potential in ARMD although careful antibody design is required to ensure that the LPS response is preserved.
C1 [Lawrence, Helen; Mawdesley, Amy Elizabeth; Kirby, John Andrew; Deehan, David John; Tyson-Capper, Alison Jane] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Holland, James Patrick; Deehan, David John] Freeman Rd Hosp, Musculoskeletal Serv, Newcastle Upon Tyne, Tyne & Wear, England.
RP Tyson-Capper, AJ (reprint author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM alison.tyson-capper@ncl.ac.uk
FU Newcastle NIHR Biomedical Research Centre; DePuy Synthes Ltd.
FX HL is supported by a studentship from the Newcastle NIHR Biomedical
   Research Centre and DePuy Synthes Ltd.
CR AAOS, 2012, CURR MET ON MET HIP
   Daniel J, 2012, J BONE JOINT SURG AM, V94A, P86, DOI 10.2106/JBJS.J.01612
   de Steiger RN, 2010, ACTA ORTHOP, V81, P72, DOI 10.3109/17453671003667176
   DRANSFIELD I, 1994, J IMMUNOL, V153, P1254
   Ekaney ML, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0543-8
   Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562
   Jiang X, 2015, J ORTHOPAEDIC RES
   Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770
   Lawrence H, 2014, BONE JOINT J B, V69B, P1172
   Lima CX, 2015, PLOS ONE, V10
   Monnet E, 2015, ANN RHEUMATIC DIS
   Pajarinen J, 2015, J BIOMED MATER RES A, V103, P1339, DOI 10.1002/jbm.a.35278
   Perino G, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-39
   Potnis PA, 2013, CELL IMMUNOL, V282, P53, DOI 10.1016/j.cellimm.2013.04.003
   Powers-Freeling L, 2015, NATL JOINT REGISTRY
   Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155
   Tyson-Capper AJ, 2013, ANN RHEUM DIS, V72, P460, DOI 10.1136/annrheumdis-2012-202468
   Watters TS, 2010, AM J CLIN PATHOL, V134, P886, DOI 10.1309/AJCPLTNEUAH8XI4W
NR 18
TC 4
Z9 4
U1 1
U2 8
PU IMPACT JOURNALS LLC
PI ALBANY
PA 6211 TIPTON HOUSE, STE 6, ALBANY, NY 12203 USA
SN 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 16
PY 2016
VL 7
IS 7
BP 7578
EP 7585
DI 10.18632/oncotarget.7105
PG 8
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DE0PD
UT WOS:000370325900018
PM 26840091
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Masoom, H
   Courtier-Murias, D
   Farooq, H
   Soong, R
   Kelleher, BP
   Zhang, C
   Maas, WE
   Fey, M
   Kumar, R
   Monette, M
   Stronks, HJ
   Simpson, MJ
   Simpson, AJ
AF Masoom, Hussain
   Courtier-Murias, Denis
   Farooq, Hashim
   Soong, Ronald
   Kelleher, Brian P.
   Zhang, Chao
   Maas, Werner E.
   Fey, Michael
   Kumar, Rajeev
   Monette, Martine
   Stronks, Henry J.
   Simpson, Myrna J.
   Simpson, Andre J.
TI Soil Organic Matter in Its Native State: Unravelling the Most Complex
   Biomaterial on Earth
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID POLYCYCLIC AROMATIC-HYDROCARBONS; HUMIC SUBSTANCES; NMR-SPECTROSCOPY;
   MINERAL SURFACES; CARBON SEQUESTRATION; MOLECULAR-STRUCTURE; SORPTION;
   MODEL; STABILIZATION; LIGNIN
AB Since the isolation of soil organic matter in 1786, tens of thousands of publications have searched for its structure. Nuclear magnetic resonance (NMR) spectroscopy has played a critical role in defining soil organic matter but traditional approaches remove key information such as the distribution of components at the soil water interface and conformational information. Here a novel form of NMR with capabilities to study all physical phases termed Comprehensive Multiphase NMR, is applied to analyze soil in its natural swollen-state. The key structural components in soil organic matter are identified to be largely composed of macro molecular inputs from degrading biomass. Polar lipid heads and carbohydrates dominate the soil water interface while lignin and microbes are arranged in a more hydrophobic interior. Lignin domains cannot be penetrated by aqueous solvents even at extreme pH indicating they are the most hydrophobic environment in soil and are ideal for sequestering hydrophobic contaminants. Here, for the first time, a complete range of physical states of a whole soil can be studied. This provides a more detailed understanding of soil organic matter at the molecular level itself key to develop the most efficient soil remediation and agricultural techniques, and better predict carbon sequestration and climate change.
C1 [Masoom, Hussain; Courtier-Murias, Denis; Farooq, Hashim; Soong, Ronald; Zhang, Chao; Simpson, Myrna J.; Simpson, Andre J.] Univ Toronto, Dept Chem, Toronto, ON M1C 1A4, Canada.
   [Kelleher, Brian P.] Dublin City Univ, Sch Chem Sci, Dublin 9, Ireland.
   [Maas, Werner E.; Fey, Michael] Bruker BioSpin Corp, Billerica, MA 01821 USA.
   [Kumar, Rajeev; Monette, Martine; Stronks, Henry J.] Bruker BioSpin Canada, Milton, ON L9T 1Y6, Canada.
RP Simpson, AJ (reprint author), Univ Toronto, Dept Chem, Toronto, ON M1C 1A4, Canada.
EM andre.simpson@utoronto.ca
OI Simpson, Myrna/0000-0002-8084-411X; Courtier-Murias,
   Denis/0000-0001-8023-738X
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Ontario Graduate Scholarship; NSERC; Canada Foundation for Innovation
   (CFI); Ministry of Research and Innovation (MRI); Krembil Foundation;
   Government of Ontario; Irish EPA
FX H.M. thanks the Natural Sciences and Engineering Research Council of
   Canada (NSERC) for a postgraduate doctoral award and the Ontario
   Graduate Scholarship for funding. A.J.S. thanks NSERC, (Strategic and
   Discovery Programs), the Canada Foundation for Innovation (CFI), and the
   Ministry of Research and Innovation (MRI) and Krembil Foundation for
   providing funding. A.J.S. also thanks the Government of Ontario for an
   Early Researcher Award. B.K thanks the Irish EPA for funding through the
   STRIVE programme.
CR Alexander M, 2000, ENVIRON SCI TECHNOL, V34, P4259, DOI 10.1021/es001069+
   Almendros G, 1998, SOIL BIOL BIOCHEM, V30, P755, DOI 10.1016/S0038-0717(97)00175-2
   Almendros G, 1996, ORG GEOCHEM, V24, P651, DOI 10.1016/0146-6380(96)00056-3
   BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628
   Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8
   Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004
   Brady NC, 2007, NATURE PROPERTIES SO
   Brown RB, 2008, J R SOC INTERFACE, V5, pS131, DOI 10.1098/rsif.2008.0009.focus
   Chefetz B, 2003, ENVIRON TOXICOL CHEM, V22, P2492, DOI 10.1897/02-461
   Clemente JS, 2013, ORG GEOCHEM, V58, P1, DOI 10.1016/j.orggeochem.2013.02.007
   Clemente JS, 2011, ORG GEOCHEM, V42, P1169, DOI 10.1016/j.orggeochem.2011.08.010
   Conte P, 1997, GEODERMA, V80, P339, DOI 10.1016/S0016-7061(97)00059-1
   Conte P, 2008, ANAL SCI, V24, P1183, DOI 10.2116/analsci.24.1183
   Courtier-Murias D, 2013, AGR ECOSYST ENVIRON, V171, P9, DOI 10.1016/j.agee.2013.03.010
   Courtier-Murias D, 2012, J MAGN RESON, V217, P61, DOI 10.1016/j.jmr.2012.02.009
   DAVID NA, 1972, ANNU REV PHARMACOLOG, V12, P353, DOI 10.1146/annurev.pa.12.040172.002033
   Derenne S, 2014, CR GEOSCI, V346, P53, DOI 10.1016/j.crte.2014.02.005
   Emery EF, 2001, ENVIRON SCI TECHNOL, V35, P2973, DOI 10.1021/es9911566
   Feng XJ, 2005, ORG GEOCHEM, V36, P1553, DOI 10.1016/j.orggeochem.2005.06.008
   Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3
   Heim A, 2007, EUR J SOIL SCI, V58, P599, DOI 10.1111/j.1365-2389.2006.00848.x
   Heim A, 2007, ORG GEOCHEM, V38, P2001, DOI 10.1016/j.orggeochem.2007.08.009
   Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4
   JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0
   Johnson MD, 2001, ENVIRON SCI TECHNOL, V35, P1680, DOI 10.1021/es001390s
   Kaiser J, 2004, SCIENCE, V304, P1616, DOI 10.1126/science.304.5677.1616
   Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009
   Kelleher BP, 2006, ENVIRON SCI TECHNOL, V40, P4605, DOI 10.1021/es0608085
   Kim J, 2004, SCIENCE, V303, P830, DOI 10.1126/science.1093245
   KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S
   Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5
   KOGELKNABNER I, 1994, ORG GEOCHEM, V21, P1219, DOI 10.1016/0146-6380(94)90165-1
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Lal R, 2007, SOIL SCI, V172, P943, DOI 10.1097/ss.0b013e31815cc498
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   Maas WE, 1999, J MAGN RESON, V141, P29, DOI 10.1006/jmre.1999.1892
   Masoom H, 2013, ENVIRON TOXICOL CHEM, V32, P129, DOI 10.1002/etc.2028
   Okx JP, 1996, ENVIRON SCI POLLUT R, V3, P229, DOI 10.1007/BF02986966
   Perminova IV, 1999, ENVIRON SCI TECHNOL, V33, P3781, DOI 10.1021/es990056x
   Plaza C, 2013, SOIL BIOL BIOCHEM, V57, P124, DOI 10.1016/j.soilbio.2012.07.026
   Poirier N, 2000, ORG GEOCHEM, V31, P813, DOI 10.1016/S0146-6380(00)00067-X
   SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407
   SCHULTEN HR, 1993, NATURWISSENSCHAFTEN, V80, P29, DOI 10.1007/BF01139754
   Semple KT, 2003, EUR J SOIL SCI, V54, P809, DOI [10.1046/j.1351-0754.2003.0564.x, 10.1046/j.1365-2389.2003.00564.x]
   Shirzadi A, 2008, ENVIRON SCI TECHNOL, V42, P5514, DOI 10.1021/es800115b
   Simpson AJ, 2001, ENVIRON SCI TECHNOL, V35, P3321, DOI 10.1021/es010607v
   Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P8070, DOI 10.1021/es071217x
   Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P876, DOI 10.1021/es061576c
   Simpson AJ, 2011, PROG NUCL MAG RES SP, V58, P97, DOI 10.1016/j.pnmrs.2010.09.001
   Song XY, 2013, SCI TOTAL ENVIRON, V458, P319, DOI 10.1016/j.scitotenv.2013.04.052
   Stevenson F. J., 1994, HUMUS CHEM GENESIS C
   Sun K, 2008, ENVIRON SCI TECHNOL, V42, P1961, DOI 10.1021/es7024627
   Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q
   Xing BS, 1996, ENVIRON SCI TECHNOL, V30, P2432, DOI 10.1021/es950350z
   Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394
NR 55
TC 9
Z9 9
U1 6
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD FEB 16
PY 2016
VL 50
IS 4
BP 1670
EP 1680
DI 10.1021/acs.est.5b03410
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DE2JS
UT WOS:000370454200006
PM 26783947
DA 2018-10-20
ER

PT J
AU Mahmoud, AA
   Salama, AH
AF Mahmoud, Azza A.
   Salama, Alaa H.
TI Norfloxacin-loaded collagen/chitosan scaffolds for skin reconstruction:
   Preparation, evaluation and in-vivo wound healing assessment
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Chitosan; Collagen; Scaffold; Wound healing; Terahertz imaging
ID CHITOSAN SPONGE SCAFFOLD; EXTRACELLULAR-MATRIX; ANTIBACTERIAL ACTIVITY;
   MECHANICAL-PROPERTIES; THERAPEUTIC-EFFICACY; MEDICAL APPLICATIONS;
   ARTIFICIAL SKIN; COLLAGEN SPONGE; DIABETIC-RATS; FIBROBLASTS
AB Biomaterial scaffolds are versatile tools as drug carrier for treatment of wounds. A series of norfloxacin-loaded scaffolds were synthesized for treatment of wounds by combining collagen with two different types of chitosan using freeze-drying technique. Subsequently, scaffolds were screened in terms of morphology, water absorption and retention capacity, biodegradation, ex-vivo bioadhesive strength, in-vitro drug release biological compatibility, X-ray diffractometry, differential scanning calorimetry as well as in-vivo evaluation. The results indicate that the scaffold mechanical strength is dependent on the type of used chitosan. The prepared scaffolds contained interconnected porous architecture. The scaffolds had highwater uptake and retention capacity with extended biodegradation rate. Scaffolds prepared with chitosan HCl showed superior bioadhesive strength compared to those prepared with low molecular weight chitosan. All scaffolds showed almost 100% drug release within 24 h. As identified by the terahertz pulsed imaging measurements, there is single scaffold area with the same concentration. After 28 days of wound dressing with selected norfoloxacin-loaded or unloaded collagen/chitosan scaffolds in Albino rats, it was found that the tissue regeneration time was fast compared to non-treated wounds. Furthermore, the drug-loaded scaffolds showed normal structure of an intact epidermal layer as well as the underlying dermis as revealed by histopathological studies. The obtained results suggest that the investigated norfloxacin-loaded collagen/chitosan scaffold is a potential candidate for skin regeneration application. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mahmoud, Azza A.; Salama, Alaa H.] Natl Res Ctr, Dept Pharmaceut Technol, Cairo, Egypt.
   [Mahmoud, Azza A.] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut & Pharmaceut Technol, Cairo, Egypt.
RP Salama, AH (reprint author), Natl Res Ctr, Dept Pharmaceut Technol, Cairo, Egypt.
RI Mahmoud, Azza/S-1502-2016
OI Salama, Alaa/0000-0003-0028-2645; Mahmoud, Azza/0000-0002-4716-7524
CR Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   [Anonymous], 2000, F163595 ASTM INT
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   COOPER DR, 1966, BIOCHEM J, V98, P655, DOI 10.1042/bj0980655
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   De Lima MSP, 2009, CARBOHYD RES, V344, P1709, DOI 10.1016/j.carres.2009.05.024
   Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406
   Dua K., 2010, EPLASTY, V10
   Dutta PK, 2011, ADV POLYM SCI, V244, P45, DOI 10.1007/12_2011_112
   Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Han F, 2014, INT J PHARMACEUT, V476, P124, DOI 10.1016/j.ijpharm.2014.09.036
   He X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104323
   Huang MH, 2008, INT J PHARM, V346, P38, DOI 10.1016/j.ijpharm.2007.06.021
   Jayakumar GC, 2014, RSC ADV, V4, P42846, DOI 10.1039/c4ra07683d
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kane J.B., 1996, BIOMATERIALS SCI INT
   Kane J.B., 1996, BURN DRESSINGS
   KHAN KA, 1972, PHARM ACTA HELV, V47, P594
   Kim JY, 2014, OPT EXPRESS, V22, P1735, DOI 10.1364/OE.22.001735
   Kim MN, 2005, J APPL POLYM SCI, V96, P936, DOI 10.1002/app.21543
   Kirk J.F, 2013, BIOMATTER, V3
   KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0
   Koide T, 1997, Dent Mater J, V16, P1
   Kozen BG, 2008, ACAD EMERG MED, V15, P74, DOI 10.1111/j.1553-2712.2007.00009.x
   Lan Y, 2014, ACTA BIOMATER, V10, P3167, DOI 10.1016/j.actbio.2014.03.029
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Lee WF, 2001, J APPL POLYM SCI, V82, P2487, DOI 10.1002/app.2099
   Li CQ, 2010, J MATER SCI-MATER M, V21, P741, DOI 10.1007/s10856-009-3871-5
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   Lockhart LK, 2001, THROMB HAEMOSTASIS, V85, P882
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x
   Malipeddi V.R., 2006, J BURNS WOUNDS, V5
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   O'Meara S., 1999, HEALTH TECHNOL ASSES, V4, P1
   Portieri A, 2011, PHARM MANUFACTURING
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   Saito A, 2012, ACTA BIOMATER, V8, P2932, DOI 10.1016/j.actbio.2012.04.019
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shen YC, 2008, IEEE J SEL TOP QUANT, V14, P407, DOI [10.1109/JSTQE.2007.911309, 10.1109/.2007.JSTQE.911309]
   Synytsya A, 2009, BIOMACROMOLECULES, V10, P1067, DOI 10.1021/bm8011715
   Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   Thomas AM, 2013, J CONTROL RELEASE, V170, P421, DOI 10.1016/j.jconrel.2013.06.013
   Ti DD, 2015, TISSUE ENG PT A, V21, P541, DOI [10.1089/ten.tea.2013.0750, 10.1089/ten.TEA.2013.0750]
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Van Bambeke F, 2005, CLIN MICROBIOL INFEC, V11, P256, DOI 10.1111/j.1469-0691.2005.01131.x
   Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074508
   Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 60
TC 27
Z9 28
U1 3
U2 78
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD FEB 15
PY 2016
VL 83
BP 155
EP 165
DI 10.1016/j.ejps.2015.12.026
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DD8OU
UT WOS:000370187300018
PM 26733072
DA 2018-10-20
ER

PT J
AU Vilas, V
   Philip, D
   Mathew, J
AF Vilas, Vidya
   Philip, Daizy
   Mathew, Joseph
TI Facile one-pot synthesis of crystalline palladium nanoparticles with
   exceptional catalytic and antiradical activities
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Nanostructures; Electron microscopy; Fourier transform
   infrared spectroscopy
ID RAPID GREEN SYNTHESIS; SILVER NANOPARTICLES; METHYL RED; REDUCTION;
   EXTRACT; PD; IRRADIATION; ORANGE; LEAVES; DYES
AB It is for the first time that the essential oils of medicinal plants are used for the synthesis of palladium nanoparticles, one of the rarest and precious transition metals known to mankind. In the present study, leaf essential oil of Coleus aromaticus and Myristica fragrans is used as the bioreductant. The appearance of an absorption continuum in the UV-vis spectrum indicates the formation of palladium nanoparticles. The effect of varying quantities of biomaterial on the synthesis of nanopalladium is studied. TEM micrographs disclose the formation of clusters of well dispersed nanospheroids of size similar to 2.8 nm. Sharp peaks in the XRD are indexed to Bragg reflections from planes corresponding to face centred cubic crystalline structure. FTIR spectral analyses reveal the participation of terpenoids and phenolic ether derivatives in reduction and capping. The synthesized nanoparticles exhibit significantly high catalytic efficiency in degrading a broad spectrum of organic pollutants including methyl red, methyl orange, eriochrome black T, methylene blue, rhodamine B, ortho-, meta- and para-nitrophenols. The reduction reactions are observed to obey pseudo first order kinetics. Antioxidant potential of the as synthesized palladium nanoparticles is portrayed through DPPH assay, nitric oxide and hydroxyl radical scavenging activities and reducing power activity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Vilas, Vidya; Philip, Daizy] Mar Ivanios Coll, Dept Phys, Thiruvananthapuram 695015, Kerala, India.
   [Vilas, Vidya; Mathew, Joseph] Mar Ivanios Coll, Dept Chem, Thiruvananthapuram 695015, Kerala, India.
RP Philip, D (reprint author), Mar Ivanios Coll, Dept Phys, Thiruvananthapuram 695015, Kerala, India.
EM daizyp@rediffmail.com
FU Kerala State Council for Science, Technology and Environment,
   Thiruvananthapuram
FX Vidya Vilas thanks Kerala State Council for Science, Technology and
   Environment, Thiruvananthapuram for a research fellowship. The authors
   further acknowledge NIIST, Thiruvananthapuram for the TEM imaging.
CR ARBELOA IL, 1981, CHEM PHYS LETT, V79, P347, DOI 10.1016/0009-2614(81)80219-9
   Astruc D, 2007, INORG CHEM, V46, P1884, DOI 10.1021/ic062183h
   Azad UP, 2011, J NANOPART RES, V13, P3951, DOI 10.1007/s11051-011-0317-z
   Baruwati B, 2009, CHEMSUSCHEM, V2, P1041, DOI 10.1002/cssc.200900220
   Coates J., 2000, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A5606
   Del Nero J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1860372
   HAMED MMA, 1994, DYES PIGMENTS, V26, P297, DOI 10.1016/0143-7208(94)80043-X
   Hussein M. A., 2011, International Journal of Phytomedicine, V3, P459
   Hwang CG, 2008, J IND ENG CHEM, V14, P864, DOI 10.1016/j.jiec.2008.05.010
   Joseph S, 2015, MATER SCI ENG B-ADV, V195, P90, DOI 10.1016/j.mseb.2015.02.007
   Khalwar N. H., 2014, INT J MET, V2014, P1
   Krikunova N., 2011, CHEM CHEM TECH, V5, P161
   Kumar KM, 2013, SPECTROCHIM ACTA A, V102, P128, DOI 10.1016/j.saa.2012.10.015
   Masoud MS, 2001, SPECTROCHIM ACTA A, V57, P977, DOI 10.1016/S1386-1425(00)00416-9
   Miyajima M, 2000, BIOCHEM BIOPH RES CO, V275, P752, DOI 10.1006/bbrc.2000.3367
   Molaie R., 2012, P 4 INT C NAN, P12
   Muniyappan N, 2014, PROCESS BIOCHEM, V49, P1054, DOI 10.1016/j.procbio.2014.03.015
   Rastogi L, 2011, MATER CHEM PHYS, V129, P558, DOI 10.1016/j.matchemphys.2011.04.068
   Raut RW, 2013, ADV MAT LETT, V4, P650, DOI DOI 10.5185/amlett.2012.11470
   Saha M., 2012, ADV NANOPART, V1, P61
   Sathishkumar M, 2009, J HAZARD MATER, V171, P400, DOI 10.1016/j.jhazmat.2009.06.014
   Sathishkumar M., 2009, INT J MAT SCI, V4, P11
   Shen XS, 2009, CHINESE J CHEM PHYS, V22, P440, DOI 10.1088/1674-0068/22/04/440-446
   Sheny DS, 2012, SPECTROCHIM ACTA A, V91, P35, DOI 10.1016/j.saa.2012.01.063
   Sinha T, 2015, J MOL LIQ, V201, P113, DOI 10.1016/j.molliq.2014.09.031
   Subramanian R., 2013, SPRING PLUS, V2, P1
   TAWARAH KM, 1991, DYES PIGMENTS, V17, P203, DOI 10.1016/0143-7208(91)80027-7
   Venkatesham M., 2014, APP NANOSCI, V5, P315
   Vilas V, 2014, J MOL LIQ, V200, P390, DOI 10.1016/j.molliq.2014.11.002
   Xiong YJ, 2005, NANO LETT, V5, P1237, DOI 10.1021/nl0508826
   Yilmaz M, 2011, MATER CHEM PHYS, V130, P1195, DOI 10.1016/j.matchemphys.2011.08.068
   Zhao MQ, 1999, ANGEW CHEM INT EDIT, V38, P364, DOI 10.1002/(SICI)1521-3773(19990201)38:3<364::AID-ANIE364>3.0.CO;2-L
NR 32
TC 4
Z9 4
U1 2
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD FEB 15
PY 2016
VL 170
BP 1
EP 11
DI 10.1016/j.matchemphys.2015.12.011
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DC8ML
UT WOS:000369473600001
DA 2018-10-20
ER

PT J
AU Nishikawa, H
   Hasegawa, T
   Miyake, A
   Tashiro, Y
   Hashimoto, Y
   Blank, DHA
   Rijnders, G
AF Nishikawa, Hiroaki
   Hasegawa, Tsukasa
   Miyake, Akiko
   Tashiro, Yuichiro
   Hashimoto, Yoshiya
   Blank, Daveh H. A.
   Rijnders, Guus
TI Relationship between the Ca/P ratio of hydroxyapatite thin films and the
   spatial energy distribution of the ablation laser in pulsed laser
   deposition
SO MATERIALS LETTERS
LA English
DT Article
DE Pulsed laser deposition; Hydroxyapatite; Laser spot size; Ca/P ratio;
   Biomaterial
ID CALCIUM-PHOSPHATE COATINGS; BEAM SPUTTER-DEPOSITION; HYDROXYL-APATITE;
   TITANIUM; IMPLANTS; SURFACE
AB Variation of the Ca/P ratio in hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) thin films was studied in relation to the spot size of the ablation laser for two different spatial energy distributions in pulsed laser deposition. One energy distribution is the defocus method with a raw distribution and the other is the projection method without the weak portion at the edges of the ablation laser spot. A Ca/P ratio closer to that of stoichiometry was obtained with the larger spot sizes for both methods, and with the projection method compared to the defocus method. It is considered that a more uniform spatial energy distribution of the ablation laser improves the Ca/P ratio. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Nishikawa, Hiroaki] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan.
   [Hasegawa, Tsukasa] Kinki Univ, Grad Sch Biol Oriented Sci & Technol, Wakayama 6496493, Japan.
   [Miyake, Akiko; Tashiro, Yuichiro] Osaka Dent Univ, Dept Removable Prosthodont & Occlus, Hirakata, Osaka 5731121, Japan.
   [Hashimoto, Yoshiya] Osaka Dent Univ, Dept Biomat, Hirakata, Osaka 5731121, Japan.
   [Blank, Daveh H. A.; Rijnders, Guus] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.
RP Nishikawa, H (reprint author), Kinki Univ, Fac Biol Oriented Sci & Technol, 930 Nishi Mitani, Wakayama 6496493, Japan.
EM nishik32@waka.kindai.ac.jp
OI Nishikawa, Hiroaki/0000-0001-7753-3866
FU Strategic Research Foundation Grant-aided Project for Private
   Universities from the Ministry of Education, Culture, Sports, Science,
   and Technology, Japan [S1311045]; Project Research of the Faculty of
   Biology-Oriented Science and Technology, Kinki University [14-I-3]
FX This work was supported in part by a grant from the Strategic Research
   Foundation Grant-aided Project for Private Universities from the
   Ministry of Education, Culture, Sports, Science, and Technology, Japan,
   2013-2017 (No. S1311045) and a grant from the Project Research of the
   Faculty of Biology-Oriented Science and Technology, Kinki University,
   2015-2016 (No. 14-I-3).
CR Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   Hontsu S, 1996, JPN J APPL PHYS 2, V35, pL1208
   Kekkonen V, 2011, J EUR OPT SOC-RAPID, V6, DOI 10.2971/jeos.2011.11013s
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   Nishikawa H., 2015, T MAT RES SOC JPN, V40, P111
   Nishikawa H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.088001
   Ohnishi T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146069
   Okazaki M, 1979, J Osaka Univ Dent Sch, V19, P87
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   Sakoishi Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.115501
   Song JH, 2008, ADV MATER, V20, P2528, DOI 10.1002/adma.200701919
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Tyunina M, 2000, J APPL PHYS, V87, P8132, DOI 10.1063/1.373508
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Yoshinari M, 1997, J BIOMED MATER RES, V37, P60, DOI 10.1002/(SICI)1097-4636(199710)37:1<60::AID-JBM8>3.0.CO;2-H
   Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2
NR 20
TC 12
Z9 12
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 15
PY 2016
VL 165
BP 95
EP 98
DI 10.1016/j.matlet.2015.11.115
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CZ6UM
UT WOS:000367236500024
DA 2018-10-20
ER

PT J
AU Christo, SN
   Diener, KR
   Manavis, J
   Grimbaldeston, MA
   Bachhuka, A
   Vasilev, K
   Hayball, JD
AF Christo, Susan N.
   Diener, Kerrilyn R.
   Manavis, Jim
   Grimbaldeston, Michele A.
   Bachhuka, Akash
   Vasilev, Krasimir
   Hayball, John D.
TI Inflammasome components ASC and AIM2 modulate the acute phase of
   biomaterial implant-induced foreign body responses
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; MESENCHYMAL PROGENITOR CELLS;
   VIVO HOST RESPONSE; MAST-CELLS; NLRP3 INFLAMMASOME; IN-VIVO; PRODUCE
   INTERLEUKIN-13; MURINE MACROPHAGES; NALP3 INFLAMMASOME; HUMAN
   CHONDROCYTES
AB Detailing the inflammatory mechanisms of biomaterial-implant induced foreign body responses (FBR) has implications for revealing targetable pathways that may reduce leukocyte activation and fibrotic encapsulation of the implant. We have adapted a model of poly(methylmethacrylate) (PMMA) bead injection to perform an assessment of the mechanistic role of the ASC-dependent inflammasome in this process. We first demonstrate that ASC(-/-) mice subjected to PMMA bead injections had reduced cell infiltration and altered collagen deposition, suggesting a role for the inflammasome in the FBR. We next investigated the NLRP3 and AIM2 sensors because of their known contributions in recognising damaged and apoptotic cells. We found that NLRP3 was dispensable for the fibrotic encapsulation; however AIM2 expression influenced leukocyte infiltration and controlled collagen deposition, suggesting a previously unexplored link between AIM2 and biomaterial-induced FBR.
C1 [Christo, Susan N.; Diener, Kerrilyn R.; Hayball, John D.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [Christo, Susan N.; Diener, Kerrilyn R.; Hayball, John D.] Univ S Australia, Sch Pharm & Med Sci, Hanson Inst, Adelaide, SA 5000, Australia.
   [Diener, Kerrilyn R.; Hayball, John D.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA 5005, Australia.
   [Manavis, Jim] SA Pathol, Ctr Neurol Dis, Adelaide, SA 5000, Australia.
   [Grimbaldeston, Michele A.] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.
   [Grimbaldeston, Michele A.] SA Pathol, Adelaide, SA 5000, Australia.
   [Bachhuka, Akash; Vasilev, Krasimir] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
   [Hayball, John D.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia.
RP Hayball, JD (reprint author), Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.; Hayball, JD (reprint author), Univ S Australia, Sch Pharm & Med Sci, Hanson Inst, Adelaide, SA 5000, Australia.
EM john.hayball@unisa.edu.au
RI Hayball, John/F-4137-2013
OI Hayball, John/0000-0002-3089-4506
CR Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Blaney Davidson EN, 2006, ANN RHEUM DIS, V65, P1414, DOI DOI 10.1136/ARD.2005.045971
   Blaney DE, 2005, ARTHRITIS RES THER, V7, pR1338, DOI DOI 10.1186/AR1833
   Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987
   Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960
   Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39
   BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373
   Castro PR, 2012, MICROVASC RES, V84, P9, DOI 10.1016/j.mvr.2012.04.003
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Garcia-Romo GS, 2011, SCI TRANSL MED, V3, P20, DOI DOI 10.1126/SCITRANSLMED.3001201
   Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30
   GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823
   Hamilton RF, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0043-7
   Hari A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07281
   Hwang SG, 2007, IUBMB LIFE, V59, P90, DOI 10.1080/15216540701245022
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kanbe N, 1999, INT ARCH ALLERGY IMM, V119, P138, DOI 10.1159/000024189
   Kawakita K, 2012, OSTEOARTHR CARTILAGE, V20, P1603, DOI 10.1016/j.joca.2012.08.022
   Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lande R., 2011, SCI TRANSL MED, V3, P19
   Lee HH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02683
   Li TF, 2005, FRONT BIOSCI, V10, P681, DOI 10.2741/1563
   Lu A., 2014, FEBS J, V282, P435
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016
   Nelson CE, 2014, ADV MATER, V26, P607, DOI 10.1002/adma.201303520
   Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puolakkainen P, 2003, AM J PATHOL, V162, P627, DOI 10.1016/S0002-9440(10)63856-4
   Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045
   Rezzani R, 2004, ARCH HISTOL CYTOL, V67, P211, DOI 10.1679/aohc.67.211
   Rujitanaroj PO, 2013, ACTA BIOMATER, V9, P4513, DOI 10.1016/j.actbio.2012.09.029
   Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   van der Kraan PM, 1998, OSTEOARTHR CARTILAGE, V6, P417, DOI 10.1053/joca.1998.0145
   Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908
   Winter M, 2011, NANOTOXICOLOGY, V5, P326, DOI 10.3109/17435390.2010.506957
   Yang EJ, 2012, BIOMATERIALS, V33, P6858, DOI 10.1016/j.biomaterials.2012.06.016
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 56
TC 4
Z9 5
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 10
PY 2016
VL 6
AR 20635
DI 10.1038/srep20635
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD2HC
UT WOS:000369742300001
PM 26860464
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Powell, LC
   Khan, S
   Chinga-Carrasco, G
   Wright, CJ
   Hill, KE
   Thomas, DW
AF Powell, Lydia C.
   Khan, Saira
   Chinga-Carrasco, Gary
   Wright, Chris J.
   Hill, Katja E.
   Thomas, David W.
TI An investigation of Pseudomonas aeruginosa biofilm growth on novel
   nanocellulose fibre dressings
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Nanocellulose; Biofilm; Pseudomonas aeniginosa; Atomic force microscopy;
   Characterisation
ID MICROFIBRILLATED CELLULOSE; WOUND DRESSINGS; RAW-MATERIALS; TRANSPARENT;
   NANOFIBRILS; MICROSCOPY; OXIDATION; HYDROGELS; ULCERS; FILMS
AB Nanocellulose from wood is a novel biomaterial, which is highly fibrillated at the nanoscale. This affords the material a number of advantages, including self-assembly, biodegradability and the ability to absorb and retain moisture, which highlights its potential usefulness in clinical wound-dressing applications. In these in vitro studies, the wound pathogen Pseudomonas aeruginosa PAO1 was used to assess the ability of two nanocellulose materials to impair bacterial growth (<48 h). The two nanocelluloses had a relatively small fraction of residual fibres (<4%) and thus a large fraction of nanofibrils (widths <20 nm). Scanning electron microscopy and confocal laser scanning microscopy imaging demonstrated impaired biofilm growth on the nanocellulose films and increased cell death when compared to a commercial control wound dressing, Aquacel (R). Nanocellulose suspensions inhibited bacterial growth, whilst UV-vis spectrophotometry and laser profilometry also revealed the ability of nanocellulose to form smooth, translucent films. Atomic force microscopy studies of the surface properties of nanocellulose demonstrated that PAO1 exhibited markedly contrasting morphology when grown on the nanocellulose film surfaces compared to an Aquacel (R) control dressing (p <0.05). This study highlights the potential utility of these biodegradable materials, from a renewable source, for wound dressing applications in the prevention and treatment of biofilm development. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Powell, Lydia C.; Khan, Saira; Hill, Katja E.; Thomas, David W.] Cardiff Univ, Sch Dent, Coll Biomed & Life Sci, Adv Therapies Grp, Cardiff CF14 4XY, S Glam, Wales.
   [Powell, Lydia C.; Wright, Chris J.] Univ Swansea, Coll Engn, Ctr NanoHlth, Syst & Proc Engn Ctr, Swansea SA2 8PP, W Glam, Wales.
   [Chinga-Carrasco, Gary] Paper & Fibre Res Inst PFI, NO-7491 Trondheim, Norway.
RP Chinga-Carrasco, G (reprint author), Paper & Fibre Res Inst PFI, NO-7491 Trondheim, Norway.
EM gary.chinga.carrasco@pfi.no
RI Chinga-Carrasco, Gary/J-1661-2014
OI Chinga-Carrasco, Gary/0000-0002-6183-2017; Wright,
   Chris/0000-0003-2375-8159
FU Research Council of Norway [219733]
FX This work has been funded by the Research Council of Norway through the
   NANO2021 program, Grant no. 219733 - NanoHeal: Bio-compatible cellulose
   nanostructures for advanced wound healing applications.
CR Alexandrescu L, 2013, CELLULOSE, V20, P1765, DOI 10.1007/s10570-013-9948-9
   Alila S, 2013, IND CROP PROD, V41, P250, DOI 10.1016/j.indcrop.2012.04.028
   Andresen M, 2007, BIOMACROMOLECULES, V8, P2149, DOI 10.1021/bm070304e
   Anghel I, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-12
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Chinga-Carrasco G, 2014, J BIOMATER APPL, V29, P423, DOI 10.1177/0885328214531511
   Chinga-Carrasco G, 2014, MICRON, V56, P80, DOI 10.1016/j.micron.2013.09.002
   Chinga-Carrasco G, 2013, MICRON, V48, P42, DOI 10.1016/j.micron.2013.02.005
   Chinga-Carrasco G, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-192
   Chinga-Carrasco G, 2011, MICROSC MICROANAL, V17, P563, DOI 10.1017/S1431927611000444
   Davies CE, 2004, J CLIN MICROBIOL, V42, P3549, DOI 10.1128/JCM.42.8.3549-3557.2004
   Dong S., 2012, NANO LIFE, V3
   Dufresne A, 2013, MATER TODAY, V16, P220, DOI 10.1016/j.mattod.2013.06.004
   Fukuzumi H, 2013, CARBOHYD POLYM, V93, P172, DOI 10.1016/j.carbpol.2012.04.069
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x
   Gottrup F, 2004, AM J SURG, V187, p38S, DOI 10.1016/S0002-9610(03)00303-9
   Hill KE, 2010, J ANTIMICROB CHEMOTH, V65, P1195, DOI 10.1093/jac/dkq105
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Jonoobi M, 2012, IND CROP PROD, V40, P232, DOI 10.1016/j.indcrop.2012.03.018
   Jorfi M, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41719
   Josefsson G, 2015, RSC ADV, V5, P58091, DOI 10.1039/c5ra04016g
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Liimatainen H, 2012, BIOMACROMOLECULES, V13, P1592, DOI 10.1021/bm300319m
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Newman GR, 2006, BIOMATERIALS, V27, P1129, DOI 10.1016/j.biomaterials.2005.07.046
   Nogi M, 2009, ADV MATER, V21, P1595, DOI 10.1002/adma.200803174
   Oh YJ, 2009, ULTRAMICROSCOPY, V109, P874, DOI 10.1016/j.ultramic.2009.03.042
   Parr GR, 2002, J PROSTHET DENT, V88, P139, DOI 10.1067/mpr.2002.127399
   Rees A, 2015, BIOMED RES INT, DOI 10.1155/2015/925757
   Sai P, 2000, BURNS, V26, P54
   Saito T, 2013, BIOMACROMOLECULES, V14, P248, DOI 10.1021/bm301674e
   Saito T, 2009, BIOMACROMOLECULES, V10, P1992, DOI 10.1021/bm900414t
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Steinberger RE, 2002, MICROBIAL ECOL, V43, P416, DOI 10.1007/s00248-001-1063-z
   Syverud K, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-626
   Syverud K, 2011, CARBOHYD POLYM, V84, P1033, DOI 10.1016/j.carbpol.2010.12.066
   Tran PL, 2009, APPL ENVIRON MICROB, V75, P3586, DOI 10.1128/AEM.02683-08
   Transparency Market Research, 2013, WOUND DRESS MARK GLO
   Vartiainen J, 2011, CELLULOSE, V18, P775, DOI 10.1007/s10570-011-9501-7
   Veves A, 2002, ARCH SURG-CHICAGO, V137, P822, DOI 10.1001/archsurg.137.7.822
   Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v
   Walker M, 2003, BIOMATERIALS, V24, P883, DOI 10.1016/S0142-9612(02)00414-3
   Wright CJ, 2010, SCANNING, V32, P134, DOI 10.1002/sca.20193
NR 47
TC 15
Z9 16
U1 2
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 10
PY 2016
VL 137
BP 191
EP 197
DI 10.1016/j.carbpol.2015.10.024
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CZ2MB
UT WOS:000366938200022
PM 26686120
DA 2018-10-20
ER

PT J
AU Pinto, FCM
   De-Oliveira, ACAX
   De-Carvalho, RR
   Gomes-Carneiro, MR
   Coelho, DR
   Lima, SVC
   Paumgartten, FJR
   Aguiar, JLA
AF Morono Pinto, Flavia Cristina
   De-Oliveira, Ana Cecilia A. X.
   De-Carvalho, Rosangela R.
   Gomes-Carneiro, Maria Regina
   Coelho, Deise R.
   Lima, Salvador Vilar C.
   Paumgartten, Francisco Jose R.
   Aguiar, Jose Lamartine A.
TI Acute toxicity, cytotoxicity, genotoxicity and antigenotoxic effects of
   a cellulosic exopolysaccharide obtained from sugarcane molasses
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Antigenotoxicity; Bacterial Cellulose; Biomaterial; Cytotoxicity;
   Exopolysaccharide; Genotoxicity
ID RABBITS; BIOPOLYMER; MODEL
AB The acute toxicity, cytotoxicity, genotoxicity and antigenotoxic effects of BC were studied. Cytotoxicity of BC was evaluated in cultured C3A hepatoma cells (HepG2/C3A) using a lactate dehydrogenase (LDH) activity assay. Acute toxicity was tested in adults Wistar rats treated with a single dose of BC. The genotoxicity of BC was evaluated in vivo by the micronucleus assay. BC (0.33-170 tig/mL) added to C3A cell culture medium caused no elevation in LDH release over the background level recorded in untreated cell wells. The treatment with the BC in a single oral dose (2000 mg/kg body weight) caused no deaths or signs of toxicity. BC attenuated CP-induced and inhibition the incidence of MNPCE (female: 46.94%; male: 22.7%) and increased the ratio of PCE/NCE (female: 46.10%; male: 35.25%). There was no alteration in the LDH release in the wells where C3A cells were treated with increasing concentrations of BC compared to the wells where the cells received the cell culture medium only (background of approximately 20% cell death), indicated that in the dose range tested BC was not cytotoxic. BC was not cytotoxic, genotoxic or acutely toxic. BC attenuated CP-induced genotoxic and myelotoxic effects. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Morono Pinto, Flavia Cristina; Lima, Salvador Vilar C.; Aguiar, Jose Lamartine A.] Univ Fed Pernambuco, UFPE, Ctr Hlth Sci, Ctr Expt Surg,Dept Surg, Recife, PE, Brazil.
   [De-Oliveira, Ana Cecilia A. X.; De-Carvalho, Rosangela R.; Gomes-Carneiro, Maria Regina; Coelho, Deise R.; Paumgartten, Francisco Jose R.] Fiocruz MS, Oswaldo Cruz Fdn, Natl Sch Publ Hlth, Lab Environm Toxicol, BR-21045900 Rio De Janeiro, Brazil.
RP Pinto, FCM (reprint author), Rua Futuro 551-201, Recife, PE, Brazil.
EM fcmorone@gmail.com
OI Pinto, Flavia/0000-0003-2038-9984
FU Brazil's Science, Technology, and Innovation Ministry (MCTI): FINEP
   (Financier of Studies and Projects); CNPq (National Counsel of
   Technological and Scientific Development).
FX This study was supported by Brazil's Science, Technology, and Innovation
   Ministry (MCTI): FINEP (Financier of Studies and Projects) and CNPq
   (National Counsel of Technological and Scientific Development).
CR Castro CMMB, 2004, AN FAC MED U FED PER, V49, P119
   Chagas H. M., 2005, ANN INT BRAZILIAN J, V30, P43
   Coelho MCOC, 2002, ACTA CIR BRAS, V17, P1
   Cordeiro-Barbosa FD, 2012, ARQ BRAS OFTALMOL, V75, P267, DOI 10.1590/S0004-27492012000400010
   Albuquerque Paulo Cezar Vidal Carneiro de, 2011, Rev. bras. ortop., V46, P577, DOI [10.1016/S2255-4971(15)30415-8, 10.1590/S0102-36162011000500016]
   Pita PCD, 2015, ACTA CIR BRAS, V30, P296, DOI 10.1590/S0102-865020150040000009
   FDA, 2000, TOX PRINC SAF ASS FO
   FDA, 1994, GUID IND DET TOX REP
   Teixeira FMF, 2014, ACTA CIR BRAS, V29, P231, DOI 10.1590/S0102-86502014000400003
   Fragoso AS, 2014, J MATER SCI-MATER M, V25, P229, DOI 10.1007/s10856-013-5056-5
   Goncalves R., 2006, ANN I BRAZ J UROL S2, V32, P41
   Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2
   Kublbeck J., 2011, MOL PHARM, V5, P2424
   Lee KY, 2014, MACROMOL BIOSCI, V14, P10, DOI 10.1002/mabi.201300298
   Lima S. V. C., 2015, UROLOGY, V85, pe1
   Lima S. V. C., 2015, UROLOGY, V85, P1520
   Lucena M. T, 2015, J MATER SCI-MATER M, V26, P82
   Lucena RG, 2005, INT BRAZ J UROL, V30, P105
   Naik P, 2013, ENVIRON TOXICOL PHAR, V36, P135, DOI 10.1016/j.etap.2013.03.004
   OECD, 2001, 423 OECD
   OECD, 2013, 474 OECD
   Paterson-Beedle M, 2000, CARBOHYD POLYM, V42, P375, DOI 10.1016/S0144-8617(99)00179-4
   Martins AGS, 2013, INT BRAZ J UROL, V39, P408, DOI 10.1590/S1677-5538.IBJU.2013.03.15
   Silva DB, 2006, AN FM U FED PERNAMB, V51, P45
   WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E
NR 25
TC 9
Z9 10
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 10
PY 2016
VL 137
BP 556
EP 560
DI 10.1016/j.carbpol.2015.10.071
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CZ2MB
UT WOS:000366938200065
PM 26686163
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhang, S
   Tang, YG
   Vlahovic, B
AF Zhang, Shu
   Tang, Yongan
   Vlahovic, Branislav
TI A Review on Preparation and Applications of Silver-Containing Nanofibers
SO NANOSCALE RESEARCH LETTERS
LA English
DT Review
DE Silver nanoparticle; Biomaterial; Polymer nanofiber; Electrospinning
ID GRAM-NEGATIVE BACTERIA; ANTIBACTERIAL ACTIVITY; LASER-ABLATION; METAL
   NANOPARTICLES; PHOTOCHEMICAL-SYNTHESIS; PATHOGENIC BACTERIA; ANTIFUNGAL
   ACTIVITY; GOLD NANOPARTICLES; SIZE; PARTICLES
AB Silver-containing nanofibers are of great interest recently because of the dual benefits from silver particles and nanofibers. Silver nanoparticles are extensively used for biomedical applications due to the antibacterial and antiviral properties. In addition, silver nanoparticles can excite resonance effect of light trapping when pairing with dielectric materials, such as polymer. Comparing to the traditional fabrics, polymer nanofibers can provide larger number of reaction sites and higher permeability contributed to their high surface-to-volume ratio and high porosity. By embedding the silver nanoparticles into polymer nanofiber matrix, the composite is promising candidates for biomaterials, photovoltaic materials, and catalysts. This work demonstrates and evaluates the methods employed to synthesize silver nanoparticle-containing nanofibers and their potential applications.
C1 [Zhang, Shu; Tang, Yongan; Vlahovic, Branislav] North Carolina Cent Univ, Dept Math & Phys, Durham, NC 27707 USA.
RP Tang, YG (reprint author), North Carolina Cent Univ, Dept Math & Phys, Durham, NC 27707 USA.
EM tangy@nccu.edu
OI Tang, Yongan/0000-0001-9312-1378
FU NSF [HRD-1345219, DMR-1523617]; NASA [NNX09AV07A]; ARO
   [W911NF-13-1-0165]; XSEDE [TG-DMR130018, TG-PHY140023]
FX This work was supported in part by NSF: HRD-1345219, NSF: DMR-1523617,
   NASA: NNX09AV07A, ARO: W911NF-13-1-0165, and XSEDE grant: TG-DMR130018
   and TG-PHY140023.
CR Abou El-Nour KMM, 2010, ARAB J CHEM, V3, P135, DOI 10.1016/j.arabjc.2010.04.008
   Ahmad A, 2003, NANOTECHNOLOGY, V14, P824, DOI 10.1088/0957-4484/14/7/323
   Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924
   Bai J, 2007, MATER CHEM PHYS, V106, P412, DOI 10.1016/j.matchemphys.2007.06.021
   Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937
   BIRRINGER R, 1989, MAT SCI ENG A-STRUCT, V117, P33, DOI 10.1016/0921-5093(89)90083-X
   Bu YY, 2013, RSC ADV, V3, P24118, DOI 10.1039/c3ra44047h
   Callegari A, 2003, NANO LETT, V3, P1565, DOI 10.1021/nl034757a
   Chen JY, 2014, PLASMON ENHANCED POL, P1
   Chou KS, 2005, MATER CHEM PHYS, V94, P429, DOI 10.1016/j.mathchemphys.2005.05.029
   Chou KS, 2004, MATER CHEM PHYS, V83, P82, DOI 10.1016/j.matchemphys.2003.09.026
   CREIGHTON JA, 1979, J CHEM SOC FARAD T 2, V75, P790, DOI 10.1039/f29797500790
   Daoud WA, 2005, SURF SCI, V599, P69, DOI 10.1016/j.susc.2005.09.038
   Duran N, 2011, APPL MICROBIOL BIOT, V90, P1609, DOI 10.1007/s00253-011-3249-8
   Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002
   Esteban-Cubillo A, 2006, J MATER SCI, V41, P5208, DOI 10.1007/s10853-006-0432-x
   FOJTIK A, 1993, BER BUNSEN PHYS CHEM, V97, P252
   Fraser A.N., 1932, Canadian Journal of Research, V7, P133
   Ghule K, 2006, GREEN CHEM, V8, P1034, DOI 10.1039/b605623g
   Goia DV, 1998, NEW J CHEM, V22, P1203, DOI 10.1039/a709236i
   Gong P, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/28/285604
   Gonzalez-Castillo JR, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1105-y
   Guo YM, 2005, CHEM J CHINESE U, V26, P209
   Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007
   He SY, 2007, MATER LETT, V61, P3984, DOI 10.1016/j.matlet.2007.01.018
   Henglein A, 1999, J PHYS CHEM B, V103, P9533, DOI 10.1021/jp9925334
   Henglein A, 1998, CHEM MATER, V10, P444, DOI 10.1021/cm970613j
   Hennebel T, 2009, TRENDS BIOTECHNOL, V27, P90, DOI 10.1016/j.tibtech.2008.11.002
   Horiuchi Y, 2009, J MATER CHEM, V19, P6745, DOI 10.1039/b910474g
   Huang CJ, 2006, J APPL POLYM SCI, V100, P1457, DOI 10.1002/app.23576
   Huang HH, 1996, LANGMUIR, V12, P909, DOI 10.1021/la950435d
   Ingle A, 2008, CURR NANOSCI, V4, P141, DOI 10.2174/157341308784340804
   Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368
   Jo YK, 2009, PLANT DIS, V93, P1037, DOI 10.1094/PDIS-93-10-1037
   Kamyshny A, 2010, PREPARATION STABILIZ, V147
   Kasprowicz MJ, 2010, CAN J MICROBIOL, V56, P247, DOI [10.1139/W10-012, 10.1139/w10-012]
   Kim JS, 2014, NANOMED-NANOTECHNOL, V10, P1119, DOI 10.1016/j.nano.2014.04.007
   Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2
   Klasen HJ, 2000, BURNS, V30, P1
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30
   Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI 10.1186/1477-3155-8-1
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Li L, 2015, NANOTECHNOLOGY, V26, P44
   Liu X, 2010, J BIOMED MATER RES A, V94A, P499, DOI 10.1002/jbm.a.32718
   Mafune F, 2000, J PHYS CHEM B, V104, P9111, DOI 10.1021/jp001336y
   Makhluf S, 2005, ADV FUNCT MATER, V15, P1708, DOI 10.1002/adfm.200500029
   Mallick K, 2004, J MATER SCI, V39, P4459, DOI 10.1023/B:JMSC.0000034138.80116.50
   Manea F, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-331
   Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6
   Marun F, 2000, J PHYS CHEM B, V104, P8333
   Mayer AB, 2002, POLYM J, V32, P15
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758
   Nangia Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3141519
   NEDDERSEN J, 1993, APPL SPECTROSC, V47, P1959, DOI 10.1366/0003702934066460
   Ocwieja M, 2014, ADV COLLOID INTERFAC, V7, P1
   Oliveira MM, 2005, J COLLOID INTERF SCI, V292, P429, DOI 10.1016/j.jcis.2005.05.068
   Palza H, 2015, INT J MOL SCI, V16, P2099, DOI 10.3390/ijms16012099
   Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065
   Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592
   Pietrobon B, 2008, CHEM MATER, V20, P5186, DOI 10.1021/cm800926u
   Prochazka M, 1997, ANAL CHEM, V69, P5103, DOI 10.1021/ac970683+
   Pyatenko A, 2004, APPL PHYS A-MATER, V79, P803, DOI 10.1007/s00339-004-2841-5
   Pyatenko A, 2010, SILVER NANOPARTICLES, P121
   Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007
   Rodriguez-Leon E, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-318
   Salehi-Khojin A, 2013, J PHYS CHEM C, V117, P1627, DOI 10.1021/jp310509z
   Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j
   Shi Q, 2011, EUR POLYM J, V47, P1402, DOI 10.1016/j.eurpolymj.2011.04.002
   Shi Q, 2011, J MATER CHEM, V21, P10330, DOI 10.1039/c1jm11492a
   Shi YL, 2009, MATER LETT, V63, P2698, DOI 10.1016/j.matlet.2009.09.046
   Sivaraman SK, 1997, CURR SCI, V7, P1055
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sui ZM, 2005, CHEM LETT, V34, P100, DOI 10.1246/cl.2005.100
   Tang YA, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-394
   Tolaymat TM, 2010, SCI TOTAL ENVIRON, V408, P999, DOI 10.1016/j.scitotenv.2009.11.003
   Wright JB, 1999, AM J INFECT CONTROL, V27, P344, DOI 10.1016/S0196-6553(99)70055-6
   Yoosaf K, 2007, J PHYS CHEM C, V111, P12839, DOI 10.1021/jp073923q
   Zhai HJ, 2006, J NANOSCI NANOTECHNO, V6, P1968, DOI 10.1166/jnn.2006.320
   Zhang S, 2009, MATER DESIGN, V30, P3659, DOI 10.1016/j.matdes.2009.02.017
   Zielinska A, 2009, PROCEDIA CHEM, V1, P1560, DOI 10.1016/j.proche.2009.11.004
NR 82
TC 15
Z9 15
U1 6
U2 307
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD FEB 9
PY 2016
VL 11
AR 80
DI 10.1186/s11671-016-1286-z
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA EH4NR
UT WOS:000391748400004
PM 26858162
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jiang, XC
   Lin, HW
   Jiang, DP
   Xu, GF
   Fang, XL
   He, L
   Xu, MS
   Tang, BQ
   Wang, ZY
   Cui, DX
   Chen, F
   Geng, HQ
AF Jiang, Xincheng
   Lin, Houwei
   Jiang, Dapeng
   Xu, Guofeng
   Fang, Xiaoliang
   He, Lei
   Xu, Maosheng
   Tang, Bingqiang
   Wang, Zhiyong
   Cui, Daxiang
   Chen, Fang
   Geng, Hongquan
TI Co-delivery of VEGF and bFGF via a PLGA nanoparticle-modified BAM for
   effective contracture inhibition of regenerated bladder tissue in
   rabbits
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACELLULAR MATRIX GRAFT; SMALL-INTESTINAL SUBMUCOSA; ENDOTHELIAL
   GROWTH-FACTOR; LOWER URINARY-TRACT; FUNCTIONAL-EVALUATION; MICROVESSEL
   DENSITY; SUSTAINED-RELEASE; RAT BLADDER; MODEL; AUGMENTATION
AB Graft contracture is a common problem associated with the regeneration processes of tissue-engineered bladders. Currently, most strategies used for incorporating bioactive molecules into biomaterial designs do not work during all phases of tissue regeneration. In this study, we used a growth factor-PLGA nanoparticle thermo-sensitive gel system (i.e., BAM with incorporated VEGF and bFGF-loaded PLGA nanoparticles and mixed with a hydrophilic gel) to promote bladder tissue regeneration in a rabbit model. At 4 and 12 weeks after surgery, contracture rate assessment and histological examination were conducted to evaluate bladder tissue regeneration. The results indicated that the functional composite scaffold continuously and effectively released VEGF and bFGF and promoted bladder reconstruction with a significant decrease in graft contracture. In addition, the number and arrangement of regenerated urothelial cells and smooth muscle cells as well as microvascular density and maturity were improved in the VEGF/bFGF nanoparticle group compared with the single factor VEGF or bFGF nanoparticle group and BAM alone. The nanoparticle thermo-sensitive gel system, which exhibited favourable performance, may effectively inhibit graft contracture and promote bladder tissue regeneration in rabbits.
C1 [Jiang, Xincheng; Lin, Houwei; Jiang, Dapeng; Xu, Guofeng; Fang, Xiaoliang; He, Lei; Xu, Maosheng; Tang, Bingqiang; Geng, Hongquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Urol, Shanghai 200030, Peoples R China.
   [Wang, Zhiyong] Shanghai Inst Pharmaceut Ind, Shanghai, Peoples R China.
   [Cui, Daxiang] Shanghai Jiao Tong Univ, Inst Micronano Sci & Technol, Dept Bionano Sci & Engn, Key Lab Thin Film & Microfabricat,Minist Educ, Shanghai 200030, Peoples R China.
   [Chen, Fang] Shanghai Jiao Tong Univ, Sch Med, Childrens Hosp Affiliated, Dept Urol, Shanghai 200030, Peoples R China.
RP Geng, HQ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Urol, Shanghai 200030, Peoples R China.
EM ghongquan@hotmail.com
FU National Natural Science Foundation of China [81170639]
FX This research was supported by a grant from the National Natural Science
   Foundation of China (No. 81170639). We thank Dr. Zhixiang Wu (Xinhua
   Hospital, Shanghai Jiao Tong University School of Medicine, China) for
   assistance with the in vitro studies.
CR Ashley RA, 2010, BJU INT, V105, P1462, DOI 10.1111/j.1464-410X.2009.08965.x
   Biers SM, 2012, BJU INT, V109, P1280, DOI 10.1111/j.1464-410X.2011.10650.x
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Cartwright L, 2006, J BIOMED MATER RES A, V77A, P390, DOI 10.1002/jbm.a.30648
   Castellan M, 2012, J UROLOGY, V187, P1823, DOI 10.1016/j.juro.2011.12.105
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   Chen W, 2014, TISSUE ENG PT A, V20, P2234, DOI [10.1089/ten.tea.2013.0730, 10.1089/ten.TEA.2013.0730]
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Geng HQ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-312
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Kanematsu A, 2007, INT J UROL, V14, P673, DOI 10.1111/j.1442-2042.2007.01768.x
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kispal Z, 2011, BJU INT, V108, P282, DOI 10.1111/j.1464-410X.2010.09862.x
   Liao X., 2010, NANO BIOMED ENG, V2, P133
   Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Mataveli FD, 2009, GROWTH FACTORS, V27, P22, DOI 10.1080/08977190802574765
   Mondalek FG, 2010, J BIOMED MATER RES A, V94A, P712, DOI 10.1002/jbm.a.32748
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Roth CC, 2011, BJU INT, V108, P148, DOI 10.1111/j.1464-410X.2010.09757.x
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Song LJ, 2014, TISSUE ENG PART B-RE, V20, P163, DOI [10.1089/ten.teb.2013.0103, 10.1089/ten.TEB.2013.0103]
   Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957
   Weidner N, 2008, METHOD ENZYMOL, V444, P305, DOI 10.1016/S0076-6879(08)02814-0
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 35
TC 10
Z9 11
U1 4
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 8
PY 2016
VL 6
AR 20784
DI 10.1038/srep20784
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC8TV
UT WOS:000369493500001
PM 26854200
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sacks, MS
   Zhang, W
   Wognum, S
AF Sacks, Michael S.
   Zhang, Will
   Wognum, Silvia
TI A novel fibre-ensemble level constitutive model for exogenous
   cross-linked collagenous tissues
SO INTERFACE FOCUS
LA English
DT Article
DE collagenous tissues; cross-linking; constitutive model
ID VALVE ANTERIOR LEAFLET; TENSILE VISCOELASTIC PROPERTIES; BOVINE
   PERICARDIAL XENOGRAFT; FINITE-ELEMENT IMPLEMENTATION; BIAXIAL
   MECHANICAL-BEHAVIOR; BIOPROSTHETIC HEART-VALVES; PLANAR SOFT-TISSUES;
   HETEROGRAFT BIOMATERIALS; CONNECTIVE TISSUES; STRESS-RELAXATION
AB Exogenous cross-linking of soft collagenous tissues is a common method for biomaterial development and medical therapies. To enable improved applications through computational methods, physically realistic constitutive models are required. Yet, despite decades of research, development and clinical use, no such model exists. In this study, we develop the first rigorous full structural model (i.e. explicitly incorporating various features of the collagen fibre architecture) for exogenously cross-linked soft tissues. This was made possible, in-part, with the use of native to cross-linked matched experimental datasets and an extension to the collagenous structural constitutive model so that the uncross-linked collagen fibre responses could be mapped to the cross-linked configuration. This allowed us to separate the effects of cross-linking from kinematic changes induced in the cross-linking process, which in turn allowed the non-fibrous tissue matrix component and the interaction effects to be identified. It was determined that the matrix could be modelled as an isotropic material using a modified Yeoh model. The most novel findings of this study were that: (i) the effective collagen fibre modulus was unaffected by cross-linking and (ii) fibre-ensemble interactions played a large role in stress development, often dominating the total tissue response (depending on the stress component and loading path considered). An important utility of the present model is its ability to separate the effects of exogenous cross-linking on the fibres from changes due to the matrix. Applications of this approach include the utilization in the design of novel chemical treatments to produce specific mechanical responses and the study of fatigue damage in bioprosthetic heart valve biomaterials.
C1 [Sacks, Michael S.; Zhang, Will] Univ Texas Austin, Dept Biomed Engn, Inst Computat Engn & Sci, Ctr Cardiovasc Simulat, 201 East 24th St,POB 5-236,Stop C0200, Austin, TX 78712 USA.
   [Wognum, Silvia] Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.
RP Sacks, MS (reprint author), Univ Texas Austin, Dept Biomed Engn, Inst Computat Engn & Sci, Ctr Cardiovasc Simulat, 201 East 24th St,POB 5-236,Stop C0200, Austin, TX 78712 USA.
EM msacks@ices.utexas.edu
OI Zhang, Will/0000-0003-1986-6253
FU NIH [R01 HL108330]
FX This study was supported by NIH grant no. R01 HL108330.
CR Alferiev I, 2003, J BIOMED MATER RES A, V66A, P385, DOI 10.1002/jbm.a.10896
   Barber J E, 1999, Biomed Sci Instrum, V35, P29
   Bini A, 1999, ARTERIOSCL THROM VAS, V19, P1852, DOI 10.1161/01.ATV.19.8.1852
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004
   CHEUNG DT, 1983, J BIOL CHEM, V258, P7774
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   CHEUNG DT, 1990, CONNECT TISSUE RES, V25, P27, DOI 10.3109/03008209009009810
   Coughlin MF, 1996, J APPL PHYSIOL, V80, P1880
   Eckert CE, 2013, ACTA BIOMATER, V9, P4653, DOI 10.1016/j.actbio.2012.09.031
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fan R, 2014, J BIOMECH, V47, P2043, DOI 10.1016/j.jbiomech.2014.03.014
   Fata B, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026457
   Garikipati K, 2008, J MECH PHYS SOLIDS, V56, P1693, DOI 10.1016/j.jmps.2007.07.005
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Grashow JS, 2006, ANN BIOMED ENG, V34, P1509, DOI 10.1007/s10439-006-9183-8
   Grashow JS, 2006, ANN BIOMED ENG, V34, P315, DOI [10.1007/s10439-005-9027-y, 10.1007/s10439-005-9027-v]
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   Kojic M, 1998, COMPUT MECH, V21, P189, DOI 10.1007/s004660050294
   LANIR Y, 1994, J APPL MECH-T ASME, V61, P695, DOI 10.1115/1.2901516
   LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6
   LANIR Y, 1979, J BIOMECH, V12, P423, DOI 10.1016/0021-9290(79)90027-7
   Lee CH, 2015, BIOPHYS J, V108, P2074, DOI 10.1016/j.bpj.2015.03.019
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEE JM, 1989, J BIOMED MATER RES, V23, P477, DOI 10.1002/jbm.820230503
   LEE JM, 1989, J BIOMED MATER RES, V23, P491, DOI 10.1002/jbm.820230504
   LEE JM, 1994, AM SOC TEST MATER, V1173, P19, DOI 10.1520/STP18091S
   Lee TC, 2001, J BIOMECH, V34, P203, DOI 10.1016/S0021-9290(00)00187-1
   Liao J, 2005, ACTA BIOMATER, V1, P45, DOI 10.1016/j.actbio.2004.09.007
   Liao J, 2004, ANN BIOMED ENG, V32, P977, DOI 10.1023/B:ABME.0000032460.97278.e9
   Liao J, 2007, J BIOMECH ENG-T ASME, V129, P78, DOI 10.1115/1.2401186
   Merodio J, 2006, INT J NONLINEAR MECH, V41, P556, DOI [10.1016/j.ijnonlinmec.2006.02.001, 10.1016/j.ijnonlinmec.2006.11.002]
   Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004
   NAIMARK WA, 1992, AM J PHYSIOL, V263, pH1095
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nimni ME., 1988, COLLAGEN VOLUME II B
   PARRY DAD, 1988, BIOPHYS CHEM, V29, P195, DOI 10.1016/0301-4622(88)87039-X
   PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871
   Sacks MS, 2006, EXPERT REV MED DEVIC, V3, P817, DOI 10.1586/17434440.3.6.817
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 2000, COMPUT MECH, V26, P243, DOI 10.1007/s004660000175
   Sacks MS, 2003, ANNU REV BIOMED ENG, V5, P251, DOI 10.1146/annurev.bioeng.5.011303.120714
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   Sacks MS, 1999, CALCIFICATION INDEPE
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 2005, CARDIOVASC PATHOL, V14, P189, DOI 10.1016/j.carpath.2005.03.005
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Schoen FJ, 2001, CARDIOVASC PATHOL, P629
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   Shen ZL, 2008, BIOPHYS J, V95, P3956, DOI 10.1529/biophysj.107.124602
   Stella JA, 2007, J BIOMECH, V40, P3169, DOI 10.1016/j.jbiomech.2007.04.001
   Sun W, 2005, BIOMECH MODEL MECHAN, V4, P190, DOI 10.1007/s10237-005-0075-x
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Sun W, 2003, J BIOMECH ENG-T ASME, V125, P372, DOI 10.1115/1.1572518
   Sun W, 2005, J BIOMECH ENG-T ASME, V127, P905, DOI 10.1115/1.2049337
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Wells S. M., 2000, T 6 WORLD BIOM C KAM, V2, P794
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
   Wells SM, 2002, BIOMATERIALS, V23, P2389, DOI 10.1016/S0142-9612(01)00375-1
   Wells SM, 1999, ASME ADV BIOENG, V43, P91
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yang L, 2007, J BIOMED MATER RES A, V82A, P160, DOI 10.1002/jbm.a.31127
   Zhang W., J MECH BEHA IN PRESS
   Zhang W, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029266
NR 71
TC 9
Z9 9
U1 0
U2 4
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD FEB 6
PY 2016
VL 6
IS 1
AR 20150090
DI 10.1098/rsfs.2015.0090
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DG4TM
UT WOS:000372065600016
PM 26855761
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Colpitts, C
   Kiani, A
AF Colpitts, Candace
   Kiani, Amirkianoosh
TI Synthesis of Bioactive Three-dimensional Silicon-oxide Nanofibrous
   Structures on the Silicon Substrate for Bionic Devices' Fabrication
SO NANOMATERIALS AND NANOTECHNOLOGY
LA English
DT Article
DE Bionic Devices; Biocompatible Materials; Silicon Oxide Nanofibres; Laser
   Ablation; Surface Modification; Three-dimensional Nanostructure
ID OPTICAL-ABSORPTION ENHANCEMENT; NANOPARTICLES
AB Bionic devices are implants that replace biological functions that have been lost due to damaged or lost tissue. The challenge of this area is to find the appropriate materials to match the biocompatible criteria with the same mechanical and electrical performance. In this research, a new method is introduced for the enhancement of silicon biocompatibility by fabrication of a 3D nanofibrous layer on the silicon surface, induced by nanosecond laser pulses at a high repetition rate and power. It was found that the laser treatment with smaller line spacing and a higher overlap number enhanced the biocompatibility of silicon. The results display a promising improvement in the biocompatibility of silicon for the production of biomedical devices such as sensors, bio-MEMS and nano-biomaterial fabrications.
C1 [Colpitts, Candace; Kiani, Amirkianoosh] Univ New Brunswick, Mech Engn, Fredericton, NB, Canada.
RP Kiani, A (reprint author), Univ New Brunswick, Mech Engn, Fredericton, NB, Canada.
EM a.kiani@unb.ca
RI bagheri, amir/C-3274-2017
OI Kiani, Amirkianoosh/0000-0002-9125-3219
FU Natural Science and Engineering Research Council of Canada (NSERC); New
   Brunswick Innovation Foundation (NBIF); McCain Foundation
FX This research is funded by the Natural Science and Engineering Research
   Council of Canada (NSERC), New Brunswick Innovation Foundation (NBIF)
   and the McCain Foundation.
CR Aouani H, 2013, J PHYS CHEM C, V117, P18620, DOI 10.1021/jp404535x
   Bayliss SC, 1999, MATER WORLD, V7, P213
   Bergmann PA, 2012, EUR J PLAST SURG, V35, P19, DOI 10.1007/s00238-011-0579-9
   Caldarola M., 2015, NATURE COMMUNICATION, V6
   Carpentier A, 2015, LANCET, V386, P1556, DOI 10.1016/S0140-6736(15)60511-6
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   Green ML, 2001, J APPL PHYS, V90, P2057, DOI 10.1063/1.1385803
   Jeong S, 2012, J AM CHEM SOC, P2971
   Kiani A, 2015, OPT EXPRESS, V23, pA569, DOI 10.1364/OE.23.00A569
   Kiani A, 2014, OPT EXPRESS, V22, pA120, DOI 10.1364/OE.22.00A120
   Kiani A, 2011, SOL ENERGY, V85, P1817, DOI 10.1016/j.solener.2011.04.020
   Kiani A, 2009, OPT EXPRESS, V17, P16518, DOI 10.1364/OE.17.016518
   Kinnari PJ, 2013, BIOMATERIALS, V34, P9134, DOI 10.1016/j.biomaterials.2013.08.034
   Konig M, 2014, ACS NANO, V8, P9188, DOI 10.1021/nn5028714
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Li X, 2013, J NANOMATERIALS, V14
   Low S. P, 2014, HDB POROUS SILICON, P381
   Radmanesh M., 2015, J BIOMATERIALS NANOB, V6, P168, DOI DOI 10.4236/JBNB.2015.63017
   Schweicher J, 2014, HDB POROUS SILICON, P787
   Secret E, 2013, ADV HEALTHC MATER, V2, P718, DOI 10.1002/adhm.201200335
   Someya T, 2014, 2014 IEEE 27TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL SYSTEMS (MEMS), P68, DOI 10.1109/MEMSYS.2014.6765575
   Soysal K., 2010, THESIS MIDDLE E TU
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Tang DH, 2014, J MATER CHEM A, V2, P10375, DOI 10.1039/c4ta01343c
   Tavangar A, 2011, ACTA BIOMATER, V7, P2726, DOI 10.1016/j.actbio.2011.02.020
   Tolli MA, 2014, BIOMATERIALS, V35, P8394, DOI 10.1016/j.biomaterials.2014.05.078
   Vallet-Regi M, 2011, CHEM SOC REV, V40, P596, DOI 10.1039/c0cs00025f
   Vorobyev A Y, 2005, ENHANCED ABSORPTANCE
   Yokoi K, 2013, CANCER LETT, V334, P319, DOI 10.1016/j.canlet.2012.09.001
   Yue ZL, 2013, ADV DRUG DELIVER REV, V65, P559, DOI 10.1016/j.addr.2012.06.002
   Zhang W, 2015, SCI REPORTS
NR 32
TC 6
Z9 6
U1 1
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1847-9804
J9 NANOMATER NANOTECHNO
JI Nanomater. Nanotechnol.
PD FEB 5
PY 2016
VL 6
AR 8
DI 10.5772/62312
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DD8IB
UT WOS:000370168600001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lin, WJ
   Zhang, DY
   Zhang, G
   Sun, HT
   Qi, HP
   Chen, LP
   Liu, ZQ
   Gao, RL
   Zheng, W
AF Lin, Wen-Jiao
   Zhang, De-Yuan
   Zhang, Gui
   Sun, Hong-Tao
   Qi, Hai-Ping
   Chen, Li-Ping
   Liu, Zi-Qiang
   Gao, Run-Lin
   Zheng, Wei
TI Design and characterization of a novel biocorrodible iron-based
   drug-eluting coronary scaffold
SO MATERIALS & DESIGN
LA English
DT Article
DE Nitrided iron; Coating design; Effective scaffolding; Shortened
   corrosion period; Biosafety
ID FE-MN ALLOYS; IN-VITRO; PURE IRON; CELL VIABILITY; STENTS; DEGRADATION;
   VIVO; BIOCOMPATIBILITY; BIOMATERIAL; ARTERIES
AB Long corrosion period and slow resorption in vivo remain major limitations for iron-based bioresorbable scaffolds. This work focused on the design and characterization of a novel iron-based drug-eluting coronary scaffold (IBS scaffold) made of nitrided ironmaterials. The 53 mu m IBS scaffold shows good device performance comparable to a current mainstream drug-eluting coronary stent (Xience Prime (TM)) due to the good comprehensive mechanical performance of nitrided iron materials. The novel design of a zinc barrier layer makes it possible for the IBS scaffold to have ultrathin struts and thick PDLLA coating of 12 mu m to maintain adequate scaffolding (125 kPa) after 3 months implantation while having a significantly shortened corrosion period (13 months). The biocorrosion and bioresorption of the IBS scaffold could be effectively evaluated using Micro-CT, OCT and MRI methods. Although complete bioresorption of the corrosion products has not been observed yet, there are no identified biological problems for the IBS scaffold after implantation in rabbit abdominal aorta up to 13 months. This study demonstrates that the IBS scaffold with novel design has significantly shortened corrosion period and less amount of corrosion products without causing any biological problems after implantation up to 13 months, therefore is promising for coronary application. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Lin, Wen-Jiao; Zhang, De-Yuan; Zhang, Gui; Sun, Hong-Tao; Qi, Hai-Ping; Chen, Li-Ping; Liu, Zi-Qiang] Lifetech Sci Shenzhen Co Ltd, Ctr Res & Dev, Shenzhen 518057, Peoples R China.
   [Lin, Wen-Jiao; Zheng, Wei] Harbin Engn Univ, Ctr Biomed Mat & Engn, Harbin 150001, Peoples R China.
   [Gao, Run-Lin] Fuwai Hosp, Cardiac Catheterizat Lab, Beijing 200071, Peoples R China.
RP Zhang, DY (reprint author), Lifetech Sci Shenzhen Co Ltd, Ctr Res & Dev, Cybio Elect Bldg,Langshan 2nd St, Shenzhen 518057, Peoples R China.
EM zhangdeyuan_2012@163.com
FU China National High-tech Research and Development Program Research
   Project [2011AA030103]; Municipal Science and Technology Plans of
   Shenzhen [JSGG20140701161153656]
FX This study was supported by the China National High-tech Research and
   Development Program Research Project No. 2011AA030103 and the Municipal
   Science and Technology Plans of Shenzhen No. JSGG20140701161153656.
CR Bourantas CV, 2013, INT J CARDIOL, V167, P11, DOI 10.1016/j.ijcard.2012.05.093
   Bowen PK, 2015, MAT SCI ENG C-MATER, V56, P467, DOI 10.1016/j.msec.2015.07.022
   Bowen PK, 2013, ADV MATER, V25, P2577, DOI 10.1002/adma.201300226
   Bowen PK, 2012, J BIOMED MATER RES B, V100B, P2101, DOI 10.1002/jbm.b.32775
   Cheng J, 2015, MAT SCI ENG C-MATER, V48, P679, DOI 10.1016/j.msec.2014.12.053
   Drynda A, 2015, J BIOMED MATER RES B, V103, P649, DOI 10.1002/jbm.b.33234
   Feng QM, 2013, J MATER SCI-MATER M, V24, P713, DOI 10.1007/s10856-012-4823-z
   Foin N, 2014, INT J CARDIOL, V177, P800, DOI 10.1016/j.ijcard.2014.09.143
   Foin N, 2013, EUROINTERVENTION, V8, P1315, DOI 10.4244/EIJV8I11A200
   Garcia-Garcia HM, 2014, JACC-CARDIOVASC IMAG, V7, P1130, DOI 10.1016/j.jcmg.2014.06.018
   Hermawan H, 2013, ACTA BIOMATER, V9, P8585, DOI 10.1016/j.actbio.2013.04.027
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Iqbal J, 2014, EUR HEART J, V35, P765, DOI 10.1093/eurheartj/eht542
   Kraus T, 2014, ACTA BIOMATER, V10, P3346, DOI 10.1016/j.actbio.2014.04.007
   Li HF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10719
   Li HF, 2015, MATER DESIGN, V83, P95, DOI 10.1016/j.matdes.2015.05.089
   Li HF, 2014, PROG NAT SCI-MATER, V24, P414, DOI 10.1016/j.pnsc.2014.08.014
   Lin WJ, 2015, J BIOMED MATER RES B, V103, P764, DOI 10.1002/jbm.b.33246
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Liu B, 2011, MATER LETT, V65, P540, DOI 10.1016/j.matlet.2010.10.068
   Liu X., 2015, MAT LETT
   Liu XW, 2015, MATER LETT, V161, P53, DOI 10.1016/j.matlet.2015.06.107
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, MATER SCI ENG B-ADV, V176, P1812, DOI 10.1016/j.mseb.2011.02.031
   Mueller PP, 2012, J BIOMED MATER RES A, V100A, P2881, DOI 10.1002/jbm.a.34223
   Obayi C.S., 2014, BIOMATERIALS
   Obayi CS, 2015, ACTA BIOMATER, V17, P68, DOI 10.1016/j.actbio.2015.01.024
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Purnama A., 2014, J BIOMATER TISS ENG, V4, P1
   Schinhammer M., 2012, ACTA MAT, V60, P2764
   Schinhammer M., 2012, MAT SCI ENG C, V33, P1882
   Simon C, 2000, J LONG-TERM EFF MED, V10, P143
   Sudhir K., 2013, ISRN CARDIOL, V2013, P1
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Wang Y., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.2337/DB14-0480
   Wu C, 2013, CHINESE MED J-PEKING, V126, P4752, DOI 10.3760/cma.j.issn.0366-6999.20131120
   Yusop A.H.M., 2015, SCI REP
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 39
TC 15
Z9 15
U1 4
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-1275
EI 1873-4197
J9 MATER DESIGN
JI Mater. Des.
PD FEB 5
PY 2016
VL 91
BP 72
EP 79
DI 10.1016/j.matdes.2015.11.045
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA CZ6UB
UT WOS:000367235400009
DA 2018-10-20
ER

PT J
AU Carvalho, A
   Pelaez-Vargas, A
   Hansford, DJ
   Fernandes, MH
   Monteiro, FJ
AF Carvalho, Angela
   Pelaez-Vargas, Alejandro
   Hansford, Derek J.
   Fernandes, Maria H.
   Monteiro, Fernando J.
TI Effects of Line and Pillar Array Microengineered SiO2 Thin Films on the
   Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem
   Cells
SO LANGMUIR
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; CONTACT GUIDANCE; CYTOSKELETAL ORGANIZATION;
   FIBROBLAST MIGRATION; SURFACE-ROUGHNESS; IN-VITRO; PROLIFERATION;
   TITANIUM; GROWTH; TOPOGRAPHIES
AB A primary goal in bone tissue engineering is the design of implants that induce controlled, guided, and rapid healing. The events that normally lead to the integration of an implant into bone and determine the performance of the device occur mainly at the tissue implant interface. Topographical surface modification of a biomaterial might be an efficient tool for inducing stem cell osteogenic differentiation and replace the use of biochemical stimuli. The main goal of this work was to develop micropatterned bioactive silica thin films to induce the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hMSCs) only through topographical stimuli. Line and pillar micropatterns were developed by a combination of sol-gel/soft lithography and characterized by scanning electron microscopy, atomic force microscopy, and contact angle measurements. hMSCs were cultured onto the microfabricated thin films and flat control for up to 21 days under basal conditions. The micropatterned groups induced levels of osteogenic differentiation and expression of osteoblast-associated markers higher than those of the flat controls. Via comparison of the micropatterns, the pillars caused a stronger response of the osteogenic differentiation of hMSCs with a higher level of expression of osteoblast-associated markers, ALP activity, and extracellular matrix mineralization after the cells had been cultured for 21 days. These findings suggest that specific microtopographic cues can direct hMSCs toward osteogenic differentiation.
C1 [Carvalho, Angela; Monteiro, Fernando J.] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Carvalho, Angela; Monteiro, Fernando J.] Univ Porto, INEB Inst Engn Biomed, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Carvalho, Angela; Monteiro, Fernando J.] Univ Porto, Fac Engn, Dept Engn Met & Mat, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
   [Pelaez-Vargas, Alejandro] Univ Cooperat Colombia, Fac Dent, Carrera 47 37sur 18, Medellin, Colombia.
   [Hansford, Derek J.] Ohio State Univ, Dept Biomed Engn, 1080 Carmack Rd, Columbus, OH 43210 USA.
   [Fernandes, Maria H.] Univ Porto, Lab Bone Metab & Regenerat, Fac Med Dent, Rua Dr Manuel Pereira da Silva, P-4200393 Oporto, Portugal.
RP Carvalho, A (reprint author), Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Carvalho, A (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Carvalho, A (reprint author), Univ Porto, Fac Engn, Dept Engn Met & Mat, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.
EM angela.carvalho@ineb.up.pt
RI Carvalho, Angela/L-3224-2014; Fernandes, Maria Helena/K-6917-2014
OI Carvalho, Angela/0000-0002-4837-6539; Pelaez-Vargas,
   Alejandro/0000-0001-7582-2760; Monteiro, Fernando/0000-0002-1361-4605;
   Fernandes, Maria Helena/0000-0001-9391-9574
FU FEDER funds through Programa Operacional Factores de Competitividade
   (COMPETE); Portuguese funds through FCT (Fundacao para a Ciencia e a
   Tecnologia) [SFRH/BD/87624/2012]
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade (COMPETE) and by Portuguese funds through
   FCT (Fundacao para a Ciencia e a Tecnologia) in the framework of A.C.'s
   Ph.D. grant (SFRH/BD/87624/2012), whose support is acknowledged.
CR Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Bitar M, 2013, J MATER SCI-MATER M, V24, P1285, DOI 10.1007/s10856-013-4876-7
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Carreira AC, 2014, ARCH BIOCHEM BIOPHYS, V561, P64, DOI 10.1016/j.abb.2014.07.011
   Carvalho A, 2012, DENT MATER, V28, P1250, DOI 10.1016/j.dental.2012.09.002
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   Csaderova L, 2010, SMALL, V6, P2755, DOI 10.1002/smll.201000193
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Engel E, 2009, ANN ANAT, V191, P136, DOI 10.1016/j.aanat.2008.07.013
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   GUIDO S, 1993, J CELL SCI, V105, P317
   Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103
   Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   Kim EJ, 2010, ACTA BIOMATER, V6, P160, DOI 10.1016/j.actbio.2009.06.016
   Laranjeira MS, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/2/025001
   Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lim JY, 2009, TISSUE ENG REGEN MED, V6, P365
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Logan N., 2013, STEM CELLS INT, V2013, P1
   Marzolin C, 1998, ADV MATER, V10, P571, DOI 10.1002/(SICI)1521-4095(199805)10:8<571::AID-ADMA571>3.0.CO;2-P
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mikami Y, 2007, BIOCHEM BIOPH RES CO, V362, P368, DOI 10.1016/j.bbrc.2007.07.192
   Mills CA, 2007, SMALL, V3, P871, DOI 10.1002/smll.200600683
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Nava M. M., 2012, J BIOMED BIOTECHNOL, V2012, P1
   Navarro M, 2006, ADV POLYM SCI, V200, P209, DOI 10.1007/12_068
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Pelaez-Vargas A, 2011, DENT MATER, V27, P581, DOI 10.1016/j.dental.2011.02.014
   Pelaez-Vargas A, 2010, MICROSC MICROANAL, V16, P670, DOI 10.1017/S1431927610094158
   Pelaez-Vargas A, 2013, J BIOMED MATER RES B, V101B, P762, DOI 10.1002/jbm.b.32879
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Rani VVD, 2012, ACTA BIOMATER, V8, P1976, DOI 10.1016/j.actbio.2012.01.021
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Schwartz Zvi, 2005, Alpha Omegan, V98, P9
   Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077
   Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676
   Sun JR, 2010, BIOMACROMOLECULES, V11, P3067, DOI 10.1021/bm100883m
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Von Recum A. F., 1996, J BIOMAT SCI-POLYM E, V7, P181
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n
   Yu BY, 2006, J MEMBRANE SCI, V273, P31, DOI 10.1016/j.memsci.2005.10.012
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zinger O., 2005, BIOMATERIALS, V26, P1837
   zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x
NR 62
TC 17
Z9 17
U1 1
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 2
PY 2016
VL 32
IS 4
BP 1091
EP 1100
DI 10.1021/acs.langmuir.5b03955
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA DC8LV
UT WOS:000369472000019
PM 26771563
DA 2018-10-20
ER

PT J
AU Do Nascimento, ES
   Lima, HLS
   Barroso, MKD
   Brigida, AIS
   Andrade, FK
   Borges, MD
   Morais, JPS
   Muniz, CR
   Rosa, MD
AF Do Nascimento, Eligenes Sampaio
   Silva Lima, Helder Levi
   De Araujo Barroso, Maria Karolina
   Santa Brigida, Ana Iraidy
   Andrade, Fabia Karine
   Borges, Maria De Fatima
   Saraiva Morais, Joao Paulo
   Muniz, Celli Rodrigues
   Rosa, Morsyleide De Freitas
TI Mesquite (Prosopis juliflora (Sw.)) Extract is an Alternative Nutrient
   Source for Bacterial Cellulose Production
SO JOURNAL OF BIOBASED MATERIALS AND BIOENERGY
LA English
DT Article
DE Fermentation; Nanotechnology; Agribusiness; Biotechnology; Agroindustry;
   Carbohydrate
ID WATER
AB Bacterial cellulose (BC) is a naturally occurring, nanoscale biomaterial with a high purity grade and excellent physical and chemical properties. There are several natural, renewable sugar-rich sources and byproducts that function as potential fermentative media in order to replace the synthetic medium that is used in BC production. In this study, mesquite pod extract was evaluated as an alternative fermentation medium for the production of bacterial cellulose using Gluconobacter hansenii ATCC 23769 fermentation. Initially, we characterized the total sugar content, pH, nitrogen content, and soluble solids of mesquite pod extract. We also evaluated the bacterial cellulose yields in relation to the various culture conditions while the initial concentration of sugars, pH and supplementary nitrogen sources were being analyzed. Highest cellulose yield was obtained at 30 g.L-1 carbohydrate concentration, pH 4.0 and additional yeast extract content of 10 g.L-1). Therefore, it is possible to produce BC using a fermentative medium from an agroindustrial source and achieve a better mass production in comparison to those generated with a synthetic medium.
C1 [Do Nascimento, Eligenes Sampaio; Silva Lima, Helder Levi; De Araujo Barroso, Maria Karolina] Univ Fed Ceara, Ave Univ 2853, BR-60020181 Fortaleza, Ceara, Brazil.
   [Santa Brigida, Ana Iraidy] Embrapa Agroind Alimentos, Av Amer 29501, BR-23020470 Rio De Janeiro, RJ, Brazil.
   [Andrade, Fabia Karine; Borges, Maria De Fatima; Muniz, Celli Rodrigues; Rosa, Morsyleide De Freitas] Embrapa Agroind Trop, Rua Dra Sara Mesquita 2270, BR-60511110 Fortaleza, Ceara, Brazil.
   [Saraiva Morais, Joao Paulo] Embrapa Algodao, Rua Oswaldo Cruz 1143, BR-58428095 Campina Grande, PB, Brazil.
RP Morais, JPS (reprint author), Embrapa Algodao, Rua Oswaldo Cruz 1143, BR-58428095 Campina Grande, PB, Brazil.
EM joao.morais@embrapa.br
RI Santa Brigida, Ana Iraidy/E-2626-2013
OI Santa Brigida, Ana Iraidy/0000-0002-4687-0736; Saraiva Morais, Joao
   Paulo/0000-0002-2190-248X
FU Embrapa; CAPES; FUNCAP; CNPq
FX This work was funded by Embrapa, CAPES, FUNCAP, and CNPq.
CR Almeida IF, 2014, EUR J PHARM BIOPHARM, V86, P332, DOI 10.1016/j.ejpb.2013.08.008
   Andrade FK, 2010, BIOTECH AGR IND MED, P427
   AOAC, 1995, OFFICIAL METHODS ANA, V2
   Ayanu Y., 2015, REG ENV CHANG, V15, P1
   Bahru T., 2014, ETHIOP J SCI, V32, P2
   Carreira P., 2011, BIORESOURCE TECHNOL, V102, P15
   Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107
   Choge SK, 2007, WATER SA, V33, P419
   Chopra D., 2001, INDIAN J ANIM NUTR, V18, P3
   Cobain E. P., 2011, AFR J BIOTECHNOL, V10, P27
   da Silva C. G. M., 2010, ELECTRON J BIOTECHN, V13, P5
   da Silva C. G. M., 2001, SCI AGR, V69, P1
   Embuscado M. E., 1994, FOOD HYDROCOLLOID, V8, P5
   Fugelsang K. C., 2007, WINE MICROBIOLOGY PR
   Goldeberg R. N., 2012, J PHYS CHEM REF DATA, V31, P2
   Gomes FP, 2013, BIOMASS BIOENERG, V55, P205, DOI 10.1016/j.biombioe.2013.02.004
   Guilherme AA, 2009, J FOOD PROCESS ENG, V32, P606, DOI 10.1111/j.1745-4530.2007.00233.x
   Hestrin S., 1954, BIOCHEM J, V58, P2
   Hong F., 2008, CARBOHYD POLYM, V72, P3
   Huang Y, 2014, CELLULOSE, V21, P1, DOI 10.1007/s10570-013-0088-z
   Iguchi M., 2000, J MATER SCI, V35, P2
   Jiang FJ, 2015, J POWER SOURCES, V279, P21, DOI 10.1016/j.jpowsour.2014.12.090
   Jozala A. F., 2014, APPL MICROBIOL BIOT, V99, P3
   Jung H. I, 2010, BIORESOURCE TECHNOL, V101, P10
   Kanauchi O., 2015, CURR MED CHEM, V12, P26
   Kattak W. A., 2014, J POLYM ENVIRON, V23, P1
   Keshk S., 2006, ENZYME MICROB TECHNO, V40, P1
   Keshk S., 2005, AFR J BIOTECHNOL, V4, P6
   Kiziltas EE, 2015, CARBOHYD POLYM, V124, P131, DOI 10.1016/j.carbpol.2015.01.036
   Klemm D., 2005, ANGEW CHEM, V44, P22
   Kongruang S., 2008, APPL BIOCHEM BIOTECH, V148, P3
   Kose R., 2013, CELULOSE, V20, P6
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   Kurosumi A., 2009, CARBOHYD POLYM, V76, P2
   Li Z, 2015, CARBOHYD POLYM, V120, P115, DOI 10.1016/j.carbpol.2014.11.061
   Lin DH, 2014, BIORESOURCE TECHNOL, V151, P113, DOI 10.1016/j.biortech.2013.10.052
   MILLER GJ, 1959, ANAL CHEM, V31, P320, DOI 10.1021/ac60146a607
   Mohammadkazemi F, 2015, CARBOHYD POLYM, V117, P518, DOI 10.1016/j.carbpol.2014.10.008
   Mohan C., 2003, GUIDE PREPARATION US
   Pecoraro E., 2008, MONOMERS POLYM COMPO, V1, P369
   Ramasamy S, 2014, BIORESOURCES, V9, P7209
   Ruka D. R., 2012, CARBOHYD POLYM, V89, P2
   Santos S. S., 2013, BIORESOURCES, V8, P3
   Sawal R. K., 2004, ASIAN AUSTRALASIAN J, V17, P5
   Shitanda D., 2013, J AGR SCI TECHNOL, V15, P1
   Son HJ, 2001, BIOTECHNOL APPL BIOC, V33, P1, DOI 10.1042/BA20000065
   Suriapparao D. V., 2015, ENERG FUEL, V29, P4
   Thompson D. N., 2001, APPL BIOCHEM BIOTECH, V91-93, P1
   Tsouko E, 2015, INT J MOL SCI, V16, P14832, DOI 10.3390/ijms160714832
   Vasquez A., 2013, J POLYM ENVIRON, V21, P2
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   Yang XY, 2014, INDIAN J MICROBIOL, V54, P268, DOI 10.1007/s12088-014-0450-3
   Yoshinaga F., 1997, BIOSCI BIOTECH BIOCH, V61, P2
NR 53
TC 1
Z9 1
U1 0
U2 3
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1556-6560
EI 1556-6579
J9 J BIOBASED MATER BIO
JI J. Biobased Mater. Bioenergy
PD FEB
PY 2016
VL 10
IS 1
BP 63
EP 70
DI 10.1166/jbmb.2016.1568
PG 8
WC Chemistry, Applied; Energy & Fuels; Materials Science, Biomaterials
SC Chemistry; Energy & Fuels; Materials Science
GA DZ2SC
UT WOS:000385690500008
DA 2018-10-20
ER

PT J
AU Mohite, BV
   Suryawanshi, RK
   Patil, SV
AF Mohite, Bhavana V.
   Suryawanshi, Rahul K.
   Patil, Satish V.
TI STUDY ON THE DRUG LOADING AND RELEASE POTENTIAL OF BACTERIAL CELLULOSE
SO CELLULOSE CHEMISTRY AND TECHNOLOGY
LA English
DT Article
DE biomaterial; biocompatible; antimicrobial activity; swelling ratio; drug
   loading potential
ID HANSENII NCIM 2529; STATISTICAL OPTIMIZATION; CULTURE-CONDITIONS;
   COMPOSITES
AB Bacterial cellulose (BC) is known for its unique characteristic properties, which make it a versatile biomaterial for application in various domains. Benzalconium chloride, which is widely used as antimicrobial drug in wound dressing, was used to test the drug loading and release potential of BC. The drug loading ability increased with an increase in drug concentration. The BC gradually released up to 90% of the drug within 24 h. The antibacterial activity of drug loaded BC was tested against Escherichia coli and Staphylococcus aureus. The non-toxic biocompatible nature of BC was confirmed by an MTT assay on human PBMCs with 90% cell viability, which allows its application as a regenerative biomaterial. The liquid absorbing capacity and release rate were calculated as swelling ratio and water release rate, and the results supported its anticipated use as antimicrobial wound dressing material. Thus, BC was demonstrated as a promising candidate for application as modern wound dressing material due to its drug loading and release potential.
C1 [Mohite, Bhavana V.; Suryawanshi, Rahul K.; Patil, Satish V.] North Maharashtra Univ, Sch Life Sci, Jalgaon 425001, MS, India.
RP Patil, SV (reprint author), North Maharashtra Univ, Sch Life Sci, Jalgaon 425001, MS, India.
EM satish.patil7@gmail.com
FU UGC BSR RSSMS scheme, New Delhi
FX The Fellowship to authors (B.V.M. and R.K.S.) under UGC BSR RSSMS
   scheme, New Delhi, is greatly acknowledged. Authors are grateful to
   U.G.C. and D.S.T. for making the research facilities available under the
   UGC-SAP and UGC-FIST programmes sanctioned to the School of Life
   Sciences.
CR ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Bae S, 2005, BIOTECHNOL BIOENG, V90, P20, DOI 10.1002/bit.20325
   Bae S, 2004, J BIOSCI BIOENG, V97, P33
   Chang WS, 2016, FOOD HYDROCOLLOID, V53, P75, DOI 10.1016/j.foodhyd.2014.12.009
   FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kirby W. M., 1957, ANTIBIOT ANNU, V892, P1956
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Mohammadkazemi F, 2015, CELL CHEM TECHNOL, V49, P455
   Mohite BV, 2014, CARBOHYD POLYM, V106, P132, DOI 10.1016/j.carbpol.2014.02.012
   Mohite BV, 2013, APPL BIOCHEM BIOTECH, V169, P1497, DOI 10.1007/s12010-013-0092-7
   Mohite BV, 2012, CELLULOSE, V19, P1655, DOI 10.1007/s10570-012-9760-y
   Nakagaito AN, 2005, APPL PHYS A-MATER, V80, P93, DOI 10.1007/s00339-004-2932-3
   Shi QS, 2013, CELL CHEM TECHNOL, V47, P503
   Song C., 2011, CHEM MATER, V21, P1524
   Sulaeva I, 2015, BIOTECHNOL ADV, V33, P1547, DOI 10.1016/j.biotechadv.2015.07.009
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wei B, 2011, CARBOHYD POLYM, V84, P533, DOI 10.1016/j.carbpol.2010.12.017
   Yamanaka S., 1991, European Patent, Patent No. 0396344
NR 24
TC 4
Z9 4
U1 0
U2 5
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 0576-9787
J9 CELL CHEM TECHNOL
JI Cell Chem. Technol.
PD FEB
PY 2016
VL 50
IS 2
BP 219
EP 223
PG 5
WC Materials Science, Paper & Wood
SC Materials Science
GA DN1OP
UT WOS:000376835600005
DA 2018-10-20
ER

PT J
AU Giuliani, A
   Manescu, A
   Mohammadi, S
   Mazzoni, S
   Piattelli, A
   Mangano, F
   Iezzi, G
   Mangano, C
AF Giuliani, Alessandra
   Manescu, Adrian
   Mohammadi, Sara
   Mazzoni, Serena
   Piattelli, Adriano
   Mangano, Francesco
   Iezzi, Giovanna
   Mangano, Carlo
TI Quantitative Kinetics Evaluation of Blocks Versus Granules of Biphasic
   Calcium Phosphate Scaffolds (HA/beta-TCP 30/70) by Synchrotron Radiation
   X-ray Microtomography: A Human Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE MicroCT; histological analysis; long-term study; sinus augmentation
ID BONE REGENERATION; IMAGE-ANALYSIS; CERAMICS
AB Introduction: Successful bone regeneration using both granules and blocks of biphasic calcium phosphate materials has been reported in the recent literature, in some clinical applications for maxillary sinus elevation, but the long-term kinetics of bone regeneration has still not been fully investigated.
   Materials and Methods: Twenty-four bilateral sinus augmentation procedures were performed and grafted with hydroxyapatite/beta-tricalcium phosphate 30/70, 12 with granules and 12 with blocks. The samples were retrieved at different time points and were evaluated for bone regeneration, graft resorption, neo-vascularization, and morphometric parameters by computed microtomography and histology.
   Results: A large amount of newly formed bone was detected in the retrieved specimens, together with a good rate of biomaterial resorption and the formation of a homogeneous and rich net of new vessels. The morphometric values were comparable at 5/6 months from grafting but, 9 months after grafting, revealed that the block-based specimens mimicked slightly better than granule-based samples the healthy native bone of the maxillary site.
   Conclusion: The scaffold morphology was confirmed to influence the long-term kinetics of bone regeneration.
C1 [Giuliani, Alessandra; Manescu, Adrian; Mazzoni, Serena] Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Sez Biochim Biol & Fis, I-60131 Ancona, Italy.
   [Mohammadi, Sara] Elettra Sincrotrone Trieste SCpA, Trieste, Italy.
   [Mohammadi, Sara] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy.
   [Mohammadi, Sara] LAC1 USC Med Ctr, Los Angeles, CA USA.
   [Piattelli, Adriano; Iezzi, Giovanna; Mangano, Carlo] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
RP Giuliani, A (reprint author), Univ Politecn Marche, Dipartimento Sci Clin Specialist & Odontostomatol, Via Brecce Bianche 1, I-60131 Ancona, Italy.
EM a.giuliani@univpm.it
RI Giuliani, Alessandra/O-9097-2018
OI Giuliani, Alessandra/0000-0003-4177-7441; Manescu,
   Adrian/0000-0001-6922-289X
FU Ministero dell'Istruzione, Universita e Ricerca [Prot. 20102ZLNJ5]
FX ELETTRA User Office is kindly acknowledged for providing beam time for
   the microCT experiments. This work arises from a collaboration between
   COST NAMABIO partners (A. Manescu, A. Giuliani, S. Mazzoni, and A.
   Piattelli) and was financed from the Program PRIN funds of Ministero
   dell'Istruzione, Universita e Ricerca (Prot. 20102ZLNJ5).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Barboni B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063256
   Bostrom R. D., 1997, SYNTHETIC BIODEGRADA, P215
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Giuliani A, 2010, INNOVATIVE TECHNOLOGICAL MATERIALS: STRUCTURAL PROPERTIES BY NEUTRON SCATTERING, SYNCHROTRON RADIATION AND MODELING, P123, DOI 10.1007/978-3-642-12059-6_5
   Giuliani A, 2014, CLIN IMPLANT DENT R, V16, P736, DOI 10.1111/cid.12039
   HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kak A. C., 2001, PRINCIPLES COMPUTERI
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim YH, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035007
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Komlev VS, 2009, TISSUE ENG PART C-ME, V15, P425, DOI 10.1089/ten.tec.2008.0428
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Mangano C, 2015, J ORAL IMPLANTOL, V41, P241, DOI 10.1563/AAID-JOI-D-13-00053
   Mangano C, 2013, INT J ORAL MAX IMPL, V28, P51, DOI 10.11607/jomi.2667
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Montanan F., 2003, SYRMEP TOMO PROJECT
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Ohayon L, 2014, INT J ORAL MAX IMPL, V29, P1143, DOI 10.11607/jomi.3422
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   Rasband WS, 1997, IMAGEJ
   Renghini C, 2013, J EUR CERAM SOC, V33, P1553, DOI 10.1016/j.jeurceramsoc.2012.10.016
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   ROLDAN JC, 2007, EUR CELL MAT S, V14, P91
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schwarz F, 2009, J PERIODONTOL, V80, P1315, DOI 10.1902/jop.2009.090034
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
NR 38
TC 10
Z9 10
U1 1
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD FEB
PY 2016
VL 25
IS 1
BP 6
EP 15
DI 10.1097/ID.0000000000000363
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DN5WG
UT WOS:000377141700002
PM 26630463
DA 2018-10-20
ER

PT J
AU Jakus, AE
   Rutz, AL
   Shah, RN
AF Jakus, Adam E.
   Rutz, Alexandra L.
   Shah, Ramille N.
TI Advancing the field of 3D biomaterial printing
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE bioprinting; 3D printing; tissue engineering; biofabrication;
   regenerative engineering; bioinks; biomaterials
ID GELATIN METHACRYLATE HYDROGELS; TISSUE-ENGINEERED CONSTRUCTS;
   CELL-COMPATIBLE HYDROGELS; BIOMEDICAL APPLICATIONS; REGENERATIVE
   MEDICINE; FREEFORM FABRICATION; BIOASSEMBLY TOOL; SCAFFOLD DESIGN; PLGA
   SCAFFOLDS; CROSS-LINKING
AB 3D biomaterial printing has emerged as a potentially revolutionary technology, promising to transform both research and medical therapeutics. Although there has been recent progress in the field, on-demand fabrication of functional and transplantable tissues and organs is still a distant reality. To advance to this point, there are two major technical challenges that must be overcome. The first is expanding upon the limited variety of available 3D printable biomaterials (biomaterial inks), which currently do not adequately represent the physical, chemical, and biological complexity and diversity of tissues and organs within the human body. Newly developed biomaterial inks and the resulting 3D printed constructs must meet numerous interdependent requirements, including those that lead to optimal printing, structural, and biological outcomes. The second challenge is developing and implementing comprehensive biomaterial ink and printed structure characterization combined with in vitro and in vivo tissue- and organ-specific evaluation. This perspective outlines considerations for addressing these technical hurdles that, once overcome, will facilitate rapid advancement of 3D biomaterial printing as an indispensable tool for both investigating complex tissue and organ morphogenesis and for developing functional devices for a variety of diagnostic and regenerative medicine applications.
C1 [Jakus, Adam E.; Shah, Ramille N.] Northwestern Univ, Mat Sci & Engn, Evanston, IL 60208 USA.
   [Rutz, Alexandra L.] Northwestern Univ, Biomed Engn, Evanston, IL 60208 USA.
   [Shah, Ramille N.] Northwestern Univ, Comprehens Transplant Ctr, Chicago, IL 60611 USA.
   [Shah, Ramille N.] Northwestern Univ, Dept Surg, Chicago, IL 60611 USA.
   [Jakus, Adam E.; Rutz, Alexandra L.; Shah, Ramille N.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
RP Shah, RN (reprint author), Northwestern Univ, Mat Sci & Engn, Evanston, IL 60208 USA.; Shah, RN (reprint author), Northwestern Univ, Comprehens Transplant Ctr, Chicago, IL 60611 USA.; Shah, RN (reprint author), Northwestern Univ, Dept Surg, Chicago, IL 60611 USA.; Shah, RN (reprint author), Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
EM ramille-shah@northwestern.edu
RI Shah, Ramille/E-3737-2010
CR Abu-Absi SF, 2002, EXP CELL RES, V274, P56, DOI 10.1006/excr.2001.5467
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Bostman OM, 1998, J BONE JOINT SURG AM, V80A, P1791, DOI 10.2106/00004623-199812000-00010
   Campos DFD, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015003
   Censi R, 2011, ADV FUNCT MATER, V21, P1833, DOI 10.1002/adfm.201002428
   Chang CC, 2011, J BIOMED MATER RES B, V98B, P160, DOI 10.1002/jbm.b.31831
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Cohen DL, 2011, TISSUE ENG PART C-ME, V17, P239, DOI [10.1089/ten.tec.2010.0093, 10.1089/ten.TEC.2010.0093]
   Cohen DL, 2006, TISSUE ENG, V12, P1325, DOI 10.1089/ten.2006.12.1325
   Crawford AR, 1998, HEPATOLOGY, V28, P323, DOI 10.1002/hep.510280206
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duan B, 2011, MRS BULL, V36, P998, DOI 10.1557/mrs.2011.270
   Fedorovich NE, 2008, TISSUE ENG PT A, V14, P127, DOI 10.1089/ten.a.2007.0158
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Fedorovich NE, 2009, BIOMACROMOLECULES, V10, P1689, DOI 10.1021/bm801463q
   Franco J, 2010, ACTA BIOMATER, V6, P218, DOI 10.1016/j.actbio.2009.06.031
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gerstle TL, 2014, PLAST RECONSTR SURG, V133, P446, DOI 10.1097/01.prs.0000436844.92623.d3
   Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Hoque ME, 2009, TISSUE ENG PT A, V15, P3013, DOI [10.1089/ten.tea.2008.0355, 10.1089/ten.TEA.2008.0355]
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jakus AE, 2015, ACS NANO, V9, P4636, DOI 10.1021/acsnano.5b01179
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Krishnan SP, 2012, J BONE JOINT SURG BR, V94B, P1457, DOI 10.1302/0301-620X.94B11.29350
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee W, 2010, BIOTECHNOL BIOENG, V105, P1178, DOI 10.1002/bit.22613
   Leigh SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049365
   Lethaus B, 2012, J CRANIO MAXILL SURG, V40, P43, DOI 10.1016/j.jcms.2011.01.007
   Loozen LD, 2013, J MATER CHEM B, V1, P6619, DOI 10.1039/c3tb21093f
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Maezawa Y, 2013, SEDIN GEIBISCHS KIDN, V1, P721
   Maher P S, 2008, 4th European Conference of the International Federation for Medical and Biological Engineering - ECIFMBE 2008, P2200
   Maher PS, 2009, RAPID PROTOTYPING J, V15, P204, DOI 10.1108/13552540910960307
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Mannoor MS, 2013, NANO LETT, V13, P2634, DOI 10.1021/nl4007744
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nam D, 2012, J KNEE SURG, V25, P213, DOI 10.1055/s-0032-1319785
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Olszewski R, 2013, P BEL R ACAD MED, V2
   Paiva WS, 2007, ARQ NEURO-PSIQUIAT, V65, P443, DOI 10.1590/S0004-282X2007000300015
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Park SA, 2011, BIOPROC BIOSYST ENG, V34, P505, DOI 10.1007/s00449-010-0499-2
   Parthasarathy Jayanthi, 2014, Ann Maxillofac Surg, V4, P9, DOI 10.4103/2231-0746.133065
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Petzold R, 1999, COMPUT MED IMAG GRAP, V23, P277, DOI 10.1016/S0895-6111(99)00025-7
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Rahmati S, 2012, RAPID PROTOTYPING J, V18, P389, DOI 10.1108/13552541211250382
   Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010
   Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076
   Schepers R, 2012, HEAD NECK ONCOL, V4, P44
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Serra T, 2013, ORGANOGENESIS, V9, P239, DOI 10.4161/org.26048
   Shim JH, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/8/085014
   Sidambe AT, 2014, MATERIALS, V7, P8168, DOI 10.3390/ma7128168
   Sinn DP, 2006, J CRANIOFAC SURG, V17, P869, DOI 10.1097/01.scs.0000230618.95012.1d
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI [10.1089/ten.tea.2009.0798, 10.1089/ten.TEA.2009.0798]
   Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045
   Smith CM, 2004, TISSUE ENG, V10, P1566, DOI 10.1089/1076327042500274
   Smith CM, 2007, TISSUE ENG, V13, P373, DOI 10.1089/ten.2006.0101
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tirella A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/045002
   Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123
   van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014
   Visser J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7933
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 92
TC 20
Z9 20
U1 8
U2 136
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2016
VL 11
IS 1
AR 014102
DI 10.1088/1748-6041/11/1/014102
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL2TX
UT WOS:000375489200003
PM 26752507
DA 2018-10-20
ER

PT J
AU Renaud, M
   Farkasdi, S
   Pons, C
   Panayotov, I
   Collart-Dutilleul, PY
   Taillades, H
   Desoutter, A
   Bousquet, P
   Varga, G
   Cuisinier, F
   Yachouh, J
AF Renaud, Matthieu
   Farkasdi, Sandor
   Pons, Coline
   Panayotov, Ivan
   Collart-Dutilleul, Pierre-Yves
   Taillades, Hubert
   Desoutter, Alban
   Bousquet, Philippe
   Varga, Gabor
   Cuisinier, Frederic
   Yachouh, Jacques
TI A New Rat Model for Translational Research in Bone Regeneration
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID CALCIUM-PHOSPHATE; STEM-CELLS; DEFECTS; MARROW; RECONSTRUCTION
AB The European Union (EU) directive 2010/63/EUon the protection of animals used for scientific purpose focused on reducing the number of animals and refinement of breeding. Animal studies are necessary to protect human health. Lots of animal models exist to study bone regeneration, but a reliable, well reproducible, and relatively inexpensive model with the possibility for multiple testing in the same animal is still missing. Rats may serve as good models for this due to the small animal size and good cost/benefit ratio. The present study aimed to develop a novel rat caudal vertebrae critical size defect model for bone regeneration and implant osseointegration studies The study was performed using Wistar rats with weight from 380 to 450 g. An incision was made on the dorsal side of the tail. After skin and muscles retractions, the vertebrae were exposed. Critical size defects for bone tissue engineering or implant placements for titanium body experiments were possible in each of the first four caudal vertebrae. Micro-computed tomography (CT) and histology were used to detect bone growth. There was no bone formation in the defects after 1 or 2 months of healing. When a calcium phosphate biomaterial was used (Bio-Oss (R); Geistlich Pharma AG, Wolhusen, Switzerland), a good stability of the material in the defect was noted and bone growth was visible after 1 or 2 months. Results based on implant placement showed good primary stability after 3 months of healing. MicroCT showed integrated implant position through the vertebra. These results suggest that the rat caudal vertebrae may serve as a good new model for studying bone regeneration and implant osseointegration with the possibility of multiple testing within the same experimental animal and the potential to decrease number of experimental animals.
C1 [Renaud, Matthieu; Pons, Coline; Panayotov, Ivan; Collart-Dutilleul, Pierre-Yves; Desoutter, Alban; Bousquet, Philippe; Cuisinier, Frederic; Yachouh, Jacques] Univ Montpellier, Lab Bioingn & Nanosci EA4203, 545 Ave Prof Jean Louis Vial, F-34193 Montpellier, France.
   [Farkasdi, Sandor; Varga, Gabor] Semmelweis Univ, Dept Oral Biol, H-1085 Budapest, Hungary.
   [Taillades, Hubert] Univ Montpellier, Fac Med, Animalerie, 545 Ave Prof Jean Louis Vial, F-34193 Montpellier, France.
RP Renaud, M (reprint author), Univ Montpellier, Lab Bioingn & Nanosci EA4203, 545 Ave Prof Jean Louis Vial, F-34193 Montpellier, France.
EM matt.renaud18@live.fr
FU French-Hungarian TET-Balaton Program [TET_12_FR-2-2014-0010]
FX The authors thank the histology platform RHEM (INSERM, Montpellier).
   This work was supported by the French-Hungarian TET-Balaton Program
   (TET_12_FR-2-2014-0010).
CR Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bhardwaj A., 2012, INT J AGROVET MED SC, V6, P1
   BLAZSEK I, 1986, BIOMED PHARMACOTHER, V40, P28
   Blazsek J, 2009, PATHOL ONCOL RES, V15, P567, DOI 10.1007/s12253-009-9156-y
   Boix D, 2006, J MATER SCI-MATER M, V17, P1145, DOI 10.1007/s10856-006-0542-7
   Chen WC, 2013, BIOMATERIALS, V34, P9917, DOI 10.1016/j.biomaterials.2013.09.002
   Dannan A., 2007, INTERNET J VET MED, V5, P1
   Ebina H, 2009, ORAL DIS, V15, P273, DOI 10.1111/j.1601-0825.2009.01522.x
   Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051
   Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P285
   Kummari SR, 2009, CALCIFIED TISSUE INT, V85, P127, DOI 10.1007/s00223-009-9257-3
   Mackenzie SJ, 2015, MUSCLE NERVE, V52, P94, DOI 10.1002/mus.24498
   Morad G, 2013, ARCH ORAL BIOL, V58, P1818, DOI 10.1016/j.archoralbio.2013.08.011
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pellegrini G, 2009, J DENT RES, V88, P1065, DOI 10.1177/0022034509349748
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Streckbein P, 2013, J CRANIO MAXILL SURG, V41, P496, DOI 10.1016/j.jcms.2013.04.002
   Ysander M, 2001, J REHABIL RES DEV, V38, P183
   Zucco F., 2001, ALTERNATIVE METHODS
NR 19
TC 3
Z9 3
U1 1
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB
PY 2016
VL 22
IS 2
BP 125
EP 131
DI 10.1089/ten.tec.2015.0187
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DM4AP
UT WOS:000376288200005
DA 2018-10-20
ER

PT J
AU Liu, Z
   Vunjak-Novakovic, G
AF Liu, Zen
   Vunjak-Novakovic, Gordana
TI Modeling tumor microenvironments using custom-designed biomaterial
   scaffolds
SO CURRENT OPINION IN CHEMICAL ENGINEERING
LA English
DT Article
ID BREAST-CANCER CELLS; ROUS-SARCOMA-VIRUS; IN-VITRO; 3-DIMENSIONAL
   CULTURES; DRUG-RESISTANCE; HYALURONIC-ACID; 3D SCAFFOLDS; BONE-MARROW;
   COLLAGEN I; MATRIX
AB The dominant roles of the tumor microenvironment in regulating tumor formation, progression, and metastasis have driven the application of tissue engineering strategies in cancer biology. Highly dynamic and reciprocal communication of tumor cells with their surroundings suggests that studying cancer in custom-designed biomaterial scaffolds may lead to novel therapeutic targets and therapeutic regimens more reliably than traditional monolayer tissue culture models. As tissue engineering becomes progressively more successful in recapitulating the native tumor environment, critical insights into mechanisms of tumor resistance may be elucidated, to impact clinical practice, drug development, and biological research. We review here the recent developments in the use of custom-designed biomaterial scaffolds for modeling human tumors.
C1 [Liu, Zen; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY USA.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Med, New York, NY USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, New York, NY USA.; Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Med, New York, NY USA.
EM gv2131@columbia.edu
FU National Institutes of Health [EB002520, UH3EB017103]
FX The authors gratefully acknowledge funding support by the National
   Institutes of Health (grants EB002520 and UH3EB017103).
CR Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328
   Boghaert E, 2012, P NATL ACAD SCI USA, V109, P19632, DOI 10.1073/pnas.1118872109
   Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056
   Chwalek K, 2014, ADV DRUG DELIVER REV, V79-80, P30, DOI 10.1016/j.addr.2014.05.006
   Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006
   DOLBERG DS, 1984, NATURE, V309, P552, DOI 10.1038/309552a0
   Dunne LW, 2014, BIOMATERIALS, V35, P4940, DOI 10.1016/j.biomaterials.2014.03.003
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   Fong ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/pnas.1221403110
   Gill BJ, 2012, CANCER RES, V72, P6013, DOI 10.1158/0008-5472.CAN-12-0895
   Girard YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075345
   Goodison S, 2003, CLIN CANCER RES, V9, P3808
   Hoshiba T, 2013, BIOCHEM BIOPH RES CO, V439, P291, DOI 10.1016/j.bbrc.2013.08.038
   Huang H, 2013, PLOS ONE, V8
   Jabbari E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132377
   Ki CS, 2013, BIOMACROMOLECULES, V14, P3017, DOI 10.1021/bm4004496
   Kievit FM, 2014, BIOMATERIALS, V35, P9137, DOI 10.1016/j.biomaterials.2014.07.037
   Kievit FM, 2013, ADV HEALTHC MATER, V2, P1651, DOI 10.1002/adhm.201300092
   Ko CY, 2012, BIOMATERIALS, V33, P876, DOI 10.1016/j.biomaterials.2011.10.002
   Koch L, 2013, CURR PHARM BIOTECHNO, V14, P91
   Korah R, 2004, CANCER RES, V64, P4514, DOI 10.1158/0008-5472.CAN-03-3853
   Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   MARTIN GS, 1970, NATURE, V227, P1021, DOI 10.1038/2271021a0
   Menon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017277
   Mishra DK, 2012, ANN THORAC SURG, V93, P1075, DOI 10.1016/j.athoracsur.2012.01.011
   Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c
   Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924
   O'Brien CM, 2015, TISSUE ENG PART B-RE, V21, P103, DOI [10.1089/ten.TEB.2014.0168, 10.1089/ten.teb.2014.0168]
   Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071
   Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109
   Pathi SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008849
   Pedron S, 2013, BIOMATERIALS, V34, P7408, DOI 10.1016/j.biomaterials.2013.06.024
   Phan-Lai V, 2013, BIOMACROMOLECULES, V14, P1330, DOI 10.1021/bm301928u
   Price KJ, 2012, BIOCHEM BIOPH RES CO, V427, P343, DOI 10.1016/j.bbrc.2012.09.059
   Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38
   Reichert JC, 2010, BIOMATERIALS, V31, P7928, DOI 10.1016/j.biomaterials.2010.06.055
   Rodenhizer D, 2015, NAT MAT, V23
   Schmidt M, 2001, MOL PHARMACOL, V60, P900
   Shi ZD, 2009, AM J PHYSIOL-HEART C, V297, pH1225, DOI 10.1152/ajpheart.00369.2009
   Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254
   Sieh S, 2010, ORGANOGENESIS, V6, P181, DOI 10.4161/org.6.3.12041
   Stratmann AT, 2014, MOL ONCOL, V8, P351, DOI 10.1016/j.molonc.2013.11.009
   Szot CS, 2013, TISSUE ENG PART C-ME, V19, P864, DOI [10.1089/ten.tec.2012.0684, 10.1089/ten.TEC.2012.0684]
   Talukdar S, 2012, ADV FUNCT MATER, V22, P4778, DOI 10.1002/adfm.201200375
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Verbridge SS, 2010, TISSUE ENG PT A, V16, P2133, DOI [10.1089/ten.tea.2009.0670, 10.1089/ten.TEA.2009.0670]
   Villasante A, 2014, BIOMATERIALS, V35, P5785, DOI 10.1016/j.biomaterials.2014.03.081
   Wang F, 2002, J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494
   Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3
   Xu X, 2014, BIOTECHNOL ADV, V32, P1256, DOI 10.1016/j.biotechadv.2014.07.009
   Xu X, 2014, BIOMATERIALS, V35, P3319, DOI 10.1016/j.biomaterials.2013.12.080
   Yang ZH, 2011, INT J NANOMED, V6, P303, DOI 10.2147/IJN.S15279
   Yates C, 2007, ADV CANCER RES, V97, P225, DOI 10.1016/S0065-230X(06)97010-9
NR 59
TC 11
Z9 11
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-3398
J9 CURR OPIN CHEM ENG
JI Curr. Opin. Chem. Eng.
PD FEB
PY 2016
VL 11
BP 94
EP 105
DI 10.1016/j.coche.2016.01.012
PG 12
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA DL1QM
UT WOS:000375406800016
PM 27152253
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chen, FM
   Liu, XH
AF Chen, Fa-Ming
   Liu, Xiaohua
TI Advancing biomaterials of human origin for tissue engineering
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Raw materials; Biopolymers; Extracellular matrix; Tissue
   decellularization; Biomimetic design; Blood-derived biomaterials;
   Transplantation
ID PLATELET-RICH PLASMA; MESENCHYMAL STEM-CELLS; STROMAL-VASCULAR FRACTION;
   DEMINERALIZED BONE-MATRIX; FETAL BOVINE SERUM; AUTOLOGOUS CHONDROCYTE
   IMPLANTATION; AMNIOTIC MEMBRANE TRANSPLANTATION; HUMAN
   PERIODONTAL-LIGAMENT; GROWTH-FACTOR DELIVERY; HUMAN ADIPOSE-TISSUE
AB Biomaterials have played an increasingly prominent role in the success of biomedical devices and in the development of tissue engineering, which seeks to unlock the regenerative potential innate to human tissues organs in a state of deterioration and to restore or reestablish normal bodily function. Advances in our understanding of regenerative biomaterials and their roles in new tissue formation can potentially open a new frontier in the fast-growing field of regenerative medicine. Taking inspiration from the role and multi component construction of native extracellular matrices (ECMs) for cell accommodation, the synthetic biomaterials produced today routinely incorporate biologically active components to define an artificial in vivo milieu with complex and dynamic interactions that foster and regulate stem cells, similar to the events occurring in a natural cellular microenvironment. The range and degree of biomaterial sophistication have also dramatically increased as more knowledge has accumulated through materials science, matrix biology and tissue engineering. However, achieving clinical translation and commercial success requires regenerative biomaterials to be not only efficacious and safe but also cost-effective and convenient for use and production. Utilizing biomaterials of human origin as building blocks for therapeutic purposes has provided a facilitated approach that closely mimics the critical aspects of natural tissue with regard to its physical and chemical properties for the orchestration of wound healing and tissue regeneration. In addition to directly using tissue transfers and transplants for repair, new applications of human-derived biomaterials are now focusing on the use of naturally occurring biomacromolecules, decellularized ECM scaffolds and autologous preparations rich in growth factors/non-expanded stem cells to either target acceleration/magnification of the body's own repair capacity or use nature's paradigms to create new tissues for restoration. In particular, there is increasing interest in separating ECMs into simplified functional domains and/or biopolymeric assemblies so that these components/constituents can be discretely exploited and manipulated for the production of bioscaffolds and new biomimetic biomaterials. Here, following an overview of tissue auto-hallo-transplantation, we discuss the recent trends and advances as well as the challenges and future directions in the evolution and application of human-derived biomaterials for reconstructive surgery and tissue engineering. In particular, we focus on an exploration of the structural, mechanical, biochemical and biological information present in native human tissue for bioengineering applications and to provide inspiration for the design of future biomaterials. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Chen, Fa-Ming] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, 145th West Changle Rd, Xian 710032, Peoples R China.
   [Chen, Fa-Ming] Fourth Mil Med Univ, Sch Stomatol, Translat Res Team, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Chen, Fa-Ming] Fourth Mil Med Univ, Sch Stomatol, Biomat Unit, Xian 710032, Peoples R China.
   [Liu, Xiaohua] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA.
RP Chen, FM (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, 145th West Changle Rd, Xian 710032, Peoples R China.
EM cfmsunhh@fmmu.edu.cn
RI Liu, Xiaohua/L-7766-2014
OI Liu, Xiaohua/0000-0003-0177-0886
FU Program for New Century Excellent Talents in University [NCET-12-1005];
   Ministry of Science and Technology Innovation Talent Promotion Plan of
   Shaanxi Province [2014SR2014]; NIH/NIDCR [R03DE22838, R41DE024343];
   National Natural Science Foundation of China [31170912, 81471791];
   Program for Changjiang Scholars and Innovative Research Team in
   University [IRT13051]
FX Due to space limitations, in certain areas, review papers are cited
   instead of individual contributions; in any case, representation of the
   entire literature on research and development in the broad field of
   human-derived biomaterials in the reference list would not be possible.
   The authors also apologize to those authors whose excellent work in this
   field is not discussed and cited here due to misunderstanding, oversight
   or limitation in knowledge. Figs. 8 and 20 were generously provided by
   Dr. Zhongshan Wang in the Department of Prosthetics, School of
   Stomatology, Fourth Military Medical University. The authors acknowledge
   the reuse of certain segments of text from resources by Kretlow et al.
   (2009) [50] and Kuraitis et al. (2012) [288] in the discussion of
   autologous/allogeneic materials (Sections 3.1 and 3.2) and ECM
   components (Section 4.2) due to content overlap, although this content
   has been rephrased in our own words. Special thanks go to the anonymous
   referees for their insight and truly stimulating and valuable remarks on
   a former version of this manuscript. Dr. Chen is supported by the
   Program for New Century Excellent Talents in University (NCET-12-1005)
   and the Ministry of Science and Technology Innovation Talent Promotion
   Plan of Shaanxi Province (Youth Scientific Innovation Talents,
   2014SR2014). Dr. Liu is supported by NIH/NIDCR R03DE22838 and
   R41DE024343. Portions of the corresponding author's work discussed in
   this review were financially supported by the National Natural Science
   Foundation of China (Nos. 31170912 and 81471791) and the Program for
   Changjiang Scholars and Innovative Research Team in University
   (IRT13051).
CR Abdelrazik H, 2011, EUR J IMMUNOL, V41, P3281, DOI 10.1002/eji.201141542
   Acarturk TO, 2006, PLAST RECONSTR SURG, V118, P862, DOI 10.1097/01.prs.0000232385.81219.87
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Alekseeva T, 2012, EUR CELLS MATER, V23, P28, DOI 10.22203/eCM.v023a03
   Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546
   Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916
   Anderson DEJ, 2012, BIOCHEM BIOPH RES CO, V427, P159, DOI 10.1016/j.bbrc.2012.09.034
   Andia I, 2013, NAT REV RHEUMATOL, V9, P721, DOI 10.1038/nrrheum.2013.141
   Andreas K, 2014, TRENDS BIOTECHNOL, V32, P483, DOI 10.1016/j.tibtech.2014.06.008
   Andree B, 2013, TISSUE ENG PART B-RE, V19, P279, DOI [10.1089/ten.teb.2012.0583, 10.1089/ten.TEB.2012.0583]
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Anitua E, 2008, J BIOMED MATER RES B, V84B, P415, DOI 10.1002/jbm.b.30886
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Anitua E, 2015, J TISSUE ENG REGEN M, V9, pE1, DOI 10.1002/term.1721
   Anitua E, 2013, TRENDS BIOTECHNOL, V31, P364, DOI 10.1016/j.tibtech.2013.04.003
   Anitua E, 2013, BIODRUGS, V27, P97, DOI 10.1007/s40259-012-0004-3
   Anitua E, 2012, J CONTROL RELEASE, V157, P29, DOI 10.1016/j.jconrel.2011.07.004
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Anitua Eduardo A, 2006, J Oral Implantol, V32, P72, DOI 10.1563/736.1
   Arenas-Herrera JE, 2013, BIOMED MATER, V8
   Arnoczky SP, 2013, SPORTS MED ARTHROSC, V21, P180, DOI 10.1097/JSA.0b013e3182999712
   Aronowitz JA, 2013, PLAST RECONSTR SURG, V132, p932E, DOI 10.1097/PRS.0b013e3182a80652
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2014, TISSUE ENG PT A, V20, P445, DOI 10.1089/ten.TEA.2013.0742
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   AUMAILLEY M, 1993, KIDNEY INT, V43, P7, DOI 10.1038/ki.1993.3
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   Ayerst BI, 2014, BIOCHEM SOC T, V42, P703, DOI 10.1042/BST20140031
   Azagarsamy MA, 2013, ANGEW CHEM INT EDIT, V52, P13803, DOI 10.1002/anie.201308174
   Azagarsamy MA, 2012, BIOMACROMOLECULES, V13, P2219, DOI 10.1021/bm300646q
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baiguera S, 2014, BIOMATERIALS, V35, P6344, DOI 10.1016/j.biomaterials.2014.04.070
   Bajnrauh R, 2007, OPHTHAL PLAST RECONS, V23, P409, DOI 10.1097/IOP.0b013e318137a1a3
   Baker BM, 2009, EXPERT REV MED DEVIC, V6, P515, DOI [10.1586/erd.09.39, 10.1586/ERD.09.39]
   Bakhshalian N, 2013, INT J ORAL MAX IMPL, V28, P1655, DOI 10.11607/jomi .2833
   Balakrishnan B, 2014, ACTA BIOMATER, V10, P3650, DOI 10.1016/j.actbio.2014.04.031
   Balestrini JL, 2015, ANN BIOMED ENG, V43, P568, DOI 10.1007/s10439-014-1167-5
   Banks ND, 2008, PLAST RECONSTR SURG, V121, p230E, DOI 10.1097/01.prs.0000305391.98958.95
   Barba M, 2013, BIOMED RES INT, DOI 10.1155/2013/416391
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   Baroli B, 2009, J PHARM SCI-US, V98, P1317, DOI 10.1002/jps.21528
   Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   BASHIR MM, 1994, BIOCHEMISTRY-US, V33, P593, DOI 10.1021/bi00168a026
   Bashur CA, 2012, TISSUE ENG PART B-RE, V18, P203, DOI [10.1089/ten.teb.2011.0521, 10.1089/ten.TEB.2011.0521]
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bayrak A, 2013, TISSUE ENG PT A, V19, P1592, DOI [10.1089/ten.tea.2012.0394, 10.1089/ten.TEA.2012.0394]
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Behfar M, 2011, CHIN J TRAUMATOL, V14, P329, DOI 10.3760/cma.j.issn.1008-1275.2011.06.002
   Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97
   Benyus JM, 2002, BIOMIMICRY INNOVATIO, P1
   Bernard AB, 2014, BIOTECHNOL BIOENG, V111, P1028, DOI 10.1002/bit.25153
   Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Bhaarathy V, 2014, MAT SCI ENG C-MATER, V44, P268, DOI 10.1016/j.msec.2014.08.018
   Bhatt RA, 2012, HAND CLIN, V28, P457, DOI 10.1016/j.hcl.2012.08.001
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139
   Blande IS, 2009, TRANSFUSION, V49, P2680, DOI 10.1111/j.1537-2995.2009.02346.x
   Boffito M, 2015, J BIOMED MATER RES A, V103, P1276, DOI 10.1002/jbm.a.35253
   BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018
   Bondioli E, 2014, J TISSUE ENG REGEN M, V8, P325, DOI 10.1002/term.1530
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Bouhout S, 2010, TISSUE ENG PT A, V16, P1539, DOI [10.1089/ten.tea.2009.0473, 10.1089/ten.TEA.2009.0473]
   Bourget JM, 2012, BIOMATERIALS, V33, P9205, DOI 10.1016/j.biomaterials.2012.09.015
   Bourgine PE, 2013, BIOMATERIALS, V34, P6099, DOI 10.1016/j.biomaterials.2013.04.058
   BOYCE RG, 1994, OTOLARYNG CLIN N AM, V27, P39
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Bozzini S, 2011, J MATER SCI-MATER M, V22, P2641, DOI 10.1007/s10856-011-4451-z
   Brandl FP, 2010, BIOMATERIALS, V31, P3957, DOI 10.1016/j.biomaterials.2010.01.128
   Breitkreutz D, 2013, BIOMED RES INT, DOI 10.1155/2013/179784
   Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Bryan N, 2009, BIOMATERIALS, V30, P180, DOI 10.1016/j.biomaterials.2008.09.003
   Bryksin AV, 2014, ACTA BIOMATER, V10, P1761, DOI 10.1016/j.actbio.2014.01.019
   BUCK BE, 1994, CLIN ORTHOP RELAT R, P8
   Burd A, 2005, CLIN DERMATOL, V23, P376, DOI 10.1016/j.clindermatol.2004.07.019
   Burkus JK, 2003, J SPINAL DISORD TECH, V16, P113, DOI 10.1097/00024720-200304000-00001
   Burnouf T, 2013, BLOOD REV, V27, P77, DOI 10.1016/j.blre.2013.02.001
   Burres S, 2001, CLIN PLAST SURG, V28, P101
   Cai L, 2014, ACTA BIOMATER, V10, P1751, DOI 10.1016/j.actbio.2013.12.028
   Cairo F, 2014, J CLIN PERIODONTOL, V41, pS44, DOI 10.1111/jcpe.12182
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Calonder C, 2005, J BIOMED MATER RES A, V75A, P316, DOI 10.1002/jbm.a.30417
   Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2
   Canan LW, 2012, J CRANIOFAC SURG, V23, P1627, DOI 10.1097/SCS.0b013e31825c75ba
   Canas N, 2012, ACTA BIOMATER, V8, P282, DOI 10.1016/j.actbio.2011.08.028
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828
   Cassidy D, 2013, CLIN EXP OPTOM, V96, P165, DOI 10.1111/cxo.12047
   Castiglia S, 2014, CYTOTHERAPY, V16, P750, DOI 10.1016/j.jcyt.2013.12.008
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Celiz AD, 2014, NAT MATER, V13, P570, DOI [10.1038/NMAT3972, 10.1038/nmat3972]
   Cerqueira MT, 2014, TISSUE ENG PT A, V20, P1369, DOI [10.1089/ten.tea.2013.0460, 10.1089/ten.TEA.2013.0460]
   Cha C, 2012, ACS NANO, V6, P9353, DOI 10.1021/nn304773b
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Chattopadhyay S, 2014, BIOPOLYMERS, V101, P821, DOI 10.1002/bip.22486
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   Chen FM, 2013, BIOMATERIALS, V34, P6515, DOI 10.1016/j.biomaterials.2013.05.014
   Chen FM, 2012, BIOMATERIALS, V33, P6320, DOI 10.1016/j.biomaterials.2012.05.048
   Chen FM, 2012, BIOTECHNOL ADV, V30, P658, DOI 10.1016/j.biotechadv.2011.11.005
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144
   Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925
   Chen PW, 2015, MOL NEUROBIOL, V52, P216, DOI 10.1007/s12035-014-8862-y
   Chen PY, 2012, PROG MATER SCI, V57, P1492, DOI 10.1016/j.pmatsci.2012.03.001
   Chen ZG, 2012, ARCH ORTHOP TRAUM SU, V132, P1725, DOI 10.1007/s00402-012-1607-3
   Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Chlapanidas T, 2011, TISSUE ENG PT A, V17, P1725, DOI 10.1089/ten.tea.2010.0636
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Choi SK, 2013, J BIOMED MATER RES B, V101, P1329, DOI 10.1002/jbm.b.32950
   Choi YC, 2014, J CONTROL RELEASE, V193, P42, DOI 10.1016/j.jconrel.2014.06.032
   Chon BH, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt331
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Chung J, 2014, NAT MATER, V13, P1055, DOI [10.1038/NMAT4090, 10.1038/nmat4090]
   Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h
   CONNOLLY J, 1989, J BONE JOINT SURG AM, V71A, P684, DOI 10.2106/00004623-198971050-00007
   CONNOLLY JF, 1995, CLIN ORTHOP RELAT R, P8
   Cool SM, 2006, J CELL BIOCHEM, V99, P1040, DOI 10.1002/jcb.20936
   Cortellini P, 2012, J CLIN PERIODONTOL, V39, P674, DOI 10.1111/j.1600-051X.2012.01896.x
   Costa-Almeida R, 2014, EUR CELLS MATER, V28, P51, DOI 10.22203/eCM.v028a05
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376
   Cromar GL, 2012, PROTEINS, V80, P1522, DOI 10.1002/prot.24036
   Crowley DC, 2009, INT J MED SCI, V6, P312
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259
   Daamen WF, 2005, TISSUE ENG, V11, P1168, DOI 10.1089/ten.2005.11.1168
   Daar AS, 2013, TRANSPL P, V45, P3450, DOI 10.1016/j.transproceed.2013.09.011
   Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001
   Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Daoud J, 2010, CELL TRANSPLANT, V19, P1523, DOI 10.3727/096368910X515872
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Dave PC, 2014, NAT MATER, V13, P532, DOI 10.1038/nmat3997
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Decaris ML, 2012, TISSUE ENG PT A, V18, P2148, DOI [10.1089/ten.TEA.2011.0677, 10.1089/ten.tea.2011.0677]
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   DELL PC, 1985, J BONE JOINT SURG AM, V67A, P105, DOI 10.2106/00004623-198567010-00013
   Demirbag B, 2011, BIOTECHNOL J, V6, P1437, DOI 10.1002/biot.201100261
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6
   Diaz-Siso JR, 2013, CLIN TRANSPLANT, V27, P330, DOI 10.1111/ctr.12117
   Diesen DL, 2008, VASCULAR, V16, pS29, DOI 10.2310/6670.2008.00031
   Dijkman PE, 2012, BIOMATERIALS, V33, P4545, DOI 10.1016/j.biomaterials.2012.03.015
   Dimitroulis G, 2011, INT J ORAL MAX SURG, V40, P561, DOI 10.1016/j.ijom.2010.11.020
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   DOI K, 1977, J BONE JOINT SURG AM, V59, P809, DOI 10.2106/00004623-197759060-00015
   Doi K, 2009, MICROSURG, V29, P379, DOI 10.1002/micr.20671
   Doillon C J, 1988, J Biomater Appl, V2, P562
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   Dong B, 2015, CURR OPIN GENET DEV, V32, P129, DOI 10.1016/j.gde.2015.02.009
   Dong XC, 2009, J MATER SCI-MATER M, V20, P2327, DOI 10.1007/s10856-009-3791-4
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027
   Du P, 2014, J CONTROL RELEASE, V194, P122, DOI 10.1016/j.jconrel.2014.08.026
   Dube J, 2014, ACTA BIOMATER, V10, P3563, DOI 10.1016/j.actbio.2014.04.033
   DURKIN ME, 1995, GENOMICS, V26, P219, DOI 10.1016/0888-7543(95)80204-Y
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/nnano.2011.160, 10.1038/NNANO.2011.160]
   Edalat F, 2012, CURR OPIN BIOTECH, V23, P820, DOI 10.1016/j.copbio.2012.05.007
   Edwards PK, 2014, J ORTHOP SPORT PHYS, V44, P102, DOI [10.2519/jospt.2014.5055, 10.2519/jospt.2014.055]
   EINHORN TA, 1995, J BONE MINER RES, V10, P1272
   Elder BD, 2010, NEUROSURGERY, V66, P722, DOI 10.1227/01.NEU.0000367616.49291.9F
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Elloumi-Hannachi I, 2010, J INTERN MED, V267, P54, DOI 10.1111/j.1365-2796.2009.02185.x
   Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337
   Enea D, 2013, INT J IMMUNOPATH PH, V26, P917, DOI 10.1177/039463201302600410
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   Escobedo-Lucea C, 2012, STEM CELL REV REP, V8, P170, DOI 10.1007/s12015-011-9270-6
   Evan G, 2010, DEV CELL, V19, P185, DOI 10.1016/j.devcel.2010.07.023
   Fang NT, 2007, CHINESE MED J-PEKING, V120, P696
   Farag A, 2014, J DENT RES, V93, P1313, DOI 10.1177/0022034514547762
   Fathi A, 2014, BIOMATERIALS, V35, P5425, DOI 10.1016/j.biomaterials.2014.03.026
   Fattahi T, 2004, J ORAL MAXIL SURG, V62, P218, DOI 10.1016/j.joms.2003.01.005
   Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006
   Faulk DM, 2014, J CELL PHYSIOL, V229, P984, DOI 10.1002/jcp.24532
   Feinberg AW, 2012, WIRES SYST BIOL MED, V4, P207, DOI 10.1002/wsbm.164
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Flemming A, 2011, J CLIN IMMUNOL, V31, P1143, DOI 10.1007/s10875-011-9581-z
   Flynn A, 2007, CYTOTHERAPY, V9, P717, DOI 10.1080/14653240701584578
   Fong ELS, 2012, ADV MATER, V24, P4995, DOI 10.1002/adma.201201762
   Fonseca KB, 2014, PROG POLYM SCI, V39, P2010, DOI 10.1016/j.progpolymsci.2014.07.003
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   FRANCIS G, 1973, BIOCHEM J, V136, P45, DOI 10.1042/bj1360045
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Franco B, 2008, INDIAN J PLAST SURG, V41, P38, DOI 10.4103/0970-0358.41109
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   FREIBERG RA, 1964, ARCH SURG-CHICAGO, V89, P417
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Fu RH, 2014, CELL TRANSPLANT, V23, P621, DOI 10.3727/096368914X678382
   Fu SZ, 2012, BIOMATERIALS, V33, P4801, DOI 10.1016/j.biomaterials.2012.03.040
   Fukaya Y, 2012, EXP MOL MED, V44, P330, DOI 10.3858/emm.2012.44.5.037
   Fulco I, 2014, LANCET, V384, P337, DOI 10.1016/S0140-6736(14)60544-4
   FUNANAGE VL, 1992, J CELL PHYSIOL, V150, P251, DOI 10.1002/jcp.1041500205
   Gaafar A, 2014, TRANSPL IMMUNOL, V30, P34, DOI 10.1016/j.trim.2013.11.006
   Galliera E, 2012, J Biol Regul Homeost Agents, V26, p35S
   Gao LN, 2013, BIOMATERIALS, V34, P9937, DOI 10.1016/j.biomaterials.2013.09.017
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010
   Gentile P, 2012, STEM CELL TRANSL MED, V1, P341, DOI 10.5966/sctm.2011-0065
   Gentile P, 2012, STEM CELL TRANSL MED, V1, P230, DOI 10.5966/sctm.2011-0054
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Gessmann J, 2012, ORTHOP REV PAVIA, V4
   Ghaemi SR, 2013, BIOMATERIALS, V34, P7601, DOI 10.1016/j.biomaterials.2013.06.022
   Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39
   Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343
   Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Gimble JM, 2011, STEM CELLS, V29, P749, DOI 10.1002/stem.629
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Glentis A, 2014, CELL ADHES MIGR, V8, P236, DOI 10.4161/cam.28733
   Glowacki AJ, 2015, ANN BIOMED ENG, V43, P593, DOI 10.1007/s10439-014-1125-2
   Glynn JJ, 2015, ACTA BIOMATER, V14, P96, DOI 10.1016/j.actbio.2014.11.038
   Godwin J, 2014, INT J BIOCHEM CELL B, V56, P47, DOI 10.1016/j.biocel.2014.10.011
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Gonzalez-Perez F, 2013, INT REV NEUROBIOL, V108, P257, DOI 10.1016/B978-0-12-410499-0.00010-1
   Gordon CR, 2011, ANN PLAS SURG, V67, P309, DOI 10.1097/SAP.0b013e31822a2c8f
   Goudenege S, 2010, MOL THER, V18, P2155, DOI 10.1038/mt.2010.165
   Govindasamy V, 2011, CYTOTHERAPY, V13, P1221, DOI 10.3109/14653249.2011.602337
   Goyal D, 2013, ARTHROSCOPY, V29, P1872, DOI 10.1016/j.arthro.2013.07.271
   Grafahrend D, 2011, NAT MATER, V10, P67, DOI [10.1038/nmat2904, 10.1038/NMAT2904]
   Green DW, 2014, J R SOC INTERFACE
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Griffiths S, 2013, CYTOTHERAPY, V15, P1469, DOI 10.1016/j.jcyt.2013.05.020
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Gu XS, 2014, BIOMATERIALS, V35, P6143, DOI 10.1016/j.biomaterials.2014.04.064
   Guarino V, 2007, EXPERT REV MED DEVIC, V4, P405, DOI 10.1586/17434440.4.3.405
   Guney A, 2015, KNEE SURG SPORT TR A, V23, P2384, DOI 10.1007/s00167-013-2784-5
   Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3
   Guo WH, 2012, BIOMATERIALS, V33, P1291, DOI 10.1016/j.biomaterials.2011.09.068
   Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034
   Guo Y, 2012, J MATER SCI-MATER M, V23, P2267, DOI 10.1007/s10856-012-4684-5
   Gupta MS, 2014, CELL TISSUE RES, V358, P527, DOI 10.1007/s00441-014-1962-1
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.085405.095329
   Gustafson JA, 2013, BIOMACROMOLECULES, V14, P618, DOI 10.1021/bm3013692
   Guthrie K, 2013, TRENDS BIOTECHNOL, V31, P505, DOI 10.1016/j.tibtech.2013.05.007
   Gutierrez-Moreno S, 2011, ACTAS DERMO-SIFILOGR, V102, P284, DOI 10.1016/j.ad.2011.01.003
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hakimi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100143
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3
   Hamid MSA, 2014, AM J SPORT MED, V42, P2410, DOI 10.1177/0363546514541540
   Hammond JS, 2011, J HEPATOL, V54, P279, DOI 10.1016/j.jhep.2010.06.040
   Han QQ, 2014, J BIOMED MATER RES A, V102, P3093, DOI 10.1002/jbm.a.34979
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   Hanson S, 2014, TISSUE ENG PT A, V20, P2162, DOI 10.1089/ten.tea.2013.0359
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harrison RH, 2014, TISSUE ENG PART B-RE, V20, P1, DOI 10.1089/ten.TEB.2013.0668
   Hart R, 2014, SPINE J, V14, P1318, DOI 10.1016/j.spinee.2013.12.014
   Hasegawa M, 2004, J CLIN NEUROSCI, V11, P408, DOI 10.1016/j.jocn.2003.11.006
   He J, 2013, BIOMATERIALS, V34, P6580, DOI 10.1016/j.biomaterials.2013.05.056
   He M, 2013, TISSUE ENG PART B-RE, V19, P194, DOI [10.1089/ten.teb.2012.0340, 10.1089/ten.TEB.2012.0340]
   Hemeda H, 2014, CYTOTHERAPY, V16, P170, DOI 10.1016/j.jcyt.2013.11.004
   Hendrich C, 2009, ORTHOP REV PAVIA, V1
   Herberts CA, 2015, CELL TISSUE BANK, V16, P1, DOI 10.1007/s10561-014-9450-0
   HIATT WH, 1978, J PERIODONTOL, V49, P495, DOI 10.1902/jop.1978.49.10.495
   Higuchi A, 2014, PROG POLYM SCI, V39, P1585, DOI 10.1016/j.progpolymsci.2014.05.001
   Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holtzclaw D, 2008, J AM DENT ASSOC, V139, P1192, DOI 10.14219/jada.archive.2008.0334
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Honsawek S, 2010, ASIAN BIOMED, V4, P913, DOI 10.2478/abm-2010-0119
   Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x
   HOPP SG, 1989, J ORTHOPAED RES, V7, P579, DOI 10.1002/jor.1100070416
   Horejs CM, 2014, P NATL ACAD SCI USA, V111, P5908, DOI 10.1073/pnas.1403139111
   Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788
   Horobin AJ, 2003, BRIT J DERMATOL, V148, P923, DOI 10.1046/j.1365-2133.2003.05314.x
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hoshiba T, 2011, BIOTECHNOL PROGR, V27, P788, DOI 10.1002/btpr.592
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Hoshiba T, 2010, ADV MATER, V22, P3042, DOI 10.1002/adma.201000038
   Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676
   Hosseini V, 2014, SMALL, V10, P4851, DOI 10.1002/smll.201400263
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu XH, 2011, ACTA BIOMATER, V7, P1618, DOI 10.1016/j.actbio.2010.12.005
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Huang H, 2006, J PHYS CHEM B, V110, P19929, DOI 10.1021/jp062070j
   Huang SJ, 2013, CELL TRANSPLANT, V22, P701, DOI 10.3727/096368912X655127
   Huang W, 2015, EXPERT OPIN DRUG DEL
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Huber MC, 2014, BIOMATERIALS, V35, P8767, DOI 10.1016/j.biomaterials.2014.06.048
   Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896
   Hwang YS, 2011, REGEN MED, V6, P505, DOI [10.2217/RME.11.38, 10.2217/rme.11.38]
   Ichim TE, 2010, CELL IMMUNOL, V264, P7, DOI 10.1016/j.cellimm.2010.04.002
   IHRCKE NS, 1993, IMMUNOL TODAY, V14, P500, DOI 10.1016/0167-5699(93)90265-M
   Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055
   Iop L, 2014, PLOS ONE, V9
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.tea.2012.0375, 10.1089/ten.TEA.2012.0375]
   Jabaji Z, 2014, PLOS ONE, V9
   Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230
   Jager M, 2009, CURR STEM CELL RES T, V4, P34, DOI 10.2174/157488809787169039
   Jagota A, 2011, MAT SCI ENG R, V72, P253, DOI 10.1016/j.mser.2011.08.001
   Jakobsen RB, 2010, KNEE SURG SPORT TR A, V18, P1407, DOI 10.1007/s00167-009-1017-4
   Janetzko K, 2004, TRANSFUSION, V44, P1052, DOI 10.1111/j.1537-2995.2004.03296.x
   Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001
   Jeng L, 2013, TISSUE ENG PT A, V19, P2267, DOI [10.1089/ten.TEA.2013.0013, 10.1089/ten.tea.2013.0013]
   Jeon WB, 2013, BIOENGINEERED, V4, P368, DOI 10.4161/bioe.24158
   Jiang JJ, 2013, ADV HEALTHC MATER, V2, P25, DOI 10.1002/adhm.201200169
   Jiang T, 2015, PROG POLYM SCI, V46, P1, DOI 10.1016/j.progpolymsci.2014.12.001
   Johnson LL, 2000, ARTHROSCOPY, V16, P279, DOI 10.1016/S0749-8063(00)90052-5
   Johnson RG, 2014, SPINE, V39, P695, DOI 10.1097/BRS.0000000000000254
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Jung EM, 2011, BIOCHEM BIOPH RES CO, V404, P463, DOI 10.1016/j.bbrc.2010.12.003
   Jungbluth P, 2013, INJURY, V44, P1285, DOI 10.1016/j.injury.2013.04.015
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Junka R, 2013, J BIOMATER TISS ENG, V3, P494, DOI 10.1166/jbt.2013.1110
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Jurgens WJFM, 2013, BIORESEARCH OPEN ACC, V2, P315, DOI 10.1089/biores.2013.0024
   Kane R, 2013, MATER TODAY, V16, P418, DOI 10.1016/j.mattod.2013.11.001
   Kanie K, 2012, BIOTECHNOL BIOENG, V109, P1808, DOI 10.1002/bit.24459
   Kaufman CL, 2013, CURR OPIN ORGAN TRAN, V18, P652, DOI 10.1097/MOT.0000000000000025
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Keatch RP, 2012, CURR OPIN BIOTECH, V23, P579, DOI 10.1016/j.copbio.2012.01.017
   Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076
   Khan AA, 2014, J ARTIF ORGANS, V17, P291, DOI 10.1007/s10047-014-0780-2
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Kim A, 2012, CYTOTHERAPY, V14, P296, DOI 10.3109/14653249.2011.627915
   Kim BS, 2012, BIOTECHNOL PROGR, V28, P973, DOI 10.1002/btpr.1555
   Kim BS, 2012, CELL TISSUE RES, V348, P559, DOI 10.1007/s00441-012-1391-y
   Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001
   Kim JH, 2014, J DENT RES, V93, P1203, DOI 10.1177/0022034514540682
   Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b
   Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020
   Kinikoglu B, 2011, BIOMATERIALS, V32, P5756, DOI 10.1016/j.biomaterials.2011.04.054
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kivelio A, 2015, ACTA BIOMATER, V15, P1, DOI 10.1016/j.actbio.2014.12.011
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Ko DY, 2013, PROG POLYM SCI, V38, P672, DOI 10.1016/j.progpolymsci.2012.08.002
   Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5
   Kolle SFT, 2013, CYTOTHERAPY, V15, P1086, DOI 10.1016/j.jcyt.2013.01.217
   Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309
   Konno M, 2013, DEV GROWTH DIFFER, V55, P309, DOI 10.1111/dgd.12049
   Kretlow JD, 2010, TISSUE ENG PART C-ME, V16, P1427, DOI 10.1089/ten.tec.2010.0046
   Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009
   Kroner E, 2012, J APPL BIOMATER FUNC, V10, P287, DOI 10.5301/JABFM.2012.10365
   Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x
   Kunze A, 2010, OPHTHAL RES, V43, P108, DOI 10.1159/000247595
   Kuo YR, 2009, PLAST RECONSTR SURG, V124, P171, DOI 10.1097/PRS.0b013e3181a80594
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004
   L'Heureux N, 1998, FASEB J, V12, P47
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Lam J, 2014, ACTA BIOMATER, V10, P1571, DOI 10.1016/j.actbio.2013.07.025
   Lamichhane TN, 2015, TISSUE ENG PART B-RE, V21, P45, DOI [10.1089/ten.teb.2014.0300, 10.1089/ten.TEB.2014.0300]
   Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 2014, DRUG DISCOV TODAY, V19, P794, DOI 10.1016/j.drudis.2014.01.012
   Laurent R, 2014, CELL TISSUE BANK, V15, P267, DOI 10.1007/s10561-014-9437-x
   Lee DH, 2014, CLIN ORTHOP RELAT R, V472, P3789, DOI 10.1007/s11999-014-3548-3
   Lee E, 2014, INFLAMM REGEN, V34, P15
   Lee HK, 2009, J KOREAN MED SCI, V24, P654, DOI 10.3346/jkms.2009.24.4.654
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013
   Leotot J, 2013, ACTA BIOMATER, V9, P6630, DOI 10.1016/j.actbio.2013.02.003
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Levin F, 2011, OPHTHAL PLAST RECONS, V27, P44, DOI 10.1097/IOP.0b013e3181e2f85e
   Li JA, 2013, J BIOMAT SCI-POLYM E, V24, P1519, DOI 10.1080/09205063.2013.777227
   Li R, 2011, BIOMATERIALS, V32, P4525, DOI 10.1016/j.biomaterials.2011.03.008
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Li YY, 2012, J BIOMED MATER RES B, V100B, P265, DOI 10.1002/jbm.b.31949
   Li ZB, 2014, MAT SCI ENG C-MATER, V45, P620, DOI 10.1016/j.msec.2014.06.003
   Liang YK, 2014, ACTA BIOMATER, V10, P1588, DOI 10.1016/j.actbio.2013.07.031
   Liao HT, 2014, TISSUE ENG PART B-RE, V20, P267, DOI [10.1089/ten.teb.2013.0317, 10.1089/ten.TEB.2013.0317]
   Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012
   Lin HK, 2015, ADV DRUG DELIVER REV, V82-83, P47, DOI 10.1016/j.addr.2014.11.020
   Lin SD, 2011, TISSUE ENG PT A, V17, P1489, DOI [10.1089/ten.tea.2010.0688, 10.1089/ten.TEA.2010.0688]
   Liu B, 2013, TISSUE ENG PART C-ME, V19, DOI [10.1089/ten.tec.2012.0126, 10.1089/ten.TEC.2012.0126]
   Liu JS, 2012, TRENDS CELL BIOL, V22, P683, DOI 10.1016/j.tcb.2012.09.004
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Liu XH, 2010, BIOMATERIALS, V31, P259, DOI 10.1016/j.biomaterials.2009.09.046
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Loeffelbein DJ, 2014, BIOMED RES INT, DOI 10.1155/2014/572183
   Lozito TP, 2009, J CELL BIOCHEM, V107, P714, DOI 10.1002/jcb.22167
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Lu H, 2013, CELL TRANSPLANT, V22, P205, DOI 10.3727/096368912X656171
   Lu HX, 2012, J BIOMED MATER RES A, V100A, P2507, DOI 10.1002/jbm.a.34150
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu Q, 2013, J CONTROL RELEASE, V174, P43
   Lu WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103672
   Lubkowska A, 2012, J Biol Regul Homeost Agents, V26, p3S
   Luciani GB, 2007, J CARDIOVASC MED, V8, P91, DOI 10.2459/01.JCM.0000260208.98246.10
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lv JJ, 2014, ACS APPL MATER INTER, V6, P4954, DOI 10.1021/am4059809
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Lyu SR, 2013, COLLOID SURFACE B, V103, P304, DOI 10.1016/j.colsurfb.2012.11.002
   Ma J, 2014, BIOTECHNOL ADV, V32, P744, DOI 10.1016/j.biotechadv.2013.10.014
   Ma T, 2014, J MATER CHEM B, V2, P31, DOI 10.1039/c3tb21369b
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   MacIsaac ZM, 2012, PLAST RECONSTR SURG, V130, P625, DOI 10.1097/PRS.0b013e31825dcb75
   Magnan Martine, 2006, J Pediatr Urol, V2, P261, DOI 10.1016/j.jpurol.2005.11.019
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Mancuso L, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045011
   Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]
   Marino A, 2015, NANOSCALE, V7, P2841, DOI 10.1039/c4nr06500j
   MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Marx R E, 2001, Implant Dent, V10, P225
   Mauney J, 2010, MATRIX BIOL, V29, P657, DOI 10.1016/j.matbio.2010.08.008
   Mauney JR, 2015, ADV DRUG DELIVER REV, V82-83, P77, DOI 10.1016/j.addr.2014.10.016
   Mayo V, 2014, J DENT, V42, P1043, DOI 10.1016/j.jdent.2014.04.007
   Mbemba E, 2000, GLYCOBIOLOGY, V10, P21, DOI 10.1093/glycob/10.1.21
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   McNichols CH, 2012, J CRANIOFAC SURG, V23, pE234, DOI 10.1097/SCS.0b013e31824de5b8
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Memarzadeh F, 2008, EYE, V22, P107, DOI 10.1038/sj.eye.6702453
   Meningaud JP, 2010, PLAST RECONSTR SURG, V126, P1181, DOI 10.1097/PRS.0b013e3181ec2089
   Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854
   Mhaskar R, 2005, INT J GYNECOL OBSTET, V90, P123, DOI 10.1016/i.ijgo.2005.04.015
   Miao M, 2013, BIOPOLYMERS, V99, P392, DOI 10.1002/bip.22192
   Migliorini E, 2014, BIOMATERIALS, V35, P8903, DOI 10.1016/j.biomaterials.2014.07.017
   Mihardja SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010384
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Nguyen MK, 2014, PROG POLYM SCI, V39, P1235, DOI 10.1016/j.progpolymsci.2013.12.001
   Minteer D, 2013, ADV BIOCHEM ENG BIOT, V129, P59, DOI 10.1007/10_2012_146
   Coelho NM, 2010, EUR CELLS MATER, V19, P262, DOI 10.22203/eCM.v019a25
   Mirzarafie A, 2014, REJUV RES, V17, P159, DOI 10.1089/rej.2013.1488
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Mohammadi R, 2014, INT J SURG, V12, P33, DOI 10.1016/j.ijsu.2013.10.018
   Momtahan N, 2015, TISSUE ENG PART B-RE, V21, P115, DOI [10.1089/ten.TEB.2014.0192, 10.1089/ten.teb.2014.0192]
   Mondalek FG, 2010, J BIOMED MATER RES A, V94A, P712, DOI 10.1002/jbm.a.32748
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902
   Muiznieks LD, 2013, BBA-MOL BASIS DIS, V1832, P866, DOI 10.1016/j.bbadis.2012.11.022
   Mundinger GS, 2014, CURR OPIN ORGAN TRAN, V19, P309, DOI 10.1097/MOT.0000000000000073
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Murali S, 2011, J BIOL CHEM, V286, P17755, DOI 10.1074/jbc.M110.148874
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Naaijkens BA, 2012, CELL TISSUE RES, V348, P119, DOI 10.1007/s00441-012-1360-5
   Nagata MJH, 2014, J PERIODONTOL, V85, P1702, DOI 10.1902/jop.2014.140083
   Nakayama K, 2004, J BIOCHEM, V136, P751, DOI 10.1093/jb/mvh183
   Nakayama KH, 2014, ADV HEALTHC MATER, V3, P628, DOI 10.1002/adhm.201300620
   Nampo T, 2010, J PERIODONTOL, V81, P1264, DOI 10.1902/jop.2010.100016
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Netelenbos T, 2003, LEUKEMIA, V17, P175, DOI 10.1038/sj.leu.2402738
   Netelenbos T, 2002, J LEUKOCYTE BIOL, V72, P353
   Netelenbos T, 2001, EXP HEMATOL, V29, P884, DOI 10.1016/S0301-472X(01)00653-1
   Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x
   Ng CP, 2014, BIOMATERIALS, V35, P4046, DOI 10.1016/j.biomaterials.2014.01.081
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   Niederkorn JY, 2013, INT REV IMMUNOL, V32, P57, DOI 10.3109/08830185.2012.737877
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Sanchez-Ilarduya MB, 2013, J BIOMED MATER RES A, V101, P1478, DOI 10.1002/jbm.a.34428
   Nold P, 2013, BIOCHEM BIOPH RES CO, V430, P325, DOI 10.1016/j.bbrc.2012.11.001
   Nystrom A, 2013, J CLIN INVEST, V123, P3498, DOI 10.1172/JCI68127
   O'Brien CM, 2015, TISSUE ENG PART B-RE, V21, P103, DOI [10.1089/ten.TEB.2014.0168, 10.1089/ten.teb.2014.0168]
   O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022
   Ode A, 2010, J BIOMED MATER RES A, V95A, P1114, DOI 10.1002/jbm.a.32909
   Ogihara S, 2010, J PERIODONTOL, V81, P1734, DOI 10.1902/jop.2010.100127
   Okamoto M, 2013, PROG POLYM SCI, V38, P1487, DOI 10.1016/j.progpolymsci.2013.06.001
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Omar N, 2013, CLIN OPHTHALMOL, V7, P1311, DOI 10.2147/OPTH.S43719
   Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Palmiero C, 2010, ACTA BIOMATER, V6, P2548, DOI 10.1016/j.actbio.2010.01.026
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Pang YG, 2010, J INVEST MED, V58, P845, DOI 10.231/JIM.0b013e3181ee81f7
   Pang YG, 2010, BIOMATERIALS, V31, P878, DOI 10.1016/j.biomaterials.2009.10.007
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Papadimitropoulos A, 2015, BONE, V70, P66, DOI 10.1016/j.bone.2014.09.007
   Pape HC, 2010, J ORTHOP TRAUMA, V24, pS36, DOI 10.1097/BOT.0b013e3181cec4a1
   Park MS, 2015, CELL TRANSPLANT, V24, P1067, DOI 10.3727/096368914X681018
   Parodi Pier Camillo, 2006, Ann Ital Chir, V77, P361
   Parrish JN, 2010, AESTHET SURG J, V30, P549, DOI 10.1177/1090820X10380859
   Patel D, 2011, BIOMACROMOLECULES, V12, P432, DOI 10.1021/bm101214f
   Patel TR, 2014, MATRIX BIOL, V33, P60, DOI 10.1016/j.matbio.2013.07.009
   Pati F, 2015, BIOMATERIALS, V37, P230, DOI 10.1016/j.biomaterials.2014.10.012
   Pedraza CE, 2010, TISSUE ENG PT A, V16, P781, DOI [10.1089/ten.tea.2009.0351, 10.1089/ten.TEA.2009.0351]
   Perez-Ilzarbe M, 2009, TRANSFUSION, V49, P1901, DOI 10.1111/j.1537-2995.2009.02226.x
   Perlyn CA, 2005, PLAST RECONSTR SURG, V115, P1129, DOI 10.1097/01.PRS.0000156217.33683.2B
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Pham MT, 2003, J BIOMED MATER RES A, V66A, P310, DOI 10.1002/jbm.a.10575
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ple-Plakon PA, 2013, CORNEA, V32, P1339, DOI 10.1097/ICO.0b013e3182a0d154
   Pradhan S, 2010, REGEN MED, V5, P961, DOI 10.2217/RME.10.61
   Precheur Harry V, 2007, Dent Clin North Am, V51, P729
   Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100
   Puetzer JL, 2013, ACTA BIOMATER, V9, P7787, DOI 10.1016/j.actbio.2013.05.002
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Putzier M, 2009, EUR SPINE J, V18, P687, DOI 10.1007/s00586-008-0875-7
   Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108
   Raghunathan V, 2013, TISSUE ENG PT A, V19, P1713, DOI [10.1089/ten.tea.2012.0584, 10.1089/ten.TEA.2012.0584]
   Rai B, 2005, J CONTROL RELEASE, V107, P330, DOI 10.1016/j.jconrel.2005.07.002
   Rajabi-Zeleti S, 2014, BIOMATERIALS, V35, P970, DOI 10.1016/j.biomaterials.2013.10.045
   Ratliff BB, 2010, AM J PHYSIOL-RENAL, V299, pF178, DOI 10.1152/ajprenal.00102.2010
   Ravi S, 2013, J BIOMED MATER RES A, V101, P1915, DOI 10.1002/jbm.a.34484
   Ravindran S, 2010, TISSUE ENG PT A, V16, P327, DOI [10.1089/ten.tea.2009.0110, 10.1089/ten.TEA.2009.0110]
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Raza A, 2013, BIOMATERIALS, V34, P5117, DOI 10.1016/j.biomaterials.2013.03.086
   Reis CR, 2012, ARCH ORAL BIOL, V57, P469, DOI 10.1016/j.archoralbio.2011.10.011
   Ren XP, 2013, CNS NEUROSCI THER, V19, P1, DOI 10.1111/cns.12029
   Rennert RC, 2014, CURR STEM CELL RES T, V9, P2
   Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080
   Resende RR, 2014, J BIOMED NANOTECHNOL, V10, P1157, DOI 10.1166/jbn.2014.1850
   Reynolds Mark A, 2010, Dent Clin North Am, V54, P55, DOI 10.1016/j.cden.2009.09.003
   Rhee SC, 2011, STEM CELLS DEV, V20, P233, DOI 10.1089/scd.2009.0525
   Rhodes JM, 2007, J CELL MOL MED, V11, P176, DOI 10.1111/j.1582-4934.2007.00031.x
   Ribeiro-Filho LA, 2015, ADV DRUG DELIV REV
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rickert D, 2014, INT J ORAL MAX SURG, V43, P243, DOI 10.1016/j.ijom.2013.09.006
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Roberts TT, 2012, ORGANOGENESIS, V8, P114, DOI 10.4161/org.23306
   Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106
   ROSE JR, 1993, FASEB J, V7, pA1208
   Rosenberg E, 1998, Dent Clin North Am, V42, P467
   ROSS SE, 1968, PERIODONTICS, V6, P145
   Rossi F, 2014, TISSUE ENG PT A, V20, P2043, DOI 10.1089/ten.tea.2013.0367
   Ruan DK, 2012, TISSUE ENG PT A, V18, P167, DOI [10.1089/ten.TEA.2011.0186, 10.1089/ten.tea.2011.0186]
   Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290
   Ruggiu A, 2013, BIOMATERIALS, V34, P9318, DOI 10.1016/j.biomaterials.2013.08.018
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Russell RP, 2013, SPORTS MED ARTHROSC, V21, P186, DOI 10.1097/JSA.0000000000000007
   Sadr N, 2012, BIOMATERIALS, V33, P5085, DOI 10.1016/j.biomaterials.2012.03.082
   Saint-Cyr M, 2012, PLAST RECONSTR SURG, V130, p858E, DOI 10.1097/PRS.0b013e31826da2b7
   SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499
   Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004
   Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611
   Samal SK, 2012, CHEM SOC REV, V41, P7147, DOI 10.1039/c2cs35094g
   Sampson S, 2013, PHYSICIAN SPORTSMED, V41, P7, DOI 10.3810/psm.2013.09.2022
   Sandhu HS, 2001, EUR SPINE J, V10, pS122, DOI 10.1007/s005860100303
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P327, DOI [10.1089/ten.teb.2012.0727, 10.1089/ten.TEB.2012.0727]
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Sanz AR, 2015, PERIODONTOL 2000, V67, P251, DOI 10.1111/prd.12070
   Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Sbordone C, 2011, J ORAL MAXIL SURG, V69, P1633, DOI 10.1016/j.joms.2010.12.004
   Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x
   Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sedgley Christine M, 2012, Dent Clin North Am, V56, P549, DOI 10.1016/j.cden.2012.05.004
   Sekeroglu Hande Taylan, 2011, International Ophthalmology, V31, P433, DOI 10.1007/s10792-011-9488-y
   Semon JA, 2013, STEM CELL TRANSL MED, V2, P789, DOI 10.5966/sctm.2013-0032
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shabafrooz V, 2014, J BIOMED MATER RES A, V102, P3130, DOI 10.1002/jbm.a.34984
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.TEC.2011.0072, 10.1089/ten.tec.2011.0072]
   Shanskii YD, 2013, B EXP BIOL MED+, V156, P146, DOI 10.1007/s10517-013-2298-7
   Shichinohe H, 2011, TRANSL STROKE RES, V2, P307, DOI 10.1007/s12975-011-0088-y
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7
   Siemionow MZ, 2010, PLAST RECONSTR SURG, V125, P111, DOI 10.1097/PRS.0b013e3181c15c4c
   Silva R, 2014, BIOMATERIALS, V35, P6727, DOI 10.1016/j.biomaterials.2014.04.078
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Simson J, 2013, J ORTHOP RES, V31, P392, DOI 10.1002/jor.22247
   Singh A, 2014, NAT MATER, V13, P988, DOI [10.1038/NMAT4048, 10.1038/nmat4048]
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smith AJ, 2012, ARCH ORAL BIOL, V57, P109, DOI 10.1016/j.archoralbio.2011.07.008
   Smith JG, 2012, EXP CELL RES, V318, P2397, DOI 10.1016/j.yexcr.2012.07.008
   Smolka W, 2005, J ORAL MAXIL SURG, V63, P471, DOI 10.1016/j.joms.2004.07.021
   Soardi CM, 2011, CLIN ORAL IMPLAN RES, V22, P560, DOI 10.1111/j.1600-0501.2010.02034.x
   Soicher MA, 2013, J MECH BEHAV BIOMED, V26, P109, DOI 10.1016/j.jmbbm.2013.05.007
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Song LJ, 2014, TISSUE ENG PART B-RE, V20, P163, DOI [10.1089/ten.teb.2013.0103, 10.1089/ten.TEB.2013.0103]
   Soto-Gutierrez A, 2012, J CLIN INVEST, V122, P3817, DOI 10.1172/JCI61974
   Sowmya S, 2013, PROG POLYM SCI, V38, P1748, DOI 10.1016/j.progpolymsci.2013.05.005
   Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stanton MM, 2015, J BIOMED MATER RES B, V103, P861, DOI 10.1002/jbm.b.33244
   Steinwachs MR, 2014, ARTHROSC TEC, V3, pE279, DOI 10.1016/j.eats.2014.01.002
   Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069
   Stevenson MD, 2013, ACTA BIOMATER, V9, P7651, DOI 10.1016/j.actbio.2013.04.002
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
   Stoppel WL, 2015, ANN BIOMED ENG, V43, P657, DOI 10.1007/s10439-014-1206-2
   Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003
   Suh JH, 2013, NAT REV NEPHROL, V9, P470, DOI 10.1038/nrneph.2013.109
   SULLIVAN HS, 1968, PERIODONTICS, V6, P121
   Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836
   Sun HH, 2014, BIOMATERIALS, V35, P9459, DOI 10.1016/j.biomaterials.2014.08.003
   Sun HH, 2012, BIOTECHNOL PROGR, V28, P3, DOI 10.1002/btpr.698
   Sun Y, 2013, TISSUE ENG PT A, V19, P1754, DOI [10.1089/ten.tea.2012.0567, 10.1089/ten.TEA.2012.0567]
   Sunitha Raja V, 2008, Indian J Dent Res, V19, P42
   Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165
   Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   Suzuki S, 2010, CELLS TISSUES ORGANS, V191, P269, DOI 10.1159/000260061
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873
   Tapias LF, 2014, CURR OPIN ORGAN TRAN, V19, P145, DOI 10.1097/MOT.0000000000000051
   Tarantino R, 2014, GLOB SPINE J, V4, P137, DOI 10.1055/s-0034-1376157
   Tempel C, 2000, BIOL REPROD, V63, P134, DOI 10.1095/biolreprod63.1.134
   Teodori L, 2014, FRONT PHYSIOL, V5
   Tevlin R, 2014, J DENT RES, V93, P1187, DOI 10.1177/0022034514547271
   Thangavelu A, 2011, INT J ORAL MAX SURG, V40, P50, DOI 10.1016/j.ijom.2010.06.025
   Thibault RA, 2011, BIOMACROMOLECULES, V12, P4204, DOI 10.1021/bm200975a
   Thirumala S, 2010, J TISSUE ENG REGEN M, V4, P224, DOI 10.1002/term.232
   Thoma DS, 2014, J CLIN PERIODONTOL, V41, pS77, DOI 10.1111/jcpe.12220
   Tibbitt MW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004804
   Tibbitt MW, 2010, SOFT MATTER, V6, P5100, DOI 10.1039/c0sm00174k
   Tiedeman JJ, 1995, ORTHOPEDICS, V18, P1153
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
   Toh WS, 2014, MAT SCI ENG C-MATER, V45, P690, DOI 10.1016/j.msec.2014.04.026
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017
   Tong T, 2010, INFLAMM RES, V59, P369, DOI 10.1007/s00011-009-0109-4
   Tong XM, 2014, BIOMATERIALS, V35, P1807, DOI 10.1016/j.biomaterials.2013.11.064
   Toni R, 2011, ANN ANAT, V193, P381, DOI 10.1016/j.aanat.2011.06.004
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Torroni A, 2009, J ORAL MAXIL SURG, V67, P1121, DOI 10.1016/j.joms.2008.11.020
   Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772
   Tressler MA, 2011, ORTHOPEDICS, V34, P955, DOI 10.3928/01477447-20111021-09
   Tsay RC, 2005, J ORAL MAXIL SURG, V63, P521, DOI 10.1016/j.joms.2004.09.012
   Tsuchiya T, 2014, TISSUE ENG PART C-ME, V20, P1028, DOI [10.1089/ten.tec.2013.0492, 10.1089/ten.TEC.2013.0492]
   Tuan-Mu HY, 2014, ANN BIOMED ENG, V42, P1305, DOI 10.1007/s10439-014-1000-1
   TULI SM, 1978, J BONE JOINT SURG BR, V60, P116
   Ucakhan OO, 2002, CORNEA, V21, P169, DOI 10.1097/00003226-200203000-00008
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964
   Urciuolo Francesco, 2013, Methodist Debakey Cardiovasc J, V9, P213
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1987, METHOD ENZYMOL, V146, P294
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Uzarski JS, 2014, CURR OPIN NEPHROL HY, V23, P399, DOI 10.1097/01.mnh.0000447019.66970.ea
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   van der Smissen A, 2013, ACTA BIOMATER, V9, P7775, DOI 10.1016/j.actbio.2013.04.023
   van Hout WMMT, 2011, CLIN ORAL INVEST, V15, P297, DOI 10.1007/s00784-011-0547-6
   Vancoillie G, 2014, PROG POLYM SCI, V39, P1074, DOI 10.1016/j.progpolymsci.2014.02.005
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Varkey M, 2014, TISSUE ENG PT A, V20, P540, DOI 10.1089/ten.TEA.2013.0160
   Varner VD, 2014, ANNU REV CHEM BIOMOL, V5, P507, DOI 10.1146/annurev-chembioeng-060713-040016
   Vasudevan A, 2010, HIPPOCAMPUS, V20, P608, DOI 10.1002/hipo.20660
   Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021
   Vijayan S, 2012, J BONE JOINT SURG BR, V94B, P488, DOI 10.1302/0301-620X.94B4.27117
   Viswanathan P, 2012, J AM CHEM SOC, V134, P20103, DOI 10.1021/ja308523f
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018
   Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Walters BD, 2014, ACTA BIOMATER, V10, P1488, DOI 10.1016/j.actbio.2013.08.038
   Walters NJ, 2015, ACTA BIOMATER, V11, P3, DOI 10.1016/j.actbio.2014.09.038
   Wang CH, 2011, J PLAST RECONSTR AES, V64, P671, DOI 10.1016/j.bjps.2010.08.042
   Wang HL, 2007, IMPLANT DENT, V16, P33, DOI 10.1097/ID.0b013e318031ece6
   Wang Y, 2012, NAT MATER, V11, P724, DOI [10.1038/NMAT3362, 10.1038/nmat3362]
   Wang Y, 2014, ADV MATER, V26, P4163, DOI 10.1002/adma.201400323
   Waterhouse A, 2011, TISSUE ENG PART B-RE, V17, P93, DOI [10.1089/ten.teb.2010.0432, 10.1089/ten.TEB.2010.0432]
   Weber B, 2013, BIOMATERIALS, V34, P7269, DOI 10.1016/j.biomaterials.2013.04.059
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wildemann B, 2007, J BIOMED MATER RES A, V81A, P437, DOI 10.1002/jbm.a.31085
   Willard JJ, 2013, TISSUE ENG PT A, V19, P1507, DOI [10.1089/ten.TEA.2012.0338, 10.1089/ten.tea.2012.0338]
   Williams DF, 2014, TISSUE ENG PT A, V20, P1129, DOI 10.1089/ten.tea.2013.0769
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wolchok JC, 2010, BIOMATERIALS, V31, P9595, DOI 10.1016/j.biomaterials.2010.08.072
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wong BS, 2013, ADV DRUG DELIVER REV, V65, P1964, DOI 10.1016/j.addr.2013.08.005
   Wong TY, 2004, J ORAL MAXIL SURG, V62, P667, DOI 10.1016/j.joms.2003.08.034
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Wozney John M., 1993, P131
   Wu I, 2012, PLAST RECONSTR SURG, V129, P1247, DOI 10.1097/PRS.0b013e31824ec3dc
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Xia Z, 2014, J MATER CHEM B, V2, P1998, DOI 10.1039/c3tb21595d
   Xing Q, 2015, TISSUE ENG PART C-ME, V21, P77, DOI [10.1089/ten.tec.2013.0666, 10.1089/ten.TEC.2013.0666]
   Xing Q, 2014, ADV FUNCT MATER, V24, P3027, DOI 10.1002/adfm.201303460
   Xu F, 2012, J AM CHEM SOC, V134, P47, DOI 10.1021/ja2077894
   Xu Y, 2015, J BIOMED MATER RES B, V103, P670, DOI 10.1002/jbm.b.33231
   Yagihashi K, 2009, CALCIFIED TISSUE INT, V84, P210, DOI 10.1007/s00223-008-9205-7
   Yamada Y, 2006, INT J PERIODONT REST, V26, P363
   Yang B, 2012, BIOMATERIALS, V33, P2449, DOI 10.1016/j.biomaterials.2011.11.074
   Yang H, 2013, BIOMATERIALS, V34, P7033, DOI 10.1016/j.biomaterials.2013.05.025
   Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Yasuda H, 2012, J ORTHOP SCI, V17, P299, DOI 10.1007/s00776-012-0196-x
   Yasui H, 2014, BIOMATERIALS, V35, P7839, DOI 10.1016/j.biomaterials.2014.05.080
   Yildirimer L, 2014, BIOTECHNOL ADV, V32, P984, DOI 10.1016/j.biotechadv.2014.04.014
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
   Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4
   Yu YL, 2014, BIOMATERIALS, V35, P6822, DOI 10.1016/j.biomaterials.2014.04.074
   Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006
   Zafar M, 2007, JCPSP-J COLL PHYSICI, V17, P107
   ZEHNDER JL, 1990, BLOOD, V76, P2011
   Zhang G, 2012, ORGANOGENESIS, V8, P101, DOI 10.4161/org.23395
   Zhang HM, 2012, TISSUE ENG PT A, V18, P677, DOI [10.1089/ten.tea.2011.0269, 10.1089/ten.TEA.2011.0269]
   Zhang J, 2012, BIOMATERIALS, V33, P6974, DOI 10.1016/j.biomaterials.2012.06.032
   Zhang M, 1997, J PERIODONTOL, V68, P1085, DOI 10.1902/jop.1997.68.11.1085
   Zhang R, 2011, J ENDODONT, V37, P26, DOI 10.1016/j.joen.2010.08.042
   Zhang Y, 2008, CIRC-CARDIOVASC IMAG, V1, P197, DOI 10.1161/CIRCIMAGING.108.781120
   Zhao CY, 2013, BIOTECHNOL ADV, V31, P654, DOI 10.1016/j.biotechadv.2012.08.001
   Zhao J, 2014, PROG POLYM SCI, V39, P1668, DOI 10.1016/j.progpolymsci.2014.06.001
   Zhao L, 2011, J BIOMED MATER RES B, V97B, P1, DOI 10.1002/jbm.b.31768
   Zhao N, 2014, ADV MATER, V26, P6994, DOI 10.1002/adma.201401718
   Zhao YL, 2010, BIOMATERIALS, V31, P296, DOI 10.1016/j.biomaterials.2009.09.049
   Zhao YH, 2013, BIOMATERIALS, V34, P5506, DOI 10.1016/j.biomaterials.2013.03.079
   Zhi KK, 2014, FRONT BIOSCI-LANDMRK, V19, P768, DOI 10.2741/4243
   Zhou Q, 2015, LIVER INT, V35, P687, DOI 10.1111/liv.12581
   Zhu JM, 2012, BIOMACROMOLECULES, V13, P706, DOI 10.1021/bm201596w
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zhu Y, 2013, OSTEOARTHR CARTILAGE, V21, P1627, DOI 10.1016/j.joca.2013.07.017
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 757
TC 95
Z9 98
U1 43
U2 377
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD FEB
PY 2016
VL 53
BP 86
EP 168
DI 10.1016/j.progpolymsci.2015.02.004
PG 83
WC Polymer Science
SC Polymer Science
GA DJ2ZN
UT WOS:000374074300003
PM 27022202
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Chamorro, CI
   Zeiai, S
   Engberg, GR
   Fossum, M
AF Chamorro, Clara I.
   Zeiai, Said
   Engberg, Gisela Reinfeldt
   Fossum, Magdalena
TI Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant
   for Single-staged Reconstructive Repair
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 108; Tissue Engineering; Biomaterial; Tissue
   Scaffold; Cell Expansion; Bladder; Plastic Compression; Collagen; Minced
   Tissue; Polymer; Autograft
ID SKIN
AB Conventional techniques for cell expansion and transplantation of autologous cells for tissue engineering purposes can take place in specially equipped human cell culture facilities. These methods include isolation of cells in single cell suspension and several laborious and time-consuming events before transplantation back to the patient. Previous studies suggest that the body itself could be used as a bioreactor for cell expansion and regeneration of tissue in order to minimize ex vivo manipulations of tissues and cells before transplanting to the patient. The aim of this study was to demonstrate a method for tissue harvesting, isolation of continuous epithelium, mincing of the epithelium into small pieces and incorporating them into a three-layered biomaterial. The three-layered biomaterial then served as a delivery vehicle, to allow surgical handling, exchange of nutrition across the transplant, and a controlled degradation. The biomaterial consisted of two outer layers of collagen and a core of a mechanically stable and slowly degradable polymer. The minced epithelium was incorporated into one of the collagen layers before transplantation. By mincing the epithelial tissue into small pieces, the pieces could be spread and thereby the propagation of cells was stimulated. After the initial take of the transplants, cell expansion and reorganization would take place and extracellular matrix mature to allow ingrowth of capillaries and nerves and further maturation of the extracellular matrix. The technique minimizes ex vivo manipulations and allow cell harvesting, preparation of autograft, and transplantation to the patient as a simple one-stage intervention. In the future, tissue expansion could be initiated around a 3D mold inside the body itself, according to the specific needs of the patient. Additionally, the technique could be performed in an ordinary surgical setting without the need for sophisticated cell culturing facilities.
C1 [Chamorro, Clara I.; Zeiai, Said; Engberg, Gisela Reinfeldt; Fossum, Magdalena] Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Mol Med, S-10401 Stockholm, Sweden.
   [Zeiai, Said; Engberg, Gisela Reinfeldt; Fossum, Magdalena] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Urol Sect, Dept Pediat Surg, Stockholm, Sweden.
RP Fossum, M (reprint author), Karolinska Inst, Dept Womens & Childrens Hlth, Ctr Mol Med, S-10401 Stockholm, Sweden.; Fossum, M (reprint author), Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Urol Sect, Dept Pediat Surg, Stockholm, Sweden.
EM magdalena.fossum@ki.se
OI Fossum, Magdalena/0000-0002-6997-663X
FU Swedish Society for Medical Research; Promobilia Foundation; Crown
   Princess Lovisa Foundation; Freemason Foundation for Children's Welfare;
   Swedish Society of Medicine; Solstickan Foundation; Karolinska
   Institutet; Stockholm City Council
FX The authors thank the Swedish Society for Medical Research, the
   Promobilia Foundation, the Crown Princess Lovisa Foundation, the
   Freemason Foundation for Children's Welfare, the Swedish Society of
   Medicine, the Solstickan Foundation, Karolinska Institutet, and the
   Stockholm City Council for financial support.
CR Ajalloueian F, 2014, BIOMATERIALS, V35, P5741, DOI 10.1016/j.biomaterials.2014.04.002
   Ajalloueian F, 2013, TISSUE ENG PART C-ME, V19, P688, DOI [10.1089/ten.tec.2012.0633, 10.1089/ten.TEC.2012.0633]
   Blais M, 2013, STEM CELL TRANSL MED, V2, P545, DOI 10.5966/sctm.2012-0181
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Fossum M, 2004, TISSUE ENG, V10, P175, DOI 10.1089/107632704322791826
   Fossum M, 2010, J UROLOGY, V184, P757, DOI 10.1016/j.juro.2010.04.031
   Fossum M, 2009, TISSUE ENG PT A, V15, P2085, DOI 10.1089/ten.tea.2008.0149
   MEEK CP, 1958, AM J SURG, V96, P557, DOI 10.1016/0002-9610(58)90975-9
   Muangman P, 2006, ANN PLAS SURG, V57, P199, DOI 10.1097/01.sap.0000218636.61803.d6
   Orabi H, 2013, EUR UROL, V63, P531, DOI 10.1016/j.eururo.2012.07.041
   Reinfeldt Engberg G., 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/212734
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Romario UF, 2013, SURG ENDOSC, V27, P1798, DOI 10.1007/s00464-012-2683-8
   Salmikangas P, 2015, REGEN MED, V10, P65, DOI [10.2217/rme.14.65, 10.2217/RME.14.65]
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Svensjo T, 2002, J SURG RES, V103, P19, DOI 10.1006/jsre.2001.6331
   TANNER J C Jr, 1964, Plast Reconstr Surg, V34, P287
NR 18
TC 1
Z9 1
U1 1
U2 6
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2016
IS 108
AR e53061
DI 10.3791/53061
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0WF
UT WOS:000372504100004
PM 26967119
OA Green Published
DA 2018-10-20
ER

PT J
AU Mastellos, DC
   Ricklin, D
   Hajishengallis, E
   Hajishengallis, G
   Lambris, JD
AF Mastellos, D. C.
   Ricklin, D.
   Hajishengallis, E.
   Hajishengallis, G.
   Lambris, J. D.
TI Complement therapeutics in inflammatory diseases: promising drug
   candidates for C3-targeted intervention
SO MOLECULAR ORAL MICROBIOLOGY
LA English
DT Review
DE C3; complement; compstatin Cp40; inflammation, periodontitis; primate
   models; therapeutics
ID PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; INFLAMED HUMAN GINGIVA; HUMAN
   WHOLE-BLOOD; BONE LOSS; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE;
   PHARMACOKINETIC PROPERTIES; POLYMICROBIAL SYNERGY; BIOMATERIAL SURFACES;
   MACULAR DEGENERATION
AB There is increasing appreciation that complement dysregulation lies at the heart of numerous immune-mediated and inflammatory disorders. Complement inhibitors are therefore being evaluated as new therapeutic options in various clinical translation programs and the first clinically approved complement-targeted drugs have profoundly impacted the management of certain complement-mediated diseases. Among the many members of the intricate protein network of complement, the central component C3 represents a 'hot-spot' for complement-targeted therapeutic intervention. C3 modulates both innate and adaptive immune responses and is linked to diverse immunomodulatory systems and biological processes that affect human pathophysiology. Compelling evidence from preclinical disease models has shown that C3 interception may offer multiple benefits over existing therapies or even reveal novel therapeutic avenues in disorders that are not commonly regarded as complement-driven, such as periodontal disease. Using the clinically developed compstatin family of C3 inhibitors and periodontitis as illustrative examples, this review highlights emerging therapeutic concepts and developments in the design of C3-targeted drug candidates as novel immunotherapeutics for oral and systemic inflammatory diseases.
C1 [Mastellos, D. C.] Natl Ctr Sci Res Demokritos, Div Biodiagnost Sci & Technol, INRASTES, Aghia Paraskevi, Greece.
   [Ricklin, D.; Lambris, J. D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Hajishengallis, E.] Univ Penn, Sch Dent Med, Dept Prevent & Restorat Sci, Philadelphia, PA 19104 USA.
   [Hajishengallis, G.] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Lambris, JD (reprint author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM lambris@upenn.edu
OI Hajishengallis, George/0000-0001-7392-8852
FU US National Institutes of Health [DE015254, DE017138, DE021685,
   DE024716, AI003040, AI068730, EY020633, GM097747]; European Community's
   Seventh Framework Program [602699]; Greek General Secretariat for
   Research and Technology; European Regional Development Fund under the
   Action 'Development Grants For Research Institutions - KRIPIS' of OPCE
   II
FX The authors are supported by grants from the US National Institutes of
   Health: DE015254, DE017138, DE021685, and DE024716 (GH); AI003040,
   AI068730, EY020633, and GM097747 (JDL), the European Community's Seventh
   Framework Program under grant agreement number 602699 (DIREKT) (JDL) and
   the Greek General Secretariat for Research and Technology and the
   European Regional Development Fund under the Action 'Development Grants
   For Research Institutions - KRIPIS' of OPCE II (DCM).
CR Abe T, 2014, J IMMUNOL, V193, P1383, DOI 10.4049/jimmunol.1400970
   Abe T, 2012, J IMMUNOL, V189, P5442, DOI 10.4049/jimmunol.1202339
   Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174
   Assuma R, 1998, J IMMUNOL, V160, P403
   Banda NK, 2009, J IMMUNOL, V183, P5928, DOI 10.4049/jimmunol.0901826
   Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x
   Belibasakis GN, 2012, J CLIN PERIODONTOL, V39, P239, DOI 10.1111/j.1600-051X.2011.01810.x
   Bosmann M, 2013, TRENDS IMMUNOL, V34, P129, DOI 10.1016/j.it.2012.09.004
   Colombo APV, 2012, J PERIODONTOL, V83, P1279, DOI 10.1902/jop.2012.110566
   DeAngelis RA, 2012, IMMUNOBIOLOGY, V217, P1097, DOI 10.1016/j.imbio.2012.07.012
   Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10
   Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23
   Egge KH, 2014, INNATE IMMUN-LONDON, V20, P68, DOI 10.1177/1753425913482993
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373
   Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260
   Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646
   Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191
   Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359
   Hajishengallis G, 2014, MOL ORAL MICROBIOL, V29, P248, DOI 10.1111/omi.12065
   Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x
   Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785
   Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001
   Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006
   Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918
   Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002
   Han Y W, 2014, Adv Dent Res, V26, P47, DOI 10.1177/0022034514528334
   Harris CL, 2012, TRENDS IMMUNOL, V33, P513, DOI 10.1016/j.it.2012.06.001
   Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021
   Holers VM, 2013, ADV EXP MED BIOL, V735, P137, DOI 10.1007/978-1-4614-4118-2_9
   Huang YJ, 2014, CHEMMEDCHEM, V9, P2223, DOI 10.1002/cmdc.201402212
   Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200
   Jiao YZ, 2013, CELL HOST MICROBE, V13, P595, DOI 10.1016/j.chom.2013.04.005
   Jorth P, 2014, MBIO, V5, DOI DOI 10.1128/MBIO.01012-14
   Jusko M, 2012, J IMMUNOL, V188, P2338, DOI 10.4049/jimmunol.1101240
   Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281
   Klapper Y, 2014, BIOMATERIALS, V35, P3688, DOI 10.1016/j.biomaterials.2013.12.085
   Kourtzelis I, 2015, HORM METAB RES, V47, P36, DOI 10.1055/s-0034-1390452
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Krayer Joe W, 2010, Dent Clin North Am, V54, P13, DOI 10.1016/j.cden.2009.08.010
   Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06
   Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106
   LALLY ET, 1982, J PERIODONTAL RES, V17, P257, DOI 10.1111/j.1600-0765.1982.tb01152.x
   Lamont RJ, 2015, TRENDS MOL MED, V21, P172, DOI 10.1016/j.molmed.2014.11.004
   Liang SA, 2011, J IMMUNOL, V186, P869, DOI 10.4049/jimmunol.1003252
   Lin ZE, 2015, BLOOD, V126, P891, DOI 10.1182/blood-2015-02-625871
   Luzzatto L, 2010, HAEMATOL-HEMATOL J, V95, P523, DOI 10.3324/haematol.2009.017848
   Maekawa T, 2014, CELL HOST MICROBE, V15, P768, DOI 10.1016/j.chom.2014.05.012
   Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569
   Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419
   Mastellos DC, 2014, EXPERT REV HEMATOL, V7, P583, DOI 10.1586/17474086.2014.953926
   Miller DP, 2012, J BIOL CHEM, V287, P12715, DOI 10.1074/jbc.M112.339721
   Moutsopoulos NM, 2014, SCI TRANSL MED, V6, P229, DOI DOI 10.1126/SCITRANSLMED.3007696
   NIEKRASH CE, 1985, J PERIODONTAL RES, V20, P268, DOI 10.1111/j.1600-0765.1985.tb00434.x
   NIKOLOPOULOUPAPACONSTANTINOU AA, 1987, ACTA ODONTOL SCAND, V45, P187
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084
   Page RC, 1982, PERIODONTITIS MAN OT
   PATTERS MR, 1989, J CLIN PERIODONTOL, V16, P33, DOI 10.1111/j.1600-051X.1989.tb01609.x
   Perez-Chaparro PJ, 2014, J DENT RES, V93, P846, DOI 10.1177/0022034514542468
   Pickering M C, 2000, Adv Immunol, V76, P227
   Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242
   Potempa M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000316
   Qu H., 2009, P 21 AM PEPT S JUN 7, P219
   Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003
   Qu H, 2009, MOL IMMUNOL, V47, P185, DOI 10.1016/j.molimm.2009.08.032
   Rams TE, 2014, J PERIODONTOL, V85, P1792, DOI 10.1902/jop.2014.130291
   Reis E. S., 2014, IMMUNOBIOLOGY, V220, P476
   Reis S, 2006, SCAND J IMMUNOL, V63, P155
   Ricklin D., 2015, IMMUNOBIOLOGY
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487
   Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Risitano AM, 2015, HEMATOL ONCOL CLIN N, V29, P561, DOI 10.1016/j.hoc.2015.01.009
   Risitano AM, 2014, BLOOD, V123, P2094, DOI 10.1182/blood-2013-11-536573
   Risitano AM, 2013, ADV EXP MED BIOL, V735, P155, DOI 10.1007/978-1-4614-4118-2_10
   Risitano AM, 2012, IMMUNOBIOLOGY, V217, P1080, DOI 10.1016/j.imbio.2012.07.014
   Sahu A, 1996, J IMMUNOL, V157, P884
   Sahu A, 2003, MOL IMMUNOL, V39, P557, DOI 10.1016/S0161-5890(02)00212-2
   SCHENKEIN HA, 1995, J IMMUNOL, V154, P5331
   SCHENKEIN HA, 1977, J PERIODONTOL, V48, P778, DOI 10.1902/jop.1977.48.12.778
   Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548
   Schramm EC, 2014, MOL IMMUNOL, V61, P118, DOI 10.1016/j.molimm.2014.06.032
   Scott D., 2015, IMMUNOBIOLOGY
   Settem RP, 2012, INFECT IMMUN, V80, P2436, DOI 10.1128/IAI.06276-11
   Shaughnessy AF, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8346
   Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746
   TOTO PD, 1978, J DENT RES, V57, P696, DOI 10.1177/00220345780570050501
   Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697
   WINGROVE JA, 1992, J BIOL CHEM, V267, P18902
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Zhan YB, 2014, J PERIODONTOL, V85, P1059, DOI 10.1902/jop.2014.130523
   Zhang YZ, 2015, IMMUNOBIOLOGY, V220, P993, DOI 10.1016/j.imbio.2015.04.001
NR 97
TC 18
Z9 18
U1 3
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2041-1006
EI 2041-1014
J9 MOL ORAL MICROBIOL
JI Mol. Oral Microbiol.
PD FEB
PY 2016
VL 31
IS 1
BP 3
EP 17
DI 10.1111/omi.12129
PG 15
WC Dentistry, Oral Surgery & Medicine; Microbiology
SC Dentistry, Oral Surgery & Medicine; Microbiology
GA DG8KM
UT WOS:000372332700002
PM 26332138
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ajdukovic, ZR
   Mihajilov-Krstev, TM
   Ignjatovic, NL
   Stojanovic, Z
   Mladenovic-Antic, SB
   Kocic, BD
   Najman, S
   Petrovic, ND
   Uskokovic, DP
AF Ajdukovic, Zorica R.
   Mihajilov-Krstev, Tatjana M.
   Ignjatovic, Nenad L.
   Stojanovic, Zoran
   Mladenovic-Antic, Snezana B.
   Kocic, Branislava D.
   Najman, Stevo
   Petrovic, Nenad D.
   Uskokovic, Dragan P.
TI In Vitro Evaluation of Nanoscale Hydroxyapatite-Based Bone
   Reconstructive Materials with Antimicrobial Properties
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Cobalt-Substituted Hydroxyapatite; PLGA; S. aureus; E. coli;
   Antimicrobial Activity; Hemolytic Activity
ID ENHANCED OSTEOINDUCTIVITY; ANTIBACTERIAL ACTIVITY;
   STAPHYLOCOCCUS-AUREUS; SILVER NANOPARTICLES; BIOFILM FORMATION;
   STAINLESS-STEEL; CELLS; ACID; VIVO; ION
AB In the field of oral implantology the loss of bone tissue prevents adequate patient care, and calls for the use of synthetic biomaterials with properties that resemble natural bone. Special attention is paid to the risk of infection after the implantation of these materials. Studies have suggested that some nanocontructs containing metal ions have antimicrobial properties. The aim of this study was to examine the antimicrobial and hemolytic activity of cobalt-substituted hydroxyapatite nanoparticles, compared to hydroxyapatite and hydroxyapatite/poly-lactide-co-glycolide. The antibacterial effects of these powders were tested against two pathogenic bacterial strains: Escherichia coli (ATCC 25922) and Staphylococcus aureus (ATCC 25923), using the disc diffusion method and the quantitative antimicrobial test in a liquid medium. The quantitative antimicrobial test showed that all of the tested biomaterials have some antibacterial properties. The effects of both tests were more prominent in case of S. aureus than in E. coli. A higher percentage of cobalt in the crystal structure of cobalt-substituted hydroxyapatite nanoparticles led to an increased antimicrobial activity. All of the presented biomaterial samples were found to be non-hemolytic. Having in mind that the tested of cobalt-substituted hydroxyapatite (Ca/Co-HAp) material in given concentrations shows good hemocompatibility and antimicrobial effects, along with its previously studied biological properties, the conclusion can be reached that it is a potential candidate that could substitute calcium hydroxyapatite as the material of choice for use in bone tissue engineering and clinical practices in orthopedic, oral and maxillofacial surgery.
C1 [Ajdukovic, Zorica R.] Univ Nis, Fac Med, Clin Stomatol, Dept Prosthodont, Bulevar Zorana Dind 81, Nish 18000, Serbia.
   [Mihajilov-Krstev, Tatjana M.] Univ Nis, Fac Sci & Math, Dept Biol & Ecol, Visegradska 33,POB 224, Nish 18000, Serbia.
   [Ignjatovic, Nenad L.; Stojanovic, Zoran; Uskokovic, Dragan P.] Serbian Acad Arts & Sci, Inst Tech Sci, Ctr Fine Particle Proc & Nanotechnol, Knez Mihailova 35-4,POB 377, Belgrade 11000, Serbia.
   [Mladenovic-Antic, Snezana B.; Kocic, Branislava D.] Univ Nis, Fac Med, Inst Publ Hlth, Ctr Microbiol, Bulevar Zorana Dind 81, Nish 18000, Serbia.
   [Najman, Stevo] Univ Nis, Fac Med, Dept Biol & Human Genet, Bulevar Zorana Dind 81, Nish 18000, Serbia.
   [Petrovic, Nenad D.] Univ Nis, Fac Med, Dept Dent, Bulevar Zorana Dind 81, Nish 18000, Serbia.
RP Uskokovic, DP (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, Ctr Fine Particle Proc & Nanotechnol, Knez Mihailova 35-4,POB 377, Belgrade 11000, Serbia.
RI Uskokovic, Dragan/B-4129-2008; Stojanovic, Zoran/A-7417-2011;
   Ignjatovic, Nenad/C-4489-2008
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Stojanovic, Zoran S./0000-0002-5989-0031
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [III45004, III41017]
FX The research presented in this paper was supported by the Ministry of
   Education, Science and Technological Development of the Republic of
   Serbia, under Projects No. III45004 and No. III41017. The authors would
   like to thank to Jelena Rajkovic for her help in conducting hemolityc
   activity tests.
CR Allaker RP, 2008, T ROY SOC TROP MED H, V102, P1, DOI 10.1016/j.trstmh.2007.07.003
   Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Atamaca S., 1998, TURK J MED SCI, V28, P595
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Boeckh C, 2002, CARIES RES, V36, P101, DOI 10.1159/000057867
   Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   Dair BJ, 2010, J NANOSCI NANOTECHNO, V10, P8456, DOI 10.1166/jnn.2010.3566
   Du WL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085707
   Franchi M, 2005, MICRON, V36, P665, DOI 10.1016/j.micron.2005.05.010
   Fu OY, 2009, ANTICANCER RES, V29, P3131
   Guo C, 2011, ADV MATER RES-SWITZ, V311-313, P1746, DOI 10.4028/www.scientific.net/AMR.311-313.1746
   He PF, 2013, J BIOMED MATER RES A, V101, P555, DOI 10.1002/jbm.a.34333
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   Ignjatovic N, 2013, J MATER SCI-MATER M, V24, P343, DOI 10.1007/s10856-012-4793-1
   Jadalannagari S, 2014, APPL NANOSCI, V4, P133, DOI 10.1007/s13204-013-0197-x
   Jamuna-Thevi K, 2011, VACUUM, V86, P235, DOI 10.1016/j.vacuum.2011.06.011
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Kovacic P, 2010, J NANOSCI NANOTECHNO, V10, P7919, DOI 10.1166/jnn.2010.3028
   Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361
   Nan L, 2008, J MATER SCI-MATER M, V19, P3057, DOI 10.1007/s10856-008-3444-z
   OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Perrone S, 2012, J MATERN-FETAL NEO M, V25, P104, DOI 10.3109/14767058.2012.715471
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Phan TN, 2004, ORAL MICROBIOL IMMUN, V19, P31, DOI 10.1046/j.0902-0055.2003.00109.x
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Schaller M, 2004, SKIN PHARMACOL PHYSI, V17, P31, DOI 10.1159/000074060
   Sreenivasan PK, 2004, ORAL MICROBIOL IMMUN, V19, P297, DOI 10.1111/j.1399-302x.2004.00158.x
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   Stojanovic Z, 2009, MATER MANUF PROCESS, V24, P1096, DOI 10.1080/10426910903032113
   SUGARMAN B, 1983, REV INFECT DIS, V5, P137
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Tank KP, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1644-z
   Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021
   Trampuz A, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000087324.60612.93
   Veselinovic L, 2010, J APPL CRYSTALLOGR, V43, P320, DOI 10.1107/S0021889809051395
   von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046
   Waldvogel FA, 2000, INFECT ASS INDWELLIN
   Weir E, 2008, ANALYST, V133, P835, DOI 10.1039/b715532h
   WIESSNER J, 1988, CALCIFIED TISSUE INT, V42, P210, DOI 10.1007/BF02553746
   Xiong AM, 1998, J BACTERIOL, V180, P4024
   Yang SJ, 2004, J BIOCHEM MOL BIOL, V37, P480
   Zhu M, 2001, ORAL MICROBIOL IMMUN, V16, P24, DOI 10.1034/j.1399-302x.2001.160104.x
NR 52
TC 1
Z9 1
U1 1
U2 14
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2016
VL 16
IS 2
BP 1420
EP 1428
DI 10.1166/jnn.2016.10699
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DG8UJ
UT WOS:000372358800026
PM 27433598
DA 2018-10-20
ER

PT J
AU Ji, FY
   Li, SP
   Yang, H
   Wang, ZR
   Li, AW
AF Ji, Fengying
   Li, Shanpeng
   Yang, Hai
   Wang, Zhirui
   Li, Aiwu
TI Versatile Photocrosslinked Protein Hydrogel Matrix for
   Magnetic-Nanoparticle-Doping and Biomineralization
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Protein Hydrogel; Photocrosslink; Magnetic-Nanoparticle-Doped
   Biomaterils; Biomineralization
ID 2-PHOTON POLYMERIZATION; CROSS-LINKING; SILK FIBROIN; ELECTRONICS;
   ALBUMIN; FILMS; OXIDE
AB A versatile template biomaterial was facilely obtained by ultraviolet (UV) photocrosslinking approach using protein molecules as building blocks. As-formed photocrosslinked protein hydrogel matrix (PPHM) was proved to be composed of covalently bound and dense packing protein molecules. Therefore, the PPHM was endowed with highly smooth topograghy with an average roughness of similar to 5 nm, and was self-supporting and flexible. The PPHM could be easily functionalized by doping Fe3O4 magnetic nanoparticles inside the protein hydrogel. Further, PPHM was experimentally demonstrated to be used as a applicable template for biomineralization.
C1 [Ji, Fengying; Li, Shanpeng] Qingdao Municipal Ctr Dis Control & Prevent, Qingdao 266033, Peoples R China.
   [Yang, Hai] Gen Res Inst Nonferrous Met, Beijing 100088, Peoples R China.
   [Wang, Zhirui; Li, Aiwu] Jilin Univ, State Key Lab Integrated Optoelect, Coll Elect Sci & Engn, Changchun 130012, Peoples R China.
RP Li, AW (reprint author), Jilin Univ, State Key Lab Integrated Optoelect, Coll Elect Sci & Engn, Changchun 130012, Peoples R China.
FU National Natural Science Foundation of China [61107024]
FX This research was supported by the National Natural Science Foundation
   of China (61107024).
CR Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Currie HA, 2011, ADV FUNCT MATER, V21, P2889, DOI 10.1002/adfm.201100249
   Dickerson MB, 2008, CHEM REV, V108, P4935, DOI 10.1021/cr8002328
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   FUJIMORI E, 1981, FEBS LETT, V135, P257, DOI 10.1016/0014-5793(81)80795-8
   Gueevel X. L., 2011, J PHYS CHEM C, V115, P10955
   Guo L, 2012, CARBON, V50, P1667, DOI 10.1016/j.carbon.2011.12.011
   Kaehr B, 2009, LAB CHIP, V9, P2632, DOI 10.1039/b908119d
   Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kochevar IE, 2000, PHOTOCHEM PHOTOBIOL, V72, P548, DOI 10.1562/0031-8655(2000)072<0548:SOBNOR>2.0.CO;2
   Kowalczyk T, 2008, BIOMACROMOLECULES, V9, P2087, DOI 10.1021/bm800421s
   Leroux F, 2010, ADV MATER, V22, P2193, DOI 10.1002/adma.200903657
   Liebetraut P, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.54
   Ma Z, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.24
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pritchard EM, 2013, ADV FUNCT MATER, V23, P854, DOI 10.1002/adfm.201201636
   Ryu J, 2010, ADV MATER, V22, P5537, DOI 10.1002/adma.201000669
   Shen HR, 2000, J PHOTOCH PHOTOBIO A, V130, P1, DOI 10.1016/S1010-6030(99)00200-2
   Sun YL, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.10
   Sun YL, 2012, OPT LETT, V37, P2973, DOI 10.1364/OL.37.002973
   Sun YL, 2012, ANGEW CHEM INT EDIT, V51, P1558, DOI 10.1002/anie.201105925
   Tian Y, 2010, LAB CHIP, V10, P2902, DOI 10.1039/c005277a
   Wang J, 2009, OPT LETT, V34, P581, DOI 10.1364/OL.34.000581
   Wu D, 2011, ADV FUNCT MATER, V21, P2927, DOI 10.1002/adfm.201002733
   Wu D, 2011, ADV MATER, V23, P545, DOI 10.1002/adma.201001688
   Wu D, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3297881
   Xia H, 2010, ADV MATER, V22, P3204, DOI 10.1002/adma.201000542
   Xia H, 2009, J PHYS CHEM C, V113, P18542, DOI 10.1021/jp905871k
   Xie JP, 2009, J AM CHEM SOC, V131, P888, DOI 10.1021/ja806804u
   Xiong W, 2012, LIGHT-SCI APPL, V1, DOI 10.1038/lsa.2012.6
   Zhang L, 2013, NANOSCALE, V5, P7664, DOI 10.1039/c3nr01616a
   Zhang L, 2011, SOFT MATTER, V7, P7375, DOI 10.1039/c1sm05184a
   Zhang L, 2011, CHEM COMMUN, V47, P1225, DOI 10.1039/c0cc03946b
NR 35
TC 1
Z9 1
U1 2
U2 44
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2016
VL 16
IS 2
BP 1471
EP 1476
DI 10.1166/jnn.2016.10749
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DG8UJ
UT WOS:000372358800034
PM 27433606
DA 2018-10-20
ER

PT J
AU Kim, H
   Lee, J
AF Kim, Hyeongmin
   Lee, Jaehwi
TI Strategies to Maximize the Potential of Marine Biomaterials as a
   Platform for Cell Therapy
SO MARINE DRUGS
LA English
DT Review
DE marine biomaterials; cell therapy; tissue engineering; optimization;
   stimuli-responsive systems; delivery systems
ID TISSUE-ENGINEERING APPLICATIONS; REGENERATIVE MEDICINE APPLICATIONS;
   CARRAGEENAN-BASED HYDROGELS; POROUS CHITOSAN SCAFFOLDS; MESENCHYMAL
   STEM-CELLS; SEA HYDROTHERMAL VENTS; ALGINATE HYDROGELS; IN-VITRO;
   MECHANICAL-PROPERTIES; DRUG-DELIVERY
AB Marine biopolymers have been explored as a promising cell therapy system for efficient cell delivery and tissue engineering. However, the marine biomaterial-based systems themselves have exhibited limited performance in terms of maintenance of cell viability and functions, promotion of cell proliferation and differentiation as well as cell delivery efficiency. Thus, numerous novel strategies have been devised to improve cell therapy outcomes. The strategies include optimization of physical and biochemical properties, provision of stimuli-responsive functions, and design of platforms for efficient cell delivery and tissue engineering. These approaches have demonstrated substantial improvement of therapeutic outcomes in a variety of research settings. In this review, therefore, research progress made with marine biomaterials as a platform for cell therapy is reported along with current research directions to further advance cell therapies as a tool to cure incurable diseases.
C1 [Kim, Hyeongmin; Lee, Jaehwi] Chung Ang Univ, Coll Pharm, Pharmaceut Formulat Design Lab, Seoul 156756, South Korea.
   [Kim, Hyeongmin; Lee, Jaehwi] Chung Ang Univ, Biointegrat Res Ctr Nutrapharmaceut Epigenet, Seoul 156756, South Korea.
RP Lee, J (reprint author), Chung Ang Univ, Coll Pharm, Pharmaceut Formulat Design Lab, Seoul 156756, South Korea.; Lee, J (reprint author), Chung Ang Univ, Biointegrat Res Ctr Nutrapharmaceut Epigenet, Seoul 156756, South Korea.
EM hm.kim8905@gmail.com; jaehwi@cau.ac.kr
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [2015R1A5A1008958]; National Research Foundation of Korea (NRF) -
   Ministry of Education [2015R1D1A1A02062278]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No.
   2015R1A5A1008958). This work was also supported by Basic Science
   Research Program through the National Research Foundation of Korea (NRF)
   funded by the Ministry of Education (No. 2015R1D1A1A02062278).
CR Abdi SIH, 2012, TISSUE ENG REGEN MED, V9, P1, DOI 10.1007/s13770-012-0001-0
   ACOSTA N, 1993, BIOMASS BIOENERG, V5, P145, DOI 10.1016/0961-9534(93)90096-M
   Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Martel-Estrada SA, 2010, CARBOHYD POLYM, V81, P775, DOI 10.1016/j.carbpol.2010.03.032
   Albanna MZ, 2013, J MECH BEHAV BIOMED, V20, P217, DOI 10.1016/j.jmbbm.2012.09.012
   Albanna MZ, 2012, J MECH BEHAV BIOMED, V5, P171, DOI 10.1016/j.jmbbm.2011.08.021
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Araki C., 1966, P INT SEAWEED S, P3
   Aranaz I, 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Aymard P, 2001, BIOPOLYMERS, V59, P131, DOI 10.1002/1097-0282(200109)59:3<131::AID-BIP1013>3.0.CO;2-8
   Bagheri-Khoulenjani S, 2009, CARBOHYD POLYM, V78, P773, DOI 10.1016/j.carbpol.2009.06.020
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002
   Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006
   Bidarra SJ, 2011, BIOMATERIALS, V32, P7897, DOI 10.1016/j.biomaterials.2011.07.013
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Bromberg L, 1998, J PHYS CHEM B, V102, P10736, DOI 10.1021/jp983162e
   Burrows F., 2007, American-Eurasian Journal of Agricultural and Environmental Science, V2, P103
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Cezar CA, 2014, ADV HEALTHC MATER, V3, P1869, DOI 10.1002/adhm.201400095
   Chanana A, 2012, ISOR J PHARM, V2, P72, DOI DOI 10.9790/3013-02107273
   Chang SCN, 2010, J BIOMED MATER RES A, V94A, P433, DOI 10.1002/jbm.a.32685
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Chen JP, 2006, MACROMOL BIOSCI, V6, P1026, DOI 10.1002/mabi.200600142
   Chen L, 2015, MOL MED REP, V12, P7263, DOI 10.3892/mmr.2015.4371
   Colliec-Jouault S, 2004, PATHOL BIOL, V52, P127, DOI 10.1016/j.patbio.2003.05.005
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   Dainiak MB, 2006, P NATL ACAD SCI USA, V103, P849, DOI 10.1073/pnas.0508432103
   Dendukuri D, 2007, LANGMUIR, V23, P4669, DOI 10.1021/la062512i
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Draget KI, 2006, FOOD HYDROCOLLOID, V20, P170, DOI 10.1016/j.foodhyd.2004.03.009
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Elahi F., 2013, BIOENG BIOMED SCI J, V3, P1
   Fang JJ, 2014, ACTA BIOMATER, V10, P276, DOI 10.1016/j.actbio.2013.09.002
   Fonseca KB, 2013, SOFT MATTER, V9, P3283, DOI 10.1039/c3sm27560d
   Fonseca KB, 2011, ACTA BIOMATER, V7, P1674, DOI 10.1016/j.actbio.2010.12.029
   Frohbergh ME, 2012, BIOMATERIALS, V33, P9167, DOI 10.1016/j.biomaterials.2012.09.009
   Fusco S, 2006, J BIOACT COMPAT POL, V21, P149, DOI 10.1177/0883911506063207
   Gantenbein-Ritter B, 2012, EUR SPINE J, V21, P819, DOI DOI 10.1007/S00586-011-2026-9
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Grieshaber SE, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P9, DOI 10.1007/978-3-7091-0385-2_2
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032
   Grunkemeier JM, 2000, J BIOMED MATER RES, V51, P669, DOI 10.1002/1097-4636(20000915)51:4<669::AID-JBM15>3.0.CO;2-#
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Ha CW, 2012, CYTOTHERAPY, V14, P247, DOI 10.3109/14653249.2011.629645
   Haraguchi Y, 2012, STEM CELL TRANSL MED, V1, P136, DOI [10.5966/sctm.2011-0030, 10.5966/sctm.2012-0030]
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano S, 1999, CARBOHYD POLYM, V38, P293, DOI 10.1016/S0144-8617(98)00126-X
   Holland TA, 2003, J CONTROL RELEASE, V86, P1, DOI 10.1016/S0168-3659(02)00373-5
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Hsieh WC, 2007, COLLOID SURFACE B, V57, P250, DOI 10.1016/j.colsurfb.2007.02.004
   Hu J, 2008, BIOMACROMOLECULES, V9, P2637, DOI 10.1021/bm800705t
   Hua FJ, 2003, POLYMER, V44, P1911, DOI 10.1016/S0032-3861(03)00025-9
   Huang CC, 2012, BIOMATERIALS, V33, P4069, DOI 10.1016/j.biomaterials.2012.02.024
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hussain A, 2013, BIOTECHNOL BIOENG, V110, P637, DOI 10.1002/bit.24727
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jana S, 2014, ACTA BIOMATER, V10, P2877, DOI 10.1016/j.actbio.2014.03.014
   Jeong SI, 2010, MACROMOL BIOSCI, V10, P934, DOI 10.1002/mabi.201000046
   Jing W, 2007, CELL TISSUE RES, V330, P567, DOI 10.1007/s00441-007-0493-4
   Kabanov AV, 2002, CRIT REV THER DRUG, V19, P1, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.10
   Kang SW, 2011, MACROMOL BIOSCI, V11, P673, DOI 10.1002/mabi.201000479
   Kara S, 2007, J BIOACT COMPAT POL, V22, P42, DOI 10.1177/0883911506073361
   Karoubi G, 2009, BIOMATERIALS, V30, P5445, DOI 10.1016/j.biomaterials.2009.06.035
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P643, DOI 10.1002/jbm.a.30866
   Kim J, 2015, J BIOL ENG, V9, DOI 10.1186/1754-1611-9-1
   Kim WS, 2012, TISSUE ENG PT A, V18, P737, DOI [10.1089/ten.tea.2011.0250, 10.1089/ten.TEA.2011.0250]
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Krol S, 2006, NANO LETT, V6, P1933, DOI 10.1021/nl061049r
   Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lai JY, 2012, INT J MOL SCI, V13, P10970, DOI 10.3390/ijms130910970
   Lakard B, 2009, BIOELECTROCHEMISTRY, V75, P148, DOI 10.1016/j.bioelechem.2009.03.010
   Laurienzo P, 2010, MAR DRUGS, V8, P2435, DOI 10.3390/md8092435
   Lee CSD, 2013, TISSUE ENG PT A, V19, P1451, DOI [10.1089/ten.TEA.2012.0233, 10.1089/ten.tea.2012.0233]
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee KY, 2007, PROG POLYM SCI, V32, P669, DOI 10.1016/j.progpolymsci.2007.04.001
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2003, ADV MATER, V15, P1828, DOI 10.1002/adma.200305406
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee SB, 2014, BIOTECHNOL BIOPROC E, V19, P866, DOI 10.1007/s12257-014-0622-3
   Leedy MR, 2011, ADV POLYM SCI, V244, P129, DOI 10.1007/12_2011_115
   Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Leung A, 2005, BIOTECHNOL BIOENG, V92, P45, DOI 10.1002/bit.20597
   Lim JI, 2011, J BIOMAT SCI-POLYM E, V22, P1319, DOI 10.1163/092050610X504783
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu F, 2000, LIFE SCI, V66, P725, DOI 10.1016/S0024-3205(99)00643-8
   Liu JH, 2005, EUR J PHARM SCI, V25, P237, DOI 10.1016/j.ejps.2005.02.013
   Ma GP, 2012, CARBOHYD POLYM, V87, P737, DOI 10.1016/j.carbpol.2011.08.055
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Man Y, 2012, BIOMATERIALS, V33, P8802, DOI 10.1016/j.biomaterials.2012.08.054
   Mata JP, 2005, J COLLOID INTERF SCI, V292, P548, DOI 10.1016/j.jcis.2005.06.013
   Mi FL, 2001, J BIOMAT SCI-POLYM E, V12, P835, DOI 10.1163/156856201753113051
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   Miura S, 2006, BIOMATERIALS, V27, P5828, DOI 10.1016/j.biomaterials.2006.07.039
   Montjovent MO, 2008, BONE, V42, P554, DOI 10.1016/j.bone.2007.10.018
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Munarin F, 2011, BIOMACROMOLECULES, V12, P568, DOI 10.1021/bm101110x
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Muzzarelli RAA, 2014, MAR DRUGS, V12, P5468, DOI 10.3390/md12115468
   Muzzarelli RAA, 2011, MAR DRUGS, V9, P1510, DOI 10.3390/md9091510
   Neamnark A, 2006, CARBOHYD POLYM, V66, P298, DOI 10.1016/j.carbpol.2006.03.015
   Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2
   Nie HR, 2008, BIOMACROMOLECULES, V9, P1362, DOI 10.1021/bm701349j
   Nishizawa M, 2007, BIOMATERIALS, V28, P1480, DOI 10.1016/j.biomaterials.2006.11.034
   Nisisako T, 2008, LAB CHIP, V8, P287, DOI 10.1039/b713141k
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   Oliveira SM, 2008, J BIOMED MATER RES B, V87B, P49, DOI 10.1002/jbm.b.31066
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park JH, 2010, BIOTECHNOL BIOENG, V106, P138, DOI 10.1002/bit.22667
   Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Pavinatto FJ, 2010, BIOMACROMOLECULES, V11, P1897, DOI 10.1021/bm1004838
   Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007
   Pereira L, 2009, FOOD HYDROCOLLOID, V23, P1903, DOI 10.1016/j.foodhyd.2008.11.014
   Popa EG, 2015, J TISSUE ENG REGEN M, V9, P550, DOI 10.1002/term.1683
   Popa EG, 2014, J BIOMED MATER RES A, V102, P4087, DOI 10.1002/jbm.a.35081
   Popa EG, 2011, BIOMACROMOLECULES, V12, P3952, DOI 10.1021/bm200965x
   Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   RIVERACARRO H, 1990, HYDROBIOLOGIA, V204, P533, DOI 10.1007/BF00040282
   Rocha PM, 2011, J BIOACT COMPAT POL, V26, P493, DOI 10.1177/0883911511420700
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Saad FA, 2011, INT ORTHOP, V35, P447, DOI 10.1007/s00264-010-1076-7
   Sahay R, 2012, J MATER CHEM, V22, P12953, DOI 10.1039/c2jm30966a
   Sakai S, 2005, BIOMATERIALS, V26, P4786, DOI 10.1016/j.biomaterials.2004.11.043
   Sakai S, 2007, J BIOSCI BIOENG, V103, P22, DOI 10.1263/jbb.103.22
   Salgado CL, 2012, TISSUE ENG PT A, V18, P137, DOI [10.1089/ten.tea.2011.0294, 10.1089/ten.TEA.2011.0294]
   Sandvig I, 2015, J BIOMED MATER RES A, V103, P896, DOI 10.1002/jbm.a.35230
   Santo VE, 2009, BIOMACROMOLECULES, V10, P1392, DOI 10.1021/bm8014973
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Schinella GR, 2002, LIFE SCI, V70, P1023, DOI 10.1016/S0024-3205(01)01482-5
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Senni K, 2011, MAR DRUGS, V9, P1664, DOI 10.3390/md9091664
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Shah A, 2008, PEDIATR RES, V63, P535, DOI 10.1203/PDR.0b013e31816bdf54
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Silva Tiago H, 2012, Biomatter, V2, P278, DOI 10.4161/biom.22947
   SMIDSROD O, 1973, CARBOHYD RES, V27, P107, DOI 10.1016/S0008-6215(00)82430-1
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Sosnik A, 2005, BIOMATERIALS, V26, P7425, DOI 10.1016/j.biomaterials.2005.05.086
   SUDARSHAN NR, 1992, FOOD BIOTECHNOL, V6, P257, DOI 10.1080/08905439209549838
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun C, 2005, J BIOTECHNOL, V115, P137, DOI 10.1016/j.jbiotec.2004.08.011
   Sun C, 2004, LIFE SCI, V75, P1063, DOI 10.1016/j.lfs.2004.02.015
   Sun HH, 2009, CARBOHYD POLYM, V78, P117, DOI 10.1016/j.carbpol.2009.04.017
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tan HP, 2007, J MATER SCI-MATER M, V18, P1961, DOI 10.1007/s10856-007-3095-5
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Tan RW, 2012, CARBOHYD POLYM, V87, P1515, DOI 10.1016/j.carbpol.2011.09.048
   Tchemtchoua VT, 2011, BIOMACROMOLECULES, V12, P3194, DOI 10.1021/bm200680q
   Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9
   Thornton AJ, 2004, J UROLOGY, V172, P763, DOI 10.1097/01.ju.0000130466.84214.f7
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Torigoe I, 2007, CELL TRANSPLANT, V16, P729, DOI 10.3727/000000007783465109
   Tran NQ, 2010, BIOMACROMOLECULES, V11, P617, DOI 10.1021/bm100047y
   Tsai WB, 2012, CARBOHYD POLYM, V89, P379, DOI 10.1016/j.carbpol.2012.03.017
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421
   Valmikinathan CM, 2012, SOFT MATTER, V8, P1964, DOI 10.1039/c1sm06629c
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wallace GG, 1999, TRAC-TREND ANAL CHEM, V18, P245, DOI 10.1016/S0165-9936(98)00113-7
   Wang JY, 2009, J MATER SCI-MATER M, V20, P583, DOI 10.1007/s10856-008-3593-0
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   Wang Q, 2005, INNOV FOOD SCI EMERG, V6, P465, DOI 10.1016/j.ifset.2005.05.002
   Wang XJ, 2009, J BIOMAT SCI-POLYM E, V20, P1995, DOI 10.1163/156856208X396083
   Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Yang CX, 2011, J POROUS MAT, V18, P545, DOI 10.1007/s10934-010-9407-z
   YANG H, 1994, BIOMATERIALS, V15, P113, DOI 10.1016/0142-9612(94)90259-3
   Yang J, 2008, J BIOMED MATER RES B, V84B, P131, DOI 10.1002/jbm.b.30853
   Yu Zhai, 2008, J Biomed Mater Res A, V85, P582, DOI 10.1002/jbm.a.31189
   Zakhem E, 2015, J FUNCT BIOMATER, V6, P999, DOI 10.3390/jfb6040999
   Zhang L, 2012, J BIOMED MATER RES A, V100A, P2717, DOI 10.1002/jbm.a.34194
   Zhang Lixiao, 2011, AGR ENG, V1, P1, DOI DOI 10.1038/CR.2011.158
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
   Zhao LB, 2009, LAB CHIP, V9, P2981, DOI 10.1039/b907478c
   Zhao QH, 2011, J MATER RES, V26, P347, DOI 10.1557/jmr.2010.23
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zhi ZL, 2010, BIOMACROMOLECULES, V11, P610, DOI 10.1021/bm901152k
   Zhong C, 2010, ACTA BIOMATER, V6, P3908, DOI 10.1016/j.actbio.2010.04.011
   Zrinyi M, 1997, POLYM GELS NETW, V5, P415, DOI 10.1016/S0966-7822(97)00010-5
   Zrinyi M, 1996, J CHEM PHYS, V104, P8750, DOI 10.1063/1.471564
NR 220
TC 3
Z9 3
U1 3
U2 30
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD FEB
PY 2016
VL 14
IS 2
AR 29
DI 10.3390/md14020029
PG 37
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA DG2LX
UT WOS:000371899800001
PM 26821034
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dong, CJ
   Lv, YG
AF Dong, Chanjuan
   Lv, Yonggang
TI Application of Collagen Scaffold in Tissue Engineering: Recent Advances
   and New Perspectives
SO POLYMERS
LA English
DT Review
DE collagen; biomaterial; scaffold; tissue engineering; extracellular
   matrix
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   ORGANIC-INORGANIC COMPOSITES; CROSS-LINKING; PERIPHERAL-NERVE; SILK
   FIBROIN; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES; ELECTROSPUN
   FIBERS; BONE REGENERATION
AB Collagen is the main structural protein of most hard and soft tissues in animals and the human body, which plays an important role in maintaining the biological and structural integrity of the extracellular matrix (ECM) and provides physical support to tissues. Collagen can be extracted and purified from a variety of sources and offers low immunogenicity, a porous structure, good permeability, biocompatibility and biodegradability. Collagen scaffolds have been widely used in tissue engineering due to these excellent properties. However, the poor mechanical property of collagen scaffolds limits their applications to some extent. To overcome this shortcoming, collagen scaffolds can be cross-linked by chemical or physical methods or modified with natural/synthetic polymers or inorganic materials. Biochemical factors can also be introduced to the scaffold to further improve its biological activity. This review will summarize the structure and biological characteristics of collagen and introduce the preparation methods and modification strategies of collagen scaffolds. The typical application of a collagen scaffold in tissue engineering (including nerve, bone, cartilage, tendon, ligament, blood vessel and skin) will be further provided. The prospects and challenges about their future research and application will also be pointed out.
C1 [Dong, Chanjuan; Lv, Yonggang] Chongqing Univ, Bioengn Coll, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.
   [Dong, Chanjuan; Lv, Yonggang] Chongqing Univ, Bioengn Coll, Mech & Regenerat Med Lab, Chongqing 400044, Peoples R China.
RP Lv, YG (reprint author), Chongqing Univ, Bioengn Coll, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.; Lv, YG (reprint author), Chongqing Univ, Bioengn Coll, Mech & Regenerat Med Lab, Chongqing 400044, Peoples R China.
EM happydcj@126.com; yglv@cqu.edu.cn
FU Fundamental Research Funds for the Central Universities
   [CQDXWL-2012-Z001]
FX This work was supported in part by grants from the Fundamental Research
   Funds for the Central Universities (CQDXWL-2012-Z001).
CR Adachi T, 2006, J BIOTECHNOL, V126, P205, DOI 10.1016/j.jbiotec.2006.04.035
   Arafat MT, 2015, POLYMER, V77, P102, DOI 10.1016/j.polymer.2015.09.037
   Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.11.010305.104258
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   Basad E, 2015, KNEE SURG SPORT TR A, V23, P3729, DOI 10.1007/s00167-014-3295-8
   Berninger MT, 2013, JOVE-J VIS EXP, DOI 10.3791/4423
   Boecker A. H., 2015, EUR J NEUROSCI, DOI [10.1111/ejn.1305226296589, DOI 10.1111/EJN.1305226296589]
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Bornes TD, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0075-4
   Bozkurt A, 2016, BIOMATERIALS, V75, P112, DOI 10.1016/j.biomaterials.2015.10.009
   BURGESON RE, 1992, CLIN ORTHOP RELAT R, P250
   BURGESON RE, 1982, J INVEST DERMATOL, V79, pS25, DOI 10.1111/1523-1747.ep12544829
   Cao H, 2015, COLLOID SURFACE B, V136, P1098, DOI 10.1016/j.colsurfb.2015.10.022
   Cardwell RD, 2014, J TISSUE ENG REGEN M, V8, P937, DOI 10.1002/term.1589
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chandika P, 2015, INT J BIOL MACROMOL, V81, P504, DOI 10.1016/j.ijbiomac.2015.08.038
   Chen G., 2015, J BIOMED MATER RES A, DOI [10.1002/jbm.a.3562226650620, DOI 10.1002/JBM.A.3562226650620]
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chen GB, 2015, ACS APPL MATER INTER, V7, P15790, DOI 10.1021/acsami.5b02662
   Chen GB, 2015, CURR PHARM DESIGN, V21, P1967, DOI 10.2174/1381612821666150302152704
   Chen GB, 2015, CURR STEM CELL RES T, V10, P99, DOI 10.2174/1574888X09666140812112631
   Chen GB, 2013, CURR STEM CELL RES T, V8, P313, DOI 10.2174/1574888X11308040007
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Cui Y, 2014, BIOMATERIALS, V35, P7819, DOI 10.1016/j.biomaterials.2014.05.065
   de Val JEMS, 2018, CLIN ORAL IMPLAN RES, V29, P816, DOI 10.1111/clr.12656
   Di Felice V, 2015, J TISSUE ENG REGEN M, V9, pE51, DOI 10.1002/term.1739
   Fan ZH, 2013, CELL TRANSPLANT, V22, pS39, DOI 10.3727/096368913X672190
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   FUJII K, 1986, NEUROCHEM RES, V11, P1439, DOI 10.1007/BF00966223
   Gebauer J. M., 2015, MATRIX BIOL, DOI [10.1016/j.matbio.2015.07.00126235539, DOI 10.1016/J.MATBIO.2015.07.00126235539]
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Ghazanfari S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127847
   Gigante A, 2013, J ORTHOP RES, V31, P738, DOI 10.1002/jor.22270
   Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4
   Griffin DJ, 2015, J BIOMECH, V48, P1944, DOI 10.1016/j.jbiomech.2015.04.010
   Guarino V, 2015, EXPERT REV MED DEVIC, V12, P113, DOI 10.1586/17434440.2014.953058
   Haaparanta AM, 2014, J MATER SCI-MATER M, V25, P1129, DOI 10.1007/s10856-013-5129-5
   Hadjipanayi E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135618
   Hajimiri M, 2015, J BIOMED MATER RES A, V103, P819, DOI 10.1002/jbm.a.35193
   Hardy JG, 2015, J BIOMAT SCI-POLYM E, V26, P143, DOI 10.1080/09205063.2014.975393
   Harrison S, 2011, AM J SPORT MED, V39, P729, DOI 10.1177/0363546511401576
   Heo Y, 2015, COLLOID SURFACE B, V134, P196, DOI 10.1016/j.colsurfb.2015.07.003
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Jia L, 2013, MAT SCI ENG C-MATER, V33, P4640, DOI 10.1016/j.msec.2013.07.021
   Kanayama I, 2014, INT J NANOMED, V9, P3363, DOI 10.2147/IJN.S62342
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kavet R, 2015, HEALTH PHYS, V109, P556, DOI 10.1097/HP.0000000000000351
   Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001
   Kim T, 2015, MAT SCI ENG C-MATER, V49, P281, DOI 10.1016/j.msec.2015.01.014
   Kontturi LS, 2014, DRUG DELIV TRANSL RE, V4, P149, DOI 10.1007/s13346-013-0188-1
   Koobatian MT, 2016, BIOMATERIALS, V76, P344, DOI 10.1016/j.biomaterials.2015.10.020
   Koopmans G, 2009, INT REV NEUROBIOL, V87, P363, DOI 10.1016/S0074-7742(09)87019-0
   Koppes AN, 2014, TISSUE ENG PT A, V20, P494, DOI 10.1089/ten.TEA.2013.0012
   Koulikovska M, 2015, TISSUE ENG PT A, V21, P1116, DOI [10.1089/ten.tea.2014.0562, 10.1089/ten.TEA.2014.0562]
   Lee JH, 2014, ACTA BIOMATER, V10, P4425, DOI 10.1016/j.actbio.2014.06.023
   Lee JH, 2014, TISSUE ENG PT A, V20, P2031, DOI 10.1089/ten.tea.2013.0282
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Lee YS, 2011, POLYMERS-BASEL, V3, P413, DOI 10.3390/polym3010413
   Li XR, 2015, ADV HEALTHC MATER, V4, P1869, DOI 10.1002/adhm.201500271
   Liu S, 2015, J BIOMED MATER RES A, V103, P581, DOI 10.1002/jbm.a.35206
   Liu TX, 2013, ACTA OPHTHALMOL, V91, pE253, DOI 10.1111/aos.12172
   Liu T, 2014, J BIOMED MATER RES A, V102, P3754, DOI 10.1002/jbm.a.35025
   Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]
   Long K, 2015, J BIOMED MATER RES A, V103, P1159, DOI 10.1002/jbm.a.35268
   Lu C, 2015, J BIOMED MATER RES A, V103, P1669, DOI 10.1002/jbm.a.35305
   Lv YG, 2015, BIOTECHNOL LETT, V37, P2497, DOI 10.1007/s10529-015-1939-5
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Martinez A, 2015, CARBOHYD POLYM, V132, P606, DOI 10.1016/j.carbpol.2015.06.084
   Maslennikova A, 2015, INT J RADIAT BIOL, V91, P240, DOI 10.3109/09553002.2014.969848
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Meimandi-Parizi A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-28
   Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2
   Miyazaki T, 2015, FRONT ORAL BIOL, V17, P33, DOI 10.1159/000381691
   Miyazaki T, 2013, BIOL PHARM BULL, V36, P1670
   Muhonen V., 2015, J ORTHOP RES, DOI [10.1002/jor.2309926573959, DOI 10.1002/JOR.2309926573959]
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Nagaoka H., 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/70282124795891, DOI 10.1155/2014/70282124795891]
   Ngiam M, 2009, TISSUE ENG PT A, V15, P535, DOI 10.1089/ten.tea.2008.0011
   Nilsen-Nygaard J, 2015, POLYMERS-BASEL, V7, P552, DOI 10.3390/polym7030552
   Offeddu GS, 2015, J MECH BEHAV BIOMED, V42, P19, DOI 10.1016/j.jmbbm.2014.10.015
   Peng YY, 2014, APPL MICROBIOL BIOT, V98, P1807, DOI 10.1007/s00253-013-5475-8
   Perumal S, 2015, J MECH BEHAV BIOMED, V52, P131, DOI 10.1016/j.jmbbm.2015.04.006
   Raghavendran HRB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104389
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024
   Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978
   Ristic D, 2014, NEUROMODULATION, V17, P686, DOI 10.1111/ner.12133
   Roelofs LAJ, 2016, TISSUE ENG PT A, V22, P83, DOI [10.1089/ten.tea.2015.0096, 10.1089/ten.TEA.2015.0096]
   Sarikaya B., 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/576532 26504812, DOI 10.1155/2015/57653226504812]
   Sell SA, 2010, POLYMERS-BASEL, V2, P522, DOI 10.3390/polym2040522
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Shah S, 2014, ADV MATER, V26, P3673, DOI 10.1002/adma.201400523
   Sharma J, 2015, POLYMERS-BASEL, V7, P186, DOI 10.3390/polym7020186
   Shen Y, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015015
   Shen Y, 2013, LARYNGOSCOPE, V123, P1976, DOI 10.1002/lary.23940
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Shim JH, 2013, J MATER SCI-MATER M, V24, P1053, DOI 10.1007/s10856-013-4867-8
   Shin YC, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0081-9
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   SPIRA M, 1994, J BIOMED MATER RES, V28, P91, DOI 10.1002/jbm.820280112
   Suchy T, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/6/065008
   Sun Kai, 2015, Eur J Orthop Surg Traumatol, V25, P243, DOI 10.1007/s00590-014-1515-z
   Takitoh T, 2015, J BIOSCI BIOENG, V119, P217, DOI 10.1016/j.jbiosc.2014.07.008
   Talukdar Y, 2014, BIOMATERIALS, V35, P4863, DOI 10.1016/j.biomaterials.2014.02.054
   UITTO J, 1980, BIOCHIM BIOPHYS ACTA, V624, P545, DOI 10.1016/0005-2795(80)90095-1
   VANDERREST M, 1991, FASEB J, V5, P2814
   Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3105, DOI 10.1166/jbn.2014.1969
   Vrana NE, 2007, J BIOMAT SCI-POLYM E, V18, P1527
   Wang WH, 2015, INT J BIOL MACROMOL, V81, P920, DOI 10.1016/j.ijbiomac.2015.09.032
   Willers C, 2005, TISSUE ENG, V11, P1065, DOI 10.1089/ten.2005.11.1065
   Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005
   Yamada S., 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/30293224982861, DOI 10.1155/2014/30293224982861]
   Yan F, 2015, NEURAL REGEN RES, V10, P1421, DOI 10.4103/1673-5374.163466
   Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434
   Yoshioka SA, 2008, J MATER SCI-MATER M, V19, P1215, DOI 10.1007/s10856-007-0151-0
   Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003
   Yunoki S, 2015, J BIOMED MATER RES A, V103, P3054, DOI 10.1002/jbm.a.35440
   Zander NE, 2013, POLYMERS-BASEL, V5, P19, DOI 10.3390/polym5010019
   Zhang Q, 2015, INT J BIOL MACROMOL, V76, P94, DOI 10.1016/j.ijbiomac.2015.01.063
   Zheng L, 2014, ACM T KNOWL DISCOV D, V9, DOI 10.1145/2611380
   Zheng XY, 2016, MAT SCI ENG C-MATER, V58, P1071, DOI 10.1016/j.msec.2015.07.066
   Zhu CH, 2014, BIO-MED MATER ENG, V24, P1999, DOI 10.3233/BME-141009
   Zhu CH, 2014, MAT SCI ENG C-MATER, V34, P393, DOI 10.1016/j.msec.2013.09.044
   Zuber M, 2015, INT J BIOL MACROMOL, V80, P366, DOI 10.1016/j.ijbiomac.2015.07.001
NR 128
TC 40
Z9 40
U1 16
U2 165
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD FEB
PY 2016
VL 8
IS 2
AR 42
DI 10.3390/polym8020042
PG 20
WC Polymer Science
SC Polymer Science
GA DG2KJ
UT WOS:000371895500025
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Vasilescu, VG
   Patrascu, I
   Cotrut, C
   Vasilescu, E
AF Vasilescu, Vlad Gabriel
   Patrascu, Ion
   Cotrut, Cosmin
   Vasilescu, Elisabeta
TI Experimental Research on the Behaviour of the Alloy Ti10Zr in Simulated
   Oral Environment
SO REVISTA DE CHIMIE
LA English
DT Article
DE Ti10Zr alloy; biocompatibility; corrosion; electrochemical parameters;
   artificial saliva; pH of the solution
ID TITANIUM-ALLOYS; ELECTROCHEMICAL-BEHAVIOR; METALLIC BIOMATERIALS;
   IN-VITRO; CORROSION; COCRMO
AB Biocompatibility of materials is a complex concept that takes into account all processes occurring at the interaction between biomaterial and a living organism and is assessed by determining the material behaviour to changes in pH, the application of force, or the effects of degradation of the biological fluids. The oral environment is highly aggressive chemically. In this environment, dental materials can dissolve, can release products by processes of diffusion, can erode due to the presence of acidic substances, can change colour, or corrode. The paper presents results of experimental research on the assessment of corrosion resistance of a titanium alloy, the Ti10Zr alloy, intended for making dental implants, In developing the alloy was taken into account, on the one hand elimination of chemical composition considered harmful elements such as aluminium, vanadium, etc., on the other hand increased resistance to fatigue in corrosive environments with additions of zirconium, In conclusion we aimed to improve the biocompatibility of dental implant alloy and sustainability. Evaluation of corrosion behaviour of the alloy by electrochemical measurements in environments simulating oral environment showed that regardless of the electrolyte used (four artificial saliva solution) at values higher than 250m V and corrosion current values very close there is a passivation with very close values of corrosion which shows that the alloy forms on its surface a protective and adherent oxide layer.
C1 [Vasilescu, Vlad Gabriel; Patrascu, Ion] Carola Davila Univ Bucharest, 37 Dionisie Lupu Str, Bucharest 020022, Romania.
   [Cotrut, Cosmin] Univ Politehn Bucuresti, 313 Splaiul Independentei, Bucharest 060042, Romania.
   [Vasilescu, Elisabeta] Dunarea de Jos Univ Galati, 47 Domneasca Str, Galati 800008, Romania.
RP Vasilescu, E (reprint author), Dunarea de Jos Univ Galati, 47 Domneasca Str, Galati 800008, Romania.
EM elisabeta.vasilescu@yahoo.com
RI Cotrut, Mihai Cosmin/G-4505-2011
OI Cotrut, Mihai Cosmin/0000-0002-8991-7485
CR ASM Handbook Committee, 1987, ASM HDB COMMITTEE, V13
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Boyer RF, 1994, ASM INT
   Bratu DC, 2013, MATER PLAST, V50, P49
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   Brunski J. B., 2004, BIOMATERIALS SCI INT, P137
   Chivu AE, 2012, UNIV POLITEH BUCHAR, V74, P249
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   DIMA O., 2014, METALLURGY MAT SCI, V1, P81
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Fleck C, 2010, INT J FATIGUE, V32, P929, DOI 10.1016/j.ijfatigue.2009.09.009
   Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383
   Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   LEYENS C., 2004, TITANIUM TITANIUM AL, P4
   LUTJERING G., 2003, TITANIUM, P21
   Mareci D, 2015, MATER PLAST, V52, P150
   Minciuna MG, 2014, REV CHIM-BUCHAREST, V65, P1138
   Minciuna MG, 2014, REV CHIM-BUCHAREST, V65, P335
   MOSEKE C., 2009, ADV ENG MATER, V1, P81
   Novac RI, 2014, REV CHIM-BUCHAREST, V65, P1306
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   PATRASCU I., 2004, DEV CORROSION PROTEC, P171
   PATRASCU I., 2004, DEV CORROSION PROTEC, P633
   Petrescu HP, 2013, MATER PLAST, V50, P53
   RACK H. J., 2006, SCI ENG C, V26, P1269
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   STANBURY E. E., 2000, ASM INT, V7, P219
   VASILESCU E., 2013, ANN DUNAREA JOS GALA, P298
   VASILESCU V. G., 2014, ANN DUNAREA JOS U GA, P32
   ZHUO C., 2003, BIOMATERIALS, V24, P213
NR 32
TC 4
Z9 4
U1 1
U2 4
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD FEB
PY 2016
VL 67
IS 2
BP 263
EP 266
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DG6CV
UT WOS:000372170700013
DA 2018-10-20
ER

PT J
AU Berteau, JP
   Oyen, M
   Shefelbine, SJ
AF Berteau, J. -Ph.
   Oyen, M.
   Shefelbine, S. J.
TI Permeability and shear modulus of articular cartilage in growing mice
SO BIOMECHANICS AND MODELING IN MECHANOBIOLOGY
LA English
DT Article; Proceedings Paper
CT 11th World Congress on Computational Mechanics (WCCM) / 5th European
   Conference on Computational Mechanics (ECCM) / 6th European Conference
   on Computational Fluid Dynamics (ECFD)
CY JUL 20-25, 2014
CL Barcelona, SPAIN
SP Spanish Assoc Numer Methods Engn, Cambridge Univ Press, CIMNE Technologia, CRC Press, Taylor & Francis Grp, ELSEVIER, ECCOMAS, GID, iacm, John Wiley & Sons ltd, Korea Soc Computat Mech, Portable Multimedia Solutions Inflatable Struct, Springer, Collegi Enginyers Camins Canals Ports Catalunya
DE Cartilage; Permeability; Shear modulus; Growth
ID CORTICAL BONE; MECHANICAL-PROPERTIES; REGIONAL-VARIATIONS; GROOVE MODEL;
   COLLAGEN; GROWTH; OSTEOARTHRITIS; INDENTATION; MATURATION; STIFFNESS
AB Articular cartilage maturation is the postnatal development process that adapts joint surfaces to their site-specific biomechanical demands. Understanding the changes in mechanical tissues properties during growth is a critical step in advancing strategies for orthopedics and for cell- and biomaterial- based therapies dedicated to cartilage repair. We hypothesize that at the microscale, the articular cartilage tissue properties of the mouse (i.e., shear modulus and permeability) change with the growth and are dependent on location within the joint. We tested cartilage on the medial femoral condyle and lateral femoral condyle of seven C57Bl6 mice at different ages (2, 3, 5, 7, 9, 12, and 17 weeks old) using a micro-indentation test. Results indicated that permeability decreased with age from 2 to 17 weeks. Shear modulus reached a peak at the end of the growth (9 weeks). Within an age group, shear modulus was higher in the MFC than in the LFC, but permeability did not change. We have developed a method that can measure natural alterations in cartilage material properties in a murine joint, which will be useful in identifying changes in cartilage mechanics with degeneration, pathology, or treatment.
C1 [Berteau, J. -Ph.; Shefelbine, S. J.] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.
   [Berteau, J. -Ph.] CUNY, Grad Ctr, New York, NY USA.
   [Berteau, J. -Ph.] CUNY Coll Staten Isl, Dept Phys Therapy, 2800 Victory Blvd, New York, NY USA.
   [Oyen, M.] Univ Cambridge, Dept Engn, Trumpington St, Cambridge CB2 1PZ, England.
RP Berteau, JP (reprint author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.; Berteau, JP (reprint author), CUNY, Grad Ctr, New York, NY USA.; Berteau, JP (reprint author), CUNY Coll Staten Isl, Dept Phys Therapy, 2800 Victory Blvd, New York, NY USA.
EM jph.berteau@gmail.com
CR ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345
   Berteau JP, 2014, ULTRASONICS, V54, P1270, DOI 10.1016/j.ultras.2013.09.014
   Brommer H, 2005, EQUINE VET J, V37, P148, DOI 10.2746/0425164054223769
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   Burgin LV, 2014, MED ENG PHYS, V36, P226, DOI 10.1016/j.medengphy.2013.11.002
   Caine DJ, 2011, BRIT J SPORT MED, V45, P298, DOI 10.1136/bjsm.2010.081984
   Caliari SR, 2014, J BIOMED MATER RES A, V102, P917, DOI 10.1002/jbm.a.35058
   Chan EF, 2012, ORTHOP CLIN N AM, V43, P173, DOI 10.1016/j.ocl.2012.01.005
   Christensen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033397
   Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436
   GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351
   Hamann N, 2013, J ANAT, V222, P248, DOI 10.1111/joa.12003
   HOCH D H, 1983, Journal of Orthopaedic Research, V1, P4, DOI 10.1002/jor.1100010102
   Hu K, 2006, ARTHRITIS RHEUM, V54, P2891, DOI 10.1002/art.22040
   Hu YH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3370354
   Julkunen P, 2009, OSTEOARTHR CARTILAGE, V17, P1628, DOI 10.1016/j.joca.2009.07.002
   KEENE DR, 1995, J HISTOCHEM CYTOCHEM, V43, P967, DOI 10.1177/43.10.7560887
   Khan IM, 2013, BIOMATERIALS, V34, P1478, DOI 10.1016/j.biomaterials.2012.09.076
   Koester KJ, 2011, J MECH BEHAV BIOMED, V4, P1504, DOI 10.1016/j.jmbbm.2011.05.020
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Kulin RM, 2011, J MECH BEHAV BIOMED, V4, P57, DOI 10.1016/j.jmbbm.2010.09.006
   Kuroki H, 2006, OSTEOARTHR CARTILAGE, V14, P784, DOI 10.1016/j.joca.2006.02.001
   Kutz M., 2003, STANDARD HDB BIOMEDI
   LAM FC, 1983, BIOMETRIKA, V70, P510
   Lilledahl MB, 2011, IEEE T MED IMAGING, V30, P1635, DOI 10.1109/TMI.2011.2139222
   Manda K, 2014, BIOMECH MODEL MECHAN, V13, P599, DOI 10.1007/s10237-013-0521-0
   Marijnissen ACA, 2002, OSTEOARTHR CARTILAGE, V10, P282, DOI 10.1053/joca.2001.0507
   MAROUDAS A, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P166
   Mastbergen SC, 2008, OSTEOARTHR CARTILAGE, V16, P919, DOI 10.1016/j.joca.2007.11.010
   Mattice JM, 2006, J MATER RES, V21, P2003, DOI 10.1557/JMR.2006.0243
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Nyman JS, 2013, J MECH BEHAV BIOMED, V22, P136, DOI 10.1016/j.jmbbm.2012.08.013
   Oyen ML, 2005, J MATER RES, V20, P2094, DOI 10.1557/JMR.2005.0259
   Pierce DM, 2013, COMPUT METHOD BIOMEC, V16, P1344, DOI 10.1080/10255842.2012.670854
   Rasanen T, 1996, J BIOMED MATER RES, V31, P519
   Rodriguez-Florez N, 2013, J MECH BEHAV BIOMED, V18, P90, DOI 10.1016/j.jmbbm.2012.11.005
   Roemhildt ML, 2006, J BIOMECH, V39, P2331, DOI 10.1016/j.jbiomech.2005.07.017
   Scott WN, 2012, INSALL SCOTT SURG KN
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/NNANO.2008.410, 10.1038/nnano.2008.410]
   Strange DGT, 2012, J MECH BEHAV BIOMED, V11, P16, DOI 10.1016/j.jmbbm.2011.10.003
   Turnhout MC, 2010, BMC DEV BIOL, V10, P62
   Wang H., 2000, THEORY LINEAR POROEL
   Wei XC, 1998, OSTEOARTHR CARTILAGE, V6, P400, DOI 10.1053/joca.1998.0143
   Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5
   ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602
NR 47
TC 10
Z9 10
U1 1
U2 10
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1617-7959
EI 1617-7940
J9 BIOMECH MODEL MECHAN
JI Biomech. Model. Mechanobiol.
PD FEB
PY 2016
VL 15
IS 1
SI SI
BP 205
EP 212
DI 10.1007/s10237-015-0671-3
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA DF8VU
UT WOS:000371639300014
PM 25847455
DA 2018-10-20
ER

PT J
AU Savilova, AM
   Yushina, MN
   Rudimova, YV
   Khil'kevich, EG
   Chuprynin, VD
AF Savilova, A. M.
   Yushina, M. N.
   Rudimova, Y. V.
   Khil'kevich, E. G.
   Chuprynin, V. D.
TI Characteristics of Multipotent Mesenchymal Stromal Cells Isolated from
   Human Endometrium
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE endometrium; multipotent mesenchymal stromal cells; immunophenotype;
   viability
ID STEM-CELLS; EXPRESSION
AB Cell cultures isolated from human endometrium by enzyme digestion consisted of highly viable fibroblast-like mesenchymal cells expressing CD90, CD73, and CD105. During passage 1, the cultures contained a small fraction of cytokeratin-7(+) epithelial cells that disappeared by passage 2. The cultures from the endometrium could be induced to adipogenic, osteogenic and chondrogenic differentiation in vitro. These findings suggest that human endometrium is a convenient source of biomaterial for minimally invasive isolation of cultures that exhibit typical morphology and immunophenotypic profile of resident multipotent mesenchymal stromal cells retain high viability in vitro.
C1 [Savilova, A. M.; Yushina, M. N.; Rudimova, Y. V.; Khil'kevich, E. G.; Chuprynin, V. D.] Minist Hlth Russian Federat, VI Kulakov Res Ctr Obstet Gynecol & Perinatol, Moscow, Russia.
RP Savilova, AM (reprint author), Minist Hlth Russian Federat, VI Kulakov Res Ctr Obstet Gynecol & Perinatol, Moscow, Russia.
EM bushueva@gmail.com
FU Russian Science Foundation [14-25-00179]
FX The study was supported by the Russian Science Foundation (grant No.
   14-25-00179).
CR Allickson Julie G, 2011, Open Stem Cell J, V3, P4
   Anisimova S V, 2013, Tsitologiia, V55, P5
   Cho NH, 2004, FERTIL STERIL, V81, P403, DOI 10.1016/j.fertnstert.2003.07.015
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   [Домнина А.П. Domnina A.P.], 2013, [Цитология, Cell and Tissue Biology, Tsitologiya], V55, P69
   French Kristin M, 2014, Methods Mol Biol, V1181, P39, DOI 10.1007/978-1-4939-1047-2_4
   Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061
   Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226
   Hu JG, 2011, MED SCI MONITOR, V17, pBR103, DOI 10.12659/MSM.881710
   Pacchiarotti A, 2011, FERTIL STERIL, V95, P1171, DOI 10.1016/j.fertnstert.2010.10.029
   Rangel EB, 2013, STEM CELLS, V31, P1644, DOI 10.1002/stem.1412
   Schuring AN, 2011, FERTIL STERIL, V95, P423, DOI 10.1016/j.fertnstert.2010.08.035
   Taghavi S, 2015, CTS-CLIN TRANSL SCI, V8, P425, DOI 10.1111/cts.12251
   Veryasov VN, 2014, B EXP BIOL MED+, V157, P119, DOI 10.1007/s10517-014-2506-0
NR 14
TC 3
Z9 3
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
EI 1573-8221
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD FEB
PY 2016
VL 160
IS 4
BP 560
EP 564
DI 10.1007/s10517-016-3218-4
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DF8XL
UT WOS:000371643800037
PM 26899840
DA 2018-10-20
ER

PT J
AU Tylko, G
AF Tylko, G.
TI Cells on biomaterials - some aspects of elemental analysis by means of
   electron probes
SO JOURNAL OF MICROSCOPY
LA English
DT Article
DE Biological elements; biomaterials; low-Z materials; organic matter;
   quantification of elements; X-ray microanalysis
ID X-RAY-MICROANALYSIS; BIOLOGICAL SAMPLES; COATINGS; CALCIUM; FILMS;
   LOCALIZATION; CALIBRATION; SIMULATION; MICROSCOPY; EMISSION
AB Electron probe X-ray microanalysis enables concomitant observation of specimens and analysis of their elemental composition. The method is attractive for engineers developing tissue-compatible biomaterials. Either changes in element composition of cells or biomaterial can be defined according to well-established preparation and quantification procedures. However, the qualitative and quantitative elemental analysis appears more complicated when cells or thin tissue sections are deposited on biomaterials. X-ray spectra generated at the cell/tissue-biomaterial interface are modelled using a Monte Carlo simulation of a cell deposited on borosilicate glass. Enhanced electron backscattering from borosilicate glass was noted until the thickness of the biological layer deposited on the substrate reached 1.25 mu m. It resulted in significant increase in X-ray intensities typical for the elements present in the cellular part. In this case, the mean atomic number value of the biomaterial determines the strength of this effect. When elements are present in the cells only, the positive linear relationship appears between X-ray intensities and cell thickness. Then, spatial dimensions of X-ray emission for the particular elements are exclusively in the range of the biological part and the intensities of X-rays become constant. When the elements are present in both the cell and the biomaterial, X-ray intensities are registered for the biological part and the substrate simultaneously leading to a negative linear relationship of X-ray intensities in the function of cell thickness. In the case of the analysis of an element typical for the biomaterial, strong decrease in X-ray emission is observed in the function of cell thickness as the effect of X-ray absorption and the limited excitation range to biological part rather than to the substrate. Correction procedures for calculations of element concentrations in thin films and coatings deposited on substrates are well established in materials science, but little is known about factors that have to be taken into account to accurately quantify bioelements in thin and semi-thick biological samples. Thus thorough tests of currently available quantification procedures are required to verify their applicability to cells or tissues deposited on the biomaterials.
C1 [Tylko, G.] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, Gronostajowa 9, PL-30060 Krakow, Poland.
RP Tylko, G (reprint author), Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, Gronostajowa 9, PL-30060 Krakow, Poland.
EM grzegorz.tylko@uj.edu.pl
FU  [K/ZDS/004840]
FX The author would like to thank Dr. Anna Jurkiewicz for her helpful
   linguistic instructions. This work was funded by the grant K/ZDS/004840.
CR Babilas D, 2013, MATER LETT, V100, P252, DOI 10.1016/j.matlet.2013.03.047
   Balamurugan A., 2012, TRENDS BIOMAT ARTIF, V26, P114
   Bastin GF, 2000, X-RAY SPECTROM, V29, P212, DOI 10.1002/(SICI)1097-4539(200005/06)29:3<212::AID-XRS422>3.0.CO;2-K
   Benhayoune H, 2002, J PHYS D APPL PHYS, V35, P1526, DOI 10.1088/0022-3727/35/13/312
   BIELEFELD U, 1992, HISTOCHEM J, V24, P927, DOI 10.1007/BF01046498
   Boekstein A., 1983, SCANNING ELECTRON MI, VII, P725
   Budka D, 2005, NUCL INSTRUM METH B, V231, P338, DOI 10.1016/j.nimb.2005.01.080
   Carter KP, 2014, CHEM REV, V114, P4564, DOI 10.1021/cr400546e
   Dragomir A, 2001, J MICROSC-OXFORD, V203, P277, DOI 10.1046/j.1365-2818.2001.00924.x
   Drevet R, 2013, RSC ADV, V3, P11148, DOI 10.1039/c3ra23255g
   Dumelie N, 2007, J PHYS D APPL PHYS, V40, P2124, DOI 10.1088/0022-3727/40/7/040
   Erk I, 1998, J MICROSC-OXFORD, V189, P236
   Filipowska J, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/6/065001
   Gandolfi MG, 2009, J APPL BIOMATER BIOM, V7, P160
   Gauvin R, 2000, MIKROCHIM ACTA, V132, P201
   Goldstein J., 2003, SCANNING ELECT MICRO
   Hovington P, 1997, SCANNING, V19, P1
   Janik P, 2010, MICROSC RES TECHNIQ, V73, P1134, DOI 10.1002/jemt.20860
   KITAZAWA T, 1983, ULTRAMICROSCOPY, V11, P251, DOI 10.1016/0304-3991(83)90005-0
   Krzakala A, 2013, ELECTROCHIM ACTA, V104, P425, DOI 10.1016/j.electacta.2012.12.081
   Krzakala A, 2013, ELECTROCHIM ACTA, V104, P407, DOI 10.1016/j.electacta.2012.07.075
   Lavrent'ev YG, 2004, J ANAL CHEM+, V59, P600, DOI 10.1023/B:JANC.0000035269.96076.d2
   Llovet X., 2008, PENEPMA MONTE CARLO
   Marshall A.T., 1982, SCAN ELECT MICROSC, VII, P243
   MARSHALL AT, 1985, J MICROSC-OXFORD, V140, P99, DOI 10.1111/j.1365-2818.1985.tb02665.x
   MARSHALL AT, 1987, MICRON MICROSC ACTA, V18, P23, DOI 10.1016/0739-6260(87)90015-3
   MERLET C, 1994, MIKROCHIM ACTA, V114, P363, DOI 10.1007/BF01244563
   Mizuhira Vinci, 2000, Progress in Histochemistry and Cytochemistry, V35, P67
   Morgan A.J., 1979, SCANNING ELECTRON MI, VII, P635
   NICHOLSON WAP, 1980, SCANNING ELECTRON MI, V2, P517
   PALSGARD E, 1994, MICROSC RES TECHNIQ, V28, P254
   Palumbo C, 2013, MICRON, V47, P1, DOI 10.1016/j.micron.2012.02.017
   Pamula E, 2011, ANN BIOMED ENG, V39, P2114, DOI 10.1007/s10439-011-0307-4
   Pouchou JL, 2002, MIKROCHIM ACTA, V138, P133, DOI 10.1007/s006040200020
   POUCHOU JL, 1991, ELECTRON PROBE QUANTITATION, P31
   Roomans G.M., 1981, SCANNING ELECTRON MI, V2, P345
   ROOMANS GM, 1988, J ELECTRON MICR TECH, V9, P19, DOI 10.1002/jemt.1060090104
   Roomans Godfried M., 2002, European Cells & Materials, V3, P1
   Sabel N, 2009, SWED DENT J, V33, P75
   SUMNER AT, 1984, SCAN ELECTRON MICROS, P905
   Szostek K., 2012, MINERALOGIA, V42, P93, DOI [10.2478/v10002-011-0009-4, DOI 10.2478/V10002-011-0009-4]
   Tylko G, 2004, MICROCHIM ACTA, V144, P271, DOI 10.1007/s00604-003-0108-z
   Tylko G, 2002, MIKROCHIM ACTA, V139, P189, DOI 10.1007/s006040200060
   Tylko G, 2010, IOP CONF SER-MAT SCI, V7, DOI 10.1088/1757-899X/7/1/012028
   Tylko G, 2000, FOLIA HISTOCHEM CYTO, V38, P79
   Tylko G, 2013, MICROSC MICROANAL, V19, P56, DOI 10.1017/S1431927612013803
   WARLEY A, 1983, J CELL SCI, V60, P217
   Warley A, 1997, XRAY MICROANALYSIS B
   WROBLEWSKI J, 1983, HISTOCHEMISTRY, V77, P447, DOI 10.1007/BF00495800
   Yamamoto M, 1997, J BIOMED MATER RES, V37, P29, DOI 10.1002/(SICI)1097-4636(199710)37:1<29::AID-JBM4>3.0.CO;2-L
NR 50
TC 3
Z9 3
U1 4
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-2720
EI 1365-2818
J9 J MICROSC-OXFORD
JI J. Microsc..
PD FEB
PY 2016
VL 261
IS 2
BP 185
EP 195
DI 10.1111/jmi.12318
PG 11
WC Microscopy
SC Microscopy
GA DF8UQ
UT WOS:000371635800007
PM 26444561
DA 2018-10-20
ER

PT J
AU Harris, JP
   Struzyna, LA
   Murphy, PL
   Adewole, DO
   Kuo, E
   Cullen, DK
AF Harris, J. P.
   Struzyna, L. A.
   Murphy, P. L.
   Adewole, D. O.
   Kuo, E.
   Cullen, D. K.
TI Advanced biomaterial strategies to transplant preformed micro-tissue
   engineered neural networks into the brain
SO JOURNAL OF NEURAL ENGINEERING
LA English
DT Article
DE neurotransplantation; transplantation; bioengineering; cell replacement;
   axonal tracts; tissue engineering; biomaterials
ID LONG-TERM SURVIVAL; STEM-CELL TRANSPLANTATION; SPINAL-CORD-INJURY;
   NERVOUS-SYSTEM; IN-VITRO; CARBOXYMETHYL CELLULOSE; FUNCTIONAL RECOVERY;
   PARKINSONS-DISEASE; CHONDROITINASE ABC; NEURITE OUTGROWTH
AB Objective. Connectome disruption is a hallmark of many neurological diseases and trauma with no current strategies to restore lost long-distance axonal pathways in the brain. We are creating transplantable micro-tissue engineered neural networks (micro-TENNs), which are preformed constructs consisting of embedded neurons and long axonal tracts to integrate with the nervous system to physically reconstitute lost axonal pathways. Approach. We advanced micro-tissue engineering techniques to generate micro-TENNs consisting of discrete populations of mature primary cerebral cortical neurons spanned by long axonal fascicles encased in miniature hydrogel micro-columns. Further, we improved the biomaterial encasement scheme by adding a thin layer of low viscosity carboxymethylcellulose (CMC) to enable needle-less insertion and rapid softening for mechanical similarity with brain tissue. Main results. The engineered architecture of cortical micro-TENNs facilitated robust neuronal viability and axonal cytoarchitecture to at least 22 days in vitro. Micro-TENNs displayed discrete neuronal populations spanned by long axonal fasciculation throughout the core, thus mimicking the general systems-level anatomy of gray matter-white matter in the brain. Additionally, micro-columns with thin CMC-coating upon mild dehydration were able to withstand a force of 893 +/- 457 mN before buckling, whereas a solid agarose cylinder of similar dimensions was predicted to withstand less than 150 mu N of force. This thin CMC coating increased the stiffness by three orders of magnitude, enabling needle-less insertion into brain while significantly reducing the footprint of previous needle-based delivery methods to minimize insertion trauma. Significance. Our novel micro-TENNs are the first strategy designed for minimally invasive implantation to facilitate nervous system repair by simultaneously providing neuronal replacement and physical reconstruction of long-distance axon pathways in the brain. The micro-TENN approach may offer the ability to treat several disorders that disrupt the connectome, including Parkinson's disease, traumatic brain injury, stroke, and brain tumor excision.
C1 [Harris, J. P.; Struzyna, L. A.; Murphy, P. L.; Adewole, D. O.; Kuo, E.; Cullen, D. K.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.
   [Harris, J. P.; Struzyna, L. A.; Adewole, D. O.; Kuo, E.; Cullen, D. K.] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA.
   [Struzyna, L. A.; Adewole, D. O.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Cullen, DK (reprint author), Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Cullen, DK (reprint author), Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA.
EM dkacy@mail.med.upenn.edu
FU Penn Medicine Neuroscience Center; National Science Foundation
   [DGE-1321851]; National Institutes of Health [T32-NS043126,
   T32-GM007517]; Department of Veterans Affairs (RRD Merit Review)
   [B1097-I]; US Army Medical Research and Materiel Command through the
   Joint Warfighter Medical Research Program [W81XWH-13-207 004]
FX Financial support was provided by the Penn Medicine Neuroscience Center,
   National Science Foundation (Graduate Research Fellowship DGE-1321851),
   National Institutes of Health (T32-NS043126 & T32-GM007517), Department
   of Veterans Affairs (RR&D Merit Review #B1097-I), and the US Army
   Medical Research and Materiel Command through the Joint Warfighter
   Medical Research Program (#W81XWH-13-207 004). The authors would like to
   thank Rob Mauck and Mike Hast in the Penn Center for Musculoskeletal
   Disorders Core for help in mechanical testing. Additional thanks go to
   Vincent Wu, Norma Alexis Brown, Alan He, Camila Robles-Oteiza, and
   Parker Schabel for technical contributions.
CR BAR A, 1995, FOOD CHEM TOXICOL, V33, P909, DOI 10.1016/0278-6915(95)00069-E
   BENARI Y, 1994, PROG BRAIN RES, V102, P261
   Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2
   Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007
   Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505
   Chen ZJ, 2004, J NEUROSURG, V101, P314, DOI 10.3171/jns.2004.101.2.0314
   Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5
   Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434
   Cullen DK, 2007, J NEURAL ENG, V4, P159, DOI 10.1088/1741-2560/4/2/015
   Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z
   Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.TEA.2011.0534, 10.1089/ten.tea.2011.0534]
   Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201
   Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Deng L, 2007, J NEUROSCI, V27, P10860, DOI 10.1523/JNEUROSCI.2744-07.2007
   Denham M, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00011
   Dubois-Dauphin ML, 2010, BIOMATERIALS, V31, P7032, DOI 10.1016/j.biomaterials.2010.06.017
   Elliot J. H., 1974, Rheologica Acta, V13, P670, DOI 10.1007/BF01527058
   FAWCETT JW, 1995, EXP BRAIN RES, V106, P275
   Feng XH, 2006, IND ENG CHEM RES, V45, P6665, DOI 10.1021/ie060511f
   Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820
   Ghanbarzadeh B, 2011, INT J BIOL MACROMOL, V48, P44, DOI 10.1016/j.ijbiomac.2010.09.014
   Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017
   Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066011
   Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046010
   Harris James P., 2013, Critical Reviews in Biomedical Engineering, V41, P435
   He ZG, 2010, J BIOMED RES, V24, P2, DOI 10.1016/S1674-8301(10)60002-4
   Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003
   Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294
   Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161
   Jensen W, 2006, IEEE T BIO-MED ENG, V53, P934, DOI 10.1109/TBME.2006.872824
   Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016
   Kato-Negishi M, 2013, ADV HEALTHC MATER, V2, P1564, DOI 10.1002/adhm.201300052
   Kim H J, 2010, BIOCH BIOPHYS ACTA
   Kozai TDY, 2014, BIOMATERIALS, V35, P9255, DOI 10.1016/j.biomaterials.2014.07.039
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   LaPlaca MC, 2010, ARTECH HSE METH BIOE, P187
   Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603
   Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031675
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006
   Mingorance A, 2006, FASEB J, V20, P491, DOI 10.1096/fj.05-5121fje
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038
   NAJAFI K, 1990, IEEE T BIO-MED ENG, V37, P474, DOI 10.1109/10.55638
   Nguyen JK, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056014
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   Orlacchio A, 2010, CURR MED CHEM, V17, P595, DOI 10.2174/092986710790416272
   Ouardouz M, 2005, DEV BRAIN RES, V160, P78, DOI 10.1016/j.devbrainres.2005.09.001
   Paralikar Kunal J, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2958
   Ren HM, 2013, INT J CLIN EXP PATHO, V6, P230
   Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024
   Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026
   Stabenfeldt SE, 2006, J BIOMED MATER RES A, V77A, P718, DOI 10.1002/jbm.a.30638
   Steinschneider R, 1996, DEV BRAIN RES, V95, P15, DOI 10.1016/0165-3806(96)00052-1
   Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x
   Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]
   Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943
   Sudheimer K D, 2014, HUMAN BRAIN ATLAS
   Tang XQ, 2007, J NEUROSCI, V27, P6068, DOI 10.1523/JNEUROSCI.1442-07.2007
   Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.men.2004.05.001
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Vukasinovic J, 2009, BIOMED MICRODEVICES, V11, P1155, DOI 10.1007/s10544-009-9332-6
   Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11
   Warnock F V, 1965, MECH SOLIDS STRENGTH
   Yip PK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000399
   Yoo Sang Jin, 2011, Exp Neurobiol, V20, P110, DOI 10.5607/en.2011.20.2.110
NR 83
TC 13
Z9 14
U1 1
U2 29
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1741-2560
EI 1741-2552
J9 J NEURAL ENG
JI J. Neural Eng.
PD FEB
PY 2016
VL 13
IS 1
AR 016019
DI 10.1088/1741-2560/13/1/016019
PG 19
WC Engineering, Biomedical; Neurosciences
SC Engineering; Neurosciences & Neurology
GA DF7XD
UT WOS:000371570200020
PM 26760138
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Guarnieri, R
   Belleggia, F
   Grande, M
AF Guarnieri, Renzo
   Belleggia, Fabrizio
   Grande, Maurizio
TI Immediate versus Delayed Treatment in the Anterior Maxilla Using Single
   Implants with a Laser-Microtextured Collar: 3-Year Results of a Case
   Series on Hard- and Soft-Tissue Response and Esthetics
SO JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY
LA English
DT Article
DE Immediate implant treatment; delayed implant treatment; esthetic zone;
   laser-microtextured surface
ID FRESH EXTRACTION SOCKETS; MARGINAL BONE LEVEL; DEFINED BIOMATERIAL
   SURFACES; BEAM COMPUTED-TOMOGRAPHY; TOOTH IMPLANTS; DENTAL IMPLANT;
   HEALED SITES; BUCCAL BONE; RADIOGRAPHIC EVALUATION; HISTOLOGIC EVIDENCE
AB PurposeTo compare peri-implant marginal bone loss, soft tissue response, and esthetics following single immediate implant treatment (IIT) and delayed implant treatment (DIT) in the esthetic zone of the maxilla in well-selected patients.
   Materials and MethodsAdequate bone volume and ideal soft tissue level/contour were considered requirements for implant therapy, with additional prerequisites for IIT of residual alveolar bone wall integrity and a thick gingival biotype. IIT included immediate placement and provisionalization, while DIT included extraction socket preservation followed by implant placement and provisionalization 4 months later. Cortical bone levels and peri-implant mucosal conditions were evaluated at regular intervals. The esthetic outcome was objectively rated after 3 years using the pink esthetic score (PES) and white esthetic score (WES).
   ResultsTwelve patients received an immediate Laser-Lok (R) implant, and 13 patients received a delayed Laser-Lok (R) implant. No significant differences were found between the study groups regarding survival rate (100%). The mean bone level from the implant/abutment interface was 0.35 0.18 mm for IIT and 0.42 +/- 0.21 mm for DIT after 3 years (p > 0.05). Mesial and distal papillae remained stable over time in DIT. A tendency for regrowth of mesial and distal papillae was found following IIT (p < 0.05). Midfacial soft tissues remained stable over time following DIT and IIT.
   ConclusionsWithin the limitations of this study (e.g., small sample size, short follow-up duration), the results suggest that regarding success rate, hard/soft tissue responses, and esthetics, DIT and IIT with single Laser-Lok (R) implants in the anterior maxilla are comparable and predictable options for well-selected patients.
C1 [Guarnieri, Renzo; Belleggia, Fabrizio; Grande, Maurizio] Via Deserto Gobi 85 A-2, I-00144 Rome, Italy.
RP Guarnieri, R (reprint author), Via Deserto Gobi 85 A-2, I-00144 Rome, Italy.
EM renzoguarnieri@gmail.com
FU Classimplant s.r.l, Roma, Italy
FX This study was funded by Classimplant s.r.l, Roma, Italy.
CR Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Bateli M, 2011, INT J ORAL MAX IMPL, V26, P290
   Belser UC, 2009, J PERIODONTOL, V80, P140, DOI [10.1902/jop.2009.080435, 10.1902/jop.2009.080435 ]
   Bengazi F, 1996, CLIN ORAL IMPLAN RES, V7, P303, DOI 10.1034/j.1600-0501.1996.070401.x
   Benic GI, 2012, CLIN ORAL IMPLAN RES, V23, P560, DOI 10.1111/j.1600-0501.2011.02253.x
   Benic GI, 2012, J CLIN PERIODONTOL, V39, P160, DOI 10.1111/j.1600-051X.2011.01840.x
   Block MS, 2009, J ORAL MAXIL SURG, V67, P89, DOI 10.1016/j.joms.2009.07.009
   Botos S, 2011, INT J ORAL MAX IMPL, V26, P492
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Buser D, 2012, CLIN IMPLANT DENT R, V14, P839, DOI 10.1111/j.1708-8208.2012.00456.x
   Chang M, 1999, CLIN ORAL IMPLAN RES, V10, P185, DOI 10.1034/j.1600-0501.1999.100301.x
   Chang M, 2013, CLIN ORAL IMPLAN RES, V24, P556, DOI 10.1111/j.1600-0501.2012.02422.x
   Chen ST, 2004, INT J ORAL MAX IMPL, V19, P12
   Chen ST, 2007, CLIN ORAL IMPLAN RES, V18, P552, DOI 10.1111/j.1600-0501.2007.01388.x
   Chen ST, 2014, INT J ORAL MAX IMPL, V29, P186, DOI 10.11607/jomi.2014suppl.g3.3
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P186
   Chow YC, 2010, IMPLANT DENT, V19, P208, DOI 10.1097/ID.0b013e3181d43bd6
   Chu SJ, 2009, J ESTHET RESTOR DENT, V21, P113, DOI 10.1111/j.1708-8240.2009.00242.x
   Cosyn J, 2012, CLIN IMPLANT DENT R, V14, P517, DOI 10.1111/j.1708-8208.2010.00300.x
   Cosyn J, 2013, CLIN IMPLANT DENT R, V15, P517, DOI 10.1111/j.1708-8208.2011.00417.x
   Cosyn J, 2012, J CLIN PERIODONTOL, V39, P582, DOI 10.1111/j.1600-051X.2012.01888.x
   Cosyn J, 2011, J CLIN PERIODONTOL, V38, P746, DOI 10.1111/j.1600-051X.2011.01748.x
   den Hartog L, 2008, J CLIN PERIODONTOL, V35, P1073, DOI 10.1111/j.1600-051X.2008.01330.x
   DesBruyn H, 2011, CLIN IMPLANT DENT R, V13, P175
   DesRouck T., 2009, J CLIN PERIODONTOL, V36, P428
   DesRouck T., 2008, INT J ORAL MAXILLOF, V23, P897
   DesRouck T., 2009, CLIN ORAL IMPLAN RES, V20, P566
   Dumas V, 2012, J BIOMED MATER RES A, V100A, P3108, DOI 10.1002/jbm.a.34239
   Eghbali A, 2010, CLIN IMPLANT DENT R, V14, P336
   Eghbali A, 2012, CLIN IMPLANT DENT R, V14, P336, DOI 10.1111/j.1708-8208.2010.00283.x
   Enriquez-Sacristan C, 2011, MED ORAL PATOL ORAL, V16, P919
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   Farronato D, 2014, INT J PERIODONT REST, V34, P79, DOI 10.11607/prd.1747
   Felice P, 2011, EUR J ORAL IMPLANTOL, V4, P329
   Furhauser R, 2005, CLIN ORAL IMPLAN RES, V16, P639, DOI 10.1111/j.1600-0501.2005.01193.x
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Guarnieri R, 2013, CLIN IMPLANT DENT R, DOI [10.1111/cid/12111., DOI 10.1111/CID/12111]
   Guarnieri R, 2014, INT J ORAL MAX IMPL, V29, P354, DOI 10.11607/jomi.3250
   Guarnieri R, 2014, IMPLANT DENT, V23, P144, DOI 10.1097/ID.0000000000000061
   Hall JAG, 2007, CLIN IMPLANT DENT R, V9, P34, DOI 10.1111/j.1708-8208.2007.00029.x
   Hammerle CHF, 2004, INT J ORAL MAX IMPL, V19, P26
   Hansson S, 1999, CLIN ORAL IMPLAN RES, V10, P394, DOI 10.1034/j.1600-0501.1999.100506.x
   Hermann JS, 2001, CLIN ORAL IMPLAN RES, V12, P559, DOI 10.1034/j.1600-0501.2001.120603.x
   Jemt T, 2005, CLIN IMPLANT DENT R, V7, P127, DOI 10.1111/j.1708-8208.2005.tb00056.x
   Jemt T, 1999, Int J Periodontics Restorative Dent, V19, P20
   Kan JYK, 2007, J ORAL MAXIL SURG, V65, P13, DOI 10.1016/j.joms.2007.04.006
   Ketabi M, 2013, INT J PERIODONT REST, V33, pE145, DOI 10.11607/prd.1629
   Knoernschild Kent L, 2012, J Evid Based Dent Pract, V12, P209, DOI 10.1016/S1532-3382(12)70039-8
   Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x
   Lee DW, 2007, CLIN ORAL IMPLAN RES, V18, P465, DOI 10.1111/j.1600-0501.2007.01302.x
   Lindeboom JAH, 2006, ORAL SURG ORAL MED O, V101, P705, DOI 10.1016/j.tripleo.2005.08.022
   Mangano FG, 2013, J ORAL IMPLANTOL, V39, P172, DOI 10.1563/AAID-JOI-D-11-00112
   Mijiritsky E, 2009, IMPLANT DENT, V18, P326, DOI 10.1097/ID.0b013e31819ecaaa
   Miyamoto Y, 2011, INT J PERIODONT REST, V31, P215
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Nevins M, 2010, INT J PERIODONT REST, V30, P245
   Novaes AB, 2012, J ORAL IMPLANTOL, V38, P687, DOI 10.1563/AAID-JOI-D-10-00176
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   Ortega-Martinez J, 2012, MED ORAL PATOL ORAL, V17, pE251, DOI 10.4317/medoral.17469
   Palattella P, 2008, CLIN ORAL IMPLAN RES, V19, P1148, DOI 10.1111/j.1600-0501.2008.01578.x
   Raes F, 2011, J CLIN PERIODONTOL, V38, P385, DOI 10.1111/j.1600-051X.2010.01687.x
   RAMS TE, 1984, J PROSTHET DENT, V51, P529, DOI 10.1016/0022-3913(84)90309-3
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Rompen E, 2007, J PROSTHET DENT, V97, pS119, DOI 10.1016/S0022-3913(07)60015-8
   Ryser MR, 2005, J ORAL MAXIL SURG, V63, P1184, DOI 10.1016/j.joms.2005.04.025
   Sanz I, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2011.02339.x
   Shi JY, 2015, CLIN ORAL IMPLAN RES, V26, P768, DOI 10.1111/clr.12334
   Shin SY, 2010, CLIN ORAL IMPLAN RES, V21, P804, DOI 10.1111/j.1600-0501.2010.01917.x
   Shin YK, 2006, INT J ORAL MAX IMPL, V21, P789
   Turkyilmaz I, 2007, CLIN IMPLANT DENT R, V9, P222, DOI 10.1111/j.1708-8208.2007.00045.x
NR 72
TC 5
Z9 5
U1 1
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-941X
EI 1532-849X
J9 J PROSTHODONT
JI J. Prosthodont.
PD FEB
PY 2016
VL 25
IS 2
BP 135
EP 145
DI 10.1111/jopr.12295
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DF5XN
UT WOS:000371426300006
PM 25963199
DA 2018-10-20
ER

PT J
AU An, B
   Lin, YS
   Brodsky, B
AF An, Bo
   Lin, Yu-Shan
   Brodsky, Barbara
TI Collagen interactions: Drug design and delivery
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Collagen; Triple helix; Peptide; Recombinant collagen; Interaction;
   Targeting; Drug delivery; Extracellular matrix
ID MOLECULAR-DYNAMICS SIMULATIONS; TRIPLE-HELIX STABILIZATION; C-TERMINAL
   TELOPEPTIDE; MELANOMA CELL-ADHESION; VON-WILLEBRAND-FACTOR;
   AMINO-ACID-SEQUENCE; CHAIN FV ANTIBODY; I COLLAGEN; BINDING-SITES;
   RECOMBINANT COLLAGEN
AB Collagen is a major component in a wide range of drug delivery systems and biomaterial applications. Its basic physical and structural properties, together with its low immunogenicity and natural turnover, are keys to its biocompatibility and effectiveness. In addition to its material properties, the collagen triple-helix interacts with a large number of molecules that trigger biological events. Collagen interactions with cell surface receptors regulate many cellular processes, while interactions with other ECM components are critical for matrix structure and remodeling. Collagen also interacts with enzymes involved in its biosynthesis and degradation, including matrix metalloproteinases. Over the past decade, much information has been gained about the nature and specificity of collagen interactions with its partners. These studies have defined collagen sequences responsible for binding and the high-resolution structures of triple-helical peptides bound to its natural binding partners. Strategies to target collagen interactions are already being developed, including the use of monoclonal antibodies to interfere with collagen fibril formation and the use of triple-helical peptides to direct liposomes to melanoma cells. The molecular information about collagen interactions will further serve as a foundation for computational studies to design small molecules that can interfere with specific interactions or target tumor cells. Intelligent control of collagen biological interactions within a material context will expand the effectiveness of collagen based drug delivery. (C) 2015 Elsevier B.V. All rights reserved.
C1 [An, Bo; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Lin, Yu-Shan] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
RP Brodsky, B (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM Barbara.Brodsky@tufts.edu
OI Lin, Yu-Shan/0000-0001-6460-2877
FU NIH [GM 60048, EB011620]; Tufts Start-up Fund; Knez Family Faculty
   Investment Fund
FX The authors would like to thank Dr. Vittorio Abbonante, Dr. Alessandra
   Balduini and Dr. Birgit Leitinger for part of the data presented in Fig.
   7. This work was funded in part by NIH grant GM 60048 (B.B.) and
   EB011620 (B.B.), Tufts Start-up Fund (Y-S.L.) and the Knez Family
   Faculty Investment Fund (Y-S.L).
CR Abbonante V, 2013, J BIOL CHEM, V288, P16738, DOI 10.1074/jbc.M112.431528
   Abd-Elgaliel WR, 2013, BIOPOLYMERS, V100, P167, DOI 10.1002/bip.22188
   Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   Aliev AE, 2014, PROTEINS, V82, P195, DOI 10.1002/prot.24350
   An B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00040
   An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Anantharajan J, 2013, STRUCTURE, V21, P2107, DOI 10.1016/j.str.2013.09.005
   Aziz Omer, 2005, Surg Technol Int, V14, P35
   Barhoumi A, 2015, ADV HEALTHC MATER, V4, P1159, DOI 10.1002/adhm.201400768
   Bauer R, 2013, J BACTERIOL, V195, P318, DOI 10.1128/JB.00010-12
   Bella J, 2010, J STRUCT BIOL, V170, P377, DOI 10.1016/j.jsb.2010.02.003
   Berisio R, 2009, J PEPT SCI, V15, P131, DOI 10.1002/psc.1082
   Bodian DL, 2011, BIOCOMPUT-PAC SYM, P193
   Boiers U, 2008, EUR J IMMUNOL, V38, P2784, DOI 10.1002/eji.200838238
   Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200
   Broadhead ML, 2010, GROWTH FACTORS, V28, P280, DOI 10.3109/08977191003604513
   Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Brodsky B., 2005, COLLAGENS GELATINS B
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Brondijk THC, 2012, P NATL ACAD SCI USA, V109, P5253, DOI 10.1073/pnas.1112388109
   Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012
   Caravan P, 2007, ANGEW CHEM INT EDIT, V46, P8171, DOI 10.1002/anie.200700700
   Caravan P, 2009, CHEM COMMUN, P430, DOI 10.1039/b819098d
   Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200
   Cereceres S, 2015, ADV WOUND CARE, V4, P444, DOI 10.1089/wound.2014.0614
   Cerofolini L, 2013, J BIOL CHEM, V288, P30659, DOI 10.1074/jbc.M113.477240
   Chang SW, 2012, BIOMATERIALS, V33, P3852, DOI 10.1016/j.biomaterials.2012.02.001
   Chang SW, 2012, BIOPHYS J, V102, P640, DOI 10.1016/j.bpj.2011.11.3999
   Chattopadhyay S., 2014, J TISSUE ENG REGEN M
   CHELBERG MK, 1990, J CELL BIOL, V111, P261, DOI 10.1083/jcb.111.1.261
   Chin YKY, 2013, J BIOL CHEM, V288, P36796, DOI 10.1074/jbc.M113.480251
   Chow WY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12556
   Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318
   Cicchi R, 2013, J BIOPHOTONICS, V6, P129, DOI 10.1002/jbio.201200092
   Cockett MI, 1998, BIOCHEM SOC SYMP, P295
   Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   De Simone A, 2008, BIOCHEM BIOPH RES CO, V372, P121, DOI 10.1016/j.bbrc.2008.04.190
   DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904
   Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002
   DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584
   Erat MC, 2013, J BIOL CHEM, V288, P17441, DOI 10.1074/jbc.M113.469841
   Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106
   Fallas JA, 2010, CHEM SOC REV, V39, P3510, DOI 10.1039/b919455j
   FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043
   Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7
   Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fertala J, 2014, CONNECT TISSUE RES, V55, P115, DOI 10.3109/03008207.2013.862528
   Fertala J, 2013, CONNECT TISSUE RES, V54, P187, DOI 10.3109/03008207.2013.778839
   FIELDS CG, 1993, J BIOL CHEM, V268, P14153
   Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002
   Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a
   Fleck Cynthia Ann, 2010, J Am Col Certif Wound Spec, V2, P50, DOI 10.1016/j.jcws.2010.12.003
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gautieri A, 2009, J MECH BEHAV BIOMED, V2, P130, DOI 10.1016/j.jmbbm.2008.03.001
   Gautieri A, 2012, J BIOMECH, V45, P2079, DOI 10.1016/j.jbiomech.2012.05.047
   Gautieri A, 2012, RSC ADV, V2, P3890, DOI 10.1039/c2ra01047j
   Gautieri A, 2012, MATRIX BIOL, V31, P141, DOI 10.1016/j.matbio.2011.11.005
   Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u
   Gautieri A, 2009, BIOPHYS J, V97, P857, DOI 10.1016/j.bpj.2009.04.059
   Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x
   Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200
   GLATTAUER V, 1991, INT J BIOL MACROMOL, V13, P140, DOI 10.1016/0141-8130(91)90038-V
   Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575
   Gurry T, 2010, BIOPHYS J, V98, P2634, DOI 10.1016/j.bpj.2010.01.065
   Halland N, 2014, ACS MED CHEM LETT, V5, P193, DOI 10.1021/ml4004556
   HARPER E, 1980, ANNU REV BIOCHEM, V49, P1063, DOI 10.1146/annurev.bi.49.070180.005215
   Heino J, 2009, CURR PHARM DESIGN, V15, P1309, DOI 10.2174/138161209787846720
   Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105
   Howes JM, 2014, J BIOL CHEM, V289, P24091, DOI 10.1074/jbc.M114.583443
   Huang C C, 1998, Pac Symp Biocomput, P349
   Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833
   Improta R, 2001, J AM CHEM SOC, V123, P12568, DOI 10.1021/ja010599i
   INGHAM KC, 1988, J BIOL CHEM, V263, P4624
   Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2
   Ito H, 2006, J BIOMED MATER RES A, V76A, P551, DOI 10.1002/jbm.a.30551
   Iwai LK, 2013, BIOCHEM J, V454, P501, DOI 10.1042/BJ20121750
   Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472
   Jehle K S, 2007, J Wound Care, V16, P36
   Jin HE, 2014, BIOMATERIALS, V35, P9236, DOI 10.1016/j.biomaterials.2014.07.044
   JONES EY, 1991, J MOL BIOL, V218, P209, DOI 10.1016/0022-2836(91)90885-A
   Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13
   Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200
   Jung SM, 2012, J BIOL CHEM, V287, P30000, DOI 10.1074/jbc.M112.359125
   KADLER KE, 1988, J BIOL CHEM, V263, P10517
   Kagan HM, 2000, ACTA TROP, V77, P147, DOI 10.1016/S0001-706X(00)00128-5
   Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200
   Katikaneni R, 2014, ANTI-CANCER DRUG, V25, P30, DOI 10.1097/CAD.0b013e3283650bff
   Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200
   Keshwani N, 2013, BIOPHYS J, V105, P1681, DOI 10.1016/j.bpj.2013.08.018
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jc.M509707200
   Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200
   Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200
   Kojima C, 2009, J AM CHEM SOC, V131, P6052, DOI 10.1021/ja809639c
   Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200
   Kontturi LS, 2014, DRUG DELIV TRANSL RE, V4, P149, DOI 10.1007/s13346-013-0188-1
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454
   Krishna OD, 2009, BIOMACROMOLECULES, V10, P2626, DOI 10.1021/bm900551c
   Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005
   Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040
   Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007
   Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5
   Li Y, 2013, BIOCONJUGATE CHEM, V24, P9, DOI 10.1021/bc3005842
   Li Y, 2012, P NATL ACAD SCI USA, V109, P14767, DOI 10.1073/pnas.1209721109
   Liang H, 2015, J CONTROL RELEASE, V209, P101, DOI 10.1016/j.jconrel.2015.04.029
   Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965
   Lo Conte L, 1999, J MOL BIOL, V285, P2177
   Lu KG, 2013, J MOL BIOL, V425, P1815, DOI 10.1016/j.jmb.2013.02.002
   Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001
   Luo TZ, 2013, EUR POLYM J, V49, P2998, DOI 10.1016/j.eurpolymj.2013.05.013
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081
   Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b
   Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109
   Masic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6942
   Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200
   McKleroy W, 2013, AM J PHYSIOL-LUNG C, V304, pL709, DOI 10.1152/ajplung.00418.2012
   MENZEL J, 1983, COLLAGEN REL RES, V3, P217
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Mooney SD, 2002, BIOPOLYMERS, V64, P63, DOI 10.1002/bip.10123
   Myllyharju Johanna, 2009, V522, P51, DOI 10.1007/978-1-59745-413-1_3
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720
   Ndinguri MW, 2012, J DRUG DELIV, V2012
   Nerenberg PS, 2008, J MOL BIOL, V382, P246, DOI 10.1016/j.jmb.2008.07.009
   Nerenberg Paul S., 2007, Cancer Genomics & Proteomics, V4, P319
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Park S, 2005, J COMPUT CHEM, V26, P1612, DOI 10.1002/jcc.20301
   Park S, 2007, BIOPHYS J, V93, P4108, DOI 10.1529/biophysj.107.108100
   Payne LS, 2013, MOL CANCER RES, V11, P1129, DOI 10.1158/1541-7786.MCR-13-0236
   Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898
   Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200
   Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r
   Philominathan STL, 2012, PROTEIN SCI, V21, P1554, DOI 10.1002/pro.2145
   Philominathan STL, 2008, BIOMOL NMR ASSIGN, V2, P127, DOI 10.1007/s12104-008-9102-z
   Ponnapakkam T, 2012, CALCIFIED TISSUE INT, V91, P196, DOI 10.1007/s00223-012-9626-1
   Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598
   Przybyla DE, 2013, J AM CHEM SOC, V135, P3418, DOI 10.1021/ja307651e
   Przybyla DE, 2010, BIOCHEMISTRY-US, V49, P4411, DOI 10.1021/bi902129p
   Punitha V, 2009, J PHYS CHEM B, V113, P8983, DOI 10.1021/jp808690m
   Radmer RJ, 2006, BIOPHYS J, V90, P578, DOI 10.1529/biophysj.105.065276
   Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   Raman SS, 2008, J PHYS CHEM B, V112, P1533, DOI 10.1021/jp0728297
   Raman SS, 2006, J PHYS CHEM B, V110, P20678, DOI 10.1021/jp0625715
   Raman SS, 2011, J PHYS CHEM B, V115, P2593, DOI 10.1021/jp109133v
   Ramshaw JAM, 2014, BIOENGINEERED, V5, P227, DOI 10.4161/bioe.28791
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Ravikumar KM, 2008, PROTEINS, V72, P1320, DOI 10.1002/prot.22026
   Ravikumar KM, 2007, J MECH MATER STRUCT, V2, P999, DOI 10.2140/jomms.2007.2.999
   Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200
   Rezler EM, 2007, J AM CHEM SOC, V129, P4961, DOI 10.1021/ja066929m
   Ricard-Blum S, 2014, EXP DERMATOL, V23, P457, DOI 10.1111/exd.12435
   Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   Rosloniec EF, 2006, J IMMUNOL, V177, P3884, DOI 10.4049/jimmunol.177.6.3884
   Rowley MJ, 2008, MOD RHEUMATOL, V18, P429, DOI 10.1007/s10165-008-0080-x
   ROYCE PM, 2002, CONNECTIVE TISSUE IT
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sacca B, 2002, CHEMBIOCHEM, V3, P904, DOI 10.1002/1439-7633(20020902)3:9<904::AID-CBIC904>3.0.CO;2-I
   Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025
   Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Sekiya A, 2011, J BIOL CHEM, V286, P26364, DOI 10.1074/jbc.M111.252684
   Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357
   Shami A, 2014, CURR OPIN LIPIDOL, V25, P394, DOI 10.1097/MOL.0000000000000112
   Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Shoulders MD, 2009, ADV EXP MED BIOL, V611, P251, DOI 10.1007/978-0-387-73657-0_115
   Siebert HC, 2010, PROTEIN CELL, V1, P393, DOI 10.1007/s13238-010-0038-6
   SIEGEL RC, 1974, P NATL ACAD SCI USA, V71, P4826, DOI 10.1073/pnas.71.12.4826
   Singam ERA, 2014, BIOPOLYMERS, V101, P779, DOI 10.1002/bip.22457
   Singam ERA, 2012, BIOPOLYMERS, V97, P847, DOI 10.1002/bip.22085
   Slatter DA, 2012, PEPTIDES, V36, P86, DOI 10.1016/j.peptides.2012.04.013
   Slatter DA, 2011, BIOMATERIALS, V32, P6621, DOI 10.1016/j.biomaterials.2011.05.025
   Stawikowski MJ, 2015, BIOCHEMISTRY-US, V54, P3110, DOI 10.1021/acs.biochem.5b00110
   Steplewski A, 2007, J STRUCT BIOL, V157, P297, DOI 10.1016/j.jsb.2006.10.009
   Steplewski A, 2015, TISSUE ENG PT A, V21, P1207, DOI [10.1089/ten.tea.2014.0401, 10.1089/ten.TEA.2014.0401]
   Streeter I, 2011, SOFT MATTER, V7, P3373, DOI 10.1039/c0sm01192d
   Streeter I, 2010, J PHYS CHEM B, V114, P13263, DOI 10.1021/jp1059984
   Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7
   Stultz CM, 2006, PROTEIN SCI, V15, P2166, DOI 10.1110/ps062124606
   Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200
   Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275
   Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006
   Veld PJ, 2008, BIOPHYS J, V95, P33, DOI 10.1529/biophysj.107.120659
   Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V
   Vitagliano L, 2011, BIOPHYS J, V100, P2253, DOI 10.1016/j.bpj.2011.03.033
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang AY, 2005, J AM CHEM SOC, V127, P4130, DOI 10.1021/ja0431915
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
   Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109
   Wu D, 2015, AIP ADV, V5, DOI 10.1063/1.4915295
   Xiao JX, 2015, J BIOL CHEM, V290, P24201, DOI 10.1074/jbc.M115.654871
   Xiao JX, 2009, J AM CHEM SOC, V131, P18194, DOI 10.1021/ja9056823
   Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004
   Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
   Yagi-Utsumi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045930
   Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003
   Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979
   Zaman MH, 2007, BIOPHYS J, V92, pL17, DOI 10.1529/biophysj.106.097519
   Zhao YC, 2015, STRUCTURE, V23, P257, DOI 10.1016/j.str.2014.11.021
   Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888
   Zwolanek D, 2014, BIOCHEM J, V459, P217, DOI 10.1042/BJ20130642
NR 224
TC 50
Z9 51
U1 17
U2 119
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD FEB 1
PY 2016
VL 97
BP 69
EP 84
DI 10.1016/j.addr.2015.11.013
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DE8SE
UT WOS:000370906200006
PM 26631222
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Qin, J
   Wang, L
   Sun, Y
   Sun, XL
   Wen, CJ
   Shahmoradi, M
   Zhou, YM
AF Qin, Jie
   Wang, Lin
   Sun, Yue
   Sun, Xiaolin
   Wen, Chaoju
   Shahmoradi, Mahdi
   Zhou, Yanmin
TI Concentrated growth factor increases Schwann cell proliferation and
   neurotrophic factor secretion and promotes functional nerve recovery in
   vivo
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE concentrated growth factor; nerve regeneration; Schwann cells;
   proliferation; secretion
ID PLATELET-RICH FIBRIN; PERIPHERAL-NERVE; IMPLANT-SURGERY; STEM-CELLS;
   L-PRF; PLASMA; REGENERATION; VITRO; EXPRESSION; RELEASE
AB Concentrated growth factor (CGF) is a newly generated complex that comprises a fibrin matrix incorporating growth factors and plasmatic and leukocyte cytokines. It has been widely used in bone regenerative medicine. However, the effect of CGF on peripheral nerve regeneration had not been previously investigated. The aim of the present study was to evaluate the possibility of using CGF for nerve regeneration by i) investigating the effect of CGF on the proliferation of Schwann cells (SCs) and secretion of neurotrophic factors nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) in vitro; and ii) analyzing the effect of CGF on functional nerve recovery after nerve injury in vivo. CGF was prepared from venous blood taken from rats, and using scanning electron microscopy (SEM) we noted that it featured a fiber-like appearance with pore size ranging from 0.1 to 1.0 mu m. The soluble component of CGF was used to produce conditioned media with which to treat the Schwann cell line. A cell counting kit-8 assay and cell cycle analysis were both used to study the proliferative effect of CGF on SCs. Reverse transcription-quantitative PCR and western blot analysis demonstrated that there was an increase in the mRNA and protein expression of NGF and GDNF, both of which are markers of SC neurotrophic secretion. A model of sciatic nerve crush injury was established for the in vivo experiment, and CGF was found to increase the sciatic functional index ( indicative of nerve function). We noted that CGF increased SC proliferation and secretion of neurotrophic factors in vitro, and promoted functional recovery after peripheral nerve injuries in vivo. These results suggest that CGF is a promising candidate biomaterial for peripheral nerve regeneration, and may potentially be utilized to repair nerve injuries.
C1 [Qin, Jie; Sun, Yue; Sun, Xiaolin; Wen, Chaoju; Zhou, Yanmin] Jilin Univ, Sch & Hosp Stomatol, Dept Dent Implantol, Qinghua Rd 1500, Changchun 130021, Jilin, Peoples R China.
   [Wang, Lin] Jilin Univ, Sch & Hosp Stomatol, Dept Very Important People, Changchun 130021, Jilin, Peoples R China.
   [Shahmoradi, Mahdi] Univ Sydney, Sch Dent, Dept Bioengn, Sydney, NSW 2006, Australia.
RP Zhou, YM (reprint author), Jilin Univ, Sch & Hosp Stomatol, Dept Dent Implantol, Qinghua Rd 1500, Changchun 130021, Jilin, Peoples R China.
EM zhouym62@126.com
OI Shahmoradi, Mahdi/0000-0003-0516-199X
FU Jilin University; National Natural Science Foundation of China (Youth
   Scholar program) [81400487]; Jilin Province Science Foundation for
   Youths [20150520043JH]; Excellent Youth Scholars of Bethune Medical
   Department in Jilin University [2013208064]
FX Financial support from the Funding for Top Talents among PhD students in
   Jilin University, the National Natural Science Foundation of China
   (Youth Scholar program, grant no. 81400487), Jilin Province Science
   Foundation for Youths (grant no. 20150520043JH) and the Excellent Youth
   Scholars of Bethune Medical Department in Jilin University (grant no.
   2013208064) is gratefully acknowledged.
CR Alhassani AA, 2010, J ORAL IMPLANTOL, V36, P401, DOI 10.1563/AAID-JOI-D-09-00059
   Badache A, 1998, J CELL PHYSIOL, V177, P334, DOI 10.1002/(SICI)1097-4652(199811)177:2<334::AID-JCP15>3.0.CO;2-9
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104
   Cheng HL, 1999, ENDOCRINOLOGY, V140, P4478, DOI 10.1210/en.140.10.4478
   Cho HH, 2010, LARYNGOSCOPE, V120, P907, DOI 10.1002/lary.20860
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Coetzee JC, 2005, FOOT ANKLE INT, V26, P840, DOI 10.1177/107110070502601009
   D'Antonio M, 2006, J NEUROSCI, V26, P8417, DOI 10.1523/JNEUROSCI.1578-06.2006
   Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727
   Ehrenfest DMD, 2012, CURR PHARM BIOTECHNO, V13, P1145
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Fukuda K, 2012, INT J DENT, V2012
   Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.2005.01203.x
   Honda H, 2013, J ARTIF ORGANS, V16, P305, DOI 10.1007/s10047-013-0711-7
   Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055
   Jiang MR, 2014, NEUROCHEM RES, V39, P2047, DOI 10.1007/s11064-014-1387-y
   Juodzbalys G, 2013, CLIN ORAL IMPLAN RES, V24, P183, DOI 10.1111/j.1600-0501.2011.02314.x
   Kim JM, 2014, IMPLANT DENT, V23, P168, DOI 10.1097/ID.0000000000000053
   Kim TH, 2014, ARCH ORAL BIOL, V59, P550, DOI 10.1016/j.archoralbio.2014.02.004
   Kim YT, 2013, J KOR ASSOC ORAL MAX, V39, P127, DOI 10.5125/jkaoms.2013.39.3.127
   Lee JY, 2015, J ORAL MAXIL SURG, V73, P410, DOI 10.1016/j.joms.2014.07.009
   Lee JY, 2014, J KOR ASSOC ORAL MAX, V40, P3, DOI 10.5125/jkaoms.2014.40.1.3
   Li Q, 2014, INT J MOL SCI, V15, P8509, DOI 10.3390/ijms15058509
   Li Q, 2013, BIOMED RES INT, DOI 10.1155/2013/638043
   Liang W, 2010, BRAIN RES, V1357, P19, DOI 10.1016/j.brainres.2010.07.091
   Lichtenfels M, 2013, MICROSURG, V33, P383, DOI 10.1002/micr.22105
   Liu YW, 2002, WOUND REPAIR REGEN, V10, P336, DOI 10.1046/j.1524-475X.2002.10510.x
   Lundquist R, 2008, WOUND REPAIR REGEN, V16, P356, DOI 10.1111/j.1524-475X.2007.00344.x
   Luo LH, 2015, BIOCHEM BIOPH RES CO, V457, P507, DOI 10.1016/j.bbrc.2014.12.121
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Misch K, 2008, IMPLANT DENT, V17, P159, DOI 10.1097/ID.0b013e3181752f61
   Rodella LF, 2011, MICROSC RES TECHNIQ, V74, P772, DOI 10.1002/jemt.20968
   Schar MO, 2015, CLIN ORTHOP RELAT R, V473, P1635, DOI 10.1007/s11999-015-4192-2
   Shakhbazau A, 2013, J CONTROL RELEASE, V172, P841, DOI 10.1016/j.jconrel.2013.10.004
   Sohn DS, 2011, IMPLANT DENT, V20, P389, DOI 10.1097/ID.0b013e31822f7a70
   Wakatsuki S, 2014, GENES CELLS, V19, P66, DOI 10.1111/gtc.12108
   Yazdani SO, 2012, J PHOTOCH PHOTOBIO B, V107, P9, DOI 10.1016/j.jphotobiol.2011.11.001
   Yu BH, 2014, MOL MED REP, V9, P235, DOI 10.3892/mmr.2013.1756
   Zheng CB, 2016, J TISSUE ENG REGEN M, V10, P428, DOI 10.1002/term.1756
   Zhou YK, 2015, MOL CELL ENDOCRINOL, V404, P75, DOI 10.1016/j.mce.2015.01.005
   Zumstein MA, 2012, CURR PHARM BIOTECHNO, V13, P1196
NR 42
TC 17
Z9 21
U1 4
U2 26
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD FEB
PY 2016
VL 37
IS 2
BP 493
EP 500
DI 10.3892/ijmm.2015.2438
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DE7ZL
UT WOS:000370855500026
PM 26709397
DA 2018-10-20
ER

PT J
AU Shi, XY
   Fang, Q
   Ding, M
   Wu, J
   Ye, F
   Lv, ZB
   Jin, J
AF Shi, Xinyi
   Fang, Qiang
   Ding, Miao
   Wu, Jing
   Ye, Fei
   Lv, Zhengbing
   Jin, Jia
TI Microspheres of carboxymethyl chitosan, sodium alginate and collagen for
   a novel hemostatic in vitro study
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Microsphere; carboxymethyl chitosan; sodium alginate; collagen;
   hemostatic
ID HEMORRHAGE MODEL; BLOOD-LOSS; SWINE; INJURY; AGENT; POLYETHYLENE;
   BIOMATERIAL; SURVIVAL; FILMS
AB To develop biocompatible composite microspheres for novel hemostatic use, we designed and prepared a novel biomaterial, composite microspheres consisting of carboxymethyl chitosan, sodium alginate, and collagen (CSCM). The ultra-structure of CSCM was investigated by scanning electron microscopy assay. In hemostatic function experiment, it was found that CSCM could facilitate platelet adherence, platelet aggregation, and platelet activation in vitro. Besides, the maximum swelling of CSCM submerged in PBS for 50min was over 300% of that exhibited by commercial hemostatic compound microporous polysaccharide haemostatic powder (CMPHP). In addition, CSCM exhibited good biodegradability and non-cytotoxicity. These results demonstrated that CSCM may be useful in platelet plug formation, and this study would provide important information for further research on hemostasis experiment in vivo.
C1 [Shi, Xinyi; Fang, Qiang; Ding, Miao; Wu, Jing; Ye, Fei; Lv, Zhengbing; Jin, Jia] Zhejiang Sci Tech Univ, Coll Life Sci, 928,2nd St, Hangzhou 310018, Zhejiang, Peoples R China.
   [Ye, Fei; Lv, Zhengbing; Jin, Jia] Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou, Zhejiang, Peoples R China.
RP Jin, J (reprint author), Zhejiang Sci Tech Univ, Coll Life Sci, 928,2nd St, Hangzhou 310018, Zhejiang, Peoples R China.
EM aukaukauk@163.com
FU Zhejiang Province Natural Science Foundation [LQ14H300003]; National
   Natural Science Foundation of China [81402849]; Public Projects of
   Zhejiang Province [2015C33159]; Zhejiang Provincial Top Key Discipline
   of Biology
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by grants from Zhejiang Province Natural Science
   Foundation (LQ14H300003), The National Natural Science Foundation of
   China (81402849), Public Projects of Zhejiang Province (2015C33159) and
   Zhejiang Provincial Top Key Discipline of Biology.
CR Alam HB, 2004, J TRAUMA, V56, P974, DOI 10.1097/01.TA.0000127763.90890.31
   Baik SH, 2010, J SURG RES, V164, pE221, DOI 10.1016/j.jss.2010.08.004
   Bloomfield MR, 2012, J ARTHROPLASTY, V27, P695, DOI 10.1016/j.arth.2011.09.014
   Bonifazi M, 2004, J BIOMED MATER RES B, V68B, P53, DOI 10.1002/jbm.b.10083
   Devlin JJ, 2011, J EMERG MED, V41, P237, DOI 10.1016/j.jemermed.2009.02.017
   Erdogan D, 2008, J BIOMED MATER RES B, V85B, P272, DOI 10.1002/jbm.b.30916
   Fujimoto Y, 2014, NEUROL MED-CHIR, V54, P617, DOI 10.2176/nmc.tn.2014-0024
   Gardner RL, 2004, METH MOL B, V254, P383
   He Q, 2013, J BIOMATER APPL, V27, P1032, DOI 10.1177/0885328211432487
   Huang XF, 2015, CHINESE J POLYM SCI, V33, P284, DOI 10.1007/s10118-015-1580-8
   Huang XF, 2015, INT J BIOL MACROMOL, V75, P322, DOI 10.1016/j.ijbiomac.2015.01.049
   Izuha Hitoshi, 2005, J Artif Organs, V8, P41, DOI 10.1007/s10047-004-0280-x
   Kheirabadi BS, 2007, J TRAUMA, V62, P94, DOI 10.1097/01.ta.0000251595.45451.d0
   Kunio NR, 2013, AM J SURG, V205, P505, DOI 10.1016/j.amjsurg.2013.01.014
   Lewis KM, 2014, J BIOMATER APPL, V29, P780, DOI 10.1177/0885328214545500
   Li DH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/981321
   Liapina LA, 2006, IZVESTIIA AKAD NAUK, V33, P381
   Lin CY, 2015, HUM VACC IMMUNOTHER, V11, P650, DOI 10.1080/21645515.2015.1009345
   Littlejohn LF, 2011, ACAD EMERG MED, V18, P340, DOI 10.1111/j.1553-2712.2011.01036.x
   Misgav M, 2014, J PEDIAT HEMATOL ONC, V36, P140, DOI 10.1097/MPH.0b013e31828ac8b6
   Morimoto N, 2015, BIOMED RES INT, V2015
   Pinkas O, 2014, J BIOMAT SCI-POLYM E, V25, P555, DOI 10.1080/09205063.2014.881681
   Pusateri AE, 2004, J TRAUMA, V57, P555, DOI 10.1097/01.TA.0000136155.97758.CD
   Rong JJ, 2015, INT J BIOL MACROMOL, V75, P479, DOI 10.1016/j.ijbiomac.2014.12.043
   Sayed EG, 2015, DRUG DES DEV THER, V9, P1427, DOI 10.2147/DDDT.S80697
   Taskin AK, 2013, ULUS TRAVMA ACIL CER, V19, P195, DOI 10.5505/tjtes.2013.30676
   Vasconcellos FC, 2011, POWDER TECHNOL, V205, P65, DOI 10.1016/j.powtec.2010.08.066
   Vournakis JN, 2003, J SURG RES, V113, P1, DOI 10.1016/S0022-4804(03)00161-6
   Wagner WR, 1996, J SURG RES, V66, P100, DOI 10.1006/jsre.1996.0379
   Zohuriaan-Mehr MJ, 2010, J MATER SCI, V45, P5711, DOI 10.1007/s10853-010-4780-1
NR 30
TC 14
Z9 16
U1 14
U2 89
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2016
VL 30
IS 7
BP 1092
EP 1102
DI 10.1177/0885328215618354
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DE1ZD
UT WOS:000370424700020
PM 26611230
DA 2018-10-20
ER

PT J
AU Hussain, A
   Curry, B
   Cahalan, L
   Minkin, S
   Gartner, M
   Cahalan, P
AF Hussain, Ali
   Curry, Benjamin
   Cahalan, Linda
   Minkin, Steven
   Gartner, Mark
   Cahalan, Patrick
TI Development and invitro evaluation of infection resistant materials: A
   novel surface modification process for silicone and Dacron
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Infection resistance; silicone; dacron; implant; collagen surface; drug;
   release; surface modification
ID ASSIST DEVICE SUPPORT; TITANIUM; IMPLANTS; TRANSPLANTATION;
   IMMOBILIZATION; POLYURETHANE
AB Silicone and Dacron are used in a wide spectrum of implantable and indwelling medical products. They elicit a foreign body response, which results in a chronic inflammatory environment and collagenous encapsulation of the medical device that compromises the immune system's ability to effectively fight infections at the biomaterial surface. The objective of this work is to evaluate a novel process to modify silicone and Dacron with a bioactive collagen surface coupled to a gentamicin impregnated hydrogel graft and assess the surface's cytocompatibility and infection resistance properties. Samples of silicone and polyethylene terephthalate (Dacron velour) were modified by plasma deposition and activation followed by a co-polymer acrylic acid (AA)/acrylamide (AAm) hydrogel graft and covalent immobilization of a bioactive collagen surface. The modified surfaces were characterized using FTIR, contact angle, staining, SEM, and XPS. The poly (AA-AAm) hydrogel was impregnated with gentamicin and tested for controlled release characteristics. Each modified surface was evaluated for its ability to resist infection and to promote normal healing as measured by bacterial growth inhibition (Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa) in both broth and agar conditions as well as using fluorescence microscopy to observe adherence of 3T3-NIH fibroblasts. The addition of the poly (AA-AAm) hydrogel with gentamicin inhibited bacterial growth and the subsequent addition of the collagen surface promoted robust fibroblast adhesion on both silicone and Dacron materials. Thorough surface characterization and invitro bacterial and fibroblast evaluation results suggest that this novel surface bioengineering process generated a highly effective surface on silicone and Dacron with the potential to reduce infection and promote healing.
C1 [Hussain, Ali; Curry, Benjamin; Cahalan, Linda; Minkin, Steven; Gartner, Mark; Cahalan, Patrick] Ension Inc, 240 William Pitt Way, Pittsburgh, PA 15238 USA.
RP Hussain, A (reprint author), Ension Inc, 240 William Pitt Way, Pittsburgh, PA 15238 USA.
EM ahussain@ension.com
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bronk JK, 2014, ACTA BIOMATER, V10, P3354, DOI 10.1016/j.actbio.2014.04.005
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chen XN, 2012, EUR CELLS MATER, V24, P237, DOI 10.22203/eCM.v024a17
   Gristina A, 1987, MED PROGR TECHNOL, V14, P205
   Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x
   Jensen C, 2012, J BIOMED MATER RES A, V100A, P3400, DOI 10.1002/jbm.a.34284
   Koval CE, 2013, AM J TRANSPLANT, V13, P348, DOI 10.1111/ajt.12126
   Marin-Pareja N, 2014, COLLOID SURFACE B, V122, P601, DOI 10.1016/j.colsurfb.2014.07.038
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   NAIR PD, 1990, J POLYM SCI POL CHEM, V28, P3775, DOI 10.1002/pola.1990.080281320
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Poston RS, 2003, J HEART LUNG TRANSPL, V22, P914, DOI 10.1016/S1053-2498(02)00645-9
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Toda K, 2012, ANN THORAC SURG, V94, P1387, DOI 10.1016/j.athoracsur.2012.03.021
   Valencia-Lazcano AA, 2014, J MECH BEHAV BIOMED, V40, P140, DOI 10.1016/j.jmbbm.2014.08.018
   van Wachem PB, 2002, BIOMATERIALS, V23, P1401, DOI 10.1016/S0142-9612(01)00174-0
   Zierer A, 2007, ANN THORAC SURG, V84, P515, DOI 10.1016/j.athoracsur.2007.03.085
NR 20
TC 2
Z9 2
U1 2
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2016
VL 30
IS 7
BP 1103
EP 1113
DI 10.1177/0885328215607378
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DE1ZD
UT WOS:000370424700021
PM 26608459
DA 2018-10-20
ER

PT J
AU Xie, DL
   Ren, XL
   Xie, YH
   Zhang, XY
   Liao, SJ
AF Xie, Delong
   Ren, Xiaolin
   Xie, Yuhui
   Zhang, Xinya
   Liao, Shijun
TI Large-Scale Synthesis of Monodisperse Red Blood Cell (RBC)-Like Polymer
   Particles
SO ACS MACRO LETTERS
LA English
DT Article
ID 2-STAGE DISPERSION POLYMERIZATION; SIZED POLYSTYRENE PARTICLES; ONE-POT
   SYNTHESIS; COLLOIDAL CRYSTALS; BIOMATERIAL PARTICLES; REACTION
   PARAMETERS; LATEX-PARTICLES; FABRICATION; MIMICKING; MICROPARTICLES
AB Red blood cell (RBC)-like particles have shown great interest as a model for the understanding of the cell behavior and as promising biomaterials in targeted drug delivery. In this study, a simple and versatile route was proposed for the large-scale synthesis of monodisperse and well-defined RBC-like PS particles using divinylbenzene (DVB) as the cross-linker and ethanol as reaction medium. RBC-like particles were obtained due to the asymmetric shrinkage of a cross-linked network during the phase separation process. An ordered self-assembly monolayer with the concave facing up at the air water interface was also demonstrated.
C1 [Xie, Delong; Ren, Xiaolin; Xie, Yuhui; Zhang, Xinya; Liao, Shijun] S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China.
RP Zhang, XY (reprint author), S China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China.
EM cexyzh@scut.edu.cn
FU Science and Technology Planning Project of Guangdong Province, China
   [2015A010105008]
FX The authors gratefully acknowledge the financial support from the
   Science and Technology Planning Project of Guangdong Province, China
   (2015A010105008).
CR Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104
   Cheng ZF, 2013, SOFT MATTER, V9, P11392, DOI 10.1039/c3sm52279b
   Choi J, 2002, J POLYM SCI POL CHEM, V40, P4368, DOI 10.1002/pola.10514
   Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Du CG, 2010, J NANOSCI NANOTECHNO, V10, P7766, DOI 10.1166/jnn.2010.2859
   Gong T, 2008, J MATER SCI, V43, P1926, DOI 10.1007/s10853-007-2441-9
   Hayashi K, 2010, SMALL, V6, P2384, DOI 10.1002/smll.201000399
   Hosein ID, 2007, LANGMUIR, V23, P8810, DOI 10.1021/la700865t
   Huang Y, 2011, MACROMOLECULES, V44, P2404, DOI 10.1021/ma200169w
   Im SH, 2002, LANGMUIR, V18, P9642, DOI 10.1021/la025888e
   Jiang P, 2001, SCIENCE, V291, P453, DOI 10.1126/science.291.5503.453
   Kim JW, 2000, POLYMER, V41, P6181, DOI 10.1016/S0032-3861(99)00846-0
   Kim SH, 2008, ADV MATER, V20, P4129, DOI 10.1002/adma.200801167
   Kim SH, 2010, ANGEW CHEM INT EDIT, V49, P2535, DOI 10.1002/anie.201000108
   Li ZF, 2012, RSC ADV, V2, P1322, DOI 10.1039/c2ra01209j
   Lippi G, 2010, INT J SPORTS MED, V31, P75, DOI 10.1055/s-0030-1247540
   Okubo M, 2000, MACROMOL SYMP, V150, P201, DOI 10.1002/1521-3900(200002)150:1<201::AID-MASY201>3.0.CO;2-0
   PAINE AJ, 1990, MACROMOLECULES, V23, P3104, DOI 10.1021/ma00214a012
   Ricci M, 2008, SOFT MATTER, V4, P2030, DOI 10.1039/b804782k
   Seiffert S, 2010, J AM CHEM SOC, V132, P6606, DOI 10.1021/ja102156h
   She SP, 2013, ADV MATER, V25, P5814, DOI 10.1002/adma.201302875
   Smeets NMB, 2012, ACS MACRO LETT, V1, P171, DOI 10.1021/mz200158e
   Song JS, 2004, J AM CHEM SOC, V126, P6562, DOI 10.1021/ja048862d
   Song JS, 2005, MACROMOLECULES, V38, P8300, DOI 10.1021/ma050992z
   Wang JX, 2011, ACCOUNTS CHEM RES, V44, P405, DOI 10.1021/ar1001236
   Wei W, 2008, J AM CHEM SOC, V130, P15808, DOI 10.1021/ja8039585
   Xu LA, 2010, MACROMOL RAPID COMM, V31, P1422, DOI 10.1002/marc.201000156
   Zhao T, 2011, LANGMUIR, V27, P12771, DOI 10.1021/la2028912
   Zhu DF, 2010, LANGMUIR, V26, P14276, DOI 10.1021/la102243c
NR 30
TC 12
Z9 12
U1 2
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD FEB
PY 2016
VL 5
IS 2
BP 174
EP 176
DI 10.1021/acsmacrolett.5b00852
PG 3
WC Polymer Science
SC Polymer Science
GA DE4CE
UT WOS:000370576000004
DA 2018-10-20
ER

PT J
AU Melke, J
   Midha, S
   Ghosh, S
   Ito, K
   Hofmann, S
AF Melke, Johanna
   Midha, Swati
   Ghosh, Sourabh
   Ito, Keita
   Hofmann, Sandra
TI Silk fibroin as biomaterial for bone tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Bone tissue engineering; Silk fibroin; Regenerative medicine; Drug
   delivery; Scaffold
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PLATELET-RICH PLASMA;
   BETA-SHEET CRYSTALS; BOMBYX-MORI SILK; IN-VITRO; GROWTH-FACTOR;
   MORPHOGENETIC PROTEIN-2; SPIDER SILK; MECHANICAL-PROPERTIES
AB Silk fibroin (SF) is a fibrous protein which is produced mainly by silkworms and spiders. Its unique mechanical properties, tunable biodegradation rate and the ability to support the differentiation of mesenchymal stem cells along the osteogenic lineage, have made SF a favorable scaffold material for bone tissue engineering. SF can be processed into various scaffold forms, combined synergistically with other biomaterials to form composites and chemically modified, which provides an impressive toolbox and allows SF scaffolds to be tailored to specific applications. This review discusses and summarizes recent advancements in processing SF, focusing on different fabrication and functionalization methods and their application to grow bone tissue in vitro and in vivo. Potential areas for future research, current challenges, uncertainties and gaps in knowledge are highlighted.
   Statement of significance
   Silk fibroin is a natural biomaterial with remarkable biomedical and mechanical properties which make it favorable for a broad range of bone tissue engineering applications. It can be processed into different scaffold forms, combined synergistically with other biomaterials to form composites and chemically modified which provides a unique toolbox and allows silk fibroin scaffolds to be tailored to specific applications. This review discusses and summarizes recent advancements in processing silk fibroin, focusing on different fabrication and functionalization methods and their application to grow bone tissue in vitro and in vivo. Potential areas for future research, current challenges, uncertainties and gaps in knowledge are highlighted. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Melke, Johanna; Ito, Keita; Hofmann, Sandra] Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, POB 513, NL-5600 MB Eindhoven, Netherlands.
   [Melke, Johanna; Ito, Keita; Hofmann, Sandra] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.
   [Midha, Swati; Ghosh, Sourabh] Indian Inst Technol Delhi, Dept Text Technol, New Delhi 110016, India.
   [Ito, Keita] UMC Utrecht, Dept Orthopaed, NL-3508 GA Utrecht, Netherlands.
   [Hofmann, Sandra] Swiss Fed Inst Technol, Inst Biomech, CH-8093 Zurich, Switzerland.
RP Hofmann, S (reprint author), Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM j.melke@tue.nl; swati.mid@gmail.com; sghosh08@textile.iitd.ac.in;
   K.Ito@tue.nl; S.Hofmann.Boss@tue.nl
RI Hofmann, Sandra/F-2832-2010; Ito, Keita/A-8592-2017
OI Hofmann, Sandra/0000-0002-2568-8388; Ito, Keita/0000-0002-7372-4072;
   Melke, Johanna/0000-0002-4858-2092; /0000-0003-0295-5356
FU European Union [336043]; Department of Biotechnology, India
   [BT/PR8038/MED/32/303/2013]
FX The research leading to these results has received funding from the
   European Union's Seventh Framework Programme (FP/2007-2013) under Grant
   Agreement No. 336043 and funding from the Department of Biotechnology,
   India (BT/PR8038/MED/32/303/2013).
CR Aghaloo TL, 2004, INT J ORAL MAX IMPL, V19, P59
   Ak F, 2013, BIOMACROMOLECULES, V14, P719, DOI 10.1021/bm3018033
   Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012
   Bhardwaj N, 2011, INT J BIOL MACROMOL, V49, P260, DOI 10.1016/j.ijbiomac.2011.04.013
   Bhattacharjee M, 2013, BIOMATERIALS, V34, P8161, DOI 10.1016/j.biomaterials.2013.07.018
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Boyce BF, 2009, CRIT REV EUKAR GENE, V19, P171, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.10
   Buckwalter J A, 1996, Instr Course Lect, V45, P371
   Burger EH, 1999, FASEB J, V13, pS101
   Calabrese R, 2012, BIOMATERIALS, V33, P7375, DOI 10.1016/j.biomaterials.2012.06.043
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Chirila TV, 2013, PROG BIOMATER, V2, DOI 10.1186/2194-0517-2-14
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Dababneh AB, 2014, J MANUF SCI E-T ASME, V136, DOI 10.1115/1.4028512
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026
   Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Diab T, 2012, J MECH BEHAV BIOMED, V11, P123, DOI 10.1016/j.jmbbm.2011.11.007
   Ding XL, 2015, J MATER CHEM B, V3, P3177, DOI 10.1039/c5tb00046g
   Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095
   Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gil ES, 2011, J BIOMED MATER RES A, V99A, P16, DOI 10.1002/jbm.a.33158
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Han QQ, 2015, TISSUE ENG PT A, V21, P2156, DOI [10.1089/ten.tea.2014.0484, 10.1089/ten.TEA.2014.0484]
   Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6
   Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   He PF, 2013, J BIOMED MATER RES A, V101, P555, DOI 10.1002/jbm.a.34333
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hofmann S, 2013, EUR J PHARM BIOPHARM, V85, P119, DOI 10.1016/j.ejpb.2013.02.011
   HOLLANDER DH, 1994, MED HYPOTHESES, V43, P155, DOI 10.1016/0306-9877(94)90142-2
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hsieh YF, 2002, J ORTHOP RES, V20, P764, DOI 10.1016/S0736-0266(01)00161-9
   Huang GP, 2014, J MATER SCI-MATER M, V25, P1833, DOI 10.1007/s10856-014-5220-6
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Joly P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073545
   Jones GL, 2009, BIOMATERIALS, V30, P5376, DOI 10.1016/j.biomaterials.2009.07.028
   Jung SR, 2013, NUTR RES, V33, P162, DOI 10.1016/j.nutres.2012.11.006
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Kanthan SR, 2011, INJURY, V42, P782, DOI 10.1016/j.injury.2011.01.015
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   Kim J.-H., 2013, J TISSUE ENG, P4
   Kim J. S. J., 2008, SIGNALING RESPONSES, V10, P138, DOI [10.1007/s00774-007-0804-6, DOI 10.1007/S00774-007-0804-6]
   Kim JY, 2014, J ADV PROSTHODONT, V6, P539, DOI 10.4047/jap.2014.6.6.539
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Klein-Nulend J, 2012, EUR CELLS MATER, V24, P278, DOI 10.22203/eCM.v024a20
   KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Liu H, 2015, BIOMATERIALS, V49, P103, DOI 10.1016/j.biomaterials.2015.01.017
   Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x
   Lu Q, 2011, ACTA BIOMATER, V7, P2394, DOI 10.1016/j.actbio.2011.02.032
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   McMurray R. J., 2013, SCI REP, P3
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mhuka V, 2013, INT J BIOL MACROMOL, V52, P305, DOI 10.1016/j.ijbiomac.2012.09.010
   Midha S, 2013, ACTA BIOMATER, V9, P9169, DOI 10.1016/j.actbio.2013.07.014
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Padol Amol R, 2011, Toxicol Int, V18, P17, DOI 10.4103/0971-6580.75847
   Pallotta I, 2014, BIOMATERIALS, V35, P3678, DOI 10.1016/j.biomaterials.2013.12.065
   Panda N, 2014, J BIOMAT SCI-POLYM E, V25, P1440, DOI 10.1080/09205063.2014.943548
   Panda NN, 2015, J BIOMED MATER RES B, V103, P971, DOI 10.1002/jbm.b.33272
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Perez-Rigueiro J, 2002, J APPL POLYM SCI, V84, P1431, DOI 10.1002/app.10366
   Perez-Rigueiro J, 2001, J APPL POLYM SCI, V82, P1928, DOI 10.1002/app.2038
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Ribeiro M, 2015, EUR POLYM J, V67, P66, DOI 10.1016/j.eurpolymj.2015.03.056
   ROACH HI, 1994, CELL BIOL INT, V18, P617, DOI 10.1006/cbir.1994.1088
   Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Sahu N., ADV HEALTHC IN PRESS
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Samal SK, 2013, MACROMOL MATER ENG, V298, P1201, DOI 10.1002/mame.201200377
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Santos A, 2011, CALCIFIED TISSUE INT, V89, P318, DOI 10.1007/s00223-011-9521-1
   Santos A, 2009, J ORTHOP RES, V27, P1280, DOI 10.1002/jor.20888
   Schacht K, 2015, ANGEW CHEM INT EDIT, V54, P2816, DOI 10.1002/anie.201409846
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Sengupta S, 2010, TISSUE ENG PT A, V16, P3623, DOI [10.1089/ten.tea.2010.0302, 10.1089/ten.TEA.2010.0302]
   Shi PJ, 2013, BIOMACROMOLECULES, V14, P4465, DOI 10.1021/bm401381s
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998
   SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66
   Suganya S, 2014, J BIOMATER TISS ENG, V4, P9, DOI 10.1166/jbt.2014.1139
   Sun L, 2012, ADV HEALTHC MATER, V1, P729, DOI 10.1002/adhm.201200057
   Suntivich R, 2014, BIOMACROMOLECULES, V15, P1428, DOI 10.1021/bm500027c
   Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401
   Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Techawiboonwong A, 2008, RADIOLOGY, V248, P824, DOI 10.1148/radiol.2482071995
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Thimm BW, 2011, ACTA BIOMATER, V7, P2218, DOI 10.1016/j.actbio.2011.02.004
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uebersax L, 2013, EUR J PHARM BIOPHARM, V85, P107, DOI 10.1016/j.ejpb.2013.05.008
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Vaananen HK, 2000, J CELL SCI, V113, P377
   Vetsch JR, 2015, ACTA BIOMATER, V13, P277, DOI 10.1016/j.actbio.2014.11.025
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Won YW, 2014, BIOMATERIALS, V35, P5627, DOI 10.1016/j.biomaterials.2014.03.070
   Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054
   Ye JH, 2011, BIOMATERIALS, V32, P5065, DOI 10.1016/j.biomaterials.2011.03.053
   You RC, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015003
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zaoming W., 1996, Journal of Allergy and Clinical Immunology, V97, P210, DOI 10.1016/S0091-6749(96)80327-7
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 184
TC 94
Z9 100
U1 38
U2 267
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 1
EP 16
DI 10.1016/j.actbio.2015.09.005
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100001
PM 26360593
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Kapoor, S
   Kundu, SC
AF Kapoor, Sonia
   Kundu, Subhas C.
TI Silk protein-based hydrogels: Promising advanced materials for
   biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Silk proteins; Fibroin; Hydrogel; Biomaterial; Biomedical applications
ID BOMBYX-MORI SILK; SPIDER DRAGLINE SILK; INTERPENETRATING POLYMER
   NETWORK; TISSUE ENGINEERING SCAFFOLDS; CONTROLLED DRUG-DELIVERY;
   MESENCHYMAL STEM-CELLS; ORAL DOSAGE FORM; CONTROLLED-RELEASE; IN-VITRO;
   GELATIN HYDROGEL
AB Hydrogels are a class of advanced material forms that closely mimic properties of the soft biological tissues. Several polymers have been explored for preparing hydrogels with structural and functional features resembling that of the extracellular matrix. Favourable material properties, biocompatibility and easy processing of silk protein fibers into several forms make it a suitable material for biomedical applications. Hydrogels made from silk proteins have shown a potential in overcoming limitations of hydro gels prepared from conventional polymers. A great deal of effort has been made to control the properties and to integrate novel topographical and functional characteristics in the hydrogel composed from silk proteins. This review provides overview of the advances in silk protein-based hydrogels with a primary emphasis on hydrogels of fibroin. It describes the approaches used to fabricate fibroin hydrogels. Attempts to improve the existing properties or to incorporate new features in the hydrogels by making composites and by improving fibroin properties by genetic engineering approaches are also described. Applications of the fibroin hydrogels in the realms of tissue engineering and controlled release are reviewed and their future potentials are discussed.
   Statement of Significance
   This review describes the potentiality of silk fibroin hydrogel. Silk Fibroin has been widely recognized as an interesting biomaterial. Due to its properties including high mechanical strength and excellent biocompatibility, it has gained wide attention. Several groups are exploring silk-based materials including films, hydrogels, nanofibers and nanoparticles for different biomedical applications. Although there is a good amount of literature available on general properties and applications of silk based biomaterials, there is an inadequacy of extensive review articles that specifically focus on silk based hydrogels. Silk based hydrogels have a strong potential to be utilized in biomedical applications. Our work is an effort to highlight the research that has been done in the area of silk-based hydrogels. It aims to provide an overview of the advances that have been made and the future course available. It will provide an overview of the silk-based hydrogels as well as may direct the readers to the specific areas of application. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kapoor, Sonia; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Kapoor, Sonia] Panjab Univ, Univ Inst Engn & Technol, Chandigarh 160014, India.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
OI Kundu, Subhas C./0000-0002-7170-2291
FU University Grant Commission, Government of India; Indo Australia
   Biotechnology Fund; Department of Biotechnology and its Bioinformatics
   facility; Indo-Russia Biotechnology Programme; Department of Science and
   Technology; Indo US Science and Technology Forum, New Delhi; Indian
   Council of Medical Research, Govt of India
FX This work is supported by start-up grant from University Grant
   Commission, Government of India to SK. We appreciate Ms Sarani Ghoshal
   for taking interest during the initial stages of this write up. We are
   greatly indebted to Dr. Alyssa Panitch, Weldon School of Biomedical
   Engineering of Purdue University for critical reading, excellent
   scientific inputs and suggestions for the improvement of the manuscript.
   SCK's laboratory has financially been supported by Indo Australia
   Biotechnology Fund, Department of Biotechnology and its Bioinformatics
   facility, Indo-Russia Biotechnology Programme, Department of Science and
   Technology, Indian Council of Medical Research, Govt of India, and Indo
   US Science and Technology Forum, New Delhi.
CR AARON BB, 1981, BIOPOLYMERS, V20, P1247, DOI 10.1002/bip.1981.360200611
   Aigner T, 2003, ADV DRUG DELIVER REV, V55, P1569, DOI 10.1016/j.addr.2003.08.009
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Andani MT, 2014, ACTA BIOMATER, V10, P4058, DOI 10.1016/j.actbio.2014.06.025
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Asmani MN, 2013, CELL BIOL INT, V37, P1340, DOI 10.1002/cbin.10171
   AYUB ZH, 1993, BIOSCI BIOTECH BIOCH, V57, P1910, DOI 10.1271/bbb.57.1910
   Bai SM, 2014, BIOMACROMOLECULES, V15, P3044, DOI 10.1021/bm500662z
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Cabello J. C. R., 2005, PROG POLYM SCI, V30, P1119
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   CAPPELLO J, 1997, CONTROLLED DRUG DELI, P439
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   CHEN JY, 1994, POLYMER, V35, P2853, DOI 10.1016/0032-3861(94)90317-4
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Choi J, 2009, CURR APPL PHYS, V9, pE259, DOI 10.1016/j.cap.2009.06.054
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Chua CEL, 2015, CELL MOL LIFE SCI, V72, P2289, DOI 10.1007/s00018-015-1862-x
   Cordonnier T, 2011, ADV ENG MATER, V13, pB135, DOI 10.1002/adem.201080098
   Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9
   Craig CL, 2002, COMP BIOCHEM PHYS B, V133, P493, DOI 10.1016/S1096-4959(02)00095-7
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Dandu R, 2007, PROG POLYM SCI, V32, P1008, DOI 10.1016/j.progpolymsci.2007.05.015
   Dandu R, 2009, POLYMER, V50, P366, DOI 10.1016/j.polymer.2008.11.047
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Datta A, 2001, INSECT BIOCHEM MOLEC, V31, P1013, DOI 10.1016/S0965-1748(01)00049-2
   des Rieux A, 2009, J CONTROL RELEASE, V136, P148, DOI 10.1016/j.jconrel.2009.02.004
   Diab T, 2012, J MECH BEHAV BIOMED, V11, P123, DOI 10.1016/j.jmbbm.2011.11.007
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eissa AS, 2005, J AGR FOOD CHEM, V53, P5010, DOI 10.1021/jf047957w
   Elia R, 2013, J BIOMATER APPL, V27, P749, DOI 10.1177/0885328211424516
   Elliott WH, 2015, ACS APPL MATER INTER, V7, P12099, DOI 10.1021/acsami.5b02308
   Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fang HY, 2006, CHEM PHARM BULL, V54, P156
   Fathi A, 2014, BIOMATERIALS, V35, P5425, DOI 10.1016/j.biomaterials.2014.03.026
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Floren ML, 2012, BIOMACROMOLECULES, V13, P2060, DOI 10.1021/bm300450a
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   FOURNIER A, 1979, BIOCHIMIE, V61, P283, DOI 10.1016/S0300-9084(79)80073-5
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Gagner JE, 2014, ACTA BIOMATER, V10, P1542, DOI 10.1016/j.actbio.2013.10.001
   Gamboa-Martinez TC, 2015, J BIOMED MATER RES A, V103, P614, DOI 10.1002/jbm.a.35210
   Gao CD, 2014, INT J MOL SCI, V15, P4714, DOI 10.3390/ijms15034714
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Gil ES, 2005, BIOMACROMOLECULES, V6, P3079, DOI 10.1021/bm050396c
   Gil ES, 2007, BIOMACROMOLECULES, V8, P258, DOI 10.1021/bm060543m
   Gil ES, 2010, LANGMUIR, V26, P15614, DOI 10.1021/la102509a
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Gunasekaran S, 2007, J FOOD ENG, V83, P31, DOI 10.1016/j.jfoodeng.2006.11.001
   Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Haider M, 2008, PHARM RES, V25, P692, DOI 10.1007/s11095-007-9282-8
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Hakimi O., 2007, COMPOS B, V38, P324
   Hall H, 2007, CURR PHARM DESIGN, V13, P3597, DOI 10.2174/138161207782794158
   HANAWA T, 1995, CHEM PHARM BULL, V43, P872
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Harjanto D, 2010, ORG BIOMOL CHEM, V8, P299, DOI 10.1039/b913064k
   Hatefi A, 2007, PHARM RES, V24, P773, DOI 10.1007/s11095-006-9200-5
   Helary C, 2015, CURR PHARM BIOTECHNO, V16, P635, DOI 10.2174/138920101607150427112208
   Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003
   Hirabayashi K., 1990, SEN-I GAKKAISHI, V46, P521
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hosseinkhani H, 2013, CHEM REV, V113, P4837, DOI 10.1021/cr300131h
   Hu JG, 2012, J MATER SCI-MATER M, V23, P711, DOI 10.1007/s10856-011-4533-y
   Hu K, 2008, J BIOMED MATER RES A, V84A, P483, DOI 10.1002/jbm.a.31440
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Huang WW, 2015, EXPERT OPIN DRUG DEL, V12, P779, DOI 10.1517/17425247.2015.989830
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Hwang D, 2009, INT J PHARM, V368, P215, DOI 10.1016/j.ijpharm.2008.10.021
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jung B, 2013, ADV POLYM SCI, V253, P37, DOI 10.1007/12_2012_169
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khutoryanskaya OV, 2010, SOFT MATTER, V6, P551, DOI 10.1039/b918007a
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HH, 2014, INT J BIOL MACROMOL, V70, P516, DOI 10.1016/j.ijbiomac.2014.06.052
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kimura Y, 2010, J BIOMAT SCI-POLYM E, V21, P37, DOI 10.1163/156856209X410193
   Kludkiewicz B, 1993, Postepy Biochem, V39, P105
   Konishi M, 2003, J CONTROL RELEASE, V92, P301, DOI 10.1016/S0168-3659(03)00364-X
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Kundu B, 2014, INT J BIOL MACROMOL, V70, P70, DOI 10.1016/j.ijbiomac.2014.06.022
   Kundu B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055003
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Kweon H, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034115
   Kweon HY, 2001, J APPL POLYM SCI, V80, P1848, DOI 10.1002/app.1281
   Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049
   Li G., 2015, J BIOMAT SCI-POLYM E, V26, P1
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lovett M.L., 2015, EUR J PHARM BIOPHARM
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG, P397
   Lv Q, 2008, J BIOMED MATER RES A, V84A, P198, DOI 10.1002/jbm.a.31366
   Mallepally R. R., 2014, ACTA BIOMATER
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MATSUO ES, 1988, J CHEM PHYS, V89, P1695, DOI 10.1063/1.455115
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2004, BIOMACROMOLECULES, V5, P793, DOI 10.1021/bm0343491
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Min S, 1998, SEN-I GAKKAISHI, V54, P85, DOI 10.2115/fiber.54.2_85
   Ming JF, 2015, MAT SCI ENG C-MATER, V51, P287, DOI 10.1016/j.msec.2015.03.014
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Mirahmadi F, 2013, MAT SCI ENG C-MATER, V33, P4786, DOI 10.1016/j.msec.2013.07.043
   Miyaguchi Y, 2005, FOOD SCI TECHNOL RES, V11, P37, DOI 10.3136/fstr.11.37
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Morita Y, 2002, BIO-MED MATER ENG, V12, P291
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Myung D, 2007, POLYMER, V48, P5376, DOI 10.1016/j.polymer.2007.06.070
   Naba A, 2015, MATRIX BIOL
   Nagarkar S, 2009, IND ENG CHEM RES, V48, P8014, DOI 10.1021/ie801723f
   Nagarsekar A, 2002, J BIOMED MATER RES, V62, P195, DOI 10.1002/jbm.10272
   Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417
   Numata K, 2014, MACROMOL BIOSCI, V14, P799, DOI 10.1002/mabi.201300482
   OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park CH, 2013, CARBOHYD POLYM, V98, P1179, DOI 10.1016/j.carbpol.2013.07.028
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3
   Phillips JB, 2014, ORGANOGENESIS, V10, P6, DOI 10.4161/org.27487
   Placzek Marysia, 2008, V461, P325, DOI 10.1007/978-1-60327-483-8_23
   Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012
   Pollock CM, 1994, AM J PHYSL 2, V35, P1016
   Poursaid A, 2015, BIOMATERIALS, V57, P142, DOI 10.1016/j.biomaterials.2015.04.015
   Price R., 2015, J CONTROL RELEASE
   Price R., 2014, J CONTROL RELEASE
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rattanaruengsrikul V, 2009, MACROMOL BIOSCI, V9, P1004, DOI 10.1002/mabi.200900131
   Remondetto GE, 2004, J AGR FOOD CHEM, V52, P8137, DOI 10.1021/jf040286h
   Ribeiro Marta, 2014, Biomatter, V4, pe28536, DOI 10.4161/biom.28536
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Schacht K, 2011, BIOMACROMOLECULES, V12, P2488, DOI 10.1021/bm200154k
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   SCHMOLKA IR, 1991, J AM OIL CHEM SOC, V68, P206, DOI 10.1007/BF02657771
   Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591
   Shangkai C, 2007, TISSUE ENG, V13, P483, DOI 10.0189/ten.2006.0181
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276
   Sperling L. H., 1994, INTERPENETRATING POL, P3, DOI 10.1021/ba-1994-0239.ch001
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Sun W., 2015, J TISSUE ENG REGEN M
   Sun W., 2014, J TISSUE ENG REGEN M
   Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Takaya R., 2006, EUR CELLS MATER, V12, P40
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2008, BIOSCI BIOTECH BIOCH, V72, P3189, DOI 10.1271/bbb.80375
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Thitiwuthikiat P, 2015, TISSUE ENG PT A, V21, P1309, DOI [10.1089/ten.tea.2014.0237, 10.1089/ten.TEA.2014.0237]
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Varghese S, 2006, ADV POLYM SCI, P95, DOI 10.1007/12_072
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vendrely Charlotte, 2008, V474, P3, DOI 10.1007/978-1-59745-480-3_1
   Venkatesan J, 2014, ADV FOOD NUTR RES, V73, P45, DOI 10.1016/B978-0-12-800268-1.00004-4
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang HY, 2015, BIOTECHNOL PROGR, V31, P630, DOI 10.1002/btpr.2058
   Wang HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06182
   Wang L, 2005, COLLOID SURFACE A, V254, P159, DOI 10.1016/j.colsurfa.2004.12.003
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2015, ACTA BIOMATER, V12, P51, DOI 10.1016/j.actbio.2014.10.027
   Wang Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep07064
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Williams David, 2003, Med Device Technol, V14, P9
   Wu X., 2012, J BIOMAT SCI-POLYM E, V8, P2185
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
   Ziv K, 2014, BIOMATERIALS, V35, P3736, DOI 10.1016/j.biomaterials.2014.01.029
NR 215
TC 55
Z9 57
U1 22
U2 279
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 17
EP 32
DI 10.1016/j.actbio.2015.11.034
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100002
PM 26602821
DA 2018-10-20
ER

PT J
AU Dearth, CL
   Slivka, PF
   Stewart, SA
   Keane, TJ
   Tay, JK
   Londono, R
   Goh, QN
   Pizza, FX
   Badylak, SF
AF Dearth, Christopher L.
   Slivka, Peter F.
   Stewart, Scott A.
   Keane, Timothy J.
   Tay, Justin K.
   Londono, Ricardo
   Goh, Qingnian
   Pizza, Francis X.
   Badylak, Stephen F.
TI Inhibition of COX1/2 alters the host response and reduces ECM scaffold
   mediated constructive tissue remodeling in a rodent model of skeletal
   muscle injury
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Extracellular matrix; Host response; Biologic scaffold; Macrophage
   polarization; Skeletal muscle injury; Regenerative medicine; Extremity
   Trauma
ID SATELLITE CELL-PROLIFERATION; SMALL-INTESTINAL SUBMUCOSA; BODY-WALL
   REPAIR; EXTRACELLULAR-MATRIX; MACROPHAGE PHENOTYPE; BIOLOGIC SCAFFOLD;
   COX-2 PATHWAY; ECCENTRIC EXERCISE; URINARY-BLADDER; IN-VITRO
AB Extracellular matrix (ECM) has been used as a biologic scaffold material to both reinforce the surgical repair of soft tissue and serve as an inductive template to promote a constructive tissue remodeling response. Success of such an approach is dependent on macrophage-mediated degradation and remodeling of the biologic scaffold. Macrophage phenotype during these processes is a predictive factor of the eventual remodeling outcome. ECM scaffolds have been shown to promote an anti-inflammatory or M2-like macrophage phenotype in vitro that includes secretion of downstream products of cycolooxygenases 1 and 2 (COX1/2). The present study investigated the effect of a common COX1/2 inhibitor (Aspirin) on macrophage phenotype and tissue remodeling in a rodent model of ECM scaffold treated skeletal muscle injury. Inhibition of COX1/2 reduced the constructive remodeling response by hindering myogenesis and collagen deposition in the defect area. The inhibited response was correlated with a reduction in M2-like macrophages in the defect area. The effects of Aspirin on macrophage phenotype were corroborated using an established in vitro macrophage model which showed a reduction in both ECM induced prostaglandin secretion and expression of a marker of M2-like macrophages (CD206). These results raise questions regarding the common peri-surgical administration of COX1/2 inhibitors when biologic scaffold materials are used to facilitate muscle repair/regeneration.
   Statement of significance
   COX1/2 inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely administered post surgically for analgesic purposes. While COX1/2 inhibitors are important in pain management, they have also been shown to delay or diminish the healing process, which calls to question their clinical use for treating musculotendinous injuries. The present study aimed to investigate the influence of a common NSAID, Aspirin, on the constructive remodeling response mediated by an ECM scaffold (UBM) in a rat skeletal muscle injury model.
   The COX1/2 inhibitor, Aspirin, was found to mitigate the ECM scaffold-mediated constructive remodeling response both in an in vitro co-culture system and an in vivo rat model of skeletal muscle injury. The results presented herein provide data showing that NSAIDs may significantly alter tissue remodeling outcomes when a biomaterial is used in a regenerative medicine/tissue engineering application. Thus, the decision to prescribe NSAIDs to manage the symptoms of inflammation post-ECM scaffold implantation should be carefully considered. Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Dearth, Christopher L.; Slivka, Peter F.; Stewart, Scott A.; Keane, Timothy J.; Tay, Justin K.; Londono, Ricardo; Badylak, Stephen F.] McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Dearth, Christopher L.; Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Dearth, Christopher L.] Walter Reed Natl Mil Med Ctr, DoD VA Extrem Trauma & Amputat Ctr Excellence, Bethesda, MD 20889 USA.
   [Keane, Timothy J.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA.
   [Londono, Ricardo] Univ Pittsburgh, Med Scientist Training Program, Pittsburgh, PA 15261 USA.
   [Goh, Qingnian; Pizza, Francis X.] Univ Toledo, Dept Kinesiol, Toledo, OH 43606 USA.
RP Dearth, CL (reprint author), Walter Reed Natl Mil Med Ctr, DoD VA Extrem Trauma & Amputat Ctr Excellence, Bethesda, MD 20889 USA.
EM Christopher.L.Dearth.civ@mail.mil
OI Keane, Timothy/0000-0002-7975-0538; Pizza, Francis/0000-0002-0857-6384
FU National Institute of Health [1R03EB018889-01A1, 5T32EB001026-09];
   National Science Foundation [DGE-1247842]; DoD-VA Extremity Trauma &
   Amputation Center of Excellence [110-417, 723]
FX This material is based upon work supported by the National Institute of
   Health under Grant No. 1R03EB018889-01A1 (to C.L. D. & P.F.S) and Grant
   No. 5T32EB001026-09 (R.L.), National Science Foundation Graduate
   Research Fellowship under Grant No. DGE-1247842 (to T.J.K.), and the
   DoD-VA Extremity Trauma & Amputation Center of Excellence (Public Law
   110-417, National Defense Authorization Act 2009, Section 723).
CR Agrawal V, 2009, J TISSUE ENG REGEN M, V3, P590, DOI 10.1002/term.200
   ALMEKINDERS LC, 1995, AM J SPORT MED, V23, P119, DOI 10.1177/036354659502300120
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   ASTROM M, 1992, ACTA ORTHOP SCAND, V63, P631
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baldwin AC, 2001, J GERONTOL A-BIOL, V56, pM510, DOI 10.1093/gerona/56.8.M510
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83
   Bondesen BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1651, DOI 10.1152/ajpcell.00518.2005
   Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004
   Brewer C, 2012, J TRAINOL, V1, P45
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cuttle L, 2005, WOUND REPAIR REGEN, V13, P198, DOI 10.1111/j.1067-1927.2005.130211.x
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Daly KA, 2011, TISSUE ENG PART C-ME, V17, P631, DOI 10.1089/ten.tec.2010.0699
   Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Flower RJ, 2003, NAT REV DRUG DISCOV, V2, P179, DOI 10.1038/nrd.1034
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Gilbert TW, 2005, BIOMATERIALS, V26, P1431, DOI 10.1016/j.biomaterials.2004.04.042
   Goh Q., 2014, EXP CELL RES
   GREENE JM, 1992, ARCH INTERN MED, V152, P1995, DOI 10.1001/archinte.152.10.1995
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Harris HW, 2013, SURG CLIN N AM, V93, P1217, DOI 10.1016/j.suc.2013.06.001
   Harth KC, 2009, SURG INNOV, V16, P324, DOI 10.1177/1553350609353609
   Hope W. W., 2012, PLAST SURG INT, V2012
   Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085
   Keane TJ, 2013, BIOMATERIALS, V34, P6729, DOI 10.1016/j.biomaterials.2013.05.052
   Kharraz Y, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/491497
   Kissane NA, 2012, PLAST RECONSTR SURG, V130, p194S, DOI 10.1097/PRS.0b013e318265a5ec
   KULICK MI, 1986, J HAND SURG-AM, V11A, P110, DOI 10.1016/S0363-5023(86)80116-2
   Lane NE, 1997, J RHEUMATOL, V24, P20
   Mendias CL, 2004, MUSCLE NERVE, V30, P497, DOI 10.1002/mus.20102
   Mikkelsen UR, 2009, J APPL PHYSIOL, V107, P1600, DOI 10.1152/japplphysiol.00707.2009
   Mikkelsen UR, 2008, J APPL PHYSIOL, V104, P534, DOI 10.1152/japplphysiol.01016.2007
   Mo Chenglin, 2012, Recent Pat Biotechnol, V6, P223
   Mofid MM, 2012, EUR J PLAST SURG, V35, P717, DOI 10.1007/s00238-012-0736-9
   Na YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063451
   Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040
   Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128
   Rakoff-Nahoum S, 2007, J CLIN INVEST, V117, P83, DOI 10.1172/JCI30865
   Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003
   Shah BC, 2011, HERNIA, V15, P165, DOI 10.1007/s10029-010-0768-7
   Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x
   Shen W, 2005, AM J PATHOL, V167, P1105, DOI 10.1016/S0002-9440(10)61199-6
   Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212
   Shen W, 2006, J APPL PHYSIOL, V101, P1215, DOI 10.1152/japplphysiol.01331.2005
   Sicari B, 2013, METHODS MOL BIOL, V1037, P3, DOI 10.1007/978-1-62703-505-7_1
   Sicari BM, 2014, BIOMATERIALS, V35, P8605, DOI 10.1016/j.biomaterials.2014.06.060
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Slatyer MA, 1997, AM J SPORT MED, V25, P544, DOI 10.1177/036354659702500419
   Slivka PF, 2014, BIOMATER SCI-UK, V2, P1521, DOI 10.1039/c4bm00189c
   Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092
   Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Turner NJ, 2012, J SURG RES, V176, P490, DOI 10.1016/j.jss.2011.11.1029
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   van den Bekerom MP, 2014, KNEE SURG SPORTS TRA
   Van Ly D, 2012, AM J PHYSIOL-LUNG C, V303, pL239, DOI 10.1152/ajplung.00097.2012
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Wolf M. T., 2013, J BIOMED MAT RES A
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Xian CJ, 2009, NAT CLIN PRACT RHEUM, V5, P92, DOI 10.1038/ncprheum0982
   Zhang L., 2011, J BIOL CHEM, V287, P6177
NR 74
TC 15
Z9 15
U1 2
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 50
EP 60
DI 10.1016/j.actbio.2015.11.043
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100004
PM 26612417
OA Green Accepted, Other Gold
DA 2018-10-20
ER

PT J
AU Kundu, J
   Michaelson, A
   Talbot, K
   Baranov, P
   Young, MJ
   Carrier, RL
AF Kundu, Joydip
   Michaelson, Andrew
   Talbot, Kristen
   Baranov, Petr
   Young, Michael J.
   Carrier, Rebecca L.
TI Decellularized retinal matrix: Natural platforms for human retinal
   progenitor cell culture
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Retina; Extracellular matrix (ECM); Decellularization; Tissue
   engineering; Retinal progenitor cell (RPC)
ID ACELLULAR NERVE GRAFTS; EMBRYONIC STEM-CELLS; SYSTEM
   EXTRACELLULAR-MATRIX; IN-VITRO; GROWTH-FACTOR; DIFFERENTIATION;
   REGENERATION; SCAFFOLDS; TRANSPLANTATION; INTEGRATION
AB Tissue decellularization strategies have enabled engineering of scaffolds that preserve native extracellular matrix (ECM) structure and composition. In this study, we developed decellularized retina (decell-retina) thin films. We hypothesized that these films, mimicking the retina niche, would promote human retinal progenitor cell (hRPC) attachment, proliferation and differentiation. Retinas isolated from bovine eyes were decellularized using 1% w/v sodium dodecyl sulfate (SDS) and pepsin digested. The resulting decell-retina was biochemically assayed for composition and cast dried to develop thin films. Attachment, viability, morphology, proliferation and gene expression of hRPC cultured on the films were studied in vitro. Biochemical analyses of decell-retina compared to native retina indicated the bulk of DNA (94%) was removed, while the majority of sulfated GAGs (55%), collagen (83%), hyaluronic acid (87%), and key growth factors were retained. The decell-retina films supported hRPC attachment and growth, with cell number increasing 1.5-fold over a week. RT-PCR analysis revealed hRPC expression of rhodopsin, rod outer membrane, neural retina-specific leucine zipper neural and cone-rod homeobox gene on decell-retina films, indicating photoreceptor development. In conclusion, novel decell-retina films show promise as potential substrates for culture and/or transplantation of retinal progenitor cells to treat retinal degenerative disorders.
   Statement of significance
   In this study, we report the development of a novel biomaterial, based on decellularized retina (decell-retina) that mimics the retina niche and promotes human retinal progenitor cell (hRPC) attachment, proliferation and differentiation. We estimated, for the first time, the amounts of collagen I, GAGs and HA present in native retina, as well as the decell-retina. We demonstrated that retinas can be decellularized using ionic detergents and can be processed into mechanically stable thin films, which can act as substrates for culturing hRPCs. Rhodopsin, ROM1, NRL and CRX gene expression on the decell-retina films indicated photoreceptor development from RPCs. These results support the potential of decell-retina as a cell delivery platform to treat and manage retinal degenerative disease like AMD. (C) 2016 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Kundu, Joydip; Michaelson, Andrew; Talbot, Kristen; Carrier, Rebecca L.] Northeastern Univ, Dept Chem Engn, 360 Huntington Ave, Boston, MA 02115 USA.
   [Kundu, Joydip; Baranov, Petr; Young, Michael J.] Harvard Univ, Sch Med, Massachusetts Eye & Ear, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.
RP Carrier, RL (reprint author), Northeastern Univ, Dept Chem Engn, 360 Huntington Ave, Boston, MA 02115 USA.
EM j.kundu@neu.edu; malachad@gmail.com; talbot.kristen@gmail.com;
   petr.baranov@schepens.harvard.edu; michael.young@schepens.harvard.edu;
   rebecca@coe.neu.edu
FU Northeastern University; NIH [1R21EY021312]
FX This study was supported by Northeastern University (Tier 1 Provost
   Grant) and NIH Grant 1R21EY021312 (NEI).
CR Abmad I, 2001, INVEST OPHTH VIS SCI, V42, P2743
   Araki M, 2007, DEV GROWTH DIFFER, V49, P109, DOI 10.1111/j.1440-169x.2007.00911.x
   Aramant RB, 2004, PROG RETIN EYE RES, V23, P475, DOI 10.1016/j.preteyeres.2004.05.003
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   BAIRD A, 1985, BIOCHEMISTRY-US, V24, P7855, DOI 10.1021/bi00348a001
   Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Baranov P, 2013, TISSUE ENG PART C-ME, V19, P265, DOI [10.1089/ten.tec.2012.0217, 10.1089/ten.TEC.2012.0217]
   Chacko DM, 2003, VISION RES, V43, P937, DOI 10.1016/S0042-6989(02)00688-0
   Chacko DM, 2000, BIOCHEM BIOPH RES CO, V268, P842, DOI 10.1006/bbrc.2000.2153
   Clark SJ, 2011, INVEST OPHTH VIS SCI, V52, P6511, DOI 10.1167/iovs.11-7909
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Farrell SMJ, 2011, EUR J NEUROSCI, V33, P632, DOI 10.1111/j.1460-9568.2010.07559.x
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Gholipourmalekabadi M, 2015, ADV HEALTHC MATER, V4, P918, DOI 10.1002/adhm.201400704
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346
   JERDAN JA, 1986, INVEST OPHTH VIS SCI, V27, P194
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511
   Krekoski CA, 2002, J NEUROSCI, V22, P10408
   Kundu J, 2014, DEV OPHTHALMOL, V53, P143, DOI 10.1159/000357369
   Kwan ASL, 1999, EXP NEUROL, V159, P21, DOI 10.1006/exnr.1999.7157
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Li Z, 2008, EXP NEUROL, V214, P47, DOI 10.1016/j.expneurol.2008.07.007
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Meyer JS, 2006, STEM CELLS, V24, P274, DOI 10.1634/stemcells.2005-0059
   Meyer JS, 2004, BRAIN RES, V1014, P131, DOI 10.1016/j.braines.2004.04.019
   Neubauer D, 2007, EXP NEUROL, V207, P163, DOI 10.1016/j.expneurol.2007.06.006
   Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011
   Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]
   Qiu GT, 2005, EXP EYE RES, V80, P515, DOI 10.1016/j.exer.2004.11.001
   Redenti Stephen, 2008, J Ocul Biol Dis Infor, V1, P19, DOI 10.1007/s12177-008-9005-3
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309
   Sivilia S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-52
   Sommer F, 2006, ADV EXP MED BIOL, V585, P413
   Tomita M, 2005, STEM CELLS, V23, P1579, DOI 10.1634/stemcells.2005-0111
   Tucker BA, 2010, BIOMATERIALS, V31, P9, DOI 10.1016/j.biomaterials.2009.09.015
   Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002
   Wang LN, 2013, ACTA BIOMATER, V9, P8921, DOI 10.1016/j.actbio.2013.06.035
   Wang LN, 2013, BIOMATERIALS, V34, P2641, DOI 10.1016/j.biomaterials.2012.12.048
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
NR 56
TC 13
Z9 13
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 61
EP 70
DI 10.1016/j.actbio.2015.11.028
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100005
PM 26621699
DA 2018-10-20
ER

PT J
AU Vyner, MC
   Amsden, BG
AF Vyner, Moira C.
   Amsden, Brian G.
TI Polymer chain flexibility-induced differences in fetuin A adsorption and
   its implications on cell attachment and proliferation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Protein adsorption; Polymer chain mobility; Elastomer; Cell
   proliferation; Fetuin A
ID SERUM-FREE MEDIUM; PROTEIN ADSORPTION; SUBSTRATE STIFFNESS; PROTEOMIC
   ANALYSIS; MOLECULAR-WEIGHT; GROWTH; ADHESION; CALCIUM; TISSUE; ELASTOMER
AB Tissue cells are known to respond to the stiffness of the polymer substrate on which they are grown. It has been suggested that material stiffness influences the composition of the protein layer that adsorbs to the material surface, which affects subsequent cell behavior. Previously, the stiffness of a biomaterial elastomer formed from an acrylated star-poly(D,L lactide-co-epsilon-caprolactone) was found to influence both fibroblast proliferation as well as the adsorption of certain proteins. However, it remained unresolved as to whether material stiffness influenced protein adsorption from serum supplemented environments and which protein(s) may have been responsible for the difference in fibroblast proliferation. Using quantitative proteomics, we show that polymer stiffness influenced the composition of the protein layers that adsorb from serum supplemented media. Fetuin A was identified as a protein that influenced fibroblast proliferation and, when combined with basic fibroblast growth factor as a medium supplement, improved fibroblast proliferation over 14 days. This study is the first to correlate cell proliferation to surface adsorbed fetuin A and presents the potential new application for fetuin A as biomaterial coating or surface modifier. This work also demonstrates a novel application of quantitative proteomics for the investigation of competitive protein adsorption to biomaterial surfaces.
   Statement of significance
   Cells are able to respond to the stiffness of their material substrate, but the method by which they sense material stiffness is still under investigation. Previously, material stiffness was found to impact the individual adsorption of fibronectin, a protein associated with cell attachment; however, it was unclear if stiffness was able to affect protein adsorption in environments with multiple proteins. This study shows that material stiffness affects the compositions of protein layers adsorbed from supplemented media, and suggests that cells may sense material stiffness via the adsorbed protein layer. Interestingly, fetuin A was found to be affecting cell proliferation and not fibronectin. Finally, this research demonstrates the use of relative quantitation proteomics as a potentially powerful method to improve biomaterial compatibility. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Vyner, Moira C.; Amsden, Brian G.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Amsden, BG (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM brian.amsden@queensu.ca
FU Natural Sciences and Engineering Research Council of Canada through the
   20/20 Ophthalmic Biomaterials Network; Natural Sciences and Engineering
   Research Council of Canada through the CRE-ATE Biointerfaces Training
   Program
FX The authors gratefully acknowledge operational funding from the Natural
   Sciences and Engineering Research Council of Canada through the 20/20
   Ophthalmic Biomaterials Network and the CREATE Biointerfaces Training
   Program, and infrastructure support from the Canadian Foundation for
   Innovation and the Ontario Research Infrastructure Fund. The authors
   also thank Kim Munro of the Protein Function and Discovery Facility,
   Queen's University for his assistance in the collection of the SPR data
   and Suzanne Perry and Jason Rogalski of the Proteomics Facility at the
   Center for High Throughput Biology, University of British Columbia for
   their assistance in the collection of the proteomics data.
CR Amsden BG, 2004, BIOMACROMOLECULES, V5, P2479, DOI 10.1021/bm049578h
   Berglin M, 2009, LANGMUIR, V25, P5602, DOI 10.1021/la803686m
   Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21
   Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297
   BOYNTON AL, 1974, IN VITRO CELL DEV B, V10, P12, DOI 10.1007/BF02615333
   Brown W. M., 1992, BIOESSAYS
   Chen NX, 2007, AM J PHYSIOL-RENAL, V292, pF599, DOI 10.1152/ajprenal.00303.2006
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204
   Guiseppi-Elie A, 2012, J MATER CHEM, V22, P19529, DOI 10.1039/c2jm32516k
   Henning AK, 2014, VET J, V199, P175, DOI 10.1016/j.tvjl.2013.10.029
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ilagan BG, 2009, ACTA BIOMATER, V5, P2429, DOI 10.1016/j.actbio.2009.03.023
   Kundranda MN, 2004, BBA-MOL CELL RES, V1693, P111, DOI 10.1016/j.bbamcr.2004.06.005
   Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433
   Linscott W D, 1981, Adv Exp Med Biol, V137, P413
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   MALANSHIBLEY L, 1983, IN VITRO CELL DEV B, V19, P749, DOI 10.1007/BF02618094
   Patstone G, 1996, J BIOL CHEM, V271, P3343
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   RIZZINO A, 1978, P NATL ACAD SCI USA, V75, P1844, DOI 10.1073/pnas.75.4.1844
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926
   Tan PS, 2007, MAT SCI ENG C-BIO S, V27, P304, DOI 10.1016/j.msec.2006.03.010
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vyner MC, 2014, BIOMATERIALS, V35, P9041, DOI 10.1016/j.biomaterials.2014.07.023
   Vyner MC, 2013, BIOMATERIALS, V34, P9287, DOI 10.1016/j.biomaterials.2013.08.086
   Wang K, 2010, BIOMACROMOLECULES, V11, P2748, DOI 10.1021/bm1008102
   WANG SQ, 1994, IN VITRO CELL DEV-AN, V30A, P859, DOI 10.1007/BF02639396
   WILLIAMS MR, 1975, RES VET SCI, V18, P314
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yang JM, 2001, J MEMBRANE SCI, V187, P159, DOI 10.1016/S0376-7388(01)00340-4
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yu K, 2014, ACS NANO, V8, P7687, DOI 10.1021/nn504186b
   Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o
NR 36
TC 4
Z9 4
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 89
EP 98
DI 10.1016/j.actbio.2015.11.039
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100008
PM 26607770
DA 2018-10-20
ER

PT J
AU Floren, M
   Bonani, W
   Dharmarajan, A
   Motta, A
   Migliaresi, C
   Tan, W
AF Floren, Michael
   Bonani, Walter
   Dharmarajan, Anirudh
   Motta, Antonella
   Migliaresi, Claudio
   Tan, Wei
TI Human mesenchymal stem cells cultured on silk hydrogels with variable
   stiffness and growth factor differentiate into mature smooth muscle cell
   phenotype
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin; Tunable hydrogel; Stem cell differentiation; Growth factor
ID EXTRACELLULAR-MATRIX; FIBROIN; BIOMATERIALS; REGENERATION; EXPRESSION;
   LINEAGE; ACID; SIZE; CONTRACTION; ENVIRONMENT
AB Cell-matrix and cell-biomolecule interactions play critical roles in a diversity of biological events including cell adhesion, growth, differentiation, and apoptosis. Evidence suggests that a concise crosstalk of these environmental factors may be required to direct stem cell differentiation toward matured cell type and function. However, the culmination of these complex interactions to direct stem cells into highly specific phenotypes in vitro is still widely unknown, particularly in the context of implantable biomaterials. In this study, we utilized tunable hydrogels based on a simple high pressure CO2 method and silk fibroin (SF) the structural protein of Bombyx mori silk fibers. Modification of SF protein starting water solution concentration results in hydrogels of variable stiffness while retaining key structural parameters such as matrix pore size and beta-sheet crystallinity. To further resolve the complex crosstalk of chemical signals with matrix properties, we chose to investigate the role of 3D hydrogel stiffness and transforming growth factor (TGF-beta 1), with the aim of correlating the effects on the vascular commitment of human mesenchymal stem cells. Our data revealed the potential to upregulate matured vascular smooth muscle cell phenotype (myosin heavy chain expression) of hMSCs by employing appropriate matrix stiffness and growth factor (within 72 h). Overall, our observations suggest that chemical and physical stimuli within the cellular microenvironment are tightly coupled systems involved in the fate decisions of hMSCs. The production of tunable scaffold materials that are biocompatible and further specialized to mimic tissue specific niche environments will be of considerable value to future tissue engineering platforms.
   Statement of Significance
   This article investigates the role of silk fibroin hydrogel stiffness and transforming growth factor (TGF-beta 1), with the aim of correlating the effects on the vascular commitment of human mesenchymal stem cells. Specifically, we demonstrate the upregulation of mature vascular smooth muscle cell phenotype (myosin heavy chain expression) of hMSCs by employing appropriate matrix stiffness and growth factor (within 72 h). Moreover, we demonstrate the potential to direct specialized hMSC differentiation by modulating stiffness and growth factor using silk fibroin, a well-tolerated and-defined biomaterial with an impressive portfolio of tissue engineering applications. Altogether, our study reinforce the fact that complex differentiation protocols may be simplified by engineering the cellular microenvironment on multiple scales, i.e. matrix stiffness with growth factor. Crown Copyright (C) 2015 Published by Elsevier Ltd. on behalf of Acta Materialia Inc. All rights reserved.
C1 [Floren, Michael; Dharmarajan, Anirudh; Tan, Wei] Univ Colorado, Dept Mech Engn, 427 UCB, Boulder, CO 80309 USA.
   [Floren, Michael; Bonani, Walter; Motta, Antonella; Migliaresi, Claudio] Univ Trento, Dept Ind Engn, Via Sommar 9, I-38123 Trento, Italy.
   [Floren, Michael; Bonani, Walter; Motta, Antonella; Migliaresi, Claudio] Univ Trento, Biotech Res Ctr, Via Sommar 9, I-38123 Trento, Italy.
RP Tan, W (reprint author), Univ Colorado, Dept Mech Engn, 427 UCB, Boulder, CO 80309 USA.
EM wtan@colorado.edu
RI Bonani, Walter/A-2934-2015
OI Bonani, Walter/0000-0003-0178-4241; Motta, Antonella/0000-0003-4893-6863
FU National Institute for Health [K25HL097246, R01 HL119371]
FX The authors would like to acknowledge the financial support from the
   National Institute for Health K25HL097246 (W.T.) and R01 HL119371
   (W.T.). The authors would also like to thank the BioFrontiers Advanced
   Light Microscopy Core for their excellent microscopy and imaging
   support.
CR Andreadis ST, 2013, CARDIOVASC RES, V98, P1, DOI 10.1093/cvr/cvt038
   Bajpai VK, 2012, TISSUE ENG PART B-RE, V18, P405, DOI 10.1089/ten.teb.2011.0264
   Bonani W, 2011, J BIOMED MATER RES B, V96B, P276, DOI 10.1002/jbm.b.31763
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   El-Mounayri O, 2013, CARDIOVASC RES, V98, P125, DOI 10.1093/cvr/cvs357
   Elliott W.H., 2015, ACS APPL MATER INTER, V22, P12099
   Engler J. A., 2006, CELL, V126, P677
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Floren ML, 2012, BIOMACROMOLECULES, V13, P2060, DOI 10.1021/bm300450a
   Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Hinz B., 2015, MATRIX BIOL
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liu YX, 2013, DEV GROWTH DIFFER, V55, P591, DOI 10.1111/dgd.12052
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0
   O'Shea CA, 2010, TISSUE ENG PT A, V16, P1657, DOI [10.1089/ten.tea.2009.0468, 10.1089/ten.TEA.2009.0468]
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Roelen Bernard A J, 2003, J Orthop Sci, V8, P740, DOI 10.1007/s00776-003-0702-2
   Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Suzuki S, 2010, CELLS TISSUES ORGANS, V191, P269, DOI 10.1159/000260061
   Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Wang X., 2008, J BIOMAT SCI-POLYM E, V19, P653
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Wingate K, 2014, TISSUE ENG PT A, V20, P2503, DOI [10.1089/ten.tea.2013.0249, 10.1089/ten.TEA.2013.0249]
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Xue RY, 2013, J ORTHOP RES, V31, P1360, DOI 10.1002/jor.22374
   Yang H., 2014, BIOMED RES INT, V2014
   Yang MC, 2010, BIOMATERIALS, V31, P854, DOI 10.1016/j.biomaterials.2009.09.096
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 59
TC 35
Z9 35
U1 9
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 156
EP 166
DI 10.1016/j.actbio.2015.11.051
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100014
PM 26621695
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, JT
   Liu, WZ
   Gauthier, O
   Sourice, S
   Pilet, P
   Rethore, G
   Khairoun, K
   Bouler, JM
   Tancret, F
   Weiss, P
AF Zhang, Jingtao
   Liu, Weizhen
   Gauthier, Olivier
   Sourice, Sophie
   Pilet, Paul
   Rethore, Gildas
   Khairoun, Khalid
   Bouler, Jean-Michel
   Tancret, Franck
   Weiss, Pierre
TI A simple and effective approach to prepare injectable macroporous
   calcium phosphate cement for bone repair: Syringe-foaming using a
   viscous hydrophilic polymeric solution
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Calcium phosphate cements; Si-HPMC hydrogel; Silated polymer;
   Macropores; Bone regeneration
ID HYDROXYPROPYL METHYLCELLULOSE HYDROGEL; IN-VIVO PERFORMANCE; OF-THE-ART;
   MECHANICAL-PROPERTIES; HYDROXYAPATITE SCAFFOLDS; 3-DIMENSIONAL CULTURE;
   HISTOLOGICAL-EVALUATION; SPINAL SURGERY; DRUG-DELIVERY; COMPOSITE
AB In this study, we propose a simple and effective strategy to prepare injectable macroporous calcium phosphate cements (CPCs) by syringe-foaming via hydrophilic viscous polymeric solution, such as using silanized-hydroxypropyl methylcellulose (Si-HPMC) as a foaming agent. The Si-HPMC foamed CPCs demonstrate excellent handling properties such as injectability and cohesion. After hardening the foamed CPCs possess hierarchical macropores and their mechanical properties (Young's modulus and compressive strength) are comparable to those of cancellous bone. Moreover, a preliminary in vivo study in the distal femoral sites of rabbits was conducted to evaluate the biofunctionality of this injectable macroporous CPC. The evidence of newly formed bone in the central zone of implantation site indicates the feasibility and effectiveness of this foaming strategy that will have to be optimized by further extensive animal experiments.
   Statement of significance
   A major challenge in the design of biomaterial-based injectable bone substitutes is the development of cohesive, macroporous and self-setting calcium phosphate cement (CPC) that enables rapid cell invasion with adequate initial mechanical properties without the use of complex processing and additives. Thus, we propose a simple and effective strategy to prepare injectable macroporous CPCs through syringe foaming using a hydrophilic viscous polymeric solution (silanized-hydroxypropyl methylcellulose, Si-HPMC) as a foaming agent, that simultaneously meets all the aforementioned aims. Evidence from our in vivo studies shows the existence of newly formed bone within the implantation site, indicating the feasibility and effectiveness of this foaming strategy, which could be used in various CPC systems using other hydrophilic viscous polymeric solutions. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Jingtao; Liu, Weizhen; Sourice, Sophie; Pilet, Paul; Rethore, Gildas; Khairoun, Khalid; Weiss, Pierre] Univ Nantes, INSERM, UMRS 791, Lab Ingn Osteoarticulaire & Dentaire, 1 Pl Alexis Ricordeau,BP 84215, F-44042 Nantes 1, France.
   [Zhang, Jingtao; Liu, Weizhen; Tancret, Franck] Univ Nantes, Polytech Nantes, Inst Mat Jean Rouxel, CNRS,UMR 6502, Rue Christian Pauc,BP 50609, F-44306 Nantes 3, France.
   [Gauthier, Olivier] Ecole Natl Vet Nantes, ONIRIS, BP 40706, F-44307 Nantes 3, France.
   [Bouler, Jean-Michel] Univ Nantes, CEISAM, CNRS, UMR 6230, 2 Rue Houssiniere,BP 92208, F-44307 Nantes 3, France.
   [Weiss, Pierre] CHU Nantes, Nantes Univ Hosp, PHU OTONN 4, 1 Pl A Ricordeau, F-44035 Nantes 01, France.
RP Weiss, P (reprint author), LIOAD, INSERM, UMRS 791, UFR Odontol, 1 Pl Alexis Ricordeau, F-44042 Nantes 1, France.
EM pierre.weiss@univ-nantes.fr
RI Weiss, Pierre/P-1372-2014
OI Weiss, Pierre/0000-0002-6159-8590; BOULER,
   Jean-Michel/0000-0001-9784-5584; Liu, Weizhen/0000-0002-4402-3293;
   Tancret, Franck/0000-0001-8960-4406
FU Inserm; regional program BIOREGOS II (Pays de la Loire, France)
FX We acknowledge financial support from the Inserm and the regional
   program BIOREGOS II (Pays de la Loire, France). Excellent technical
   assistance from Fanch Guillou and Yann B orjon-Piron is greatly
   acknowledged.
CR Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Bohner M, 2010, BIOMATERIALS, V31, P4609
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Charriere E, 2003, BIOMATERIALS, V24, P809, DOI 10.1016/S0142-9612(02)00406-4
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Chow LC, 2001, J RES NATL INST STAN, V106, P1029, DOI 10.6028/jres.106.053
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   del Valle S, 2007, J MATER SCI-MATER M, V18, P353, DOI 10.1007/s10856-006-0700-y
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011
   Fatimi A, 2008, BIOMATERIALS, V29, P533, DOI 10.1016/j.biomaterials.2007.10.032
   Fatimi A, 2009, ACTA BIOMATER, V5, P3423, DOI 10.1016/j.actbio.2009.05.030
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Fellah BH, 2009, ACTA BIOMATER, V5, P735, DOI 10.1016/j.actbio.2008.09.005
   Flautre B, 2001, J MATER SCI-MATER M, V12, P679, DOI 10.1023/A:1011256107282
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Ginebra MP, 2007, J BIOMED MATER RES A, V80A, P351, DOI 10.1002/jbm.a.30886
   Habib M, 2008, ACTA BIOMATER, V4, P1465, DOI 10.1016/j.actbio.2008.03.004
   Habraken WJEM, 2008, J BIOMED MATER RES A, V87A, P643, DOI 10.1002/jbm.a.31703
   Hoekstra JWM, 2013, ACTA BIOMATER, V9, P7518, DOI 10.1016/j.actbio.2013.03.007
   Igawa Kazuyo, 2006, J Artif Organs, V9, P234, DOI 10.1007/s10047-006-0347-y
   Kanter B, 2014, ACTA BIOMATER, V10, P3279, DOI 10.1016/j.actbio.2014.04.020
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   Kovtun A, 2015, ACTA BIOMATER, V12, P242, DOI 10.1016/j.actbio.2014.10.034
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Laib S, 2009, BIOMATERIALS, V30, P1568, DOI 10.1016/j.biomaterials.2008.11.031
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   Link DP, 2006, BIOMATERIALS, V27, P4941, DOI 10.1016/j.biomaterials.2006.05.022
   Liu WZ, 2014, ACTA BIOMATER, V10, P3335, DOI 10.1016/j.actbio.2014.03.009
   Liu WZ, 2013, ACTA BIOMATER, V9, P5740, DOI 10.1016/j.actbio.2012.11.020
   Montufar EB, 2010, ACTA BIOMATER, V6, P876, DOI 10.1016/j.actbio.2009.10.018
   Montufar EB, 2011, MAT SCI ENG C-MATER, V31, P1498, DOI 10.1016/j.msec.2011.06.008
   Montufar EB, 2010, J MATER SCI-MATER M, V21, P863, DOI 10.1007/s10856-009-3918-7
   O'Hara RM, 2012, ACTA BIOMATER, V8, P4043, DOI 10.1016/j.actbio.2012.07.003
   Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Pastorino D, 2015, ACTA BIOMATER, V12, P250, DOI 10.1016/j.actbio.2014.10.031
   Perut F, 2011, ACTA BIOMATER, V7, P1780, DOI 10.1016/j.actbio.2010.12.012
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Rederstorff E, 2011, ACTA BIOMATER, V7, P2119, DOI 10.1016/j.actbio.2011.01.025
   Sarda S, 2003, J BIOMED MATER RES A, V65A, P215, DOI 10.1002/jbm.a.10458
   Sohier J, 2010, ACTA BIOMATER, V6, P2932, DOI 10.1016/j.actbio.2010.02.013
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001
   Verron E, 2014, ACTA BIOMATER, V10, P4887, DOI 10.1016/j.actbio.2014.07.012
   Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   Wagoner JAJ, 2011, ACTA BIOMATER, V7, P16, DOI [DOI 10.1016/J.ACTBIO.2010.07.012, 10.1016/j.actbio.2010.07.012]
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Xu HHK, 2004, J BIOMED MATER RES A, V69A, P267, DOI 10.1002/jbm.a.20124
   Xu HHK, 2002, BIOMATERIALS, V23, P193, DOI 10.1016/S0142-9612(01)00095-3
   Xu HHK, 2007, BIOMATERIALS, V28, P3786, DOI 10.1016/j.biomaterials.2007.05.015
   Zhang JT, 2011, MAT SCI ENG C-MATER, V31, P740, DOI 10.1016/j.msec.2010.10.014
   Zhang JT, 2014, ACTA BIOMATER, V10, P1035, DOI 10.1016/j.actbio.2013.11.001
NR 68
TC 20
Z9 21
U1 7
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 326
EP 338
DI 10.1016/j.actbio.2015.11.055
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100029
PM 26631875
DA 2018-10-20
ER

PT J
AU Muller, WEG
   Tolba, E
   Schroder, HC
   Munoz-Espi, R
   Diehl-Seifert, B
   Wang, XH
AF Mueller, Werner E. G.
   Tolba, Emad
   Schroeder, Heinz C.
   Munoz-Espi, Rafael
   Diehl-Seifert, Bearbel
   Wang, Xiaohong
TI Amorphous polyphosphate-hydroxyapatite: A morphogenetically active
   substrate for bone-related SaOS-2 cells in vitro
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyphosphate; Microparticles; Hydroxyapatite; Collagen type I; Alkaline
   phosphatase; Morphogenetic activity
ID INTRACELLULAR CALCIUM-PHOSPHATE; APATITE FORMATION; CARBONIC-ANHYDRASE;
   CRYSTAL-FORMATION; STROMAL CELLS; COLLAGEN; PHASE; DIFFERENTIATION;
   MINERALIZATION; TRANSFORMATION
AB There is increasing evidence that inorganic calcium-polyphosphates (polyp) are involved in human bone hydroxyapatite (HA) formation. Here we investigated the morphology of the particles, containing calcium phosphate (Cap) with different concentrations of various Na-polyP concentrations, as well as their effects in cell culture. We used both SaOS-2 cells and human mesenchymal stem cells. The polymeric phosphate readily binds calcium ions under formation of insoluble precipitates. We found that addition of low concentrations of polyP (<10 wt.%, referred to the CaP deposits) results in an increased size of the HA crystals. Surprisingly, at higher polyp concentrations (>10 wt.%) the formation of crystalline HA is prevented and amorphous polyP/HA hybrid particles with a size of a similar to 50 nm are formed, most likely consisting of polyp molecules linked via Ca2+ bridges to the surface of the CaP deposits. Further studies revealed that the polyp-Cap particles cause a strong upregulation of the expression of the genes encoding for two marker proteins of bone formation, collagen type I and alkaline phosphatase. Based on their morphogenetic activity the amorphous polyp-Cap particles offer a promising material for the development of bone implants, formed from physiological inorganic precursors/polymers.
   Statement of significance
   Hydroxyapatite (HA) is a naturally occurring mineral of vertebrate bone. Natural HA, a bio-ceramic material which is crystalline to different scale, has been used as a biomaterial to fabricate scaffolds for in situ bone regeneration and other tissue engineering purposes. In contrast to natural HA, synthetic apatite is much less effective. In general, while HA is bioactive, its interaction and biocompatibility with existing bone tissue is low. These properties have been attributed to a minimal degradability in the physiological environment. In the present study we introduce a new Ca-phosphate (Cap) fabrication, technology, starting from calcium chloride and dibasic ammonium phosphate with the HA characteristic Ca/P molar ratio of 10:6 and report that after addition >10% (by weight) of polyphosphate (polyp) amorphous CaP/HA samples were obtained. Those samples elicits strong morphogenetic activity let us to conclude that polyP/HA-based material might be beneficial for application as bone substitute implant. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mueller, Werner E. G.; Tolba, Emad; Schroeder, Heinz C.; Wang, Xiaohong] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
   [Munoz-Espi, Rafael] Max Planck Inst Polymer Res, Dept Phys Chem Polymers, Ackermannweg 10, D-55128 Mainz, Germany.
   [Diehl-Seifert, Bearbel] NanotecMARIN GmbH, Duesbergweg 6, D-55128 Mainz, Germany.
RP Muller, WEG; Wang, XH (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
EM wmueller@uni-mainz.de; wang013@uni-mainz.de
RI Munoz-Espi, Rafael/C-1686-2014
OI Munoz-Espi, Rafael/0000-0002-8146-2332; Tolba, Emad/0000-0002-3422-2344
FU ERC [268476 "BIOSILICA"]; Deutsche Forschungsgemeinschaft [Schr
   277/10-3]; European Commission [604036, 268476, 311848]; International
   Human Frontier Science Program
FX W.E.G. M. is a holder of an ERC Advanced Investigator Grant (No. 268476
   "BIOSILICA"). This work was supported by grants from the Deutsche
   Forschungsgemeinschaft (Schr 277/10-3), the European Commission
   ("Bio-Scaffolds": No. 604036; "MarBioTec<INF>*</INF>EU-CN<INF>*</INF>":
   No. 268476; and "BlueGenics": No. 311848), and the International Human
   Frontier Science Program.
CR ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
   AR Ten Cate, 1994, ORAL HISTOLOGY DEV S
   Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001
   BONUCCI E, 1992, CALCIFICATION BIOL S
   Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109
   BOSKEY AL, 1973, J PHYS CHEM-US, V77, P2313, DOI 10.1021/j100638a011
   Cacciotti I, 2009, J EUR CERAM SOC, V29, P2969, DOI 10.1016/j.jeurceramsoc.2009.04.038
   Calvert P, 1997, NATURE, V386, P127, DOI 10.1038/386127a0
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f
   FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221
   Garnero P, 2015, CALCIFIED TISSUE INT, V97, P229, DOI 10.1007/s00223-015-9996-2
   Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Ito N, 2013, KEY ENG MATER, V529-530, P11, DOI 10.4028/www.scientific.net/KEM.529-530.11
   Jeon SH, 2011, J MATER CHEM, V21, P2550, DOI 10.1039/c0jm02340j
   Jiang SQ, 2015, FARADAY DISCUSS, V179, P451, DOI 10.1039/c4fd00212a
   Kobayashi K, 2014, ACS APPL MATER INTER, V6, P22602, DOI 10.1021/am5067139
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Lee D.S.H., 2013, J BIOMATER NANOBIOTE, V4, P114
   Lee HS, 2005, MATER CHEM PHYS, V93, P376, DOI 10.1016/j.matchemphys.2005.03.037
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lin KL, 2014, ACTA BIOMATER, V10, P4071, DOI 10.1016/j.actbio.2014.06.017
   Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105
   Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014
   Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107
   MANN S, 1983, PROC R SOC SER B-BIO, V218, P415, DOI 10.1098/rspb.1983.0048
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   Muller WEG, 2015, MACROMOL BIOSCI, V15, P1182, DOI 10.1002/mabi.201500100
   Muller WEG, 2015, CHEMBIOCHEM, V16, P1323, DOI 10.1002/cbic.201500057
   Muller WEG, 2015, MATER LETT, V148, P163, DOI 10.1016/j.matlet.2015.02.070
   Muller WEG, 2013, BIOMATERIALS, V34, P8671, DOI 10.1016/j.biomaterials.2013.07.096
   Muller WEG, 2015, J CELL SCI, V128, P2202, DOI 10.1242/jcs.170605
   Muller W.E.G., 2015, FEBS J
   Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3
   Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008
   Nathanael AJ, 2013, J NANOMATER, DOI 10.1155/2013/962026
   Nayak A. K., 2010, INT J CHEMTECH RES, V2, P903
   Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   PELLEGRINO ED, 1970, CALC TISS RES, V6, P168, DOI 10.1007/BF02196196
   Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434
   Prevey PS, 2000, J THERM SPRAY TECHN, V9, P369, DOI 10.1361/105996300770349827
   Price PA, 2009, J BIOL CHEM, V284, P17092, DOI 10.1074/jbc.M109.007013
   Prins HJ, 2014, STEM CELL RES, V12, P428, DOI 10.1016/j.scr.2013.12.001
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Reznikov N, 2014, BONE, V59, P93, DOI 10.1016/j.bone.2013.10.023
   Rivas M, 2015, DALTON T, V44, P9980, DOI 10.1039/c5dt00209e
   Sachs L, 1984, ANGEW STAT, P242
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Schlossmacher U, 2013, RSC ADV, V3, P11185, DOI 10.1039/c3ra23341c
   Schroder H. C., 1999, PROGR MOL SUBCELLULA, V23
   Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196
   Shepard N, 1992, CALCIFICATION BIOL S, P41
   Shepherd JH, 2011, JOM-US, V63, P83, DOI 10.1007/s11837-011-0063-9
   Simkiss K., 1989, BIOMINERALIZATION CE, P284
   Skrtic D, 2002, J BIOMED MATER RES, V59, P597, DOI 10.1002/jbm.10017
   TORTORA GJ, 1995, PRINCIPLES HUMAN ANA, P796
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Wang MC, 2015, CERAM INT, V41, P2999, DOI 10.1016/j.ceramint.2014.10.135
   Wang X.H., 2015, BIOTECHNOLO IN PRESS
   Wang XH, 2014, INT REV CEL MOL BIO, V313, P27, DOI 10.1016/B978-0-12-800177-6.00002-5
   Wang XH, 2014, TRENDS BIOTECHNOL, V32, P441, DOI 10.1016/j.tibtech.2014.05.004
   Wang XH, 2014, CALCIFIED TISSUE INT, V94, P495, DOI 10.1007/s00223-013-9833-4
   Wang XH, 2014, MAR DRUGS, V12, P1131, DOI 10.3390/md12021131
   Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6
   Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002
   Yokota S, 2014, IMPLANT DENT, V23, P343, DOI 10.1097/ID.0000000000000098
   Zanotto A., 2012, ADV NANOPARTICLES, V1, P21
NR 75
TC 12
Z9 12
U1 6
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 358
EP 367
DI 10.1016/j.actbio.2015.11.060
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100032
PM 26654764
DA 2018-10-20
ER

PT J
AU Hotchkiss, KM
   Reddy, GB
   Hyzy, SL
   Schwartz, Z
   Boyan, BD
   Olivares-Navarrete, R
AF Hotchkiss, Kelly M.
   Reddy, Gireesh B.
   Hyzy, Sharon L.
   Schwartz, Zvi
   Boyan, Barbara D.
   Olivares-Navarrete, Rene
TI Titanium surface characteristics, including topography and wettability,
   alter macrophage activation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Macrophages; M1 activation; M2 activation; Surface roughness;
   Wettability; Immune response; Titanium
ID IN-VITRO; IMPLANT SURFACES; TISSUE-REPAIR; BIOMATERIALS; POLARIZATION;
   BONE; VIVO; OSSEOINTEGRATION; MICROSTRUCTURE; HYDROPHILICITY
AB Biomaterial surface properties including chemistry, topography, and wettability regulate cell response. Previous studies have shown that increasing surface roughness of metallic orthopaedic and dental implants improved bone formation around the implant. Little is known about how implant surface properties can affect immune cells that generate a wound healing microenvironment. The aim of our study was to examine the effect of surface modifications on macrophage activation and cytokine production. Macrophages were cultured on seven surfaces: tissue culture polystyrene (TCPS) control; hydrophobic and hydrophilic smooth Ti (PT and oxygen-plasma-treated (plasma) PT); hydrophobic and hydrophilic microrough Ti (SLA and plasma SLA), and hydrophobic and hydrophilic nano-and micro-rough Ti (aged modSLA and modSLA). Smooth Ti induced inflammatory macrophage (M1-like) activation, as indicated by increased levels of interleukins IL-1 beta, IL-6, and TNF alpha. In contrast, hydrophilic rough titanium induced macrophage activation similar to the anti-inflammatory M2-like state, increasing levels of interleukins IL-4 and IL-10. These results demonstrate that macrophages cultured on high surface wettability materials produce an anti-inflammatory microenvironment, and this property may be used to improve the healing response to biomaterials.
   Statement of significance
   Metals like titanium (Ti) are common in orthopaedics and dentistry due to their ability to integrate with surrounding tissue and good biocompatibility. Roughness- and wettability-increasing surface modifications promote osteogenic differentiation of stem cells on Ti. While these modifications increase production of osteoblastic factors and bone formation, little is known about their effect on immune cells. The initial host response to a biomaterial is controlled primarily by macrophages and the factors they secrete in response to the injury caused by surgery and the material cues. Here we demonstrate the effect of surface roughness and wettability on the activation and production of inflammatory factors by macrophages. Control of inflammation will inform the design of surface modification procedures to direct the immune response and enhance the success of implanted materials. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hotchkiss, Kelly M.; Reddy, Gireesh B.; Hyzy, Sharon L.; Schwartz, Zvi; Boyan, Barbara D.; Olivares-Navarrete, Rene] Virginia Commonwealth Univ, Dept Biomed Engn, Sch Engn, Richmond, VA USA.
   [Boyan, Barbara D.] Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA USA.
   [Boyan, Barbara D.] Emory Univ, Georgia Inst Technol, Atlanta, GA 30322 USA.
RP Olivares-Navarrete, R (reprint author), VCU Sch Engn, Dept Biomed Engn, 401 W Main St,E1254, Richmond, VA 23284 USA.
EM ronavarrete@vcu.edu
OI Olivares-Navarrete, Rene/0000-0003-1232-9164; Reddy,
   Gireesh/0000-0001-6112-2309
FU International Association of Dental Research-Academy of Osseointegration
   Innovation in Implant Sciences Award; National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health [AR052102]
FX Ti surfaces were provided by Institut Straumann AG, Basel, Switzerland.
   This research was funded by the International Association of Dental
   Research-Academy of Osseointegration Innovation in Implant Sciences
   Award (PI: RON). Research reported in this publication was supported by
   the National Institute of Arthritis and Musculoskeletal and Skin
   Diseases of the National Institutes of Health under Award Number
   AR052102 (PI: BDB). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health.
CR Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Alfarsi M. A., 2013, J BIOMED MAT RES A
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bosshardt DD, 2011, CLIN ORAL IMPLAN RES, V22, P357, DOI 10.1111/j.1600-0501.2010.02107.x
   Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chaudhary H. H., 2014, WORLD J PHARM PHARM, V3, P341
   Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Davison NL, 2015, EUR CELLS MATER, V29, P314, DOI 10.22203/eCM.v029a24
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Davison N.L., 2014, EUR CELLS MATER, V27, P96
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Hamlet S, 2012, CLIN ORAL IMPLAN RES, V23, P584, DOI 10.1111/j.1600-0501.2011.02325.x
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   Kopf BS, 2015, J BIOMED MATER RES A, V103, P2661, DOI 10.1002/jbm.a.35401
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Mavrogenis AF, 2009, J MUSCULOSKEL NEURON, V9, P61
   Morant C, 2003, APPL SURF SCI, V220, P79, DOI 10.1016/S0169-4332(03)00746-3
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512
   Olivares-Navarrete R, 2013, SPINE J, V13, P1563, DOI 10.1016/j.spinee.2013.03.047
   Pajarinen J, 2013, ACTA BIOMATER, V9, P9229, DOI 10.1016/j.actbio.2013.06.027
   Park JH, 2012, ACTA BIOMATER, V8, P1966, DOI 10.1016/j.actbio.2011.11.026
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Ueha S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00071
   Wennerberg A, 2013, CLIN ORAL IMPLAN RES, V24, P203, DOI 10.1111/j.1600-0501.2012.02429.x
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107
   Zhang X, 2008, CURRENT PROTOCOLS IM
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 36
TC 61
Z9 64
U1 22
U2 134
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2016
VL 31
BP 425
EP 434
DI 10.1016/j.actbio.2015.12.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7EI
UT WOS:000370086100038
PM 26675126
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, JY
   Zhao, G
   Shu, ZQ
   Zhou, P
   Cao, YX
   Gao, DY
AF Wang, Jianye
   Zhao, Gang
   Shu, Zhiquan
   Zhou, Ping
   Cao, Yunxia
   Gao, Dayong
TI Effect of iron oxide nanoparticles on the permeability properties of
   Sf21 cells
SO CRYOBIOLOGY
LA English
DT Article
DE Iron oxide nanoparticles; Permeability properties; Sf21 cell;
   Cryopreservation; Microperfusion system
ID MEMBRANE-TRANSPORT-PROPERTIES; WATER PERMEABILITY; MAGNETIC
   NANOPARTICLES; ACTIVATION-ENERGY; OSMOTIC RESPONSE; TISSUES;
   DEVITRIFICATION; TEMPERATURES; MICROSCOPE; MECHANISMS
AB It was recently reported that nanoparticles could significantly modulate the thermal properties of solutions at subzero temperatures, and as a result, nanoparticles have been widely used in both cryopreservation and cryosurgery. In cryopreservation, the water permeability coefficient of cell membrane is an essential parameter for quantitative investigation of cell dehydration and intracellular ice formation. However, few studies were focused on the effects of nanoparticles on the permeability properties of cell membrane. In order to optimize the processes of cryopreservation with nano particles, we measured the permeability properties of Sf21 cells in the presence of iron oxide nano particles in this study. The responses of Sf21 cells with iron oxide nanoparticles were obtained by the microperfusion system at 2, 5, 15 and 25 degrees C, respectively. The osmotically inactive cell volume (V-b), the cell membrane hydraulic conductivity (L-p) and it's activation energy (E-Lp), and the reference value of L-p at the reference temperature (L-pg) with 0.02%, 0.1% and 0.5% (w/w) iron oxide nanoparticles were determined by 2 -parameter (2-p) model at -2, 5, 15 and 25 degrees C. We analyzed the effects of iron oxide nanoparticles on the permeability properties of the Sf21 cells. The results indicated that iron oxide nanoparticles have a significant influence on membrane permeability properties (L-pg and E-Lp) of Sf21 cells. The introduction of iron oxide nanoparticles tends to increase the values of V-b and L-pg, while decrease the value of E-Lp. These findings may provide a new route to optimize the biomaterial cryopreservation. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wang, Jianye; Zhao, Gang; Gao, Dayong] Univ Sci & Technol China, Dept Elect Sci & Technol, Ctr Biomed Engn, Hefei 230027, Peoples R China.
   [Zhao, Gang; Zhou, Ping; Cao, Yunxia] Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei 230027, Peoples R China.
   [Zhou, Ping; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp, Ctr Reprod Med, Hefei 230032, Peoples R China.
   [Shu, Zhiquan; Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.
RP Zhao, G (reprint author), Univ Sci & Technol China, Dept Elect Sci & Technol, 96 JinZhai Rd, Hefei 230027, Peoples R China.
EM zhaog@ustc.edu.cn
RI Zhao, Gang/C-8125-2011
OI Zhao, Gang/0000-0002-7002-4652; Zhao, Gang/0000-0002-0201-1825
FU NSFC [51276179, 51476160, 51528601]
FX This work was partially supported by grants from NSFC (Nos. 51276179,
   51476160 and 51528601).
CR Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH
   Bothun Geoffrey D., 2008, Journal of Nanobiotechnology, V6, P13, DOI 10.1186/1477-3155-6-13
   Chen HH, 2007, CRYOBIOLOGY, V55, P200, DOI 10.1016/j.cryobiol.2007.08.001
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Devireddy RV, 1999, BIOL REPROD, V61, P764, DOI 10.1095/biolreprod61.3.764
   Furlani EP, 2010, MATERIALS, V3, P2412, DOI 10.3390/ma3042412
   GAO DY, 1994, J REPROD FERTIL, V102, P385
   Gao DY, 1996, BIOPHYS J, V71, P443, DOI 10.1016/S0006-3495(96)79246-9
   Gao JH, 2009, ACCOUNTS CHEM RES, V42, P1097, DOI 10.1021/ar9000026
   Guha A, 2010, Journal of Nanotechnology in Engineering and Medicine, V1, DOI 10.1115/1.4001290
   Han X, 2008, MICROFLUID NANOFLUID, V4, P357, DOI 10.1007/s10404-007-0186-z
   Hao B., 2011, ASME J NAONTECHNOL E, V2
   Higgins AZ, 2012, CRYOLETTERS, V33, P96
   HUNTER JE, 1992, CRYOBIOLOGY, V29, P240, DOI 10.1016/0011-2240(92)90022-T
   Jingru Y., 2014, J NANOTECHNOL ENG ME, V5
   Jun YW, 2008, ACCOUNTS CHEM RES, V41, P179, DOI 10.1021/ar700121f
   Kleinhans FW, 1998, CRYOBIOLOGY, V37, P271, DOI 10.1006/cryo.1998.2135
   LEIBO SP, 1980, J MEMBRANE BIOL, V53, P179, DOI 10.1007/BF01868823
   LEVIN RL, 1976, BIOPHYS J, V16, P1411, DOI 10.1016/S0006-3495(76)85784-0
   LOVELOCK JE, 1957, PROC R SOC SER B-BIO, V147, P427, DOI 10.1098/rspb.1957.0062
   Lv FK, 2014, CRYOBIOLOGY, V68, P84, DOI 10.1016/j.cryobiol.2013.12.006
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   MCGRATH JJ, 1985, J MICROSC-OXFORD, V139, P249, DOI 10.1111/j.1365-2818.1985.tb02641.x
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Qiao R, 2007, NANO LETT, V7, P614, DOI 10.1021/nl062515f
   Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26
   Takamatsu H, 2004, J BIOMECH ENG-T ASME, V126, P402, DOI 10.1115/1.1784474
   TONER M, 1993, BIOPHYS J, V64, P1908, DOI 10.1016/S0006-3495(93)81562-5
   Tseng HY, 2011, BIOPRESERV BIOBANK, V9, P355, DOI 10.1089/bio.2011.0027
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Wang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072836
   Wang T, 2014, CRYOBIOLOGY, V68, P234, DOI 10.1016/j.cryobiol.2014.02.002
   Yan JF, 2008, NANOMED-NANOTECHNOL, V4, P79, DOI 10.1016/j.nano.2007.11.002
   Yoshimori T, 2009, CRYOBIOLOGY, V58, P52, DOI 10.1016/j.cryobiol.2008.10.128
   Yu TH, 2005, CRYOBIOLOGY, V50, P174, DOI 10.1016/j.cryobiol.2005.01.001
   Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295
   Yue C, 2014, CRYOBIOLOGY, V69, P273, DOI 10.1016/j.cryobiol.2014.07.017
   Zhao G, 2010, CRYOLETTERS, V31, P279
   Zi-Qiao S., 2008, NAN MICR MOL SYST 20, P885
NR 41
TC 0
Z9 0
U1 1
U2 24
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
EI 1090-2392
J9 CRYOBIOLOGY
JI Cryobiology
PD FEB
PY 2016
VL 72
IS 1
BP 21
EP 26
DI 10.1016/j.cryobiol.2015.12.002
PG 6
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA DE0GV
UT WOS:000370304000004
PM 26705894
DA 2018-10-20
ER

PT J
AU Puiggali-Jou, A
   Medina, J
   del Valle, LJ
   Aleman, C
AF Puiggali-Jou, Anna
   Medina, Judith
   del Valle, Luis J.
   Aleman, Carlos
TI Nanoperforations in poly(lactic acid) free-standing nanomembranes to
   promote interactions with cell filopodia
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Nanofeatures; Perforated nanomembranes; Phase segregation;
   Self-supported nanomembranes; Tissue engineering; Ultra-thin films
ID POLYMER-BLEND FILMS; NANOSHEETS
AB Nanoperforated poly(lactic acid) (PLA) free-standing nanomembranes (FsNMs) have been prepared using a two-step process: (1) spin-coating a mixture of immiscible polymers to provoke phase segregation and formation of appropriated nanofeatures (i.e. phase separation domains with dimensions similar to the entire film thickness); and (2) selective solvent etching to transform such nanofeatures into nanoperforations. For this purpose, PLA has been mixed with polyethylene glycol (PEG) and poly(vinyl alcohol) (PVA). Unfortunately, the characteristics of PLA:PEG mixtures were not appropriated to prepare nanoperforated FsNMs. In contrast, perforated PLA FsNMs with pores crossing the entire film thickness, which have been characterized by scanning electron microscopy and atomic force microscopy, were obtained using PLA:PVA mixtures. The diameter (0) of such pores has been controlled through both the PLA:PVA ratio and the processing conditions of the mixtures, FsNMs with pores of phi approximate to 0.8 mu m, 170 nm and 65 nm being achieved. Investigations on nanoperforated FsNMs (i.e. those with phi approximate to 170 and 65 nm), which are the more regular, reveal that pores crossing the entire membrane thickness do not affect the surface wettability of PLA but drastically enhances the cellular response of this biomaterial. Thus, cell proliferation assays indicate that cell viability in PLA with perforations of phi approximate to 170 nm is similar to 2.6 and similar to 2.2 higher than in non-perforated PLA and PLA with perforations of phi approximate to 0 65 nm, respectively. This excellent response has been attributed to the similarity between the nanoperforations with phi approximate to 170 nm and the filopodia filaments in cells (phi approximate to 100-200 nm), which play a crucial role in cell migration processes. The favorable interaction between the perforated membrane nanofeatures and cell filopodia has been corroborated by optical and scanning electron microscopies. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [del Valle, Luis J.; Aleman, Carlos] Univ Politecn Cataluna, ETS Engn Ind Barcelona, Dept Engn Quim, Diagonal 647, E-08028 Barcelona, Spain.
   Univ Politecn Cataluna, Ctr Res Nanoengn, Edifici C,C-Pasqual & Vila S-N, E-08028 Barcelona, Spain.
RP del Valle, LJ; Aleman, C (reprint author), Univ Politecn Cataluna, ETS Engn Ind Barcelona, Dept Engn Quim, Diagonal 647, E-08028 Barcelona, Spain.
EM luis.javier.del.valle@upc.edu; carlos.aleman@upc.edu
OI Aleman, Carlos/0000-0003-4462-6075; Puiggali Jou,
   Anna/0000-0001-7822-9807
FU MINECO; FEDER [MAT2012-34498]
FX Authors are in debt to supports from MINECO and FEDER (MAT2012-34498).
CR Adamson AW, 1990, PHYS CHEM SURFACES
   Armelin E, 2012, J MATER CHEM, V22, P585, DOI 10.1039/c1jm14168f
   Birnie DP, 2001, J MATER RES, V16, P1145, DOI 10.1557/JMR.2001.0158
   Correia NT, 1997, J COLLOID INTERF SCI, V189, P361, DOI 10.1006/jcis.1997.4857
   Fujie T, 2011, LANGMUIR, V27, P13173, DOI 10.1021/la203140a
   Heriot SY, 2005, NAT MATER, V4, P782, DOI 10.1038/nmat1476
   LAMOUREUX P, 1989, Nature (London), V340, P159, DOI 10.1038/340159a0
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Miyazaki H, 2012, WOUND REPAIR REGEN, V20, P573, DOI 10.1111/j.1524-475X.2012.00811.x
   Molino P.J., 2012, LANGMUIR, V30, P2178
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Okamura Y, 2013, ADV MATER, V25, P545, DOI 10.1002/adma.201202851
   Okamura Y, 2009, ADV MATER, V21, P4388, DOI 10.1002/adma.200901035
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pensabene V, 2011, ACTA BIOMATER, V7, P2883, DOI 10.1016/j.actbio.2011.03.013
   Perez-Madrigal M. M., 2013, POLYM CHEM, V4, P568
   Perez-Madrigal MM, 2015, J MATER CHEM B, V3, P5904, DOI 10.1039/c5tb00624d
   Perez-Madrigal MM, 2014, ACS APPL MATER INTER, V6, P9719, DOI 10.1021/am502150q
   Perez-Madrigal MM, 2012, POLYM CHEM-UK, V3, P979, DOI 10.1039/c2py00584k
   Sattler K.D., 2011, HDB NANOPHYSICS FUNC
   Steketee MB, 2002, J NEUROSCI, V22, P8071
   Swaminathan V, 2007, J BIOMAT SCI-POLYM E, V18, P1321, DOI 10.1163/156856207782177864
   Vendamme R, 2006, NAT MATER, V5, P494, DOI 10.1038/nmat1655
   Walheim S, 1997, MACROMOLECULES, V30, P4995, DOI 10.1021/ma9619288
   Watanabe H, 2009, J MATER CHEM, V19, P2425, DOI 10.1039/b819213h
   Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895
   Zhang H, 2012, MACROMOLECULES, V45, P4315, DOI 10.1021/ma3005394
NR 27
TC 3
Z9 3
U1 0
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD FEB
PY 2016
VL 75
BP 552
EP 564
DI 10.1016/j.eurpolymj.2016.01.019
PG 13
WC Polymer Science
SC Polymer Science
GA DE0IW
UT WOS:000370309400047
DA 2018-10-20
ER

PT J
AU Zhang, XS
   Brugger, J
   Kim, B
AF Zhang, Xiao-Sheng
   Brugger, Juergen
   Kim, Beomjoon
TI A silk-fibroin-based transparent triboelectric generator suitable for
   autonomous sensor network
SO NANO ENERGY
LA English
DT Article
DE Triboelectric generator; Energy harvesting; High-transparency; Silk
   fibroin; Mechanical microsystem
ID PLASMA TREATMENT; POWER SOURCE; NANOGENERATOR; ENERGY; SCALE;
   BIOMATERIAL; ELECTRONICS; FABRICATION; OXYGEN
AB In recent years, a new electrification-based mechanism called triboelectric generator (TEG) has been demonstrated as a stable and renewable power source to convert ambient energy into remarkable electrical output. Various TEG configurations have been proposed to enhance the output performance focusing on improvements to its working principle and structural geometry. In order for TEG to make an impact in real life applications, further improvement is needed in particular in the choice of the pair of electrification materials beyond the choice of traditional materials that have been employed in the construction of TEGs. Here, we investigate silk fibroin as a novel material for TEG that occupies a top-tier position in the triboelectric series and possesses the outstanding ability of losing electrons easily. Several technical challenges have been successfully addressed and are shown herein. For instance, an oxygen plasma process is employed to improve the interfacial energy between silk fibroin film and substrate by chemical modification and nanoscale roughness increase, which allows for the reliable switching mechanism needed to generate the electric power. The comprehensive study and the systematical measurement were carried out to study the fabricated TEG, including electrical output test, stability and reliability, humidity effect, and performance comparison with traditional materials. The silk fibroin is proven to be a promising material to construct TEG, and the fabricated TEG exhibits stable high-output performance, with maximum voltage, current, and power density of 268 V, 5.78 mu A, and 193.6 mu W/cm(2), respectively, to a load of 40 M Omega Furthermore, this silk fibroin film has two advantageous potentials for the development of TEGs: higher than 90% transmittance in the visible spectrum region and controllable solubility in aqueous solutions. The former property preserves the intrinsic optical property of TEG and enables the realisation of an ultra-transparent device, while the latter moves us closer to the attractive future vision of realising TEG systems that biodegradable for environmental sensing or implantable for biomedical applications. Additionally, we demonstrate that this silk-fibroin-based TEG can directly produce energy to power two 4-bit liquid crystal displays (LCDs) and to actuate a microscale cantilever. As the first demonstration of TEG applied to power a mechanical micro-device, this TEG-micro-cantilever microsystem shows an attractive potential to realise fully integrated smart transducers that are needed for autonomous sensor networks. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xiao-Sheng; Brugger, Juergen] Ecole Polytech Fed Lausanne, Microsyst Lab, CH-1015 Lausanne, Switzerland.
   [Zhang, Xiao-Sheng; Kim, Beomjoon] Univ Tokyo, Inst Ind Sci, CIRMM, Tokyo 1538505, Japan.
RP Brugger, J (reprint author), Ecole Polytech Fed Lausanne, Microsyst Lab, CH-1015 Lausanne, Switzerland.
EM juergen.brugger@epfl.ch
RI Kim, Beomjoon/A-6043-2010; Brugger, Juergen/C-5357-2009
OI Kim, Beomjoon/0000-0001-9565-299X; Brugger, Juergen/0000-0002-7710-5930;
   ZHANG, XIAO-SHENG/0000-0001-9719-0573
FU European Commission [295089]
FX The authors thank Prof. Kimihiko Nakano, Dr. Rencheng Zheng, and Mr.
   Yunshun Zhang for their assistance with the vibration experiments, Prof.
   Tetsu Tatsuma and Dr. Hiroyasu Nishi for their assistance with the
   optical measurements, Prof. Teruyasu Mizoguchi and Mr. Tomohiro Miyata
   for their assistance with the FTIR tests, and the members of Kim
   Laboratory for helpful assistance and discussions. This research was
   funded by the European Commission (FP7-INCO-2011-7), EUJO-LIMMS, under
   Grant Agreement No. 295089.
CR Diaz AF, 2004, J ELECTROSTAT, V62, P277, DOI 10.1016/j.elstat.2004.05.005
   Fan FR, 2012, NANO ENERGY, V1, P328, DOI 10.1016/j.nanoen.2012.01.004
   Ha M, 2015, ACS NANO, V9, P3421, DOI 10.1021/acsnano.5b01478
   Han MD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04811
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu YF, 2015, NANO ENERGY, V14, P3, DOI 10.1016/j.nanoen.2014.11.038
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim KN, 2015, NANO ENERGY, V14, P87, DOI 10.1016/j.nanoen.2015.01.004
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lee JH, 2014, ADV MATER, V26, P765, DOI 10.1002/adma.201303570
   Lee KY, 2014, ADV MATER, V26, P5037, DOI 10.1002/adma.201401184
   Meng B, 2013, ENERG ENVIRON SCI, V6, P3235, DOI 10.1039/c3ee42311e
   Niu SM, 2013, ENERG ENVIRON SCI, V6, P3576, DOI 10.1039/c3ee42571a
   Niu SM, 2013, ADV MATER, V25, P6184, DOI 10.1002/adma.201302808
   Rebeiz G., 2003, RF MEMS THEORY DESIG
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seol M. L., 2014, 2014 IEEE INT EL DEV
   Seung W, 2015, ACS NANO, V9, P3501, DOI 10.1021/nn507221f
   Sun H, 2013, NANOSCALE, V5, P6117, DOI 10.1039/c3nr00866e
   Tian BZ, 2007, NATURE, V449, P885, DOI 10.1038/nature06181
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vesel A, 2008, SURF INTERFACE ANAL, V40, P1444, DOI 10.1002/sia.2923
   Nguyen V, 2015, NANO ENERGY, V14, P49, DOI 10.1016/j.nanoen.2014.11.049
   Wang SH, 2015, NANO ENERGY, V11, P436, DOI 10.1016/j.nanoen.2014.10.034
   Wang SH, 2012, NANO LETT, V12, P6339, DOI 10.1021/nl303573d
   Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366
   Wang XD, 2012, NANO ENERGY, V1, P13, DOI 10.1016/j.nanoen.2011.09.001
   Wang ZL, 2013, ACS NANO, V7, P9533, DOI 10.1021/nn404614z
   Wang ZL, 2012, ANGEW CHEM INT EDIT, V51, P11700, DOI 10.1002/anie.201201656
   Xu S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1098
   Yamamoto T, 2013, SURF INTERFACE ANAL, V45, P817, DOI 10.1002/sia.5170
   Zhang XS, 2015, NANO ENERGY, V11, P304, DOI 10.1016/j.nanoen.2014.11.012
   Zhang XS, 2014, NANO ENERGY, V4, P123, DOI 10.1016/j.nanoen.2013.12.016
   Zhang XS, 2013, NANO LETT, V13, P1168, DOI 10.1021/nl3045684
   Zhu G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4426
   Zhu G, 2013, NANO LETT, V13, P847, DOI 10.1021/nl4001053
NR 38
TC 24
Z9 24
U1 16
U2 84
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2211-2855
EI 2211-3282
J9 NANO ENERGY
JI Nano Energy
PD FEB
PY 2016
VL 20
BP 37
EP 47
DI 10.1016/j.nanoen.2015.11.036
PG 11
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DE2PD
UT WOS:000370468300005
DA 2018-10-20
ER

PT J
AU Ruvinov, E
   Freeman, I
   Fredo, R
   Cohen, S
AF Ruvinov, Emil
   Freeman, Inbar
   Fredo, Roei
   Cohen, Smadar
TI Spontaneous Coassembly of Biologically Active Nanoparticles via Affinity
   Binding of Heparin-Binding Proteins to Alginate-Sulfate
SO NANO LETTERS
LA English
DT Article
DE Affinity binding; alginate-sulfate; coassembly; heparin-binding
   proteins; nanoparticles; repair
ID TRACKING ANALYSIS; MYOCARDIAL-INFARCTION; SEQUENTIAL DELIVERY;
   DRUG-DELIVERY; IN-VIVO; MICROSCOPY; ARTERIOGENESIS; ANGIOGENESIS;
   BIOMATERIAL; MECHANISMS
AB Controlled delivery of heparin-binding (HB) proteins represents a challenge in regenerative medicine strategies. Here, we describe the features of novel nanoparticles (NPs); spontaneously coassembled due to affinity interactions between HB proteins and the semisynthetic anionic polysaccharide, alginate-sulfate. The NPs efficiently encapsulated and protected the proteins from proteolysis. Injection of a combination of NPs encapsulating multiple therapeutic growth factors promoted effective and long-term tissue repair in, animal models of severe ischemia (murine model of hindlimb ischemia and acute myocardial infarction in rats). This simple yet efficient NP fabrication method is amenable, for clinical use.
C1 [Ruvinov, Emil; Freeman, Inbar; Fredo, Roei; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-8410501 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Regenerat Med & Stem Cell RMSC Res Ctr, IL-8410501 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-8410501 Beer Sheva, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-8410501 Beer Sheva, Israel.; Cohen, S (reprint author), Ben Gurion Univ Negev, Regenerat Med & Stem Cell RMSC Res Ctr, IL-8410501 Beer Sheva, Israel.; Cohen, S (reprint author), Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-8410501 Beer Sheva, Israel.
EM scohen@bgu.ac.il
FU Israel Science Foundation [1368/08]; European Union FWP7 (INELPY)
FX The research was supported in part by a grant from the Israel Science
   Foundation (1368/08) and European Union FWP7 (INELPY). The authors
   greatly thank Professor Jonathan Leor and his team from Sheba Medical
   Center for the animal experiments. Professor Cohen holds the Claire and
   Harold Oshry Professor Chair in Biotechnology.
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Borgstrom J, 1996, INT J BIOL MACROMOL, V18, P223, DOI 10.1016/0141-8130(95)01081-5
   Bravo-Osuna I, 2007, EUR J PHARM SCI, V30, P143, DOI 10.1016/j.ejps.2006.10.007
   Bruno BJ, 2013, THER DELIV, V4, P1443, DOI [10.4155/tde.13.104, 10.4155/TDE.13.104]
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Cooper CL, 2006, BIOMACROMOLECULES, V7, P1025, DOI 10.1021/bm050592j
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   Decho AW, 1999, CARBOHYD RES, V315, P330, DOI 10.1016/S0008-6215(99)00006-3
   Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7
   Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0
   Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994
   Honary S, 2013, TROP J PHARM RES, V12, P265, DOI 10.4314/tjpr.v12i2.20
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   La Rocca A, 2014, TRIBOL INT, V70, P142, DOI 10.1016/j.triboint.2013.09.018
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127
   Patel A, 2014, PROTEIN PEPTIDE LETT, V21, P1102, DOI 10.2174/0929866521666140807114240
   Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0
   Ruvinov E, 2016, ADV DRUG DELIVER REV, V96, P54, DOI 10.1016/j.addr.2015.04.021
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5
   Sun W, 2008, EUR J PHARM BIOPHARM, V69, P417, DOI 10.1016/j.ejpb.2008.01.016
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Vasudev R, 2015, J PHARM SCI-US, V104, P1622, DOI 10.1002/jps.24411
NR 30
TC 11
Z9 11
U1 1
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
EI 1530-6992
J9 NANO LETT
JI Nano Lett.
PD FEB
PY 2016
VL 16
IS 2
BP 883
EP 888
DI 10.1021/acs.nanolett.5b03598
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DD8ZK
UT WOS:000370215200009
PM 26745552
DA 2018-10-20
ER

PT J
AU Suarez, SL
   Munoz, A
   Mitchell, AC
   Braden, RL
   Luo, CL
   Cochran, JR
   Almutairi, A
   Christman, KL
AF Suarez, Sophia L.
   Munoz, Adam
   Mitchell, Aaron C.
   Braden, Rebecca L.
   Luo, Colin
   Cochran, Jennifer R.
   Almutairi, Adah
   Christman, Karen L.
TI Degradable Acetalated Dextran Microparticles for Tunable Release of an
   Engineered Hepatocyte Growth Factor Fragment
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE acetalated dextran; HGF; myocardial infarction; tunable release;
   microparticle
ID ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; POSTMYOCARDIAL INFARCTION;
   ALGINATE BIOMATERIAL; CARDIAC-FUNCTION; FACTOR PREVENTS; DELIVERY;
   ANGIOGENESIS; HGF; MODEL
AB Injectable biomaterials are promising as new therapies to treat myocardial infarction (MI). One useful property of biomaterials is the ability to protect and sustain the release of therapeutic payloads. In order to create a platform for optimizing the release rate of cardioprotective molecules, we utilized the tunable degradation of acetalated dextran (AcDex). We created microparticles with three distinct degradation profiles and showed that the consequent protein release profiles could be modulated within the infarcted heart. This enabled us to determine how delivery rate impacted the efficacy of a model therapeutic, an engineered hepatocyte growth factor fragment (HGF-f). Our results showed that the cardioprotective efficacy of HGF-f was optimal when delivered over 3 days postintramyocardial injection, yielding the largest arterioles, fewest apoptotic cardiomyocytes bordering the infarct, and the smallest infarcts compared to that of empty particle treatment 4 weeks after injection. This work demonstrates the potential of using AcDex particles as a delivery platform to optimize the time frame for delivering therapeutic proteins to the heart.
C1 [Suarez, Sophia L.; Munoz, Adam; Braden, Rebecca L.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Luo, Colin] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Suarez, Sophia L.; Munoz, Adam; Braden, Rebecca L.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
   [Suarez, Sophia L.; Almutairi, Adah] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Mitchell, Aaron C.; Cochran, Jennifer R.] Stanford Univ, Stanford Cardiovasc Inst, Dept Bioengn, Stanford, CA 94305 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Christman, KL (reprint author), Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.; Almutairi, A (reprint author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
EM aalmutairi@ucsd.edu; christman@eng.ucsd.edu
FU NIH Director's Transformative Research Award [HL117326]; NIH
   [5R01EY024134-02, R01CA151706]; NIH NIGMS [5T32GM008412];
   Stanford-Agilent Fellowship
FX This work was supported by a NIH Director's Transformative Research
   Award (HL117326), NIH R01 grants (5R01EY024134-02 and R01CA151706), as
   well as a NIH NIGMS Training Grant in Biotechnology [5T32GM008412], and
   a Stanford-Agilent Fellowship (both to A.C.M.).
CR Bachelder EM, 2010, MOL PHARMACEUT, V7, P826, DOI 10.1021/mp900311x
   Broaders KE, 2009, P NATL ACAD SCI USA, V106, P5497, DOI 10.1073/pnas.0901592106
   Cho KR, 2008, EUR J CARDIO-THORAC, V34, P857, DOI 10.1016/j.ejcts.2008.05.045
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Jayasankar V, 2005, J CARDIAC SURG, V20, P93, DOI 10.1111/j.0886-0440.2005.200373.x
   Jayasankar V, 2003, CIRCULATION, V108, P230, DOI 10.1161/01.cir.0000087444.53354.66
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Jones DS, 2011, P NATL ACAD SCI USA, V108, P13035, DOI 10.1073/pnas.1102561108
   Kauffman KJ, 2012, INT J PHARMACEUT, V422, P356, DOI 10.1016/j.ijpharm.2011.10.034
   Khabbaz KR, 2001, ANN THORAC SURG, V72, pS2227, DOI 10.1016/S0003-4975(01)03284-2
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kobayashi H, 2006, BLOOD, V108, P1260, DOI 10.1182/blood-2005-09-012807
   Kumbhani DJ, 2004, SURGERY, V136, P190, DOI 10.1016/j.surg.2004.04.015
   Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8
   Liu CJ, 2014, FEBS LETT, V588, P4831, DOI 10.1016/j.febslet.2014.11.018
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556
   Rafatian N, 2014, AM J PHYSIOL-REG I, V307, pR879, DOI 10.1152/ajpregu.00075.2014
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rastogi S, 2011, AM J PHYSIOL-HEART C, V300, pH1501, DOI 10.1152/ajpheart.00636.2010
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   Suarez S, 2015, BIOMATER SCI-UK, V3, P564, DOI [10.1039/c4bm00441h, 10.1039/C4BM00441H]
   Suarez S, 2013, BIOMACROMOLECULES, V14, P3927, DOI 10.1021/bm401050j
   Thurston G, 2002, J ANAT, V200, P575, DOI 10.1046/j.1469-7580.2002.00061.x
   Ungerleider JL, 2014, STEM CELL TRANSL MED, V3, P1090, DOI 10.5966/sctm.2014-0049
   Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004
   Yang F, 2002, EXP PHYSIOL, V87, P547, DOI 10.1113/eph8702385
NR 35
TC 6
Z9 6
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD FEB
PY 2016
VL 2
IS 2
BP 197
EP 204
DI 10.1021/acsbiomaterials.5b00335
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DD4FA
UT WOS:000369876700007
PM 29333489
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nakamura, M
   Hiratai, R
   Hentunen, T
   Salonen, J
   Yamashita, K
AF Nakamura, Miho
   Hiratai, Rumi
   Hentunen, Teuvo
   Salonen, Jukka
   Yamashita, Kimihiro
TI Hydroxyapatite with High Carbonate Substitutions Promotes Osteoclast
   Resorption through Osteocyte-like Cells
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE bone marrow; calcium phosphate; coculture; osteoclast; surface energy;
   wettability
ID SURFACE FREE-ENERGY; SYNTHETIC HYDROXYAPATITE; DISPERSIVE COMPONENT;
   BONE-MARROW; ADHESION; CALCIUM; DIFFERENTIATION; PHOSPHATE; CERAMICS;
   APATITE
AB The role of ceramic biomaterials in the repair of bone defects varies from materials that purely fill the physical defects of the injured bone to scaffolds that control cellular behaviors. In this study, we investigated the osteoclast formation related to the osteoconductivity of ceramic biomaterials. We performed in vitro cocultures using osteocyte-like cells and bone marrow cells and in vivo implantations of hydroxyapatite with different amounts of carbonate substitutions into rat femurs. The analyses of the cocultures revealed that bone marrow cells differentiated into osteoclasts and were activated to resorb the substratum when grown on hydroxyapatite with higher numbers of carbonate substitutions. This was indicated by the expression of macrophage colony-stimulating factor and receptor activator of the nuclear factor-kappa B ligand that induce osteoclast differentiation by osteocyte-like cells and characteristic resorption pits. The increased osteoclastogenesis in vivo was observed near the hydroxyapatite with more carbonate substitutions after implantation into the rat femurs. These results suggest that the content of carbonate ions in an apatite crystal lattice has an inductive effect on osteoclastogenesis in the vicinity of the implanted ceramic biomaterial. The results contribute to the design of biomaterials that would be resorbed by osteoclasts after fulfilling their primary function as scaffolds for cell growth and eventually bone regeneration.
C1 [Nakamura, Miho; Hiratai, Rumi; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
   [Hentunen, Teuvo; Salonen, Jukka] Univ Turku, Inst Biomed Cell Biol & Anat, FIN-20520 Turku, Finland.
RP Nakamura, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM miho.bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
FU Sumitomo Foundation [15K20472, 26670847]; Shiseido Female Researcher
   Science Grant; Murata Foundation
FX This study was supported in part by Grants-in-Aid for Young Scientists
   (B) (15K20472) and for Exploratory Research (26670847), Grant for Basic
   Science Research Projects from The Sumitomo Foundation, the Shiseido
   Female Researcher Science Grant and the Murata Foundation.
CR Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Cassella AR, 2000, FRESEN J ANAL CHEM, V367, P556, DOI 10.1007/s002160000368
   CHASSIN P, 1986, CLAY MINER, V21, P899, DOI 10.1180/claymin.1986.021.5.04
   Costa-Rodrigues J, 2012, ACTA BIOMATER, V8, P1137, DOI 10.1016/j.actbio.2011.11.032
   DOI Y, 1993, J DENT RES, V72, P1279, DOI 10.1177/00220345930720090401
   Doi Y, 1999, J BIOMED MATER RES, V47, P424, DOI 10.1002/(SICI)1097-4636(19991205)47:3<424::AID-JBM19>3.0.CO;2-0
   Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018
   GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Honma M, 2013, J BONE MINER RES, V28, P1936, DOI 10.1002/jbmr.1941
   Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z
   Juffer P, 2014, CALCIFIED TISSUE INT, V94, P319, DOI 10.1007/s00223-013-9813-8
   Kanatan M, 2003, J CELL PHYSIOL, V196, P180, DOI 10.1002/jcp.10270
   Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014
   Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S
   Kurata K, 2006, J BONE MINER RES, V21, P616, DOI 10.1359/JBMR.060106
   LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817
   Lakkakorpi PT, 1996, J CELL PHYSIOL, V168, P668, DOI 10.1002/(SICI)1097-4652(199609)168:3<668::AID-JCP19>3.0.CO;2-V
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   SCHULTZ J, 1977, J COLLOID INTERF SCI, V59, P272, DOI 10.1016/0021-9797(77)90008-X
   SCHULTZ J, 1977, J COLLOID INTERF SCI, V59, P277, DOI 10.1016/0021-9797(77)90009-1
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   TAKAHASHI N, 1989, J CLIN INVEST, V83, P543, DOI 10.1172/JCI113916
   VAANANEN HK, 1995, J CELL SCI, V108, P2729
   Valta MP, 2006, ENDOCRINOLOGY, V147, P2171, DOI 10.1210/en.2005-1502
   Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   ZAPANTAL.R, 1965, NATURE, V206, P403, DOI 10.1038/206403a0
   Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068
NR 36
TC 11
Z9 11
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD FEB
PY 2016
VL 2
IS 2
BP 259
EP 267
DI 10.1021/acsbiomaterials.5b00509
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DD4FA
UT WOS:000369876700014
DA 2018-10-20
ER

PT J
AU Tsukamoto, M
   Kawa, T
   Shinonaga, T
   Chen, P
   Nagai, A
   Hanawa, T
AF Tsukamoto, M.
   Kawa, T.
   Shinonaga, T.
   Chen, P.
   Nagai, A.
   Hanawa, T.
TI Cell spreading on titanium periodic nanostructures with periods of 200,
   300 and 600 nm produced by femtosecond laser irradiation
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID ALIGNMENT; ABLATION; SURFACES; PLATE
AB Titanium (Ti) is an important biomaterial. We have used femtosecond laser irradiation to form periodic nanostructures on Ti plate for control of the cell spreading. In this study, periodic nanostructures with periodicities of 200, 300 and 600 nm were formed on a Ti plates using a femtosecond laser with wavelengths of 258, 388 and 775 nm, respectively. Cell spreading on the Ti plate for periodic nanostructures with periodicity of 200 nm lacked a definite direction, whereas cell spreadings on the Ti plate for periodic nanostructures with periodicities of 300 and 600 nm occurred along the grooves.
C1 [Tsukamoto, M.] Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.
   [Kawa, T.] Osaka Univ, Grad Sch Engn, 1-1 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Shinonaga, T.] Okayama Univ, Fac Engn, Kita Ku, 3-1-1 Tsushima Naka, Okayama, Okayama 7000082, Japan.
   [Chen, P.; Nagai, A.; Hanawa, T.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
RP Tsukamoto, M (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.
EM tukamoto@jwri.osaka-u.ac.jp
CR Das SK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117509
   Dufft D, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074106
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Hanawa T, 2010, JPN DENT SCI REV, V46, P93, DOI 10.1016/j.jdsr.2009.11.001
   Hashida M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803940
   Jia TQ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125429
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Miyaji G, 2008, OPT EXPRESS, V16, P16265, DOI 10.1364/OE.16.016265
   Miyaji G, 2012, OPT EXPRESS, V20, P14848, DOI 10.1364/OE.20.014848
   Miyazaki K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4826078
   Okamuro K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165417
   Reif J, 2002, APPL SURF SCI, V197, P891, DOI 10.1016/S0169-4332(02)00450-6
   Sakabe S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.033409
   Shimotsume Y., 2003, PHYS REV LETT, V91, DOI DOI 10.1103/PhysRevLett.91.247405
   Shinonaga T., 2015, APPL PHYS B, V119, P494
   Shinonaga T, 2014, OPT EXPRESS, V22, P14696, DOI 10.1364/OE.22.014696
   Shinonaga T, 2014, APPL SURF SCI, V288, P649, DOI 10.1016/j.apsusc.2013.10.090
   Tsukamoto M, 2007, J PHYS CONF SER, V59, P666, DOI 10.1088/1742-6596/59/1/140
   Tsukamoto M, 2006, VACUUM, V80, P1346, DOI 10.1016/j.vacuum.2006.01.016
NR 21
TC 0
Z9 0
U1 1
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD FEB
PY 2016
VL 122
IS 2
AR 120
DI 10.1007/s00339-016-9626-5
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DD5OB
UT WOS:000369972400075
DA 2018-10-20
ER

PT J
AU Gkikas, M
   Avery, RK
   Olsen, BD
AF Gkikas, Manos
   Avery, Reginald K.
   Olsen, Bradley D.
TI Thermoresponsive and Mechanical Properties of Poly(L-proline) Gels
SO BIOMACROMOLECULES
LA English
DT Article
ID POLY-L-PROLINE; POLYPROLINE-II HELIX; BLOCK-COPOLYMERS; COPOLYPEPTIDE
   HYDROGELS; N-CARBOXYANHYDRIDES; CIRCULAR-DICHROISM; PROTEIN HYDROGELS;
   DESIGNED PEPTIDE; SMALL MOLECULES; DRUG-DELIVERY
AB Gelation of the left helical N-substituted homopolypeptide poly(L-proline) (PLP) in water was explored, employing rheological and small-angle scattering studies at different temperatures and concentrations in order to investigate the network structure and its mechanical properties. Stiff gels were obtained at 10 wt % or higher at 5 degrees C, the first time gelation has been observed for homopolypeptides. The secondary structure and helical rigidity of PLP has large structural similarities to gelatin but as gels the two materials show contrasting trends with temperature. With increasing temperature in D2O, the network stiffens, with broad scattering features of similar correlation length for all concentrations and molar masses of PLP. A thermoresponsive transition was also achieved between 5 and 35 degrees C, with moduli at 35 degrees C higher than gelatin at 5 degrees C. The brittle gels could tolerate strains of 1% before yielding with a frequency-independent modulus over the observed range, similar to natural proline-rich proteins, suggesting the potential for thermoresponsive or biomaterial-based applications.
C1 [Gkikas, Manos; Olsen, Bradley D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Avery, Reginald K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
RP Olsen, BD (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM bdolsen@mit.edu
OI Olsen, Bradley/0000-0002-7272-7140
FU U.S. Army Research Office [W911NF-13-D-0001]; NIH Interdepartmental
   Biotechnology Training Program [NIH/NIGMS 5T32GM008334]
FX This work was supported by the U.S. Army Research Office under contract
   W911NF-13-D-0001. We thank ORNL for support in the SANS experiments and
   especially Urban Volker for his guidance, as well as Boualem Hammouda
   for helpful discussions. We also acknowledge the MIT Department of
   Chemistry Instrumentation Facility for the NMR instrumentation and the
   Biophysical Instrumentation Facility for the CD spectroscopy work.
   R.K.A. was supported by an NIH Interdepartmental Biotechnology Training
   Program (NIH/NIGMS 5T32GM008334)
CR ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047
   Adzhubei AA, 2013, J MOL BIOL, V425, P2100, DOI 10.1016/j.jmb.2013.03.018
   Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355
   BERGER A, 1954, J AM CHEM SOC, V76, P5552, DOI 10.1021/ja01650a082
   Biberoglu K, 2012, FEBS J, V279, P3844, DOI 10.1111/j.1742-4658.2012.08744.x
   Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f
   Cheng J., 2011, TOP CURR CHEM, V310, P1
   Chopko CM, 2012, ACS MACRO LETT, V1, P727, DOI 10.1021/mz300088w
   CIFERRI A, 1966, J PHYS CHEM-US, V70, P3277, DOI 10.1021/j100882a042
   CONTI F, 1969, BIOPOLYMERS, V7, P411, DOI 10.1002/bip.1969.360070311
   COSANI A, 1978, MACROMOLECULES, V11, P1041, DOI 10.1021/ma60065a038
   Crespo L, 2002, J AM CHEM SOC, V124, P8876, DOI 10.1021/ja020364m
   DEBER CM, 1970, J AM CHEM SOC, V92, P6191, DOI 10.1021/ja00724a016
   Deming TJ, 2014, WIRES NANOMED NANOBI, V6, P283, DOI 10.1002/wnan.1262
   Deming TJ, 2000, J AM CHEM SOC, V122, P5710, DOI 10.1021/ja994281q
   Deng C, 2014, PROG POLYM SCI, V39, P330, DOI 10.1016/j.progpolymsci.2013.10.008
   Dimitrov I, 2003, CHEM COMMUN, P2944, DOI 10.1039/b308990h
   DJABOUROV M, 1988, CONTEMP PHYS, V29, P273, DOI 10.1080/00107518808224377
   ENGEL J, 1966, BIOPOLYMERS, V4, P945, DOI 10.1002/bip.1966.360040809
   Engler AC, 2009, ANGEW CHEM INT EDIT, V48, P9334, DOI 10.1002/anie.200904070
   FASMAN GD, 1963, BIOPOLYMERS, V1, P3, DOI 10.1002/bip.360010103
   Fillon YA, 2005, J AM CHEM SOC, V127, P11798, DOI 10.1021/ja052377g
   Gaharwar AK, 2014, ACS NANO, V8, P9833, DOI 10.1021/nn503719n
   Gandhi SS, 2014, ACS MACRO LETT, V3, P1210, DOI 10.1021/mz500499q
   Gkikas M, 2015, BIOMACROMOLECULES, V16, P3686, DOI 10.1021/acs.biomac.5b01198
   Gkikas M, 2014, BIOMACROMOLECULES, V15, P3923, DOI 10.1021/bm5009734
   Gkikas M, 2011, BIOMACROMOLECULES, V12, P2396, DOI 10.1021/bm200495n
   Glassman MJ, 2013, ADV FUNCT MATER, V23, P1182, DOI 10.1002/adfm.201202034
   GORNICK F, 1964, J AM CHEM SOC, V86, P2549, DOI 10.1021/ja01067a004
   Graf R, 2012, MACROMOLECULES, V45, P9326, DOI 10.1021/ma301906m
   Greenfield MA, 2010, LANGMUIR, V26, P3641, DOI 10.1021/la9030969
   Hadjichristidis N, 2009, CHEM REV, V109, P5528, DOI 10.1021/cr900049t
   Hamley IW, 2014, BIOMACROMOLECULES, V15, P1543, DOI 10.1021/bm500246w
   Hammouda B, 2004, MACROMOLECULES, V37, P6932, DOI 10.1021/ma049623d
   Hernandez H. R., 2003, J POLYM SCI A, V41, P1167
   Horkay F, 2008, COLLOID POLYM SCI, V286, P611, DOI 10.1007/s00396-008-1849-3
   Huang J, 2013, BIOMACROMOLECULES, V14, P200, DOI 10.1021/bm301629f
   Iatrou H, 2014, MACROMOL BIOSCI, V14, P1222, DOI 10.1002/mabi.201400137
   JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308
   Kim M, 2013, J POLYM SCI POL PHYS, V51, P587, DOI 10.1002/polb.23270
   Klok HA, 2001, ADV MATER, V13, P1217, DOI 10.1002/1521-4095(200108)13:16<1217::AID-ADMA1217>3.0.CO;2-D
   Kricheldorf HR, 2006, ANGEW CHEM INT EDIT, V45, P5752, DOI 10.1002/anie.200600693
   KRIMM S, 1971, P NATL ACAD SCI USA, V68, P2468, DOI 10.1073/pnas.68.10.2468
   KURTZ J, 1956, NATURE, V178, P1066, DOI 10.1038/1781066a0
   Liu DL, 2013, CHEM COMMUN, V49, P1229, DOI 10.1039/c2cc38343h
   MANDELKERN L, 1967, J PHYS CHEM-US, V71, P1163, DOI 10.1021/j100863a073
   Matsunaga T, 2009, MACROMOLECULES, V42, P6245, DOI 10.1021/ma901013q
   Mavrogiorgis D, 2014, POLYM CHEM-UK, V5, P6256, DOI 10.1039/c4py00687a
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Mi K, 2009, MACROMOL BIOSCI, V9, P437, DOI 10.1002/mabi.200800262
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Osada K, 2006, ADV POLYM SCI, V202, P113, DOI 10.1007/12_084
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Pochan DJ, 2002, MACROMOLECULES, V35, P5358, DOI 10.1021/ma025526d
   Saffer EM, 2014, SOFT MATTER, V10, P1905, DOI 10.1039/c3sm52395k
   Sato S, 2007, J AM CHEM SOC, V129, P873, DOI 10.1021/ja0655643
   Schatz C, 2009, ANGEW CHEM INT EDIT, V48, P2572, DOI 10.1002/anie.200805895
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Shi LQ, 2014, J AM CHEM SOC, V136, P12702, DOI 10.1021/ja505899g
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   STEINBERG IZ, 1958, BIOCHIM BIOPHYS ACTA, V28, P647, DOI 10.1016/0006-3002(58)90537-7
   STEINBERG IZ, 1960, J AM CHEM SOC, V82, P5263, DOI 10.1021/ja01505a001
   Tifany M. L., 1972, BIOPOLYMERS, V11, P2309
   Tooke L, 2010, BIOPOLYMERS, V93, P451, DOI 10.1002/bip.21361
   WALEY SG, 1949, PROC R SOC LON SER-A, V199, P499, DOI 10.1098/rspa.1949.0151
   Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035
   Yeon B, 2013, BIOMACROMOLECULES, V14, P3256, DOI 10.1021/bm400868j
   Zhang AF, 2008, CHEM-EUR J, V14, P8939, DOI 10.1002/chem.200801191
   Zhang SS, 2015, BIOMACROMOLECULES, V16, P1331, DOI 10.1021/acs.biomac.5b00124
   Zhang YF, 2011, MACROMOLECULES, V44, P6641, DOI 10.1021/ma201678r
NR 73
TC 3
Z9 3
U1 1
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2016
VL 17
IS 2
BP 399
EP 406
DI 10.1021/acs.biomac.5b01168
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DD4ES
UT WOS:000369875900001
PM 26736072
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Panzella, L
   Melone, L
   Pezzella, A
   Rossi, B
   Pastori, N
   Perfetti, M
   D'Errico, G
   Punta, C
   d'Ischia, M
AF Panzella, Lucia
   Melone, Lucio
   Pezzella, Alessandro
   Rossi, Bianca
   Pastori, Nadia
   Perfetti, Marco
   D'Errico, Gerardino
   Punta, Carlo
   d'Ischia, Marco
TI Surface-Functionalization of Nanostructured Cellulose Aerogels by Solid
   State Eumelanin Coating
SO BIOMACROMOLECULES
LA English
DT Article
ID TEMPO; CHEMISTRY; POLYDOPAMINE; NANOFIBRILS; TEMPLATES; POLYMER
AB Bioinspired aerogel functionalization by surface modification and coating is in high demand for biomedical and technological applications. In this paper, we report an expedient three-step entry to all-natural surface-functionalized nanostructured aerogels based on (a) TEMPO/NaClO promoted synthesis of cellulose nanofibers (TOCNF); (b) freeze-drying for aerogel preparation; and (c) surface coating with a eumelanin thin film by ammonia-induced solid state polymerization (AISSP) of 5,6-dihydroxyindole (DHI) or 5,6-dihydroxyindole-2-carboxylic acid (DHICA) previously deposited from an organic solution. Scanning electron microscopy showed uniform deposition of the dark eumelanin coating on the template surface without affecting porosity, whereas solid state C-13 NMR and electron paramagnetic resonance (EPR) spectroscopy confirmed the eumelanin-type character of the coatings. DHI melanin coating was found to confer to TOCNF templates a potent antioxidant activity, as tested by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays as well as strong dye adsorption capacity, as tested on methylene blue. The unprecedented combination of nanostructured cellulose and eumelanin thin films disclosed herein implements an original all-natural multifunctional aerogel biomaterial realized via an innovative coating methodology.
C1 [Panzella, Lucia; Pezzella, Alessandro; Perfetti, Marco; D'Errico, Gerardino; d'Ischia, Marco] Univ Naples Federico II, Dept Chem Sci, Complesso Univ Monte S Angelo,Via Cintia 4, I-80126 Naples, Italy.
   [Melone, Lucio; Rossi, Bianca; Pastori, Nadia; Punta, Carlo] Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Via Mancinelli 7, I-20131 Milan, Italy.
   [Melone, Lucio; Rossi, Bianca; Pastori, Nadia; Punta, Carlo] Politecn Milan, Natl Consortium Mat Sci & Technol, INSTM, Local Unit, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
   [Melone, Lucio] Univ E Campus, Via Isimbardi 10, I-22060 Novedrate, Como, Italy.
   [Perfetti, Marco; D'Errico, Gerardino] CSGI Consorzio Sviluppo Sistemi Grande Interfase, Florence, Italy.
RP Panzella, L (reprint author), Univ Naples Federico II, Dept Chem Sci, Complesso Univ Monte S Angelo,Via Cintia 4, I-80126 Naples, Italy.; Punta, C (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Via Mancinelli 7, I-20131 Milan, Italy.; Punta, C (reprint author), Politecn Milan, Natl Consortium Mat Sci & Technol, INSTM, Local Unit, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
EM panzella@unina.it; carlo.punta@polimi.it
RI Punta, Carlo/C-2657-2008; Pezzella, Alessandro/E-1440-2011
OI Punta, Carlo/0000-0002-7239-9554; Pezzella,
   Alessandro/0000-0001-6925-922X
FU Italian MIUR (PRIN) [2010PFLRJR_005]; Regione Toscana (POR FESR) [RSI
   2014]
FX We are grateful to Enrico Caneva (Centro Interdipartimentale Grandi
   Apparecchiature-CIGA, University of Milan, Italy) for <SUP>13</SUP>C
   CP-MAS NMR spectra. Italian MIUR (PRIN 2010-2011, PROxi Project
   2010PFLRJR_005) and Regione Toscana (POR FESR 2014-2020, Call RSI 2014,
   Project NanoBonD) are acknowledged for financial support
CR Aulin C, 2010, SOFT MATTER, V6, P3298, DOI 10.1039/c001939a
   Biliuta G, 2013, CARBOHYD POLYM, V91, P502, DOI 10.1016/j.carbpol.2012.08.047
   Boday DJ, 2010, J MATER CHEM, V20, P6863, DOI 10.1039/c0jm01448f
   Bonadies I, 2015, BIOMACROMOLECULES, V16, P1667, DOI 10.1021/acs.biomac.5b00239
   Cesareo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048849
   Chen WS, 2014, CHEMSUSCHEM, V7, P154, DOI 10.1002/cssc.201300950
   Chen WS, 2011, SOFT MATTER, V7, P10360, DOI 10.1039/c1sm06179h
   Coseri S, 2013, CARBOHYD POLYM, V93, P207, DOI 10.1016/j.carbpol.2012.03.086
   d'Ischia M, 2014, ACCOUNTS CHEM RES, V47, P3541, DOI 10.1021/ar500273y
   d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Dischia M., 2009, ANGEW CHEM, V121, P3972
   Dong H, 2013, BIOMACROMOLECULES, V14, P3338, DOI 10.1021/bm400993f
   Dreyer DR, 2013, CHEM SCI, V4, P3796, DOI 10.1039/c3sc51501j
   Edge R, 2006, PIGM CELL RES, V19, P443, DOI 10.1111/j.1600-0749.2006.00327.x
   GESSER HD, 1989, CHEM REV, V89, P765, DOI 10.1021/cr00094a003
   Gokmen V, 2009, TRENDS FOOD SCI TECH, V20, P278, DOI 10.1016/j.tifs.2009.03.010
   Goupy P, 2003, J AGR FOOD CHEM, V51, P615, DOI 10.1021/jf025938l
   Husing N, 1998, ANGEW CHEM INT EDIT, V37, P23, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<22::AID-ANIE22>3.0.CO;2-I
   Husing N., 1998, ANGEW CHEM INT EDIT, V110, P22
   Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e
   Ito S, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P167
   Jiang F, 2014, J MATER CHEM A, V2, P6337, DOI 10.1039/c4ta00743c
   Jiang F, 2014, J MATER CHEM A, V2, P350, DOI 10.1039/c3ta13629a
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kettunen M, 2011, ADV FUNCT MATER, V21, P510, DOI 10.1002/adfm.201001431
   Kobayashi Y, 2014, ANGEW CHEM, V126, P10562, DOI DOI 10.1002/ANGE.201405123
   Kobayashi Y, 2014, ANGEW CHEM INT EDIT, V53, P10394, DOI 10.1002/anie.201405123
   Korhonen JT, 2011, ACS NANO, V5, P1967, DOI 10.1021/nn200108s
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Leventis N, 2007, ACCOUNTS CHEM RES, V40, P874, DOI 10.1021/ar600033s
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Melone L, 2015, RSC ADV, V5, P83197, DOI 10.1039/c5ra16764g
   Melone L, 2015, CHEMPLUSCHEM, V80, P1408, DOI 10.1002/cplu.201500145
   Melone L, 2013, J PHOTOCH PHOTOBIO A, V261, P53, DOI 10.1016/j.jphotochem.2013.04.004
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Mostert AB, 2013, J PHYS CHEM B, V117, P4965, DOI 10.1021/jp401615e
   Mueller S, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41740
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Panzella L., 2013, ANGEW CHEM, V125, P12916
   Panzella L, 2013, ANGEW CHEM INT EDIT, V52, P12684, DOI 10.1002/anie.201305747
   PEKALA RW, 1989, J MATER SCI, V24, P3221, DOI 10.1007/BF01139044
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Pezzella A, 2015, MATER HORIZ, V2, P212, DOI 10.1039/c4mh00097h
   Pezzella A, 2013, J AM CHEM SOC, V135, P12142, DOI 10.1021/ja4067332
   Pierre AC, 2002, CHEM REV, V102, P4243, DOI 10.1021/cr0101306
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343
   Shimotoyodome A, 2011, BIOMACROMOLECULES, V12, P3812, DOI 10.1021/bm2010609
   Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y
   Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Vismara E, 2009, J HAZARD MATER, V170, P798, DOI 10.1016/j.jhazmat.2009.05.042
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Xu Q, 2014, RSC ADV, V4, P7845, DOI 10.1039/c3ra45879b
   Yang X, 2014, CHEM MATER, V26, P6016, DOI 10.1021/cm502873c
   Yordanov ND, 1999, J RADIOANAL NUCL CH, V240, P619, DOI 10.1007/BF02349422
NR 58
TC 17
Z9 17
U1 11
U2 116
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2016
VL 17
IS 2
BP 564
EP 571
DI 10.1021/acs.biomac.5b01497
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DD4ES
UT WOS:000369875900018
PM 26734842
DA 2018-10-20
ER

PT J
AU Liu, JMH
   Zhang, J
   Zhang, XM
   Hlavaty, KA
   Ricci, CF
   Leonard, JN
   Shea, LD
   Gower, RM
AF Liu, Jeffrey M. H.
   Zhang, Jesse
   Zhang, Xiaomin
   Hlavaty, Kelan A.
   Ricci, Christine F.
   Leonard, Joshua N.
   Shea, Lonnie D.
   Gower, R. Michael
TI Transforming growth factor-beta 1 delivery from microporous scaffolds
   decreases inflammation post-implant and enhances function of
   transplanted islets
SO BIOMATERIALS
LA English
DT Article
DE Immunoengineering; Immunomodulation; Transplant; Scaffold; Leukocyte
ID T-CELL-ACTIVATION; ALLOGRAFT-REJECTION; TGF-BETA; IN-VIVO; HYDROGEL
   SCAFFOLDS; POLYMER SCAFFOLDS; CHITOSAN SCAFFOLD; CARTILAGE REPAIR;
   DENDRITIC CELLS; IMMUNE CELLS
AB Biomaterial scaffolds are central to many regenerative strategies as they create a space for infiltration of host tissue and provide a platform to deliver growth factors and progenitor cells. However, biomaterial implantation results in an unavoidable inflammatory response, which can impair tissue regeneration and promote loss or dysfunction of transplanted cells. We investigated localized TGF-beta 1 delivery to modulate this immunological environment around scaffolds and transplanted cells. TGF-beta 1 was delivered from layered scaffolds, with protein entrapped within an inner layer and outer layers designed for cell seeding and host tissue integration. Scaffolds were implanted into the epididymal fat pad, a site frequently used for cell transplantation. Expression of cytokines TNF-alpha, IL-12, and MCP-1 were decreased by at least 40% for scaffolds releasing TGF-beta 1 relative to control scaffolds. This decrease in inflammatory cytokine production corresponded to a 60% decrease in leukocyte infiltration. Transplantation of islets into diabetic mice on TGF-beta 1 scaffolds significantly improved the ability of syngeneic islets to control blood glucose levels within the first week of transplant and delayed rejection of allogeneic islets. Together, these studies emphasize the ability of localized TGF-beta 1 delivery to modulate the immune response to biomaterial implants and enhance cell function in cell-based therapies. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Liu, Jeffrey M. H.] Northwestern Univ, Interdisciplinary Biol Sci Program, Evanston, IL 60208 USA.
   [Liu, Jeffrey M. H.; Shea, Lonnie D.] Univ Michigan, Dept Biomed Engn, 1119 Carl A Gerstacker Bldg,2200 Bonisteel Blvd, Ann Arbor, MI 48109 USA.
   [Zhang, Jesse; Hlavaty, Kelan A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Zhang, Xiaomin] Northwestern Univ, Dept Surg, Div Transplantat, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Ricci, Christine F.; Leonard, Joshua N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   [Gower, R. Michael] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.
   [Gower, R. Michael] Univ S Carolina, Biomed Engn Program, Columbia, SC 29208 USA.
RP Shea, LD (reprint author), Univ Michigan, Dept Biomed Engn, 1119 Carl A Gerstacker Bldg,2200 Bonisteel Blvd, Ann Arbor, MI 48109 USA.; Gower, RM (reprint author), Univ S Carolina, Dept Chem Engn, Swearingen Engn Ctr, Room 2C21,301 Main St, Columbia, SC 29108 USA.
EM ldshea@umich.edu; gowerrm@mailbox.sc.edu
RI Leonard, Joshua/B-7649-2009
OI Liu, Jeffrey/0000-0003-0129-8569; Leonard, Joshua/0000-0003-4359-6126
FU National Institutes of Biomedical Imaging and Bioengineering (NIBIB) at
   the National Institutes of Health (NIH) [R01 EB009910, R01 EB005678, R01
   CA173745]; National Institute of General Medical Sciences at the NIH
   [P20 GM103641, T32 GM008449]; Juvenile Diabetes Research Foundation;
   Northwestern University RHLCCC Flow Cytometry Facility; Cancer Center
   Support Grant (NCI) [CA060553]
FX Financial support for this research was provided by the National
   Institutes of Biomedical Imaging and Bioengineering (NIBIB) at the
   National Institutes of Health (NIH) through grant number R01 EB009910,
   R01 EB005678, and R01 CA173745, the National Institute of General
   Medical Sciences at the NIH through grant numbers P20 GM103641 and T32
   GM008449, and the Juvenile Diabetes Research Foundation. This work was
   also supported by the Northwestern University RHLCCC Flow Cytometry
   Facility and a Cancer Center Support Grant (NCI CA060553).
CR Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007
   Agostini C, 2001, AM J PATHOL, V158, P1703, DOI 10.1016/S0002-9440(10)64126-0
   Arita S, 1998, TRANSPLANTATION, V65, P1429, DOI 10.1097/00007890-199806150-00003
   Beilke JN, 2005, NAT MED, V11, P1059, DOI 10.1038/nm1296
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Bonham C A, 1996, Transpl Immunol, V4, P186, DOI 10.1016/S0966-3274(96)80015-3
   Bryant J, 2014, BIOMATERIALS, V35, P8887, DOI 10.1016/j.biomaterials.2014.06.044
   Chen XJ, 2007, TRANSPLANTATION, V84, P122, DOI 10.1097/01.tp.0000266909.58117.e3
   Chou CH, 2006, J BIOMED MATER RES B, V77B, P338, DOI 10.1002/jbm.b.30432
   Clatworthy MR, 2013, AM J TRANSPLANT, V13, P1629, DOI 10.1111/ajt.12309
   Cogger K, 2015, ENDOCRINOLOGY, V156, P8, DOI 10.1210/en.2014-1691
   Cucchiarini M, 2006, CENT EUR J BIOL, V1, P43, DOI 10.2478/s11535-006-0004-8
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706
   Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040
   Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x
   Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2
   Geissmann F, 1999, J IMMUNOL, V162, P4567
   Gibly RF, 2011, BIOMATERIALS, V32, P9677, DOI 10.1016/j.biomaterials.2011.08.084
   Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31
   Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Heeger PS, 2003, AM J TRANSPLANT, V3, P525, DOI 10.1034/j.1600-6143.2003.00123.x
   Hlavaty KA, 2014, AM J TRANSPLANT, V14, P1523, DOI 10.1111/ajt.12742
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kobie JJ, 2003, CANCER RES, V63, P1860
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183
   Lee JE, 2004, ARTIF ORGANS, V28, P829, DOI 10.1111/j.1525-1594.2004.00020.x
   Leshansky L, 2014, STEM CELLS, V32, P3137, DOI 10.1002/stem.1833
   Li YS, 2013, CELL TRANSPLANT, V22, P685, DOI 10.3727/096368912X655163
   Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200
   Liu WT, 2012, J IMMUNOL, V188, P2703, DOI 10.4049/jimmunol.1102997
   Makhlouf L, 2003, J AM SOC NEPHROL, V14, P2168, DOI 10.1097/01.ASN.0000079041.15707.A9
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Oberbarnscheidt MH, 2014, J CLIN INVEST, V124, P3579, DOI 10.1172/JCI74370
   Olieslagers S, 2011, CARDIOVASC RES, V91, P510, DOI 10.1093/cvr/cvr100
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Piccotti JR, 1999, TRANSPLANTATION, V67, P1453, DOI 10.1097/00007890-199906150-00011
   ROAKE JA, 1993, EXP NEPHROL, V1, P90
   Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x
   Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219
   Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778
   Stolp J, 2014, NAT REV NEPHROL, V10, P389, DOI 10.1038/nrneph.2014.80
   Vassalli G, 2013, J TRANSPLANT, DOI 10.1155/2013/761429
   WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44
   Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20
   Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002
   Zecher D, 2009, J IMMUNOL, V183, P7810, DOI 10.4049/jimmunol.0902194
   Zeng Q, 2014, J CLIN INVEST, V124, P1052, DOI 10.1172/JCI70084
NR 61
TC 15
Z9 16
U1 6
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2016
VL 80
BP 11
EP 19
DI 10.1016/j.biomaterials.2015.11.065
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7HS
UT WOS:000370094900002
PM 26701143
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hu, WW
   Wang, Z
   Krebsbach, PH
AF Hu, Wei-Wen
   Wang, Zhuo
   Krebsbach, Paul H.
TI Virus immobilization on biomaterial scaffolds through biotin-avidin
   interaction for improving bone regeneration
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE tissue engineering; gene delivery; biotin-avidin; biomaterial scaffolds;
   bone regeneration; gene therapy; critical-sized bone defect
ID MARROW STROMAL CELLS; VIVO GENE-THERAPY; MORPHOGENETIC PROTEIN-2;
   IN-VIVO; DELIVERY; ADENOVIRUS; DEFECTS; STRATEGIES; EXPRESSION;
   HYDROGELS
AB To spatially control therapeutic gene delivery for potential tissue engineering applications, a biotin-avidin interaction strategy was applied to immobilize viral vectors on biomaterial scaffolds. Both adenoviral vectors and gelatin sponges were biotinylated and avidin was applied to link them in a virus-biotin-avidin-biotin-material (VBABM) arrangement. The tethered viral particles were stably maintained within scaffolds and SEM images illustrated that viral particles were evenly distributed in three-dimensional (3D) gelatin sponges. An in vivo study demonstrated that transgene expression was restricted to the implant sites only and transduction efficiency was improved using this conjugation method. For an orthotopic bone regeneration model, adenovirus encoding BMP-2 (AdBMP2) was immobilized to gelatin sponges before implanting into critical-sized bone defects in rat calvaria. Compared to gelatin sponges with AdBMP2 loaded in a freely suspended form, the VBABM method enhanced gene transfer and bone regeneration was significantly improved. These results suggest that biotin-avidin immobilization of viral vectors to biomaterial scaffolds may be an effective strategy to facilitate tissue regeneration. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Hu, Wei-Wen; Wang, Zhuo; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, K1030,1011 N Univ Ave, Ann Arbor, MI 48109 USA.
   [Hu, Wei-Wen] Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongda Rd, Jhongli, Taoyuan County, Taiwan.
   [Hu, Wei-Wen; Krebsbach, Paul H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Krebsbach, PH (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, K1030,1011 N Univ Ave, Ann Arbor, MI 48109 USA.; Hu, WW (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongda Rd, Jhongli, Taoyuan County, Taiwan.
EM huweiwen@cc.ncu.edu.tw; paulk@umich.edu
FU National Institutes of Health [RO1 DE018890]; National Science Council
   of Taiwan [NSC 98-2218-E-008-009]
FX This research was supported by the National Institutes of Health (Grant
   No. RO1 DE018890, to P.H.K.) and the National Science Council of Taiwan
   (NSC 98-2218-E-008-009). The authors acknowledge and thank Dr Renny
   Franceschi for the use of the AdBMP construct.
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   Adachi N, 2002, J RHEUMATOL, V29, P1920
   ASGHAR A, 1982, ADV FOOD RES, V28, P231
   Betz OB, 2006, J BONE JOINT SURG AM, V88A, P355, DOI 10.2106/JBJS.E.00464
   Bleiziffer O, 2007, J CELL MOL MED, V11, P206, DOI 10.1111/j.1582-4934.2007.00027.x
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carragee EJ, 2011, SPINE J, V11, P463, DOI 10.1016/j.spinee.2011.06.001
   Costa-Pinto AR, 2012, J TISSUE ENG REGEN M, V6, P21, DOI 10.1002/term.391
   Drosse I, 2008, INJURY, V39, pS9, DOI 10.1016/S0020-1383(08)70011-1
   Dupont KM, 2012, CELL TISSUE RES, V347, P575, DOI 10.1007/s00441-011-1197-3
   Evans CH, 2012, ADV DRUG DELIVER REV, V64, P1331, DOI 10.1016/j.addr.2012.03.013
   Fishbein I, 2005, J CONTROL RELEASE, V109, P37, DOI 10.1016/j.jconrel.2005.09.031
   Gersbach CA, 2007, BIOMATERIALS, V28, P5121, DOI 10.1016/j.biomaterials.2007.07.047
   Giannoni P, 2008, J TISSUE ENG REGEN M, V2, P253, DOI 10.1002/term.90
   Giannoudis PV, 2005, INJURY, V36, P47, DOI 10.1016/j.injury.2005.07.035
   Gonzalez AM, 2009, J GENE MED, V11, P679, DOI 10.1002/jgm.1354
   Gu DL, 2004, MOL THER, V9, P699, DOI 10.1016/j.ymthe.2004.02.018
   Hellio-Serughetti D, 2006, LANGMUIR, V22, P8509, DOI 10.1021/la060375j
   Hirashima M, 2003, P NATL ACAD SCI USA, V100, P15637, DOI 10.1073/pnas.2635424100
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Hu WW, 2008, J GENE MED, V10, P1102, DOI 10.1002/jgm.1233
   Hu WW, 2009, BIOMATERIALS, V30, P5785, DOI 10.1016/j.biomaterials.2009.06.041
   Hu WW, 2009, J CONTROL RELEASE, V135, P250, DOI 10.1016/j.jconrel.2009.01.020
   Jang JH, 2010, GENE THER, V17, P1384, DOI 10.1038/gt.2010.81
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Luhmann SJ, 2005, SPINE, V30, pS110, DOI 10.1097/01.brs.0000175184.27407.6a
   Musgrave DS, 2002, J BONE JOINT SURG BR, V84B, P120, DOI 10.1302/0301-620X.84B1.11708
   Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934
   Peterson CY, 2009, BIOMATERIALS, V30, P6788, DOI 10.1016/j.biomaterials.2009.07.069
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Saito E, 2013, J TISSUE ENG REGEN M, V7, P99, DOI 10.1002/term.497
   Schek RM, 2006, BIOMATERIALS, V27, P1160, DOI 10.1016/j.biomaterials.2005.07.029
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Uemura T, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/3/034405
   Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110
   Zhang Y, 2010, BIOMATERIALS, V31, P3231, DOI 10.1016/j.biomaterials.2010.01.029
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
   Zhang YF, 2011, TISSUE ENG PART C-ME, V17, P789, DOI 10.1089/ten.tec.2010.0453
NR 40
TC 3
Z9 3
U1 4
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD FEB
PY 2016
VL 10
IS 2
BP E63
EP E72
DI 10.1002/term.1774
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DD7UX
UT WOS:000370131300003
PM 23798490
DA 2018-10-20
ER

PT J
AU Chun, YY
   Wang, JK
   Tan, NS
   Chan, PPY
   Tan, TTY
   Choong, C
AF Chun, Yong Yao
   Wang, Jun Kit
   Tan, Nguan Soon
   Chan, Peggy Puk Yik
   Tan, Timothy Thatt Yang
   Choong, Cleo
TI A Periosteum-Inspired 3D Hydrogel-Bioceramic Composite for Enhanced Bone
   Regeneration
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; biomaterial; biomineralization; biopolymers; hydrogels
ID MESENCHYMAL STEM-CELLS; GRAFT; HYDROXYAPATITE; SCAFFOLD;
   DIFFERENTIATION; SUBSTITUTES; EXTRACTION; POROSITY
AB A 3D injectable hydrogel-bioceramic composite consisting of gelatin-3-(4-hydroxyphenyl) propionic acid (Gtn-HPA) and carboxymethyl cellulose-tyramine (CMC-Tyr), incorporated with fish scale-derived calcium phosphate (CaP), is developed for bone applications. The hydrogel-bioceramic composite has significantly improved the elastic modulus compared to the non-filled hydrogel, of which the addition of 10w/v% CaP showed zero order fluorescein isothiocyanate (FITC)-dextran release profile and a significantly higher proliferation rate of encapsulated cells. All the samples promote the nucleation and growth of CaP minerals when exposed to 1x SBF. Overall, the hydrogel-bioceramic composite with 10w/v% CaP can potentially be used as a periosteum-mimicking membrane to facilitate bone regeneration.
C1 [Chun, Yong Yao; Tan, Timothy Thatt Yang] Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.
   [Choong, Cleo] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Tan, Nguan Soon; Choong, Cleo] KK Womens & Children Hosp, KK Res Ctr, 100 Bukit Timah Rd, Singapore 229899, Singapore.
   [Wang, Jun Kit] Nanyang Technol Univ, Residues & Resource Reclamat Ctr, Nanyang Environm & Water Res Inst, 1 Cleantech Loop, Singapore 637141, Singapore.
   [Wang, Jun Kit] Nanyang Technol Univ, Interdisciplinary Grad Sch, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Tan, Nguan Soon] ASTAR, Inst Mol & Cell Biol, Proteos, 61 Biopolis Dr, Singapore 138673, Singapore.
   [Chan, Peggy Puk Yik] Swinburne Univ Technol, Dept Telecommun Elect Robot & Biomed Engn, Hawthorn, Vic 3122, Australia.
   [Chan, Peggy Puk Yik] Melbourne Ctr Nanofabricat, Clayton, Vic 3168, Australia.
RP Tan, TTY (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.; Choong, C (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.; Choong, C (reprint author), KK Womens & Children Hosp, KK Res Ctr, 100 Bukit Timah Rd, Singapore 229899, Singapore.
EM tytan@ntu.edu.sg
RI Choong, Cleo/A-2240-2011
OI Tan, Nguan Soon/0000-0003-0136-7341
FU Singapore Ministry of Education Academic Research Fund (AcRF [ARC16/11];
   Singapore National Research Foundation under its Environmental & Water
   Technologies Strategic Research Programme
FX The authors would like to acknowledge the funding support from the
   Singapore Ministry of Education Academic Research Fund (AcRF) Tier 2
   ARC16/11. This research grant is also supported by the Singapore
   National Research Foundation under its Environmental & Water
   Technologies Strategic Research Programme and administered by the
   Environment & Water Industry Programme Office (EWI) of the Public
   Utility Board (PUB).
CR Al-Abboodi A, 2014, ADV HEALTHC MATER, V3, P725, DOI 10.1002/adhm.201300303
   Al-Abboodi A, 2013, BIOTECHNOL BIOENG, V110, P318, DOI 10.1002/bit.24612
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Daculsi G, 2014, SPRING SER BIOMAT S, V2, P71, DOI 10.1007/978-3-642-53980-0_4
   Elbert DL, 2011, ACTA BIOMATER, V7, P31, DOI 10.1016/j.actbio.2010.07.028
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Hoffman MD, 2013, BIOMATERIALS, V34, P8887, DOI 10.1016/j.biomaterials.2013.08.005
   Kang YQ, 2014, ACS APPL MATER INTER, V6, P9622, DOI 10.1021/am502056q
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lewicki J. P., 2008, SCI TECHNOLOGY ADV M, V9, P1
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Lu L. X., 2012, ACS APPL MATER INTER, V5, P319
   Ma P.X., 2005, SCAFFOLDING TISSUE E
   Manjubala I, 2002, J BIOMED MATER RES, V63, P200, DOI 10.1002/jbm.10128
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Murphy K. A., 2008, REGULATION MATRIX ME
   Neffe AT, 2011, ACTA BIOMATER, V7, P1693, DOI 10.1016/j.actbio.2010.11.025
   Panda NN, 2014, BIOPROC BIOSYST ENG, V37, P433, DOI 10.1007/s00449-013-1009-0
   Park KM, 2011, J MATER CHEM, V21, P13180, DOI 10.1039/c1jm12527c
   Pek YS, 2009, BIOMATERIALS, V30, P822, DOI 10.1016/j.biomaterials.2008.10.053
   Reddy AS, 2005, J PHYS CHEM A, V109, P8893, DOI 10.1021/jp0525179
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Sun HL, 2014, BIOMATERIALS, V35, P1176, DOI 10.1016/j.biomaterials.2013.10.054
   Wang LS, 2012, ACTA BIOMATER, V8, P1826, DOI 10.1016/j.actbio.2012.02.002
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
   Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Xu D, 2015, MACROMOLECULES, V48, P840, DOI 10.1021/ma502111p
   Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6
NR 33
TC 5
Z9 5
U1 12
U2 70
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD FEB
PY 2016
VL 16
IS 2
BP 276
EP 287
DI 10.1002/mabi.201500258
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DD7DD
UT WOS:000370083000012
PM 26445013
DA 2018-10-20
ER

PT J
AU Gerber, L
   Ohman, D
   Kumar, M
   Ranocha, P
   Goffner, D
   Sundberg, B
AF Gerber, Lorenz
   Ohman, David
   Kumar, Manoj
   Ranocha, Philippe
   Goffner, Deborah
   Sundberg, Bjorn
TI High-throughput microanalysis of large lignocellulosic sample sets by
   pyrolysis-gas chromatography/mass spectrometry
SO PHYSIOLOGIA PLANTARUM
LA English
DT Article
ID CELL WALL POLYSACCHARIDES; FT-IR MICROSPECTROSCOPY; COBRA-LIKE PROTEIN;
   LIGNIN DEPOSITION; HYBRID POPLAR; WOOD; ENCODES; PLANTS; AUXIN; XYLEM
AB High-throughput analytical techniques to assess the chemistry of lignocellulosic plant material are crucial to plant cell-wall research. We have established an analytical platform for this purpose and demonstrated its usefulness with two applications. The system is based on analytical pyrolysis, coupled to gas chromatography/mass spectrometry - a technique particularly suited for analysis of lignocellulose. Automated multivariate-based data-processing methods are used to obtain results within a few hours after analysis, with an experimental batch of 500 analyzed samples. The usefulness of multivariate sample discrimination methods and hierarchical clustering of samples is demonstrated. We have analyzed an Arabidopsis mutant collection consisting of 300 samples representing 31 genotypes. The mutant collection is presented through cluster analysis, based on chemotypic difference, with respect to wild type. Further, we have analyzed 500 thin sections from five biological replicate trees to create a spatial highly resolved profile of the proportions of syringyl-, guaiacyl- and p-hydroxyphenyl lignin across phloem, developing and mature wood in aspen. The combination of biologically easy to interpret information, the low demand of sample amount and the flexibility in sample types amenable to analysis makes this technique a valuable extension to the range of established high-throughput biomaterial analytical platforms.
C1 [Gerber, Lorenz; Ohman, David; Kumar, Manoj; Sundberg, Bjorn] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.
   [Ranocha, Philippe; Goffner, Deborah] Univ Toulouse, Lab Rech Sci Vegetales, Castanet Tolosan, France.
   [Ranocha, Philippe; Goffner, Deborah] CNRS, Lab Rech Sci Vegetales, Castanet Tolosan, France.
   [Kumar, Manoj] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.
   [Goffner, Deborah] Fac Med, Sect Nord, UMI 3189, Environm,Sante,Soc, 51 Bd Pierre Dramard, F-133444 Marseille 15, France.
RP Gerber, L (reprint author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.
EM lorenz.gerber@slu.se
OI Ohman, David/0000-0001-6006-8494; Goffner, Deborah/0000-0002-1232-7911
FU FORMAS (Func-Fiber/Bioimprove - centre of excellence in wood science);
   Vetenskapsradet; Swedish Energy Agency; EU Programme Renewall; VINNOVA;
   French National Research Agency (ANR Genoplante WALLTALK)
   [ANR-07-GPLA-014]; Bio4Energy; Swedish Programme for renewable energy
FX This work was supported by grants from FORMAS (Func-Fiber/Bioimprove -
   centre of excellence in wood science), Vetenskapsradet, the Swedish
   Energy Agency, EU Programme Renewall (FP7/2007-2013), VINNOVA, the
   French National Research Agency (ANR Genoplante WALLTALK
   ANR-07-GPLA-014) and Bio4Energy, the Swedish Programme for renewable
   energy. The authors would like to thank Amandine Freydier for her
   invaluable help in identifying the homozygous Arabidopsis lines.
CR Alves A, 2006, J ANAL APPL PYROL, V76, P209, DOI 10.1016/j.jaap.2005.11.004
   Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103
   Bauer S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00045
   Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542
   Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006
   Coleman HD, 2008, P NATL ACAD SCI USA, V105, P4501, DOI 10.1073/pnas.0706537105
   del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n
   Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x
   DONALDSON LA, 1994, WOOD SCI TECHNOL, V28, P111
   Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8
   FAIX O, 1990, HOLZ ROH WERKST, V48, P281
   FUKUSHIMA K, 1990, J WOOD CHEM TECHNOL, V10, P413, DOI 10.1080/02773819008050250
   Gerber L, 2012, J ANAL APPL PYROL, V95, P95, DOI 10.1016/j.jaap.2012.01.011
   Gorzsas A, 2014, METHODS MOL BIOL, V1062, P317, DOI 10.1007/978-1-62703-580-4_18
   Gorzsas A, 2011, PLANT J, V66, P903, DOI 10.1111/j.1365-313X.2011.04542.x
   Goubet F, 2002, ANAL BIOCHEM, V300, P53, DOI 10.1006/abio.2001.5444
   Gunl M, 2011, METHODS MOL BIOL, V715, P43, DOI 10.1007/978-1-61779-008-9_3
   Hedenstrom M, 2009, MOL PLANT, V2, P933, DOI 10.1093/mp/ssp047
   Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398
   Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a
   Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047
   Kolukisaoglu U, 2010, PLANT SCI, V178, P476, DOI 10.1016/j.plantsci.2010.03.006
   Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775
   Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064
   Meier D., 1992, METHODS LIGNIN CHEM, P177
   Moldoveanu SC, 2005, ANAL PYROLYSIS SYNTH, P439
   Moldoveanu SC, 1998, ANAL PYROLYSIS NATUR, V3-7, P291
   Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x
   Mouille G, 2003, PLANT J, V35, P393, DOI 10.1046/j.1365-313X.2003.01807.x
   Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985
   Pesquet E, 2005, PLANT PHYSIOL, V139, P1821, DOI 10.1104/pp.105.064337
   Pinto RC, 2012, ANAL CHEM, V84, P8675, DOI 10.1021/ac301869p
   R Core Team, 2013, R LANG ENV STAT COMP
   Ranocha P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3625
   Ranocha P, 2010, PLANT J, V63, P469, DOI 10.1111/j.1365-313X.2010.04256.x
   Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x
   Rolando C, 1992, METHODS LIGNIN CHEM, P334
   Ruegger M, 2001, GENETICS, V159, P1741
   Santoro N, 2010, BIOENERG RES, V3, P93, DOI 10.1007/s12155-009-9074-6
   Sindhu A, 2007, PLANT PHYSIOL, V145, P1444, DOI 10.1104/pp.107.102582
   Terashima N, 2004, CR BIOL, V327, P903, DOI 10.1016/j.crvi.2004.08.001
   TERASHIMA N, 1990, J PULP PAP SCI, V16, pJ150
   Tuskan G, 1999, APPL BIOCHEM BIOTECH, V77-9, P55, DOI 10.1385/ABAB:77:1-3:55
   Uggla C, 1998, PLANT PHYSIOL, V117, P113, DOI 10.1104/pp.117.1.113
   Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282
   Uggla C, 2001, WOOD FORMATION TREES, P215
   WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967
   Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971
   Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501
NR 49
TC 3
Z9 3
U1 1
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0031-9317
EI 1399-3054
J9 PHYSIOL PLANTARUM
JI Physiol. Plant.
PD FEB
PY 2016
VL 156
IS 2
BP 127
EP 138
DI 10.1111/ppl.12397
PG 12
WC Plant Sciences
SC Plant Sciences
GA DD8JE
UT WOS:000370171900001
PM 26477543
OA Green Published
DA 2018-10-20
ER

PT J
AU Viti, F
   Landini, M
   Mezzelani, A
   Petecchia, L
   Milanesi, L
   Scaglione, S
AF Viti, Federica
   Landini, Martina
   Mezzelani, Alessandra
   Petecchia, Loredana
   Milanesi, Luciano
   Scaglione, Silvia
TI Osteogenic Differentiation of MSC through Calcium Signaling Activation:
   Transcriptomics and Functional Analysis
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VIVO; BONE
   REGENERATION; POROUS HYDROXYAPATITE; PHOSPHATE CERAMICS; GENE LISTS;
   MODEL; TISSUE; BEHAVIOR
AB The culture of progenitor mesenchymal stem cells (MSC) onto osteoconductive materials to induce a proper osteogenic differentiation and mineralized matrix regeneration represents a promising and widely diffused experimental approach for tissue-engineering (TE) applications in orthopaedics. Among modern biomaterials, calcium phosphates represent the best bone substitutes, due to their chemical features emulating the mineral phase of bone tissue. Although many studies on stem cells differentiation mechanisms have been performed involving calcium-based scaffolds, results often focus on highlighting production of in vitro bone matrix markers and in vivo tissue ingrowth, while information related to the biomolecular mechanisms involved in the early cellular calcium-mediated differentiation is not well elucidated yet. Genetic programs for osteogenesis have been just partially deciphered, and the description of the different molecules and pathways operative in these differentiations is far from complete, as well as the activity of calcium in this process. The present work aims to shed light on the involvement of extracellular calcium in MSC differentiation: a better understanding of the early stage osteogenic differentiation program of MSC seeded on calcium-based biomaterials is required in order to develop optimal strategies to promote osteogenesis through the use of new generation osteoconductive scaffolds. A wide spectrum of analysis has been performed on time-dependent series: gene expression profiles are obtained from samples (MSC seeded on calcium-based scaffolds), together with related microRNAs expression and in vivo functional validation. On this basis, and relying on literature knowledge, hypotheses are made on the biomolecular players activated by the biomaterial calcium-phosphate component. Interestingly, a key role of miR-138 was highlighted, whose inhibition markedly increases osteogenic differentiation in vitro and enhance ectopic bone formation in vivo. Moreover, there is evidence that Ca-P substrate triggers osteogenic differentiation through genes (SMAD and RAS family) that are typically regulated during dexamethasone (DEX) induced differentiation.
C1 [Viti, Federica; Petecchia, Loredana] CNR, Inst Biophys, Genoa, Italy.
   [Viti, Federica; Landini, Martina; Mezzelani, Alessandra; Milanesi, Luciano] CNR, Inst Biomed Technol, Segrate, MI, Italy.
   [Scaglione, Silvia] CNR, Inst Elect Comp & Telecommun Engn, Genoa, Italy.
   [Scaglione, Silvia] Adv Biotechnol Ctr CBA, Genoa, Italy.
RP Scaglione, S (reprint author), CNR, Inst Elect Comp & Telecommun Engn, Genoa, Italy.; Scaglione, S (reprint author), Adv Biotechnol Ctr CBA, Genoa, Italy.
EM silvia.scaglione@ieiit.cnr.it
RI Mezzelani, Alessandra/B-3355-2014; Scaglione, Silvia/B-7124-2014
OI Scaglione, Silvia/0000-0002-9464-3554; Milanesi,
   Luciano/0000-0002-1201-3939; MEZZELANI, ALESSANDRA/0000-0001-7563-5869
FU Italian Ministry of Education and Research (MIUR) [PB05, RBFR13V4M2]
FX This work has been supported by the Italian Ministry of Education and
   Research (MIUR) through Flagship "InterOmics" (PB05) (received by SS)
   and through "Futuro in Ricerca 2013" (RBFR13V4M2) (received by FV).
CR Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bosch P, 2000, J ORTHOP RES, V18, P933, DOI 10.1002/jor.1100180613
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Carlier A, 2011, ACTA BIOMATER, V7, P3573, DOI 10.1016/j.actbio.2011.06.021
   Caterson E J, 2001, MedGenMed, pE1
   Chai YC, 2011, TISSUE ENG PT A, V17, P1083, DOI [10.1089/ten.TEA.2010.0160, 10.1089/ten.tea.2010.0160]
   Chan WC, 2012, GENOMICS, V100, P141, DOI 10.1016/j.ygeno.2012.06.007
   Delaine-Smith RM, 2011, VITAM HORM, V87, P417, DOI 10.1016/B978-0-12-386015-6.00039-1
   Deshpande S, 2013, J SURG RES, V185, P278, DOI 10.1016/j.jss.2013.06.063
   Dua R, 2014, J BIOMED MATER RES B, V102, P922, DOI 10.1002/jbm.b.33073
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093
   Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108
   Eyckmans J, 2010, J CELL MOL MED, V14, P1845, DOI 10.1111/j.1582-4934.2009.00807.x
   Farina NM, 2008, J MATER SCI-MATER M, V19, P1565, DOI 10.1007/s10856-008-3400-y
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009
   Gosain AK, 2005, PLAST RECONSTR SURG, V116, P1044, DOI 10.1097/01.prs.0000178402.77445.44
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Graneli C, 2014, STEM CELL RES, V12, P153, DOI 10.1016/j.scr.2013.09.009
   Guasch G, 2004, M S-MED SCI, V20, P265, DOI 10.1051/medsci/2004203265
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Hronik-Tupaj M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-9
   Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107
   Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183
   Johnston N, 2004, DRUG DISCOV TODAY, V9, P994, DOI 10.1016/S1359-6446(04)03271-4
   Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129
   Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371
   Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Lee MW, 2013, BIOMED RES INT, DOI 10.1155/2013/154919
   Levi B, 2013, PLAST RECONSTR SURG, V132, P580, DOI 10.1097/PRS.0b013e31829ace13
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031
   Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264
   MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mizuno Hiroshi, 2003, Journal of Nippon Medical School, V70, P300
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   Nair MB, 2009, J BIOMED MATER RES A, V90A, P533, DOI 10.1002/jbm.a.32114
   Noro T, 1999, BIO-MED MATER ENG, V9, P319
   Olszewski Waldemar L, 2004, Ann Transplant, V9, P34
   Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5
   Parrington J, 2014, ACTA PHYSIOL, V211, P285, DOI 10.1111/apha.12298
   Pennesi G, 2011, CURR PHARM BIOTECHNO, V12, P151, DOI 10.2174/138920111794295684
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   R Development Core Team, 2008, R LANG ENV STAT COMP
   Reh TA, 2001, BRAIN BEHAV EVOLUT, V58, P296, DOI 10.1159/000057571
   Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378
   Ren JQ, 2011, CYTOTHERAPY, V13, P661, DOI 10.3109/14653249.2010.548379
   Rezaee F, 2010, PLOS ONE, V5, P9690
   Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101
   Scaglione S., 2012, SCI REPORTS, V2
   Schellenberg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094353
   Shah A, 2013, RAVAZI INT J MED, V1, P5
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Song W, 2011, J BIOACT COMPAT POL, V26, P242, DOI 10.1177/0883911511406327
   Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com
   Teixeira S, 2010, J BIOMED MATER RES A, V93A, P567, DOI 10.1002/jbm.a.32532
   Tsuzuki N, 2012, RES VET SCI, V93, P1021, DOI 10.1016/j.rvsc.2011.12.002
   von Heydebreck A, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P623
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
   Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061
   Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675
   Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 79
TC 11
Z9 12
U1 3
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 1
PY 2016
VL 11
IS 2
AR e0148173
DI 10.1371/journal.pone.0148173
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9NL
UT WOS:000369548200078
PM 26828589
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Javanbakht, M
   Salahinejad, E
   Hadianfard, MJ
AF Javanbakht, M.
   Salahinejad, E.
   Hadianfard, M. J.
TI The effect of sintering temperature on the structure and mechanical
   properties of medical-grade powder metallurgy stainless steels
SO POWDER TECHNOLOGY
LA English
DT Article
DE Nanostructured materials; Sintering; Mechanical properties
ID BIOMEDICAL APPLICATIONS; SLIDING WEAR; NITROGEN; EVOLUTION; BEHAVIOR;
   ALLOY
AB Nanostructured medical-grade stainless steel powders with the chemical composition of ASTM F2581 were liquid-phase sintered with 6 wt.% Mn-Si additive at different temperatures ranging from 1000 degrees C to 1300 degrees C. The effect of sintering temperature on the structure and mechanical properties of the samples was investigated. Structural characteristics like porosity, austenite crystallite/grain size, and retained ferrite were analyzed by optical microscopy, Archimedes densitometry, X-ray diffraction, transmission electron microscopy, and ferritometry. The corresponding results showed that residual porosity in the sintered specimens was reduced by increasing the sintering temperature; in contrast, the crystallite/grain sizes were enhanced. The study of the mechanical properties, including hardness, compressive, and abrasive wear behaviors, of the samples indicated that the optimum mechanical properties were obtained for the sintering temperature of 1150 degrees C, which were superior to those of AISI 316L stainless steel used as a conventional biomaterial. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Javanbakht, M.; Hadianfard, M. J.] Shiraz Univ, Sch Engn, Dept Mat Sci & Engn, Shiraz, Iran.
   [Salahinejad, E.] KN Toosi Univ Technol, Fac Mat Sci & Engn, Tehran, Iran.
RP Salahinejad, E (reprint author), KN Toosi Univ Technol, Fac Mat Sci & Engn, Tehran, Iran.
EM salahinejad@kntu.ac.ir
CR Amini R, 2011, J ALLOY COMPD, V509, P3252, DOI 10.1016/j.jallcom.2010.12.097
   Amini R, 2010, MAT SCI ENG A-STRUCT, V527, P1135, DOI 10.1016/j.msea.2009.09.061
   [Anonymous], 1992, HDB ASM INT
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Dewidar MM, 2007, T NONFERR METAL SOC, V17, P468, DOI 10.1016/S1003-6326(07)60117-4
   Disegi JA, 2000, INJURY, V31, pS2
   Farid A, 2007, J IRON STEEL RES INT, V14, P61
   Gulsoy HO, 2007, WEAR, V262, P491, DOI 10.1016/j.wear.2006.05.003
   Javanbakht M, 2015, J ALLOY COMPD, V624, P17, DOI 10.1016/j.jallcom.2014.11.080
   Kameo K, 2006, WEAR, V260, P674, DOI 10.1016/j.wear.2005.03.029
   Li HB, 2009, J IRON STEEL RES INT, V16, P58, DOI 10.1016/S1006-706X(09)60011-X
   Li MH, 2014, MAT SCI ENG C-MATER, V43, P641, DOI 10.1016/j.msec.2014.06.038
   Mendez M, 2002, METALL MATER TRANS A, V33, P3273, DOI 10.1007/s11661-002-0313-0
   Onomoto T, 2009, ISIJ INT, V49, P1246, DOI 10.2355/isijinternational.49.1246
   Salahinejad E, 2013, ADV POWDER TECHNOL, V24, P605, DOI 10.1016/j.apt.2012.11.004
   Salahinejad E, 2012, MAT SCI ENG C-MATER, V32, P2215, DOI 10.1016/j.msec.2012.06.004
   Salahinejad E, 2012, POWDER TECHNOL, V215-16, P247, DOI 10.1016/j.powtec.2011.10.012
   Salahinejad E, 2010, J ALLOY COMPD, V497, P369, DOI 10.1016/j.jallcom.2010.03.071
   Salahinejad E, 2010, MATER DESIGN, V31, P2259, DOI 10.1016/j.matdes.2009.10.008
   Salahinejad E, 2009, MATER CHEM PHYS, V118, P71, DOI 10.1016/j.matchemphys.2009.07.005
   Salahinejad E., 2013, IN VITRO ELECTROCHEM
   Salahinejad E, 2012, METALL MATER TRANS A, V43A, P2994, DOI 10.1007/s11661-012-1186-5
   Salahinejad E, 2010, MATER DESIGN, V31, P527, DOI 10.1016/j.matdes.2009.07.024
   Sumita M, 2004, MAT SCI ENG C-BIO S, V24, P753, DOI 10.1016/j.msec.2004.08.030
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Talha M, 2015, MAT SCI ENG C-MATER, V47, P196, DOI 10.1016/j.msec.2014.10.078
   Talha M, 2013, MAT SCI ENG C-MATER, V33, P3563, DOI 10.1016/j.msec.2013.06.002
   Yang K, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014105
NR 28
TC 10
Z9 10
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD FEB
PY 2016
VL 289
BP 37
EP 43
DI 10.1016/j.powtec.2015.11.054
PG 7
WC Engineering, Chemical
SC Engineering
GA DD7HX
UT WOS:000370095400006
DA 2018-10-20
ER

PT J
AU Prajapati, VS
   Purohit, HJ
   Raje, DV
   Parmar, N
   Patel, AB
   Jones, OAH
   Joshi, CG
AF Prajapati, Vimalkumar S.
   Purohit, Hemant J.
   Raje, Dhananjay V.
   Parmar, Nidhi
   Patel, Anand B.
   Jones, Oliver A. H.
   Joshi, Chaitanya G.
TI The effect of a high-roughage diet on the metabolism of aromatic
   compounds by rumen microbes: a metagenomic study using Mehsani buffalo
   (Bubalus bubalis)
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Metagenome; MG-RAST; Personal genome machine; Aromatic compound
   metabolism; Bubalus bubalis
ID GENE-CENTRIC METAGENOMICS; GUT MICROBIOME; BACTERIA; DIVERSITY;
   COMMUNITY; CAPACITY; IMPACT; FORAGE; FLUID; FLORA
AB In developing countries, livestock are often fed a high-lignin, low-nutrient diet that is rich in aromatic compounds. It is therefore important to understand the structure of the microbial community responsible for the metabolism of these substances. A metagenomic analysis was therefore carried out to assess the microbial communities associated with the liquid and solid fractions of rumen biomaterial from domestic Mehsani buffalo (Bubalus bubalis) fed with varying proportions of roughage. The experimental design consisted of three feeding regimes (50, 75 and 100 % roughage) and two roughage types (green and dry). Genes associated with aromatic compound degradation were assessed via high-throughput DNA sequencing. A total of 3914.94 Mb data were generated from all treatment groups. Genes coding for functional responses associated with aromatic compound metabolism were more prevalent in the liquid fraction of rumen samples than solid fractions. Statistically significant differences (p<0.05) were also observed between treatment groups. These differences were dependent on the proportion of roughage fed to the animal, with the type of roughage having little effect. The genes present in the highest abundance in all treatment groups were those related to aromatic compound catabolism. At the phylum level, Bacteroidetes were dominant in all treatments closely followed by the Firmicutes. This study demonstrates the use of feed type to selectively enrich microbial communities capable of metabolizing aromatic compounds in the rumen of domestic buffalo. The results may help to improve nutrient utilization efficiency in livestock and are thus of interest to farming industries, particularly in developing countries, worldwide.
C1 [Prajapati, Vimalkumar S.; Parmar, Nidhi; Patel, Anand B.; Joshi, Chaitanya G.] AAU, Coll Vet Sci & Anim Husb, Dept Anim Biotechnol, Anand, Gujarat, India.
   [Purohit, Hemant J.] Natl Environm Engn Res Inst CSIR NEERI, Environm Genom Div, Nagpur, Maharashtra, India.
   [Raje, Dhananjay V.] MDS Bioanalyt Pvt Ltd, Nagpur, Maharashtra, India.
   [Jones, Oliver A. H.] RMIT Univ, Sch Appl Sci, ACROSS, GPO Box 2476, Melbourne, Vic 3001, Australia.
RP Joshi, CG (reprint author), AAU, Coll Vet Sci & Anim Husb, Dept Anim Biotechnol, Anand, Gujarat, India.
EM cgjoshi@aau.in
RI Jones, Oliver/B-9778-2008; Prajapati, Vimalkumar/F-4822-2014
OI Jones, Oliver/0000-0002-4541-662X; Prajapati,
   Vimalkumar/0000-0003-4257-1728; Joshi, Chaitanya/0000-0003-4680-2861
FU Indian Council of Agricultural Research (ICAR), New Delhi
FX This study was funded by the Indian Council of Agricultural Research
   (ICAR), New Delhi.
CR Arey LB, 1957, AM J MED SCI, V234, P733
   Bhatt VD, 2013, MOL BIOL REP, V40, P3363, DOI 10.1007/s11033-012-2411-4
   Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105
   BRYANT MP, 1970, AM J CLIN NUTR, V23, P1440
   Dodd D, 2011, MOL MICROBIOL, V79, P292, DOI 10.1111/j.1365-2958.2010.07473.x
   Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57
   Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10
   Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x
   FONTY G, 1987, J GEN MICROBIOL, V133, P1835
   Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289
   Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200
   GIBSON DT, 1968, SCIENCE, V161, P1093
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Hernandez-Sanabria E, 2012, APPL ENVIRON MICROB, V78, P1203, DOI 10.1128/AEM.05114-11
   Hespell R, 1997, GASTROINTESTINAL MIC
   Hoffmann R., 2011, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Agriculture, V68, P168
   Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103
   Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004
   Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725
   Mitsumori M, 2008, ASIAN AUSTRAL J ANIM, V21, P144, DOI 10.5713/ajas.2008.r01
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Reddy B, 2014, MOL BIOL REP, V32, P1
   Romero-Perez GA, 2011, APPL ENVIRON MICROB, V77, P258, DOI 10.1128/AEM.01289-09
   Sahu NP, 2004, ASIAN AUSTRAL J ANIM, V17, P199, DOI 10.5713/ajas.2004.199
   Saro C, 2012, J ANIM SCI, V90, P4487, DOI 10.2527/jas.2012-5265
   SIEBER R, 1995, INT DAIRY J, V5, P227, DOI 10.1016/0958-6946(94)00005-A
   Singh KM, 2014, META GENE, V2, P252, DOI 10.1016/j.mgene.2014.01.005
   Singh KM, 2012, GENE, V507, P146, DOI 10.1016/j.gene.2012.07.037
   Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162
   Tun HM, 2012, J MICROBIOL METH, V88, P369, DOI 10.1016/j.mimet.2012.01.001
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Wahidullah S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083647
   Wallace RJ, 1996, J NUTR, V126, pS1326
   Wu MQ, 2012, APPL BIOCHEM BIOTECH, V168, P129, DOI 10.1007/s12010-011-9359-z
   Xu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056565
NR 41
TC 1
Z9 1
U1 1
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD FEB
PY 2016
VL 100
IS 3
BP 1319
EP 1331
DI 10.1007/s00253-015-7239-0
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DC6DB
UT WOS:000369308900023
PM 26711277
DA 2018-10-20
ER

PT J
AU Ciasca, G
   Papi, M
   Businaro, L
   Campi, G
   Ortolani, M
   Palmieri, V
   Cedola, A
   De Ninno, A
   Gerardino, A
   Maulucci, G
   De Spirito, M
AF Ciasca, G.
   Papi, M.
   Businaro, L.
   Campi, G.
   Ortolani, M.
   Palmieri, V.
   Cedola, A.
   De Ninno, A.
   Gerardino, A.
   Maulucci, G.
   De Spirito, M.
TI Recent advances in superhydrophobic surfaces and their relevance to
   biology and medicine
SO BIOINSPIRATION & BIOMIMETICS
LA English
DT Review
DE superhydrophobic surfaces; bioinspired artificial surfaces;
   nano-manipulation
ID X-RAY-SCATTERING; INTRINSICALLY DISORDERED PROTEIN; DRUG-DELIVERY
   SYSTEMS; EMERGING APPLICATIONS; HYDROPHOBIC SURFACES; SELF-ORGANIZATION;
   HIGH-RESOLUTION; IN-SITU; ARRAYS; ANGLE
AB By mimicking naturally occurring superhydrophobic surfaces, scientists can now realize artificial surfaces on which droplets of a few. microliters of water are forced to assume an almost spherical shape and an extremely high contact angle. In recent decades, these surfaces have attracted much attention due to their technological applications for anti-wetting and self-cleaning materials. Very recently, researchers have shifted their interest to investigate whether superhydrophobic surfaces can be exploited to study biological systems. This research effort has stimulated the design and realization of new devices that allow us to actively organize, visualize and manipulate matter at both the microscale and nanoscale levels. Such precise control opens up wide applications in biomedicine, as it allows us to directly manipulate objects at the typical length scale of cells and macromolecules. This progress report focuses on recent biological and medical applications of superhydrophobicity. Particular regard is paid to those applications that involve the detection, manipulation and study of extremely small quantities of molecules, and to those that allow high throughput cell and biomaterial screening.
C1 [Ciasca, G.; Papi, M.; Palmieri, V.; Maulucci, G.; De Spirito, M.] Univ Cattolica Sacro Cuore, Ist Fis, Largo F Vito 1, I-00168 Rome, Italy.
   [Businaro, L.; De Ninno, A.; Gerardino, A.] CNR Ist Foton Nanotecnol, Via Cineto Romano 42, I-00146 Rome, Italy.
   [Campi, G.; Cedola, A.] Inst Crystallog CNR, Via Salaria Km 29300, I-00015 Monterotondo Roma, Italy.
   [Ortolani, M.] Univ Roma La Sapienza, Dipartimento Fis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
RP Papi, M (reprint author), Univ Cattolica Sacro Cuore, Ist Fis, Largo F Vito 1, I-00168 Rome, Italy.
EM massimiliano.papi@unicatt.it
RI De Ninno, Adele/M-8087-2017; Ortolani, Michele/K-7989-2016; Cedola,
   Alessia/F-3865-2012; Gerardino, Annamaria/C-8403-2012; Campi,
   Gaetano/H-1981-2018; Palmieri, Valentina/H-7836-2012
OI De Ninno, Adele/0000-0003-3139-2820; Ortolani,
   Michele/0000-0002-7203-5355; Gerardino, Annamaria/0000-0003-1869-1092;
   Campi, Gaetano/0000-0001-9845-9394; Palmieri,
   Valentina/0000-0002-6358-9647; BUSINARO, LUCA/0000-0002-5251-093X; Papi,
   Massimiliano/0000-0002-0029-1309; Maulucci,
   Giuseppe/0000-0002-2154-319X; Cedola, Alessia/0000-0002-9256-8853; De
   Spirito, Marco/0000-0003-4260-5107; Ciasca, Gabriele/0000-0002-3694-8229
CR Accardo A, 2013, NANOSCALE, V5, P2295, DOI 10.1039/c3nr34032e
   Accardo A, 2011, LANGMUIR, V27, P8216, DOI 10.1021/la2014336
   Accardo A, 2010, LANGMUIR, V26, P15057, DOI 10.1021/la102958w
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Altamura D, 2012, J APPL CRYSTALLOGR, V45, P869, DOI 10.1107/S0021889812025733
   Baldassarre L, 2015, NANO LETT, V15, P7225, DOI 10.1021/acs.nanolett.5b03247
   Bartolo D, 2006, EUROPHYS LETT, V74, P299, DOI 10.1209/epl/i2005-10522-3
   Battisti A, 2013, MOL SIMULAT, V39, P1084, DOI 10.1080/08927022.2013.794275
   Battisti A, 2012, MOL SIMULAT, V38, P525, DOI 10.1080/08927022.2011.633347
   Bormashenko E, 2007, LANGMUIR, V23, P6501, DOI 10.1021/la700935x
   Browne AW, 2011, LAB CHIP, V11, P2440, DOI 10.1039/c1lc20144a
   Businaro L, 2012, MICROELECTRON ENG, V97, P197, DOI 10.1016/j.mee.2012.02.025
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Campi G, 2012, ACTA BIOMATER, V8, P3411, DOI 10.1016/j.actbio.2012.05.034
   Campi G, 2014, CURR PROTEIN PEPT SC, V15, P394, DOI 10.2174/1389203715666140327104023
   Campi G, 2011, NANOSCALE, V3, P3774, DOI 10.1039/c1nr10474h
   Campi G, 2010, NANOSCALE, V2, P2447, DOI 10.1039/c0nr00390e
   Capellini G, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117837
   Chiarpotto M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4818749
   Ciasca G, 2014, NANO-MICRO LETT, V6, P280, DOI 10.5101/nml140030a
   Ciasca G, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/49/495302
   Ciasca G, 2013, MICROELECTRON ENG, V111, P304, DOI 10.1016/j.mee.2013.02.020
   Ciasca G, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685706
   Ciasca G, 2011, J NANOPART RES, V13, P6149, DOI 10.1007/s11051-011-0294-2
   Ciasca G, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085302
   Ciasca G, 2012, LANGMUIR, V28, P13405, DOI 10.1021/la302628y
   Danielson DT, 2006, J APPL PHYS, V100, DOI 10.1063/1.2357345
   De Angelis F, 2011, NAT PHOTONICS, V5, P683, DOI [10.1038/NPHOTON.2011.222, 10.1038/nphoton.2011.222]
   De Ninno A, 2015, PHYS CHEM CHEM PHYS, V17, P21337, DOI 10.1039/c4cp05023a
   De Sole P, 2013, CLIN BIOCHEM, V46, P89, DOI 10.1016/j.clinbiochem.2012.10.023
   Di Gaspare L, 2014, MICROELECTRON ENG, V124, P86, DOI 10.1016/j.mee.2014.06.003
   Dicuangco M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4878322
   Drake RR, 2007, PROTEOM CLIN APPL, V1, P758, DOI 10.1002/prca.200700175
   Easley CJ, 2006, P NATL ACAD SCI USA, V103, P19272, DOI 10.1073/pnas.0604663103
   Falde EJ, 2015, J CONTROL RELEASE, V214, P23, DOI 10.1016/j.jconrel.2015.06.042
   Gaspari M, 2006, J PROTEOME RES, V5, P1261, DOI 10.1021/pr050417+
   Gentile F, 2012, MICROELECTRON ENG, V97, P349, DOI 10.1016/j.mee.2012.03.025
   Gentile F, 2011, MICROELECTRON ENG, V88, P1749, DOI 10.1016/j.mee.2010.12.076
   Gentile F, 2014, MICROMACHINES-BASEL, V5, P239, DOI 10.3390/mi5020239
   Gentile F, 2012, NANO LETT, V12, P6453, DOI 10.1021/nl3039162
   Gentile F, 2012, ACS APPL MATER INTER, V4, P3213, DOI 10.1021/am300556w
   Geyer FL, 2011, ANGEW CHEM INT EDIT, V50, P8424, DOI 10.1002/anie.201102545
   Grinstaff M, 2012, ABSTR PAP AM CHEM S, P244
   Guan JJ, 2005, P NATL ACAD SCI USA, V102, P18321, DOI 10.1073/pnas.0506902102
   Hong LF, 2011, MICROFLUID NANOFLUID, V10, P991, DOI 10.1007/s10404-010-0728-7
   Hu Y, 2010, ACS NANO, V4, P439, DOI 10.1021/nn901322d
   Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033
   Kijlstra J, 2002, COLLOID SURFACE A, V206, P521, DOI 10.1016/S0927-7757(02)00089-4
   Kwon HM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.036102
   Latthe SS, 2014, MOLECULES, V19, P4256, DOI 10.3390/molecules19044256
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lebofsky Ronald, 2003, Briefings in Functional Genomics & Proteomics, V1, P385, DOI 10.1093/bfgp/1.4.385
   Lima AC, 2015, NANOMEDICINE-UK, V10, P271, DOI [10.2217/NNM.14.175, 10.2217/nnm.14.175]
   Lima AC, 2015, NANOMEDICINE-UK, V10, P103, DOI 10.2217/nnm.14.174
   Limongi T, 2013, SMALL, V9, P402, DOI 10.1002/smll.201201377
   Liu JQ, 2013, ACTA BIOMATER, V9, P9243, DOI 10.1016/j.actbio.2013.08.016
   MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602
   Manukyan G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014501
   Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518
   Neto AI, 2011, SOFT MATTER, V7, P4147, DOI 10.1039/c1sm05169e
   Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599
   Nosonovsky M, 2009, CURR OPIN COLLOID IN, V14, P270, DOI 10.1016/j.cocis.2009.05.004
   Palmieri V, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2583-z
   Papadopoulos P, 2013, P NATL ACAD SCI USA, V110, P3254, DOI 10.1073/pnas.1218673110
   Papi M, 2015, RSC ADV, V5, P81638, DOI 10.1039/c5ra15083c
   Pifferi A, 2009, CROAT CHEM ACTA, V82, P449
   Ressine A, 2007, BIOTECHNOL ANN REV, V13, P149, DOI 10.1016/S1387-2656(07)13007-6
   Riekel C, 2000, J APPL CRYSTALLOGR, V33, P421, DOI 10.1107/S0021889899014375
   Salgado CL, 2012, INTEGR BIOL-UK, V4, P318, DOI 10.1039/c2ib00170e
   Schwarz B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5085
   Schwarz B, 2013, SENSORS-BASEL, V13, P2196, DOI 10.3390/s130202196
   Shirtcliffe NJ, 2010, ADV COLLOID INTERFAC, V161, P124, DOI 10.1016/j.cis.2009.11.001
   Sibillano T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06985
   Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755
   Su B, 2013, ADV MATER, V25, P3968, DOI 10.1002/adma.201301003
   Su B, 2012, ADV MATER, V24, P2780, DOI 10.1002/adma.201200294
   Su B, 2012, ADV MATER, V24, P559, DOI 10.1002/adma.201104019
   Tan JMR, 2014, PHYS CHEM CHEM PHYS, V16, P26983, DOI 10.1039/c4cp03679d
   Ueda E, 2013, ADV MATER, V25, P1234, DOI 10.1002/adma.201204120
   Wallace RA, 2014, ANAL CHEM, V86, P11819, DOI 10.1021/ac5033947
   Wilczewska AZ, 2012, PHARMACOL REP, V64, P1020, DOI 10.1016/S1734-1140(12)70901-5
   Yamada K, 2002, J NEUROSURG, V96, P731, DOI 10.3171/jns.2002.96.4.0731
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
   Yao X, 2010, ADV FUNCT MATER, V20, P656, DOI 10.1002/adfm.200901775
   Yohe S T, 2012, ABSTR PAP AM CHEM S, P244
   Yohe ST, 2013, ADV HEALTHC MATER, V2, P1204, DOI 10.1002/adhm.201200381
   Yohe ST, 2012, J CONTROL RELEASE, V162, P92, DOI 10.1016/j.jconrel.2012.05.047
   Yohe ST, 2012, J AM CHEM SOC, V134, P2016, DOI 10.1021/ja211148a
   Zilberman M, 2011, STUD MECHANOBIOL TIS, V8, P1, DOI 10.1007/978-3-642-18065-1
NR 89
TC 17
Z9 17
U1 6
U2 105
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-3182
EI 1748-3190
J9 BIOINSPIR BIOMIM
JI Bioinspir. Biomim.
PD FEB
PY 2016
VL 11
IS 1
AR 011001
DI 10.1088/1748-3190/11/1/011001
PG 15
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA DD1DL
UT WOS:000369661300001
PM 26844980
DA 2018-10-20
ER

PT J
AU Li, XL
   Dou, QY
   Kong, QQ
AF Li, Xiaolong
   Dou, Qingyu
   Kong, Qingquan
TI Repair and Regenerative Therapies of the Annulus Fibrosus of the
   Intervertebral Disc
SO JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
LA English
DT Review
DE Annulus fibrosus tissue engineering; Disc herniation; Biomaterial
   scaffold; Annulus fibrosus regeneration
ID EXTRACELLULAR-MATRIX PRODUCTION; IN-VITRO; DIFFERENTIATION FACTOR-5;
   ELECTROSPUN SCAFFOLDS; CELL-PROLIFERATION; NUCLEUS PULPOSUS; CANINE
   MODEL; STEM-CELLS; TISSUE; DEGENERATION
AB Degeneration of the intervertebral disc is implicated as the main cause of low back pain. Current treatment strategies for degenerative disc disease, such as conservative treatments and surgeries, only relieve the symptoms of low back pain without treating the causes of underlying degeneration. Surgical treatments cannot reverse the degeneration of the intervertebral disc degeneration, and may even accelerate the degeneration. The development of tissue engineering and regenerative therapeutic strategies have brought new hope for repair and regeneration of the degenerated intervertebral disc. These strategies have been developed mainly targeting to the repair and regeneration of the nucleus pulposus of the degenerated but intervertebral disc. Although many studies that focused on the nucleus pulposus repair have achieved successes in laboratory settings but disc repair without giving much regard to annulus fibrosus could not recover the normal mechanical environment, which might make the disc degenerative change continuously exacerbate. Lately, the strategy to simultaneously repair the damaged annulus fibrosus and nucleus pulposus has attracted more attention, which could be considered to slow the disc degenerative rate and obtain better repair effect. An extensive literature search up to March 2015 for annulus fibrosus repair and regeneration in vitro or in vivo studies and clinical trials with the key words of "annulus fibrosus, repair, regeneration, tissue engineering, intervertebral disc and scaffold" were performed through PubMed, China National Knowledge Infrastructure and China Biology Medicine. The goal of this paper was to review the current research progress of annulus fibrosus repair and regeneration, and also suggest directions for future research.
C1 [Li, Xiaolong; Dou, Qingyu; Kong, Qingquan] Sichuan Univ, West China Hosp, Dept Orthoped, 37 Guoxue Lane,Wainan St, Chengdu 610041, Sichuan, Peoples R China.
RP Kong, QQ (reprint author), Sichuan Univ, West China Hosp, Dept Orthoped, 37 Guoxue Lane,Wainan St, Chengdu 610041, Sichuan, Peoples R China.
EM kongspine@126.com
CR Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Assietti R, 2011, ACTA NEUROCHIR SUPPL, V108, P103, DOI 10.1007/978-3-211-99370-5_15
   Block JE, 2008, PAIN PHYSICIAN, V11, P659
   Bowles RD, 2012, NMR BIOMED, V25, P443, DOI 10.1002/nbm.1651
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Chang G, 2010, J BIOMED MATER RES A, V92A, P43, DOI 10.1002/jbm.a.32326
   Cho H, 2013, CONNECT TISSUE RES, V54, P181, DOI 10.3109/03008207.2013.775258
   Fukui S, 2012, KOREAN J PAIN, V25, P155, DOI 10.3344/kjp.2012.25.3.155
   Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157
   Gruber HE, 2014, EXP MOL PATHOL, V96, P225, DOI 10.1016/j.yexmp.2014.02.005
   Gruber HE, 2009, SPINE, V34, P4, DOI 10.1097/BRS.0b013e31818f8c02
   Grunert P, 2014, SPINE, V39, P198, DOI 10.1097/BRS.0000000000000103
   Guo QP, 2015, J CELL MOL MED, V19, P1582, DOI 10.1111/jcmm.12533
   Hegewald AA, 2012, SPINE, V37, P101, DOI 10.1097/BRS.0b013e318210ed55
   Helen W, 2008, ACTA BIOMATER, V4, P230, DOI 10.1016/j.actbio.2007.09.010
   Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2
   Huang B, 2011, SPINE, V36, P2252, DOI 10.1097/BRS.0b013e318209fd85
   Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012
   Jin L, 2013, EUR SPINE J, V22, P1090, DOI 10.1007/s00586-013-2663-2
   Kandel R, 2014, TISSUE ENG PART A, V23, P3261
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Lei B, 2012, J MATER CHEM, V22, P14133, DOI 10.1039/c2jm31290e
   Li B, 2015, J INTERF CYTOK RES, V35, P569, DOI 10.1089/jir.2014.0216
   Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108239
   Michalek AJ, 2012, J BIOMECH, V45, P1227, DOI 10.1016/j.jbiomech.2012.01.042
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Moon HJ, 2014, OSTEOARTHR CARTILAGE, V22, P344, DOI 10.1016/j.joca.2013.12.008
   Nerurkar NL, 2011, BIOMECH MODEL MECHAN, V10, P973, DOI 10.1007/s10237-011-0288-0
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Pirvu TN, 2014, EUR SPINE J, V23, P745, DOI 10.1007/s00586-014-3198-x
   Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI 10.1089/ten.TEA.2009.0770
   Saraiya M, 2010, TISSUE ENG PT A, V16, P1443, DOI [10.1089/ten.tea.2009.0343, 10.1089/ten.TEA.2009.0343]
   Sato Masato, 2003, J Biomed Mater Res A, V64, P248, DOI 10.1002/jbm.a.10287
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schutgens EM, 2015, EUR CELLS MATER, V30, P210, DOI 10.22203/eCM.v030a15
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sharifi S., 2012, DEV NOVEL BIODEGRADA, P202
   Sharifi S, 2015, J TISSUE ENG REGEN M, V9, P1120, DOI 10.1002/term.1866
   Sharifi S, 2013, BIOMATERIALS, V34, P8105, DOI 10.1016/j.biomaterials.2013.07.061
   Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403
   Stoyanov JV, 2011, EUR CELLS MATER, V21, P533, DOI 10.22203/eCM.v021a40
   Tsai TL, 2014, SPINE J, P2127
   Vadala G, 2012, EUR SPINE J S, V21, P20
   Vergroesen PPA, 2015, SPINE, V40, P622, DOI 10.1097/BRS.0000000000000792
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Wang H., 2013, TISSUE ENG PART A, V20, P908
   Wismer N, 2014, TISSUE ENG PT A, V20, P672, DOI 10.1089/ten.TEA.2012.0679
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
NR 50
TC 3
Z9 4
U1 1
U2 17
PU COLL PHYSICIANS & SURGEONS PAKISTAN
PI KARACHI
PA SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN
SN 1022-386X
EI 1681-7168
J9 JCPSP-J COLL PHYSICI
JI JCPSP-J. Coll. Physicians Surg.
PD FEB
PY 2016
VL 26
IS 2
BP 138
EP 144
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD1TH
UT WOS:000369704200015
PM 26876403
DA 2018-10-20
ER

PT J
AU Moreno, PMD
   Santos, JC
   Gomes, CP
   Varela-Moreira, A
   Costa, A
   Leiro, V
   Mansur, H
   Pego, AP
AF Moreno, Pedro M. D.
   Santos, Joyce C.
   Gomes, Carla P.
   Varela-Moreira, Aida
   Costa, Artur
   Leiro, Victoria
   Mansur, Herman
   Pego, Ana P.
TI Delivery of Splice Switching Oligonucleotides by Amphiphilic
   Chitosan-Based Nanoparticles
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE chitosan; trimethylchitosan; hydrophobic; nanoparticles; splice
   switching oligonucleotides
ID NONVIRAL GENE DELIVERY; ANTISENSE OLIGONUCLEOTIDES; CELLULAR UPTAKE;
   IN-VITRO; INTRACELLULAR TRAFFICKING; CATIONIC POLYMERS; POLYPLEXES;
   TRANSFECTION; EXPRESSION; SYSTEM
AB Splice switching oligonucleotides (SSOs) are a class of single-stranded antisense oligonucleotides (ssONs) being used as gene therapeutics and demonstrating great therapeutic potential. The availability of biodegradable and biocompatible delivery vectors that could improve delivery efficiencies, reduce dosage, and, in parallel, reduce toxicity concerns could be advantageous for clinical translation. In this work we explored the use of quaternized amphiphilic chitosan-based vectors in nanocomplex formation and delivery of splice switching oligonucleotides (SSO) into cells, while providing insights regarding cellular uptake of such complexes. Results show that the chitosan amphiphilic character is important when dealing with SSOs, greatly improving colloidal stability under serum conditions, as analyzed by dynamic light scattering, and enhancing cellular association. Nanocomplexes were found to follow an endolysosomal route with a long lysosome residence time. Conjugation of a hydrophobic moiety, stearic acid, to quaternized chitosan was a necessary condition to achieve transfection, as an unmodified quaternary chitosan was completely ineffective. We thus demonstrate that amphiphilic quaternized chitosan is a biomaterial that holds promise and warrants further development as a platform for SSO delivery strategies.
C1 [Moreno, Pedro M. D.; Santos, Joyce C.; Gomes, Carla P.; Varela-Moreira, Aida; Costa, Artur; Leiro, Victoria; Pego, Ana P.] Univ Porto UPorto, INEB Inst Engn Biomed, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.
   [Moreno, Pedro M. D.; Santos, Joyce C.; Gomes, Carla P.; Varela-Moreira, Aida; Costa, Artur; Leiro, Victoria; Pego, Ana P.] UPorto, I3S Inst Invest & Inovacao Saude, P-4200135 Oporto, Portugal.
   [Santos, Joyce C.; Mansur, Herman] Univ Fed Minas Gerais, Dept Met & Mat Engn, CeNano2I, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gomes, Carla P.; Pego, Ana P.] UPorto FEUP, Fac Engn, P-4200319 Oporto, Portugal.
   [Varela-Moreira, Aida] UPorto FEUP, Fac Med, P-4200319 Oporto, Portugal.
   [Pego, Ana P.] UPorto, Inst Ciencias Biomed Abel Salazar ICBAS, P-4050313 Oporto, Portugal.
RP Moreno, PMD; Pego, AP (reprint author), Univ Porto UPorto, INEB Inst Engn Biomed, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal.; Moreno, PMD; Pego, AP (reprint author), UPorto, I3S Inst Invest & Inovacao Saude, P-4200135 Oporto, Portugal.; Pego, AP (reprint author), UPorto FEUP, Fac Engn, P-4200319 Oporto, Portugal.; Pego, AP (reprint author), UPorto, Inst Ciencias Biomed Abel Salazar ICBAS, P-4050313 Oporto, Portugal.
EM pedro.moreno@ineb.up.pt; apego@ineb.up.pt
RI Pego, Ana Paula/C-6942-2012
OI Pego, Ana Paula/0000-0001-5169-328X; Moreno, Pedro/0000-0002-3773-3262;
   Leiro, Victoria/0000-0002-8907-9151
FU Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)
   [HMSP-ICT/0020/2010, PTDC/CTM-NAN/NAN/115124/2009]; Marie Curie Actions
   of the European Community's 7th Framework Program [PIEF-GA-2011-300485];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Ministry of Science and Technology, Brazil); FCT [SFRH/BD/79930/2011,
   SFRH/BPD/69110/2010]
FX This work was cofinanced by Fundacao para a Ciencia e a Tecnologia (FCT,
   Portugal) within projects HMSP-ICT/0020/2010 and
   PTDC/CTM-NAN/NAN/115124/2009. Additionally, P.M.D.M. acknowledges the
   support from the Marie Curie Actions of the European Community's 7th
   Framework Program (PIEF-GA-2011-300485); J.C.S. acknowledges the
   graduate fellowship from Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq, Ministry of Science and Technology, Brazil); C.P.G.
   and V.L. acknowledge FCT for their scholarships (SFRH/BD/79930/2011 and
   SFRH/BPD/69110/2010). We thank M. Lazaro from the Bioimaging Center for
   Biomaterials and Regenerative Therapies (b.IMAGE) for help with confocal
   microscopy. <SUP>1</SUP>H NMR and Cryo-SEM were performed at the Centro
   de Materiais da Universidade do Porto (CEMUP).
CR Administration U. S. F. a. D., 2012, GUID IND PYR END TES
   Agarwal A, 2007, J CONTROL RELEASE, V121, P28, DOI 10.1016/j.jconrel.2007.05.008
   Bauman JA, 2010, NUCLEIC ACIDS RES, V38, P8348, DOI 10.1093/nar/gkq731
   BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
   Bestas B, 2014, J CLIN INVEST, V124, P4067, DOI 10.1172/JCI76175
   Bolcato-Bellemin AL, 2007, P NATL ACAD SCI USA, V104, P16050, DOI 10.1073/pnas.0707831104
   BROWN DA, 1994, J BIOL CHEM, V269, P26801
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Buschmann MD, 2013, ADV DRUG DELIVER REV, V65, P1234, DOI 10.1016/j.addr.2013.07.005
   Buyens K, 2010, J CONTROL RELEASE, V141, P38, DOI 10.1016/j.jconrel.2009.08.026
   Chen J, 2015, ONCOGENE, V34, P1, DOI 10.1038/onc.2013.570
   Cheng JJ, 2006, J MED CHEM, V49, P6522, DOI 10.1021/jm060736s
   Chiu YL, 2010, J CONTROL RELEASE, V146, P152, DOI 10.1016/j.jconrel.2010.05.023
   Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028
   Disterer P, 2014, HUM GENE THER, V25, P587, DOI 10.1089/hum.2013.234
   Disterer P, 2013, MOL THER, V21, P602, DOI 10.1038/mt.2012.264
   Gao SY, 2005, EUR J PHARM BIOPHARM, V60, P327, DOI 10.1016/j.ejpb.2005.02.011
   Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680, 10.1517/17425250902877680 ]
   Geary RS, 2009, BIOCHEM PHARMACOL, V78, P284, DOI 10.1016/j.bcp.2009.04.013
   Gomes CP, 2014, MRS BULL, V39, P60, DOI 10.1557/mrs.2013.314
   Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P696, DOI 10.1021/bc000015m
   Hoffman EP, 2013, DISCOV MED, V16, P233
   Holzerny P, 2012, J CONTROL RELEASE, V157, P297, DOI 10.1016/j.jconrel.2011.08.023
   Hong HJ, 2008, BIOMATERIALS, V29, P4831, DOI 10.1016/j.biomaterials.2008.08.023
   Hsu CYM, 2012, BIOMATERIALS, V33, P7834, DOI 10.1016/j.biomaterials.2012.06.093
   Hu FQ, 2006, INT J PHARM, V315, P158, DOI 10.1016/j.ijpharm.2006.02.026
   Juliano RL, 2012, ACCOUNTS CHEM RES, V45, P1067, DOI 10.1021/ar2002123
   Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h
   Kim ST, 2007, BIOMATERIALS, V28, P3360, DOI 10.1016/j.biomaterials.2007.03.029
   Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089
   Koo T, 2013, HUM GENE THER, V24, P479, DOI 10.1089/hum.2012.234
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Korchagina EV, 2012, LANGMUIR, V28, P7880, DOI 10.1021/la3013409
   Lazzari S, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0920-7
   Le Tien C, 2003, J CONTROL RELEASE, V93, P1, DOI 10.1016/S0168-3659(03)00327-4
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   Li ZT, 2010, CARBOHYD POLYM, V80, P254, DOI 10.1016/j.carbpol.2009.11.021
   Liang XH, 2015, NUCLEIC ACIDS RES, V43, P2927, DOI 10.1093/nar/gkv143
   Liu XD, 2007, BIOMATERIALS, V28, P1280, DOI 10.1016/j.biomaterials.2006.11.004
   Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Matsuda M, 2014, BIOCONJUGATE CHEM, V25, P2134, DOI 10.1021/bc500465j
   Moreira C, 2009, ACTA BIOMATER, V5, P2995, DOI 10.1016/j.actbio.2009.04.021
   Mourya VK, 2009, J MATER SCI-MATER M, V20, P1057, DOI 10.1007/s10856-008-3659-z
   Muzzarelli RAA, 1998, ANAL BIOCHEM, V260, P255, DOI 10.1006/abio.1998.2705
   Neu M, 2006, BIOMACROMOLECULES, V7, P3428, DOI 10.1021/bm060788z
   Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909
   Noh SM, 2011, BIOMATERIALS, V32, P849, DOI 10.1016/j.biomaterials.2010.09.027
   Ozbas-Turan S, 2010, OLIGONUCLEOTIDES, V20, P147, DOI 10.1089/oli.2009.0222
   Passini MA, 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3001777
   Philippova OE, 2012, POLYM SCI SER A+, V54, P552, DOI 10.1134/S0965545X12060107
   Pires LR, 2011, NANOMEDICINE-UK, V6, P1499, DOI [10.2217/nnm.11.51, 10.2217/NNM.11.51]
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106
   Taetz S, 2009, EUR J PHARM BIOPHARM, V72, P358, DOI 10.1016/j.ejpb.2008.07.011
   Tavares IS, 2012, COLLOID SURFACE B, V90, P254, DOI 10.1016/j.colsurfb.2011.10.025
   Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017
   Teramura Y, 2008, BIOMATERIALS, V29, P1345, DOI 10.1016/j.biomaterials.2007.11.048
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Thibault M, 2011, BIOMATERIALS, V32, P4639, DOI 10.1016/j.biomaterials.2011.03.010
   Thibault M, 2010, MOL THER, V18, P1787, DOI 10.1038/mt.2010.143
   THILO L, 1995, J CELL SCI, V108, P1791
   van de Vosse E, 2009, BLOOD, V113, P4548, DOI 10.1182/blood-2008-12-196220
   Van Rompaey E, 2001, PHARMACEUT RES, V18, P928, DOI 10.1023/A:1010975908915
   Varkouhi AK, 2010, BIOCONJUGATE CHEM, V21, P2339, DOI 10.1021/bc1003789
   Wang JQ, 2010, BIOMATERIALS, V31, P4426, DOI 10.1016/j.biomaterials.2010.02.007
   Wang M, 2014, GENE THER, V21, P52, DOI 10.1038/gt.2013.57
   Zammarchi F, 2011, P NATL ACAD SCI USA, V108, P17779, DOI 10.1073/pnas.1108482108
   Zhang HL, 2011, J BIOMED MATER RES A, V98A, P296, DOI 10.1002/jbm.a.33115
   Zheng M., 2012, ACS NANO, V6, P9447
NR 71
TC 7
Z9 7
U1 3
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD FEB
PY 2016
VL 13
IS 2
BP 344
EP 356
DI 10.1021/acs.molpharmaceut.5b00538
PG 13
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA DC6VE
UT WOS:000369356900004
PM 26702499
DA 2018-10-20
ER

PT J
AU Chua, ILS
   Kim, HW
   Lee, JH
AF Chua, Ing Loon Sean
   Kim, Hae-Won
   Lee, Jae Ho
TI Signaling of extracellular matrices for tissue regeneration and
   therapeutics
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Review
DE Extracellular matrix; Signaling; Tissue regeneration; Biomaterials;
   Tissue engineering
ID MESENCHYMAL STEM-CELLS; FOCAL ADHESION KINASE; FLUID SHEAR-STRESS;
   PROMOTES OSTEOGENIC DIFFERENTIATION; INTEGRIN CYTOPLASMIC DOMAIN;
   MECHANICAL STIMULATION; IN-VIVO; BINDING PROTEINS; SKELETAL-MUSCLE;
   GROWTH-CONTROL
AB Cells receive important regulatory signals from their extracellular matrix (ECM) and the physical property of the ECM regulates important cellular behaviors like cell proliferation, migration and differentiation. A large part of tissue formation and regeneration depends on cellular interaction with its ECM. A comprehensive understanding of the mechanistic biochemical pathway of the ECM components is necessary for the design of a biomaterial scaffold for tissue engineering. Depending on the type of tissue, the ECM requirement might be different and this would influence its downstream intracellular cell signaling. Here, we reviewed the ECM and its signaling pathway by discussing: 1) classification of the ECM into hard, elastic and soft tissue based on its physical properties, 2) proliferation and differentiation control of the ECM, 3) roles of membrane receptor and its intracellular regulation factor, 4) ECM remodeling via inside-out signaling. By providing a comprehensive overview of the ECM's role in mechanotransduction and the self-regulatory effect of cells back on the ECM, we hope to provide a better insight of the physical and biochemical cues from the ECM. A sound understanding on the in vivo ECM has implication on the choice of materials and surface coating of biomimetic scaffolds used for tissue regeneration and therapeutics in a cell-free scaffold.
C1 [Chua, Ing Loon Sean; Lee, Jae Ho] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Kim, Hae-Won; Lee, Jae Ho] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
   [Kim, Hae-Won; Lee, Jae Ho] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea.
   [Kim, Hae-Won; Lee, Jae Ho] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan, South Korea.
   [Kim, Hae-Won] Dankook Univ, Dept Biomat Sci, Coll Dent, Cheonan, South Korea.
RP Lee, JH (reprint author), Inst Tissue Engn & Regenerat, Dept Nanobiomed Sci, 119 Dandae Ro, Cheonan 31116, South Korea.
EM drjaeho@gmail.com
FU Priority Research Centers Program [2009-0093829]; Basic Science Research
   Program, National Research Foundation, South Korea [2013R1A1A4A01012572]
FX This study was supported by grants from, Priority Research Centers
   Program (2009-0093829) and Basic Science Research Program
   (2013R1A1A4A01012572) National Research Foundation, South Korea.
CR Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017
   Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293
   Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002
   Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781
   Boudreau J, 1999, BIOCHEM J, V339, P481
   Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004
   Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2
   Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171
   CHIU AY, 1991, GLIA, V4, P11, DOI 10.1002/glia.440040103
   CORNBROOKS CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3850, DOI 10.1073/pnas.80.12.3850
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Dallas S. L., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P370
   Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Fernandez-Tresguerres-Hernandez-Gil Isabel, 2006, Med Oral Patol Oral Cir Bucal, V11, pE47
   Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158
   Fu Q, 2008, J BIOMECH, V41, P3225, DOI 10.1016/j.jbiomech.2008.08.010
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364
   GLUCK U, 1992, EXP CELL RES, V202, P477, DOI 10.1016/0014-4827(92)90102-E
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.085405.095329
   Haasper C, 2008, EXP TOXICOL PATHOL, V59, P355, DOI [10.1016/j.etp.2007.11.008, 10.1016/j.etp.2007.11.013]
   Haque MA, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014106
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087
   Jaasma MJ, 2008, TISSUE ENG PT A, V14, P1213, DOI [10.1089/ten.tea.2007.0321, 10.1089/tea.2007.0321]
   Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1
   Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037
   Kawai S, 2003, VIRCHOWS ARCH, V443, P78, DOI 10.1007/s00428-003-0804-4
   Kawarizadeh A, 2005, J DENT RES, V84, P902, DOI 10.1177/154405910508401006
   Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003
   Klees RF, 2007, MATRIX BIOL, V26, P106, DOI 10.1016/j.matbio.2006.10.001
   Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443
   Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Lee DY, 2008, J BONE MINER RES, V23, P1140, DOI [10.1359/jbmr.080302, 10.1359/JBMR.080302]
   Lee JH, 2011, J R SOC INTERFACE, V8, P998, DOI 10.1098/rsif.2010.0613
   LEFCORT F, 1992, DEVELOPMENT, V116, P767
   Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013
   Leucht P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000390
   Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058
   Liu SC, 2000, J CELL SCI, V113, P3563
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   McIlhenny SE, 2010, TISSUE ENG PT A, V16, P245, DOI 10.1089/ten.TEA.2009.0238
   McKee MD, 2011, CELLS TISSUES ORGANS, V194, P313, DOI 10.1159/000324244
   MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x
   Mecham RP, 1996, THE LAMININS, P159
   Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Moriwake T, 1997, ACTA PAEDIATR JAPON, V39, P521
   Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   Patwari P, 2008, CIRC RES, V103, P234, DOI 10.1161/CIRCRESAHA.108.175331
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004
   Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005
   Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2
   Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin MK, 2008, CELL SIGNAL, V20, P613, DOI 10.1016/j.cellsig.2007.11.012
   Snyman C, 2015, J MUSCLE RES CELL M, V36, P215, DOI 10.1007/s10974-015-9414-4
   Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048
   Spofford CM, 2001, AM J PHYSIOL-HEART C, V280, pH1354
   Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945
   Suh H, 2000, YONSEI MED J, V41, P681, DOI 10.3349/ymj.2000.41.6.681
   Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   TERMINE JD, 1981, J BIOL CHEM, V256, P403
   Titushkin I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743476
   Tlatli R, 2013, FEBS J, V280, P139, DOI 10.1111/febs.12056
   Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673
   Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659
   Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012
   Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400
   Waddington R. J., 2003, European Cells & Materials, V6, P12
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Weyts FAA, 2002, J CELL BIOCHEM, V87, P85, DOI 10.1002/jcb.10278
   Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200
   Young SRL, 2009, J BONE MINER RES, V24, P411, DOI [10.1359/jbmr.081102, 10.1359/JBMR.081102]
   Zhang J, 2009, J CELL PHYSIOL, V220, P30, DOI 10.1002/jcp.21768
   Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765
   Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066
NR 104
TC 16
Z9 16
U1 2
U2 41
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD FEB
PY 2016
VL 13
IS 1
BP 1
EP 12
DI 10.1007/s13770-016-9075-0
PG 12
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA DC6GD
UT WOS:000369317000001
DA 2018-10-20
ER

PT J
AU Sung, CY
   Yang, CY
   Yeh, JA
   Cheng, CM
AF Sung, Chun-Yen
   Yang, Chung-Yao
   Yeh, J. Andrew
   Cheng, Chao-Min
TI Integrated Circuit-Based Biofabrication with Common Biomaterials for
   Probing Cellular Biomechanics
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MICROPOST ARRAY MEMBRANE; IN-VITRO; MECHANICAL STIMULATION; SUBSTRATE
   TOPOGRAPHY; NEURITE OUTGROWTH; ENDOTHELIAL-CELLS; SOFT LITHOGRAPHY;
   MAMMALIAN-CELLS; MOLECULAR-BASIS; SHEAR-FLOW
AB Recent advances in bioengineering have enabled the development of biomedical tools with modifiable surface features (small-scale architecture) to mimic extracellular matrices and aid in the development of well-controlled platforms that allow for the application of mechanical stimulation for studying cellular biomechanics. An overview of recent developments in common biomaterials that can be manufactured using integrated circuit-based biofabrication is presented. Integrated circuit-based biofabrication possesses advantages including mass and diverse production capacities for fabricating in vitro biomedical devices. This review highlights the use of common biomaterials that have been most frequently used to study cellular biomechanics. In addition, the influence of various small-scale characteristics on common biomaterial surfaces for a range of different cell types is discussed.
C1 [Sung, Chun-Yen; Yang, Chung-Yao; Yeh, J. Andrew] Natl Tsing Hua Univ, Inst Nanoengn & Microsyst, Hsinchu 30013, Taiwan.
   [Cheng, Chao-Min] Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu 30013, Taiwan.
RP Cheng, CM (reprint author), Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu 30013, Taiwan.
EM chaomin@mx.nthu.edu.tw
FU National Science Council (NSC) [101-2623-E-007-005-ET, NSC
   104-2628-E-007-001-MY3]
FX Support for the preparation of this review was provided by No. National
   Science Council (NSC) 101-2623-E-007-005-ET (to JAY.) and NSC
   104-2628-E-007-001-MY3 (to C-M.C.).
CR Ananthanarayanan A, 2011, TRENDS BIOTECHNOL, V29, P110, DOI 10.1016/j.tibtech.2010.10.006
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Azeem A, 2015, NANOMEDICINE-UK, V10, P693, DOI [10.2217/NNM.14.218, 10.2217/nnm.14.218]
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073
   Bellin RM, 2009, P NATL ACAD SCI USA, V106, P22102, DOI 10.1073/pnas.0902639106
   Blong CC, 2010, J NEUROSCI RES, V88, P1445, DOI 10.1002/jnr.22324
   Borghi N, 2010, P NATL ACAD SCI USA, V107, P13324, DOI 10.1073/pnas.1002662107
   Chen WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083394
   Chen WQ, 2013, ACS NANO, V7, P566, DOI 10.1021/nn304719q
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Cheng C. C., 2008, MOL BIOSYST, V2, P299
   Cheng CM, 2011, J BIOMECH, V44, P856, DOI 10.1016/j.jbiomech.2010.12.006
   Cheng CM, 2010, NAT PROTOC, V5, P714, DOI 10.1038/nprot.2010.15
   Cheng CM, 2009, J BIOMECH, V42, P187, DOI 10.1016/j.jbiomech.2008.10.014
   Cheng J., 2013, J NEUROSCI METH, V213, P196
   Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Chou SY, 2011, SOFT MATTER, V7, P9871, DOI 10.1039/c1sm06336g
   Chou SY, 2009, BIOMATERIALS, V30, P3136, DOI 10.1016/j.biomaterials.2009.02.037
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   English A, 2015, ACTA BIOMATER, V27, P3, DOI 10.1016/j.actbio.2015.08.035
   Fan ZZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02176
   Farrugia BL, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025001
   Ferrari A, 2010, BIOMATERIALS, V31, P4682, DOI 10.1016/j.biomaterials.2010.02.032
   Fleischer S, 2013, CURR OPIN BIOTECH, V24, P664, DOI 10.1016/j.copbio.2012.10.016
   Fozdar DY, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035005
   Frimat JP, 2010, LAB CHIP, V10, P701, DOI 10.1039/b922193j
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Garcia-Parra P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00010
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Goehring N. W., 2012, TRENDS BIOTECHNOL, V23, P72
   Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545
   Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011
   Ham H. I. C., 2015, EXP DERMATOL, V24, P579
   Hanson JN, 2009, LAB CHIP, V9, P122, DOI 10.1039/b803595d
   Hur SS, 2012, P NATL ACAD SCI USA, V109, P11110, DOI 10.1073/pnas.1207326109
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Killen K. A., 2010, P NATL ACAD SCI USA, V107, P4872
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k
   Koufaki N, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045004
   Kshitiz, 2011, TRENDS BIOTECHNOL, V29, P399, DOI 10.1016/j.tibtech.2011.03.006
   Kumar S, 2009, EXP MECH, V49, P11, DOI 10.1007/s11340-007-9063-7
   Lam RHW, 2012, INTEGR BIOL-UK, V4, P1289, DOI 10.1039/c2ib20134h
   Lam RHW, 2012, LAB CHIP, V12, P1865, DOI 10.1039/c2lc21146g
   Lee H. H., 2012, P NATL ACAD SCI USA, V110, P2840
   Lee JY, 2008, LANGMUIR, V24, P2232, DOI 10.1021/la702883d
   Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293
   Mann JM, 2012, LAB CHIP, V12, P731, DOI 10.1039/c2lc20896b
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Palchesko RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07955
   Pesen D, 2009, ACS APPL MATER INTER, V1, P543, DOI 10.1021/am800264h
   Poudel I, 2013, ACTA BIOMATER, V9, P4592, DOI 10.1016/j.actbio.2012.08.039
   Qi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059022
   Qi SJ, 2009, ACS APPL MATER INTER, V1, P30, DOI 10.1021/am800027d
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Shao Y, 2014, ADV MATER, V26, P1494, DOI 10.1002/adma.201304431
   Shao Y, 2014, INTEGR BIOL-UK, V6, P300, DOI 10.1039/c3ib40223a
   Shuai HH, 2013, CHEM SCI, V4, P3058, DOI 10.1039/c3sc50533b
   Steward RL, 2015, J BIOMECH, V48, P613, DOI 10.1016/j.jbiomech.2014.12.047
   Steward RL, 2011, SCI REP-UK, V1, DOI 10.1038/srep00147
   Steward RL, 2010, CELL BIOCHEM BIOPHYS, V56, P115, DOI 10.1007/s12013-009-9075-2
   Sung C. Y., BIOFABRICAT IN PRESS
   Tang QY, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015011
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tee S. Y., 2011, BIOPHYS J, V100, P25
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]
   Tsai TT, 2014, J CELL MOL MED, V18, P2351, DOI 10.1111/jcmm.12377
   Wang X, 2015, NANO LETT, V15, P1457, DOI 10.1021/nl5049862
   Wang YK, 2013, J CELL MOL MED, V17, P823, DOI 10.1111/jcmm.12061
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wu CC, 2007, P NATL ACAD SCI USA, V104, P1254, DOI 10.1073/pnas.0609806104
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Yang CY, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/044406
   Yang CY, 2012, BIOMATERIALS, V33, P4988, DOI 10.1016/j.biomaterials.2012.03.071
   Yang CY, 2010, EUR CELLS MATER, V20, P415
   Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 88
TC 2
Z9 2
U1 1
U2 23
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD FEB
PY 2016
VL 34
IS 2
BP 171
EP 186
DI 10.1016/j.tibtech.2015.11.005
PG 16
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DC8MK
UT WOS:000369473500008
PM 26708959
DA 2018-10-20
ER

PT J
AU Couture, C
   Zaniolo, K
   Carrier, P
   Lake, J
   Patenaude, J
   Germain, L
   Guerin, SL
AF Couture, Camille
   Zaniolo, Karine
   Carrier, Patrick
   Lake, Jennifer
   Patenaude, Julien
   Germain, Lucie
   Guerin, Sylvain L.
TI The tissue-engineered human cornea as a model to study expression of
   matrix metalloproteinases during corneal wound healing
SO BIOMATERIALS
LA English
DT Article
DE Tissue-engineering; Biomaterial; Cornea; Wound healing; Matrix
   metalloproteinase; Extracellular matrix; Gene expression
ID EPIDERMAL-GROWTH-FACTOR; FINE-STRUCTURAL LOCALIZATION; SUBUNIT GENE
   PROMOTER; AGED HUMAN CORNEA; EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX;
   BASEMENT-MEMBRANE; IN-VITRO; FACTOR-BETA; DIFFERENTIAL EXPRESSION
AB Corneal injuries remain a major cause of consultation in the ophthalmology clinics worldwide. Repair of corneal wounds is a complex mechanism that involves cell death, migration, proliferation, differentiation, and extracellular matrix (ECM) remodeling. In the present study, we used a tissue-engineered, two layers (epithelium and stroma) human cornea as a biomaterial to study both the cellular and molecular mechanisms of wound healing. Gene profiling on microarrays revealed important alterations in the pattern of genes expressed by tissue-engineered corneas in response to wound healing. Expression of many MMPs-encoding genes was shown by microarray and qPCR analyses to increase in the migrating epithelium of wounded corneas. Many of these enzymes were converted into their enzymatically active form as wound closure proceeded. In addition, expression of MMPs by human corneal epithelial cells (HCECs) was affected both by the stromal fibroblasts and the collagen-enriched ECM they produce. Most of all, results from mass spectrometry analyses provided evidence that a fully stratified epithelium is required for proper synthesis and organization of the ECM on which the epithelial cells adhere. In conclusion, and because of the many characteristics it shares with the native cornea, this human two layers corneal substitute may prove particularly useful to decipher the mechanistic details of corneal wound healing. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Couture, Camille; Zaniolo, Karine; Carrier, Patrick; Lake, Jennifer; Patenaude, Julien; Germain, Lucie; Guerin, Sylvain L.] Univ Laval, CUO Rech, Med Regeneratrice, Ctr Rech FRQS,CHU Quebec, Quebec City, PQ, Canada.
   [Couture, Camille; Zaniolo, Karine; Carrier, Patrick; Lake, Jennifer; Patenaude, Julien; Germain, Lucie; Guerin, Sylvain L.] Univ Laval, Ctr Rech Organogenese Expt, LOEX, Quebec City, PQ, Canada.
   [Couture, Camille; Zaniolo, Karine; Carrier, Patrick; Lake, Jennifer; Patenaude, Julien; Germain, Lucie; Guerin, Sylvain L.] Univ Laval, Fac Med, Dept Ophtalmol, Quebec City, PQ G1K 7P4, Canada.
   [Couture, Camille; Carrier, Patrick; Patenaude, Julien; Germain, Lucie] Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ G1K 7P4, Canada.
RP Guerin, SL (reprint author), CHU Quebec, CUO Rech, LOEX, Hop St Sacrement,Ctr Rech, Quebec City, PQ, Canada.
EM Sylvain.Guerin@fmed.ulaval.ca
FU 'Canadian Institutes of Health Research' (CIHR) [MOP-53170]; Roseau de
   Recherche en Sante de la Vision from the 'Fonds de Recherche du
   Quebec-Sante' (FRQS); FRQS; Canadian Research Chair on Stem Cell and
   Tissue Engineering
FX This study was supported by a grant from the 'Canadian Institutes of
   Health Research' (CIHR) (MOP-53170) to L.G., S.L.G and Francois A.
   Auger. The Banque d'yeux Nationale is partly supported by the Roseau de
   Recherche en Sante de la Vision from the 'Fonds de Recherche du
   Quebec-Sante' (FRQS). C.C. was supported by a studentship from the FRQS.
   L.G. is the recipient of a Tier 1 Canadian Research Chair on Stem Cell
   and Tissue Engineering.
CR Agrawal Vinay B, 2003, Indian J Ophthalmol, V51, P5
   Beliveau A, 2000, INVEST OPHTH VIS SCI, V41, P2363
   BRAZZELL RK, 1991, INVEST OPHTH VIS SCI, V32, P336
   Burling K, 2000, AM J VET RES, V61, P1150, DOI 10.2460/ajvr.2000.61.1150
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Carrier P, 2009, INVEST OPHTH VIS SCI, V50, P2645, DOI 10.1167/iovs.08-2001
   Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196
   Duval C, 2015, EXP EYE RES, V135, P146, DOI 10.1016/j.exer.2015.03.001
   Filenius S, 2001, EXP EYE RES, V72, P93, DOI 10.1006/exer.2000.0933
   Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607
   FINI ME, 1995, INVEST OPHTH VIS SCI, V36, P622
   Gaal Csaba, 2002, Orv Hetil, V143, P2449
   Gama-De-Souza LN, 2008, MATRIX BIOL, V27, P402, DOI 10.1016/j.matbio.2008.02.007
   Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577
   Garzon I, 2014, INVEST OPHTH VIS SCI, V55, P4073, DOI 10.1167/iovs.14-14304
   Gaudreault M, 2003, INVEST OPHTH VIS SCI, V44, P1447, DOI 10.1167/iovs.02-0707
   Gaudreault M, 2007, INVEST OPHTH VIS SCI, V48, P3490, DOI 10.1167/iovs.07-0016
   Gendron SP, 2015, AGING CELL, V14, P433, DOI 10.1111/acel.12324
   Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7
   Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064
   Germain LGC, 2004, ENCY BIOMATERIALS BI, P1534
   Ghezzi C. E., 2015, TISSUE ENG PART B-RE, V21, P276
   Gingras ME, 2003, INVEST OPHTH VIS SCI, V44, P3742, DOI 10.1167/iovs.03-0191
   GIRARD MT, 1991, INVEST OPHTH VIS SCI, V32, P2441
   Gordon GM, 2011, J CELL PHYSIOL, V226, P1461, DOI 10.1002/jcp.22306
   Gordon GM, 2009, J CELL PHYSIOL, V221, P402, DOI 10.1002/jcp.21869
   GRANT MB, 1992, INVEST OPHTH VIS SCI, V33, P3292
   Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1
   Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5
   JACOBSEN IE, 1984, ACTA OPHTHALMOL, V62, P39
   Joo CK, 2008, CELL ADHES MIGR, V2, P252, DOI 10.4161/cam.2.4.6772
   Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341
   Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   Kim HS, 2004, EXP EYE RES, V79, P263, DOI 10.1016/j.exer.2004.05.003
   Kim MJ, 2001, CURR EYE RES, V22, P272, DOI 10.1076/ceyr.22.4.272.5507
   Ko JA, 2012, BIOCHEM BIOPH RES CO, V419, P537, DOI 10.1016/j.bbrc.2012.02.055
   Lake J, 2013, BIOMATERIALS, V34, P6367, DOI 10.1016/j.biomaterials.2013.05.007
   Larouche K, 2000, J BIOL CHEM, V275, P39182, DOI 10.1074/jbc.M002945200
   Li DQ, 2003, INVEST OPHTH VIS SCI, V44, P2928, DOI 10.1167/iovs.02-0874
   Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241
   LJUBIMOV AV, 1995, LAB INVEST, V72, P461
   Lu L, 2001, EXP BIOL MED, V226, P653
   Lyu J, 2005, J BIOL CHEM, V280, P21653, DOI 10.1074/jbc.m500374200
   MALDONADO BA, 1995, INVEST OPHTH VIS SCI, V36, P2120
   MARSHALL GE, 1991, GRAEF ARCH CLIN EXP, V229, P164, DOI 10.1007/BF00170551
   MARSHALL GE, 1991, GRAEF ARCH CLIN EXP, V229, P157, DOI 10.1007/BF00170550
   MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cb.03.110187.000421
   MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R
   Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X
   Michel M, 1999, IN VITRO CELL DEV-AN, V35, P318
   Michelacci YM, 2003, BRAZ J MED BIOL RES, V36, P1037, DOI 10.1590/S0100-879X2003000800009
   Mulholland B, 2005, EYE, V19, P584, DOI 10.1038/sj.eye.6701557
   NAKAYASU K, 1986, OPHTHALMIC RES, V18, P1, DOI 10.1159/000265406
   NELSON JD, 1990, CURR EYE RES, V9, P277, DOI 10.3109/02713689009044524
   Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   NEWSOME DA, 1982, INVEST OPHTH VIS SCI, V22, P376
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Paquet C, 2010, ANN NY ACAD SCI, V1197, P166, DOI 10.1111/j.1749-6632.2009.05373.x
   Philipp K, 2004, INT J MOL MED, V14, P589
   Pouliot R, 2002, TRANSPLANTATION, V73, P1751, DOI 10.1097/00007890-200206150-00010
   Proulx S, 2010, MOL VIS, V16, P2192
   Reddy VS, 2010, AM J PHYSIOL-HEART C, V299, pH1242, DOI 10.1152/ajpheart.00451.2010
   Robert L, 2001, PATHOL BIOL, V49, P353, DOI 10.1016/S0369-8114(01)00144-4
   Saghizadeh M, 2001, AM J PATHOL, V158, P723, DOI 10.1016/S0002-9440(10)64015-1
   Saika Shizuya, 2004, Cornea, V23, pS25, DOI 10.1097/01.ico.0000136668.41000.73
   Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033
   Saravanan C, 2010, GLYCOBIOLOGY, V20, P13, DOI 10.1093/glycob/cwp133
   Schlotzer-Schrehardt U, 2015, OPHTHALMOLOGY, V122, P693, DOI 10.1016/j.ophtha.2014.09.037
   Shan N, 2015, PLACENTA, V36, P809, DOI 10.1016/j.placenta.2015.04.008
   Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5
   SIMMONS SJ, 1987, TOXICOL APPL PHARM, V88, P13, DOI 10.1016/0041-008X(87)90265-1
   Siqueira AS, 2010, TUMOR BIOL, V31, P46, DOI 10.1007/s13277-009-0008-x
   Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Taliana L, 2000, INVEST OPHTH VIS SCI, V41, P103
   Torricelli AAM, 2015, EXP EYE RES, V134, P33, DOI 10.1016/j.exer.2015.03.016
   Torricelli AAM, 2013, INVEST OPHTH VIS SCI, V54, P6390, DOI 10.1167/iovs.13-12547
   Tseng HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057955
   Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Woreta FA, 2015, SURV OPHTHALMOL, V60, P115, DOI 10.1016/j.survophthal.2014.08.003
   Ye HQQ, 2000, INVEST OPHTH VIS SCI, V41, P2894
   ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300
   Zieske JD, 2001, INVEST OPHTH VIS SCI, V42, P1465
NR 85
TC 8
Z9 8
U1 3
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2016
VL 78
BP 86
EP 101
DI 10.1016/j.biomaterials.2015.11.006
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DC1CU
UT WOS:000368955200009
PM 26686051
DA 2018-10-20
ER

PT J
AU Ratto, C
   Buntzen, S
   Aigner, F
   Altomare, DF
   Heydari, A
   Donisi, L
   Lundby, L
   Parello, A
AF Ratto, C.
   Buntzen, S.
   Aigner, F.
   Altomare, D. F.
   Heydari, A.
   Donisi, L.
   Lundby, L.
   Parello, A.
TI Multicentre observational study of the Gatekeeper (TM) for faecal
   incontinence
SO BRITISH JOURNAL OF SURGERY
LA English
DT Article
ID INJECTABLE SILICONE BIOMATERIAL; ANAL-SPHINCTER DYSFUNCTION; STABILIZED
   HYALURONIC-ACID; LONG-TERM EFFICACY; BULKING AGENTS; INJECTION;
   MANAGEMENT; IMPLANTS; DEXTRANOMER; COLLAGEN
AB Background: A variety of therapeutic approaches are available for faecal incontinence. Implantation of Gatekeeper T prostheses is a new promising option. The primary endpoint of this prospective observational multicentre study was to assess the clinical efficacy of Gatekeeper T implantation in patients with faecal incontinence. Secondary endpoints included the assessment of patients' quality of life, and the feasibility and safety of implantation.
   Methods: Patients with faecal incontinence, with either intact sphincters or internal anal sphincter lesions extending for less than 60 degrees of the anal circumference, were selected. Intersphincteric implantation of six prostheses was performed. At baseline, and 1, 3 and 12months after implantation, the number of faecal incontinence episodes, Cleveland Clinic Faecal Incontinence, Vaizey and American Medical Systems, Faecal Incontinence Quality of Life Scale and Short Form 36 Health Survey scores were recorded. Endoanal ultrasonography was performed at baseline and follow-up.
   Results: Fifty-four patients were implanted. After Gatekeeper T implantation, incontinence to gas, liquid and solid stool improved significantly, soiling was reduced, and ability to defer defaecation enhanced. All faecal incontinence severity scores were significantly reduced, and patients' quality of life improved. At 12 months, 30 patients (56 per cent) showed at least 75 per cent improvement in all faecal incontinence parameters, and seven (13 per cent) became fully continent. In three patients a single prosthesis was extruded during surgery, but was replaced immediately. After implantation, prosthesis dislodgement occurred in three patients; no replacement was required.
   Conclusion: Anal implantation of the Gatekeeper T in patients with faecal incontinence was effective and safe. Clinical benefits were sustained at 1-year follow-up. The copyright line for this article was changed on 7th January 2016 after original online publication.
C1 [Ratto, C.; Donisi, L.; Parello, A.] Catholic Univ, Dept Surg Sci, Proctol Unit, Largo A Gemelli 8, I-00165 Rome, Italy.
   [Altomare, D. F.] Univ Bari, Gen Surg Unit, Dept Emergency & Organ Transplantat, Bari, Italy.
   [Heydari, A.] Nuovo Osped Civile St Agostino Estense, Dept Gen Surg, Modena, Italy.
   [Buntzen, S.; Lundby, L.] Aarhus Univ Hosp, Dept Surg P, DK-8000 Aarhus, Denmark.
   [Aigner, F.] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria.
   [Aigner, F.] Charite, Dept Gen Visceral & Transplant Surg, Campus Virchow Klinikum, D-13353 Berlin, Germany.
RP Ratto, C (reprint author), Catholic Univ, Dept Surg Sci, Proctol Unit, Largo A Gemelli 8, I-00165 Rome, Italy.
EM carloratto@tiscali.it
OI Heydari, Azhdar/0000-0002-0617-6977; Ratto, Carlo/0000-0002-0556-0037
CR American Medical Systems (AMS), 1996, FEC INC SCOR SYST
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   Guerra F, 2015, TECH COLOPROCTOL, V19, P23, DOI 10.1007/s10151-014-1236-7
   Hussain ZI, 2011, BRIT J SURG, V98, P1526, DOI 10.1002/bjs.7645
   Kumar D, 1998, BRIT J SURG, V85, P978
   La Torre F, 2013, COLORECTAL DIS, V15, P569, DOI 10.1111/codi.12155
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Maeda Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub3
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Mellgren A, 2014, NEUROGASTROENT MOTIL, V26, P1087, DOI 10.1111/nmo.12360
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   Van Koughnett JAM, 2013, WORLD J GASTROENTERO, V19, P9216, DOI 10.3748/wjg.v19.i48.9216
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
NR 30
TC 5
Z9 5
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1323
EI 1365-2168
J9 BRIT J SURG
JI Br. J. Surg.
PD FEB
PY 2016
VL 103
IS 3
BP 290
EP 299
DI 10.1002/bjs.10050
PG 10
WC Surgery
SC Surgery
GA DB8ZC
UT WOS:000368804700017
PM 26621029
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Godinho, JF
   Berti, FV
   Muller, D
   Rambo, CR
   Porto, LM
AF Godinho, Joanna F.
   Berti, Fernanda V.
   Mueller, Daliana
   Rambo, Carlos R.
   Porto, Luismar M.
TI Incorporation of Aloe vera extracts into nanocellulose during
   biosynthesis
SO CELLULOSE
LA English
DT Article
DE Aloe vera; Bacterial nanocellulose; Nanocomposites; Polysaccharides
ID CELL-WALL POLYSACCHARIDES; BACTERIAL CELLULOSE; BIOMEDICAL APPLICATIONS;
   ACETOBACTER-XYLINUM; FT-IR; MEMBRANES; GEL; GLUCOMANNAN; BEHAVIOR; FILMS
AB Bacterial nanocellulose (BC) and Aloe vera composites were synthesized in situ by Gluconacetobacter hansenii using mannitol-based medium supplemented with 60 % (v/v) of three different Aloe vera portions (Aloe vera gel pulp, Aloe vera gel extract and polysaccharide fraction) under static conditions. The chemical interactions, morphology, crystallinity and mechanical properties influenced by aloe supplementation into BC medium were characterized. The interactions between BC and Aloe, characterized by X-ray photoelectron spectroscopy and Fourier transform infrared spectroscopy, revealed the presence of nitrogenous compounds and aliphatic chains into BC-Aloe composites (BCAC). Moreover, Aloe portions reduced the crystallinity and crystallite size of BCAC, as shown by X-ray diffractometry. The Aloe vera compounds deposited onto BC fibers disrupted the hydroxyl interactions, decreasing the Young's modulus as well as the tensile strength and water uptake of BCAC. However, aloe incorporation of aloe fractions promoted an increase of the extensibility of BCAC (elongation at break), allowing fiber movement. Live/Dead(A (R)) cell viability assays revealed a strong adhesion between L929 cells and the surface of BC and BCAC. The results indicated that this material could be successfully applied as a biomaterial for several biomedical applications, a scaffold for skin substitution and regeneration, and cell culture substrates.
C1 [Godinho, Joanna F.; Berti, Fernanda V.; Porto, Luismar M.] Univ Fed Santa Catarina, Dept Chem & Food Engn, BR-88040900 Florianopolis, SC, Brazil.
   [Mueller, Daliana] Univ Fed Santa Catarina, Dept Mech Engn, BR-88040900 Florianopolis, SC, Brazil.
   [Rambo, Carlos R.] Univ Fed Santa Catarina, Dept Elect & Elect Engn, BR-88040900 Florianopolis, SC, Brazil.
RP Rambo, CR (reprint author), Univ Fed Santa Catarina, Dept Elect & Elect Engn, BR-88040900 Florianopolis, SC, Brazil.
EM carlos.rambo@ufsc.br
RI Berti, Fernanda/O-8760-2016
OI Berti, Fernanda/0000-0003-2185-3822
FU Coordination of Improvement of Higher Education Personnel (CAPES,
   Brazil); Financier of Studies and Projects (FINEP, Brazil); National
   Council for Scientific and Technological Development (CNPq, Brazil);
   UFSC laboratory team: INTELAB; UFSC laboratory team: LAMATE; UFSC
   laboratory team: LFFS; UFSC laboratory team: LCME at UFSC
FX The authors acknowledge the financial support of the Coordination of
   Improvement of Higher Education Personnel (CAPES, Brazil), Financier of
   Studies and Projects (FINEP, Brazil) and National Council for Scientific
   and Technological Development (CNPq, Brazil). The authors also
   appreciate the commitment and support of the UFSC laboratory teams:
   INTELAB, LAMATE, LFFS and LCME at UFSC.
CR Annaidh AN, 2012, J MECH BEHAV BIOMED, V5, P139, DOI 10.1016/j.jmbbm.2011.08.016
   BADER DL, 1983, BIOMATERIALS, V4, P305, DOI 10.1016/0142-9612(83)90033-9
   Berti FV, 2013, MAT SCI ENG C-MATER, V33, P4684, DOI 10.1016/j.msec.2013.07.029
   Cagniant D, 2002, J ANAL APPL PYROL, V65, P1, DOI 10.1016/S0165-2370(01)00172-3
   Campestrini LH, 2013, CARBOHYD POLYM, V94, P511, DOI 10.1016/j.carbpol.2013.01.020
   CARLSSON CMG, 1991, LANGMUIR, V7, P2492, DOI 10.1021/la00059a016
   Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Grace OM, 2008, J ETHNOPHARMACOL, V119, P604, DOI 10.1016/j.jep.2008.07.002
   GRINDLAY D, 1986, J ETHNOPHARMACOL, V16, P117, DOI 10.1016/0378-8741(86)90085-1
   Guo J, 2012, CARBOHYD POLYM, V87, P1026, DOI 10.1016/j.carbpol.2011.07.060
   Jithendra P, 2013, ACS APPL MATER INTER, V5, P7291, DOI 10.1021/am401637c
   Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X
   Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7
   Khoshgozaran-Abras S, 2012, CARBOHYD POLYM, V87, P2058, DOI 10.1016/j.carbpol.2011.10.020
   Kim K, 2009, PHYTOMEDICINE, V16, P856, DOI 10.1016/j.phymed.2009.02.014
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Muller D, 2012, CELLULOSE, V19, P1645, DOI 10.1007/s10570-012-9754-9
   NIEDUSZY.I, 1970, NATURE, V225, P273, DOI 10.1038/225273a0
   Oh SY, 2005, CARBOHYD RES, V340, P417, DOI 10.1016/j.carres.2004.11.027
   Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011
   Pereira R, 2013, PROC CIRP, V5, P210, DOI 10.1016/j.procir.2013.01.042
   Pereira R, 2013, INT J BIOL MACROMOL, V52, P221, DOI 10.1016/j.ijbiomac.2012.09.031
   Pertile RAN, 2010, CARBOHYD POLYM, V82, P692, DOI 10.1016/j.carbpol.2010.05.037
   Reynolds T., 2004, ALOES GENUS ALOE
   Saibuatong OA, 2010, CARBOHYD POLYM, V79, P455, DOI 10.1016/j.carbpol.2009.08.039
   Shaik J, 2013, NANO LIFE, V3, DOI 10.1142/S1793984413420014
   Silva SS, 2013, CARBOHYD POLYM, V98, P581, DOI 10.1016/j.carbpol.2013.06.022
   Silva SS, 2013, ACTA BIOMATER, V9, P6790, DOI 10.1016/j.actbio.2013.02.027
   Stumpf TR, 2013, MAT SCI ENG C-MATER, V33, P4739, DOI 10.1016/j.msec.2013.07.035
   Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y
   Tokoh C, 1998, CELLULOSE, V5, P249, DOI 10.1023/A:1009211927183
   Tokoh C, 2002, CELLULOSE, V9, P65, DOI 10.1023/A:1015827121927
   Tokoh C, 2002, CELLULOSE, V9, P351, DOI 10.1023/A:1021150520953
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   Whitney SEC, 1998, CARBOHYD RES, V307, P299, DOI 10.1016/S0008-6215(98)00004-4
   Yu LH, 2012, LANGMUIR, V28, P12373, DOI 10.1021/la3024277
   Zhang LN, 1996, IMMUNOPHARMACOLOGY, V35, P119, DOI 10.1016/S0162-3109(96)00135-X
NR 38
TC 2
Z9 2
U1 1
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD FEB
PY 2016
VL 23
IS 1
BP 545
EP 555
DI 10.1007/s10570-015-0844-3
PG 11
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA DB8YI
UT WOS:000368802700037
DA 2018-10-20
ER

PT J
AU Favero, V
   Lang, NP
   Canullo, L
   Velez, JU
   Bengazi, F
   Botticelli, D
AF Favero, Vittorio
   Lang, Niklaus P.
   Canullo, Luigi
   Urbizo Velez, Joaquin
   Bengazi, Franco
   Botticelli, Daniele
TI Sinus floor elevation outcomes following perforation of the Schneiderian
   membrane. An experimental study in sheep
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE alloplast; animal study; bone; bone graft; bone healing; collagen
   membrane; histology; morphometry; sinus floor elevation
ID AUGMENTATION; REPAIR; GRAFT; CLASSIFICATION; SURVIVAL; SUCCESS; MONKEYS;
   SYSTEM; MODEL
AB ObjectiveTo assess the influence of a collagen membrane covering a perforation of the sinus (Schneiderian) membrane on the outcome (bone fill) of a sinus floor elevation.
   Materials and MethodsEighteen Pelibuey sheep were used. The animals underwent sinus floor elevation on both sides of the upper jaw. A perforation of 5x4mm in dimension of the sinus mucosa was performed on both sides and, at a randomly selected test site, a collagen membrane was placed to cover the perforation. A graft of biphasic calcium phosphate (60% HA/40% beta-TCP) was subsequently placed bilaterally, and the access window was closed with a membrane made of polylactic acid and a citric acid ester acetyl. The sacrifices were performed after 2, 4, and 12weeks of healing.
   ResultsAfter 2weeks of healing, the augmented volume was filled with biomaterial surrounded by connective tissue and minimal new bone was detected. After 4weeks of healing, new bone was found mainly in connection with the sinus bony walls with percentages of 18.012.9% at the test and 12.3 +/- 7.9% at the control sites. After 12weeks of healing, similar amounts of newly formed bone were found compared to the previous healing period, namely 16.7 +/- 8.0% and 13.7 +/- 10.1% at the test and control sites, respectively, with the highest amount detected in the bottom of the sinus cavity. The newly formed bone was distributed more evenly within the sinus cavity also including the central areas. The differences between test and control sites did not reach statistical significance.
   ConclusionEven though there were trends for more bone formation when applying a collagen membrane on a sinus mucosal perforation of relatively small dimensions, this study failed to establish the absolute necessity of such a procedure to achieve bone fill in the sinus cavity.
C1 [Lang, Niklaus P.] Univ Zurich, Ctr Dent Med, Zurich, Switzerland.
   [Lang, Niklaus P.] Univ Bern, Bern, Switzerland.
   [Urbizo Velez, Joaquin; Bengazi, Franco; Botticelli, Daniele] Univ Med Sci, Fac Dent, Havana, Cuba.
   [Botticelli, Daniele] ARDEC, Ariminum Odontol, Rimini, Italy.
RP Botticelli, D (reprint author), Ave Salvador Allende & G Vedado, Havana, Cuba.
EM daniele.botticelli@gmail.com
OI Botticelli, Daniele/0000-0003-2804-1632
FU Degradable Solutions AG, a Sunstar Group Company, CH Schlieren ZH,
   Switzerland; Ariminum Odontologica s.r.l., Rimini, Italy; Clinical
   Research Foundation (CRF) for the Promotion of Oral Health, CH Brienz,
   Switzerland
FX This study has been funded in part by Degradable Solutions AG, a Sunstar
   Group Company, CH-8952 Schlieren ZH, Switzerland, Ariminum Odontologica
   s.r.l., Rimini, Italy, and the Clinical Research Foundation (CRF) for
   the Promotion of Oral Health, CH-3855 Brienz, Switzerland. The authors
   gratefully acknowledge the company Mectron s.p.a, Carasco, Genova,
   Italy, for having provided the Piezosurgery.
CR Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   Barone A, 2013, CLIN ORAL IMPLAN RES, V24, P1, DOI 10.1111/j.1600-0501.2011.02340.x
   Choi KS, 2009, INT J ORAL MAX IMPL, V24, P73
   Fugazzotto PA, 2003, J PERIODONTOL, V74, P1534, DOI 10.1902/jop.2003.74.10.1534
   Khoury F, 1999, INT J ORAL MAX IMPL, V14, P557
   Kim YK, 2014, J KOR ASSOC ORAL MAX, V40, P188, DOI 10.5125/jkaoms.2014.40.4.188
   Kim YK, 2008, INT J ORAL MAX IMPL, V23, P1139
   Nolan PJ, 2014, J ORAL MAXIL SURG, V72, P47, DOI 10.1016/j.joms.2013.07.020
   Pikos M A, 1999, Implant Dent, V8, P29, DOI 10.1097/00008505-199901000-00003
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Proussaefs Periklis, 2003, J Oral Implantol, V29, P235, DOI 10.1563/1548-1336(2003)029<0235:EOSTPS>2.3.CO;2
   Scala A., 2014, CLIN ORAL IMPLAN RES, V26, P419
   Scala A, 2012, CLIN ORAL IMPLAN RES, V23, P175, DOI 10.1111/j.1600-0501.2011.02227.x
   Scala A, 2010, CLIN ORAL IMPLAN RES, V21, P1320, DOI 10.1111/j.1600-0501.2010.01964.x
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schwartz-Arad D, 2004, J PERIODONTOL, V75, P511, DOI 10.1902/jop.2004.75.4.511
   Shlomi B, 2004, INT J ORAL MAX IMPL, V19, P559
   Testori T, 2008, INT J PERIODONT REST, V28, P9
   Vlassis JM, 1999, J PERIODONTOL, V70, P692, DOI 10.1902/jop.1999.70.6.692
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
NR 20
TC 9
Z9 10
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2016
VL 27
IS 2
BP 233
EP 240
DI 10.1111/clr.12576
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DB7KL
UT WOS:000368693900024
PM 25712609
DA 2018-10-20
ER

PT J
AU Ayre, WN
   Scott, T
   Hallam, K
   Blom, AW
   Denyer, S
   Bone, HK
   Mansell, JP
AF Ayre, Wayne Nishio
   Scott, Tom
   Hallam, Keith
   Blom, Ashley W.
   Denyer, Stephen
   Bone, Heather K.
   Mansell, Jason P.
TI Fluorophosphonate-functionalised titanium via a pre-adsorbed alkane
   phosphonic acid: a novel dual action surface finish for bone
   regenerative applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MG63 OSTEOBLAST MATURATION; LYSOPHOSPHATIDIC ACID; GROWTH-FACTOR;
   FATTY-ACIDS; ANALOGS; DIFFERENTIATION; MONOLAYERS; MG-63; LPA
AB Enhancing vitamin D-induced human osteoblast (hOB) maturation at bone biomaterial surfaces is likely to improve prosthesis integration with resultant reductions in the need for revision arthroplasty consequent to aseptic loosening. Biomaterials that are less appealing to microorganisms implicated in implant failures through infection are also highly desirable. However, finding surfaces that enhance hOB maturation to active vitamin D yet deter bacteria remain elusive. In addressing this, we have sought to bio-functionalise titanium (Ti) with lysophosphatidic acid (LPA) and related, phosphatase-resistant, LPA analogues. The impetus for this follows our discovery that LPA co-operates with active vitamin D3 metabolites to secure hOB maturation in vitro including cells grown upon Ti. LPA has also been found, by others, to inhibit virulence factor production and biofilm formation of the human opportunistic pathogen Pseudomonas aeruginosa. Collectively, selected LPA species might offer potential dual-action surface finishes for contemporary bone biomaterials. In attaching a phosphatase-resistant LPA analogue to Ti we took advantage of the affinity of alkane phosphonic acids for TiO2. Herein, we provide evidence for the facile development of a dual-action Ti surface for potential orthopaedic and dental applications. Successful conjugation of an LPA analogue (3S) 1-fluoro-3-hydroxy-4-(oleoyloxy) butyl-1-phosphonate (FHBP) to the Ti surface was supported through physiochemical characterisation using x-ray photoelectron spectroscopy and secondary ion mass spectrometry. hOB maturation to active vitamin D3 was enhanced for cells grown on FHBP-Ti whilst these same surfaces exhibited clear antiadherent properties towards a clinical isolate of Staphylococcus aureus.
C1 [Ayre, Wayne Nishio] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales.
   [Scott, Tom; Hallam, Keith] Univ Bristol, Interface Anal Ctr, Sch Phys, Bristol BS8 1TL, Avon, England.
   [Blom, Ashley W.] Univ Bristol, Southmead Hosp, Musculoskeletal Res Unit, Bristol BS10 5NB, Avon, England.
   [Denyer, Stephen] Univ Brighton, Mithras House, Brighton BN2 4AT, E Sussex, England.
   [Bone, Heather K.] Univ W England, CATIM, Frenchay Campus, Bristol BS16 1QY, Avon, England.
   [Mansell, Jason P.] Univ W England, Dept Biol Biomed & Analyt Sci, Coldharbour Lane, Bristol BS16 1QY, Avon, England.
RP Mansell, JP (reprint author), Univ W England, Dept Biol Biomed & Analyt Sci, Coldharbour Lane, Bristol BS16 1QY, Avon, England.
EM jason.mansell@uwe.ac.uk
OI Nishio Ayre, Wayne/0000-0003-2405-1876
FU Severnside Alliance for Translational Research (SARTRE, University of
   Bristol, UK)
FX The authors acknowledge the generous support of Professor Lars Sundstrom
   and colleagues of the Severnside Alliance for Translational Research
   (SARTRE, University of Bristol, UK) for their research funding. JPM
   would like to thank Xavier Bell, Research, Business & Innovation,
   University of the West of England, for his hard work in securing a
   patent application for the technology we describe herein; P119087 GB was
   filed at the UK Intellectual Property Office, Newport, UK (patent
   application number 1509693.6) on the 4th June 2015.
CR Baltatu OC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00263
   Blackburn J, 2012, BONE, V50, P756, DOI 10.1016/j.bone.2011.12.002
   BONEWALD LF, 1992, J BIOL CHEM, V267, P8943
   Brause BD, 2005, PRINCIPLES PRACTICE, P1330
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Gidley J, 2006, PROSTAG OTH LIPID M, V80, P46, DOI 10.1016/j.prostaglandins.2006.04.001
   Hanson EL, 2003, J AM CHEM SOC, V125, P16074, DOI 10.1021/ja035956z
   KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kohal RJ, 2000, CLIN ORAL IMPLAN RES, V15, P683
   Krogfelt KA, 2000, J ANTIMICROB CHEMOTH, V46, P377, DOI 10.1093/jac/46.3.377
   Lancaster ST, 2014, STEROIDS, V83, P52, DOI 10.1016/j.steroids.2014.01.010
   Laux DC, 2002, MICROBIOL-SGM, V148, P1709, DOI 10.1099/00221287-148-6-1709
   Mansell JP, 2012, EUR CELLS MATER, V23, P348, DOI 10.22203/eCM.v023a27
   Mansell JP, 2013, BBA-MOL CELL BIOL L, V1831, P105, DOI 10.1016/j.bbalip.2012.04.005
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12
   Paz YR, 2011, BEILSTEIN J NANOTECH, V2, P845, DOI 10.3762/bjnano.2.94
   Prestwich GD, 2008, BBA-MOL CELL BIOL L, V1781, P588, DOI 10.1016/j.bbalip.2008.03.008
   Queffelec C, 2012, CHEM REV, V112, P3777, DOI 10.1021/cr2004212
   Rasband WS, 1997, IMAGEJ
   von Salis-Soglio M, 2014, J FUNCT BIOMATER, V5, P135, DOI 10.3390/jfb5030135
   Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x
   Xu Y, 2005, J MED CHEM, V48, P3319, DOI 10.1021/jm049186t
   Xu Y, 2003, J ORG CHEM, V68, P5320, DOI 10.1021/jo0207291
   Yarram SJ, 2004, MOL CELL ENDOCRINOL, V220, P9, DOI 10.1016/j.mce.2004.04.005
NR 27
TC 1
Z9 1
U1 1
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2016
VL 27
IS 2
AR 36
DI 10.1007/s10856-015-5644-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB7WA
UT WOS:000368726300015
PM 26704553
DA 2018-10-20
ER

PT J
AU Guillaume, O
   Park, J
   Monforte, X
   Gruber-Blum, S
   Redl, H
   Petter-Puchner, A
   Teuschl, AH
AF Guillaume, O.
   Park, J.
   Monforte, X.
   Gruber-Blum, S.
   Redl, H.
   Petter-Puchner, A.
   Teuschl, A. H.
TI Fabrication of silk mesh with enhanced cytocompatibility: preliminary in
   vitro investigation toward cell-based therapy for hernia repair
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ABDOMINAL-WALL REPAIR; 2-STAGE BREAST RECONSTRUCTION; SERI SURGICAL
   SCAFFOLD; MESENCHYMAL STEM-CELLS; POLYPROPYLENE-MESH; FIBROIN SOLUTION;
   PLANT-LECTINS; MODEL; ACTIVATION; ADHESION
AB Recent studies have demonstrated that combining cells with meshes prior to implantation successfully enhanced hernia repair. The idea is to create a biologic coating surrounding the mesh with autologous cells, before transplantation into the patient. However, due to the lack of a prompt and robust cell adhesion to the meshes, extensive in vitro cultivation is required to obtain a homogenous cell layer covering the mesh. In this context, the objective of this publication is to manufacture meshes made of silk fibres and to enhance the cytoadhesion and cytocompatibility of the biomaterial by surface immobilization of a pro-adhesive wheat germ agglutinin (lectin WGA). We first investigated the affinity between the glycoprotein WGA and cells, in solution and then after covalent immobilization of WGA on silk films. Then, we manufactured meshes made of silk fibres, tailored them with WGA grafting and finally evaluated the cytocompatibility and the inflammatory response of silk and silk-lectin meshes compared to common polypropylene mesh, using fibroblasts and peripheral blood mononuclear cells, respectively. The in vitro experiments revealed that the cytocompatibility of silk can be enhanced by surface immobilization with lectin WGA without exhibiting negative response in terms of pro-inflammatory reaction. Grafting lectin to silk meshes could bring advantages to facilitate cell-coating of meshes prior to implantation, which is an imperative prerequisite for abdominal wall tissue regeneration using cell-based therapy.
C1 [Guillaume, O.; Park, J.; Gruber-Blum, S.; Redl, H.; Petter-Puchner, A.] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Monforte, X.; Teuschl, A. H.] Univ Appl Sci Technikum Wien, Dept Biochem Engn, A-1200 Vienna, Austria.
   [Gruber-Blum, S.; Petter-Puchner, A.] Wilhelminenspital Stadt Wien, Dept Gen Visceral & Oncol Surg, A-1171 Vienna, Austria.
   [Guillaume, O.; Park, J.; Monforte, X.; Redl, H.; Petter-Puchner, A.; Teuschl, A. H.] Austrian Cluster Tissue Regenerat, Vienna, Austria.
RP Guillaume, O (reprint author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM olivier.guillaume@trauma.lbg.ac.at
OI Guillaume, Olivier/0000-0003-0735-113X
FU City of Vienna [MA 27, 12-06, MA 23, 14-06]
FX This work was supported with resources/facilities of the Ludwig
   Boltzmann Institute of Experimental and Clinical Traumatology in Vienna
   and the FemTech grant programme. The financial support by the City of
   Vienna (MA 27, Project 12-06 and MA 23, Project 14-06) is gratefully
   acknowledged. Furthermore, we would like to thank M. Jafarmadar, A.
   Klotz and A. Khadem for their technical assistance.
CR Altman AM, 2010, PLAST RECONSTR SURG, V126, P845, DOI 10.1097/PRS.0b013e3181e6044f
   Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012
   Ayele T, 2010, J MATER SCI-MATER M, V21, P1721, DOI 10.1007/s10856-010-4007-7
   Cheung RCF, 2015, APPL MICROBIOL BIOT, V99, P3755, DOI 10.1007/s00253-015-6518-0
   Clemens MW, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000217
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Dolce CJ, 2010, SURG ENDOSC, V24, P2687, DOI 10.1007/s00464-010-1026-x
   Drewa T, 2005, J PEDIATR SURG, V40, P317, DOI 10.1016/j.jpedsurg.2004.10.019
   Ekwall B., 1990, SHORT TERM TOXICITY, P75
   Fine NA, 2015, PLAST RECONSTR SURG, V135, P339, DOI 10.1097/PRS.0000000000000987
   Gabor F, 1998, J CONTROL RELEASE, V55, P131, DOI 10.1016/S0168-3659(98)00043-1
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Gross JE, 2014, PLAST RECONSTR SURG, V134, p700E, DOI 10.1097/PRS.0000000000000697
   Guillaume O, 2015, ADV HEALTHC MATER, V4, P1763, DOI 10.1002/adhm.201500201
   Handley W. S., 1963, LANGENBECKS ARCH KLI, V304, P296
   Haupt J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0379-8
   Horan RL, 2009, HERNIA, V13, P189, DOI 10.1007/s10029-008-0459-9
   Hossain KS, 2003, BIOMACROMOLECULES, V4, P350, DOI 10.1021/bm020109u
   Hughes RC, 1992, CURR OPIN STRUC BIOL, V2, P687
   Iyyanki TS, 2015, TISSUE ENG PT A, V21, P475, DOI [10.1089/ten.tea.2014.0235, 10.1089/ten.TEA.2014.0235]
   Kapischke M, 2005, SURG ENDOSC, V19, P791, DOI 10.1007/s00464-004-9222-1
   KleinJan GH, 2014, MOLECULES, V19, P9876, DOI 10.3390/molecules19079876
   Klinge U, 1999, BIOMATERIALS, V20, P613, DOI 10.1016/S0142-9612(98)00211-7
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lai JY, 2003, J PEDIATR SURG, V38, P1752, DOI 10.1016/S0022-3468(03)00617-1
   LIS H, 1986, LECTINS PROPERTIES F, P265
   Mestak O, 2014, ARTIF ORGANS, V38, P572, DOI 10.1111/aor.12224
   Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7
   Orenstein SB, 2010, SURG ENDOSC, V24, P805, DOI 10.1007/s00464-009-0664-3
   Petter-Puchner AH, 2015, HERNIA, V19, P25, DOI 10.1007/s10029-014-1288-7
   Pott PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046978
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sannino A, 2005, J MATER SCI-MATER M, V16, P289, DOI 10.1007/s10856-005-0626-9
   Song ZC, 2013, TISSUE ENG PT A, V19, P1543, DOI [10.1089/ten.tea.2011.0748, 10.1089/ten.TEA.2011.0748]
   Teuschl AH, 2014, ACTA BIOMATER, V10, P2506, DOI 10.1016/j.actbio.2014.02.012
   Wirth M, 2002, J CONTROL RELEASE, V79, P183, DOI 10.1016/S0168-3659(01)00538-7
   Wittmann V, 2013, CHEM SOC REV, V42, P4492, DOI 10.1039/c3cs60089k
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zhao YL, 2012, ARTIF ORGANS, V36, P247, DOI 10.1111/j.1525-1594.2011.01343.x
NR 41
TC 3
Z9 3
U1 1
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2016
VL 27
IS 2
AR 37
DI 10.1007/s10856-015-5648-3
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB7WA
UT WOS:000368726300016
PM 26704554
DA 2018-10-20
ER

PT J
AU Vivan, RR
   Mecca, CE
   Biguetti, CC
   Renno, ACM
   Okamoto, R
   Cavenago, BC
   Duarte, MH
   Matsumoto, MA
AF Vivan, Rodrigo Ricci
   Mecca, Carlos Eduardo
   Biguetti, Claudia Cristina
   Muniz Renno, Ana Claudia
   Okamoto, Roberta
   Cavenago, Bruno Cavalini
   Duarte, Marco Hungaro
   Matsumoto, Mariza Akemi
TI Experimental maxillary sinus augmentation using a highly bioactive glass
   ceramic
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID AUTOGENOUS BONE; DENTAL IMPLANTS; LIFT PROCEDURES; RABBITS; MATRIX;
   MODEL; OSSEOINTEGRATION; BIOSILICATE(R); BIOMATERIALS; BIO-OSS(R)
AB Physicochemical characteristics of a biomaterial directly influence its biological behavior and fate. However, anatomical and physiological particularities of the recipient site also seem to contribute with this process. The present study aimed to evaluate bone healing of maxillary sinus augmentation using a novel bioactive glass ceramic in comparison with a bovine hydroxyapatite. Bilateral sinus augmentation was performed in adult male rabbits, divided into 4 groups according to the biomaterial used: BO-particulate bovine HA Bio-Oss (R) (BO), BO? G-particulate bovine HA ? particulate autogenous bone graft (G), BS-particulate glass ceramic (180-212 mu m) Biosilicate (R) (BS), and BS+G-particulate glass ceramic + G. After 45 and 90 days, animals were euthanized and the specimens prepared to be analyzed under light and polarized microscopy, immunohistochemistry, scanning electron microscopy (SEM), and micro-computed tomography (mu CT). Results revealed different degradation pattern between both biomaterials, despite the association with bone graft. BS caused a more intense chronic inflammation with foreign body reaction, which led to a difficulty in bone formation. Besides this evidence, SEM and mu CT confirmed direct contact between newly formed bone and biomaterial, along with osteopontin and osteocalcin immunolabeling. Bone matrix mineralization was late in BS group but became similar to BO at day 90. These results clearly indicate that further studies about Biosilicate (R) are necessary to identify the factors that resulted in an unfavorable healing response when used in maxillary sinus augmentation.
C1 [Vivan, Rodrigo Ricci; Cavenago, Bruno Cavalini; Duarte, Marco Hungaro] Univ Sao Paulo FOB USP, Bauru Sch Dent, Dept Dent Endodont & Dent Mat, BR-17012901 Bauru, SP, Brazil.
   [Mecca, Carlos Eduardo] Sagrado Coracao Univ USC, Oral Biol Masters Program, BR-17011160 Bauru, SP, Brazil.
   [Biguetti, Claudia Cristina] Univ Sao Paulo FOB USP, Bauru Sch Dent, Oral Biol Doctorals Program, BR-17012901 Bauru, SP, Brazil.
   [Muniz Renno, Ana Claudia] Univ Fed Sao Paulo, Dept Biosci, BR-11060001 Santos, SP, Brazil.
   [Okamoto, Roberta; Matsumoto, Mariza Akemi] Sao Paulo State Univ FOA UNESP, Aracatuba Sch Dent, Dept Basic Sci, BR-16015050 Aracatuba, SP, Brazil.
   [Matsumoto, Mariza Akemi] Sagrado Coracao Univ, USC, Oral Biol Doctorals Program, Bauru, Brazil.
   [Okamoto, Roberta] CNPq Conselho Nacl Dev Cient & Tecnol, Brasilia, DF, Brazil.
RP Matsumoto, MA (reprint author), Sao Paulo State Univ FOA UNESP, Aracatuba Sch Dent, Dept Basic Sci, Rua Jose Bonifacio 1193, BR-16015050 Aracatuba, SP, Brazil.
EM vicmak.blv@terra.com.br
RI Duarte, Marco/B-9833-2012; Vivan, Rodrigo/I-3616-2014; Matsumoto,
   Mariza/C-5183-2012; Biguetti, Claudia Cristina/F-5118-2012
OI Duarte, Marco/0000-0003-3051-737X; Okamoto, Roberta/0000-0002-6773-6966;
   Cavenago, Bruno/0000-0003-3203-0899
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/SP)
   [2008/11485-8, 2009/17294-1]
FX The authors are grateful to Maira Cristina Rondina Couto for histology
   and imunohistochemical assistance. This work was supported by Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/SP), Grant Numbers
   2008/11485-8; 2009/17294-1.
CR Andani MT, 2014, ACTA BIOMATER, V10, P4058, DOI 10.1016/j.actbio.2014.06.025
   Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   Azenha Marcelo Rodrigues, 2010, Braz. Dent. J., V21, P383, DOI 10.1590/S0103-64402010000500001
   Barone A, 2013, INT J PERIODONT REST, V33, P795, DOI 10.11607/prd.1690
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Christo SN, 2015, BIOMED RES INT, DOI 10.1155/2015/342304
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P7
   Garavello-Freltas I, 2003, J PHOTOCH PHOTOBIO B, V70, P81, DOI 10.1016/S1011-1344(03)00058-7
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Hammerle CHF, 2001, CLIN ORAL IMPLAN RES, V12, P9, DOI 10.1034/j.1600-0501.2001.012001009.x
   Hench LL, 2004, BIOMATERIALS SCI INT, P153
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Jones Julian R, 2015, Acta Biomater, V23 Suppl, pS53, DOI 10.1016/j.actbio.2015.07.019
   Kido HW, 2013, J BIOMED MATER RES A, V101, P667, DOI 10.1002/jbm.a.34360
   Kido HW, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5411-9
   Marks SC, 1997, LARYNGOSCOPE, V107, P1579, DOI 10.1097/00005537-199712000-00001
   Matsumoto MA, 2012, J MATER SCI-MATER M, V23, P1447, DOI 10.1007/s10856-012-4612-8
   Nunes LSD, 2010, CLIN ORAL IMPLAN RES, V21, P584, DOI 10.1111/j.1600-0501.2009.01858.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Ozcan KM, 2011, INDIAN J OTOLARYNGOL, V63, P56, DOI 10.1007/s12070-011-0120-2
   Pedrosa WF, 2009, CLIN ORAL IMPLAN RES, V20, P1254, DOI 10.1111/j.1600-0501.2009.01747.x
   Peitl O, 1997, Patent, Patent No. [WO/1997/041079, 1997041079]
   Renno ACM, 2013, BIOMED RES INT, DOI 10.1155/2013/141427
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Srouji S, 2009, CALCIFIED TISSUE INT, V84, P138, DOI 10.1007/s00223-008-9202-x
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Trindade R, 2015, ORAL MAXIL SURG CLIN, V27, P175, DOI 10.1016/j.coms.2015.01.004
   Trindade R, 2016, CLIN IMPLANT DENT R, V18, P192, DOI 10.1111/cid.12274
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
NR 35
TC 3
Z9 3
U1 3
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2016
VL 27
IS 2
AR 41
DI 10.1007/s10856-015-5652-7
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB7WA
UT WOS:000368726300020
PM 26712707
DA 2018-10-20
ER

PT J
AU McEntire, BJ
   Enomoto, Y
   Zhu, WL
   Boffelli, M
   Marin, E
   Pezzotti, G
AF McEntire, Bryan J.
   Enomoto, Yuto
   Zhu, Wenliang
   Boffelli, Marco
   Marin, Elia
   Pezzotti, Giuseppe
TI Surface toughness of silicon nitride bioceramics: II, Comparison with
   commercial oxide materials
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE ZTA; Si3N4; Confocal Raman piezo-spectroscopy; Surface toughness;
   Toughening mechanisms; Environmental degradation
ID RAMAN-SPECTROSCOPIC ANALYSIS; HIP JOINTS; PHASE-TRANSFORMATION; BRIDGING
   STRESSES; WEAR-RESISTANCE; ZIRCONIUM-OXIDE; CERAMICS; MODES
AB Raman microprobe-assisted indentation, a rnicromechanics method validated in a companion paper, was used to compare the surface toughening behaviors of silicon nitride (Si3N4) and alumina-based bioceramics employed in joint arthroplasty (i.e., monolithic alumina, Al2O3, and yttria-stabilized zirconia (ZrO2)-toughened alumina, ZTA). Quantitative assessments of microscopic stress fields both ahead and behind the tip of Vickers indentation cracks propagated under increasing indentation loads were systematically made using a Raman microprobe with spatial resolution on the order of a single micrometer. Concurrently, crack opening displacement (COD) profiles were monitored on the same microcracks screened by Raman spectroscopy. The Raman eye clearly visualized different mechanisms operative in toughening Si3N4 and ZTA bioceramics (i.e., crack-face bridging and ZrO2 polymorphic transformation, respectively) as compared to the brittle behavior of monolithic Al2O3. Moreover, emphasis was placed on assessing not only the effectiveness but also the durability of such toughening effects when the biomaterials were aged in a hydrothermal environment. A significant degree of embrittlement at the biomaterial surface was recorded in the transformation-toughened ZTA, with the surface toughness reduced by exposure to the hydrothermal environment. Conversely, the Si3N4 biomaterial experienced a surface toughness value independent of hydrothermal attack. Crack-face bridging thus appears to be a durable surface toughening mechanism for biomaterials in joint arthroplasty. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [McEntire, Bryan J.] AMEDICA Corp, 1885 West 2100, South Salt Lake City, UT 84119 USA.
   [Enomoto, Yuto; Zhu, Wenliang; Boffelli, Marco; Marin, Elia; Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
EM pezzotti@kit.ac.jp
OI Marin, Elia/0000-0002-0981-7821
CR Adachi K, 1997, WEAR, V203, P291, DOI 10.1016/S0043-1648(96)07363-2
   Chevalier J, 2009, BIOMATERIALS, V30, P5279, DOI 10.1016/j.biomaterials.2009.06.022
   Daramola DA, 2010, J PHYS CHEM B, V114, P9323, DOI 10.1021/jp9077135
   Evans A.G., 1980, FUNDAMENTALS FRICTIO, P439
   EVANS AG, 1976, ACTA METALL MATER, V24, P939, DOI 10.1016/0001-6160(76)90042-0
   Fett T, 2005, ENG FRACT MECH, V72, P647, DOI 10.1016/j.engfracmech.2004.07.003
   FISCHER TE, 1989, J AM CERAM SOC, V72, P252, DOI 10.1111/j.1151-2916.1989.tb06110.x
   Fukatsu K, 2012, ACTA BIOMATER, V8, P1639, DOI 10.1016/j.actbio.2011.12.019
   Greil P., 1991, Journal of the European Ceramic Society, V7, P353, DOI 10.1016/0955-2219(91)90058-8
   Honda K, 1999, J APPL PHYS, V85, P7380, DOI 10.1063/1.369366
   Hosseinzadeh H. R. S., 2012, BEARING SURFACES TOT
   Kato K, 2002, WEAR, V253, P1097, DOI 10.1016/S0043-1648(02)00240-5
   Kerkwijk B, 1999, J AM CERAM SOC, V82, P2087
   Kim BK, 1997, PHYS STATUS SOLIDI B, V203, P557, DOI 10.1002/1521-3951(199710)203:2<557::AID-PSSB557>3.0.CO;2-C
   Lu Z, 1997, P I MECH ENG H, V211, P101, DOI 10.1243/0954411971534728
   Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010
   Michel D., 1986, ADV CERAM, V24, P555
   Pezzotti G, 2004, J BIOMED OPT, V9, P372, DOI 10.1117/1.1647547
   Pezzotti G, 2001, J AM CERAM SOC, V84, P1785
   Pezzotti G, 1999, J AM CERAM SOC, V82, P1249
   Pezzotti G., 2013, ADV MAT JOINT IMPLAN
   Pezzotti G, 2008, J AM CERAM SOC, V91, P1199, DOI 10.1111/j.1551-2916.2007.01507.x
   Pezzotti G, 2014, MATERIALS, V7, P4367, DOI 10.3390/ma7064367
   Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035
   Sarin V. K., 1985, CARBIDE TOOL J, V14, P4
   Takahashi Y, 2011, J MECH BEHAV BIOMED, V4, P993, DOI 10.1016/j.jmbbm.2011.02.014
   TAKASE A, 1984, J MATER SCI LETT, V3, P1058, DOI 10.1007/BF00719763
   YOFFE EH, 1982, PHILOS MAG A, V46, P617, DOI 10.1080/01418618208236917
   Zhu WL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127002
NR 29
TC 7
Z9 7
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2016
VL 54
BP 346
EP 359
DI 10.1016/j.jmbbm.2015.08.044
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DC1AX
UT WOS:000368950300032
PM 26437609
DA 2018-10-20
ER

PT J
AU Herman-Bausier, P
   Dufrene, YF
AF Herman-Bausier, Philippe
   Dufrene, Yves F.
TI Atomic force microscopy reveals a dual collagen-binding activity for the
   staphylococcal surface protein SdrF
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID CELL-ADHESION; EPIDERMIDIS; SPECTROSCOPY; FIBRINOGEN; AUREUS; BACTERIA;
   AFFINITY; MSCRAMM; LOCK; DOCK
AB Staphylococcus epidermidis causes nosocomial infections by colonizing and forming biofilms on indwelling medical devices. This process involves specific interactions between cell wall-anchored (CWA) proteins and host proteins adsorbed onto the biomaterial. Here, we have explored the molecular forces by which the S.epidermidisCWA protein serine-aspartate repeat protein F (SdrF) binds to type I collagen, by means of advanced atomic force microscopy (AFM) techniques. Using single-cell force spectroscopy, we found that SdrF mediates bacterial adhesion to collagen-coated substrates through both weak and strong bonds. Single-molecule force spectroscopy demonstrated that these bonds involve the A and B regions of SdrF, thus revealing that the protein is capable of dual ligand-binding activity. Both weak and strong bonds showed high dissociation rates, indicating they are much less stable than those formed by the well-characterized dock, lock and latch' mechanism. Collectively, our results show that CWA proteins can bind to ligands by novel mechanisms. We anticipate that AFM will greatly contribute to the identification of novel binding partners and binding mechanisms in staphylococcal CWA proteins.
C1 [Herman-Bausier, Philippe; Dufrene, Yves F.] Catholic Univ Louvain, Inst Life Sci, Croix Sud 1,Bte L7-04-01, B-1348 Louvain La Neuve, Belgium.
   [Dufrene, Yves F.] Walloon Excellence Life Sci & Biotechnol WELBIO, Louvain La Neuve, Belgium.
RP Dufrene, YF (reprint author), Catholic Univ Louvain, Inst Life Sci, Croix Sud 1,Bte L7-04-01, B-1348 Louvain La Neuve, Belgium.
EM Yves.Dufrene@uclouvain.be
OI Dufrene, Yves/0000-0002-7289-4248
FU National Fund for Scientific Research (FNRS); FNRS-WELBIO
   [WELBIO-CR-2015A-05]; Universite catholique de Louvain (Fonds Speciaux
   de Recherche); Federal Office for Scientific, Technical and Cultural
   Affairs (Interuniversity Poles of Attraction Programme); Research
   Department of the Communaute francaise de Belgique (Concerted Research
   Action)
FX Work at the Universite catholique de Louvain was supported by the
   National Fund for Scientific Research (FNRS), the FNRS-WELBIO under
   Grant number WELBIO-CR-2015A-05, the Universite catholique de Louvain
   (Fonds Speciaux de Recherche), the Federal Office for Scientific,
   Technical and Cultural Affairs (Interuniversity Poles of Attraction
   Programme) and the Research Department of the Communaute francaise de
   Belgique (Concerted Research Action). YFD is a Research Director of the
   FNRS. We thank F. Lowy (Columbia University) and T. Foster (Trinity
   College Dublin) for providing us with bacterial strains used in this
   study, and T. Foster and J. Geoghegan (Trinity College Dublin) for
   fruitful discussion.
CR Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107
   Andre G, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1027
   Arrecubieta C, 2007, J BIOL CHEM, V282, P18767, DOI 10.1074/jbc.M610940200
   Arrecubieta C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000411
   Barbu EM, 2014, MOL MICROBIOL, V94, P172, DOI 10.1111/mmi.12750
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   Beaussart A, 2014, NAT PROTOC, V9, P1049, DOI 10.1038/nprot.2014.066
   Beaussart A, 2013, NANOSCALE, V5, P10894, DOI 10.1039/c3nr03272h
   Beaussart A, 2013, BIOPHYS J, V104, P1886, DOI 10.1016/j.bpj.2013.03.046
   Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Dufrene Y. F., 2014, MBIO, V5, pe1363
   Dufrene YF, 1999, J BACTERIOL, V181, P5350
   Dufrene YF, 2015, TRENDS MICROBIOL, V23, P376, DOI 10.1016/j.tim.2015.01.011
   Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769
   Dupres V, 2009, NAT CHEM BIOL, V5, P857, DOI 10.1038/nchembio.220
   Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s
   El-Kirat-Chatel S, 2014, ACS NANO, V8, P1690, DOI 10.1021/nn4060489
   Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283
   Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999
   Herman P, 2014, MOL MICROBIOL, V93, P356, DOI 10.1111/mmi.12663
   Herman-Bausier P, 2015, MBIO, V6, DOI 10.1128/mBio.00413-15
   Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871
   Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x
   Lower SK, 2010, BIOPHYS J, V99, P2803, DOI 10.1016/j.bpj.2010.08.063
   McCrea KW, 2000, MICROBIOL-UK, V146, P1535, DOI 10.1099/00221287-146-7-1535
   Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181
   Oberhauser AF, 1998, NATURE, V393, P181
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Vanzieleghem T, 2015, LANGMUIR, V31, P4713, DOI 10.1021/acs.langmuir.5b00360
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Xu L.-C., 2012, J BIOMATER NANOBIOTE, V3, P487
NR 36
TC 7
Z9 8
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD FEB
PY 2016
VL 99
IS 3
BP 611
EP 621
DI 10.1111/mmi.13254
PG 11
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA DC3YO
UT WOS:000369156200013
PM 26481199
OA Bronze
DA 2018-10-20
ER

PT J
AU Saladini, F
   Vuai, SA
   Langat, BK
   Gustavsson, M
   Bayitse, R
   Gidamis, AB
   Belmakki, M
   Owis, AS
   Rashamuse, K
   Sila, DN
   Bastianoni, S
AF Saladini, Fabrizio
   Vuai, Said A.
   Langat, Benard K.
   Gustavsson, Mathias
   Bayitse, Richard
   Gidamis, Andrew B.
   Belmakki, Mohammed
   Owis, Amal S.
   Rashamuse, Konanani
   Sila, Daniel N.
   Bastianoni, Simone
TI Sustainability assessment of selected biowastes as feedstocks for
   biofuel and biomaterial production by emergy evaluation in five African
   countries
SO BIOMASS & BIOENERGY
LA English
DT Article
DE Sustainability; Emergy evaluation; Biowaste; Residues; Biofuels; Africa
ID ENERGY; RESIDUES; ETHANOL; BIOMASS
AB Africa is a continent with enormous natural resources in the form of biomass and innovative ways are needed to exploit those ones available from agricultural processes and other production systems. This paper aims to assess the sustainability of a set of potential feedstocks for the production of biofuels and other value added products in Egypt, Ghana, Kenya, Morocco and South Africa. These feedstocks are residues from agricultural and industrial food processing systems that we assess by emergy evaluation for insights into their sustainability. The feedstocks are grouped into sugar-rich (corn stover, cassava peels, pineapple peels, olive oil pomace and rejected bananas) and nutrient-rich (cocoa pods, discarded cabbage leaves, cattle manure and soybean processing residues). Where possible, comparison is made between traditional and commercial production of the same good. Despite higher environmental impacts, commercial systems were found to perform better in exploiting natural resources. Finally, sugar-and nutrient-rich feedstocks were compared on the basis of glucan and ash content, respectively. Cassava peels and cattle manure gave the best performance from an emergy point of view. This approach enabled emergy evaluation of feedstocks that also considered their potential for the production of useful bioproducts. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Saladini, Fabrizio; Vuai, Said A.; Langat, Benard K.; Bastianoni, Simone] Univ Siena, Ecodynam Grp, Dept Earth Environm & Phys Sci, I-53100 Siena, Italy.
   [Vuai, Said A.; Langat, Benard K.; Gidamis, Andrew B.; Sila, Daniel N.] African Inst Capac Dev AICAD, Nairobi, Kenya.
   [Gustavsson, Mathias] IVL Swedish Environm Res Inst, SE-40014 Gothenburg, Sweden.
   [Bayitse, Richard] Council Sci & Ind Res CSIR GH, Legon, Ghana.
   [Belmakki, Mohammed] Agron & Vet Inst Hassan II, Infrastruct & Environm Dept, Rabat, Morocco.
   [Owis, Amal S.] ARC, Giza 12619, Egypt.
   [Rashamuse, Konanani] CSIR, Prot Technol, ZA-0001 Pretoria, South Africa.
RP Bastianoni, S (reprint author), Univ Siena, Ecodynam Grp, Dept Earth Environm & Phys Sci, Pian Mantellini 44, I-53100 Siena, Italy.
EM bastianoni@unisi.it
RI Bastianoni, Simone/K-6721-2015
OI Bastianoni, Simone/0000-0002-6470-7377; Saladini,
   Fabrizio/0000-0002-5951-1652
FU European Commission [KBBE.2012.3.4-01]; Conversion of bio-waste in
   developing countries - SICA (African ACP, Mediterranean Partner
   Countries) [312111]
FX This study was conducted in the context of the project "Bio-waste4SP"
   (Turning biowaste into sustainable products: development of appropriate
   conversion technologies applicable in developing countries), funded by
   the European Commission's Seventh Framework Programme for Research and
   Technological Development (FP7/2007-2013); theme KBBE.2012.3.4-01,
   Conversion of bio-waste in developing countries - SICA (African ACP,
   Mediterranean Partner Countries); grant agreement no: 312111.
CR Agostinho F, 2013, J CLEAN PROD, V47, P474, DOI 10.1016/j.jclepro.2012.05.025
   Bastianoni S, 1996, BIOMASS BIOENERG, V11, P411, DOI 10.1016/S0961-9534(96)00037-2
   Bastianoni S, 2009, ECOL MODEL, V220, P40, DOI 10.1016/j.ecolmodel.2008.09.003
   Bastianoni S, 2011, ECOL MODEL, V222, P2903, DOI 10.1016/j.ecolmodel.2011.05.013
   Brandt-Williams S., 2002, HDB EMERGY EVALUATIO
   Brown M. T., 1992, EMERGY ANAL PERSPECT
   Brown MT, 1996, ECOL ECON, V19, P219, DOI 10.1016/S0921-8009(96)00046-8
   Buranakarn V., 1998, THESIS U FLORIDA
   Cabezas H., 2010, SAN LUIS BASIN SUSTA
   Campbell D. E., 1999, EMERGY SYNTHESIS, V1, P255
   Campbell D.E., 2005, ENV ACCOUNTING USING
   Castellini C, 2006, AGR ECOSYST ENVIRON, V114, P343, DOI 10.1016/j.agee.2005.11.014
   Chen B, 2009, COMMUN NONLINEAR SCI, V14, P923, DOI 10.1016/j.cnsns.2007.05.034
   Cohen MJ, 2006, AGR ECOSYST ENVIRON, V114, P249, DOI 10.1016/j.agee.2005.10.021
   Gustavsson M., 2014, CATALOGUE BIOWASTE B
   Li LJ, 2010, ECOL MODEL, V221, P411, DOI 10.1016/j.ecolmodel.2009.10.015
   Liu Z, 2014, ADV MECH ENG, V2014, P1, DOI DOI 10.1186/S13068-014-0167-X
   Marvuglia A, 2013, ECOL MODEL, V248, P80, DOI 10.1016/j.ecolmodel.2012.09.013
   Nzila C, 2010, RENEW ENERG, V35, P2698, DOI 10.1016/j.renene.2010.04.016
   Odum H. T, 1996, ENV ACCOUNTING EMERG
   Odum HT, 2006, ENERGY, V31, P21, DOI 10.1016/j.energy.2004.05.012
   Okello C, 2013, BIOMASS BIOENERG, V56, P515, DOI 10.1016/j.biombioe.2013.06.003
   Patrizi N, 2015, J CLEAN PROD, V96, P549, DOI 10.1016/j.jclepro.2014.03.079
   Pordesimo LO, 2004, BIOMASS BIOENERG, V26, P337, DOI 10.1016/S0961-9534(03)00124-7
   Pulselli RM, 2008, ECOL INDIC, V8, P647, DOI 10.1016/j.ecolind.2007.10.001
   Sweeney S., 2007, EMERGY SYNTHESIS, V4, P2310
   Thomsen ST, 2014, BIOMASS BIOENERG, V63, P210, DOI 10.1016/j.biombioe.2014.01.045
   Ulgiati S, 2001, CRIT REV PLANT SCI, V20, P71, DOI 10.1080/20013591099191
NR 28
TC 6
Z9 6
U1 5
U2 41
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0961-9534
EI 1873-2909
J9 BIOMASS BIOENERG
JI Biomass Bioenerg.
PD FEB
PY 2016
VL 85
BP 100
EP 108
DI 10.1016/j.biombioe.2015.11.016
PG 9
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA DB3TW
UT WOS:000368435800013
DA 2018-10-20
ER

PT J
AU Priyadarshani, P
   Li, Y
   Yao, L
AF Priyadarshani, P.
   Li, Y.
   Yao, L.
TI Advances in biological therapy for nucleus pulposus regeneration
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Review
DE Nucleus pulposus; Biomaterial; Stem cell; Gene therapy
ID INTERVERTEBRAL DISC DEGENERATION; MESENCHYMAL STEM-CELLS; IN-VIVO;
   RABBIT MODEL; TISSUE REGENERATION; MOLECULAR THERAPY; GENE-TRANSFER;
   CANINE MODEL; PROTEOGLYCANS; TRANSPLANTATION
AB Objective: The intervertebral disc (IVD) is composed of the external annulus fibrosus (AF) and the inner gel-like center, the nucleus pulposus (NP). The elastic NP can function to relieve stress and maintain IVD function by distributing hydraulic pressure evenly to annulus and endplate. Degeneration of the NP, which leads to increased death of NP cells, the loss of proteoglycan (PG), and aberrant gene expression, may result in an overall alteration of the biomechanics of the spinal column and cause low back pain. Recent advances in biological therapy strategies that target therapy at the regeneration of degenerated and damaged NP have been investigated in in vitro and in vivo studies and demonstrated promising outcomes. In this article, we review recent studies of biological approaches for NP regeneration.
   Method: The articles regarding NP regeneration using biomaterials, stem cells, and gene vectors were identified in PubMed databases.
   Results: Stem cell-mediated cell therapy demonstrates the potential to restore the function and structure of the NP. The viral or non-viral vectors encoding functional genes may generate a therapeutic effect when they are introduced into grafted cells or native cells in the NP. Biomaterial scaffolds generate an initial permissive environment for cell growth and allow the remodeling of scaffolds in the regeneration process. Biomaterial scaffolds provide structural support for NP regeneration and serve as a carrier for stem cell and gene vector delivery.
   Conclusion: Though recent studies advance the body of knowledge needed to treat degenerated discs, many challenges need to be overcome before the application of these approaches can be successful clinically. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Priyadarshani, P.; Li, Y.; Yao, L.] Wichita State Univ, Dept Biol Sci, Wichita, KS 67260 USA.
RP Yao, L (reprint author), Wichita State Univ, Dept Biol Sci, Wichita, KS 67260 USA.
EM pxpriyadarshani@wichita.edu; liyongchao32@yahoo.com; li.yao@wichita.edu
RI Yao, Li/J-1372-2016
CR Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760
   ADAMS P, 1977, RHEUMATOL REHABIL, V16, P22, DOI 10.1093/rheumatology/16.1.22
   Allon AA, 2010, SPINE J, V10, P1089, DOI 10.1016/j.spinee.2010.09.014
   An HS, 2005, SPINE, V30, P25, DOI 10.1097/01.brs.0000148002.68656.4d
   Anderson DG, 2013, AM J PHYS MED REHAB, V92, P420, DOI 10.1097/PHM.0b013e31825f148a
   Bach FC, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-3
   Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001
   Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354
   Bucher C, 2013, STEM CELLS INT, DOI 10.1155/2013/326828
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chan SCW, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13598
   CHELBERG MK, 1995, J ANAT, V186, P43
   Chen YF, 2013, INT J MED SCI, V10, P1805, DOI 10.7150/ijms.6530
   Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86
   Chun HJ, 2012, WORLD NEUROSURG, V78, P364, DOI 10.1016/j.wneu.2011.12.084
   COLE TC, 1985, BIOCHIM BIOPHYS ACTA, V839, P127, DOI 10.1016/0304-4165(85)90029-7
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Cs-Szabo G, 2002, SPINE, V27, P2212, DOI 10.1097/01.BRS.0000029249.02864.5B
   DIFABIO JL, 1987, BIOCHEM J, V244, P27, DOI 10.1042/bj2440027
   Doege KJ, 1997, J BIOL CHEM, V272, P13974, DOI 10.1074/jbc.272.21.13974
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Endres M, 2010, BIOMATERIALS, V31, P5836, DOI 10.1016/j.biomaterials.2010.03.078
   Feng GJ, 2011, J NEUROSURG-SPINE, V14, P322, DOI 10.3171/2010.11.SPINE10285
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Ganey T, 2009, SPINE, V34, P2297, DOI 10.1097/BRS.0b013e3181a54157
   Harris SS, 1997, J BONE MINER RES, V12, P1043, DOI 10.1359/jbmr.1997.12.7.1043
   Hegewald AA, 2015, J TISSUE ENG REGEN M, V9, P405, DOI 10.1002/term.1831
   Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584
   Huang B, 2011, SPINE, V36, P2252, DOI 10.1097/BRS.0b013e318209fd85
   Hunter CJ, 2003, TISSUE ENG, V9, P667, DOI 10.1089/107632703768247368
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Jin ES, 2013, J KOREAN NEUROSURG S, V53, P207, DOI 10.3340/jkns.2013.53.4.207
   JOHNSTONE B, 1995, SPINE, V20, P674, DOI 10.1097/00007632-199503150-00008
   Kandel R, 2008, EUR SPINE J, V17, pS480, DOI 10.1007/s00586-008-0746-2
   Kawaguchi Y, 2002, J BONE JOINT SURG AM, V84A, P2022, DOI 10.2106/00004623-200211000-00018
   Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003
   Kim DJ, 2003, SPINE, V28, P2679, DOI 10.1097/01.BRS.0000101445.46487.16
   Kim DH, 2015, ACTA BIOMATER, V12, P21, DOI 10.1016/j.actbio.2014.10.030
   Kirzner Yakira, 2012, J Long Term Eff Med Implants, V22, P73
   Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d
   Le Maitre CL, 2006, BIOTECH HISTOCHEM, V81, P125, DOI 10.1080/10520290601005298
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   Leckie SK, 2012, SPINE J, V12, P7, DOI 10.1016/j.spinee.2011.09.011
   Leung VYL, 2011, ORTHOP CLIN N AM, V42, P575, DOI 10.1016/j.ocl.2011.07.003
   Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c
   Longo UG, 2012, STEM CELLS INT, V2012
   Longo UG, 2012, STEM CELLS INT, V2012
   Lv FJ, 2014, RHEUMATOLOGY, V53, P600, DOI 10.1093/rheumatology/ket303
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MAROUDAS A, 1975, Journal of Anatomy, V120, P113
   Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b
   MCDEVITT CA, 1981, SEMIN ARTHRITIS RHEU, V11, P17, DOI 10.1016/0049-0172(81)90018-4
   Mercuri J, 2014, J BIOMED MATER RES A, V102, P4380, DOI 10.1002/jbm.a.35104
   Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583
   Miyamoto T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3182
   Mwale F, 2004, EUR CELLS MATER, V8, P63
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Nishida K, 1999, SPINE, V24, P2419, DOI 10.1097/00007632-199912010-00002
   Nishida K, 1998, SPINE, V23, P2437, DOI 10.1097/00007632-199811150-00016
   Park SH, 2011, TISSUE ENG PT A, V17, P2999, DOI [10.1089/ten.TEA.2010.0747, 10.1089/ten.tea.2010.0747]
   Pei M, 2012, SPINE, V37, P1538, DOI 10.1097/BRS.0b013e31825150bf
   Peng BG, 2013, WORLD J ORTHOP, V4, P42, DOI 10.5312/wjo.v4.i2.42
   Phillips KLE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4408
   Poiraudeau S, 1999, SPINE, V24, P837, DOI 10.1097/00007632-199905010-00002
   Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x
   Ren S, 2013, INT J MOL MED, V32, P1063, DOI 10.3892/ijmm.2013.1497
   Renani Hamid Bahramian, 2012, Adv Biomed Res, V1, P81, DOI 10.4103/2277-9175.102996
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Ruan DK, 2010, TISSUE ENG PT A, V16, P2381, DOI 10.1089/ten.TEA.2009.0770
   Sakai D, 2006, BIOMATERIALS, V27, P335, DOI 10.1016/j.biomaterials.2005.06.038
   Sakai D, 2015, ADV DRUG DELIVER REV, V84, P159, DOI 10.1016/j.addr.2014.06.009
   Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5
   Scapinelli R, 1993, Acta Orthop Belg, V59, P371
   Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI 10.1002/jor.21147
   Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403
   Sun Z, 2013, INT J CLIN EXP PATHO, V6, P2376
   THOMPSON JP, 1991, SPINE, V16, P253, DOI 10.1097/00007632-199103000-00001
   Vadala G, 2015, J TISSUE ENG REGEN M, V9, P679, DOI 10.1002/term.1719
   Walker MH, 2004, SPINE J, V4, p158S, DOI DOI 10.1016/J.SPINEE.2004.07.010
   Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94
   Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F
   Wang BC, 2012, J BIOMED MATER RES A, V100A, P646, DOI 10.1002/jbm.a.33300
   Wang CF, 2013, J ORTHOP RES, V31, P1366, DOI 10.1002/jor.22369
   Wang F, 2011, ASIAN SPINE J, V5, P73, DOI 10.4184/asj.2011.5.2.73
   Wang H, 2014, TISSUE ENG PT A, V20, P908, DOI [10.1089/ten.tea.2012.0703, 10.1089/ten.TEA.2012.0703]
   Wang ZH, 2013, J BIOMATER APPL, V27, P739, DOI 10.1177/0885328211424518
   Watanabe T, 2010, J ORTHOP RES, V28, P623, DOI 10.1002/jor.21036
   Woiciechowsky C, 2014, J TISSUE ENG REGEN M, V8, P811, DOI 10.1002/term.1582
   Woods BI, 2011, ORTHOP CLIN N AM, V42, P563, DOI 10.1016/j.ocl.2011.07.002
   Wu JH, 2014, J ORTHOP RES, V32, P159, DOI 10.1002/jor.22474
   Zhang YJ, 2009, AM J PHYS MED REHAB, V88, P455, DOI 10.1097/PHM.0b013e3181a5f0aa
NR 93
TC 17
Z9 18
U1 3
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD FEB
PY 2016
VL 24
IS 2
BP 206
EP 212
DI 10.1016/j.joca.2015.08.014
PG 7
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA DB2LZ
UT WOS:000368341600003
PM 26342641
OA Bronze
DA 2018-10-20
ER

PT J
AU Kuppusamy, S
   Thavamani, P
   Megharaj, M
   Venkateswarlu, K
   Lee, YB
   Naidu, R
AF Kuppusamy, Saranya
   Thavamani, Palanisami
   Megharaj, Mallavarapu
   Venkateswarlu, Kadiyala
   Lee, Yong Bok
   Naidu, Ravi
TI Oak (Quercus robur) Acorn Peel as a Low-Cost Adsorbent for Hexavalent
   Chromium Removal from Aquatic Ecosystems and Industrial Effluents
SO WATER AIR AND SOIL POLLUTION
LA English
DT Article
DE Oak residue; Biosorption; Hexavalent chromium; Reduction; Trivalent
   chromium; Wastewater treatment
ID AQUEOUS-SOLUTIONS; CR(VI) REMOVAL; ADSORPTION; WASTE; REDUCTION;
   BIOMASS; BIOSORBENT
AB The efficiency of low-cost, abundantly available local forestry waste, oak (Quercus robur) acorn peel (OP), to remove toxic Cr(VI) from aqueous solutions was studied in a batch system as a function of contact time, adsorbate concentration, adsorbent dosage, and pH. In an equilibrium time of 420 min, the maximum Cr removal by OP at pH 2 and 10 was 100 and 97 %, respectively. The sorption data fitted well with Langmuir adsorption model. Evaluation using Langmuir expression presented a monolayer sorption capacity of 47.39 mg g(-1) with an equilibrium sorbent dose of 5 g L-1 and pH 7. Uptake of Cr by OP was described by pseudo-second-order chemisorption model. ICP-OES, LC-ICPMS analysis of the aqueous and solid phases revealed that the mechanism of Cr(VI) removal is by 'integrated adsorption and reduction' mechanism. ESEM-EDX and XRD analysis of OP before and after adsorption also confirmed that both adsorption and reduction of Cr(VI) to less toxic Cr3+ forms followed by complexation onto the adsorbent surface contributed to the removal of Cr(VI). Consistent with batch studies, OP effectively removed (>95 %) Cr from the real water samples collected from lake and sea. The results of this study illustrate that OP could be an economical, green, and effective biomaterial for Cr(VI) removal from natural aquatic ecosystems and industrial effluents.
C1 [Kuppusamy, Saranya; Lee, Yong Bok] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
   [Kuppusamy, Saranya; Megharaj, Mallavarapu; Naidu, Ravi] Univ S Australia, CERAR, Mawson Lakes, SA 5095, Australia.
   [Kuppusamy, Saranya; Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] CRC CARE, POB 486, Salisbury South, SA 5106, Australia.
   [Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] Univ Newcastle, Fac Sci & Informat Technol, GCER, Callaghan, NSW 2308, Australia.
   [Venkateswarlu, Kadiyala] Sri Krishnadevaraya Univ, Dept Microbiol, Anantapur 515055, Andhra Pradesh, India.
RP Kuppusamy, S (reprint author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.; Kuppusamy, S (reprint author), Univ S Australia, CERAR, Mawson Lakes, SA 5095, Australia.; Kuppusamy, S (reprint author), CRC CARE, POB 486, Salisbury South, SA 5106, Australia.
EM saran.miles2go@gmail.com
RI Kuppusamy, Saranya/L-3912-2017; Mallavarapu, Megharaj/D-3408-2011
OI Kuppusamy, Saranya/0000-0002-6271-7475; Mallavarapu,
   Megharaj/0000-0002-6230-518X; Lee, Yong Bok/0000-0002-7651-4556;
   KADIYALA, VENKATESWARLU/0000-0003-2147-1357
CR Acar FN, 2004, BIORESOURCE TECHNOL, V94, P13, DOI [10.1016/j.biortech.2003.10.032, 10.1016/j.biotech.2003.10.032]
   Anandkumar J, 2009, J HAZARD MATER, V168, P633, DOI 10.1016/j.jhazmat.2009.02.136
   Augustin S., 2000, J NUTR, V130, P2073
   Babu BV, 2008, ADSORPTION, V14, P85, DOI 10.1007/s10450-007-9057-x
   Bhatti HN, 2010, DESALINATION, V253, P78, DOI 10.1016/j.desal.2009.11.029
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Dakiky M, 2002, ADV ENVIRON RES, V6, P533, DOI 10.1016/S1093-0191(01)00079-X
   Daneshvar N, 2002, J HAZARD MATER, V94, P49, DOI 10.1016/S0304-3894(02)00054-7
   Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u
   Dittert IM, 2014, CHEM ENG J, V237, P443, DOI 10.1016/j.cej.2013.10.051
   Dubey SP, 2007, J HAZARD MATER, V145, P465, DOI 10.1016/j.jhazmat.2006.11.041
   Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0
   Khomdram S. D., 2011, Notulae Scientia Biologicae, V3, P108
   Kuppusamy S, 2015, ENVIRON TECHNOL INNO, V4, P17, DOI 10.1016/j.eti.2015.04.001
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P117, DOI 10.1007/978-3-319-20013-2_2
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P1, DOI 10.1007/978-3-319-20013-2_1
   Luo P, 2011, IND ENG CHEM RES, V50, P10246, DOI 10.1021/ie200951n
   Malkoc E, 2007, SEP PURIF TECHNOL, V54, P291, DOI 10.1016/j.seppur.2006.09.017
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Mallampati R, 2012, RSC ADV, V2, P9914, DOI 10.1039/c2ra21108d
   Moulton MC, 2010, NANOSCALE, V2, P763, DOI 10.1039/c0nr00046a
   Moure A, 2001, FOOD CHEM, V72, P145, DOI 10.1016/S0308-8146(00)00223-5
   OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Rao RAK, 2010, J HAZARD MATER, V181, P405, DOI 10.1016/j.jhazmat.2010.05.025
   Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005
   Saha R, 2011, J COORD CHEM, V64, P1782, DOI 10.1080/00958972.2011.583646
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   Sarkar B, 2010, J HAZARD MATER, V183, P87, DOI 10.1016/j.jhazmat.2010.06.110
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Sreenivas KM, 2014, J ENVIRON CHEM ENG, V2, P455, DOI 10.1016/j.jece.2014.01.017
   Vaghetti JCP, 2008, BIOCHEM ENG J, V42, P67, DOI 10.1016/j.bej.2008.05.021
   Venkateswarlu P, 2007, INT J PHYS SCI, V2, P188
   Zakaria ZA, 2009, DESALINATION, V244, P109, DOI 10.1016/j.desal.2008.05.018
   Zhang YZ, 2011, MACROMOLECULES, V44, P683, DOI 10.1021/ma102492c
NR 35
TC 4
Z9 4
U1 4
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0049-6979
EI 1573-2932
J9 WATER AIR SOIL POLL
JI Water Air Soil Pollut.
PD FEB
PY 2016
VL 227
IS 2
AR 62
DI 10.1007/s11270-016-2760-z
PG 11
WC Environmental Sciences; Meteorology & Atmospheric Sciences; Water
   Resources
SC Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences;
   Water Resources
GA DB8BL
UT WOS:000368741300020
DA 2018-10-20
ER

PT J
AU Zustiak, SP
   Dadhwal, S
   Medina, C
   Steczina, S
   Chehreghanianzabi, Y
   Ashraf, A
   Asuri, P
AF Zustiak, Silviya Petrova
   Dadhwal, Smritee
   Medina, Carlos
   Steczina, Sonette
   Chehreghanianzabi, Yasaman
   Ashraf, Anisa
   Asuri, Prashanth
TI Three-Dimensional Matrix Stiffness and Adhesive Ligands Affect Cancer
   Cell Response to Toxins
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE 3D cell culture; matrix stiffness; cell-matrix adhesions; drug toxicity;
   cancer drug screening
ID DRUG DISCOVERY; LUNG-CANCER; ACTOMYOSIN CONTRACTILITY; ALGINATE
   HYDROGELS; TISSUE STIFFNESS; IN-VITRO; RESISTANCE; TUMOR; APOPTOSIS; 3D
AB There is an immediate need to develop highly predictive in vitro cell-based assays that provide reliable information on cancer drug efficacy and toxicity. Development of biomaterial-based three-dimensional (3D) cell culture models as drug screening platforms has recently gained much scientific interest as 3D cultures of cancer cells have been shown to more adequately mimic the in vivo tumor conditions. Moreover, it has been recognized that the biophysical and biochemical properties of the 3D microenvironment can play key roles in regulating various cancer cell fates, including their response to chemicals. In this study, we employed alginate-based scaffolds of varying mechanical stiffness and adhesive ligand presentation to further explore the role of 3D microenvironmental cues on glioblastoma cell response to cytotoxic compounds. Our experiments suggested the ability of both matrix stiffness and cell-matrix adhesions to strongly influence cell responses to toxins. Cells were found to be more susceptible to the toxins when cultured in softer matrices that emulated the stiffness of brain tissue. Furthermore, the effect of matrix stiffness on differential cell responses to toxins was negated by the presence of the adhesive ligand RGD, but regained when integrin-based cell-matrix interactions were inhibited. This study therefore indicates that both 3D matrix stiffness and cell-matrix adhesions are important parameters in the design of more predictive in vitro platforms for drug development and toxicity screening. (C) 2015 Wiley Periodicals, Inc.
C1 [Zustiak, Silviya Petrova; Chehreghanianzabi, Yasaman; Ashraf, Anisa] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.
   [Dadhwal, Smritee; Medina, Carlos; Steczina, Sonette; Asuri, Prashanth] Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA.
RP Asuri, P (reprint author), Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA.
EM asurip@scu.edu
FU Santa Clara University; Saint Louis University; President's Research
   Fund, Saint Louis University
FX Contract grant sponsor: Santa Clara University; Contract grant sponsor:
   Saint Louis University; Contract grant sponsor: President's Research
   Fund, Saint Louis University
CR Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554
   Aoudjit F., 2012, CHEMOTHER RES PRACT
   Chen WLK, 2011, ADV DRUG DELIVER REV, V63, P269, DOI 10.1016/j.addr.2011.01.004
   Cordes N, 2003, INT J RADIAT BIOL, V79, P709, DOI 10.1080/09553000310001610240
   Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dragunow M, 2008, NAT REV NEUROSCI, V9, P779, DOI 10.1038/nrn2492
   Feurstein D, 2011, TOXICOL SCI, V124, P424, DOI 10.1093/toxsci/kfr243
   FRIEDMAN MA, 1995, FUND APPL TOXICOL, V27, P95, DOI 10.1006/faat.1995.1112
   Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x
   Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708
   Golmohamadi M, 2013, CARBOHYD POLYM, V94, P82, DOI 10.1016/j.carbpol.2013.01.046
   GRIFFIN JW, 1977, J NEUROBIOL, V8, P355, DOI 10.1002/neu.480080407
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guelcher SA, 2012, [No title captured], Patent No. [US 20120183622 A1, 20120183622]
   HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948
   Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943
   Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242
   Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Janouskova H, 2012, CANCER RES, V72, P3463, DOI 10.1158/0008-5472.CAN-11-4199
   Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.tea.2012.0581, 10.1089/ten.TEA.2012.0581]
   Ju LX, 2010, J CELL BIOCHEM, V111, P1565, DOI 10.1002/jcb.22888
   Kumper S, 2011, CANCER CELL, V19, P695, DOI 10.1016/j.ccr.2011.05.021
   Lan SF, 2011, TOXICOL APPL PHARM, V256, P62, DOI 10.1016/j.taap.2011.07.013
   Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Lilienblum W, 2008, ARCH TOXICOL, V82, P211, DOI 10.1007/s00204-008-0279-9
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103
   Martinez-Rico C, 2010, J CELL SCI, V123, P712, DOI 10.1242/jcs.047878
   Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0
   McVaya K, 2014, MIAMI ENG COMP REV, V2
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Oshita F, 2002, ANTICANCER RES, V22, P1065
   Park HR, 2010, TOXICOL LETT, V193, P86, DOI 10.1016/j.toxlet.2009.12.015
   Pettikiriarachchi JTS, 2010, AUST J CHEM, V63, P1143, DOI 10.1071/CH10159
   Polacheck WJ, 2013, CELL MOL LIFE SCI, V70, P1335, DOI 10.1007/s00018-012-1115-1
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Ramamoorthi K, 2014, CELL MOL BIOENG, V7, P278, DOI 10.1007/s12195-014-0326-y
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Russo MA, 2013, INT J ONCOL, V42, P83, DOI 10.3892/ijo.2012.1708
   Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108
   Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511
   Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346
   Syed S, 2015, JOVE-J VIS EXP, V97
   TANAKA H, 1984, BIOTECHNOL BIOENG, V26, P53, DOI 10.1002/bit.260260111
   Wang C, 2014, MOL PHARMACEUT, V11, P2115, DOI 10.1021/mp5000828
   Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3
   WONG KL, 1982, TOXICOL APPL PHARM, V63, P330, DOI 10.1016/0041-008X(82)90261-7
   Zanders ED, 2011, SCIENCE AND BUSINESS OF DRUG DISCOVERY: DEMYSTIFYING THE JARGON, P93, DOI 10.1007/978-1-4419-9902-3_5
   Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104
   ZIRINO A, 1972, LIMNOL OCEANOGR, V17, P661, DOI 10.4319/lo.1972.17.5.0661
   Zustiak S., 2013, BIOTECHNOL BIOENG, V111, P396
   Zustiak SP, 2010, SOFT MATTER, V6, P3609, DOI [10.1039/c0sm00111b, 10.1039/C0SM00111B]
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
   Zustiak SP, 2015, MACROMOL BIOSCI, V15, P589, DOI 10.1002/mabi.201400507
NR 60
TC 8
Z9 8
U1 2
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD FEB
PY 2016
VL 113
IS 2
BP 443
EP 452
DI 10.1002/bit.25709
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DB0HG
UT WOS:000368188600022
PM 26184715
DA 2018-10-20
ER

PT J
AU Barbeck, M
   Motta, A
   Migliaresi, C
   Sader, R
   Kirkpatrick, CJ
   Ghanaati, S
AF Barbeck, Mike
   Motta, Antonella
   Migliaresi, Claudio
   Sader, Robert
   Kirkpatrick, Charles James
   Ghanaati, Shahram
TI Heterogeneity of biomaterial-induced multinucleated giant cells:
   Possible importance for the regeneration process?
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; multinucleated giant cells; macrophages; inflammation;
   foreign body reaction; heterogeneity
ID FOREIGN-BODY REACTION; IN-VIVO; TISSUE REACTION; BETA; MACROPHAGES;
   SCAFFOLDS; OUTCOMES
AB Biomaterial-associated multinucleated giant cells (BMGCs) have been found within the implantation beds of many different biomaterials. However, their exact differentiation and their involvement in the inflammatory and healing events of the foreign body response still remain mostly unclear. Silk fibroin (SF) scaffolds, which induces a tissue reaction involving both macrophages and BMGCs, was implanted in the subcutaneous connective tissue of four CD-1 mice for 15 days using an established subcutaneous implantation model. Analysis of macrophage polarization and BMGCs was performed by immunohistochemcial detection of pro-(cyclooxygenase-2 (COX-2), C-C chemokine receptor type 7 (CCR7), nuclear factor "kappa-light-chain-enhancer" (NF-kappa B)) and anti-(heme oxygenase-1 (HO-1) and mannose receptor (MR, also known as CD206)). Furthermore, histochemical detection of tartrate-resistant acid phosphatase (TRAP) was conducted to test its predictive efficiency for the proinflammatory differentiation of cells. An established system for histomorphometrical analysis was used for counting of BMGCs expressing these molecules. The results show that BMGCs express both pro-and anti-inflammatory molecules within the implantation beds of SF scaffolds in comparable numbers, while only statistically significantly lower numbers of TRAP-positive BMGCs were measured in comparison to the BMGCs expressing the above-mentioned molecules. As these data substantiate the heterogeneity of BMGCs, the question arises to what extent BMGCs can "support" the process of tissue regeneration. Furthermore, the data prompt the question to what extent TRAP-expression within a biomaterial implantation bed can be seen as a predictive marker for an inflammatory condition, as in this study no obvious correlation between TRAP-expression and other pro-inflammatory markers could be observed. (c) 2015 Wiley Periodicals, Inc.
C1 [Barbeck, Mike; Sader, Robert; Ghanaati, Shahram] Goethe Univ Frankfurt, Univ Med Ctr, Clin Oromaxillofacial & Plast Surg, FORM Lab, D-60054 Frankfurt, Germany.
   [Barbeck, Mike; Kirkpatrick, Charles James; Ghanaati, Shahram] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, REPAIR Lab, D-55122 Mainz, Germany.
   [Motta, Antonella; Migliaresi, Claudio] Univ Trent, Dept Mat Engn & Ind Technol, I-38050 Trento, Italy.
   [Motta, Antonella; Migliaresi, Claudio] Univ Trent, BIOtech Res Ctr, I-38050 Trento, Italy.
RP Ghanaati, S (reprint author), Goethe Univ Frankfurt, Med Ctr, Dept Oral Craniomaxillofacial & Facial Plast Surg, FORM Lab, Theodor Stern Kai 7,Bldg 23 B UG, D-60596 Frankfurt, Germany.
EM shahram.ghanaati@kgu.de
OI Barbeck, Mike/0000-0002-3001-1347; Motta, Antonella/0000-0003-4893-6863
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Armato U., 2002, Patent PTC, Patent No. [WO 02/29141 A1, 0229141]
   Barbeck M, 2014, Ann Maxillofac Surg, V4, P150, DOI 10.4103/2231-0746.147106
   Barbeck M, J ORAL IMPL IN PRESS
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Darden AG, 1996, J BONE MINER RES, V11, P671
   Ghanaati S, 2011, ACTA BIOMATER, V7, P4018, DOI 10.1016/j.actbio.2011.07.003
   Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005
   Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Lorenz J, 2014, J ORAL IMPL IN PRESS
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005
   McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yang J, 2014, J BIOMED MATER RES A, V102, P2017, DOI 10.1002/jbm.a.35152
   Yang YQ, 2012, INT J ORAL SCI, V4, P64, DOI 10.1038/ijos.2012.33
NR 24
TC 12
Z9 12
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2016
VL 104
IS 2
BP 413
EP 418
DI 10.1002/jbm.a.35579
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB1MF
UT WOS:000368271600008
PM 26422451
DA 2018-10-20
ER

PT J
AU Khorshidi, KJ
   Lenjannezhadian, H
   Jamalan, M
   Zeinali, M
AF Khorshidi, Kaveh Jafari
   Lenjannezhadian, Hengameh
   Jamalan, Mostafa
   Zeinali, Majid
TI Preparation and characterization of nanomagnetic cross-linked cellulase
   aggregates for cellulose bioconversion
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE cellulase; cellulose; bioconversion; magnetic core-shell nanoparticles;
   cross-linked enzyme aggregates
ID LIGNOCELLULOSIC BIOMASS; ENZYME; IMMOBILIZATION; STABILIZATION;
   RESIDUES; CLEAS; NANOPARTICLES; PERSPECTIVES; ENVIRONMENT; HYDROLYSIS
AB BACKGROUNDCellulose as a renewable biomaterial has forced attention on the use of cellulose-hydrolyzing enzymes for industrial bioconversion of lignocellulosic materials to glucose. This paper reports immobilization of cross-linked cellulase aggregates (CLEA) on the amine-functionalized Fe3O4@silica core-shell magnetic nanoparticles (MNPs).
   RESULTSThe optimum pH of the cellulase cocktail upon immobilization (cellulase CLEA-MNP) shifted a little to the acidic side whereas the optimum temperature did not change significantly. The behavior of CMCase activity in the cellulase CLEA-MNP at pH and temperature values higher than the optimum was significantly different compared with free cellulase. Cellulase CLEA-MNP retained about 45% of its maximum activity at pH values higher than 4.8, while free cellulase lost its activity sharply. Immobilized cellulase in contrast to the free form retained about 65% of its maximum activity at 80 degrees C. Cellulase CLEA-MNP had improved thermal stability at 65 degrees C. Operational stability of the immobilized cellulase was also noticeable. After a sharp decrease during two cycles of CMC hydrolysis, cellulase CLEA-MNP retained 30% of its initial activity through six cycles of reuse.
   CONCLUSIONSimple separation of MNPs from reaction medium and durability of CLEA-MNP composite during repeated use may overcome the major bottleneck against comprehensive applications of cellulase enzymes in industry. (c) 2014 Society of Chemical Industry
C1 [Khorshidi, Kaveh Jafari] Islamic Azad Univ, Shoushtar Branch, Dept Agr, Shoushtar, Iran.
   [Lenjannezhadian, Hengameh] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.
   [Jamalan, Mostafa] Ahvaz Jundishapur Univ Med Sci, Dept Biochem, Ahwaz, Iran.
   [Zeinali, Majid] Res Inst Petr Ind, Biotechnol Res Ctr, Tehran, Iran.
RP Zeinali, M (reprint author), Res Inst Petr Ind, Biotechnol Res Ctr, Tehran, Iran.
EM zeinalim@ripi.ir
FU Department of Agriculture, Islamic Azad University-Shoushtar branch
FX The funding from Department of Agriculture, Islamic Azad
   University-Shoushtar branch, supporting this research is greatly
   appreciated.
CR AKIBA S, 1995, J FERMENT BIOENG, V79, P125, DOI 10.1016/0922-338X(95)94078-6
   Aytar BS, 2008, PROCESS BIOCHEM, V43, P125, DOI 10.1016/j.procbio.2007.11.001
   Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7
   Bilen J, 1998, PROGR BIOTECHNOL, V15, P151
   Bumb A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/33/335601
   Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   Champagne P, 2007, RESOUR CONSERV RECY, V50, P211, DOI 10.1016/j.resconrec.2006.09.003
   CHIMANAGE P, 1986, BIOTECHNOL BIOENG, V28, P1876, DOI 10.1002/bit.260281215
   Collings AF, 1997, REP PROG PHYS, V60, P1397, DOI 10.1088/0034-4885/60/11/005
   Dalal S, 2007, J MOL CATAL B-ENZYM, V44, P128, DOI 10.1016/j.molcatb.2006.10.003
   Daoud FBO, 2010, COLLOID SURFACE B, V75, P93, DOI 10.1016/j.colsurfb.2009.08.019
   Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578
   GARCIA A, 1989, BIOTECHNOL BIOENG, V33, P321, DOI 10.1002/bit.260330311
   Gokhale AA, 2013, J MOL CATAL B-ENZYM, V90, P76, DOI 10.1016/j.molcatb.2013.01.025
   Gupta P, 2009, BIORESOURCE TECHNOL, V100, P4074, DOI 10.1016/j.biortech.2009.03.076
   Hirsh SL, 2010, LANGMUIR, V26, P14380, DOI 10.1021/la1019845
   Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004
   Ju H, 2013, BIORESOURCE TECHNOL, V128, P81, DOI 10.1016/j.biortech.2012.10.016
   KATCHALSKIKATZIR E, 1993, TRENDS BIOTECHNOL, V11, P471, DOI 10.1016/0167-7799(93)90080-S
   Kim M, 2010, J BASIC MICROB, V50, P218, DOI 10.1002/jobm.200900099
   Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002
   Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6
   Lopez-Serrano P, 2002, BIOTECHNOL LETT, V24, P1379, DOI 10.1023/A:1019863314646
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009
   Mao XP, 2006, J CHEM TECHNOL BIOT, V81, P189, DOI 10.1002/jctb.1378
   MARTINEK K, 1977, BIOCHIM BIOPHYS ACTA, V485, P1, DOI 10.1016/0005-2744(77)90188-7
   Matijosyte I, 2010, J MOL CATAL B-ENZYM, V62, P142, DOI 10.1016/j.molcatb.2009.09.019
   Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025
   Nigam P., 2009, BIOTECHNOLOGY AGROIN, P13
   REMBAUM A, 1980, SCIENCE, V208, P364, DOI 10.1126/science.6768131
   Roberge C, 2009, J MOL CATAL B-ENZYM, V56, P41, DOI 10.1016/j.molcatb.2008.04.002
   Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001
   Sangeetha K, 2008, INT J BIOL MACROMOL, V43, P314, DOI 10.1016/j.ijbiomac.2008.07.001
   SCOUTEN WH, 1995, TRENDS BIOTECHNOL, V13, P178, DOI 10.1016/S0167-7799(00)88935-0
   Shah S, 2006, ANAL BIOCHEM, V351, P207, DOI 10.1016/j.ab.2006.01.028
   Sheehan J, 1999, BIOTECHNOL PROGR, V15, P817, DOI 10.1021/bp990110d
   Sheldon RA, 2007, BIOCHEM SOC T, V35, P1583, DOI 10.1042/BST0351583
   Sheldon RA, 2011, APPL MICROBIOL BIOT, V92, P467, DOI 10.1007/s00253-011-3554-2
   SIMIONESCU CI, 1990, J APPL POLYM SCI, V39, P1837, DOI 10.1002/app.1990.070390902
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   STREAMER M, 1975, EUR J BIOCHEM, V59, P607, DOI 10.1111/j.1432-1033.1975.tb02489.x
   Sun WQ, 1998, BBA-GEN SUBJECTS, V1425, P245, DOI 10.1016/S0304-4165(98)00077-4
   Taherzadeh MJ, 2007, BIORESOURCES, V2, P707
   Talekar S, 2012, BIORESOURCE TECHNOL, V123, P542, DOI 10.1016/j.biortech.2012.07.044
   Tu MB, 2006, BIOTECHNOL LETT, V28, P151, DOI 10.1007/s10529-005-5328-3
   Vaidya BK, 2012, J MOL CATAL B-ENZYM, V74, P184, DOI 10.1016/j.molcatb.2011.10.003
   van Langen LM, 2005, ORG LETT, V7, P327, DOI 10.1021/ol047647z
   Wang MF, 2011, J BIOTECHNOL, V156, P30, DOI 10.1016/j.jbiotec.2011.08.002
   Wang P, 1997, NAT BIOTECHNOL, V15, P789, DOI 10.1038/nbt0897-789
   Wu W, 2009, NANOSCALE RES LETT, V3, P397
   Xu ZD, 2011, APPL BIOCHEM BIOTECH, V163, P153, DOI 10.1007/s12010-010-9024-y
   Yang D, 2009, J PHYS CHEM C, V113, P7646, DOI 10.1021/jp900868d
   Zhou JQ, 2010, J AGR FOOD CHEM, V58, P6741, DOI 10.1021/jf100759c
NR 57
TC 16
Z9 16
U1 3
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD FEB
PY 2016
VL 91
IS 2
BP 539
EP 546
DI 10.1002/jctb.4615
PG 8
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA DA6YG
UT WOS:000367951200030
DA 2018-10-20
ER

PT J
AU Baran, T
   Mentes, A
AF Baran, Talat
   Mentes, Ayfer
TI Highly efficient Suzuki cross-coupling reaction of biomaterial supported
   catalyst derived from glyoxal and chitosan
SO JOURNAL OF ORGANOMETALLIC CHEMISTRY
LA English
DT Article
DE Heterogeneous catalyst; C-C coupling; O-Carboxymethyl chitosan; TG/DTG;
   Glyoxal
ID BASE MODIFIED CHITOSAN; CARBOXYMETHYL CHITOSAN; SCHIFF-BASE;
   THERMAL-DECOMPOSITION; PD(II) COMPLEXES; CU(II); DEACETYLATION; CO(II);
   CHITIN
AB In this study a new chitosan based water soluble Schiff base was produced through carboxymethylation of chitosan and its Pd(II) complex were synthesized and characterized by FTIR, H-1 NMR, C-13 CP-MAS NMR, TG/DTG, SEM/EDAX, XRD, ICP-OES, UV-Vis, magnetic moment measurements, molar conductivity measurements. The catalytic activity of the complex was tested in Suzuki coupling reactions for synthesis of biaryls containing various substrates. The identifications of the biarlys were performed by H-1 NMR and GC-MS. The catalytic activity tests revealed that high selectivity was achieved with a small addition of the catalyst. Moreover by-product formation was not observed in the spectra of H-1 NMR and GC-MS. Mercury poisoning and leaching test confirmed that the catalyst has heterogeneous character. The reusability tests showed that the catalyst did not lose its activity after six runs. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Baran, Talat; Mentes, Ayfer] Aksaray Univ, Fac Sci & Letters, Dept Chem, TR-68100 Aksaray, Turkey.
RP Baran, T (reprint author), Aksaray Univ, Fac Sci & Letters, Dept Chem, TR-68100 Aksaray, Turkey.
EM talatbaran_66@hotmail.com; ayfermentes@yahoo.com
RI Mentes, Ayfer/F-8710-2011; University, Aksaray/A-1857-2018; Science and
   Arts Faculty, Aksaray University/Q-7606-2016
OI BARAN, TALAT/0000-0003-0206-3841; MENTES, AYFER/0000-0003-3946-4075
FU Scientific and Technological Research Council of Turkey (TUBITAK)
   [113Z296]
FX The authors thank The Scientific and Technological Research Council of
   Turkey (TUBITAK) (Project Number: 113Z296) for financial support.
CR Anan NA, 2011, CARBOHYD RES, V346, P775, DOI 10.1016/j.carres.2011.01.014
   Antony R, 2013, J MOL STRUCT, V1050, P53, DOI 10.1016/j.molstruc.2013.07.006
   Antony R, 2013, SPECTROCHIM ACTA A, V103, P423, DOI 10.1016/j.saa.2012.09.101
   Baran T, 2015, J MOL CATAL A-CHEM, V407, P47, DOI 10.1016/j.molcata.2015.06.008
   Baran T, 2015, INT J BIOL MACROMOL, V79, P542, DOI 10.1016/j.ijbiomac.2015.05.021
   Baran T, 2015, INT J BIOL MACROMOL, V72, P94, DOI 10.1016/j.ijbiomac.2014.07.029
   Baskar D, 2009, CARBOHYD POLYM, V78, P767, DOI 10.1016/j.carbpol.2009.06.013
   Das P, 2010, TETRAHEDRON LETT, V51, P1479, DOI 10.1016/j.tetlet.2010.01.032
   Delgadillo-Armendariz NL, 2014, SPECTROCHIM ACTA A, V120, P524, DOI 10.1016/j.saa.2013.09.112
   Demetgul C, 2012, CARBOHYD POLYM, V89, P354, DOI 10.1016/j.carbpol.2012.03.013
   Fabris R, 2010, WATER SCI TECHNOL, V61, P2119, DOI 10.2166/wst.2010.833
   FOLEY P, 1980, J AM CHEM SOC, V102, P6713, DOI 10.1021/ja00542a009
   Hardy JJE, 2004, GREEN CHEM, V6, P53, DOI 10.1039/b312145n
   Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001
   Jin XX, 2009, CARBOHYD RES, V344, P825, DOI 10.1016/j.carres.2009.01.022
   Justi KC, 2005, MACROMOL SYMP, V229, P203, DOI 10.1002/masy.200551125
   Karthikeyan P, 2013, TETRAHEDRON LETT, V54, P7193, DOI 10.1016/j.tetlet.2013.10.111
   Kaya M, 2014, BIOTECHNOL BIOPROC E, V19, P58, DOI 10.1007/s12257-013-0488-9
   Kofuji K, 2005, EUR POLYM J, V41, P2784, DOI 10.1016/j.eurpolymj.2005.04.041
   Kong XP, 2012, CARBOHYD POLYM, V88, P336, DOI 10.1016/j.carbpol.2011.12.019
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumar S, 2010, J APPL POLYM SCI, V115, P3056, DOI 10.1002/app.31385
   Kwaskowska-Chec E., 1998, TRANSIT METAL CHEM, V23, P641
   Leonhardt SES, 2010, APPL CATAL A-GEN, V379, P30, DOI 10.1016/j.apcata.2010.02.029
   Linninger CS, 2008, J MOL STRUCT, V890, P192, DOI 10.1016/j.molstruc.2008.05.037
   Littke AF, 2000, J AM CHEM SOC, V122, P4020, DOI 10.1021/ja0002058
   Makhubela BCE, 2011, APPL CATAL A-GEN, V393, P231, DOI 10.1016/j.apcata.2010.12.002
   MIYAURA N, 1981, SYNTHETIC COMMUN, V11, P513, DOI 10.1080/00397918108063618
   MUZZARELLI RAA, 1994, CARBOHYD POLYM, V23, P155, DOI 10.1016/0144-8617(94)90097-3
   Tirkistani FAA, 1998, POLYM DEGRAD STABIL, V60, P67, DOI 10.1016/S0141-3910(97)00020-7
   Tong JH, 2005, J MOL CATAL A-CHEM, V231, P197, DOI 10.1016/j.molcata.2005.01.011
   Uozumi Y, 2004, TOP CURR CHEM, V242, P77, DOI 10.1007/b96874
   WHITESIDES GM, 1985, ORGANOMETALLICS, V4, P1819, DOI 10.1021/om00129a023
   Xu QH, 2007, CATAL LETT, V118, P98, DOI 10.1007/s10562-007-9157-y
   Yin XQ, 2012, POLYM BULL, V68, P1215, DOI 10.1007/s00289-011-0599-4
   Zhang YQ, 2005, CARBOHYD RES, V340, P1914, DOI 10.1016/j.carres.2005.05.005
NR 36
TC 20
Z9 20
U1 2
U2 47
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0022-328X
EI 1872-8561
J9 J ORGANOMET CHEM
JI J. Organomet. Chem.
PD FEB 1
PY 2016
VL 803
BP 30
EP 38
DI 10.1016/j.jorganchem.2015.12.011
PG 9
WC Chemistry, Inorganic & Nuclear; Chemistry, Organic
SC Chemistry
GA DA8XO
UT WOS:000368090500005
DA 2018-10-20
ER

PT J
AU Choudhury, AJ
   Gogoi, D
   Chutia, J
   Kandimalla, R
   Kalita, S
   Kotoky, J
   Chaudhari, YB
   Khan, MR
   Kalita, K
AF Choudhury, Arup Jyoti
   Gogoi, Dolly
   Chutia, Joyanti
   Kandimalla, Raghuram
   Kalita, Sanjeeb
   Kotoky, Jibon
   Chaudhari, Yogesh B.
   Khan, Mojibur R.
   Kalita, Kasturi
TI Controlled antibiotic-releasing Antheraea assama silk fibroin suture for
   infection prevention and fast wound healing
SO SURGERY
LA English
DT Article
ID SURGICAL SITE INFECTIONS; PLASMA; BIOMATERIAL; POLYMERS; FIBER
AB Background. The quest for developing silk fibroin as a biomaterial for drug release systems continues to draw research interest owing to its impressive mechanical properties as well as biocompatibility and biodegradability. The aim of this study is to develop low-temperature O-2 plasma-treated muga (Antheraea assama) silk fibroin (AASF) yarn impregnated with amoxicillin trihydrate as controlled antibiotic-releasing suture (AASF/O-2/AMOX) for preventing postoperative site bacterial infection and fast wound healing
   Methods. In this experimental study, AASF and AASF/O-2/AMOX sutures are used to close the surgical wounds of adult male Wistar rats of 4 months old and weighing 200-230 g.
   Results. Surface hydrophilicity induced by O-2 plasma results in an increase in drug-impregnation efficiency of AASF/O-2 yarn by 16.7%. In vitro drug release profiles show continuous and prolonged release of AMOX from AASF/O-2/AMOX yarn up to 336 hours. In vitro hemolysis assay reveals that O-2 plasma treatment and subsequent impregnation of AMOX do not affect the heertetmocompatibility of AASF yarn. The AASF/O-2/AMOX yarn proves to be effective for in vitro growth inhibition of Staphylococcus aureus and Escherichia coli, whereas AASF offers no antibacterial activity against both types of bacteria. In vivo histopathology studies and colony-forming unit count data revealed accelerated wound healing activity of AASF/O-2/AMOX over AASF yarn through rapid synthesis and proliferation of collagen, hair follicle, and connective tissues.
   Conclusion. Outcomes of this work clearly demonstrate the potential use of AASF/O-2/AMOX yarn as a controlled antibiotic-releasing suture biomaterial for superficial surgical applications.
C1 [Choudhury, Arup Jyoti] Tezpur Univ, Dept Phys, Sonitpur 784028, Assam, India.
   [Gogoi, Dolly; Chutia, Joyanti] Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati, Assam, India.
   [Kandimalla, Raghuram; Kalita, Sanjeeb; Kotoky, Jibon] Inst Adv Study Sci & Technol, Drug Discovery Lab, Gauhati, Assam, India.
   [Chaudhari, Yogesh B.; Khan, Mojibur R.] Inst Adv Study Sci & Technol, Mol Biol & Microbial Biotechnol Lab, Gauhati, Assam, India.
   [Kalita, Kasturi] Hayat Hosp, Dept Pathol, Gauhati, Assam, India.
RP Choudhury, AJ (reprint author), Tezpur Univ, Dept Phys, Sonitpur 784028, Assam, India.
EM arupjchoudhury@gmail.com
OI Kandimalla, Raghuram/0000-0002-9202-4071
FU Department of Science and Technology (DST), Government of India through
   DST Inspire Faculty Scheme
FX Arup Jyoti Choudhury thanks the Department of Science and Technology
   (DST), Government of India for providing financial support through DST
   Inspire Faculty Scheme in carrying out above research work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Galal I, 2011, AM J SURG, V202, P133, DOI 10.1016/j.amjsurg.2010.06.011
   Gogoi D, 2011, APPL SURF SCI, V258, P126, DOI 10.1016/j.apsusc.2011.08.018
   Gogoi D, 2014, BIOPOLYMERS, V101, P355, DOI 10.1002/bip.22369
   Kar S, 2013, TISSUE ENG REGEN MED, V10, P200, DOI 10.1007/s13770-012-0008-6
   Kasoju N, 2009, MATER LETT, V63, P2466, DOI 10.1016/j.matlet.2009.08.037
   Kumar AS, 2010, J MATER CHEM, V20, P10152, DOI 10.1039/c0jm02262d
   Li GQ, 2013, AM J INFECT CONTROL, V41, P1268, DOI 10.1016/j.ajic.2013.03.305
   Obermayer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097784
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Sanchez DA, 2014, NANOMED-NANOTECHNOL, V10, P269, DOI 10.1016/j.nano.2013.06.002
   SAUER BB, 1990, LANGMUIR, V6, P1002, DOI 10.1021/la00095a020
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Tsougeni K, 2009, MICROELECTRON ENG, V86, P1424, DOI 10.1016/j.mee.2008.11.082
   Young PY, 2014, SURG CLIN N AM, V94, P1245, DOI 10.1016/j.suc.2014.08.008
   Zhang DR, 2006, NANOTECHNOLOGY, V17, P5821, DOI 10.1088/0957-4484/17/23/018
NR 18
TC 11
Z9 11
U1 2
U2 31
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0039-6060
J9 SURGERY
JI Surgery
PD FEB
PY 2016
VL 159
IS 2
BP 539
EP 547
DI 10.1016/j.surg.2015.07.022
PG 9
WC Surgery
SC Surgery
GA DA5UZ
UT WOS:000367869400021
PM 26328475
DA 2018-10-20
ER

PT J
AU Kazemirad, S
   Heris, HK
   Mongeau, L
AF Kazemirad, Siavash
   Heris, Hossein K.
   Mongeau, Luc
TI Viscoelasticity of hyaluronic acid-gelatin hydrogels for vocal fold
   tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE viscoelastic properties; hyaluronan hydrogels; vocal folds; injectable
   biomaterials; wave propagation method
ID CROSS-LINKED HYALURONAN; SYNTHETIC EXTRACELLULAR-MATRIX; LOW AUDIO
   FREQUENCIES; PHONATORY FREQUENCIES; GLOTTAL INSUFFICIENCY; BIOMATERIALS
AB Crosslinked injectable hyaluronic acid (HA)-gelatin (Ge) hydrogels have remarkable viscoelastic and biological properties for vocal fold tissue engineering. Patient-specific tuning of the viscoelastic properties of this injectable biomaterial could improve tissue regeneration. The frequency-dependent viscoelasticity of crosslinked HA-Ge hydrogels was measured as a function of the concentration of HA, Ge, and crosslinker. Synthetic extracellular matrix hydrogels were fabricated using thiol-modified HA and Ge, and crosslinked by poly(ethylene glycol) diacrylate. A recently developed characterization method based on Rayleigh wave propagation was used to quantify the frequency-dependent viscoelastic properties of these hydrogels, including shear storage and loss moduli, over a broad frequency range; that is, from 40 to 4000 Hz. The viscoelastic properties of the hydrogels increased with frequency. The storage and loss moduli values and the rate of increase with frequency varied with the concentrations of the constituents. The range of the viscoelastic properties of the hydrogels was within that of human vocal fold tissue obtained from in vivo and ex vivo measurements. Frequency-dependent parametric relations were obtained using a linear least-squares regression. The results are useful to better fine-tune the storage and loss moduli of HA-Ge hydrogels by varying the concentrations of the constituents for use in patient-specific treatments. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 283-290, 2016.
C1 [Kazemirad, Siavash; Heris, Hossein K.; Mongeau, Luc] McGill Univ, Dept Mech Engn, Biomech Res Lab, Montreal, PQ H3A 0C3, Canada.
RP Heris, HK (reprint author), McGill Univ, Dept Mech Engn, Biomech Res Lab, Montreal, PQ H3A 0C3, Canada.
EM hossein.khadiviheris@mail.mcgill.ca
RI Kazemirad, Siavash/S-9385-2018
OI Mongeau, Luc/0000-0003-0344-227X
FU National Institute on Deafness and Other Communication Disorders
   [DC005788]
FX Contract grant sponsor: National Institute on Deafness and Other
   Communication Disorders; contract grant number: DC005788
CR Lebl MDA, 2007, LARYNGOSCOPE, V117, P595, DOI 10.1097/MLG.0b013e31802ffe17
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Butler JE, 2001, LARYNGOSCOPE, V111, P907, DOI 10.1097/00005537-200105000-00029
   Caton T, 2007, LARYNGOSCOPE, V117, P516, DOI 10.1097/MLG.0b013e31802e9291
   Chan A, 2013, J ACOUST SOC AM, V133, P1667, DOI 10.1121/1.4789937
   Chan RW, 2008, J ACOUST SOC AM, V124, P1207, DOI 10.1121/1.2946715
   Chan RW, 1998, LARYNGOSCOPE, V108, P725, DOI 10.1097/00005537-199805000-00019
   Chan RW, 1999, LARYNGOSCOPE, V109, P1142, DOI 10.1097/00005537-199907000-00026
   Chan RW, 2001, OTOLARYNG HEAD NECK, V124, P607, DOI 10.1067/mhn.2001.115906
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Ghosh K, 2005, BIOMACROMOLECULES, V6, P2857, DOI 10.1021/bm050361c
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hertegard S, 2004, ACTA OTO-LARYNGOL, V124, P1208, DOI 10.1080/00016480410017701
   Hertegard S, 2002, LARYNGOSCOPE, V112, P2211, DOI 10.1097/00005537-200212000-00016
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Kazemirad S, 2014, J BIOMECH, V47, P1173, DOI 10.1016/j.jbiomech.2013.11.034
   Kazemirad S, 2013, J ACOUST SOC AM, V133, P4332, DOI 10.1121/1.4804318
   Kazemirad S, 2013, J ACOUST SOC AM, V133, P3186, DOI 10.1121/1.4798668
   Kimura M, 2010, LARYNGOSCOPE, V120, P764, DOI 10.1002/lary.20816
   Klemuk SA, 2004, LARYNGOSCOPE, V114, P1597, DOI 10.1097/00005537-200409000-00018
   Lakes R, 2009, VISCOELASTIC MATERIALS, P1, DOI 10.1017/CBO9780511626722
   Nenadic IZ, 2011, PHYS MED BIOL, V56, P6723, DOI 10.1088/0031-9155/56/20/014
   Shu XZ, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P475
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Titze IR, 2004, J ACOUST SOC AM, V115, P392, DOI 10.1121/1.1631941
   TITZE IR, 1994, PRINCIPLES VOICE PRO
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
   Ward PD, 2002, J VOICE, V16, P303, DOI 10.1016/S0892-1997(02)00101-7
NR 30
TC 9
Z9 9
U1 0
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2016
VL 104
IS 2
BP 283
EP 290
DI 10.1002/jbm.b.33358
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DA5HO
UT WOS:000367834100006
PM 25728914
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Majumdar, S
   Guo, QY
   Garza-Madrid, M
   Calderon-Colon, X
   Duan, D
   Carbajal, P
   Schein, O
   Trexler, M
   Elisseeff, J
AF Majumdar, Shoumyo
   Guo, Qiongyu
   Garza-Madrid, Marcos
   Calderon-Colon, Xiomara
   Duan, Derek
   Carbajal, Priscilla
   Schein, Oliver
   Trexler, Morgana
   Elisseeff, Jennifer
TI Influence of collagen source on fibrillar architecture and properties of
   vitrified collagen membranes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cornea; conjunctiva; extracellular matrix; eye; ocular
ID CROSS-LINKING; I COLLAGEN; VITRIGEL MEMBRANES; REPAIR; TRANSPLANTATION;
   RECONSTRUCTION; CARBODIIMIDE; PHENOTYPE; SCAFFOLDS; HYDROGELS
AB Collagen vitrigel membranes are transparent biomaterials characterized by a densely organized, fibrillar nanostructure that show promise in the treatment of corneal injury and disease. In this study, the influence of different type I collagen sources and processing techniques, including acid-solubilized collagen from bovine dermis (Bov), pepsin-solubilized collagen from human fibroblast cell culture (HuCC), and ficin-solubilized collagen from recombinant human collagen expressed in tobacco leaves (rH), on the properties of the vitrigel membranes was evaluated. Postvitrification carbodiimide crosslinking (CX) was also carried out on the vitrigels from each collagen source, forming crosslinked counterparts BovXL, HuCCXL, and rHXL, respectively. Collagen membrane ultrastructure and biomaterial properties were found to rely heavily on both collagen source and crosslinking. Bov and HuCC samples showed a random fibrillar organization of collagen, whereas rH vitrigels showed remarkable regional fibril alignment. After CX, light transmission was enhanced in all groups. Denaturation temperatures after CX increased in all membranes, of which the highest increase was seen in rH (14.71 degrees C), suggesting improved thermal stability of the collagen fibrils in the membranes. Noncrosslinked rH vitrigels may be reinforced through CX to reach levels of mechanical strength and thermal stability comparable to Bov. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 300-307, 2016.
C1 [Majumdar, Shoumyo; Guo, Qiongyu; Garza-Madrid, Marcos; Elisseeff, Jennifer] Johns Hopkins Sch Med, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA.
   [Majumdar, Shoumyo; Guo, Qiongyu; Garza-Madrid, Marcos; Elisseeff, Jennifer] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD USA.
   [Garza-Madrid, Marcos] Tecnol Monterrey, Sch Med & Hlth Sci, Ophthalmol & Visual Sci Res Chair, Monterrey, Mexico.
   [Calderon-Colon, Xiomara; Trexler, Morgana] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA.
   [Duan, Derek; Carbajal, Priscilla] Eyegenix LLC, Honolulu, HI USA.
   [Schein, Oliver; Elisseeff, Jennifer] Johns Hopkins Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD USA.
RP Elisseeff, J (reprint author), Johns Hopkins Sch Med, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA.
EM jhe@jhu.edu
RI Guo, Qiongyu/J-3118-2014
OI Guo, Qiongyu/0000-0002-1916-9100
FU Congressionally Directed Medical Research Program under the U.S. Army
   Medical Research and Materiel Command [W81XWH-09-2-0173]; Arthritis
   Foundation Postdoctoral Fellowship; Jules Stein Professorship from
   Research to Prevent Blindness (RPB) Foundation
FX Contract grant sponsor: Congressionally Directed Medical Research
   Program under the U.S. Army Medical Research and Materiel Command;
   contract grant number: W81XWH-09-2-0173 (Program Manager Dr. Charmaine
   Richman); Contract grant sponsor: Arthritis Foundation Postdoctoral
   Fellowship (to Q.G.); Contract grant sponsor: The Jules Stein
   Professorship from Research to Prevent Blindness (RPB) Foundation
CR Ambrose WM, 2009, J BIOMED MATER RES B, V90B, P818, DOI 10.1002/jbm.b.31351
   Bron AJ, 2001, BRIT J OPHTHALMOL, V85, P379, DOI 10.1136/bjo.85.4.379
   Browne S, 2013, TISSUE ENG PT A, V19, P1491, DOI [10.1089/ten.tea.2012.0721, 10.1089/ten.TEA.2012.0721]
   Calderon-Colon X, 2012, BIOMATERIALS, V33, P8286, DOI 10.1016/j.biomaterials.2012.07.062
   Cassidy D, 2013, CLIN EXP OPTOM, V96, P165, DOI 10.1111/cxo.12047
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037
   DiVito MD, 2012, INVEST OPHTH VIS SCI, V53, P8192, DOI 10.1167/iovs.12-10561
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Guan LN, 2013, J MOL HISTOL, V44, P609, DOI 10.1007/s10735-013-9508-5
   Guo QY, 2013, BIOMATERIALS, V34, P9365, DOI 10.1016/j.biomaterials.2013.08.061
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Hwang YJ, 2013, BIOPOLYMERS, V99, P349, DOI 10.1002/bip.22183
   Hwang YJ, 2012, ACS APPL MATER INTER, V4, P261, DOI 10.1021/am2013147
   Kwitko S, 2012, ARQ BRAS OFTALMOL, V75, P447, DOI 10.1590/S0004-27492012000600017
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   OHNISHI H, 1984, CLIN EXP IMMUNOL, V58, P206
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Puleo CM, 2009, LAB CHIP, V9, P3221, DOI 10.1039/b908332d
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Schwab I R, 1999, Trans Am Ophthalmol Soc, V97, P891
   Shoseyov O, 2013, TISSUE ENG PT A, V19, P1527, DOI [10.1089/ten.tea.2012.0347, 10.1089/ten.TEA.2012.0347]
   Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188
   Takezawa T, 2004, CELL TRANSPLANT, V13, P463, DOI 10.3727/000000004783983882
   Trichet E, 2013, J FR OPHTALMOL, V36, P393, DOI 10.1016/j.jfo.2012.06.023
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
NR 33
TC 6
Z9 6
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2016
VL 104
IS 2
BP 300
EP 307
DI 10.1002/jbm.b.33381
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DA5HO
UT WOS:000367834100008
PM 25766399
DA 2018-10-20
ER

PT J
AU Andrade, FAC
   Vercik, LCD
   Monteiro, FJ
   Rigo, ECD
AF Cavadas Andrade, Flavio Augusto
   de Oliveira Vercik, Luci Cristina
   Monteiro, Fernando Jorge
   da Silva Rigo, Eliana Cristina
TI Preparation, characterization and antibacterial properties of silver
   nanoparticles-hydroxyapatite composites by a simple and eco-friendly
   method
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Nano-hydroxyapatite; Silver nanoparticle; Antibacterial effect;
   Adsorption
ID MEDICAL APPLICATIONS; CALCIUM-PHOSPHATE; ANTIMICROBIAL ACTIVITY;
   BIOLOGICAL-PROPERTIES; AQUEOUS-SOLUTION; MINERAL APATITE; METAL-IONS;
   COATINGS; RELEASE; AG
AB Hydroxyapatite (HA) has been widely used as an implant material due to its high chemical similarity with the mineral component of bone extracellular matrix. Silver nanoparticles (AgNPs), when used in adequate amounts, are known to provide beneficial effects on biomaterials due to their powerful antimicrobial activity. In this work, HA powder was obtained by chemical precipitation and AgNPs were synthesized in colloidal suspension in the presence of chitosan. The HA powder was immersed in as-prepared AgNPs colloids to produce silver nanoparticle hydroxyapatite composites (HA-AgNPs) with theoretical silver proportion ranging from 0.016 to 0.40 wt%. The AgNPs synthesis and adsorption onto HA were studied by a UV vis technique, while the presence of silver in HA-AgNPs was confirmed by ICP-AES and EDS analysis. XRD and TEM characterization showed no significant changes in the structure and morphology of HA after AgNPs incorporated. High-resolution SEM showed spherical AgNPs (5-10 nm diameter) and TEM analysis revealed nanosized rod-shaped HA particles (100-150 nm long and 40-50 nm wide). A good antibacterial ability was observed in all materials against two bacterial strains (Escherichia coli and Staphylococcus aureus) using the disk diffusion method. Considering the simple methodology involved in the production of these materials, it is suggested that the HA-AgNPs can be used for development of antibacterial biomaterial applications. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Cavadas Andrade, Flavio Augusto; da Silva Rigo, Eliana Cristina] Univ Sao Paulo, EESC FMRP IQSC, Interunidades Bioengn, BR-13566590 Sao Carlos, SP, Brazil.
   [de Oliveira Vercik, Luci Cristina; da Silva Rigo, Eliana Cristina] Univ Sao Paulo, FZEA, Dept Ciencias Basicas, BR-13635900 Pirassununga, SP, Brazil.
   [Monteiro, Fernando Jorge] Univ Porto, Fac Engn, Dept Engn Met & Mat, P-4200465 Oporto, Portugal.
   [Monteiro, Fernando Jorge] INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
RP Andrade, FAC (reprint author), Univ Sao Paulo, EESC FMRP IQSC, Interunidades Bioengn, Ave Trabalhador Sao Carlense 400, BR-13566590 Sao Carlos, SP, Brazil.
EM flavio.andrade@usp.br
RI Rigo, Eliana/H-4926-2012
OI Rigo, Eliana/0000-0003-3368-5707; Monteiro, Fernando/0000-0002-1361-4605
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Sao
   Paulo Research Foundation FAPESP [2012/19.994-3]; project NanoforBone
   [NORTE-01-0202-FEDER-005372]
FX The authors would like to thank the financial support of Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - CAPES, Sao Paulo Research
   Foundation FAPESP (Process no. 2012/19.994-3) and project NanoforBone
   (NORTE-01-0202-FEDER-005372) for partial funding this work. Also, the
   authors are thankful to Biocomposites Group from INEB (Institut de
   Engenharia Biomedica, Porto, Portugal), Maria Ines Basso Bernardi, Ph.D.
   for the ICP-AES analyses, German Ayala Valencia, M.Sc. for support with
   AgNPs synthesis, and Wagner Correr, M.Sc. for manuscript review and
   support with image processing.
CR BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Bera T, 2009, J MATER SCI, V44, P2264, DOI 10.1007/s10853-008-2861-1
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen XB, 1997, WATER AIR SOIL POLL, V98, P57, DOI 10.1023/A:1026425931811
   Chen XB, 1997, ENVIRON SCI TECHNOL, V31, P624
   Chen YK, 2008, J MATER SCI-MATER M, V19, P3603, DOI 10.1007/s10856-008-3529-8
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chung RJ, 2005, J SOL-GEL SCI TECHN, V33, P229, DOI 10.1007/s10971-005-5618-1
   Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078
   Feng QL, 1998, THIN SOLID FILMS, V335, P214, DOI 10.1016/S0040-6090(98)00956-0
   Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10
   Gross KA, 1998, INT J ORAL MAX IMPL, V13, P601
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Ichikawa Y, 2009, J CERAM SOC JPN, V117, P294, DOI 10.2109/jcersj2.117.294
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   JEANJEAN J, 1994, J SOLID STATE CHEM, V108, P68, DOI 10.1006/jssc.1994.1010
   Jorgensen JH, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1152
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Krestou A, 2004, MINER ENG, V17, P373, DOI 10.1016/j.mineng.2003.11.019
   Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30
   Laranjeira MS, 2010, J BIOMED MATER RES A, V95A, P891, DOI 10.1002/jbm.a.32916
   Lee IS, 2006, NUCL INSTRUM METH B, V242, P45, DOI 10.1016/j.nimb.2005.08.010
   Lin JH, 2009, SENSOR ACTUAT B-CHEM, V137, P768, DOI 10.1016/j.snb.2009.01.033
   Manna S, 2006, J PHYS CHEM B, V110, P12318, DOI 10.1021/jp061445y
   Marsich E, 2013, J MATER SCI-MATER M, V24, P1799, DOI 10.1007/s10856-013-4923-4
   Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016
   Miranda M, 2010, INT J MATER RES, V101, P122, DOI 10.3139/146.110256
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nazari AG, 2011, MICRO NANO LETT, V6, P713, DOI 10.1049/mnl.2011.0381
   Noda I, 2009, J BIOMED MATER RES B, V89B, P456, DOI 10.1002/jbm.b.31235
   Oh KS, 2004, KEY ENG MAT, V264-268, P2111, DOI 10.4028/www.scientific.net/KEM.264-268.2111
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Poelstra KA, 2000, SPINE, V25, P406, DOI 10.1097/00007632-200002150-00003
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Reichert J, 1996, J MATER SCI, V31, P1231, DOI 10.1007/BF00353102
   Sanpo N, 2009, J THERM SPRAY TECHN, V18, P10, DOI 10.1007/s11666-008-9283-0
   SHIRKHANZADEH M, 1995, MATER LETT, V24, P7, DOI 10.1016/0167-577X(95)00059-3
   Simon V, 2008, J NON-CRYST SOLIDS, V354, P1751, DOI 10.1016/j.jnoncrysol.2007.08.063
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Sugiyama S, 2003, J COLLOID INTERF SCI, V259, P408, DOI 10.1016/S0021-9797(02)00211-4
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021
   Verret DJ, 2005, OTOLARYNG HEAD NECK, V133, P897, DOI 10.1016/j.otohns.2005.09.001
   Wei DW, 2008, COLLOID SURFACE B, V62, P136, DOI 10.1016/j.colsurfb.2007.09.030
   Wei DW, 2009, J NANOSCI NANOTECHNO, V9, P2566, DOI 10.1166/jnn.2009.448
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f
   Zakharov NA, 2004, INORG MATER+, V40, P641, DOI 10.1023/B:INMA.0000032000.83171.9f
NR 55
TC 21
Z9 22
U1 6
U2 137
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD FEB 1
PY 2016
VL 42
IS 2
BP 2271
EP 2280
DI 10.1016/j.ceramint.2015.10.021
PN A
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA CZ7JZ
UT WOS:000367277000021
DA 2018-10-20
ER

PT J
AU Oliveira, IR
   Andrade, TL
   Araujo, KCML
   Luz, AP
   Pandolfelli, VC
AF Oliveira, I. R.
   Andrade, T. L.
   Araujo, K. C. M. L.
   Luz, A. P.
   Pandolfelli, V. C.
TI Hydroxyapatite synthesis and the benefits of its blend with calcium
   aluminate cement
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Precipitation; Mechanosynthesis; Hydroxyapatite; Calcium aluminate
   cement
ID NANOCRYSTALLINE HYDROXYAPATITE; IN-VITRO; ENDODONTIC CEMENT;
   MECHANOSYNTHESIS; BIOCOMPATIBILITY; BIOACTIVITY
AB Hydroxyapatite (HA) is a calcium phosphate and the main mineral component of bones and teeth. However, its use as a biomaterial is limited due to the poor mechanical strength presented by this compound. Various techniques have been investigated for HA production, considering its good biocompatibility and chemical stability in the implanted area. In this paper, two methods for hydroxyapatite synthesis (precipitation and mechanosynthesis) were evaluated and compared, in order to select the most viable HA processing route before adding this component to calcium aluminate cement (CAC). The blend of HA+CAC aimed to attain a biomaterial presenting the biological activity of calcium phosphate and the optimized green mechanical strength derived from the selected cement. The obtained HA powders were characterized via XRD, SEM and particle size distribution measurements. The mechanical strength, apparent porosity and pore size distribution of the prepared HA CAC samples were analyzed. Both studied routes induced hydroxyapatite generation, but the mechanosynthesis was the most suitable one due to the reduced reaction time required. The main advantage of adding HA powders to CAC was associated with the production of a compound with higher mechanical strength, when compared to the original materials. Besides that, the HA favored the bioactivity of the prepared compositions, as observed by the Ca2+ ions release and pH increase of the analyzed aqueous medium, leading to apatite precipitation on the HA+CAC samples' surface. This latter transformation also resulted in the decrease of both, apparent porosity and pores diameter, of the samples. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Oliveira, I. R.; Andrade, T. L.; Araujo, K. C. M. L.] Univ Vale Paraiba, Inst Res & Dev, BR-2911 Sao Jose Dos Campos, SP, Brazil.
   [Luz, A. P.; Pandolfelli, V. C.] Univ Fed Sao Carlos, UFSCar, Mat Engn Dept, BR-13560 Sao Carlos, SP, Brazil.
RP Oliveira, IR (reprint author), Univ Vale Paraiba, Inst Res & Dev, Ave Shishima Hifumi, BR-2911 Sao Jose Dos Campos, SP, Brazil.
EM ivoneregina.oliveira@gmail.com
FU Fapesp [2013/22502-8, 2014/08988-8]; CNPq
FX The authors are grateful to Fapesp (2013/22502-8 and 2014/08988-8) and
   CNPq for supporting this work.
CR Aguilar FG, 2012, J ENDODONT, V38, P367, DOI 10.1016/j.joen.2011.11.002
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Castro-Raucci Larissa Moreira Spinola de, 2011, Braz. Dent. J., V22, P99, DOI 10.1590/S0103-64402011000200002
   Chang SW, 2011, J ENDODONT, V37, P1673, DOI 10.1016/j.joen.2011.08.020
   Coreno AJ, 2005, OPT MATER, V27, P1281, DOI 10.1016/j.optmat.2004.11.025
   Costa A.C.F.M., 2009, ELECT J MAT PROCESS, V43, P29
   Goloshchapov DL, 2013, CERAM INT, V39, P4539, DOI 10.1016/j.ceramint.2012.11.050
   Hermansson L, 2011, BIOMATERIALS - PHYSICS AND CHEMISTRY, P47
   Jacobovitz M, 2009, ORAL SURG ORAL MED O, V108, P140, DOI 10.1016/j.tripleo.2009.03.013
   Khorami M, 2011, MAT SCI ENG C-MATER, V31, P1584, DOI 10.1016/j.msec.2011.07.011
   Kopanda J.E., 1990, ALUMINA CHEM SCI TEC, P171
   Kraft L., 2002, THESIS, P65
   Loof J., 2008, THESIS, P87
   Mandal T, 2014, POWDER TECHNOL, V253, P650, DOI [10.1016/j.powtec.2013.12.026, 10.1016/j.powtec2013.12.026]
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Mochales C, 2011, J ALLOY COMPD, V509, P7389, DOI 10.1016/j.jallcom.2011.04.033
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Nordin JA, 2015, MAT SCI ENG C-MATER, V51, P294, DOI 10.1016/j.msec.2015.03.019
   Oliveira IR, 2010, INT ENDOD J, V43, P1069, DOI 10.1111/j.1365-2591.2010.01770.x
   Oliveira I.R., 2014, MAT RES, V17, P1295
   Oliveira IR, 2013, J ENDODONT, V39, P774, DOI 10.1016/j.joen.2013.01.013
   Pandolfelli V.C., 2009, Patent Registration, Patent No. [WO/2009/067774, 2009/067774]
   Rigo E. C. S., 2007, REV DENT PRESS PERIO, V1, P39
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Silva CC, 2005, J NON-CRYST SOLIDS, V351, P2945, DOI 10.1016/j.jnoncrysol.2005.04.082
   Silva CC, 2003, SOLID STATE SCI, V5, P553, DOI 10.1016/S1293-2558(03)00035-9
   Silva Junior PE, 2001, POLIMEROS, V11, P109
   Suresh Kumar G, 2010, J COLLOID INTERF SCI, V349, P56
   Wu Chengtie, 2009, BONE TISSUE REGENERA, V2, P25
   Zhu JM, 2011, J POLYM RES, V18, P2011, DOI 10.1007/s10965-011-9609-3
NR 31
TC 8
Z9 8
U1 2
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD FEB 1
PY 2016
VL 42
IS 2
BP 2542
EP 2549
DI 10.1016/j.ceramint.2015.10.056
PN A
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA CZ7JZ
UT WOS:000367277000054
DA 2018-10-20
ER

PT J
AU Valente, FL
   Santos, LC
   Sepulveda, RV
   Goncalves, GP
   Eleoterio, RB
   Reis, ECC
   Borges, APB
AF Valente, Fabricio Luciani
   Santos, Leticia Correa
   Sepulveda, Rodrigo Viana
   Goncalves, Gustavo Pereira
   Eleoterio, Renato Barros
   Carlo Reis, Emily Correna
   Batista Borges, Andrea Pacheco
TI Hydroxyapatite-lignin composite as a metallic implant-bone tissue
   osseointegration improver: experimental study in dogs
SO CIENCIA RURAL
LA English
DT Article
DE biomaterial; biocompatibility; osseointegration; osteoconduction; tissue
   regeneration
ID SYNTHETIC HYDROXYAPATITE; IN-VIVO; POLYHYDROXYBUTYRATE; TITANIUM;
   DEFECTS
AB The study aimed to evaluate biocompatibility, osteoconduction and osseointegration of a pasty composite of hydroxyapatite (20%) and lignin (80%) as a promoter of metal implant and bone tissue integration. An intramedullary Schanz pin was implanted in both tibias of fifteen bitches. In the left tibia, the pin was coated with the biomaterial at the time of surgery. Marrow cavity was also filled with the biomaterial. Right limb did not receive the biomaterial, then constituting the control group. Tibias were harvested from five animals at 8, 60 and 150 days after surgery; three of them were analyzed by histological and biomechanical assessment and the two remaining tibias by X-ray diffraction. Results showed that the biomaterial is biocompatible, with osteoconductivity and osseointegration properties. Histological analysis and diffractograms showed the presence of hydroxyapatite in samples in all periods, although the presence of organic material of low crystallinity was variable. There was no statistical difference in the forces required for removal of the intramedullary pin between times or treatments. Although the biomaterial showed biocompatibility, osteoconductivity and osseointegration, it was not able to promote a better intramedullary pin anchorage.
C1 [Valente, Fabricio Luciani; Santos, Leticia Correa; Sepulveda, Rodrigo Viana; Goncalves, Gustavo Pereira; Eleoterio, Renato Barros; Carlo Reis, Emily Correna] Univ Fed Vicosa, BR-36570900 Vicosa, MG, Brazil.
   [Batista Borges, Andrea Pacheco] Univ Fed Vicosa, Dept Vet, BR-36570900 Vicosa, MG, Brazil.
RP Borges, APB (reprint author), Univ Fed Vicosa, Dept Vet, BR-36570900 Vicosa, MG, Brazil.
EM andrea@ufv.br
OI Borges, Andrea Pacheco Batista/0000-0002-7489-3847
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)
FX The authors thank Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) and Fundacao de Amparo a Pesquisa do estado de Minas
   Gerais (FAPEMIG) for financial support, JHS Ltda. for providing the
   composite and Prof. Mauricio Fontes (UFV) for XRD analyses.
CR Borges APB, 2000, ARQ BRAS MED VET ZOO, V52, P616, DOI 10.1590/S0102-09352000000600011
   Carlo EC, 2009, ARQ BRAS MED VET ZOO, V61, P844, DOI 10.1590/S0102-09352009000400011
   Crespi R, 2012, INT J ORAL MAX IMPL, V27, P95
   Damien E, 2003, J BIOMED MATER RES A, V66A, P241, DOI 10.1002/jbm.a.10564
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   Duarte TS, 2006, ARQ BRAS MED VET ZOO, V58, P849, DOI 10.1590/S0102-09352006000500021
   Epinette JA, 2007, J BONE JOINT SURG BR, V89B, P34, DOI 10.1302/0301-620X.89B1.17864
   Erakovic S, 2012, PROG ORG COAT, V75, P275, DOI 10.1016/j.porgcoat.2012.07.005
   Fabbri P, 2010, J MATER SCI-MATER M, V21, P343, DOI 10.1007/s10856-009-3839-5
   Hettlich BF, 2013, VET SURG, V42, P693, DOI 10.1111/j.1532-950X.2013.12040.x
   Hunt S, 2011, CAN J SURG, V54, P33, DOI 10.1503/cjs.001110
   Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1
   Alves EGL, 2011, J FELINE MED SURG, V13, P546, DOI 10.1016/j.jfms.2011.03.002
   Martinez MM, 2009, ARQ BRAS MED VET ZOO, V61, P835, DOI 10.1590/S0102-09352009000400010
   Martínez Mastoby, 2009, rev.udcaactual.divulg.cient., V12, P19
   PEREIRA G. A., 2007, REV BRAS ORTOP, V42, P24
   Rajzer I, 2014, J MATER SCI-MATER M, V25, P1239, DOI 10.1007/s10856-014-5149-9
   Rigo E. C. S., 2007, REV DENT PRESS PERIO, V1, P39
   Shokrollahi P, 2014, J MATER SCI-MATER M, V25, P23, DOI 10.1007/s10856-013-5039-6
   Tonino AJ, 2009, CLIN ORTHOP RELAT R, V467, P478, DOI 10.1007/s11999-008-0559-y
   Ugartondo V, 2008, BIORESOURCE TECHNOL, V99, P6683, DOI 10.1016/j.biortech.2007.11.038
   Waanders D, 2010, J BIOMECH, V43, P1167, DOI 10.1016/j.jbiomech.2009.11.033
   Yamada M, 2012, INT J NANOMED, V7, P859, DOI 10.2147/IJN.S28082
NR 23
TC 3
Z9 3
U1 3
U2 26
PU UNIV FEDERAL SANTA MARIA
PI SANTA MARIA
PA CIDADE UNIV, BAIRRO CAMOBI, SANTA MARIA, RS 97105-900, BRAZIL
SN 0103-8478
EI 1678-4596
J9 CIENC RURAL
JI Cienc. Rural
PD FEB
PY 2016
VL 46
IS 2
BP 324
EP 329
DI 10.1590/0103-8478cr20150110
PG 6
WC Agronomy
SC Agriculture
GA CZ5HV
UT WOS:000367134300022
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhao, YD
   Tan, K
   Zhou, Y
   Ye, ZY
   Tan, WS
AF Zhao, Yingdi
   Tan, Ke
   Zhou, Yan
   Ye, Zhaoyang
   Tan, Wen-Song
TI A combinatorial variation in surface chemistry and pore size of
   three-dimensional porous poly(epsilon-caprolactone) scaffolds modulates
   the behaviors of mesenchymal stem cells
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tissue engineering; Mesenchymal stem cells; Three-dimensional porous
   scaffolds; Surface chemistry; Pore size
ID SMALL FUNCTIONAL-GROUPS; IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   POLYCAPROLACTONE SCAFFOLDS; EXTRACELLULAR-MATRIX; GRADIENT SCAFFOLD;
   INTEGRIN BINDING; BONE; ADHESION; PROLIFERATION
AB Biomaterial properties play significant roles in controlling cellular behaviors. The objective of the present study was to investigate how pore size and surface chemistry of three-dimensional (3D) porous scaffolds regulate the fate of mesenchymal stem cells (MSCs) in vitro in combination. First, on poly(epsilon-caprolactone) (PCL) films, the hydrolytic treatment was found to stimulate the adhesion, spreading and proliferation of human MSCs (hMSCs) in comparison with pristine films, while the aminolysis showed mixed effects. Then, 3D porous PCL scaffolds with varying pore sizes (100-200 mu m, 200-300 mu m and 300-450 mu m) were fabricated and subjected to either hydrolysis or aminolysis. It was found that a pore size of 200-300 mu m with hydrolysis in 3D scaffolds was the most favorable condition for growth of hMSCs. Importantly, while a pore size of 200-300 mu m with hydrolysis for 1 h supported the best osteogenic differentiation of hMSCs, the chondrogenic differentiation was greatest in scaffolds with a pore size of 300-450 mu m and treated with aminolysis for 1 h. Taken together, these results suggest that surface chemistry and pore size of 3D porous scaffolds may potentially have a synergistic impact on the behaviors of MSCs. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhao, Yingdi; Tan, Ke; Zhou, Yan; Ye, Zhaoyang; Tan, Wen-Song] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Bioengn, Shanghai 200237, Peoples R China.
RP Ye, ZY (reprint author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, 130 Mei Long Rd,POB 309, Shanghai 200237, Peoples R China.
EM zhaoyangye@ecust.edu.cn
FU National Special Fund for State Key Laboratory of Bioreactor Engineering
   [2060204]; Basic Research Project of Shanghai Science and Technology
   Commission [12JC1403101, 15JC1401402]; National Natural Science
   Foundation of China [31000424, 31170951]
FX This research was supported by the National Special Fund for State Key
   Laboratory of Bioreactor Engineering (2060204), Basic Research Project
   of Shanghai Science and Technology Commission (12JC1403101,
   15JC1401402), and National Natural Science Foundation of China
   (31000424, 31170951).
CR Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bouchet BY, 2000, J BIOMED MATER RES, V52, P716, DOI 10.1002/1097-4636(20001215)52:4<716::AID-JBM17>3.0.CO;2-T
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054
   Chen M, 2015, COLLOID SURFACE B, V134, P322, DOI 10.1016/j.colsurfb.2015.07.018
   Chieh HF, 2013, J BIOMAT SCI-POLYM E, V24, P94, DOI 10.1163/156856212X626208
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   de Luca AC, 2014, J TISSUE ENG REGEN M, V8, P153, DOI 10.1002/term.1509
   Declercq HA, 2014, TISSUE ENG PT A, V20, P434, DOI [10.1089/ten.tea.2013.0179, 10.1089/ten.TEA.2013.0179]
   Declercq HA, 2013, ACTA BIOMATER, V9, P7699, DOI 10.1016/j.actbio.2013.05.003
   Duan PG, 2014, J BIOMED MATER RES A, V102, P180, DOI 10.1002/jbm.a.34683
   Edalat F, 2012, CURR OPIN BIOTECH, V23, P820, DOI 10.1016/j.copbio.2012.05.007
   Fu RH, 2014, CELL TRANSPLANT, V23, P621, DOI 10.3727/096368914X678382
   Fu X, 2012, J BIOMED MATER RES B, V100B, P314, DOI 10.1002/jbm.b.31916
   Ghaemi SR, 2013, BIOMATERIALS, V34, P7601, DOI 10.1016/j.biomaterials.2013.06.022
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106
   Huri PY, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045003
   Im GI, 2012, CELL TRANSPLANT, V21, P2397, DOI 10.3727/096368912X638865
   Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Kim TH, 2013, MACROMOL RES, V21, P878, DOI 10.1007/s13233-013-1099-1
   Kolambkar YM, 2014, TISSUE ENG PT A, V20, P398, DOI [10.1089/ten.tea.2012.0426, 10.1089/ten.TEA.2012.0426]
   Koo S, 2014, ACTA BIOMATER, V10, P1975, DOI 10.1016/j.actbio.2014.01.015
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Liu XJ, 2014, ACS APPL MATER INTER, V6, P9733, DOI 10.1021/am502170s
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Mathews S, 2014, J TISSUE ENG REGEN M, V8, P143, DOI 10.1002/term.1507
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Oh SH, 2010, BIOMACROMOLECULES, V11, P1948, DOI 10.1021/bm100199m
   Pamula E, 2008, J MATER SCI-MATER M, V19, P425, DOI 10.1007/s10856-007-3001-1
   Pati F, 2015, BIOMATERIALS, V37, P230, DOI 10.1016/j.biomaterials.2014.10.012
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422
   Stenhamre H, 2011, J TISSUE ENG REGEN M, V5, P578, DOI 10.1002/term.350
   Tejeda-Montes E, 2014, ACTA BIOMATER, V10, P134, DOI 10.1016/j.actbio.2013.09.001
   Uppanan P, 2015, J BIOMED MATER RES A, V103, P2322, DOI 10.1002/jbm.a.35370
   Wang M, 2010, BIOTECHNOL BIOPROC E, V15, P1047, DOI 10.1007/s12257-009-3147-4
   Wu XH, 2012, ACS APPL MATER INTER, V4, P4966, DOI 10.1021/am301334s
   Yildirim ED, 2011, PLASMA PROCESS POLYM, V8, P256, DOI 10.1002/ppap.201000009
   Zhang HN, 2009, J BIOMAT SCI-POLYM E, V20, P1975, DOI 10.1163/156856208X396074
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang QC, 2013, MAT SCI ENG C-MATER, V33, P2094, DOI 10.1016/j.msec.2013.01.025
NR 56
TC 13
Z9 14
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2016
VL 59
BP 193
EP 202
DI 10.1016/j.msec.2015.10.017
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CZ4XW
UT WOS:000367107400023
PM 26652364
DA 2018-10-20
ER

PT J
AU Campelo, CS
   Lima, LD
   Rebelo, LM
   Mantovani, D
   Beppu, MM
   Vieira, RS
AF Campelo, Clayton Souza
   Lima, Luana Dias
   Rebelo, Luciana Magalhaes
   Mantovani, Diego
   Beppu, Marisa Masumi
   Vieira, Rodrigo Silveira
TI In vitro evaluation of anti-calcification and anti-coagulation on
   sulfonated chitosan and carrageenan surfaces
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcification; Chitosan; Carrageenan; Platelet adhesion
ID KAPPA-CARRAGEENAN; SULFATED POLYSACCHARIDES; CHITOSAN/CARRAGEENAN
   NANOPARTICLES; PROTEIN ADSORPTION; PLATELET-ADHESION; FILMS;
   THROMBOGENICITY; PROTEOGLYCAN; AGGREGATION; PERICARDIUM
AB In recent years, great effort has been devoted to the development of biomaterials that come into contact with blood. The surfaces of these materials need to be of suitable mechanical strength, and present anti-thrombogenic and anti-calcification properties. Chitosan is a natural polymer that has attracted attention due to its potential to act as a biomaterial. However, chitosan contains amino groups in its structure that may promote thrombogenesis and calcification. A strategy to reduce these properties constitutes the introduction of sulfonate groups (R-SO3-) in the chitosan chain. Another interesting biopolymer with similar characteristics to those of heparin is carrageenan, which has sulfate groups in its structure. As such, we evaluated "in vitro" calcification and thrombogenic processes on surfaces of pristine and sulfonated chitosan and on polyelectrolyte complexes (PEC) of chitosan and carrageenan. Results indicate that PEC demonstrate significant reductions in calcification and thrombogenic potential, probably due to the presence of sulfonate groups in both the carrageenan and treated chitosan. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Campelo, Clayton Souza; Lima, Luana Dias; Vieira, Rodrigo Silveira] Univ Fed Ceara, Dept Engn Quim, BR-60455760 Fortaleza, Ceara, Brazil.
   [Rebelo, Luciana Magalhaes] Univ Fed Ceara, Dept Phys, BR-60455900 Fortaleza, Ceara, Brazil.
   [Mantovani, Diego] Univ Laval, Dept Min Met Mat Engn, Quebec City, PQ G1V 0A6, Canada.
   [Mantovani, Diego] Univ Hosp Res Ctr, Quebec City, PQ G1V 0A6, Canada.
   [Beppu, Marisa Masumi] Univ Estadual Campinas, Fac Chem Engn, BR-13081970 Campinas, SP, Brazil.
RP Vieira, RS (reprint author), Univ Fed Ceara, Dept Engn Quim, Bl 709,Campus Pici, BR-60455760 Fortaleza, Ceara, Brazil.
RI BEPPU, MARISA/E-1057-2012; UFC, DF/E-1564-2017; Rebelo Alencar,
   Luciana/O-6736-2018; Universidade Federal do Ceara, Physics
   Department/J-4630-2016
OI Universidade Federal do Ceara, Physics Department/0000-0002-9247-6780;
   Mantovani, Diego/0000-0001-9672-895X; Silveira Vieira,
   Rodrigo/0000-0003-4569-9655; Souza Campelo, Clayton/0000-0003-1938-2937
FU CNPq [482961/2012-0 - APQ]
FX The authors thank CNPq (Grant Number 482961/2012-0 - APQ) for financial
   support, and UNICAMP and UFC for the infrastructure required for this
   study.
CR Aimoli CG, 2006, COLLOID SURFACE B, V53, P15, DOI 10.1016/j.colsurfb.2006.07.012
   Aimoli CG, 2006, MAT SCI ENG C-BIO S, V26, P78, DOI 10.1016/j.msec.2005.06.037
   Amiji MM, 1998, COLLOID SURFACE B, V10, P263, DOI 10.1016/S0927-7765(98)00005-8
   Arenaz B, 2004, BIOMATERIALS, V25, P3359, DOI 10.1016/j.biomaterials.2003.09.105
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bondu S., 2010, Carbohydrate Polymers, V81, P448
   Carneiro TN, 2013, MACROMOL BIOSCI, V13, P1072, DOI 10.1002/mabi.201200482
   CHANDA J, 1994, BIOMATERIALS, V15, P465, DOI 10.1016/0142-9612(94)90226-7
   Chanda J, 1999, BIOMATERIALS, V20, P1753, DOI 10.1016/S0142-9612(98)00078-7
   Grenha A, 2010, J BIOMED MATER RES A, V92A, P1265, DOI 10.1002/jbm.a.32466
   Hoven VP, 2007, CARBOHYD POLYM, V68, P44, DOI 10.1016/j.carbpol.2006.07.008
   Ikeda S, 1997, FOOD HYDROCOLLOID, V11, P303, DOI 10.1016/S0268-005X(97)80060-4
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   JURD KM, 1995, J APPL PHYCOL, V7, P339, DOI 10.1007/BF00003790
   Karagkiozaki V, 2008, MATER SCI ENG B-ADV, V152, P16, DOI 10.1016/j.mseb.2008.06.013
   Karagkiozaki V, 2009, NANOMED-NANOTECHNOL, V5, P64, DOI 10.1016/j.nano.2008.07.005
   Keuren JFW, 2003, BIOMATERIALS, V24, P1917, DOI 10.1016/S0142-9612(02)00620-8
   KINDNESS G, 1980, BRIT J PHARMACOL, V69, P675, DOI 10.1111/j.1476-5381.1980.tb07921.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Lee WK, 2001, J BIOMED MATER RES, V58, P27, DOI 10.1002/1097-4636(2001)58:1<27::AID-JBM40>3.0.CO;2-2
   Lima PHL, 2013, COLLOID SURFACE B, V111, P719, DOI 10.1016/j.colsurfb.2013.06.002
   Mandavinia G.R., 2014, J BIOMAT SCI-POLYM E, V25, P1891, DOI DOI 10.1080/09205063.2014.956166
   Mandavinia G. R., 2004, IRAN POLYM J, V40, P1399
   Mangione MR, 2003, BIOPHYS CHEM, V104, P95, DOI 10.1016/S0301-4622(02)00341-1
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Nickerson MT, 2004, CARBOHYD POLYM, V58, P25, DOI 10.1016/j.carbpol.2004.06.017
   Nogueira GM, 2010, MAT SCI ENG C-MATER, V30, P575, DOI 10.1016/j.msec.2010.02.011
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   Opoku G, 2006, CARBOHYD POLYM, V65, P134, DOI 10.1016/j.carbpol.2005.12.033
   Padera Jr R.F., 1996, BIOMATERIAL SCI INTR
   Park D.K., 1997, BIOMATERIALS, V18, P47
   Park SY, 2001, MATER RES BULL, V36, P511, DOI 10.1016/S0025-5408(01)00545-1
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   Periayah MH, 2013, INT J BIOL MACROMOL, V52, P244, DOI 10.1016/j.ijbiomac.2012.10.001
   ROCHAS C, 1987, CARBOHYD POLYM, V7, P435, DOI 10.1016/0144-8617(87)90011-7
   Rodrigues S, 2012, CARBOHYD POLYM, V89, P282, DOI 10.1016/j.carbpol.2012.03.010
   Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab
   Shanmugam M, 2000, CURR SCI INDIA, V79, P1672
   Tan A, 2013, J BIOTECHNOL, V164, P151, DOI 10.1016/j.jbiotec.2013.01.020
   World Health Organization, 2012, WORLD HLTH STAT 2012
   Yuan H, 2008, J NANJING MED U, V22, P372
   Yuan SJ, 2013, COLLOID SURFACE B, V106, P11, DOI 10.1016/j.colsurfb.2012.12.048
NR 43
TC 7
Z9 7
U1 2
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2016
VL 59
BP 241
EP 248
DI 10.1016/j.msec.2015.10.020
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA CZ4XW
UT WOS:000367107400029
PM 26652370
DA 2018-10-20
ER

PT J
AU Andrei, M
   Galateanu, B
   Hudita, A
   Costache, M
   Osiceanu, P
   Moreno, JMC
   Drob, SI
   Demetrescu, I
AF Andrei, M.
   Galateanu, B.
   Hudita, A.
   Costache, M.
   Osiceanu, P.
   Moreno, J. M. Calderon
   Drob, S. I.
   Demetrescu, I.
TI Electrochemical comparison and biological performance of a new
   CoCrNbMoZr alloy with commercial CoCrMo alloy
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE New CoCrNbMoZr alloy; Microstructure; Surface features; Corrosion
   resistance; Biocompatibility; Adipose stem cells (hASCs)
ID CO-CR; CORROSION BEHAVIOR; PHYSIOLOGICAL SOLUTION; TITANIUM-ALLOYS; ION
   RELEASE; IMPLANTS; SURFACE; RESISTANCE; ZIRCONIUM; WEAR
AB A new CoCrNbMoZr alloy, with Nb and Zr content is characterized from the point of view of surface features, corrosion resistance and biological performance in order to be proposed as dental restorative material. Its properties are discussed in comparison with commercial Heraenium CE alloy based on Co, Cr and Mo as well. The microstructure of both alloys was revealed by scanning electron microscopy (SEM). The composition and thickness of the alloy native passive films were identified by X-ray photoelectron spectroscopy (XPS). The surface characteristics were analyzed by atomic force microscopy (AFM) and contact angle techniques. The quantity of ions released from alloys in artificial saliva was evaluated with inductively coupled plasma-mass spectroscopy (ICP-MS) measurements. The electrochemical stability was studied in artificial Carter-Brugirard saliva, performing open circuit potentials, polarization resistances and corrosion currents and rates. The biological performance of the new alloy was tested in vitro in terms of human adipose stem cells (hASCs) morphology, viability and proliferation status. The new alloy is very resistant to the attack of the aggressive ions from the artificial saliva. The surface properties, the roughness and wettabiliy sustain the cell behavior. The comparison of the new alloy behavior with that of existing commercial CoCrMo alloy showed the superior properties of the new metallic biomaterial. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Andrei, M.; Demetrescu, I.] Univ Politehn Bucuresti, Dept Gen Chem, Bucharest 060042, Romania.
   [Galateanu, B.; Hudita, A.; Costache, M.] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest 050095, Romania.
   [Galateanu, B.] Vasile Goldis Western Univ Arad, Inst Life Sci, Arad 310414, Romania.
   [Osiceanu, P.; Moreno, J. M. Calderon; Drob, S. I.] Romanian Acad, Inst Phys Chem Ilie Murgulescu, Bucharest 060021, Romania.
RP Drob, SI (reprint author), Romanian Acad, Inst Phys Chem Ilie Murgulescu, Spl Independentei 202, Bucharest 060021, Romania.
EM sidrob@chimfiz.icf.ro
RI Calderon Moreno, Jose/B-2867-2008; Costache, Marieta/F-2806-2016;
   Galateanu, Bianca/D-1632-2015; Hudita, Ariana/I-5502-2016
OI Calderon Moreno, Jose/0000-0001-8376-9082; Costache,
   Marieta/0000-0002-8103-3693; Galateanu, Bianca/0000-0001-8093-1750;
   Hudita, Ariana/0000-0002-9439-9432
FU Sectorial Operational Programme Human Resources Development of the
   Ministry of European Funds through the Financial Agreement
   [POSDRU/159/1.5/S/132397]; Romanian UEFISCDI, Project PCE [130/2014];
   Project "Doctoral and post-doctoral programs of excellence for highly
   qualified human resources training for research in the field of Life
   sciences, Environment and Earth Science" [POSDRU/159/1.5/S/133391];
   European Social Found within the Sectorial Operational Program Human
   Resources Development
FX The work has been funded by the Sectorial Operational Programme Human
   Resources Development 2007-2013 of the Ministry of European Funds
   through the Financial Agreement POSDRU/159/1.5/S/132397. This work was
   supported by Romanian UEFISCDI, Project PCE no. 130/2014 as well. The
   authors thank Dr. Andrei Bogdan Stoian for AFM analysis. The authors
   thank Assoc. Prof. MD PhD Dana Jianu from the ProEstetica Medical Clinic
   who kindly supplied this study with human subcutaneous adipose tissue.;
   This work was supported by the strategic Grant POSDRU/159/1.5/S/133391,
   Project "Doctoral and post-doctoral programs of excellence for highly
   qualified human resources training for research in the field of Life
   sciences, Environment and Earth Science" cofinanced by the European
   Social Found within the Sectorial Operational Program Human Resources
   Development 2007-2013.
CR [Anonymous], 2000, 80442000 ISO BS EN
   [Anonymous], 2012, F7512 ASTM INT
   Baer DR, 2010, J VAC SCI TECHNOL A, V28, P1060, DOI 10.1116/1.3456123
   Barucca G, 2015, MAT SCI ENG C-MATER, V48, P263, DOI 10.1016/j.msec.2014.12.009
   Bates C, 2013, CLIN IMPLANT DENT R, V15, P53, DOI 10.1111/j.1708-8208.2010.00327.x
   Bedolla-Gil Y, 2013, J MATER ENG PERFORM, V22, P541, DOI 10.1007/s11665-012-0261-9
   Biocompatible CoCrMo alloy, 2014, [No title captured], Patent No. [US20140271317 A1, 20140271317]
   BLACK J, 1992, BIOL PERFORMANCE MAT
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   Cimpean A, 2014, MAT SCI ENG C-MATER, V38, P127, DOI 10.1016/j.msec.2014.01.056
   Contu F, 2005, CORROS SCI, V47, P1863, DOI 10.1016/j.corsci.2004.09.003
   Cortes DA, 2004, J BIOMED MATER RES A, V70A, P341, DOI 10.1002/jbmn.a.30092
   Cvijovic-Alagic I, 2011, CORROS SCI, V53, P796, DOI 10.1016/j.corsci.2010.11.014
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Dittrick S, 2011, MAT SCI ENG C-MATER, V31, P809, DOI 10.1016/j.msec.2010.07.009
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Elshahawy W., 2014, TANTA DENT J, V11, P150
   Galateanu B, 2012, INT J MOL SCI, V13, P15881, DOI 10.3390/ijms131215881
   GHOSH S, 1992, BIOL TRACE ELEM RES, V35, P247, DOI 10.1007/BF02783770
   Golgovici F, 2015, REV CHIM-BUCHAREST, V66, P660
   Hanawa T., 2011, J MATER SCI-MATER M, V22, P437
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   Imirzalioglu P, 2012, J PROSTHET DENT, V107, P24, DOI 10.1016/S0022-3913(12)60013-4
   Ionita D, 2007, KEY ENG MATER, V330-332, P545, DOI 10.4028/www.scientific.net/KEM.330-332.545
   Ionita D, 2011, APPL SURF SCI, V257, P9164, DOI 10.1016/j.apsusc.2011.05.125
   Jakubowicz J, 2012, MATER CHARACT, V70, P55, DOI 10.1016/j.matchar.2012.05.006
   Laine J, 1997, CONTACT DERMATITIS, V36, P141, DOI 10.1111/j.1600-0536.1997.tb00396.x
   Lu YJ, 2015, MAT SCI ENG C-MATER, V49, P517, DOI 10.1016/j.msec.2015.01.023
   Matusiewicz H, 2014, ACTA BIOMATER, V10, P2379, DOI 10.1016/j.actbio.2014.02.027
   Metikos-Hukovic M, 2009, CORROS SCI, V51, P70, DOI 10.1016/j.corsci.2008.10.004
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Milosev I, 2003, ELECTROCHIM ACTA, V48, P2767, DOI 10.1016/S0013-4686(03)00396-7
   Moulder J.F., 1995, HDB XRAY PHOTOELECTR
   Narayan RJ, 2013, MATER TODAY, V16, P204, DOI 10.1016/j.mattod.2013.06.007
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Nocholson J.W., 2002, R SOC CHEM, P107
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Pelaez-Abellan E, 2007, CORROS SCI, V49, P1645, DOI 10.1016/j.corsci.2006.08.010
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   Reclaru L, 2005, BIOMATERIALS, V26, P4747, DOI 10.1016/j.biomaterials.2005.01.004
   Rincic N., 2003, ACTA STOMAT CROAT, V37, P13
   Robin A, 2008, MATER CORROS, V59, P929, DOI 10.1002/maco.200805014
   Rydzynski K., 2012, PATTYS TOXICOL, V37, P511
   Souza JCM, 2012, WEAR, V292, P82, DOI 10.1016/j.wear.2012.05.030
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Vasilescu E, 2009, CORROS SCI, V51, P2885, DOI 10.1016/j.corsci.2009.08.014
   Vilaplana J, 1998, CONTACT DERMATITIS, V39, P55, DOI 10.1111/j.1600-0536.1998.tb05832.x
   Pham VH, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-197
   Walker JC, 2013, WEAR, V301, P250, DOI 10.1016/j.wear.2013.02.002
   Wang B.L., 2010, BIOMED MATER, V5
   Wang SC, 2005, J MICROSC-OXFORD, V217, P118, DOI 10.1111/j.1365-2818.2005.01394.x
NR 51
TC 3
Z9 3
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2016
VL 59
BP 346
EP 355
DI 10.1016/j.msec.2015.10.031
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CZ4XW
UT WOS:000367107400042
PM 26652383
DA 2018-10-20
ER

PT J
AU Godoy-Gallardo, M
   Guillem-Marti, J
   Sevilla, P
   Manero, JM
   Gil, FJ
   Rodriguez, D
AF Godoy-Gallardo, Maria
   Guillem-Marti, Jordi
   Sevilla, Pablo
   Manero, Jose M.
   Gil, Francisco J.
   Rodriguez, Daniel
TI Anhydride-functional silane immobilized onto titanium surfaces induces
   osteoblast cell differentiation and reduces bacterial adhesion and
   biofilm formation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bacterial adhesion; Biofilm; Osteoblast differentiation; Silane;
   Titanium
ID TISSUE INTEGRATION; SILANIZATION; BIOMATERIAL; GROWTH; ENERGY;
   3-AMINOPROPYLTRIETHOXYSILANE; ATTACHMENT; EXPRESSION; ROUGHNESS; PEPTIDE
AB Bacterial infection in dental implants along with osseointegration failure usually leads to loss of the device. Bioactive molecules with antibacterial properties can be attached to titanium surfaces with anchoring molecules such as silanes, preventing biofilm formation and improving osseointegration. Properties of silanes as molecular binders have been thoroughly studied, but research on the biological effects of these coatings is scarce. The aim of the present study was to determine the in vitro cell response and antibacterial effects of triethoxysilypropyl succinic anhydride (TESPSA) silane anchored on titanium surfaces. X-ray photoelectron spectroscopy confirmed a successful silanization. The silanized surfaces showed no cytotoxic effects. Gene expression analyses of Sarcoma Osteogenic (SaOS-2) osteoblast-like cells cultured on TESPSA silanized surfaces reported a remarkable increase of biochemical markers related to induction of osteoblastic cell differentiation. A manifest decrease of bacterial adhesion and biofilm formation at early stages was observed on treated substrates, while favoring cell adhesion and spreading in bacteria-cell co-cultures.
   Surfaces treated with TESPSA could enhance a biological sealing on implant surfaces against bacteria colonization of underlying tissues. Furthermore, it can be an effective anchoring platform of biomolecules on titanium surfaces with improved osteoblastic differentiation and antibacterial properties. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Godoy-Gallardo, Maria; Guillem-Marti, Jordi; Manero, Jose M.; Gil, Francisco J.; Rodriguez, Daniel] Tech Univ Catalonia UPC, Dept Mat Sci & Met, ETSEIB, Biomat Biomech & Tissue Engn Grp, Barcelona 08028, Spain.
   [Godoy-Gallardo, Maria; Guillem-Marti, Jordi; Manero, Jose M.; Gil, Francisco J.; Rodriguez, Daniel] UPC, Ctr Res NanoEngn CRNE, Barcelona 08028, Spain.
   [Sevilla, Pablo] EUSS, Dept Mech, Barcelona 08017, Spain.
RP Rodriguez, D (reprint author), Tech Univ Catalonia UPC, Dept Mat Sci & Met Engn, ETSEIB, UPC, Ave Diagonal 647, Barcelona 08028, Spain.
EM maria.godoy.gallardo@upc.edu; jordi.guillem.marti@upc.edu;
   psevilla@euss.es; jose.maria.manero@upc.edu;
   francesc.xavier.gil@upc.edu; daniel.rodriguez.rius@upc.edu
RI Godoy Gallardo, Maria/E-1890-2015; Guillem-Marti, Jordi/G-8411-2015
OI Godoy Gallardo, Maria/0000-0002-7232-3998; Guillem-Marti,
   Jordi/0000-0003-0307-2221; Sevilla, Pablo/0000-0002-8335-0318
FU Fundacion Ramon Areces; Spanish Government (MINECO) [MAT2009-12547,
   MAT2012-30706]; European Union through European Regional Development
   Funds
FX This work was supported by Fundacion Ramon Areces and the Spanish
   Government (MINECO) under Grants MAT2009-12547 and MAT2012-30706, both
   co-funded by the European Union through European Regional Development
   Funds.
CR Aparicio C, 2011, J MECH BEHAV BIOMED, V4, P1672, DOI 10.1016/j.jmbbm.2011.05.005
   Aubin J.E, 1996, PRINCIPLES BONE BIOL, P59
   Barabanova AI, 2012, APPL SURF SCI, V258, P3168, DOI 10.1016/j.apsusc.2011.11.057
   Barbour ME, 2007, J MATER SCI-MATER M, V18, P1439, DOI 10.1007/s10856-007-0141-2
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005
   Cras JJ, 1999, BIOSENS BIOELECTRON, V14, P683, DOI 10.1016/S0956-5663(99)00043-3
   Godoy-Gallardo M., 2014, CLIN ORAL IMPLANTS R
   Godoy-Gallardo M, 2015, ACS APPL MATER INTER, V7, P5992, DOI 10.1021/acsami.5b00402
   Godoy-Gallardo M, 2015, BIOMACROMOLECULES, V16, P483, DOI 10.1021/bm501528x
   Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grivet M, 2000, J MATER SCI-MATER M, V11, P637, DOI 10.1023/A:1008913915399
   Gulati K, 2012, ACTA BIOMATER, V8, P449, DOI 10.1016/j.actbio.2011.09.004
   Han Y, 2006, THIN SOLID FILMS, V510, P175, DOI 10.1016/j.tsf.2005.11.048
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Howarter JA, 2006, LANGMUIR, V22, P11142, DOI 10.1021/la061240g
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Lian JB, 2003, CONNECT TISSUE RES, V44, P141, DOI 10.1080/03008200390152232
   Ma YB, 2012, ANTIMICROB AGENTS CH, V56, P5923, DOI 10.1128/AAC.01739-12
   Martin HJ, 2008, APPL SURF SCI, V254, P4599, DOI 10.1016/j.apsusc.2008.01.066
   Mayanagi G, 2005, INT C SER, V1284, P195
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Perinpanayagam H, 2006, ARCH ORAL BIOL, V51, P406, DOI 10.1016/j.archoralbio.2005.09.004
   Pham LC, 2009, ARCH ORAL BIOL, V54, P132, DOI 10.1016/j.archoralbio.2008.09.007
   Raines AL, 2010, BIOMATERIALS, V31, P4909, DOI 10.1016/j.biomaterials.2010.02.071
   RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85
   Sista S, 2013, MAT SCI ENG C-MATER, V33, P1573, DOI 10.1016/j.msec.2012.12.063
   Song YY, 2010, SURF SCI, V604, P346, DOI 10.1016/j.susc.2009.11.027
   Strevett KA, 2003, RES MICROBIOL, V154, P329, DOI 10.1016/S0923-2508(03)00038-X
   Subbiahdoss G, 2010, J BIOMED MATER RES A, V94A, P533, DOI 10.1002/jbm.a.32731
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Tan GX, 2011, THIN SOLID FILMS, V519, P4997, DOI 10.1016/j.tsf.2011.01.068
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Wang ZJ, 2014, DENT MATER, V30, pE1, DOI 10.1016/j.dental.2013.12.001
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411
   Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001
NR 42
TC 9
Z9 9
U1 1
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2016
VL 59
BP 524
EP 532
DI 10.1016/j.msec.2015.10.051
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA CZ4XW
UT WOS:000367107400063
PM 26652404
DA 2018-10-20
ER

PT J
AU Mihailescu, N
   Stan, GE
   Duta, L
   Chifiriuc, MC
   Bleotu, C
   Sopronyi, M
   Luculescu, C
   Oktar, FN
   Mihailescu, IN
AF Mihailescu, Natalia
   Stan, G. E.
   Duta, L.
   Chifiriuc, Mariana Carmen
   Bleotu, Coralia
   Sopronyi, M.
   Luculescu, C.
   Oktar, F. N.
   Mihailescu, I. N.
TI Structural, compositional, mechanical characterization and biological
   assessment of bovine-derived hydroxyapatite coatings reinforced with
   MgF2 or MgO for implants functionalization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bovine bone; Reinforced hydroxyapatite; Highly adherent coatings;
   Titanium; Pulsed laser deposition
ID PULSED-LASER DEPOSITION; THIN-FILMS; IN-VITRO; NANO-HYDROXYAPATITE;
   MAGNESIUM FLUORIDE; BONE-CEMENT; SOL-GEL; TITANIUM; SURFACE; CELLS
AB Hydroxyapatite (HA) is a consecrated biomaterial for bone reconstruction. In the form of thin films deposited by pulsed laser technologies, it can be used to cover metallic implants aiming to increase biocompatibility and osseointegration rate. HA of animal origin (bovine, BHA) reinforced with MgF2 (2 wt.%) or MgO (5 wt.%) were used for deposition of thin coatings with improved adherence, biocompatibility and antimicrobial activity. For pulsed laser deposition experiments, a KrF* (lambda = 248 nm, T-EWHM <= 25 ns) excimer laser source was used. The deposited structures were characterized from a physical-chemical point of view by X-Ray Diffraction, Fourier Transform Infra-Red Spectroscopy, Scanning Electron Microscopy in top- and cross-view modes, Energy Dispersive X-Ray Spectroscopy and Pull-out adherence tests. The microbiological assay using the HEp-2 cell line revealed that all target materials and deposited thin films are non-cytotoxic. We conducted tests on three strains isolated from patients with dental implants failure, i.e. Microccocus sp., Enterobacter sp. and Candida albi cans sp. The most significant anti-biofilm effect against Microcococcus sp. strain, at 72 h, was obtained in the presence of BHA:MgO thin films. For Enterobacter sp. strain a superior antimicrobial activity at 72 h was noticed, in respect with simple BHA or Ti control.
   The enhanced antimicrobial performances, correlated with good cytocompatibility and mechanical properties recommend these biomaterials as an alternative to synthetic HA for the fabrication of reliable implant coatings for dentistry and other applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mihailescu, Natalia; Duta, L.; Sopronyi, M.; Luculescu, C.; Mihailescu, I. N.] Natl Inst Lasers Plasma & Radiat Phys, RO-077125 Magurele, Romania.
   [Stan, G. E.] Natl Inst Mat Phys, RO-077125 Magurele, Romania.
   [Chifiriuc, Mariana Carmen] Fac Biol, Dept Microbiol, RO-060101 Bucharest, Romania.
   [Bleotu, Coralia] Stefan S Nicolau Inst Virol, RO-030304 Bucharest, Romania.
   [Oktar, F. N.] Marmara Univ, Dept Bioengn, Fac Engn, TR-34722 Istanbul, Turkey.
   [Oktar, F. N.] Marmara Univ, Adv Nanomat Res Lab, TR-34722 Istanbul, Turkey.
RP Mihailescu, IN (reprint author), Natl Inst Lasers Plasma & Radiat Phys, RO-077125 Magurele, Romania.
EM ion.mihailescu@inflpr.ro
RI Sopronyi, Mihai/P-4351-2014; Stan, George/B-5690-2011; Luculescu,
   Catalin/A-7999-2010; Chifiriuc, Mariana Carmen/F-9136-2016; MIHAILESCU
   (Serban), Natalia/C-5879-2011; Coralia, Bleotu/B-5976-2011; Duta, Liviu
   Marian/G-3417-2011
OI Sopronyi, Mihai/0000-0002-8877-9789; Stan, George/0000-0003-0289-8988;
   Luculescu, Catalin/0000-0001-6852-401X; Chifiriuc, Mariana
   Carmen/0000-0001-6098-1857; Coralia, Bleotu/0000-0002-9031-338X; Duta,
   Liviu Marian/0000-0002-6408-6056
FU UEFISCDI [19_RO-FR/2014]; NIMP Core Programme [PN4501-3]
FX NM, LD, MS and INM acknowledge with thanks UEFISCDI for the financial
   support of this work under the contract 19_RO-FR/2014; GES acknowledge
   with thanks the financial support of the NIMP Core Programme PN4501-3.
   All authors thank G. Soricila for the technical assistance in
   microbiological testing and C. Ristoscu for the useful discussions.
CR Alcoforado G A, 1991, J Parodontol, V10, P11
   Bollimuntha S, 2006, BRAIN RES, V1099, P141, DOI 10.1016/j.brainres.2006.04.104
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   Braissant O., 2014, J BIOMED MAT RES B
   Brook I, 2012, J BIOMATER APPL, V27, P291, DOI 10.1177/0885328211403020
   Brunette D. M., 2001, TITANIUM MED
   Cacciotti I, 2009, J EUR CERAM SOC, V29, P2969, DOI 10.1016/j.jeurceramsoc.2009.04.038
   Cai Y., 2013, ADV MATER SCI ENG, P55
   Cai YL, 2011, THIN SOLID FILMS, V519, P4629, DOI 10.1016/j.tsf.2011.01.007
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Carrado A, 2011, BIOMEDICAL ENGINEERING - FROM THEORY TO APPLICATIONS, P253
   Di Benedetto A, 2014, P NATL ACAD SCI USA, V111, P16502, DOI 10.1073/pnas.1419349111
   Dinda GP, 2009, ACTA BIOMATER, V5, P1821, DOI 10.1016/j.actbio.2009.01.027
   Duta L, 2013, OPTOELECTRON ADV MAT, V7, P1040
   Duta L, 2013, APPL SURF SCI, V265, P41, DOI 10.1016/j.apsusc.2012.10.077
   Eason R., 2007, PULSED LASER DEPOSIT
   Eichert D, 2007, BIOMATERIALS RES ADV, P93
   Ellingsen JE, 1995, J MATER SCI-MATER M, V6, P749, DOI 10.1007/BF00134312
   Erakovic S, 2014, APPL SURF SCI, V293, P37, DOI 10.1016/j.apsusc.2013.12.029
   Evis Z, 2008, MATER CHEM PHYS, V110, P68, DOI 10.1016/j.matchemphys.2008.01.009
   Ge X, 2010, J BIOMED MATER RES A, V95A, P588, DOI 10.1002/jbm.a.32862
   Grigorescu S, 2007, APPL SURF SCI, V254, P1150, DOI 10.1016/j.apsusc.2007.09.056
   Grumezescu AM, 2012, INT J PHARMACEUT, V436, P771, DOI 10.1016/j.ijpharm.2012.07.063
   Holban AM, 2014, VIRULENCE, V5, P303, DOI 10.4161/viru.27571
   Khalid M, 2013, J MATER SCI TECHNOL, V29, P557, DOI 10.1016/j.jmst.2013.02.003
   Khandaker M, 2013, J BIOMECH, V46, P1035, DOI 10.1016/j.jbiomech.2012.12.006
   KIM CS, 1991, BIOMATERIALS, V12, P461, DOI 10.1016/0142-9612(91)90143-X
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Lee JH, 2005, BIOMATERIALS, V26, P3249, DOI 10.1016/j.biomaterials.2004.08.033
   Lellouche J, 2012, INT J NANOMED, V7, P1175, DOI 10.2147/IJN.S26770
   Lellouche J, 2009, BIOMATERIALS, V30, P5969, DOI 10.1016/j.biomaterials.2009.07.037
   Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x
   Levingstone T., 2008, THESIS
   Ligot S, 2012, ACTA MATER, V60, P3435, DOI 10.1016/j.actamat.2012.02.024
   Limban C, 2008, MOLECULES, V13, P567, DOI 10.3390/molecules13030567
   Lu X, 2007, MATER LETT, V61, P3970, DOI 10.1016/j.matlet.2006.12.089
   Lutterotti L, 2010, NUCL INSTRUM METH B, V268, P334, DOI 10.1016/j.nimb.2009.09.053
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mihailescu I N, 1999, INT TRENDS OPTICS PH, P201
   Mohseni E, 2014, INT J ADHES ADHES, V48, P238, DOI 10.1016/j.ijadhadh.2013.09.030
   Nelea V., 2007, PULSED LASER DEPOSIT, P421
   Oktar FN, 2007, J MATER SCI-MATER M, V18, P2137, DOI 10.1007/s10856-007-3200-9
   Oshida Y, 2010, INT J MOL SCI, V11, P1580, DOI 10.3390/ijms11041580
   Ozyegin LS, 2004, MATER LETT, V58, P2605, DOI 10.1016/j.matlet.2004.03.033
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Perumal D, 2014, ONCOTARGET, V5, P10486, DOI 10.18632/oncotarget.2395
   Rey C, 2014, SPRING SER BIOMAT S, V2, P229, DOI 10.1007/978-3-642-53980-0_8
   Ricker A, 2008, INT J NANOMED, V3, P125
   Rosu T, 2006, MOLECULES, V11, P904, DOI 10.3390/11110904
   Roveri N., 2012, BIOMIMETIC APPROACHE
   Salman S, 2009, CERAM INT, V35, P2965, DOI 10.1016/j.ceramint.2009.04.004
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   Samit Kumar N., 2011, BIOMATERIALS APPL NA, P69
   Schmidlin PR, 2013, J APPL ORAL SCI, V21, P48, DOI 10.1590/1678-7757201302312
   Sima LE, 2010, J BIOMED MATER RES A, V95A, P1203, DOI 10.1002/jbm.a.32947
   Slosarczyk A., 2010, CERAM MAT, V62, P369
   Socol G, 2004, BIOMATERIALS, V25, P2539, DOI 10.1016/j.biomaterials.2003.09.044
   Stoica TF, 2008, THIN SOLID FILMS, V516, P8112, DOI 10.1016/j.tsf.2008.04.071
   Swartjes JJTM, 2015, CURR MED CHEM, V22, P2116, DOI 10.2174/0929867321666140916121355
   Talib R J, 2004, Med J Malaysia, V59 Suppl B, P153
   Tan CY, 2013, CERAM INT, V39, P8979, DOI 10.1016/j.ceramint.2013.04.098
   Thian ES, 2006, J BIOMED MATER RES B, V76B, P326, DOI 10.1002/jbm.b.30368
   Urbanelli L, 2011, BIOSCIENCE REP, V31, P477, DOI 10.1042/BSR20110020
   Vidic J, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1595-4
   Visan A, 2014, MATER SCI ENG B-ADV, V181, P56, DOI 10.1016/j.mseb.2013.11.007
   Vladescu A, 2014, J MECH BEHAV BIOMED, V40, P362, DOI 10.1016/j.jmbbm.2014.08.025
   Wang L, 2013, J BIOL CHEM, V288, P11887, DOI 10.1074/jbc.M112.425702
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Yang HH, 2010, TRANS ELECTR ELECTRO, V11, P33, DOI 10.4313/TEEM.2010.11.1.033
NR 69
TC 19
Z9 19
U1 3
U2 90
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2016
VL 59
BP 863
EP 874
DI 10.1016/j.msec.2015.10.078
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA CZ4XW
UT WOS:000367107400101
PM 26652442
DA 2018-10-20
ER

PT J
AU Ma, YH
   Bai, TC
   Wang, F
AF Ma, Yahui
   Bai, Tongchun
   Wang, Fei
TI The physical and chemical properties of the
   polyvinylalcohol/polyvinylpyrrolidone/hydroxyapatite composite hydrogel
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Polyvinylalcohol; Polyvinylpyrrolidone; Hydroxyapatite; Hydrogel;
   Storage modulus; Water content; Swelling kinetics; Dehydration kinetics
ID ARTICULAR-CARTILAGE REPLACEMENT; MECHANICAL-PROPERTIES;
   POLYVINYL-ALCOHOL; NANO-HYDROXYAPATITE; BEHAVIOR; BIOCOMPOSITES;
   BIOMATERIAL; ATTACHMENT; SCAFFOLDS; FRICTION
AB A hydrogel cif polyvinylalcohol (PVA)/polyvinylpyrrolidone (PVP)/hydroxyapatite (HA) was prepared by a repeated freezing and thawing technique. The effect of HA on the hydrogel was evaluated by comparing the physical and chemical properties of PVA/PVP/HA and PVA/PVP hydrogels. By using theoretical models, the information about the swelling kinetics and the dehydration kinetics have been obtained. From the analysis of structure, mechanical properties, and molecular interaction, the application of PVA/PVP/HA hydrogel as a biomaterial has been evaluated.
   Relative to PVA/PVP, the PVA/PVP/HA hydrogel is of denser network structure, lower water content, larger storage modulus, and higher dehydration activation energy. These results reveal that, as HA fills in the hydrogel, the molecular interaction is enhanced, the free space of network is compressed, and the diffusion activation energy of water is increased. In spite of its water content being decreased, it is still in the range of meeting the requirement of bio-application. When the hydrogel is subjected to external forces, the matrix will transfer the load to the HA powder, thus enhance the strength of the hydrogel. For application in bio-materials, HA will still have osteoinductivity because its crystalline structure is not interrupted in PVA/PVP/HA hydrogel environment. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ma, Yahui; Bai, Tongchun; Wang, Fei] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
RP Bai, TC (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
EM tcbai@suda.edu.cn
RI bagheri, amir/C-3274-2017
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions
FX This project was funded by the Priority Academic Program Development of
   Jiangsu Higher Education Institutions.
CR Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Du MC, 2011, J MATER CHEM, V21, P2228, DOI 10.1039/c0jm02869j
   Elashmawi IS, 2012, CURR APPL PHYS, V12, P141, DOI 10.1016/j.cap.2011.05.011
   Ganji F., 2010, IRAN POLYM J, V119, P375
   Gonzalez JS, 2014, J MECH BEHAV BIOMED, V34, P47, DOI 10.1016/j.jmbbm.2014.01.019
   Han J, 2010, INT J BIOL MACROMOL, V46, P199, DOI 10.1016/j.ijbiomac.2009.11.004
   Huang X, 2009, MATER RES INNOV, V13, P98, DOI 10.1179/143307509X435187
   Katta JK, 2007, J BIOMED MATER RES A, V83A, P471, DOI 10.1002/jbm.a.31238
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kucerik J, 2011, THERMOCHIM ACTA, V523, P245, DOI 10.1016/j.tca.2011.04.034
   Liu LM, 2013, CARBOHYD POLYM, V97, P152, DOI 10.1016/j.carbpol.2013.04.043
   Liu YR, 2010, J MECH BEHAV BIOMED, V3, P203, DOI 10.1016/j.jmbbm.2009.07.001
   Ma RY, 2009, MAT SCI ENG C-MATER, V29, P1979, DOI 10.1016/j.msec.2009.03.010
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   NISHIO Y, 1990, J POLYM SCI POL PHYS, V28, P355, DOI 10.1002/polb.1990.090280308
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Oka M, 2001, J Orthop Sci, V6, P448, DOI 10.1007/s007760170014
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   Pereira DR, 2013, J TISSUE ENG REGEN M, V7, P85, DOI 10.1002/term.500
   Rawal B. R., 2013, J MED SCI, V13, P615, DOI [10.3923/jms.2013.615.620, DOI 10.3923/JMS.2013.615.620]
   Maiolo AS, 2012, MAT SCI ENG C-MATER, V32, P1490, DOI 10.1016/j.msec.2012.04.030
   Shi Y, 2013, WEAR, V305, P280, DOI 10.1016/j.wear.2012.12.020
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Spiller K.L, 2008, ACTA BIOMATER, P17
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Toth K, 2010, THERMOCHIM ACTA, V506, P94, DOI 10.1016/j.tca.2010.04.027
   Turco G, 2009, BIOMACROMOLECULES, V10, P1575, DOI 10.1021/bm900154b
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   Wu G, 2008, MATER CHEM PHYS, V107, P364, DOI 10.1016/j.matchemphys.2007.07.028
   Wu SC, 2011, MATER CHARACT, V62, P526, DOI 10.1016/j.matchar.2011.03.014
   Zhou CC, 2013, BIOMATER SCI-UK, V1, P1012, DOI 10.1039/c3bm60058k
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 42
TC 10
Z9 10
U1 4
U2 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2016
VL 59
BP 948
EP 957
DI 10.1016/j.msec.2015.10.081
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA CZ4XW
UT WOS:000367107400111
PM 26652452
DA 2018-10-20
ER

PT J
AU Yin, NN
   Han, YM
   Xu, HL
   Gao, YS
   Yi, T
   Yao, JL
   Dong, L
   Cheng, DJ
   Chen, ZB
AF Yin, Nina
   Han, Yongming
   Xu, Hanlin
   Gao, Yisen
   Yi, Tao
   Yao, Jiale
   Dong, Li
   Cheng, Dejun
   Chen, Zebin
TI VEGF-conjugated alginate hydrogel prompt angiogenesis and improve
   pancreatic islet engraftment and function in type 1 diabetes
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE VEGF; Alginate; Biomaterials; Angiogenesis; Islet transplantation; Type
   I diabetes
ID ENDOTHELIAL GROWTH-FACTOR; PORCINE ISLETS; TRANSPLANTATION; CELLS; MICE;
   BIOCOMPATIBILITY; MICROCAPSULES; MICROBEADS; RELEASE
AB Type 1 diabetes was a life-long disease that affected numerous people around the world. Insulin therapy has its limitations that may involve hyperglycemia and heavy burden of patient by repeated dose. Islet transplantation emerged as a promising approach to reach periodical reverse of diabetes, however, transplanted islets suffer from foreign body reaction and lack of nutrition and oxygen supply, especially in the blood-vessel-shortage subcutaneous site which was preferred by patient and surgeon. In this study, we designed and synthesized a vascular endothelial growth factor (VEGF) conjugated alginate material to encapsulate the transplanted islets via 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction, and successful conjugation was confirmed by Nuclear Magnetic Resonance H1 spectrum. The best VEGF concentration (100 ng/ml) was determined by the combined studies of the mechanical property and endothelial cell growth assay. In vivo study, conjugated VEGF on alginate exhibited sustained promoting angiogenesis property after subcutaneous transplantation by histology study and islets encapsulated in this material achieved long term therapeutic effect (up to 50 days) in the diabetic mice model. In conclusion, this study establishes a simple biomaterial strategy for islet transplantation to enhance islet survival and function, which could be a feasible therapeutic alternative for type 1 diabetes. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Yin, Nina; Han, Yongming] Hubei Univ Chinese Med, Basic Med Coll, Dept Anat, Wuhan, Hubei, Peoples R China.
   [Xu, Hanlin] Hubei Univ Chinese Med, Fac Pharm, Wuhan, Hubei, Peoples R China.
   [Gao, Yisen; Yi, Tao] Hubei Univ Chinese Med, Acupuncture & Moxibust Coll, Wuhan, Hubei, Peoples R China.
   [Yao, Jiale; Dong, Li; Cheng, Dejun] Hubei Univ Chinese Med, Basic Med Coll, Wuhan, Hubei, Peoples R China.
   [Chen, Zebin] Hubei Univ Chinese Med, Acupuncture & Moxibust Coll, Hubei Prov Collaborat Innovat Ctr Prevent Treatme, Wuhan, Hubei, Peoples R China.
RP Chen, ZB (reprint author), Hubei Univ Chinese Med, Acupuncture & Moxibust Coll, Hubei Prov Collaborat Innovat Ctr Prevent Treatme, Wuhan, Hubei, Peoples R China.
EM chenzebin-hbtcm@outlook.com
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Balyura M, 2015, P NATL ACAD SCI USA, V112, P2527, DOI 10.1073/pnas.1500242112
   Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0
   Cheng Y, 2007, WORLD J GASTROENTERO, V13, P2862
   Cornish W, 2014, CAN J DIABETES, V38, P94, DOI 10.1016/j.jcjd.2014.01.002
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   Souza Yngrid Ellyn Dias Maciel de, 2011, Arq. Gastroenterol., V48, P146, DOI 10.1590/S0004-28032011000200011
   Emerich DF, 1996, CELL TRANSPLANT, V5, P589, DOI 10.1016/0963-6897(96)00086-3
   Figliuzzi M, 2006, ACTA BIOMATER, V2, P221, DOI 10.1016/j.actbio.2005.12.002
   Hunt NC, 2013, TISSUE ENG PT A, V19, P905, DOI [10.1089/ten.TEA.2012.0197, 10.1089/ten.tea.2012.0197]
   Johansson A, 2009, TRANSPL INT, V22, P1182, DOI 10.1111/j.1432-2277.2009.00939.x
   Lai HJ, 2014, ACTA BIOMATER, V10, P4156, DOI 10.1016/j.actbio.2014.05.001
   Li WJ, 2014, J DIABETES RES, DOI 10.1155/2014/192093
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Moya ML, 2010, J SURG RES, V160, P208, DOI 10.1016/j.jss.2009.06.003
   Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009
   O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8
   Socarras TO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110945
   Pascual M, 2013, J SURG RES, V183, P270, DOI 10.1016/j.jss.2012.12.041
   Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211
   Phelps EA, 2015, DRUG DELIV TRANSL RE, V5, P125, DOI 10.1007/s13346-013-0142-2
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Rayat GR, 2000, TRANSPLANTATION, V69, P1084, DOI 10.1097/00007890-200003270-00011
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Veriter S, 2010, TISSUE ENG PT A, V16, P1503, DOI [10.1089/ten.tea.2009.0286, 10.1089/ten.TEA.2009.0286]
   Watada H, 2010, ENDOCR J, V57, P185, DOI 10.1507/endocrj.K09E-035
   Wen JP, 2006, J GENE MED, V8, P362, DOI 10.1002/jgm.852
   Yang HK, 2015, J DIABETES COMPLICAT, V29, P737, DOI 10.1016/j.jdiacomp.2015.03.017
   Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049
NR 31
TC 10
Z9 10
U1 4
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2016
VL 59
BP 958
EP 964
DI 10.1016/j.msec.2015.11.009
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA CZ4XW
UT WOS:000367107400112
PM 26652453
DA 2018-10-20
ER

PT J
AU Ungureanu, C
   Dumitriu, C
   Popescu, S
   Enculescu, M
   Tofan, V
   Popescu, M
   Pirvu, C
AF Ungureanu, Camelia
   Dumitriu, Cristina
   Popescu, Simona
   Enculescu, Monica
   Tofan, Vlad
   Popescu, Marian
   Pirvu, Cristian
TI Enhancing antimicrobial activity of TiO2/Ti by torularhodin bioinspired
   surface modification
SO BIOELECTROCHEMISTRY
LA English
DT Article
DE Torularhodin; Carotenoid pigment; Bioinspired surface modification;
   Polydopamine; Antimicrobial activity
ID TITANIUM-DIOXIDE; BIOFILM FORMATION; FREE-ENERGY; NANOTUBES; FILMS;
   INFECTIONS; HEMOCOMPATIBILITY; BIOCOMPATIBILITY; MICROSTRUCTURE;
   POLY(DOPAMINE)
AB Implant-associated infections are a major cause of morbidity and mortality. This study was performed using titanium,samples coated by anodization with a titanium dioxide (TiO2) shielded nanotube layer. TiO2/Ti surface was modified by simple immersion in torularhodin solution and by using a mussel-inspired method based on polydopamine as bio adhesive for torularhodin immobilization. SEM analysis revealed tubular microstructures of torularhodin and the PDA ability to function as a catchy anchor between torularhodin and TiO2 surface. Corrosion resistance was associated with TiO2 barrier oxide layer and nano-organized oxide layer and the torularhodin surface modification does not bring significant changes in resistance of the oxide layer. Our results demonstrated that the torularhodin modified TiO2/Ti surface could effectively prevent adhesion and proliferation of Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Bacillus subtilis, and Pseudomonas aeruginosa. The new modified titanium surface showed good biocompatibility and well-behaved haemocompatibility. This biomaterial with enhanced antimicrobial activity holds great potential for future biomedical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ungureanu, Camelia; Dumitriu, Cristina; Popescu, Simona; Pirvu, Cristian] Univ Politehn Bucuresti, Bucharest 060042, Romania.
   [Enculescu, Monica] Natl Inst Mat Phys, Bucharest 77125, Romania.
   [Tofan, Vlad] Cantacuzino Natl Inst Res Dev Microbiol & Immunol, Bucharest 050096, Romania.
   [Popescu, Marian] Natl Inst Res & Dev Microtechnol, Bucharest 077190, Romania.
RP Pirvu, C (reprint author), Univ Politehn Bucuresti, 313 Splaiul Independentei,Sect 6, Bucharest 060042, Romania.
EM c_pirvu@chim.pub.ro
RI 崔, 大鹏/O-6295-2015; Enculescu, Monica/C-2091-2011; bagheri,
   amir/C-3274-2017
OI Enculescu, Monica/0000-0002-4476-5545; Pirvu,
   Cristian/0000-0003-0339-6146
FU CNCS - UEFISCDI [PN2-253/2014 - NANOCOAT]; Romanian National Authority
   for Scientific Research [PN 45 N]
FX This work was supported by a project of CNCS - UEFISCDI, PN2-253/2014 -
   NANOCOAT.; For EDX analysis, M. Enculescu acknowledges the support of
   the Romanian National Authority for Scientific Research by Nucleu
   Project. No. PN 45 N.
CR Ahmed G.F., 2014, J INFECT PUBLIC HEAL, P436
   [Anonymous], 2004, F75600 ASTM
   Barbinta-Patrascu ME, 2014, J MATER CHEM B, V2, P3221, DOI 10.1039/c4tb00262h
   Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, pXII
   Bernard SA, 2011, ACTA BIOMATER, V7, P1902, DOI 10.1016/j.actbio.2011.01.004
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Boo HO, 2012, IND CROP PROD, V40, P129, DOI 10.1016/j.indcrop.2012.02.042
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Cucco M, 2007, COMP BIOCHEM PHYS A, V147, P1038, DOI 10.1016/j.cbpa.2007.03.014
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Demetrescu I, 2010, BIOELECTROCHEMISTRY, V79, P122, DOI 10.1016/j.bioelechem.2010.02.001
   Dimitrijevic NM, 2003, J PHYS CHEM B, V107, P7368, DOI 10.1021/jp034064i
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b
   Dumitriu C, 2013, J ELECTROCHEM SOC, V160, pG55, DOI 10.1149/2.035302jes
   Dumitriu C, 2015, APPL SURF SCI, V341, P157, DOI 10.1016/j.apsusc.2015.02.183
   Fang F.C., 2011, MBIO, V2
   Frengova GI, 2009, J IND MICROBIOL BIOT, V36, P163, DOI 10.1007/s10295-008-0492-9
   Geiseler B, 2012, J NANOMATER, DOI 10.1155/2012/708519
   Goldmann AS, 2010, MACROMOL RAPID COMM, V31, P1608, DOI 10.1002/marc.201000193
   Han V, 2010, VOX SANG, V98, P116, DOI 10.1111/j.1423-0410.2009.01249.x
   Hochmannova L, 2010, PROG ORG COAT, V67, P1, DOI 10.1016/j.porgcoat.2009.09.016
   IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668
   Jacoby WA, 1998, ENVIRON SCI TECHNOL, V32, P2650, DOI 10.1021/es980036f
   Jing-zhong Z., 2015, CERAM INT, V41, P7235
   Jorgensen J. H., 2007, SUSCEPTIBILITY TEST
   Konovalova TA, 1999, J PHYS CHEM B, V103, P4672, DOI 10.1021/jp9900638
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee KE, 2010, LANGMUIR, V26, P9575, DOI 10.1021/la100137u
   Lee K, 2014, CHEM REV, V114, P9385, DOI 10.1021/cr500061m
   Lilja M, 2012, BIOTECHNOL LETT, V34, P2299, DOI 10.1007/s10529-012-1040-2
   Luo J, 2013, J PHYS CHEM C, V117, P18448, DOI 10.1021/jp405171w
   Ma MH, 2012, J BIOMED MATER RES A, V100A, P278, DOI 10.1002/jbm.a.33251
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   Mazare A, 2014, SURF COAT TECH, V252, P87, DOI 10.1016/j.surfcoat.2014.04.049
   Mindroiu M, 2010, ELECTROCHIM ACTA, V56, P193, DOI 10.1016/j.electacta.2010.08.100
   Mohan CC, 2013, ACTA BIOMATER, V9, P9568, DOI 10.1016/j.actbio.2013.08.023
   Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a
   Niculescu VC, 2012, J ORGANOMET CHEM, V700, P13, DOI 10.1016/j.jorganchem.2011.10.036
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Pirvu C, 2011, ELECTROCHIM ACTA, V56, P9893, DOI 10.1016/j.electacta.2011.08.061
   Popescu S, 2014, PROG ORG COAT, V77, P1890, DOI 10.1016/j.porgcoat.2014.06.023
   Portan DV, 2012, J BIOMED MATER RES A, V100A, P2546, DOI 10.1002/jbm.a.34188
   Raines AL, 2010, BIOMATERIALS, V31, P4909, DOI 10.1016/j.biomaterials.2010.02.071
   Roy SC, 2007, BIOMATERIALS, V28, P4667, DOI 10.1016/j.biomaterials.2007.07.045
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   SIMMONS BP, 1995, DIAGN MICR INFEC DIS, V22, P155, DOI 10.1016/0732-8893(95)00080-T
   Soare LC, 2012, NOT BOT HORTI AGROBO, V40, P53
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sun YH, 2013, COLLOID SURFACE B, V111, P107, DOI 10.1016/j.colsurfb.2013.05.037
   Ungureanu C, 2012, ADV SCI LETT, V5, P1, DOI [10.1166/asl.2012.4403, DOI 10.1166/ASL.2012.4403]
   Ungureanu C, 2014, MAT SCI ENG C-MATER, V42, P726, DOI 10.1016/j.msec.2014.06.020
   Ungureanu C, 2013, BIORESOURCE TECHNOL, V132, P406, DOI 10.1016/j.biortech.2012.11.105
   Walsh FM, 2004, CURR OPIN MICROBIOL, V7, P439, DOI 10.1016/j.mib.2004.08.007
   Wang Y, 2014, J BIOMED MATER RES A, V102, P743, DOI 10.1002/jbm.a.34738
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
   Zhang F, 2013, J PHYS CHEM C, V117, P14659, DOI 10.1021/jp404439p
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 65
TC 12
Z9 13
U1 3
U2 141
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1567-5394
EI 1521-186X
J9 BIOELECTROCHEMISTRY
JI Bioelectrochemistry
PD FEB
PY 2016
VL 107
BP 14
EP 24
DI 10.1016/j.bioelechem.2015.09.001
PG 11
WC Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Biophysics; Electrochemistry
GA CX0CD
UT WOS:000365363600003
PM 26414412
DA 2018-10-20
ER

PT J
AU Ozboyaci, M
   Kokh, DB
   Corni, S
   Wade, RC
AF Ozboyaci, Musa
   Kokh, Daria B.
   Corni, Stefano
   Wade, Rebecca C.
TI Modeling and simulation of protein-surface interactions: achievements
   and challenges
SO QUARTERLY REVIEWS OF BIOPHYSICS
LA English
DT Review
DE Biomolecular adsorption; protein-solid state interactions; bio-inorganic
   interface; molecular simulation; molecular modeling
ID MOLECULAR-DYNAMICS SIMULATION; SELF-ASSEMBLED MONOLAYERS;
   DENSITY-FUNCTIONAL THEORY; FREE-ENERGY CALCULATIONS; ADSORPTION
   FREE-ENERGY; CHARGED SOLID-SURFACE; BONE MORPHOGENETIC PROTEIN-2; WHITE
   LYSOZYME ADSORPTION; ATOMIC-FORCE MICROSCOPY; IMPLICIT SOLVENT MODELS
AB Understanding protein-inorganic surface interactions is central to the rational design of new tools in biomaterial sciences, nano-biotechnology and nanomedicine. Although a significant amount of experimental research on protein adsorption onto solid substrates has been reported, many aspects of the recognition and interaction mechanisms of biomolecules and inorganic surfaces are still unclear. Theoretical modeling and simulations provide complementary approaches for experimental studies, and they have been applied for exploring protein-surface binding mechanisms, the determinants of binding specificity towards different surfaces, as well as the thermodynamics and kinetics of adsorption. Although the general computational approaches employed to study the dynamics of proteins and materials are similar, the models and force-fields (FFs) used for describing the physical properties and interactions of material surfaces and biological molecules differ. In particular, FF and water models designed for use in biomolecular simulations are often not directly transferable to surface simulations and vice versa. The adsorption events span a wide range of time- and length-scales that vary from nanoseconds to days, and from nanometers to micrometers, respectively, rendering the use of multi-scale approaches unavoidable. Further, changes in the atomic structure of material surfaces that can lead to surface reconstruction, and in the structure of proteins that can result in complete denaturation of the adsorbed molecules, can create many intermediate structural and energetic states that complicate sampling. In this review, we address the challenges posed to theoretical and computational methods in achieving accurate descriptions of the physical, chemical and mechanical properties of protein-surface systems. In this context, we discuss the applicability of different modeling and simulation techniques ranging from quantum mechanics through all atom molecular mechanics to coarse grained approaches. We examine uses of different sampling methods, as well as free energy calculations. Furthermore, we review computational studies of protein-surface interactions and discuss the successes and limitations of current approaches.
C1 [Ozboyaci, Musa; Kokh, Daria B.; Wade, Rebecca C.] HITS, Schloss Wolfsbrunnenweg 35, D-69118 Heidelberg, Germany.
   [Ozboyaci, Musa] Heidelberg Univ, Heidelberg Grad Sch Math & Computat Methods Sci H, Neuenheimer Feld 368, D-69120 Heidelberg, Germany.
   [Corni, Stefano] CNR Inst Nanosci, Ctr S3, Via Campi 213-A, I-41125 Modena, Italy.
   [Wade, Rebecca C.] Heidelberg Univ, DKFZ ZMBH Allianz, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.
   [Wade, Rebecca C.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, D-69120 Heidelberg, Germany.
RP Ozboyaci, M; Wade, RC (reprint author), HITS, Schloss Wolfsbrunnenweg 35, D-69118 Heidelberg, Germany.; Ozboyaci, M (reprint author), Heidelberg Univ, Heidelberg Grad Sch Math & Computat Methods Sci H, Neuenheimer Feld 368, D-69120 Heidelberg, Germany.; Wade, RC (reprint author), Heidelberg Univ, DKFZ ZMBH Allianz, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.; Wade, RC (reprint author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, D-69120 Heidelberg, Germany.
EM musa.oezboyaci@h-its.org; rebecca.wade@h-its.org
RI bagheri, amir/C-3274-2017
OI Wade, Rebecca/0000-0001-5951-8670; Corni, Stefano/0000-0001-6707-108X
FU Heidelberg Graduate School of Mathematical and Computational Methods for
   the Sciences (HGS MathComp), Heidelberg University; MIUR through PRIN
   [2012A7LMS3003]; Klaus Tschira Foundation
FX M. O. acknowledges the support of Heidelberg Graduate School of
   Mathematical and Computational Methods for the Sciences (HGS MathComp),
   Heidelberg University. S. C. acknowledges funding from MIUR through PRIN
   2012A7LMS3003. Our work is supported by the Klaus Tschira Foundation.
CR Aarts IMP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.166104
   Adnan A, 2011, MOL PHARMACEUT, V8, P368, DOI 10.1021/mp1002398
   Akdim B, 2013, ACS APPL MATER INTER, V5, P7470, DOI 10.1021/am401731c
   Al-Mekhnaqi AM, 2009, MOL SIMULAT, V35, P292, DOI 10.1080/08927020802468364
   Alava T, 2013, ANAL CHEM, V85, P2754, DOI 10.1021/ac303268z
   Alessandrini A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1896087
   Aliaga AE, 2011, J PHYS CHEM C, V115, P3982, DOI 10.1021/jp1107153
   ALLISON SA, 1986, BIOPHYS J, V49, P167, DOI 10.1016/S0006-3495(86)83632-3
   Alvarez-Paggi D, 2013, J AM CHEM SOC, V135, P4389, DOI 10.1021/ja311786b
   Alvarez-Paggi D, 2010, J AM CHEM SOC, V132, P5769, DOI 10.1021/ja910707r
   Anand G, 2009, LANGMUIR, V25, P4998, DOI 10.1021/la803771d
   Andolfi L, 2004, J ELECTROANAL CHEM, V565, P21, DOI 10.1016/j.jelechem.2003.09.038
   Andreescu S., 2012, FINE PARTICLES MED P, P57
   Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162
   Ansari SA, 2012, BIOTECHNOL ADV, V30, P512, DOI 10.1016/j.biotechadv.2011.09.005
   Apicella A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058794
   Arrouvel C, 2007, J PHYS CHEM C, V111, P18164, DOI 10.1021/jp0741408
   Austin BM, 2012, CHEM REV, V112, P263, DOI 10.1021/cr2001564
   Baier J, 2014, CRYSTENGCOMM, V16, P5301, DOI 10.1039/c4ce00520a
   Balamurugan K, 2010, J PHYS CHEM B, V114, P14048, DOI 10.1021/jp106177n
   Bandura AV, 2003, J PHYS CHEM B, V107, P11072, DOI 10.1021/jp034093t
   BARABINO G, 1984, CHEM PHYS LETT, V104, P478, DOI 10.1016/0009-2614(84)85626-2
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Bellucci L, 2012, ACS SYM SER, V1120, P229
   Bellucci L, 2014, J PHYS CHEM C, V118, P11357, DOI 10.1021/jp502494k
   Bhirde AA, 2014, J PHYS CHEM C, V118, P16199, DOI 10.1021/jp5034068
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Biswas PK, 2012, J COMPUT CHEM, V33, P1458, DOI 10.1002/jcc.22979
   Bizzarri AR, 2006, BIOPHYS CHEM, V122, P206, DOI 10.1016/j.bpc.2006.03.012
   Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305
   Borodin O, 2003, MACROMOLECULES, V36, P7873, DOI 10.1021/ma0346005
   Boughton AP, 2010, LANGMUIR, V26, P16031, DOI 10.1021/la1024394
   Brancolini G, 2015, ACS NANO, V9, P2600, DOI 10.1021/nn506161j
   Brancolini G, 2014, NANOSCALE, V6, P7903, DOI 10.1039/c4nr01514b
   Brancolini G, 2012, ACS NANO, V6, P9863, DOI 10.1021/nn303444b
   Braun R, 2002, J BIOMAT SCI-POLYM E, V13, P747, DOI 10.1163/156856202760197384
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Buimaga-Iarinca L, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/03/035707
   Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601
   Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w
   Butenuth A, 2012, PHYS STATUS SOLIDI B, V249, P292, DOI 10.1002/pssb.201100786
   Calzolai L, 2010, NANO LETT, V10, P3101, DOI 10.1021/nl101746v
   Calzolari A, 2010, J AM CHEM SOC, V132, P4790, DOI 10.1021/ja909823n
   Camden AN, 2013, J PHYS CHEM B, V117, P10691, DOI 10.1021/jp403505y
   Cardone A, 2013, J PHYS CHEM B, V117, P12360, DOI 10.1021/jp4050594
   Carravetta V, 2006, J PHYS CHEM B, V110, P6160, DOI 10.1021/jp056760j
   Carravetta V, 2009, THEOR CHEM ACC, V123, P299, DOI 10.1007/s00214-009-0513-4
   Carrillo-Parramon O, 2013, BIONANOSCIENCE, V3, P12, DOI 10.1007/s12668-012-0073-2
   Casals E., 2008, CONTRIBUTIONS SCI, V4, P171
   Castells V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031912
   Chaki NK, 2002, BIOSENS BIOELECTRON, V17, P1, DOI 10.1016/S0956-5663(01)00277-9
   Chen HB, 2009, LANGMUIR, V25, P1588, DOI 10.1021/la8030304
   Chen Q, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3148025
   Chen Y, 2012, ACS NANO, V6, P8847, DOI 10.1021/nn3027408
   Chiu CC, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3276915
   Choi JW, 2009, BIOCHIP J, V3, P157
   Ciacchi LC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196101
   Cicero G, 2011, J PHYS CHEM LETT, V2, P2582, DOI 10.1021/jz200989n
   Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693
   Cohavi O, 2011, CHEM-EUR J, V17, P1327, DOI 10.1002/chem.201001781
   Cohavi O, 2010, J MOL RECOGNIT, V23, P259, DOI 10.1002/jmr.993
   Cole DJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799196
   Collier G, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0024-z
   Coppage R, 2013, J AM CHEM SOC, V135, P11048, DOI 10.1021/ja402215t
   Coppage R, 2011, J AM CHEM SOC, V133, P12346, DOI 10.1021/ja203726n
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Corni S, 2013, J PHYS CHEM C, V117, P16990, DOI 10.1021/jp404057h
   Costa D, 2013, J BIOMED MATER RES A, V101, P1210, DOI 10.1002/jbm.a.34416
   Cruz-Chu ER, 2006, J PHYS CHEM B, V110, P21497, DOI 10.1021/jp063896o
   Cygan RT, 2004, J PHYS CHEM B, V108, P1255, DOI 10.1021/jp0363287
   DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106
   de Leeuw NH, 2010, J MATER CHEM, V20, P5376, DOI 10.1039/b921400c
   Demann Eric T K, 2005, J Long Term Eff Med Implants, V15, P687
   Di Felice R, 2004, J CHEM PHYS, V120, P4906, DOI 10.1063/1.1645789
   Di Felice R, 2003, J PHYS CHEM B, V107, P1151, DOI 10.1021/jp0272421
   Di Felice R, 2011, J PHYS CHEM LETT, V2, P1510, DOI 10.1021/jz200297k
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Ding F, 2013, NANOSCALE, V5, P9162, DOI 10.1039/c3nr02147e
   Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Dufort S, 2012, ADV DRUG DELIVER REV, V64, P179, DOI 10.1016/j.addr.2011.09.009
   Durdagi S, 2008, BIOORGAN MED CHEM, V16, P9957, DOI 10.1016/j.bmc.2008.10.039
   Emami FS, 2014, CHEM MATER, V26, P5725, DOI 10.1021/cm5026987
   Emami FS, 2014, CHEM MATER, V26, P2647, DOI 10.1021/cm500365c
   Eralp T, 2011, SURF SCI, V605, P468, DOI 10.1016/j.susc.2010.12.001
   Euston SR, 2008, BIOMACROMOLECULES, V9, P1443, DOI 10.1021/bm701227g
   Euston SR, 2005, LANGMUIR, V21, P4227, DOI 10.1021/la046977p
   Evers CHJ, 2012, LANGMUIR, V28, P11852, DOI 10.1021/la300892p
   Fajin JLC, 2013, LANGMUIR, V29, P8856, DOI 10.1021/la401057f
   Feng J, 2011, SOFT MATTER, V7, P2113, DOI 10.1039/c0sm01118e
   Fenoglio I, 2011, ADV DRUG DELIVER REV, V63, P1186, DOI 10.1016/j.addr.2011.08.001
   FINNIS MW, 1991, SURF SCI, V241, P61, DOI 10.1016/0039-6028(91)90212-B
   Folliet N, 2013, J PHYS CHEM C, V117, P4104, DOI 10.1021/jp312195a
   Freeman CL, 2007, J PHYS CHEM C, V111, P11943, DOI 10.1021/jp071887p
   Freeman CL, 2011, J PHYS CHEM C, V115, P8175, DOI 10.1021/jp200145m
   Freeman CL, 2010, ANGEW CHEM INT EDIT, V49, P5135, DOI 10.1002/anie.201000679
   Freeman CL, 2009, J PHYS CHEM C, V113, P3666, DOI 10.1021/jp807051u
   Frenkel D., 2001, UNDERSTANDING MOL SI
   Friddle RW, 2011, ANGEW CHEM INT EDIT, V50, P7541, DOI 10.1002/anie.201100181
   Friedrichs W, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4883555
   Friedrichs W, 2013, SURF SCI, V617, P42, DOI 10.1016/j.susc.2013.07.010
   Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510
   Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1
   Gagner JE, 2012, J PHYS CHEM LETT, V3, P3149, DOI 10.1021/jz301253s
   Gagner JE, 2011, BIOMATERIALS, V32, P7241, DOI 10.1016/j.biomaterials.2011.05.091
   de la Torre JG, 2009, J CHEM THEORY COMPUT, V5, P2606, DOI 10.1021/ct900269n
   Garland A, 2012, PROG SURF SCI, V87, P1, DOI 10.1016/j.progsurf.2012.02.001
   Ghiringhelli LM, 2008, J AM CHEM SOC, V130, P13460, DOI 10.1021/ja804350v
   Ghiringhelli LM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035437
   Ghosh S, 2012, J PHYS CHEM B, V116, P1155, DOI 10.1021/jp2094752
   GIBBS D, 1990, PHYS REV B, V42, P7330, DOI 10.1103/PhysRevB.42.7330
   Gooding JJ, 2003, ELECTROANAL, V15, P81, DOI 10.1002/elan.200390017
   Gorba C, 2003, SOFT MATER, V1, P187, DOI 10.1081/SMTS-120021736
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Griepernau B., 2008, COMPUTATIONAL BIOPHY, P223
   Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078
   Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344
   Guldi DM, 2006, CHEM SOC REV, V35, P471, DOI 10.1039/b511541h
   Guo JJ, 2014, RSC ADV, V4, P9953, DOI 10.1039/c3ra45876h
   Hagiwara T, 2009, LANGMUIR, V25, P226, DOI 10.1021/la8024149
   Hahm JI, 2014, LANGMUIR, V30, P9891, DOI 10.1021/la404481t
   Halgren TA, 2001, CURR OPIN STRUC BIOL, V11, P236, DOI 10.1016/S0959-440X(00)00196-2
   Hamdi M, 2008, MICROELECTRON J, V39, P190, DOI 10.1016/j.mejo.2006.12.003
   Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6
   Hansmann UHE, 1999, CURR OPIN STRUC BIOL, V9, P177, DOI 10.1016/S0959-440X(99)80025-6
   Hassan SA, 2011, J PHYS CHEM B, V115, P14668, DOI 10.1021/jp208184e
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Heinz H, 2008, J PHYS CHEM C, V112, P17281, DOI 10.1021/jp801931d
   Heinz H, 2013, LANGMUIR, V29, P1754, DOI 10.1021/la3038846
   Heinz H, 2011, J R SOC INTERFACE, V8, P220, DOI 10.1098/rsif.2010.0318
   Heinz H, 2009, J AM CHEM SOC, V131, P9704, DOI 10.1021/ja900531f
   Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6
   Hill HD, 2007, ANAL CHEM, V79, P9218, DOI 10.1021/ac701626y
   Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020925
   Hoefling M, 2010, CHEMPHYSCHEM, V11, P1763, DOI 10.1002/cphc.200900990
   Hoefling M, 2010, LANGMUIR, V26, P8347, DOI 10.1021/la904765u
   Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   Holthaus SG, 2012, J CHEM THEORY COMPUT, V8, P4517, DOI 10.1021/ct3007106
   Hong GY, 2009, ACS APPL MATER INTER, V1, P388, DOI 10.1021/am800099z
   Horbett T. A., 1995, PROTEINS INTERFACES
   Horinek D, 2008, LANGMUIR, V24, P1271, DOI 10.1021/la702485r
   Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a
   Hsu HJ, 2008, COLLOID SURFACE B, V67, P183, DOI 10.1016/j.colsurfb.2008.08.017
   Hu Y, 2005, LANGMUIR, V21, P9103, DOI 10.1021/la046857h
   Huang LL, 2014, LANGMUIR, V30, P14832, DOI 10.1021/la5037426
   Huang XH, 2007, J PHYS CHEM B, V111, P5405, DOI 10.1021/jp068826w
   Hughes ZE, 2014, NANOSCALE, V6, P5438, DOI 10.1039/c4nr00468j
   Hung A, 2011, J AM CHEM SOC, V133, P1438, DOI 10.1021/ja108285u
   Imamura K, 2003, J COLLOID INTERF SCI, V267, P294, DOI 10.1016/S0021-9797(03)00700-8
   Imamura K, 2007, J BIOSCI BIOENG, V103, P7, DOI 10.1263/jbb.103.7
   Iori F, 2008, J COMPUT CHEM, V29, P1656, DOI 10.1002/jcc.20928
   Iori F, 2009, J COMPUT CHEM, V30, P1465, DOI 10.1002/jcc.21165
   Iori F, 2008, J PHYS CHEM C, V112, P13540, DOI 10.1021/jp801542s
   Iwamatsu M, 2004, CHEM PHYS LETT, V399, P396, DOI 10.1016/j.cplett.2004.10.032
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804
   Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690
   Jeyachandran YL, 2009, LANGMUIR, V25, P11614, DOI 10.1021/la901453a
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   JONSSON U, 1991, BIOTECHNIQUES, V11, P620
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Jose JC, 2013, EUR BIOPHYS J BIOPHY, V42, P487, DOI 10.1007/s00249-013-0900-6
   Juffer AH, 1996, J COMPUT CHEM, V17, P1783, DOI 10.1002/(SICI)1096-987X(199612)17:16<1783::AID-JCC1>3.0.CO;2-J
   Kang SG, 2013, J AM CHEM SOC, V135, P3150, DOI 10.1021/ja310989u
   Kang Y, 2010, J PHYS CHEM C, V114, P14496, DOI 10.1021/jp1037156
   Kang Y, 2009, BIOMATERIALS, V30, P2807, DOI 10.1016/j.biomaterials.2009.01.024
   Kantarci N, 2005, POLYMER, V46, P4307, DOI 10.1016/j.polymer.2005.03.016
   Kastner J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2052648
   Katti DR, 2005, BIOMACROMOLECULES, V6, P3276, DOI 10.1021/bm0503219
   Katti DR, 2005, CLAY CLAY MINER, V53, P171, DOI 10.1346/CCMN.2005.0530207
   Khlebtsov NG, 2010, J QUANT SPECTROSC RA, V111, P1, DOI 10.1016/j.jqsrt.2009.07.012
   Kievit FM, 2011, ACCOUNTS CHEM RES, V44, P853, DOI 10.1021/ar2000277
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Kim SY, 2013, LANGMUIR, V29, P7838, DOI 10.1021/la4006983
   Klimes J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195131
   Klimes J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/2/022201
   Knotts TA, 2005, PROTEINS, V61, P385, DOI 10.1002/prot.20581
   Knotts TA, 2008, BIOPHYS J, V94, P4473, DOI 10.1529/biophysj.107.123158
   Koch R, 2011, J MOL MODEL, V17, P1467, DOI 10.1007/s00894-010-0853-y
   Koppen S, 2008, J PHYS CHEM C, V112, P13600, DOI 10.1021/jp803354z
   Koppen S, 2010, LANGMUIR, V26, P15248, DOI 10.1021/la101687m
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   Kokh DB, 2010, J CHEM THEORY COMPUT, V6, P1753, DOI 10.1021/ct100086j
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Korzeniewski C, 2012, ELECTROANAL CHEM, V24, P75
   Kraszewski S, 2010, ACS NANO, V4, P4158, DOI 10.1021/nn100723r
   Kubiak-Ossowska K, 2012, LANGMUIR, V28, P15577, DOI 10.1021/la303323r
   Kubiak-Ossowska K, 2010, LANGMUIR, V26, P15954, DOI 10.1021/la102960m
   Kubiak-Ossowska K, 2010, LANGMUIR, V26, P7690, DOI 10.1021/la101276v
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187
   Laera S, 2011, NANO LETT, V11, P4480, DOI 10.1021/nl202909s
   Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399
   Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601
   Lal M, 2004, J PHYS CHEM B, V108, P6052, DOI 10.1021/jp036776e
   Lal M, 2006, J PHYS CHEM B, V110, P20879, DOI 10.1021/jp0633650
   Landau D. P, 2009, GUIDE MONTE CARLO SI
   Latour RA, 2008, BIOINTERPHASES, V3, pFC2, DOI 10.1116/1.2965132
   Lee K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081101
   Lee SS, 2014, J PHYS CHEM C, V118, P20840, DOI 10.1021/jp412438f
   Li C, 2014, LANGMUIR, V30, P8819, DOI 10.1021/la5014973
   Li C, 2012, J PHYS CHEM C, V116, P18318, DOI 10.1021/jp3060729
   Li HY, 2011, BIOPHYS J, V101, P2267, DOI 10.1016/j.bpj.2011.09.046
   Li JY, 2005, J PHYS CHEM B, V109, P13639, DOI 10.1021/jp044090w
   Li Y, 2010, J PHYS CHEM B, V114, P2749, DOI 10.1021/jp904550b
   LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611
   Liang J, 2012, IND ENG CHEM RES, V51, P16049, DOI 10.1021/ie301407b
   Liao CY, 2014, J PHYS CHEM B, V118, P5843, DOI 10.1021/jp501463r
   Liao CY, 2014, RSC ADV, V4, P15759, DOI 10.1039/c3ra47381c
   Liu H, 1999, POLYMER, V40, P7285, DOI 10.1016/S0032-3861(99)00081-6
   Liu J, 2013, LANGMUIR, V29, P11366, DOI 10.1021/la401171v
   Liu P, 2005, P NATL ACAD SCI USA, V102, P13749, DOI 10.1073/pnas.0506346102
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Liu YZ, 2012, J PHYS CHEM B, V116, P12227, DOI 10.1021/jp304796p
   Liu Z, 2012, THERANOSTICS, V2, P235, DOI 10.7150/thno.4156
   Lopes PEM, 2006, J PHYS CHEM B, V110, P2782, DOI 10.1021/jp055341j
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Lund M, 2005, LANGMUIR, V21, P8385, DOI 10.1021/la050607z
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   MADURA JD, 1994, REV COMP CH, V5, P229, DOI 10.1002/9780470125823.ch4
   Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g
   Mahon E, 2012, J CONTROL RELEASE, V161, P164, DOI 10.1016/j.jconrel.2012.04.009
   Mandal D, 2014, ORG BIOMOL CHEM, V12, P3544, DOI 10.1039/c4ob00447g
   Manecka GM, 2014, ACS SUSTAIN CHEM ENG, V2, P996, DOI 10.1021/sc400564r
   MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X
   Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f
   Martin R M, 2004, ELECT STRUCTURE BASI
   Marx D., 2000, MODERN METHODS ALGOR, V1, P301
   Matsui M, 1991, MOL SIMULAT, V6, P239, DOI 10.1080/08927029108022432
   Meissner RH, 2014, LANGMUIR, V30, P3487, DOI 10.1021/la500285m
   Mereghetti P, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-2
   METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114
   Mijajlovic M, 2013, LANGMUIR, V29, P2919, DOI 10.1021/la3047966
   Millo D, 2009, J PHYS CHEM B, V113, P15344, DOI 10.1021/jp906575r
   Mirau PA, 2011, J AM CHEM SOC, V133, P18243, DOI 10.1021/ja205454t
   Mishra RK, 2013, J PHYS CHEM C, V117, P10417, DOI 10.1021/jp312815g
   Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002
   Monti S, 2008, LANGMUIR, V24, P3205, DOI 10.1021/la702956t
   Monti S, 2007, J PHYS CHEM C, V111, P16962, DOI 10.1021/jp075154g
   Mori T, 2013, J CHEM THEORY COMPUT, V9, P5059, DOI 10.1021/ct400487e
   Motta A, 2012, J PHYS CHEM C, V116, P23418, DOI 10.1021/jp307565p
   Mucksch C, 2011, LANGMUIR, V27, P12938, DOI 10.1021/la201972f
   Muir JMR, 2014, SURF SCI, V624, P8, DOI 10.1016/j.susc.2014.01.005
   Nada H, 2014, J PHYS CHEM C, V118, P14335, DOI 10.1021/jp502332c
   Nadler R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4752235
   Nawrocki G, 2013, PHYS CHEM CHEM PHYS, V15, P13628, DOI 10.1039/c3cp52198b
   Nazmutdinov RR, 2007, RUSS J ELECTROCHEM+, V43, P328, DOI 10.1134/S1023193507030111
   Neves RS, 2007, J ELECTROANAL CHEM, V609, P140, DOI 10.1016/j.jelechem.2007.06.020
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/nnano.2009.453, 10.1038/NNANO.2009.453]
   Nonella M, 2008, CHEMPHYSCHEM, V9, P414, DOI 10.1002/cphc.200700546
   Noon WH, 2002, P NATL ACAD SCI USA, V99, P6466, DOI 10.1073/pnas.022532599
   Notman R, 2009, LANGMUIR, V25, P1638, DOI 10.1021/la803324x
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Nowinski AK, 2012, J AM CHEM SOC, V134, P6000, DOI 10.1021/ja3006868
   O'Brien CP, 2008, LANGMUIR, V24, P14115, DOI 10.1021/la802588n
   O'Mahony S, 2013, LANGMUIR, V29, P7271, DOI 10.1021/la304545n
   Oberle M, 2015, J PHYS CHEM B, V119, P3250, DOI 10.1021/jp5119986
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   Oren EE, 2005, NANO LETT, V5, P415, DOI 10.1021/nl048425x
   Oren EE, 2010, LANGMUIR, V26, P11003, DOI 10.1021/la100049s
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Palafox-Hernandez JP, 2014, CHEM MATER, V26, P4960, DOI 10.1021/cm501529u
   Pan H, 2012, LANGMUIR, V28, P12779, DOI 10.1021/la302258k
   Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   Patwardhan SV, 2012, J AM CHEM SOC, V134, P6244, DOI 10.1021/ja211307u
   Penna MJ, 2014, J AM CHEM SOC, V136, P5323, DOI 10.1021/ja411796e
   Pincus DL, 2008, PROG MOL BIOL TRANSL, V84, P203, DOI 10.1016/S0079-6603(08)00406-6
   Praprotnik M, 2008, ANNU REV PHYS CHEM, V59, P545, DOI 10.1146/annurev.physchem.59.032607.093707
   Predota M, 2004, J PHYS CHEM B, V108, P12049, DOI 10.1021/jp037197c
   Puddu V, 2012, ACS NANO, V6, P6356, DOI 10.1021/nn301866q
   Qin L, 2007, NANO LETT, V7, P3849, DOI 10.1021/nl072606s
   Qin LD, 2007, J AM CHEM SOC, V129, P14870, DOI 10.1021/ja0772391
   Qin Z, 2014, J MECH PHYS SOLIDS, V62, P19, DOI 10.1016/j.jmps.2013.08.015
   Qu ZG, 2013, NANOMEDICINE-UK, V8, P995, DOI [10.2217/NNM.13.81, 10.2217/nnm.13.81]
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Raffaini G, 2006, J BIOMED MATER RES A, V76A, P638, DOI 10.1002/jbm.a.30546
   Raffaini G, 2004, J PHYS CHEM B, V108, P13850, DOI 10.1021/jp0477452
   Raffaini G, 2004, LANGMUIR, V20, P3371, DOI 10.1021/la0357716
   Raffaini G, 2003, LANGMUIR, V19, P3403, DOI 10.1021/la026853h
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Raffaini G, 2013, LANGMUIR, V29, P4883, DOI 10.1021/la3050779
   Raffaini G, 2012, PHILOS T R SOC A, V370, P1444, DOI 10.1098/rsta.2011.0266
   Raffaini G, 2010, LANGMUIR, V26, P5679, DOI 10.1021/la903769c
   Ravichandran S, 2001, J PHYS CHEM B, V105, P3610, DOI 10.1021/jp010223r
   Ravichandran S, 2000, BIOPHYS J, V78, P110, DOI 10.1016/S0006-3495(00)76577-5
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127
   Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+
   RICK SW, 1994, J CHEM PHYS, V101, P6141, DOI 10.1063/1.468398
   Rimola A, 2013, CHEM REV, V113, P4216, DOI 10.1021/cr3003054
   Rimola A, 2012, J AM CHEM SOC, V134, P10899, DOI 10.1021/ja302262y
   Rimola A, 2009, J PHYS CHEM C, V113, P5741, DOI 10.1021/jp811193f
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roman T, 2006, EUR PHYS J D, V38, P117, DOI 10.1140/epjd/e2006-00043-1
   Rosa M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.125448
   Rosa M, 2014, J CHEM THEORY COMPUT, V10, P1707, DOI 10.1021/ct401117g
   Rosa M, 2012, J PHYS CHEM C, V116, P21366, DOI 10.1021/jp305833c
   Salata O.V., 2004, J NANOBIOTECHNOL, V2, P3, DOI DOI 10.1186/1477-3155-2-3
   Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26
   Schlick T., 2002, MOL MODELING SIMULAT
   Schneider J, 2012, J AM CHEM SOC, V134, P2407, DOI 10.1021/ja210744g
   Schneider J, 2011, J CHEM THEORY COMPUT, V7, P473, DOI 10.1021/ct1004388
   Schneider J, 2010, SURF SCI, V604, P1105, DOI 10.1016/j.susc.2010.03.021
   Schreiber F, 2004, J PHYS-CONDENS MAT, V16, pR881, DOI 10.1088/0953-8984/16/28/R01
   Schyman P, 2013, J PHYS CHEM LETT, V4, P468, DOI 10.1021/jz302085c
   Scida K, 2011, ANAL CHIM ACTA, V691, P6, DOI 10.1016/j.aca.2011.02.025
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Seo M, 2012, J CHEM THEORY COMPUT, V8, P1774, DOI 10.1021/ct200876v
   Sethuraman A, 2005, BIOPHYS J, V88, P1322, DOI 10.1529/biophysj.104.051797
   Shaw CP, 2012, ACS NANO, V6, P1416, DOI 10.1021/nn204214x
   Shelley JC, 1997, J CHEM PHYS, V107, P2122, DOI 10.1063/1.474562
   Shemetov AA, 2012, ACS NANO, V6, P4585, DOI 10.1021/nn300415x
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shuang-Kou Chen, 2010, 2010 2nd Conference on Environmental Science and Information Application Technology (ESIAT 2010), P533, DOI 10.1109/ESIAT.2010.5568296
   SIEPMANN JI, 1995, J CHEM PHYS, V102, P511, DOI 10.1063/1.469429
   Singh N, 2010, PROTEINS, V78, P1705, DOI 10.1002/prot.22687
   Siwko ME, 2013, PHYS CHEM CHEM PHYS, V15, P5945, DOI 10.1039/c3cp00146f
   Skelton AA, 2011, J PHYS CHEM C, V115, P2076, DOI 10.1021/jp109446d
   Skepo M, 2006, J PHYS CHEM B, V110, P12141, DOI 10.1021/jp056033o
   Skepo M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3002317
   Slocik JM, 2011, NANO LETT, V11, P701, DOI 10.1021/nl1038242
   SMITH NV, 1989, PHYS REV B, V40, P7565, DOI 10.1103/PhysRevB.40.7565
   Snyder JA, 2008, J PHYS CHEM B, V112, P7095, DOI 10.1021/jp7103769
   Snyder JA, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0056-4
   Somorjai GA, 2011, P NATL ACAD SCI USA, V108, P917, DOI 10.1073/pnas.1006669107
   Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0
   SPOHR E, 1995, ACTA CHEM SCAND, V49, P189, DOI 10.3891/acta.chem.scand.49-0189
   Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+
   Steckbeck S, 2014, ANAL METHODS-UK, V6, P1501, DOI 10.1039/c3ay42042f
   Strodel B, 2008, J CHEM THEORY COMPUT, V4, P657, DOI 10.1021/ct700305w
   Stuart D. A., 2005, IEE Proceedings Nanobiotechnology, V152, P13, DOI 10.1049/ip-nbt:20045012
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200
   Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764
   Sun CH, 2010, J MATER CHEM, V20, P10319, DOI 10.1039/c0jm01491e
   Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v
   Sun TY, 2014, BIOMATER SCI-UK, V2, P1090, DOI 10.1039/c4bm00021h
   Sun XT, 2014, ACS APPL MATER INTER, V6, P7153, DOI 10.1021/am500167c
   Sun Y, 2005, LANGMUIR, V21, P5616, DOI 10.1021/la046932o
   Sun Y, 2007, J COMPUT CHEM, V28, P1883, DOI 10.1002/jcc.20716
   Sun Y, 2006, J COMPUT CHEM, V27, P1908, DOI 10.1002/jcc.20488
   Suttiponparnit K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9772-1
   Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9
   SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607
   Szott LM, 2011, CURR OPIN CHEM BIOL, V15, P683, DOI 10.1016/j.cbpa.2011.04.016
   Tallury SS, 2010, J PHYS CHEM B, V114, P4122, DOI 10.1021/jp908001d
   Tang ZH, 2013, ACS NANO, V7, P9632, DOI 10.1021/nn404427y
   Tavanti F, 2015, NEW J CHEM, V39, P2474, DOI 10.1039/c4nj01752h
   Taylor RD, 2002, J COMPUT AID MOL DES, V16, P151, DOI 10.1023/A:1020155510718
   Tkatchenko A, 2010, MRS BULL, V35, P435, DOI 10.1557/mrs2010.581
   Todorova N, 2014, NANO LETT, V14, P5229, DOI 10.1021/nl5021848
   Todorova N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003360
   Tomasio SD, 2007, MOL PHYS, V105, P221, DOI 10.1080/00268970701197445
   Tomasio SM, 2009, J PHYS CHEM C, V113, P8778, DOI 10.1021/jp8087594
   Tomba G, 2009, ADV MATER, V21, P1055, DOI 10.1002/adma.200802610
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0
   Tosaka R, 2010, LANGMUIR, V26, P9950, DOI 10.1021/la1004352
   Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005
   Utesch T, 2013, LANGMUIR, V29, P673, DOI 10.1021/la303635q
   Utesch T, 2012, LANGMUIR, V28, P5761, DOI 10.1021/la205055g
   Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w
   Vallee A, 2010, ACCOUNTS CHEM RES, V43, P1297, DOI 10.1021/ar100017n
   van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u
   VANBEEST BWH, 1990, PHYS REV LETT, V64, P1955, DOI 10.1103/PhysRevLett.64.1955
   VASHISHTA P, 1990, PHYS REV B, V41, P12197, DOI 10.1103/PhysRevB.41.12197
   Velasco-Velez JJ, 2014, SCIENCE, V346, P831, DOI 10.1126/science.1259437
   Vellore NA, 2010, LANGMUIR, V26, P7396, DOI 10.1021/la904415d
   Venkat AS, 2007, SMALL, V3, P1431, DOI 10.1002/smll.200700001
   Verde AV, 2011, LANGMUIR, V27, P5918, DOI 10.1021/la104814z
   Verde AV, 2009, BIOMACROMOLECULES, V10, P2118, DOI 10.1021/bm9002464
   Vertegel AA, 2004, LANGMUIR, V20, P6800, DOI 10.1021/la0497200
   VIGMOND SJ, 1994, LANGMUIR, V10, P2860, DOI 10.1021/la00021a003
   Voicescu M, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1174-0
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Wales DJ, 1997, J PHYS CHEM A, V101, P5111, DOI 10.1021/jp970984n
   Walsh TR, 2008, MOL PHYS, V106, P1613, DOI 10.1080/00268970802225533
   Walther JH, 2001, J PHYS CHEM B, V105, P9980, DOI 10.1021/jp011344u
   Wang DW, 2011, J AM CHEM SOC, V133, P2192, DOI 10.1021/ja108154a
   Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054
   Wang MH, 2014, CHEM PHYS LETT, V599, P86, DOI 10.1016/j.cplett.2014.03.024
   Wang QM, 2010, LANGMUIR, V26, P12722, DOI 10.1021/la1017906
   Wang QM, 2010, LANGMUIR, V26, P3308, DOI 10.1021/la903070y
   Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833
   Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P8004, DOI 10.1002/anie.201400546
   Wei T, 2011, LANGMUIR, V27, P12074, DOI 10.1021/la202622s
   Wei Y, 2010, LANGMUIR, V26, P18852, DOI 10.1021/la103685d
   Wei Y, 2009, LANGMUIR, V25, P5637, DOI 10.1021/la8042186
   Whaley SR, 2000, NATURE, V405, P665
   WIERZBICKI A, 1994, CALCIFIED TISSUE INT, V54, P133, DOI 10.1007/BF00296064
   Wilt FH, 1999, J STRUCT BIOL, V126, P216, DOI 10.1006/jsbi.1999.4105
   Wright LB, 2013, J PHYS CHEM C, V117, P24292, DOI 10.1021/jp4061329
   Wright LB, 2013, J CHEM THEORY COMPUT, V9, P1616, DOI 10.1021/ct301018m
   Wright LB, 2013, PHYS CHEM CHEM PHYS, V15, P4715, DOI 10.1039/c3cp42921k
   Wright LB, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769727
   Wu CY, 2013, ACS APPL MATER INTER, V5, P2567, DOI 10.1021/am3031568
   Wu X, 2001, J CHEM PHYS, V115, P8748, DOI 10.1063/1.1412004
   Wu XY, 2008, BBA-PROTEINS PROTEOM, V1784, P1694, DOI 10.1016/j.bbapap.2008.06.008
   Wu XY, 2009, MOL SIMULAT, V35, P974, DOI 10.1080/08927020903015338
   Xie LG, 2014, NANOSCALE, V6, P9752, DOI 10.1039/c4nr01005a
   Xie Y, 2012, APPL SURF SCI, V258, P8153, DOI 10.1016/j.apsusc.2012.05.013
   Xie Y, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3305244
   Xu Y, 2010, ANAL CHEM, V82, P3352, DOI 10.1021/ac1002646
   Xu ZJ, 2008, J PHYS CHEM B, V112, P13802, DOI 10.1021/jp8055009
   Xu ZP, 2006, CHEM ENG SCI, V61, P1027, DOI 10.1016/j.ces.2005.06.019
   Yancey JA, 2010, BIOINTERPHASES, V5, P85, DOI 10.1116/1.3493470
   Yang JA, 2013, LANGMUIR, V29, P4603, DOI 10.1021/la400266u
   Yang ZY, 2007, ENG ANAL BOUND ELEM, V31, P402, DOI 10.1016/j.enganabound.2006.07.012
   Yang ZY, 2006, MAT SCI ENG A-STRUCT, V423, P84, DOI 10.1016/j.msea.2005.10.078
   Yu J, 2012, LANGMUIR, V28, P1408, DOI 10.1021/la204109r
   Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]
   Yu X, 2012, LANGMUIR, V28, P6595, DOI 10.1021/la3002306
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
   Zanetti-Polzi L, 2014, J AM CHEM SOC, V136, P12929, DOI 10.1021/ja505251a
   Zhang L, 2010, BIOCHEM ENG J, V48, P408, DOI 10.1016/j.bej.2009.12.003
   Zhang L, 2009, J PHYS CHEM B, V113, P6873, DOI 10.1021/jp809754k
   Zhang Z, 2009, J SERB CHEM SOC, V74, P407, DOI 10.2298/JSC0904407Z
   Zhdanov VP, 2000, PROTEINS, V40, P539, DOI 10.1002/1097-0134(20000901)40:4<539::AID-PROT10>3.0.CO;2-8
   Zhdanov VP, 2000, PROTEINS, V39, P76, DOI 10.1002/(SICI)1097-0134(20000401)39:1<76::AID-PROT8>3.0.CO;2-U
   Zhou J, 2004, J PHYS CHEM B, V108, P17418, DOI 10.1021/jp038048x
NR 429
TC 31
Z9 32
U1 16
U2 131
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0033-5835
EI 1469-8994
J9 Q REV BIOPHYS
JI Q. Rev. Biophys.
PD JAN 29
PY 2016
VL 49
AR e4
DI 10.1017/S0033583515000256
PG 45
WC Biophysics
SC Biophysics
GA DN5PP
UT WOS:000377122900001
PM 26821792
OA Bronze
DA 2018-10-20
ER

PT J
AU Chen, F
   Yu, SR
   Liu, B
   Ni, YZ
   Yu, CY
   Su, Y
   Zhu, XY
   Yu, XW
   Zhou, YF
   Yan, DY
AF Chen, Feng
   Yu, Songrui
   Liu, Bing
   Ni, Yunzhou
   Yu, Chunyang
   Su, Yue
   Zhu, Xinyuan
   Yu, Xiaowei
   Zhou, Yongfeng
   Yan, Deyue
TI An Injectable Enzymatically Crosslinked Carboxymethylated
   Pullulan/Chondroitin Sulfate Hydrogel for Cartilage Tissue Engineering
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POLYSACCHARIDE-BASED SCAFFOLDS; CHONDROITIN SULFATE; HYALURONIC-ACID;
   REGENERATIVE MEDICINE; BIOMIMETIC SCAFFOLDS; CHONDROCYTE CULTURE;
   DEXTRAN; PULLULAN; REPAIR; CELLS
AB In this study, an enzymatically cross-linked injectable and biodegradable hydrogel system comprising carboxymethyl pullulan-tyramine (CMP-TA) and chondroitin sulfate-tyramine (CS-TA) conjugates was successfully developed under physiological conditions in the presence of both horseradish peroxidase (HRP) and hydrogen peroxide (H2O2) for cartilage tissue engineering (CTTE). The HRP crosslinking method makes this injectable system feasible, minimally invasive and easily translatable for regenerative medicine applications. The physicochemical properties of the mechanically stable hydrogel system can be modulated by varying the weight ratio and concentration of polymer as well as the concentrations of crosslinking reagents. Additionally, the cellular behaviour of porcine auricular chondrocytes encapsulated into CMP-TA/CS-TA hydrogels demonstrates that the hydrogel system has a good cyto-compatibility. Specifically, compared to the CMP-TA hydrogel, these CMP-TA/CS-TA composite hydrogels have enhanced cell proliferation and increased cartilaginous ECM deposition, which significantly facilitate chondrogenesis. Furthermore, histological analysis indicates that the hydrogel system exhibits acceptable tissue compatibility by using a mouse subcutaneous implantation model. Overall, the novel injectable pullulan/chondroitin sulfate composite hydrogels presented here are expected to be useful biomaterial scaffold for regenerating cartilage tissue.
C1 [Chen, Feng; Yu, Songrui; Ni, Yunzhou; Yu, Chunyang; Su, Yue; Zhu, Xinyuan; Zhou, Yongfeng; Yan, Deyue] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
   [Yu, Xiaowei] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.
   [Liu, Bing] Harbin Med Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp 1, 23 Youzheng St, Harbin, Peoples R China.
   [Zhou, Yongfeng; Yan, Deyue] Nanjing Normal Univ, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Coll Chem & Mat Sci, Jiangsu Key Lab Biomed Mat, Nanjing 210046, Jiangsu, Peoples R China.
RP Zhou, YF (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.; Yu, XW (reprint author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.; Zhou, YF (reprint author), Nanjing Normal Univ, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Coll Chem & Mat Sci, Jiangsu Key Lab Biomed Mat, Nanjing 210046, Jiangsu, Peoples R China.
EM yuxw@sjtu.edu.cn; yfzhou@sjtu.edu.cn
FU National Basic Research Program [2013CB834506]; China National Funds for
   Distinguished Young Scholar [21225420]; National Natural Science
   Foundation of China [21474062, 91527304]; Shanghai Municipal Education
   commission and Shanghai Education Development Foundation [13SG14]
FX The authors thank the National Basic Research Program (2013CB834506),
   China National Funds for Distinguished Young Scholar (21225420),
   National Natural Science Foundation of China (21474062, 91527304) and
   "Shu Guang" project supported by Shanghai Municipal Education commission
   and Shanghai Education Development Foundation (13SG14) for financial
   support.
CR Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004
   Bae H, 2011, SOFT MATTER, V7, P1903, DOI 10.1039/c0sm00697a
   Balakrishnan B, 2014, ACTA BIOMATER, V10, P3650, DOI 10.1016/j.actbio.2014.04.031
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Bouten PJM, 2014, PROG POLYM SCI, V39, P1375, DOI 10.1016/j.progpolymsci.2014.02.001
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Bulman SE, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0011-7
   Chang KY, 2009, ACTA BIOMATER, V5, P1937, DOI 10.1016/j.actbio.2009.02.002
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072
   Guerrero J, 2015, TISSUE ENG PT A, V21, P861, DOI [10.1089/ten.tea.2014.0367, 10.1089/ten.TEA.2014.0367]
   Heymann D., 2014, PLOS ONE, V9
   Hou JX, 2015, POLYM CHEM-UK, V6, P2204, DOI 10.1039/c4py01757a
   Ingavle GC, 2013, TISSUE ENG PT A, V19, P1349, DOI [10.1089/ten.tea.2012.0160, 10.1089/ten.TEA.2012.0160]
   Izumikawa T., 2014, SCI REP, V4, P3710
   Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013
   Jin R, 2014, POLYM CHEM-UK, V5, P391, DOI 10.1039/c3py00864a
   Jin R, 2010, TISSUE ENG PT A, V16, P2429, DOI [10.1089/ten.tea.2009.0764, 10.1089/ten.TEA.2009.0764]
   Jin R, 2011, J CONTROL RELEASE, V152, P186, DOI 10.1016/j.jconrel.2011.01.031
   Jung YS, 2013, J CONTROL RELEASE, V171, P143, DOI 10.1016/j.jconrel.2013.07.012
   Kyung M. P., 2010, BIOMACROMOLECULES, V11, P706
   Lavergne M, 2012, MACROMOL BIOSCI, V12, P901, DOI 10.1002/mabi.201100431
   Le Visage C, 2012, TISSUE ENG PT A, V18, P35, DOI [10.1089/ten.tea.2011.0053, 10.1089/ten.TEA.2011.0053]
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Liao JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09879
   Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037
   Menzies DJ, 2013, BIOMACROMOLECULES, V14, P413, DOI 10.1021/bm301652q
   Mocanu G, 2002, J CONTROL RELEASE, V83, P41, DOI 10.1016/S0168-3659(02)00169-4
   Mujeeb A, 2013, ACTA BIOMATER, V9, P4609, DOI 10.1016/j.actbio.2012.08.044
   Park KM, 2012, BIOMACROMOLECULES, V13, P604, DOI 10.1021/bm201712z
   Park KM, 2011, J MATER CHEM, V21, P13180, DOI 10.1039/c1jm12527c
   Portalska KJ, 2014, TISSUE ENG PT A, V20, P819, DOI 10.1089/ten.TEA.2013.0280
   Ren KX, 2015, BIOMATERIALS, V51, P238, DOI 10.1016/j.biomaterials.2015.02.026
   Ren KX, 2014, POLYM CHEM-UK, V5, P5069, DOI 10.1039/c4py00420e
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041
   Shi LY, 2012, MACROMOL BIOSCI, V12, P395, DOI 10.1002/mabi.201100336
   Singh RS, 2015, CARBOHYD POLYM, V123, P190, DOI 10.1016/j.carbpol.2015.01.032
   Teixeira LSM, 2012, BIOMATERIALS, V33, P3164, DOI 10.1016/j.biomaterials.2012.01.001
   Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Victor W. Wong, 2011, TISSUE ENG PART A, V17, P631
   Villanueva I, 2009, TISSUE ENG PT A, V15, P3037, DOI [10.1089/ten.tea.2009.0001, 10.1089/ten.TEA.2009.0001]
   Villanueva I, 2010, MATRIX BIOL, V29, P51, DOI 10.1016/j.matbio.2009.08.004
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wang LS, 2014, BIOMATERIALS, V35, P2207, DOI 10.1016/j.biomaterials.2013.11.070
   Weng LH, 2007, BIOMACROMOLECULES, V8, P1109, DOI 10.1021/bm0610065
   Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006
   Yang XC, 2014, BIOMATERIALS, V35, P3873, DOI 10.1016/j.biomaterials.2014.01.036
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
NR 53
TC 40
Z9 40
U1 9
U2 126
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 28
PY 2016
VL 6
AR 20014
DI 10.1038/srep20014
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB8PI
UT WOS:000368778500002
PM 26817622
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mundargi, RC
   Potroz, MG
   Park, JH
   Seo, J
   Tan, EL
   Lee, JH
   Cho, NJ
AF Mundargi, Raghavendra C.
   Potroz, Michael G.
   Park, Jae Hyeon
   Seo, Jeongeun
   Tan, Ee-Lin
   Lee, Jae Ho
   Cho, Nam-Joon
TI Eco-friendly streamlined process for sporopollenin exine capsule
   extraction
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LYCOPODIUM-CLAVATUM; DRUG-DELIVERY; CONTROLLED-RELEASE; PLANT SPORES;
   POLLEN; MICROCAPSULES; NANOPARTICLES; ENCAPSULATION; ABSORPTION; SINGLE
AB Sporopollenin exine capsules (SECs) extracted from Lycopodium clavatum spores are an attractive biomaterial possessing a highly robust structure suitable for microencapsulation strategies. Despite several decades of research into SEC extraction methods, the protocols commonly used for L. clavatum still entail processing with both alkaline and acidolysis steps at temperatures up to 180 degrees C and lasting up to 7 days. Herein, we demonstrate a significantly streamlined processing regimen, which indicates that much lower temperatures and processing durations can be used without alkaline lysis. By employing CHN elemental analysis, scanning electron microscopy (SEM), confocal laser scanning microscopy (CLSM), and dynamic image particle analysis (DIPA), the optimum conditions for L. clavatum SEC processing were determined to include 30 hours acidolysis at 70 degrees C without alkaline lysis. Extending these findings to proof-of-concept encapsulation studies, we further demonstrate that our SECs are able to achieve a loading of 0.170 +/- 0.01 g BSA per 1 g SECs by vacuum-assisted loading. Taken together, our streamlined processing method and corresponding characterization of SECs provides important insights for the development of applications including drug delivery, cosmetics, personal care products, and foods.
C1 [Mundargi, Raghavendra C.; Potroz, Michael G.; Park, Jae Hyeon; Seo, Jeongeun; Tan, Ee-Lin; Lee, Jae Ho; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Mundargi, Raghavendra C.; Potroz, Michael G.; Park, Jae Hyeon; Seo, Jeongeun; Tan, Ee-Lin; Lee, Jae Ho; Cho, Nam-Joon] Nanyang Technol Univ, Ctr Biomimet Sensor Sci, Singapore 637553, Singapore.
   [Cho, Nam-Joon] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore.
RP Cho, NJ (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.; Cho, NJ (reprint author), Nanyang Technol Univ, Ctr Biomimet Sensor Sci, Singapore 637553, Singapore.; Cho, NJ (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore.
EM njcho@ntu.edu.sg
RI Cho, Nam-Joon/J-7816-2012
OI Cho, Nam-Joon/0000-0002-8692-8955
FU National Research Foundation [NRF-NRFF2011-01]; National Medical
   Research Council [NMRC/CBRG/0005/2012]
FX This work was supported by the National Research Foundation
   (NRF-NRFF2011-01) and the National Medical Research Council
   (NMRC/CBRG/0005/2012).
CR Aqel A, 2015, CHROMATOGRAPHIA, V78, P481, DOI 10.1007/s10337-015-2861-7
   Archibald SJ, 2014, J MATER CHEM B, V2, P945, DOI 10.1039/c3tb21523g
   Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312
   Atkin S.L., 2007, Patent No. [2007012857A1, 2007012857, WO 2007/012857]
   Atwe SU, 2014, J CONTROL RELEASE, V194, P45, DOI 10.1016/j.jconrel.2014.08.010
   Banerjee J, 2014, J PHARMACOGN PHYTOCH, V3, P207
   Barrier S., 2008, THESIS U HULL
   Barrier S, 2011, J MATER CHEM, V21, P975, DOI 10.1039/c0jm02246b
   Barrier S, 2010, LWT-FOOD SCI TECHNOL, V43, P73, DOI 10.1016/j.lwt.2009.07.001
   Beckett S. T., 2009, Dosage Form, Patent No. [US 07608270, 07608270, 7,608,270 B2, 7608270]
   Bishayee K, 2013, EUR J PHARMACOL, V698, P110, DOI 10.1016/j.ejphar.2012.10.041
   Bohne G, 2005, ANN BOT-LONDON, V96, P201, DOI 10.1093/aob/mci169
   de Souza SP, 2015, CATAL SCI TECHNOL, V5, P3130, DOI 10.1039/c4cy01682c
   Diego-Taboada Alberto, 2014, Pharmaceutics, V6, P80, DOI 10.3390/pharmaceutics6010080
   Diego-Taboada A, 2013, J MATER CHEM B, V1, P707, DOI 10.1039/c2tb00228k
   Diego-Taboada A, 2012, J MATER CHEM, V22, P9767, DOI [10.1039/c2jmo0103a, 10.1039/c2jm00103a]
   Dominguez E, 1999, SEX PLANT REPROD, V12, P171, DOI 10.1007/s004970050189
   Durdun C., 2011, Scientific Works - University of Agronomical Sciences and Veterinary Medicine, Bucharest Series C, Veterinary Medicine, V57, P61
   Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031
   Gomez IJ, 2015, J MATER CHEM C, V3, P632, DOI 10.1039/c4tc01938e
   Hamad SA, 2011, J MATER CHEM, V21, P18018, DOI 10.1039/c1jm13719k
   Herve G, 2014, RSC ADV, V4, P18558, DOI 10.1039/c3ra47911k
   Jardine P.E., 2015, J MICROPALAEONTOL, DOI [10.1144/jmpaleo2014-022, DOI 10.1144/JMPALE02014-022]
   Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P63
   Lin HS, 2015, J COLLOID INTERF SCI, V442, P133, DOI 10.1016/j.jcis.2014.11.065
   Lorch M, 2009, CHEM COMMUN, P6442, DOI 10.1039/b909551a
   Lu Q, 2015, J AGR FOOD CHEM, V63, P4771, DOI 10.1021/jf505938w
   Ma HB, 2014, J MICROENCAPSUL, V31, P667, DOI 10.3109/02652048.2014.913723
   Ma XQ, 2004, NAT PROD REP, V21, P752, DOI 10.1039/b409720n
   Mackenzie G., 2014, ICROENCAPSULATION FO, P283
   Mizuta Y, 2015, PROTOPLASMA, V252, P1231, DOI 10.1007/s00709-014-0754-5
   Mundargi RC, 2016, SMALL, V12, P1167, DOI 10.1002/smll.201500860
   Orhan I, 2007, J ETHNOPHARMACOL, V109, P146, DOI 10.1016/j.jep.2006.07.018
   Pathak S, 2009, INDIAN J EXP BIOL, V47, P602
   Paunov VN, 2007, J MATER CHEM, V17, P609, DOI 10.1039/b615865j
   Pohlker C, 2013, ATMOS MEAS TECH, V6, P3369, DOI 10.5194/amt-6-3369-2013
   Quilichini TD, 2015, PHYTOCHEMISTRY, V113, P170, DOI 10.1016/j.phytochem.2014.05.002
   Rowley JR, 2003, CAN J BOT, V81, P1070, DOI [10.1139/b03-095, 10.1139/B03-095]
   Sargin I, 2016, DESALIN WATER TREAT, V57, P10664, DOI 10.1080/19443994.2015.1038738
   Sargin I, 2015, INT J BIOL MACROMOL, V75, P230, DOI 10.1016/j.ijbiomac.2015.01.039
   Shaw G, 1996, GRANA, V35, P125, DOI 10.1080/00173139609429483
   Southworth D., 2013, MICROSPORES EVOLUTIO, P193
   Wakil A, 2010, LIPIDS, V45, P645, DOI 10.1007/s11745-010-3427-y
   Wang CJ, 2015, J QUANT SPECTROSC RA, V153, P4, DOI 10.1016/j.jqsrt.2014.11.004
   Xie LL, 2012, J MATER CHEM, V22, P6053, DOI 10.1039/c2jm16831f
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zivcova Z, 2007, J MATER SCI, V42, P8760, DOI 10.1007/s10853-007-1852-y
NR 47
TC 11
Z9 11
U1 4
U2 51
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 28
PY 2016
VL 6
AR 19960
DI 10.1038/srep19960
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB8OT
UT WOS:000368777000001
PM 26818918
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU de Breij, A
   Riool, M
   Kwakman, PHS
   de Boer, L
   Cordfunke, RA
   Drijfhout, JW
   Cohen, O
   Emanuel, N
   Zaat, SAJ
   Nibbering, PH
   Moriarty, TF
AF de Breij, A.
   Riool, M.
   Kwakman, P. H. S.
   de Boer, L.
   Cordfunke, R. A.
   Drijfhout, J. W.
   Cohen, O.
   Emanuel, N.
   Zaat, S. A. J.
   Nibbering, P. H.
   Moriarty, T. F.
TI Prevention of Staphylococcus aureus biomaterial-associated infections
   using a polymer-lipid coating containing the antimicrobial peptide
   OP-145
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Antimicrobial peptides; OP-145; Staphylococcus aureus; Antimicrobial
   coating; Orthopaedic implant; Rabbit
ID IMPLANT-RELATED OSTEOMYELITIS; TOTAL HIP-ARTHROPLASTY; BIOFILM
   FORMATION; LOCAL INFECTION; EPIDERMIDIS; BACTERIAL; PERSISTENCE; LL-37;
   MICROTOPOGRAPHY; SUSCEPTIBILITY
AB The scarcity of current antibiotic-based strategies to prevent biomaterial-associated infections (BAI) and their risk of resistance development prompted us to develop a novel antimicrobial implant-coating to prevent Staphylococcus aureus-induced BAI. We incorporated the antimicrobial peptide OP-145 into a Polymer-Lipid Encapsulation MatriX (PLEX)-coating to obtain high peptide levels for prolonged periods at the implant-tissue interphase. We first confirmed that OP-145 was highly effective in killing S. aureus and inhibiting biofilm formation in vitro. OP-145 injected along S. aureus-inoculated implants in mice significantly reduced the number of culture-positive implants. OP-145 was released from the PLEX coating in a controlled zero-order kinetic rate after an initial 55%-burst release and displayed bactericidal activity in vitro. In a rabbit intramedullary nail-related infection model, 67% of rabbits with PLEX-OP-145-coated nails had culture-negative nails after 28 days compared to 29% of rabbits with uncoated nails. In rabbits with PLEX-OP-145-coated nails, bone and soft tissue samples were culture-negative in 67% and 80%, respectively, whereas all bone samples and 71% of the soft tissue samples of rabbits with uncoated nails were infected. Together, PLEX-OP-145 coatings, of which both compounds have already been found safe in man, can prevent implant colonization and S. aureus-induced BAIs. (C) 2015 Elsevier B.V. All rights reserved.
C1 [de Breij, A.; Nibbering, P. H.] Leiden Univ, Med Ctr, Dept Infect Dis, NL-9600 RC Leiden, Netherlands.
   [Riool, M.; Kwakman, P. H. S.; de Boer, L.; Zaat, S. A. J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.
   [Cordfunke, R. A.; Drijfhout, J. W.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-9600 RC Leiden, Netherlands.
   [Cohen, O.; Emanuel, N.] PolyPid Ltd, IL-4959376 St Petach Tikva, Israel.
   [Moriarty, T. F.] AO Fdn, AO Res Inst Davos, CH-7270 Davos, Switzerland.
RP de Breij, A (reprint author), Leiden Univ, Med Ctr, Dept Infect Dis, Albinusdreef 2,2333 ZA,POB 9600, NL-9600 RC Leiden, Netherlands.
EM a.de_breij@lumc.nl
RI Riool, Martijn/A-8404-2018
OI Riool, Martijn/0000-0002-5444-3179
FU BALI - Biofilm Alliance [278890]
FX Inga Potapova, Tanja Schmid, Iris Keller, Pamela Furlong and Nora
   Goudsouzian (AO Research Institute, Davos, Switzerland) are thanked for
   their technical and histological assistance with the rabbit study. Niels
   Kamp (Animal Research Institute AMC (ARIA), Amsterdam, The Netherlands)
   is thanked for assisting with the mouse study. This work was supported
   by FP7-HEALTH-2011 grant 278890, BALI - Biofilm Alliance.
CR Anagnostakos K, 2008, ACTA ORTHOP, V79, P302, DOI 10.1080/17453670710015120
   Bahar AA, 2013, PHARMACEUTICALS, V6, P1543, DOI 10.3390/ph6121543
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Brooks B., 2012, BIOMATERIALS ASS INF, P307
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   DUNCAN CP, 1993, ORTHOP CLIN N AM, V24, P751
   Emanuel N, 2012, J CONTROL RELEASE, V160, P353, DOI 10.1016/j.jconrel.2012.03.027
   Fuchs T, 2011, ARCH ORTHOP TRAUM SU, V131, P1419, DOI 10.1007/s00402-011-1321-6
   Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14
   Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1111/j.1574-6968.2002.tb11000.x
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313
   Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718
   Jorge P, 2012, BIOFOULING, V28, P1033, DOI 10.1080/08927014.2012.728210
   Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   Malanovic N, 2015, BBA-BIOMEMBRANES, V1848, P2437, DOI 10.1016/j.bbamem.2015.07.010
   Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004
   Masri BA, 2007, J ARTHROPLASTY, V22, P72, DOI 10.1016/j.arth.2006.02.156
   Metsemakers WJ, 2015, J CONTROL RELEASE, V209, P47, DOI 10.1016/j.jconrel.2015.04.022
   Moriarty TF, 2010, INT J ARTIF ORGANS, V33, P667
   Moriarty TF, 2009, INT J ARTIF ORGANS, V32, P663
   Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Nishimura S, 2006, J ORTHOP SCI, V11, P46, DOI 10.1007/s00776-005-0968-7
   Over U, 2001, CLIN MICROBIOL INFEC, V7, P470, DOI 10.1046/j.1198-743x.2001.00284.x
   Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08
   Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971
   Peek F.A.W., 2009, L1337 ICAAC
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   Sitaram N, 1999, BBA-BIOMEMBRANES, V1462, P29, DOI 10.1016/S0005-2736(99)00199-6
   Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606
   Svenson J, 2007, J MED CHEM, V50, P3334, DOI 10.1021/jm0703542
   Thomes B, 2002, J Bone Joint Surg Br, V84, P758
   Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047
   van der Does AM, 2010, ANTIMICROB AGENTS CH, V54, P811, DOI 10.1128/AAC.00652-09
   Walker JN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00039
   WHO, 2014, ANT RES
   Zaat S.A.J., 2012, BIOMATERIALS ASS INF, P175
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang BGX, 2014, INT J MOL SCI, V15, P11878, DOI 10.3390/ijms150711878
NR 42
TC 23
Z9 23
U1 4
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 28
PY 2016
VL 222
BP 1
EP 8
DI 10.1016/j.jconrel.2015.12.003
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA DA9CP
UT WOS:000368105300009
PM 26658071
DA 2018-10-20
ER

PT J
AU Gaharwar, AK
   Arpanaei, A
   Andresen, TL
   Dolatshahi-Pirouz, A
AF Gaharwar, Akhilesh K.
   Arpanaei, Ayyoob
   Andresen, Thomas L.
   Dolatshahi-Pirouz, Alireza
TI 3D Biomaterial Microarrays for Regenerative Medicine: Current
   State-of-the-Art, Emerging Directions and Future Trends
SO ADVANCED MATERIALS
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; 3-DIMENSIONAL CELLULAR MICROARRAY;
   HIGH-THROUGHPUT; NEURODEGENERATIVE DISEASES; RHEUMATOID-ARTHRITIS;
   SURFACE INTERFACE; CULTURE-SYSTEMS; MICROWELL ARRAY; COMBINATORIAL;
   HYDROGELS
AB Three dimensional (3D) biomaterial microarrays hold enormous promise for regenerative medicine because of their ability to accelerate the design and fabrication of biomimetic materials. Such tissue-like biomaterials can provide an appropriate microenvironment for stimulating and controlling stem cell differentiation into tissue-specific lineages. The use of 3D biomaterial microarrays can, if optimized correctly, result in a more than 1000-fold reduction in biomaterials and cells consumption when engineering optimal materials combinations, which makes these miniaturized systems very attractive for tissue engineering and drug screening applications.
C1 [Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
   [Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA.
   [Arpanaei, Ayyoob] Natl Inst Genet Engn & Biotechnol, Dept Ind & Environm Biotechnol, Tehran, Iran.
   [Andresen, Thomas L.; Dolatshahi-Pirouz, Alireza] Tech Univ Denmark, DTU Nanotech, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark.
RP Dolatshahi-Pirouz, A (reprint author), Tech Univ Denmark, DTU Nanotech, Ctr Nanomed & Theranost, DK-2800 Lyngby, Denmark.
EM aldo@nanotech.dtu.dk
RI Dolatshahi-Pirouz, Alireza/P-8179-2014
OI Dolatshahi-Pirouz, Alireza/0000-0001-6326-0836; arpanaei,
   ayyoob/0000-0003-3872-2933; Andresen, Thomas Lars/0000-0002-1048-127X;
   Gaharwar, Akhilesh/0000-0002-0284-0201
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bagherifard S, 2014, ACS APPL MATER INTER, V6, P7963, DOI 10.1021/am501119k
   Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Carrow J. K., 2014, MACROMOL CHEM PHYS, V3, P248
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chhabra P, 2009, CURR OPIN ORGAN TRAN, V14, P46, DOI 10.1097/MOT.0b013e328322f989
   Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115
   Cui X, 2011, OSTEOARTHR CARTILAGE, V19, pS47, DOI 10.1016/S1063-4584(11)60119-2
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Discher D. E., 2007, BIOPHYS J A, p32A
   Discher D. E., 2006, ABSTR PAP AM CHEM S, P232
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Dolatshahi-Pirouz A., 2014, SCI REP, V4
   Dolatshahi-Pirouz A, 2011, J FUNCT BIOMATER, V2, P88, DOI 10.3390/jfb2030088
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dunn D. A., 2000, DRUG DISCOV TODAY, V5, P84
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661
   Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Fung M, 2001, DRUG INF J, V35, P293, DOI 10.1177/009286150103500134
   Gaharwar A. K., ACS NANO, V8, P9833
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gupta N, 2012, NAT CHEM, V4, P424, DOI 10.1038/NCHEM.1328
   Gurkan UA, 2014, MOL PHARMACEUT, V11, P2151, DOI 10.1021/mp400573g
   Gurkan UA, 2013, ADV MATER, V25, P1192, DOI 10.1002/adma.201203261
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Hull R, 2002, MAT SCI ENG C-BIO S, V19, P383, DOI 10.1016/S0928-4931(01)00426-X
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Jensen T, 2011, J BIOMED MATER RES A, V99A, P94, DOI 10.1002/jbm.a.33166
   Jensen T, 2010, COLLOID SURFACE B, V75, P186, DOI 10.1016/j.colsurfb.2009.08.029
   Jessen KA, 2005, MOL CANCER THER, V4, P761, DOI 10.1158/1535-7163.MCT-04-0333
   Jia X. Q., 2011, ABSTR PAP AM CHEM S, P242
   Kang LF, 2010, J BIOMED MATER RES A, V93A, P547, DOI 10.1002/jbm.a.32557
   Kerativitayanan P, 2015, ADV HEALTHC MATER, V4, P1600, DOI 10.1002/adhm.201500272
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Kolind K, 2010, BIOMATERIALS, V31, P9182, DOI 10.1016/j.biomaterials.2010.08.048
   Kwon S. J., 2014, NAT COMMUN, P5
   Langle D, 2014, ACS CHEM BIOL, V9, P57, DOI 10.1021/cb4008277
   Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105
   Li C, 2013, INT J HYDROGEN ENERG, V38, P9310, DOI 10.1016/j.ijhydene.2013.05.025
   Lleo A, 2007, CELL MOL LIFE SCI, V64, P1403, DOI 10.1007/s00018-007-6516-1
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1
   Mason C, 2010, REGEN MED, V5, P307, DOI [10.2217/rme.10.37, 10.2217/RME.10.37]
   Mei Y, 2012, MATER TODAY, V15, P444, DOI 10.1016/S1369-7021(12)70196-7
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Meli L, 2014, STEM CELL RES, V13, P36, DOI 10.1016/j.scr.2014.04.004
   Meli L, 2012, BIOMATERIALS, V33, P9087, DOI 10.1016/j.biomaterials.2012.08.065
   Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498
   Mueller H, 2004, J BIOMOL SCREEN, V9, P506, DOI 10.1177/1087057104265386
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Oliveira MB, 2014, TISSUE ENG PART C-ME, V20, P851, DOI [10.1089/ten.tec.2013.0738, 10.1089/ten.TEC.2013.0738]
   Oliveira MB, 2013, SMALL, V9, P768, DOI 10.1002/smll.201201436
   Park S.B., 2012, PLOS ONE, V7
   Pataky K, 2012, ADV MATER, V24, P391, DOI 10.1002/adma.201102800
   Peak C. W., CELL MOL BIOENG, V8, P404
   Pina S, 2015, ADV MATER, V27, P1143, DOI 10.1002/adma.201403354
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ranga A., 2014, NAT COMMUN, P5
   Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761
   Rocha PM, 2011, J BIOACT COMPAT POL, V26, P493, DOI 10.1177/0883911511420700
   Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721
   Salgado CL, 2012, INTEGR BIOL-UK, V4, P318, DOI 10.1039/c2ib00170e
   Shin SR, 2014, ADV FUNCT MATER, V24, P6136, DOI 10.1002/adfm.201401300
   Simon CG, 2011, ADV MATER, V23, P369, DOI 10.1002/adma.201001763
   Simon CG, 2009, COMB CHEM HIGH T SCR, V12, P533
   Soen Y., 2006, MOL SYS BIOL, P2
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stevens MM, 2011, BIOPHYS J, V100, P189
   Sureda FX, 2011, CURR PHARM DESIGN, V17, P230
   The R, 2013, IEEE INT C INT ROBOT, P502, DOI 10.1109/IROS.2013.6696398
   Tian XF, 2008, SCAND J CLIN LAB INV, V68, P58, DOI 10.1080/00365510701466416
   Woodruff K, 2013, NAT METHODS, V10, P550, DOI [10.1038/NMETH.2473, 10.1038/nmeth.2473]
   WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319
   Wu JH, 2011, BIOMATERIALS, V32, P841, DOI 10.1016/j.biomaterials.2010.09.026
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
   Yuan B, 2010, ADV FUNCT MATER, V20, P3715, DOI 10.1002/adfm.201001298
NR 92
TC 25
Z9 25
U1 5
U2 85
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JAN 27
PY 2016
VL 28
IS 4
BP 771
EP 781
DI 10.1002/adma.201503918
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DB9PD
UT WOS:000368847800025
PM 26607415
DA 2018-10-20
ER

PT J
AU Mundargi, RC
   Potroz, MG
   Park, S
   Park, JH
   Shirahama, H
   Lee, JH
   Seo, J
   Cho, NJ
AF Mundargi, Raghavendra C.
   Potroz, Michael G.
   Park, Soohyun
   Park, Jae Hyeon
   Shirahama, Hitomi
   Lee, Jae Ho
   Seo, Jeongeun
   Cho, Nam-Joon
TI Lycopodium Spores: A Naturally Manufactured, Superrobust Biomaterial for
   Drug Delivery
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE Lycopodium clavatum; macromolecules; microencapsulation; microridges;
   microstructure; natural spores
ID GASTROINTESTINAL MUCUS; CONTROLLED-RELEASE; TARGETED DELIVERY; PLANT
   SPORES; MICROENCAPSULATION; ENCAPSULATION; MICROCAPSULES; ABSORPTION;
   CLAVATUM
AB Herein, the exploration of natural plant-based spores for the encapsulation of macromolecules as a drug delivery platform is reported. Benefits of encapsulation with natural spores include highly uniform size distribution and materials encapsulation by relatively economical and simple versatile methods. The natural spores possess unique micromeritic properties and an inner cavity for significant macromolecule loading with retention of therapeutic spore constituents. In addition, these natural spores can be used as advanced materials to encapsulate a wide variety of pharmaceutical drugs, chemicals, cosmetics, and food supplements. Here, for the first time a strategy to utilize natural spores as advanced materials is developed to encapsulate macromolecules by three different microencapsulation techniques including passive, compression, and vacuum loading. The natural spore formulations developed by these techniques are extensively characterized with respect to size uniformity, shape, encapsulation efficiency, and localization of macromolecules in the spores. In vitro release profiles of developed spore formulations in simulated gastric and intestinal fluids have also been studied, and alginate coatings to tune the release profile using vacuum-loaded spores have been explored. These results provide the basis for further exploration into the encapsulation of a wide range of therapeutic molecules in natural plant spores.
C1 [Mundargi, Raghavendra C.; Potroz, Michael G.; Park, Soohyun; Park, Jae Hyeon; Shirahama, Hitomi; Lee, Jae Ho; Seo, Jeongeun; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Mundargi, Raghavendra C.; Potroz, Michael G.; Park, Soohyun; Park, Jae Hyeon; Shirahama, Hitomi; Lee, Jae Ho; Seo, Jeongeun; Cho, Nam-Joon] Nanyang Technol Univ, Ctr Biomimet Sensor Sci, 50 Nanyang Dr, Singapore 637553, Singapore.
   [Cho, Nam-Joon] Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.
RP Cho, NJ (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM njcho@ntu.edu.sg
RI Cho, Nam-Joon/J-7816-2012
OI Cho, Nam-Joon/0000-0002-8692-8955
FU National Research Foundation [NRF-NRFF2011-01]; NRF Competitive Research
   Programme [NRF-CRP10-2012-07]
FX This work was supported by the National Research Foundation
   (NRF-NRFF2011-01) and an NRF Competitive Research Programme
   (NRF-CRP10-2012-07).
CR Anal AK, 2007, TRENDS FOOD SCI TECH, V18, P240, DOI 10.1016/j.tifs.2007.01.004
   Archibald SJ, 2014, J MATER CHEM B, V2, P945, DOI 10.1039/c3tb21523g
   Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312
   Atwe SU, 2014, J CONTROL RELEASE, V194, P45, DOI 10.1016/j.jconrel.2014.08.010
   Aya K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1552
   Bai F, 2013, P NATL ACAD SCI USA, V110, P4273, DOI 10.1073/pnas.1301814110
   Banerjee J, 2014, J PHARMACOGN PHYTOCH, V3, P207
   Barrier S, 2011, J MATER CHEM, V21, P975, DOI 10.1039/c0jm02246b
   Barrier S, 2010, LWT-FOOD SCI TECHNOL, V43, P73, DOI 10.1016/j.lwt.2009.07.001
   Chen XT, 2014, INT J NANOMED, V9, P1957, DOI 10.2147/IJN.S57048
   da Silva GH, 2015, HOMEOPATHY, V104, P29, DOI 10.1016/j.homp.2014.05.005
   Diego-Taboada Alberto, 2014, Pharmaceutics, V6, P80, DOI 10.3390/pharmaceutics6010080
   Diego-Taboada A, 2013, J MATER CHEM B, V1, P707, DOI 10.1039/c2tb00228k
   Diego-Taboada A, 2012, J MATER CHEM, V22, P9767, DOI [10.1039/c2jmo0103a, 10.1039/c2jm00103a]
   Duncanson WJ, 2012, LAB CHIP, V12, P2135, DOI 10.1039/c2lc21164e
   Durdun C., 2011, Scientific Works - University of Agronomical Sciences and Veterinary Medicine, Bucharest Series C, Veterinary Medicine, V57, P61
   Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009
   Fattahi P, 2013, ADV MATER, V25, P4555, DOI 10.1002/adma.201301033
   Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904
   Hanif K, 2015, HOMEOPATHY, V104, P24, DOI 10.1016/j.homp.2014.08.003
   Jamil F., 2011, INT J RES PHARM BIOM, V2, P1427
   KNOX RB, 1970, J CELL SCI, V6, P1
   Lee ES, 2007, BIOMATERIALS, V28, P2754, DOI 10.1016/j.biomaterials.2007.01.049
   Lee W, 2009, BIOMATERIALS, V30, P6648, DOI 10.1016/j.biomaterials.2009.08.035
   Lorch M, 2009, CHEM COMMUN, P6442, DOI 10.1039/b909551a
   Ma GH, 2014, J CONTROL RELEASE, V193, P324, DOI 10.1016/j.jconrel.2014.09.003
   Ma HB, 2014, J MICROENCAPSUL, V31, P667, DOI 10.3109/02652048.2014.913723
   MACADAM A, 1993, ADV DRUG DELIVER REV, V11, P201, DOI 10.1016/0169-409X(93)90010-2
   Mackenzie G, 2014, MICROENCAPSULATION IN THE FOOD INDUSTRY: A PRACTICAL IMPLEMENTATION GUIDE, P283, DOI 10.1016/B978-0-12-404568-2.00024-8
   McEntee MKE, 2008, J APPL POLYM SCI, V107, P2956, DOI 10.1002/app.27478
   Mitsumoto K, 2009, J BIOSCI BIOENG, V107, P90, DOI 10.1016/j.jbiosc.2008.10.001
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Orhan I, 2007, J ETHNOPHARMACOL, V109, P146, DOI 10.1016/j.jep.2006.07.018
   Paunov VN, 2007, J MATER CHEM, V17, P609, DOI 10.1039/b615865j
   Rask-Andersen A, 2000, ALLERGY, V55, P836, DOI 10.1034/j.1398-9995.2000.00484.x
   Roshchina VV, 1999, BIOL PLANTARUM, V42, P273, DOI 10.1023/A:1002120904588
   SALEN ERNST B., 1951, ACTA ALLERGOL, V4, P308, DOI 10.1111/j.1398-9995.1951.tb03422.x
   Satwara S. R., 2011, INVENTI RAPID PHARM, V3, P1
   STANLEY R G, 1974, P307
   Wakil A, 2010, LIPIDS, V45, P645, DOI 10.1007/s11745-010-3427-y
   Wang AM, 2003, P NATL ACAD SCI USA, V100, P14487, DOI 10.1073/pnas.2231254100
   Wang ChaoYuan, 2013, Natural Science, V5, P84, DOI 10.4236/ns.2013.51014
   Wang MB, 2010, POLYM DEGRAD STABIL, V95, P6, DOI 10.1016/j.polymdegradstab.2009.10.015
   Yu D, 2013, P NATL ACAD SCI USA, V110, pE746, DOI 10.1073/pnas.1300083110
   Zhang HB, 2014, ADV MATER, V26, P4497, DOI 10.1002/adma.201400953
NR 45
TC 9
Z9 9
U1 5
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JAN 26
PY 2016
VL 26
IS 4
BP 487
EP 497
DI 10.1002/adfm.201502322
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DC0DA
UT WOS:000368886000002
DA 2018-10-20
ER

PT J
AU Willinger, MG
   Checa, AG
   Bonarski, JT
   Faryna, M
   Berent, K
AF Willinger, Marc G.
   Checa, Antonio G.
   Bonarski, Jan T.
   Faryna, Marek
   Berent, Katarzyna
TI Biogenic Crystallographically Continuous Aragonite Helices: The
   Microstructure of the Planktonic Gastropod Cuvierina
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE aragonite; biomineralization; crystals; shells; spirals; twins
ID GROWTH; SHELL; NACRE; SUPERSTRUCTURES; MESOCRYSTALS; RESISTANCE
AB The pteropod Cuvierina constructs very lightweight, thin, flexible, and resistant shells with the most unusual microstructure: densely packed, continuous crystalline aragonite fibers that coil helically around axes perpendicular to the shell surface. The high degree of fiber intergrowth results in a particular interlocking structure. The shell is constructed by guided self-assembly, outside the animal's soft body. A prerequisite to understand its formation is to resolve the underlying crystallographic building principle. This is basic in order to use this hierarchically structured and highly functional biomaterial as inspiration for the production of new materials. It teaches us about the optimization of structures over millions of years of evolution under strict consideration of energetic costs and efficient use of available resources and materials. We have described how helical coiling proceeds by using a combination of diffraction and imaging techniques, which complement at different levels of resolution. Despite their curling, the fibers are continuously crystalline and show a preferred crystallographic growth direction. When the latter can no more be maintained due to the imposed curving, abrupt changes across twins permit to continue growth in the desired direction. This is a nice example of how crystallographically continuous fibers can grow helically.
C1 [Willinger, Marc G.] Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, D-14195 Berlin, Germany.
   [Checa, Antonio G.] Univ Granada, Dept Estratig & Paleontol, E-18071 Granada, Spain.
   [Bonarski, Jan T.; Faryna, Marek; Berent, Katarzyna] Polish Acad Sci, Inst Met & Mat Sci, PL-30059 Krakow, Poland.
   [Berent, Katarzyna] AGH Univ Sci & Technol, Acad Ctr Mat & Nanotechnol, PL-30059 Krakow, Poland.
RP Checa, AG (reprint author), Univ Granada, Dept Estratig & Paleontol, E-18071 Granada, Spain.
EM acheca@ugr.es
RI Willinger, Marc Georg/C-1836-2015; Checa, Antonio/A-6157-2008
OI Willinger, Marc Georg/0000-0002-9996-7953; Checa,
   Antonio/0000-0001-7873-7545
FU MNHN; Spanish Ministerio de Ciencia e Innovacion [CGL2010-20748-C02-01,
   CGL2013-48247-P]; Andalusian Consejeria de Economia, Investigacion,
   Ciencia y Empleo, of the Junta de Andalucia [P10-RNM6433]; latter
   Institution [RNM363]
FX M.G.W and A.G.C. contributed equally to this work. The loan from the
   MNHN was facilitated by Prof. Serge Gofas (Department of Animal Biology,
   University of Malaga). The authors also thank Achim Klein (Fritz-Haber
   Institut, Berlin) for TEM sample preparation. Funding was provided by
   Research Projects CGL2010-20748-C02-01 and CGL2013-48247-P of the
   Spanish Ministerio de Ciencia e Innovacion, and P10-RNM6433 of the
   Andalusian Consejeria de Economia, Investigacion, Ciencia y Empleo, of
   the Junta de Andalucia, and by the Research Group RNM363 (latter
   Institution). A.G.C. also benefited from a Short Term Scientific Mission
   of the European FP7 COST Action TD0903 of the European Community at the
   IMIM (Krakow).
CR Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036
   Baron H. H., 2014, THESIS WEIZMANN I SC
   Be A.W.H, 1972, Biomineralization Res Rep, V4, P47
   Bierman MJ, 2008, SCIENCE, V320, P1060, DOI 10.1126/science.1157131
   Boggild O. B., 1930, Kongelige Danske Videnskabernes Selskabs Skrifter, Vix 2, P231
   BOULIGAND Y, 1972, TISSUE CELL, V4, P189, DOI 10.1016/S0040-8166(72)80042-9
   Carter J. G., 1985, MOLLUSKS NOTES SHORT, P50
   Checa AG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0425
   Checa AG, 2009, CRYST GROWTH DES, V9, P4574, DOI 10.1021/cg9005949
   Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496
   Corse E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059439
   Freer A, 2010, CRYST GROWTH DES, V10, P344, DOI 10.1021/cg901265x
   Hackman R. H., 1987, Chitin and benzoylphenyl ureas., P1
   Li L, 2015, ADV FUNCT MATER, V25, P3463, DOI 10.1002/adfm.201500380
   Li L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7216
   Neuser RD, 2007, SEDIMENT GEOL, V194, P149, DOI 10.1016/j.sedgeo.2006.05.015
   NEVILLE AC, 1993, BIOL FIBROUS COMPOSI, P214
   Olson IC, 2013, J STRUCT BIOL, V184, P454, DOI 10.1016/j.jsb.2013.10.002
   Olson IC, 2013, J STRUCT BIOL, V183, P180, DOI 10.1016/j.jsb.2013.06.006
   Rodriguez-Navarro AB, 2012, ACTA BIOMATER, V8, P830, DOI 10.1016/j.actbio.2011.11.001
   Sato-Okoshi W, 2010, POLAR BIOL, V33, P1577, DOI 10.1007/s00300-010-0849-1
   Song RQ, 2010, ADV MATER, V22, P1301, DOI 10.1002/adma.200901365
   WADA K, 1966, NATURE, V211, P1427, DOI 10.1038/2111427a0
   Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764
   Williams A, 1970, Spec. Pap. Paleont., VNo. 7, P1
   Zhang TJ, 2011, ANGEW CHEM INT EDIT, V50, P10361, DOI 10.1002/anie.201103407
NR 26
TC 3
Z9 3
U1 0
U2 20
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JAN 26
PY 2016
VL 26
IS 4
BP 553
EP 561
DI 10.1002/adfm.201504034
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DC0DA
UT WOS:000368886000009
DA 2018-10-20
ER

PT J
AU Shao, DD
   Ren, XM
   Wen, J
   Hu, S
   Xiong, J
   Jiang, T
   Wang, XL
   Wang, XK
AF Shao, Dadong
   Ren, Xuemei
   Wen, Jun
   Hu, Sheng
   Xiong, Jie
   Jiang, Tao
   Wang, Xiaolin
   Wang, Xiangke
TI Immobilization of uranium by biomaterial stabilized FeS nanoparticles:
   Effects of stabilizer and enrichment mechanism
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Stabilized FeS; Immobilization mechanisms; Uranium; Biomaterial;
   Radioactive wastewater
ID IRON-OXIDE NANOPARTICLES; ZERO-VALENT IRON; CARBOXYMETHYL CELLULOSE;
   REDUCTIVE IMMOBILIZATION; GELATIN; WATER; ADSORPTION; SULFIDE;
   DECHLORINATION; GROUNDWATER
AB Iron sulfide (FeS) nanoparticles have been recognized as effective scavengers for multi-valent metal ions. However, the aggregation of FeS nanoparticles in aqueous solution greatly restricts their application in real work. Herein, different biomaterial-FeS nanoparticles were developed for the in-situ immobilization of uranium(VI) in radioactive waste management. TEM images suggested that sodium carboxymethyl cellulose (CMC) and gelatin can effectively suppress the aggregation of FeS nanoparticles in aqueous solutions. The resulting CMC-FeS and gelatin-FeS were stable in aqueous solutions and showed high adsorption capacity for U(VI). Specially, gelatin-FeS showed the best performance in U(VI) adsorption-reduction immobilization under experimental conditions. The maximum enrichment capacity of U(VI) on CMC-FeS and gelatin-FeS at pH 5.0 and 20 degrees C achieved to similar to 430 and similar to 556 mg/g, respectively. Additionally, gelatin-FeS and CMC-FeS nanoparticles presented excellent tolerance to environmental salinity. The immobilized U(VI) on the surfaces of CMC-FeS and gelatin-FeS remained stable more than one year. These findings highlight the possibility of using ggelatin-FeS for efficient immobilization of U(VI) from radioactive wastewater. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Shao, Dadong; Wen, Jun; Hu, Sheng; Xiong, Jie; Jiang, Tao] China Acad Engn Phys, Inst Nucl Phys & Chem, Mianyang 621900, Peoples R China.
   [Shao, Dadong; Ren, Xuemei] Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Peoples R China.
   [Wang, Xiaolin] China Acad Engn Phys, Mianyang 621900, Peoples R China.
   [Wang, Xiangke] North China Elect Power Univ, Sch Environm & Chem Engn, Beijing 102206, Peoples R China.
RP Ren, XM (reprint author), Chinese Acad Sci, Inst Plasma Phys, POB 1126, Hefei 230031, Peoples R China.
EM renxm_nana@163.com; xlwang@caep.ac.cn; xkwang@ncepu.edu.cn
RI Wang, Xiangke/I-5806-2012
OI Wang, Xiangke/0000-0002-3352-1617
FU National Natural Science Foundation of China [21307135, 91326110,
   21225730, 91326202]; NSAF [1U1530131]; Anhui Provincial Natural Science
   Foundation [1508085MB29]; Science Foundation of Institute of Plasma
   Physics, Chinese Academy of Sciences [DSJJ-13-YY01]; Radiochemistry 909
   Project in the China Academy of Engineering Physics; Science and
   Technology Development Foundation of China Academy of Engineering
   Physics [2014B0301034]
FX The financial support from the National Natural Science Foundation of
   China (21307135, 91326110, 21225730, 91326202), NSAF (1U1530131), Anhui
   Provincial Natural Science Foundation (1508085MB29), the Science
   Foundation of Institute of Plasma Physics, Chinese Academy of Sciences
   (DSJJ-13-YY01), the Radiochemistry 909 Project in the China Academy of
   Engineering Physics, the Science and Technology Development Foundation
   of China Academy of Engineering Physics (2014B0301034) are acknowledged.
CR Almeida JMA, 2008, J MAGN MAGN MATER, V320, pE304, DOI 10.1016/j.jmmm.2008.02.062
   Bargar JR, 2013, P NATL ACAD SCI USA, V110, P4506, DOI 10.1073/pnas.1219198110
   Beyenal H, 2004, ENVIRON SCI TECHNOL, V38, P2067, DOI 10.1021/es0348703
   Bi Y., 2014, ENVIRON SCI TECHNOL, V18, P13402
   Bi YQ, 2014, ENVIRON SCI TECHNOL, V48, P632, DOI 10.1021/es4043353
   Bi YQ, 2013, GEOCHIM COSMOCHIM AC, V102, P175, DOI 10.1016/j.gca.2012.10.032
   Bruggeman C, 2010, ENVIRON SCI TECHNOL, V44, P4210, DOI 10.1021/es100919p
   Crane RA, 2011, WATER RES, V45, P2931, DOI 10.1016/j.watres.2011.03.012
   Druhan JL, 2008, ENVIRON SCI TECHNOL, V42, P7842, DOI 10.1021/es800414s
   Dullies F, 2010, SCI TOTAL ENVIRON, V408, P6260, DOI 10.1016/j.scitotenv.2010.08.018
   Gaihre B, 2009, J MATER SCI-MATER M, V20, P573, DOI 10.1007/s10856-008-3565-4
   Gaihre B, 2008, MAT SCI ENG C-BIO S, V28, P1297, DOI 10.1016/j.msec.2008.01.001
   Gaihre B, 2009, INT J PHARM, V365, P180, DOI 10.1016/j.ijpharm.2008.08.020
   Gallegos TJ, 2013, ENVIRON SCI TECHNOL, V47, P7357, DOI 10.1021/es400450z
   Gong YY, 2014, ENVIRON SCI TECHNOL, V48, P3986, DOI 10.1021/es404418a
   Gong YY, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/29/294007
   Hansen MR, 2009, FOOD HYDROCOLLOID, V23, P2038, DOI 10.1016/j.foodhyd.2009.05.008
   He F, 2005, ENVIRON SCI TECHNOL, V39, P3314, DOI 10.1021/es048743y
   He F, 2007, ENVIRON SCI TECHNOL, V41, P6216, DOI 10.1021/es0705543
   He F, 2007, IND ENG CHEM RES, V46, P29, DOI 10.1021/ie0610896
   Hua B, 2008, ENVIRON SCI TECHNOL, V42, P8703, DOI 10.1021/es801225z
   Larson-Smith K, 2012, LANGMUIR, V28, P11734, DOI 10.1021/la301896c
   Ma XC, 2005, J CRYST GROWTH, V277, P314, DOI 10.1016/j.jcrysgro.2005.01.048
   Sakulchaicharoen N, 2010, J CONTAM HYDROL, V118, P117, DOI 10.1016/j.jconhyd.2010.09.004
   Scott TB, 2007, GEOCHIM COSMOCHIM AC, V71, P5044, DOI 10.1016/j.gca.2007.08.017
   Shao DD, 2015, ENVIRON SCI-WAT RES, V1, P169, DOI [10.1039/C4EW00014E, 10.1039/c4ew00014e]
   Shao DD, 2014, SCI CHINA CHEM, V57, P1449, DOI 10.1007/s11426-014-5195-7
   Shao DD, 2014, CHEM ENG J, V255, P604, DOI 10.1016/j.cej.2014.06.063
   Tan XL, 2014, TRAC-TREND ANAL CHEM, V61, P107, DOI 10.1016/j.trac.2014.06.010
   Thakur SS, 2014, IND ENG CHEM RES, V53, P4838, DOI 10.1021/ie401997g
   Wan JM, 2005, ENVIRON SCI TECHNOL, V39, P6162, DOI 10.1021/es048236g
   Wei W, 2014, APPL SURF SCI, V292, P1020, DOI 10.1016/j.apsusc.2013.12.127
   Wittekindt C, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739538
   Wu QF, 2003, CATAL TODAY, V85, P291, DOI 10.1016/S0920-5861(03)00395-X
   Xiong Z, 2009, WATER RES, V43, P5171, DOI 10.1016/j.watres.2009.08.018
   Xu C, 2012, ACS NANO, V6, P4713, DOI 10.1021/nn2045714
   Zhang MY, 2010, CHINESE SCI BULL, V55, P365, DOI 10.1007/s11434-009-0703-4
   Zhang SX, 2010, CHEM ENG J, V158, P599, DOI 10.1016/j.cej.2010.02.013
NR 38
TC 20
Z9 21
U1 12
U2 176
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JAN 25
PY 2016
VL 302
BP 1
EP 9
DI 10.1016/j.jhazmat.2015.09.043
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA CY2FX
UT WOS:000366225300001
PM 26448488
DA 2018-10-20
ER

PT J
AU Heris, HK
   Daoud, J
   Sheibani, S
   Vali, H
   Tabrizian, M
   Mongeau, L
AF Heris, Hossein K.
   Daoud, Jamal
   Sheibani, Sara
   Vali, Hojatollah
   Tabrizian, Maryam
   Mongeau, Luc
TI Investigation of the Viability, Adhesion, and Migration of Human
   Fibroblasts in a Hyaluronic Acid/Gelatin Microgel-Reinforced Composite
   Hydrogel for Vocal Fold Tissue Regeneration
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; IN-VIVO; SUBSTRATE
   STIFFNESS; ACID; GELATIN; GROWTH; 3D; BIOMATERIALS; BIOMECHANICS
AB The potential use of a novel scaffold biomaterial consisting of cross-linked hyaluronic acid (HA)-gelatin (Ge) composite microgels is investigated for use in treating vocal fold injury and scarring. Cell adhesion integrins and kinematics of cell motion are investigated in 2D and 3D culture conditions, respectively. Human vocal fold fibroblast (hVFF)cells are seeded on HA-Ge microgels attached to a HA hydrogel thin film. The results show that hVFF cells establish effective adhesion to HA-Ge microgels through the ubiquitous expression of beta(1) integrin in the cell membrane. The microgels are then encapsulated in a 3D HA hydrogel for the study of cell migration. The cells within the HA-Ge microgel-reinforced composite hydrogel (MRCH) scaffold have an average motility speed of 0.24 +/- 0.08 mu m min(-1). The recorded microscopic images reveal features that are presumably associated with lobopodial and lamellipodial cell migration modes within the MRCH scaffold. Average cell speed during lobopodial migration is greater than that during lamellipodial migration. The cells move faster in the MRCH than in the HA-Ge gel without microgels. These findings support the hypothesis that HA-Ge MRCH promotes cell adhesion and migration; thereby they constitute a promising biomaterial for vocal fold repair.
C1 [Heris, Hossein K.; Mongeau, Luc] McGill Univ, Dept Mech Engn, Biomech Lab, Fac Engn, 817 Rue Sherbrooke Ouest, Montreal, PQ H3A 0C3, Canada.
   [Daoud, Jamal; Tabrizian, Maryam] McGill Univ, Fac Med, Dept Biomed Engn, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.
   [Sheibani, Sara] Def R&D Canada Suffield, Biol Threat Def Sect, Stn Main, Medicine Hat, AB T1A 8K6, Canada.
   [Sheibani, Sara; Vali, Hojatollah; Tabrizian, Maryam] McGill Univ, Dept Anat & Cell Biol, Fac Med, 3640 Univ St, Montreal, PQ H3A 0C7, Canada.
RP Mongeau, L (reprint author), McGill Univ, Dept Mech Engn, Biomech Lab, Fac Engn, 817 Rue Sherbrooke Ouest, Montreal, PQ H3A 0C3, Canada.; Tabrizian, M (reprint author), McGill Univ, Fac Med, Dept Biomed Engn, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.
EM maryam.tabrizian@mcgill.ca; luc.mongeau@mcgill.ca
OI Mongeau, Luc/0000-0003-0344-227X
FU NCDCD Grant [R01-DC005788]; Natural Science and Engineering Research
   Council of Canada (NSERC); M. Tabrizian NSERC Discovery Grant; Canadian
   Institute of Health Research (CIHR); Fonds Quebecois de la recherche sur
   la nature et les technologies (FQRNT)
FX The authors gratefully thank NCDCD Grant R01-DC005788, the Natural
   Science and Engineering Research Council of Canada (NSERC), M. Tabrizian
   NSERC Discovery Grant,Canadian Institute of Health Research (CIHR), and
   the Fonds Quebecois de la recherche sur la nature et les technologies
   (FQRNT) for their financial support. The authors would like to thank
   Prof. Susan Thibeault (Division of Otolaryngology, Head and Neck
   Surgery, University of Wisconsin) for providing them with immortalized
   hVFF cells.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arimura H, 2005, J BIOMAT SCI-POLYM E, V16, P1347, DOI 10.1163/156856205774472353
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Borzacchiello A, 2005, J MATER SCI-MATER M, V16, P553, DOI 10.1007/s10856-005-0531-2
   Butler JE, 2001, LARYNGOSCOPE, V111, P907, DOI 10.1097/00005537-200105000-00029
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Chan RW, 2001, OTOLARYNG HEAD NECK, V124, P607, DOI 10.1067/mhn.2001.115906
   Chang MC, 2003, BIOMATERIALS, V24, P3087, DOI 10.1016/S0142-9612(03)00150-9
   Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390
   Ciper M, 2005, INT J PHARM, V303, P62, DOI 10.1016/j.ijpharm.2005.07.004
   Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r
   Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Eugene W. L., 2014, RSC ADV, V4, P31581
   Fon D, 2014, ADV HEALTHC MATER, V3, P761, DOI 10.1002/adhm.201300287
   Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033
   Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001
   Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022
   Harland B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015011
   Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hirano Shigeru, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P143, DOI 10.1097/01.moo.0000162261.49739.b7
   Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61
   Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   Kazemirad S., 2015, J BIOMED MAT RES B, DOI 10.1002.33358
   Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   Li JX, 2006, BIOMACROMOLECULES, V7, P2243, DOI 10.1021/bm0603342
   Liu YC, 2004, J BIOMED MATER RES A, V68A, P142, DOI 10.1002/jbm.a.10142
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mason B., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2
   Mekhail M, 2014, ADV HEALTHC MATER, V3, P1529, DOI 10.1002/adhm.201300586
   Na K, 2007, J BIOMED MATER RES A, V83A, P779, DOI 10.1002/jbm.a.31374
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Park H, 2010, TISSUE ENG PT A, V16, P535, DOI [10.1089/ten.tea.2009.0029, 10.1089/ten.TEA.2009.0029]
   Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732
   Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124
   Schuldt Alison, 2013, Nat Rev Mol Cell Biol, V14, P462, DOI 10.1038/nrm3627
   Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Shull KR, 2012, NATURE, V489, P36, DOI 10.1038/489036a
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Sixt M, 2012, J CELL BIOL, V197, P346, DOI 10.1083/jcb.201204039
   Slater JH, 2015, ACS APPL MATER INTER, V7, P4390, DOI 10.1021/am508906f
   Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403
   Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299
   Thibeault Susan L, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P148, DOI 10.1097/01.moo.0000163450.90455.fb
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Vincent LG, 2013, BIOTECHNOL J, V8, P472, DOI 10.1002/biot.201200205
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
   Yanai M, 1996, CELL MOTIL CYTOSKEL, V33, P22
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 62
TC 11
Z9 11
U1 6
U2 63
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN 21
PY 2016
VL 5
IS 2
BP 255
EP 265
DI 10.1002/adhm.201500370
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DD5ZN
UT WOS:000370003600008
PM 26501384
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, LQ
   Mahara, A
   Tong, ZX
   Levenson, EA
   McGann, CL
   Jia, XQ
   Yamaoka, T
   Kiick, KL
AF Li, Linqing
   Mahara, Atsushi
   Tong, Zhixiang
   Levenson, Eric A.
   McGann, Christopher L.
   Jia, Xinqiao
   Yamaoka, Tetsuji
   Kiick, Kristi L.
TI Recombinant Resilin-Based Bioelastomers for Regenerative Medicine
   Applications
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID FOLD LAMINA PROPRIA; ELASTIN-LIKE POLYPEPTIDES; MESENCHYMAL STEM-CELLS;
   PROTEIN-ENGINEERED BIOMATERIALS; SYNTHETIC EXTRACELLULAR-MATRIX;
   RUBBER-LIKE PROTEIN; IN-VIVO; MECHANICAL-PROPERTIES; CROSS-LINKING;
   SOUND PRODUCTION
AB The outstanding elasticity, excellent resilience at high-frequency, and hydrophilic capacity of natural resilin have motivated investigations of recombinant resilin-based biomaterials as a new class of bio-elastomers in the engineering of mechanically active tissues. Accordingly, here the comprehensive characterization of modular resilin-like polypeptide (RLP) hydrogels is presented and their suitability as a novel biomaterial for in vivo applications is introduced. Oscillatory rheology confirmed that a full suite of the RLPs can be rapidly cross-linked upon addition of the tris(hydroxymethyl phosphine) cross-linker, achieving similar in situ shear storage moduli (20 k +/- 3.5 Pa) across various material compositions. Uniaxial stress relaxation tensile testing of hydrated RLP hydrogels under cyclic loading and unloading showed negligible stress reduction and hysteresis, superior reversible extensibility, and high resilience with Young's moduli of 30 +/- 7.4 kPa. RLP hydrogels containing MMP-sensitive domains are susceptible to enzymatic degradation by matrix metalloproteinase-1 (MMP-1). Cell culture studies revealed that RLP-based hydrogels supported the attachment and spreading (2D) of human mesenchymal stem cells and did not activate cultured macrophages. Subcutaneous transplantation of RLP hydrogels in a rat model, which to our knowledge is the first such reported in vivo analysis of RLP-based hydrogels, illustrated that these materials do not elicit a significant inflammatory response, suggesting their potential as materials for tissue engineering applications with targets of mechanically demanding tissues such as vocal fold and cardiovascular tissues.
C1 [Li, Linqing; Tong, Zhixiang; Levenson, Eric A.; McGann, Christopher L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Mahara, Atsushi; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Dept Biomed Engn, Res Inst, Osaka 5658565, Japan.
   [Jia, Xinqiao; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Dept Biomed Engn, Newark, DE 19716 USA.
RP Kiick, KL (reprint author), Univ Delaware, Dept Mat Sci & Engn, Dept Biomed Engn, Newark, DE 19716 USA.
EM kiick@udel.edu
RI Tong, Zhixiang/G-5685-2016; Levenson, Eric/A-7963-2008
OI Levenson, Eric/0000-0002-3896-3908; Li, Linqing/0000-0003-3003-9902
FU National Center for Research Resources (NCRR), a component of National
   Institutes of Health [P20-RR017716]; National Institute on Deafness and
   Other Communication Disorders (NIDCD) [RO1 DC008965, RO1 DC011377A];
   National Institutes of Health [1 P30 GM110758-01]
FX The authors acknowledge funding support from the National Center for
   Research Resources (NCRR), a component of the National Institutes of
   Health (P20-RR017716 (K.L.K.)), and the National Institute on Deafness
   and Other Communication Disorders (NIDCD, RO1 DC008965 to X.J. and RO1
   DC011377A to K.L.K.). This publication was also supported by the
   Delaware COBRE program (NIGMS; 1 P30 GM110758-01) from the National
   Institutes of Health.
CR Alipour-Haghighi F., 1990, ADV BIOENG, V17, P21
   ALIPOURHAGHIGHI F, 1985, J ACOUST SOC AM, V78, P1939, DOI 10.1121/1.392701
   Amschler K, 2014, ACS NANO, V8, P9113, DOI 10.1021/nn502690b
   ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5
   Annabi N, 2013, BIOMATERIALS, V34, P5496, DOI 10.1016/j.biomaterials.2013.03.076
   Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3
   Assmann A, 2013, BIOMATERIALS, V34, P6015, DOI 10.1016/j.biomaterials.2013.04.037
   Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108
   Baldwin AD, 2013, POLYM CHEM-UK, V4, P133, DOI 10.1039/c2py20576a
   Bartlett RS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024103
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Benitez PL, 2013, ADV HEALTHC MATER, V2, P114, DOI 10.1002/adhm.201200115
   Bennet-Clark H, 2007, J EXP BIOL, V210, P3879, DOI 10.1242/jeb.001339
   Bhatia SK, 2007, BIOTECHNOL LETT, V29, P1645, DOI 10.1007/s10529-007-9465-8
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Cai L, 2014, ACTA BIOMATER, V10, P1751, DOI 10.1016/j.actbio.2013.12.028
   Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c
   Chen X, 2016, J TISSUE ENG REGEN M, V10, P437, DOI 10.1002/term.1757
   Chen X, 2010, ACTA BIOMATER, V6, P2940, DOI 10.1016/j.actbio.2010.01.032
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Cui J, 2012, MACROMOLECULES, V45, P6104, DOI 10.1021/ma300593g
   Cui J, 2012, BIOMACROMOLECULES, V13, P584, DOI 10.1021/bm300015s
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Farran A. E., 2012, ENG BIOMATERIALS REG, P253
   Ferreira DS, 2015, ADV HEALTHC MATER, V4, P602, DOI 10.1002/adhm.201400586
   Gagner JE, 2014, ACTA BIOMATER, V10, P1542, DOI 10.1016/j.actbio.2013.10.001
   Gaston Joel, 2013, Biomatter, V3, DOI 10.4161/biom.23799
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Grieshaber SE, 2009, MACROMOLECULES, V42, P2532, DOI 10.1021/ma802791z
   Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022
   Haines-Butterick LA, 2008, BIOMATERIALS, V29, P4164, DOI 10.1016/j.biomaterials.2008.07.009
   Hanson SE, 2010, LARYNGOSCOPE, V120, P546, DOI 10.1002/lary.20797
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hertegard S, 2003, OTOLARYNG HEAD NECK, V128, P401, DOI 10.1067/mhn.2003.96
   Hrabchak C, 2010, ACTA BIOMATER, V6, P2108, DOI 10.1016/j.actbio.2009.12.034
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hughes LA, 2015, ACTA BIOMATER, V13, P111, DOI 10.1016/j.actbio.2014.10.039
   Hunter EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090762
   Jiao T, 2009, EXP MECH, V49, P235, DOI 10.1007/s11340-008-9126-4
   Kappiyoor R, 2011, SOFT MATTER, V7, P11006, DOI 10.1039/c1sm06163a
   Kiick KL, 2007, POLYM REV, V47, P1, DOI 10.1080/15583720601109545
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057
   Kutty JK, 2009, TISSUE ENG PART B-RE, V15, P249, DOI 10.1089/ten.TEB.2008.0588
   Kutty JK, 2009, J BIOMAT SCI-POLYM E, V20, P737, DOI 10.1163/156856209X426763
   Kyburz KA, 2015, ANN BIOMED ENG, V43, P489, DOI 10.1007/s10439-015-1297-4
   Lee JH, 2014, OTOLARYNG HEAD NECK, V151, P830, DOI 10.1177/0194599814549527
   Li LQ, 2015, MACROMOL RAPID COMM, V36, P90, DOI 10.1002/marc.201400521
   Li LQ, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00021
   Li L, 2013, ACS MACRO LETT, V2, P635, DOI 10.1021/mz4002194
   Li LQ, 2013, SOFT MATTER, V9, P665, DOI 10.1039/c2sm26812d
   Li LQ, 2011, BIOMACROMOLECULES, V12, P2302, DOI 10.1021/bm200373p
   Li LQ, 2010, POLYM CHEM-UK, V1, P1160, DOI 10.1039/b9py00346k
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Liu B, 2010, J AM CHEM SOC, V132, P13630, DOI 10.1021/ja1054669
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Lyons RE, 2009, BIOMACROMOLECULES, V10, P3009, DOI 10.1021/bm900601h
   Mabry KM, 2015, BIOMATERIALS, V49, P47, DOI 10.1016/j.biomaterials.2015.01.047
   MacEwan SR, 2014, J CONTROL RELEASE, V190, P314, DOI 10.1016/j.jconrel.2014.06.028
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   McGann CL, 2013, MACROMOL CHEM PHYS, V214, P203, DOI 10.1002/macp.201200412
   MIN YB, 1995, ANN OTO RHINOL LARYN, V104, P563, DOI 10.1177/000348949510400711
   Miri AK, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2014.03.001
   Mithieux SM, 2013, ADV DRUG DELIVER REV, V65, P421, DOI 10.1016/j.addr.2012.06.009
   Moore J, 2012, J VOICE, V26, P269, DOI 10.1016/j.jvoice.2011.05.003
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   Nagapudi K, 2003, CELL TRANSPLANT, V12, P170
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Nettles DL, 2008, TISSUE ENG PT A, V14, P1133, DOI [10.1089/ten.tea.2007.0245, 10.1089/tea.2007.0245]
   Nettles DL, 2010, ADV DRUG DELIVER REV, V62, P1479, DOI 10.1016/j.addr.2010.04.002
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   Olsen BD, 2013, AICHE J, V59, P3558, DOI 10.1002/aic.14223
   Ozsvar J, 2015, BIOMATER SCI-UK, V3, P800, DOI [10.1039/c5bm00038f, 10.1039/C5BM00038F]
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   Raeber GP, 2007, ACTA BIOMATER, V3, P615, DOI 10.1016/j.actbio.2007.03.013
   Renner JN, 2012, BIOMACROMOLECULES, V13, P3678, DOI 10.1021/bm301129b
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005
   Sengupta D., 2009, TISSUE ENG PART B-RE, V16, P285
   Sengupta D, 2012, ADV HEALTHC MATER, V1, P785, DOI 10.1002/adhm.201200195
   Simnick AJ, 2007, POLYM REV, V47, P121, DOI 10.1080/15583720601109594
   Skals N, 1999, J EXP BIOL, V202, P2937
   Smits FCM, 2015, MACROMOL BIOSCI, V15, P36, DOI 10.1002/mabi.201400419
   Sridhar BV, 2015, ADV HEALTHC MATER, V4, P702, DOI 10.1002/adhm.201400695
   Srokowski EM, 2008, J BIOMAT SCI-POLYM E, V19, P785, DOI 10.1163/156856208784522038
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Swartzlander MD, 2015, BIOMATERIALS, V41, P79, DOI 10.1016/j.biomaterials.2014.11.020
   Teller SS, 2012, TISSUE ENG PT A, V18, P2008, DOI [10.1089/ten.TEA.2012.0023, 10.1089/ten.tea.2012.0023]
   Thibeault SL, 2008, ANN OTO RHINOL LARYN, V117, P221, DOI 10.1177/000348940811700310
   Thibeault SL, 2011, J VOICE, V25, P249, DOI 10.1016/j.jvoice.2009.10.003
   Tong ZX, 2014, TISSUE ENG PT A, V20, P1922, DOI [10.1089/ten.tea.2013.0496, 10.1089/ten.TEA.2013.0496]
   Tong ZX, 2013, TISSUE ENG PT A, V19, P1862, DOI [10.1089/ten.tea.2012.0694, 10.1089/ten.TEA.2012.0694]
   Truong MY, 2011, BIOMATERIALS, V32, P8462, DOI 10.1016/j.biomaterials.2011.07.064
   Tse JR, 2014, LARYNGOSCOPE, V124, pE326, DOI 10.1002/lary.24605
   Ullm S, 2014, BIOMATERIALS, V35, P9755, DOI 10.1016/j.biomaterials.2014.08.023
   van Eldijk MB, 2012, TOP CURR CHEM, V310, P71, DOI 10.1007/128_2011_205
   Wang HY, 2014, BIOMACROMOLECULES, V15, P3421, DOI 10.1021/bm500969d
   WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   WEISFOGH T, 1970, NATURE, V227, P718, DOI 10.1038/227718a0
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wu XY, 2008, BIOMACROMOLECULES, V9, P1787, DOI 10.1021/bm800012x
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xiao LX, 2010, SOFT MATTER, V6, P5293, DOI 10.1039/c0sm00511h
   Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d
   Yeo GC, 2015, ADV HEALTHC MATER, V4, P2530, DOI 10.1002/adhm.201400781
   YOUNG D, 1995, J EXP BIOL, V198, P1001
   Zeitels SM, 2002, ANN OTO RHINOL LARYN, V111, P21
   Zhang K, 2009, J MECH BEHAV BIOMED, V2, P93, DOI 10.1016/j.jmbbm.2008.05.005
NR 119
TC 8
Z9 8
U1 4
U2 46
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JAN 21
PY 2016
VL 5
IS 2
BP 266
EP 275
DI 10.1002/adhm.201500411
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DD5ZN
UT WOS:000370003600009
PM 26632334
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Han, HY
   Ning, HY
   Liu, SS
   Lu, Q
   Fan, ZH
   Lu, HJ
   Lu, GZ
   Kaplan, DL
AF Han, Hongyan
   Ning, Hongyan
   Liu, Shanshan
   Lu, Qiang
   Fan, Zhihai
   Lu, Haijun
   Lu, Guozhong
   Kaplan, David L.
TI Silk Biomaterials with Vascularization Capacity
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SELF-ASSEMBLY PROCESS; FIBROIN SCAFFOLDS;
   MECHANICAL-PROPERTIES; COLLAGEN SCAFFOLDS; BONE REGENERATION; IN-VITRO;
   MATRIX; DIFFERENTIATION; ELASTICITY
AB Functional vascularization is critical for the clinical regeneration of complex tissues such as kidney, liver, or bone. The immobilization or delivery of growth factors has been explored to improve vascularization capacity of tissue-engineered constructs; however, the use of growth factors has inherent problems such as the loss of signaling capability and the risk of complications including immunological responses and cancer. Here, a new method of preparing water-insoluble silk protein scaffolds with vascularization capacity using an all-aqueous process is reported. Acid is added temporally to tune the self-assembly of silk in the lyophilization process, resulting in water-insoluble scaffold formation directly. These biomaterials are mainly noncrystalline, offering improved cell proliferation than previously reported silk materials. These systems also have an appropriate softer mechanical property that could provide physical cues to promote cell differentiation into endothelial cells, and enhance neovascularization and tissue ingrowth in vivo without the addition of growth factors. Therefore, silk-based degradable scaffolds represent an exciting biomaterial option, with vascularization capacity for soft tissue engineering and regenerative medicine.
C1 [Han, Hongyan; Ning, Hongyan; Liu, Shanshan; Lu, Qiang; Kaplan, David L.] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Han, Hongyan; Ning, Hongyan; Liu, Shanshan] Soochow Univ, Coll Text & Clothing Engn, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China.
   [Han, Hongyan; Ning, Hongyan] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215123, Peoples R China.
   [Fan, Zhihai; Lu, Haijun] Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou 215000, Peoples R China.
   [Lu, Guozhong] Nantong Univ, Affiliated Hosp 3, Dept Burns & Plast Surg, Wuxi 214041, Peoples R China.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Lu, Q (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.; Lu, GZ (reprint author), Nantong Univ, Affiliated Hosp 3, Dept Burns & Plast Surg, Wuxi 214041, Peoples R China.
EM Lvqiang78@suda.edu.cn; Luguozhong@hotmail.com
OI Lu, Guozhong/0000-0002-1207-7975
FU National Basic Research Program of China (973 Program) [2013CB934400];
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD); Excellent Youth Foundation of Jiangsu Province
   [BK2012009]; Natural Science Foundation of Jiangsu Province [BK20140397,
   BK20140401]; Jiangsu Provincial Special Program of Medical Science
   [BL2012004]
FX H.H., H.N., and S.L. contributed equally to this work. The authors thank
   National Basic Research Program of China (973 Program, 2013CB934400),
   NSFC (21174097, 81272106, 51403144), and the NIH (R01 DE017207, P41
   EB002520). The authors also thank the Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD), the
   Excellent Youth Foundation of Jiangsu Province (BK2012009), the Natural
   Science Foundation of Jiangsu Province (Grant Nos. BK20140397 and
   BK20140401), and the Jiangsu Provincial Special Program of Medical
   Science (BL2012004) for support of this work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bai S, 2013, ACTA BIOMATER, V9, P7806, DOI 10.1016/j.actbio.2013.04.033
   Bai SM, 2014, BIOMACROMOLECULES, V15, P3044, DOI 10.1021/bm500662z
   Bigalke C, 2014, ACTA BIOMATER, V10, P5081, DOI 10.1016/j.actbio.2014.09.002
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Han F, 2014, ACTA BIOMATER, V10, P921, DOI 10.1016/j.actbio.2013.09.026
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Huang NF, 2013, BIOMATERIALS, V34, P4038, DOI 10.1016/j.biomaterials.2013.02.036
   Karakutuk I, 2012, BIOMACROMOLECULES, V13, P1122, DOI 10.1021/bm300006r
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Ko HCH, 2007, EUR CELLS MATER, V14, P1
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Lin SS, 2014, J MATER CHEM B, V2, P2622, DOI 10.1039/c4tb00019f
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mansbridge J, 2008, J BIOMAT SCI-POLYM E, V19, P955, DOI 10.1163/156856208784909417
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526
   Pei YZ, 2015, ACTA BIOMATER, V13, P168, DOI 10.1016/j.actbio.2014.11.016
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Ren LL, 2014, BONE, V64, P173, DOI 10.1016/j.bone.2014.04.011
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932
   Stahl PJ, 2014, ADV FUNCT MATER, V24, P3213, DOI 10.1002/adfm.201303217
   Stoppato M, 2013, BIOMATERIALS, V34, P4573, DOI 10.1016/j.biomaterials.2013.02.009
   Sun HL, 2014, BIOMATERIALS, V35, P1176, DOI 10.1016/j.biomaterials.2013.10.054
   Sun Y., 2012, PLOS ONE, V7, P37178
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Valarmathi MT, 2009, BIOMATERIALS, V30, P1098, DOI 10.1016/j.biomaterials.2008.10.044
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wingate K, 2012, ACTA BIOMATER, V8, P1440, DOI 10.1016/j.actbio.2011.12.032
   Wray LS, 2013, ADV FUNCT MATER, V23, P3404, DOI 10.1002/adfm.201202926
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
   Zhang WJ, 2014, EUR CELLS MATER, V27, P1
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
   Zhu MF, 2014, ACTA BIOMATER, V10, P2014, DOI 10.1016/j.actbio.2014.01.022
   Ziv K, 2014, BIOMATERIALS, V35, P3736, DOI 10.1016/j.biomaterials.2014.01.029
   Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012
NR 58
TC 31
Z9 32
U1 19
U2 137
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JAN 20
PY 2016
VL 26
IS 3
BP 421
EP 432
DI 10.1002/adfm.201504160
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DC0CR
UT WOS:000368885100010
PM 27293388
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akar, T
   Turkyilmaz, S
   Celik, S
   Akar, ST
AF Akar, Tamer
   Turkyilmaz, Serpil
   Celik, Sema
   Akar, Sibel Tunali
TI Treatment design and characteristics of a biosorptive decolourization
   process by a green type sorbent
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Biosorption; Box-Behnken design; Isotherms; Pisum sativum; Reactive
   Violet 1 (RV1)
ID RESPONSE-SURFACE METHODOLOGY; BOX-BEHNKEN DESIGN; HEAVY-METAL IONS;
   AQUEOUS-SOLUTION; WASTE-WATER; METHYLENE-BLUE; ADSORPTION; OPTIMIZATION;
   EXTRACTION; REMOVAL
AB Contamination of water sources by synthetic dyes is a problem of global concern given their potential toxicities and environmental impacts. A significant increase has been noted in the studies related to developing alternative and efficient systems for the treatment of coloured effluents. This study focused on the development of an environmentally friendly process for the treatment of dye contaminated aqueous media. A natural biosorbent prepared from spent biomass of Pisum sativum was characterized and employed for the removal of a reactive dye for the first time in the literature. Experimental design, modelling and optimization techniques were applied to the batch biosorption process. Process variables were screened using response surface methodology coupled with a Box-Behnken design matrix. Solution pH, biosorbent dosage, reaction time and temperature were considered as key factors. The interactive effects of factor variables on the biosorption, characteristics of the biosorbent and possible dye biosorbent interactions were discussed. The maximum decolourization yield of biomaterial was 83.2% at an initial concentration of 100 mg L-1. The best operating conditions were as follows: pH: 2.0, biosorbent amount: 0.6 g (in 25 mL dye solution), reaction time: 56.9 min and temperature 27.3 degrees C. The Langmuir isotherm model satisfactorily described the equilibrium biosorption data. IR spectra of unloaded and dye-loaded biosorbent indicated the functional groups on the biosorbent, such as a carbonyl that interacted with Reactive Violet 1 dye molecules. SEM micrographs indicated that microprecipitation can also play a role in the decolourization process. This study demonstrates that developed waste biosorbent could be successfully employed as an effective and eco-friendly alternative cleaner to remove reactive dyes from wastewaters. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Akar, Tamer; Akar, Sibel Tunali] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
   [Turkyilmaz, Serpil] Bilecik Seyh Edebali Univ, Fac Arts & Sci, Dept Math, TR-11210 Bilecik, Turkey.
   [Celik, Sema] Eskisehir Osmangazi Univ, Grad Sch Nat & Appl Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
RP Akar, T (reprint author), Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
EM takar@ogu.edu.tr
CR Akar ST, 2013, CHEM ENG J, V229, P257, DOI 10.1016/j.cej.2013.06.009
   Akar T, 2013, CHEM ENG J, V221, P461, DOI 10.1016/j.cej.2013.01.082
   Al-Asheh S, 2003, J CLEAN PROD, V11, P321, DOI 10.1016/S0959-6526(02)00045-8
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   Amini M, 2009, COLLOID SURFACE A, V337, P67, DOI 10.1016/j.colsurfa.2008.11.053
   Asian N., 2007, POWDER TECHNOL, V174, P127
   Asian N., 2007, FUEL, V86, P90, DOI DOI 10.1016/J.FUE1.2006.06.010
   BOX GEP, 1960, TECHNOMETRICS, V2, P455, DOI DOI 10.1080/00401706.1960.10489912
   Ferreira SLC, 2007, J CHROMATOGR A, V1158, P2, DOI 10.1016/j.chroma.2007.03.051
   Dod R, 2012, BIOTECHNOL BIOPROC E, V17, P862, DOI 10.1007/s12257-011-0614-5
   Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011
   Fomina M, 2014, BIORESOURCE TECHNOL, V160, P3, DOI 10.1016/j.biortech.2013.12.102
   Freundlich H., 1906, ABSORPTION LOSUNGEN
   Gecgel O., 2013, J CHEM, V2013, P1
   Ghaedi M, 2014, SPECTROCHIM ACTA A, V125, P264, DOI 10.1016/j.saa.2013.12.082
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Kaiser S, 2013, IND CROP PROD, V48, P153, DOI 10.1016/j.indcrop.2013.04.026
   LAGERGREN S, 1989, KUNGLIGA SVENSKA VET, V24, P1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Ma XM, 2012, J HAZARD MATER, V209, P467, DOI 10.1016/j.jhazmat.2012.01.054
   Martin-Lara MA, 2014, J CLEAN PROD, V81, P120, DOI 10.1016/j.jclepro.2014.06.036
   Moawed EA, 2013, J TAIBAH UNIV SCI, V7, P26, DOI 10.1016/j.jtusci.2013.03.002
   Montgomery D C, 2005, DESIGN ANAL EXPT
   Murali K., 2013, INT J SCI RES PUBL, V3, P48
   Myers R. H., 2002, RESPONSE SURFACE MET
   Nitayaphat W, 2015, J CLEAN PROD, V87, P850, DOI 10.1016/j.jclepro.2014.10.003
   Ozcan AS, 2009, DESALINATION, V244, P188, DOI 10.1016/j.desal.2008.05.023
   Pereira L, 2012, STRAT SUSTAIN, P111, DOI 10.1007/978-94-007-1591-2_4
   Pouralinazar F, 2012, J SUPERCRIT FLUID, V62, P88, DOI 10.1016/j.supflu.2011.12.009
   Pritee G., 2010, GREEN CHEM ENV SUSTA, P79
   Rangabhashiyam S, 2014, J ENVIRON CHEM ENG, V2, P398, DOI 10.1016/j.jece.2014.01.014
   Rangabhashiyam S, 2013, J ENVIRON CHEM ENG, V1, P629, DOI 10.1016/j.jece.2013.07.014
   Rathod M, 2014, J CLEAN PROD, V84, P484, DOI 10.1016/j.jclepro.2014.03.064
   Sanal IS, 2005, J SUPERCRIT FLUID, V34, P331, DOI 10.1016/j.supflu.2004.08.005
   Sanjay K. S., 2010, GREEN CHEM ENV SUSTA, P1
   Sathishkumar P, 2012, J CLEAN PROD, V22, P67, DOI 10.1016/j.jclepro.2011.09.017
   Shin KY, 2011, J HAZARD MATER, V190, P36, DOI 10.1016/j.jhazmat.2010.12.102
   Solis M, 2012, PROCESS BIOCHEM, V47, P1723, DOI 10.1016/j.procbio.2012.08.014
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
   Witek-Krowiak A, 2014, BIORESOURCE TECHNOL, V160, P150, DOI 10.1016/j.biortech.2014.01.021
   Yargic AS, 2015, J CLEAN PROD, V88, P152, DOI 10.1016/j.jclepro.2014.05.087
   Yetilmezsoy K, 2009, J HAZARD MATER, V171, P551, DOI 10.1016/j.jhazmat.2009.06.035
NR 43
TC 6
Z9 6
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD JAN 20
PY 2016
VL 112
BP 4844
EP 4853
DI 10.1016/j.jclepro.2015.06.049
PN 5
PG 10
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA DB0ON
UT WOS:000368207500122
DA 2018-10-20
ER

PT J
AU Zhang, L
   Liu, YH
   Chen, Z
   Liu, PX
AF Zhang, Lin
   Liu, Yuhong
   Chen, Zhe
   Liu, Pengxiao
TI Behavior and mechanism of ultralow friction of basil seed gel
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article
DE Liquid superlubricity; Basil seed gel; Polysaccharide; Hydration layer
ID BRASENIA-SCHREBERI MUCILAGE; OCIMUM-BASILICUM; HYDROPHILIC POLYMERS;
   SOLID-SURFACES; GUM; WATER; L.; POLYSACCHARIDE; STATES
AB In the present work, a plant-based biomaterial named basil seed gel (BSG) is found to have an excellent lubricating property. The lubricating behavior of BSG is evaluated by a specifically designed apparatus without damaging its natural structure. An ultralow friction coefficient about 0.003 is obtained between BSG and the glass plate surface. Further characterizations reveal that the gel of basil seed has a three-dimensional network microstructure, which may provide a favorable condition for holding water molecules and forming hydration layers. The network constitutes of crosslinking polysaccharide sheets, which are easy to shear and easily adsorbed on the glass surface to form a stable nanoscale flat layer. A possible lubrication mechanism is employed that the easy-to-shear and easy-to-adsorb performance of BSG as well as the superior lubricating properties of hydration layer lead to the ultralow friction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhang, Lin; Liu, Yuhong; Chen, Zhe; Liu, Pengxiao] Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.
RP Liu, YH (reprint author), Tsinghua Univ, State Key Lab Tribol, Beijing 100084, Peoples R China.
EM liuyuhong@tsinghua.edu.cn
FU National Natural Science Foundation of China; Innovative Research Groups
   of the National Natural Science Foundation of China [51522504, 51321092]
FX The work is financially supported by the National Natural Science
   Foundation of China, and the (51522504) Innovative Research Groups of
   the National Natural Science Foundation of China (51321092).
CR Anjaneyalu Y., 1972, CURR SCI INDIA, P214
   Anjaneyalu Y., 1975, AUST J CHEM, P1345
   Anjaneyalu Y., 1971, AUST J CHEM, P1501
   Anjaneyalu Y., 1979, CARBOHYD RES, P251
   Arad S, 2006, LANGMUIR, V22, P7313, DOI 10.1021/la060600x
   BahramParvar M, 2012, INT J FOOD SCI TECH, V47, P2655, DOI 10.1111/j.1365-2621.2012.03148.x
   Biswal M, 2013, RSC ADV, V3, P2288, DOI 10.1039/c2ra22473a
   Chakraborty D, 2007, BIORESOURCE TECHNOL, V98, P2949, DOI 10.1016/j.biortech.2006.09.035
   GIDLEY MJ, 1991, CARBOHYD RES, V214, P299, DOI 10.1016/0008-6215(91)80037-N
   Gong JP, 1999, J PHYS CHEM B, V103, P6007, DOI 10.1021/jp990256v
   Gong JP, 1999, J PHYS CHEM B, V103, P6001, DOI 10.1021/jp9902553
   Gourdon D, 2008, LANGMUIR, V24, P1534, DOI 10.1021/la702259c
   Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0
   Hiltunen R., 1999, BASIL GENUS OCIMUM, P74
   Hosseini-Parvar SH, 2010, J FOOD ENG, V101, P236, DOI 10.1016/j.jfoodeng.2010.06.025
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   Javanmardi J, 2002, J AGR FOOD CHEM, V50, P5878, DOI 10.1021/jf020487q
   Khazaei N, 2014, CARBOHYD POLYM, V102, P199, DOI 10.1016/j.carbpol.2013.10.062
   Klein J, 2004, J PHYS-CONDENS MAT, V16, pS5437, DOI 10.1088/0953-8984/16/45/008
   Li JJ, 2013, SCI CHINA TECHNOL SC, V56, P2877, DOI 10.1007/s11431-013-5387-y
   Li JJ, 2012, LANGMUIR, V28, P7797, DOI 10.1021/la300957v
   Li WB, 2005, POLYMER, V46, P12026, DOI 10.1016/j.polymer.2005.09.016
   Liu PX, 2014, LANGMUIR, V30, P3811, DOI 10.1021/la500193n
   Martin M.J., 2007, SUPERLUBRICITY
   Melo JS, 2004, BIORESOURCE TECHNOL, V92, P151, DOI 10.1016/j.biortech.2003.08.015
   Mukherjee M, 2007, PLANT ARCH, V7, P473
   NAVARINI L, 1990, CARBOHYD POLYM, V12, P169, DOI 10.1016/0144-8617(90)90017-M
   Ping ZH, 2001, POLYMER, V42, P8461, DOI 10.1016/S0032-3861(01)00358-5
   Rafe A, 2013, INT J FOOD SCI TECH, V48, P1924, DOI 10.1111/ijfs.12172
   Rafe A, 2013, INT J FOOD SCI TECH, V48, P556, DOI 10.1111/j.1365-2621.2012.03221.x
   Razavi SMA, 2010, J FOOD PROCESS ENG, V33, P51, DOI 10.1111/j.1745-4530.2008.00259.x
   Razavi SMA, 2009, INT J FOOD SCI TECH, V44, P1755, DOI 10.1111/j.1365-2621.2009.01993.x
   Tuinier R, 1999, BIOPOLYMERS, V50, P641, DOI 10.1002/(SICI)1097-0282(199911)50:6<641::AID-BIP8>3.0.CO;2-D
   Vats V, 2002, J ETHNOPHARMACOL, V79, P95, DOI 10.1016/S0378-8741(01)00374-9
   Xu J, 2008, TRIBOL-MATER SURF IN, V2, P72, DOI 10.1179/175158308X300469
NR 35
TC 6
Z9 7
U1 5
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
EI 1873-4359
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD JAN 20
PY 2016
VL 489
BP 454
EP 460
DI 10.1016/j.colsurfa.2015.11.019
PG 7
WC Chemistry, Physical
SC Chemistry
GA CZ2NZ
UT WOS:000366943200052
DA 2018-10-20
ER

PT J
AU Sacco, P
   Sechi, A
   Trevisan, A
   Picotti, F
   Gianni, R
   Stucchi, L
   Fabbian, M
   Bosco, M
   Paoletti, S
   Marsich, E
AF Sacco, Pasquale
   Sechi, Alessandra
   Trevisan, Antonia
   Picotti, Fabrizio
   Gianni, Rita
   Stucchi, Luca
   Fabbian, Matteo
   Bosco, Marco
   Paoletti, Sergio
   Marsich, Eleonora
TI A silver complex of hyaluronan-lipoate (SHLS12): Synthesis,
   characterization and biological properties
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Hyaluronan; Hyaluronan-lipoate; Silver complex; Gel; Bacteria barrier
   effect
ID ALPHA-LIPOIC ACID; ANTIMICROBIAL COATINGS; ANTIBACTERIAL ACTIVITY;
   IN-VITRO; NANOPARTICLES; CHITOSAN; THERMOSETS; SCAFFOLDS; MEMBRANE;
   EFFICACY
AB In this study we present a novel silver complex of hyaluronan-lipoate (SHLS12) in a gel-state form. NMR analysis, conductometry and elemental analysis demonstrated stable non-covalent interactions between silver ions and the polysaccharide-lipoate backbone, whereas rheological investigations confirmed its gel-like physical-chemical behavior. Biological studies showed the ability of SHLS12 to exert a straightforward activity against different bacterial strains grown in sessile/planktonic state. The biocompatibility was also proved toward two eukaryotic cell lines. By considering both its ability to preserve antibacterial properties when exposed to the serum protein BSA and its low susceptibility to be degraded by hyaluronidase enzyme, this novel complex may be considered as a promising biomaterial for future in vivo applications. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Sacco, Pasquale; Paoletti, Sergio] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
   [Sechi, Alessandra; Trevisan, Antonia; Picotti, Fabrizio; Gianni, Rita; Stucchi, Luca; Fabbian, Matteo; Bosco, Marco] SIGEA Srl, I-34149 Trieste, Italy.
   [Marsich, Eleonora] Univ Trieste, Dept Med Surg & Hlth Sci, I-34129 Trieste, Italy.
RP Marsich, E (reprint author), Univ Trieste, Dept Med Surg & Hlth Sci, I-34129 Trieste, Italy.
EM emarsich@units.it
OI MARSICH, ELEONORA/0000-0002-0700-4464; Paoletti,
   Sergio/0000-0001-5944-8182
FU Friuli-Venezia Giulia Regional Government [LR 47/78]; Friuli-Venezia
   Giulia Regional Government; European Social Fund (S.H.A.R.M. project)
   [850/2012]
FX This study was supported by the Friuli-Venezia Giulia Regional
   Government (Project: "Nuovi biomateriali per terapie innovative nel
   trattamento delle ferite difficili"-LR 47/78). The financial support to
   P.S. (PhD scholarship) by the Friuli-Venezia Giulia Regional Government
   and by the European Social Fund (S.H.A.R.M. project-Supporting human
   assets in research and mobility) according to d.r. 850/2012 - 07.25.2012
   is gratefully acknowledged.
CR Abdel-Mohsen AM, 2012, CARBOHYD POLYM, V89, P411, DOI 10.1016/j.carbpol.2012.03.022
   Bal W, 2013, BBA-GEN SUBJECTS, V1830, P5444, DOI 10.1016/j.bbagen.2013.06.018
   Barui A, 2014, J MATER SCI-MATER M, V25, P2659, DOI 10.1007/s10856-011-4456-7
   Brambilla E, 2012, INT J ARTIF ORGANS, V35, P792, DOI 10.5301/ijao.5000165
   Bustamante J, 1998, FREE RADICAL BIO MED, V24, P1023, DOI 10.1016/S0891-5849(97)00371-7
   Chudobova D, 2013, INT J MOL SCI, V14, P13592, DOI 10.3390/ijms140713592
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Deng BY, 2010, ANAL CHIM ACTA, V683, P58, DOI 10.1016/j.aca.2010.10.018
   Duff MR, 2009, METALLOMICS, V1, P518, DOI 10.1039/b910253a
   Durgadas CV, 2011, ANALYST, V136, P933, DOI 10.1039/c0an00424c
   Gunasekaran Thirumurugan, 2011, J Am Coll Clin Wound Spec, V3, P82, DOI 10.1016/j.jcws.2012.05.001
   Hindi KM, 2009, BIOMATERIALS, V30, P3771, DOI 10.1016/j.biomaterials.2009.03.044
   Huang LY, 2011, ANTIMICROB AGENTS CH, V55, P3432, DOI 10.1128/AAC.01803-10
   KAGAN VE, 1992, BIOCHEM PHARMACOL, V44, P1637, DOI 10.1016/0006-2952(92)90482-X
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Lee SJ, 2014, CARBOHYD POLYM, V111, P530, DOI 10.1016/j.carbpol.2014.04.026
   Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021
   Marsich E, 2013, ACTA BIOMATER, V9, P5088, DOI 10.1016/j.actbio.2012.10.002
   Marsich E, 2013, J MATER SCI-MATER M, V24, P1799, DOI 10.1007/s10856-013-4923-4
   Ostermeyer AK, 2013, ENVIRON SCI TECHNOL, V47, P14403, DOI 10.1021/es4033106
   Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011
   Picotti F, 2013, CARBOHYD POLYM, V93, P273, DOI 10.1016/j.carbpol.2012.04.009
   Ramachandran L, 2011, NANOMATER NANOTECHNO, V1, P17, DOI 10.5772/50956
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Sacco P, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5474-7
   Travan A, 2011, ACTA BIOMATER, V7, P337, DOI 10.1016/j.actbio.2010.07.024
   Travan A, 2009, BIOMACROMOLECULES, V10, P1429, DOI 10.1021/bm900039x
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w
   Yang JS, 2015, RSC ADV, V5, P2378, DOI 10.1039/c4ra12836b
   Zhao XC, 2011, SCI TOTAL ENVIRON, V409, P892, DOI 10.1016/j.scitotenv.2010.11.004
NR 31
TC 7
Z9 8
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 20
PY 2016
VL 136
BP 418
EP 426
DI 10.1016/j.carbpol.2015.09.057
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CX8RP
UT WOS:000365972000051
PM 26572372
DA 2018-10-20
ER

PT J
AU Liu, YJ
   Liu, YJ
   Zhang, D
   Zhang, RQ
   Li, ZL
AF Liu, Yujie
   Liu, Yuanjun
   Zhang, Dan
   Zhang, Ruiqing
   Li, Zhili
TI Kapok Fiber: A Natural Biomaterial for Highly Specific and Efficient
   Enrichment of Sialoglycopeptides
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID TITANIUM-DIOXIDE CHROMATOGRAPHY; MASS-SPECTROMETRY; SIALIC ACIDS;
   AFFINITY-CHROMATOGRAPHY; N-GLYCOPEPTIDES; GLYCOSYLATION; GLYCOPROTEINS;
   IDENTIFICATION; DIVERSITY; DISEASE
AB Cancer development and chronic diseases are associated with the overexpression of sialoglycans terminated to the surface proteins and lipids of cancer cells compared with normal cells. The isolation and detection of sialoglycopeptides from complex peptides mixture still remain challenges due to their low abundance, low ionization, and losses of sialic acid residues and water molecule during analytical processes. In this study, kapok fiber, a natural fiber derived from the kapok tree (Bombax ceiba L.), has shown excellent capability to specifically and efficiently enrich sialoglycopeptides, without losses of sialic acid residues and water molecule from sialoglycans. The main components on the surface of kapok fiber are syringyl and guaiacyl lignins which play an important role in isolating sialoglycopeptides from complex peptide mixtures.
C1 [Liu, Yujie; Zhang, Dan; Zhang, Ruiqing; Li, Zhili] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Beijing 100005, Peoples R China.
   [Liu, Yujie; Zhang, Dan; Zhang, Ruiqing; Li, Zhili] Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.
   [Liu, Yuanjun] Shandong Nonmetall Mat Inst, Jinan 250031, Peoples R China.
RP Li, ZL (reprint author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Beijing 100005, Peoples R China.; Li, ZL (reprint author), Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.
EM lizhili@ibms.pumc.edu.cn
FU National Natural Science Foundation of China [21575164]
FX This study was supported by the National Natural Science Foundation of
   China (Grant No. 21575164) to Z.L.
CR Bull C, 2014, BBA-REV CANCER, V1846, P238, DOI 10.1016/j.bbcan.2014.07.005
   Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728
   Chen GQ, 2013, ELECTROPHORESIS, V34, P2407, DOI 10.1002/elps.201200455
   Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148
   CUMMINGS RD, 1982, J BIOL CHEM, V257, P1235
   Faix O., 1991, HOLZFORSCHUNG, V45, P21
   Larsen MR, 2007, MOL CELL PROTEOMICS, V6, P1778, DOI 10.1074/mcp.M700086-MCP200
   Lewandrowski U, 2007, MOL CELL PROTEOMICS, V6, P1933, DOI 10.1074/mcp.M600390-MCP200
   Li FJ, 2013, ANAL CHIM ACTA, V787, P140, DOI 10.1016/j.aca.2013.05.044
   Lim TT, 2007, IND CROP PROD, V26, P125, DOI 10.1016/j.indcrop.2007.02.007
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   Nie H, 2012, J PROTEOMICS, V75, P3098, DOI 10.1016/j.jprot.2012.03.050
   Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167
   Selman MHJ, 2011, ANAL CHEM, V83, P2492, DOI 10.1021/ac1027116
   Takegawa Y, 2006, J SEP SCI, V29, P2533, DOI 10.1002/jssc.200600133
   Tian Y., 2012, MOL CELL PROTEOMICS, V11, DOI DOI 10.1074/MCP.M111.011403
   Tserki V, 2005, COMPOS PART A-APPL S, V36, P1110, DOI 10.1016/j.compositesa.2005.01.004
   Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002
   Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656
   Wu J, 2013, J PROTEOME RES, V12, P3342, DOI 10.1021/pr400169n
   Xin L, 2012, RAPID COMMUN MASS SP, V26, P269, DOI 10.1002/rcm.5327
   Yang ZP, 2005, J CHROMATOGR A, V1070, P57, DOI 10.1016/j.chroma.2005.02.034
   Yodoshi M, 2010, ANAL SCI, V26, P75, DOI 10.2116/analsci.26.75
   Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827
NR 24
TC 5
Z9 5
U1 6
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JAN 19
PY 2016
VL 88
IS 2
BP 1067
EP 1072
DI 10.1021/acs.analchem.5b04014
PG 6
WC Chemistry, Analytical
SC Chemistry
GA DB5OA
UT WOS:000368562300001
PM 26690944
DA 2018-10-20
ER

PT J
AU Rufaihah, AJ
   Seliktar, D
AF Rufaihah, Abdul Jalil
   Seliktar, Dror
TI Hydrogels for therapeutic cardiovascular angiogenesis
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Biomaterial; Myocardial infarction; Growth factor delivery; Cell
   therapy; Ischemia; Minimally invasive
ID FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR
   CELLS; PHOTOCROSSLINKABLE CHITOSAN HYDROGEL; MYOCARDIAL-INFARCTION;
   IN-VITRO; POLY(ETHYLENE GLYCOL); FIBRIN MATRICES; FACTOR DELIVERY;
   SUSTAINED DELIVERY
AB Acute myocardial infarction (MI) caused by ischemia is the most common cause of cardiac dysfunction. While growth factor or cell therapy is promising, the retention of bioactive agents in the highly vascularized myocardium is limited and prevents sustained activation needed for adequate cellular responses. Various types of biomaterials with different physical and chemical properties have been developed to improve the localized delivery of growth factor and/or cells for therapeutic angiogenesis in ischemic tissues. Hydrogels are particularly advantageous as carrier systems because they are structurally similar to the tissue extracellular matrix (ECM), they can be processed under relatively mild conditions and can be delivered in a minimally invasive manner. Moreover, hydrogels can be designed to degrade in a timely fashion that coincides with the angiogenic process. For these reasons, hydrogels have shown great potential as pro-angiogenic matrices. This paper reviews a few of the hydrogel systems currently being applied together with growth factor delivery and/or cell therapy to promote therapeutic angiogenesis in ischemic tissues, with emphasis on myocardial applications. (C) 2015 Published by Elsevier B.V.
C1 [Rufaihah, Abdul Jalil] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117548, Singapore.
   [Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.acil
RI Abdul Jalil, Rufaihah/A-4572-2012
OI Abdul Jalil, Rufaihah/0000-0002-9764-8668; Seliktar,
   Dror/0000-0001-6964-8567
FU National Research Foundation (NRF)
FX The authors would like to acknowledge funding support from National
   Research Foundation (NRF)-Technion-NUS Grant for Regenerative Medicine
   Initiative in Cardiac Restoration Therapy. The authors acknowledge Dr.
   Alexandra Berdichevski for Figure 2.
CR ALBES JM, 1994, ANN THORAC SURG, V57, P444, DOI 10.1016/0003-4975(94)91015-4
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Amrani D L, 2001, Ann N Y Acad Sci, V936, P566
   Antonitsis P, 2008, THORAC CARDIOV SURG, V56, P77, DOI 10.1055/s-2007-989328
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   ASAHARA T, 2004, AM J PHYSIOL-CELL PH, V287, P572
   Auxenfans C, 2012, J TISSUE ENG REGEN M, V6, P512, DOI 10.1002/term.454
   Barsotti MC, 2011, CELL PROLIFERAT, V44, P33, DOI 10.1111/j.1365-2184.2010.00715.x
   Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9
   Belair DG, 2014, CHEM COMMUN, V50, P15651, DOI 10.1039/c4cc04317k
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Chekanov VS, 2002, J CARDIAC SURG, V17, P502, DOI 10.1046/j.1540-8191.2002.01006.x
   Chinen N, 2003, J BIOMED MATER RES A, V67A, P61, DOI 10.1002/jbm.a.10061
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Chung E, 2015, ACTA BIOMATER, V17, P78, DOI 10.1016/j.actbio.2015.01.012
   Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414
   Cortes-Morichetti M, 2007, TISSUE ENG, V13, P2681, DOI 10.1089/ten.2006.0447
   Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321
   DOWNS EC, 1992, J CELL PHYSIOL, V152, P422, DOI 10.1002/jcp.1041520225
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Elgin Y.M., 2001, ARTIF ORGANS, V25, P558
   Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x
   FASOL R, 1994, J THORAC CARDIOV SUR, V107, P1432
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355
   Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   Genasetti A, 2008, CONNECT TISSUE RES, V49, P120, DOI 10.1080/03008200802148462
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317
   Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   HARADA K, 1994, J CLIN INVEST, V94, P623, DOI 10.1172/JCI117378
   Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226
   Horowitz JR, 1997, ARTERIOSCL THROM VAS, V17, P2793, DOI 10.1161/01.ATV.17.11.2793
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Kipshidze N, 2003, INT ANGIOL, V22, P349
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Laham RJ, 1999, CIRCULATION, V100, P1865, DOI 10.1161/01.CIR.100.18.1865
   Lee KY, 2003, J CONTROL RELEASE, V87, P49, DOI 10.1016/S0168-3659(02)00349-8
   Lee KY, 2000, NATURE, V408, P998
   Lee RJ, 2000, CIRCULATION, V102, P898
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Lopez JJ, 1997, J PHARMACOL EXP THER, V282, P385
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Minguell JJ, 2006, EXP BIOL MED, V231, P39
   Mironi-Harpaz I, 2015, ADV MATER, V27, P1933, DOI 10.1002/adma.201404185
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Neufeld G, 1999, FASEB J, V13, P9
   Ng YS, 2001, CURR CONTR TRIALS C, V2, P278, DOI 10.1186/CVM-2-6-278
   Obara K, 2005, WOUND REPAIR REGEN, V13, P390, DOI 10.1111/j.1067-1927.2005.130406.x
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Peattie RA, 2006, BIOMATERIALS, V27, P1868, DOI 10.1016/j.biomaterials.2005.09.035
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Ratliff BB, 2010, AM J PHYSIOL-RENAL, V299, pF178, DOI 10.1152/ajprenal.00102.2010
   Reagan J, 2011, J TISSUE ENG REGEN M, V5, P620, DOI 10.1002/term.354
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Riley CM, 2006, BIOMATERIALS, V27, P5935, DOI 10.1016/j.biomaterials.2006.08.029
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511
   Rufaihah AJ, 2013, BIOMATERIALS, V34, P8195, DOI 10.1016/j.biomaterials.2013.07.031
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111
   Saik JE, 2011, ACTA BIOMATER, V7, P133, DOI 10.1016/j.actbio.2010.08.018
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Shireman PK, 1999, J VASC SURG, V29, P852, DOI 10.1016/S0741-5214(99)70213-2
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Simpson DL, 2013, J TISSUE ENG REGEN M, V7, P192, DOI 10.1002/term.511
   Sun QH, 2005, PHARM RES, V22, P1110, DOI 10.1007/s11095-005-5644-2
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   Williams D, 2014, CAMB TEXT BIOMED ENG, P1
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yang HS, 2010, TISSUE ENG PT A, V16, P2113, DOI [10.1089/ten.tea.2009.0673, 10.1089/ten.TEA.2009.0673]
   Yee D, 2011, TISSUE ENG PT A, V17, P1351, DOI [10.1089/ten.tea.2010.0481, 10.1089/ten.TEA.2010.0481]
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 97
TC 28
Z9 29
U1 4
U2 78
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JAN 15
PY 2016
VL 96
BP 31
EP 39
DI 10.1016/j.addr.2015.07.003
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DD7HT
UT WOS:000370095000004
PM 26212158
DA 2018-10-20
ER

PT J
AU Ruvinov, E
   Cohen, S
AF Ruvinov, Emil
   Cohen, Smadar
TI Alginate biomaterial for the treatment of myocardial infarction:
   Progress, translational strategies, and clinical outlook From ocean
   algae to patient bedside
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Affinity binding; Alginate; Biomaterials; Clinical trials; Myocardial
   infarction; Regeneration; Scaffolds; Tissue engineering
ID HEPATOCYTE GROWTH-FACTOR; MOLECULAR-WEIGHT DISTRIBUTION;
   LEFT-VENTRICULAR FUNCTION; CHRONIC HEART-FAILURE; FACTOR-I; MARINE
   POLYSACCHARIDES; REGENERATIVE MEDICINE; PARACRINE MECHANISMS;
   EXTRACELLULAR-MATRIX; SEQUENTIAL DELIVERY
AB Alginate biomaterial is widely utilized for tissue engineering and regeneration due to its biocompatibility, non-thrombogenic nature, mild and physical gelation process, and the resemblance of its hydrogel matrix texture and stiffness to that of the extracellular matrix. In this review, we describe the versatile biomedical applications of alginate, from its use as a supporting cardiac implant in patients after acute myocardial infarction (MI) to its employment as a vehicle for stem cell delivery and for the controlled delivery and presentation of multiple combinations of bioactive molecules and regenerative factors into the heart. Preclinical and first-in-man clinical trials are described in details, showing the therapeutic potential of injectable acellular alginate implants to inhibit the damaging processes after MI, leading to myocardial repair and tissue reconstruction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ruvinov, Emil; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-8410501 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Regenerat Med & Stem Cell RMSC Res Ctr, IL-8410501 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-8410501 Beer Sheva, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-8410501 Beer Sheva, Israel.
EM scohen@bgu.ac.il
FU Israel Science Foundation [793/04, 1368/08]; European Union; BioLineRx,
   Jerusalem, Israel
FX The research was supported in part by grants from the Israel Science
   Foundation (793/04 and 1368/08), European Union Framework Programme 7
   (INELPY), and sponsored in part by BioLineRx, Jerusalem, Israel. Prof.
   Cohen holds the Claire and Harold Oshry Professor Chair in
   Biotechnology.
CR Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   [Anonymous], 2010, IK 5001 PREV REM VEN
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   BioLineRx Ltd, 2007, SAF FEAS INJ BL 1040
   Blackburn NJR, 2015, BIOMATERIALS, V39, P182, DOI 10.1016/j.biomaterials.2014.11.004
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3003997
   Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/nnano.2011.160, 10.1038/NNANO.2011.160]
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386
   Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Frey N, 2014, CIRC-CARDIOVASC INTE, V7, P806, DOI 10.1161/CIRCINTERVENTIONS.114.001478
   Gandhi JK, 2013, THER DELIV, V4, P327, DOI [10.4155/TDE.12.163, 10.4155/tde.12.163]
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hausenloy DJ, 2009, CARDIOVASC RES, V83, P179, DOI 10.1093/cvr/cvp062
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.0.CO;2-G
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Laurienzo P, 2010, MAR DRUGS, V8, P2435, DOI 10.3390/md8092435
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee LC, 2013, INT J CARDIOL, V168, P2022, DOI 10.1016/j.ijcard.2013.01.003
   Lee R.J., 2012, CELL TRANSPLANT, V22, P529
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J., 2009, J AM COLL CARDIOL, V54
   Levit RD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000367
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Loeser RF, 2002, BIORHEOLOGY, V39, P119
   LoneStar Heart Inc, 2009, SAF FEAS ALG LVR MET
   LoneStar Heart Inc, 2011, RAND CONTR STUD EV A
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Makino H, 2000, KIDNEY INT, V58, pS67, DOI 10.1046/j.1523-1755.2000.07711.x
   Maltais S, 2010, J CARDIOVASC TRANSL, V3, P652, DOI 10.1007/s12265-010-9198-2
   Menasche P., 2014, CURR OPIN CARDIOL, V30, P179
   Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005
   Nakamura T, 2005, AM J PHYSIOL-HEART C, V288, pH2131, DOI 10.1152/ajpheart.01239.2003
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruvinov E, 2012, CARDIAC TISSUE ENG P
   Ruvinov Emil, 2008, Expert Rev Cardiovasc Ther, V6, P669, DOI 10.1586/14779072.6.5.669
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Sabbah HN, 2013, JACC-HEART FAIL, V1, P252, DOI 10.1016/j.jchf.2013.02.006
   Sapir Y, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014009
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Senni K, 2011, MAR DRUGS, V9, P1664, DOI 10.3390/md9091664
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Suleiman MS, 2007, PHARMACOL THERAPEUT, V114, P278, DOI 10.1016/j.pharmthera.2007.03.001
   Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338
   Templin C, 2011, INT J DEV BIOL, V55, P407, DOI 10.1387/ijdb.103219ct
   Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Ueno M., 2014, ADV FOOD NUTR RES, P95
   Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004
   Webster KA, 2007, TRENDS PHARMACOL SCI, V28, P492, DOI 10.1016/j.tips.2007.07.004
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 88
TC 49
Z9 50
U1 21
U2 166
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JAN 15
PY 2016
VL 96
BP 54
EP 76
DI 10.1016/j.addr.2015.04.021
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DD7HT
UT WOS:000370095000006
PM 25962984
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Wang, RM
   Christman, KL
AF Wang, Raymond M.
   Christman, Karen L.
TI Decellularized myocardial matrix hydrogels: In basic research and
   preclinical studies
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Myocardial infarction; Biomaterial; Hydrogel; Tissue engineering;
   Regenerative medicine
ID CARDIAC EXTRACELLULAR-MATRIX; EMBRYONIC STEM-CELLS; POSTMYOCARDIAL
   INFARCTION; PORCINE HEART; IN-VITRO; SCAFFOLD; DELIVERY; PLATFORM;
   DIFFERENTIATION; DISEASE
AB A variety of decellularized materials have been developed that have demonstrated potential for treating cardiovascular diseases and improving our understanding of cardiac development. Of these biomaterials, decellularized myocardial matrix hydrogels have shown great promise for creating cellular microenvironments representative of the native cardiac tissue and treating the heart after a myocardial infarction. Decellularized myocardial matrix hydrogels derived from porcine cardiac tissue form a nanofibrous hydrogel once thermally induced at physiological temperatures. Use of isolated cardiac extracellular matrix in 2D and 3D in vitro platforms has demonstrated the capability to provide tissue specific cues for cardiac cell growth and differentiation. Testing of the myocardial matrix hydrogel as a therapy after myocardial infarction in both small and large animal models has demonstrated improved left ventricular function, increased cardiac muscle, and cellular recruitment into the treated infarct. Based on these results, steps are currently being taken to translate these hydrogels into a clinically used injectable biomaterial therapy. In this review, we will focus on the basic science and preclinical studies that have accelerated the development of decellularized myocardial matrix hydrogels into an emerging novel therapy for treating the heart after a myocardial infarction. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Wang, Raymond M.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU NIH [R01HL113468]
FX The authors would like to thank the NIH (R01HL113468) for supporting
   this work. Dr. Christman is co-founder, board member, and holds equity
   interest in Ventrix, Inc.
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Cleutjens JPM, 2002, J CARD FAIL, V8, pS344, DOI 10.1054/jcaf.2002.129261
   Daub JT, 2013, B MATH BIOL, V75, P1377, DOI 10.1007/s11538-013-9826-5
   DeQuach J.A., 2010, PLOS ONE, V5
   Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Gershlaka JR, 2015, EXP CELL RES, V330, P311, DOI 10.1016/j.yexcr.2014.09.007
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Grover G.N., 2014, NANOTECHNOLOGY, V25
   Higuchi S, 2013, J BIOSCI BIOENG, V115, P320, DOI 10.1016/j.jbiosc.2012.10.004
   Johnson T.D., 2011, NANOTECHNOLOGY, V22
   Johnson T.D., 2014, BIOMATER SCI, V2
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Momtahan N, 2014, TISSUE ENG PART B-RE, V21, P115
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034
   Pok S, 2014, TISSUE ENG PT A, V20, P1877, DOI [10.1089/ten.tea.2013.0620, 10.1089/ten.TEA.2013.0620]
   RUBIN SA, 1983, J AM COLL CARDIOL, V1, P1435, DOI 10.1016/S0735-1097(83)80046-1
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Sarig U, 2015, TISSUE ENG PT A, V21, P1507, DOI [10.1089/ten.tea.2014.0477, 10.1089/ten.TEA.2014.0477]
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Schulte JB, 2013, TISSUE ENG PART C-ME, V19, P518, DOI [10.1089/ten.tec.2012.0536, 10.1089/ten.TEC.2012.0536]
   Seif-Naraghi S., 2010, J VIS EXP
   Seif-Naraghi S.B., 2013, SCI TRANSL MED, V5
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   Sullivan K.E., 2014, STEM CELL RES THER, V5
   Ungerleider J.L., 2014, STEM CELL TRANSL MED, P1090
   Ungerleider J.L., 2015, METHODS IN PRESS
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Vanhoutte D, 2006, CARDIOVASC RES, V69, P604, DOI 10.1016/j.cardiores.2005.10.002
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang B, 2012, J MATER SCI-MATER M, V23, P1835, DOI 10.1007/s10856-012-4660-0
   Wang B, 2010, J BIOMED MATER RES A, V94A, P1100, DOI 10.1002/jbm.a.32781
   Weymann A, 2011, CIRC J, V75, P852, DOI 10.1253/circj-CJ-10-0717
   Williams C, 2014, ACTA BIOMATER, V10, P194, DOI 10.1016/j.actbio.2013.08.037
   Williams C, 2015, ACTA BIOMATER, V14, P84, DOI 10.1016/j.actbio.2014.11.035
   Yasui H, 2014, BIOMATERIALS, V35, P7839, DOI 10.1016/j.biomaterials.2014.05.080
NR 55
TC 35
Z9 40
U1 14
U2 73
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JAN 15
PY 2016
VL 96
BP 77
EP 82
DI 10.1016/j.addr.2015.06.002
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DD7HT
UT WOS:000370095000007
PM 26056717
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Mitchell, AC
   Briquez, PS
   Hubbell, JA
   Cochran, JR
AF Mitchell, Aaron C.
   Briquez, Priscilla S.
   Hubbell, Jeffrey A.
   Cochran, Jennifer R.
TI Engineering growth factors for regenerative medicine applications
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Regenerative medicine; Growth factors; Protein engineering; Protein
   library; Mutagenesis; High-throughput screening; Extracellular matrix;
   Biomaterials; Drug delivery systems; Controlled release
ID ENDOTHELIAL-CELL PROLIFERATION; BONE MORPHOGENETIC PROTEIN-2;
   FACTOR-BINDING DOMAIN; EXTRACELLULAR-MATRIX; HEPARIN-BINDING; FACTOR
   RECEPTOR; BIOLOGICAL-ACTIVITY; CONTROLLED-RELEASE; ESCHERICHIA-COLI;
   DELIVERY VEHICLE
AB Growth factors are important morphogenetic proteins that instruct cell behavior and guide tissue repair and renewal. Although their therapeutic potential holds great promise in regenerative medicine applications, translation of growth factors into clinical treatments has been hindered by limitations including poor protein stability, low recombinant expression yield, and suboptimal efficacy. This review highlights current tools, technologies, and approaches to design integrated and effective growth factor-based therapies for regenerative medicine applications. The first section describes rational and combinatorial protein engineering approaches that have been utilized to improve growth factor stability, expression yield, biodistribution, and serum half-life, or alter their cell trafficking behavior or receptor binding affinity. The second section highlights elegant biomaterial-based systems, inspired by the natural extracellular matrix milieu, that have been developed for effective spatial and temporal delivery of growth factors to cell surface receptors. Although appearing distinct, these two approaches are highly complementary and involve principles of molecular design and engineering to be considered in parallel when developing optimal materials for clinical applications.
   Statement of significance
   Growth factors are promising therapeutic proteins that have the ability to modulate morphogenetic behaviors, including cell survival, proliferation, migration and differentiation. However, the translation of growth factors into clinical therapies has been hindered by properties such as poor protein stability, low recombinant expression yield, and non-physiological delivery, which lead to suboptimal efficacy and adverse side effects. To address these needs, researchers are employing clever molecular and material engineering and design strategies to both improve the intrinsic properties of growth factors and effectively control their delivery into tissue. This review highlights examples of interdisciplinary tools and technologies used to augment the therapeutic potential of growth factors for clinical applications in regenerative medicine. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mitchell, Aaron C.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
   [Briquez, Priscilla S.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.
   [Briquez, Priscilla S.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland.
   [Hubbell, Jeffrey A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.
   [Hubbell, Jeffrey A.] Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.
   [Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
RP Cochran, JR (reprint author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Hubbell, JA (reprint author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.; Hubbell, JA (reprint author), Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland.; Hubbell, JA (reprint author), Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.; Hubbell, JA (reprint author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.; Cochran, JR (reprint author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
EM jhubbell@uchicago.edu; jennifer.cochran@stanford.edu
FU European Research Council through the grant Cytrix; NIH/NCI [R01
   CA151706]; NIH NIGMS Training Grant in Biotechnology [5T32GM008412];
   Stanford-Agilent Fellowship
FX The authors would like to acknowledge Dr. Elif Vardar, Dr. Hans M.
   Larsson, and Cheuk Lun (Alan) Leung for helpful discussions. Work
   described in this review was supported by the European Research Council
   through the grant Cytrix (to J.A.H.) and NIH/NCI R01 CA151706 (to
   J.R.C). A.C.M. is supported in part by a NIH NIGMS Training Grant in
   Biotechnology [5T32GM008412], and a Stanford-Agilent Fellowship.
CR Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200
   [Anonymous], 2015, BON GRAFT SURG TRAUM, P1
   ARAKAWA T, 1993, ADV DRUG DELIVER REV, V10, P1, DOI 10.1016/0169-409X(93)90003-M
   Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049
   Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200
   Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561
   Baker A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2638
   Barendt P. A., 2009, PROTEIN ENG DES
   Belair DG, 2014, CHEM COMMUN, V50, P15651, DOI 10.1039/c4cc04317k
   Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729
   Briquez P. S., 2015, ADV WOUND CARE
   BROWN GL, 1986, J EXP MED, V163, P1319
   BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Cochran JR, 2006, PROTEIN ENG DES SEL, V19, P245, DOI 10.1093/protein/gzl006
   Coco WM, 2002, NAT BIOTECHNOL, V20, P1246, DOI 10.1038/nbt757
   COOK AL, 1992, BIOCHEM J, V281, P57, DOI 10.1042/bj2810057
   Craik DJ, 2013, J PEPT SCI, V19, P393, DOI 10.1002/psc.2523
   De Laporte L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062076
   Drug com, 2015, HUM SOM FDA PRESCR I, P1
   EBNER R, 1991, CELL REGUL, V2, P599
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Epstein NE, 2013, SURG NEUROL INT, V4, P343
   Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590
   FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Grazul-Bilska AT, 2003, DRUGS TODAY, V39, P787, DOI 10.1358/dot.2003.39.10.799472
   Hajimiri M., 2014, J BIOMED MATER RES, V103, P819
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Haugh JM, 2004, BIOTECHNOL PROGR, V20, P1337, DOI 10.1021/bp0499101
   Hubbell J. A., 2006, SWISS MED WEEKLY, P1
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Igai H, 2006, ASAIO J, V52, P86, DOI 10.1097/01.mat.0000196513.97411.3d
   Ige O. O., 2012, ISRN MAT SCI, V2012, P1
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jewett MC, 2004, BIOTECHNOL BIOENG, V86, P19, DOI 10.1002/bit.20026
   Jones DS, 2011, P NATL ACAD SCI USA, V108, P13035, DOI 10.1073/pnas.1102561108
   Kariduraganavar MY, 2014, NATURAL AND SYNTHETIC BIOMEDICAL POLYMERS, P1
   Keane TJ, 2014, SEMIN PEDIATR SURG, V23, P112, DOI 10.1053/j.sempedsurg.2014.06.010
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Lahti JL, 2011, FEBS LETT, V585, P1135, DOI 10.1016/j.febslet.2011.03.044
   Lee J., 2013, J PROTEINS PROTEOMIC
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lenferink AEG, 2000, J BIOL CHEM, V275, P26748
   Levin AM, 2006, MOL BIOSYST, V2, P49, DOI 10.1039/b511782h
   Lipovgek D., 2009, PROTEIN ENG DEC
   Liu CJ, 2014, FEBS LETT, V588, P4831, DOI 10.1016/j.febslet.2014.11.018
   Lorentz KM, 2012, BIOMATERIALS, V33, P494, DOI 10.1016/j.biomaterials.2011.09.088
   LOWMAN HB, 1991, BIOCHEMISTRY-US, V30, P10832, DOI 10.1021/bi00109a004
   Lui BH, 2011, J MOL BIOL, V413, P406, DOI 10.1016/j.jmb.2011.08.028
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Martino M. M., 2015, ASS ERUM PHOSPHORUS, P1
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1
   Medtronic, 2015, INF BON GRAFT LT CAG, P1
   Miller RE, 2010, ARTHRITIS RHEUM-US, V62, P3686, DOI 10.1002/art.27709
   Moore S. J., 2009, PROTEIN ENG DES
   Ogiwara K, 2005, BIOTECHNOL LETT, V27, P1633, DOI 10.1007/s10529-005-2605-0
   ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240
   Park JS, 2010, PROTEIN EXPRES PURIF, V70, P231, DOI 10.1016/j.pep.2009.10.004
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008
   Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151
   Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100
   Reddy CC, 1996, NAT BIOTECHNOL, V14, P1696, DOI 10.1038/nbt1296-1696
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Ross J, 2012, GASTROENTEROLOGY, V142, P897, DOI 10.1053/j.gastro.2011.12.006
   Sahni A, 2000, BLOOD, V96, P3772
   Sahni A, 2003, J THROMB HAEMOST, V1, P1304, DOI 10.1046/j.1538-7836.2003.00250.x
   Sakiyama-Elbert S. E., 2000, J CONTROL RELEASE
   Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725
   Schonherr E., 2000, J IMMUNOL RES
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Schultz GS, 2005, WORLD WIDE WOUNDS
   Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130
   Simon CD, 2015, CHEM SCI, P1
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Sonnenberg SB, 2015, BIOMATERIALS, V45, P56, DOI 10.1016/j.biomaterials.2014.12.021
   Souriau C, 1997, NUCLEIC ACIDS RES, V25, P1585, DOI 10.1093/nar/25.8.1585
   Stahl SJ, 1997, BIOCHEM J, V326, P763, DOI 10.1042/bj3260763
   STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747
   Stryker, 2015, OP1BMP7OP1 STRYK, P1
   Sun WJ, 2010, J BIOMED MATER RES A, V92A, P887, DOI 10.1002/jbm.a.32445
   Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037
   Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012
   U. S. Food and Drug Administration, 2008, SAF NEWSL POSTM REV, P1
   Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148
   Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x
   Veronese FM, 2009, MILESTONES DRUG THER, P1, DOI 10.1007/978-3-7643-8679-5
   Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66
   Xie Y, 2011, J CONTROL RELEASE, V153, P225, DOI 10.1016/j.jconrel.2011.03.021
   Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305
   Yang HS, 2012, EXP MOL MED, V44, P350, DOI 10.3858/emm.2012.44.5.039
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 108
TC 42
Z9 42
U1 4
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2016
VL 30
BP 1
EP 12
DI 10.1016/j.actbio.2015.11.007
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB5ON
UT WOS:000368563600001
PM 26555377
DA 2018-10-20
ER

PT J
AU Junter, GA
   Thebault, P
   Lebrun, L
AF Junter, Guy-Alain
   Thebault, Pascal
   Lebrun, Laurent
TI Polysaccharide-based antibiofilm surfaces
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Bacterial adhesion; Bactericidal coating; Biomaterial; Chitosan; Surface
   functionalization
ID ANTIBACTERIAL MULTILAYER FILMS; BONE MORPHOGENETIC PROTEIN-2; BACTERIAL
   ADHESION; TITANIUM SURFACES; BIOFILM FORMATION; POLYELECTROLYTE
   MULTILAYERS; SULFATED POLYSACCHARIDES; ANTIMICROBIAL PROPERTIES;
   OSTEOBLAST FUNCTIONS; STAPHYLOCOCCUS-AUREUS
AB Surface treatment by natural or modified polysaccharide polymers is a promising means to fight against implant-associated biofilm infections. The present review focuses on polysaccharide-based coatings that have been proposed over the last ten years to impede biofilm formation on material surfaces exposed to bacterial contamination. Anti-adhesive and bactericidal coatings are considered. Besides classical hydrophilic coatings based on hyaluronic acid and heparin, the promising anti-adhesive properties of the algal polysaccharide ulvan are underlined. Surface functionalization by antimicrobial chitosan and derivatives is extensively surveyed, in particular chitosan association with other polysaccharides in layer-by-layer assemblies to form both anti-adhesive and bactericidal coatings.
   Statement of Significance
   Bacterial contamination of surfaces, leading to biofilm formation, is a major problem in fields as diverse as medicine, first, but also food and cosmetics. Many prophylactic strategies have emerged to try to eliminate or reduce bacterial adhesion and biofilm formation on surfaces of materials exposed to bacterial contamination, in particular implant materials.
   Polysaccharides are widely distributed in nature. A number of these natural polymers display antibiofilm properties. Hence, surface treatment by natural or modified polysaccharides is a promising means to fight against implant-associated biofilm infections. The present manuscript is an in-depth look at polysaccharide-based antibiofilm surfaces that have been proposed over the last ten years. This review, which is a novelty compared to published literature, will bring well documented and updated information to readers of Acta Biomaterialia. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Junter, Guy-Alain; Thebault, Pascal; Lebrun, Laurent] Normandie Univ, PBS Lab, CNRS, UMR 6270,UR, F-76821 Mont St Aignan, France.
RP Junter, GA (reprint author), Normandie Univ, PBS Lab, CNRS, UMR 6270,UR, F-76821 Mont St Aignan, France.
EM guy-alain.junter@univ-rouen.fr
OI Thebault, Pascal/0000-0002-0108-1071
CR Abdelkefi Abderrahman, 2007, J Support Oncol, V5, P273
   Abou Zeid AH, 2014, CARBOHYD POLYM, V113, P62, DOI 10.1016/j.carbpol.2014.06.004
   Almodovar J, 2013, BIOTECHNOL BIOENG, V110, P609, DOI 10.1002/bit.24710
   Asadinezhad A, 2010, MOLECULES, V15, P1007, DOI 10.3390/molecules15021007
   Azzaroni O, 2012, J POLYM SCI POL CHEM, V50, P3225, DOI 10.1002/pola.26119
   Baker S., 2014, U. S. Patent Application, Patent No. [US 2014/0221308 A1, 20140221308]
   Bernal P, 2012, MICROB BIOTECHNOL, V5, P670, DOI 10.1111/j.1751-7915.2012.00359.x
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Bratskaya S, 2007, BIOMACROMOLECULES, V8, P2960, DOI 10.1021/bm700620j
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chen KS, 2005, MAT SCI ENG C-BIO S, V25, P472, DOI 10.1016/j.msec.2004.12.006
   Cheng HR, 2013, CARBOHYD POLYM, V96, P101, DOI 10.1016/j.carbpol.2013.03.072
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cobrado L, 2013, J ANTIMICROB CHEMOTH, V68, P126, DOI 10.1093/jac/dks376
   Costa EM, 2013, ANAEROBE, V20, P27, DOI 10.1016/j.anaerobe.2013.02.002
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Crouzier T, 2010, CURR OPIN COLLOID IN, V15, P417, DOI 10.1016/j.cocis.2010.05.007
   Cui D, 2010, ADV FUNCT MATER, V20, P3303, DOI 10.1002/adfm.201000601
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   de Paz LEC, 2011, APPL ENVIRON MICROB, V77, P3892, DOI 10.1128/AEM.02941-10
   Deng HB, 2011, CARBOHYD POLYM, V83, P239, DOI 10.1016/j.carbpol.2010.07.042
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   Elsabee MZ, 2008, CARBOHYD POLYM, V71, P187, DOI 10.1016/j.carbpol.2007.05.022
   Farnbacher MJ, 2012, SCAND J GASTROENTERO, V47, P1141, DOI 10.3109/00365521.2012.711849
   Ferreira I.C.F.R, 2014, PHYTOCHEMISTRY, V114, P38
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Follmann HDM, 2012, BIOMACROMOLECULES, V13, P3711, DOI 10.1021/bm3011962
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Fujie T, 2010, BIOMATERIALS, V31, P6269, DOI 10.1016/j.biomaterials.2010.04.051
   Gadenne V, 2015, J BIOMED MATER RES A, V103, P1021, DOI 10.1002/jbm.a.35245
   Gadenne V, 2013, COLLOID SURFACE B, V112, P229, DOI 10.1016/j.colsurfb.2013.07.061
   Garcia-Fuentes M, 2012, J CONTROL RELEASE, V161, P496, DOI 10.1016/j.jconrel.2012.03.017
   Garrett TR, 2008, PROG NAT SCI, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001
   Giavaresi G, 2014, INT ORTHOP, V38, P1505, DOI 10.1007/s00264-013-2237-2
   Gilbert R.E., 2008, CURR OPIN INFECT DIS, V1, P235
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Green JBD, 2011, BIOINTERPHASES, V6, pMR13, DOI 10.1116/1.3645195
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   He F, 2010, FOOD CONTROL, V21, P1257, DOI 10.1016/j.foodcont.2010.02.013
   Hoven VP, 2007, CARBOHYD POLYM, V68, P44, DOI 10.1016/j.carbpol.2006.07.008
   Hu XF, 2010, BIOMATERIALS, V31, P8854, DOI 10.1016/j.biomaterials.2010.08.006
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Jain G, 2009, CLIN J AM SOC NEPHRO, V4, P1787, DOI 10.2215/CJN.03920609
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jou CH, 2005, POLYM ADVAN TECHNOL, V16, P821, DOI 10.1002/pat.658
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q
   Lange D., 2009, THER ADV UROL, P143
   Lange D, 2009, J UROLOGY, V182, P1194, DOI 10.1016/j.juro.2009.05.008
   Lee H.S., 2015, U.S. Patent Application, Patent No. [US 2015/0071982 A1, 20150071982]
   Lee H.S., 2014, U.S. Patent Application, Patent No. [US 2014/0114055 A1, 20140114055]
   Lee HS, 2012, J MATER CHEM, V22, P19605, DOI 10.1039/c2jm34316a
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Lequeux I, 2014, EUR POLYM J, V51, P182, DOI 10.1016/j.eurpolymj.2013.11.012
   Li SJ, 2014, J DAIRY SCI, V97, P7334, DOI 10.3168/jds.2014-7912
   Li SQ, 2014, FOOD CHEM, V165, P262, DOI 10.1016/j.foodchem.2014.05.110
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Martin HJ, 2008, APPL SURF SCI, V254, P4599, DOI 10.1016/j.apsusc.2008.01.066
   Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558
   Martinez LR, 2010, BIOMATERIALS, V31, P669, DOI 10.1016/j.biomaterials.2009.09.087
   Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b
   Mary C.B.E., 2014, U. S. Patent, Patent No. [US 8,709,470 B2, 8709470]
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   McArthur SL, 2000, COLLOID SURFACE B, V17, P37, DOI 10.1016/S0927-7765(99)00086-7
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Orgaz B, 2011, INT J MOL SCI, V12, P817, DOI 10.3390/ijms12010817
   Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4
   Palumbo F.S., 2015, PHARM, V478, P70
   Peng ZX, 2011, ANTIMICROB AGENTS CH, V55, P860, DOI 10.1128/AAC.01005-10
   Pierre G, 2011, BIOTECHNOL BIOPROC E, V16, P937, DOI 10.1007/s12257-011-0224-2
   Pitarresi G, 2013, INT J PHARMACEUT, V449, P84, DOI 10.1016/j.ijpharm.2013.03.059
   Poortinga A. T., 2002, SURF SCI REP, P1, DOI [10.1016/S0167-5729(02)00032-8, DOI 10.1016/S0167-5729(02)00032-8]
   Popelka A, 2012, CARBOHYD POLYM, V90, P1501, DOI 10.1016/j.carbpol.2012.07.021
   Qian ZG, 2014, CARBOHYD POLYM, V101, P432, DOI 10.1016/j.carbpol.2013.09.071
   Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x
   Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Saito A, 2012, ACTA BIOMATER, V8, P2932, DOI 10.1016/j.actbio.2012.04.019
   Schweizer S, 2010, MACROMOL MATER ENG, V295, P535, DOI 10.1002/mame.200900347
   Shao P, 2014, CARBOHYD POLYM, V113, P365, DOI 10.1016/j.carbpol.2014.07.008
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Shunmugaperumal T., 2010, BIOFILM ERADICATION
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Tan YL, 2011, CARBOHYD POLYM, V84, P1365, DOI 10.1016/j.carbpol.2011.01.036
   Tenke P, 2004, INT J ANTIMICROB AG, V23, pS67, DOI 10.1016/j.ijantimicag.2003.12.007
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   van den Broek LAM, 2015, CARBOHYD POLYM, V116, P237, DOI 10.1016/j.carbpol.2014.07.039
   Wang BL, 2015, RSC ADV, V5, P3597, DOI 10.1039/c4ra13499k
   Wang R, 2012, BIOTECHNOL BIOENG, V109, P336, DOI 10.1002/bit.23342
   Wang YF, 2012, COLLOID SURFACE B, V100, P77, DOI 10.1016/j.colsurfb.2012.05.030
   Wang YF, 2010, COLLOID SURFACE B, V81, P629, DOI 10.1016/j.colsurfb.2010.08.015
   Wu MH, 2010, INT J FOOD MICROBIOL, V144, P104, DOI 10.1016/j.ijfoodmicro.2010.09.003
   Xu FM, 2011, MACROMOL BIOSCI, V11, P257, DOI 10.1002/mabi.201000313
   Yahiaoui A., 2013, U.S. Patent, Patent No. [US 8,545,951 B2, 8545951]
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Yu DG, 2007, BIOCONJUGATE CHEM, V18, P1521, DOI 10.1021/bc060098s
   Zhang XX, 2013, RSC ADV, V3, P12003, DOI 10.1039/c3ra40497h
   Zhang YY, 2011, FOOD HYDROCOLLOID, V25, P196, DOI 10.1016/j.foodhyd.2010.02.001
NR 122
TC 43
Z9 43
U1 10
U2 218
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2016
VL 30
BP 13
EP 25
DI 10.1016/j.actbio.2015.11.010
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB5ON
UT WOS:000368563600002
PM 26555378
DA 2018-10-20
ER

PT J
AU Fan, GR
   Fan, MM
   Wang, Q
   Jiang, JY
   Wan, Y
   Gong, T
   Zhang, ZR
   Sun, X
AF Fan, Gerui
   Fan, Minmin
   Wang, Qin
   Jiang, Jiayu
   Wan, Yu
   Gong, Tao
   Zhang, Zhirong
   Sun, Xun
TI Bio-inspired polymer envelopes around adenoviral vectors to reduce
   immunogenicity and improve in vivo kinetics
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Adenovirus; Cleavable PEG; beta-Cyclodextrin; PEI; Gene therapy
ID LOW-MOLECULAR-WEIGHT; GENE DELIVERY; PEGYLATED ADENOVIRUS;
   IMMUNE-RESPONSES; NEUTRALIZING ANTIBODY; POLYETHYLENE-GLYCOL; COATED
   ADENOVIRUS; THERAPY; CELLS; VITRO
AB Adenoviral vectors have attracted substantial interest for systemic tumor gene therapy, but further work is needed to reduce their immunogenicity and alter their biodistribution before they can be used in the clinic. Here we describe a bio-inspired, cleavable PEGylated beta-cyclodextrin-polyethyleneimine conjugate (CDPCP) that spontaneously coats adenovirus in solution. This cleavable PEG coating reduces the innate and adaptive immunogenicity of adenovirus particles, as well as improves their biodistribution away from the liver and into the tumor. Insertion of a matrix metalloproteinase substrate sequence into the conjugate allows PEG cleavage at the tumor site, simultaneously reducing liver biodistribution and increasing transgene expression in tumors, thereby avoiding the "PEG dilemma". Cationic beta-cyclodextrin-PEI not only provides electrostatic attraction to promote envelope attachment to the viral capsid, but it also improves vector internalization and transduction after PEG cleavage. These results suggest that CDPCP may help expand the use of adenoviral vectors in cancer gene therapy.
   Statement of significance
   The synthesized beta-cyclodextrin-PEI-MMP-cleavable-PEG polymer (CDPCP), held great potential for gene therapy when applied for adenovirus coating. The beta-cyclodextrin-PEI provided a powerful electrostatic attraction to attach the whole polymer onto the viral capsid, while the MMPs-cleavable PEG reduced innate and adaptive immunogenicity and improved the biodistribution of adenovirus vectors due to the tumor-specific enzyme triggered PEG cleavage. More importantly, an ingenious cooperation between the two components could solve the PEG dilemma. The CDPCP/Ad complexes exhibited a comprehensive and valued profile to be a candidate vector for future tumor gene therapy, we believe the current investigation on this kind of biomaterial may be of particular interest to the readership of Acta biomaterialia. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Fan, Gerui; Fan, Minmin; Wang, Qin; Jiang, Jiayu; Wan, Yu; Gong, Tao; Zhang, Zhirong; Sun, Xun] Sichuan Univ, Key Lab Drug Targeting & Novel Drug Delivery Syst, Minist Educ, West China Sch Pharm, Chengdu 610041, Sichuan, Peoples R China.
RP Sun, X (reprint author), Sichuan Univ, West China Sch Pharm, 17,Sect 3,Southern Renmin Rd, Chengdu 610041, Peoples R China.
EM xunsun22@gmail.com
OI Sun, Xun/0000-0002-0218-1664
FU National Natural Science Foundation of China [81173011, 81422044];
   National Science and Technology Major Project of China [2012ZX09304004]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81173011 and 81422044) and the National Science
   and Technology Major Project of China (No. 2012ZX09304004).
CR Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605
   Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471
   Cichon G, 2001, GENE THER, V8, P1794, DOI 10.1038/sj.gt.3301611
   Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009
   Danielsson A, 2010, GENE THER, V17, P752, DOI 10.1038/gt.2010.18
   Dmitriev I, 1998, J VIROL, V72, P9706
   Fasbender A, 1997, J BIOL CHEM, V272, P6479, DOI 10.1074/jbc.272.10.6479
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389
   Forrest ML, 2005, BIOTECHNOL BIOENG, V89, P416, DOI 10.1002/bit.20356
   Gao JQ, 2007, J CONTROL RELEASE, V122, P102, DOI 10.1016/j.jconrel.2007.06.010
   Han JF, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105106
   Hatakeyama H, 2007, GENE THER, V14, P68, DOI 10.1038/sj.gt.3302843
   Hatakeyama H, 2011, BIOMATERIALS, V32, P4306, DOI 10.1016/j.biomaterials.2011.02.045
   Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001
   Huang HL, 2006, CHEM COMMUN, P2382, DOI 10.1039/b601130f
   Jung Y, 2007, J CONTROL RELEASE, V123, P164, DOI 10.1016/j.jconrel.2007.08.002
   Kanerva A, 2004, INT J CANCER, V110, P475, DOI 10.1002/ijc.20129
   Kawamata Y, 2002, BIOMATERIALS, V23, P4573, DOI 10.1016/S0142-9612(02)00203-X
   Kawashima H, 2003, CANCER SCI, V94, P70, DOI 10.1111/j.1349-7006.2003.tb01354.x
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Kim J., 2013, BIOMATERIALS
   Kim J, 2012, BIOMATERIALS, V33, P1838, DOI 10.1016/j.biomaterials.2011.11.020
   MeunierDurmort C, 1997, GENE THER, V4, P808, DOI 10.1038/sj.gt.3300450
   Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015
   Molnar-Kimber KL, 1998, HUM GENE THER, V9, P2121, DOI 10.1089/hum.1998.9.14-2121
   Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364
   O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021
   Oberholzer C, 2004, J ENDOTOXIN RES, V10, P393, DOI 10.1179/096805104225005832
   Oh IK, 2006, BIOCONJUGATE CHEM, V17, P721, DOI 10.1021/bc060030c
   Pun SH, 2004, BIOCONJUGATE CHEM, V15, P831, DOI 10.1021/bc049891g
   Sahneh FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064690
   Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005
   Stolberg S. G., 1999, NY TIMES MAGAZINE, V28, P136
   Tang GP, 2006, J GENE MED, V8, P736, DOI 10.1002/jgm.874
   Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410
   Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016
   Wan Y., 2013, BIOMATERIALS
   Wang J, 2011, NANOMEDICINE-UK, V6, P1605, DOI [10.2217/NNM.11.141, 10.2217/nnm.11.141]
   Weaver EA, 2008, HUM GENE THER, V19, P1369, DOI [10.1089/hum.2008.091, 10.1089/hgt.2008.091]
   Yao H, 2013, CURR MED CHEM, V20, P2601, DOI 10.2174/0929867311320200008
   Yao H, 2009, BIOMATERIALS, V30, P5793, DOI 10.1016/j.biomaterials.2009.06.051
   Yao X, 2009, GENE THER, V16, P1395, DOI 10.1038/gt.2009.95
   Zeng Q, 2012, INT J NANOMED, V7, P985, DOI 10.2147/IJN.S27526
   ZIELINSKI T, 1969, Nowotwory, V19, P217
NR 45
TC 9
Z9 9
U1 2
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2016
VL 30
BP 94
EP 105
DI 10.1016/j.actbio.2015.11.005
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB5ON
UT WOS:000368563600008
PM 26546972
DA 2018-10-20
ER

PT J
AU Long, RG
   Burki, A
   Zysset, P
   Eglin, D
   Grijpma, DW
   Blanquer, SBG
   Hecht, AC
   Iatridis, JC
AF Long, Rose G.
   Buerki, Alexander
   Zysset, Philippe
   Eglin, David
   Grijpma, Dirk W.
   Blanquer, Sebastien B. G.
   Hecht, Andrew C.
   Iatridis, James C.
TI Mechanical restoration and failure analyses of a hydrogel and scaffold
   composite strategy for annulus fibrosus repair
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Annulus fibrosus repair; Annular closure; Intervertebral disk
   herniation; Spine biomechanics; Intervertebral disk degeneration
ID INTERVERTEBRAL DISC; LUMBAR SPINE; NUCLEUS REPLACEMENT; NEEDLE PUNCTURE;
   ANULAR REPAIR; DEGENERATION; MODEL; HERNIATION; DISKECTOMY; BIOMECHANICS
AB Unrepaired defects in the annulus fibrosus of intervertebral disks are associated with degeneration and persistent back pain. A clinical need exists for a disk repair strategy that can seal annular defects, be easily delivered during surgical procedures, and restore biomechanics with low risk of herniation. Multiple annulus repair strategies were developed using poly(trimethylene carbonate) scaffolds optimized for cell delivery, polyurethane membranes designed to prevent herniation, and fibrin-genipin adhesive tuned to annulus fibrosus shear properties. This three-part study evaluated repair strategies for biomechanical restoration, herniation risk and failure mode in torsion, bending and compression at physiological and hyper-physiological loads using a bovine injury model. Fibrin-genipin hydrogel restored some torsional stiffness, bending ROM and disk height loss, with negligible herniation risk and failure was observed histologically at the fibrin-genipin mid-substance following rigorous loading. Scaffold-based repairs partially restored biomechanics, but had high herniation risk even when stabilized with sutured membranes and failure was observed histologically at the interface between scaffold and fibrin-genipin adhesive. Fibrin-genipin was the simplest annulus fibrosus repair solution evaluated that involved an easily deliverable adhesive that filled irregularly-shaped annular defects and partially restored disk biomechanics with low herniation risk, suggesting further evaluation for disk repair may be warranted.
   Statement of significance
   Lower back pain is the leading cause of global disability and commonly caused by defects and failure of intervertebral disk tissues resulting in herniation and compression of adjacent nerves. Annulus fibrosus repair materials and techniques have not been successful due to the challenging mechanical and chemical microenvironment and the needs to restore biomechanical behaviors and promote healing with negligible herniation risk while being delivered during surgical procedures. This work addressed this challenging biomaterial and clinical problem using novel materials including an adhesive hydrogel, a scaffold capable of cell delivery, and a membrane to prevent herniation. Composite repair strategies were evaluated and optimized in quantitative three-part study that rigorously evaluated disk repair and provided a framework for evaluating alternate repair techniques. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Long, Rose G.; Hecht, Andrew C.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.
   [Buerki, Alexander; Zysset, Philippe] Univ Bern, Inst Surg Technol & Biomech, Bern, Switzerland.
   [Eglin, David] AO Res Inst Davos, Davos, Switzerland.
   [Long, Rose G.; Eglin, David; Grijpma, Dirk W.; Blanquer, Sebastien B. G.; Iatridis, James C.] AO Fdn, Collaborat Res Partner Annulus Fibrosus Rupture P, Davos, Switzerland.
   [Grijpma, Dirk W.; Blanquer, Sebastien B. G.] Univ Twente, Dept Biomat Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
   [Iatridis, James C.] Icahn Sch Med Mt Sinai, Dept Orthopaed, One Gustave Levy Pl,Box 1188, New York, NY 10029 USA.
RP Iatridis, JC (reprint author), Icahn Sch Med Mt Sinai, Dept Orthopaed, One Gustave Levy Pl,Box 1188, New York, NY 10029 USA.
EM james.iatridis@mssm.edu
RI Zysset, Philippe/B-2997-2018; Long, Rose/E-8969-2017
OI Zysset, Philippe/0000-0002-4712-7047; Long, Rose/0000-0001-9999-9288;
   Iatridis, James/0000-0002-2186-0590
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [R01AR057397]; National Institute of General Medical Sciences;
   Collaborative Research Partner Program grant on Annulus Fibrosus Rupture
   from the AO Foundation, Davos, Switzerland; Traineeship of the National
   Institutes of Health [T32 GM062754]
FX The research reported in this publication was supported by grants from
   the National Institute of Arthritis and Musculoskeletal and Skin
   Diseases (R01AR057397) and National Institute of General Medical
   Sciences; Traineeship (T32 GM062754) of the National Institutes of
   Health and a Collaborative Research Partner Program grant on Annulus
   Fibrosus Rupture from the AO Foundation, Davos, Switzerland. The authors
   gratefully acknowledge the technical contributions and helpful
   discussions from Keegan Cole, Sarah Elsharkawy, Dr. Stephen Ferguson,
   Warren Horn, Damien Laudier, Diana Litsas, and Dr. Morakot
   Likhitpanichkul, Philip Nasser, Carine Rognon.
CR Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4
   Asch HL, 2002, J NEUROSURG, V96, P34, DOI 10.3171/spi.2002.96.1.0034
   Bailey A, 2013, SPINE, V38, P1161, DOI 10.1097/BRS.0b013e31828b2e2f
   Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0
   Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2
   Gray DT, 2006, SPINE, V31, P1957, DOI 10.1097/01.brs.0000229148.63418.c1
   Gruber HE, 2002, BIOTECH HISTOCHEM, V77, P81, DOI 10.1080/714028181
   Guterl C. C., 2014, TISSUE ENG A, V20
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Johannessen W, 2006, ANN BIOMED ENG, V34, P687, DOI 10.1007/s10439-005-9070-8
   Lee SH, 2014, J SPINAL DISORD TECH, V27, P111, DOI 10.1097/BSD.0b013e3182a1ddef
   Li GA, 2009, EUR SPINE J, V18, P1013, DOI 10.1007/s00586-009-0936-6
   Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P25, DOI 10.22203/eCM.v028a03
   Likhitpanichkul M, 2014, EUR CELLS MATER, V28, P37
   March L, 2014, BEST PRACT RES CL RH, V28, P353, DOI 10.1016/j.berh.2014.08.002
   Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20
   McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a
   Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001
   Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z
   Nagel TM, 2014, EUR SPINE J, V23, P754, DOI 10.1007/s00586-014-3195-0
   O'Connell GD, 2007, SPINE, V32, P328, DOI 10.1097/01.brs.0000253961.40910.c1
   OSHIMA H, 1993, J ORTHOPAED RES, V11, P332, DOI 10.1002/jor.1100110304
   PEARCY M, 1984, SPINE, V9, P294, DOI 10.1097/00007632-198404000-00013
   PEARCY MJ, 1984, SPINE, V9, P582, DOI 10.1097/00007632-198409000-00008
   Pirvu T, 2015, BIOMATERIALS, V42, P11, DOI 10.1016/j.biomaterials.2014.11.049
   Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Tan JS, 2012, SPINE, V37, pE1238, DOI 10.1097/BRS.0b013e31826111a3
   Trummer M, 2013, CLIN NEUROL NEUROSUR, V115, P1440, DOI 10.1016/j.clineuro.2013.01.007
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Walter B. A., 2014, J ANAT, V25, P390
   Watters WC, 2009, SPINE J, V9, P240, DOI 10.1016/j.spinee.2008.08.005
   Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4
   Wilke HJ, 2013, SPINE, V38, pE587, DOI 10.1097/BRS.0b013e31828ca4bc
   Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005
   Xia Q, 2010, J BIOMECH, V43, P1905, DOI 10.1016/j.jbiomech.2010.03.023
NR 41
TC 14
Z9 14
U1 6
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2016
VL 30
BP 116
EP 125
DI 10.1016/j.actbio.2015.11.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB5ON
UT WOS:000368563600010
PM 26577987
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Rossi, F
   Papa, S
   Violatto, MB
   Bigini, P
   Sorbona, M
   Redaelli, F
   Veglianese, P
   Hilborn, J
   Ossipov, DA
AF Zhang, Yu
   Rossi, Filippo
   Papa, Simonetta
   Violatto, Martina Bruna
   Bigini, Paolo
   Sorbona, Marco
   Redaelli, Francesca
   Veglianese, Pietro
   Hilborn, Jons
   Ossipov, Dmitri A.
TI Non-invasive in vitro and in vivo monitoring of degradation of
   fluorescently labeled hyaluronan hydrogels for tissue engineering
   applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hyaluronan; Hydrogel degradation; Non-invasive imaging; Spinal cord;
   Tissue engineering
ID DRUG-DELIVERY; ACID HYDROGEL; INJECTABLE HYDROGELS; SCAFFOLDS; SYSTEM;
   REPAIR; BIOMATERIAL; CHEMISTRY; TRACKING
AB Tracking of degradation of hydrogels-based biomaterials in vivo is very important for rational design of tissue engineering scaffolds that act as delivery carriers for bioactive factors. During the process of tissue development, an ideal scaffold should remodel at a rate matching with scaffold degradation. To reduce amount of animals sacrificed, non-invasive in vivo imaging of biomaterials is required which relies on using of biocompatible and in situ gel forming compounds carrying suitable imaging agents. In this study we developed a method of in situ fabrication of fluorescently labeled and injectable hyaluronan (HA) hydrogel based on one pot sequential use of Michael addition and thiol-disulfide exchange reactions for the macromolecules labeling and cross-linking respectively. Hydrogels with different content of HA were prepared and their enzymatic degradation was followed in vitro and in vivo using fluorescence multispectral imaging. First, we confirmed that the absorbance of the matrix-linked near-IR fluorescent IRDye (R) 800CW agent released due to the matrix enzymatic degradation in vitro matched the amount of the degraded hydrogel measured by classical gravimetric method. Secondly, the rate of degradation was inversely proportional to the hydrogel concentration and this structure-degradation relationship was similar for both in vitro and in vivo studies. It implies that the degradation of this disulfide cross-linked hyaluronan hydrogel in vivo can be predicted basing on the results of its in vitro degradation studies. The compliance of in vitro and in vivo methods is also promising for the future development of predictive in vitro tissue engineering models.
   Statement of significance
   The need for engineered hydrogel scaffolds that deliver bioactive factors to endogenous progenitor cells in vivo via gradual matrix resorption and thus facilitate tissue regeneration is increasing with the aging population. Importantly, scaffold should degrade at a modest rate that will not be too fast to support tissue growth nor too slow to provide space for tissue development. The present work is devoted to longitudinal tracking of a hydrogel material in vivo from the time of its implantation to the time of complete resorption without sacrificing animals. The method demonstrates correlation of resorption rates in vivo and in vitro for hydrogels with varied structural parameters. It opens the possibility to develop predictive in vitro models for tissue engineered scaffolds and reduce animal studies. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Yu; Sorbona, Marco; Redaelli, Francesca; Hilborn, Jons; Ossipov, Dmitri A.] Uppsala Univ, Sci Life Lab, Div Polymer Chem, Dept Chem Angstrom, SE-75121 Uppsala, Sweden.
   [Rossi, Filippo] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Via Mancinelli, I-20131 Milan, Italy.
   [Papa, Simonetta; Veglianese, Pietro] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via La Masa 19, I-20156 Milan, Italy.
   [Violatto, Martina Bruna; Bigini, Paolo] IRCCS Ist Ric Farmacol Mario Negri, Dept Biochem & Mol Pharmacol, Via La Masa 19, I-20156 Milan, Italy.
RP Ossipov, DA (reprint author), Lagerhyddsvagen 1,Box 538, S-75121 Uppsala, Sweden.; Rossi, F (reprint author), Politecn Milan, Via Mancinelli 7, I-20131 Milan, MI, Italy.
EM filippo.rossi@polimi.it; dmitri.ossipov@kemi.uu.se
RI Violatto, Martina Bruna/K-4238-2016
OI Violatto, Martina Bruna/0000-0002-9016-410X; Rossi,
   Filippo/0000-0003-2665-120X; Veglianese, Pietro/0000-0002-0183-9428
FU European Community's Seventh Frame-work Programme (BIODESIGN); China
   Scholar Council (CSC)
FX The research leading to these results has received funding from the
   European Community's Seventh Frame-work Programme (BIODESIGN). Y. Zhang
   thanks to scholarship supported by China Scholar Council (CSC).
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Bae KH, 2013, J MATER CHEM B, V1, P5371, DOI 10.1039/c3tb20940g
   Benny O, 2008, FASEB J, V22, P488, DOI 10.1096/fj.07-8801com
   Berdichevski A, 2015, P NATL ACAD SCI USA, V112, P5147, DOI 10.1073/pnas.1502232112
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Caron I, 2014, WIRES NANOMED NANOBI, V6, P506, DOI 10.1002/wnan.1276
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Cunha-Reis C, 2013, J TISSUE ENG REGEN M, V7, P39, DOI 10.1002/term.494
   Elliott Donaghue I, 2015, BIOMATER SCI-UK, V3, P65, DOI 10.1039/c4bm00311j
   Ganesh S, 2013, BIOMATERIALS, V34, P3489, DOI 10.1016/j.biomaterials.2013.01.077
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   GROSS J, 1974, BIOCHEM BIOPH RES CO, V61, P605, DOI 10.1016/0006-291X(74)91000-6
   Grover GN, 2013, ADV MATER, V25, P2937, DOI 10.1002/adma.201205234
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hulsart-Billstrom G, 2013, BIOMACROMOLECULES, V14, P3055, DOI 10.1021/bm400639e
   Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024
   KANEKO T, 1991, BIOCONJUGATE CHEM, V2, P133, DOI 10.1021/bc00009a001
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim S, 2013, SCI WORLD J, DOI 10.1155/2013/175702
   Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Lenthea G., 2007, BIOMINERALS, V28, P2479
   Liang YJ, 2015, BIOMATERIALS, V42, P144, DOI 10.1016/j.biomaterials.2014.11.050
   Mandavi A.FerreiraL, 2008, P NATL ACAD SCI USA, V105, P2307
   Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5
   Moller L, 2011, MACROMOL SYMP, V309-310, P222, DOI 10.1002/masy.201100045
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Ossipov D, 2013, MACROMOLECULES, V46, P4105, DOI 10.1021/ma400543u
   Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025
   Rodell CB, 2015, ADV FUNCT MATER, V25, P636, DOI 10.1002/adfm.201403550
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Soranno DE, 2014, J BIOMED MATER RES A, V102, P2173, DOI 10.1002/jbm.a.34902
   Takahashi A, 2013, BIOMACROMOLECULES, V14, P3581, DOI 10.1021/bm4009606
   Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237
   Tan HP, 2011, MACROMOL RAPID COMM, V32, P905, DOI 10.1002/marc.201100125
   Wang WW, 2014, J MATER CHEM B, V2, P4185, DOI 10.1039/c4tb00275j
   Wei X, 2013, BIOCONJUGATE CHEM, V24, P658, DOI 10.1021/bc300632w
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Zhang JX, 2008, BIOMATERIALS, V29, P4521, DOI 10.1016/j.biomaterials.2008.08.008
   Zhang Y, 2014, MACROMOL BIOSCI, V14, P1249, DOI 10.1002/mabi.201400117
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 46
TC 24
Z9 25
U1 9
U2 82
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2016
VL 30
BP 188
EP 198
DI 10.1016/j.actbio.2015.11.053
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB5ON
UT WOS:000368563600017
PM 26621694
DA 2018-10-20
ER

PT J
AU Kim, J
   Gilbert, JL
AF Kim, Jua
   Gilbert, Jeremy L.
TI Cytotoxic effect of galvanically coupled magnesium-titanium particles
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Galvanic Corrosion; Cytotoxicity; Magnesium alloy; Reactive oxygen
   species; Oxidation and reduction reactions
ID IN-VITRO; INTRAVASCULAR ULTRASOUND; SILVER NANOPARTICLES; ORTHOPEDIC
   IMPLANTS; ESCHERICHIA-COLI; METAL-IONS; ALLOYS; CORROSION; APOPTOSIS;
   BONE
AB Recent work has shown that reduction reactions at metallic biomaterial surfaces can induce significant killing of cells in proximity to the surface. To exploit this phenomenon for therapeutic purposes, for example, for cancer tumor killing or antibacterial effects (amongst other applications), magnesium metal particles, galvanically coupled to titanium by sputtering, have been evaluated for their cell-killing capability (i.e. cytotoxicity). Magnesium (Mg) particles large enough to prevent particle phagocytosis were investigated, so that only electrochemical reactions, and not particle toxicity per se, caused cytotoxic effects. Titanium (Ti) coated magnesium particles, as well as magnesium-only particles were introduced into MC3T3-E1 mouse pre-osteoblast cell cultures over a range of particle concentrations, and cells were observed to die in a dosage-dependent manner. Ti-coated magnesium particles killed more cells at lower particle concentration than magnesium alone (P < 0.05), although the pH measured for magnesium and magnesium-titanium had no significant difference at similar particle concentrations. Complete cell killing occurred at 750 mu g/ml and 1500 mu g/ml for Mg-Ti and Mg, respectively. Thus, this work demonstrates that galvanically coupled Mg-Ti particles have a significant cell killing capability greater than Mg alone. In addition, when the pH associated with complete killing with particles was created using NaOH only (no particles), then the percentage of cells killed was significantly less (P < 0.05). Together, these findings show that pH is not the sole factor associated with cell killing and that the electrochemical reactions, including the reduction reactions, play an important role. Reduction reactions on galvanically coupled Mg-Ti and Mg particles may generate reactive oxygen intermediates that are able to kill cells in close proximity to the particles and this approach may lead to potential therapies for infection and cancer.
   Statement of Significance
   This paper demonstrates that during active corrosion of both Mg and Mg-Ti particles cells cultured with the particles are killed in a dose-dependent particle concentration fashion. Additionally, galvanically coupled magnesium-titanium microparticles kill cells more effectively than magnesium particles alone. The killing effect was shown to not be due to pH shifts since no differences were seen for different particle types and pH adjusted medium without particles did not exhibit the same level of killing. The significance of this work is the recognition of this killing effect with Mg particles and the potential therapeutic applications in infection control and cancer treatment that this process may provide. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kim, Jua; Gilbert, Jeremy L.] Syracuse Univ, LC Smith Coll Engn & Comp Sci, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
   [Kim, Jua; Gilbert, Jeremy L.] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA.
   [Gilbert, Jeremy L.] Univ Leeds, Inst Med & Biol Engn, Leeds, W Yorkshire, England.
RP Gilbert, JL (reprint author), Syracuse Univ, LC Smith Coll Engn & Comp Sci, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.
EM jkim90@syr.edu; gilbert@syr.edu
OI Kim, Jua/0000-0002-3949-9019
FU DePuy Synthes; Cheney International Faculty Fellowship at the University
   Of Leeds
FX This work was supported, in part, by DePuy Synthes and the Cheney
   International Faculty Fellowship at the University Of Leeds.
CR Barlis P, 2007, EUR HEART J, V28, P2319, DOI 10.1093/eurheartj/ehm119
   Bianco PD, 1996, BIOMATERIALS, V17, P1937, DOI 10.1016/0142-9612(96)00023-3
   Blake DM, 1999, SEPAR PURIF METHOD, V28, P1, DOI 10.1080/03602549909351643
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Cao HL, 2011, BIOMATERIALS, V32, P693, DOI 10.1016/j.biomaterials.2010.09.066
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   Cowan JA, 2002, BIOMETALS, V15, P225, DOI 10.1023/A:1016022730880
   DHAR HP, 1982, J ELECTROCHEM SOC, V129, P2178, DOI 10.1149/1.2123471
   Ehrensberger MT, 2010, J BIOMED MATER RES A, V93A, P1500, DOI 10.1002/jbm.a.32622
   Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005
   Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2
   Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849
   Gilbert J. L., 2015, Patent, Patent No. [9,039,764, 9039764]
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Ha KY, 2005, SPINE, V30, P38, DOI 10.1097/01.brs.0000147801.63304.8a
   Haeri M, 2012, BIOMATERIALS, V33, P6295, DOI 10.1016/j.biomaterials.2012.05.054
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Jia-Cheng Gao, 2010, Frontiers of Materials Science in China, V4, P126, DOI 10.1007/s11706-010-0030-3
   KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   NEEDHAM JV, 1993, BIOCHEMISTRY-US, V32, P3363, DOI 10.1021/bi00064a020
   Robinson DA, 2010, ACTA BIOMATER, V6, P1869, DOI 10.1016/j.actbio.2009.10.007
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Sivan S, 2013, J BIOMED MATER RES B, V101, P1489, DOI 10.1002/jbm.b.32970
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   STAINDL O, 1989, ARCH OTO-RHINO-LARYN, V246, P213, DOI 10.1007/BF00453665
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Sun ZL, 1997, J BIOMED MATER RES, V34, P29, DOI 10.1002/(SICI)1097-4636(199701)34:1<29::AID-JBM5>3.0.CO;2-P
   Tan ALK, 2005, SURF COAT TECH, V198, P478, DOI 10.1016/j.surfcoat.2004.10.066
   Tsuang YH, 2008, ARTIF ORGANS, V32, P167, DOI 10.1111/j.1525-1594.2007.00530.x
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Waizy H, 2013, J MATER SCI, V48, P39, DOI 10.1007/s10853-012-6572-2
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wang JL, 2015, ACTA BIOMATER, V21, P237, DOI 10.1016/j.actbio.2015.04.011
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   WILFLINGSEDER P, 1981, CHIR PLAST, V6, P105, DOI 10.1007/BF00289635
   Williams David, 2006, Med Device Technol, V17, P9
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
NR 52
TC 7
Z9 7
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN 15
PY 2016
VL 30
BP 368
EP 377
DI 10.1016/j.actbio.2015.11.030
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB5ON
UT WOS:000368563600033
PM 26596564
DA 2018-10-20
ER

PT J
AU Boccaccio, A
   Uva, AE
   Fiorentino, M
   Mori, G
   Monno, G
AF Boccaccio, Antonio
   Uva, Antonio Emmanuele
   Fiorentino, Michele
   Mori, Giorgio
   Monno, Giuseppe
TI Geometry Design Optimization of Functionally Graded Scaffolds for Bone
   Tissue Engineering: A Mechanobiological Approach
SO PLOS ONE
LA English
DT Article
ID MANDIBULAR DISTRACTION OSTEOGENESIS; MECHANO-REGULATION MODEL;
   HYDROXYAPATITE CERAMICS; COMPUTATIONAL ANALYSIS; BIOMATERIAL SCAFFOLDS;
   LATENCY PERIOD; DIFFERENTIATION; REGENERATION; FABRICATION; POROSITY
AB Functionally Graded Scaffolds (FGSs) are porous biomaterials where porosity changes in space with a specific gradient. In spite of their wide use in bone tissue engineering, possible models that relate the scaffold gradient to the mechanical and biological requirements for the regeneration of the bony tissue are currently missing. In this study we attempt to bridge the gap by developing a mechanobiology-based optimization algorithm aimed to determine the optimal graded porosity distribution in FGSs. The algorithm combines the parametric finite element model of a FGS, a computational mechano-regulation model and a numerical optimization routine. For assigned boundary and loading conditions, the algorithm builds iteratively different scaffold geometry configurations with different porosity distributions until the best microstructure geometry is reached, i.e. the geometry that allows the amount of bone formation to be maximized. We tested different porosity distribution laws, loading conditions and scaffold Young's modulus values. For each combination of these variables, the explicit equation of the porosity distribution law-i.e the law that describes the pore dimensions in function of the spatial coordinates-was determined that allows the highest amounts of bone to be generated. The results show that the loading conditions affect significantly the optimal porosity distribution. For a pure compression loading, it was found that the pore dimensions are almost constant throughout the entire scaffold and using a FGS allows the formation of amounts of bone slightly larger than those obtainable with a homogeneous porosity scaffold. For a pure shear loading, instead, FGSs allow to significantly increase the bone formation compared to a homogeneous porosity scaffolds. Although experimental data is still necessary to properly relate the mechanical/biological environment to the scaffold microstructure, this model represents an important step towards optimizing geometry of functionally graded scaffolds based on mechanobiological criteria.
C1 [Boccaccio, Antonio; Uva, Antonio Emmanuele; Fiorentino, Michele; Monno, Giuseppe] Politecn Bari, Dipartimento Meccan Matemat & Management, I-70126 Bari, Italy.
   [Mori, Giorgio] Univ Foggia, Dipartimento Med Clin & Sperimentale, I-71122 Foggia, Italy.
RP Boccaccio, A (reprint author), Politecn Bari, Dipartimento Meccan Matemat & Management, I-70126 Bari, Italy.
EM a.boccaccio@poliba.it
RI Mori, Giorgio/P-1370-2014; Uva, Antonio/O-4176-2016
OI Mori, Giorgio/0000-0001-6731-0247; BOCCACCIO,
   ANTONIO/0000-0002-9623-7189
CR Bailey BM, 2013, ACTA BIOMATER, V9, P8254, DOI 10.1016/j.actbio.2013.05.012
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336
   Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1
   Boccaccio A, 2007, ANN BIOMED ENG, V35, P1940, DOI 10.1007/s10439-007-9367-x
   Boccaccio A, 2012, MED BIOL ENG COMPUT, V50, P947, DOI 10.1007/s11517-012-0937-1
   Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112
   Boccaccio A, 2008, J MECH MED BIOL, V8, P203, DOI 10.1142/S0219519408002644
   Boccaccio A, 2016, INT J BIOL SCI, V12, P1, DOI 10.7150/ijbs.13158
   Boccaccio A, 2011, J ORTHOP RES, V29, P433, DOI 10.1002/jor.21231
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9
   Chua CK, 2011, MRS BULL, V36, P1006, DOI 10.1557/mrs.2011.271
   Coelho PG, 2015, MED ENG PHYS, V37, P287, DOI 10.1016/j.medengphy.2015.01.004
   Dias MR, 2014, MED ENG PHYS, V36, P448, DOI 10.1016/j.medengphy.2014.02.010
   Feng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049955
   Giannitelli SM, 2015, MAT SCI ENG C-MATER, V51, P329, DOI 10.1016/j.msec.2015.03.002
   Guyot Y, 2014, BIOMECH MODEL MECHAN, V13, P1361, DOI 10.1007/s10237-014-0577-5
   Hendrikson WJ, 2014, BIOTECHNOL BIOENG, V111, P1864, DOI 10.1002/bit.25231
   Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6
   Lee BT, 2006, J EUR CERAM SOC, V26, P3525, DOI 10.1016/j.jeurceramsoc.2005.12.017
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Lu WW, 2003, J MATER SCI-MATER M, V14, P1039, DOI 10.1023/B:JMSM.0000004000.56814.9e
   Macchetta A, 2009, ACTA BIOMATER, V5, P1319, DOI 10.1016/j.actbio.2008.11.009
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Mia X, 2010, MATERIALS, V3, P26
   Muthutantri A, 2008, J R SOC INTERFACE, V5, P1459, DOI 10.1098/rsif.2008.0092
   Pan Z., 2015, REGENETATIVE BIOMATE, P9
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Rainer A, 2012, ANN BIOMED ENG, V40, P966, DOI 10.1007/s10439-011-0465-4
   Rodriguez-Lorenzo LM, 2004, MATER RES BULL, V39, P83, DOI 10.1016/j.materresbull.2003.09.014
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Wieding J, 2014, J MECH BEHAV BIOMED, V37, P56, DOI 10.1016/j.jmbbm.2014.05.002
   Yang JW, 2015, J CRANIOFAC SURG, V26, pE148, DOI 10.1097/SCS.0000000000001383
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yavari SA, 2014, J BIOMECH, V47, P2700, DOI 10.1016/j.jbiomech.2014.05.006
   Zadpoor AA, 2015, BIOMATER SCI-UK, V3, P231, DOI 10.1039/c4bm00291a
NR 42
TC 14
Z9 14
U1 5
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 15
PY 2016
VL 11
IS 1
AR e0146935
DI 10.1371/journal.pone.0146935
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB6ME
UT WOS:000368628300044
PM 26771746
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rohanova, D
   Horkavcova, D
   Helebrant, A
   Boccaccini, AR
AF Rohanova, Dana
   Horkavcova, Diana
   Helebrant, Ales
   Boccaccini, Aldo Roberto
TI Assessment of in vitro testing approaches for bioactive inorganic
   materials
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Biomaterial; In vitro test; Hydroxyapatite; SBF; Dynamic arrangement
ID CALCIUM-PHOSPHATE FILMS; GLASS; HYDROXYAPATITE; APATITE; FLUID; SBF
AB This paper deals with non-standard in vitro testing of bioactive inorganic materials shaped as granules or scaffolds. The ISO 23317 standard describes the in vitro test arrangement of bulk bioactive materials under static conditions. However, this norm has not dealt with bioactive materials shaped as granules (with large surface area) that are commonly used in clinical practice. We found that in the case of highly reactive (bioactive) materials, the biogenic elements were exhausted from simulated body fluid (SBF) solution very quickly (within hours) under static conditions. In such exhausted SBF solution the formation of Ca-P layer (hydroxyapatite - HAp) was stopped in agreement with the decrease of Ca and P concentrations. On the contrary, highly soluble materials (glass-ceramic scaffold) induced the formation of a new mineral layer also on the walls of the PE container used. For a non-standard shape of the tested materials the usage of dynamic or static-dynamic in vitro test arrangement was confirmed to be a better option to test bioactivity. However, also for this type of arrangement it is essential to determine the S/V or S/F ratios (the surface area/volume or flow of SBF solution) very precisely. For detailed understanding of the interaction between the tested material and SBF it is important to analyze the leachates (monitoring Ca2+, (PO4)(3-) and minor element concentrations) and to monitor the pH value. An expected result of the in vitro test (according ISO standard) is the formation of HAp on the surfaces of tested samples in SBF. However, the formation of hydroxyapatite may not be the proof of their potential bioactivity necessarily (e.g. due to the use of TRIS buffer). (C) 2015 Elsevier B.V. All rights reserved.
C1 [Rohanova, Dana; Horkavcova, Diana; Helebrant, Ales] Univ Chem & Technol Prague, Fac Chem Technol, Dept Glass & Ceram, Tech 5, Prague 16628 6, Czech Republic.
   [Boccaccini, Aldo Roberto] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Rohanova, D (reprint author), Univ Chem & Technol Prague, Fac Chem Technol, Dept Glass & Ceram, Tech 5, Prague 16628 6, Czech Republic.
EM dana.rohanova@vscht.cz
RI Boccaccini, Aldo/C-7905-2013
FU Technology Agency of the Czech Republic within Center for development of
   modern metallic biomaterials for medicinal implants [TE01020390]
FX This work was supported by the Technology Agency of the Czech Republic
   within the project TE01020390 Center for development of modern metallic
   biomaterials for medicinal implants. The authors would like to express
   their thanks for SEM/EDS analyses to Ing. Zuzana Zlamalova Cilova, PhD.,
   and to our students Iva Brezovska, Pavlina Bozdechova, Klara Zitkova,
   Lenka Kuncova and Jitka Kulhava from the Department of Glass and
   Ceramics of the University of Chemistry and Technology Prague.
CR [Anonymous], 2014, 23317 ISO
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bozdechova P., 2013, THESIS
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   FUJIU T, 1984, J BIOMED MATER RES, V18, P845, DOI 10.1002/jbm.820180714
   Greenspan D. C., 1994, BIOCERAMICS, V7, P55
   Helebrant A., 2001, CERAM-SILIKATY, V46, P9
   Holand W., 1991, BIOCERAMICS, V4, P171
   Horkavcova D, 2010, CERAM-SILIKATY, V54, P398
   Horvathova R, 2006, CERAM-SILIKATY, V50, P153
   Kim HM, 2001, KEY ENG MATER, V192-195, P47, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.47
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Macon A.L.B., 2015, J MATER SCI-MATER M, V26, P1, DOI DOI 10.1007/S10856-015-5403-9
   Massera J, 2014, J NON-CRYST SOLIDS, V402, P28, DOI 10.1016/j.jnoncrysol.2014.05.006
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   Ramila A, 2001, BIOMATERIALS, V22, P2301, DOI 10.1016/S0142-9612(00)00419-1
   Rohanova D., 2011, SKLAR KERAMIK C, V61, P125
   Rohanova D, 2014, J MATER CHEM B, V2, P5068, DOI 10.1039/c4tb00187g
   Rohanova D, 2011, ACTA BIOMATER, V7, P2623, DOI 10.1016/j.actbio.2011.02.028
   Siriphannon P, 2002, J BIOMED MATER RES, V60, P175, DOI 10.1002/jbm.10056
   Strnad J, 2004, J THERM ANAL CALORIM, V76, P17, DOI 10.1023/B:JTAN.0000027799.48305.1c
   Tas AC, 2014, ACTA BIOMATER, V10, P1771, DOI 10.1016/j.actbio.2013.12.047
   Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b
   Varila L, 2012, J EUR CERAM SOC, V32, P2757, DOI 10.1016/j.jeurceramsoc.2012.01.025
   Zhang D, 2008, ACTA BIOMATER, V4, P1498, DOI 10.1016/j.actbio.2008.04.007
   Zhang D, 2008, MATER CHEM PHYS, V111, P497, DOI 10.1016/j.matchemphys.2008.04.055
NR 31
TC 4
Z9 4
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD JAN 15
PY 2016
VL 432
BP 53
EP 59
DI 10.1016/j.jnoncrysol.2015.03.016
PN A
PG 7
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA DA4KP
UT WOS:000367769100009
DA 2018-10-20
ER

PT J
AU Crovace, MC
   Souza, MT
   Chinaglia, CR
   Peitl, O
   Zanotto, ED
AF Crovace, Murilo C.
   Souza, Marina T.
   Chinaglia, Clever R.
   Peitl, Oscar
   Zanotto, Edgar D.
TI Biosilicate (R) - A multipurpose, highly bioactive glass-ceramic. In
   vitro, in vivo and clinical trials
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Bioactive; Glass; Glass-ceramic; In vivo; In vitro; Clinical trial;
   Biosilicate
ID KAPPA-B LIGAND; RECEPTOR ACTIVATOR; LASER IRRADIATION; BIOGLASS(R) 45S5;
   BORATE GLASSES; SCAFFOLDS; OSTEOPROTEGERIN; HYDROXYAPATITE;
   MICROORGANISMS; BIOMATERIALS
AB In this review we critically analyze 28 theses and dissertations and over 30 scientific papers that tested Biosilicate (R), a highly bioactive glass-ceramic, in a number of applications throughout the past 20 years. Biosilicate (R) presents a combination of positive features for bone tissue regeneration: it is highly bioactive, osteoconductive, osteoinductive, non-cytotoxic, non-genotoxic and has antibacterial properties. In addition, in the monolithic form, it is quite strong and tough. Its in vitro bioactivity is similar to that of the gold standard Bioglass 45S5. Biosilicate (R) has shown to be a very versatile, multipurpose biomaterial. It can be applied in powder, monolithic and 3D scaffold forms that could be easily machined during surgical procedures. This material has been successfully tested in a number of in vitro, in vivo and clinical studies, and several trials are ongoing. Biosilicate (R) is indeed a great option for a wide range of tissue engineering applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Crovace, Murilo C.; Souza, Marina T.; Chinaglia, Clever R.; Peitl, Oscar; Zanotto, Edgar D.] Fed Univ Sao Carlos UFSCar, Vitreous Mat Lab, Dept Mat Engn, Ctr Res Educ & Technol Vitreous Mat CeRTEV, Sao Paulo, SP, Brazil.
RP Crovace, MC (reprint author), Fed Univ Sao Carlos UFSCar, Vitreous Mat Lab, Dept Mat Engn, Ctr Res Educ & Technol Vitreous Mat CeRTEV, Sao Paulo, SP, Brazil.
EM murilocc@yahoo.com.br
RI Zanotto, Edgar/A-7992-2011; CerTEV, CeRTEV/J-6817-2015
OI Zanotto, Edgar/0000-0003-4931-4505; Crovace, Murilo/0000-0002-6993-6363
FU CNPq; FAPESP - Sao Paulo Research Foundation [2013/07793-6]; CeRTEV
   (Center for Research, Technology and Education in Vitreous Materials)
FX The authors are thankful to the Brazilian funding agency CNPq for
   granting student fellowships and to FAPESP - Sao Paulo Research
   Foundation grant number 2013/07793-6 and CeRTEV (Center for Research,
   Technology and Education in Vitreous Materials) for funding this
   research. We are especially indebted to the numerous collaborators and
   Biosilicate (R) enthusiasts throughout these past 20 years of research.
CR Abou Neel EA, 2009, J MATER CHEM, V19, P690, DOI 10.1039/b810675d
   Ahmed I, 2004, BIOMATERIALS, V25, P491, DOI 10.1016/S0142-9612(03)00546-5
   Alves O. C., 2011, THESIS
   Anandarajah AP, 2009, TRENDS ENDOCRIN MET, V20, P88, DOI 10.1016/j.tem.2008.10.007
   Azenha Marcelo Rodrigues, 2010, Braz. Dent. J., V21, P383, DOI 10.1590/S0103-64402010000500001
   Baino F, 2014, ACTA BIOMATER, V10, P1064, DOI 10.1016/j.actbio.2013.12.014
   Black J., 1998, HDB BIOMATERIAL PROP
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Brandao SM, 2012, ORBIT, V31, P143, DOI 10.3109/01676830.2011.648798
   Brandao SM, 2013, REV BRAS OFTALMOL, V72, P21, DOI 10.1590/S0034-72802013000100005
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Crovace M. C., 2010, 6 LAT AM C ART ORG B
   Crovace M. C., 2009, THESIS
   Day DE, 2003, GLASS TECHNOL, V44, P75
   Desimone D, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/045008
   Dorland D. A., 2012, DORLANDS ILLUSTRATED
   Fangel R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3598847
   Martins CHG, 2011, J MATER SCI-MATER M, V22, P1439, DOI 10.1007/s10856-011-4330-7
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Han X, 2007, J MATER SCI-MATER M, V18, P1837, DOI 10.1007/s10856-007-3053-2
   Hench L., 2004, J AUST CERAM SOC, V40, P1
   Hench L. L., 2013, INTRO BIOCERAMICS
   Hench L.L., 2013, INTRO BIOCERAMICS, P49
   Hench L.L., 2006, J MATER SCI-MATER M, P967
   Hench LL, 2010, INT J APPL GLASS SCI, V1, P104, DOI 10.1111/j.2041-1294.2010.00001.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1997, Bioactive ceramic composition useful in load-bearing prosthetic devices-comprises silicon dioxide, calcium oxide, sodium oxide and phosphorus pentoxide, and forms hydroxy-carbonate apatite layer on implanted surface, Patent No. [WO9741079-A, 9741079]
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Holand W., 2012, GLASS CERAMIC TECHNO
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jabur R. O., 2009, ORAL SURG, V2, P161
   Jones JR, 2007, ELEMENTS, V3, P393, DOI 10.2113/GSELEMENTS.3.6.393
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014
   Kido HW, 2013, J BIOMED MATER RES A, V101, P667, DOI 10.1002/jbm.a.34360
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004
   Lebecq I, 2007, J BIOMED MATER RES A, V83A, P156, DOI 10.1002/jbm.a.31228
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   MARTINS C. C. A, 2012, THESIS
   Massuda Eduardo Tanaka, 2009, Braz. j. otorhinolaryngol., V75, P665, DOI 10.1590/S1808-86942009000500009
   Massuda ET, 2007, THESIS
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Mules P. H., 1885, T OPHTHAL SOC UK, V5, P200
   Renno ACM, 2010, PHOTOMED LASER SURG, V28, P131, DOI 10.1089/pho.2009.2487
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Peitl O, 2012, ACTA BIOMATER, V8, P321, DOI 10.1016/j.actbio.2011.10.014
   PINHEIRO H. M. P., 2009, THESIS
   Proff P, 2009, CLIN ORAL INVEST, V13, P355, DOI 10.1007/s00784-009-0268-2
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Raucci L. M. S. C., 2009, THESIS
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Schellini S. A., 2012, COMMUNICATION
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Tirapelli C, 2011, J ORAL REHABIL, V38, P253, DOI 10.1111/j.1365-2842.2010.02157.x
   Tirapelli C, 2007, THESIS
   Tirapelli Camila, 2010, Braz. oral res., V24, P381, DOI 10.1590/S1806-83242010000400002
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Young L, BIOMATERIALS ISSUES
   Pinto KNZ, 2013, PHOTOMED LASER SURG, V31, P252, DOI 10.1089/pho.2012.3435
   Zanotto E.D., 2007, Patent, Patent No. [WO 2004074199 A1, 2004074199]
   Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681
NR 73
TC 20
Z9 22
U1 1
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD JAN 15
PY 2016
VL 432
BP 90
EP 110
DI 10.1016/j.jnoncrysol.2015.03.022
PN A
PG 21
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA DA4KP
UT WOS:000367769100014
DA 2018-10-20
ER

PT J
AU Kadlec, K
   Adamska, K
   Voelkel, A
AF Kadlec, Karol
   Adamska, Katarzyna
   Voelkel, Adam
TI Characterization of ceramic hydroxyapatite surface by inverse liquid
   chromatography in aquatic systems
SO TALANTA
LA English
DT Article
DE Inverse liquid chromatography; Biomaterials; Surface characterization;
   Linear free energy relationship; Hydroxyapatite
ID EXCESS ISOTHERMS; ABRAHAM MODEL; PHASE; RETENTION; PHOSPHATE; ENERGY;
   SELECTIVITY; PREDICTION; PARTITION; MOLECULES
AB The novel approach for hydroxyapatite (HA) surface characterization was proposed. The main aim of this investigation was to estimate surface properties of HA as a biomaterial in real system i.e. in simulated body fluid (SBF). One of the method, which might be used to reflect the influence of liquid environment on sorption properties of material being surrounded by this liquid, is called inverse liquid chromatography (ILC). The lowercase letters of LFER equation (e, s, a, b, v) served for this characterization. The sorption abilities of examined material were also estimated for two different aqueous mobile phases: deionized water and water solution of 0.1 M Na2HPO4. It enabled to observe the change in physiochemical properties of surface, considered in Abraham model, dependence on ions concentration in the mobile phase. Moreover pH of every aquatic solution, normally about 7, was adjusted to 5.5 and 9 to observe the influence of hydrogen and hydroxyl ions concentration on HA sorption properties. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kadlec, Karol; Adamska, Katarzyna; Voelkel, Adam] Poznan Univ Tech, Inst Chem Technol & Engn, PL-60965 Poznan, Poland.
RP Kadlec, K (reprint author), Poznan Univ Tech, Inst Chem Technol & Engn, Ul Berdychowo 4, PL-60965 Poznan, Poland.
EM celdak@gmail.com
RI Voelkel, Adam/G-3436-2014; Adamska, Katarzyna/G-3535-2014
OI Voelkel, Adam/0000-0002-6536-8952; 
CR Abraham MH, 2004, J CHROMATOGR A, V1037, P29, DOI 10.1016/j.chroma.2003.12.004
   Abraham MH, 2007, FLUID PHASE EQUILIBR, V251, P93, DOI 10.1016/j.fluid.2006.11.007
   Agougui H, 2010, APPL SURF SCI, V257, P1377, DOI 10.1016/j.apsusc.2010.08.021
   Bednar I, 2014, LANGMUIR, V30, P5435, DOI 10.1021/la5000809
   Bio-Rad Laboratories Inc., BIOR B, V6086
   Bocian S, 2013, ANALYST, V138, P5221, DOI 10.1039/c3an00371j
   Buszewski B, 2008, J CHROMATOGR A, V1191, P72, DOI 10.1016/j.chroma.2007.11.074
   Cengiz B, 2008, COLLOID SURFACE A, V322, P29, DOI 10.1016/j.colsurfa.2008.02.011
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Fatemi MH, 2008, J CHROMATOGR A, V1190, P241, DOI 10.1016/j.chroma.2008.03.021
   Gagnon P., BIOR B, V2156
   GORBUNOFF MJ, 1990, METHOD ENZYMOL, V182, P329
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Jandera P, 2009, J CHROMATOGR A, V1216, P237, DOI 10.1016/j.chroma.2008.11.055
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Nie L, 2015, BIOCHEM ENG J, V98, P29, DOI 10.1016/j.bej.2015.02.026
   Poole CF, 2002, J CHROMATOGR A, V965, P263, DOI 10.1016/S0021-9673(01)01361-9
   Rustamov I, 2001, J CHROMATOGR A, V913, P49, DOI 10.1016/S0021-9673(00)01076-1
   Schroder E, 2003, ANAL BIOCHEM, V313, P176, DOI 10.1016/S0003-2697(02)00567-5
   Shadat-Shojai M., 2013, ACTA BIOMATER, V9, P7591
   Sprunger L, 2007, J CHROMATOGR A, V1175, P162, DOI 10.1016/j.chroma.2007.10.058
   Sprunger L, 2007, J CHROMATOGR A, V1160, P235, DOI 10.1016/j.chroma.2007.05.051
   Sprunger LM, 2008, FLUID PHASE EQUILIBR, V270, P30, DOI 10.1016/j.fluid.2008.06.001
   Szubert M, 2014, MAT SCI ENG C-MATER, V34, P236, DOI 10.1016/j.msec.2013.09.023
   Tanaka H, 1998, J COLLOID INTERF SCI, V206, P205, DOI 10.1006/jcis.1998.5634
   Vajda P, 2013, J CHROMATOGR A, V1308, P139, DOI 10.1016/j.chroma.2013.07.113
   Vajda P, 2012, J CHROMATOGR A, V1228, P155, DOI 10.1016/j.chroma.2011.12.024
NR 27
TC 5
Z9 5
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD JAN 15
PY 2016
VL 147
BP 44
EP 49
DI 10.1016/j.talanta.2015.09.044
PG 6
WC Chemistry, Analytical
SC Chemistry
GA CY0EC
UT WOS:000366078200006
PM 26592574
DA 2018-10-20
ER

PT J
AU Shi, K
   Wang, YL
   Qu, Y
   Liao, JF
   Chu, BY
   Zhang, HP
   Luo, F
   Qian, ZY
AF Shi, Kun
   Wang, Ya-Li
   Qu, Ying
   Liao, Jin-Feng
   Chu, Bing-Yang
   Zhang, Hua-Ping
   Luo, Feng
   Qian, Zhi-Yong
TI Synthesis, characterization, and application of reversible
   PDLLA-PEG-PDLLA copolymer thermogels in vitro and in vivo
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; BLOCK-COPOLYMERS; AQUEOUS-SOLUTIONS;
   POSTOPERATIVE ADHESION; POLY(ETHYLENE GLYCOL); TRIBLOCK COPOLYMERS;
   THERMOREVERSIBLE GELATION; THERMOSENSITIVE HYDROGEL; ABDOMINAL
   ADHESIONS; PREVENTION
AB In this study, a series of injectable thermoreversible and thermogelling PDLLA-PEG-PDLLA copolymers were developed and a systematic evaluation of the thermogelling system both in vitro and in vivo was performed. The aqueous PDLLA-PEG-PDLLA solutions above a critical gel concentration could transform into hydrogel spontaneously within 2 minutes around the body temperature in vitro or in vivo. Modulating the molecular weight, block length and polymer concentration could adjust the sol-gel transition behavior and the mechanical properties of the hydrogels. The gelation was thermally reversible due to the physical interaction of copolymer micelles and no crystallization formed during the gelation. Little cytotoxicity and hemolysis of this polymer was found, and the inflammatory response after injecting the hydrogel to small-animal was acceptable. In vitro and in vivo degradation experiments illustrated that the physical hydrogel could retain its integrity as long as several weeks and eventually be degraded by hydrolysis. A rat model of sidewall defect-bowel abrasion was employed, and a significant reduction of post-operative adhesion has been found in the group of PDLLA-PEG-PDLLA hydrogel-treated, compared with untreated control group and commercial hyaluronic acid (HA) anti-adhesion hydrogel group. As such, this PDLLA-PEG-PDLLA hydrogel might be a promising candidate of injectable biomaterial for medical applications.
C1 [Qian, Zhi-Yong] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
   Sichuan Univ, Ctr Canc, West China Hosp, Chengdu 610041, Peoples R China.
   Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
EM anderson-qian@163.com
OI Liao, Jinfeng/0000-0001-8101-4030
FU National High-Tech Project of China (863-Project) [2015AA020316];
   National Natural Science Foundation [NSFC31525009, 31222023];
   International Science & Technology Cooperation Program of China
   [2013DFG52300]
FX This work was financially supported by National High-Tech Project of
   China (863-Project, 2015AA020316), National Natural Science Foundation
   (NSFC31525009, and 31222023), and International Science & Technology
   Cooperation Program of China (2013DFG52300).
CR Aamer KA, 2004, BIOMATERIALS, V25, P1087, DOI 10.1016/S0142-9612(03)00632-X
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   BROWN W, 1991, J PHYS CHEM-US, V95, P1850, DOI 10.1021/j100157a064
   Ci TY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05473
   Fu SZ, 2014, J BIOMED NANOTECHNOL, V10, P427, DOI 10.1166/jbn.2014.1726
   Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.3.CO;2-8
   Gao X, 2013, INT J NANOMED, V8, P2453, DOI 10.2147/IJN.S46357
   Gong C, 2013, CURR MED CHEM, V20, P79
   Gong CY, 2009, J PHARM SCI-US, V98, P4684, DOI 10.1002/jps.21780
   Gong CY, 2012, NANOSCALE, V4, P3095, DOI 10.1039/c2nr30278k
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Hiemstra C, 2005, MACROMOL SYMP, V224, P119, DOI 10.1002/masy.200550611
   Hiemstra C, 2006, BIOMACROMOLECULES, V7, P2790, DOI 10.1021/bm060630e
   Hillel AT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002331
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jiang ZQ, 2007, J POLYM SCI POL CHEM, V45, P4091, DOI 10.1002/pola.22222
   JOHNSTON TP, 1993, BIOCHEM PHARMACOL, V46, P1037, DOI 10.1016/0006-2952(93)90668-M
   JOHNSTON TP, 1992, PHARMACEUT RES, V9, P425, DOI 10.1023/A:1015815624334
   Ko DY, 2013, PROG POLYM SCI, V38, P672, DOI 10.1016/j.progpolymsci.2012.08.002
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Lee HT, 2002, MACROMOL RES, V10, P359, DOI 10.1007/BF03218330
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Lei KW, 2015, CHEM COMMUN, V51, P6080, DOI 10.1039/c5cc00049a
   Li F, 2007, LANGMUIR, V23, P2778, DOI 10.1021/la0629025
   Li L, 2014, BIOMATERIALS, V35, P3903, DOI 10.1016/j.biomaterials.2014.01.050
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Park SY, 2003, MACROMOLECULES, V36, P4115, DOI 10.1021/ma021639l
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   ten Broek RPG, 2013, HUM REPROD UPDATE, V19, P12, DOI 10.1093/humupd/dms032
   Wei CZ, 2009, BIOMATERIALS, V30, P5534, DOI 10.1016/j.biomaterials.2009.05.084
   Yea Y, 2007, J CONTROL RELEASE, V120, P178, DOI 10.1016/j.jconrel.2007.04.016
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Zhang Y, 2010, INT J PHARMACEUT, V386, P15, DOI 10.1016/j.ijpharm.2009.10.045
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/0l.sla.0000143302.48223.7e
NR 38
TC 29
Z9 29
U1 14
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 11
PY 2016
VL 6
AR 19077
DI 10.1038/srep19077
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA9LL
UT WOS:000368130200001
PM 26752008
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Martinez-Abad, A
   Ruthes, AC
   Vilaplana, F
AF Martinez-Abad, Antonio
   Ruthes, Andrea C.
   Vilaplana, Francisco
TI Enzymatic-assisted extraction and modification of lignocellulosic plant
   polysaccharides for packaging applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Review
DE biopolymers and renewable polymers; cellulose and other wood products;
   packaging; polysaccharides
ID INDEPENDENT PECTIN METHYLESTERASE; MECHANICAL-PROPERTIES; CELL-WALLS;
   BARRIER PROPERTIES; WHEAT BRAN; MICROFIBRILLATED CELLULOSE;
   PHYSICOCHEMICAL PROPERTIES; TAILORED ARABINOXYLANS; MODEL
   HOMOGALACTURONAN; COMPOSITE FILMS
AB Plant polysaccharides comprise the main renewable resource available in the biosphere for biomaterial production. However, the recalcitrant and heterogeneous structure of lignocellulosic biomass hinders the effective fractionation and exploitation of the polysaccharide components for the design of carbohydrate-based materials. Carbohydrate-active enzymes constitute a selective and versatile biotechnological tool that can assist during the biomass pretreatment steps to extract and fractionate the polysaccharide macromolecular components. Moreover, this enzymatic toolbox can be as well exploited for the tailored modification of the molecular structure of relatively pure polysaccharide components to achieve customized macroscopic properties. This review critically discusses the potential and challenges of the use of plant lignocellulosic polysaccharides and enzymatic modifications to design and prepare suitable materials for packaging applications in terms of their structure-property relations. Structural factors such as the molar mass and crystallinity of the polysaccharide fractions and functional factors such as water sensitivity and processability of the derived films are critical for the material performance. (C) 2015 Wiley Periodicals, Inc.
C1 [Martinez-Abad, Antonio; Ruthes, Andrea C.; Vilaplana, Francisco] AlbaNova Univ Ctr, KTH Royal Inst Technol, Sch Biotechnol, Div Glycosci, Stockholm, Sweden.
   [Vilaplana, Francisco] KTH Royal Inst Technol, Wallenberg Wood Sci Ctr, Stockholm, Sweden.
RP Vilaplana, F (reprint author), AlbaNova Univ Ctr, KTH Royal Inst Technol, Sch Biotechnol, Div Glycosci, Stockholm, Sweden.
EM franvila@kth.se
RI Ruthes, Andrea/G-3189-2012
OI Ruthes, Andrea/0000-0002-8533-1022; Martinez-Abad,
   Antonio/0000-0002-6656-2917; Vilaplana, Francisco/0000-0003-3572-7798
CR Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111
   AHOLA S, 2008, J LANGMUIR, V24, P11592, DOI DOI 10.1021/LA801550J
   Akkus M, 2014, RSC ADV, V4, P62295, DOI 10.1039/c4ra10478a
   Alekhina M, 2014, CARBOHYD POLYM, V100, P89, DOI 10.1016/j.carbpol.2013.03.048
   Azhar S., 2011, BIORESOURCES, P6
   Bahcegul E, 2014, RSC ADV, V4, P34117, DOI 10.1039/c4ra05109b
   Brumer H, 2004, J AM CHEM SOC, V126, P5715, DOI 10.1021/ja0316770
   Burgert I, 2013, J EXP BOT, V64, P4635, DOI 10.1093/jxb/ert255
   Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/nchembio.439, 10.1038/NCHEMBIO.439]
   Cameron RG, 2008, CARBOHYD POLYM, V71, P287, DOI [10.1016/j.carbpol.2007.07.007, 10.1016/.j.carbpol.2007.07.007]
   Cameron RG, 2011, J AGR FOOD CHEM, V59, P2717, DOI 10.1021/jf104845j
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Carpita N. C., 2000, BIOCH MOL BIOL PLANT
   CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x
   Cheng HN, 2012, POLYMERS-BASEL, V4, P1311, DOI 10.3390/polym4021311
   Cheng H. N., 1999, APPL POLYM FOODS
   Chimphango AFA, 2012, J CHEM TECHNOL BIOT, V87, P1419, DOI 10.1002/jctb.3761
   Chimphango AFA, 2012, CARBOHYD POLYM, V88, P1109, DOI 10.1016/j.carbpol.2012.01.077
   Cosgrove DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00204
   Courtin CM, 2009, FOOD CHEM, V112, P831, DOI 10.1016/j.foodchem.2008.06.039
   Cunha AG, 2010, CELLULOSE, V17, P875, DOI 10.1007/s10570-010-9434-6
   Denes JM, 2000, CARBOHYD RES, V327, P385, DOI 10.1016/S0008-6215(00)00070-7
   Dominiak M, 2014, FOOD HYDROCOLLOID, V40, P273, DOI 10.1016/j.foodhyd.2014.03.009
   Dumon C, 2012, PROCESS BIOCHEM, V47, P346, DOI 10.1016/j.procbio.2011.06.017
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Eronen P, 2011, CARBOHYD POLYM, V86, P1281, DOI 10.1016/j.carbpol.2011.06.031
   Escarnot E, 2012, J CEREAL SCI, V55, P243, DOI 10.1016/j.jcs.2011.12.009
   Fabra M. J., 2014, FOOD SCI TECHNOL, V59, P760
   Faulds C. B., 1990, EFFECT ENZYMES DERIV
   Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237
   Fox S. C., 2011, J BIOMACROMOLECULES, V12, P1956
   Gehmayr V, 2011, CELLULOSE, V18, P479, DOI 10.1007/s10570-010-9483-x
   Gidley Michael J., 2006, P181, DOI 10.1201/9781420015164.ch6
   Glasser W. G., 1998, CELLULOSE DERIVATIVE
   Goldbeck R., APPL MICROBIOL BIOTE, V98, P8513
   Gourlay K., 2012, BIOTECHNOL BIOFUELS, V5, P170
   Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053
   Granstrom TB, 2007, APPL MICROBIOL BIOT, V74, P273, DOI 10.1007/s00253-006-0760-4
   Gremos S, 2011, BIORESOURCE TECHNOL, V102, P1378, DOI 10.1016/j.biortech.2010.09.021
   Grubb H. B., 2012, C TRAD SHOW 2012 PAP, P116
   Gubitz GM, 2003, CURR OPIN BIOTECH, V14, P577, DOI 10.1016/j.copbio.2003.09.010
   Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2
   Haigler C. H., 1985, FUNCTIONS BIOGENESIS
   Hakala TK, 2013, CARBOHYD POLYM, V93, P102, DOI 10.1016/j.carbpol.2012.05.013
   Heikkinen SL, 2014, BIORESOURCES, V9, P906
   Heikkinen SL, 2013, CARBOHYD POLYM, V92, P733, DOI 10.1016/j.carbpol.2012.09.085
   Heinze T, 2005, MACROMOL SYMP, V223, P13, DOI 10.1002/masy.200550502
   Heinze T., 2006, ESTERIFICATION POLYS
   Hendriks ATWM, 2008, BIORESOURCE TECHNOL, V100, P10, DOI DOI 10.1016/J.BI0RTECH.2008.05.027
   Henriksson M, 2007, EUR POLYM J, V43, P3434, DOI 10.1016/j.eurpolymj.2007.05.038
   Hoije A, 2008, BIOMACROMOLECULES, V9, P2042, DOI 10.1021/bm800290m
   Hoije A, 2005, CARBOHYD POLYM, V61, P266, DOI 10.1016/j.carbpol.2005.02.009
   Ibarra D, 2010, ENZYME MICROB TECH, V47, P355, DOI 10.1016/j.enzmictec.2010.07.016
   Ibarra D, 2010, BIORESOURCE TECHNOL, V101, P7416, DOI 10.1016/j.biortech.2010.04.050
   IMMERZEEL P, 2014, FOOD SCI TECHNOL, V56, P321, DOI DOI 10.1016/J.LWT.2013.12.013
   Isogai A., 2010, GEL COMPOSITION CONT
   Isogai A., 2010, COSMETICS COMPOSITIO
   Izydorczyk MS, 1995, CARBOHYD POLYM, V28, P33, DOI 10.1016/0144-8617(95)00077-1
   Jausovec D, 2015, CARBOHYD POLYM, V116, P74, DOI 10.1016/j.carbpol.2014.03.014
   Johansson K, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-1
   Johansson K, 2012, J BIOTECHNOL, V161, P14, DOI 10.1016/j.jbiotec.2012.06.004
   Villanueva-Suarez MJ, 2013, FOOD CHEM, V141, P1114, DOI 10.1016/j.foodchem.2013.03.066
   Kilpelainen PO, 2014, GREEN CHEM, V16, P3186, DOI 10.1039/c4gc00274a
   Kisonen V, 2014, CARBOHYD POLYM, V99, P755, DOI 10.1016/j.carbpol.2013.09.009
   Kochumalayil J, 2010, J MATER CHEM, V20, P4321, DOI 10.1039/c0jm00367k
   Kochumalayil JJ, 2014, GREEN CHEM, V16, P1904, DOI 10.1039/c3gc41823e
   Kochumalayil JJ, 2013, CARBOHYD POLYM, V93, P466, DOI 10.1016/j.carbpol.2012.12.041
   Kopcke V., 2010, POLYM RENEWABLE RESO, V1, P17
   Krawczyk H, 2013, CHEM ENG J, V225, P292, DOI 10.1016/j.cej.2013.03.089
   KUNZEK H, 1999, LEBENSM UNTERS FOR A, V208, P233
   Lagaron JM, 2012, J PLAST FILM SHEET, V28, P79, DOI 10.1177/8756087911427756
   Laine C, 2013, IND CROP PROD, V44, P692, DOI 10.1016/j.indcrop.2012.08.033
   Lawoko M, 2005, BIOMACROMOLECULES, V6, P3467, DOI 10.1021/bm058014q
   Le Moigne N, 2010, CARBOHYD POLYM, V79, P325, DOI 10.1016/j.carbpol.2009.08.009
   Leppanen AS, 2013, MACROMOL RAPID COMM, V34, P1056, DOI 10.1002/marc.201300275
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Lundqvist J, 2002, CARBOHYD POLYM, V48, P29, DOI 10.1016/S0144-8617(01)00210-7
   Luzio GA, 2008, CARBOHYD POLYM, V71, P300, DOI 10.1016/.carbpol.2007.05.038
   Mali S, 2006, J FOOD ENG, V75, P453, DOI 10.1016/j.jfoodeng.2005.04.031
   Martinez-Sanz M, 2013, J APPL POLYM SCI, V128, P2197, DOI 10.1002/app.38432
   Martinez-Sanz M, 2012, BIOMACROMOLECULES, V13, P3887, DOI 10.1021/bm301430j
   Matthew J. A., 1990, CARBOHYD POLYM, V13, P290
   McCleary B. V., 1989, Patent, Patent No. [WO 1990006343 A1, 1990006343]
   Menon V, 2012, PROG ENERG COMBUST, V38, P522, DOI 10.1016/j.pecs.2012.02.002
   Mikkonen K. S., 2012, INT J POLYM SCI, P2012
   Mikkonen KS, 2008, BIORESOURCES, V3, P178
   Mikkonen KS, 2007, BIOMACROMOLECULES, V8, P3198, DOI 10.1021/bm700538c
   Mikkonen KS, 2014, RSC ADV, V4, P11884, DOI 10.1039/c3ra47440b
   Mikkonen KS, 2013, TRENDS FOOD SCI TECH, V34, P124, DOI 10.1016/j.tifs.2013.10.003
   Mikkonen KS, 2012, TRENDS FOOD SCI TECH, V28, P90, DOI 10.1016/j.tifs.2012.06.012
   Mikkonen KS, 2013, J MATER SCI, V48, P4205, DOI 10.1007/s10853-013-7233-9
   Mikkonen KS, 2012, CELLULOSE, V19, P467, DOI 10.1007/s10570-012-9655-y
   Mikkonen KS, 2010, CELLULOSE, V17, P69, DOI 10.1007/s10570-009-9380-3
   Mikkonen KS, 2009, J APPL POLYM SCI, V114, P457, DOI 10.1002/app.30513
   Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006
   Moms E. R., 1990, FOOD GELS
   Moon R. J., 2011, CHEM SOC REV, V40, P3941, DOI DOI 10.1039/C0CS00108B
   Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4
   Nghiem NP, 2011, APPL BIOCHEM BIOTECH, V164, P1390, DOI 10.1007/s12010-011-9220-4
   Ochoa-Villarreal M., 2012, PLANT CELL WALL POLY
   Oinonen P, 2013, CARBOHYD POLYM, V95, P690, DOI 10.1016/j.carbpol.2013.03.016
   Oosterveld A, 2002, CARBOHYD POLYM, V48, P73, DOI 10.1016/S0144-8617(01)00216-8
   Oosterveld A., 2000, J CARBOHYDR POLYM, V43, P249
   Parikka K, 2012, FOOD HYDROCOLLOID, V26, P212, DOI 10.1016/j.foodhyd.2011.05.012
   Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t
   Peng F, 2012, BIOTECHNOL ADV, V30, P879, DOI 10.1016/j.biotechadv.2012.01.018
   Peng XW, 2011, BIOMACROMOLECULES, V12, P3321, DOI 10.1021/bm2008795
   PIPPEN EL, 1950, J AM CHEM SOC, V72, P813, DOI 10.1021/ja01158a043
   Pitkanen L, 2011, INT J BIOL MACROMOL, V49, P963, DOI 10.1016/j.ijbiomac.2011.08.020
   Potthast A., 2006, ADV POLYM SCI, V1, P1
   Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843
   Reisinger M, 2014, BIORESOURCE TECHNOL, V170, P53, DOI 10.1016/j.biortech.2014.07.068
   Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3
   Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171
   Saadatmand S, 2013, BIOMACROMOLECULES, V14, P2929, DOI 10.1021/bm400844b
   Sarossy Z, 2013, FOOD HYDROCOLLOID, V30, P206, DOI 10.1016/j.foodhyd.2012.05.022
   Sarossy Z, 2012, ACS APPL MATER INTER, V4, P3378, DOI 10.1021/am3002956
   SAULNIER L, 2007, PLANT CELL WALL POLY
   Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315
   Schmelter T, 2002, CARBOHYD POLYM, V47, P99, DOI 10.1016/S0144-8617(01)00170-9
   Shirakawa M, 1998, FOOD HYDROCOLLOID, V12, P25, DOI 10.1016/S0268-005X(98)00052-6
   Smaali I, 2012, BIOTECHNOL BIOPROC E, V17, P385, DOI 10.1007/s12257-011-0388-9
   Stephen A. M., 2006, FOOD POLYSACCHARIDES
   Stevanic JS, 2011, J APPL POLYM SCI, V122, P1030, DOI 10.1002/app.34217
   Strom A, 2012, ANN T NORDIC RHEOL S, V20, P159
   Tayal A., 2002, ENZYMATIC MODIFICATI
   Teeri TT, 2007, TRENDS BIOTECHNOL, V25, P299, DOI 10.1016/j.tibtech.2007.05.002
   Tenkanen M., 2003, ENZYMATIC TAILORING
   Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231
   Valenzuela R, 2014, J EXP NANOSCI, V9, P177, DOI 10.1080/17458080.2011.651167
   Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V51, P606, DOI 10.1007/s002530051439
   Voragen A.G.J., 1995, FOOD POLYSACCHARIDES
   Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z
   Voragen F., 2001, CHEM ENZYMOLOGY PECT
   Wang J, 2014, FOOD CHEM, V150, P482, DOI 10.1016/j.foodchem.2013.10.121
   Wang Y., 2014, J WOOD CHEM TECHNOL, V35, P91
   Whistler R. L., 1997, CARBOHYDRATE CHEM FO
   Whistler RL, 1993, IND GUMS
   Willats WGT, 2006, TRENDS FOOD SCI TECH, V17, P97, DOI 10.1016/j.tifs.2005.10.008
   Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200
   Willfor S, 2008, CARBOHYD POLYM, V72, P197, DOI 10.1016/j.carbpol.2007.08.006
   Wu L, 2013, BIORESOURCE TECHNOL, V140, P90, DOI 10.1016/j.biortech.2013.04.072
   Wypych G., 2012, HDB POLYM, P172
   Yang K, 2003, BIOTECHNOL PROGR, V19, P1664, DOI 10.1021/bp0341388
   Yilmaz ND, 2013, J TEXT I, V104, P396, DOI 10.1080/00405000.2012.736707
   Zhang Y, 2011, CARBOHYD POLYM, V86, P852, DOI 10.1016/j.carbpol.2011.05.036
   Zhou Q, 2005, MACROMOLECULES, V38, P3547, DOI 10.1021/ma047712k
NR 147
TC 1
Z9 1
U1 5
U2 111
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 10
PY 2016
VL 133
IS 2
SI SI
AR 42523
DI 10.1002/app.42523
PG 15
WC Polymer Science
SC Polymer Science
GA CT6FS
UT WOS:000362908900022
OA Bronze
DA 2018-10-20
ER

PT J
AU Lin, DJ
   Hung, FY
   Jakfar, S
   Yeh, ML
AF Lin, Da-Jun
   Hung, Fei-Yi
   Jakfar, Subhaini
   Yeh, Ming-Long
TI Tailored coating chemistry and interfacial properties for construction
   of bioactive ceramic coatings on magnesium biomaterial
SO MATERIALS & DESIGN
LA English
DT Article
DE Magnesium-based materials; Biodegradability; Hydroxyapatite; Sol-gel
   process; Electrochemical corrosion; Cytocompatibility
ID CORROSION BEHAVIOR; NANOSTRUCTURED HYDROXYAPATITE;
   MECHANICAL-PROPERTIES; PROTECTIVE-COATINGS; MG ALLOY; NITRATE;
   PERFORMANCE; DEPOSITION; CARCINOGENICITY; COMPOSITES
AB Magnesium has the potential to replace materials currently used for medical implants, but its high corrosion rate limits its practical application. For the practical application purpose, a multilayer coating method that combined MgF2 layer and the sol-gel-synthesized hydroxyapatite (HA) layer on Mg substrate was proposed in this study to enhance corrosion resistance and biocompatibility. As characterized by SEM, TEM and electrochemical test, the MgF2 layer not only increases the interfacial stability during the coating process, but also provides a fluorine source that leads to the formation of low-solubility fluorine-substituted HA (FHA), resulting in excellent coating properties. The synthesized coatings were calcined at 400 and 500 degrees C, respectively, to control their crystallinity and impurities. The results show that the corrosion resistance of the specimens calcined at 500 degrees C was 11 times higher than that calcined at 400 degrees C. MG63 cells cultured on the optimized HA/MgF2 coatings were more viable than other surface. Furthermore, the spreading behavior of the cells was significantly higher on the optimized HA/MgF2 coatings. These results suggest that the designed-multilayer process and optimized calcination temperature can effectively control the coating chemistry and interfacial properties, which improves biocompatibility and allows for orthopedic application. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Lin, Da-Jun; Hung, Fei-Yi] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.
   [Jakfar, Subhaini; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
   [Jakfar, Subhaini] Syiah Kuala Univ, Dept Dent Mat, Fac Dent, Darussalam, Indonesia.
   [Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan.
RP Hung, FY (reprint author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.
EM fyhung@mail.ncku.edu.tw; mlyeh@mail.ncku.edu.tw
CR Amaravathy P, 2012, J SOL-GEL SCI TECHN, V64, P694, DOI 10.1007/s10971-012-2904-6
   [Anonymous], 1999, 1099935I ANSIAAMI
   Asl SKF, 2015, SURF COAT TECH, V270, P197, DOI 10.1016/j.surfcoat.2015.03.003
   ATIK M, 1995, CERAM INT, V21, P403, DOI 10.1016/0272-8842(95)94466-N
   Bonnel K, 1999, ELECTROCHIM ACTA, V44, P4259, DOI 10.1016/S0013-4686(99)00141-3
   Chen J, 2007, ELECTROCHIM ACTA, V52, P3299, DOI 10.1016/j.electacta.2006.10.007
   Chung SC, 2000, CORROS SCI, V42, P1249, DOI 10.1016/S0010-938X(99)00129-8
   Creus J, 2000, SURF COAT TECH, V130, P224, DOI 10.1016/S0257-8972(99)00659-3
   Cullity BD, 1978, ELEMENTS XRAY DIFFRA, P102
   Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181
   Drynda A, 2010, J BIOMED MATER RES A, V93A, P763, DOI 10.1002/jbm.a.32582
   El Sawy EN, 2010, J ALLOY COMPD, V492, P69, DOI 10.1016/j.jallcom.2009.11.091
   Zafer E, 2007, J MATER SCI, V42, P3739, DOI 10.1007/s10853-006-0485-x
   Ghali E, 2004, J MATER ENG PERFORM, V13, P7, DOI 10.1361/10599490417533
   Grosse Y, 2006, LANCET ONCOL, V7, P628, DOI 10.1016/S1470-2045(06)70789-6
   Guo JW, 2015, SURF COAT TECH, V269, P183, DOI 10.1016/j.surfcoat.2015.02.010
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Hsieh MF, 2001, BIOMATERIALS, V22, P2601, DOI 10.1016/S0142-9612(00)00448-8
   Islam M, 2010, J ENVIRON MANAGE, V91, P1883, DOI 10.1016/j.jenvman.2010.04.013
   Jang Y, 2014, MAT SCI ENG C-MATER, V45, P45, DOI 10.1016/j.msec.2014.08.052
   Kamkarrad H, 2014, INT J ADV MANUF TECH, V74, P1237, DOI 10.1007/s00170-014-6051-9
   Kim EJ, 2014, THIN SOLID FILMS, V572, P113, DOI 10.1016/j.tsf.2014.08.035
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kim IS, 2004, MAT SCI ENG B-SOLID, V111, P232, DOI 10.1016/j.mseb.2004.04.011
   Kim SJ, 2009, CERAM INT, V35, P1647, DOI 10.1016/j.ceramint.2008.07.016
   Li N, 2013, SURF INTERFACE ANAL, V45, P1217, DOI 10.1002/sia.5257
   Lin DJ, 2015, MAT SCI ENG C-MATER, V51, P300, DOI 10.1016/j.msec.2015.03.004
   MAEKAWA A, 1982, FOOD CHEM TOXICOL, V20, P25, DOI 10.1016/S0278-6915(82)80005-7
   MATTHES B, 1991, SURF COAT TECH, V49, P489, DOI 10.1016/0257-8972(91)90105-6
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   MUHLER JC, 1950, J DENT RES, V29, P182, DOI 10.1177/00220345500290021201
   Phani AR, 2005, MATER CORROS, V56, P77, DOI 10.1002/maco.200403823
   Pinto R, 2011, ELECTROCHIM ACTA, V56, P1535, DOI 10.1016/j.electacta.2010.09.081
   Razavi M, 2014, CERAM INT, V40, P9473, DOI 10.1016/j.ceramint.2014.02.020
   Rezabeigi E, 2014, MAT SCI ENG C-MATER, V40, P248, DOI 10.1016/j.msec.2014.03.042
   Roy A, 2011, MATER SCI ENG B-ADV, V176, P1679, DOI 10.1016/j.mseb.2011.08.007
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Shi HW, 2009, PROG ORG COAT, V66, P183, DOI 10.1016/j.porgcoat.2009.07.004
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   Tschoppe P, 2011, J DENT, V39, P430, DOI 10.1016/j.jdent.2011.03.008
   Uan JY, 2010, J MATER CHEM, V20, P761, DOI 10.1039/b917177k
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   *WHO, 2006, GUID DRINK WAT QUAL
   Zhang W, 2011, INT J ELECTROCHEM SC, V6, P5228
   Zhang YJ, 2009, J BIOMED MATER RES B, V89B, P408, DOI 10.1002/jbm.b.31228
   Zhong XK, 2008, CORROS SCI, V50, P2304, DOI 10.1016/j.corsci.2008.05.016
NR 53
TC 10
Z9 10
U1 2
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
EI 1873-4197
J9 MATER DESIGN
JI Mater. Des.
PD JAN 5
PY 2016
VL 89
BP 235
EP 244
DI 10.1016/j.matdes.2015.09.144
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA CY2FW
UT WOS:000366225200028
DA 2018-10-20
ER

PT J
AU Ghiasi, M
   Kalhor, N
   Qomi, RT
   Sheykhhasan, M
AF Ghiasi, Mahdieh
   Kalhor, Naser
   Qomi, Reza Tabatabaei
   Sheykhhasan, Mohsen
TI The effects of synthetic and natural scaffolds on viability and
   proliferation of adipose-derived stem cells
SO FRONTIERS IN LIFE SCIENCE
LA English
DT Article
DE PLGA; PRP; MTT assay; fibrin glue; alginate; Adipose-derived stem cells
ID PLATELET-RICH PLASMA; BONE-MARROW; CHONDROGENIC DIFFERENTIATION; STROMAL
   CELLS; TISSUE; CHONDROCYTES; REGENERATION; REPAIR; DEFECTS; SCIENCE
AB This study presents a comparative assessment of adipose-derived stem cell (ADSCs) proliferation rates and their viability on five different scaffolds. Five different biomaterial scaffolds were prepared: alginate, poly lactic-co-glycolic acid, fibrin glue, inactive platelet-rich plasma, and active platelet-rich plasma (APRP). Stem cells were isolated from human adipose tissue. Flow cytometry analysis was performed. Specifically, adipogenesis/osteogenesis/chondrogenesis-associated genes expression was analyzed by real-time polymerase chain reaction. These cells were seeded in the prepared scaffolds. After 14 days, the proliferation and viability of MSCs were evaluated using an MTT assay. Also, stemness genes expression was analyzed with the reverse transcriptasepolymerase chain reaction (RT-PCR) method. In addition, the DNA content assay was also performed. The obtained results showed a significant difference between cell proliferation and viability of different scaffolds. APRP and alginate were shown to be the most and least suitable scaffolds in terms of enhancing cell proliferation and maintaining cell viability respectively (p < .05). RT-PCR reactions demonstrated the expression of the various stemness-related markers (Nanog, Octamer4A, and Sox2) when ADSC cells were grown separately on the five different scaffolds. Our study indicates that compared with the scaffolds, APRP could be the best scaffold for support of ADSC proliferation.
C1 [Ghiasi, Mahdieh; Kalhor, Naser; Qomi, Reza Tabatabaei; Sheykhhasan, Mohsen] Acad Ctr Educ Culture & Res, Dept Stem Cell, Qom Branch, Shabnam St,Isar Sq, Qom, Iran.
RP Sheykhhasan, M (reprint author), Acad Ctr Educ Culture & Res, Dept Stem Cell, Qom Branch, Shabnam St,Isar Sq, Qom, Iran.
EM m.sheykhhasan@acecr.ac.ir
OI Sheykhhasan, Mohsen/0000-0001-8599-7492; Sheykhhasan,
   Mohsen/0000-0002-2522-4292
CR Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008
   Alipour R, 2010, INT J PREVENTIVE MED, V1, P164
   Berghoff WJ, 2006, ORTHOPEDICS, V29, P590
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Cheng XB, 2008, ULUS TRAVMA ACIL CER, V14, P87
   Dickneite G, 2003, THROMB RES, V112, P73, DOI 10.1016/j.thromres.2003.10.010
   Drengk A, 2009, CELLS TISSUES ORGANS, V189, P317, DOI 10.1159/000151290
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51
   Fortier LA, 2011, OPER TECHN SPORT MED, V19, P154, DOI 10.1053/j.otsm.2011.03.004
   Gamradt SC, 2007, TECH ORTHOP, V22, P26, DOI 10.1097/01.bto.0000261868.03232.dd
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Hashemibeni B, 2012, J PEDIATR SURG, V47, P1997, DOI 10.1016/j.jpedsurg.2012.06.030
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JY, 2011, IN VITRO CELL DEV-AN, V47, P157, DOI 10.1007/s11626-010-9364-5
   Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Milano G, 2010, OSTEOARTHR CARTILAGE, V18, P971, DOI 10.1016/j.joca.2010.03.013
   Miller Y, 2007, PRACTICE GUIDELINE B, P56
   Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850
   Mishra A, 2009, TISSUE ENG PART C-ME, V15, P431, DOI 10.1089/ten.tec.2008.0534
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Mountford JC, 2008, TRANSFUSION MED, V18, P1, DOI 10.1111/j.1365-3148.2007.00807.x
   Natalia MB, 2011, BIOMATERIALS SCI ENG, P211
   Ning C., 2011, BIOMEDICAL ENG J, V12, P1
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Shengyun H, 2012, ORAL SURG ORAL MED O, V114, P32
   Sheykhhasan M, 2014, INT J ADV BIOL SCI E, V1, P86
   Smyth NA, 2012, TECH FOOT ANKLE SURG, V11, P18, DOI 10.1097/BTF.0b013e3182463ca1
   Stocum DL, 2008, DEV DYNAM, V237, P3648, DOI 10.1002/dvdy.21774
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Tabele C, 2012, J PHARM PHARM SCI, V15, P124, DOI 10.18433/J39K5H
   Togel F, 2007, DEV DYNAM, V236, P3321, DOI 10.1002/dvdy.21258
   Tuan RS, 2004, CLIN ORTHOP RELAT R, pS105, DOI 10.1097/01.blo.0000143560.41767.ee
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Wang P, 2010, CYTOTHERAPY, V12, P701, DOI 10.3109/14653249.2010.487901
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Xie XT, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4493
   Xie XT, 2012, BIOMATERIALS, V33, P7008, DOI 10.1016/j.biomaterials.2012.06.058
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Yang JF, 2010, J BIOMED MATER RES A, V92A, P817, DOI 10.1002/jbm.a.32378
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 43
TC 3
Z9 3
U1 1
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2155-3769
EI 2155-3777
J9 FRONT LIFE SCI
JI Front. Life Sci.
PD JAN 2
PY 2016
VL 9
IS 1
BP 32
EP 43
DI 10.1080/21553769.2015.1077477
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG5PL
UT WOS:000372130200005
OA Bronze
DA 2018-10-20
ER

PT J
AU Hussain, MA
   Muhammad, G
   Jantan, I
   Bukhari, SNA
AF Hussain, Muhammad A.
   Muhammad, Gulzar
   Jantan, Ibrahim
   Bukhari, Syed Nasir Abbas
TI Psyllium Arabinoxylan: A Versatile Biomaterial for Potential Medicinal
   and Pharmaceutical Applications
SO POLYMER REVIEWS
LA English
DT Review
DE psyllium; Plantago ovata; drug delivery; arabinoxylan; hydrogel;
   pharmacological attributes
ID PLANTAGO-OVATA FORSK; DRUG-DELIVERY SYSTEM; GASTRORETENTIVE FLOATING
   TABLETS; CHRONIC FUNCTIONAL CONSTIPATION; RANDOMIZED CLINICAL-TRIAL;
   CORONARY-HEART-DISEASE; AFRICAN-GREEN MONKEYS; BILE-ACID EXCRETION;
   SUSTAINED-RELEASE; SEED HUSK
AB Psyllium (PS), a water-swellable dietary fiber from seeds of widely distributed plant, Plantago ovata (PO) is esteemed for its medicinal and nutraceutical values. PS has been attributed to its broad range of pharmacological activities like anti-tumor, anti-inflammatory, anti-diabetic, hypolipidemic, laxative, anti-obesity, anti-diarrheal, anti-amoebic, and anti-nociceptive, and has been employed for sustained/delayed/targeted drug delivery due to its biocompatible and biodegradable nature. Interestingly, PS can be utilized for the absorption of toxic materials from industrial waste and is also used as substituent of gluten in breads for better acceptance. This review focuses upon the utilization of PS in drug delivery systems, medicinal uses, and pharmacological attributes to explore its potential in the nutraceutical industry.
C1 [Hussain, Muhammad A.; Muhammad, Gulzar] Univ Sargodha, Dept Chem, Sargodha 40100, Pakistan.
   [Jantan, Ibrahim; Bukhari, Syed Nasir Abbas] Univ Kebangsaan Malaysia, Fac Pharm, Drug & Herbal Res Ctr, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
RP Hussain, MA (reprint author), Univ Sargodha, Dept Chem, Sargodha 40100, Pakistan.; Bukhari, SNA (reprint author), Univ Kebangsaan Malaysia, Fac Pharm, Drug & Herbal Res Ctr, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
EM majaz172@yahoo.com; snab@ukm.edu.my
RI Bukhari, Syed Nasir Abbas/R-3825-2017
OI Bukhari, Syed Nasir Abbas/0000-0001-8125-7972
CR ABRAHAM ZD, 1988, AM J CLIN NUTR, V47, P67
   Adibkia K, 2014, Drug Res (Stuttg), V64, P118, DOI 10.1055/s-0033-1353186
   Agarwal M, 2001, MACROMOL MATER ENG, V286, P560, DOI 10.1002/1439-2054(20010901)286:9<560::AID-MAME560>3.3.CO;2-2
   Ahmadi R, 2012, J FOOD ENG, V109, P745, DOI 10.1016/j.jfoodeng.2011.11.010
   Ahmed I., 2010, WORLD ACAD SCI ENG T, V37, P1229
   Al-Hamadani YAJ, 2011, J HAZARD MATER, V190, P582, DOI 10.1016/j.jhazmat.2011.03.087
   ALABASTER O, 1993, CANCER LETT, V75, P53, DOI 10.1016/0304-3835(93)90207-P
   Allen KGD, 2004, J AGR FOOD CHEM, V52, P4998, DOI 10.1021/jf0497206
   An JK, 2012, INT J POLYM MATER, V61, P906, DOI 10.1080/00914037.2011.610056
   Anderson JW, 2000, AM J CLIN NUTR, V71, P1433
   Anderson JW, 2000, AM J CLIN NUTR, V71, P472
   ANDERSON JW, 1995, METABOLISM, V44, P848, DOI 10.1016/0026-0495(95)90236-8
   Anderson JW, 1999, J NUTR, V129, p1457S, DOI 10.1093/jn/129.7.1457S
   Aranda Jorge Barroso, 2002, Journal of Medicine (Westbury), V33, P209
   Asnaashari S, 2011, PHARM DEV TECHNOL, V16, P400, DOI 10.3109/10837451003774393
   Asvarujanon P, 2004, BIOSCI BIOTECH BIOCH, V68, P1737, DOI 10.1271/bbb.68.1737
   Bedouet L, 2014, INT J PHARMACEUT, V459, P51, DOI 10.1016/j.ijpharm.2013.11.004
   Belknap D, 1997, HEART LUNG, V26, P229, DOI 10.1016/S0147-9563(97)90060-1
   Belscak-Cvitanovic A, 2015, FOOD CHEM, V167, P378, DOI 10.1016/j.foodchem.2014.07.011
   Bernstein AM, 2013, NUTRIENTS, V5, P1471, DOI 10.3390/nu5051471
   Bhatia M, 2015, INT J BIOL MACROMOL, V72, P495, DOI 10.1016/j.ijbiomac.2014.08.051
   Bouchoucha M, 2004, GASTROEN CLIN BIOL, V28, P438, DOI 10.1016/S0399-8320(04)94953-6
   Brown L, 1999, AM J CLIN NUTR, V69, P30
   Cannon SJ, 2010, J DAIRY SCI, V93, P4744, DOI 10.3168/jds.2010-3077
   Cannon SJ, 2010, J DAIRY SCI, V93, P3652, DOI 10.3168/jds.2009-2731
   Cappa C, 2013, CARBOHYD POLYM, V98, P1657, DOI 10.1016/j.carbpol.2013.08.007
   CASTELLI WP, 1988, CAN J CARDIOL, V4, pA5
   Chan MY, 2008, NUTRITION, V24, P57, DOI 10.1016/j.nut.2007.08.009
   Chavanpatil M, 2005, INT J PHARM, V304, P178, DOI 10.1016/j.ijpharm.2005.08.009
   Chavanpatil MD, 2006, INT J PHARM, V316, P86, DOI 10.1016/j.ijpharm.2006.02.038
   Chawla R, 2014, EXPERT OPIN DRUG DEL, V11, P31, DOI 10.1517/17425247.2013.807794
   Cheng CW, 2009, WORLD J GASTROENTERO, V15, P4886, DOI 10.3748/wjg.15.4886
   Cheng YJ, 2004, BRIT J NUTR, V91, P715, DOI 10.1079/BJN20041107
   Cheng YH, 2013, CARBOHYD POLYM, V92, P1512, DOI 10.1016/j.carbpol.2012.10.074
   CHOMCHAI C, 1974, DIS COLON RECTUM, V17, P310, DOI 10.1007/BF02586971
   Choonara YE, 2011, COLLOID SURFACE B, V87, P243, DOI 10.1016/j.colsurfb.2011.05.025
   Chourasia MK, 2004, DRUG DELIV, V11, P129, DOI 10.1080/10717540490280778
   Chourasia MK, 2003, J PHARM PHARM SCI, V6, P33
   Cicero AFG, 2007, CLIN EXP HYPERTENS, V29, P383, DOI 10.1080/10641960701578378
   Cicero AFG, 2010, MEDITERR J NUTR META, V3, P47, DOI 10.1007/s12349-009-0056-1
   Cummings J. H., 1993, DIETARY FIBER HUMAN, P263
   Dagar JC, 2006, LAND DEGRAD DEV, V17, P275, DOI 10.1002/ldr.700
   Daggy BP, 1997, J LIPID RES, V38, P491
   Davidson MH, 1998, AM J CLIN NUTR, V67, P367
   Davidson MH, 1996, AM J CLIN NUTR, V63, P96
   de Bock M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041735
   Desai Angira, 2007, Indian Journal of Pharmaceutical Sciences, V69, P206
   Dettmar PW, 1998, CURR MED RES OPIN, V14, P227, DOI 10.1185/03007999809113363
   Dey S, 2014, BIOMED RES INT, DOI 10.1155/2014/396106
   Dhar MK, 2002, CURR SCI INDIA, V83, P150
   EVERSON GT, 1992, J LIPID RES, V33, P1183
   Feinglos M, 2013, BIOACTIVE CARBOHYDRA, V1, P156
   FERNANDEZ ML, 1995, J LIPID RES, V36, P1128
   FERNANDEZ ML, 1995, J LIPID RES, V36, P2394
   Fernandez N, 2005, EUR NEUROPSYCHOPHARM, V15, P505, DOI 10.1016/j.euroneuro.2005.01.006
   Fernandez-Banares F, 1999, AM J GASTROENTEROL, V94, P427
   Fischer MH, 2004, CARBOHYD RES, V339, P2009, DOI 10.1016/j.carres.2004.05.023
   FLORHOLMEN J, 1982, ACTA MED SCAND, V212, P237
   Foschia M, 2015, FOOD CHEM, V172, P245, DOI 10.1016/j.foodchem.2014.09.062
   Freiche V, 2011, J FELINE MED SURG, V13, P903, DOI 10.1016/j.jfms.2011.07.008
   FUKAGAWA NK, 1990, AM J CLIN NUTR, V52, P524
   Galisteo M, 2005, J NUTR, V135, P2399
   Garcia JJ, 2005, EUR NEUROPSYCHOPHARM, V15, P497, DOI 10.1016/j.euroneuro.2005.01.005
   Garg Rajeev, 2009, Current Drug Delivery, V6, P437
   Garg R, 2009, CHEM PHARM BULL, V57, P545, DOI 10.1248/cpb.57.545
   GELISSEN IC, 1994, AM J CLIN NUTR, V59, P395
   Gilani A. H., 1992, NATURAL DRUGS DIGEST, P117
   Gilani AH, 2005, J ETHNOPHARMACOL, V100, P43, DOI 10.1016/j.jep.2005.06.001
   Giri TK, 2013, J MATER SCI-MATER M, V24, P1179, DOI 10.1007/s10856-013-4884-7
   Gnekow AK, 2004, KLIN PADIATR, V216, P331, DOI 10.1055/s-2004-832355
   Gohel MC, 2003, DRUG DEV IND PHARM, V29, P565, DOI 10.1081/DDC-120018645
   Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372
   Guo Q, 2008, CARBOHYD POLYM, V73, P35, DOI 10.1016/j.carbpol.2007.11.001
   GUPTA RR, 1994, INDIAN J MED RES, V100, P237
   Guthrie D. W., 2004, CRIT CARE NURS Q, V27, P113
   HASKELL WL, 1992, AM J CARDIOL, V69, P433, DOI 10.1016/0002-9149(92)90980-D
   Hasler C M, 2000, Curr Atheroscler Rep, V2, P467, DOI 10.1007/s11883-000-0045-9
   Iqbal MS, 2011, CARBOHYD POLYM, V83, P1218, DOI 10.1016/j.carbpol.2010.09.024
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
   Izydorczyk MS, 1995, CARBOHYD POLYM, V28, P33, DOI 10.1016/0144-8617(95)00077-1
   Kaialy W, 2014, PHARM DEV TECHNOL, V19, P269, DOI 10.3109/10837450.2013.775156
   Kaith BS, 2007, EXPRESS POLYM LETT, V1, P474, DOI 10.3144/expresspolymlett.2007.66
   Kaith BS, 2007, IRAN POLYM J, V16, P529
   Kecmanovic DM, 2006, PHYTOTHER RES, V20, P655, DOI 10.1002/ptr.1926
   KENNEDY JF, 1979, CARBOHYD RES, V75, P265, DOI 10.1016/S0008-6215(00)84646-7
   Khalil MI, 1998, J APPL POLYM SCI, V69, P45, DOI 10.1002/(SICI)1097-4628(19980705)69:1<45::AID-APP6>3.0.CO;2-M
   Kharia AA, 2010, INDIAN J PHARM SCI, V72, P599, DOI 10.4103/0250-474X.78527
   Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197
   Kumar K, 2012, J APPL POLYM SCI, V124, P4969, DOI 10.1002/app.35605
   Kumar R, 2013, APPL WATER SCI, V3, P285, DOI 10.1007/s13201-013-0081-6
   Kura AU, 2013, INT J NANOMED, V8, P1103, DOI 10.2147/IJN.S39740
   Landes AD, 2008, J EQUINE VET SCI, V28, P79, DOI 10.1016/j.jevs.2008.01.004
   Li L, 2013, PAK J PHARM SCI, V26, P929
   Liebelt Erica L., 1998, Current Opinion in Pediatrics, V10, P461, DOI 10.1097/00008480-199810000-00002
   Lin ZQ, 2014, J CONTROL RELEASE, V174, P161, DOI 10.1016/j.jconrel.2013.10.026
   LIU K, 1979, LANCET, V2, P782
   Liu SM, 1999, AM J CLIN NUTR, V70, P412
   Liu W, 2010, J AGR FOOD CHEM, V58, P1615, DOI 10.1021/jf903691z
   Liu W, 2010, J AGR FOOD CHEM, V58, P172, DOI 10.1021/jf902731p
   Luccia BHD, 2002, FOOD CHEM, V77, P139, DOI 10.1016/S0308-8146(01)00168-6
   Luccia BHD, 2002, NUTR RES, V22, P1027, DOI 10.1016/S0271-5317(02)00408-6
   Mandal K, 2009, J PLANT DIS PROTECT, V116, P164, DOI 10.1007/BF03356305
   Marlett JA, 2000, AM J CLIN NUTR, V72, P784
   Marlett JA, 2003, P NUTR SOC, V62, P207, DOI 10.1079/PNS2002201
   Marlett JA, 2002, J NUTR, V132, P2638
   MARTEAU P, 1994, GUT, V35, P1747, DOI 10.1136/gut.35.12.1747
   MCCALL MR, 1992, AM J CLIN NUTR, V56, P385
   MCCALL MR, 1992, AM J CLIN NUTR, V56, P376
   McRorie JW, 1998, ALIMENT PHARM THERAP, V12, P491
   Mehmood MH, 2011, DIGEST DIS SCI, V56, P1460, DOI 10.1007/s10620-010-1466-0
   Mishra A, 2002, IRAN POLYM J, V11, P381
   Mishra S, 2014, CARBOHYD POLYM, V99, P462, DOI 10.1016/j.carbpol.2013.08.047
   Moreaux SJJ, 2011, J EQUINE VET SCI, V31, P160, DOI 10.1016/j.jevs.2011.02.002
   Moreyra AE, 2005, ARCH INTERN MED, V165, P1161, DOI 10.1001/archinte.165.10.1161
   Morita T, 1998, J NUTR, V128, P1156
   NARISAWA T, 1974, JNCI-J NATL CANCER I, V53, P1093, DOI 10.1093/jnci/53.4.1093
   Neeru Yadav, 2006, International Journal of Plant Sciences (Muzaffarnagar), V1, P167
   Negi J. S., 2011, PHARM GLOBALE IJCP, V4, P1
   Nemes Zsuzsanna, 2009, Orvosi Hetilap, V150, P353, DOI 10.1556/OH.2009.28549
   Ngwuluka NC, 2013, AAPS PHARMSCITECH, V14, P605, DOI 10.1208/s12249-013-9945-1
   Niu YG, 2012, FOOD CHEM, V132, P1025, DOI 10.1016/j.foodchem.2011.11.090
   ODA Y, 1985, Neurological Surgery, V13, P1305
   Olson BH, 1997, J NUTR, V127, P1973
   Ouyang H, 2004, ALIMENT PHARM THERAP, V20, P831, DOI 10.1111/j.1365-2036.2004.02196.x
   Pal S, 2012, BRIT J NUTR, V107, P725, DOI 10.1017/S0007114511003497
   Pasricha PJ, 2006, PHARMACOL BASIS THER, P983
   PASTORS JG, 1991, AM J CLIN NUTR, V53, P1431
   Patil BS, 2011, ORIENTAL PHARM EXP M, V11, P123, DOI 10.1007/s13596-011-0012-8
   Pawar H, 2014, INT J BIOL MACROMOL, V69, P52, DOI 10.1016/j.ijbiomac.2014.05.019
   Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Popkin BM, 2001, J NUTR, V131, p871S
   Quitadamo P, 2012, J PEDIATR-US, V161, P710, DOI 10.1016/j.jpeds.2012.04.043
   QVITZAU S, 1988, SCAND J GASTROENTERO, V23, P1237, DOI 10.3109/00365528809090197
   Rachlis A, 2005, HIV CLIN TRIALS, V6, P203, DOI 10.1310/2BJL-J62N-BFJX-4995
   Rahn K, 1996, BOT J LINN SOC, V120, P145, DOI 10.1111/j.1095-8339.1996.tb00484.x
   Ram HNA, 2010, PHARMACOGN RES, V2, P304, DOI 10.4103/0974-8490.72329
   Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x
   Raymundo A., 2014, Bioactive Carbohydrates and Dietary Fibre, V3, P96
   Robert A., 1999, DIABETES, V18, P446
   ROBERTS-ANDERSEN J, 1987, Nutrition and Cancer, V10, P129
   Rodriguez-Moran M, 1998, J DIABETES COMPLICAT, V12, P273, DOI 10.1016/S1056-8727(98)00003-8
   Romero AL, 2002, J NUTR, V132, P1194
   Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301
   Rosu MC, 2014, PROG NAT SCI-MATER, V24, P205, DOI 10.1016/j.pnsc.2014.05.007
   Roy DS, 2002, EUR J PHARM SCI, V16, P193
   Saghir S, 2008, CARBOHYD POLYM, V74, P309, DOI 10.1016/j.carbpol.2008.02.019
   Saghir S, 2009, CARBOHYD POLYM, V77, P125, DOI 10.1016/j.carbpol.2008.12.009
   Samantaroy S, 1997, J APPL POLYM SCI, V66, P1485, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1485::AID-APP9>3.0.CO;2-A
   Samuelsen AB, 1999, CARBOHYD POLYM, V38, P133, DOI 10.1016/S0144-8617(98)00115-5
   SANDHU JS, 1981, CARBOHYD RES, V93, P247, DOI 10.1016/S0008-6215(00)80854-X
   Sanghi R, 2005, WATER QUAL RES J CAN, V40, P97
   Sen G, 2012, INT J BIOL MACROMOL, V50, P369, DOI 10.1016/j.ijbiomac.2011.12.014
   Siahi-Shadbad MR, 2011, AAPS PHARMSCITECH, V12, P1176, DOI 10.1208/s12249-011-9687-x
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Singh B, 2007, CARBOHYD POLYM, V67, P559, DOI 10.1016/j.carbpol.2006.06.030
   Singh B, 2006, INT J PHARM, V325, P15, DOI 10.1016/j.ijpharm.2006.06.007
   Singh B, 2014, INT J BIOL MACROMOL, V65, P524, DOI 10.1016/j.ijbiomac.2014.02.004
   Singh B, 2013, INT J POLYM MATER PO, V62, P68, DOI 10.1080/00914037.2011.641639
   Singh B, 2012, CHEM ENG RES DES, V90, P346, DOI 10.1016/j.cherd.2011.07.023
   Singh B, 2012, J MATER SCI-MATER M, V23, P1021, DOI 10.1007/s10856-012-4582-x
   Singh B, 2010, FOOD RES INT, V43, P1065, DOI 10.1016/j.foodres.2010.01.015
   Sola R, 2007, AM J CLIN NUTR, V85, P1157
   SPILLER GA, 1979, J CLIN PHARMACOL, V19, P313, DOI 10.1002/j.1552-4604.1979.tb02485.x
   Srinivasan R, 2002, WATER QUAL RES J CAN, V37, P371
   STEVENS J, 1988, J AM DIET ASSOC, V88, P323
   Sujjaareevath J, 1996, INT J PHARM, V139, P53, DOI 10.1016/0378-5173(96)04573-5
   Svirskis D, 2014, PHARM DEV TECHNOL, V19, P571, DOI 10.3109/10837450.2013.813539
   Tack J, 2009, CLIN GASTROENTEROL H, V7, P502, DOI 10.1016/j.cgh.2008.12.006
   Tengku SA, 2011, TROP BIOMED, V28, P194
   Trautwein EA, 1999, J NUTR, V129, P896
   Udayakumar T., 2012, INT J PHARM SCI LETT, V2, P21
   UDAYBHASKAR P, 1990, J APPL POLYM SCI, V39, P739, DOI 10.1002/app.1990.070390322
   Uehleke B, 2008, PHYTOMEDICINE, V15, P153, DOI 10.1016/j.phymed.2007.11.024
   Vega-Lopez S, 2003, J NUTR, V133, P67
   Vega-Lopez S, 2001, AM J CLIN NUTR, V74, P435
   Wang HJ, 2004, CLIN DRUG INVEST, V24, P569, DOI 10.2165/00044011-200424100-00002
   Washington N, 1998, AM J CLIN NUTR, V67, P317
   Wei ZH, 2009, EUR J CLIN NUTR, V63, P821, DOI 10.1038/ejcn.2008.49
   WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637
   WORLD HEALTH ORGANIZATION - WHO, 2009, DIARRH WHY CHILDR AR
   Yasir M., 2010, International Journal of ChemTech Research, V2, P792
   Yu LG, 2003, J AGR FOOD CHEM, V51, P492, DOI [10.1021/jf020644l, 10.1021/jf.0206441]
   Zaman V, 2002, PHYTOTHER RES, V16, P78
   Zandonadi RP, 2009, J AM DIET ASSOC, V109, P1781, DOI 10.1016/j.jada.2009.07.032
   Ziai S. A., 2004, Journal of Medicinal Plants, V3, P41
   Ziai SA, 2005, J ETHNOPHARMACOL, V102, P202, DOI 10.1016/j.jep.2005.06.042
NR 187
TC 9
Z9 9
U1 5
U2 40
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1558-3724
EI 1558-3716
J9 POLYM REV
JI Polym. Rev.
PD JAN 2
PY 2016
VL 56
IS 1
BP 1
EP 30
DI 10.1080/15583724.2015.1078351
PG 30
WC Polymer Science
SC Polymer Science
GA DG3VH
UT WOS:000371998100001
DA 2018-10-20
ER

PT J
AU Turk, T
   Fidler, A
AF Turk, Tugba
   Fidler, Ales
TI Effect of medicaments used in endodontic regeneration technique on
   push-out bond strength of MTA and Biodentine
SO BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
LA English
DT Article
DE Antibiotic pastes; calcium hydroxide; Biodentine; biomaterial; mineral
   trioxide aggregate; regenerative endodontics
ID MINERAL TRIOXIDE AGGREGATE; CALCIUM HYDROXIDE; ACIDIC ENVIRONMENT;
   RADICULAR DENTIN; IN-VITRO; OUTCOMES; FLUID; TEETH
AB The aim of the present study was to evaluate the effect of the intracanal medicaments used in regenerative endodontic treatment on push-out bond strength (PBS) of mineral trioxide aggregate (MTA) and Biodentine (BD). The root canals of 102 maxillary incisors were enlarged to simulate immature roots and were randomly divided into three groups (n = 34): a control group (no intracanal medicament) and two test groups, subjected to calcium hydroxide (CH) or triple antibiotic paste (TAP) medication for two weeks. After the medication removal, each group was divided in two subgroups and the coronal portion of each canal was filled with MTA or BD. After one week of storage, the coronal region of each root was horizontally sectioned and push-out test was performed. Data were analyzed by two-way analysis of variance and the Tukey post hoc test (P = 0.05). PBS values were significantly affected by the type of material (P < 0.001) and the type of medication used (P = 0.049), but no interaction was found (P = 0.97). The BD group showed significantly higher push-out resistance values than those of the MTA group (P < 0.001). TAP showed the lowest PBS values, which were significantly lower than those of the control group (P = 0.043) but not than those of CH (P = 0.229). After a two-week application period, TAP seemed to decrease the PBS of both cements, while CH did not. BD appeared to have higher PBS compared to MTA, regardless of medication.
C1 [Turk, Tugba] Ege Univ, Dept Endodont, Fac Dent, Izmir, Turkey.
   [Fidler, Ales] Univ Ljubljana, Fac Dent, Dept Restorat Dent & Endodont, Ljubljana, Slovenia.
RP Turk, T (reprint author), Ege Univ, Dept Endodont, Fac Dent, Izmir, Turkey.
EM tugba.turk@ege.edu.tr
RI Fidler, Ales/C-5722-2008; Turk, Tugba/A-2324-2017
OI Fidler, Ales/0000-0003-3916-1111; 
CR Berkhoff JA, 2014, J ENDODONT, V40, P1172, DOI 10.1016/j.joen.2013.12.027
   Bidar M, 2010, J ENDODONT, V36, P1679, DOI 10.1016/j.joen.2010.06.010
   Cehreli ZC, 2011, J ENDODONT, V37, P1327, DOI 10.1016/j.joen.2011.05.033
   CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45
   El-Ma'aita AM, 2013, DENT MATER, V29, P797, DOI 10.1016/j.dental.2013.04.020
   Elnaghy AM, 2014, J ENDODONT, V40, P953, DOI 10.1016/j.joen.2013.11.007
   Fouad Ashraf F, 2014, J Endod, V40, pS58, DOI 10.1016/j.joen.2014.01.022
   Goracci C, 2004, EUR J ORAL SCI, V112, P353, DOI 10.1111/j.1600-0722.2004.00146.x
   Guneser MB, 2013, J ENDODONT, V39, P380, DOI 10.1016/j.joen.2012.11.033
   Han L, 2011, INT ENDOD J, V44, P1081, DOI 10.1111/j.1365-2591.2011.01924.x
   Hashem AAR, 2012, J ENDODONT, V38, P245, DOI 10.1016/j.joen.2011.09.013
   Jeeruphan T, 2012, J ENDODONT, V38, P1330, DOI 10.1016/j.joen.2012.06.028
   Kim JR, 2015, J DENT, V43, P241, DOI 10.1016/j.jdent.2014.11.004
   Law AS, 2013, J ENDODONT, V39, pS44, DOI 10.1016/j.joen.2012.11.019
   Marending M, 2009, DENT TRAUMATOL, V25, P126, DOI 10.1111/j.1600-9657.2008.00735.x
   Martin G, 2013, J ENDODONT, V39, P138, DOI 10.1016/j.joen.2012.09.015
   Nakashima M, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P461
   Parirokh M, 2010, J ENDODONT, V36, P16, DOI 10.1016/j.joen.2009.09.006
   Reyes-Carmona JF, 2010, J ENDODONT, V36, P286, DOI 10.1016/j.joen.2009.10.009
   Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011
   Sahebi S, 2010, DENT TRAUMATOL, V26, P43, DOI 10.1111/j.1600-9657.2009.00834.x
   Saoud TMA, 2014, J ENDODONT, V40, P1946, DOI 10.1016/j.joen.2014.08.023
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Shokouhinejad N, 2010, J ENDODONT, V36, P871, DOI 10.1016/j.joen.2009.12.025
   Topcuoglu HS, 2014, INT ENDOD J, V46, P688
   Yassen GH, 2013, INT ENDOD J, V46, P688, DOI 10.1111/iej.12046
   Yassen GH, 2013, J ENDODONT, V39, P269, DOI 10.1016/j.joen.2012.09.020
NR 27
TC 0
Z9 0
U1 1
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1310-2818
EI 1314-3530
J9 BIOTECHNOL BIOTEC EQ
JI Biotechnol. Biotechnol. Equip.
PD JAN 2
PY 2016
VL 30
IS 1
BP 140
EP 144
DI 10.1080/13102818.2015.1109477
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DD3WQ
UT WOS:000369854400020
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Jendelova, P
   Kubinova, S
   Sandvig, I
   Erceg, S
   Sandvig, A
   Sykova, E
AF Jendelova, Pavla
   Kubinova, Sarka
   Sandvig, Ioanna
   Erceg, Slaven
   Sandvig, Axel
   Sykova, Eva
TI Current developments in cell- and biomaterial-based approaches for
   stroke repair
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE clinical trials; ischemic lesion; mesenchymal stem cells; neural
   progenitors; neurogenesis; noninvasive imaging; stem cells; stroke;
   translation
ID NEURAL STEM-CELLS; MARROW STROMAL CELLS; FOCAL CEREBRAL-ISCHEMIA;
   SPINAL-CORD-INJURY; PROMOTE FUNCTIONAL RECOVERY; OLFACTORY ENSHEATHING
   CELLS; PEPTIDE NANOFIBER SCAFFOLD; EPI-CORTICAL DELIVERY; DAMAGED
   RAT-BRAIN; BONE-MARROW
AB Introduction: Stroke is one of the most devastating diseases and a leading cause of mortality worldwide. So far, clinical management of stroke involves surgical clot retrieval or thrombolytic treatment inducing reperfusion of the occluded vessels in the cerebral infarcted area, which is dependent on early intervention following insult. New treatment strategies involve the promotion of angiogenesis and neuroplasticity, stimulation of endogenous neurogenesis, remyelinization, and immunomodulation by means of cell transplantation and sustained drug delivery.Areas covered: This review describes different types of stem cells (endogenous and exogenous neural progenitors, pluripotent stem cell derivatives, mesenchymal stem cells [MSCs], olfactory ensheathing cells) and biomaterials, their routes of administration, means of noninvasive imaging, and the prerequisites and hurdles for the successful translation of the cell therapies to the clinic.Expert opinion: Neural precursors (NPs) derived from pluripotent stem cells, unlike MSCs, can not only remodel the CNS by promoting neuroplasticity, angiogenesis, and immunomodulation, but also replace damaged cells. To transfer NPs into the clinic, step by step guidelines for researchers are identified and discussed.
C1 [Jendelova, Pavla; Kubinova, Sarka; Erceg, Slaven; Sykova, Eva] Acad Sci Czech Republ, Inst Expt Med, Dept Neurosci, Prague, Czech Republic.
   [Sandvig, Ioanna; Sandvig, Axel] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway.
RP Jendelova, P (reprint author), Acad Sci Czech Republ, Inst Expt Med, Dept Neurosci, Prague, Czech Republic.
EM jendel@biomed.cas.cz
RI Jendelova, Pavla/H-2516-2014
OI Jendelova, Pavla/0000-0002-4644-9212
FU Norwegian Financial Mechanism; Ministry of Education, Youth and Sports
   [MSMT-28477/2014, 7F14057]
FX The study was supported from the Norwegian Financial Mechanism 2009-2014
   and the Ministry of Education, Youth and Sports under Project Contract
   no. MSMT-28477/2014, project 7F14057. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript. This includes
   employment, consultancies, honoraria, stock ownership or options, expert
   testimony, grants or patents received or pending, or royalties.
CR Amemori T, 2010, CYTOTHERAPY, V12, P212, DOI 10.3109/14653240903440103
   Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Aswendt M, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fnce1.2014.00226, 10.3389/fncel.2014.00226]
   Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174
   Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108
   Bhasin A, 2011, CEREBROVASC DIS EXTR, V1, P93, DOI 10.1159/000333381
   Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002
   Canazza A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00019
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chang DJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.93
   Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486
   Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3
   Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452
   Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015
   Chu K, 2004, NEUROSCI RES, V50, P459, DOI 10.1016/j.neures.2004.08.015
   Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032
   Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339
   D'Aiuto L, 2014, ORGANOGENESIS, V10, P365, DOI 10.1080/15476278.2015.1011921
   Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104
   Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x
   Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81
   Doeppner TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00357
   Doeppner TR, 2012, STEM CELLS, V30, P1297, DOI 10.1002/stem.1098
   Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278
   Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122
   Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597
   Faralli A, 2013, NEURAL PLAST, DOI 10.1155/2013/854597
   Gomi M, 2012, BRAIN RES, V1459, P52, DOI 10.1016/j.brainres.2012.03.049
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159
   Hermann DM, 2009, J CEREBR BLOOD F MET, V29, P1620, DOI 10.1038/jcbfm.2009.100
   Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x
   Hicks C, 2013, CELL TRANSPLANT, V22, P1541, DOI 10.3727/096368912X657936
   Horak D, 2009, J MAGN MAGN MATER, V321, P1539, DOI 10.1016/j.jmmm.2009.02.082
   Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056
   Hu W, 2015, MOL NEUROBIOL
   Huang W, 2013, NEUROL RES, V35, P320, DOI 10.1179/1743132812Y.0000000151
   Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041
   Jeong CH, 2014, BIOMED RES INT, V2014
   Jiang M, 2011, MOL CELL BIOCHEM, V354, P67, DOI 10.1007/s11010-011-0806-5
   Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063
   Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010
   Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Jin Y, 2014, ACTA BIOMATER, V10, P3126, DOI 10.1016/j.actbio.2014.02.045
   Ju RK, 2014, CELL TRANSPLANT, V23, pS83, DOI 10.3727/096368914X684998
   Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X
   Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373
   Kawai H, 2010, J CEREBR BLOOD F MET, V30, P1487, DOI 10.1038/jcbfm.2010.32
   Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002
   Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005
   Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005
   Kneipp M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096118
   Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106
   Kubinova S, 2015, FUTUR NEUROL, V10, P129, DOI 10.2217/FNL.14.71
   Kubinova S, 2012, REGEN MED, V7, P207, DOI [10.2217/RME.11.121, 10.2217/rme.11.121]
   Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430
   Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654
   Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/aw1207
   Liu N, 2012, J NEUROSCI RES, V90, P2086, DOI 10.1002/jnr.23104
   Low SW, 2015, J NEUROSURG, V123, P662, DOI 10.3171/2014.11.JNS141553
   Meneghello G, 2015, NEUROSCIENCE, V301, P204, DOI 10.1016/j.neuroscience.2015.05.071
   Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006
   Mitkari B, 2014, BEHAV BRAIN RES, V259, P50, DOI 10.1016/j.bbr.2013.10.030
   Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054036
   Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1
   Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062
   O'Brien LC, 2015, STEM CELLS DEV, V24, P1984, DOI 10.1089/scd.2015.0076
   Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046
   Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527
   Ortega FJ, 2013, ACTA NEUROBIOL EXP, V73, P66
   Peplow PV, 2014, NEURAL REGEN RES, V9, P1425, DOI 10.4103/1673-5374.139457
   Plane JM, 2008, EXP NEUROL, V214, P125, DOI 10.1016/j.expneurol.2008.08.006
   Polentes J, 2012, CELL TRANSPLANT, V21, P2587, DOI 10.3727/096368912X653228
   Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011
   Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947
   Roese-Koerner B, 2013, CURR MOL MED, V13, P707
   Rueger MA, 2010, J NEUROSCI, V30, P6454, DOI 10.1523/JNEUROSCI.6092-09.2010
   Sandvig I, 2014, METHODS MOL BIOL, V1162, P233, DOI 10.1007/978-1-4939-0777-9_19
   Sandvig I, 2012, CONTRAST MEDIA MOL I, V7, P403, DOI 10.1002/cmmi.1465
   Sandvig I, 2012, NMR BIOMED, V25, P620, DOI 10.1002/nbm.1778
   Savitz SI, 2014, STROKE, V45, P634, DOI 10.1161/STROKEAHA.113.003379
   Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914
   Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015
   Shah PP, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00888
   Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311
   Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951
   Sobesky J, 2012, J CEREBR BLOOD F MET, V32, P1416, DOI 10.1038/jcbfm.2012.54
   Steiner B, 2012, NEUROSCI LETT, V513, P25, DOI 10.1016/j.neulet.2012.01.078
   Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008
   Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483
   Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1
   Tajiri N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091408
   Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278
   Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010
   Vandeputte C, 2014, NEUROBIOL DIS, V69, P144, DOI 10.1016/j.nbd.2014.05.014
   Velasco I, 2014, STEM CELLS, V32, P2811, DOI 10.1002/stem.1782
   Wang J.B., 2014, APPL PHYS FRONT, V2, P1, DOI DOI 10.1080/17544750.2014.988634
   Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032
   Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031
   Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863
   Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152
   Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010
   Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387
   Yu HW, 2010, ANAT REC, V293, P911, DOI 10.1002/ar.20941
   Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369
   Zheng ZG, 2003, ANN NEUROL, V53, P259, DOI 10.1002/ana.10467
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
NR 115
TC 10
Z9 10
U1 4
U2 37
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD JAN 2
PY 2016
VL 16
IS 1
BP 43
EP 56
DI 10.1517/14712598.2016.1094457
PG 14
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA DB6SJ
UT WOS:000368645000004
PM 26419582
DA 2018-10-20
ER

PT J
AU Gaur, PK
   Mishra, S
   Verma, A
   Verma, N
AF Gaur, Praveen Kumar
   Mishra, Shikha
   Verma, Anurag
   Verma, Navneet
TI Ceramide-palmitic acid complex based Curcumin solid lipid nanoparticles
   for transdermal delivery: pharmacokinetic and pharmacodynamic study
SO JOURNAL OF EXPERIMENTAL NANOSCIENCE
LA English
DT Article
DE ceramide 2; Curcumin; permeation; pharmacokinetics; anti-inflammatory
ID DRUG-DELIVERY; IN-VITRO; SKIN; MICROPARTICLES; BIOMATERIAL; FORMULATION;
   STABILITY; ENHANCERS; CARRIER; RAT
AB Curcumin is an important anti-inflammatory natural compound with low bioavailability which is due to poor solubility and absorption. Solid lipid nanoparticles (SLNs) loaded with Curcumin were formulated and evaluated for physical parameters and in vitro/ex vivo permeation. Further the optimised SLN was assessed for pharmacokinetic/pharmacodynamic considerations. SLNs were formulated by emulsion-solvent evaporation technique and evaluated for physical properties and in vitro drug release. Selected SLNs were evaluated for stability and then characterised for pharmacokinetic parameters and anti-inflammatory activity with reference to a commercial formulation. Spherical SLNs were obtained in the size range of 102-156 nm with negative potential. C-SLN category has shown highest entrapment efficiency. The order of drug release was S-SLN > G-SLN > C-SLN. Selected SLN formulation C-SLN-3 has shown good stability under various conditions. C-SLN-3 has demonstrated highest drug permeation through human skin and 171.623 mg drug content permeated in 24 h. It has also shown lowest lag time 0.375 h. Similarly, it has shown maximum value for C-max in in vivo determination and increased the bioavailability upto 68.12%. C-SLN-3 provided 90.75% edema inhibition in 6 h. Present study shows that nature of lipids and its physical-chemical properties are critical for SLN formulation and can be used for designing better drug delivery systems with optimum transdermal permeation.
C1 [Gaur, Praveen Kumar] Uttar Pradesh Tech Univ, ITS Paramed Coll Pharm, Dept Pharmaceut, Muradnagar 201206, Ghaziabad, India.
   [Mishra, Shikha] Jamia Hamdard, Dept Pharmacognosy & Phytochem, New Delhi 110062, India.
   [Verma, Anurag; Verma, Navneet] IFTM Univ, Dept Pharmaceut, Sch Pharmaceut Sci, Moradabad 244001, India.
RP Gaur, PK (reprint author), Uttar Pradesh Tech Univ, ITS Paramed Coll Pharm, Dept Pharmaceut, Muradnagar 201206, Ghaziabad, India.
EM gaurmpharma@rediffmail.com
OI Gaur, Praveen/0000-0002-4221-1485
CR Anto Ruby John, 1998, Pharmacy and Pharmacology Communications, V4, P103
   Asai A, 2000, LIFE SCI, V67, P2785, DOI 10.1016/S0024-3205(00)00868-7
   Babu RJ, 2005, PERCUTANEOUS PENETRA, P137
   Batheja Priya, 2006, Expert Opin Drug Deliv, V3, P127
   Castangia I, 2014, ACTA BIOMATER, V10, P1292, DOI 10.1016/j.actbio.2013.11.005
   Chaudhary H, 2013, INT J PHARMACEUT, V454, P367, DOI 10.1016/j.ijpharm.2013.07.031
   Denet AR, 2004, ADV DRUG DELIVER REV, V56, P659, DOI 10.1016/j.addr.2003.10.027
   El-Kamel Amal H, 2008, Curr Drug Deliv, V5, P20, DOI 10.2174/156720108783331014
   Falzarano MS, 2013, BIOMED RES INT, V2013, P13
   Gaur PK, 2013, BIOMED RES INT, V2013, P10
   Gaur PK, 2014, SCI ADV MATER, V6, P736, DOI 10.1166/sam.2014.1762
   Gaur PK, 2014, DRUG DEV IND PHARM, V40, P568, DOI 10.3109/03639045.2013.782502
   Gaur PK, 2013, J BIOMAT SCI-POLYM E, V24, P2126, DOI 10.1080/09205063.2013.828579
   Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011
   HUANG MT, 1988, CANCER RES, V48, P5941
   Jasper AW, 2005, J PHYS CHEM B, V109, P3915, DOI 10.1021/jp044805v
   Kumar Virender, 2002, Indian Journal of Physiology and Pharmacology, V46, P209
   Lee JW, 2011, J CONTROL RELEASE, V154, P58, DOI 10.1016/j.jconrel.2011.05.003
   Liu CH, 2011, COLLOID SURFACE B, V82, P63, DOI 10.1016/j.colsurfb.2010.08.018
   Manconi M, 2011, EUR J PHARM BIOPHARM, V78, P27, DOI 10.1016/j.ejpb.2010.12.010
   Morel S, 1996, INT J PHARM, V132, P259, DOI 10.1016/0378-5173(95)04388-8
   Mulik RS, 2010, INT J PHARMACEUT, V398, P190, DOI 10.1016/j.ijpharm.2010.07.021
   Nemmar A, 2013, BIOMED RES INT, V2013, P22
   PHILLIPS CA, 1995, J PHARM SCI, V84, P1427, DOI 10.1002/jps.2600841208
   Preetha A, 2007, MOL PHARM, V4, P807
   RAO DS, 1970, J NUTR, V100, P1307
   RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5
   Reithmeier H, 2001, INT J PHARM, V218, P133, DOI 10.1016/S0378-5173(01)00620-2
   SCHWARZ C, 1994, J CONTROL RELEASE, V30, P83, DOI 10.1016/0168-3659(94)90047-7
   SREEJAYAN RMN, 1994, J PHARM PHARMACOL, V46, P1013
   SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x
   Tiyaboonchai W, 2007, INT J PHARM, V337, P299, DOI 10.1016/j.ijpharm.2006.12.043
   TONNESEN HH, 1986, Z LEBENSM UNTERS FOR, V183, P116, DOI 10.1007/BF01041928
   Varshosaz J., 2013, BIOMED RES INT, V2013, P8
   Vidyalakshmi K, 2004, J MACROMOL SCI PURE, VA41, P1115, DOI 10.1081/MA-200026554
   Wang XY, 2008, FOOD CHEM, V108, P419, DOI 10.1016/j.foodchem.2007.10.086
   Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9
   Wartewig S, 2007, SKIN PHARMACOL PHYS, V20, P220, DOI 10.1159/00010442
NR 38
TC 4
Z9 4
U1 1
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1745-8080
EI 1745-8099
J9 J EXP NANOSCI
JI J. Exp. Nanosci.
PD JAN 2
PY 2016
VL 11
IS 1
BP 38
EP 53
DI 10.1080/17458080.2015.1025301
PG 16
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA CX7BZ
UT WOS:000365857100004
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Vijayalakshmi, U
   Chellappa, M
   Anjaneyulu, U
   Manivasagam, G
   Sethu, S
AF Vijayalakshmi, U.
   Chellappa, M.
   Anjaneyulu, U.
   Manivasagam, Geetha
   Sethu, Swaminathan
TI Influence of Coating Parameter and Sintering Atmosphere on the Corrosion
   Resistance Behavior of Electrophoretically Deposited Composite Coatings
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
DE Corrosion; Sol-gel; Ti-6Al-4V alloy; TiO2; ZnO
ID STAINLESS-STEEL; TITANIUM-ALLOYS; OXIDE-FILMS; GEL; NANOPARTICLES;
   BIOCOMPATIBILITY; HYDROXYAPATITE; BIOMATERIAL; MORPHOLOGY; OXIDATION
AB The purpose of this study is to synthesize and characterize nanosized titania (TiO2), zinc oxide (ZnO), and its composite coating on Ti-6Al-4V to enhance its corrosion protection behavior in Ringer's solution. Nanosized powders of TiO2 and ZnO was characterized by Fourier transform infrared spectroscopy (FTIR), powder X-ray diffraction (XRD), and scanning electron microscopy - energy dispersive atomic spectroscopy (SEM-EDAX) analysis. As a result of antibacterial activity, both ZnO and TiO2/ZnO have produce remarkable inhibition zone on Escherichia coli. The antibacterial activity of composites are due to the combined effect of ZnO on TiO2. The adherence and surface uniformity of TiO2/ZnO composite film on titanium implant was examined by optical microscopy and Vickers microhardness test. Corrosion resistant behavior of the coating on titanium implant was investigated by tafel polarization and impedance analysis. The composite coatings on Ti-6Al-4V have produced improved corrosion resistance with a pronounced shift in the anodic corrosion potential (E-corr) with a corresponding less corrosion current density (I-corr) compared to monophase coating. Similar results have been obtained for impedance analysis which indicated a reduction in double layer capacitance (C-dl) and with enhancement in charge transfer resistance (R-ct). These observations suggest improved corrosion resistance property of TiO2/ZnO composite coating on Ti-6Al-4V.
C1 [Vijayalakshmi, U.; Chellappa, M.; Anjaneyulu, U.] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore, Tamil Nadu, India.
   [Manivasagam, Geetha] VIT Univ, Ctr Biomat Sci & Technol, Vellore, Tamil Nadu, India.
   [Sethu, Swaminathan] Narayana Nethralaya Fdn, GROW Res Lab, Bangalore, Karnataka, India.
RP Vijayalakshmi, U (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore, Tamil Nadu, India.
EM lakesminat@yahoo.com
OI Manivasagam, Geetha/0000-0003-3326-3176
FU Department of Science and Technology (DST-SERB) [SB/FT/CS-091/2012]
FX The authors are grateful to the Department of Science and Technology
   (DST-SERB sanction order no. SB/FT/CS-091/2012) to render financial
   support to carry out this work.
CR Bally A. Z., 1989, J APPL PHYS, V31, P1149
   Baszkiewicz J, 2005, VACUUM, V78, P143, DOI 10.1016/j.vacuum.2005.01.017
   Chew K., 2012, NATURAL SCI, V4, P184
   Delplancke J. L., 2003, ELECTROCHIM ACTA, V48, P1131
   Dikici B, 2009, CORROS SCI, V51, P469, DOI 10.1016/j.corsci.2008.12.023
   French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n
   Golic DL, 2012, J SOL-GEL SCI TECHN, V63, P116, DOI 10.1007/s10971-012-2773-z
   Gopi D, 2009, MAT SCI ENG C-BIO S, V29, P955, DOI 10.1016/j.msec.2008.08.020
   Guleryuz H, 2004, BIOMATERIALS, V25, P3325, DOI 10.1016/j.biomaterials.2003.10.009
   Hamadanian M, 2010, J IRAN CHEM SOC, V7, pS52, DOI 10.1007/BF03246184
   Hou YH, 2013, INT J NANOMED, V8, P3619, DOI 10.2147/IJN.S38992
   Huaa Y., 2013, APPL SURF SCI, P775
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Jung CK, 2002, J CRYST GROWTH, V235, P450, DOI 10.1016/S0022-0248(01)01939-X
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kim JD, 2003, ELECTROCHIM ACTA, V48, P1123, DOI 10.1016/S0013-4686(02)00823-X
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopez MF, 2003, ELECTROCHIM ACTA, V48, P1395, DOI 10.1016/S0013-4686(03)00006-9
   Padhy N, 2010, SURF COAT TECH, V204, P2782, DOI 10.1016/j.surfcoat.2010.02.047
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Popescu S, 2007, J MATER SCI-MATER M, V18, P2075, DOI 10.1007/s10856-007-3133-3
   Rajeswari S, 2012, J SOL-GEL SCI TECHN, V43, P251
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   Vijayalakshmi U, 2008, J BIOMED MATER RES A, V87A, P739, DOI 10.1002/jbm.a.31773
   Wang BG, 1997, CRYST RES TECHNOL, V32, P659, DOI 10.1002/crat.2170320509
   Zhang H, 2004, NANOTECHNOLOGY, V15, P622, DOI 10.1088/0957-4484/15/5/037
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zitomirsky I., 2006, J MATER SCI, V41, P8186
NR 28
TC 7
Z9 7
U1 3
U2 57
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1042-6914
EI 1532-2475
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PD JAN 2
PY 2016
VL 31
IS 1
BP 95
EP 106
DI 10.1080/10426914.2015.1070424
PG 12
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA CT5IR
UT WOS:000362842700016
DA 2018-10-20
ER

PT S
AU Li, A
   Wang, J
   Zhang, W
   McNaughton, R
   Anderson, S
   Zhang, X
AF Li, A.
   Wang, J.
   Zhang, W.
   McNaughton, R.
   Anderson, S.
   Zhang, X.
GP IOP
TI Sol-gel based TiO2 thin film deposition on frustules towards facile and
   scalable manufacturing
SO 16TH INTERNATIONAL CONFERENCE ON MICRO AND NANOTECHNOLOGY FOR POWER
   GENERATION AND ENERGY CONVERSION APPLICATIONS (POWERMEMS 2016)
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 16th International Conference on Micro- and Nano-Technology for Power
   Generation and Energy Conversion Applications (PowerMEMS)
CY DEC 06-09, 2016
CL Paris, FRANCE
ID NANOTECHNOLOGY; EFFICIENCY; DIATOMS
AB Diatom frustules have drawn a lot of attention from engineering researchers in the past decades. As a type of biomaterial, diatom frustules have been applied in a variety of areas such as biosensors and solar cells due to their excellent material and optical properties. Titanium dioxide (TiO2), on the other hand, is also semiconductor material and photocatalyst, micro and nanoparticles of which can be found in applications such as dye sensitised solar cells (DSSC). It has been demonstrated that by using diatom frustule-TiO2 composite particles in DSSCs, the performance of the solar cells could be increased. In this paper, we introduce a sol-gel based method to deposit TiO2 layers on the surface of diatom frustules. TiO2 nanoparticles were deposited on the surface of the frustules. After a subsequent annealing process, TiO2 crystal grains were formed. The method in this paper has the potential for scalable manufacturing of frustule-TiO2 composite materials for future solar cell applications.
C1 [Li, A.; Wang, J.; Zhang, W.; McNaughton, R.; Zhang, X.] Boston Univ, Mech Engn, Boston, MA 02215 USA.
   [Anderson, S.] Boston Univ, Med Ctr, Boston, MA 02118 USA.
RP Zhang, X (reprint author), Boston Univ, Mech Engn, Boston, MA 02215 USA.
EM xinz@bu.edu
CR Dolatabadi JEN, 2011, TRAC-TREND ANAL CHEM, V30, P1538, DOI 10.1016/j.trac.2011.04.015
   Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003
   Lin J, 2013, ADV FUNCT MATER, V23, P5952, DOI 10.1002/adfm.201301066
   Toster J, 2013, NANOSCALE, V5, P873, DOI 10.1039/c2nr32716c
   Zhang QQ, 2012, J OCEAN U CHINA, V11, P507, DOI 10.1007/s11802-012-2031-6
NR 5
TC 0
Z9 0
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2016
VL 773
AR UNSP 012112
DI 10.1088/1742-6596/773/1/012112
PG 4
WC Energy & Fuels; Physics, Applied
SC Energy & Fuels; Physics
GA BI2MG
UT WOS:000409402200109
OA Other Gold
DA 2018-10-20
ER

PT S
AU Coelho, NM
   Llopis-Hernandez, V
   Salmeron-Sanchez, M
   Altankov, G
AF Coelho, N. M.
   Llopis-Hernandez, V.
   Salmeron-Sanchez, M.
   Altankov, G.
BE Christov, CZ
TI Dynamic Reorganization and Enzymatic Remodeling of Type IV Collagen at
   Cell-Biomaterial Interface
SO INSIGHTS INTO ENZYME MECHANISMS AND FUNCTIONS FROM EXPERIMENTAL AND
   COMPUTATIONAL METHODS
SE Advances in Protein Chemistry and Structural Biology
LA English
DT Review; Book Chapter
ID SUBSTRATUM-BOUND FIBRONECTIN; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES;
   ENDOTHELIAL-CELLS; INTEGRIN BINDING; ADHESION; BIOCOMPATIBILITY;
   METALLOPROTEINASES; WETTABILITY; SURFACES
AB Vascular basement membrane remodeling involves assembly and degradation of its main constituents, type IV collagen (Col IV) and laminin, which is critical during development, angiogenesis, and tissue repair. Remodeling can also occur at cell-biomaterials interface altering significantly the biocompatibility of implants. Here we describe the fate of adsorbed Col IV in contact with endothelial cells adhering on positively charged NH2 or hydrophobic CH3 substrata, both based on self-assembly monolayers (SAMs) and studied alone or mixed in different proportions. AFM studies revealed distinct pattern of adsorbed Col IV, varying from single molecular deposition on pure NH2 to network-like assembly on mixed SAMs, turning to big globular aggregates on bare CH3. Human umbilical endothelial cells (HUVECs) interact better with Col IV adsorbed as single molecules on NH2 surface and readily rearrange it in fibril-like pattern that coincide with secreted fibronectin fibrils. The cells show flattened morphology and well-developed focal adhesion complexes that are rich on phosphorylated FAK while expressing markedly low pericellular proteolytic activity. Conversely, on hydrophobic CH3 substrata HUVECs showed abrogated spreading and FAK phosphorylation, combined with less reorganization of the aggregated Col IV and significantly increased proteolytic activity. The later involves both MMP-2 and MMP-9, as measured by zymography and FITC-Col IV release. The mixed SAMs support intermediate remodeling activity. Taken together these results show that chemical functionalization combined with Col IV pre-adsorption provides a tool for guiding the endothelial cells behavior and pericellular proteolytic activity, events that strongly affect the fate of cardiovascular implants.
C1 [Coelho, N. M.; Altankov, G.] Inst Bioengn Catalonia IBEC, Barcelona, Spain.
   [Llopis-Hernandez, V.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia, Spain.
   [Llopis-Hernandez, V.; Salmeron-Sanchez, M.] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland.
   [Altankov, G.] ICREA, Barcelona, Spain.
   [Coelho, N. M.] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada.
RP Altankov, G (reprint author), Inst Bioengn Catalonia IBEC, Barcelona, Spain.; Altankov, G (reprint author), ICREA, Barcelona, Spain.
EM altankov@abv.bg
OI Coelho, Nuno/0000-0001-7128-1362; Salmeron-Sanchez,
   Manuel/0000-0002-8112-2100
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   Altankov G, 2010, NATO SCI PEACE SEC A, P19, DOI 10.1007/978-90-481-8790-4_2
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Charonis A, 2005, CURR MED CHEM, V12, P1495, DOI 10.2174/0929867054039071
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Fleischmajer R, 1998, ANN NY ACAD SCI, V857, P212, DOI 10.1111/j.1749-6632.1998.tb10118.x
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GEIGER B, 2009, MOL CELL BIOL, V10, P21, DOI DOI 10.1038/NRM2593
   Goody MF, 2010, MOL REPROD DEV, V77, P475, DOI 10.1002/mrd.21157
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Gustavsson J, 2008, J MATER SCI-MATER M, V19, P1839, DOI 10.1007/s10856-008-3384-7
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   Kolahi KS, 2010, WIRES SYST BIOL MED, V2, P625, DOI 10.1002/wsbm.79
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Llopis-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019610
   Lu Pengfei, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005058
   Maneva-Radicheva L, 2008, HISTOL HISTOPATHOL, V23, P833, DOI 10.14670/HH-23.833
   Coelho NM, 2010, EUR CELLS MATER, V19, P262, DOI 10.22203/eCM.v019a25
   Coelho NM, 2013, BIOMATER SCI-UK, V1, P494, DOI 10.1039/c3bm00163f
   Coelho NM, 2011, BIOTECHNOL BIOENG, V108, P3009, DOI 10.1002/bit.23265
   Coelho NM, 2011, TISSUE ENG PT A, V17, P2245, DOI [10.1089/ten.tea.2010.0713, 10.1089/ten.TEA.2010.0713]
   Moon IS, 1999, J CLIN PERIODONTOL, V26, P658, DOI 10.1034/j.1600-051X.1999.261005.x
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009
   Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   Toromanov G, 2015, ACS BIOMATER SCI ENG, V1, P927, DOI 10.1021/acsbiomaterials.5b00147
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
   Yurchenco P. D., 2011, COLD SPRING HARBOR P, V3
   YURCHENCO PD, 1990, FASEB J, V4, P1577
NR 63
TC 2
Z9 3
U1 0
U2 0
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1876-1623
BN 978-0-12-804825-2
J9 ADV PROTEIN CHEM STR
JI Adv. Protein Chem. Struct. Biol.
PY 2016
VL 105
BP 81
EP 104
DI 10.1016/bs.apcsb.2016.06.001
PG 24
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BI0WX
UT WOS:000405229500005
PM 27567485
DA 2018-10-20
ER

PT S
AU Saxena, S
   Devnani, H
   Verma, SK
   Satsangee, SP
AF Saxena, Sachin
   Devnani, Harsha
   Verma, Sudhir Kumar
   Satsangee, Soami P.
GP IEEE
TI Agricultural by-product based Carbon Paste Sensor for the Trace
   Determination of heavy metals Pb and Cd by Adsorptive Stripping
   Voltammetry
SO 2016 IEEE REGION 10 HUMANITARIAN TECHNOLOGY CONFERENCE (R10-HTC)
SE IEEE Region 10 Humanitarian Technology Conference
LA English
DT Proceedings Paper
CT IEEE-Region-10 Humanitarian Technology Conference (R10-HTC)
CY DEC 21-23, 2016
CL Dayalbagh, INDIA
SP IEEE Reg 10, Dayalbagh Educ Inst
DE Carbon Paste Electrode; Bagasse; Adsorptive Voltammetry; Lead; Cadmium
ID MODIFIED ELECTRODE; ELECTROCHEMICAL SENSOR; OXYGEN REDUCTION; FILM
   ELECTRODE; COMPOSITE; IONS; NANOPARTICLE; MERCURY(II); COPPER; URINE
AB Low cost agricultural byproduct based sensors have opened new branch and equipped us with fabricated highly sensitive tools for the analysis and administration in food and water industries. They not only lowered the cost with reliable trace determinations but also are ecofriendly in nature. This paper reports utilization of bagasse (sugarcane waste) as a biomaterial used in the sensor for the detection of Pb and Cd toxic metals. The electrochemical technique was used for the performance study of the bagasse based carbon paste sensor. Surface characterization of modifier was carried using cyclic voltammetry, BET analysis, SEM and FTIR studies. The BET analysis reveals the pore distribution of bagasse falls in the mesoporous domain. The specific surface area are typically found as S-BET = 89.3 m(2)/g. In order to find the adsorption phenomenon of the characterized modifier and its interaction with the heavy metals, the bagasse modified carbon paste electrode was fabricated and studied by adsorptive stripping voltammetry technique. The fabricated electrode offered high sensitivity towards metals estimation and optimization of the electrochemical parameters were obtained with reference to amount of modifier, accumulating electrolyte, accumulation time, pH and supporting electrolyte. The effect of surfactants on the determination of the ions has been investigated with CTAB, SDS and Triton X-100. Analysis of Pb and Cd under optimized conditions with acetate buffer of pH 6 as accumulating solvent, hydrochloric acid as stripping electrolyte at a scan rate of 50mV/s resulted in stripping responses with good linearity. Linear calibration curves were obtained in the concentration ranges of 100-600 mu g L-1 and 500-1200 mu g L-1, respectively, for lead and cadmium at an accumulated time of 10 min with limits of detection 10.1 and 170.64 mu g L-1.
C1 [Saxena, Sachin; Devnani, Harsha; Verma, Sudhir Kumar; Satsangee, Soami P.] Dayalbagh Educ Inst, Dept Chem, Agra 282005, Uttar Pradesh, India.
RP Saxena, S (reprint author), Dayalbagh Educ Inst, Dept Chem, Agra 282005, Uttar Pradesh, India.
EM sachinusic@gmail.com
FU M.H.R.D project (under NMEICT), Dayalbagh Educational Institute,
   Dayalbagh, Agra; UGC; DST
FX Authors acknowledge their work to M.H.R.D project (under NMEICT),
   Dayalbagh Educational Institute, Dayalbagh, Agra, for providing
   financial assistance. They would like to thank UGC and DST for
   fellowship to two of the Authors (Sachin Saxena and Harsha Devnani
   respectively). Further, authors are also thankful to University of
   Lucknow for BET and SEM analysis.
CR Berbel F, 1998, ELECTROANAL, V10, P417
   Buica GO, 2009, ELECTROANAL, V21, P77, DOI 10.1002/elan.200804386
   Chen XL, 2010, ELECTROCHIM ACTA, V56, P636, DOI 10.1016/j.electacta.2010.10.001
   Chow E, 2006, ELECTROANAL, V18, P1437, DOI 10.1002/elan.200603558
   Cobelo G. A., 2005, ELECTROANAL, V17, P906
   Dabrowski A, 2001, ADV COLLOID INTERFAC, V93, P135, DOI 10.1016/S0001-8686(00)00082-8
   Duan HM, 2015, ELECTROCHIM ACTA, V152, P417, DOI 10.1016/j.electacta.2014.11.160
   Elbaz L, 2014, J ELECTROANAL CHEM, V720, P34, DOI 10.1016/j.jelechem.2014.02.023
   Fiol N, 2007, SENSOR ACTUAT B-CHEM, V122, P187, DOI 10.1016/j.snb.2006.05.038
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   Gupta VK, 2013, SENSOR ACTUAT B-CHEM, V186, P603, DOI 10.1016/j.snb.2013.06.048
   Heitzmann M, 2005, ELECTROANAL, V17, P1970, DOI 10.1002/elan.200503325
   Jain Rajeev, 2013, J Pharm Anal, V3, P452, DOI 10.1016/j.jpha.2013.07.005
   Jain R, 2011, DRUG TEST ANAL, V3, P171, DOI 10.1002/dta.200
   Jain R, 2010, ANAL BIOCHEM, V407, P79, DOI 10.1016/j.ab.2010.07.027
   Jannat B, 2009, IRAN J PHARM RES, V8, P159
   Kozan JVB, 2007, ANAL CHIM ACTA, V591, P200, DOI 10.1016/j.aca.2007.03.058
   Liawrungrath S, 2008, TALANTA, V77, P500, DOI 10.1016/j.talanta.2008.06.031
   Mojica E. E., 2007, J APPL SCI ENV MANAG, V11, P69
   Mojica E. R. E., 2007, J APPL SCI, V7, P1286
   Raj KR, 2010, E-J CHEM, V7, pS169
   Rajawat DS, 2011, RES J CHEM ENVIRON, V15, P55
   Rezaei B, 2008, IEEE SENS J, V8, P1523, DOI 10.1109/JSEN.2008.923585
   Satsangee SP, 2014, J ELECTROCHEM SOC, V161, pH780, DOI 10.1149/2.0671412jes
   Saxena S, 2014, J ELECTROCHEM SOC, V161, pH934, DOI 10.1149/2.0891414jes
   Saxena S, 2012, MACED J CHEM CHEM EN, V31, P195
   Saxena S, 2012, INT J ELECTROCHEM SC, V7, P4636
   Serrano N, 2009, ELECTROANAL, V21, P431, DOI 10.1002/elan.200804417
   Shrivastava R, 2012, J ELECTROCHEM SOC, V159, pB795, DOI 10.1149/2.020210jes
   Singh K, 2011, IND ENG CHEM RES, V50, P10074, DOI 10.1021/ie200501p
   Sk MP, 2013, CHEM COMMUN, V49, P8235, DOI 10.1039/c3cc43726d
   Tamer U, 2008, ELECTROANAL, V20, P1805, DOI 10.1002/elan.200804221
   Tamer U, 2007, ELECTROANAL, V19, P2565, DOI 10.1002/elan.200704013
   Torma F, 2009, ELECTROANAL, V21, P1961, DOI 10.1002/elan.200904634
   Wang F, 2009, J CHIN CHEM SOC-TAIP, V56, P778, DOI 10.1002/jccs.200900115
   Won MS, 2005, ELECTROANAL, V17, P1952, DOI 10.1002/elan.200503303
NR 36
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2374-023X
J9 IEEE REG 10 HUMANIT
PY 2016
PG 6
WC Engineering, Multidisciplinary
SC Engineering
GA BI1HZ
UT WOS:000405948000002
DA 2018-10-20
ER

PT J
AU Nai, GA
   Logar, GD
   Mori, GG
   Teixeira, LM
   da Silva, BCF
   de Moraes, AEM
   Cabral, FA
AF Nai, Gisele Alborghetti
   Logar, Gustavo de Almeida
   Mori, Graziela Garrido
   Teixeira, Ligia Moraes
   Ferreira da Silva, Bruna Camila
   Maranho de Moraes, Ana Elisa
   Cabral, Felipe Andre
TI Evaluation of the genotoxicity and mutagenicity of Ca3SiO5-based cement
SO BRAZILIAN ORAL RESEARCH
LA English
DT Article
DE silicate cement; genotoxicity; mutagenicity; biomaterial
ID MICRONUCLEUS ASSAY; WORKING GROUP; COMET ASSAY; DNA-DAMAGE; CELLS;
   CYTOTOXICITY; TOXICOLOGY; INDUCTION; DENTIN
AB Ca3SiO5 is new cement based on the composition of Portland that has been developed to have superior physicochemical and biological properties. In a clinical evaluation, the cement did not appear to have cytotoxic properties and allowed for the proliferation of pulp cells and gingival fibroblasts. However, no previous studies have evaluated the genotoxicity or the mutagenicity of Ca3SiO5 in vivo. Therefore, the goal of this study is to evaluate the genotoxic and mutagenic potential of Ca3SiO5-based cement in vivo. Twenty-four male Wistar rats were divided into 3 groups (n = 8). Group A rats received subcutaneous implantation of Ca3SiO5 in the dorsum. Group B rats received a single dose of cyclophosphamide (positive control). Group C rats received subcutaneous implantation of empty tubes in the dorsum (negative control). After 24 hours, all animals were euthanized and the bone marrow of the femurs was collected for use in the comet assay and the micronucleus test. The comet assay revealed that the Ca3SiO5 group had a tail intensity of 23.57 +/- 7.70%, the cyclophosphamide group had a tail intensity of 27.43 +/- 7.40%, and the negative control group had a tail intensity of 24.75 +/- 5.55%. The average number of micronuclei was 6.25 (standard deviation, SD = 3.53) in the Ca3SiO5 group, 9.75 (SD = 2.49) in the cyclophosphamide group, and 0.75 (SD = 1.03) in the negative control group. There was an increase in the micronuclei frequency in the Ca3SiO5 group compared to that of the negative control group (p < 0.05). Our data showed that exposure to the Ca3SiO5\-based cement resulted in an increase in the frequency of micronuclei, but no genotoxicity was detected according to the comet assay.
C1 [Nai, Gisele Alborghetti] Univ Oeste Paulista UNOESTE, Dept Pathol, Presidente Prudente, SP, Brazil.
   [Logar, Gustavo de Almeida; Teixeira, Ligia Moraes; Maranho de Moraes, Ana Elisa; Cabral, Felipe Andre] Univ Oeste Paulista UNOESTE, Dent Sch Presidente Prudente, Presidente Prudente, SP, Brazil.
   [Mori, Graziela Garrido] Univ Oeste Paulista UNOESTE, Dent Sch Presidente Prudente, Dept Endodont, Presidente Prudente, SP, Brazil.
   [Ferreira da Silva, Bruna Camila] Univ Oeste Paulista UNOESTE, Med Coll, Presidente Prudente, SP, Brazil.
RP Nai, GA (reprint author), Univ Oeste Paulista UNOESTE, Dept Pathol, Presidente Prudente, SP, Brazil.
EM patologia@unoeste.br
OI Mori, Graziela/0000-0002-8690-5294
FU National Council for Scientific and Technological Development
   (PIBIC/CNPq)
FX The authors would like to thank Jose Luiz Santos Parizi, Ms, DDS, a
   professor in the Department of Pathology of Universidade do Oeste
   Paulista (UNOESTE), for technical support in the experiment. Bruna C F
   da Silva is fellow of the Institutional Program for Scientific
   Initiation Scholarships of the National Council for Scientific and
   Technological Development (PIBIC/CNPq).
CR Bin CV, 2012, J ENDODONT, V38, P495, DOI 10.1016/j.joen.2011.11.003
   Fenech M, 1999, MUTAT RES-FUND MOL M, V428, P271, DOI 10.1016/S1383-5742(99)00053-8
   Flores M., 2008, J HLTH RES, V1, P337
   Garrido G, 2014, J ENDODONT, V40, P1485, DOI 10.1016/j.joen.2014.02.027
   Hagiwara M, 2006, MUTAT RES-GEN TOX EN, V603, P111, DOI 10.1016/j.mrgentox.2005.08.011
   Han L, 2011, INT ENDOD J, V44, P1081, DOI 10.1111/j.1365-2591.2011.01924.x
   Hayashi M, 2000, ENVIRON MOL MUTAGEN, V35, P234, DOI 10.1002/(SICI)1098-2280(2000)35:3<234::AID-EM10>3.0.CO;2-L
   Hovhannisyan GG, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-17
   Kaplan C, 2004, BIOMATERIALS, V25, P4019, DOI 10.1016/j.biomaterials.2003.10.101
   Kirsch-Volders M, 2003, MUTAT RES-GEN TOX EN, V540, P153, DOI 10.1016/j.mrgentox.2003.07.005
   Kleinsasser NH, 2004, J DENT, V32, P229, DOI 10.1016/j.jdent.2003.11.002
   Koubi G, 2013, CLIN ORAL INVEST, V17, P243, DOI 10.1007/s00784-012-0701-9
   Koubi S, 2012, INT J DENT, DOI 10.1155/2012/105863
   Laurent P, 2012, INT ENDOD J, V45, P439, DOI 10.1111/j.1365-2591.2011.01995.x
   Laurent P, 2008, DENT MATER, V24, P1486, DOI 10.1016/j.dental.2008.02.020
   MACGREGOR JT, 1987, MUTAT RES, V189, P103, DOI 10.1016/0165-1218(87)90016-4
   Mateuca R, 2006, BIOCHIMIE, V88, P1515, DOI 10.1016/j.biochi.2006.07.004
   Moraes AP, 2016, INT ENDOD J, V49, P526, DOI 10.1111/iej.12487
   Mori Graziela Garrido, 2009, Braz. Dent. J., V20, P17, DOI 10.1590/S0103-64402009000100002
   Odabas ME, 2013, THESCIENTIFICWORLDJO, V2013
   Paiva FP, 2005, COURSE HANDLING LAB
   Perard M, 2013, J MATER SCI-MATER M, V24, P1527, DOI 10.1007/s10856-013-4908-3
   Ribeiro DA, 2006, ORAL SURG ORAL MED O, V101, P260, DOI 10.1016/j.tripleo.2005.02.080
   Roslindo NC, 1997, REV ODONTOL UNESP, V26, P265
   Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   TOLBERT PE, 1992, MUTAT RES, V271, P69, DOI 10.1016/0165-1161(92)90033-I
   Tweats DJ, 2007, MUTAT RES-GEN TOX EN, V627, P92, DOI 10.1016/j.mrgentox.2006.10.006
   Zhou HM, 2013, J ENDODONT, V39, P478, DOI 10.1016/j.joen.2012.11.026
NR 29
TC 0
Z9 0
U1 0
U2 0
PU SOCIEDADE BRASILEIRA DE PESQUISA ODONTOLOGICA
PI SAO PAULO
PA CIDADE UNIV, AV PROF LINEU PRESTES, ARMANDO SALLE OLIVEIRA, AVENIDA
   LINEU PRESTES, 2227, CP 8216, SAO PAULO, SP 05508-900, BRAZIL
SN 1807-3107
J9 BRAZ ORAL RES
JI Braz. Oral Res.
PY 2016
VL 30
IS 1
DI 10.1590/1807-3107BOR-2016.vol30.0097
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EZ1GK
UT WOS:000404458100029
PM 27556557
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Vyguzova, M
   Ilyin, A
   Kudriashova, A
AF Vyguzova, M.
   Ilyin, A.
   Kudriashova, A.
GP IEEE
TI Development of the Mathematical Model of Vermicomposting Process
SO 2016 2ND INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING,
   APPLICATIONS AND MANUFACTURING (ICIEAM)
LA English
DT Proceedings Paper
CT 2nd International Conference on Industrial Engineering, Applications and
   Manufacturing (ICIEAM)
CY MAY 19-20, 2016
CL Chelyabinsk, RUSSIA
SP Russia Siberia Sect Joint PES IES IAS CSS Chapter, S Ural State Univ, IEEE
DE processing; vermicomposting; mathematical model; separation
AB This article covers process of vermicomposting using infrared heating in ready product separation. Introduction shows issues of current importance in this technological process. A method of separating biomaterial in vermicomposting is suggested. The process of vermicomposting with this method is described. Several methods of separating ready vermicompost and worms used in vermicomposting are reviewed in the article. The main drawback of these methods is damaging adult worms resulting in decrease of breeding stock population. An alternative way of separation was suggested: creating unfavorable conditions for worms. The section devoted to materials and methods describes experimental equipment for separating worms biomass from ready vermicomposting mass. Microwave and infrared heating is considered. Infrared heating was chosen as the most appropriate way to heat biological targets. In addition, linear quartz infrared lamps and nichrome heating elements were selected as the means of heating that can be used in vermicomposting. A mathematical model of the heat exchange at separation with infrared heating has been developed. This model allows adequately describing processes of heat exchange in vermireactors. Modelling results are presented as diagrams describing heating process and can be used to automate the management of the separation process in vermicomposting.
C1 [Vyguzova, M.; Ilyin, A.; Kudriashova, A.] Kamsky Inst Humanitarian & Engn Technol, Izhevsk, Russia.
RP Vyguzova, M (reprint author), Kamsky Inst Humanitarian & Engn Technol, Izhevsk, Russia.
CR Frolov V. F., 2008, LECT PROCESSES DEVIC
   Gmurman V. E., 2003, THEORY PROBABILITY M
   Ilyin A. P., 2011, ILYIN AP
   Kudriashova A. G., 2013, P 6 ALL RUSS INT PAR
   Vyguzova M. A., MULTIDISCIPLINARY NE, P498
NR 5
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-1322-7
PY 2016
PG 4
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA BH8RU
UT WOS:000403604400108
DA 2018-10-20
ER

PT B
AU Mezyk, A
   Klein, W
   Pawlak, M
   Dudek, O
AF Mezyk, Arkadiusz
   Klein, Wojciech
   Pawlak, Mariusz
   Dudek, Olaf
BE NaitAli, A
   AlDoori, M
   Pangracious, V
   Moukayed, M
TI Preliminary tests of new composite material based on shape memory alloys
   for artificial aortic valve leaflets
SO 2016 INTERNATIONAL CONFERENCE ON BIO-ENGINEERING FOR SMART TECHNOLOGIES
   (BIOSMART)
LA English
DT Proceedings Paper
CT International Conference on Bio-engineering for Smart Technologies
   (BioSMART)
CY DEC 04-07, 2016
CL Dubai, U ARAB EMIRATES
SP IEEE UAE Sect, IEEE, Amer Univ Dubai, Sch Engn, Univ Paris Est Creteil Marne, Web Sci, TELECOM SudParis, Inst Mines Telecom
DE shape memory alloys (SMA); composite; aortic valve leaflets
ID FABRICATION
AB Nowadays bioengineers actively search for new materials for different kind of implants. The natural tissues used for these purposes have many defects, of which the most important is the possibility of transplant rejection. However, properties of artificial biomaterials have also many deficiencies among which there are insufficient mechanical and fatigue properties. The example of this can be the aortic valve leaflets, which anatomy is complicated both in terms of geometrical shape and internal structure. This causes significant difficulties with finding suitable material for this type of implants. The most frequently used methods of obtaining material for that purpose are based on the processing of biopolymers (e.g. electrospinning) and also on extraction of porcine pericardial tissue. This paper presents a new concept of composite biomaterial based on shape memory alloys (SMA) with biopolymer matrix. The SMA thin fibers imitate collagen fibers in aortic valve leaflets which stabilize the aortic valve motion and reduce stresses. The numerical simulation of blood flow was done to verify assumptions and investigate the extent of deformation of the new composite structure.
C1 [Mezyk, Arkadiusz; Klein, Wojciech; Pawlak, Mariusz; Dudek, Olaf] Silesian Tech Univ, Fac Mech Engn, Gliwice, Poland.
RP Mezyk, A (reprint author), Silesian Tech Univ, Fac Mech Engn, Gliwice, Poland.
EM arkadiusz.mezyk@polsl.pl; wojciech.klein@polsl.pl;
   mariusz.pawlak@polsl.pl
RI Pawlak, Mariusz/Q-2983-2017
FU National Centre for Research and Development, Poland, under STRATEGMED
   grant [1/233166/6/NCBR/2014]
FX The authors have been supported by The National Centre for Research and
   Development, Poland, under STRATEGMED grant no. 1/233166/6/NCBR/2014.
CR Bhatt R., 2015, EXCIPIENT APPL FORMU, P311
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Loger K, 2014, CARDIOVASC ENG TECHN, V5, P308, DOI 10.1007/s13239-014-0194-6
   Marom G., 2013, J BIOMECHANICAL ENG, V135
   Mezyk A., 2016, P 6 INT C STRUCT ENG, P223
   Otsuka K., 1999, SHAPE MEMORY MAT, P27
   SHEREBRIN MH, 1983, CAN J PHYSIOL PHARM, V61, P539, DOI 10.1139/y83-083
   Vesely I, 1998, J HEART VALVE DIS, V7, P34
   YVES B, 2002, ENCY SMART MAT, P620
   Zhou D, 2015, J BIONIC ENG, V12, P575, DOI 10.1016/S1672-6529(14)60147-5
NR 10
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-4568-6
PY 2016
PG 3
WC Computer Science, Artificial Intelligence; Engineering, Biomedical
SC Computer Science; Engineering
GA BH6CX
UT WOS:000401661400012
DA 2018-10-20
ER

PT S
AU Jaligama, S
   Huang, PJ
   Kameoka, J
AF Jaligama, Sravani
   Huang, Po-Jung
   Kameoka, Jun
BE Patton, J
   Barbieri, R
   Ji, J
   Jabbari, E
   Dokos, S
   Mukkamala, R
   Guiraud, D
   Jovanov, E
   Dhaher, Y
   Panescu, D
   Vangils, M
   Wheeler, B
   Dhawan, AP
TI Novel 3D coaxial flow-focusing nozzle device for the production of
   monodispersed collagen microspheres
SO 2016 38TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 38th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY AUG 16-20, 2016
CL Orlando, FL
SP IEEE Engn Med & Biol Soc
ID CROSS-LINKING; BIOMATERIALS; DELIVERY; KINETICS; RELEASE; EDC
AB We have developed a 3D coaxial flow-focusing nozzle device for the mass production of monodispersed collagen microspheres and chemically crosslinked them using EDC (1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide) and N-hydroxysuccinimide (NHS). The size of the microspheres was varied between 200 mu m and 600 mu m by adjusting the ratio of the flow rates of the dispersed and continuous phases. MDA231-GFP cells were attached to the surface of these particles and their viability was investigated. Because they are comprised of a natural biomaterial, these collagen microspheres will have numerous applications, including bone regeneration scaffolds for tissue engineering and analyses of cancer cell interactions in a 3D environment.
C1 [Jaligama, Sravani; Huang, Po-Jung; Kameoka, Jun] Texas A&M Univ, College Stn, TX 77840 USA.
RP Jaligama, S (reprint author), Texas A&M Univ, College Stn, TX 77840 USA.
EM jali143@tamu.edu; dimo741109@tamu.edu; kameoka@tamu.edu
FU NSF CBET [1264848]; NIH [RO1-B214765]
FX We would like to thank the following individuals at Texas A&M
   University: Po Jung Huang for assistance with the culturing of the
   MDA231 cells; the Texas A&M Microscopy and Imaging Center (MIC) for
   their assistance with the SEM sample preparation and imaging of the
   collagen microspheres; and Dr. Hirohito Yamaguchi from the MD Anderson
   Cancer center for providing us with the GFP-modified MDA-MB-231 breast
   cancer cells. This research is supported by NSF CBET 1264848 and NIH
   RO1-B214765.
CR BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998
   Chan Barbara Pui, 2010, TISSUE ENG C, V16
   Chan OCM, 2008, J CONTROL RELEASE, V129, P135, DOI 10.1016/j.jconrel.2008.04.011
   Cheng Hiu- Wa, 2009, TISSUE ENG C, V15
   Chowdhury DK, 1999, INT J PHARM, V193, P113, DOI 10.1016/S0378-5173(99)00328-2
   Gomes C, 2009, INT J FOOD MICROBIOL, V135, P238, DOI 10.1016/j.ijfoodmicro.2009.08.026
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Hong SM, 2012, LAB CHIP, V12, P3277, DOI 10.1039/c2lc40558j
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Kim HW, 2007, TISSUE ENG, V13, P965, DOI 10.1089/ten.2006.0299
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   Li Chun-hei, 2011, TISSUE ENG A, V17
   Li YY, 2014, ACTA BIOMATER, V10, P1919, DOI 10.1016/j.actbio.2014.01.002
   Meena C, 1999, P INDIAN AS-CHEM SCI, V111, P319
   MOON AG, 1993, AICHE J, V39, P163, DOI 10.1002/aic.690390116
   Morimoto Y, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054031
   Morimoto Y, 2009, BIOMED MICRODEVICES, V11, P369, DOI 10.1007/s10544-008-9243-y
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   OPHIR J, 1980, ULTRASONIC IMAGING, V2, P67, DOI 10.1016/0161-7346(80)90204-7
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Ramtani S, 2004, J BIOMECH, V37, P1709, DOI 10.1016/j.jbiomech.2004.01.028
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V54, P125, DOI 10.1016/S0939-6411(02)00046-2
   Tsuda Yukiko, 2010, 14 INT C MIN SYST CH
   Vrana NE, 2007, J BIOMAT SCI-POLYM E, V18, P1527
NR 26
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
J9 IEEE ENG MED BIO
PY 2016
BP 4220
EP 4223
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BH3NG
UT WOS:000399823504140
PM 28269214
DA 2018-10-20
ER

PT S
AU Kartikasari, N
   Yuliati, A
   Listiana, I
   Setijanto, D
   Suardita, K
   Ariani, MD
   Sosiawan, A
AF Kartikasari, Nadia
   Yuliati, Anita
   Listiana, Indah
   Setijanto, Darmawan
   Suardita, Ketut
   Ariani, Maretaningtyas Dwi
   Sosiawan, Agung
GP IEEE
TI Characteristic of Bovine Hydroxyapatite-Gelatin-Chitosan Scaffolds as
   Biomaterial Candidate for Bone Tissue Engineering
SO 2016 IEEE EMBS CONFERENCE ON BIOMEDICAL ENGINEERING AND SCIENCES
   (IECBES)
SE IEEE EMBS Conference on Biomedical Engineering and Sciences
LA English
DT Proceedings Paper
CT IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES)
CY DEC 04-08, 2016
CL Kuala Lumpur, MALAYSIA
SP IEEE EMBS, IEEE EMB Soc, Engn Med & Biol, IEEE EMBS Malaysia Chapter, Engn Med & Biol, Malaysia Convent & Exhibit Bur, IEEE Stand Assoc, IEEE Humanitarian Activities Comm, NAMAN Technol, Materialise, BioFit Technol & Serv, IEEE RIO Educ Activities, EMB
DE scaffolds; BHA-GEL-K; FTIR; SEM-EDX; swelling; degradation
AB Bone defect is still a major problem in dentistry. Solving this problem, tissue engineering becomes one of the promising methods for bone regeneration. One of main component of tissue engineering is scaffolds. Hydroxyapatite (HA) and natural polymer are widely used for scaffolds in bone tissue engineering due to similarity to the natural bone. In this study, the author prepared the scaffolds from bovine hydroxyapatite (BHA), gelatin (GEL) and chitosan (K). The prepared scaffolds were analyzed by using FTIR and SEM-EDX. In addition, its swelling and degradation rate are also included in this analysis. The results are (1) FTIR reveals the compositions of the scaffolds, and it consists of BHA, GEL, and K; (2) SEM-EDX reveals the elements of the scaffolds, and it consists of carbon (C), oxygen (0), natrium (Na), magnesium (Mg), phosphor (P), and calcium (Ca); (3) the scaffolds' swelling rate is good due to its hydrophilic composition; (4) and the degradation rate is low within three days. The four results show that the BHA-GEL-K scaffolds could be one of biomaterial candidate for bone tissue engineering.
C1 [Kartikasari, Nadia; Yuliati, Anita; Listiana, Indah; Setijanto, Darmawan; Suardita, Ketut; Ariani, Maretaningtyas Dwi; Sosiawan, Agung] Airlangga Univ, Fac Dent Med, Surabaya, Indonesia.
RP Kartikasari, N (reprint author), Airlangga Univ, Fac Dent Med, Surabaya, Indonesia.
EM nadiakartikasari88@gmail.com; nitaruslan@hotmail.com;
   indahkrisfkg@gmail.com; darmawansetijanto@g-mail.com;
   suardita@hotmail.com; etaprosto@yahoo.com; athaya2100@yahoo.com
CR Agustina S, 2015, JURNAL KIMIA, P271
   Alizadeh M, 2013, MAT SCI ENG C-MATER, V33, P3958, DOI 10.1016/j.msec.2013.05.039
   Berzina-Cimdina L., 2012, RES CALCIUM PHOSPHAT
   Costa-Pinto AR., 2011, TISSUE ENG PART B-RE, V17, P5
   Ferdiansyah D., 2011, JBP, V13, P3
   Kini U., 2012, PHYSL BONE FORMATION
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Lee J., 2014, J MAT CHEM B, V2
   Li S., 2011, STEM CELL TISSUE ENG, P8
   Mohamed KR, 2014, J ADV RES, V5, P201, DOI 10.1016/j.jare.2013.02.004
   Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038
   Peter M, 2010, CHEM ENG J, V158, P353, DOI 10.1016/j.cej.2010.02.003
   Rodriguez I., 2013, THESIS, P23
   Sadeghi D., 2013, J DENTAL SCH, V30
   Sobczak A., 2009, ACTA BIOENGINEERING, V11, P45
   Tangsadthakun C, 2006, J MET MAT MINER, V16, P37
   Wattanutchariya W., 2014, INT MULT ENG COMP SC, VII
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 18
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2374-3220
BN 978-1-4673-7791-1
J9 IEEE EMBS CONF BIO
PY 2016
BP 623
EP 626
PG 4
WC Engineering, Biomedical
SC Engineering
GA BH4SE
UT WOS:000400605700122
DA 2018-10-20
ER

PT B
AU Suharyadi, E
   Pardede, I
   Hasibuan, FA
AF Suharyadi, Edi
   Pardede, Indra
   Hasibuan, Ferawati A.
GP IEEE
TI Giant Magnetoresistance (GMR) Sensors Based on Co/Cu Multilayers for
   Biomaterial Detection Applications
SO 2016 PROGRESS IN ELECTROMAGNETICS RESEARCH SYMPOSIUM (PIERS)
LA English
DT Proceedings Paper
CT Progress in Electromagnetic Research Symposium (PIERS)
CY AUG 08-11, 2016
CL Shanghai, PEOPLES R CHINA
SP Electromagnet Acad, Tongji Univ, Tongji Univ, Depat Elect Sci & Technol, Nanjing Univ Sci & Technol, Shanghai Key Lab Electromagnet Environm Effects Aerosp Vehicle, Sci & Technol Electromagneti Scattering Lab, Univi Tunku Abdul Rahman, Dev & Res Acad Global Opt Neo Technol, Zhejiang Univ, Coll Informat Sci & Elect Engn, IEEE Geoscience & Remote Sensing Soc, Zhejiang Univ, Electromagnet Acad
ID BIOSENSORS
AB In this study, a potential biomaterial detection technology was successfully developed based on giant magnetoresistance (GMR) sensors. The GMR sensors were performed using [Co(1.5 nm)/Cu(x)](20) multilayer structures (x = 0.8, 0.9 and 1.0 nm) fabricated by DC magnetron sputtering. The X-ray diffraction (XRD) patterns showed that Co/Cu film multilayer has a high degree of crystallinity with a single peak correspond to face-centered cubic (111) structure at 2 theta = 44.1 degrees. Co/Cu multilayers exhibit soft magnetic behavior with the saturation magnetization (Ms) of 1416, 1463 and 1489 emu/cc and the coercivity (H-c) of 1.5, 1.6, and 112 Oe for x = 0.8, 0.9 and 1.0 nm, respectively. The magnetoresistance (MR) of Co/Cu was about 4.3%, 6.9% and 14.8% for x = 0.8, 0.9 and 1.0 nm, respectively. Furthermore, we used magnetite (Fe3O4) nanoparticles as a biomolecular label (nanotag) synthesized by coprecipitation method. XRD patterns and transmission electron microscopy (TEM) images showed that Fe3O4 had well crystallized and grow in their inverse spinel structure, highly uniform morphology with grain size of about 12 nm. The M-H loop of Fe(3)O(4)exhibit soft magnetic behavior with Ms of 77 emu/gram and Hc of 47 Oe. The GMR sensor design was used to detect a biomolecule such as formaldehyda and alpha-amylase enzyme with concentration 20 ppm captured using nanoparticles magnetite coated with polyethylene glycol (PEG) polymer for surface functionalization. Various applied magnetic field of 0-600 Gauss has been performed using electromagnetic with the various current of 0-4.5 A. Induction which cause a shift in MR ratio shown the best response with t(Cu) = 0.9 nm was about 18.3% and t(Cu) = 1.0 nm was about 4.7% for detection formaldehyda and alpha-amylase enzyme respectively. Furthermore, we present the linearly output signal and saturation signals in real time measurement from sensors. Based on this result, we can conclude that the combination of Co/Cu film multilayer, magnetite, and PEG polymer are potential in biodetection technology.
C1 [Suharyadi, Edi; Pardede, Indra; Hasibuan, Ferawati A.] Gadjah Mada Univ, Dept Phys, Sekip Utara BLS 21, Yogyakarta 55281, Indonesia.
RP Suharyadi, E (reprint author), Gadjah Mada Univ, Dept Phys, Sekip Utara BLS 21, Yogyakarta 55281, Indonesia.
FU PUPT [733/UNI-P.III/LT/DIT-LIT/2016]
FX Grant of PUPT, Minister of Research, Technology, and Higher Education,
   Indonesia, Contract number: 733/UNI-P.III/LT/DIT-LIT/2016.
CR Besse PA, 2002, APPL PHYS LETT, V80, P4199, DOI 10.1063/1.1483909
   Kasatkin SI, 2010, AUTOMAT REM CONTR+, V71, P156, DOI 10.1134/S0005117910010121
   Lee S, 2002, APPL PHYS LETT, V81, P3094, DOI 10.1063/1.1515122
   Li GX, 2006, SENSOR ACTUAT A-PHYS, V126, P98, DOI 10.1016/j.sna.2005.10.001
   Ma SC, 2000, J MAGN MAGN MATER, V209, P131, DOI 10.1016/S0304-8853(99)00666-6
   Miller MM, 2002, APPL PHYS LETT, V81, P2211, DOI 10.1063/1.1507832
   Rife JC, 2003, SENSOR ACTUAT A-PHYS, V107, P209, DOI 10.1016/S0924-4247(03)00380-7
   Wiesen K., 2003, APPL PHYS LETT, V39
NR 8
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-5090-6093-1
PY 2016
BP 566
EP 571
PG 6
WC Engineering, Electrical & Electronic
SC Engineering
GA BH3TZ
UT WOS:000400013900187
DA 2018-10-20
ER

PT S
AU Ibrahim, NF
   Mohamad, H
   Noor, SNFM
AF Ibrahim, Nurul Farhana
   Mohamad, Hasmaliza
   Noor, Siti Noor Fazliah Mohd
BE Das, KT
   Ismail, K
   Mohamad, D
   Noor, SNFM
   Razak, SRA
   Ramachandran, MR
   Azman, N
   Roslan, H
   Ngalim, SH
   Vuanghao, L
   Zubir, SA
TI Effects of Milling Media on The Fabrication of Melt-derived Bioactive
   Glass Powder for Biomaterial Application
SO TRANSLATIONAL CRANIOFACIAL CONFERENCE 2016, (TCC 2016)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 1st Translational Craniofacial Conference
CY AUG 09-11, 2016
CL Pinang, MALAYSIA
SP Adv Med & Dental Inst, Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Univ Sains Malaysia, Sch Dental Sci
DE melt-derived; glass powder; milling media
ID APATITE FORMATION; DECOMPOSITION; CERAMICS
AB The present work aims to study the effects of using different milling media on bioactive glass produced through melt-derived method for biomaterial application. The bioactive glass powder based on SiO2-CaO-Na2O-P2O5 system was fabricated using two different types of milling media which are tungsten carbide (WC) and zirconia (ZrO2) balls. However, in this work, no P2O5 was added in the new composition. XRF analysis indicated that tungsten trioxide (WO3) was observed in glass powder milled using WC balls whereas ZrO2 was observed in glass powder milled using ZrO2 balls. Amorphous structure was detected with no crystalline peak observed through XRD analysis for both glass powders. FTIR analysis confirmed the formation of silica network with the existence of functional groups Si-O-Si (bend), Si-O-Si (tetrahedral) and Si-O-Si (stretch) for both glass powders. The results revealed that there was no significant effect of milling media on amorphous silica network glass structure which shows that WC and zirconia can be used as milling media for bioactive glass fabrication without any contamination. Therefore, the fabricated BG can be tested safely for bioactivity assessment in biological fluids environment.
C1 [Ibrahim, Nurul Farhana; Mohamad, Hasmaliza] Univ Sains Malaysia, Biomat Res Niche Grp, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
   [Noor, Siti Noor Fazliah Mohd] Univ Sains Malaysia, Craniofacial & Biomat Sci Cluster, Adv Med & Dent Inst, Kepala Batas 13200, Pulau Pinang, Malaysia.
RP Ibrahim, NF (reprint author), Univ Sains Malaysia, Biomat Res Niche Grp, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
EM nf_ibrahim@yahoo.com; hasmaliza@usm.my; fazliah@usm.my
OI Mohd Noor, Siti Noor Fazliah/0000-0001-9200-265X
FU Ministry of Science, Technology and Industry (MOSTI) Malaysia
   [203.PBAHAN.6071282]; Ministry of Education Malaysia
FX The authors acknowledged the support from Ministry of Science,
   Technology and Industry (MOSTI) Malaysia through Science Fund Grant
   203.PBAHAN.6071282, Universiti Sains Malaysia for the equipment
   facilities and Ministry of Education Malaysia for MyPhd scholarship.
CR Abdellahi M, 2014, CERAM INT, V40, P16259, DOI 10.1016/j.ceramint.2014.07.063
   BELLUCCI D, 2014, SOL GEL DERIVED BIOA, V43, P573
   Bergs T., 2016, TOOL TECHNOLOGIES MI, V46, P299
   Broseghini M., 2016, MODELING PLANETARY B, V36, P2205
   Cheng JS, 2012, J NON-CRYST SOLIDS, V358, P3294, DOI 10.1016/j.jnoncrysol.2012.08.030
   D'Onofrio A, 2016, DENT MATER, V32, P703, DOI 10.1016/j.dental.2016.03.006
   Groh D, 2014, ACTA BIOMATER, V10, P4465, DOI 10.1016/j.actbio.2014.05.019
   Hannora E. A., 2015, SYNTHESIS LEAD BORAT, V429, P1
   Holzapfel M. B., 2013, SMART BIOMATERIALS N, V65, P581
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kumar S. R., 2012, EFFECT MOLYBDENUM DI, V66, P451
   Liao C. Y., 2012, GLASS FOAM MIXTURE R, V38, P4415
   Marghussian VK, 2000, CERAM INT, V26, P415, DOI 10.1016/S0272-8842(99)00072-3
   ODonnell D. M., 2010, MAT CHARACTERISATION, V20, P8934
   Orava J., 2016, FAST CRYSTAL GROWTH
   Ozarslan C. A., 2016, FABRICATION CHARACTE, V68, P350
   Rabiee S. M., 2015, EFFECT ION SUBSTITUT, V41, P7241
   Rezabeigi E, 2014, MAT SCI ENG C-MATER, V40, P248, DOI 10.1016/j.msec.2014.03.042
   Rohanova D, 2011, ACTA BIOMATER, V7, P2623, DOI 10.1016/j.actbio.2011.02.028
   Shah FA, 2015, MATER LETT, V153, P143, DOI 10.1016/j.matlet.2015.04.013
   Shankhwar N, 2016, MAT SCI ENG C-MATER, V62, P190, DOI 10.1016/j.msec.2016.01.054
   Srivastava A. K., 2012, CHARACTERIZATION CUO, V1, P2
   Yan ZQ, 2015, J ANAL APPL PYROL, V113, P491, DOI 10.1016/j.jaap.2015.03.019
   Zohra M. Fatima, 2013, REACTIVITY KINETICS, V361, P111
NR 24
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1455-6
J9 AIP CONF PROC
PY 2016
VL 1791
AR UNSP 020010
DI 10.1063/1.4968865
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BH2SD
UT WOS:000399212600010
OA Bronze
DA 2018-10-20
ER

PT S
AU Rahim, TNAT
   Abdullah, AM
   Akil, HM
   Mohamad, D
AF Rahim, Tuan Noraihan Azila Tuan
   Abdullah, Abdul Manaf
   Akil, Hazizan Md
   Mohamad, Dasmawati
BE Das, KT
   Ismail, K
   Mohamad, D
   Noor, SNFM
   Razak, SRA
   Ramachandran, MR
   Azman, N
   Roslan, H
   Ngalim, SH
   Vuanghao, L
   Zubir, SA
TI Comparison of mechanical properties for polyamide 12 composite-based
   biomaterials fabricated by fused filament fabrication and injection
   molding
SO TRANSLATIONAL CRANIOFACIAL CONFERENCE 2016, (TCC 2016)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 1st Translational Craniofacial Conference
CY AUG 09-11, 2016
CL Pinang, MALAYSIA
SP Adv Med & Dental Inst, Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Univ Sains Malaysia, Sch Dental Sci
ID POLYETHYLENE COMPOSITES; PARTICLE-SIZE; DEPOSITION; NANOCOMPOSITES
AB The emergence of 3D printing technology known as fused filament fabrication (FFF) has offered the possibility of producing an anatomically accurate, patient specific implant with more affordable prices. The only weakness of this technology is related to incompatibility and lack of properties of current material to be applied in biomedical. Therefore, this study aims to develop a new, polymer composite-based biomaterial that exhibits a high processability using FFF technique, strong enough and shows acceptable biocompatibility, and safe for biomedical use. Polyamide 12 (PA12), which meets all these requirements was incorporated with two bioceramic fillers, zirconia and hydroxyapatite in order to improve the mechanical and bioactivity properties. The obtained mechanical properties were compared with injection-molded specimens and also a commercial biomedical product, HAPEXTM which is composed of hydroxyapatite and polyethylene. The yield strength and modulus of the PA12 composites increased steadily with increasing filler loading. Although the strength of printed PA12 composites were reduced compared with injection molded specimen, but still higher than HAPEXTM material. The higher surface roughness obtained by printed PA12 was expected to enhance the cell adhesion and provide better implant fixation.
C1 [Rahim, Tuan Noraihan Azila Tuan; Akil, Hazizan Md] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Pulau Pinang, Malaysia.
   [Abdullah, Abdul Manaf; Mohamad, Dasmawati] Univ Sains Malaysia, Sch Dent Sci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.
RP Akil, HM (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Pulau Pinang, Malaysia.
EM hazizan@usm.my
RI abdullah, abdul manaf/I-3212-2017
OI Abdullah, Abdul Manaf/0000-0001-6080-7605
FU Universiti Sains Malaysia [1001/PPSG/852004]; MyBrain15 Program under
   the Ministry of Higher Education, Malaysia
FX The authors gratefully acknowledge Universiti Sains Malaysia for the
   financial support of RUT grant 1001/PPSG/852004. First and second
   authors are supported by MyBrain15 Program under the Ministry of Higher
   Education, Malaysia.
CR Afzal A, 2014, MATER EXPRESS, V4, P1, DOI 10.1166/mex.2014.1148
   Anderson JA, 2015, HB ORIENT ST SECT 3, V22, P1, DOI 10.1163/9789004282483_002
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Dul S, 2016, COMPOS PART A-APPL S, V85, P181, DOI 10.1016/j.compositesa.2016.03.013
   Hwang S, 2015, J ELECTRON MATER, V44, P771, DOI 10.1007/s11664-014-3425-6
   Juhasz JA, 2004, BIOMATERIALS, V25, P949, DOI 10.1016/j.biomaterials.2003.07.005
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Rocha CR, 2014, J MATER RES, V29, P1859, DOI 10.1557/jmr.2014.158
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Weng ZX, 2016, MATER DESIGN, V102, P276, DOI 10.1016/j.matdes.2016.04.045
   Zhong WH, 2001, MAT SCI ENG A-STRUCT, V301, P125, DOI 10.1016/S0921-5093(00)01810-4
   Zhou S, 2014, POLYM ENG SCI, V54, P1003, DOI 10.1002/pen.23636
NR 13
TC 0
Z9 0
U1 4
U2 7
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1455-6
J9 AIP CONF PROC
PY 2016
VL 1791
AR UNSP 020007
DI 10.1063/1.4968862
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BH2SD
UT WOS:000399212600007
OA Bronze
DA 2018-10-20
ER

PT S
AU Rodzi, SNHM
   Zuhailawati, H
AF Rodzi, Siti Nur Hazwani Mohamad
   Zuhailawati, Hussain
BE Das, KT
   Ismail, K
   Mohamad, D
   Noor, SNFM
   Razak, SRA
   Ramachandran, MR
   Azman, N
   Roslan, H
   Ngalim, SH
   Vuanghao, L
   Zubir, SA
TI The Effects of Processing Techniques on Magnesium-Based Composite
SO TRANSLATIONAL CRANIOFACIAL CONFERENCE 2016, (TCC 2016)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 1st Translational Craniofacial Conference
CY AUG 09-11, 2016
CL Pinang, MALAYSIA
SP Adv Med & Dental Inst, Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Univ Sains Malaysia, Sch Dental Sci
DE Magnesium based composite; Mechanical properties; Mechanical alloying
AB The aim of this study is to investigate the effect of processing techniques on the densification, hardness and compressive strength of Mg alloy and Mg-based composite for biomaterial application. The control sample (pure Mg) and Mg-based composite (Mg-Zn/HAp) were fabricated through mechanical alloying process using high energy planetary mill, whilst another Mg-Zn/HAp composite was fabricated through double step processing (the matrix Mg-Zn alloy was fabricated by planetary mill, subsequently HAp was dispersed by roll mill). Asmilled powder was then consolidated by cold press into 10 mm diameter pellet under 400 MPa compaction pressure before being sintered at 300 degrees C for 1 hour under the flow of argon. The densification of the sintered pellets were then determined by Archimedes principle. Mechanical properties of the sintered pellets were characterized by microhardness and compression test. The results show that the density of the pellets was significantly increased by addition of HAp, but the most optimum density was observed when the sample was fabricated through double step processing (1.8046 g/cm(3)). Slight increment in hardness and ultimate compressive strength were observed for Mg-Zn/HAp composite that was fabricated through double step processing (58.09 HV, 132.19 MPa), as compared to Mg-Zn/HAp produced through single step processing (47.18 HV, 122.49 MPa).
C1 [Rodzi, Siti Nur Hazwani Mohamad; Zuhailawati, Hussain] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Struct Mat Niche Area, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.
RP Zuhailawati, H (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Struct Mat Niche Area, Engn Campus, Nibong Tebal 14300, Penang, Malaysia.
EM zuhaila@usm.my
FU Universiti Sains Malaysia [203/PBAHAN/6071304]
FX The authors would like to thank to Universiti Sains Malaysia for FRGS
   Grant No. 203/PBAHAN/6071304.
CR Mezbahul-Islam M., 2014, J MAT, V2014, P1
   Omar MF, 2013, MATER DESIGN, V45, P539, DOI 10.1016/j.matdes.2012.09.026
   Salleh EM, 2015, J ALLOY COMPD, V644, P476, DOI 10.1016/j.jallcom.2015.04.090
   Suryanarayana C, 2001, MAT SCI ENG A-STRUCT, V304, P151, DOI 10.1016/S0921-5093(00)01465-9
   Yang YW, 2016, MATERIALS, V9, DOI 10.3390/ma9040216
NR 5
TC 0
Z9 0
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1455-6
J9 AIP CONF PROC
PY 2016
VL 1791
AR UNSP 020022
DI 10.1063/1.4968877
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BH2SD
UT WOS:000399212600022
OA Bronze
DA 2018-10-20
ER

PT J
AU Kumbhar, SG
   Pawar, SH
AF Kumbhar, Sneha G.
   Pawar, S. H.
TI Synthesis and characterization of chitosan-alginate scaffolds for
   seeding human umbilical cord derived mesenchymal stem cells
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Alginate; biodegradable scaffolds; chitosan; mesenchymal stem cells;
   tissue engineering
ID IN-VITRO; DIFFERENTIATION; TISSUES; MARROW
AB BACKGROUND: Chitosan and alginate are two natural and accessible polymers that are known to be biocompatible, biodegradable and possesses good antimicrobial activity. When combined, they exhibit desirable characteristics and can be created into a scaffold for cell culture.
   OBJECTIVE: In this study interaction of chitosan-alginate scaffolds with mesenchymal stem cells are studied.
   METHODS: Mesenchymal stem cells were derived from human umbilical cord tissues, characterized by flow cytometry and other growth parameters studied as well. Proliferation and viability of cultured cells were studied by MTT Assay and Trypan Blue dye exclusion assay.
   RESULTS: Besides chitosan-alginate scaffold was prepared by freeze-drying method and characterized by FTIR, SEM and Rheological properties. The obtained 3D porous structure allowed very efficient seeding of hUMSCs that are able to inhabit the whole volume of the scaffold, showing good adhesion and proliferation. These materials showed desirable rheological properties for facile injection as tissue scaffolds.
   CONCLUSION: The results of this study demonstrated that chitosan-alginate scaffold may be promising biomaterial in the field of tissue engineering, which is currently under a great deal of examination for the development and/or restoration of tissue and organs. It combines the stem cell therapy and biomaterials.
C1 [Kumbhar, Sneha G.; Pawar, S. H.] DY Patil Univ, Ctr Interdisciplinary Res, Maharashtra State Highway 277,Line Bazar, Kolhapur 416006, Maharashtra, India.
RP Pawar, SH (reprint author), DY Patil Univ, Ctr Interdisciplinary Res, Maharashtra State Highway 277,Line Bazar, Kolhapur 416006, Maharashtra, India.
EM ksneha.22@gmail.com; Shpawar1946@gmail.com
CR Chen A., 2009, ENG TECHNOLOGY
   Coimbra P, 2011, INT J BIOL MACROMOL, V48, P112, DOI 10.1016/j.ijbiomac.2010.10.006
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Cruz DMG, 2010, J BIOMED MATER RES A, V95A, P1182, DOI 10.1002/jbm.a.32906
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6
   Martin I, 1997, IEEE ENG MED BIOL, V16, P73, DOI 10.1109/51.582179
   Norazril S A H, 2004, Med J Malaysia, V59 Suppl B, P186
   Paunescu V, 2007, J CELL MOL MED, V11, P502, DOI 10.1111/j.1582-4934.2007.00041.x
   Penolazzi L, 2012, J CELL PHYSIOL, V227, P857, DOI 10.1002/jcp.22983
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   RYKKE M, 1990, SCAND J DENT RES, V98, P401
   Schugar RC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/789526
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang Q., PLGA CHITOSAN PLGA A
   Whu SW, 2009, J MED BIOL ENG, V29, P52
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
NR 22
TC 3
Z9 3
U1 1
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2016
VL 27
IS 6
BP 561
EP 575
DI 10.3233/BME-161609
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EN1EX
UT WOS:000395754400002
PM 28234241
DA 2018-10-20
ER

PT J
AU Ramrakhiani, L
   Ghosh, S
   Sarkar, S
   Majumdar, S
AF Ramrakhiani, Lata
   Ghosh, Sourja
   Sarkar, Subhendu
   Majumdar, Swachchha
TI Heavy metal biosorption in multi component system on dried activated
   sludge: investigation of adsorption mechanism by surface
   characterization
SO MATERIALS TODAY-PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Advances in Bioprocess Engineering and
   Technology (ICABET)
CY JAN 20-22, 2016
CL Kolkata, INDIA
DE Heavy metal; biosorption mechanism; chemical pretreatment; FTIR; XPS
ID HEXAVALENT CHROMIUM; FUNGAL BIOMASS; REMOVAL; ZN(II); CU(II);
   PERFORMANCES; CR(VI); PB(II); LIVE; RAW
AB The dried activated sludge collected from STP- Kolkata Municipal Corporation and Tannery industry, leather complex, Kolkata were used as complex biosorbent for removal of heavy metals. The metal ion concentrations were measured using ion chromatography. The adsorption efficiency with respect to time was performed; the Zn (II) and Cd (II) showed 99% removals within 10 min while Ni (II) and Co (II) attained 98% removal at 20-24 h of contact time both in single and multi metal system. The elucidation of the mechanism of biosorption is necessary to enable the technology to be developed. Mechanism of biosorption of Ni (II), Cd (II), Co (II) and Zn (II) in multi metal removal system was studied by the characterization of the structure and surface chemistry of biomaterial using functional group modification, FT-IR, FESEM-EDX and XPS analysis. FT-IR spectra of before and after multiple metal uptake revealed that the functional groups (amino, carboxylic, hydroxyl, phosphate, sulfonyl and carbonyl) present on surface of the biomaterial were involved in the biosorption process. The wide scanning XPS spectra for dried tannery sludge after biosorption of multi metals showed peaks of Cd, Zn, Ni and Co. The deconvolution of peaks C1s spectra and N1s spectra assigned to C atoms in form of C-C, C-O, O-C-O, O-C=O and N atom in the R-NH2, R-NH3+ group. Change in the peak pattern and shift in the binding energies confirm the involvement of these functional groups.
C1 [Ramrakhiani, Lata; Ghosh, Sourja; Sarkar, Subhendu; Majumdar, Swachchha] CSIR Cent Glass & Ceram Res Inst, Ceram Membrane Div, 196 Raja SC Mullick Rd, Kolkata 700032, India.
RP Ghosh, S (reprint author), CSIR Cent Glass & Ceram Res Inst, Ceram Membrane Div, 196 Raja SC Mullick Rd, Kolkata 700032, India.
EM lata_ram@hotmail.com; sourja@cgcri.res.in
FU Department of Science and Technology (DST), Government of India
   [SR/WOS-A/CS-15/2014]
FX The financial support from the Department of Science and Technology
   (DST), Government of India vide grant no. SR/WOS-A/CS-15/2014 dated
   08.08.2014 is gratefully acknowledged.
CR Arief VO, 2008, CLEAN-SOIL AIR WATER, V36, P937, DOI 10.1002/clen.200800167
   Bai RS, 2002, WATER RES, V36, P1224, DOI 10.1016/S0043-1354(01)00330-X
   Bayramoglu G, 2005, J HAZARD MATER, V119, P219, DOI 10.1016/j.jhazmat.2004.12.022
   Bhatti HN, 2009, CHEM ENG J, V148, P434, DOI 10.1016/j.cej.2008.09.028
   Boota R, 2009, SEP SCI TECHNOL, V44, P4000, DOI 10.1080/01496390903183196
   Bulgariu L., 2014, J BIOPROCESS BIOTECH, V4, P146, DOI [10.4172/2155-9821.1000146, DOI 10.4172/2155-9821.1000146]
   Bulgariu L, 2011, SEP SCI TECHNOL, V46, P1023, DOI 10.1080/01496395.2010.536192
   Chen GQ, 2012, ENVIRON TECHNOL, V33, P2653, DOI 10.1080/09593330.2012.673015
   Chen JP, 2006, LANGMUIR, V22, P8906, DOI 10.1021/la060770+
   Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087
   Drake LR, 1996, ENVIRON SCI TECHNOL, V30, P110, DOI 10.1021/es950131d
   Gardea-Torresdey J. L., 1995, P 10 ANN C HAZ WAST
   Gardea-Torresdey J. L., P 1998 C HAZ WAST RE
   Gupta VK, 2008, J HAZARD MATER, V152, P407, DOI 10.1016/j.jhazmat.2007.07.028
   He JS, 2014, BIORESOURCE TECHNOL, V160, P67, DOI 10.1016/j.biortech.2014.01.068
   Kapoor A, 1998, BIORESOURCE TECHNOL, V63, P109, DOI 10.1016/S0960-8524(97)00118-1
   Lata Ramrakhiani, 2012, International Journal of Integrative Sciences, Innovation and Technology (IJIIT), V1, P7
   Li HF, 2010, J HAZARD MATER, V179, P151, DOI 10.1016/j.jhazmat.2010.02.072
   Liu HJ, 2011, WATER RES, V45, P145, DOI 10.1016/j.watres.2010.08.017
   Areco MM, 2012, J HAZARD MATER, V213, P123, DOI 10.1016/j.jhazmat.2012.01.073
   Nascente PAP, 2005, J MOL CATAL A-CHEM, V228, P145, DOI 10.1016/j.molcata.2004.09.075
   Ofudje EA, 2015, BIORESOURCES, V10, P3462, DOI 10.15376/biores.10.2.3462-3480
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Paulino A. L. G., 2013, WATER TREAT, P1
   Ramrakhiani L, 2011, CHEM ENG J, V171, P1060, DOI 10.1016/j.cej.2011.05.002
   Reddy DHK, 2012, CARBOHYD POLYM, V88, P1077, DOI 10.1016/j.carbpol.2012.01.073
   Shukla PM, 2013, SEP SCI TECHNOL, V48, P421, DOI 10.1080/01496395.2012.691933
   Tunali S, 2005, MINER ENG, V18, P681, DOI 10.1016/j.mineng.2004.11.002
   Vieira RS, 2011, COLLOID SURFACE A, V374, P108, DOI 10.1016/j.colsurfa.2010.11.022
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
   Xia L, 2015, INT J MOL SCI, V16, P15670, DOI 10.3390/ijms160715670
NR 31
TC 3
Z9 3
U1 4
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-7853
J9 MATER TODAY-PROC
JI Mater. Today-Proc.
PY 2016
VL 3
IS 10
BP 3538
EP 3552
DI 10.1016/j.matpr.2016.10.036
PN A
PG 15
GA ER0XK
UT WOS:000398511500037
DA 2018-10-20
ER

PT J
AU Braune, S
   Basu, S
   Kratz, K
   Johansson, JB
   Reinthaler, M
   Lendlein, A
   Jung, F
AF Braune, S.
   Basu, S.
   Kratz, K.
   Johansson, J. Baeckemo
   Reinthaler, M.
   Lendlein, A.
   Jung, F.
TI Strategy for the hemocompatibility testing of microparticles
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterial; polymer; microparticle; thrombogenicity; hemocompatibility;
   dynamic in-vitro test
ID POLY(ETHER IMIDE) MICROPARTICLES; IN-VITRO HEMOCOMPATIBILITY;
   PLATELET-FUNCTION; SURFACE-ROUGHNESS; AIR EXPOSURE; ADSORPTION;
   RECOMMENDATIONS; BIOMATERIALS; ACTIVATION; MEMBRANES
AB Polymer-based microparticles are applied as non-thrombogenic or thrombogenic materials in a wide variety of intra-or extra-corporeal medical devices. As demanded by the regulatory agencies, the hemocompatibility of these blood contacting biomaterials has to be evaluated in vitro to ensure that the particle systems appropriately fulfill the envisioned function without causing undesired events such as thrombosis or inflammation. Currently described in vitro assays for hemocompatibility testing of particles comprise tests with different single cell types (e.g. erythrocytes or leukocytes), varying concentrations/dilutions of the used blood cells or whole blood, which are not standardized.
   Here, we report about an in vitro dynamic test system for studying the hemocompatibility of polymeric microparticles utilizing fresh human whole blood from apparently healthy subjects, collected and processed under standardized conditions. Spherical poly(ether imide) microparticles with an average diameter of 140 +/- 30 mu m were utilized as model systems. Reported as candidate materials for the removal of uremic toxins, these microparticles are anticipated to facilitate optimal flow conditions in a dialyzer with minimal backflow and blood cell damage. Pristine (PEI) and potassium hydroxide (PEI-KOH) functionalized microparticles exhibited similarly nanoporous surfaces (PEI: (empty set)(External pore) = 90 +/- 60 nm; PEI-KOH (empty set)(External pore) = 150 +/- 130 nm) but varying water wettabilities (PEI:theta(adv) = 112 +/- 10 degrees PEI-KOH theta(adv) = 60 +/- 2 degrees). The nanoporosity of the microparticle surfaces allows the exchange of toxic solutes from blood towards the interconnective pores in the particle core, while an immigration of the substantially larger blood cells is inhibited.
   Sterilized PEI microparticles were incorporated - air-free - in a syringe-based test system and exposed to whole blood for 60 minutes under gentle agitation. Thereafter, thrombi formation on the particles surfaces were analyzed microscopically. In the collected whole blood the non-adherent/circulating single blood cells were quantified via a differentiated complete blood cell count and the activation of platelets (P-Selectin expression, secretion and release), platelet function (PFA100 closure time) as well as thrombin formation (thrombin-antithrombin-complex) was analyzed. Free hemoglobin (HGB) levels were quantified as a measure of hemolysis.
   Microscopic evaluation revealed thrombi formation and particle aggregates for all tested microparticles. Reduction of circulating blood cells differed significantly between the particle types. Particularly, platelet and monocyte counts decreased up to 50% compared to the control (syringe filled with whole blood but without microparticles). In accordance, platelet activation, thrombin levels and degrees of hemolysis were clearly elevated in the particle loaded test systems and allowed a differentiation between the particle types. Increased PFA100 closure times (as activating agent a combination of collagen/ADP was used) indicated a similarly reduced ability of platelets to adhere and form stable aggregates independent from the particle type tested. This observation is most probably a consequence of the strong thrombus formation in the test system, which is associated with a reduction of the circulating blood cells.
   The reported in vitro dynamic whole blood test system allowed the sensitive analysis of the hemocompatibility of polymer-based microparticles and was successfully validated for porous PEI microparticles with different water wettabilities. Beyond the qualitative and quantitative analysis of cell-material interactions, the test also allowed the functional evaluation of platelets in whole blood.
C1 [Braune, S.; Basu, S.; Kratz, K.; Johansson, J. Baeckemo; Reinthaler, M.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
   [Braune, S.; Basu, S.; Kratz, K.; Johansson, J. Baeckemo; Reinthaler, M.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Kantstr 55, D-14513 Teltow, Germany.
   [Basu, S.; Lendlein, A.] Univ Potsdam, Inst Chem, Potsdam, Germany.
   [Reinthaler, M.] Charite, Campus Benjamin Franklin, Dept Cardiol, Berlin, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.; Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Kantstr 55, D-14513 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Lendlein, Andreas/K-9553-2013; Jung, Friedrich/L-1301-2013; Braune,
   Steffen/D-2315-2015; Kratz, Karl/K-7115-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Jung,
   Friedrich/0000-0001-8098-7180; Kratz, Karl/0000-0002-9229-4266
FU Federal Ministry of Education and Research, Germany [13GW0098];
   Indo-German Science and Technology Centre (BMBF) [01DQ13006B]
FX The authors thank the Federal Ministry of Education and Research,
   Germany, for funding through the Program Health Research (Grant No.
   13GW0098) and through the Indo-German Science and Technology Centre
   (BMBF Grant No. 01DQ13006B). The authors acknowledge the experimental
   assistance by Mr. Mario Rettschlag and characterization support by Ms.
   Yvonne Pieper.
CR Anonymous, 2016, CLIN HEMORHEOL MICRO, V63, P1
   Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]
   Basu S, 2015, POLYM ADVAN TECHNOL, V26, P1447, DOI 10.1002/pat.3684
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Braune S, 2016, J BIOMED MATER RES B, V104, P210, DOI 10.1002/jbm.b.33366
   Braune S, 2014, CLIN HEMORHEOL MICRO, V58, P159, DOI 10.3233/CH-141876
   Braune S, 2013, CLIN HEMORHEOL MICRO, V54, P235, DOI 10.3233/CH-131729
   Cattaneo M, 2013, J THROMB HAEMOST, V11, P1183, DOI 10.1111/jth.12231
   Cheah W.K., 2016, J BIOMED MAT RES B
   De Oliveira S, 2012, BBA-BIOMEMBRANES, V1818, P481, DOI 10.1016/j.bbamem.2011.10.028
   El-Sabbagh AM, 2013, ASAIO J, V59, P474, DOI 10.1097/MAT.0b013e31829f0e6e
   Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P709, DOI 10.1055/s-0029-1145254
   Freynhofer MK, 2015, THROMB HAEMOSTASIS, V114, P459, DOI 10.1160/TH15-02-0179
   Geis S, 2016, CLIN HEMORHEOL MICRO, V62, P205, DOI 10.3233/CH-151964
   Gester K, 2016, ARTIF ORGANS, V40, P201, DOI 10.1111/aor.12516
   Giovanetti Thayse Vanessa, 2011, Rev. Bras. Hematol. Hemoter., V33, P164, DOI 10.5581/1516-8484.20110040
   Gu L, 2016, NAT REV CANCER, V16, P56, DOI 10.1038/nrc.2015.3
   Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051
   Harrison P, 2011, BRIT J HAEMATOL, V155, P30, DOI 10.1111/j.1365-2141.2011.08793.x
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Jung F, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4938557
   Kaito K, 2005, BRIT J HAEMATOL, V128, P698, DOI 10.1111/j.1365-2141.2004.05357.x
   Kaliviotis E, 2016, CLIN HEMORHEOL MICRO, V63, P123, DOI 10.3233/CH-151980
   Kumar RK, 2016, CLIN HEMORHEOL MICRO, V61, P667, DOI 10.3233/CH-152027
   Kuroda K, 2009, CHEM-EUR J, V15, P1123, DOI 10.1002/chem.200801523
   Linneweber J, 2007, ARTIF ORGANS, V31, P345, DOI 10.1111/j.1525-1594.2007.00391.x
   Lippi G., SYSTEMATIC ASSESSMEN
   Liu XL, 2014, J MATER CHEM B, V2, P5718, DOI 10.1039/c4tb00881b
   Lordkipanidze M, 2016, SEMIN THROMB HEMOST, V42, P258, DOI 10.1055/s-0035-1564834
   Neffe AT, 2014, J MATER CHEM B, V2, P3626, DOI 10.1039/c4tb00184b
   Neffe AT, 2013, EXPERT REV MED DEVIC, V10, P813, DOI 10.1586/17434440.2013.839209
   Pohlmann JR, 2009, ASAIO J, V55, P469, DOI 10.1097/MAT.0b013e3181b28a5a
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Reviakine I., 2016, BLOOD REV IN PRESS, DOI [10.1002/jbm.b.33475, DOI 10.1002/JBM.B.33475]
   Serda RE, 2013, INT J NANOMED, V8, P1683, DOI 10.2147/IJN.S31756
   Shi J, 2012, ACTA BIOMATER, V8, P3478, DOI 10.1016/j.actbio.2012.04.024
   Sovadinova I, 2011, BIOMACROMOLECULES, V12, P260, DOI 10.1021/bm1011739
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Takada K, 2014, INT HEART J, V55, P228, DOI 10.1536/ihj.13-295
   Tetali SD, 2016, CLIN HEMORHEOL MICRO, V61, P657, DOI 10.3233/CH-152026
   Thyparambil AA, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4906485
   Tschulena U., 2015, ADSORBER GRANULES RE
   Vienken J, 2010, MATERIALWISS WERKST, V41, P1081, DOI 10.1002/mawe.201000712
   Wendel HP, 2000, BIOMED TECH, V45, P282, DOI 10.1515/bmte.2000.45.10.282
   Wykrzykowska JJ, 2009, J THROMB THROMBOLYS, V28, P410, DOI 10.1007/s11239-009-0354-y
   Zwart A, 1996, J CLIN PATHOL, V49, P271, DOI 10.1136/jcp.49.4.271
NR 46
TC 2
Z9 2
U1 1
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2016
VL 64
IS 3
BP 345
EP 353
DI 10.3233/CH-168114
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA EN2FO
UT WOS:000395825400011
PM 27886001
DA 2018-10-20
ER

PT J
AU Bojar, W
   Kucharska, M
   Ciach, T
   Pasnik, I
   Korobowicz, E
   Patkowski, K
   Gruszecki, T
   Szymanowski, M
   Rzodkiewicz, P
AF Bojar, Witold
   Kucharska, Martyna
   Ciach, Tomasz
   Pasnik, Iwona
   Korobowicz, Elzbieta
   Patkowski, Krzysztof
   Gruszecki, Tomasz
   Szymanowski, Marek
   Rzodkiewicz, Przemyslaw
TI IN VIVO PERFORMANCE OF THE EXPERIMENTAL CHITOSAN BASED BONE SUBSTITUTE -
   ADVANCED THERAPY MEDICINAL PRODUCT. A STUDY IN SHEEP
SO ACTA POLONIAE PHARMACEUTICA
LA English
DT Article
DE alginate bone substitute material; chilosan; guided bone regeneration;
   beta-tricalcium phosphate; sheep model; stem cells
ID SINUS AUGMENTATION; MAXILLARY SINUS; BOVINE BONE; STEM-CELLS; IMPLANTS;
   REGENERATION
AB When evaluating a novel bone substitute material, advanced in viva testing is an important step in development and safety affirmation. Sheep seems to be a valuable model for human hone turnover and remod-eling activity. The experimental material composed with the stem cells is an advanced therapy medicinal prod-uct (ace, to EC Regulation 1394/2007). Our research focuses on histological differences in hone formation (guided bone regeneration - GBR) in sheep maxillas after implantation of the new chitosan / tricalcium phos-phate / alginate (CH/TCP/Alg) biomaterial in comparison to the commercially available xenogenic bone graft and a/m enhanced with the stem cells isolated from the adipose tissue. Twelve adult female sheep of BCP syn-thetic line, weighing 60-70 kg were used for the study. The It mm diameter defects in maxilla bone were pre-pared with a trephine bur under general anesthesia and then filled with the bone substitute materials: CH/TCP/Alg, BioOss Collagen, Geistlich AG (BO), CH/TCP/Alg composed with the stem cells (CH/S) or left just with the blood clot (BC). Inbreeding cycle of the animals terminated at 4 months after surgery. Dissected specimens of the maxilla were evaluated histologically and preliminary under nticrotomography. Histological evaluation showed early new bone formation observed around the experimental biomaterial and commercially available BO. There were no features of purulent inflammation and necrosis, or granulomalous inflammation. Microscopic examination after 4 months following the surgery revealed trabecular bone formation around chi-tosan based bone graft and xenogenic material with no significant inflammatory response. Different results no hone recreation were observed for the negative control (BC). In conclusion, the tested materials (CH/TCP/Alg and BO) showed a high degree of biocompatibility and some osteoconductivity in comparison with the control group. Although the handiness, granules size and setting time of CH/TCP/Alg may be refined for future clini-cal tests. The relevant beneficial influence of using the adipose derived stem cells in GBR was not confirmed in this model.
C1 [Bojar, Witold] Natl Med Inst, Med Devices Dept, Chelmska 30-34, PL-00725 Warsaw, Poland.
   [Kucharska, Martyna] Warsaw Univ Technol, Polish Acad Sci, Inst Fundamental Technol Res, Engn Lab,Fac Chem & Proc Engn, PL-00661 Warsaw, Poland.
   [Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00661 Warsaw, Poland.
   [Pasnik, Iwona; Korobowicz, Elzbieta] Med Univ Lublin, Dept Clin Pathomorfol, Lublin, Poland.
   [Patkowski, Krzysztof; Gruszecki, Tomasz; Szymanowski, Marek] Univ Life Sci, Fac Biol & Anim Breeding, Lublin, Poland.
   [Rzodkiewicz, Przemyslaw] Inst Rheumatol, Dept Biochem & Mol Biol, Warsaw, Poland.
   [Rzodkiewicz, Przemyslaw] Med Univ Warsaw, Dept Gen & Expt Pathol, Warsaw, Poland.
RP Bojar, W (reprint author), Natl Med Inst, Med Devices Dept, Chelmska 30-34, PL-00725 Warsaw, Poland.
EM w.bojar@nil.gov.pl
OI Rzodkiewicz, Przemyslaw/0000-0002-3799-9204; Ciach,
   Tomasz/0000-0002-8726-8944
CR Aaboc M., 2000, CLIN ORAL IMPLAN RES, V11, P422
   Artzi Z, 2001, INT J PERIODONT REST, V21, P395
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Bojar W, 2014, J BIOMATER APPL, V28, P1060, DOI 10.1177/0885328213493682
   Bojar W, 2012, ACTA BIOENG BIOMECH, V14, P39
   Brandi F., 2008, BIOMATERIALS, V28, P134
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Ciechowicz K, 2002, PROT STOM, V52, P273
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Estaca E, 2008, CLIN ORAL IMPLAN RES, V19, P1044, DOI 10.1111/j.1600-0501.2008.01557.x
   Horovitz RA, 2009, TITANIUM, V1, P1
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kozakiewicz M, 2009, DENT MED PROBL, V46, P384
   Kozlik M, 2011, DENT MED PROBL, V48, P547
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kuo SM, 2009, J APPL POLYM SCI, V112, P3127, DOI 10.1002/app.29664
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lukomska-Symanska M, 2010, FOLIA HISTOCHEM CYTO, V48, P339, DOI 10.2478/v10042-10-0050-y
   Maiorana C, 2000, INT J ORAL MAX IMPL, V15, P873
   Markowska J., 2005, POLIM MED, V35, P1
   Mendonca T.A., 2008, BRAZ ORAL RES, V22, P5
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Pagni G, 2012, INT J DENT, DOI 10.1155/2012/151030
   Paknejad M, 2008, IMPLANT DENT, V17, P471, DOI 10.1097/ID.0b013e3181815596
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Vlaminck L, 2008, IMPLANT DENT, V17, P439, DOI 10.1097/ID.0b013e31818c5c18
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Wojtowicz A, 2013, DENT MED PROBL, V50, P20
NR 34
TC 1
Z9 1
U1 0
U2 2
PU POLSKIE TOWARZYSTWO FARMACEUTYCZNE
PI WARSAW
PA DLUGA 16, 00-238 WARSAW, POLAND
SN 0001-6837
EI 2353-5288
J9 ACTA POL PHARM
JI ACTA POL. PHARM.
PD JAN-FEB
PY 2016
VL 73
IS 1
BP 209
EP 217
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EL1XB
UT WOS:000394413600021
PM 27008815
DA 2018-10-20
ER

PT J
AU Rougerie, P
   Pieuchot, L
   Pontes, B
   de Sa, F
   Sgambato, N
   Bigerelle, M
   Viana, NB
   Anselme, K
   de Souza, MF
AF Rougerie, P.
   Pieuchot, L.
   Pontes, B.
   de Sa, F.
   Sgambato, N.
   Bigerelle, M.
   Bessa Viana, N.
   Anselme, K.
   Farina de Souza, M.
TI Single-cell and collective geometry sensing of biomaterial surfaces with
   micron-scale, smoothly curved topologies
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Cell-Biology (ASCB)
CY DEC 03-07, 2016
CL San Francisco, CA
SP Amer Soc Cell Biol
C1 [Rougerie, P.; de Sa, F.; Sgambato, N.; Farina de Souza, M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Pieuchot, L.; Anselme, K.] Univ Haute Alsace, Inst Sci Mat Mulhouse, Mulhouse, France.
   [Pontes, B.; Bessa Viana, N.] Univ Fed Rio de Janeiro, Inst Fis, Rio De Janeiro, Brazil.
   [Bigerelle, M.] Univ Valenciennes & Hainaut Cambresis, Dept Mecan, Valenciennes, France.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2016
VL 27
MA P2287
PG 1
WC Cell Biology
SC Cell Biology
GA EN5LO
UT WOS:000396047200587
DA 2018-10-20
ER

PT J
AU Schulz, C
   Vukicevic, R
   Kruger-Genge, A
   Neffe, AT
   Lendlein, A
   Jung, F
AF Schulz, Christian
   Vukicevic, Radovan
   Krueger-Genge, Anne
   Neffe, Axel T.
   Lendlein, Andreas
   Jung, Friedrich
TI Monolayer formation and shearresistance of human vein endothelial cells
   on gelatin-based hydrogels with tailorable elasticity and degradability
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Endothelial cells; biomaterial; gelatin; hydrogel; shear stress
ID IN-VITRO; SHEAR-STRESS; BIOMATERIALS; ADHESION; RELEASE; THROMBOXANE-A2;
   STRATEGIES; INDUCTION; MODULATE; FILMS
AB The formation of a functionally-confluent and shear-resistant endothelial cell (EC) monolayer on cardiovascular implants is a promising strategy to prevent thrombogenic processes after implantation. On the basis of existing studies with arterial endothelial cells adhering after two hours on gelatin-based hydrogels in marked higher numbers compared to tissue culture plates, we hypothesized that also venous endothelial cells (HUVEC) should be able to adhere and form an endothelial monolayer on these hydrogels after days. Furthermore, variation of the hydrogel composition, which slightly influences the materials elasticity and even more the degradation behaviour, should have no considerable effect on HUVEC. Therefore, the monolayer formation and shear resistance of HUVEC were explored on two gelatin-based hydrogels differing in their elasticity (Young's moduli between 35 and 55 kPa) in comparison to a positive control (HUVEC on glass cover slips) and a negative control (HUVEC on glass cover slips activated with interleukin-1 beta) after 9 days of culturing. HUVEC density after 9 days of culturing under static conditions was lower on the hydrogels compared to both controls (p < 0.05 each). On G10 LNCO8 slightly more EC adhered than on G10 LNCO5. Staining of the actin cytoskeleton and VE-cadherin revealed a pronounced cell- substrate interaction while the cell- cell interaction was comparable to the controls (HUVEC on glass). The secretion of vasoactive and inflammatory mediators did not differ between the hydrogels and the controls. Adherent HUVEC seeded on the hydrogels were able to resist physiological shear forces and the release of cyto-and chemokines in response to the shear forces did not differ from controls (HUVEC on glass). Therefore, both gelatin-based hydrogels are a suitable substrate for EC and a promising candidate for cardiovascular applications.
C1 [Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
   [Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Kantstr 55, D-14513 Teltow, Germany.
RP Lendlein, A; Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.; Lendlein, A; Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de; friedrich.jung@hzg.de
RI Jung, Friedrich/L-1301-2013; Neffe, Axel/H-6997-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Neffe, Axel/0000-0002-5056-3990;
   Lendlein, Andreas/0000-0003-4126-4670
FU Helmholtz Association
FX This work was funded by the Helmholtz Association through
   Helmholtz-Portfolio Topic "Technology and Medicine" and through
   programme-orientated funding. The Authors thank J. Reinert and A.
   Ritschel for their technical assistance and measurements.
CR ALLY AI, 1980, PROSTAG LEUKOTR ESS, V4, P431, DOI 10.1016/0161-4630(80)90051-8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arbogast H P, 2005, Hamostaseologie, V25, P394
   Avci-Adali M, 2013, PATHOBIOLOGY, V80, P176, DOI 10.1159/000347222
   Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737
   De Mel A., 2012, INT J BIOMATER, V2012
   Dobrowolski S, 2007, SURG TODAY, V37, P831, DOI 10.1007/s00595-007-3511-y
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   HECKER M, 1993, AM J PHYSIOL, V265, pH828
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Inoue M, 2013, J BIOMED MATER RES A, V101, P2049, DOI 10.1002/jbm.a.34488
   Jensen N., 1991, VASA, V21, P365
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369
   Liu T, 2014, J BIOMED MATER RES A, V102, P3754, DOI 10.1002/jbm.a.35025
   Melchiorri AJ, 2015, BIOMACROMOLECULES, V16, P437, DOI 10.1021/bm501853s
   Meyers SR, 2012, CHEM REV, V112, P1615, DOI 10.1021/cr2000916
   Neffe AT, 2013, MRS ONLINE P LIBR, V1569, P3
   Nilsen EM, 1998, GUT, V42, P635, DOI 10.1136/gut.42.5.635
   Niu QX, 2008, CLIN EXP PHARMACOL P, V35, P89, DOI 10.1111/j.1440-1681.2007.04755.x
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Patel S D, 2010, Ther Adv Cardiovasc Dis, V4, P129, DOI 10.1177/1753944710362903
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Schonwalder SMS, 2014, BIOMACROMOLECULES, V15, P2398, DOI 10.1021/bm500750v
   Schopka S, 2010, MATERIALS, V3, P638, DOI 10.3390/ma3010638
   Schulz C, 2014, CLIN HEMORHEOL MICRO, V57, P147, DOI 10.3233/CH-141826
   Sirova M, 2014, J BIOMED MATER RES A, V102, P1982, DOI 10.1002/jbm.a.34873
   SLOTMAN GJ, 1988, J SURG ONCOL, V38, P33, DOI 10.1002/jso.2930380110
   Tabata Y, 1998, BIOMATERIALS, V19, P1781, DOI 10.1016/S0142-9612(98)00089-1
   Takei T, 2013, J BIOMAT SCI-POLYM E, V24, P1333, DOI 10.1080/09205063.2012.757727
   Tonsomboon K, 2013, IEEE ENG MED BIO, P6671, DOI 10.1109/EMBC.2013.6611086
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Ullm S, 2014, BIOMATERIALS, V35, P9755, DOI 10.1016/j.biomaterials.2014.08.023
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Xiong GM, 2014, J MATER CHEM B, V2, P485, DOI 10.1039/c3tb20760a
   Zhang J, 2010, TOXICOL PATHOL, V38, P856, DOI 10.1177/0192623310378866
NR 43
TC 2
Z9 2
U1 0
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2016
VL 64
IS 4
BP 699
EP 710
DI 10.3233/CH-168007
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA EN3UU
UT WOS:000395934200021
PM 27767964
DA 2018-10-20
ER

PT J
AU Roch, T
   Kratz, K
   Ma, N
   Lendlein, A
AF Roch, Toralf
   Kratz, Karl
   Ma, Nan
   Lendlein, Andreas
TI Inflammatory responses of primary human dendritic cells towards
   polydimethylsiloxane and polytetrafluoroethylene
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Biomaterials; dendritic cells; polydimethylsiloxane;
   polytetrafluoroethylene; cell culture devices
ID FOREIGN-BODY REACTION; BIOMATERIAL; ACTIVATION; INSERTS; REPAIR
AB Although frequently used as implants materials, both polydimethylsiloxane (PDMS) and polytetrafluoroethylene (PTFE) are often associated with adverse effects including foreign body responses. Dendritic cells (DC) are crucial for the initiation of immune reactions and could also play a role in foreign body associated inflammations. Therefore, the interaction of DC with PDMS and PTFE was investigated regarding their capacity to induce undesired cell activation. Medical grade PDMS and PTFE films were embedded into polystyrene PS inserts via injection molding to prevent the DC from migrating belowthe substrate and thereby, interacting not only with the test sample but also with the culture vessel material. The viability, the expression of co- stimulatory molecules, and the cytokine/chemokine profiles were determined after 24 hours incubation of the DC with PDMS or PTFE. Blank PS inserts and tissue culture polystyrene (TCP) served as reference materials. The viability of DC was not substantially influenced after incubation with PDMS and PTFE. However, both polymers induced DC activation indicated by the upregulation of co- stimulatory molecules. The release profiles of 14 soluble inflammatory mediators showed substantial differences between PDMS, PTFE, PS, and TCP. This study showed the potential of PTFE and PDMS to activate primary human dendritic cells, which could be an explanation for the often observed inflammatory events associated with the implantation of these polymers.
C1 [Roch, Toralf; Kratz, Karl; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Roch, Toralf; Kratz, Karl; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
   [Lendlein, Andreas] Univ Potsdam, Inst Chem, Potsdam, Germany.
   [Ma, Nan; Lendlein, Andreas] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.
   [Roch, Toralf; Kratz, Karl; Ma, Nan; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Kratz, Karl; Ma, Nan; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Lendlein, A (reprint author), Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.; Lendlein, A (reprint author), Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
EM andreas.lendlein@hzg.de
RI Ma, Nan/L-1282-2013; Kratz, Karl/K-7115-2013; Lendlein,
   Andreas/K-9553-2013
OI Ma, Nan/0000-0003-4006-1003; Kratz, Karl/0000-0002-9229-4266; Lendlein,
   Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU Federal Ministry of Education and Research, Germany [1315848B];
   Helmholtz-Association [VH-VI-423]
FX The authors acknowledge Robert Jeziorski, Ruth Hesse and Anja
   Muller-Heyn for their technical assistance. This work was financially
   supported partially by the Federal Ministry of Education and Research,
   Germany (grant no. 1315848B) and the Helmholtz-Association
   (programme-oriented funding and grant no. VH-VI-423).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anonymous, 2016, CLIN HEMORHEOL MICRO, V63, P1
   [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   Bhaskar TBV, 2015, CLIN HEMORHEOL MICRO, V61, P119, DOI 10.3233/CH-151991
   Bilsel Y, 2012, INT J SURG, V10, P317, DOI 10.1016/j.ijsu.2012.05.002
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Jim Curtis A.C., 2013, MED APPL SILICONES B
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Klinge U, 1999, EUR J SURG, V165, P665
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kou PM, 2011, ACTA BIOMATER, V7, P1354, DOI 10.1016/j.actbio.2010.10.020
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   Roch T, 2015, CLIN HEMORHEOL MICRO, V61, P347, DOI 10.3233/CH-152004
   Roch T, 2013, CLIN HEMORHEOL MICRO, V55, P157, DOI 10.3233/CH-131699
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wischke C, 2012, J CONTROL RELEASE, V164, P299, DOI 10.1016/j.jconrel.2012.06.034
   Wolfram D, 2012, PLAST RECONSTR SURG, V129, p327E, DOI 10.1097/PRS.0b013e31823aeacf
   Xu X, 2014, ADV HEALTHC MATER, V3, P1991, DOI 10.1002/adhm.201400415
   Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118
NR 28
TC 2
Z9 2
U1 1
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2016
VL 64
IS 4
BP 899
EP 910
DI 10.3233/CH-168033
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA EN3UU
UT WOS:000395934200041
PM 27791995
DA 2018-10-20
ER

PT J
AU Kumar, RK
   Basu, S
   Lemke, HD
   Jankowski, J
   Kratz, K
   Lendlein, A
   Tetali, SD
AF Kumar, Reddi K.
   Basu, Sayantani
   Lemke, Horst-Dieter
   Jankowski, Joachim
   Kratz, Karl
   Lendlein, Andreas
   Tetali, Sarada D.
TI Influence of nanoporous poly(ether imide) particle extracts on human
   aortic endothelial cells (HAECs)
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Poly(ether imide) (PEI); biomaterial; inflammation; apoptosis; medical
   devices; Tumor necrosis factor alpha (TNF-alpha)
ID HUMAN MONOCYTIC THP-1; UREMIC TOXINS; ATHEROSCLEROSIS; INFLAMMATION;
   DYSFUNCTION; ACTIVATION; EXPRESSION; APOPTOSIS; RELEVANCE; PATHWAYS
AB Accumulated uremic toxins like indoxyl sulphate, hippuric acid and p-cresyl sulphates in renal failure patients stimulate proinflammatory effects, and consequently kidney and cardiovascular diseases. Low clearance rate of these uremic toxins from the blood of uremic patients by conventional techniques like hemodialysis is due to their strong covalent albumin binding (greater than 95%) and hydrophobic nature, which led to alternatives like usage of hydrophobic adsorber's in removing these toxins from the plasma of kidney patients. Polymers like polyethylene, polyurethane, polymethylmethacrylate, cellophane and polytetrafluoroethylene were already in use as substitutes for metal devices as dialysis membranes. Among new synthetic polymers, one such ideal adsorber material are highly porous microparticles of poly(ether imide) (PEI) with diameters in the range from 50-180 mu m and a porosity around 88 +/- 2% prepared by a spraying and coagulation process.
   It is essential to make sure that these synthetic polymers should not evoke any inflammatory or apoptotic response during dialysis. Therefore in our study we evaluated in vitro effect of PEI microparticle extracts in human aortic endothelial cells (HEACs) concerning toxicity, inflammation and apoptosis. No cell toxicity was observed when HAECs were treated with PEI extracts and inflammatory/apoptotic markers were not upregulated in presence of PEI extracts. Our results ensure biocompatibility of PEI particles and further hemocompatibility of particles will be tested.
C1 [Kumar, Reddi K.; Tetali, Sarada D.] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500046, Telangana, India.
   [Basu, Sayantani; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Basu, Sayantani; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
   [Lendlein, Andreas] Univ Potsdam, Inst Chem, Potsdam, Germany.
   [Lemke, Horst-Dieter] EXcorLab GmbH, Ind Ctr Obernburg, Obernburg, Germany.
   [Jankowski, Joachim] RTWTH Aachen Univ, Univ Hosp, Inst Mol Cardiovasc Res IMCAR, Pauwelsstr 30, Aachen, Germany.
   [Jankowski, Joachim] Maastricht Univ, Sch Cardiovasc Dis CARIM, Univ Singel 50, Maastricht, Netherlands.
RP Tetali, SD (reprint author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500046, Telangana, India.
EM stetali@uohyd.ac.in
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670
FU IGSTC [IGSTC/NPORE/SDT/2012]; Indo-German Science and Technology Centre
   [IGSTC/NPORE/SDT/2012]; German Federal Ministry for Education and
   Research (BMBF) [01DQ13006A, 01DQ13006B, 01DQ13006C]; UGC-SAP;
   DBT-CREBB; DST-FIST; UPE
FX Reddi Kiran Kumar, first author of this manuscript is a recipient of
   fellowship as an SRF (senior research fellowship) from IGSTC funded
   project (Grant No. IGSTC/NPORE/SDT/2012). Indo-German Science and
   Technology Centre (Grant No. IGSTC/NPORE/SDT/2012) and German Federal
   Ministry for Education and Research (BMBF), (Grant Nos. 01DQ13006A,
   01DQ13006B and 01DQ13006C) are acknowledged for financial support.
   Funding bodies UGC-SAP, DBT-CREBB, DST-FIST and UPE are thanked for
   providing central facilities required to carry out research work at
   University of Hyderabad in the Dept. of Plant Sciences and School of
   Life sciences.
CR Adesso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076778
   Albrecht W, 2006, J MEMBRANE SCI, V273, P106, DOI 10.1016/j.memsci.2005.09.043
   Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000
   Chen YH, 2001, J CELL BIOCHEM, V82, P512, DOI 10.1002/jcb.1176
   Choudhury SS, 2014, J ETHNOPHARMACOL, V154, P148, DOI 10.1016/j.jep.2014.03.049
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Gerszten RE, 1999, NATURE, V398, P718
   Glorieux G, 2015, CLIN KIDNEY J, V8, P353, DOI 10.1093/ckj/sfv034
   Hajjar DP, 2013, AM J PATHOL, V182, P1474, DOI 10.1016/j.ajpath.2013.01.010
   Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x
   Kokkiripati PK, 2013, J ETHNOPHARMACOL, V146, P456, DOI 10.1016/j.jep.2012.12.050
   Kumar RK, 2016, CLIN HEMORHEOL MICRO, V61, P667, DOI 10.3233/CH-152027
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004
   Namekawa K, 2014, BIOMATER SCI-UK, V2, P674, DOI 10.1039/c3bm60263j
   Querfeld U, 2002, NEPHROL DIAL TRANSPL, V17, P719, DOI 10.1093/ndt/17.5.719
   Singh Raja B, 2002, Exp Clin Cardiol, V7, P40
   Sternberg Katrin, 2009, GMS Curr Top Otorhinolaryngol Head Neck Surg, V8, pDoc11, DOI 10.3205/cto000063
   Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005
   Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911
   Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377
   Wu WH, 2010, MOL NUTR FOOD RES, V54, P1340, DOI 10.1002/mnfr.200900271
   Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52
   Yang Xiao-Feng, 2008, Drug Discov Today Ther Strateg, V5, P125, DOI 10.1016/j.ddstr.2008.11.003
NR 25
TC 0
Z9 0
U1 1
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2016
VL 64
IS 4
BP 931
EP 940
DI 10.3233/CH-168046
PG 10
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA EN3UU
UT WOS:000395934200044
DA 2018-10-20
ER

PT J
AU Bizo, L
   Gorea, M
   Katona, G
AF Bizo, Liliana
   Gorea, Maria
   Katona, Gabriel
TI INFLUENCE OF MgO/SiO2 RATIO AND ADDITIVES ON BIONANOFORSTERITE POWDERS
   CHARACTERISTICS
SO STUDIA UNIVERSITATIS BABES-BOLYAI CHEMIA
LA English
DT Article
DE nano forsterite; biomaterial; synthesis
ID SOL-GEL SYNTHESIS; FORSTERITE; BIOCOMPATIBILITY; PRECURSORS; MAGNESIUM;
   MECHANISM; CERAMICS; NANO
AB Forsterite (Mg2SiO4) powders were synthesized by solid state reaction from basic magnesium carbonate and silicon dioxide. The MgO/SiO2 molar ratio was established at 2:1, 2:1.05 and 2:1.10. In order to realize a complete reaction between compounds and avoiding the MgO (periclase) presence in the final product, an excess of SiO2 was added. Boric acid in small quantity was used as a mineralizer. The six mixtures were designed and prepared in the laboratory. After a good homogenization and mechanical activation, the raw mixtures were thermally treated at 800 degrees C, 900 degrees C, 1000 degrees C, 1200 degrees C, 1300 degrees C and 1350 degrees C with a heating rate of 2 degrees C/min and one hour plateau at maximum temperature. The grain size distribution of the powders obtained at 800 degrees C, 900 degrees C and 1000 degrees C, according to the particle analyzes, are in the nanometer range. Increasing the temperature the size of grains is increased at micrometer dimensions indicating the presence of agglomerates. The mineralogical compositions evidenced by X-ray powder diffraction (XRPD) showed as the main crystalline compound the forsterite beginning of 1200 degrees C temperature. The crystallinity index of forsterite depends on the thermal treatment conditions, being highest at 1350 degrees C. A small quantity of MgO at the maximum temperature in compositions without boric acid was identified. The shape and morphology of forsterite crystals were evidenced by TEM analyses.
C1 [Bizo, Liliana; Gorea, Maria; Katona, Gabriel] Univ Babes Bolyai, Fac Chem & Chem Engn, 11 Arany Janos Str, RO-400028 Cluj Napoca, Romania.
RP Gorea, M (reprint author), Univ Babes Bolyai, Fac Chem & Chem Engn, 11 Arany Janos Str, RO-400028 Cluj Napoca, Romania.
EM mgorea@chem.ubbcluj.ro
CR Ando M, 2007, JPN J APPL PHYS 1, V46, P7112, DOI 10.1143/JJAP.46.7112
   Belyakov AV, 2012, INORG MATER+, V48, P176, DOI 10.1134/S0020168512020045
   BRINDLEY GW, 1965, PHILOS MAG, V12, P505, DOI 10.1080/14786436508218896
   Chen L, 2015, CERAM INT, V41, P12651, DOI 10.1016/j.ceramint.2015.06.096
   Chen LG, 2015, CERAM INT, V41, P2234, DOI 10.1016/j.ceramint.2014.10.025
   [陈勇 Chen Yong], 2012, [硅酸盐通报, Bulletin of the Chinese Ceramic Society], V31, P622
   Diba M, 2014, CURR OPIN SOLID ST M, V18, P147, DOI 10.1016/j.cossms.2014.02.004
   Gorea M, 2013, CERAM-SILIKATY, V57, P87
   Hassanzadeh-Tabrizi SA, 2016, MAT SCI ENG C-MATER, V58, P737, DOI 10.1016/j.msec.2015.09.020
   Kharaziha M, 2010, J MECH BEHAV BIOMED, V3, P530, DOI 10.1016/j.jmbbm.2010.06.003
   Kharaziha M, 2009, CERAM INT, V35, P2449, DOI 10.1016/j.ceramint.2009.02.001
   Klug HP, 1956, XRAY DIFFRACTION PRO
   MARTIN MHE, 1992, J AM CERAM SOC, V75, P1831, DOI 10.1111/j.1151-2916.1992.tb07204.x
   Naghiu MA, 2014, CERAM-SILIKATY, V58, P303
   Naghiu MA, 2013, J MATER SCI TECHNOL, V29, P628, DOI 10.1016/j.jmst.2013.04.007
   Sano S, 2006, J AM CERAM SOC, V89, P568, DOI 10.1111/j.1551-2916.2005.00766.x
   Sanosh KP, 2010, J ALLOY COMPD, V495, P113, DOI 10.1016/j.jallcom.2010.01.097
   Tan CY, 2015, INT J APPL CERAM TEC, V12, P437, DOI 10.1111/ijac.12172
   Tavangarian F, 2010, POWDER TECHNOL, V203, P180, DOI 10.1016/j.powtec.2010.05.007
   Tavangarian F, 2010, MATER RES BULL, V45, P388, DOI 10.1016/j.materresbull.2009.12.032
   YAMAGUCHI O, 1976, CHEM LETT, P401, DOI 10.1246/cl.1976.401
NR 21
TC 0
Z9 0
U1 0
U2 0
PU UNIV BABES-BOLYAI
PI CLUJ-NAPOCA
PA MIHAIL KOGALNICEANU NR. 1, CLUJ-NAPOCA RO-3400, ROMANIA
SN 1224-7154
J9 STUD U BABES-BOL CHE
JI Stud. Univ. Babes-Bolyai Chem.
PY 2016
VL 61
IS 3
BP 239
EP 249
PN 1
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA EJ9WH
UT WOS:000393577300023
DA 2018-10-20
ER

PT J
AU Marudova, M
   Bodurov, I
   Sotirov, S
   Uzunova, Y
   Pilicheva, B
   Avramova, I
   Viraneva, A
   Vlaeva, I
   Exner, G
   Yovcheva, T
AF Marudova, M.
   Bodurov, I.
   Sotirov, S.
   Uzunova, Y.
   Pilicheva, B.
   Avramova, I.
   Viraneva, A.
   Vlaeva, I.
   Exner, G.
   Yovcheva, T.
TI Nanostructured polyelectrolyte multilayer drug delivery systems for
   buccal administration
SO BULGARIAN CHEMICAL COMMUNICATIONS
LA English
DT Article; Proceedings Paper
CT 15th International Scientific Conference on Renewable Energy and
   Innovative Technologies
CY JUN 10-11, 2016
CL Tech Coll Smolyan, Smolyan, BULGARIA
HO Tech Coll Smolyan
DE polyelectrolyte multilayers; drug delivery; mucoadhesion; chitosan;
   xanthan; charged poly-epsilon-caprolacton substrates
ID ATOMIC-FORCE MICROSCOPY; BY-LAYER FILMS; EXPONENTIAL-GROWTH;
   CHARGE-DENSITY
AB Polyelectrolyte multilayers (PEMs) are well-defined nanoarchitectures with many potential applications, usually as biomaterial coatings. They possess excellent characteristics, such as fine tuning of thickness, stiffness, stability, morphology and topography. Hence they may exhibit special biological properties, such as mucoadhesion and local drug delivery. We present our recent investigations on layer-by-layer assembled polyelectrolyte multilayers from chitosan and xanthan on preliminary corona charged substrates from poly-epsilon-caprolacton. Polyelectrolyte multilayers were deposited by two different techniques - dip-coating and spincoating. The presence of PEMs on the substrates was proved by ATR FT-IR spectroscopy. The surface chemical composition was established by X-ray photoelectron spectroscopy (XPS). Further investigations on the morphology and topography of the samples were done by scanning electron microscopy (SEM) and atomic force microscopy (AFM). All the experimental data confirmed differences in the structure and surface properties of the PEMs assembled by dip-coating and spin-coating. An interfusion of the polyelectrolyte layers was observed in dip-coated PEMs, while flat and clearly separated layers were deposited by spin-coating. The ability to control the inner structure of the PEMs enables to manipulate the physical properties or chemical activity of the functionalized thin films. In this way tunable mucoadhesion and drug release properties could be achieved.
C1 [Marudova, M.; Bodurov, I.; Sotirov, S.; Viraneva, A.; Exner, G.; Yovcheva, T.] Plovdiv Univ P Hilendarski, Fac Phys, 24 Tsar Assen Str, Plovdiv, Bulgaria.
   [Uzunova, Y.; Pilicheva, B.] Med Univ Plovdiv, Fac Pharm, 15A Vassil Aprilov Blvd, Plovdiv, Bulgaria.
   [Avramova, I.] Bulgarian Acad Sci, Inst Gen & Inorgan Chem, Acad G Bonchev Blvd,Block 11, Sofia, Bulgaria.
   [Vlaeva, I.] Univ Food Technol, 26 Maritsa Blvd, Plovdiv, Bulgaria.
RP Marudova, M (reprint author), Plovdiv Univ P Hilendarski, Fac Phys, 24 Tsar Assen Str, Plovdiv, Bulgaria.
EM margo@uni-plovdiv.bg
FU Bulgarian National Scientific Fund [DFNI B-02/7]; Department of
   Scientific Research at the Plovdiv University
   [MU-15-FFIT-003/23.04.2015]
FX This study was financial supported by Project No DFNI B-02/7 of
   Bulgarian National Scientific Fund and Project MU-15-FFIT-003/23.04.2015
   of Department of Scientific Research at the Plovdiv University.
CR Decher G., 2012, SEQUENTIAL ASSEMBLY
   Dickinson E., 2007, FOOD COLLOIDS SELF A
   Fukuda M, 2006, INT J PHARM, V310, P90, DOI 10.1016/j.ijpharm.2005.11.042
   Glinel K, 2002, LANGMUIR, V18, P1408, DOI 10.1021/la0113670
   Katugampola P, 2014, INT J PHARM SCI INVE, V3, P24
   Kulkarni N, 2015, INT J PHARM INVESTIG, V5, P73, DOI 10.4103/2230-973X.153381
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lee YM, 2009, J NANOSCI NANOTECHNO, V9, P7467, DOI 10.1166/jnn.2009.1755
   Lobo RFM, 2003, NANOTECHNOLOGY, V14, P101, DOI 10.1088/0957-4484/14/1/322
   Losche M, 1998, MACROMOLECULES, V31, P8893, DOI 10.1021/ma980910p
   Marken E, 2008, THIN SOLID FILMS, V516, P7770, DOI 10.1016/j.tsf.2008.05.054
   Maurstad G, 2003, J PHYS CHEM B, V107, P8172, DOI 10.1021/jp0271965
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C., 2014, DECHER LAYER BY LAYE
   Schoeler B, 2002, MACROMOLECULES, V35, P889, DOI 10.1021/ma011349p
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Zhuk A, 2015, LANGMUIR, V31, P3889, DOI 10.1021/acs.langmuir.5b00401
NR 17
TC 1
Z9 1
U1 5
U2 6
PU BULGARIAN ACAD SCIENCE
PI SOFIA
PA CENTRAL LIBRARY 7 NOEMVRI NO 1, SOFIA, 00000, BULGARIA
SN 0324-1130
J9 BULG CHEM COMMUN
JI Bulg. Chem. Commun.
PY 2016
VL 48
SI E2
BP 468
EP 474
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA EI3DP
UT WOS:000392370200041
DA 2018-10-20
ER

PT S
AU Papezova, M
   Faktorova, D
AF Papezova, Maria
   Faktorova, Dagmar
BE Hajek, P
   Sahota, T
   Jones, MA
TI MICROWAVE PROPAGATION IN TOOTH AND DENTAL DEFECT
SO CBU INTERNATIONAL CONFERENCE PROCEEDINGS 2016: INNOVATIONS IN SCIENCE
   AND EDUCATION
SE CBU International Conference Proceedings
LA English
DT Proceedings Paper
CT CBU International Conference on Innovations in Science and Education
   (CBUIC)
CY MAR 23-25, 2016
CL Prague, CZECH REPUBLIC
SP Central Bohemia Univ, Unicorn College
DE Dental diagnoses; microwave frequencies; transmission coefficients;
   reflection coefficients; tooth
AB INTRODUCTION: The most common method of conventional dental diagnosis involves X-rays, such as Radio Tomography (RT) or Computer Tomography (CT). Such methods are used for diagnosing pores in dental material that can lead to premature failure of dental material. Diagnosis by X-ray provides an objective analysis. However, repeated radiation from X-rays can cause biological damage to human tissues. From this point of view, there is a significant need to progress to quantitative non-invasive and non-destructive testing (NDT) methods to measure dental material and improve treatment options. This article focuses on applying microwave technology to characterize teeth and teeth replacements. Knowledge of microwave propagation in biomaterial with no defects, using a defined microwave frequency range, and subsequently comparing the result with defective material could provide a means of dental diagnosis without the risk of radiation for the patient, i.e. without Xray.
   OBJECTIVES: The primary objective of this study was to examine microwave technology in the field of dental medical diagnosis as a new NDT method.
   METHODS: The basic concept of applying microwave technology to characterize teeth in dental diagnosis was examined using a basic algorithm designed in the MATLAB programming language. Tests used dielectric properties of tooth and tooth decay and propagated electromagnetic (EM) waves to show different characteristics of chosen materials.
   RESULTS: The analyses of frequency dependent reflection and transmission coefficients of the chosen material, specifically teeth, at frequency range 0 GHz to 30 GHz, computed differences between healthy and defective dental material.
   CONCLUSION: Thus, this could be used in providing a dental diagnosis without exposing patients to radiation, i.e. without X-ray. The next stage will involve creating a complete model of a jaw with teeth, and designing a sensor for crack detection for comparisons using this basic algorithm.
C1 [Papezova, Maria; Faktorova, Dagmar] Univ Zilina, Fac Elect Engn, Dept Measurement & Appl Engn, Zilina, Slovakia.
RP Papezova, M (reprint author), Univ Zilina, Fac Elect Engn, Dept Measurement & Appl Engn, Zilina, Slovakia.
EM maria.papezova@fel.uniza.sk; dagmar.faktorova@fel.uniza.sk
CR Babusiak B., 2014, INFORM TECHNOLOGIES, V4, P249
   Faktorova D., 2011, ELECT REV, V87, P34
   Faktorova D, 2015, PROCEDIA ENGINEER, V100, P1686, DOI 10.1016/j.proeng.2015.01.544
   Hoshi N., 1998, MICROWAVE THEORY TEC, V46, P834
   Papezova M., 2016, INT J APPL ELECTROM, P1
   Sakaguchi R. L., 2012, CRAIGS RESTORATIVE D, P5
   Zoughi R., 2012, MICROWAVE NONDESTRUC, V4, P13
NR 7
TC 0
Z9 0
U1 0
U2 1
PU CENTRAL BOHEMIA UNIV
PI PRAGUE 8
PA POD VODARENSKOU VEZI 4, PRAGUE 8, 18200, CZECH REPUBLIC
SN 1805-9961
BN 978-80-88042-04-4
J9 CBU INT CONF PROC
PY 2016
BP 658
EP 661
DI 10.12955/cbup.v4.828
PG 4
WC Business; Economics; Multidisciplinary Sciences; Social Sciences,
   Interdisciplinary
SC Business & Economics; Science & Technology - Other Topics; Social
   Sciences - Other Topics
GA BG8HE
UT WOS:000392271000098
OA Other Gold
DA 2018-10-20
ER

PT J
AU Liu, RJ
   Li, Y
   Han, J
   Fu, HX
AF Liu, R. J.
   Li, Y.
   Han, J.
   Fu, H. X.
TI Covalent Immobilization and Characterization of Penicillin G Acylase on
   Magnetic NiFe2O4 Nanorods Prepared via a Novel Rapid Combustion Process
SO CHEMICAL AND BIOCHEMICAL ENGINEERING QUARTERLY
LA English
DT Article
DE NiFe2O4 nanorods; rapid combustion process; penicillin G acylase;
   immobilization
ID MESOSTRUCTURED CELLULAR FOAMS; NANOPARTICLES
AB The surface of magnetic NiFe2O4 nanorods prepared via a novel rapid combustion process was modified by sodium silicate and glutaraldehyde, and the penicillin G acylase ( PGA) was successfully immobilized on the surface-modified magnetic NiFe2O4 nanorods. The properties of immobilized PGA were investigated, and the results showed that the immobilized PGA with high effective activity, good stability of enzyme catalyst, and good reusability was less affected by pH and temperature than free PGA. The immobilized PGA on magnetic NiFe2O4 nanorods could be separated easily from the reaction solutions by the external magnetic field for cyclic utilization, and they could retain over 70 % of initial enzyme activity after 10 consecutive operations. All the results suggested that the surface-modified magnetic NiFe2O4 nanorods would be promising for applications in the biomaterial fields.
C1 [Liu, R. J.; Li, Y.; Han, J.; Fu, H. X.] Jiangsu Univ, Sch Pharm, Zhenjiang 212013, Peoples R China.
   [Liu, R. J.] Jiangsu Univ, Affiliated Kunshan Hosp, Kunshan 215300, Peoples R China.
RP Liu, RJ (reprint author), Jiangsu Univ, Sch Pharm, Zhenjiang 212013, Peoples R China.; Liu, RJ (reprint author), Jiangsu Univ, Affiliated Kunshan Hosp, Kunshan 215300, Peoples R China.
EM luckystar_lrj@ujs.edu.cn
FU China Postdoctoral Science Foundation [2016M591778]; Jiangsu
   Postdoctoral Foundation [1501086C]; Technology Development Project of
   Jiangsu ZTE Pharmaceutical Co., Ltd.
FX This work was supported by the China Postdoctoral Science Foundation
   (Grant No. 2016M591778), Jiangsu Postdoctoral Foundation (Grant No.
   1501086C), and the Technology Development Project of Jiangsu ZTE
   Pharmaceutical Co., Ltd.
CR Adikane HV, 2010, APPL BIOCHEM BIOTECH, V160, P1130, DOI 10.1007/s12010-009-8686-9
   BALASINGHAM K, 1972, BIOCHIM BIOPHYS ACTA, V276, P250, DOI 10.1016/0005-2744(72)90027-7
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chong ASM, 2004, CATAL TODAY, V93-5, P293, DOI 10.1016/j.cattod.2004.06.064
   Eldin MSM, 2012, J APPL POLYM SCI, V125, P3820, DOI 10.1002/app.36690
   Elnashar MMM, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40295
   Gao ZY, 2015, MICROPOR MESOPOR MAT, V202, P90, DOI 10.1016/j.micromeso.2014.09.053
   Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617
   Luo XG, 2010, BIOMACROMOLECULES, V11, P2896, DOI 10.1021/bm100642y
   Shi BF, 2009, CATAL TODAY, V148, P184, DOI 10.1016/j.cattod.2009.02.014
   Sivakumar P, 2011, MATER RES BULL, V46, P2204, DOI 10.1016/j.materresbull.2011.09.010
   Wang PX, 2011, BIOCHEM ENG J, V56, P17, DOI 10.1016/j.bej.2011.04.011
   Wang W, 2007, ENZYME MICROB TECH, V40, P255, DOI 10.1016/j.enzmictec.2006.04.020
   Yang L, 2014, MICROPOR MESOPOR MAT, V197, P1, DOI 10.1016/j.micromeso.2014.05.044
   Yang L, 2014, ENZYME MICROB TECH, V60, P32, DOI 10.1016/j.enzmictec.2014.03.011
   Yang L, 2014, MICROPOR MESOPOR MAT, V190, P17, DOI 10.1016/j.micromeso.2014.01.017
   Zhan WC, 2014, CHINESE J CATAL, V35, P1709, DOI 10.1016/S1872-2067(14)60156-X
   Zhao JQ, 2010, BIORESOURCE TECHNOL, V101, P7211, DOI 10.1016/j.biortech.2010.04.067
   Zhou HC, 2012, CHINESE J CHEM ENG, V20, P146, DOI 10.1016/S1004-9541(12)60374-7
NR 19
TC 5
Z9 5
U1 0
U2 1
PU CROATIAN SOC CHEMICAL ENGINEERING TECHNOLOGY
PI ZAGREB
PA BERISLAVICEVA 6, PO BOX 123, HR-10000 ZAGREB, CROATIA
SN 0352-9568
EI 1846-5153
J9 CHEM BIOCHEM ENG Q
JI Chem. Biochem. Eng. Q.
PY 2016
VL 30
IS 4
BP 511
EP 517
DI 10.15255/CABEQ.2015.2319
PG 7
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA EI6ZL
UT WOS:000392646300013
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Roslan, MR
   Nasir, NFM
   Cheng, EM
   Mamat, N
AF Roslan, M. Riza
   Nasir, N. F. Mohd
   Cheng, E. M.
   Mamat, N.
GP IEEE
TI Preliminary Characterization of nanoHA-Bubuk Wangi Rice Starch Tissue
   Scaffold
SO 2016 INTERNATIONAL CONFERENCE ON ELECTRICAL, ELECTRONICS, AND
   OPTIMIZATION TECHNIQUES (ICEEOT)
LA English
DT Proceedings Paper
CT International Conference on Electrical, Electronics, and Optimization
   Techniques (ICEEOT)
CY MAR 03-05, 2016
CL Palnchur, INDIA
SP DMI Coll Engn, IEEE DMI Coll Student Branch
DE Bubuk Wangi rice; Starch; Hydroxyapatite; Bone tissue scaffold
ID POLYURETHANE SCAFFOLDS; COMPOSITE SCAFFOLDS; BONE REGENERATION;
   POROSITY; FILMS
AB Scaffolds is an artificial bone implant to assist the regeneration of natural bone formation. Starch is a common polymer used to fabricate the scaffold. Generally, starch exhibits various properties corresponding to its botanical origin, granules size and structure. In Malaysia, different type and origin of soil may produce different properties of crops especially rice. Bubuk Wangi is a rice variant planted originally in Sarawak, Malaysia. This study is to fabricate the scaffold based on Bubuk Wangi rice starch and hydroxyapatite via solvent casting and salt leaching. From this research, the porosity, density, and morphology showed a good versatility in comparison with natural bone. As a conclusion, nanoHydroxyapatite combined with Bubuk Wangi rice starch has is a potential biomaterial to develop bone tissue scaffold.
C1 [Roslan, M. Riza; Nasir, N. F. Mohd; Cheng, E. M.; Mamat, N.] Univ Malaysia Perlis, Sch Mech Engn, Perlis, Malaysia.
RP Roslan, MR (reprint author), Univ Malaysia Perlis, Sch Mech Engn, Perlis, Malaysia.
EM reza.roslan@yahoo.com; nashrul@unimap.edu.my; emcheng@unimap.edu.my;
   normahira@unimap.edu.my
CR Ahmed Y. M. Z., 2014, INTEGR MED RES
   [Anonymous], 2010, BIOMATERIAL SCAFFOLD, P141
   Bignon A., 2003, EFFECT MICRO MACROPO, V4, P1089
   Biojo E. M., 2005, STAROCHUCH FOOD MED
   Bovan B.D., 1996, BIOMATERIALS, V17, P137
   Briefs S., NAZNIN SULTANA MOHD
   Charoenrein S, 2012, CARBOHYD POLYM, V90, P1032, DOI 10.1016/j.carbpol.2012.06.038
   Chiu CK, 2012, J MATER SCI-MATER M, V23, P2115, DOI 10.1007/s10856-012-4691-6
   Colussi R., 2015, LWT-FOOD SCI TECHNOL, P1
   Dario Puppi E. C., 2015, BIODEGRADABLE POLYM
   EVANS LA, 1992, CALCIFIED TISSUE INT, V51, P78, DOI 10.1007/BF00296222
   Fakhouri FM, 2013, CARBOHYD POLYM, V95, P681, DOI 10.1016/j.carbpol.2013.03.027
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hing K. A., 2005, MICROPOROSITY ENHANC, V6, P467
   Janik H, 2015, MAT SCI ENG C-MATER, V48, P586, DOI 10.1016/j.msec.2014.12.037
   Kazemzadeh Narbat M., 2006, IRAN BIOMED J, V10, P215
   Ki CS, 2008, BIOTECHNOL LETT, V30, P405, DOI 10.1007/s10529-007-9581-5
   Lawton JW, 1996, CARBOHYD POLYM, V29, P203, DOI 10.1016/0144-8617(96)00028-8
   Lorente-Ayza MM, 2015, J EUR CERAM SOC, V35, P2333, DOI 10.1016/j.jeurceramsoc.2015.02.026
   Mallick S., 2015, IOSR J PHARM BIOL SC, V10, P37
   Mou ZL, 2013, MATER LETT, V105, P189, DOI 10.1016/j.matlet.2013.03.130
   Mozafari M, 2010, CERAM INT, V36, P2431, DOI 10.1016/j.ceramint.2010.07.010
   Nasri-Nasrabadi B, 2014, CARBOHYD POLYM, V108, P232, DOI 10.1016/j.carbpol.2014.02.075
   Sadjadi H. J. M.S., 2015, HYDROXYAPATITE STARC, V1
   Sadjadi MS, 2010, MATER CHEM PHYS, V124, P217, DOI 10.1016/j.matchemphys.2010.06.022
   Seetapan N, 2015, J FOOD ENG, V151, P51, DOI 10.1016/j.jfoodeng.2014.11.025
   Shakir M, 2015, INT J BIOL MACROMOL, V80, P282, DOI 10.1016/j.ijbiomac.2015.05.009
   Sopyan I, 2009, CERAM INT, V35, P3161, DOI 10.1016/j.ceramint.2009.05.012
   Sundaram J, 2008, ACTA BIOMATER, V4, P932, DOI 10.1016/j.actbio.2008.01.019
   Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001
   Venkatesan J, 2012, INT J BIOL MACROMOL, V51, P1033, DOI 10.1016/j.ijbiomac.2012.08.020
   Wani AA, 2012, COMPR REV FOOD SCI F, V11, P417, DOI 10.1111/j.1541-4337.2012.00193.x
   Whang S. M. S. K., 1999, TISSUE ENG, V5, P35
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Xie FW, 2013, PROG POLYM SCI, V38, P1590, DOI 10.1016/j.progpolymsci.2013.05.002
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 37
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4673-9939-5
PY 2016
BP 1560
EP 1564
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BG7JO
UT WOS:000391380901123
DA 2018-10-20
ER

PT J
AU Ziegler, AR
   Bajwa, SG
   Holt, GA
   McIntyre, G
   Bajwa, DS
AF Ziegler, A. R.
   Bajwa, S. G.
   Holt, G. A.
   McIntyre, G.
   Bajwa, D. S.
TI EVALUATION OF PHYSICO-MECHANICAL PROPERTIES OF MYCELIUM REINFORCED GREEN
   BIOCOMPOSITES MADE FROM CELLULOSIC FIBERS
SO APPLIED ENGINEERING IN AGRICULTURE
LA English
DT Article
DE Biocomposite; Biodegradable; Biomaterial; Cellulosic; Mechanical
   properties; Mycelium; Physical properties
ID COMPOSITES
AB Biodegradable and sustainable feedstocks are increasingly replacing petroleum-based materials commonly used for single-or multi-use packaging applications. A study was conducted to evaluate the potential of an innovative biocomposite material patented by Ecovative Design LLC (Green Island, N.Y.) for use in commercial products and packaging. The biocomposite material utilizes the fungus mycelium as a matrix to bind cellulosic plant fibers. The test samples were manufactured with different fiber-fungal strain combinations, using cotton ginning waste and hemp pith as core material and fiber fabric on the surface. The physico-mechanical properties of the biocomposites were evaluated to develop a thorough understanding of the material which may lead to future applications. The properties evaluated included specific gravity, surface hardness, water absorption, coefficient of linear thermal expansion, and resistance to tension and compression. The density profile results indicated that the material is extremely light, buoyant, and highly hydrophilic. Surface hardness test showed that the material has a soft outer surface with high elasticity. The tensile and compression properties showed the material can be used in targeted packaging applications where lightweight, resiliency, and biodegradability are desirable.
C1 [Ziegler, A. R.] Univ Arkansas, Fayetteville, AR 72701 USA.
   [Bajwa, S. G.] North Dakota State Univ, Dept Agr & Biosyst Engn, 1221 Albrecht Blvd,Dept 7260,POB 6050, Fargo, ND 58108 USA.
   [Holt, G. A.] USDA ARS, Lubbock, TX USA.
   [McIntyre, G.] Ecovat Design LLC, New York, NY USA.
   [Bajwa, D. S.] North Dakota State Univ, Dept Mech Engn, Fargo, ND USA.
RP Bajwa, SG (reprint author), North Dakota State Univ, Dept Agr & Biosyst Engn, 1221 Albrecht Blvd,Dept 7260,POB 6050, Fargo, ND 58108 USA.
EM Sreekala.Bajwa@ndsu.edu
CR [Anonymous], 2010, D63810 ASTM INT
   ASTM, 2003, D6111 ASTM INT
   ASTM, 2012, D1037 ASTM INT
   ASTM, 2014, D6341 ASTM INT
   Bayer E., 2010, ARE MUSHROOMS NEW PL, V9
   Campbell F. C., 2010, STRUCTURAL COMPOSITE
   CAMPBELL G, 1982, PROSTHET ORTHOT INT, V6, P48
   Curbell Plastics Inc, 2013, TYP PROP COMP CHART
   Dicker MPM, 2014, COMPOS PART A-APPL S, V56, P280, DOI 10.1016/j.compositesa.2013.10.014
   Dittenber DB, 2012, COMPOS PART A-APPL S, V43, P1419, DOI 10.1016/j.compositesa.2011.11.019
   Dow Chemical Company, 2012, STYR BRAND HIGHL 100
   Forest Products Laboratory, 2000, FPLGTR190 USDA FOR S
   George F. F., 1969, ENG PLASTICS THEIR C
   Holt GA, 2012, J BIOBASED MATER BIO, V6, P431, DOI 10.1166/jbmb.2012.1241
   Klyosov A. A., 2007, WOOD PLASTIC COMPOSI
   Koronis G, 2013, COMPOS PART B-ENG, V44, P120, DOI 10.1016/j.compositesb.2012.07.004
   La Mantia FP, 2011, COMPOS PART A-APPL S, V42, P579, DOI 10.1016/j.compositesa.2011.01.017
   Morlan J., 2009, WOOD JANKA HARDNESS
   Song F, 2011, BIOMACROMOLECULES, V12, P3369, DOI 10.1021/bm200904x
   United States Environmental Protection Agency, 2014, MUN SOL WAST GEN REC
   World Packaging Organisation, 2008, MARK STAT FUT TRENDS
NR 21
TC 1
Z9 1
U1 7
U2 25
PU AMER SOC AGRICULTURAL & BIOLOGICAL ENGINEERS
PI ST JOSEPH
PA 2950 NILES RD, ST JOSEPH, MI 49085-9659 USA
SN 0883-8542
EI 1943-7838
J9 APPL ENG AGRIC
JI Appl. Eng. Agric.
PY 2016
VL 32
IS 6
BP 931
EP 938
DI 10.13031/aea.32.11830
PG 8
WC Agricultural Engineering
SC Agriculture
GA EH7GN
UT WOS:000391941100025
DA 2018-10-20
ER

PT J
AU Cieslik-Bielecka, A
   Glik, J
   Skowronski, R
   Bielecki, T
AF Cieslik-Bielecka, Agata
   Glik, Justyna
   Skowronski, Rafal
   Bielecki, Tomasz
TI Benefit of Leukocyte- and Platelet-Rich Plasma in Operative Wound
   Closure in Oral and Maxillofacial Surgery
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID GROWTH-FACTOR; GEL; CYSTS
AB This article reports the influence of an autologous leukocyte-and platelet-rich plasma (L-PRP) injection as a minimally invasive method on supporting wound healing processes after a mandibular odontogenic cystectomy and double mandibular fracture fixation. 113 patients were enrolled into a control group (received no L-PRP injection) and 102 patients were enrolled into an L-PRP group with an oral mucosa incision. 18 patients after a double mandibular fracture were operated on using 2 external submandibular approaches receiving no fluids in the right site (a control group) and an L-PRP injection in the left incision (L-PRP group). Clinical observations showed that the oral mucosa healed faster in patients treated with L-PRP, in comparison to cases where inductive biomaterial was not added. Pain at the L-PRP injection site was relieved within few hours after an operation in patients with double mandibular fractures. However, there were no differences observed in the progression of the healing process. L-PRP possesses inductive properties that could stimulate healing processes and it seems to be one of the most promising methods in the future for the treatment of soft tissue defects.
C1 [Cieslik-Bielecka, Agata] Med Univ Silesia, Dept Maxillofacial Surg, Sosnowiec, Poland.
   [Glik, Justyna] Burn Ctr, Burn Wound Unit, Siemianowice Slaskie, Poland.
   [Skowronski, Rafal] Med Univ Bialystok, Orthoped Surg & Traumatol Dept, Bialystok, Poland.
   [Bielecki, Tomasz] Med Univ Silesia, Dept & Clin Orthopaed Trauma & Reconstruct Surg, Ctr Trauma, St Barbara Hosp, Sosnowiec, Poland.
RP Bielecki, T (reprint author), Med Univ Silesia, Dept & Clin Orthopaed Trauma & Reconstruct Surg, Ctr Trauma, St Barbara Hosp, Sosnowiec, Poland.
EM tomekbiel@o2.pl
CR Bielecki T., 2015, J BIOMEDICAL SCI ENG, V8, P659
   Bielecki T, 2012, TRANSFUS APHER SCI, V47, P133, DOI 10.1016/j.transci.2012.06.017
   Blaine TA, 2005, J SHOULDER ELB SURG, V14, p84S, DOI 10.1016/j.jse.2004.09.022
   Chambers RC, 2002, BIOCHEM SOC T, V30, P194, DOI 10.1042/bst0300194
   Cieslik-Bielecka A., 2012, J BIOL REGU HOMEOST, V26, P43
   Cieslik-Bielecka A, 2008, ORAL SURG ORAL MED O, V105, P423, DOI 10.1016/j.tripleo.2007.07.039
   Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004
   Dohan Ehrenfest DM, 2014, MUSCLES LIGAMENTS TE, V4, P3
   Everts PA, 2008, EUR SURG RES, V40, P203, DOI 10.1159/000110862
   Everts PAM, 2006, GROWTH FACTORS, V24, P165, DOI 10.1080/08977190600821327
   Frechette JP, 2005, J DENT RES, V84, P434, DOI 10.1177/154405910508400507
   Glover J L, 1997, Adv Wound Care, V10, P33
   GRIGG P, 1986, J NEUROPHYSIOL, V55, P635
   Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Ogino Y, 2005, ORAL SURG ORAL MED O, V100, P302, DOI 10.1016/j.tripleo.2005.03.007
   Sammartino G, 2016, BIOMED RES INT, V2016
   SANTAVIRTA S, 1992, ARCH ORTHOP TRAUM SU, V111, P336, DOI 10.1007/BF00420062
   Sprott H, 2000, WIEN KLIN WOCHENSCHR, V112, P580
   Trowbridge Cody C, 2005, J Extra Corpor Technol, V37, P381
NR 20
TC 0
Z9 0
U1 0
U2 1
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 7649206
DI 10.1155/2016/7649206
PG 5
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA EH4SB
UT WOS:000391759800001
PM 28097149
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Huang, YC
   Huang, KY
   Yang, BY
   Ko, CH
   Huang, HM
AF Huang, Yu-Chih
   Huang, Kuen-Yu
   Yang, Bing-Yuan
   Ko, Chun-Han
   Huang, Haw-Ming
TI Fabrication of Novel Hydrogel with Berberine-Enriched
   Carboxymethylcellulose and Hyaluronic Acid as an Anti-Inflammatory
   Barrier Membrane
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID GUIDED BONE REGENERATION; COLLAGEN MEMBRANES; HYBRID HYDROGEL; IN-VIVO;
   ADHESIONS; IMPLANT; MODEL
AB An antiadhesion barrier membrane is an important biomaterial for protecting tissue from postsurgical complications. However, there is room to improve these membranes. Recently, carboxymethylcellulose (CMC) incorporated with hyaluronic acid (HA) as an antiadhesion barrier membrane and drug delivery system has been reported to provide excellent tissue regeneration and biocompatibility. The aim of this study was to fabricate a novel hydrogel membrane composed of berberine-enriched CMC prepared from bark of the P. amurense tree and HA (PE-CMC/HA). In vitro anti-inflammatory properties were evaluated to determine possible clinical applications. The PE-CMC/HAmembraneswere fabricated by mixing PE-CMCandHA as a base with the addition of polyvinyl alcohol to form a film. Tensile strength and ultramorphology of the membrane were evaluated using a universal testing machine and scanning electron microscope, respectively. Berberine content of the membrane was confirmed using a UV-Vis spectrophotometer at a wavelength of 260nm. Anti-inflammatory property of the membrane was measured using a Griess reaction assay. Our results showed that fabricated PE-CMC/HA releases berberine at a concentration of 660 mu g/ml while optimal plasticity was obtained at a 30 : 70 PE-CMC/HA ratio. Theberberine-enrichedPE-CMC/HA had an inhibited 60% of inflammation stimulated by LPS. These results suggest that the PE-CMC/HA membrane fabricated in this study is a useful anti-inflammatory berberine release system.
C1 [Huang, Yu-Chih; Huang, Haw-Ming] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan.
   [Huang, Kuen-Yu; Huang, Haw-Ming] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan.
   [Yang, Bing-Yuan; Ko, Chun-Han] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei, Taiwan.
   [Huang, Haw-Ming] Taipei Med Univ, Grad Inst Biomed Optomechatron, Coll Biomed Engn, Taipei, Taiwan.
RP Huang, HM (reprint author), Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan.; Huang, HM (reprint author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan.; Ko, CH (reprint author), Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei, Taiwan.; Huang, HM (reprint author), Taipei Med Univ, Grad Inst Biomed Optomechatron, Coll Biomed Engn, Taipei, Taiwan.
EM chunhank@ntu.edu.tw; hhm@tmu.edu.tw
OI KO, CHUN-HAN/0000-0002-8112-3381; Huang, Haw-Ming/0000-0003-4184-3744
FU Lake Forest Co., Guizhou, China
FX Authors would like to express their sincere appreciation to Lake Forest
   Co., Guizhou, China, which provided the bark of P. amurense tree and the
   great support of the research resources.
CR Azad MAK, 2006, IN VITRO CELL DEV-PL, V42, P502, DOI 10.1079/IVP2006808
   Becker W, 1999, Clin Implant Dent Relat Res, V1, P27, DOI 10.1111/j.1708-8208.1999.tb00088.x
   Burns JW, 1997, EUR J SURG, V163, P40
   Buser D, 1993, Int J Periodontics Restorative Dent, V13, P29
   Chen JY, 2013, J SEX MED, V10, P1575, DOI 10.1111/jsm.12125
   Correia CR, 2011, TISSUE ENG PART C-ME, V17, P717, DOI 10.1089/ten.tec.2010.0467
   Dahiya Parveen, 2013, N Am J Med Sci, V5, P309, DOI 10.4103/1947-2714.112473
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Epstein-Barash H, 2012, ACTA BIOMATER, V8, P1703, DOI 10.1016/j.actbio.2012.01.028
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Isik S, 1999, BRIT J PLAST SURG, V52, P373, DOI 10.1054/bjps.1999.3128
   Jentsch H, 2003, J CLIN PERIODONTOL, V30, P159, DOI 10.1034/j.1600-051X.2003.300203.x
   Kablik J, 2009, DERMATOL SURG, V35, P302, DOI 10.1111/j.1524-4725.2008.01046.x
   Korn P, 2014, J BIOMED MATER RES A, V102, P2334, DOI 10.1002/jbm.a.34913
   Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002
   Liu Jie, 2014, Open Dent J, V8, P56, DOI 10.2174/1874210601408010056
   Liu YL, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862312
   Machtei EE, 2001, J PERIODONTOL, V72, P512, DOI 10.1902/jop.2001.72.4.512
   Necas J, 2008, VET MED-CZECH, V53, P397
   Owens K. W., 2001, IMPLANT DENT, V10, P48
   Park JS, 2011, CLIN ORTHOP SURG, V3, P315, DOI 10.4055/cios.2011.3.4.315
   Pasqui D, 2014, J BIOMED MATER RES A, V102, P1568, DOI 10.1002/jbm.a.34810
   Piattelli A, 1998, BIOMATERIALS, V19, P889, DOI 10.1016/S0142-9612(97)00173-7
   Picaud L, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-40
   Rojsanga P, 2006, MED PRIN PRACT, V15, P373, DOI 10.1159/000094272
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Sagar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077578
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P166
   Srinivasan GV, 2008, INDIAN J PHARM SCI, V70, P96, DOI 10.4103/0250-474X.40341
   Diaz MS, 2009, PHOTOCH PHOTOBIO SCI, V8, P970, DOI 10.1039/b822363g
   Uchida K, 2011, SURG SCI, V2, P431, DOI [10.4236/ss.2011.29094, DOI 10.4236/SS.2011.29094]
   Wang HL, 2001, QUINTESSENCE INT, V32, P504
   Xue JJ, 2014, INT J PHARMACEUT, V475, P566, DOI 10.1016/j.ijpharm.2014.09.026
   Yamamoto M, 2010, J ORTHOP RES, V28, P284, DOI 10.1002/jor.21004
   Yi ZB, 2007, J PHARMACEUT BIOMED, V44, P301, DOI 10.1016/j.jpba.2007.02.018
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 36
TC 0
Z9 0
U1 2
U2 9
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 3640182
DI 10.1155/2016/3640182
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA EH8AT
UT WOS:000391994700001
PM 28119926
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chen, SH
   Liu, YS
   Dong, Q
   Zhou, YS
   Yin, XZ
   Chen, DZ
   Xu, CG
   Xu, WL
AF Chen, Shaohua
   Liu, Yuansen
   Dong, Qi
   Zhou, Yingshan
   Yin, Xianze
   Chen, Dongzhi
   Xu, Changan
   Xu, Weilin
TI Photocrosslinked Poly(vinyl alcohol) Nanofibrous Scaffolds
SO JOURNAL OF PHOTOPOLYMER SCIENCE AND TECHNOLOGY
LA English
DT Article
DE electrospinning; poly(vinyl alcohol); photopolymerization; wound;
   dressing
ID WOUND DRESSINGS; ELECTROSPINNING METHOD; MECHANICAL-PROPERTIES; BLEND
   NANOFIBERS; TISSUE; FABRICATION; MEMBRANE; SKIN; BIOMATERIAL; DEPOSITION
AB Biocompatible photocrosslinked poly(vinyl alcohol) nanofibrous Scaffolds were successfully prepared by electrospinning and consequent photopolymerization. The nanofibrous membranes were subjected to detailed analysis by scanning electron microscopy (SEM), differential scanning calorimetry (DSC) and X-ray diffraction (XRD). SEM images showed that morphology and diameter of the nanofibers were mainly affected by degree of substitute of metharyloyl group. XRD and DSC demonstrated form of a larger fraction of amorphous phase due to destroyed hydrogen bonding through methacrylation. Water stability test showed that the nanofibrous membranes improved its water stability with crosslinking degree increased. The indirect cytotoxicity assessments of the nanofibers were studied. And the result indicated the nanofibers was nontoxic to the L929 cells. This novel electrospun matrix would be used as potential wound dressing for skin regeneration.
C1 [Chen, Shaohua; Dong, Qi; Zhou, Yingshan; Yin, Xianze; Chen, Dongzhi; Xu, Weilin] Wuhan Text Univ, Minist Educ, Key Lab Green Proc & Funct Text New Text Mat, Wuhan 430073, Peoples R China.
   [Liu, Yuansen; Xu, Changan] State Ocean Adm, Inst Oceanog 3, Engn Res Ctr Marine Biol Resource Comprehens Util, Xiamen 361005, Peoples R China.
RP Zhou, YS (reprint author), Wuhan Text Univ, Minist Educ, Key Lab Green Proc & Funct Text New Text Mat, Wuhan 430073, Peoples R China.
FU Project of Wuhan Science and Technology Bureau [2015070404010210];
   Educational Commission of Hubei Province of China [D20151605]; Xiamen
   Southern Oceanographic Center [14GZP004NF04, 14GQT61HJ31, 15GZP023NF01]
FX This study was supported by Project of Wuhan Science and Technology
   Bureau (No. 2015070404010210), Educational Commission of Hubei Province
   of China (No. D20151605), and Xiamen Southern Oceanographic Center
   (14GZP004NF04, 14GQT61HJ31, 15GZP023NF01).
CR Abrigo M, 2014, MACROMOL BIOSCI, V14, P772, DOI 10.1002/mabi.201300561
   Ali IH, 2016, ACS APPL MATER INTER, V8, P14453, DOI 10.1021/acsami.6b04369
   Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Cay A, 2014, EUR POLYM J, V61, P253, DOI 10.1016/j.eurpolymj.2014.10.017
   Chahal S, 2016, CHEM ENG SCI, V144, P17, DOI 10.1016/j.ces.2015.12.030
   Cordoba A. L., 2016, MAT SCI ENG C, V69, P726
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Crispim EG, 2006, POLYM TEST, V25, P377, DOI 10.1016/j.polymertesting.2005.12.003
   Dijk-Wolthuis W. N. E. V., 1995, MACROMOLECULES, V28, P6317
   Ding B, 2002, FIBER POLYM, V3, P73, DOI 10.1007/BF02875403
   Dong RH, 2016, NANOSCALE, V8, P3482, DOI 10.1039/c5nr08367b
   Islam MS, 2010, COLLOID SURFACE A, V366, P135, DOI 10.1016/j.colsurfa.2010.05.038
   Jannesari Marziyeh, 2011, Int J Nanomedicine, V6, P993, DOI 10.2147/IJN.S17595
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Ko H, 2006, J PHOTOPOLYM SCI TEC, V19, P413, DOI 10.2494/photopolymer.19.413
   Liu YR, 2009, MATER LETT, V63, P419, DOI 10.1016/j.matlet.2008.10.060
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Mohammadi M. R., 2013, MAT SCI ENG C, V33, P4935
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nakane K, 1999, J APPL POLYM SCI, V74, P133, DOI 10.1002/(SICI)1097-4628(19991003)74:1<133::AID-APP16>3.0.CO;2-N
   Pelipenko J, 2013, INT J PHARMACEUT, V456, P125, DOI 10.1016/j.ijpharm.2013.07.078
   Rosic R, 2013, EUR POLYM J, V49, P290, DOI 10.1016/j.eurpolymj.2012.11.013
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Stepanyan R, 2016, POLYMER, V97, P428, DOI 10.1016/j.polymer.2016.05.045
   Uzun M, 2016, J IND TEXT, V45, P1383, DOI 10.1177/1528083714560254
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Xu F, 2009, J MATER SCI-MATER M, V20, P1331, DOI 10.1007/s10856-008-3686-9
   Yang CC, 2009, MATER CHEM PHYS, V114, P948, DOI 10.1016/j.matchemphys.2008.11.009
   Yuan J, 2012, J APPL POLYM SCI, V124, P1067, DOI 10.1002/app.33889
   Zhou YS, 2008, BIOMACROMOLECULES, V9, P349, DOI 10.1021/bm7009015
NR 32
TC 1
Z9 1
U1 3
U2 8
PU TECHNICAL ASSOC PHOTOPOLYMERS,JAPAN
PI CHIBA
PA CHIBA UNIV, FACULTY ENGINEERING, YAYOICHO, CHIBA, 263-8522, JAPAN
SN 0914-9244
J9 J PHOTOPOLYM SCI TEC
JI J. Photopolym Sci. Technol.
PY 2016
VL 29
IS 6
BP 841
EP 847
DI 10.2494/photopolymer.29.841
PG 7
WC Polymer Science
SC Polymer Science
GA EH6TF
UT WOS:000391906100011
OA Bronze
DA 2018-10-20
ER

PT S
AU Anchugova, E
   Markarova, M
   Tarabukin, D
   Volodin, V
   Shchemelinina, T
AF Anchugova, Elena
   Markarova, Maria
   Tarabukin, Dmitriy
   Volodin, Vladimir
   Shchemelinina, Tatyana
GP SGEM
TI BIOFILTER FOR TREATMENT OF OILY WATER EFFLUENTS
SO NANO, BIO AND GREEN - TECHNOLOGIES FOR A SUSTAINABLE FUTURE CONFERENCE
   PROCEEDINGS, SGEM 2016, VOL I
SE International Multidisciplinary Scientific GeoConference-SGEM
LA English
DT Proceedings Paper
CT 16th International Multidisciplinary Scientific Geoconference (SGEM
   2016)
CY JUN 30-JUL 06, 2016
CL Albena, BULGARIA
SP Bulgarian Acad Sci, Acad Sci Czech Republ, Latvian Acad Sci, Polish Acad Sci, Russian Acad Sci, Serbian Acad Sci & Arts, Slovak Acad Sci, Natl Acad Sci Ukraine, Inst Water Problem & Hydropower NAS KR, Natl Acad Sci Armenia, Sci Council Japan, World Acad Sci, European Acad Sci Arts & Lett, Acad Sci Moldova, Montenegrin Acad Sci & Arts, Croatian Acad Sci & Arts, Georgian Natl Acad Sci, Acad Fine Arts & Design Bratislava, Turkish Acad Sci, Bulgarian Ind Assoc, Bulgarian Minist Environm & Water
DE oily water effluents; biofilter; treatment; Rhodotorula; technology
   improvement
ID FLOCCULATION; EFFICIENCY
AB In this study, the efficiency of the biofiltering material for the treatment of oily water effluents from total petroleum hydrocarbons (TPH) was evaluated. The soil yeast strain Rhodotorula sp. 51-18-2R (99) Y-2993D [7] isolated from the oil-polluted soils of the Usinsk region of the Republic of Komi, was immobilized on basalt fibre as a matrix, and the ability of the biomaterial to degrade oily water effluents obtained from treatment facilities of the automobile operating company of Syktyvkar, Republic of Komi, Russia was investigated. During the first stage, Rhodotorula sp. cell culture fluid with a cell titre of 10(8) CFU mL(-1) was sprayed on the basalt matrix. The basalt fibre was air-dried within 24 h and was filled into cartridges of the filter of the treatment facilities. Effluents were sampled from both the input and output flow. To improve cell retention on the material and to obtain the basalt fibre matrix (BFM), cationic starch (CS) oxamyl processing was conducted as follows: 1 g of the fibrous material was immersed in a CS solution with a CS concentration of 0.1 (BFM-0.1) or 0.5 mg mL(-1) (BFM-0.5) for 1 hour and kept at standard conditions. Then, the sample was air-dried and immersed for 24 h in Rhodotorula cell culture fluid and then air-dried again. To estimate the number of immobilized cells, microphotographic images were obtained with a scanning electron microscope and MICROS MC-200 x 100 oil-immersion objective after 80 days of sample incubation. An experimental continuous flow apparatus was constructed for continuous treatment of artificially contaminated water samples. A separable silicone tube (10 mm x 100 mm) was used for the bioreactor. The model water (1 L) was continuously fed into the bioreactor filled with 1 g of the biofiltering material with a peristaltic pump. The model water flow rate was controlled to be 1 mL, s(-1). Water exiting the bioreactor was uviolized to halt the biological processes. Model water that passed through the column filled with raw basalt fibre was used as a control. TPH in water was analysed using a fluorescence analyser, "FLUORAT-02-3M", according to Federal Environmental Normative Document 16.1.21-98 [8]. All experiments were performed in triplicate.
C1 [Anchugova, Elena; Markarova, Maria; Tarabukin, Dmitriy; Volodin, Vladimir; Shchemelinina, Tatyana] RAS, Inst Biol, Komi Sci Ctr, Ural Dept, Moscow, Russia.
RP Anchugova, E (reprint author), RAS, Inst Biol, Komi Sci Ctr, Ural Dept, Moscow, Russia.
CR Ahmadun FR, 2009, J HAZARD MATER, V170, P530, DOI 10.1016/j.jhazmat.2009.05.044
   [Anonymous], 1998, METHOD DETERMINATION
   Bakke T, 2013, MAR ENVIRON RES, V92, P154, DOI 10.1016/j.marenvres.2013.09.012
   Hutchens Elena, 2009, Fungal Biology Reviews, V23, P115, DOI 10.1016/j.fbr.2009.10.002
   Ji GD, 2011, BIORESOURCE TECHNOL, V102, P550, DOI 10.1016/j.biortech.2010.07.075
   Lobakova E.S., 2014, MOSCOW U BIOL SCI B, V69, P173, DOI DOI 10.3103/S0096392514040099
   Magnin D, 2004, CARBOHYD POLYM, V55, P437, DOI 10.1016/j.carbpol.2003.11.013
   Markarova M. Y., 2014, RU Patent, Patent No. [2 526 496 C1, 2526496]
   Strand SP, 2002, WATER RES, V36, P4745, DOI 10.1016/S0043-1354(02)00173-2
   Vandamme D, 2010, J APPL PHYCOL, V22, P525, DOI 10.1007/s10811-009-9488-8
   Zheng HL, 2012, BIORESOURCE TECHNOL, V112, P212, DOI 10.1016/j.biortech.2012.02.086
NR 11
TC 0
Z9 0
U1 2
U2 3
PU STEF92 TECHNOLOGY LTD
PI SOFIA
PA 1 ANDREY LYAPCHEV BLVD, SOFIA, 1797, BULGARIA
SN 1314-2704
BN 978-619-7105-68-1
J9 INT MULTI SCI GEOCO
PY 2016
BP 451
EP 456
PG 6
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA BG7RJ
UT WOS:000391648800059
DA 2018-10-20
ER

PT J
AU Li, YL
   Li, H
   Zhang, J
   Zhao, WK
   Shen, JL
   Jiang, DM
AF Li, Yuling
   Li, Hong
   Zhang, Jing
   Zhao, Weikang
   Shen, Jieliang
   Jiang, Dianming
TI In vitro evaluation of an yttria-stabilized zirconia reinforced
   nano-hydroxyapatite/polyamide 66 ternary biomaterial: biomechanics,
   biocompatibility and bioactivity
SO RSC ADVANCES
LA English
DT Article
ID STROMAL CELL-CULTURE; MECHANICAL-PROPERTIES; CERVICAL CORPECTOMY;
   IMPLANT MATERIAL; VIVO EVALUATION; BIOCOMPOSITE; TITANIUM;
   DIFFERENTIATION; COMPOSITES; PROSTHESES
AB Nano-hydroxyapatite/polyamide 66 (nHA/PA66) is a bioactive composite that is widely applied in orthopedics. However, imperfect mechanical behavior is the main drawback of the nHA/PA66 composite, and this is a limitation for further applications. Meanwhile, zirconia has been attracting increasing attention in recent years, owing to its excellent mechanical behavior and biocompatibility. A novel ternary biomaterial composed of nHA/PA66/yttria-stabilized tetragonal zirconia (YTZ) was prepared in the present research. The material was analyzed by X-ray diffraction and Fourier transform infrared spectrometry; mechanical behavior was also tested. The results of the mechanical-behavior testing showed that the mechanical behaviors of nHA/PA66/YTZ were significantly better than those of nHA/PA66. Besides, the cross-section of this biocomposite was characterized by scanning electron microscopy. Furthermore, the biocompatibility and bioactivity were evaluated in vitro using MC3T3-E1 cells. From the results of the biocompatibility and bioactivity experiments (cell counting kit-8 tests, cell immunofluorescence analysis, alizarin red S staining and western blotting), it was observed that nHA/PA66/YTZ could facilitate the biological function of MC3T3-E1 cells. The results showed that the attachment, proliferation, spreading, calcium nodule formation, and expression of osteogenic-related proteins (collagen 1, osteopontin, osteocalcin) of cells cultured with the nHA/PA66/YTZ composite were better than for control groups. The ternary biomaterial has promising mechanical properties, biocompatibility and bioactivity. Thus, it deserves more attention and is worthy of further research.
C1 [Li, Yuling; Zhao, Weikang; Shen, Jieliang; Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China.
   [Li, Hong] Sichuan Univ, Analyt & Testing Ctr, Res Ctr Nanobiomat, Chengdu, Peoples R China.
   [Zhang, Jing] North Sichuan Med Coll, Affiliated Hosp, Dept Gastroenterol, Nanchong, Peoples R China.
RP Jiang, DM (reprint author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China.
EM jdm571026@vip.163.com
FU National Natural Science Foundation of China [81501876]; Key Medical
   Program of Science and Technology Development of Chongqing [2013-1-011]
FX This study was supported by grants of National Natural Science
   Foundation of China (81501876), and the Key Medical Program of Science
   and Technology Development of Chongqing (2013-1-011).
CR Abedi G, 2014, POL J PATHOL, V65, P40, DOI 10.5114/PJP.2014.42668
   Ballo AM, 2009, CLIN ORAL IMPLAN RES, V20, P608, DOI 10.1111/j.1600-0501.2008.01700.x
   Barber FA, 2011, ARTHROSCOPY, V27, P637, DOI 10.1016/j.arthro.2010.11.056
   Bartolome JF, 2016, BIOMATERIALS, V76, P313, DOI 10.1016/j.biomaterials.2015.10.058
   Basaran EG, 2013, J PROSTHET DENT, V109, P88, DOI 10.1016/S0022-3913(13)60022-0
   Chen T, 2009, CELL BIOL TOXICOL, V25, P573, DOI 10.1007/s10565-008-9113-7
   Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Elpers M, 2014, J ARTHROPLASTY, V29, P2219, DOI 10.1016/j.arth.2014.08.011
   Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145
   Gyorgyey A, 2013, MAT SCI ENG C-MATER, V33, P4251, DOI 10.1016/j.msec.2013.06.020
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Knabe C, 2002, BIOMATERIALS, V23, P3235, DOI 10.1016/S0142-9612(02)00078-9
   Kohal RJ, 2010, CLIN ORAL IMPLAN RES, V21, P1345, DOI 10.1111/j.1600-0501.2010.01954.x
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   Lee WT, 2012, J BIOMED MATER RES B, V100B, P1044, DOI 10.1002/jbm.b.32669
   Li H, 2012, INT J NANOMED, V7, P1287, DOI 10.2147/IJN.S28978
   Li JD, 2011, J BIOMAT SCI-POLYM E, V22, P263, DOI [10.1163/092050609X12602753096279, 10.1163/0920506O9XI2602753O96279]
   Ma R, 2014, INT J NANOMED, V9, P3949, DOI 10.2147/IJN.S67358
   Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]
   Matsumoto TJ, 2011, DENT MATER, V27, pE205, DOI 10.1016/j.dental.2011.07.009
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mihatovic I, 2017, CLIN ORAL INVEST, V21, P523, DOI 10.1007/s00784-016-1904-2
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Qiao B, 2014, INT J NANOMED, V9, P1423, DOI 10.2147/IJN.S57353
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Saito N, 2011, CHEM SOC REV, V40, P3824, DOI 10.1039/c0cs00120a
   Sarsilmaz F, 2007, ACTA BIOENG BIOMECH, V9, P9
   Shao RX, 2016, J BIOMATER APPL, V30, P1312, DOI 10.1177/0885328215627616
   Shokrollahi P, 2010, J BIOMED MATER RES A, V95A, P209, DOI 10.1002/jbm.a.32828
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Su B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068342
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   Tan HL, 2012, ACTA BIOMATER, V8, P2166, DOI 10.1016/j.actbio.2012.03.013
   UHTHOFF HK, 1994, J BONE JOINT SURG AM, V76A, P1507, DOI 10.2106/00004623-199410000-00010
   UHTHOFF HK, 1983, J BONE JOINT SURG BR, V65, P66
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xiong Y, 2014, INT J NANOMED, V9, P485, DOI 10.2147/IJN.S52990
   Yang P, 2014, ARCH ORTHOP TRAUM SU, V134, P103, DOI 10.1007/s00402-013-1885-4
   Yang X, 2012, ORTHOPEDICS, V35, pE66, DOI 10.3928/01477447-20111122-10
   Zhang XS, 2015, J MECH BEHAV BIOMED, V42, P267, DOI 10.1016/j.jmbbm.2014.11.027
   Zhang Y., 2014, EURASIP J ADV SIG PR, V2014, P1, DOI DOI 10.1016/J.ENGGE0.2014.08.024
   Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26751
   Zhao ZH, 2012, J CLIN NEUROSCI, V19, P536, DOI 10.1016/j.jocn.2011.05.043
NR 45
TC 1
Z9 1
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 115
BP 114086
EP 114095
DI 10.1039/c6ra24509a
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA EH0ME
UT WOS:000391457400032
DA 2018-10-20
ER

PT J
AU Maktedar, SS
   Avashthi, G
   Singh, M
AF Maktedar, Shrikant S.
   Avashthi, Gopal
   Singh, Man
TI Understanding the significance of O-doped graphene towards biomedical
   applications
SO RSC ADVANCES
LA English
DT Article
ID HIGH THERMAL-CONDUCTIVITY; GRAPHITE OXIDE; DIRECT FUNCTIONALIZATION;
   ROBUST APPROACH; REDUCTION; NANOCOMPOSITES; CARBON; NANOSHEETS;
   OXIDATION; BIOCOMPATIBILITY
AB The inherent stability and solvent processability restrict the functional expression of graphene for biomedical applications. To resolve this problem graphene oxide (GrO) has emerged as a biomaterial for biomedical applications of graphene. The participation of O_K edges has been confirmed with synchrotron radiation near edge X-ray absorption fine structure (SR-NEXAFS). The as-prepared graphene oxide has been confirmed with C-13 cross polymerization magic angle spinning (CP-MAS) solid state NMR, HRXPS, HRTEM, SAED, SEM, AFM, Raman, XRD, FTIR, UV, TGA, DTA, BET and Porosimeter, etc. The biomedical significance of graphene oxide has been supported by an extensive structural investigation. The underlying mechanism of biological activity of graphene oxide has been inferred through the synergistic impact of contributory factors (SICF). The cytotoxicity of graphene oxide has been evaluated with an SRB assay with living mammalian cell lines, human breast cancer cell line MCF-7 and monkey normal kidney cell line Vero. The estimated cell viabilities are greater than 80% over a 10-80 mu g mL(-1) concentration. The high cytocompatibility of graphene oxide has confirmed its low toxicity and hence its excellent biocompatibility. Moreover, the morphological effect on the Vero cell line has been endorsed by in vitro behaviour. The sensitivity of graphene oxide has been evaluated with minimum inhibitory concentration (MIC) against antifungal strain C. albicans (ATCC 10231) at 128 mu g mL(-1). However, for antibacterial strains S. aureus (ATCC 25923) and E. coli (ATCC 25922) the MIC of graphene oxide is 256 mu g mL(-1). The genetic variability greatly increases during the sub-culturing of strains; therefore the resistant behaviour of graphene oxide has been observed against NCIM strains. Additionally, the antioxidant activity of graphene oxide is 50.57-45.89%, at over 40-100 mu g mL(-1) concentration. Hence, the structural investigations of graphene oxide have complemented the findings for biological activity and emerged as an advanced functional biomaterial for biomedical applications of graphene.
C1 [Maktedar, Shrikant S.; Avashthi, Gopal; Singh, Man] Cent Univ Gujarat, Sch Chem Sci, Gandhinagar 382030, India.
RP Singh, M (reprint author), Cent Univ Gujarat, Sch Chem Sci, Gandhinagar 382030, India.
EM shrikantmaktedar@gmail.com; gopalavashthi@gmail.com;
   mansingh50@hotmail.com
OI Maktedar, Shrikant/0000-0001-5930-2060
FU UGC, New Delhi
FX Authors are thankful to Central University of Gujarat for
   infrastructural support and instrumentation facility. UGC, New Delhi is
   acknowledged for fellowship support. The National Chemical Laboratory is
   acknowledged for the solid-state NMR facility. Dr Dinesh Kumar Shukla
   and Mr Rakesh Kumar Sah, UGC-DAE CSR Indore, were acknowledged for their
   valuable guidance and help for so. X-ray absorption measurements,
   respectively. Dr Vasant Sathe, UGC-DAE CSR Indore, was acknowledged for
   providing Raman facility. Dr Ulhas Patil, Microbiology Department, R. C.
   Patel College, Shirpur, Maharashtra, was acknowledged for antimicrobial
   tests and fruitful discussion. Dr Jyoti A. Kode, ACTREC, Tata Memorial
   Centre, Mumbai, was acknowledged for providing in vitro cytotoxicity
   screening facility.
CR Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872
   Banerjee SS, 2014, BIOMATER SCI-UK, V2, P57, DOI 10.1039/c3bm60082c
   Barbolina I, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/2/025025
   Bhaisare ML, 2016, BIOMATER SCI-UK, V4, P183, DOI 10.1039/c5bm00342c
   Brodie B. C., 1859, PHILOS T R SOC LONDO, V149, P249, DOI DOI 10.1098/RSTL.1859.0013
   Chng ELK, 2015, RSC ADV, V5, P3074, DOI 10.1039/c4ra12624f
   CLAUSS A, 1957, Z ANORG ALLG CHEM, V291, P205, DOI 10.1002/zaac.19572910502
   Dey RS, 2012, CHEM COMMUN, V48, P1787, DOI 10.1039/c2cc16031e
   Dimiev A, 2012, J AM CHEM SOC, V134, P2815, DOI 10.1021/ja211531y
   Eigler S, 2013, ADV MATER, V25, P3583, DOI 10.1002/adma.201300155
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Gandhiraman RP, 2014, J PHYS CHEM C, V118, P18706, DOI 10.1021/jp503941t
   Gao W, 2009, NAT CHEM, V1, P403, DOI [10.1038/NCHEM.281, 10.1038/nchem.281]
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gu HB, 2016, J MATER CHEM C, V4, P5890, DOI 10.1039/c6tc01210h
   Gu JW, 2016, IND ENG CHEM RES, V55, P10941, DOI 10.1021/acs.iecr.6b03093
   Gu JW, 2016, RSC ADV, V6, P35809, DOI 10.1039/c6ra04513h
   Gu JW, 2016, INT J HEAT MASS TRAN, V92, P15, DOI 10.1016/j.ijheatmasstransfer.2015.08.081
   Gu JW, 2015, RSC ADV, V5, P36334, DOI 10.1039/c5ra03284a
   Gurunathan S, 2013, INT J NANOMED, V8, P2719, DOI 10.2147/IJN.S45174
   Hofmann U, 1939, BER DTSCH CHEM GES, V72, P754, DOI 10.1002/cber.19390720417
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Inwati GK, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1653-9
   Jeong HK, 2008, J AM CHEM SOC, V130, P1362, DOI 10.1021/ja076473o
   Jiang B, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-016-3458-2
   Katsnelson M.I., 2007, MATER TODAY, V10, P1
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lerf A, 1998, J PHYS CHEM B, V102, P4477, DOI 10.1021/jp9731821
   Li B, 2016, RSC ADV, V6, P19797, DOI 10.1039/c5ra23990g
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Li X., 2010, CHINESE J CHEM, V68, P1915
   Liu Y, 2010, LANGMUIR, V26, P6158, DOI 10.1021/la100886x
   Maktedar SS, 2017, ULTRASON SONOCHEM, V34, P856, DOI 10.1016/j.ultsonch.2016.07.016
   Maktedar SS, 2017, ULTRASON SONOCHEM, V34, P67, DOI 10.1016/j.ultsonch.2016.05.015
   Maktedar SS, 2014, ULTRASON SONOCHEM, V21, P1407, DOI 10.1016/j.ultsonch.2014.02.022
   Malik P, 2016, J MOL LIQ, V220, P604, DOI 10.1016/j.molliq.2016.04.126
   Malik P, 2014, CHEM-BIOL INTERACT, V222, P77, DOI 10.1016/j.cbi.2014.07.013
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Mehetre SS, 2016, APPL SURF SCI, V366, P514, DOI 10.1016/j.apsusc.2016.01.108
   MERMOUX M, 1991, CARBON, V29, P469, DOI 10.1016/0008-6223(91)90216-6
   NAKAJIMA T, 1988, CARBON, V26, P357, DOI 10.1016/0008-6223(88)90227-8
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Nurunnabi M, 2015, RSC ADV, V5, P42141, DOI 10.1039/c5ra04756k
   Patange M, 2015, PHYS CHEM CHEM PHYS, V17, P32398, DOI 10.1039/c5cp05830a
   Pinto AM, 2016, CARBON, V99, P318, DOI 10.1016/j.carbon.2015.11.076
   Ruess G., 1947, MONATSH CHEM, V76, P381, DOI DOI 10.1007/BF00898987
   Sayyar S, 2015, J MATER CHEM B, V3, P481, DOI 10.1039/c4tb01636j
   SCHOLZ W, 1969, Z ANORG ALLG CHEM, V369, P327, DOI 10.1002/zaac.19693690322
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y
   Sun ZZ, 2011, J PHYS CHEM LETT, V2, P2425, DOI 10.1021/jz201000a
   Sydlik SA, 2015, ACS NANO, V9, P3866, DOI 10.1021/acsnano.5b01290
   Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258
   Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI [10.1038/nnano.2008.329, 10.1038/NNANO.2008.329]
   Urbas K, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-656
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Wang JL, 2013, RSC ADV, V3, P15776, DOI 10.1039/c3ra40392k
   Wang JY, 2015, J ENERGY CHEM, V24, P127, DOI 10.1016/S2095-4956(15)60293-5
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Zappacosta R, 2015, J MATER CHEM B, V3, P6520, DOI 10.1039/c5tb00798d
   Zhang HC, 2013, J MATER CHEM B, V1, P2542, DOI 10.1039/c3tb20405g
   Zhang L, 2017, APPL CATAL B-ENVIRON, V201, P470, DOI 10.1016/j.apcatb.2016.08.056
   Zhang QB, 2015, J NANOSCI NANOTECHNO, V15, P9807, DOI 10.1166/jnn.2015.10625
   Zhang WY, 2015, RSC ADV, V5, P49521, DOI 10.1039/c5ra05051k
   Zhao WF, 2016, NANOSCALE, V8, P19984, DOI 10.1039/c6nr06622d
   Zuo PP, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-39
NR 68
TC 15
Z9 15
U1 10
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 115
BP 114264
EP 114275
DI 10.1039/c6ra23416j
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA EH0ME
UT WOS:000391457400050
DA 2018-10-20
ER

PT S
AU Dhabale, R
   Jatti, VS
AF Dhabale, R.
   Jatti, V. S.
BE Rao, CSP
   Basavarajappa, S
TI A bio-material: mechanical behaviour of LDPE-Al2O3-TiO2
SO INTERNATIONAL CONFERENCE ON ADVANCES IN MATERIALS AND MANUFACTURING
   APPLICATIONS (ICONAMMA-2016)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT International Conference on Advances in Materials and Manufacturing
   Applications (IConAMMA)
CY JUL 14-16, 2016
CL Bangalore, INDIA
SP Amrita Vishwa Vidyapeetham Univ, Amrita Sch Engn, Dept Mech Engn, Mat Characterizat Syst
ID TITANIUM
AB Polymer composites are prominent candidate for polymeric bio-composites due to its low cost, high strength and ease of manufacturing. However, they suffer from low mechanical properties such as high wear rate and low hardness. In view of this, present study focuses on the synthesis of hybrid bio polymer matrix composites using low density polyethylene as matrix material with reinforcing material namely, alumina and titanium oxide. The samples were fabricated as per ASTM standard by varying the percentage of reinforcing particles using injection moulding machine. Various tests namely, tensile, flexural, impact, hardness, wear, SEM and corrosion were conducted on the prepared samples. On the basis of the experimental results, it can be concluded that injection moulding process can fabricate defect free cast samples. Polymer matrix composites of 70%LDPE +10% TiO2 +20% Al2O3 composition is biocompatible and a good candidate for biomaterial. Thus based on the inference of this study the above polymer matrix composite is suitable for orthopaedic applications and can be applied on hard and soft tissues of implantable materials in a human body.
C1 [Dhabale, R.; Jatti, V. S.] Symbiosis Int Univ, Symbiosis Inst Technol, Dept Mech Engn, Pune, Maharashtra, India.
RP Dhabale, R (reprint author), Symbiosis Int Univ, Symbiosis Inst Technol, Dept Mech Engn, Pune, Maharashtra, India.
EM rahulbdhabale@gmail.com; vijaykjatti@gmail.com
CR Akindapo J O, 2014, INT J ENG RES TECHNO, V3, P2337
   Dinesh K R, 2013, INT J APPL INNOV ENG, V2, P376
   Haneef M, INT J MODERN ENG RES, V3, P970
   Kumar N. R., 2013, INT J ENG RES TECHNO, V2, P3701
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Rao T V, 2014, INT J ENG RES TECHNO, V3, P725
   Sidambe AT, 2014, MATERIALS, V7, P8168, DOI 10.3390/ma7128168
   Tamboli SM, 2004, INDIAN J CHEM TECHN, V11, P853
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
   Thimmanagouda A, 2014, IOSR J MECH CIVIL EN, V11, P40
NR 10
TC 2
Z9 2
U1 1
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2016
VL 149
AR UNSP 012043
DI 10.1088/1757-899X/149/1/012043
PG 9
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BG7AL
UT WOS:000391127300043
OA Other Gold
DA 2018-10-20
ER

PT B
AU Chudacik, V
   Smetana, M
   Behun, L
AF Chudacik, Vladimir
   Smetana, Milan
   Behun, Lukas
BE Mikulka, J
TI Three-dimensional Representation of Intrinsic Magnetic Field of
   Austenitic Biomaterial
SO INTERNATIONAL INTERDISCIPLINARY PHD WORKSHOP 2016
LA English
DT Proceedings Paper
CT International Interdisciplinary PhD Workshop
CY SEP 12-15, 2016
CL Brno, CZECH REPUBLIC
SP Brno Univ Technol, Fac Elect Engn & Commun, Dept Theoret & Experimental Elect Engn, FEI Czech Republic s r o, West Pomerian Univ Technol Szczecin, Fac Elect Engn, Electrotechn Inst Warsaw, Lublin Univ Technol, Budapest Univ Technol & Econ, Slovak Univ Technol Bratislava, Fac Elect Engn & Informat Technol, Brno Univ Technol, Fac Elect Engn & Commun
AB This paper deals with non-destructive evaluation of weak intrinsic magnetic field of the biomaterial. Austenitic stainless steels AISI 316L is investigated using the commercial magnetic field sensor. Biomaterial specimens are evaluated under the same conditions after its plastic deformation at defined level. The martensitic domains are generated inside the austenitic specimens and biomaterials magnetic field is increased. Except electromagnetic properties, the mechanical properties were changed, too. The experimental measurements are followed by the creation of a numerical model. The position of the martensitic domains is localized and reconstructed in 3D representation.
C1 [Chudacik, Vladimir; Smetana, Milan; Behun, Lukas] Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Univ 1, Zilina 01026, Slovakia.
RP Chudacik, V (reprint author), Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Univ 1, Zilina 01026, Slovakia.
EM vladimir.chudacik@fel.uniza.sk; milan.smetana@fel.uniza.sk;
   lukas.behun@fel.uniza.sk
CR Boltz E.S., 1998, REV PROG QUANT NONDE, V17, P1033
   Hellier C., 2001, HDB NONDESTRUCTIVE E
   Oravcova M., 2015, 19 INT WORKSH ADV EX
   Smetana M., 2015, STUDIES APPL ELECTRO, V40, P35
   Yuan SF, 2008, J INTEL MAT SYST STR, V19, P373, DOI [10.1177/1045389X07087302, 10.1177/1046389X07087302]
NR 5
TC 0
Z9 0
U1 0
U2 0
PU BRNO UNIV TECHNOLOGY VUT PRESS
PI BRNO
PA ANTONINSKA 548-1, BRNO 601 90, CZECH REPUBLIC
BN 978-80-214-5387-6
PY 2016
BP 97
EP 101
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA BG7HD
UT WOS:000391280700020
DA 2018-10-20
ER

PT S
AU Istrate, B
   Munteanu, C
   Matei, MN
   Oprisan, B
   Chicet, D
   Earar, K
AF Istrate, B.
   Munteanu, C.
   Matei, M. N.
   Oprisan, B.
   Chicet, D.
   Earar, K.
BE Sandu, AV
   Abdullah, MMB
   Vizureanu, P
   AbdRahim, SZ
   Sandu, I
TI Influence of ZrO2-Y2O3 and ZrO2-CaO coatings on microstructural and
   mechanical properties on Mg-1,3Ca-5,5Zr biodegradable alloy
SO INTERNATIONAL CONFERENCE ON INNOVATIVE RESEARCH - ICIR EUROINVENT 2016
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT EUROINVENT International Conference on Innovative Research (ICIR
   Euroinvent)
CY MAY 19-20, 2016
CL Iasi, ROMANIA
SP EUROINVENT, Romanian Inventors Forum, Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Univ Malaysia Perlis, Ctr Excellence Geopolymer & Green Technol, Alexandru Ioan Cuza Univ Iasi, ARHEOINVEST Platform, Malaysian Res & Innovat Soc
ID LOW-POWER PLASMA; BIOMEDICAL APPLICATIONS; MAGNESIUM; CORROSION; CA
AB Zirconia (ZrO2) as a ceramic biomaterial facilitates the osteoconductivity in new bone formation around implant. In order to improve the degradation and the surface properties, it is necessary to apply a surface film to satisfy multiple clinical requirements such as mechanical strength, biocompatibility, and degradation rate. Therefore, surface changing to form a tenacious, biocompatible and corrosion resistant modified layer has become a necessary study in biodegradable materials. The aim of the study is to observe the morphology, structural and scratch analysis for some coatings of ZrO2-CaO and ZrO2-Y2O3 having similar thickness deposited with an atmospheric plasma spraying facility, Sulzer Metco 9MCE, using scanning electron microscopy and X-Ray diffraction. Some mechanical aspects were highlighted during the scratch test. Comparative scratch tests were carried out to study the bonding properties between the coatings and the substrates.
C1 [Istrate, B.; Munteanu, C.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, 43 D Mangeron St, Iasi 700050, Romania.
   [Matei, M. N.; Earar, K.] Dunarea Jos Univ Galati, Fac Med, Dent Med, Al I Cuza 35 St, Galati, Romania.
   [Oprisan, B.] Gr T Popa Med Univ Iasi, Fac Gen Med, Univ St 16, Iasi, Romania.
   [Chicet, D.] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, 61-63 D Mangeron St, Iasi 700050, Romania.
RP Munteanu, C (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, 43 D Mangeron St, Iasi 700050, Romania.
EM cornelmun@gmail.com
RI Bogdan, Istrate/P-5182-2014
OI Bogdan, Istrate/0000-0003-0817-3523
CR Bozzini B, 2011, J MATER SCI-MATER M, V22, P193, DOI 10.1007/s10856-010-4187-1
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   Li JN, 2010, J MATER SCI, V45, P6038, DOI 10.1007/s10853-010-4688-9
   Morks MF, 2006, MATER LETT, V60, P1049, DOI 10.1016/j.matlet.2005.10.073
   Morks MF, 2005, SURF COAT TECH, V199, P66, DOI 10.1016/j.surfcoat.2005.02.159
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Qiao ZX, 2012, CORROS SCI, V61, P185, DOI 10.1016/j.corsci.2012.04.030
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Zhang WJ, 2012, MATER DESIGN, V39, P379, DOI 10.1016/j.matdes.2012.03.006
   Zhou YL, 2012, MATER TECHNOL, V27, P52, DOI 10.1179/175355511X13240279340200
NR 13
TC 4
Z9 4
U1 2
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2016
VL 133
AR UNSP 012010
DI 10.1088/1757-899X/133/1/012010
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA BG7AT
UT WOS:000391140000010
OA Other Gold
DA 2018-10-20
ER

PT J
AU Salvetr, P
   Novak, P
   Vojtech, D
AF Salvetr, Pavel
   Novak, Pavel
   Vojtech, Dalibor
TI POROUS MAGNESIUM ALLOYS PREPARED BY POWDER METALLURGY
SO MATERIALI IN TEHNOLOGIJE
LA English
DT Article
DE magnesium alloys; powder metallurgy; porosity; biomaterial
ID MECHANICAL-PROPERTIES; HYDROGEN STORAGE; SCAFFOLDS; POROSITY; MG
AB This paper deals with the development of porous magnesium alloys that can be used in medicine for bone fixations and implants. The individual components of the alloys were chosen so that the biodegradability of the material is maintained. The advantage of these magnesium materials should be an ability to decompose after some time. This should reduce the number of surgeries and consequently increase the comfort of patients. All the samples were prepared using the method of powder metallurgy. The influence of particular alloying elements - aluminium, zinc, yttrium - on the structure of the alloys was explored, with changes being seen in the area of the fraction of pores, the size and the shapes of the pores, according to the alloying elements and the prolongation of the time of sintering the powders. By altering the chemical composition and the time of sintering the demanded porosity was not achieved, and that is the reason why a pore-forming agent (ammonium carbonate) was added. It was removed by thermal decomposition before the powder's sintering. By adding ammonium carbonate we managed to increase the porosity and at the same time we obtained more pores (in equivalent diameter 200-400 mu m). The mechanical properties of the samples were tested in compression. In the samples without the pore-forming agent the values of the ultimate strength were larger than the values of natural bones. After adding the pore-forming agent the ultimate strength and modulus elasticity were reduced.
C1 [Salvetr, Pavel; Novak, Pavel; Vojtech, Dalibor] Univ Chem & Technol, Dept Met & Corros Engn, Tech 5, Prague 16628 6, Czech Republic.
RP Salvetr, P (reprint author), Univ Chem & Technol, Dept Met & Corros Engn, Tech 5, Prague 16628 6, Czech Republic.
EM psalvetr@seznam.cz
RI Novak, Pavel/F-1049-2017
OI Novak, Pavel/0000-0001-9947-2566
FU Czech Science Foundation [P108/12/G043]
FX This research was financially supported by Czech Science Foundation,
   project No. P108/12/G043.
CR Capek J, 2014, MAT SCI ENG C-MATER, V35, P21, DOI 10.1016/j.msec.2013.10.014
   Capek J, 2013, MAT SCI ENG C-MATER, V33, P564, DOI 10.1016/j.msec.2012.10.002
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Kainer KU, 2010, SHREIR'S CORROSION, VOL 3: CORROSION AND DEGRADATION OF ENGINEERING MATERIALS, P2011
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kirkland NT, 2011, MATER SCI ENG B-ADV, V176, P1666, DOI 10.1016/j.mseb.2011.04.006
   Klacnik G., 2010, MATER TEHNOL, V44, P261
   Kubasek J, 2014, MATER TEHNOL, V48, P623
   Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005
   Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4
   Socjusz-Podosek M, 2003, MATER CHEM PHYS, V80, P472, DOI 10.1016/S0254-0584(02)00549-7
   Vojtech D, 2012, MATER TEHNOL, V46, P247
   Vojtech D, 2011, CHEM LISTY, V105, P678
   Wen CE, 2004, MATER LETT, V58, P357, DOI 10.1016/S0167-577X(03)004500-7
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Zhuang HY, 2008, MAT SCI ENG C-BIO S, V28, P1462, DOI 10.1016/j.msec.2008.04.001
NR 17
TC 3
Z9 3
U1 2
U2 9
PU INST ZA KOVINSKE MATERIALE I IN TEHNOLOGIE
PI LJUBJANA
PA LEPI POT 11, LJUBJANA, 10000, SLOVENIA
SN 1580-2949
EI 1580-3414
J9 MATER TEHNOL
JI Mater. Tehnol.
PY 2016
VL 50
IS 6
BP 917
EP 922
DI 10.17222/mit.2015.226
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA EG7JV
UT WOS:000391224300013
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Sionkowska, A
   Michalska, M
   Walczak, M
AF Sionkowska, Alina
   Michalska, Marta
   Walczak, Maciej
TI Preparation and characterization of silk fibroin/collagen sponge with
   nanohydroxyapatite
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article
DE Silk fibroin; collagen; hydroxyapatite; tissue engineering
ID BONE REGENERATION; COLLAGEN; FIBROIN; HYDROXYAPATITE; SCAFFOLDS;
   COMPOSITE; BIOMATERIAL; GROWTH
AB A freeze drying technique was used to form a porous three-dimensional silk fibroin/collagen/hydroxyapatite sponge. Structure of sponge was analyzed using IR spectroscopy. Mechanical properties of sponge were tested and compared with composites containing different ratios of components in samples. Microstructure of porous 3D scaffolds was analyzed by Scanning Electron Microscope. Results showed that scaffolds made of blend of silk fibroin and collagen with inorganic particles of nanohydroxyapatite were less flexible and more stiff than biopolymeric sponge without inorganic part. Moreover, microstructure of those samples was less regular and the size of pores was bigger.
C1 [Sionkowska, Alina; Michalska, Marta] Nicolaus Copernicus Univ Torun, Fac Chem, Dept Chem Biomat & Cosmet, Torun, Poland.
   [Walczak, Maciej] Nicolaus Copernicus Univ Torun, Fac Biol & Environm Protect, Dept Environm Microbiol & Biotechnol, Torun, Poland.
RP Sionkowska, A (reprint author), Nicolaus Copernicus Univ Torun, Fac Chem, Dept Chem Biomat & Cosmet, Torun, Poland.
EM as@chem.umk.pl
CR Ajisawa A, 1998, J SERIC SCI JPN, V67, P91
   Azhar FF, 2014, DES MONOMERS POLYM, V17, P654, DOI 10.1080/15685551.2014.907621
   Bhuiyan D, 2015, ACTA BIOMATER, V15, P181, DOI 10.1016/j.actbio.2014.11.044
   Chang SW, 2012, BIOPHYS J, V102, P640, DOI 10.1016/j.bpj.2011.11.3999
   Chen L, 2014, INT J BIOL MACROMOL, V65, P1, DOI 10.1016/j.ijbiomac.2014.01.003
   Cholas R, 2016, MAT SCI ENG C-MATER, V63, P499, DOI 10.1016/j.msec.2016.03.022
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Jin YS, 2015, COLLOID SURFACE B, V134, P339, DOI 10.1016/j.colsurfb.2015.07.015
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Li YC, 2008, APPL SURF SCI, V255, P1681, DOI 10.1016/j.apsusc.2008.06.009
   Ma X, 2016, COLLOID SURFACE B, V143, P81, DOI 10.1016/j.colsurfb.2016.03.025
   Melke J, 2016, ACTA BIOMATER, V31, P1, DOI 10.1016/j.actbio.2015.09.005
   Minh Thuy L. T., 2014, J MOL LIQ, V149, P264
   Miyamoto S, 2013, J BIOSCI BIOENG, V115, P575, DOI [10.1016/j.biosc.2012.11.021, 10.1016/j.jbiosc.2012.11.021]
   Mou ZL, 2013, MATER LETT, V105, P189, DOI 10.1016/j.matlet.2013.03.130
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Sionkowska A, 2016, J MOL LIQ, V215, P323, DOI 10.1016/j.molliq.2015.12.047
   Sionkowska A, 2014, MOL CRYST LIQ CRYST, V590, P17, DOI 10.1080/15421406.2013.873624
   Sionkowska A, 2010, INT J BIOL MACROMOL, V47, P483, DOI 10.1016/j.ijbiomac.2010.07.002
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 23
TC 1
Z9 1
U1 2
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1542-1406
EI 1563-5287
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2016
VL 640
IS 1
BP 106
EP 112
DI 10.1080/15421406.2016.1257332
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA EG2OH
UT WOS:000390882500013
DA 2018-10-20
ER

PT S
AU Kiyotake, EA
   Beck, EC
   Detamore, MS
AF Kiyotake, Emi A.
   Beck, Emily C.
   Detamore, Michael S.
BE Sun, HB
TI Cartilage extracellular matrix as a biomaterial for cartilage
   regeneration
SO MUSCULOSKELETAL REPAIR AND REGENERATION
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 4th Annual Musculoskeletal Repair and Regeneration Symposium
CY OCT, 2015
CL New York City, NY
DE cartilage matrix; decellularization; devitalization; cartilage tissue
   engineering
ID MESENCHYMAL STEM-CELLS; BOVINE ARTICULAR-CARTILAGE; CROSS-LINKING;
   CHONDROGENIC DIFFERENTIATION; PROMOTE CHONDROGENESIS; COMPRESSIVE
   MODULUS; STROMAL CELLS; BONE-MATRIX; TISSUE; SCAFFOLD
AB The extracellular matrix (ECM) of various tissues possesses the model characteristics that biomaterials for tissue engineering strive to mimic; however, owing to the intricate hierarchical nature of the ECM, it has yet to be fully characterized and synthetically fabricated. Cartilage repair remains a challenge because the intrinsic properties that enable its durability and long-lasting function also impede regeneration. In the last decade, cartilage ECM has emerged as a promising biomaterial for regenerating cartilage, partly because of its potentially chondroinductive nature. As this research area of cartilage matrix-based biomaterials emerged, investigators facing similar challenges consequently developed convergent solutions in constructing robust and bioactive scaffolds. This review discusses the challenges, emerging trends, and future directions of cartilage ECM scaffolds, including a comparison between two different forms of cartilage matrix: decellularized cartilage (DCC) and devitalized cartilage (DVC). To overcome the low permeability of cartilage matrix, physical fragmentation greatly enhances decellularization, although the process itself may reduce the chondroinductivity of fabricated scaffolds. The less complex processing of a scaffold composed of DVC, which has not been decellularized, appears to have translational advantages and potential chondroinductive and mechanical advantages over DCC, without detrimental immunogenicity, to ultimately enhance cartilage repair in a clinically relevant way.
C1 [Kiyotake, Emi A.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA.
   [Beck, Emily C.] Univ Colorado, Dept Bioengn, Anschutz Med Campus, Aurora, CO USA.
RP Detamore, MS (reprint author), Univ Oklahoma, Stephenson Sch Biomed Engn, Carson Engn Ctr, 202 W Boyd St,Room 107, Norman, OK 73019 USA.
EM detamore@ou.edu
FU University of Kansas Graduate Fellowship; University of Oklahoma
   Stephenson Graduate Fellowship; National Science Foundation Graduate
   Research Fellowship
FX We gratefully acknowledge funding support from the University of Kansas
   Graduate Fellowship, the University of Oklahoma Stephenson Graduate
   Fellowship (E.A.K.), and the National Science Foundation Graduate
   Research Fellowship (E.C.B). E.A.K wrote the manuscript, and E.C.B. and
   M.S.D. critically reviewed and revised the manuscript.
CR Almeida HV, 2017, J TISSUE ENG REGEN M, V11, P2979, DOI 10.1002/term.2199
   Almeida HV, 2015, ADV HEALTHC MATER, V4, P1043, DOI 10.1002/adhm.201400687
   Almeida HV, 2014, ACTA BIOMATER, V10, P4400, DOI 10.1016/j.actbio.2014.05.030
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Barrett C., 2015, Patent No. [US 9186253 B2, 9186253]
   Beck EC, 2016, ACTA BIOMATER, V38, P94, DOI 10.1016/j.actbio.2016.04.019
   Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5
   Beck EC, 2016, TISSUE ENG PT A, V22, P665, DOI [10.1089/ten.tea.2015.0546, 10.1089/ten.TEA.2015.0546]
   Benders KEM, 2014, CARTILAGE, V5, P221, DOI 10.1177/1947603514535245
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997
   Chang CH, 2014, J BIOMED MATER RES A, V102, P2248, DOI 10.1002/jbm.a.34897
   Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Cheng NC, 2011, REGEN MED, V6, P81, DOI [10.2217/rme.10.87, 10.2217/RME.10.87]
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Farr J, 2011, CARTILAGE, V2, P346, DOI 10.1177/1947603511405838
   Garrigues NW, 2014, J BIOMED MATER RES A, V102, P3998, DOI 10.1002/jbm.a.35068
   Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Hunziker EB, 2015, OSTEOARTHR CARTILAGE, V23, P334, DOI 10.1016/j.joca.2014.12.011
   Ingavle GC, 2013, TISSUE ENG PT A, V19, P1349, DOI [10.1089/ten.tea.2012.0160, 10.1089/ten.TEA.2012.0160]
   Kang HJ, 2014, J TISSUE ENG REGEN M, V8, P442, DOI 10.1002/term.1538
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   KIEFER GN, 1989, J ORTHOPAED RES, V7, P494, DOI 10.1002/jor.1100070406
   Lew DH, 2007, J BIOMED MATER RES B, V82B, P51, DOI 10.1002/jbm.b.30704
   Lin Z, 2016, BONE, V88, P47, DOI 10.1016/j.bone.2016.03.018
   Luo L, 2016, J MECH BEHAV BIOMED, V55, P21, DOI 10.1016/j.jmbbm.2015.10.002
   Malda J, 2016, NAT REV RHEUMATOL, V12, P243, DOI 10.1038/nrrheum.2015.170
   Moradi A, 2016, J BIOMED MATER RES A, V104, P245, DOI 10.1002/jbm.a.35561
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   Nugent M, 2016, OSTEOARTHR CARTILAGE, V24, P573, DOI 10.1016/j.joca.2015.10.018
   Parmaksiz M, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/2/022003
   Pinheiro A, 2016, J ORTHOP RES, V34, P1037, DOI 10.1002/jor.23121
   Qiang Y., 2014, SCI WORLD J, V2014
   Rowland CR, 2016, BIOMATERIALS, V91, P57, DOI 10.1016/j.biomaterials.2016.03.012
   Rowland CR, 2013, BIOMATERIALS, V34, P5802, DOI 10.1016/j.biomaterials.2013.04.027
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Sridharan B, 2016, TISSUE ENG PART B-RE, V22, P15, DOI 10.1089/ten.teb.2015.0147
   Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966
   Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165
   Szarko M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-231
   Tavassoli A, 2015, IRAN J BASIC MED SCI, V18, P1221
   Thermo Fisher Scientific, 2016, CARB CROSS CHEM
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Visser J, 2015, TISSUE ENG PT A, V21, P1195, DOI [10.1089/ten.tea.2014.0362, 10.1089/ten.TEA.2014.0362]
   Wang YC, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-80
   Wang ZJ, 2014, GENET MOL RES, V13, P4599, DOI 10.4238/2014.June.18.2
   Xiao YH, 2013, TISSUE ENG PART B-RE, V19, P403, DOI [10.1089/ten.teb.2012.0461, 10.1089/ten.TEB.2012.0461]
   Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang Q, 2011, CHINESE MED J-PEKING, V124, P3930, DOI 10.3760/cma.j.issn.0366-6999.2011.23.018
   Yang YL, 2016, ADV MATER, V28, P2724, DOI 10.1002/adma.201505336
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Zhang S, 2016, OSTEOARTHR CARTILAGE, V24, P2135, DOI 10.1016/j.joca.2016.06.022
   Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212
   Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0
NR 60
TC 8
Z9 8
U1 3
U2 11
PU BLACKWELL SCIENCE PUBL
PI OXFORD
PA OSNEY MEAD, OXFORD OX2 0EL, ENGLAND
SN 0077-8923
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2016
VL 1383
BP 139
EP 159
DI 10.1111/nyas.13278
PG 21
WC Rheumatology
SC Rheumatology
GA BG6YZ
UT WOS:000391042900012
PM 27870078
DA 2018-10-20
ER

PT J
AU Siddiqi, A
   Duncan, WJ
   De Silva, RK
   Zafar, S
AF Siddiqi, A.
   Duncan, W. J.
   De Silva, R. K.
   Zafar, S.
TI One-Piece Zirconia Ceramic versus Titanium Implants in the Jaw and Femur
   of a Sheep Model: A Pilot Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID TISSUE-RESPONSE; DENTAL IMPLANTS; ANIMAL-MODELS; BONE; OSSEOINTEGRATION;
   BIOMATERIAL; TRIAL
AB Reports have documented titanium (Ti) hypersensitivity after dental implant treatment. Alternative materials have been suggested including zirconia (Zr) ceramics, which have shown predictable osseointegration in animal studies and appear free of immune responses. The aim of the research was to investigate the bone-to-implant contact (BIC) of one-piece Zr, compared with one-piece Ti implants, placed in the jaws and femurs of domestic sheep. Ten New Zealand mixed breed sheep were used. A One-piece prototype Ti (control) and one Zr (test) implant were placed in the mandible, and one of each implant (Ti and Zr) was placed into the femoral epicondyle of each animal. The femur implants were submerged and unloaded; the mandibular implants were placed using a one-stage transgingival protocol and were nonsubmerged. After a healing period of 12 weeks, %BIC was measured. The overall survival rate for mandibular and femur implants combined was 87.5%. %BIC was higher for Zr implants versus Ti implants in the femur (85.5%, versus 78.9%) (p = 0.002). Zirconia implants in the mandible showed comparable %BIC to titanium implants (72.2%, versus 60.3%) (p = 0.087). High failure rate of both Zr and Ti one-piece implants in the jaw could be attributed to the one-piece design and surface characteristics of the implant that could have influenced osseointegration. Further clinical trials are recommended to evaluate the performance of zirconia implants under loading conditions.
C1 [Siddiqi, A.] Charles Sturt Univ, Sch Dent & Hlth Sci, Orange, NSW 2800, Australia.
   [Duncan, W. J.; De Silva, R. K.] Univ Otago, Sir John Walsh Res Inst, Fac Dent, Dunedin, New Zealand.
   [Zafar, S.] Univ Western Australia, Sch Oral Hlth, Discipline Paediat Dent, Perth, WA, Australia.
RP Siddiqi, A (reprint author), Charles Sturt Univ, Sch Dent & Hlth Sci, Orange, NSW 2800, Australia.
EM asiddiqi@csu.edu.au
OI SIDDIQI, ALLAUDDIN/0000-0001-5528-9153; zafar,
   sobia/0000-0001-5551-8147; DUNCAN, WARWICK/0000-0002-5412-0089
FU Maurice and Phyllis Paykel Trust (a nonprofit organization), New
   Zealand; Southern Implants
FX The assistance of John Schofield, Lesley Schofield, and Dave Matthew
   (Department of Laboratory Animal Services, HTRU, University of Otago,
   New Zealand) in animal surgeries is gratefully acknowledged. The authors
   would like to thank Southern Implants (Ptv Ltd, South Africa) for
   providing one-piece prototype implants and their components for the
   research. This study was supported by a grant from the Maurice and
   Phyllis Paykel Trust (a nonprofit organization), New Zealand, and
   Southern Implants. One-piece prototype Zr and Ti implants were kindly
   provided by Southern Implants.
CR Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   Campbell DI, 2014, J MAXILLOFAC ORAL SU, V13, P159, DOI 10.1007/s12663-013-0482-y
   Chappard D, 1999, INT J ORAL MAX IMPL, V14, P189
   Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157
   Depprich R, 2014, CLIN IMPLANT DENT R, V16, P124, DOI 10.1111/j.1708-8208.2012.00454.x
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Duda M, 2016, IMPLANT DENT, V25, P109, DOI 10.1097/ID.0000000000000343
   Duncan W. N., 2005, THESIS
   Duncan Warwick J, 2008, Ann R Australas Coll Dent Surg, V19, P152
   Evrard L, 2010, Rev Med Brux, V31, P44
   Frisken KW, 2002, AUST DENT J, V47, P214, DOI 10.1111/j.1834-7819.2002.tb00331.x
   Hashim D, 2016, CLIN ORAL INVEST, V20, P1403, DOI 10.1007/s00784-016-1853-9
   Hettige S, 2012, ACTA NEUROCHIR, V154, P1725, DOI 10.1007/s00701-012-1429-7
   Jemat A, 2015, BIOMED RES INT, DOI 10.1155/2015/791725
   Jimbo R., 2015, IMPLANT SURFACES THE, V3, P13
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P350, DOI 10.1111/j.1600-0501.2009.01832.x
   Kohal RJ, 2011, CLIN ORAL IMPLAN RES, V22, P808, DOI 10.1111/j.1600-0501.2010.02067.x
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P333, DOI 10.1111/j.1600-0501.2008.01656.x
   Kucey BKS, 1997, J PROSTHET DENT, V77, P171, DOI 10.1016/S0022-3913(97)70231-2
   Lee BC, 2013, CLIN ORAL IMPLAN RES, V24, P1332, DOI 10.1111/clr.12004
   Lucchini JP, 1996, CLIN ORAL IMPLAN RES, V7, P397, DOI 10.1034/j.1600-0501.1996.070414.x
   Luckey T. D., 1979, METAL TOXICITY MAMMA
   Mine Y, 2010, J PROSTHODONT RES, V54, P1, DOI 10.1016/j.jpor.2009.07.003
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Nunamaker DM, 1998, CLIN ORTHOP RELAT R, pS56
   Nuss KMR, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-67
   Olmedo DG, 2010, INT J ORAL MAX SURG, V39, P503, DOI 10.1016/j.ijom.2009.11.007
   Osman RB, 2014, CLIN ORAL IMPLAN RES, V25, P1366, DOI 10.1111/clr.12272
   Ostman PO, 2007, CLIN ORAL IMPLAN RES, V18, P409, DOI 10.1111/j.1600-0501.2007.01346.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Poitout DG, 2004, BIOMECHANICS BIOMATE
   Potes J., 2008, EXPT PATHOLOGY HLTH, V1, P29
   Preez L. A., 2007, SAJD, V1, P22
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Roberts W E, 1988, J Dent Educ, V52, P804
   Rocchietta I, 2009, CLIN ORAL IMPLAN RES, V20, P844, DOI 10.1111/j.1600-0501.2009.01727.x
   Rohner D, 2003, INT J ORAL MAX SURG, V32, P383, DOI 10.1054/ijom.2002.0367
   Sakellariou VI, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-20
   Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2
   Schlegel K. A., 2011, OSTEOLOGY GUIDELINES
   Schmalz G, 2002, DENT MATER, V18, P396, DOI 10.1016/S0109-5641(01)00063-X
   Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x
   Siddiqi A, 2015, CLIN IMPLANT DENT R, V17, P483, DOI 10.1111/cid.12159
   Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x
   Smeets R, 2016, BIOMED RES INT, DOI 10.1155/2016/6285620
   Stadlinger B, 2010, INT J ORAL MAX SURG, V39, P585, DOI 10.1016/j.ijom.2010.01.015
   Tawse-Smith A, 2012, CLIN ADV PERIODONTIC, V2, P232, DOI 10.1902/cap.2012.110081
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
NR 49
TC 1
Z9 2
U1 0
U2 3
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 6792972
DI 10.1155/2016/6792972
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA EF7UD
UT WOS:000390533800001
PM 28058261
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yang, MH
   Chen, KC
   Chiang, PW
   Chung, TW
   Chen, WJ
   Chu, PY
   Chen, SCJ
   Lu, YS
   Yuan, CH
   Wang, MC
   Lin, CY
   Huang, YF
   Jong, SB
   Lin, PC
   Tyan, YC
AF Yang, Ming-Hui
   Chen, Ko-Chin
   Chiang, Pei-Wen
   Chung, Tze-Wen
   Chen, Wan-Jou
   Chu, Pei-Yu
   Chen, Sharon Chia-Ju
   Lu, Yi-Shan
   Yuan, Cheng-Hui
   Wang, Ming-Chen
   Lin, Chia-Yang
   Huang, Ying-Fong
   Jong, Shiang-Bin
   Lin, Po-Chiao
   Tyan, Yu-Chang
TI Proteomic Profiling of Neuroblastoma Cells Adhesion on Hyaluronic
   Acid-Based Surface for Neural Tissue Engineering
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID PERIPHERAL-NERVE REGENERATION; MESENCHYMAL STEM-CELLS; RNA-BINDING
   PROTEIN; GROWTH-FACTOR; IN-VIVO; ANGIOGENIC OLIGOSACCHARIDES;
   PARKINSONS-DISEASE; CONDITIONED MEDIUM; ENDOTHELIAL-CELLS; NUCLEAR-PORE
AB The microenvironment of neuron cells plays a crucial role in regulating neural development and regeneration. Hyaluronic acid (HA) biomaterial has been applied in a wide range of medical and biological fields and plays important roles in neural regeneration. PC12 cells have been reported to be capable of endogenous NGF synthesis and secretion. The purpose of this research was to assess the effect of HA biomaterial combining with PC12 cells conditioned media (PC12 CM) in neural regeneration. Using SH-SY5Y cells as an experimental model, we found that supporting with PC12 CM enhanced HA function in SH-SY5Y cell proliferation and adhesion. Through RP-nano-UPLC-ESI-MS/MS analyses, we identified increased expression of HSP60 and RanBP2 in SH-SY5Y cells grown on HA-modified surface with cotreatment of PC12 CM. Moreover, we also identified factors that were secreted from PC12 cells and may promote SH-SY5Y cell proliferation and adhesion. Here, we proposed a biomaterial surface enriched with neurotrophic factors for nerve regeneration application.
C1 [Yang, Ming-Hui; Tyan, Yu-Chang] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung 807, Taiwan.
   [Chen, Ko-Chin] Changhua Christian Hosp, Dept Pathol, Changhua 500, Taiwan.
   [Chiang, Pei-Wen; Chen, Wan-Jou; Chen, Sharon Chia-Ju; Lin, Chia-Yang; Huang, Ying-Fong; Jong, Shiang-Bin; Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 807, Taiwan.
   [Chung, Tze-Wen] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 112, Taiwan.
   [Chu, Pei-Yu] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 807, Taiwan.
   [Chu, Pei-Yu] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung 807, Taiwan.
   [Lu, Yi-Shan] Kaohsiung Med Univ, Off Safety Hlth & Environm, Kaohsiung 807, Taiwan.
   [Yuan, Cheng-Hui] Natl Univ Singapore, Dept Chem, Mass Spectrometry Lab, Chem Mol & Mat Anal Ctr, Singapore 119077, Singapore.
   [Wang, Ming-Chen] Chung Yuan Christian Univ, Dept Biomed Engn, Chungli 300, Taiwan.
   [Lin, Chia-Yang; Huang, Ying-Fong; Jong, Shiang-Bin] Kaohsiung Med Univ Hosp, Dept Nucl Med, Kaohsiung 807, Taiwan.
   [Lin, Po-Chiao] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 804, Taiwan.
   [Tyan, Yu-Chang] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan.
   [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 804, Taiwan.
RP Tyan, YC (reprint author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung 807, Taiwan.; Tyan, YC (reprint author), Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 807, Taiwan.; Tyan, YC (reprint author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan.; Tyan, YC (reprint author), Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 804, Taiwan.
EM yctyan@kmu.edu.tw
OI Chung, Tze-Wen/0000-0002-7469-9913; Chen, Wan-Jou/0000-0001-5817-8627
FU Ministry of Science and Technology [MOST 103-2320-B-037-025, MOST
   105-0210-01-12-01]; Kaohsiung Medical University [KMU-TP104E12,
   KMU-O104003]; CCH-KMU Research Project [105-CCH-KMU-005]; NSYSU-KMU
   Research Project, Taiwan [NSYSUKMU104-P032]
FX The authors thank S. Sheldon (Medical Technologist, American Society of
   Clinical Pathology, retired, MT, ASCP) of Oklahoma University Medical
   Center Edmond for fruitful discussions and editorial assistance. The
   authors thank the Center of Excellence for Environmental Medicine,
   Kaohsiung Medical University, for the assistance in protein
   identification. This work was supported by Research Grants MOST
   103-2320-B-037-025 and MOST 105-0210-01-12-01 (Taiwan Protein Project)
   from the Ministry of Science and Technology, KMU-TP104E12 and
   KMU-O104003 (Aim for the Top 500 Universities Grant) from Kaohsiung
   Medical University, 105-CCH-KMU-005 from CCH-KMU Research Project, and
   NSYSUKMU104-P032 from NSYSU-KMU Research Project, Taiwan.
CR Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Arien-Zakay H, 2007, J MOL NEUROSCI, V32, P179, DOI 10.1007/s12031-007-0027-2
   Arulmoli J, 2016, ACTA BIOMATER, V43, P122, DOI 10.1016/j.actbio.2016.07.043
   Avis JM, 1996, J CELL SCI, V109, P2423
   Baer PC, 2009, CELL PROLIFERAT, V42, P29, DOI 10.1111/j.1365-2184.2008.00572.x
   Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004
   Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757
   Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0
   Castagnet P, 2003, HUM MOL GENET, V12, P1847, DOI 10.1093/hmg/ddg202
   Cheyuo C, 2012, BIOL CHEM, V393, P429, DOI 10.1515/hsz-2012-0103
   Cho KI, 2009, CELL DEATH DIFFER, V16, P287, DOI 10.1038/cdd.2008.153
   Cho KI, 2012, CELL MOL LIFE SCI, V69, P3511, DOI 10.1007/s00018-012-1071-9
   Cho KI, 2010, DIS MODEL MECH, V3, P595, DOI 10.1242/dmm.004648
   Chung TW, 2012, J MATER SCI-MATER M, V23, P3067, DOI 10.1007/s10856-012-4764-6
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Dumont CE, 1997, TRANSPLANTATION, V63, P1210, DOI 10.1097/00007890-199705150-00004
   Evans GRD, 2000, J BIOMAT SCI-POLYM E, V11, P869, DOI 10.1163/156856200744066
   Feng MJ, 2013, NEUROCHEM RES, V38, P2180, DOI 10.1007/s11064-013-1127-8
   Gammazza AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09434
   Gill JS, 1998, MOL BRAIN RES, V57, P123, DOI 10.1016/S0169-328X(98)00080-1
   Greene JJ, 2015, FACIAL PLAST SURG CL, V23, P423, DOI 10.1016/j.fsc.2015.07.002
   HOPPEN HJ, 1990, BIOMATERIALS, V11, P286, DOI 10.1016/0142-9612(90)90012-F
   Hwang YS, 2006, TISSUE ENG, V12, P1381, DOI 10.1089/ten.2006.12.1381
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Johnson EO, 2008, INJURY, V39, pS30, DOI 10.1016/j.injury.2008.05.018
   Khaing ZZ, 2015, J MATER CHEM B, V3, P7850, DOI 10.1039/c5tb00974j
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Koyama T, 2015, J ATHEROSCLER THROMB, V22, P647, DOI 10.5551/jat.29967
   Krishna A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1154
   Lee TJ, 2014, TISSUE ENG PT A, V20, P1306, DOI [10.1089/ten.tea.2013.0265, 10.1089/ten.TEA.2013.0265]
   Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018
   Liang JR, 2016, ADV DRUG DELIVER REV, V97, P186, DOI 10.1016/j.addr.2015.10.017
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Lu BS, 2003, J BIOL CHEM, V278, P16289, DOI 10.1074/jbc.M211023200
   Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016
   MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014
   Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392
   Moshayedi Pouria, 2013, Biomatter, V3, DOI 10.4161/biom.23863
   Muheremu A, 2015, BIOMED RES INT, DOI 10.1155/2015/237507
   Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3
   Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005
   Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009
   Ohtsuka K, 2000, BRAIN RES BULL, V53, P141, DOI 10.1016/S0361-9230(00)00325-7
   Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X
   Pires-daSilva A, 2001, DEV BIOL, V233, P319, DOI 10.1006/dbio.2001.0169
   Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165
   Qu Y., 1998, ORAL MED PATHOLOGY, V3, P21
   Rhodes NP, 2004, J MATER SCI-MATER M, V15, P391, DOI 10.1023/B:JMSM.0000021108.74004.7e
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   Rochkind S, 2014, BIOMED RES INT, V2014
   ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511
   Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200
   Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736
   Schumacher JM, 1998, BIOL REPROD, V59, P69, DOI 10.1095/biolreprod59.1.69
   SCHUMACHER JM, 1995, J CELL BIOL, V129, P1023, DOI 10.1083/jcb.129.4.1023
   Sedaghati T, 2015, NEURAL REGEN RES, V10, P1191, DOI 10.4103/1673-5374.162678
   Sherman Larry S, 2015, Int J Cell Biol, V2015, P368584, DOI 10.1155/2015/368584
   Singh RR, 2015, EUR J PAEDIATR NEURO, V19, P106, DOI 10.1016/j.ejpn.2014.11.010
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Slevin M, 1998, LAB INVEST, V78, P987
   Solis M. A., 2012, BIOCH RES INT, V2012, P11, DOI DOI 10.1155/2012/346972
   Sullivan SA, 1997, DEV GENET, V20, P208, DOI 10.1002/(SICI)1520-6408(1997)20:3<208::AID-DVG4>3.0.CO;2-B
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Wu L., 2015, BRAIN NEUROTRAUMA MO, P561
   Yamada T, 2008, BIOMATERIALS, V29, P3503, DOI 10.1016/j.biomaterials.2008.03.044
   Yang M. H., 2014, J ANAL BIOANALYTICAL, VS2
   Yang MH, 2014, BIOMED RES INT, DOI 10.1155/2014/209469
   Yang MH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/901329
   Yang MH, 2012, ANALYST, V137, P4921, DOI 10.1039/c2an35368g
   Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281
NR 75
TC 1
Z9 1
U1 0
U2 6
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 1917394
DI 10.1155/2016/1917394
PG 13
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA EF6KU
UT WOS:000390440700001
PM 28053978
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, ZR
   Liu, H
   Shi, Q
   Liu, XY
   Wan, L
AF Zhang, Zhenrong
   Liu, Hui
   Shi, Qian
   Liu, Xuanyong
   Wan, Long
TI Calcium ion modification of TiO2 nanotube arrays to enhance apatite
   formation
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE TiO2 nanotube arrays; Calcium ions; Ultrasound-assisted impregnation;
   Apatite formation; Zeta potential
ID BIOACTIVE TITANIUM METAL; SIMULATED BODY-FLUID; FERRITE COMPOSITE
   NANOPARTICLES; BIOMATERIAL SYSTEM; ANODIC-OXIDATION; SOLAR-CELLS;
   PHOTOELECTROCHEMICAL PROPERTIES; PHOTOCATALYTIC SHELL; BIOMIMETIC
   GROWTH; HYDROGEN SENSOR
AB Highly ordered TiO2 nanotube arrays were fabricated by anodisation of titanium, and then anodic TiO2 nanotubes were modified in calcium ion-containing solution using ultrasound-assisted impregnation. For reference, the experiments were also carried out by conventional impregnation. The ability to form apatite on specimens was examined upon exposure to modified simulated body fluids combined with FESEM, EDS, XRD, FTIR and Zeta potential investigations. The results reveal that it had a negligible effect on the morphology of nanotubes with varying calcium source and impregnation time using conventional impregnation. Nevertheless, TiO2 nanotubes were modified by the method of ultrasound-assisted impregnation, the mouth of nanotubes became glossy, the diameter of nanotubes became non-uniform and the amount of adsorbate in the inner wall of nanotubes increased. The calcium ion-modified nanotubes were more efficient in promoting apatite formation than the unmodified nanotubes, which may be attributed to the release of calcium ions and the significantly high amount of Ti-OH groups on its surface.
C1 [Zhang, Zhenrong; Wan, Long] Hunan Univ, Coll Mat Sci & Technol, Changsha 410082, Hunan, Peoples R China.
   [Liu, Hui] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China.
   [Shi, Qian; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Zhang, ZR (reprint author), Hunan Univ, Coll Mat Sci & Technol, Changsha 410082, Hunan, Peoples R China.
EM Zhangzr_2004@126.com
RI Liu, Xuanyong/J-2609-2018; Liu, Hui/G-2051-2014
OI Liu, Hui/0000-0002-4792-9285
FU National Natural Science Foundation of China [81271704]
FX This work was financially supported by National Natural Science
   Foundation of China [grant number 81271704].
CR Albu SP, 2007, NANO LETT, V7, P1286, DOI 10.1021/nl070264k
   Chen XB, 2009, ACTA BIOMATER, V5, P1808, DOI 10.1016/j.actbio.2009.01.015
   Chun KY, 2009, THIN SOLID FILMS, V517, P4196, DOI 10.1016/j.tsf.2009.02.042
   Coreno J, 2005, J BIOMED MATER RES A, V75A, P478, DOI 10.1002/jbm.a.30447
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Grimes CA, 2003, SENSORS, V3, P69, DOI 10.3390/s30300069
   Hahn R, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105604
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Kim HM, 2003, J BIOMED MATER RES A, V67A, P1305, DOI 10.1002/jbm.a.20039
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Krupa D, 2003, VACUUM, V70, P109, DOI 10.1016/S0042-207X(02)00628-0
   Kuang SY, 2009, APPL SURF SCI, V255, P7385, DOI 10.1016/j.apsusc.2009.04.005
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Lin JG, 2009, J ALLOY COMPD, V485, P316, DOI 10.1016/j.jallcom.2009.05.048
   Liu RH, 2011, J ALLOY COMPD, V509, P2434, DOI 10.1016/j.jallcom.2010.11.040
   Liu SH, 2009, ELECTROCHEM COMMUN, V11, P1748, DOI 10.1016/j.elecom.2009.07.007
   Lowenstam HA, 1989, BIOMINERALIZATION
   Macak JM, 2007, ELECTROCHEM COMMUN, V9, P1783, DOI 10.1016/j.elecom.2007.04.002
   Misra RDK, 2010, MATER TECHNOL, V25, P118, DOI 10.1179/175355510X12723642365241
   Mor GK, 2004, J MATER RES, V19, P628, DOI 10.1557/jmr.2004.19.2.628
   Mor GK, 2007, NANO LETT, V7, P2356, DOI 10.1021/nl0710046
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Paulose M, 2006, J PHYS CHEM B, V110, P16179, DOI 10.1021/jp064020k
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Shankar K, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/6/065707
   Shankar K, 2006, J PHYS D APPL PHYS, V39, P2361, DOI 10.1088/0022-3727/39/11/008
   Stoch A, 2000, J MOL STRUCT, V555, P375, DOI 10.1016/S0022-2860(00)00623-2
   Sun L, 2009, J HAZARD MATER, V171, P1045, DOI 10.1016/j.jhazmat.2009.06.115
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   Tian T, 2008, MATER SCI-POLAND, V26, P487
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Varghese OK, 2006, SENS LETT, V4, P120, DOI 10.1166/sl.2006.022
   Varghese OK, 2009, NAT NANOTECHNOL, V4, P592, DOI [10.1038/NNANO.2009.226, 10.1038/nnano.2009.226]
   Wang JW, 2016, APPL SURF SCI, V363, P644, DOI 10.1016/j.apsusc.2015.12.038
   Xiao XF, 2009, MATER SCI-POLAND, V27, P23
   Xiao XF, 2008, J ALLOY COMPD, V466, P356, DOI 10.1016/j.jallcom.2007.11.032
   Xiao XF, 2007, MATER CHEM PHYS, V106, P27, DOI 10.1016/j.matchemphys.2007.05.014
   Xu H, 2011, APPL SURF SCI, V257, P8478, DOI 10.1016/j.apsusc.2011.04.135
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang LX, 2010, J PHYS CHEM C, V114, P4783, DOI 10.1021/jp910489h
   Yu JC, 2004, ADV FUNCT MATER, V14, P1178, DOI 10.1002/adfm.200305145
   Zhang ZR, 2014, J NANOSCI NANOTECHNO, V14, P4170, DOI 10.1166/jnn.2014.8232
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhu K, 2007, NANO LETT, V7, P69, DOI 10.1021/nl062000o
NR 56
TC 2
Z9 2
U1 4
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
IS 13
BP 791
EP 798
DI 10.1080/10667857.2016.1258516
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA EG0UU
UT WOS:000390748500006
DA 2018-10-20
ER

PT J
AU Killi, N
   Dhakare, RA
   Singam, A
   Lokanadham, M
   Chitikeshi, H
   Gundloori, RVN
AF Killi, Naresh
   Dhakare, Runali Arjun
   Singam, Amarnath
   Lokanadham, Metta
   Chitikeshi, Harshavardhan
   Gundloori, Rathna Venkata Naga
TI Design and fabrication of mechanically strong nano-matrices of linseed
   oil based polyesteramide blends
SO MEDCHEMCOMM
LA English
DT Article
ID TRICLOSAN/CYCLODEXTRIN INCLUSION COMPLEXES; POLY(ESTER AMIDE)S;
   BIODEGRADABLE POLYMERS; ENZYMATIC DEGRADATION; DICARBOXYLIC-ACIDS;
   POLY(LACTIC ACID); NANOFIBERS; GLYCINE
AB New nanomaterials of bio-origin with improved mechanical properties are in demand for biomedical application. Therefore, we propose to design and fabricate bioactive nano-matrices with good mechanical strength using polyesteramides derived from linseed oil. Polyesteramide was synthesized from linseed oil and blended with poly(L-lactide) and human serum albumin to enhance the mechanical strength, biodegradation, biocompatibility and hydrophilicity. The various blend solutions with and without drugs (triclosan and metronidazole) were electrospun into non-woven nano-matrices. The morphology of the nano-matrices represented smooth and fine nanofibers with the diameter ranging from 300 to 400 nm. Drug binding efficiency, cytotoxicity, hydrophilicity, thermal and mechanical studies indicated their suitability as biomaterials. To demonstrate their utility, the drug release kinetics and antibacterial properties were evaluated. The metronidazole loaded nano-matrices showed drug release up to 8 h, beyond which no release was observed until 72 h. Antibacterial studies were done using the drugs triclosan and metronidazole. The antibacterial activity of the drug loaded nanofiber mats increased with the increase in drug concentration. The uniqueness of the developed nano-matrices of polyesteramide blends is that their mechanical strength is 3-fold higher than that of the nano-matrices of poly(L-lactide), which is one of the essential features of these nano-matrices to be used as a biomaterial for biomedical applications.
C1 [Killi, Naresh; Dhakare, Runali Arjun; Singam, Amarnath; Lokanadham, Metta; Gundloori, Rathna Venkata Naga] CSIR, Natl Chem Lab, Polymer Sci & Engn Div, Pune, Maharashtra, India.
   [Chitikeshi, Harshavardhan] CSIR, Natl Chem Lab, Ctr Mat Characterizat, Pune, Maharashtra, India.
RP Gundloori, RVN (reprint author), CSIR, Natl Chem Lab, Polymer Sci & Engn Div, Pune, Maharashtra, India.
EM rv.gundloori@ncl.res.in
RI bagheri, amir/C-3274-2017
FU CSIR, New Delhi [CSC0302, CSC0134]; NCL-AcSIR
FX The authors are grateful to CSIR, New Delhi, for the financial support
   (projects CSC0302 and CSC0134) and NCL-AcSIR.
CR Alam M, 2014, ARAB J CHEM, V7, P469, DOI 10.1016/j.arabjc.2013.12.023
   Amna T, 2012, APPL MICROBIOL BIOT, V93, P743, DOI 10.1007/s00253-011-3459-0
   Asin L, 2001, J POLYM SCI POL CHEM, V39, P4283, DOI 10.1002/pola.10082
   Balouiri M, 2016, J PHARM ANA, V6, P71, DOI 10.1016/j.jpha.2015.11.005
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
   CAIRA MR, 1993, J PHARM SCI, V82, P1006, DOI 10.1002/jps.2600821007
   Cao X, 2003, THERMOCHIM ACTA, V406, P115, DOI 10.1016/S0040-6031(03)00252-1
   Celebioglu A, 2014, COLLOID SURFACE B, V116, P612, DOI 10.1016/j.colsurfb.2013.10.029
   Deshayes G, 2008, REACT FUNCT POLYM, V68, P1392, DOI 10.1016/j.reactfunctpolym.2008.06.020
   Dror Y, 2003, LANGMUIR, V19, P7012, DOI 10.1021/la034234i
   GAST LE, 1966, J AM OIL CHEM SOC, V43, P418, DOI 10.1007/BF02646804
   Ghosal K, 2014, EUR POLYM J, V60, P58, DOI 10.1016/j.eurpolymj.2014.08.006
   Grafahrend D, 2011, NAT MATER, V10, P67, DOI [10.1038/nmat2904, 10.1038/NMAT2904]
   Guo K, 2005, J POLYM SCI POL CHEM, V43, P3932, DOI 10.1002/pola.20781
   Hassan HHAM, 2010, J MACROMOL SCI A, V47, P521, DOI 10.1080/10601321003741909
   He Y, 2013, KEY ENG MATER, V562-565, P764, DOI 10.4028/www.scientific.net/KEM.562-565.764
   Kaczmarek H, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0091-y
   Katsarava R, 1999, J POLYM SCI POL CHEM, V37, P391, DOI 10.1002/(SICI)1099-0518(19990215)37:4<391::AID-POLA3>3.0.CO;2-E
   Kayaci F, 2013, J AGR FOOD CHEM, V61, P3901, DOI 10.1021/jf400440b
   Lim HP, 2013, AAPS PHARMSCITECH, V14, P903, DOI 10.1208/s12249-013-9971-z
   Mahapatro A., 2008, POLYM BIOMED APPL, V977, P1
   Mahfoudh J, 2015, J MACROMOL SCI A, V52, P1002, DOI 10.1080/10601325.2015.1095603
   Michnik A, 2006, POL J ENVIRON STUD, V15, P81
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Murase SK, 2015, RSC ADV, V5, P55006, DOI 10.1039/c5ra06267e
   Nagata M, 1999, MACROMOL CHEM PHYSIC, V200, P2059, DOI 10.1002/(SICI)1521-3935(19990901)200:9<2059::AID-MACP2059>3.0.CO;2-N
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Paredes N, 1998, J POLYM SCI POL CHEM, V36, P1271
   Rodriguez-Galan A, 2011, POLYMERS-BASEL, V3, P65, DOI 10.3390/polym3010065
   Rolinski OJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2747623
   STARKS CM, 1971, J AM CHEM SOC, V93, P195, DOI 10.1021/ja00730a033
   Toliwal S. D., 2009, J APPL CHEM RES, V11, P7
   Wang XX, 2016, MACROMOLECULES, V49, P891, DOI 10.1021/acs.macromol.5b02670
   Zafar F, 2007, REACT FUNCT POLYM, V67, P928, DOI 10.1016/j.reactfunctpolym.2007.05.018
   Zaza G., 2008, ACS SYM SER, V977, P10
NR 36
TC 1
Z9 1
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-2503
EI 2040-2511
J9 MEDCHEMCOMM
JI MedChemComm
PY 2016
VL 7
IS 12
BP 2299
EP 2308
DI 10.1039/c6md00380j
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA EF8BE
UT WOS:000390552300008
DA 2018-10-20
ER

PT B
AU Zhang, YH
   Liu, J
   Chu, HJ
   Wang, J
AF Zhang, Yu-heng
   Liu, Jie
   Chu, Hai-jian
   Wang, Jiang
GP DEStech Publicat Inc
TI Interface Dislocation Core-Spreading Simulation and Corresponding
   Response
SO 2016 INTERNATIONAL CONFERENCE ON APPLIED MECHANICS, ELECTRONICS AND
   MECHATRONICS ENGINEERING (AMEME 2016)
LA English
DT Proceedings Paper
CT International Conference on Applied Mechanics, Electronics and
   Mechatronics Engineering (AMEME)
CY MAY 28-29, 2016
CL Beijing, PEOPLES R CHINA
DE Dislocation; Core spreading; Anisotropic bimaterial
ID WEAK INTERFACES; MECHANISMS; SLIP
AB Dislocation can spread its core at an interface especially at a weak shear interface associated with shearing the interface. Such core-spreading dislocation can significantly reduce stress/strain concentration compared with the compact dislocation and thus trap the dislocation in the interface, correspondingly strengthening materials. Employing the Green's function for a compact dislocation, we derived analytical expressions for the elastic fields of a dislocation with core spreading in anisotropic bimaterials. We proposed a conic model to mimic the spreading core of a dislocation at an interface. The accuracy and efficiency of the conic model are validated by the boundary conditions of both traction and displacement across the interface. Numerical simulation is calculated in the Cu/Nb biomaterial. The results of displacement and stress fields show that: (1) core-spreading dislocation can greatly reduce the stress intensity near the dislocation compared with the dislocation with a condensed core; (2) dislocation core spreading has a great influence on the elastic fields near the core region, while the influence can be negligible when the distance of a field point from the center of the dislocation core is greater than 1.51 times the width of the spreading core; (3) near the core region, Peach-Koehler force induced by the core spreading dislocation is larger than that of the compact dislocation.
C1 [Zhang, Yu-heng; Liu, Jie; Chu, Hai-jian] Shanghai Univ, Shanghai Inst Appl Math & Mech, Shanghai 200072, Peoples R China.
   [Zhang, Yu-heng; Liu, Jie; Chu, Hai-jian] Shanghai Univ, Shanghai Key Lab Mech Energy Engn, Shanghai 200072, Peoples R China.
   [Chu, Hai-jian] Shanghai Univ, Dept Mech, Shanghai 200444, Peoples R China.
   [Wang, Jiang] Univ Nebraska Lincoln, Mech & Mat Engn, Lincoln, NE 68588 USA.
RP Chu, HJ (reprint author), Shanghai Univ, Shanghai Inst Appl Math & Mech, Shanghai 200072, Peoples R China.; Chu, HJ (reprint author), Shanghai Univ, Shanghai Key Lab Mech Energy Engn, Shanghai 200072, Peoples R China.; Chu, HJ (reprint author), Shanghai Univ, Dept Mech, Shanghai 200444, Peoples R China.
RI Wang, Jian/F-2669-2012
OI Wang, Jian/0000-0001-5130-300X
CR Chu HJ, 2013, INT J PLASTICITY, V41, P1, DOI 10.1016/j.ijplas.2012.08.005
   Gao HJ, 2002, J MECH PHYS SOLIDS, V50, P2169, DOI 10.1016/S0022-5096(02)00010-8
   Hoagland RG, 2006, PHILOS MAG, V86, P3537, DOI 10.1080/14786430600669790
   Wang J, 2008, ACTA MATER, V56, P3109, DOI 10.1016/j.actamat.2008.03.003
   Wang J, 2012, ACTA MATER, V60, P1503, DOI 10.1016/j.actamat.2011.11.047
   Wang J, 2011, CURR OPIN SOLID ST M, V15, P20, DOI 10.1016/j.cossms.2010.09.002
   Wang J, 2010, ACTA MATER, V58, P2262, DOI 10.1016/j.actamat.2009.12.013
   Wang J, 2008, ACTA MATER, V56, P5685, DOI 10.1016/j.actamat.2008.07.041
   Yin JL, 1998, J MATER SCI TECHNOL, V14, P75
   Zheng SL, 2015, MODEL SIMUL MATER SC, V23, DOI 10.1088/0965-0393/23/3/035002
NR 10
TC 0
Z9 0
U1 1
U2 3
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-357-1
PY 2016
BP 184
EP 188
PG 5
WC Engineering, Multidisciplinary
SC Engineering
GA BG6AK
UT WOS:000389849400035
DA 2018-10-20
ER

PT J
AU Soubihe, NV
   Albuquerque, AAS
   Arcencio, L
   Thomazini, JA
   Schmidt, A
   Evora, PRB
AF Soubihe Junior, Nathan Valle
   Albuquerque, Agnes Afrodite S.
   Arcencio, Livia
   Thomazini, Jose Antonio
   Schmidt, Andre
   Evora, Paulo Roberto B.
TI Development of a Multifunctional Needle for Percutaneous Heart Biopsy
   and Cell Therapy. A Technical Note
SO BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY
LA English
DT Article
DE Stem Cells; Biopsy; Myocardium
AB Validation of transendocardial injection as a method for delivering therapeutic agents to the diseased heart is increasing. Puncture heart biopsies should re-emerge as a possible alternative method to allow access to the myocardium and implantable biomaterial for cell therapy. Therefore, this work aims to present a percutaneous puncture device for biopsy and intramyocardial biomaterial injection, standardize the technique and attest to the safety of the method. The adaptation consists of creating myocardial microlesions that allow for better fixation of stem cells. The objective of this technical note covers only the development of the needle and the histological quality of the biopsies. It has not been used in humans yet.
C1 [Soubihe Junior, Nathan Valle; Albuquerque, Agnes Afrodite S.; Arcencio, Livia; Thomazini, Jose Antonio; Evora, Paulo Roberto B.] Univ Sao Paulo, FMRP, Dept Surg & Anat, Ave Bandeirantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil.
   [Schmidt, Andre] Univ Sao Paulo, FMRP, Dept Internal Med, Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, FMRP, Dept Surg & Anat, Lab Endothelium & Cardiovasc Funct, Ribeirao Preto, SP, Brazil.
RP Evora, PRB (reprint author), Univ Sao Paulo, FMRP, Dept Surg & Anat, Ave Bandeirantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil.
EM prbevora@fmrp.usp.br
OI SCHMIDT, ANDRE/0000-0002-1090-8165; Thomazini, Jose/0000-0003-3769-0108
FU Conselho Nacional de Pesquisa (CNPq); Fundacao de Apoio ao Ensino,
   Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina
   de Ribeirao Preto da Universidade de Sao Paulo (FAEPA/HCFMRP/USP)
FX Conselho Nacional de Pesquisa (CNPq) and Fundacao de Apoio ao Ensino,
   Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina
   de Ribeirao Preto da Universidade de Sao Paulo (FAEPA/HCFMRP/USP).
CR Galantier M, 1996, REV BRAS CIR CARDIOV, V11, P67
   Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077
   Ladage D, 2012, GENE THER, V19, P637, DOI 10.1038/gt.2012.14
   Dallan LAO, 2008, REV BRAS CIR CARDIOV, V23, P46, DOI 10.1590/S0102-76382008000100009
   Soubihe NV, 2013, REV BRAS CIR CARDIOV, V28, P405, DOI 10.5935/1678-9741.20130062
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASIL CIRURGIA CARDIOVASC
PI SAO PAULO SP
PA RUA BEIRA RIO, 45, 7 ANDAR-CJ 72 VILA OLIMPIA, SAO PAULO SP,
   CEP04548-050, BRAZIL
SN 0102-7638
EI 1678-9741
J9 BRAZ J CARDIOVA SURG
JI Braz. J. Cardiovasc. Surg.
PY 2016
VL 31
IS 6
BP 465
EP 467
DI 10.5935/1678-9741.20160092
PG 3
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA EF1NU
UT WOS:000390092400011
PM 28076626
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Schmietow, B
AF Schmietow, Bettina
BE Strech, D
   Mertz, M
TI Ethical Dimensions of Dynamic Consent in Data-Intense Biomedical
   Research-Paradigm Shift, or Red Herring?
SO ETHICS AND GOVERNANCE OF BIOMEDICAL RESEARCH: THEORY AND PRACTICE
SE Research Ethics Forum
LA English
DT Proceedings Paper
CT Conference on Ethics and Governance of Biomedical Research - Theory and
   Practice
CY AUG, 2013
CL Hanover Med Sch, Hanover, GERMANY
HO Hanover Med Sch
ID LEARNING HEALTH-CARE; OWN PATIENT JOURNEY; INFORMED-CONSENT; BROAD
   CONSENT; BIOBANK RESEARCH; BIG DATA; SCIENCE; MEDICINE; PRIVACY
AB This chapter describes the rise of digital, personalised and adaptive forms of consent to use of biomaterial and/or data in research as a reaction to the limitations of traditional informed consent standards, which have been widely perceived as inadequate in large-scale biomedical studies. It uses the approach of a "dynamic consent" as an example, initially in particular in biobanks and genomics, in which participant and patient choices are to become more influential, and, in fact, central. In elaborating on some criticism to this approach and its proposed merits, it is argued that these forms of consent have potential for adapting data-intense research to new research requirements, but that the suggestion of "participant-centrism" as leading to a shift in research ethics would require more attention to ethical and social issues that have not yet been well developed. Preliminary anchoring points for such a shift are in understanding the redefinitions of participant-patient "autonomy" and "privacy" in view of the emergence of research, as well as social norms of data sharing, and in developing the link to a broader project of "citizen science".
C1 [Schmietow, Bettina] Nuffield Council Bioeth, 28 Bedford Sq, London WC1B 3JS, England.
RP Schmietow, B (reprint author), Nuffield Council Bioeth, 28 Bedford Sq, London WC1B 3JS, England.
EM b.schmietow@gmail.com
CR Angrist M, 2009, PERS MED, V6, P691, DOI 10.2217/PME.09.48
   Boddington Paula, 2012, ETHICAL CHALLENGES G
   Dixon W.G., 2014, BMJ-BRIT MED J, V34, pg1294
   Elger B, 2010, MED LAW ETH, P1
   Faden RR, 2014, NEW ENGL J MED, V370, P766, DOI 10.1056/NEJMhle1313674
   Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134
   Francis LP, 2013, AM J BIOETHICS, V13, P38, DOI 10.1080/15265161.2013.768862
   Friend SH, 2013, NAT BIOTECHNOL, V31, P297, DOI 10.1038/nbt.2555
   Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764
   Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0
   Helgesson G, 2008, J MED ETHICS, V34, P54, DOI 10.1136/jme.2006.019190
   Hofmann B, 2009, J MED ETHICS, V35, P125, DOI 10.1136/jme.2008.024851
   Hofmann B., 2004, BLOOD DATA ETHICAL L, P237
   Ioannidis JPA, 2013, AM J BIOETHICS, V13, P40, DOI 10.1080/15265161.2013.768864
   Kanellopoulou N.K., 2011, BMJ-BRIT MED J, V343, pd6900
   Kaye J, 2015, EUR J HUM GENET, V23, P141, DOI 10.1038/ejhg.2014.71
   Kaye J, 2012, ANNU REV GENOM HUM G, V13, P415, DOI 10.1146/annurev-genom-082410-101454
   Kaye J, 2012, NAT REV GENET, V13, P371, DOI 10.1038/nrg3218
   Kaye J, 2011, HUM GENET, V130, P377, DOI 10.1007/s00439-011-1063-0
   Knoppers BM, 2014, HUM GENET, V133, P895, DOI 10.1007/s00439-014-1432-6
   Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P678, DOI 10.1001/jama.2013.194643
   Larson EB, 2013, JAMA-J AM MED ASSOC, V309, P2443, DOI 10.1001/jama.2013.5914
   Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360
   Majumder MA, 2005, J LAW MED ETHICS, V33, P31, DOI 10.1111/j.1748-720X.2005.tb00208.x
   Mamo Laura A, 2013, AMIA Annu Symp Proc, V2013, P920
   Nissenbaum H., 2010, PRIVACY CONTEXT TECH
   O'Connor D, 2013, J LAW MED ETHICS, V41, P470, DOI 10.1111/jlme.12056
   Prainsack B, 2014, THEOR TECH SOC, P147
   Richards T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3726
   Scott CT, 2012, NAT BIOTECHNOL, V30, P141, DOI 10.1038/nbt.2116
   Sheehan M, 2011, PUBLIC HEALTH ETH-UK, V4, P226, DOI 10.1093/phe/phr020
   Shickle D, 2006, STUD HIST PHI PART C, V37, P503, DOI 10.1016/j.shpsc.2006.06.007
   Steinsbekk KS, 2013, EUR J HUM GENET, V21, P897, DOI 10.1038/ejhg.2012.282
   Vayena E, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001402
   Vayena E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004798
   Wee R, 2013, J PRIM HEALTH CARE, V5, P341
   Wee R, 2013, J PRIM HEALTH CARE, V5, P259
   Welsman J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4903
NR 38
TC 0
Z9 0
U1 1
U2 4
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 2212-9529
BN 978-3-319-28731-7; 978-3-319-28729-4
J9 RES ETHICS FORUM
PY 2016
VL 4
BP 197
EP 209
DI 10.1007/978-3-319-28731-7_15
PG 13
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA BG6GP
UT WOS:000390287100015
DA 2018-10-20
ER

PT J
AU Lee, SH
   Uehara, H
   Macon, ALB
   Maeda, H
   Obata, A
   Ueda, K
   Narushima, T
   Kasuga, T
AF Lee, Sungho
   Uehara, Hirotaka
   Macon, Anthony L. B.
   Maeda, Hirotaka
   Obata, Akiko
   Ueda, Kyosuke
   Narushima, Takayuki
   Kasuga, Toshihiro
TI Preparation of Antibacterial ZnO-CaO-P2O5-Nb2O5 Invert Glasses
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT International Conference on Processing and Manufacturing of Advanced
   Materials
CY MAY 29-JUN 03, 2016
CL Graz, AUSTRIA
DE biomaterial; phosphate glass; zinc; niobium; antibacterial ability
ID INFECTION-RESISTANT SURFACES; CALCIUM-PHOSPHATE FILMS; ZINC;
   BIOMATERIALS; SILVER; SALTS
AB ZnO-CaO-P2O5-Nb2O5 invert glasses, with ZnO substituted for CaO, were successfully prepared using a melt-quenching method. Their structures, dissolution behaviors, and antibacterial abilities were evaluated. Niobate switched its role of network former to modifier with increasing ZnO content, as Zn2+ ions preferentially coordinated with phosphate groups. In parallel, with increasing content of ZnO in the glasses, P-O-Zn bonds were formed, which crosslinked phosphate groups with ZnO acting as a network former. As a result, the glass-forming ability and chemical durability of the glasses were improved. The glasses showed antibacterial ability to gram-positive and-negative bacteria.
C1 [Lee, Sungho; Uehara, Hirotaka; Macon, Anthony L. B.; Maeda, Hirotaka; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Div Adv Ceram, Nagoya, Aichi 4668555, Japan.
   [Ueda, Kyosuke; Narushima, Takayuki] Tohoku Univ, Grad Sch Engn, Dept Met Mat Sci & Mat Proc, Sendai, Miyagi 9808579, Japan.
   [Lee, Sungho] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan.
RP Macon, ALB; Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Div Adv Ceram, Nagoya, Aichi 4668555, Japan.
EM alb.macon@nitech.ac.jp; toshihiro@nitech.ac.jp
RI Macon, Anthony/B-5799-2015; Lee, Sungho/T-1734-2017
OI Macon, Anthony/0000-0002-9977-4238; Lee, Sungho/0000-0002-4367-9573
CR Atmaca S, 1998, TURK J MED SCI, V28, P595
   BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Chenu S, 2012, J NON-CRYST SOLIDS, V358, P1795, DOI 10.1016/j.jnoncrysol.2012.05.027
   Chu CM, 2011, J NON-CRYST SOLIDS, V357, P939, DOI 10.1016/j.jnoncrysol.2010.12.009
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713
   Flambard A, 2008, J NON-CRYST SOLIDS, V354, P3540, DOI 10.1016/j.jnoncrysol.2008.03.017
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARRAP GJ, 1984, ARCH ORAL BIOL, V29, P87, DOI 10.1016/0003-9969(84)90110-9
   Hsu SM, 2012, J NON-CRYST SOLIDS, V358, P14, DOI 10.1016/j.jnoncrysol.2011.08.006
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   JEHNG JM, 1991, CHEM MATER, V3, P100, DOI 10.1021/cm00013a025
   Karakassides MA, 2004, J NON-CRYST SOLIDS, V347, P69, DOI 10.1016/j.jnoncrysol.2004.08.111
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee S, 2015, J NON-CRYST SOLIDS, V426, P35, DOI 10.1016/j.jnoncrysol.2015.06.024
   Maeda H, 2016, J NON-CRYST SOLIDS, V432, P60, DOI 10.1016/j.jnoncrysol.2015.06.003
   Mandlule A, 2014, J NON-CRYST SOLIDS, V392, P31, DOI 10.1016/j.jnoncrysol.2014.04.002
   Mazali IO, 2004, J MATER SCI, V39, P1987, DOI 10.1023/B:JMSC.0000017760.85512.60
   Montagne L, 1997, J NON-CRYST SOLIDS, V215, P1, DOI 10.1016/S0022-3093(97)00032-X
   Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a
   OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22
   Phan TN, 2004, ORAL MICROBIOL IMMUN, V19, P31, DOI 10.1046/j.0902-0055.2003.00109.x
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Ueda K, 2007, BIOMED MATER, V2, pS160, DOI 10.1088/1748-6041/2/3/S14
   Kyosuke U, 2007, MATER TRANS, V48, P307, DOI 10.2320/matertrans.48.307
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
NR 33
TC 1
Z9 1
U1 0
U2 2
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PY 2016
VL 57
IS 12
BP 2072
EP 2076
DI 10.2320/matertrans.MI201503
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA EF7XW
UT WOS:000390543700017
OA Bronze
DA 2018-10-20
ER

PT B
AU Ahmad, RN
   Muhammad, N
   Sulong, A
   Wahi, A
AF Ahmad, Rozie Nani
   Muhammad, Norhamidi
   Sulong, Abu Bakar
   Wahi, Azizah
BE Haron, CHC
   Muhamad, N
   Deros, HBM
   Wahab, DA
   Sulong, AB
   Ramli, R
   Sajuri, Z
   Rahman, MNA
   BinAbdollah, MF
   Hishamuddin, H
   Mohamad, IF
   Saibani, N
   Ali, AA
   Zakaria, MY
   Rashid, MOA
   Kadiman, NN
TI Parameter Optimization of Sintering Ti-6Al-7Nb Powder and Palm Stearin
   Binder System for Highest Sintered Density using Taguchi Method
SO PROCEEDINGS OF INTERNATIONAL CONFERENCE ON ADVANCED PROCESSES AND
   SYSTEMS IN MANUFACTURING (APSIM 2016)
LA English
DT Proceedings Paper
CT International Conference on Advanced Processes and Systems in
   Manufacturing (APSIM)
CY AUG 28-30, 2016
CL Univ Kebangsaan Malaysia, Kuala Lumpur, MALAYSIA
SP Malaysian Powder Metallurgy & Particulate Mat Assoc, Malaysian Tribol Soc
HO Univ Kebangsaan Malaysia
DE Titanium Niobium; Sintering Process; Taghuci Method; Density
ID MICROSTRUCTURAL EVOLUTION; ALLOY
AB Titanium (Ti) based biomedical materials application which are widely used at present, such as Ti-6Al-7Nb. Due to the toxicity of vanadium to the human body, the Ti-6Al-7Nb alloy that has been developed for a more suitable biomaterial in place of the Ti-6Al-4V alloy. The research part was prepared by metal injection moulding process which is a kind of net-shape powder metallurgy forming process and palm stearin as a binder system. Meanwhile, Design of Experiment technique (DOE) was used in the sintering process to investigated the important quality parameter and study the effects of sintering factors on the density of the sintered parts. The density measurement was carried out by Archimedes method with electronic balance (Mettler Toledo) using distilled water as a medium. The results showed that the sintering temperature and dwell time is the highest significant parameter that contributes to highest sintered part density.
C1 [Ahmad, Rozie Nani] Univ Malaysia Perlis, Sch Mfg Engn, Kampus Tetap Pauh Putra,Jalan Arau Changlun, Arau 02600, Perlis, Malaysia.
   [Ahmad, Rozie Nani; Muhammad, Norhamidi; Sulong, Abu Bakar; Wahi, Azizah] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Bangi 43600, Selangor, Malaysia.
RP Ahmad, RN (reprint author), Univ Malaysia Perlis, Sch Mfg Engn, Kampus Tetap Pauh Putra,Jalan Arau Changlun, Arau 02600, Perlis, Malaysia.; Ahmad, RN (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Mech & Mat Engn, Bangi 43600, Selangor, Malaysia.
EM rozie@unimap.edu.my
CR Bolzoni L, 2012, J MECH BEHAV BIOMED, V9, P91, DOI 10.1016/j.jmbbm.2012.01.015
   Ibrahim MHI, 2010, KEY ENG MATER, V443, P705, DOI 10.4028/www.scientific.net/KEM.443.705
   Jamaludin Khairur Rijal, 2008, P WORLD C POWD MET P, P1
   Ji CH, 2001, MAT SCI ENG A-STRUCT, V311, P74, DOI 10.1016/S0921-5093(01)00942-X
   Moskalewicz T, 2013, APPL SURF SCI, V273, P62, DOI 10.1016/j.apsusc.2013.01.174
   Pinheiro TS, 2012, MATER RES-IBERO-AM J, V15, P792, DOI 10.1590/S1516-14392012005000102
   Rao S, 1996, BIO-MED MATER ENG, V6, P79
   Sam Froes F. H., 2007, POWDER METALLURGY ME, V46
NR 8
TC 0
Z9 0
U1 2
U2 4
PU MALAYSIAN TRIBOLOGY SOC-MYTRIBOS
PI KUALA LUMPUR
PA DEP MECHANICAL ENGINEERING, FAC ENGINEERING, UNIV MALAYA, KUALA LUMPUR,
   50603, MALAYSIA
BN 978-967-13625-1-8
PY 2016
BP 5
EP 6
PG 2
WC Engineering, Manufacturing
SC Engineering
GA BG6DN
UT WOS:000390043400003
DA 2018-10-20
ER

PT J
AU Poranki, D
   Goodwin, C
   Van Dyke, M
AF Poranki, D.
   Goodwin, C.
   Van Dyke, M.
TI Assessment of Deep Partial Thickness Burn Treatment with Keratin
   Biomaterial Hydrogels in a Swine Model
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID THROMBIN PEPTIDE; SILVER SULFADIAZINE; ENDOTHELIAL-CELLS;
   THERMAL-STRESS; IN-VITRO; TP508; PATHWAY; HAIR
AB Partial thickness burns can advance to full thickness after initial injury due to inadequate tissue perfusion and increased production of inflammatory cytokines, which has been referred to as burnwound progression. In previouswork, we demonstrated that a keratin biomaterial hydrogel appeared to reduce burn wound progression. In the present study, we tested the hypothesis that a modified keratin hydrogel could reduce burn wound progression and speed healing. Standardized burn wounds were created in Yorkshire swine and treated within 30 minutes with keratin hydrogel (modified and unmodified), collagen hydrogel, or silver sulfadiazine (SSD). Digital images of each wound were taken for area measurements immediately prior to cleaning and dressing changes. Wound tissue was collected and assessed histologically at several time points. Wound area showed a significant difference between hydrogels and SSD groups, and rates of reepithelialization at early time points showed an increase when keratin treatment was used compared to both collagen and SSD. A linear regression model predicted a time to wound closure of approximately 25 days for keratin hydrogel while SSD treatment required 35 days. There appeared to be no measurable differences between the modified and unmodified formulations of keratin hydrogels.
C1 [Poranki, D.; Goodwin, C.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
   [Van Dyke, M.] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.
RP Van Dyke, M (reprint author), Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.
EM mvandyk5@vt.edu
FU Armed Forces Institute for Regenerative Medicine (DoD)
   [W81XWH-08-20032]; KeraNetics LLC
FX This work was supported by the Armed Forces Institute for Regenerative
   Medicine (DoD Contract no. W81XWH-08-20032) and KeraNetics LLC.
CR Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   CARNEY DH, 1992, SEMIN THROMB HEMOST, V18, P91, DOI 10.1055/s-2007-1002414
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x
   Freyberg S, 2009, J VASC RES, V46, P98, DOI 10.1159/000142727
   Gaines C, 2013, BURNS, V39, P311, DOI 10.1016/j.burns.2012.06.011
   Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003
   Hussain S, 2006, EMERG MED J, V23, P929, DOI 10.1136/emj.2006.043059
   JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413
   Lansdown Alan B G, 2004, Br J Nurs, V13, pS6
   MODAK SM, 1973, BIOCHEM PHARMACOL, V22, P2391, DOI 10.1016/0006-2952(73)90341-9
   Molnar Joseph A, 2009, Eplasty, V9, pe4
   Norfleet AM, 2000, GEN PHARMACOL-VASC S, V35, P249, DOI 10.1016/S0306-3623(01)00118-5
   Nunez F, 2011, MICROCIRCULATION, V18, P663, DOI 10.1111/j.1549-8719.2011.00135.x
   Olszewska-Pazdrak B, 2010, J VASC RES, V47, P203, DOI 10.1159/000255963
   Piraino F, 2015, BIOMED RES INT, V2015
   Popescu C, 2007, CHEM SOC REV, V36, P1282, DOI 10.1039/b604537p
   Poranki D, 2014, J BIOMATER APPL, V29, P26, DOI 10.1177/0885328213513310
   Poranki DR, 2014, BIOMATERIALS, V35, P4646, DOI 10.1016/j.biomaterials.2014.02.044
   Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Selimovic S., 2015, BIOMED RES INT, V2015
   Singh V, 2007, ANN PLAS SURG, V59, P109, DOI 10.1097/01.sap.0000252065.90759.e6
   Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171
   Wasiak J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002106.pub3
   Wright JB, 2002, WOUND REPAIR REGEN, V10, P141, DOI 10.1046/j.1524-475X.2002.10308.x
NR 26
TC 1
Z9 1
U1 0
U2 4
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 1803912
DI 10.1155/2016/1803912
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA EE9EW
UT WOS:000389929700001
PM 28025638
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Maekawa, K
   Inoue, N
   Shimizu, M
   Isobe, Y
   Saku, T
   Hosoda, K
AF Maekawa, Koki
   Inoue, Naoki
   Shimizu, Masahiro
   Isobe, Yoshihiro
   Saku, Taro
   Hosoda, Koh
BE Lepora, NF
   Mura, A
   Mangan, M
   Verschure, PFMJ
   Desmulliez, M
   Prescott, TJ
TI Mutual Entrainment of Cardiac-Oscillators Through Mechanical Interaction
SO BIOMIMETIC AND BIOHYBRID SYSTEMS, LIVING MACHINES 2016
SE Lecture Notes in Computer Science
LA English
DT Proceedings Paper
CT 5th International Conference on Biomimetic and Biohybrid Systems (Living
   Machines)
CY JUL 19-22, 2016
CL Edinburgh, SCOTLAND
SP Convergence Sci Network Biomimet & Neurotechnol, Future Emerging Technologies, European Unions Framework 7 Program, Heriot Watt Univ
DE Mutual entrainment; Cardiac-oscillator; Mechanical interaction
AB This paper focus on bio-robots driven by cardiomyocyte-powered actuators. Towards biomaterial-based robotic actuators that exhibit co-operative motion, this study intends to deal with mutual entrainment between two cardiac-oscillators with mechanical interaction. The cardiac-oscillator is an oriented collagen sheet seeded cultured rat cardiomyocytes. Mechanically coupled cardiac-oscillator sysytem was developed consisting of two cardiac-oscillators connected mechanically via a PDMS film. Mechanically coupled cardiac-oscillator system and a single cardiac-oscillator was applied electric stimulation for investigating the function of mechanical structure. As a result of experiment, we observed mutual entrainment occurred in only mechanically coupled structure.
C1 [Maekawa, Koki; Inoue, Naoki; Shimizu, Masahiro; Hosoda, Koh] Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Machi, Toyonaka, Osaka 5608531, Japan.
   [Isobe, Yoshihiro; Saku, Taro] Atree Inc, 1-181 Sugi Machi, Yamatokoriyama City, Nara 6391121, Japan.
RP Maekawa, K (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama Machi, Toyonaka, Osaka 5608531, Japan.
EM maekawa.koki@arl.sys.es.osaka-u.ac.jp
CR Akiyama Y, 2012, BIOMED MICRODEVICES, V14, P979, DOI 10.1007/s10544-012-9700-5
   Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a
   Iribe G, 2011, CIRC J, V75, P2552, DOI 10.1253/circj.CJ-11-0486
   Isobe Y, 2012, MATERIALS, V5, P501, DOI 10.3390/ma5030501
   Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269
   Webster VA, 2015, LECT NOTES ARTIF INT, V9222, P429, DOI 10.1007/978-3-319-22979-9_43
NR 6
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INT PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0302-9743
BN 978-3-319-42417-0; 978-3-319-42416-3
J9 LECT NOTES COMPUT SC
PY 2016
VL 9793
BP 467
EP 471
DI 10.1007/978-3-319-42417-0_48
PG 5
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Mathematical & Computational Biology
SC Computer Science; Engineering; Mathematical & Computational Biology
GA BG5SR
UT WOS:000389727000048
DA 2018-10-20
ER

PT J
AU Xu, G
   Xu, GN
   Shi, TJ
AF Xu, Guomei
   Xu, Guangnian
   Shi, Tiejun
TI Grafting of chitosan Schiff base on graphene oxide and its
   characterization
SO FULLERENES NANOTUBES AND CARBON NANOSTRUCTURES
LA English
DT Article
DE Biomaterial; Graft; Graphene oxide; Chitosan; Schiff base
ID POLYMERS; NANOCOMPOSITE; NANOSHEETS; FILMS
AB In order to enhance the modification effect, and graphene oxide was also reported could be efficiently modified via covalent attachment. Herein, chitosan Schiff base was chosen to grafting on the surface of graphene oxide. Firstly, chitosan and parahydroxybenzaldehyde were used as raw materials to synthesizing chitosan Schiff base, which was abbreviated as CSb. Secondly, modified graphene oxide with CSb, and chitosan Schiff base moieties were grafted on the surface of graphene oxide, we called it SGO at here. The chemical structure of CSb and SGO were characterized by FT-IR, respectively. The XPS results confirmed that there was 2% nitrogen, 24% oxygen, and 74% carbon existed on the surface of SGO. The curing behavior of GO was characterized by DSC, there was only one exothermic peak during cure and its temperature was 172 degrees C. After grafted with biological groups, appeared one endothermic peak around 76 degrees C, one exothermic peak at 212 degrees C during the cure of SGO. The thermal stability was studied by TGA. The results demonstrated that the thermal stability of SGO improved after modification and obtained 36.4% char yield at 800 degrees C. The fractures properties of SGO were also characterized by FESEM in this paper.
C1 [Xu, Guomei; Xu, Guangnian] West Anhui Univ, Engn Technol Ctr Fine Chem Engn, Anhui Prov Lab Biomimet Sensor & Detecting Techno, Luan 237012, Anhui, Peoples R China.
   [Xu, Guomei; Xu, Guangnian] West Anhui Univ, Sch Mat & Chem Engn, Luan 237012, Anhui, Peoples R China.
   [Shi, Tiejun] Hefei Univ Technol, Sch Chem Engn, Hefei, Peoples R China.
RP Xu, G (reprint author), West Anhui Univ, Engn Technol Ctr Fine Chem Engn, Anhui Prov Lab Biomimet Sensor & Detecting Techno, Luan 237012, Anhui, Peoples R China.; Xu, G (reprint author), West Anhui Univ, Sch Mat & Chem Engn, Luan 237012, Anhui, Peoples R China.
EM xgm1003@126.com
FU State Key Laboratory of Materials Processing and Die & Mould Technology,
   Huazhong University of Science and Technology [P2014-17]; key project of
   nature science research in Anhui Provincial colleges and Universities
   [KJ2015A286]; National Natural Science Foundation of China [51273054]
FX This work was supported by State Key Laboratory of Materials Processing
   and Die & Mould Technology, Huazhong University of Science and
   Technology [P2014-17], key project of nature science research in Anhui
   Provincial colleges and Universities [KJ2015A286] and also supported
   from the National Natural Science Foundation of China (grant no.
   51273054).
CR Abdul Khalil H. P. S., 2016, Carbohydrate Polymers, V150, P216
   Alakayleh F, 2016, POWDER TECHNOL, V299, P107, DOI 10.1016/j.powtec.2016.05.019
   Aljawish A, 2016, FOOD HYDROCOLLOID, V60, P551, DOI 10.1016/j.foodhyd.2016.04.032
   Fang YX, 2015, SENSOR ACTUAT B-CHEM, V221, P265, DOI 10.1016/j.snb.2015.06.098
   Ganesan V, 2014, B MATER SCI, V37, P623, DOI 10.1007/s12034-014-0686-x
   Gu X, 2016, CHEM ENG J, V298, P214, DOI 10.1016/j.cej.2016.04.031
   He LH, 2014, APPL SURF SCI, V314, P510, DOI 10.1016/j.apsusc.2014.07.033
   Hu HL, 2014, MATER LETT, V125, P82, DOI 10.1016/j.matlet.2014.03.133
   Hu QB, 2016, CARBOHYD POLYM, V151, P624, DOI 10.1016/j.carbpol.2016.05.109
   Jia JF, 2016, ULTRASON SONOCHEM, V32, P300, DOI 10.1016/j.ultsonch.2016.03.027
   Kharisov BI, 2016, J COORD CHEM, V69, P1125, DOI 10.1080/00958972.2016.1170817
   Lei L, 2016, PROG ORG COAT, V97, P19, DOI 10.1016/j.porgcoat.2016.03.011
   Li HF, 2013, SENSOR ACTUAT B-CHEM, V181, P858, DOI 10.1016/j.snb.2013.02.094
   Li H, 2016, POLYMER, V85, P106, DOI 10.1016/j.polymer.2016.01.050
   Mohandes F, 2014, RSC ADV, V4, P25993, DOI 10.1039/c4ra03534h
   Mungse HP, 2012, J MATER CHEM, V22, P5427, DOI 10.1039/c2jm15644j
   Rao DJ, 2016, SENSOR ACTUAT B-CHEM, V236, P192, DOI 10.1016/j.snb.2016.05.160
   Salehi E, 2016, CARBOHYD POLYM, V152, P419, DOI 10.1016/j.carbpol.2016.07.033
   Santosh K, 2014, INT J BIOL MACROMOL, V70, P559
   Shen F, 2016, INT J BIOL MACROMOL, V91, P443, DOI 10.1016/j.ijbiomac.2016.05.103
   Soares PIP, 2016, CARBOHYD POLYM, V149, P382, DOI 10.1016/j.carbpol.2016.04.123
   Tan WQ, 2016, INT J BIOL MACROMOL, V92, P293, DOI 10.1016/j.ijbiomac.2016.07.023
   Wang DF, 2016, MATER LETT, V175, P32, DOI 10.1016/j.matlet.2016.03.135
   Xu GM, 2015, RES CHEM INTERMEDIAT, V41, P8499, DOI 10.1007/s11164-014-1906-0
   Yadav M, 2015, INT J BIOL MACROMOL, V79, P923, DOI [10.1016/j.ijbiomac.2015.05.055, 10.1016/j.dbiomac.2015.05.055]
   Yuan WZ, 2013, MATER LETT, V107, P243, DOI 10.1016/j.matlet.2013.06.028
   Zhuang XD, 2014, ADV MATER, V26, P3081, DOI 10.1002/adma.201305040
NR 27
TC 0
Z9 0
U1 5
U2 21
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1536-383X
EI 1536-4046
J9 FULLER NANOTUB CAR N
JI Fuller. Nanotub. Carbon Nanostruct.
PY 2016
VL 24
IS 12
BP 749
EP 756
DI 10.1080/1536383X.2016.1226285
PG 8
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Atomic, Molecular & Chemical
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EE3OS
UT WOS:000389501600002
DA 2018-10-20
ER

PT J
AU Mafi, A
   Dehghani, F
   Moghadam, A
   Noorafshan, A
   Vojdani, Z
   Talaei-Khozani, T
AF Mafi, Afsaneh
   Dehghani, Farzaneh
   Moghadam, Abbas
   Noorafshan, Ali
   Vojdani, Zahra
   Talaei-Khozani, Tahereh
TI Effects of platelet-rich plasma on liver regeneration in CCl4-induced
   hepatotoxicity model
SO PLATELETS
LA English
DT Article
DE Growth factors; liver; platelet-rich plasma; regeneration
ID ENDOTHELIAL-CELL APOPTOSIS; IN-VITRO; FIBROSIS; FRACTIONATOR;
   HEPATECTOMY; REPERFUSION; HEPATITIS; CULTURE; REPAIR; DAMAGE
AB Numerous bioactive growth factors and cytokines in platelet-rich plasma (PRP) have recently made it an attractive biomaterial for therapeutic purposes. These growth factors have the potential to regenerate the injured tissues. The aim of this study was to investigate the therapeutic effects of PRP in hepatotoxic animal model. Hepatotoxicity was induced in rats by oral administration of 4 mL/kg/week of CCl4 diluted 1:1 in corn oil for 10 weeks. To confirm the hepatotoxicity, 24 h after the last CCl4 administration, blood samples were collected via cardiac puncture to assess the serum levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, albumin, total protein, and total bilirubin. Twenty-four hours after blood collection, the experimental animals received a single injection of PRP (1 mL) via the anterior mesenteric vein. One week later, all biochemical tests were performed again, and the rats were scarified and their livers were removed, prepared histologically, and stained. The stereological analyses were performed to evaluate the effects of PRP on histopathological features of CCl4-treated livers. The results were compared statistically with the corresponding control and CCl4+normal saline (NS)-treated animals. A significant decrease in the number and volume of hepatocytes (p = 0.01), and also a reduction in the volume of sinusoids (p = 0.001) and connective tissue (p = 0.04), were observed in the PRP-treated animals compared with the CCl4+NS-treated ones. Our findings demonstrated that application of PRP had beneficial effects on CCl4-induced fibrosis; however, it had detrimental effects on the total number of hepatocytes and the volume of hepatocytes and sinusoidal spaces.
C1 [Mafi, Afsaneh; Moghadam, Abbas] Shiraz Univ Med Sci, Dept Anat, Shiraz, Iran.
   [Dehghani, Farzaneh; Noorafshan, Ali] Shiraz Univ Med Sci, Dept Anat, Stereol & Histomorphol Res Ctr, Shiraz, Iran.
   [Vojdani, Zahra] Shiraz Univ Med Sci, Dept Anat, Lab Stem Cell Res, Shiraz, Iran.
   [Talaei-Khozani, Tahereh] Shiraz Univ Med Sci, Dept Anat, Tissue Engn Lab, Shiraz, Iran.
RP Talaei-Khozani, T (reprint author), Shiraz Univ Med Sci, Dept Anat, Tissue Engn Lab, Shiraz, Iran.
EM talaeit@sums.ac.ir
RI Moghadam, Abbas/N-3146-2017; vojdani, zahra/U-6977-2017; Mafi,
   Afsaneh/N-3215-2017; Talaei-khozani, Tahereh/N-2344-2015
OI vojdani, zahra/0000-0001-8214-2309; Talaei-khozani,
   Tahereh/0000-0002-8425-8871
FU Shiraz University of Medical Sciences [93-7055]
FX The authors wish to thank research deputy of Shiraz University of
   Medical Sciences for the grant no. 93-7055 and also Center for
   Development of Clinical Research of Nemazee Hospital and Dr Nasrin
   Shokrpour for editorial assistance. This study was a part of
   requirements of PhD program that was fulfilled by A. Mafi.
CR Alkozai EM, 2010, ANN SURG, V251, P300, DOI 10.1097/SLA.0b013e3181b76557
   [Anonymous], 1979, STEREOLOGICAL METHOD, P1
   Basu S, 2003, TOXICOLOGY, V189, P113, DOI 10.1016/S0300-483X(03)00157-4
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   de Mos M, 2008, AM J SPORT MED, V36, P1171, DOI 10.1177/0363546508314430
   Franco D, 2012, AESTHET PLAST SURG, V36, P1254, DOI 10.1007/s00266-012-9957-3
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Fukaya Y, 2012, EXP MOL MED, V44, P330, DOI 10.3858/emm.2012.44.5.037
   Gambim MH, 2007, CRIT CARE, V11, DOI 10.1186/cc6133
   Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x
   GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x
   Gundersen HJG, 2002, J MICROSC-OXFORD, V207, P191, DOI 10.1046/j.1365-2818.2002.01054.x
   Haynesworth SE KS, 48 M ORTH RES SOC 20
   Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003
   Hesami Z, 2014, INT J HEPATOL, DOI 10.1155/2014/932930
   Hisakura K, 2010, J HEPATO-BIL-PAN SCI, V17, P855, DOI 10.1007/s00534-010-0276-2
   Ikeda N, 2012, HEPATOL RES, V42, P91, DOI 10.1111/j.1872-034X.2011.00893.x
   Jang JH, 2008, TRANSPL P, V40, P2700, DOI 10.1016/j.transproceed.2008.07.040
   Kawasaki T, 2010, J HEPATOL, V53, P648, DOI 10.1016/j.jhep.2010.04.021
   Kim J, 2010, WORLD J SURG, V34, P1052, DOI 10.1007/s00268-010-0464-x
   Kodama T, 2010, GASTROENTEROLOGY, V138, P2487, DOI 10.1053/j.gastro.2010.02.054
   Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780
   Laschke MW, 2008, BRIT J PHARMACOL, V153, P148, DOI 10.1038/sj.bjp.0707578
   Lin CS, 2008, INTERNAL MED, V47, P569, DOI 10.2169/internalmedicine.47.0595
   Loibl M, 2016, CLIN HEMORHEOL MICRO, V61, P599, DOI 10.3233/CH-141920
   Matsuo R, 2008, J SURG RES, V145, P279, DOI 10.1016/j.jss.2007.02.035
   MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x
   Mifune Y, 2013, OSTEOARTHR CARTILAGE, V21, P175, DOI 10.1016/j.joca.2012.09.018
   Murata S, 2007, SCIENCE, V31, P808
   Myronovych A, 2008, J HEPATOL, V49, P363, DOI 10.1016/j.jhep.2008.04.019
   Nakano Y, 2008, J SURG RES, V149, P192, DOI 10.1016/j.jss.2007.09.016
   Nyengaard JR, 1999, J AM SOC NEPHROL, V10, P1100
   Pacifici L, 2002, Minerva Stomatol, V51, P341
   Pak S, 2010, PLATELETS, V21, P282, DOI 10.3109/09537101003637265
   RECKNAGE RO, 1967, PHARMACOL REV, V19, P145
   Reuter JD, 2003, LAB ANIMAL MED MANAG
   Sato M, 2002, ASAIO J, V48, P360, DOI 10.1097/00002480-200207000-00006
   SCHERLE W, 1970, Mikroskopie, V26, P57
   Sindram D, 2000, GASTROENTEROLOGY, V118, P183, DOI 10.1016/S0016-5085(00)70427-6
   Wasterlain AS, 2012, OPER TECH ORTHOP, V22, P33, DOI 10.1053/j.oto.2011.11.001
   Watanabe M, 2009, J GASTROEN HEPATOL, V24, P78, DOI 10.1111/j.1440-1746.2008.05497.x
   Yamaguchi R, 2012, J SURG RES, V173, P258, DOI 10.1016/j.jss.2010.10.001
   Zaldivar MM, 2010, HEPATOLOGY, V51, P1345, DOI 10.1002/hep.23435
NR 43
TC 3
Z9 3
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0953-7104
EI 1369-1635
J9 PLATELETS
JI Platelets
PY 2016
VL 27
IS 8
BP 771
EP 776
DI 10.1080/09537104.2016.1184749
PG 6
WC Cell Biology; Hematology
SC Cell Biology; Hematology
GA EE5LX
UT WOS:000389650400009
PM 27255378
DA 2018-10-20
ER

PT S
AU Gao, HJ
   Qiao, MN
   Zhang, L
AF Gao, Hongjie
   Qiao, Minna
   Zhang, Le
BE Xu, B
TI A review: Bone remodeling biological computing model
SO PROCEEDINGS OF THE 2ND INFORMATION TECHNOLOGY AND MECHATRONICS
   ENGINEERING CONFERENCE (ITOEC 2016)
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT 2nd Information Technology and Mechatronics Engineering Conference
   (ITOEC)
CY MAY 21-22, 2016
CL Chongqing, PEOPLES R CHINA
DE agent based model; bone reconstruction; biomaterial
ID SIGNALING PATHWAY; REGENERATION; OSTEOBLAST; SCAFFOLD
AB In order to explore a suitable bone graft substitute to improve the success rate of bone graft, the bone reconstruction modeling has become a hot research topic. Over the past several decades, there have been a lot of models developed for the bone reformation. This study mainly discusses the current research progress of the bone reconstruction, several cutting edge key techniques and the challenges of bone reconstruction in the distant future.
C1 [Gao, Hongjie; Qiao, Minna; Zhang, Le] SouthWest Univ, Chongqing, Peoples R China.
RP Gao, HJ (reprint author), SouthWest Univ, Chongqing, Peoples R China.
EM 18375728313@163.com; 392242359@qq.com; zhanglcq@swu.edu.cn
CR Ahmed E. G., 2005, EXPERT REV MED DEVIC, V2, P87
   Ali S. L., 2014, ASSISTED CONVERSION
   Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9
   Clara S., 2010, BIOMATERIALS, V31, P2446
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200
   Geris L., 2008, EUR C INT FED MED BI, P2651
   He N., 2014, BONE MARROW RES, V2014
   Hosseini H. S., 2015, INT J NUMER METHOD B
   Jian F., 2005, PLASTIC RECONSTRUCTI, V116, P1379
   Kholodenko B. N., 2006, NATURE REV MOL CELL, V7
   Kolmakova T., 2013, VESTNIK IKBFU
   Lacroix D, 2002, MED BIOL ENG COMPUT, V40, P14, DOI 10.1007/BF02347690
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023
   Lin D., 2007, 5 AUSTR C APPL MECH, P639
   Miller F. P., 2010, CELL SIGNALING
   Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411
   Pivonka P, 2008, BONE, V43, P249, DOI 10.1016/j.bone.2008.03.025
   Sakaguchi K., 1966, J JAPANESE FORESTRY, V48, P358
   Sanz-Herrera JA, 2008, BIOMECH MODEL MECHAN, V7, P355, DOI 10.1007/s10237-007-0089-7
   Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015
   Sun XQ, 2012, BIOMATERIALS, V33, P8265, DOI 10.1016/j.biomaterials.2012.07.041
   Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015
   Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214
   William C., 2012, BONE, V50, P477
   Wolff J., 1986, LAW BONE REMODELLING
   ZIENKIEWICZ OC, 1972, NUCL ENG DES, V20, P507, DOI 10.1016/0029-5493(72)90125-2
NR 28
TC 0
Z9 0
U1 2
U2 4
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-6252-178-0
J9 AER ADV ENG RES
PY 2016
VL 24
BP 412
EP 416
PG 5
WC Engineering, Multidisciplinary; Engineering, Mechanical
SC Engineering
GA BG5CQ
UT WOS:000389364900079
DA 2018-10-20
ER

PT J
AU Dai, JM
   Yang, SL
   Jin, JH
   Li, G
AF Dai, Jiamu
   Yang, Shenglin
   Jin, Junhong
   Li, Guang
TI Electrospinning of PLA/pearl powder nanofibrous scaffold for bone tissue
   engineering
SO RSC ADVANCES
LA English
DT Article
ID POLY(L-LACTIC ACID); COMPOSITE; BIOCOMPATIBILITY; CRYSTALLIZATION;
   NANOPARTICLES; BIOACTIVITY; RELEASE; MATRIX; PEARL; CELLS
AB Pearl powder is a natural composite of CaCO3 and organic matter, which is a promising biomaterial for bone tissue engineering. In the present work, pearl powder incorporated polylactic (PLA) nanofibrous scaffold fabricated via electrospinning process to improve the weak biocompatibility and mineralization ability of PLA, was used as support for deposition of hydroxyapatite (HA) and supporting cell culture. Then, the as-prepared scaffolds were well characterized by several assays. Morphology observations showed that pearl powder can homogeneously distribute on the surfaces of nanofibers, and appreciably better hydrophilicity was obtained on a PLA/pearl scaffold than PLA. After a mineralization process, HA particles successfully deposited on the nanofiber, which fully covered the surfaces of PLA/pearl nanofibers, whereas coverage seemed only partial on pristine PLA. An in vitro test illustrated higher cell proliferation and better adhesion morphology of MC3T3s that appeared on the PLA/pearl nanofibrous scaffold. Therefore, electrospinning a PLA/pearl nanofibrous scaffold has superior properties to pristine PLA, and shows potential application in bone tissue engineering.
C1 [Dai, Jiamu; Yang, Shenglin; Jin, Junhong; Li, Guang] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
RP Li, G (reprint author), Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
EM lig@dhu.edu.cn
FU Fundamental Research Funds for the Central Universities [16D310610];
   Chinese Universities Scientific Fund [CUSF-DH-D-2016040]
FX This study was supported by the Fundamental Research Funds for the
   Central Universities (16D310610), Chinese Universities Scientific Fund
   (CUSF-DH-D-2016040).
CR Bai JJ, 2015, PROG NAT SCI-MATER, V25, P327, DOI 10.1016/j.pnsc.2015.07.004
   Baker KC, 2011, ACTA BIOMATER, V7, P3382, DOI 10.1016/j.actbio.2011.05.014
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   Chaudhuri B, 2014, MATER LETT, V126, P109, DOI 10.1016/j.matlet.2014.04.008
   Dai JM, 2015, ADV ENG MATER, V17, P1691, DOI 10.1002/adem.201500144
   Diao HX, 2012, MAT SCI ENG C-MATER, V32, P1796, DOI 10.1016/j.msec.2012.04.065
   He CL, 2014, ACTA BIOMATER, V10, P419, DOI 10.1016/j.actbio.2013.08.041
   Hu YY, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40951
   Kim ES, 2010, MACROMOL RES, V18, P215, DOI 10.1007/s13233-010-0316-4
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lee H, 2013, J MATER CHEM B, V1, P3670, DOI 10.1039/c3tb20424c
   Liu YS, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500206
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   Qiu KX, 2013, J MATER CHEM B, V1, P4601, DOI 10.1039/c3tb20636j
   Saandoun S., 2011, J NEUROL NEUROSUR PS, V82, P944
   Shalumon KT, 2009, CARBOHYD POLYM, V77, P863, DOI 10.1016/j.carbpol.2009.03.009
   Shao SJ, 2011, BIOMATERIALS, V32, P2821, DOI 10.1016/j.biomaterials.2011.01.051
   Shen YT, 2006, BIOMATERIALS, V27, P281, DOI 10.1016/j.biomaterials.2005.05.088
   Shieh YT, 2007, J POLYM SCI POL PHYS, V45, P1870, DOI 10.1002/polb.21184
   Shieh YT, 2007, J POLYM SCI POL PHYS, V45, P466, DOI 10.1002/polb.21056
   Song BT, 2012, ACTA BIOMATER, V8, P1901, DOI 10.1016/j.actbio.2012.01.020
   Song J, 2015, ELECTROCHIM ACTA, V177, P174, DOI 10.1016/j.electacta.2015.03.142
   Wei GB, 2006, J BIOMED MATER RES A, V78A, P306, DOI 10.1002/jbm.a.30704
   Xu DH, 2008, POLYMER, V49, P330, DOI 10.1016/j.polymer.2007.11.041
   Xu MG, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025002
   Yoon OJ, 2011, COMPOS PART A-APPL S, V42, P1978, DOI 10.1016/j.compositesa.2011.08.023
   Yun J, 2010, MATER LETT, V64, P2431, DOI 10.1016/j.matlet.2010.08.001
   Zhang XY, 2013, COLLOID SURFACE A, V431, P80, DOI 10.1016/j.colsurfa.2013.04.021
   Zhou WY, 2008, J MATER SCI-MATER M, V19, P2535, DOI 10.1007/s10856-007-3089-3
   Zhu WM, 2014, IN VITRO CELL DEV-AN, V50, P214, DOI 10.1007/s11626-013-9699-9
NR 33
TC 0
Z9 0
U1 4
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 108
BP 106798
EP 106805
DI 10.1039/c6ra21796f
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA EE1HD
UT WOS:000389330700087
DA 2018-10-20
ER

PT J
AU Jiao, W
AF Jiao, Wei
TI Facile synthesis of silver nanoparticles deposited on a calcium silicate
   hydrate composite as an efficient bactericidal agent
SO RSC ADVANCES
LA English
DT Article
ID ONE-POT SYNTHESIS; ANTIBACTERIAL PROPERTIES; ANTIMICROBIAL ACTIVITY;
   DRUG-DELIVERY; METAL-IONS; NANOCOMPOSITES; CYTOTOXICITY; SURFACE;
   NANOFIBERS; MECHANISM
AB Silver nanoparticles (Ag NPs) have been widely used for the disinfection and prevention of pathogenic bacteria. However, the aggregation and instability of Ag NPs significantly limit their bactericidal activity. As an alternative method, stabilization of Ag NPs on an inorganic biomaterial is a promising strategy. In this study, an inorganic material with good biocompatibility and bioactivity, calcium silicate hydrate (CSH), was employed as the host substance. A facile and efficient method was proposed to produce Ag NPs deposited on a CSH (CSH/Ag) composite. Ag+ ions were first embedded into the surface of CSH through ion-exchange and subsequently reduced to Ag NPs by a reducing agent. Due to the high specific surface area and great ion-exchange capacity of CSH, a series of CSH/Ag composites with different silver contents were easily synthesized. Scanning electron microscopy (SEM), transmission electron microscopy (TEM), elemental mapping, X-ray diffraction (XRD), nitrogen sorption/desorption analysis, and inductively coupled plasma-atomic emission spectrometry (ICP-AES) were employed to characterize the synthesized CSH/Ag composites. Moreover, Ag+ ions release behaviours from the CSH/Ag composites were investigated and the release profiles showed dose-dependent and long-time sustained release properties. Furthermore, the synthesized CSH/Ag composite displayed good biocompatibility and high antibacterial activities against both Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus. Overall, the newly designed CSH/Ag composite is believed to be a promising bactericidal agent in biomedical applications.
C1 [Jiao, Wei] Fudan Univ, Huashan Hosp, Dept Anesthesiol, Shanghai 200040, Peoples R China.
RP Jiao, W (reprint author), Fudan Univ, Huashan Hosp, Dept Anesthesiol, Shanghai 200040, Peoples R China.
EM weijiao_huashan@sohu.com
CR Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Belkhair S, 2015, RSC ADV, V5, P40932, DOI 10.1039/c5ra03856a
   Boanini E, 2014, RSC ADV, V4, P645, DOI 10.1039/c3ra45846f
   Chen CP, 2012, ADV FUNCT MATER, V22, P780, DOI 10.1002/adfm.201102333
   Dankovich TA, 2011, ENVIRON SCI TECHNOL, V45, P1992, DOI 10.1021/es103302t
   Dong B, 2014, NANOSCALE, V6, P10859, DOI 10.1039/c4nr03169e
   Gunawan P, 2011, ACS NANO, V5, P10033, DOI 10.1021/nn2038725
   Hu B, 2015, CHEM-EUR J, V21, P6582, DOI 10.1002/chem.201405960
   Islam MS, 2015, J MATER CHEM B, V3, P1001, DOI 10.1039/c4tb01911c
   Johnston JH, 2011, J MATER CHEM, V21, P1240, DOI 10.1039/c0jm02685a
   Kokura S, 2010, NANOMED-NANOTECHNOL, V6, P570, DOI 10.1016/j.nano.2009.12.002
   Kuwahara Y, 2013, J MATER CHEM A, V1, P7199, DOI 10.1039/c3ta11064h
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Li K, 2013, J MATER SCI-MATER M, V24, P171, DOI 10.1007/s10856-012-4788-y
   Li M, 2015, J MATER CHEM B, V3, P8796, DOI 10.1039/c5tb01597a
   Li SK, 2013, NANOSCALE, V5, P12616, DOI 10.1039/c3nr03857b
   Liang HW, 2011, ACS NANO, V5, P8148, DOI 10.1021/nn202789f
   Liong M, 2009, ADV MATER, V21, P1684, DOI 10.1002/adma.200802646
   Liu J, 2012, J MATER CHEM, V22, P13891, DOI 10.1039/c2jm31831h
   Luo HY, 2015, RSC ADV, V5, P13470, DOI 10.1039/c4ra16469e
   Lv M, 2010, ADV MATER, V22, P5463, DOI 10.1002/adma.201001934
   Markova Z, 2012, GREEN CHEM, V14, P2550, DOI 10.1039/c2gc35545k
   Mehrali M, 2014, ACS APPL MATER INTER, V6, P3947, DOI 10.1021/am500845x
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nocchetti M, 2013, J MATER CHEM B, V1, P2383, DOI 10.1039/c3tb00561e
   Qin H, 2015, ACS APPL MATER INTER, V7, P10785, DOI 10.1021/acsami.5b01310
   Shi JY, 2017, CATAL TODAY, V281, P21, DOI 10.1016/j.cattod.2016.03.039
   Shie MY, 2013, BIOMATERIALS, V34, P6589, DOI 10.1016/j.biomaterials.2013.05.075
   Tian Y, 2014, ACS APPL MATER INTER, V6, P12038, DOI 10.1021/am5026424
   Wang H, 2016, RSC ADV, V6, P34770, DOI 10.1039/c6ra07625d
   Wang X, 2013, RSC ADV, V3, P11751, DOI 10.1039/c3ra23203d
   Wang YF, 2016, J MATER CHEM B, V4, P635, DOI 10.1039/c5tb02358k
   Wu CT, 2012, J MATER CHEM, V22, P16801, DOI 10.1039/c2jm33387b
   Wu J, 2013, SMALL, V9, P2911, DOI 10.1002/smll.201300097
   Wu MC, 2016, ADV FUNCT MATER, V26, P569, DOI 10.1002/adfm.201504197
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126
   You WJ, 2016, PHYS CHEM CHEM PHYS, V18, P15564, DOI 10.1039/c6cp01199c
   Yu L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04551
   Zhang HS, 2015, RSC ADV, V5, P5904, DOI 10.1039/c4ra08678c
   Zhang J., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1109/ICNP.2013.6733609
   Zhang JH, 2014, MICROPOR MESOPOR MAT, V197, P244, DOI 10.1016/j.micromeso.2014.06.018
   Zhang JY, 2012, IND ENG CHEM RES, V51, P3081, DOI 10.1021/ie202473u
   Zhang QM, 2014, MACROMOLECULES, V47, P8018, DOI 10.1021/ma501997x
   Zhu YJ, 2014, EXPERT OPIN DRUG DEL, V11, P1337, DOI 10.1517/17425247.2014.923399
   Zhu YF, 2013, ACTA BIOMATER, V9, P6723, DOI 10.1016/j.actbio.2013.01.021
NR 48
TC 0
Z9 0
U1 2
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 114
BP 112931
EP 112938
DI 10.1039/c6ra24265k
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA EE8VR
UT WOS:000389905300024
DA 2018-10-20
ER

PT J
AU Rohullah
   Azam, A
   Qiao, SL
   Ul Islam, M
   Ali, J
   Wahab, A
   Khan, MA
   Farhan
   Hameed, A
AF Rohullah
   Azam, Andaleeb
   Qiao, Shanlin
   Ul Islam, Mazhar
   Ali, Javed
   Wahab, Abdul
   Khan, Murad Ali
   Farhan
   Hameed, Abdul
TI Facile synthesis of hair-extract-capped gold and silver nanoparticles
   and their biological applications
SO RSC ADVANCES
LA English
DT Article
ID UREASE; NANOTECHNOLOGY; CHEMISTRY; PATHOGENS; MODEL
AB Hair is a waste keratinous biomaterial. In tanneries, hair burning is a common practice, resulting in a residue containing a large amount of COD, BOD, and TDS, which are environmental hazards. Meanwhile, microorganisms have developed resistance against various drugs. Herein, with the aim to utilise this waste hair material, silver (AgHr) and gold (AuHr) nanoparticles were synthesised using NaBH4 as a reducing agent and hair extract as a stabilizing material. The formation and structure of the nanoparticles were scrutinised by different analytical techniques, including UV-Vis, TEM, and AFM. As a result, spherical shaped silver (AgHr) and gold (AuHr) nanoparticles of various sizes, ranging from 4-30 nm, were prepared. The stabilities of AgHr and AuHr toward acidity, alkalinity, salinity, and temperature were also investigated, which showed that they remained stable for more than six months. Moreover, the hair-extract-stabilised silver and gold nanoparticles underwent bioactivity evaluations. The nanoparticles showed promise in multiple applications, including as enzyme inhibitors and bactericidal agents.
C1 [Qiao, Shanlin; Hameed, Abdul] Univ Chinese Acad, Natl Ctr Nanosci & Technol, Beijing, Peoples R China.
   [Rohullah; Ali, Javed; Khan, Murad Ali; Farhan] Kohat Univ Sci & Technol, Dept Chem, Kp, Pakistan.
   [Azam, Andaleeb] Women Univ Swabi, Dept Chem, Swabi, Kp, Pakistan.
   [Wahab, Abdul] Kohat Univ Sci & Technol, Dept Pharm, Kp, Pakistan.
   [Ul Islam, Mazhar] Dhofar Univ, Coll Engn, Dept Chem Engn, Salalah, Oman.
RP Hameed, A (reprint author), Univ Chinese Acad, Natl Ctr Nanosci & Technol, Beijing, Peoples R China.
EM ham.chemist@gmail.com
RI Khan, Murad/H-7094-2016
OI Khan, Murad/0000-0002-8286-5504; Hameed, Abdul/0000-0001-8377-0227
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Ara R, 2007, CHEM BIODIVERS, V4, P58, DOI 10.1002/cbdv.200790007
   Arora K., 2013, INT J BIOASSAYS, V2, P984
   BRADBURY JH, 1966, NATURE, V210, P1333, DOI 10.1038/2101333a0
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Deng D, 2016, ACS SUSTAIN CHEM ENG, V4, P5409, DOI 10.1021/acssuschemeng.6b01689
   DUNN BE, 1990, J BIOL CHEM, V265, P9464
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Frenkel AI, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2126666
   Gabbay J, 2006, J IND TEXT, V35, P323, DOI DOI 10.1177/1528083706060785
   Gould SWJ, 2009, ANN MICROBIOL, V59, P151, DOI 10.1007/BF03175613
   Halal J., 2002, HAIR STRUCTURE CHEM
   Hameed Alaa Ali., 2012, THESIS
   Haveli SD, 2012, NANO LETT, V12, P6212, DOI 10.1021/nl303107w
   Kalpana D, 2013, ENZYME MICROB TECH, V52, P151, DOI 10.1016/j.enzmictec.2012.12.006
   Karthikeyan R, 2007, J SCI IND RES INDIA, V66, P710
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Liu SS, 2014, J MATER CHEM C, V2, P6477, DOI 10.1039/c4tc00636d
   MOBLEY HLT, 1989, MICROBIOL REV, V53, P85
   Naz SS, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0034-8
   Ponnuvel S, 2015, PROTEIN J, V34, P329, DOI 10.1007/s10930-015-9627-9
   Ravishankar Rai V., 2011, SCI MICROBIAL PATHOG, P197
   Robbins C. R, 2012, CHEM PHYS BEHAV HUMA, p10S, DOI DOI 10.1007/978-3-642-25611-0_2
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   Thamphiwatana S, 2013, LANGMUIR, V29, P12228, DOI 10.1021/la402695c
   Walter P, 2006, NANO LETT, V6, P2215, DOI 10.1021/nl061493u
   Zawrah MF, 2011, LIFE SCI J, V8, P37
   Zynio SA, 2002, SENSORS, V2, P62, DOI 10.3390/s20200062
NR 30
TC 0
Z9 0
U1 0
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 114
BP 113452
EP 113456
DI 10.1039/c6ra21455j
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA EE8VR
UT WOS:000389905300082
DA 2018-10-20
ER

PT J
AU Jones, CD
   Steed, JW
AF Jones, Christopher D.
   Steed, Jonathan W.
TI Gels with sense: supramolecular materials that respond to heat, light
   and sound
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID INDUCED EMISSION ENHANCEMENT; AGGREGATION-INDUCED EMISSION;
   SELF-ASSEMBLY SYSTEM; PLATINUM-ACETYLIDE ORGANOGELATORS; RACEMIC
   HYDROXYOCTADECANOIC ACIDS; AMPLITUDE OSCILLATORY SHEAR; MOLECULAR-WEIGHT
   GELATORS; SOFT FUNCTIONAL MATERIALS; POLY(ARYL ETHER) DENDRON; SMALL
   ORGANIC-MOLECULES
AB Advances in the field of supramolecular chemistry have made it possible, in many situations, to reliably engineer soft materials to address a specific technological problem. Particularly exciting are "smart'' gels that undergo reversible physical changes on exposure to remote, non-invasive environmental stimuli. This review explores the development of gels which are transformed by heat, light and ultrasound, as well as other mechanical inputs, applied voltages and magnetic fields. Focusing on small-molecule gelators, but with reference to organic polymers and metal-organic systems, we examine how the structures of gelator assemblies influence the physical and chemical mechanisms leading to thermo-, photo- and mechano-switchable behaviour. In addition, we evaluate how the unique and versatile properties of smart materials may be exploited in a wide range of applications, including catalysis, crystal growth, ion sensing, drug delivery, data storage and biomaterial replacement.
C1 [Jones, Christopher D.; Steed, Jonathan W.] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.
RP Steed, JW (reprint author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.
EM jon.steed@durham.ac.uk
RI Steed, Jonathan/A-7916-2008
OI Steed, Jonathan/0000-0002-7466-7794
FU Engineering and Physical Sciences Research Council [1374655]
FX We are grateful to Stephen Jones (pineta.co.uk) for assistance in the
   preparation of the graphical abstract, and to the Engineering and
   Physical Sciences Research Council for funding via a Doctoral
   Scholarship (grant 1374655).
CR Abraham S, 2012, LANGMUIR, V28, P4955, DOI 10.1021/la204412t
   Adams DJ, 2010, SOFT MATTER, V6, P4144, DOI 10.1039/c0sm00409j
   Ahmed SA, 2002, LANGMUIR, V18, P7096, DOI 10.1021/la025545g
   Ahmed SA, 2009, J PHYS ORG CHEM, V22, P593, DOI 10.1002/poc.1487
   Ajayaghosh A, 2007, ACCOUNTS CHEM RES, V40, P644, DOI 10.1021/ar7000364
   Aleman J, 2007, PURE APPL CHEM, V79, P1801, DOI 10.1351/pac200779101801
   Alex S, 2007, J PHYS CHEM A, V111, P3226, DOI 10.1021/jp068492a
   Amabilino DB, 2007, NAT MATER, V6, P924, DOI 10.1038/nmat2064
   Amabilino DB, 2010, SOFT MATTER, V6, P1605, DOI 10.1039/b923618j
   Ampornpun S, 2012, MACROMOLECULES, V45, P9038, DOI 10.1021/ma3019798
   Anderson KM, 2008, ANGEW CHEM INT EDIT, V47, P1058, DOI 10.1002/anie.200703785
   Andreasson J, 2010, CHEM SOC REV, V39, P174, DOI 10.1039/b820280j
   Andreasson J, 2011, J AM CHEM SOC, V133, P11641, DOI 10.1021/ja203456h
   Aoki K, 2004, ORG LETT, V6, P4009, DOI 10.1021/ol048364+
   Armon S, 2014, SOFT MATTER, V10, P2733, DOI 10.1039/c3sm52313f
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   Azeroual S, 2012, CHEM COMMUN, V48, P2292, DOI 10.1039/c2cc16266k
   Babu P, 2003, CHEM-EUR J, V9, P1922, DOI 10.1002/chem.200204459
   Bachl J, 2013, J MATER CHEM A, V1, P4577, DOI 10.1039/c3ta01109g
   Baddeley C, 2007, J ORG CHEM, V72, P7270, DOI 10.1021/jo071159y
   Bai X, 2016, CHEM ENG J, V288, P546, DOI 10.1016/j.cej.2015.12.021
   Bardelang D, 2008, J AM CHEM SOC, V130, P3313, DOI 10.1021/ja711342y
   Bardelang D, 2012, RSC ADV, V2, P5605, DOI 10.1039/c2ra20208e
   Bardelang D, 2009, SOFT MATTER, V5, P1969, DOI 10.1039/b821866h
   Bartlett P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021404
   Berkovic G, 2000, CHEM REV, V100, P1741, DOI 10.1021/cr9800715
   Blanco E, 1999, APPL ORGANOMET CHEM, V13, P399, DOI 10.1002/(SICI)1099-0739(199905)13:5<399::AID-AOC825>3.0.CO;2-A
   Blundell JR, 2009, MACROMOLECULES, V42, P5388, DOI 10.1021/ma9004633
   Boekhoven J, 2010, ANGEW CHEM INT EDIT, V49, P4825, DOI 10.1002/anie.201001511
   Borre E, 2016, ANGEW CHEM INT EDIT, V55, P1313, DOI 10.1002/anie.201508241
   BOWEN EJ, 1959, J PHYS CHEM-US, V63, P4, DOI 10.1021/j150571a003
   Braga D, 2011, CHEM COMMUN, V47, P5154, DOI 10.1039/c1cc10305a
   Breger JC, 2015, ACS APPL MATER INTER, V7, P3398, DOI 10.1021/am508621s
   Brinksma J, 2000, LANGMUIR, V16, P9249, DOI 10.1021/la000839s
   Bromberg L, 2004, LANGMUIR, V20, P5683, DOI 10.1021/la0359530
   Buck KKS, 1999, J FLUID MECH, V396, P287, DOI 10.1017/S0022112099006035
   Buenger D, 2012, PROG POLYM SCI, V37, P1678, DOI 10.1016/j.progpolymsci.2012.09.001
   Byrne P, 2008, CRYST GROWTH DES, V8, P3335, DOI 10.1021/cg800247f
   Byrne P, 2010, NEW J CHEM, V34, P2261, DOI 10.1039/c0nj00278j
   Cai MM, 2012, PHYS CHEM CHEM PHYS, V14, P5289, DOI 10.1039/c2cp23040b
   Cai XQ, 2013, SOFT MATTER, V9, P5807, DOI 10.1039/c3sm50577d
   Cao Y, 2008, CHEM LETT, V37, P554, DOI 10.1246/cl.2008.554
   Caplar V, 2010, CHEM-EUR J, V16, P3066, DOI 10.1002/chem.200902342
   Cardolaccia T, 2008, J AM CHEM SOC, V130, P2535, DOI 10.1021/ja0765316
   Carman P.C, 1937, CHEM ENG RES DES, V75, pS32, DOI DOI 10.1016/S0263-8762(97)80003-2
   CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953
   Cayuela A, 2015, CHEM SCI, V6, P6139, DOI 10.1039/c5sc01859e
   CHAR K, 1987, MACROMOLECULES, V20, P1833, DOI 10.1021/ma00174a023
   Chen B, 2012, CHEM COMMUN, V48, P5638, DOI 10.1039/c2cc31746j
   Chen CT, 2013, J AM CHEM SOC, V135, P5294, DOI 10.1021/ja401214t
   Chen JY, 2016, LANGMUIR, V32, P1171, DOI 10.1021/acs.langmuir.5b04384
   Chen P, 2009, LANGMUIR, V25, P8395, DOI 10.1021/la8035727
   Chen Q, 2010, ADV FUNCT MATER, V20, P3244, DOI 10.1002/adfm.201000590
   Chen Q, 2010, ADV FUNCT MATER, V20, P36, DOI 10.1002/adfm.200901358
   Chen YL, 2009, LANGMUIR, V25, P8548, DOI 10.1021/la803436h
   Cho Y, 2012, NEW J CHEM, V36, P32, DOI 10.1039/c1nj20781d
   Cigan M, 2013, J PHYS CHEM A, V117, P4870, DOI 10.1021/jp402627a
   Coates IA, 2009, CHEM-EUR J, V15, P6340, DOI 10.1002/chem.200900858
   Colquhoun C, 2014, NANOSCALE, V6, P13719, DOI 10.1039/c4nr04039b
   Coppens MO, 1999, CATAL TODAY, V53, P225, DOI 10.1016/S0920-5861(99)00118-2
   Cornwell DJ, 2015, MATER HORIZ, V2, P279, DOI 10.1039/c4mh00245h
   Cravotto G, 2006, CHEM SOC REV, V35, P180, DOI 10.1039/b503848k
   Cravotto G, 2009, CHEM SOC REV, V38, P2684, DOI 10.1039/b901840a
   Cross M. C., 2009, PATTERN FORMATION DY
   Crusats J, 2010, CHEM SOC REV, V39, P569, DOI 10.1039/b916369g
   Cussler E. L., 2009, DIFFUSION MASS TRANS
   D'Errico G, 2011, J COLLOID INTERF SCI, V359, P179, DOI 10.1016/j.jcis.2011.02.068
   Das A, 2012, CHEM-EUR J, V18, P9849, DOI 10.1002/chem.201201140
   Dastidar P, 2008, CHEM SOC REV, V37, P2699, DOI 10.1039/b807346e
   Datta S, 2012, CHEM COMMUN, V48, P877, DOI 10.1039/c1cc16232b
   Dautel OJ, 2006, J AM CHEM SOC, V128, P16213, DOI 10.1021/ja065434u
   Dawn A, 2015, CRYST GROWTH DES, V15, P4591, DOI 10.1021/acs.cgd.5b00840
   Dawn A, 2012, J AM CHEM SOC, V134, P2161, DOI 10.1021/ja211032m
   Dawn A, 2009, ORG BIOMOL CHEM, V7, P4378, DOI 10.1039/b910741j
   de Hatten X, 2011, J AM CHEM SOC, V133, P3158, DOI 10.1021/ja110575s
   de Jong JJD, 2004, SCIENCE, V304, P278, DOI 10.1126/science.1095353
   de Jong JJD, 2006, ORG BIOMOL CHEM, V4, P2387, DOI 10.1039/b603914f
   de Jong JJD, 2005, J AM CHEM SOC, V127, P13804, DOI 10.1021/ja055268a
   de Jong JJD, 2005, ANGEW CHEM INT EDIT, V44, P2373, DOI 10.1002/anie.200462500
   de Loos M, 2005, EUR J ORG CHEM, P3615, DOI 10.1002/ejoc.200400723
   de Loos M, 2000, EUR J ORG CHEM, P3675
   de Loos M, 1997, J AM CHEM SOC, V119, P12675, DOI 10.1021/ja972899z
   de Loos M, 2001, ANGEW CHEM INT EDIT, V40, P613, DOI 10.1002/1521-3773(20010202)40:3<613::AID-ANIE613>3.0.CO;2-K
   Delbecq F, 2012, J COLLOID INTERF SCI, V384, P94, DOI 10.1016/j.jcis.2012.06.045
   Deng C, 2012, CHEM COMMUN, V48, P7973, DOI 10.1039/c2cc33408a
   Diaz DD, 2011, CHEM SOC REV, V40, P427, DOI 10.1039/c005401c
   Dickinson E, 1997, J CHEM SOC FARADAY T, V93, P111, DOI 10.1039/a605550h
   Djabourov M, 2013, PHYSICAL GELS FROM BIOLOGICAL AND SYNTHETIC POLYMERS, P1, DOI 10.1017/CBO9781139024136
   Dobosz R, 2010, J MOL STRUCT, V979, P194, DOI 10.1016/j.molstruc.2010.06.024
   DOKTYCZ SJ, 1990, SCIENCE, V247, P1067, DOI 10.1126/science.2309118
   DONG LC, 1991, J CONTROL RELEASE, V15, P141, DOI 10.1016/0168-3659(91)90072-L
   Dou CD, 2011, LANGMUIR, V27, P6323, DOI 10.1021/la200382b
   Dou CD, 2010, LANGMUIR, V26, P2113, DOI 10.1021/la902663z
   Draper ER, 2015, NAT CHEM, V7, P849, DOI [10.1038/NCHEM.2347, 10.1038/nchem.2347]
   Drobizhev MA, 1996, CHEM PHYS, V211, P455, DOI 10.1016/0301-0104(96)00134-6
   Duan PF, 2011, J PHYS CHEM B, V115, P3322, DOI 10.1021/jp110636b
   Dumur F, 2013, CHEM-EUR J, V19, P1373, DOI 10.1002/chem.201202246
   Dutta S, 2013, LANGMUIR, V29, P316, DOI 10.1021/la3038389
   Eastoe J, 2004, CHEM COMMUN, P2608, DOI 10.1039/b410158h
   El-Hachemi Z, 2009, CRYST GROWTH DES, V9, P4802, DOI 10.1021/cg900638h
   Elliott GF, 1998, REP PROG PHYS, V61, P1325, DOI 10.1088/0034-4885/61/10/001
   Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874
   Escuder B, 2010, NEW J CHEM, V34, P1044, DOI 10.1039/b9nj00764d
   Escudero C, 2006, ANGEW CHEM INT EDIT, V45, P8032, DOI 10.1002/anie.200603182
   Estroff LA, 2004, ORG BIOMOL CHEM, V2, P137, DOI 10.1039/b309731e
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   Farnan D, 2002, J CHROMATOGR A, V959, P65, DOI 10.1016/S0021-9673(02)00428-4
   Feng L, 2012, SOFT MATTER, V8, P6483, DOI 10.1039/c2sm25415h
   Fialkowski M, 2006, J PHYS CHEM B, V110, P2482, DOI 10.1021/jp054153q
   Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110
   FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397
   Foster JA, 2015, J AM CHEM SOC, V137, P9722, DOI 10.1021/jacs.5b05507
   Foster JA, 2014, CHEM-EUR J, V20, P279, DOI 10.1002/chem.201303153
   Foster JA, 2010, NAT CHEM, V2, P1037, DOI 10.1038/NCHEM.859
   Foster JA, 2010, ANGEW CHEM INT EDIT, V49, P6718, DOI 10.1002/anie.201000070
   FUHRHOP JH, 1987, J AM CHEM SOC, V109, P3387, DOI 10.1021/ja00245a032
   Fujigaya T, 2007, CHEM-ASIAN J, V2, P106, DOI 10.1002/asia.200600371
   Gan KP, 2016, J MATER CHEM C, V4, P5073, DOI 10.1039/c6tc00808a
   Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087
   Gautieri A, 2009, J MECH BEHAV BIOMED, V2, P130, DOI 10.1016/j.jmbbm.2008.03.001
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P43, DOI 10.1098/rspa.1982.0088
   Gladman AS, 2016, NAT MATER, V15, P413, DOI [10.1038/nmat4544, 10.1038/NMAT4544]
   Gostl R, 2012, CHEM-EUR J, V18, P14282, DOI 10.1002/chem.201203111
   Golmohamadi M, 2013, CARBOHYD POLYM, V94, P82, DOI 10.1016/j.carbpol.2013.01.046
   Golmohamadi M, 2012, J PHYS CHEM A, V116, P6505, DOI 10.1021/jp212343g
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Grahame DAS, 2011, SOFT MATTER, V7, P7359, DOI 10.1039/c1sm05757j
   Grondin P, 2010, LANGMUIR, V26, P5184, DOI 10.1021/la903653d
   Hadjoudis E, 2004, CHEM SOC REV, V33, P579, DOI 10.1039/b303644h
   Hadjoudis E, 2011, J PHOTOCH PHOTOBIO A, V217, P293, DOI 10.1016/j.jphotochem.2010.10.022
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Hanke W, 2009, MICROGRAVITY SCI TEC, V21, P239, DOI 10.1007/s12217-008-9072-x
   Hansson P, 2009, J PHYS CHEM B, V113, P12903, DOI 10.1021/jp904866t
   Haque MA, 2012, POLYMER, V53, P1805, DOI 10.1016/j.polymer.2012.03.013
   Harada J, 1999, J AM CHEM SOC, V121, P5809, DOI 10.1021/ja9842969
   Haraguchi K, 2002, MACROMOLECULES, V35, P10162, DOI 10.1021/ma021301r
   Hardy JG, 2007, TETRAHEDRON, V63, P7397, DOI 10.1016/j.tet.2007.03.120
   He J, 2011, LANGMUIR, V27, P436, DOI 10.1021/la1040322
   He YB, 2009, NEW J CHEM, V33, P2073, DOI 10.1039/b909127k
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   Herder M, 2013, CHEM SCI, V4, P1028, DOI 10.1039/c2sc21681g
   Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022
   Hirst AR, 2008, J AM CHEM SOC, V130, P9113, DOI 10.1021/ja801804c
   Hong YN, 2011, CHEM SOC REV, V40, P5361, DOI 10.1039/c1cs15113d
   Hotta Y, 2015, CHEM COMMUN, V51, P2790, DOI 10.1039/c4cc09702e
   Hotta Y, 2014, CHEM COMMUN, V50, P5615, DOI 10.1039/c4cc02078b
   Hou YH, 2012, COLLOID SURFACE A, V414, P160, DOI 10.1016/j.colsurfa.2012.08.011
   Houton KA, 2012, LANGMUIR, V28, P9797, DOI 10.1021/la301371q
   Huang GW, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201500489
   Huang Q, 2012, J MATER CHEM, V22, P18275, DOI 10.1039/c2jm33789d
   Hyun K, 2006, RHEOL ACTA, V45, P239, DOI 10.1007/s00397-005-0014-x
   Hyun K, 2002, J NON-NEWTON FLUID, V107, P51, DOI 10.1016/S0377-0257(02)00141-6
   ILMAIN F, 1991, NATURE, V349, P400, DOI 10.1038/349400a0
   Ionov L, 2013, ADV FUNCT MATER, V23, P4555, DOI 10.1002/adfm.201203692
   Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d
   Jana P, 2012, SOFT MATTER, V8, P5621, DOI 10.1039/c2sm25062d
   Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001
   Jaspers M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6808
   Jin QX, 2012, CHEM-EUR J, V18, P4916, DOI 10.1002/chem.201103187
   Johnson EM, 1996, BIOPHYS J, V70, P1017, DOI 10.1016/S0006-3495(96)79645-5
   Jones CD, 2012, CHEM COMMUN, V48, P2110, DOI 10.1039/c2cc16691g
   Jonkheijm P, 2006, SCIENCE, V313, P80, DOI 10.1126/science.1127884
   Jung JH, 2013, CHEM SOC REV, V42, P924, DOI 10.1039/c2cs35407a
   Kamikawa Y, 2007, LANGMUIR, V23, P274, DOI 10.1021/la061581u
   Kang H, 2009, J PHYS CHEM B, V113, P3799, DOI 10.1021/jp807749f
   Kaniyoor A., 2015, ADV OPT MAT, P444
   Kapoor I, 2012, SOFT MATTER, V8, P3446, DOI 10.1039/c2sm07183e
   Karunakaran V, 2013, J PHYS CHEM C, V117, P9404, DOI 10.1021/jp400115c
   KASHA M, 1963, RADIAT RES, V20, P55, DOI 10.2307/3571331
   Kato T, 2009, CHEM LETT, V38, P634, DOI 10.1246/cl.2009.634
   Ke DM, 2011, ANGEW CHEM INT EDIT, V50, P3715, DOI 10.1002/anie.201006897
   Ke DM, 2009, J COLLOID INTERF SCI, V337, P54, DOI 10.1016/j.jcis.2009.05.024
   Kim J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7959
   Kim OV, 2014, BIOMATERIALS, V35, P6739, DOI 10.1016/j.biomaterials.2014.04.056
   Kim TH, 2008, CHEM COMMUN, P2364, DOI 10.1039/b800813b
   Kiyonaka S, 2002, J AM CHEM SOC, V124, P10954, DOI 10.1021/ja027277e
   Klein Y, 2007, SCIENCE, V315, P1116, DOI 10.1126/science.1135994
   Klinger D, 2011, SOFT MATTER, V7, P1426, DOI 10.1039/c0sm00638f
   KOHLER JM, 1995, J PHYS CHEM-US, V99, P980
   Kokufuta E, 2005, LANGMUIR, V21, P10004, DOI 10.1021/la050530e
   Komatsu H, 2009, J AM CHEM SOC, V131, P5580, DOI 10.1021/ja8098239
   Komiya N, 2011, J AM CHEM SOC, V133, P16054, DOI 10.1021/ja2039369
   KONDEPUDI DK, 1990, SCIENCE, V250, P975, DOI 10.1126/science.250.4983.975
   Koshima H, 2003, J PHOTOCH PHOTOBIO A, V156, P83, DOI 10.1016/S1010-6030(02)00431-8
   Kosto KB, 2005, BIOPHYS J, V88, P277, DOI 10.1529/biophysj.104.050302
   Koumura N, 2004, LANGMUIR, V20, P9897, DOI 10.1021/la048334f
   Kowalczuk J, 2016, J COLLOID INTERF SCI, V472, P60, DOI 10.1016/j.jcis.2016.03.033
   Kowalczuk J, 2014, J PHYS CHEM B, V118, P4005, DOI 10.1021/jp412511e
   Krekelberg WP, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651478
   Krieg E, 2009, J AM CHEM SOC, V131, P14365, DOI 10.1021/ja903938g
   Kuang GC, 2009, TETRAHEDRON, V65, P3496, DOI 10.1016/j.tet.2009.02.038
   Kumar DK, 2014, CHEM SOC REV, V43, P2080, DOI 10.1039/c3cs60224a
   Kumar V, 2011, CHEM COMMUN, V47, P4730, DOI 10.1039/c1cc00080b
   Kuroiwa K, 2004, J AM CHEM SOC, V126, P2016, DOI 10.1021/ja037847q
   Kwon JE, 2011, ADV MATER, V23, P3615, DOI 10.1002/adma.201102046
   Labille J, 2007, LANGMUIR, V23, P2083, DOI 10.1021/la0611155
   Lam R, 2010, SOFT MATTER, V6, P404, DOI 10.1039/b919477k
   Le Bideau J, 2011, CHEM SOC REV, V40, P907, DOI 10.1039/c0cs00059k
   LEBRUN L, 1993, ENZYME MICROB TECH, V15, P1057, DOI 10.1016/0141-0229(93)90054-6
   Lee S, 2013, LANGMUIR, V29, P5869, DOI 10.1021/la400159m
   Lescanne M, 2003, LANGMUIR, V19, P2013, DOI 10.1021/la026660u
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Li GH, 2016, LANGMUIR, V32, P1502, DOI 10.1021/acs.langmuir.6b00019
   Li JW, 2014, CHEM-EUR J, V20, P15709, DOI 10.1002/chem.201404977
   Li JL, 2013, SOFT MATTER, V9, P435, DOI 10.1039/c2sm27065j
   Li JL, 2010, ADV FUNCT MATER, V20, P3196, DOI 10.1002/adfm.201000744
   Li JL, 2010, CRYST GROWTH DES, V10, P2699, DOI 10.1021/cg100188w
   Li JL, 2005, J PHYS CHEM B, V109, P24231, DOI 10.1021/jp054676y
   Li SC, 1999, J APPL PHYS, V85, P5965, DOI 10.1063/1.370006
   Li T., 2016, ADV MATER INTERFACES, V3, P8
   Li W, 2011, POLYM CHEM-UK, V2, P1797, DOI 10.1039/c1py00081k
   LI Y, 1990, J CHEM PHYS, V92, P1365, DOI 10.1063/1.458148
   Li YG, 2010, CHEM-EUR J, V16, P8690, DOI 10.1002/chem.201000150
   Li YY, 2010, J PHYS CHEM B, V114, P10321, DOI 10.1021/jp1017373
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Liu C, 2013, J MATER SCI, V48, P774, DOI 10.1007/s10853-012-6794-3
   Liu CX, 2016, ADV MATER, V28, P1644, DOI 10.1002/adma.201504883
   Liu J, 2008, ADV MATER, V20, P2508, DOI 10.1002/adma.200703195
   Liu KQ, 2013, SOFT MATTER, V9, P11699, DOI 10.1039/c3sm51949j
   Liu KY, 2013, J MATER CHEM C, V1, P1753, DOI 10.1039/c2tc00643j
   Liu XY, 2001, J PHYS CHEM B, V105, P11550, DOI 10.1021/jp010671z
   Liu XY, 2002, J AM CHEM SOC, V124, P15055, DOI 10.1021/ja0206137
   Liu XY, 2002, ADV MATER, V14, P421, DOI 10.1002/1521-4095(20020318)14:6<421::AID-ADMA421>3.0.CO;2-7
   Liu Y, 2011, ADV FUNCT MATER, V21, P1575, DOI 10.1002/adfm.201002020
   Liu ZX, 2012, CHEM MATER, V24, P3751, DOI 10.1021/cm302318b
   Lloyd GO, 2011, SOFT MATTER, V7, P75, DOI 10.1039/c0sm00594k
   Lloyd GO, 2012, SOFT MATTER, V8, P204, DOI 10.1039/c1sm06448g
   Lohr A, 2005, ANGEW CHEM INT EDIT, V44, P5071, DOI 10.1002/aine.200500640
   Loren N, 2009, BIOMACROMOLECULES, V10, P275, DOI 10.1021/bm801013x
   LYKLEMA J, 2005, FUNDAMENTALS INTERFA
   Maity C, 2015, ANGEW CHEM INT EDIT, V54, P998, DOI 10.1002/anie.201409198
   Maity S, 2011, SOFT MATTER, V7, P5239, DOI 10.1039/c1sm05277b
   Malek J, 2000, THERMOCHIM ACTA, V355, P239, DOI 10.1016/S0040-6031(00)00449-4
   Malik S, 2002, J CHEM SOC PERK T 2, P1177, DOI 10.1039/b111598g
   Matsumoto S, 2008, CHEM-EUR J, V14, P3977, DOI 10.1002/chem.200701904
   Miljanic S, 2006, EUR J ORG CHEM, P1323, DOI 10.1002/ejoc.200500535
   Miljanic S, 2005, LANGMUIR, V21, P2754, DOI 10.1021/la047183d
   Minkin VI, 2013, RUSS CHEM REV+, V82, P1, DOI 10.1070/RC2013v082n01ABEH004336
   Minkin VI, 2004, CHEM REV, V104, P2751, DOI 10.1021/cr020088u
   Miyakawa K, 2000, PHYS REV E, V62, P793, DOI 10.1103/PhysRevE.62.793
   Miyamoto K, 2011, TETRAHEDRON LETT, V52, P4030, DOI 10.1016/j.tetlet.2011.05.131
   Moffat JR, 2009, LANGMUIR, V25, P8786, DOI 10.1021/la900282k
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Moriyama M, 2003, ADV MATER, V15, P1335, DOI 10.1002/adma.200305056
   Moriyama M, 2006, B CHEM SOC JPN, V79, P962, DOI 10.1246/bcsj.79.962
   Morris KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2499
   MURATA K, 1994, J AM CHEM SOC, V116, P6664, DOI 10.1021/ja00094a023
   Muro-Small ML, 2011, LANGMUIR, V27, P13248, DOI 10.1021/la202702r
   Musnicki WJ, 2011, J COLLOID INTERF SCI, V356, P165, DOI 10.1016/j.jcis.2010.12.067
   Nakagawa T, 2013, CHEM LETT, V42, P229, DOI 10.1246/cl.2013.229
   Nanda J, 2013, SOFT MATTER, V9, P4198, DOI 10.1039/c3sm27050e
   Naota T, 2005, J AM CHEM SOC, V127, P9324, DOI 10.1021/ja050809h
   Nayak MK, 2011, J PHOTOCH PHOTOBIO A, V217, P40, DOI 10.1016/j.jphotochem.2010.09.014
   Nayak MK, 2010, CHEM-EUR J, V16, P7437, DOI 10.1002/chem.200902615
   Neabo JR, 2013, LANGMUIR, V29, P3446, DOI 10.1021/la305045n
   Nebot VJ, 2014, CHEM-EUR J, V20, P14465, DOI 10.1002/chem.201402547
   Newbloom GM, 2012, MACROMOLECULES, V45, P3452, DOI 10.1021/ma202564k
   NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981
   Nishinari K, 2009, PROG COLL POL SCI S, V136, P87, DOI 10.1007/2882_2009_12
   Noorduin WL, 2008, J AM CHEM SOC, V130, P1158, DOI 10.1021/ja7106349
   O'Hern CS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011306
   Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T
   Omidian H, 2008, J DRUG DELIV SCI TEC, V18, P83, DOI 10.1016/S1773-2247(08)50016-5
   Omidian H, 2007, J PHARM PHARMACOL, V59, P317, DOI 10.1211/jpp.59.3.0001
   Osada Y., 2001, GELS HDB APPL
   Oya T, 1999, SCIENCE, V286, P1543, DOI 10.1126/science.286.5444.1543
   Ozdemir T, 2016, RSC ADV, V6, P10601, DOI 10.1039/c5ra22993f
   Paavilainen S, 2012, NORD PULP PAP RES J, V27, P282, DOI 10.3183/NPPRJ-2012-27-02-p282-286
   Pal A, 2013, LANGMUIR, V29, P2120, DOI 10.1021/la3042764
   Pappas CG, 2015, CHEM COMMUN, V51, P8465, DOI 10.1039/c5cc02049b
   Pardo R, 2011, CHEM SOC REV, V40, P672, DOI 10.1039/c0cs00065e
   Park SM, 2008, SOFT MATTER, V4, P1995, DOI 10.1039/b807791f
   Paulusse JMJ, 2006, CHEM-EUR J, V12, P4928, DOI 10.1002/chem.200600120
   Paulusse JMJ, 2006, ANGEW CHEM INT EDIT, V45, P2334, DOI 10.1002/anie.200503191
   Paulusse JMJ, 2007, J AM CHEM SOC, V129, P2392, DOI 10.1021/ja067523c
   Penaloza DP, 2013, SOFT MATTER, V9, P5166, DOI 10.1039/c3sm50225b
   Perez-Garcia L, 2002, CHEM SOC REV, V31, P342, DOI 10.1039/b201099m
   Petit L, 2009, LANGMUIR, V25, P12048, DOI 10.1021/la901244v
   Pham TTH, 2013, SOFT MATTER, V9, P8923, DOI 10.1039/c3sm51751a
   Pham TTH, 2013, SOFT MATTER, V9, P8737, DOI 10.1039/c3sm51667a
   Phillips RJ, 2000, BIOPHYS J, V79, P3350, DOI 10.1016/S0006-3495(00)76566-0
   Phillips RJ, 2009, J COLLOID INTERF SCI, V338, P250, DOI 10.1016/j.jcis.2009.05.063
   Pianowski ZL, 2016, CHEM COMMUN, V52, P3143, DOI 10.1039/c5cc09633b
   Piepenbrock MOM, 2008, CHEM COMMUN, P2644, DOI 10.1039/b804259d
   Piepenbrock MOM, 2011, SOFT MATTER, V7, P2412, DOI 10.1039/c0sm00647e
   Piepenbrock MOM, 2010, SOFT MATTER, V6, P3541, DOI 10.1039/c0sm00313a
   Piepenbrock MOM, 2010, CHEM REV, V110, P1960, DOI 10.1021/cr9003067
   Pierens GK, 2012, AUST J CHEM, V65, P552, DOI 10.1071/CH12122
   Pinaud F, 2013, J AM CHEM SOC, V135, P5517, DOI 10.1021/ja401011j
   Pluen A, 1999, BIOPHYS J, V77, P542, DOI 10.1016/S0006-3495(99)76911-0
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Poggendorf S, 2011, COLLOID POLYM SCI, V289, P545, DOI 10.1007/s00396-011-2399-7
   Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002
   Praveen VK, 2006, J AM CHEM SOC, V128, P7542, DOI 10.1021/ja0587594
   Price GJ, 2005, J PHYS CHEM B, V109, P17799, DOI 10.1021/jp0543227
   Pritchard RH, 2014, SOFT MATTER, V10, P1864, DOI 10.1039/c3sm52769g
   Qian Y, 2007, J PHYS CHEM B, V111, P5861, DOI 10.1021/jp070076i
   Qian Y, 2012, SOFT MATTER, V8, P757, DOI 10.1039/c1sm06358h
   Qiao Y, 2010, J PHYS CHEM B, V114, P11725, DOI 10.1021/jp1047369
   Qiu ZJ, 2009, CHEM COMMUN, P3342, DOI 10.1039/b822840j
   Qu SN, 2011, CHEM-EUR J, V17, P3512, DOI 10.1002/chem.201003156
   Quesada-Perez M, 2012, MACROMOLECULES, V45, P8872, DOI 10.1021/ma3014959
   Quesada-Perez M, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4729946
   Quesada-Perez M, 2011, SOFT MATTER, V7, P10536, DOI 10.1039/c1sm06031g
   Rae J, 2005, ULTRASON SONOCHEM, V12, P325, DOI 10.1016/j.ultsonch.2004.06.007
   Raeburn J, 2014, MATER HORIZ, V1, P241, DOI 10.1039/c3mh00150d
   Raghavan S., 2006, MOL GELS
   Rajamalli P, 2012, SOFT MATTER, V8, P8896, DOI 10.1039/c2sm26151k
   Rajamalli P, 2011, ORG LETT, V13, P3714, DOI 10.1021/ol201325j
   Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7
   Ran X, 2011, SOFT MATTER, V7, P8561, DOI 10.1039/c1sm05566f
   Ray S, 2007, CHEM MATER, V19, P1633, DOI 10.1021/cm062672f
   Reuter R, 2013, CHEM COMMUN, V49, P146, DOI 10.1039/c2cc35974j
   Robert F, 2012, CRYSTENGCOMM, V14, P4396, DOI 10.1039/c2ce00006g
   Robert F, 2010, EUR J ORG CHEM, P621, DOI 10.1002/ejoc.200901175
   Robert F, 2009, CHEM-EUR J, V15, P4327, DOI 10.1002/chem.200801932
   Rodriguez-Llansola F, 2012, SOFT MATTER, V8, P8865, DOI 10.1039/c2sm25647a
   Rodriguez-Llansola F, 2009, J AM CHEM SOC, V131, P11478, DOI 10.1021/ja902589f
   Rosch U, 2006, ANGEW CHEM INT EDIT, V45, P7026, DOI 10.1002/anie.200602286
   Rogers MA, 2012, CRYST GROWTH DES, V12, P5497, DOI 10.1021/cg301071x
   Rogers MA, 2009, LANGMUIR, V25, P8556, DOI 10.1021/la8035665
   Rohner SS, 2015, RSC ADV, V5, P27190, DOI 10.1039/c5ra01256b
   Rossow T, 2013, POLYM CHEM-UK, V4, P2515, DOI 10.1039/c3py00104k
   Roy B, 2012, SOFT MATTER, V8, P2366, DOI 10.1039/c2sm07225d
   Ruiz-Palomero C, 2016, CHEM COMMUN, V52, P7782, DOI 10.1039/c6cc03088b
   Sada K, 2007, CHEM SOC REV, V36, P415, DOI 10.1039/b603555h
   Safin DA, 2012, RSC ADV, V2, P11379, DOI 10.1039/c2ra21631k
   Safin DA, 2012, CRYSTENGCOMM, V14, P5523, DOI 10.1039/c2ce25600b
   Sahoo P, 2012, CHEM-EUR J, V18, P8057, DOI 10.1002/chem.201200986
   Saito Y, 2013, REV MOD PHYS, V85, P603, DOI 10.1103/RevModPhys.85.603
   Samanta SK, 2009, LANGMUIR, V25, P8567, DOI 10.1021/la8036154
   Sangeetha NM, 2005, CHEM SOC REV, V34, P821, DOI 10.1039/b417081b
   Sangeetha NM, 2004, J PHYS CHEM B, V108, P16056, DOI 10.1021/jp047272z
   Schirmer EB, 2009, AICHE J, V55, P331, DOI 10.1002/aic.11668
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schramm G, 1994, PRACTICAL APPROACH R
   Schwarz US, 2013, REV MOD PHYS, V85, P1327, DOI 10.1103/RevModPhys.85.1327
   Seki T, 2004, POLYM J, V36, P435, DOI 10.1295/polymj.36.435
   Sekikawa T, 2013, J PHYS CHEM A, V117, P2971, DOI 10.1021/jp4016036
   Shi C, 1999, SCIENCE, V286, P1540, DOI 10.1126/science.286.5444.1540
   Shi JH, 2009, J PHYS CHEM B, V113, P4549, DOI 10.1021/jp8035023
   Shi Y, 2015, NANO LETT, V15, P6276, DOI 10.1021/acs.nanolett.5b03069
   SHIH WH, 1990, PHYS REV A, V42, P4772, DOI 10.1103/PhysRevA.42.4772
   Shirakawa M, 2005, J AM CHEM SOC, V127, P4164, DOI 10.1021/ja042869d
   Shiraki Y, 2012, ANGEW CHEM INT EDIT, V51, P6112, DOI 10.1002/anie.201202028
   Shome A, 2008, LANGMUIR, V24, P4280, DOI 10.1021/la704024p
   Shumburo A, 2002, CHEM MATER, V14, P3745, DOI 10.1021/cm02042la
   Sliwa M, 2010, PHOTOCH PHOTOBIO SCI, V9, P661, DOI 10.1039/b9pp00207c
   Sollich P, 1998, PHYS REV E, V58, P738, DOI 10.1103/PhysRevE.58.738
   Solomentsev YE, 1996, PHYS FLUIDS, V8, P1119, DOI 10.1063/1.868890
   Song SS, 2013, SOFT MATTER, V9, P4209, DOI 10.1039/c3sm00006k
   Stanley CE, 2006, CHEM COMMUN, P3199, DOI 10.1039/b606373j
   Steed J. W., 2013, SUPRAMOLECULAR CHEM
   Steed JW, 2011, CHEM COMMUN, V47, P1379, DOI 10.1039/c0cc03293j
   Steed JW, 2009, CHEM SOC REV, V38, P506, DOI 10.1039/b810364j
   Stoychev G, 2012, ACS NANO, V6, P3925, DOI 10.1021/nn300079f
   Stylianopoulos T, 2010, BIOPHYS J, V99, P3119, DOI 10.1016/j.bpj.2010.08.065
   Su MM, 2015, SOFT MATTER, V11, P741, DOI 10.1039/c4sm02423k
   Sugiyasu K, 2003, ORG BIOMOL CHEM, V1, P895, DOI 10.1039/b210968a
   Sui XF, 2013, J MATER CHEM B, V1, P1658, DOI 10.1039/c3tb00209h
   Suslick KS, 1999, ANNU REV MATER SCI, V29, P295, DOI 10.1146/annurev.matsci.29.1.295
   Sutton S, 2009, LANGMUIR, V25, P10285, DOI 10.1021/la9011058
   Suzuki M, 2010, CHEM SOC REV, V39, P455, DOI 10.1039/b910604a
   Takizawa M, 2011, DYES PIGMENTS, V89, P254, DOI 10.1016/j.dyepig.2010.03.019
   Tam AYY, 2013, CHEM SOC REV, V42, P1540, DOI 10.1039/c2cs35354g
   Tan G, 2006, LANGMUIR, V22, P7416, DOI 10.1021/la060954o
   Tang SK, 2009, ADV FUNCT MATER, V19, P2252, DOI 10.1002/adfm.200801590
   Teece LJ, 2014, COLLOID SURFACE A, V458, P126, DOI 10.1016/j.colsurfa.2014.03.018
   ten Eikelder HMM, 2012, J PHYS CHEM B, V116, P5291, DOI 10.1021/jp300622m
   Terech P, 2000, LANGMUIR, V16, P4485, DOI 10.1021/la991545d
   Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282
   Terech P, 2013, PHYS CHEM CHEM PHYS, V15, P7338, DOI 10.1039/c3cp50671a
   Teunissen AJP, 2014, MACROMOLECULES, V47, P8429, DOI 10.1021/ma502047h
   Tian H, 2004, CHEM SOC REV, V33, P85, DOI 10.1039/b302356g
   Tiller JC, 2003, ANGEW CHEM INT EDIT, V42, P3072, DOI 10.1002/anie.200301647
   Tomadakis MM, 2007, CHEM ENG J, V128, P1, DOI 10.1016/j.cej.2006.10.005
   Tompkins N, 2014, P NATL ACAD SCI USA, V111, P4397, DOI 10.1073/pnas.1322005111
   Tschoegl NW, 2012, PHENOMENOLOGICAL THE
   Tsuda K, 2007, ANGEW CHEM INT EDIT, V46, P8198, DOI 10.1002/anie.200703083
   Uchida K, 2009, CHEM COMMUN, P4420, DOI 10.1039/b908303k
   Ueno K, 2007, ADV MATER, V19, P2807, DOI 10.1002/adma.200700159
   Valenta C, 1999, INT J PHARM, V185, P103, DOI 10.1016/S0378-5173(99)00170-2
   Valeur B., 2013, MOL FLUORESCENCE PRI
   van Esch JH, 2009, LANGMUIR, V25, P8392, DOI 10.1021/la901720a
   van Herpt JT, 2013, LANGMUIR, V29, P8763, DOI 10.1021/la401286a
   van Oosten ASG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19270
   Vidyasagar A, 2015, ANGEW CHEM INT EDIT, V54, P12078, DOI 10.1002/anie.201506544
   Vintiloiu A, 2008, J CONTROL RELEASE, V125, P179, DOI 10.1016/j.jconrel.2007.09.014
   Wallace M, 2013, SOFT MATTER, V9, P5483, DOI 10.1039/c3sm27793c
   Wang C, 2005, J AM CHEM SOC, V127, P16372, DOI 10.1021/ja055800u
   Wang C, 2012, J PHYS CHEM B, V116, P10617, DOI 10.1021/jp3069514
   Wang C, 2010, J AM CHEM SOC, V132, P3092, DOI 10.1021/ja910721s
   Wang E, 2013, NANO LETT, V13, P2826, DOI 10.1021/nl401088b
   Wang GQ, 2000, P NATL ACAD SCI USA, V97, P9861, DOI 10.1073/pnas.180192597
   Wang RY, 2009, CRYST GROWTH DES, V9, P3286, DOI 10.1021/cg9000494
   Wang RY, 2006, J PHYS CHEM B, V110, P25797, DOI 10.1021/jp065101j
   Wang XJ, 2011, LANGMUIR, V27, P774, DOI 10.1021/la103686n
   Wang XF, 2013, CHEM-EUR J, V19, P16072, DOI 10.1002/chem.201302200
   Wang YB, 2008, LANGMUIR, V24, P7635, DOI 10.1021/la801499y
   Wang YJ, 2008, CRYST GROWTH DES, V8, P884, DOI 10.1021/cg070619d
   Wei SC, 2015, CHEM-EUR J, V21, P7418, DOI 10.1002/chem.201406517
   Wei SC, 2014, ADV MATER, V26, P2072, DOI 10.1002/adma.201304404
   Weiss J, 2008, NANO LETT, V8, P1660, DOI 10.1021/nl080478h
   Weng WG, 2006, J AM CHEM SOC, V128, P11663, DOI 10.1021/ja063408q
   Willis-Fox N, 2015, CHEM SCI, V6, P7227, DOI 10.1039/c5sc02409a
   Wolffs M, 2007, ANGEW CHEM INT EDIT, V46, P8203, DOI 10.1002/anie.200703075
   Woodward RT, 2011, SOFT MATTER, V7, P4335, DOI 10.1039/c0sm01390k
   Wu JJ, 2012, RSC ADV, V2, P12718, DOI 10.1039/c2ra22549b
   Wu JC, 2008, ANGEW CHEM INT EDIT, V47, P1063, DOI 10.1002/anie.200703946
   Wu JC, 2009, CHEM-EUR J, V15, P6234, DOI 10.1002/chem.200900409
   Wu YP, 2011, SOFT MATTER, V7, P716, DOI 10.1039/c0sm00330a
   Wu Y, 2012, CHEM SCI, V3, P3007, DOI 10.1039/c2sc00714b
   Wu ZL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2549
   Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307
   Xiao SZ, 2007, CHEM COMMUN, P4758, DOI 10.1039/b709409d
   Xie F, 2016, CHEM COMMUN, V52, P930, DOI 10.1039/c5cc08076b
   Xie JS, 2016, INORG CHEM COMMUN, V65, P41, DOI 10.1016/j.inoche.2016.01.012
   Xie P, 2005, J MATER CHEM, V15, P2529, DOI 10.1039/b413835j
   Xin FF, 2012, COLLOID SURFACE A, V410, P18, DOI 10.1016/j.colsurfa.2012.06.008
   Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f
   Xing PY, 2013, COLLOID SURFACE A, V421, P44, DOI 10.1016/j.colsurfa.2012.12.052
   Xing PY, 2013, CARBOHYD RES, V367, P18, DOI 10.1016/j.carres.2012.11.023
   Xu HQ, 2012, SOFT MATTER, V8, P3478, DOI 10.1039/c2sm07387k
   Xu JF, 2013, ANGEW CHEM INT EDIT, V52, P9738, DOI 10.1002/anie.201303496
   Xu WT, 2012, SOFT MATTER, V8, P726, DOI 10.1039/c1sm06482g
   Xu XD, 2012, CHEM-EUR J, V18, P16000, DOI 10.1002/chem.201202902
   Xu ZY, 2013, SOFT MATTER, V9, P1091, DOI 10.1039/c2sm27208c
   Xue P, 2007, CHEM-EUR J, V13, P8231, DOI 10.1002/chem.200700321
   Xue PC, 2012, CHEM-EUR J, V18, P3549, DOI 10.1002/chem.201103566
   Xue PC, 2011, SOFT MATTER, V7, P8296, DOI 10.1039/c1sm05431g
   Xue PC, 2010, LANGMUIR, V26, P6669, DOI 10.1021/la903990m
   Yagai S, 2005, LANGMUIR, V21, P11048, DOI 10.1021/la052076k
   Yagai S, 2005, J AM CHEM SOC, V127, P11134, DOI 10.1021/ja052645a
   Yagai S, 2013, CHEM-EUR J, V19, P6971, DOI 10.1002/chem.201300282
   Yagai S, 2010, ANGEW CHEM INT EDIT, V49, P9990, DOI 10.1002/anie.201006117
   Yamane S, 2013, CHEM COMMUN, V49, P3839, DOI 10.1039/c3cc00072a
   Yan HX, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12036-7
   Yan JL, 2015, J COLLOID INTERF SCI, V448, P374, DOI 10.1016/j.jcis.2015.02.044
   Yan JL, 2012, SOFT MATTER, V8, P11697, DOI 10.1039/c2sm26332g
   Yan LW, 2010, CHEM-EUR J, V16, P2250, DOI 10.1002/chem.200902750
   Yan MH, 2013, SOFT MATTER, V9, P4428, DOI 10.1039/c3sm27941c
   Yan N, 2013, LANGMUIR, V29, P793, DOI 10.1021/la304957n
   Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b
   Yang RM, 2014, SOFT MATTER, V10, P2188, DOI 10.1039/c3sm53145g
   Yang XY, 2012, J MATER CHEM, V22, P38, DOI 10.1039/c1jm13205a
   Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914
   Yao S, 2004, J AM CHEM SOC, V126, P8336, DOI 10.1021/ja0496367
   Yashin VV, 2010, J PHYS CHEM B, V114, P6316, DOI 10.1021/jp101009h
   Yemloul M, 2011, J PHYS CHEM B, V115, P2511, DOI 10.1021/jp200281f
   Yoshida R, 1996, J AM CHEM SOC, V118, P5134, DOI 10.1021/ja9602511
   Yu C, 2014, ADV FUNCT MATER, V24, P1235, DOI 10.1002/adfm.201302058
   Yu CJ, 2013, ADV MATER, V25, P1541, DOI 10.1002/adma.201204180
   Yu HT, 2005, TETRAHEDRON, V61, P8932, DOI 10.1016/j.tet.2005.07.003
   Yu QL, 2016, TRIBOL LETT, V61, DOI 10.1007/s11249-015-0634-y
   Yu XD, 2012, SOFT MATTER, V8, P3329, DOI 10.1039/c2sm07309a
   Yu XD, 2010, CHEM-EUR J, V16, P9099, DOI 10.1002/chem.201000187
   Yuan B, 2011, SOFT MATTER, V7, P1708, DOI 10.1039/c0sm00873g
   Zaccone A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051404
   Zalc JM, 2004, CHEM ENG SCI, V59, P2947, DOI 10.1016/j.ces.2004.04.028
   Zang LB, 2013, SENSOR ACTUAT B-CHEM, V185, P389, DOI 10.1016/j.snb.2013.05.022
   Zgierski MZ, 2011, J PHYS CHEM A, V115, P9689, DOI 10.1021/jp201127f
   Zhang CX, 2016, SOFT MATTER, V12, P1525, DOI 10.1039/c5sm02535d
   Zhang JJ, 2013, ADV MATER, V25, P378, DOI 10.1002/adma.201201521
   Zhang MM, 2012, CRYSTENGCOMM, V14, P8057, DOI 10.1039/c2ce25599e
   Zhang MM, 2012, SOFT MATTER, V8, P4494, DOI 10.1039/c2sm25164g
   Zhang SZ, 2008, J SEP SCI, V31, P3782, DOI 10.1002/jssc.200800349
   Zhang SY, 2009, J AM CHEM SOC, V131, P1689, DOI 10.1021/ja808210z
   Zhang WM, 2002, ANAL CHEM, V74, P1343, DOI 10.1021/ac0107857
   Zhang Y, 2014, SOFT MATTER, V10, P8838, DOI 10.1039/c4sm01331j
   Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c
   Zhao Y, 2003, ADV MATER, V15, P1431, DOI 10.1002/adma.200305120
   Zhao ZJ, 2013, SOFT MATTER, V9, P4564, DOI 10.1039/c3sm27969c
   Zhou JL, 2007, CHEM COMMUN, P5200, DOI 10.1039/b713548c
   Zhou SL, 2005, CHEM-EUR J, V11, P1130, DOI 10.1002/chem.200400677
   Zhu LL, 2013, J AM CHEM SOC, V135, P5175, DOI 10.1021/ja400456h
   Ziolek M, 2012, PHOTOCH PHOTOBIO SCI, V11, P1389, DOI 10.1039/c2pp25081k
   Zweep N, 2009, LANGMUIR, V25, P8802, DOI 10.1021/la9004714
NR 478
TC 84
Z9 84
U1 42
U2 235
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2016
VL 45
IS 23
BP 6546
EP 6596
DI 10.1039/c6cs00435k
PG 51
WC Chemistry, Multidisciplinary
SC Chemistry
GA EE1CJ
UT WOS:000389318100008
PM 27711667
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Shamloo, A
   Sarmadi, M
AF Shamloo, Amir
   Sarmadi, Morteza
TI Investigation of the adhesive characteristics of polymer-protein systems
   through molecular dynamics simulation and their relation to cell
   adhesion and proliferation
SO Integrative Biology
LA English
DT Article
ID COMPUTER-SIMULATION; CONFORMATIONAL-ANALYSIS; MECHANICAL-PROPERTIES;
   SURFACE WETTABILITY; CRYSTAL-STRUCTURE; GRAPHITE SURFACE; DRUG-DELIVERY;
   SERUM-ALBUMIN; ADSORPTION; FIBRONECTIN
AB Protein adhesion is a prevalent, however, intricate phenomenon that occurs immediately after exposure of a biomaterial to the biological system. A study on the adhesive characteristics of biomaterial-protein systems has encountered serious hurdles as experimental methods cannot properly capture the initial stages of protein adhesion, taking place within nano/picoseconds. This propels research studies toward utilizing computational approaches to gain an understanding of the interactions between different proteins and biomaterial surfaces. Herein, we use molecular dynamics (MD) modeling, as the computational framework, to study the adhesive characteristics of different biomaterial-protein systems. To this aim, two synthetic polymeric biomaterials, namely polycaprolactone (PCL) and polyvinyl alcohol (PVA), extensively used in tissue engineering are included. Four protein fragments are also considered including two extracellular matrix (ECM) proteins: collagen type-I, and fibronectin, along with two subdomains of human serum albumin (HSA). Subsequently, the adhesive characteristics of these polymer-protein systems were quantified by calculating the work of adhesion and peeling force through MD simulations. In the next phase of the study, cell proliferation and adhesion using bone marrow cells on electrospun scaffolds composed of PCL and PVA nanofibers were investigated to gain an understanding of the connection between the protein adhesion characteristics obtained from the simulations and cell adhesion and proliferation from an experimental assay. The results indicate that generally the hydrophobic surface of PCL represents both stronger protein adhesion and better cell proliferation. However, the PVA surface represents better adhesion only for one albumin subdomain. Results of this study demonstrate a direct connection between the stronger adhesion of ECM proteins to the biomaterial surface and more desirable cell adhesion and proliferation.
C1 [Shamloo, Amir; Sarmadi, Morteza] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran.
RP Shamloo, A (reprint author), Sharif Univ Technol, Dept Mech Engn, Tehran, Iran.
EM shamloo@sharif.edu
CR Andrade J. D., 1986, BIOPOLYMERS NONEXCLU, P1, DOI DOI 10.1007/3-540-16422-7_6
   Arash B, 2014, SCI REP-UK, V4, DOI 10.1038/srep06479
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   ASENSIO JL, 1995, INT J BIOL MACROMOL, V17, P137, DOI 10.1016/0141-8130(95)92680-O
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Cadek M, 2002, APPL PHYS LETT, V81, P5123, DOI 10.1063/1.1533118
   Cadek M., 2002, STRUCTURAL ELECT PRO, V633, P1
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Cormack AN, 2004, J PHYS CHEM B, V108, P20408, DOI 10.1021/jp0463417
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106
   Ebrahimi S, 2013, COMP MATER SCI, V71, P172, DOI 10.1016/j.commatsci.2013.01.017
   Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002
   Gibas Iwona, 2010, REV SYNTHETIC POLYM
   HARDY BJ, 1993, J COMPUT CHEM, V14, P831, DOI 10.1002/jcc.540140709
   Heidari H, 2016, INT J ADHES ADHES, V64, P9, DOI 10.1016/j.ijadhadh.2015.10.002
   Hub JS, 2014, J CHEM THEORY COMPUT, V10, P381, DOI 10.1021/ct400626b
   Ibragimova GT, 1998, BIOPHYS J, V74, P2906, DOI 10.1016/S0006-3495(98)77997-4
   Jeyachandran YL, 2009, LANGMUIR, V25, P11614, DOI 10.1021/la901453a
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kenawy ER, 2007, MAT SCI ENG A-STRUCT, V459, P390, DOI 10.1016/j.msea.2007.01.039
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Kubiak-Ossowska K, 2010, LANGMUIR, V26, P15954, DOI 10.1021/la102960m
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Liu HY, 2012, J PHYS CHEM B, V116, P1570, DOI 10.1021/jp209024r
   Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363
   Maheshwari SU, 2013, POLYM BULL, V70, P2995, DOI 10.1007/s00289-013-1002-4
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Raffaini G, 2006, PHYS CHEM CHEM PHYS, V8, P2765, DOI 10.1039/b604540e
   Raffaini G, 2006, J BIOMED MATER RES A, V77A, P618, DOI 10.1002/jbm.a.30670
   Raffaini G, 2004, LANGMUIR, V20, P3371, DOI 10.1021/la0357716
   Raffaini G, 2003, LANGMUIR, V19, P3403, DOI 10.1021/la026853h
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Raffaini G, 2012, PHILOS T R SOC A, V370, P1444, DOI 10.1098/rsta.2011.0266
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Regis S, 2014, J BIOMED MATER RES A, V102, P1697, DOI 10.1002/jbm.a.34843
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692
   SIEBERT HC, 1992, BIOCHEMISTRY-US, V31, P6962, DOI 10.1021/bi00145a014
   Song W, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035006
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Taepaiboon P, 2006, NANOTECHNOLOGY, V17, P2317, DOI 10.1088/0957-4484/17/9/041
   Wang XW, 2012, LANGMUIR, V28, P14642, DOI 10.1021/la303001j
   Ying PQ, 2004, COLLOID SURFACE B, V33, P259, DOI 10.1016/j.colsurfb.2003.10.015
   Ying PQ, 2003, COLLOID SURFACE B, V32, P1, DOI 10.1016/S0927-7765(02)00133-9
NR 49
TC 1
Z9 1
U1 7
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1757-9694
EI 1757-9708
J9 INTEGR BIOL-UK
JI Integr. Biol.
PY 2016
VL 8
IS 12
BP 1276
EP 1295
DI 10.1039/c6ib00159a
PG 20
WC Cell Biology
SC Cell Biology
GA EE2ML
UT WOS:000389418300007
PM 27785511
DA 2018-10-20
ER

PT J
AU Liu, HF
   Ding, XL
   Zhou, G
   Li, XM
   Li, P
   Gong, XH
   Gu, XN
   Pu, F
   Niu, HJ
   Li, DY
   Fan, YB
AF Liu, Haifeng
   Ding, Xili
   Zhou, Gang
   Li, Xiaoming
   Li, Ping
   Gong, Xianghui
   Gu, Xuenan
   Pu, Fang
   Niu, Haijun
   Li, Deyu
   Fan, Yubo
TI Developing Practical Abilities through a Teaching Reform of Tissue
   Engineering Course for Undergraduates
SO INTERNATIONAL JOURNAL OF ENGINEERING EDUCATION
LA English
DT Article
DE interdisciplinary field; Tissue engineering; laboratory course;
   practical abilities; undergraduate students
ID SULFATED SILK FIBROIN; EMBRYONIC STEM-CELLS; ENDOTHELIAL-CELLS; BONE
   REGENERATION; SCAFFOLDS; DELIVERY; BIOMATERIALS; PERSPECTIVES;
   BIOREACTORS; EDUCATION
AB This work describes a teaching reform of Tissue Engineering course that designs a laboratory course for senior undergraduate students, where students are challenged with a real-life tissue engineering application and provided with a hands-on experience applying oriented biomaterial technology and cytotechnology by conducting an experiment. Forty senior undergraduate students coming from School of Biological Science and Medical Engineering in Beihang University attended the course. The laboratory course was designed to guide students in raising research questions, generating strong hypotheses, identifying appropriate methodologies, and collaborating with each other to solve problems. Feedback from students attended this course has indicated that, while students find the expectations challenging in the early stages of the course, finally they are able to increase awareness and deepened their understanding of this field. We hope that this kind of educational modality could spread out to other interdisciplinary fields and contribute to the fast development of modern interdisciplinary science and technology.
C1 [Liu, Haifeng; Ding, Xili; Zhou, Gang; Li, Xiaoming; Li, Ping; Gong, Xianghui; Gu, Xuenan; Pu, Fang; Niu, Haijun; Li, Deyu; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Int Res Ctr Implantable & Intervent Med Devices, Key Lab Biomech & Mechanobiol,Minist Educ, Beijing 100191, Peoples R China.
   [Fan, Yubo] Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China.
RP Liu, HF; Fan, YB (reprint author), Beihang Univ, Sch Biol Sci & Med Engn, Int Res Ctr Implantable & Intervent Med Devices, Key Lab Biomech & Mechanobiol,Minist Educ, Beijing 100191, Peoples R China.; Fan, YB (reprint author), Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China.
EM haifengliu@buaa.edu.cn; yubofan@buaa.edu.cn
FU National Key Technology RD Program [2012BAI18B06, 2014BAI11B02,
   2014BAI11B03]; National Natural Science Foundation of China [31470938,
   11421202, 61227902, 11120101001]; International Joint Research Center of
   Aerospace Biotechnology and Medical Engineering from Ministry of Science
   and Technology of China; 111 Project [B13003]; Research Fund for the
   Doctoral Program of Higher Education of China [20131102130004];
   transformation project for major achievements of Central Universities in
   Beijing [ZDZH20141000601]; Fundamental Research Funds for the Central
   Universities
FX This work was supported by the National Key Technology R&D Program
   (2012BAI18B06, 2014BAI11B02, 2014BAI11B03), National Natural Science
   Foundation of China (31470938, 11421202, 61227902, and 11120101001),
   International Joint Research Center of Aerospace Biotechnology and
   Medical Engineering from Ministry of Science and Technology of China,
   111 Project (B13003), Research Fund for the Doctoral Program of Higher
   Education of China (20131102130004), The transformation project for
   major achievements of Central Universities in Beijing (ZDZH20141000601),
   and Fundamental Research Funds for the Central Universities.
CR Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   DiCecco J, 2007, ADV PHYSIOL EDUC, V31, P45, DOI 10.1152/advan.00054.2006
   Ding XL, 2015, J MATER CHEM B, V3, P3177, DOI 10.1039/c5tb00046g
   Ditcher AK, 2001, INT J ENG EDUC, V17, P24
   Duch B. J., 2001, POWER PROBLEM BASED
   Eisenbarth E, 2007, ADV ENG MATER, V9, P1051, DOI 10.1002/adem.200700287
   Felder R. M., 2000, CHEM ENG EDUC, V34, P26
   Gong XH, 2014, BIOMATERIALS, V35, P4782, DOI [10.1016/j.biomaterials2014.02.050, 10.1016/j.biomaterials.2014.02.050]
   Handelsman J, 2007, SCI TEACHING
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035580
   Huang NF, 2010, ARTERIOSCL THROM VAS, V30, P984, DOI 10.1161/ATVBAHA.110.202796
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   KOROSSIS S, 2005, TOP TISSUE ENG, V2, P1
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kuhn LT, 2014, TISSUE ENG PT A, V20, P365, DOI [10.1089/ten.tea.2013.0321, 10.1089/ten.TEA.2013.0321]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561
   Liu HF, 2013, MACROMOL BIOSCI, V13, P755, DOI 10.1002/mabi.201200470
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Liu X, 2014, ACTA BIOMATER, V10, P4484, DOI 10.1016/j.actbio.2014.06.027
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Nourse MB, 2010, ARTERIOSCL THROM VAS, V30, P80, DOI 10.1161/ATVBAHA.109.194233
   Oyamada N, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-54
   Shen G, 2003, CELL RES, V13, P335, DOI 10.1038/sj.cr.7290178
   Shuman LJ, 2005, J ENG EDUC, V94, P41, DOI 10.1002/j.2168-9830.2005.tb00828.x
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Ventre M, 2015, IEEE PULSE, V6, P39, DOI 10.1109/MPUL.2015.2428684
   Zakhem E, 2015, J FUNCT BIOMATER, V6, P999, DOI 10.3390/jfb6040999
   Zhao JJ, 2016, BIOCHEM ENG J, V109, P268, DOI 10.1016/j.bej.2016.01.018
NR 33
TC 0
Z9 0
U1 2
U2 12
PU TEMPUS PUBLICATIONS
PI DURRUS, BANTRY
PA IJEE , ROSSMORE,, DURRUS, BANTRY, COUNTY CORK 00000, IRELAND
SN 0949-149X
J9 INT J ENG EDUC
JI Int. J. Eng. Educ
PY 2016
VL 32
IS 5
BP 2025
EP 2032
PN A
PG 8
WC Education, Scientific Disciplines; Engineering, Multidisciplinary
SC Education & Educational Research; Engineering
GA ED8VA
UT WOS:000389147800018
DA 2018-10-20
ER

PT J
AU Rahyussalim, AJ
   Marsetio, AF
   Saleh, I
   Kurniawati, T
   Whulanza, Y
AF Rahyussalim, Ahmad Jabir
   Marsetio, Aldo Fransiskus
   Saleh, Ifran
   Kurniawati, Tri
   Whulanza, Yudan
TI The Needs of Current Implant Technology in Orthopaedic Prosthesis
   Biomaterials Application to Reduce Prosthesis Failure Rate
SO JOURNAL OF NANOMATERIALS
LA English
DT Review
ID BONE MORPHOGENETIC PROTEIN-2; COATED TITANIUM IMPLANTS; TOTAL
   HIP-ARTHROPLASTY; INTEGRIN BINDING; POROUS TANTALUM; SCREW FIXATION;
   METAL IMPLANTS; CELL-ADHESION; SURFACE; OSSEOINTEGRATION
AB Today, orthopaedics is still in search for the most reliable biomaterial for prosthesis. The biomaterial needs to have good longevity and other supporting properties in order to maintain low implant failure. An ideal metallic biomaterial should be biocompatible, has similar elastic modulus to that of bone, has excellent resistance to fatigue, corrosion, aseptic loosening, and wear, and has good bone-bonding ability. The success of an implant depends on many factors. Good osseointegration is one of the factors required to reduce the rate of loosening of implants and in order to increase the chance of osseointegration, high stability of implants and early healing process encouragement are needed.
C1 [Rahyussalim, Ahmad Jabir; Marsetio, Aldo Fransiskus; Saleh, Ifran] Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Orthopaed & Traumatol, Jakarta 10320, Indonesia.
   [Kurniawati, Tri] Univ Indonesia, Dr Cipto Mangunkusumo Hosp, MERC Fac Med, Stem Cell & Tissue Engn Cluster, Jakarta, Indonesia.
   [Whulanza, Yudan] Univ Indonesia, Fac Engn, Dept Met & Mat, Depok 16424, Jawa Barat, Indonesia.
RP Rahyussalim, AJ (reprint author), Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Orthopaed & Traumatol, Jakarta 10320, Indonesia.
EM rahyussalim71@ui.ac.id
OI Rahyussalim, Ahmad Jabir/0000-0003-3248-1147
CR Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170
   Agarwal R, 2015, ADV DRUG DELIVER REV, V94, P53, DOI 10.1016/j.addr.2015.03.013
   Andersson T, 2010, J MATER SCI-MATER M, V21, P3029, DOI 10.1007/s10856-010-4154-x
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Bae DK, 2013, J ARTHROPLASTY, V28, P1130, DOI 10.1016/j.arth.2012.08.021
   Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bitar D, 2015, WORLD J ORTHOP, V6, P172, DOI 10.5312/wjo.v6.i2.172
   Bragdon CR, 1996, J ARTHROPLASTY, V11, P945, DOI 10.1016/S0883-5403(96)80136-7
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Davies John E, 2003, J Dent Educ, V67, P932
   Dimitriou R., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P253
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Goriainov V, 2014, ACTA BIOMATER, V10, P4043, DOI 10.1016/j.actbio.2014.06.004
   Grandfield K., 2012, NANOSCALE OSSEOINTEG
   Guo C.Y., 2012, INT J BIOMATER, V2012, P5
   Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Lie SA, 2004, J BONE JOINT SURG BR, V86B, P504, DOI 10.1302/0301-620X.86B4.14799
   Liu XW, 2015, INT J CLIN EXP MED, V8, P27, DOI 10.14257/ijsip.2015.8.11.04
   Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003
   Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050378
   Mavrogenis AF, 2009, J MUSCULOSKEL NEURON, V9, P61
   Nasab M.B., 2010, TRENDS BIOMATER ARTI, V24, P69
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Novaes Jr Arthur Belém, 2010, Braz. Dent. J., V21, P471, DOI 10.1590/S0103-64402010000600001
   Park JH, 2012, BIOMATERIALS, V33, P7386, DOI 10.1016/j.biomaterials.2012.06.066
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Ramazanoglu M, 2013, J CRANIO MAXILL SURG, V41, P826, DOI 10.1016/j.jcms.2013.01.037
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Rodriguez-Gonzalez F A, 2009, BIOMATERIALS ORTHOPA
   Rubin MA, 2003, BONE, V33, P270, DOI 10.1016/S8756-3282(03)00194-7
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Shah NJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005576
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055015
   Skoglund B, 2004, J ORTHOP RES, V22, P1108, DOI 10.1016/j.orthres.2003.12.015
   SOBALLE K, 1993, ACTA ORTHOP SCAND, V64, pR1
   Sul YT, 2002, CLIN ORAL IMPLAN RES, V13, P252, DOI 10.1034/j.1600-0501.2002.130304.x
   Sumita M., 2003, FAILURE PROCESSES BI
   Thorey F, 2011, INDIAN J ORTHOP, V45, P57, DOI 10.4103/0019-5413.73659
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wermelin K, 2008, BONE, V42, P365, DOI 10.1016/j.bone.2007.10.013
   Wermelin K, 2008, J BIOMED MATER RES A, V86A, P220, DOI 10.1002/jbm.a.31583
   YAMAMOTO A, 1995, J JPN I MET, V59, P463, DOI 10.2320/jinstmet1952.59.4_463
   Yuasa K, 2014, J BIOMED MATER RES A, V102, P1180, DOI 10.1002/jbm.a.34765
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 63
TC 0
Z9 0
U1 2
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2016
AR 5386924
DI 10.1155/2016/5386924
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA ED4TG
UT WOS:000388843900001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Szczuka, E
   Bosacka, K
   Kaznowski, A
AF Szczuka, Ewa
   Bosacka, Karolina
   Kaznowski, Adam
TI Characterization of Staphylococcal Cassette Chromosome mec (SCCmec) in
   Methicillin-Resistant Staphylococcus epidermidis Strains Isolated from
   Biomaterial-Associated Infections and their Antibiotic Resistance
   Patterns
SO POLISH JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Staphylococcus epidermidis; SCCmec type; antibiotic resistance
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; AUREUS; DIVERSITY; BIOFILM; CLONES
AB This work aims to provide an insight into staphylococcal cassette chromosome mec elements and antibiotic resistance in clinical isolates of Staphylococcus epidermidis. The dominating type was SCCmec - IV. Fifteen isolates were assigned to SCCmec type III, two isolates to SCCmec type II. Most isolates were resistant to at least three of the non-beta-lactam antibiotics tested. None of the strains exhibited resistance to new generation antibiotics, such as daptomycin and linezolid. Also, none of these strains showed resistance to tigecycline and only four strains were resistant to rifampin i.e. antibiotics which are very efficient in treating biofilm-associated infections.
C1 [Szczuka, Ewa; Kaznowski, Adam] Adam Mickiewicz Univ, Inst Expt Biol, Dept Microbiol, Fac Biol, Poznan, Poland.
   [Bosacka, Karolina] Reg Hosp Poznan, Dept Microbiol & Lab Diagnost, Bacteriol Lab, Poznan, Poland.
RP Szczuka, E (reprint author), Adam Mickiewicz Univ, Inst Expt Biol, Dept Microbiol, Fac Biol, Poznan, Poland.
EM ewasz@amu.edu.pl
CR Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483
   Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841
   Bonilla H, 2010, CLIN INFECT DIS, V51, P796, DOI 10.1086/656281
   European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014, BREAKP TABL INT MICS
   Garza-Gonzalez E, 2010, EPIDEMIOL INFECT, V138, P645, DOI 10.1017/S0950268809991361
   Garza-Gonzalez E, 2010, J MED MICROBIOL, V59, P323, DOI 10.1099/jmm.0.015800-0
   Gu B, 2013, J ANTIMICROB CHEMOTH, V68, P4, DOI 10.1093/jac/dks354
   Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x
   Hong T, 2007, J CLIN MICROBIOL, V45, P3277, DOI 10.1128/JCM.02048-06
   Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004
   Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001
   Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09
   Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0
   Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08
   Schoenfelder SMK, 2010, INT J MED MICROBIOL, V300, P380, DOI 10.1016/j.ijmm.2010.04.011
   Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002
   Smyth DS, 2011, INFECT GENET EVOL, V11, P446, DOI 10.1016/j.meegid.2010.12.005
   Stewart PS, 2009, ANTIMICROB AGENTS CH, V53, P3505, DOI 10.1128/AAC.01728-08
   Svensson K, 2011, APMIS, V119, P885, DOI 10.1111/j.1600-0463.2011.02801.x
   Szczuka E, 2014, FOLIA MICROBIOL, V59, P283, DOI 10.1007/s12223-013-0296-9
   Trevino M, 2009, EUR J CLIN MICROBIOL, V28, P527, DOI 10.1007/s10096-008-0657-5
   Turlej A, 2011, POL J MICROBIOL, V60, P95
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003
   Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005
NR 25
TC 0
Z9 0
U1 0
U2 1
PU POLSKIE TOWARZYSTWO MIKROBIOLOGOW-POLISH SOCIETY OF MICROBIOLOGISTS
PI WARSAW
PA CHELMSKA STR 30-34, WARSAW, 00-725, POLAND
SN 1733-1331
J9 POL J MICROBIOL
JI Pol. J. Microbiol.
PY 2016
VL 65
IS 2
BP 215
EP 217
DI 10.5604/17331331.1204482
PG 3
WC Microbiology
SC Microbiology
GA ED3ZS
UT WOS:000388787600010
PM 30015446
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Fan, ZH
   Jiang, T
   Zheng, C
   Elom, AK
   Song, JH
AF Fan, Zhihui
   Jiang, Ting
   Zheng, Chang
   Elom, Akoda Komlan
   Song, Jihua
BE Wang, H
   Zhou, S
   Wang, Z
TI Preparation of a Thermo-sensitive Poly(lysine ester-co-adipic acid) with
   Excellent Biocompatibility
SO Proceedings of the 2016 International Conference on Civil, Structure and
   Environmental Engineering
SE AER-Advances in Engineering Research
LA English
DT Proceedings Paper
CT International conference on Civil, Structure, Environmental Engineering
   (I3CSEE)
CY MAR 12-13, 2016
CL Guangzhou, PEOPLES R CHINA
DE biocompatibility; thermo-sensitive polymer; lysine acid; molecular
   design
ID POLYMERS; CHAIN
AB Good biocompatibility or no cytotoxicity is the most important characteristic for thermo-sensitive polymeric material because of its potential applications in the biomedical field. In this paper, a new poly (lysine ester-co-adipic acid) (PLA) with both thermo-sensitivity and good biocompatibility was designed and successfully prepared. UV measurements indicated that PLA showed a reversible phase transition at 17.3-31.7 degrees C (the lower critical solution temperature, LCST). LCST of PLA was affected by its molecular weight, structure and concentration. Moreover, the viability of HeLa cells after 24 h incubation in PLA solution was in the range of 98%-110%, suggesting good biocompatibility of PLA. In summary, the new thermo-sensitive PLA with no cytotoxicity could be utilized as a promising biomaterial in the biomedical field.
C1 [Fan, Zhihui; Jiang, Ting; Zheng, Chang; Elom, Akoda Komlan; Song, Jihua] Hebei Univ, Coll Chem & Environm Sci, Baoding 071002, Peoples R China.
RP Fan, ZH (reprint author), Hebei Univ, Coll Chem & Environm Sci, Baoding 071002, Peoples R China.
EM 799509158@qq.com
CR Burek M, 2014, POLYMER, V55, P6460, DOI 10.1016/j.polymer.2014.10.032
   Champ S, 2001, POLYMER, V42, P6439, DOI 10.1016/S0032-3861(01)00122-7
   Deng HY, 2015, COLLOID POLYM SCI, V293, P2341, DOI 10.1007/s00396-015-3606-8
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Jia ZF, 2006, J AM CHEM SOC, V128, P8144, DOI 10.1021/ja062314d
   Reguera J, 2003, MACROMOLECULES, V36, P8470, DOI 10.1021/ma034572q
   Wang XH, 1998, MACROMOLECULES, V31, P2972, DOI 10.1021/ma971873p
   Zhang N, 2012, MACROMOLECULES, V45, P9751, DOI 10.1021/ma3019014
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ATLANTIS PRESS
PI PARIS
PA 29 AVENUE LAVMIERE, PARIS, 75019, FRANCE
SN 2352-5401
BN 978-94-6252-180-3
J9 AER ADV ENG RES
PY 2016
VL 65
BP 363
EP 366
PG 4
WC Engineering, Environmental; Engineering, Civil; Engineering, Mechanical
SC Engineering
GA BG4XJ
UT WOS:000389238400070
DA 2018-10-20
ER

PT J
AU Kunz, RI
   Brancalhao, RMC
   Ribeiro, LDC
   Natali, MRM
AF Kunz, Regina Ines
   Costa Brancalhao, Rose Meire
   Chasko Ribeiro, Lucineia de Fatima
   Marcal Natali, Maria Raquel
TI Silkworm Sericin: Properties and Biomedical Applications
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID REDUCING OXIDATIVE STRESS; HIGH-FAT DIET; BOMBYX-MORI; PROTEIN SERICIN;
   IN-VITRO; AMINO-ACIDS; STRUCTURAL CHARACTERISTICS; EXTRACTION METHODS;
   SULFATED SERICIN; MOLECULAR-WEIGHT
AB Silk sericin is a natural polymer produced by silkworm, Bombyx mori, which surrounds and keeps together two fibroin filaments in silk thread used in the cocoon. The recovery and reuse of sericin usually discarded by the textile industry not only minimizes environmental issues but also has a high scientific and commercial value. The physicochemical properties of the molecule are responsible for numerous applications in biomedicine and are influenced by the extraction method and silkworm lineage, which can lead to variations in molecular weight and amino acid concentration of sericin. The presence of highly hydrophobic amino acids and its antioxidant potential make it possible for sericin to be applied in the food and cosmetic industry. The moisturizing power allows indications as a therapeutic agent for wound healing, stimulating cell proliferation, protection against ultraviolet radiation, and formulating creams and shampoos. The antioxidant activity associated with low digestibility of sericin that expands the application in the medical field, such as antitumour, antimicrobial and anti-inflammatory agent, anticoagulant, acts in colon health, improving constipation and protects the body from obesity through improved plasma lipid profile. In addition, the properties of sericin allow its application as a culture medium and cryopreservation, in tissue engineering and for drug delivery, demonstrating its effective use, as an important biomaterial.
C1 [Kunz, Regina Ines; Marcal Natali, Maria Raquel] Univ Estadual Maringa, Dept Morphol Sci, Av Colombo 5790, BR-87020900 Maringa, PR, Brazil.
   [Costa Brancalhao, Rose Meire; Chasko Ribeiro, Lucineia de Fatima] State Univ Western Parana, Ctr Biol Sci & Hlth, Rua Univ 2069, BR-85819110 Cascavel, PR, Brazil.
RP Brancalhao, RMC (reprint author), State Univ Western Parana, Ctr Biol Sci & Hlth, Rua Univ 2069, BR-85819110 Cascavel, PR, Brazil.
EM rosecb@gmail.com
OI Brancalhao, Rose Meire Costa/0000-0002-5344-5076; Kunz, Regina
   Ines/0000-0003-1510-7022
FU Center of Biological Sciences and Health of the State University of
   Western Parana (Unioeste); Biological Science PhD Program of the State
   University of Maringa (UEM); Araucaria Foundation [546/2014]
FX The paper was financially supported by the Center of Biological Sciences
   and Health of the State University of Western Parana (Unioeste),
   Biological Science PhD Program of the State University of Maringa (UEM),
   and Araucaria Foundation (Award no. 546/2014).
CR AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158
   Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014
   Ali Mir Mahdi, 2011, J Ayurveda Integr Med, V2, P72, DOI 10.4103/0975-9476.82527
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Aramwit P, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9991-4
   Aramwit P, 2013, ARCH DERMATOL RES, V305, P585, DOI 10.1007/s00403-013-1371-4
   Aramwit P, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-119
   Aramwit P, 2012, WASTE MANAGE RES, V30, P217, DOI 10.1177/0734242X11404733
   Aramwit P, 2010, INT J MOL SCI, V11, P2200, DOI 10.3390/ijms11052200
   Aramwit P, 2010, BIOTECHNOL APPL BIOC, V55, P91, DOI 10.1042/BA20090186
   Aramwit P, 2009, WOUNDS, V21, P198
   Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012
   Aramwit P, 2009, J BIOMAT SCI-POLYM E, V20, P1295, DOI 10.1163/156856209X453006
   ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43
   Balekar N, 2012, J ETHNOPHARMACOL, V141, P817, DOI 10.1016/j.jep.2012.03.019
   BORODY TJ, 1985, GASTROENTEROLOGY, V89, P562, DOI 10.1016/0016-5085(85)90452-4
   Hernandez-Rodas MC, 2015, INT J MOL SCI, V16, P25168, DOI 10.3390/ijms161025168
   Cavalieri EL, 2002, CARCINOGENESIS, V23, P1071, DOI 10.1093/carcin/23.6.1071
   Celedon JC, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.5.e80
   Chapman RF, 1998, INSECT STRUCTURE FUN
   Chen FJ, 2012, J R SOC INTERFACE, V9, P2299, DOI 10.1098/rsif.2011.0887
   Chen ZH, 2013, NEURAL REGEN RES, V8, P1756, DOI 10.3969/j.issn.1673-5374.2013.19.003
   Cheok CF, 2012, CELL CYCLE, V11, P2227, DOI 10.4161/cc.20961
   Chlapanidas T, 2013, INT J BIOL MACROMOL, V58, P47, DOI 10.1016/j.ijbiomac.2013.03.054
   da Silva TL, 2014, CHEM ENGINEER TRANS, V38, P103, DOI 10.3303/CET1438018
   da Silva TL, 2016, J CLEAN PROD, V137, P1470, DOI 10.1016/j.jclepro.2015.05.067
   Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019
   Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Devi R., 2011, J PHARM RES, V4, P4688
   Devi RY, 2012, INT J SCI NAT, V3, P237
   Dhawan S, 2003, DEV GENES EVOL, V213, P435, DOI 10.1007/s00427-003-0343-7
   Dinescu S, 2013, BIOMED RES INT, DOI 10.1155/2013/598056
   Dinescu S, 2013, INT J MOL SCI, V14, P1870, DOI 10.3390/ijms14011870
   Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008
   EASTWOOD MA, 1992, ANNU REV NUTR, V12, P19, DOI 10.1146/annurev.nu.12.070192.000315
   Fabiani C, 1996, DESALINATION, V105, P1, DOI 10.1016/0011-9164(96)00050-1
   Fang H, 2008, PEPTIDES, V29, P1062, DOI 10.1016/j.peptides.2008.02.005
   Ford JT, 2001, IMMUNOL CELL BIOL, V79, P23, DOI 10.1046/j.1440-1711.2001.00788.x
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   GAMO T, 1983, JARQ-JPN AGR RES Q, V16, P264
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   Gimenes M. L., 2014, INT J CHEM ENG APPL, V5, P266, DOI DOI 10.7763/IJCEA.2014.V5.391
   Gulrajani M., 1992, REV PROG COLOR RELAT, V22, P79, DOI DOI 10.1111/J.14784408.1992.TB00091.X
   Gulrajani M. L., 2005, P SOUV 20 C INT SER, P21
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hiroshi I., 1999, CHEM ABSTR, V130
   Huang S, 2010, J CONTROL RELEASE, V142, P149, DOI 10.1016/j.jconrel.2009.10.018
   Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884
   ICHIMURA S, 1985, INSECT BIOCHEM, V15, P277, DOI 10.1016/0020-1790(85)90015-0
   Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0
   Jantaruk P, 2015, J APPL BIOMED, V13, P249, DOI 10.1016/j.jab.2015.03.005
   Jo YN, 2015, INT J BIOL MACROMOL, V78, P287, DOI 10.1016/j.ijbiomac.2015.04.004
   Joseph B, 2012, FRONT LIFE SCI, V6, P55, DOI 10.1080/21553769.2012.760491
   Kaewkorn W, 2012, BIOL RES, V45, P45, DOI 10.4067/S0716-97602012000100006
   Kataoka K., 1977, NIPPON SANSHIGAKU ZA, V46, P227
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Keawkorn W, 2013, SCIENCEASIA, V39, P252, DOI 10.2306/scienceasia1513-1874.2013.39.252
   Khampieng T, 2015, INT J BIOL MACROMOL, V80, P636, DOI 10.1016/j.ijbiomac.2015.07.018
   Kim H, 2012, BRIT J NUTR, V108, P1726, DOI 10.1017/S0007114511007306
   KIMURA K, 1985, EXPERIENTIA, V41, P1167, DOI 10.1007/BF01951711
   Kitisin T., 2013, J AGR SCI, V5, P3
   Kludkiewicz B, 2009, INSECT BIOCHEM MOLEC, V39, P938, DOI 10.1016/j.ibmb.2009.11.005
   Kodama K, 1926, BIOCHEM J, V20, P1208, DOI 10.1042/bj0201208
   Krysteva M., 1981, INT C CHERN BIOT BIO, V3, P150
   Kumar P, 2015, ANIM REPROD SCI, V152, P26, DOI 10.1016/j.anireprosci.2014.11.015
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kurioka A, 2004, BIOSCI BIOTECH BIOCH, V68, P774, DOI 10.1271/bbb.68.774
   Kurioka A, 2002, BIOSCI BIOTECH BIOCH, V66, P1396, DOI 10.1271/bbb.66.1396
   Lamboni L, 2015, BIOTECHNOL ADV, V33, P1855, DOI 10.1016/j.biotechadv.2015.10.014
   Lee JH, 2016, INT J BIOL MACROMOL, V89, P273, DOI 10.1016/j.ijbiomac.2016.04.073
   Lee K.-C., 2003, 2003 IEEE COMP SOC C, V1, P1, DOI DOI 10.1186/1471-2156-4-S1-S94.[
   Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617
   Li YG, 2008, CHINESE MED J-PEKING, V121, P2083
   Li YG, 2008, ALCOHOL ALCOHOLISM, V43, P246, DOI 10.1093/alcalc/agm164
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Limpeanchob N, 2010, J AGR FOOD CHEM, V58, P12519, DOI 10.1021/jf103157w
   Liu X., 2014, OLIGOMERIZATION CHEM, V3
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Martinez-Mora C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042271
   MATSUURA S, 1968, J CELL BIOL, V38, P589, DOI 10.1083/jcb.38.3.589
   MICHAILLE JJ, 1989, INSECT BIOCHEM, V19, P19, DOI 10.1016/0020-1790(89)90005-X
   MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X
   Micheal AS, 2014, ISJ-INVERT SURVIV J, V11, P257
   Miko AG, 2000, ELECTRON J BIOTECHN, V13, P114
   Mitran V, 2015, PROG NAT SCI-MATER, V25, P122, DOI 10.1016/j.pnsc.2015.03.008
   Mondal M., 2007, Caspian Journal of Environmental Sciences, V5, P63
   Morikawa M, 2009, J HEPATO-BILIARY-PAN, V16, P223, DOI 10.1007/s00534-009-0049-y
   Morita T, 1997, J NUTR, V127, P470
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nagai N, 2013, WORLD J DIABETES, V4, P282, DOI 10.4239/wjd.v4.i6.282
   Nagai N, 2009, BIOL PHARM BULL, V32, P1594, DOI 10.1248/bpb.32.1594
   Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933
   Nagaraju J, 2002, CURR SCI INDIA, V83, P415
   Nakpathom M, 2009, J MICROSCOPY SOC THA, V23, P142
   Nayak S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074779
   Nayak S, 2013, BIOMATERIALS, V34, P2855, DOI 10.1016/j.biomaterials.2013.01.019
   Nayak S, 2012, CELL TISSUE RES, V347, P783, DOI 10.1007/s00441-011-1269-4
   Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006
   Ogawa A, 2004, J BIOSCI BIOENG, V98, P217
   Ogino M, 2006, BIOSCI BIOTECH BIOCH, V70, P66, DOI 10.1271/bbb.70.66
   Ohtani H, 1997, LAB INVEST, V77, P231
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Okazaki Y, 2011, J NUTR, V141, P1975, DOI 10.3945/jn.111.144246
   Okazaki Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1534, DOI 10.1271/bbb.100065
   Onsa-Ard A., 2013, ISRN PHARM, V2013
   Padamwar Mahesh N, 2005, J Cosmet Dermatol, V4, P250, DOI 10.1111/j.1473-2165.2005.00200.x
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   Padol A. R., 2012, INT J MAT BIOMATERIA, V2, P19
   Pak P K, 1977, SUMYU KONGHAK HOEJI, V14, P94
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Parisi OI, 2015, BIOMACROMOLECULES, V16, P3126, DOI 10.1021/acs.biomac.5b00746
   Patel R. J., 2011, International Journal of Research in Pharmaceutical and Biomedical Sciences, V2, P913
   Prasong S., 2011, Journal of Biological Sciences, V11, P336, DOI 10.3923/jbs.2011.336.339
   Purwar R, 2015, FIBER POLYM, V16, P761, DOI 10.1007/s12221-015-0761-y
   Rajput S. K., 2015, IOSR J POLYM TEXTILE, V2, P29
   Ramesan M. T., 2016, J APPL POLYM SCI, V133
   Saetae S., 2015, AIP C P, V1664
   Sano M, 2009, J BIOMAT SCI-POLYM E, V20, P773, DOI 10.1163/156856209X426853
   Sasaki M, 2000, NUTR RES, V20, P1505, DOI 10.1016/S0271-5317(00)80031-7
   Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019
   Sasaki M, 2000, ONCOL REP, V7, P1049
   Sasaki M., 2000, FOOD SCI TECHNOL RES, V6, P280
   Sehnal F., 2008, Entomological Research, V38, pS1, DOI 10.1111/j.1748-5967.2008.00168.x
   SEHNAL F, 1990, INT J INSECT MORPHOL, V19, P79, DOI 10.1016/0020-7322(90)90022-H
   Seo CW, 2011, J AGR FOOD CHEM, V59, P4192, DOI 10.1021/jf104812g
   SHAW JTB, 1951, NATURE, V168, P745, DOI 10.1038/168745a0
   Singh M. K., 2014, HDB COSMETIC SCI TEC, V4
   Singh MK, 2011, FIBRES TEXT EAST EUR, V19, P27
   SINOHARA H, 1979, COMP BIOCHEM PHYS B, V63, P87, DOI 10.1016/0305-0491(79)90239-6
   SINOHARA H, 1967, J BIOCHEM-TOKYO, V62, P129, DOI 10.1093/oxfordjournals.jbchem.a128625
   Siritientong T, 2015, MACROMOL RES, V23, P861, DOI 10.1007/s13233-015-3116-z
   Siritientong T, 2014, PHARM RES-DORDR, V31, P104, DOI 10.1007/s11095-013-1136-y
   Song CJ, 2013, NEURAL REGEN RES, V8, P506, DOI 10.3969/j.issn.1673-5374.2013.06.003
   Sonjui T., 2009, Kasetsart Journal, Natural Sciences, V43, P538
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sorg O, 2004, CR BIOL, V327, P649, DOI 10.1016/j.crvi.2004.05.007
   Sorour J., 1990, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V120, P251
   SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Takasu Yoko, 2005, Journal of Insect Biotechnology and Sericology, V74, P103
   Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009
   Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010
   Takechi T, 2014, BIOMED REP, V2, P364, DOI 10.3892/br.2014.244
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   TASHIRO Y, 1968, J CELL BIOL, V38, P574, DOI 10.1083/jcb.38.3.574
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI 10.1042/BST0331078
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Turbiani FRB, 2011, CHEM ENGINEER TRANS, V24, P1489, DOI 10.3303/CET1124249
   Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094
   Verdanova M, 2014, BIOPRESERV BIOBANK, V12, P99, DOI 10.1089/bio.2013.0078
   Verhoef P, 2004, AM J CLIN NUTR, V80, P674
   Voegeli R., 1993, COSMET TOILETRIES, V108, P101
   Walter MF, 2004, J AM COLL CARDIOL, V44, P1996, DOI 10.1016/j.jacc.2004.08.029
   Wang Y, 2006, DRUG DEVELOP RES, V67, P677, DOI 10.1002/ddr.20141
   Wang Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep07064
   Wen ZM, 1996, J INVEST ALLERG CLIN, V6, P237
   Wilding J. P. H., 2006, MEDICINE, V34, P501
   Wu JH, 2007, FOOD CHEM, V103, P1255, DOI 10.1016/j.foodchem.2006.10.042
   Yagi K, 1998, Methods Mol Biol, V108, P101
   Yamada H., 2001, Patent No. [EP 1632214 A1, 1632214]
   Yamada M., 1978, J SERICULTURAL SCI J, V47, P108
   Yang MY, 2014, ACS APPL MATER INTER, V6, P13782, DOI 10.1021/am503214g
   Zhang CD, 2012, J INSECT PHYSIOL, V58, P974, DOI 10.1016/j.jinsphys.2012.04.017
   Zhang HP, 2014, CERAM INT, V40, P985, DOI 10.1016/j.ceramint.2013.06.095
   Zhang YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12374
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhang YQ, 2006, J CONTROL RELEASE, V115, P307, DOI 10.1016/j.jconrel.2006.08.019
   Zhaorigetu S, 2003, ONCOL REP, V10, P537
   Zhaorigetu S, 2001, BIOSCI BIOTECH BIOCH, V65, P2181, DOI 10.1271/bbb.65.2181
   Zhaorigetu S, 2007, J NUTR SCI VITAMINOL, V53, P297, DOI 10.3177/jnsv.53.297
   Zhu L. J., 1996, NIPPON SANSHIGAKU ZA, V65, P270
   Zhu L. J., 1998, ZHEJIANG NONGYE DAXU, V24, P268
NR 179
TC 12
Z9 13
U1 9
U2 38
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 8175701
DI 10.1155/2016/8175701
PG 19
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA ED5HX
UT WOS:000388883400001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU McMurtrey, RJ
AF McMurtrey, Richard J.
TI Multi-compartmental biomaterial scaffolds for patterning neural tissue
   organoids in models of neurodevelopment and tissue regeneration
SO JOURNAL OF TISSUE ENGINEERING
LA English
DT Article
DE Tissue engineering; neural regeneration; cerebral organoids;
   three-dimensional stem cell culture; diffusion gradients
ID HUMAN BRAIN-DEVELOPMENT; PLURIPOTENT STEM-CELLS; RADIAL GLIAL SCAFFOLD;
   HUMAN CEREBRAL-CORTEX; SPINAL-CORD-INJURY; RETINOIC ACID;
   DOPAMINERGIC-NEURONS; REELIN EXPRESSION; SIGNALING PATHWAY; RECEPTOR
AB Biomaterials are becoming an essential tool in the study and application of stem cell research. Various types of biomaterials enable three-dimensional culture of stem cells, and, more recently, also enable high-resolution patterning and organization of multicellular architectures. Biomaterials also hold potential to provide many additional advantages over cell transplants alone in regenerative medicine. This article describes novel designs for functionalized biomaterial constructs that guide tissue development to targeted regional identities and structures. Such designs comprise compartmentalized regions in the biomaterial structure that are functionalized with molecular factors that form concentration gradients through the construct and guide stem cell development, axis patterning, and tissue architecture, including rostral/caudal, ventral/dorsal, or medial/lateral identities of the central nervous system. The ability to recapitulate innate developmental processes in a three-dimensional environment and under specific controlled conditions has vital application to advanced models of neurodevelopment and for repair of specific sites of damaged or diseased neural tissue.
C1 [McMurtrey, Richard J.] Inst Neural Regenerat & Tissue Engn, 5406 W 11000 N Ste 103-215, Highland, UT 84003 USA.
RP McMurtrey, RJ (reprint author), Inst Neural Regenerat & Tissue Engn, 5406 W 11000 N Ste 103-215, Highland, UT 84003 USA.
EM richard.mcmurtrey@neuralregeneration.org
OI McMurtrey, Richard/0000-0003-3395-5148
CR Al Oustah A, 2014, DEVELOPMENT, V141, P1392, DOI 10.1242/dev.101717
   Andoniadou CL, 2013, CELL MOL LIFE SCI, V70, P3739, DOI 10.1007/s00018-013-1269-5
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Azim K, 2014, STEM CELLS, V32, P1301, DOI 10.1002/stem.1639
   Barth KA, 1999, DEVELOPMENT, V126, P4977
   Bishop KM, 2002, J NEUROSCI, V22, P7627
   Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223
   Campo CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005505
   Carballo-Molina OA, 2016, TISSUE ENG PT A, V22, P850, DOI [10.1089/ten.tea.2016.0008, 10.1089/ten.TEA.2016.0008]
   Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862
   Cecchi C, 2002, GENE, V291, P1, DOI 10.1016/S0378-1119(02)00623-6
   Chi LK, 2017, CEREB CORTEX, V27, P2941, DOI 10.1093/cercor/bhw152
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Cholfin JA, 2008, J COMP NEUROL, V509, P144, DOI 10.1002/cne.21709
   Cook DJ, 2016, J CEREB BLOOD FLOW M
   Crino Peter, 2001, Epilepsy Curr, V1, P72, DOI 10.1046/j.1535-7597.2001.00017.x
   Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0
   D'Arcangelo G, 2005, NEURON, V47, P471, DOI 10.1016/j.neuron.2005.08.001
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Armentia ML, 2003, J NEUROSCI, V23, P6876
   DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0
   Dessaud E, 2008, DEVELOPMENT
   Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106
   Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899
   Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634
   Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933
   Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102
   Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007
   Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137
   Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061
   Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923
   Hakim JS, 2015, TISSUE ENG PT A, V21, P2099, DOI [10.1089/ten.tea.2015.0019, 10.1089/ten.TEA.2015.0019]
   Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006
   Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654
   Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718
   Irioka T, 2005, DEV BRAIN RES, V154, P63, DOI 10.1016/j.devbrainres.2004.10.004
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   KENGAKU M, 1995, DEVELOPMENT, V121, P3121
   Kiecker C, 2001, DEVELOPMENT, V128, P4189
   Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299
   Komada M, 2008, DEVELOPMENT, V135, P2717, DOI 10.1242/dev.015891
   Kudoh T, 2002, DEVELOPMENT, V129, P4335
   Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015
   Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036
   Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445
   Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Maden M, 2001, INT REV CYTOL, V209, P1
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   McMurtrey RJ, 2016, TISSUE ENG PART C-ME, V22, P221, DOI [10.1089/ten.TEC.2015.0375, 10.1089/ten.tec.2015.0375]
   McMurtrey RJ, 2015, NEURAL REGEN RES, V10, P352, DOI 10.4103/1673-5374.153674
   McMurtrey RJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/066009
   Meinhardt A, 2014, STEM CELL REP, V3, P987, DOI 10.1016/j.stemcr.2014.09.020
   Moshayedi Pouria, 2013, Biomatter, V3, DOI 10.4161/biom.23863
   Mullard A, 2015, NAT REV DRUG DISCOV, V14, P589, DOI 10.1038/nrd4708
   Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641
   Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5
   Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008
   Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454
   Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854
   Osei-Sarfo K, 2014, STEM CELLS, V32, P2061, DOI 10.1002/stem.1706
   Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009
   Sart S, 2014, BIORESEARCH OPEN ACC, V3, P137, DOI 10.1089/biores.2014.0012
   Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041
   Shimamura K, 1997, DEVELOPMENT, V124, P2709
   Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004
   Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005
   Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794
   Tieng V, 2014, STEM CELLS DEV, V23, P1535, DOI 10.1089/scd.2013.0442
   Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307
   Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200
   Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3
   Yip YP, 2009, J COMP NEUROL, V515, P260, DOI 10.1002/cne.22044
   Zhao ST, 2004, DEVELOPMENT, V131, P5117, DOI 10.1242/dev.01387
NR 76
TC 2
Z9 2
U1 1
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2041-7314
J9 J TISSUE ENG
JI J. Tissue Eng.
PD JAN-DEC
PY 2016
VL 7
AR UNSP 2041731416671926
DI 10.1177/2041731416671926
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA EC8CR
UT WOS:000388368400015
PM 27766141
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Taraballi, F
   Corradetti, B
   Minardi, S
   Powel, S
   Cabrera, F
   Van Eps, JL
   Weiner, BK
   Tasciotti, E
AF Taraballi, Francesca
   Corradetti, Bruna
   Minardi, Silvia
   Powel, Sebastian
   Cabrera, Fernando
   Van Eps, Jeff L.
   Weiner, Bradley K.
   Tasciotti, Ennio
TI Biomimetic collagenous scaffold to tune inflammation by targeting
   macrophages
SO JOURNAL OF TISSUE ENGINEERING
LA English
DT Article
DE Macrophages; inflammation; scaffold; immune modulation
ID FOREIGN-BODY REACTION; CHONDROITIN SULFATE PROTEOGLYCAN; STEM-CELL
   NICHE; TISSUE REGENERATION; CROSS-LINKING; GIANT-CELLS; RECEPTOR; CD44;
   DIFFERENTIATION; OSTEOARTHRITIS
AB The inflammatory response following implantation of a biomaterial is one of the major regulatory aspects of the overall regenerative process. The progress of inflammation determines whether functional tissue is restored or if nonfunctional fibrotic tissue is formed. This delicate balance is directed by the activity of different cells. Among these, macrophages and their different phenotypes, the inflammatory M1 to anti-inflammatory M2, are considered key players in the process. Recent approaches exploit macrophage's regenerative potential in tissue engineering. Here, we propose a collagen scaffold functionalized with chondroitin sulfate ( CSCL), a glycosaminoglycan known to be able to tune inflammation. We studied CSCL effects on bone-marrow-derived macrophages in physiological, and lipopolysaccharides-inflamed, conditions in vitro. Our data demonstrate that CSCL is able to modulate macrophage phenotype by inhibiting the LPS/CD44/NF-kB cascade. As a consequence, an upregulation of anti-inflammatory markers (TGF-beta, Arg, MRC1, and IL-10) was found concomitantly with a decrease in the expression of pro-inflammatory markers ( iNOS, TNF-alpha, IL-1 beta, IL-12 beta). We then implanted CSCL subcutaneously in a rat model to test whether the same molecular mechanism could be maintained in an in vivo environment. In vivo data confirmed the in vitro studies. A significant reduction in the number of infiltrating cells around and within the implants was observed at 72 h, with a significant downregulation of pro-inflammatory genes expression. The present work provides indications regarding the immunomodulatory potential of molecules used for the development of biomimetic materials and suggests their use to direct macrophage immune modulation for tissue repair.
C1 [Taraballi, Francesca; Corradetti, Bruna; Minardi, Silvia; Powel, Sebastian; Cabrera, Fernando; Van Eps, Jeff L.; Weiner, Bradley K.; Tasciotti, Ennio] Houston Methodist Res Inst, Dept Nanomed, 6670 Bertner Ave, Houston, TX 77030 USA.
   [Corradetti, Bruna] Univ Politecn Marche, Dept Life & Environm Sci, Ancona, Italy.
   [Van Eps, Jeff L.] Houston Methodist Hosp, Dept Surg, Houston, TX USA.
   [Weiner, Bradley K.] Houston Methodist Hosp, Dept Orthoped & Sports Med, Houston, TX USA.
RP Tasciotti, E (reprint author), Houston Methodist Res Inst, Dept Nanomed, 6670 Bertner Ave, Houston, TX 77030 USA.
EM ETasciotti@houstonmethodist.org
RI Cabrera, Fernando/L-8483-2016
OI Cabrera, Fernando/0000-0002-8651-6790; Taraballi,
   Francesca/0000-0002-4959-1169
FU Brown Foundation [18130011]; Cullen Trust for Health Care Foundation
   [18130014]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   has been supported in part by Brown Foundation (Project ID: 18130011) by
   the Cullen Trust for Health Care Foundation (Project ID: 18130014).
CR Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Baiguera S, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/398069
   Blackwell NM, 2004, ARTHRITIS RHEUM, V50, P2675, DOI 10.1002/art.20467
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Chew SY, 2011, J BIOMED MATER RES A, V97A, P355, DOI 10.1002/jbm.a.33064
   Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   Croft DR, 1997, EUR J IMMUNOL, V27, P1680, DOI 10.1002/eji.1830270713
   Eshghi S, 2008, ENG MICROENVIRONMENT
   Fujimoto T, 2001, INT IMMUNOL, V13, P359, DOI 10.1093/intimm/13.3.359
   Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   Jiang JJ, 2013, ADV HEALTHC MATER, V2, P25, DOI 10.1002/adhm.201200169
   Jin MA, 2010, CYTOKINE, V51, P53, DOI 10.1016/j.cyto.2010.03.002
   Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kuo HP, 2000, AM J RESP CRIT CARE, V161, P192, DOI 10.1164/ajrccm.161.1.9902113
   Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Liang JR, 2007, J IMMUNOL, V178, P2469, DOI 10.4049/jimmunol.178.4.2469
   Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630
   Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199
   Lovu M, 2008, OSTEOARTHR CARTILAGE, V16, pS14, DOI 10.1016/j.joca.2008.06.008
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001
   Mauge L, 2014, EUR J PHARMACOL, V730, P148, DOI 10.1016/j.ejphar.2014.02.022
   McInnes LB, 1996, J EXP MED, V184, P1519
   Minardi S, 2014, SMALL, V10, P3943, DOI 10.1002/smll.201401211
   Monfort J, 2008, ANN RHEUM DIS, V67, P735, DOI 10.1136/ard.2006.068882
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G
   Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X
   Rubbo H, 1995, ARCH BIOCHEM BIOPHYS, V324, P15, DOI 10.1006/abbi.1995.9935
   Ruffell B, 2011, J BIOL CHEM, V286, P19179, DOI 10.1074/jbc.M110.200790
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   Taraballi F, 2014, ORG BIOMOL CHEM, V12, P4089, DOI 10.1039/c4ob00160e
   Vasconcelos DP, 2015, BIOMATERIALS, V53, P566, DOI 10.1016/j.biomaterials.2015.02.120
   Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035
   Watanabe H, 1998, J BIOCHEM-TOKYO, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166
   Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080
   Willerth SM, 2008, COMBINING STEM CELLS
   Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110718
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
NR 51
TC 15
Z9 16
U1 1
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2041-7314
J9 J TISSUE ENG
JI J. Tissue Eng.
PD JAN-DEC
PY 2016
VL 7
AR UNSP 2041731415624667
DI 10.1177/2041731415624667
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA EC8CR
UT WOS:000388368400021
PM 26977285
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Xing, Y
   Xu, QL
   Lin, HB
   Li, XC
   Zhang, DF
   Yang, SX
   Meng, Y
   Li, XH
   Liu, X
AF Xing, Yage
   Xu, Qinglian
   Lin, Hongbin
   Li, Xingchen
   Zhang, Dafeng
   Yang, Simon Xianyi
   Meng, Ying
   Li, Xihong
   Liu, Xia
TI Preparation, properties and in vivo antimicrobial activity in yacon
   roots of microencapsulation containing cinnamon oil
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Properties; Antimicrobial activity; Cinnamon oil; Microencapsulation;
   Yacon roots
ID FERRITE COMPOSITE NANOPARTICLES; HYBRID NANOSCALE ARCHITECTURE;
   LACTOBACILLUS-ACIDOPHILUS; ANTIFUNGAL ACTIVITIES; BIOMATERIAL SYSTEM;
   STAINLESS-STEEL; IONS RELEASE; QUALITY; BANANA; IMMOBILIZATION
AB Preparation, properties and in vivo antimicrobial activity in yacon roots of microencapsulated cinnamon oil were investigated. The encapsulation efficiency was affected by the concentration of wall materials. Result indicated that cinnamon oil microencapsulation exhibited different particles size and irregular shape. Thermogravimetric analysis showed that the first mass loss in curves for microparticles without oil and microencapsulated oil were observed from 43.78 to 73.59 degrees C and from 43.78 to 73.59 degrees C, respectively. The oil release of from mciroparticles could increase with improving the relative humidity and/or the temperature. The counts of bacteria and, yeast and moulds in fresh-cut yacon roots treated by microencapsulated cinnamon oil with PVC film reached the level of 4.5x10(2) and 6.3x10(3) after 12day storage, respectively. Treatment of microencapsulated cinnamon oil could also keep the overall good visual quality for fresh-cut yacon roots.
C1 [Xing, Yage; Xu, Qinglian; Lin, Hongbin; Li, Xingchen; Zhang, Dafeng; Meng, Ying] Xihua Univ, Sichuan Prov Key Lab Grain & Oil Proc & Food Safe, Food & Bioengn Coll, Chengdu, Peoples R China.
   [Yang, Simon Xianyi] Univ Guelph, Sch Engn, Guelph, ON, Canada.
   [Li, Xihong; Liu, Xia] Tianjin Univ Sci Technol, Food Engn & Biotechnol Coll, Tianjin, Peoples R China.
RP Xu, QL (reprint author), Xihua Univ, Sichuan Prov Key Lab Grain & Oil Proc & Food Safe, Food & Bioengn Coll, Chengdu, Peoples R China.
EM 775938414@qq.com
RI Yang, Simon X./A-4399-2008
OI Yang, Simon X./0000-0002-6888-7993
FU Key Laboratory Open Research Fund of Grain and Oil Processing and Food
   Safety of Xihua University [szjj2015-003, szjj2014-003, szjj2014-002];
   Innovation team Research Program of the Education Department of Sichuan
   Province; Xihua University Young Scholars Training Program [01201413]
FX This study was supported by the Key Laboratory Open Research Fund of
   Grain and Oil Processing and Food Safety of Xihua University [grant
   number szjj2015-003], [grant number szjj2014-003] and [grant number
   szjj2014-002], Innovation team Research Program of the Education
   Department of Sichuan Province and Xihua University Young Scholars
   Training Program [grant number 01201413].
CR Bico SLS, 2009, FOOD CONTROL, V20, P508, DOI 10.1016/j.foodcont.2008.07.017
   de Roos KB, 2003, INT DAIRY J, V13, P593, DOI 10.1016/S0958-6946(03)00108-0
   Depan D, 2015, J BIOMED NANOTECHNOL, V11, P306, DOI 10.1166/jbn.2015.1908
   Girase B, 2011, MAT SCI ENG C-MATER, V31, P1759, DOI 10.1016/j.msec.2011.08.007
   He T, 2015, MATER TECHNOL, V30, pB68, DOI 10.1179/1753555714Y.0000000189
   Huang HH, 2015, MATER TECHNOL, V30, pB73, DOI 10.1179/1753555714Y.0000000263
   Juglal S, 2002, J FOOD PROTECT, V65, P683, DOI 10.4315/0362-028X-65.4.683
   Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x
   Li XH, 2011, ADV MATER RES-SWITZ, V152-153, P508, DOI 10.4028/www.scientific.net/AMR.152-153.508
   Li X, 2011, ADV MATER RES-SWITZ, V328-330, P2102, DOI [10.4028/www.scientific.net/AMR.328-330.2012, 10.4028/www.scientific.net/AMR.328-330.2102]
   Li Y, 2015, MATER TECHNOL, V30, pB96, DOI 10.1179/1753555714Y.0000000194
   Liakos I, 2015, J MATER CHEM B, V3, P1583, DOI 10.1039/c4tb01974a
   Liakos I, 2014, INT J PHARMACEUT, V463, P137, DOI 10.1016/j.ijpharm.2013.10.046
   Ma Z, 2015, MATER TECHNOL, V30, pB80, DOI 10.1179/1753555714Y.0000000237
   Matan N, 2006, INT J FOOD MICROBIOL, V107, P180, DOI 10.1016/j.ijfoodmicro.2005.07.007
   Misra RDK, 2012, ADV ENG MATER, V14, pB93, DOI 10.1002/adem.201180081
   Ojagh SM, 2010, FOOD CHEM, V120, P193, DOI 10.1016/j.foodchem.2009.10.006
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Ranasinghe LS, 2003, J FOOD AGRIC ENVIRON, V1, P340
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Ren L, 2015, MATER TECHNOL, V30, pB86, DOI 10.1179/1753555714Y.0000000264
   Sun D, 2015, MATER TECHNOL, V30, pB90, DOI 10.1179/1753555714Y.0000000239
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wanchaitanawong P., 2005, Kasetsart Journal, Natural Sciences, V39, P400
   Wang S, 2015, MATER TECHNOL, V30, pB115, DOI 10.1179/1753555714Y.0000000176
   Wang S, 2015, MATER TECHNOL, V30, pB120, DOI 10.1179/1753555714Y.0000000188
   Wang SY, 2005, BIORESOURCE TECHNOL, V96, P813, DOI 10.1016/j.biortech.2004.07.010
   Win NKK, 2007, POSTHARVEST BIOL TEC, V45, P333, DOI 10.1016/j.postharvbio.2007.01.020
   Xing Y., 2012, ADV SCI LETT, V13, P787, DOI [10.1166/asl.2012.3808, DOI 10.1166/ASL.2012.3808]
   Xing Y, 2015, RSC ADV, V5, P22825, DOI 10.1039/c4ra13578d
   Xing YG, 2014, FOOD FUNCT, V5, P972, DOI 10.1039/c3fo60438a
   Xing YG, 2012, J FOOD PROCESS ENG, V35, P505, DOI 10.1111/j.1745-4530.2010.00604.x
   Xing YG, 2011, ADV MATER RES-SWITZ, V236-238, P2307, DOI 10.4028/www.scientific.net/AMR.236-238.2307
   Xing YG, 2011, FOOD FUNCT, V2, P466, DOI 10.1039/c1fo10073d
   Xing YG, 2011, FOOD CHEM, V124, P1443, DOI 10.1016/j.foodchem.2010.07.105
   Xing YG, 2010, INT J FOOD SCI TECH, V45, P1837, DOI 10.1111/j.1365-2621.2010.02342.x
   Yin Y, 2015, MATER TECHNOL, V30, pB104, DOI 10.1179/1753555714Y.0000000250
   Yu L, 2015, MATER TECHNOL, V30, pB109, DOI 10.1179/1753555714Y.0000000240
   Zhang D, 2015, MATER TECHNOL, V30, pB133, DOI 10.1179/1753555714Y.0000000255
   Zhang S, 2015, MATER TECHNOL, V30, pB126, DOI 10.1179/1753555714Y.0000000236
NR 44
TC 0
Z9 0
U1 2
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
SU 1
BP 40
EP 46
DI 10.1080/10667857.2016.1160502
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA ED3NT
UT WOS:000388756500009
DA 2018-10-20
ER

PT J
AU Pichavant, L
   Carrie, H
   Durrieu, MC
   Heroguez, V
AF Pichavant, L.
   Carrie, H.
   Durrieu, M. C.
   Heroguez, V.
TI Nanoparticles highly loaded with gentamicin sulfate by a combination of
   polyhydroxylated macromonomers and ROMP for the synthesis of bioactive
   biomaterials
SO POLYMER CHEMISTRY
LA English
DT Article
ID OPENING METATHESIS POLYMERIZATION; POLY(ETHYLENE OXIDE); DRUG-DELIVERY;
   OSTEOMYELITIS; COPOLYMERS; INFECTIONS; MATRICES; PLATFORM; RABBIT; MODEL
AB Antibiotic functionalized polymeric nanoparticles (NPs) are obtained by the copolymerization of macromonomers, which is a powerful way to synthesize bioactive biomaterial surfaces able to fight a bacterial strain in the case of infection. The active molecule loading can be modulated/increased by the use of highly charged macromonomers (typically polyhydroxylated macromonomers). This paper presents the synthesis of a-norbornenyl hydroxylated macromonomers (polyglycidol and poly(ethylene oxide)-blockpolyglycidol) functionalized with an antibiotic: gentamicin sulfate. Then, these macromonomers are copolymerized with norbornene (Nb) by ring-opening metathesis polymerization in a dispersion to form core-shell NPs which have application as antibiotic platforms for the synthesis of bioactive biomaterial surfaces.
C1 [Pichavant, L.; Carrie, H.; Heroguez, V.] Univ Bordeaux, LCPO, UMR5629, F-33600 Pessac, France.
   [Pichavant, L.; Carrie, H.; Durrieu, M. C.] CBMN, Bordeaux INP, UMR5248, F-33600 Pessac, France.
RP Heroguez, V (reprint author), Univ Bordeaux, LCPO, UMR5629, F-33600 Pessac, France.
EM heroguez@enscbp.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; Helene,
   Carrie/0000-0003-3352-2940
FU SATT of Region Aquitaine (Aquitaine Science Transfert)
FX The authors thank the SATT of Region Aquitaine (Aquitaine Science
   Transfert) for providing financial support to this project. The
   microscopy was done in the Bordeaux Imaging Center, a service unit of
   the CNRS-INSERM and Bordeaux University, member of the national
   infrastructure France BioImaging.
CR Al-Abd AM, 2010, J CONTROL RELEASE, V142, P101, DOI 10.1016/j.jconrel.2009.10.003
   Anal AK, 2007, RECENT PATENTS ENDOC, V1, P83, DOI 10.2174/187221407779814598
   Chang HI, 2006, J CONTROL RELEASE, V110, P414, DOI 10.1016/j.jconrel.2005.10.028
   Chemtob A, 2002, MACROMOLECULES, V35, P9262, DOI 10.1021/ma020871o
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   del Valle EMM, 2009, IND ENG CHEM RES, V48, P2475, DOI 10.1021/ie800886m
   Denis I, 2014, BIOMACROMOLECULES, V15, P4534, DOI 10.1021/bm501338r
   Dimitrov P, 2004, MACROMOLECULES, V37, P1000, DOI 10.1021/ma0354039
   Francis R, 2003, MACROMOLECULES, V36, P8253, DOI 10.1021/ma030258k
   Gaudin A, 2011, LETT APPL MICROBIOL, V52, P253, DOI 10.1111/j.1472-765X.2010.02992.x
   Gervais M, 2010, MACROMOLECULES, V43, P1778, DOI 10.1021/ma902286a
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hans M, 2009, POLYMER, V50, P1103, DOI 10.1016/j.polymer.2009.01.012
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Heroguez V, 1996, MACROMOLECULES, V29, P4459, DOI 10.1021/ma951797v
   Koehler J, 2013, MACROMOLECULES, V46, P3708, DOI 10.1021/ma400255n
   Kwon W, 2012, ADV FUNCT MATER, V22, P5194, DOI 10.1002/adfm.201201101
   Lesniak W, 2003, CARBOHYD RES, V338, P2853, DOI 10.1016/j.carres.2003.08.005
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Naahidi S, 2013, J CONTROL RELEASE, V166, P182, DOI 10.1016/j.jconrel.2012.12.013
   Neqal M, 2016, COLLOID SURFACE A, V510, P254, DOI 10.1016/j.colsurfa.2016.04.056
   Neut D, 2009, ACTA ORTHOP, V80, P514, DOI 10.3109/17453670903350040
   Pargen S, 2012, MACROMOLECULES, V45, P1230, DOI 10.1021/ma2021437
   Pedersen AB, 2010, ACTA ORTHOP, V81, P542, DOI 10.3109/17453674.2010.519908
   Peng KT, 2010, BIOMATERIALS, V31, P5227, DOI 10.1016/j.biomaterials.2010.03.027
   Pichavant L, 2012, J CONTROL RELEASE, V162, P373, DOI 10.1016/j.jconrel.2012.06.033
   Pichavant L, 2011, MACROMOLECULES, V44, P7879, DOI 10.1021/ma2015479
   Sirivisoot S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/8/085101
   Vogely HC, 2000, J ORTHOPAED RES, V18, P485, DOI 10.1002/jor.1100180323
   Wang GH, 2004, INT J PHARM, V273, P203, DOI 10.1016/j.ijpharm.2004.01.010
   Wurm F, 2008, MACROMOLECULES, V41, P1184, DOI 10.1021/ma702308g
NR 32
TC 4
Z9 4
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2016
VL 7
IS 45
BP 7019
EP 7028
DI 10.1039/c6py01774f
PG 10
WC Polymer Science
SC Polymer Science
GA ED2OC
UT WOS:000388685600018
DA 2018-10-20
ER

PT S
AU Landi, G
   Neitzert, HC
   Sorrentino, A
AF Landi, Giovanni
   Neitzert, Heinz C.
   Sorrentino, Andrea
BE DAmore, A
   Acierno, D
   Grassia, L
TI Temperature-dependent dielectric properties of a thermoplastic gelatin
SO VIII INTERNATIONAL CONFERENCE ON TIMES OF POLYMERS AND COMPOSITES: FROM
   AEROSPACE TO NANOTECHNOLOGY
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 8th International Conference on Times of Polymers (TOP) and Composites
CY JUN 19-23, 2016
CL Naples, ITALY
SP Second Univ Naples, Univ Naples Federico II
DE Ionic conduction; Bio-based materials; Hopping transport; Dielectric
   spectroscopy
ID TRANSPORT
AB The frequency and the temperature dependence of the dielectric properties of a thermoplastic gelatin based biomaterial have been investigated. At lower frequencies the dielectric response is strongly affected by charge carrier accumulation at the electrodes which modifies the dominating hopping conduction mechanism. The variation of the ac conductivity with frequency obeys a Jonscher type power law except for a small deviation in the low frequency range due to the electrode polarization effect. The master curve of the ac conductivity data shows that the conductivity relaxation of the gelatin is temperature independent.
C1 [Landi, Giovanni; Sorrentino, Andrea] CNR, IPCB, Piazzale Enrico Fermi 1, I-80055 Portici, NA, Italy.
   [Landi, Giovanni; Neitzert, Heinz C.] Univ Salerno, Dept Ind Engn, Via G Paolo 2 132, I-84084 Fisciano, SA, Italy.
RP Landi, G (reprint author), CNR, IPCB, Piazzale Enrico Fermi 1, I-80055 Portici, NA, Italy.; Landi, G (reprint author), Univ Salerno, Dept Ind Engn, Via G Paolo 2 132, I-84084 Fisciano, SA, Italy.
EM glandi@unisa.it
RI Sorrentino, Andrea/A-1067-2008
OI Sorrentino, Andrea/0000-0003-1048-3002; Landi,
   Giovanni/0000-0002-0640-479X
CR An J, 2013, MAT SCI ENG C-MATER, V33, P2827, DOI 10.1016/j.msec.2013.03.008
   Dyre JC, 2000, REV MOD PHYS, V72, P873, DOI 10.1103/RevModPhys.72.873
   HAVRILIAK S, 1966, J POLYMER SCI      C, V14, P99
   Landi G, 2015, ADV COND MATTER PHYS, V2015, P1
   Landi G, 2015, NANO ENERGY, V17, P348, DOI 10.1016/j.nanoen.2015.09.006
   Landi G, 2014, AIP CONF PROC, V1599, P202, DOI 10.1063/1.4876813
   Lu HB, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336494
   MAURITZ KA, 1989, MACROMOLECULES, V22, P4483, DOI 10.1021/ma00202a018
   Medeiros SF, 2011, INT J PHARMACEUT, V403, P139, DOI 10.1016/j.ijpharm.2010.10.011
   NGAI KL, 1979, NATURE, V277, P185, DOI 10.1038/277185a0
   Park SJ, 2004, J COLLOID INTERF SCI, V272, P384, DOI 10.1016/j.jcis.2003.12.027
   Perez-Madrigal MM, 2015, J MATER CHEM B, V3, P5904, DOI 10.1039/c5tb00624d
   Schrieber R., 2007, GELATINE HDB THEORY, P45, DOI [DOI 10.1002/9783527610969.CH2, 10.1002/9783527610969.ch2]
   Serghei A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.184301
   Serghei A., 2012, ELECT PHENOMENA INTE, P241
   SIDEBOTTOM DL, 1995, PHYS REV B, V51, P2770, DOI 10.1103/PhysRevB.51.2770
   YongSuk Y., 2010, J KOREAN PHYS SOC, V56, P462
NR 17
TC 1
Z9 1
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1390-0
J9 AIP CONF PROC
PY 2016
VL 1736
AR UNSP 020165
DI 10.1063/1.4949740
PG 4
WC Materials Science, Composites; Physics, Applied; Polymer Science
SC Materials Science; Physics; Polymer Science
GA BG3EZ
UT WOS:000387931100165
DA 2018-10-20
ER

PT J
AU Wadood, A
AF Wadood, Abdul
TI Brief Overview on Nitinol as Biomaterial
SO ADVANCES IN MATERIALS SCIENCE AND ENGINEERING
LA English
DT Review
ID SHAPE-MEMORY ALLOYS; HIGH-TEMPERATURE APPLICATIONS; ALPHA-PHASE
   PRECIPITATION; NICKEL-TITANIUM ALLOYS; TI-CR-SN; MEDICAL APPLICATIONS;
   CORROSION BEHAVIOR; TRANSFORMATION TEMPERATURES;
   MARTENSITIC-TRANSFORMATION; SUPERELASTIC ALLOYS
AB Shape memory alloys remember their shape due to thermoelastic martensitic phase transformation. These alloys have advantages in terms of large recoverable strain and these alloys can exert continuous force during use. Equiatomic NiTi, also known as nitinol, has a great potential for use as a biomaterial as compared to other conventional materials due to its shape memory and superelastic properties. In this paper, an overview of recent research and development related to NiTi based shape memory alloys is presented. Applications and uses of NiTi based shape memory alloys as biomaterials are discussed. Biocompatibility issues of nitinol and researchers' approach to overcome this problem are also briefly discussed.
C1 [Wadood, Abdul] Inst Space Technol, Dept Mat Sci & Engn, Near Rawat Toll Plaza, Islamabad, Pakistan.
RP Wadood, A (reprint author), Inst Space Technol, Dept Mat Sci & Engn, Near Rawat Toll Plaza, Islamabad, Pakistan.
EM abdul.wadood@ist.edu.pk
FU Higher Education Commission (HEC), Pakistan
FX The author is thankful to Professor Dr. Hideki Hosoda, Professor Dr.
   Tomonari Inamura from TITECH, and Dr. Yoko Yamabe-Mitarai from High
   Temperature Materials Unit, NIMS, Japan, for their continuous technical
   and moral support and guidance. The author is also thankful to Professor
   Dr. Ibrahim Qazi, Head of the Department (HOD), Department of Materials
   Science and Engineering, Institute of Space Technology, Islamabad,
   Pakistan, for his full technical and moral support. The author is also
   thankful to Higher Education Commission (HEC), Pakistan, for IPFP and
   NRPU research funding.
CR Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   [Anonymous], 2004, ASM HDB, V9
   Avner S. H., 1974, INTRO PHYS METALLURG
   Brailovski V, 2011, MAT SCI ENG C-MATER, V31, P643, DOI 10.1016/j.msec.2010.12.008
   Breschan C, 2006, PEDIATR ANESTH, V16, P366, DOI 10.1111/j.1460-9592.2005.01836.x
   Burgos FJ, 2009, TRANSPL P, V41, P2427, DOI 10.1016/j.transproceed.2009.06.068
   Chan CW, 2012, INT J PLASTICITY, V32-33, P85, DOI 10.1016/j.ijplas.2011.12.003
   Cioffi M, 2005, ACTA BIOMATER, V1, P717, DOI 10.1016/j.actbio.2005.07.008
   Cladera A, 2014, CONSTR BUILD MATER, V63, P281, DOI 10.1016/j.conbuildmat.2014.04.032
   Dar RD, 2016, SCRIPTA MATER, V115, P113, DOI 10.1016/j.scriptamat.2016.01.014
   Dinca VC, 2006, APPL SURF SCI, V252, P4619, DOI 10.1016/j.apsusc.2005.07.093
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Duffo GS, 2004, CORROSION-US, V60, P594, DOI 10.5006/1.3287764
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hao SJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05267
   Hodgson D. E., 1990, METALS HDB, V2, P897
   Huang W, 2002, MATER DESIGN, V23, P11, DOI 10.1016/S0261-3069(01)00039-5
   Huang WM, 2013, ADV DRUG DELIVER REV, V65, P515, DOI 10.1016/j.addr.2012.06.004
   Huang WM, 2010, MATER TODAY, V13, P54, DOI 10.1016/S1369-7021(10)70128-0
   Jani JM, 2014, MATER DESIGN, V56, P1078, DOI 10.1016/j.matdes.2013.11.084
   JARDINE AP, 1994, MATER CHARACT, V32, P169
   Kauffman GB, 1997, CHEM ED, V21, P1, DOI DOI 10.1007/S00897970111A]
   Kusano Y, 2010, ADV MATER RES-SWITZ, V89-91, P307, DOI 10.4028/www.scientific.net/AMR.89-91.307
   Lai M, 2015, MATER DESIGN, V87, P466, DOI 10.1016/j.matdes.2015.07.180
   Li SJ, 2008, ACTA BIOMATER, V4, P305, DOI 10.1016/j.actbio.2007.09.009
   Ma J, 2010, INT MATER REV, V55, P257, DOI 10.1179/095066010X12646898728363
   Ma J. L., 2000, P SMST, P291
   Mahdis S, 2015, ACTA BIOMATER, V21, P20, DOI 10.1016/j.actbio.2015.03.025
   Mahtabi MJ, 2016, J MECH BEHAV BIOMED, V55, P236, DOI 10.1016/j.jmbbm.2015.10.022
   Mahtabi MJ, 2015, J MECH BEHAV BIOMED, V50, P228, DOI 10.1016/j.jmbbm.2015.06.010
   McGrath DJ, 2014, J MECH BEHAV BIOMED, V40, P252, DOI 10.1016/j.jmbbm.2014.08.029
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P1087, DOI 10.1016/j.msec.2011.11.007
   Mirjalili M, 2013, MAT SCI ENG C-MATER, V33, P2084, DOI 10.1016/j.msec.2013.01.026
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Moghaddam AO, 2013, T NONFERR METAL SOC, V23, P2896, DOI 10.1016/S1003-6326(13)62812-5
   Moore J. J., 1991, MRS P, V246, P246
   Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326
   Nematzadeh F, 2012, SCI IRAN, V19, P1564, DOI 10.1016/j.scient.2012.10.024
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Obaisi NA, 2016, DENT MATER, V32, P879, DOI 10.1016/j.dental.2016.03.017
   Oh KT, 2006, J BIOMED MATER RES B, V76B, P306, DOI 10.1002/jbm.b.30369
   Oh KT, 2005, J BIOMED MATER RES B, V74B, P649, DOI 10.1002/jbm.b.30259
   Ohgoe Y, 2006, THIN SOLID FILMS, V497, P218, DOI 10.1016/j.tsf.2005.11.003
   Oshida Y, 1990, MATER SCI FORUM, V56, P705
   Otsuka S. K., 1999, SHAPE MEMORY MAT
   Pelton AR, 2008, J MECH BEHAV BIOMED, V1, P153, DOI 10.1016/j.jmbbm.2007.08.001
   Pelton A. R., 2000, P INT C SHAP MEM SUP
   Pelton AR, 2000, MATER SCI FORUM, V327-3, P63, DOI 10.4028/www.scientific.net/MSF.327-328.63
   Pfeifer R, 2013, PROC CIRP, V5, P253, DOI 10.1016/j.procir.2013.01.050
   Polatidis E, 2015, SCRIPTA MATER, V100, P59, DOI 10.1016/j.scriptamat.2014.12.013
   Poncet P. P., 1994, APPL SUPERELASTIC NI
   Porter D. A., 1992, EASTERLING PHASE TRA
   Roberge P. R., 2000, HDB CORROSION ENG 20
   Sachdeva R. C. L., 2016, REFERENCE MODULE MAT, P1
   Sachdeva R. C. L., 2001, ENCY MAT SCI TECHNOL, P6155, DOI DOI 10.1016/B0-08-043152-6/01093-7
   Saigal A, 2011, MAT SCI ENG A-STRUCT, V528, P5536, DOI 10.1016/j.msea.2011.03.060
   Schirmer CM, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10318
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shabalovskaya S., 2009, SHAPE MEMORY ALLOYS, P194
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P468, DOI 10.1016/j.biomaterials.2008.10.014
   Shakoor RA, 2007, MAT SCI ENG A-STRUCT, V457, P169, DOI 10.1016/j.msea.2006.12.048
   Shakoor RA, 2011, MAT SCI ENG A-STRUCT, V528, P2299, DOI 10.1016/j.msea.2010.11.008
   Smrkolj T., 2015, CASE REPORTS UROLOGY, V2015
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
   Stoeckel D., 1995, P SHAP MEM ALL POW S, P1
   Sun L, 2012, MATER DESIGN, V33, P577, DOI 10.1016/j.matdes.2011.04.065
   Tathe A., 2010, INT J PHARM PHARM SC, V2, P19
   Venugopalan R, 2000, MINIM INVASIV THER, V9, P67, DOI 10.3109/13645700009063052
   Wadood A, 2015, J ALLOY COMPD, V646, P1172, DOI 10.1016/j.jallcom.2015.06.057
   Wadood A, 2014, J ALLOY COMPD, V595, P200, DOI 10.1016/j.jallcom.2014.01.050
   Wadood A, 2013, MAT SCI ENG A-STRUCT, V564, P34, DOI 10.1016/j.msea.2012.11.069
   Wadood A, 2013, MAT SCI ENG A-STRUCT, V559, P829, DOI 10.1016/j.msea.2012.09.030
   Wadood A, 2012, KEY ENG MATER, V510-511, P111, DOI [10.4028/www.scientific.net/KEM.510-511.111, 10.4028/www.scientific.net/KEM.510-511.11]
   Wadood A, 2012, MAT SCI ENG A-STRUCT, V555, P28, DOI 10.1016/j.msea.2012.06.029
   Wadood A, 2011, MAT SCI ENG A-STRUCT, V530, P504, DOI 10.1016/j.msea.2011.10.009
   Wadood A., 2012, THESIS
   Wadood A., 2012, ADV MAT RES, V409, P639
   Wadood A., 2013, P 13 INT S ADV MAT I, V60
   Wadood A., 2011, P 12 WORLD C TIT TI, V3, P2086
   Wadood A., 2008, THESIS
   Wadood A, 2014, PLATIN MET REV, V58, P61, DOI 10.1595/147106714X679241
   Wadood A, 2014, MAT SCI ENG A-STRUCT, V601, P106, DOI 10.1016/j.msea.2014.02.029
   Wadood A, 2013, J ALLOY COMPD, V577, pS427, DOI 10.1016/j.jallcom.2012.01.008
   Wadood A, 2013, MATER TRANS, V54, P566, DOI 10.2320/matertrans.MC201213
   Wadood A, 2011, MATER TRANS, V52, P1787, DOI 10.2320/matertrans.M2011153
   Wang XB, 2015, INTERMETALLICS, V62, P43, DOI 10.1016/j.intermet.2015.03.006
   Wen XJ, 1997, BIO-MED MATER ENG, V7, P1
   Yahia LH, 2008, WOODHEAD PUBL MATER, P306
   Yamabe-Mitarai Y, 2015, MATER TODAY-PROC, V2, P517, DOI 10.1016/j.matpr.2015.07.338
   Yamabe-Mitarai Yoko, 2014, Materials Science Forum, V783-786, P2541, DOI 10.4028/www.scientific.net/MSF.783-786.2541
   Yang Q, 2016, ACTA MATER, V111, P348, DOI 10.1016/j.actamat.2016.04.004
   Yeung KWK, 2007, SURF COAT TECH, V201, P5607, DOI 10.1016/j.surfcoat.2006.07.004
   Yin H, 2016, INT J FATIGUE, V88, P166, DOI 10.1016/j.ijfatigue.2016.03.023
   Yoneyama T, 2008, WOODHEAD PUBL MATER, P1
   Zamponi C, 2007, SCRIPTA MATER, V56, P1075, DOI 10.1016/j.scriptamat.2007.02.021
NR 98
TC 3
Z9 3
U1 1
U2 30
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-8434
EI 1687-8442
J9 ADV MATER SCI ENG
JI Adv. Mater. Sci. Eng.
PY 2016
AR 4173138
DI 10.1155/2016/4173138
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA EC8LU
UT WOS:000388393900001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Chen, JL
   Mei, ML
   Li, QL
   Chu, CH
AF Chen, Jialong
   Mei, May Lei
   Li, Quan-Li
   Chu, Chun-Hung
TI Mussel-inspired silver-nanoparticle coating on porous titanium surfaces
   to promote mineralization
SO RSC ADVANCES
LA English
DT Article
ID ANTIBACTERIAL PROPERTIES; TIO2 NANOTUBES; CYTOTOXICITY; SUBSTRATE;
   IMPLANTS; GROWTH; AG; ENHANCEMENT; FABRICATION; INFECTIONS
AB Biomaterials with high porosity for bone ingrowth facilitate the osseointegration of implants. However, this porosity structure is also favorable for bacterial colonization and biofilm formation, and hampers osseointegration on implant surfaces. The objective of the study was to establish a porous surface on titanium implants with antibacterial activity, enhanced mineralization and then good osteoblast-biocompatibility. A uniform, 3-dimensional, microporous structure was prepared by alkaline treatment on a titanium implant surface. Subsequently, the surface was coated with dopamine and silver nanoparticles using dopamine and silver nitrate solutions. The results of SEM, EDS, XPS, and water contact angle tests confirmed that the surface had been successfully coated with dopamine and silver nanoparticles with sizes of 30-50 nm. More mineralization happened on the surface with this coating than on the alkaline-treated surface after incubation with calcification solution for one week, which led to a rapid decrease of silver release. Antibacterial tests indicated that the coating inhibited bacterial colonization on them and growth around these samples, indicating that the coating eliminates the shortcoming of porous structure which renders the implant extremely susceptible to biomaterial-associated infection. Besides, this coating did not favor osteoblast attachment, proliferation and differentiation, however we found that the mineralized surface of this coating stimulated the proliferation of osteoblasts and enhanced the activity of alkaline phosphatase. Therefore, we conclude that the coating with dopamine and AgNPs can be effective against bacterial infections and facilitate mineralization during the early post-operative period and then can promote osseointegration due to the good osteoblast-biocompatibility of the mineralized surface.
C1 [Chen, Jialong; Mei, May Lei; Chu, Chun-Hung] Univ Hong Kong, Fac Dent, 34 Hosp Rd, Hong Kong, Hong Kong, Peoples R China.
   [Chen, Jialong; Li, Quan-Li] Anhui Med Univ, Coll & Hosp Stomatol, Key Lab Oral Dis Res Anhui Prov, Hefei, Peoples R China.
   [Chen, Jialong] Anhui Med Univ, Coll Pharm, Hefei, Peoples R China.
RP Chu, CH (reprint author), Univ Hong Kong, Fac Dent, 34 Hosp Rd, Hong Kong, Hong Kong, Peoples R China.; Li, QL (reprint author), Anhui Med Univ, Coll & Hosp Stomatol, Key Lab Oral Dis Res Anhui Prov, Hefei, Peoples R China.
EM ql-li@126.com; chchu@hku.hk
FU Natural Science Foundation of China [31300792, 31670967]; China
   Postdoctoral Science Foundation [2014M561813]; Natural Science
   Foundation of Anhui Province [1408085QH149]; Hong Kong Scholars Program
FX This work was supported by the Natural Science Foundation of China (no.
   31300792 and 31670967), China Postdoctoral Science Foundation (no.
   2014M561813), the Natural Science Foundation of Anhui Province (no.
   1408085QH149) and the Hong Kong Scholars Program.
CR Antad V, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2328-z
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1119
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Cao HL, 2011, BIOMATERIALS, V32, P693, DOI 10.1016/j.biomaterials.2010.09.066
   Chen JL, 2009, APPL SURF SCI, V255, P6894, DOI 10.1016/j.apsusc.2009.03.011
   Chen JL, 2015, J MATER CHEM B, V3, P2615, DOI 10.1039/c4tb01825g
   Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   Crawford GA, 2007, ACTA BIOMATER, V3, P359, DOI 10.1016/j.actbio.2006.08.004
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   dos Santos VE, 2014, J DENT, V42, P945, DOI 10.1016/j.jdent.2014.05.017
   Esfandiari N, 2014, J BIOMED MATER RES A, V102, P2625, DOI 10.1002/jbm.a.34934
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Fei JB, 2014, ACS NANO, V8, P8529, DOI 10.1021/nn504077c
   Fischer M, 2015, BIOMATERIALS, V56, P198, DOI 10.1016/j.biomaterials.2015.03.056
   Fullenkamp DE, 2012, BIOMATERIALS, V33, P3783, DOI 10.1016/j.biomaterials.2012.02.027
   Furuzono T, 2013, J ARTIF ORGANS, V16, P451, DOI 10.1007/s10047-013-0715-3
   GhavamiNejad A, 2015, ADV FUNCT MATER, V25, P2867, DOI 10.1002/adfm.201500389
   Guo ZJ, 2014, MATER LETT, V137, P464, DOI 10.1016/j.matlet.2014.09.081
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hu XF, 2010, BIOMATERIALS, V31, P8854, DOI 10.1016/j.biomaterials.2010.08.006
   Jia ZJ, 2016, BIOMATERIALS, V75, P203, DOI 10.1016/j.biomaterials.2015.10.035
   Li SK, 2013, NANOSCALE, V5, P12616, DOI 10.1039/c3nr03857b
   Lin KL, 2013, ACS APPL MATER INTER, V5, P8008, DOI 10.1021/am402089w
   Luo HY, 2015, RSC ADV, V5, P13470, DOI 10.1039/c4ra16469e
   Lv M, 2010, ADV MATER, V22, P5463, DOI 10.1002/adma.201001934
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Mohammad AM, 2008, COLLOID SURFACE A, V318, P78, DOI 10.1016/j.colsurfa.2007.12.013
   Necula BS, 2012, ACTA BIOMATER, V8, P4191, DOI 10.1016/j.actbio.2012.07.005
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Paquette David W, 2006, Dent Clin North Am, V50, P361, DOI 10.1016/j.cden.2006.05.002
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Rosenblatt A, 2009, J DENT RES, V88, P116, DOI 10.1177/0022034508329406
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Sharma VK, 2014, ADV COLLOID INTERFAC, V204, P15, DOI 10.1016/j.cis.2013.12.002
   Shi ZQ, 2015, J MATER CHEM B, V3, P603, DOI 10.1039/c4tb01647e
   Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h
   Soumya S, 2012, J MATER CHEM, V22, P1904, DOI 10.1039/c1jm14038h
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0
   Wang JJ, 2015, MATER EXPRESS, V5, P191, DOI 10.1166/mex.2015.1231
   Wang YG, 2012, J MATER CHEM, V22, P2575, DOI 10.1039/c1jm14090f
   Xia LG, 2013, J MATER CHEM B, V1, P5403, DOI 10.1039/c3tb20945h
   Xie CM, 2014, ACS APPL MATER INTER, V6, P8580, DOI 10.1021/am501428e
   Xu MC, 2016, NANOSCALE, V8, P13790, DOI 10.1039/c6nr01952h
   Zhang W, 2008, ACTA BIOMATER, V4, P2028, DOI 10.1016/j.actbio.2008.05.012
   Zhang XM, 2013, MAT SCI ENG C-MATER, V33, P2816, DOI 10.1016/j.msec.2013.03.010
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zheng YH, 2012, INT J NANOMED, V7, P875, DOI 10.2147/IJN.S28450
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
NR 51
TC 0
Z9 0
U1 6
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 106
BP 104025
EP 104035
DI 10.1039/c6ra20673e
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA EC4OI
UT WOS:000388111900021
DA 2018-10-20
ER

PT S
AU Jandhyala, S
   Walper, SA
   Cargill, AA
   Ozual, A
   Daniele, MA
AF Jandhyala, Sidhartha
   Walper, Scott A.
   Cargill, Allison A.
   Ozual, Abigail
   Daniele, Michael A.
BE Cullum, BM
   Kiehl, D
   McLamore, ES
TI Integration of biochemical sensors into wearable biomaterial platforms
SO SMART BIOMEDICAL AND PHYSIOLOGICAL SENSOR TECHNOLOGY XIII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Smart Biomedical and Physiological Sensor Technology XIII
CY APR 18-19, 2016
CL Baltimore, MD
SP SPIE
DE Biosensors; Wearable Electronics; Biomaterials; Nanocellulose; Glucose
   Sensor; Glucose Oxidase; Amperometric; Electrochemical
ID ELECTROCHEMICAL GLUCOSE BIOSENSORS; EPIDERMAL ELECTRONICS; ARRAYS;
   ENZYME
AB With rapidly inflating healthcare costs, a limited supply of physicians and an alarming surge in lifestyle diseases, radical changes must be made to improve preventative medicine and ensure a sustainable healthcare system. A compelling solution is to equip the population with wearable health monitors to continuously record representative and actionable physiological data. Herein, we present a preliminary design and evaluation of a biochemical sensor node enabled by a substrate comprised of a nanocellulose thin-film that conforms to the skin and carries a printed sensor element. The nanocellulose layer ensures conformal and biocompatible contact with the skin, while a printed layer provides a high surface-area electrode. While the recognition/transduction element can be exchanged for many different sensing motifs, we utilize the general structure of an electrochemical glucose sensor.
C1 [Jandhyala, Sidhartha; Daniele, Michael A.] North Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.
   [Jandhyala, Sidhartha; Daniele, Michael A.] Univ N Carolina, Raleigh, NC 27695 USA.
   [Walper, Scott A.] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.
   [Cargill, Allison A.] US Naval Res Lab, Naval Res Enterprise Internship Program, Washington, DC 20375 USA.
   [Ozual, Abigail] US Naval Res Lab, Naval Res Lab, HBCU MI Internship Program, Washington, DC 20375 USA.
   [Daniele, Michael A.] North Carolina State Univ, Dept Elect & Comp Engn, Raleigh, NC 27695 USA.
RP Daniele, MA (reprint author), North Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC 27695 USA.; Daniele, MA (reprint author), Univ N Carolina, Raleigh, NC 27695 USA.
EM mdaniel6@ncsu.edu
OI Walper, Scott/0000-0002-9436-3456
CR Bandodkar AJ, 2015, ANAL CHEM, V87, P394, DOI 10.1021/ac504300n
   Claussen JC, 2012, ADV FUNCT MATER, V22, P3399, DOI 10.1002/adfm.201200551
   Claussen JC, 2011, ACS APPL MATER INTER, V3, P1765, DOI 10.1021/am200299h
   Daniele MA, 2015, ADV MATER, V27, P1600, DOI 10.1002/adma.201404445
   Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521
   Gonzalez-Macia L, 2010, ANALYST, V135, P845, DOI 10.1039/b916888e
   Jiang DF, 2016, SENSOR ACTUAT B-CHEM, V228, P679, DOI 10.1016/j.snb.2016.01.076
   Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157
   Kim DY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3220064
   Kim J, 2015, SMALL, V11, P906, DOI 10.1002/smll.201402495
   Leitao AF, 2016, MACROMOL BIOSCI, V16, P139, DOI 10.1002/mabi.201500251
   McLamore ES, 2011, BIOSENS BIOELECTRON, V26, P2237, DOI 10.1016/j.bios.2010.09.041
   Paximada P, 2016, FOOD HYDROCOLLOID, V53, P225, DOI 10.1016/j.foodhyd.2014.12.003
   Penttila A, 2013, CELLULOSE, V20, P1413, DOI 10.1007/s10570-013-9883-9
   Roda A, 2014, ANALYST, V139, P6494, DOI 10.1039/c4an01612b
   Rose DP, 2015, IEEE T BIO-MED ENG, V62, P1457, DOI 10.1109/TBME.2014.2369991
   Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571
   Tamahkar E, 2015, PROCESS BIOCHEM, V50, P2289, DOI 10.1016/j.procbio.2015.09.026
   Tammela P, 2015, RSC ADV, V5, P16405, DOI 10.1039/c4ra15894f
   Ul-Islam M, 2015, BIOTECHNOL J, V10, P1847, DOI 10.1002/biot.201500106
   Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a
   Wang ZH, 2014, NANOSCALE, V6, P13068, DOI 10.1039/c4nr04642k
   WILSON R, 1992, BIOSENS BIOELECTRON, V7, P165, DOI 10.1016/0956-5663(92)87013-F
   Yeo WH, 2013, ADV MATER, V25, P2773, DOI 10.1002/adma.201204426
NR 24
TC 0
Z9 0
U1 0
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-5106-0104-8
J9 PROC SPIE
PY 2016
VL 9863
AR UNSP 98630Q
DI 10.1117/12.2226039
PG 6
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BG2WU
UT WOS:000387732700019
DA 2018-10-20
ER

PT J
AU Tondera, C
   Hauser, S
   Kruger-Genge, A
   Jung, F
   Neffe, AT
   Lendlein, A
   Klopfleisch, R
   Steinbach, J
   Neuber, C
   Pietzsch, J
AF Tondera, Christoph
   Hauser, Sandra
   Krueger-Genge, Anne
   Jung, Friedrich
   Neffe, Axel T.
   Lendlein, Andreas
   Klopfleisch, Robert
   Steinbach, Joerg
   Neuber, Christie
   Pietzsch, Jens
TI Gelatin-based Hydrogel Degradation and Tissue Interaction in vivo:
   Insights from Multimodal Preclinical Imaging in Immunocompetent Nude
   Mice
SO THERANOSTICS
LA English
DT Article
DE Autoradiography ex vivo; Biomaterials; Computed tomography; Magnetic
   resonance imaging; Optical imaging; Positron emission tomography
ID FOREIGN-BODY REACTION; NF-KAPPA-B; MOUSE SKIN; INFLAMMATION;
   BIOMATERIALS; ANGIOGENESIS; REGENERATION; COLLAGEN; PROTEIN; MATRIX
AB Hydrogels based on gelatin have evolved as promising multifunctional biomaterials. Gelatin is crosslinked with lysine diisocyanate ethyl ester (LDI) and the molar ratio of gelatin and LDI in the starting material mixture determines elastic properties of the resulting hydrogel. In order to investigate the clinical potential of these biopolymers, hydrogels with different ratios of gelatin and diisocyanate (3-fold (G 10_LNC03) and 8-fold (G10_LNC08) molar excess of isocyanate groups) were subcutaneously implanted in mice (uni- or bilateral implantation). Degradation and biomaterial-tissue-interaction were investigated in vivo (MRI, optical imaging, PET) and ex vivo (autoradiography, histology, serum analysis). Multimodal imaging revealed that the number of covalent net points correlates well with degradation time, which allows for targeted modification of hydrogels based on properties of the tissue to be replaced. Importantly, the degradation time was also dependent on the number of implants per animal. Despite local mechanisms of tissue remodeling no adverse tissue responses could be observed neither locally nor systemically. Finally, this preclinical investigation in immunocompetent mice clearly demonstrated a complete restoration of the original healthy tissue.
C1 [Tondera, Christoph; Hauser, Sandra; Neuber, Christie; Pietzsch, Jens] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Radiopharmaceut & Chem Biol, Dresden, Germany.
   [Tondera, Christoph; Steinbach, Joerg; Pietzsch, Jens] Tech Univ Dresden, Dept Chem & Food Chem, Dresden, Germany.
   [Krueger-Genge, Anne; Jung, Friedrich; Neffe, Axel T.; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Krueger-Genge, Anne; Jung, Friedrich; Neffe, Axel T.; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
   [Jung, Friedrich; Neffe, Axel T.; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Jung, Friedrich; Neffe, Axel T.; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
   [Klopfleisch, Robert] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany.
   [Steinbach, Joerg] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dresden, Germany.
RP Pietzsch, J (reprint author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dept Radiopharmaceut & Chem Biol, Dresden, Germany.; Pietzsch, J (reprint author), Tech Univ Dresden, Dept Chem & Food Chem, Dresden, Germany.
EM j.pietzsch@hzdr.de
RI Neffe, Axel/H-6997-2013; Steinbach, Joerg/B-5940-2015; Lendlein,
   Andreas/K-9553-2013; Pietzsch, Jens/O-5070-2017; Jung,
   Friedrich/L-1301-2013
OI Neffe, Axel/0000-0002-5056-3990; Steinbach, Joerg/0000-0002-1708-6440;
   Lendlein, Andreas/0000-0003-4126-4670; Pietzsch,
   Jens/0000-0002-1610-1493; Jung, Friedrich/0000-0001-8098-7180
FU Helmholtz Association; Europaische Sozialfonds (ESF); Helmholtz Postdoc
   Program [PD-064]
FX The excellent technical assistance of Aline Morgenegg, Catharina Heinig,
   Johanna Pufe, Mareike Barth, and Sebastian Meister (Dresden-Rossendorf)
   as well as of Jessica Reinert, Nicole Huttig, Tim P. Gebauer, Peter
   Viszokai, and Radovan Vukicevic (Teltow) is greatly acknowledged. We
   also thank Birgit Better, Ph.D., and Ralf Bergmann, Ph.D., for their
   expert advice and many fruitful discussions. The authors further wish to
   thank the staff of the Production of Radiopharmaceuticals Department at
   the Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum
   Dresden-Rossendorf for production of [<SUP>18</SUP>F]FDG. The authors
   thank the Helmholtz Association for funding of this work through
   Helmholtz-Portfolio Topic "Technologie and Medizin - Multimodale
   Bildgebung zur Aufklarung des In-vivo-Verhaltens von polymeren
   Biomaterialien". Sandra Hauser (nee Ullm) was recipient (2011-2014) of a
   fellowship by the Europaische Sozialfonds (ESF). Anne Kruger-Genge was
   recipient of a fellowship of the Helmholtz Postdoc Program 2012
   (PD-064). The authors also wish to thank Viktoria Bosak who assisted in
   the proof-reading of the final version of the manuscript.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040
   Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Endo K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3393
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Ghadially R, 2012, J INVEST DERMATOL, V132, P797, DOI 10.1038/jid.2011.434
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Haas TL, 2000, AM J PHYSIOL-HEART C, V279, pH1540
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Kniess T, 2012, BIOORGAN MED CHEM, V20, P3410, DOI 10.1016/j.bmc.2012.04.022
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kundu JK, 2006, BIOCHEM PHARMACOL, V72, P1506, DOI 10.1016/j.bcp.2006.08.005
   Kundu JK, 2006, CARCINOGENESIS, V27, P1465, DOI 10.1093/carcin/bgi349
   Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Neffe AT, 2015, ADV MATER, V27, P1738, DOI 10.1002/adma.201404787
   NEMETSCHEK T, 1979, J MOL BIOL, V133, P67, DOI 10.1016/0022-2836(79)90251-1
   NISHINAKA Y, 1993, BIOCHEM BIOPH RES CO, V193, P554, DOI 10.1006/bbrc.1993.1659
   Olde Damink L. H. H., 1995, J MATER SCI-MATER M, V6, P460, DOI [DOI 10.1007/BF00123371, 10.1007/BF00123371]
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   Roszer T., 2015, MEDIATORS INFLAMM
   Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x
   Sartori S, 2014, J MATER CHEM B, V2, P5128, DOI 10.1039/c4tb00525b
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661
   Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294
   Strobel K, 2008, J LIPID RES, V49, P473, DOI 10.1194/jlr.D700024-JLR200
   Su K, 2015, BIOTECHNOL LETT
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664
   Ullm S, 2014, BIOMATERIALS, V35, P9755, DOI 10.1016/j.biomaterials.2014.08.023
   van Putten SM, 2013, ACTA BIOMATER, V9, P6502, DOI 10.1016/j.actbio.2013.01.022
   van Waarde A, 2004, J NUCL MED, V45, P695
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   Wu CX, 2013, THERANOSTICS, V3, P448, DOI 10.7150/thno.6592
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zhang JH, 2013, CANCER RES, V73, P2770, DOI 10.1158/0008-5472.CAN-12-3022
NR 54
TC 15
Z9 15
U1 5
U2 13
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2016
VL 6
IS 12
BP 2114
EP 2128
DI 10.7150/thno.16614
PG 15
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ED0AR
UT WOS:000388505900008
PM 27698944
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Shazni, ZA
   Mariatti, M
   Nurazreena, A
   Razak, KA
AF Shazni, Z. A.
   Mariatti, M.
   Nurazreena, A.
   Razak, K. A.
BE Jaafar, M
   Razak, KA
   Ariff, ZM
   Zabidi, H
TI Properties of Calcium Phosphate Scaffolds Produced by Freeze-Casting
SO 5TH INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN MATERIALS, MINERALS
   AND ENVIRONMENT (RAMM) & 2ND INTERNATIONAL POSTGRADUATE CONFERENCE ON
   MATERIALS, MINERAL AND POLYMER (MAMIP)
SE Procedia Chemistry
LA English
DT Proceedings Paper
CT 5th International Conference on Recent Advances in Materials, Minerals
   and Environment (RAMM) / 2nd International Postgraduate Conference on
   Materials, Mineral and Polymer (MAMIP)
CY AUG 04-06, 2015
CL MALAYSIA
SP Univ Sains Malaysia, Sch Mat & Mineral Resources Engn
DE Scaffolds; Calcium Phosphate; Freeze-casting
ID PORE-SIZE
AB The pore structure of three-dimensional scaffolds applied in tissue engineering may influence the mechanical properties and cellular activity. As the optimal pore size is dependent on the specifics of the biomaterial or tissue engineering application, the ability to alter the pore size over a wide range is necessary for several scaffolds in order to meets the requirements of the applications. The aim of this study is to develop methodologies to produce calcium phosphate scaffolds with acceptable pore size and defined pore-channel interconnectivity. The pore size of calcium phosphate scaffolds is established during the freeze-drying fabrication process. In this process, material suspension is simply frozen and then dried by freeze-drier, which able to produce material with unique porous architectures, where the porosity is almost a direct replica of the frozen solvent crystals. There are two different method of freeze-casting carried out in order to study the effect of freezing temperature by which in the first method; sample being soaked with liquid nitrogen (-196 degrees C) for about 10 minutes before been place inside a freezer (-40 degrees C). In the second method, the sample was directly placed inside a freezer for casting at temperature of -40 degrees C. The results show that the pore size of the scaffolds decreased as the freezing temperature was reduced. Taken together, these results demonstrate that the methodologies applied in this study can be used to produce a range of calcium phosphate scaffolds exhibiting better compressive strength, approximately 665-875 KPa for 54-64.3% of porosity with mean pore size from 102-113 mu m. The methods developed in this study provide a basis for the investigation on the effects of different freezing temperature in freeze-casting process on the porosity, morphology, and compressive properties of the calcium phosphate scaffolds. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Shazni, Z. A.] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal, Penang, Malaysia.
RP Shazni, ZA (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal, Penang, Malaysia.
EM amyrashazni@yahoo.com
CR Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   haugh Matthew G., 2010, TISSUE ENG, P887
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   O'Brien F.J., 2007, TECHNOL HEALTH CARE, P15
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Porter B, 2005, J BIOMECH, V38, P543, DOI 10.1016/j.jbiomech.2004.04.011
   Qian L, 2011, J CHEM TECHNOL BIOT, V86, P172, DOI 10.1002/jctb.2495
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Yannas I., 2001, TISSUE ORGAN REGENER
NR 12
TC 3
Z9 3
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6196
J9 PROCEDIA CHEM
PY 2016
VL 19
BP 174
EP 180
DI 10.1016/j.proche.2016.03.090
PG 7
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Materials Science,
   Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BG2SU
UT WOS:000387668300025
OA Other Gold
DA 2018-10-20
ER

PT S
AU Htun, ZL
   Ahmad, N
   Thant, AA
   Noor, AFM
AF Htun, Zaw Linn
   Ahmad, Nurazreena
   Thant, Aye Aye
   Noor, Ahmad-Fauzi Mohd
BE Jaafar, M
   Razak, KA
   Ariff, ZM
   Zabidi, H
TI Characterization of CaO-ZrO2 Reinforced Hap Biocomposite for Strength
   and Toughness Improvement
SO 5TH INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN MATERIALS, MINERALS
   AND ENVIRONMENT (RAMM) & 2ND INTERNATIONAL POSTGRADUATE CONFERENCE ON
   MATERIALS, MINERAL AND POLYMER (MAMIP)
SE Procedia Chemistry
LA English
DT Proceedings Paper
CT 5th International Conference on Recent Advances in Materials, Minerals
   and Environment (RAMM) / 2nd International Postgraduate Conference on
   Materials, Mineral and Polymer (MAMIP)
CY AUG 04-06, 2015
CL MALAYSIA
SP Univ Sains Malaysia, Sch Mat & Mineral Resources Engn
DE Hydroxyapatite; biocomposite; strength and toughness
ID HYDROXYAPATITE-ZIRCONIA COMPOSITES; MECHANICAL-PROPERTIES; BIOMEDICAL
   APPLICATIONS; DENSIFICATION; CERAMICS; BEHAVIOR
AB Hydroxyapatite (HAp) has been used extensively in medical applications for repair or replacement of bone tissues in human body system. It is chemically similar to the mineral component of bone and teeth and will form an artificial bone-like structure with the surrounding bone tissue when implanted. However, sintered hydroxyapatite material exhibits relatively poor mechanical properties than natural bone and as such, improvement of mechanical properties are necessary. One of the candidate materials for the reinforcing phase to HAp is zirconia, ZrO2. Medical applications of ZrO2 implants confirmed their satisfactory biocompatibility, although it cannot bond well to bone tissue. In this study, ZrO2/ HApbiocomposites were fabricated with the objective to improve the strength and toughness of the biomaterial. Commercial CaO-ZrO2 (CZ) was selected as the reinforced material to the HAp matrix. Small amounts of CaF2 were added to improve sinterability and the phase stability of these biocomposites. Conventional ceramic processing route was used to prepare ZrO2/ HAp samples, which involved milling and mixing, compaction and sintering. X-ray diffraction (XRD), linear shrinkages, density and porosity, flexural strength, Vickers microhardness, toughness, and scanning electron microscopy (SEM) were used to characterize the (ZrO2/ HAp) biocomposites. XRD results indicate phase stability of biocomposites to a temperature of 1200 degrees C. Shrinkage of fired samples were very uniform with increasing temperature, with slightly lower shrinkage in thickness direction. In general, strength of the reinforced ZrO2/ HAp was successfully increased from 35.70 MPa to 52.88 MPa and the toughness was increased from 0.65 MPa.m(1/ 2) to 1.33 MPa. m(1/ 2) as well. (C) 2016 The Authors. Published Elsevier B.V.
C1 [Htun, Zaw Linn; Ahmad, Nurazreena; Noor, Ahmad-Fauzi Mohd] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Pulau Penang, Malaysia.
   [Htun, Zaw Linn; Thant, Aye Aye] Univ Yangon, Dept Phys, Kamayut 11041, Yangon, Myanmar.
RP Noor, AFM (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Engn Campus, Nibong Tebal 14300, Pulau Penang, Malaysia.
EM srafauzi@usm.my
CR Adolfsson E, 2006, KEY ENG MAT, V309-311, P1141, DOI 10.4028/www.scientific.net/KEM.309-311.1141
   Balani K, 2009, JOM-US, V61, P63, DOI 10.1007/s11837-009-0136-1
   Chiu CY, 2007, CERAM INT, V33, P715, DOI 10.1016/j.ceramint.2005.12.008
   Delgado JA, 1999, J MATER SCI-MATER M, V10, P715, DOI 10.1023/A:1008923121172
   HARDA F, 2008, THESIS
   HENCH L, 1993, INTRO BIOCERAMICS
   JARCHO M, 1977, J BIOENG, V1, P79
   Khalil KA, 2007, MAT SCI ENG A-STRUCT, V456, P368, DOI 10.1016/j.msea.2006.12.005
   Kim HW, 2002, BIOMATERIALS, V23, P4113, DOI 10.1016/S0142-9612(02)00150-3
   Kong YM, 1999, J AM CERAM SOC, V82, P2963
   LI J, 1993, J MATER SCI-MATER M, V4, P50, DOI 10.1007/BF00122977
   Li J, 1996, BIOMATERIALS, V17, P1787, DOI 10.1016/0142-9612(95)00356-8
   Matsuno T, 1998, J MATER SCI LETT, V17, P1349, DOI 10.1023/A:1026487222287
   Nayak A. K., 2010, INT J CHEMTECH RES, V2, P903
   RAMACHANDRA RR, 2002, MAT SCI ENG C, V20, P187
   Rapacz-Kmita A, 2006, J EUR CERAM SOC, V26, P1481, DOI 10.1016/j.jeurceramsoc.2005.01.059
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   TAKAGI M, 1992, J MATER SCI-MATER M, V3, P199, DOI 10.1007/BF00713450
   Vasconcelos C, 2012, SINTER CERAM NEW EME, V2, P179
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   Zhang JX, 2006, J AM CERAM SOC, V89, P3348, DOI 10.1111/j.1551-2916.2006.01237.x
NR 21
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6196
J9 PROCEDIA CHEM
PY 2016
VL 19
BP 510
EP 516
DI 10.1016/j.proche.2016.03.046
PG 7
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Materials Science,
   Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BG2SU
UT WOS:000387668300074
OA Other Gold
DA 2018-10-20
ER

PT J
AU Morouco, P
   Biscaia, S
   Viana, T
   Franco, M
   Malca, C
   Mateus, A
   Moura, C
   Ferreira, FC
   Mitchell, G
   Alves, NM
AF Morouco, Pedro
   Biscaia, Sara
   Viana, Tania
   Franco, Margarida
   Malca, Candida
   Mateus, Artur
   Moura, Carla
   Ferreira, Frederico C.
   Mitchell, Geoffrey
   Alves, Nuno M.
TI Fabrication of Poly(epsilon-caprolactone) Scaffolds Reinforced with
   Cellulose Nanofibers, with and without the Addition of Hydroxyapatite
   Nanoparticles
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID BONE TISSUE REGENERATION; MECHANICAL-PROPERTIES; POROUS SCAFFOLDS;
   NANOCOMPOSITES; COMPOSITE; MORPHOLOGY; FIBER; MATS; SIZE
AB Biomaterial properties and controlled architecture of scaffolds are essential features to provide an adequate biological and mechanical support for tissue regeneration, mimicking the ingrowth tissues. In this study, a bioextrusion system was used to produce 3D biodegradable scaffolds with controlled architecture, comprising three types of constructs: (i) poly(epsilon-caprolactone) (PCL) matrix as reference; (ii) PCL-based matrix reinforced with cellulose nanofibers (CNF); and (iii) PCL-basedmatrix reinforced with CNF and hydroxyapatite nanoparticles (HANP). The effect of the addition and/or combination of CNF and HANP into the polymeric matrix of PCL was investigated, with the effects of the biomaterial composition on the constructs (morphological, thermal, and mechanical performances) being analysed. Scaffolds were produced using a single lay-down pattern of 0/90 degrees, with the same processing parameters among all constructs being assured. The performed morphological analyses showed a satisfactory distribution of CNF within the polymer matrix and high reliability was obtained among the produced scaffolds. Significant effects on surface wettability and thermal properties were observed, among scaffolds. Regarding the mechanical properties, higher scaffold stiffness in the reinforced scaffolds was obtained. Results from the cytotoxicity assay suggest that all the composite scaffolds presented good biocompatibility. The results of this first study on cellulose and hydroxyapatite reinforced constructs with controlled architecture clearly demonstrate the potential of these 3D composite constructs for cell cultivation with enhanced mechanical properties.
C1 [Morouco, Pedro; Biscaia, Sara; Viana, Tania; Franco, Margarida; Malca, Candida; Mateus, Artur; Moura, Carla; Mitchell, Geoffrey; Alves, Nuno M.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, P-2430028 Marinha Grande, Portugal.
   [Malca, Candida] Polytech Inst Coimbra, Coimbra Inst Engn, P-3030199 Coimbra, Portugal.
   [Moura, Carla; Ferreira, Frederico C.] Univ Lisbon, Inst Super Tecn, Inst Bioengn & Biosci, P-1049001 Lisbon, Portugal.
   [Moura, Carla; Ferreira, Frederico C.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1049001 Lisbon, Portugal.
RP Morouco, P (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, P-2430028 Marinha Grande, Portugal.
EM pedro.morouco@ipleiria.pt
RI Ferreira, Frederico/K-8642-2012
OI Ferreira, Frederico/0000-0001-5177-6237; Mateus,
   Artur/0000-0003-2483-9153; Biscaia, Sara/0000-0002-2609-6878; Morouco,
   Pedro/0000-0002-5956-9790; Franco, Margarida/0000-0001-9659-7646
FU iBB H3D Grant [iBB/2015/18]; Portuguese Foundation for Science and
   Technology [SFRH/BD/73970/2010]; PORL [LISBOA-01-0145-FEDER-007317]; POR
   [007317]; ERDF Portugal;  [UID/Multi/04044/2013];  [BioMaTE:
   PTDC/EMS-SIS/7032/2014];  [UID/BIO/04565/2013]
FX The research is funded by the Projects References (UID/Multi/04044/2013,
   BioMaTE: PTDC/EMS-SIS/7032/2014, UID/BIO/04565/2013), iBB H3D Grant
   (iBB/2015/18), and SFRH/BD/73970/2010 from the Portuguese Foundation for
   Science and Technology, as well as PORL (LISBOA-01-0145-FEDER-007317)
   and POR (no. Proj. N. 007317), funded by ERDF Portugal 2020.
CR Bak T.-Y., 2014, J NANOMATER, V2014
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Canadas RF, 2014, INT J BIOL MACROMOL, V71, P131, DOI 10.1016/j.ijbiomac.2014.05.008
   Chen BQ, 2005, POLYM TEST, V24, P64, DOI 10.1016/j.polymertesting.2004.07.010
   Choi WY, 2013, J POROUS MAT, V20, P701, DOI 10.1007/s10934-012-9644-4
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Fukuya MN, 2014, POLYMER, V55, P4401, DOI 10.1016/j.polymer.2014.06.004
   Goffin AL, 2011, POLYMER, V52, P1532, DOI 10.1016/j.polymer.2011.02.004
   Guang-Mei C., 2010, ASIAN J CHEM, V22, P5902
   Guarino V, 2008, J BIOMED MATER RES B, V86B, P548, DOI 10.1002/jbm.b.31055
   Hao JY, 2002, J APPL POLYM SCI, V86, P676, DOI 10.1002/app.10955
   Kamal H, 2014, J RADIAT RES APPL SI, V7, P146, DOI 10.1016/j.jrras.2014.01.003
   Kolarova K, 2013, CELLULOSE, V20, P953, DOI 10.1007/s10570-013-9863-0
   Lee SH, 2011, COMPOS PART A-APPL S, V42, P151, DOI 10.1016/j.compositesa.2010.10.014
   Leszczak V, 2014, J FUNCT BIOMATER, V5, P58, DOI 10.3390/jfb5020058
   Mi HY, 2014, CELLULOSE, V21, P2727, DOI 10.1007/s10570-014-0327-y
   Milovac D, 2014, MAT SCI ENG C-MATER, V34, P437, DOI 10.1016/j.msec.2013.09.036
   Mota C, 2011, MATERIALS, V4, P527, DOI 10.3390/ma4030527
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nasri-Nasrabadi B, 2014, FIBER POLYM, V15, P347, DOI 10.1007/s12221-014-0347-0
   Nicoll SB, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P343, DOI 10.1007/978-3-7091-0385-2_12
   Novotna K, 2013, CELLULOSE, V20, P2263, DOI 10.1007/s10570-013-0006-4
   Olsson C., 2013, CELLULOSE FUNDAMENTA, V6
   Poletto M., 2013, CELLULOSE FUNDAMENTA, V2, P45
   Pooyan P, 2012, J MECH BEHAV BIOMED, V7, P50, DOI 10.1016/j.jmbbm.2011.09.009
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Renghini C, 2009, ACTA BIOMATER, V5, P1328, DOI 10.1016/j.actbio.2008.10.017
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Salerno A, 2012, J BIOACT COMPAT POL, V27, P210, DOI 10.1177/0883911512442564
   Sen S, 2013, ACS SUSTAIN CHEM ENG, V1, P858, DOI 10.1021/sc400085a
   Sheng LB, 2014, J MACROMOL SCI B, V53, P820, DOI 10.1080/00222348.2013.861311
   Tang D, 2016, BIOMATERIALS, V83, P363, DOI 10.1016/j.biomaterials.2016.01.024
   Thadavirul N, 2014, J BIOMAT SCI-POLYM E, V25, P1986, DOI 10.1080/09205063.2014.966800
   Van De Vyver S, 2011, CHEMCATCHEM, V3, P82, DOI 10.1002/cctc.201000302
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xiao XF, 2009, J MATER SCI-MATER M, V20, P2375, DOI 10.1007/s10856-009-3810-5
   Xiong RY, 2012, CARBOHYD POLYM, V90, P575, DOI 10.1016/j.carbpol.2012.05.080
   Zhou C., 2012, NANOCRYSTALS SYNTHES, V6, P103
   Zhou CJ, 2011, BIOMACROMOLECULES, V12, P2617, DOI 10.1021/bm200401p
NR 41
TC 2
Z9 2
U1 0
U2 4
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 1596157
DI 10.1155/2016/1596157
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA EB9DJ
UT WOS:000387692200001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT B
AU Fan, X
   Chen, WL
   Chen, ZS
AF Fan, Xin
   Chen, Wei-liang
   Chen, Zhong-sheng
GP DEStech Publications, Inc
TI Preparation of PLLA/ PLGA Composite by Melt-blending and Its Mechanical
   Property
SO INTERNATIONAL CONFERENCE ON MATERIAL SCIENCE AND CIVIL ENGINEERING, MSCE
   2016
LA English
DT Proceedings Paper
CT International Conference on Material Science and Civil Engineering
   (MSCE)
CY AUG 05-07, 2016
CL Guilin, PEOPLES R CHINA
DE PLLA; PLGA; Preparation; Melt-blending; Mechanical Property
ID POLY(L-LACTIC ACID); MISCIBILITY; COPOLYMERS; MORPHOLOGY; MEMBRANES
AB Poly(L-lactide)/poly(lactide-co-glycolide) (PLLA/PLGA) composite using PLLA and PLGA as the starting materials was successfully prepared via melt-blending method. Fourier Transform Infrared (FTIR) spectroscopy was used to characterize the structure of PLLA and PLGA in composite. The mechanical properties of composites were carried out by the tensile test, and the micrographs of cross-section of composites were observed using SEM. The results indicate that a few interactions formed between PLLA and PLGA in composite after melt-blending, and both the tensile strength and tensile modulus of composites decreased and the toughness became better with increasing PLGA content. The PLLA/PLGA composite with adjustable mechanical properties by changing the PLGA content would be an ideal and promising biomaterial for tissue regeneration.
C1 [Fan, Xin; Chen, Wei-liang; Chen, Zhong-sheng] East China Inst Technol, State Key Lab Breeding Base Nucl Resources & Envi, Nanchang 330013, Jiangxi, Peoples R China.
RP Chen, ZS (reprint author), East China Inst Technol, State Key Lab Breeding Base Nucl Resources & Envi, Nanchang 330013, Jiangxi, Peoples R China.
EM zhshcheng@ecit.cn
CR Bergsma JE, 1996, J MATER SCI-MATER M, V7, P1, DOI 10.1007/BF00121181
   Fambri L, 1997, POLYMER, V38, P79, DOI 10.1016/S0032-3861(96)00486-7
   Li YJ, 2009, EUR POLYM J, V45, P738, DOI 10.1016/j.eurpolymj.2008.12.010
   Meaurio E, 2005, MACROMOLECULES, V38, P1207, DOI 10.1021/ma047818f
   Song WT, 2016, NANOMED-NANOTECHNOL, V12, P377, DOI 10.1016/j.nano.2015.10.022
   Tsuji H, 2007, POLYM INT, V56, P258, DOI 10.1002/pi.2150
   Wan Y, 2006, BIOMACROMOLECULES, V7, P1362, DOI 10.1021/bm0600825
   Wang YB, 2001, J POLYM SCI POL CHEM, V39, P2755, DOI 10.1002/pola.1254
   Xin F, 2009, POLYM-PLAST TECHNOL, V48, P658, DOI 10.1080/03602550902824523
   Zeng JB, 2009, J MACROMOL SCI B, V48, P635, DOI 10.1080/00222340902841230
   Zhang ES, 2016, MAT SCI ENG C-MATER, V58, P278, DOI 10.1016/j.msec.2015.08.032
   Zhang LL, 1998, POLYMER, V39, P4841, DOI 10.1016/S0032-3861(97)10167-7
   Zhang XW, 2010, ACTA BIOMATER, V6, P123, DOI 10.1016/j.actbio.2009.06.007
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 14
TC 0
Z9 0
U1 2
U2 3
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-378-6
PY 2016
BP 250
EP 256
PG 7
WC Engineering, Civil; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BG3HW
UT WOS:000387946600035
DA 2018-10-20
ER

PT J
AU Nguyen, TKL
   Nguyen, TL
   Cao, XT
   Park, C
   Lim, KT
AF Thi Kim Lien Nguyen
   Thanh Luan Nguyen
   Xuan Thang Cao
   Park, Chan
   Lim, Kwon Taek
TI Preparation and characterization of poly(oligo(ethylene glycol)
   methacrylate)-grafted-layered double hydroxides by RAFT polymerization
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article
DE LDHs; Poly(oligo(ethylene glycol)methacrylate; Gentamicin; Antibacterial
ID TRANSFER RADICAL POLYMERIZATION; SURFACE; NANOCOMPOSITES; ADHESION;
   HYBRIDS; AGENTS
AB The composite material based on poly(oligo(ethylene glycol) methacrylate)-grafted-layered double hydroxides/Gentamicin (LDHs-g-POEGMA-GE) was prepared by the reversible addition fragmentation chain transfer polymerization, and its antibacterial property was investigated. Initially, the surface of LDHs was modified by S-(3-trimethoxysilyl) propyl trithiocarbonate as a chain transfer agent and then grafted with POEGMA. Subsequently, GE was covalently linked to the POEGMA chains by esterification reaction producing LDHs-g-POEGMA-GE. The composites were characterized by using FT-IR, GPC, XRD, TGA, and SEM analyses. The in-vitro assay with Staphylococcus aureus bacteria indicated the high antibacterial activity of the composites, which promises potential applications in the biomaterial field.
C1 [Thi Kim Lien Nguyen; Xuan Thang Cao; Lim, Kwon Taek] Pukyong Natl Univ, Dept Display Engn, Busan, South Korea.
   [Thanh Luan Nguyen] Pukyong Natl Univ, Dept Aquat Life Med, Coll Fisheries Sci, Busan, South Korea.
   [Park, Chan] Pukyong Natl Univ, Dept Mat Engn, Busan, South Korea.
RP Lim, KT (reprint author), Pukyong Natl Univ, Dept Display Sci & Engn, Busan 608737, South Korea.
EM ktlim@pknu.ac.kr
CR Bach LG, 2014, J ALLOY COMPD, V582, P22, DOI 10.1016/j.jallcom.2013.07.186
   Cao XT, 2015, MOL CRYST LIQ CRYST, V622, P36, DOI 10.1080/15421406.2015.1096988
   Ding P, 2007, J MATER CHEM, V17, P1117, DOI 10.1039/b615334h
   Eili M, 2015, J IND ENG CHEM, V22, P63, DOI 10.1016/j.jiec.2014.06.025
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Hu FX, 2006, BIOMACROMOLECULES, V7, P809, DOI 10.1021/bm050870e
   Hu H, 2012, J MATER CHEM, V22, P15362, DOI 10.1039/c2jm32720a
   Kuwahara Y, 2012, CATAL SCI TECHNOL, V2, P1842, DOI 10.1039/c2cy20113e
   Linares CF, 2014, B MATER SCI, V37, P941, DOI 10.1007/s12034-014-0029-y
   Wang Q, 2012, CHEM REV, V112, P4124, DOI 10.1021/cr200434v
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   Xu FJ, 2004, BIOMACROMOLECULES, V5, P2392, DOI 10.1021/bm049675a
   Cao XT, 2014, MOL CRYST LIQ CRYST, V599, P55, DOI 10.1080/15421406.2014.935921
   Zhang F, 2007, IND ENG CHEM RES, V46, P9077, DOI 10.1021/ie070795j
   Zhao Y, 2007, MACROMOLECULES, V40, P9116, DOI 10.1021/ma0716783
NR 15
TC 2
Z9 2
U1 1
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1542-1406
EI 1563-5287
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2016
VL 635
IS 1
SI SI
BP 120
EP 126
DI 10.1080/15421406.2016.1200378
PG 7
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA EB8TO
UT WOS:000387664200018
DA 2018-10-20
ER

PT S
AU Benzoni, P
   Ginestra, P
   Altomare, L
   Fiorentino, A
   De Nardo, L
   Ceretti, E
   Dell'Era, P
AF Benzoni, Patrizia
   Ginestra, Paola
   Altomare, Lina
   Fiorentino, Antonio
   De Nardo, Luigi
   Ceretti, Elisabetta
   Dell'Era, Patrizia
BE Bartolo, P
TI Biomanufacturing of a chitosan/collagen scaffold to drive adhesion and
   alignment of human cardiomyocyte derived from stem cells
SO SECOND CIRP CONFERENCE ON BIOMANUFACTURING
SE Procedia CIRP
LA English
DT Proceedings Paper
CT 2nd CIRP Conference on Biomanufacturing (CIRP-BioM)
CY JUL 29-31, 2015
CL Manchester, ENGLAND
SP CIRP
DE Cardiomyocytes; Laser micro-machining; Electrophoretic deposition;
   Biomaterial
ID ELASTOMERIC SCAFFOLDS; TISSUE; CHITOSAN
AB The in vitro generation of a three-dimensional (3D) myocardial tissue employing cells, biomaterials, and biomolecules is a promising strategy in cardiac tissue regeneration. Despite significant progresses in this field, cellular models are not yet able to provide a source of myocardial cells that will efficiently integrate and substitute damaged myocardial tissue. Stem cell-derived human cardiomyocytes (CMs) represent the most promising source for cardiac cell therapy. In order to sustain attachment, spreading, and orientation of human CMs on a scaffold we exploited an innovative negative replica patterning based on electrophoretic deposition to realize multi-scale micro-structured chitosan-collagen (C/C) scaffolds. Specific patterns were micro-structured on the cathode titanium disks using a laser machine. Cubic and hexagonal patterns were deeply characterized, and reproduced on the surface of the C/C scaffold. We initially challenged different blend with spontaneous contracting neonatal rat CMs to identificate the best substratum, finding that C/C 5:1 proportion can better sustain this type of culture. Finally, human CMs derived from induced pluripotent stem cells were seeded on these patterned scaffolds and colonization of the substrate was observed, thus confirming the validity of the chosen biomaterial. Moreover, preliminary experiments demonstrate the effectiveness of the pattern in controlling the orientation of human CMs.
   In conclusion, we designed and fabricated a scaffold that allows the attachment, spreading, and orientation of human CMs due to a correct C/C blend composition, to an innovative manufacturing process, and to an effective 3D architecture of the patterns. These data will surely help in solving the quest for a cardiac clinical patch. (C) 2015 The Authors. Published by Elsevier B.V.
C1 [Benzoni, Patrizia; Dell'Era, Patrizia] Univ Brescia, Dept Mol & Translat Med, Hlth & Wealth, Viale Europa 11, I-25123 Brescia, Italy.
   [Ginestra, Paola; Fiorentino, Antonio; Ceretti, Elisabetta] Univ Brescia, Dept Mech & Ind Engn, Hlth & Wealth, Via Branze 38, I-25123 Brescia, Italy.
   [Altomare, Lina; De Nardo, Luigi] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Via Mancinelli 7, I-20131 Milan, Italy.
RP Benzoni, P (reprint author), Univ Brescia, Dept Mol & Translat Med, Hlth & Wealth, Viale Europa 11, I-25123 Brescia, Italy.
EM p.benzoni@unibs.it
RI Ginestra, Paola/I-4179-2017
OI Ginestra, Paola/0000-0002-3858-7789; Benzoni,
   Patrizia/0000-0002-3371-3301; ALTOMARE, LINA/0000-0001-9555-1291
CR Altomare Lina, 2014, Biomatter, V4, DOI 10.4161/biom.29506
   [Anonymous], 1994, ESSENTIAL PHYS MED I
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Giorleo L., 2014, 9 CIRP C INT COMP MA
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kolewe ME, 2013, ADV MATER, V25, P4459, DOI 10.1002/adma.201301016
   Novakovic GV, 2014, COLD SPRING HARB PER, V4
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Salick MR, 2014, BIOMATERIALS, V35, P4454, DOI 10.1016/j.biomaterials.2014.02.001
   Tang G, 2013, INT J ADV MANUF TECH, V66, P1769, DOI 10.1007/s00170-012-4456-x
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558
   Zhang T, 2012, J TISSUE ENG REGEN M, V6, P748, DOI 10.1002/term.481
   Zheng B, 2015, MICROMACHINES, V6, P19
NR 18
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8271
J9 PROC CIRP
PY 2016
VL 49
BP 113
EP 120
DI 10.1016/j.procir.2015.09.004
PG 8
WC Engineering, Biomedical; Engineering, Manufacturing
SC Engineering
GA BG2SS
UT WOS:000387663500021
OA Other Gold
DA 2018-10-20
ER

PT B
AU Smetana, M
   Chudacik, V
   Konar, R
   Mician, M
AF Smetana, Milan
   Chudacik, Vladimir
   Konar, Radoslav
   Mician, Milos
BE Brida, P
   Dubovan, J
   Markovic, M
TI Real Biomaterial Cracks Evaluation by Eddy Current and Ultrasonic
   Inspection
SO 2016 ELEKTRO 11TH INTERNATIONAL CONFERENCE
LA English
DT Proceedings Paper
CT ELEKTRO 11th International Conference
CY MAY 16-18, 2016
CL SLOVAKIA
SP IEEE Reg 8, IEEE Czechoslovakia Sect, IAS/IES Joint Chapter Czechoslovakia Sect IEEE, Univ Zilina, Fac Elect Engn, Pow en, a s, VUJE a s, IBM Slovensko s r o, ASBIS SK, s r o, Orange Slovensko, a s, Eltek, s r o, KVANT, s r o, Panasonic Industrial Devices Slovakia, s r o, Marpex, s r o, NXP Semiconductors Czech Republic s r o, Teplaren, a s, HUMUSOFT, s r o
DE non-destructive evaluation; eddy current array; time of flight
   diffraction; fatigue and stress-corrosion cracking
AB The article deals with non-destructive evaluation of conductive austenitic stainless steel by eddy current and ultrasonic testing. ECA (Eddy Current Array) and TOFD (Time of Flight Diffraction) methods are used for this purpose. Real fatigue and stress-corrosion cracks are under inspection. Experimental results are presented and discussed in the paper.
C1 [Smetana, Milan; Chudacik, Vladimir] Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina, Slovakia.
   [Konar, Radoslav; Mician, Milos] Univ Zilina, Fac Mech Engn, Dept Technol Engn, Zilina, Slovakia.
RP Smetana, M (reprint author), Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina, Slovakia.
EM milan.smetana@fel.uniza.sk; vladimir.chudacik@fel.uniza.sk;
   radoslav.konar@fel.uniza.sk; milos.mician@fel.uniza.sk
CR Dopjera D., 2014, MANUFACTURING TECHNO, V14, P281
   Gruger H., 2011, ARRAY MINIATURIZED F
   Janousek L., 2011, P ISEM 2011 15 INT S
   Karban P, 2013, COMPUTING, V95, pS381, DOI 10.1007/s00607-013-0294-4
   Karban P, 2011, COMPEL, V30, P1517, DOI 10.1108/03321641111152676
   Li Y, 2008, NDT&E INT, V41, P477, DOI 10.1016/j.ndteint.2008.02.001
   Patek M., 2014, MANUFACTURING TECHNO, V14, P403
   Vrzgula P., 2014, MANUFACTURING TECHNO, V14, P487
NR 8
TC 0
Z9 0
U1 0
U2 1
PU UNIV ZILINA, FAC ELECTRICAL ENGINEERING
PI ZILINA
PA UNIVERZITNA 1, ZILINA, SK 01026, SLOVAKIA
BN 978-1-4673-8698-2
PY 2016
BP 578
EP 582
PG 5
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic
SC Computer Science; Engineering
GA BG1PR
UT WOS:000386959800117
DA 2018-10-20
ER

PT J
AU Nadlacki, B
   Suuronen, EJ
AF Nadlacki, Bora
   Suuronen, Erik J.
TI Biomaterial strategies to improve the efficacy of bone marrow cell
   therapy for myocardial infarction
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE Biomaterials; bone marrow cells; cell homing; cell therapy; engraftment;
   myocardial infarction
ID ENDOTHELIAL PROGENITOR CELLS; ISCHEMIC-HEART-DISEASE; CIRCULATING
   ANGIOGENIC CELLS; SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS;
   PRESERVES VENTRICULAR-FUNCTION; MONONUCLEAR-CELLS; PERIPHERAL-BLOOD;
   CARDIAC REPAIR; EXTRACELLULAR-MATRIX
AB Introduction: The feasibility and safety of bone marrow cell (BMC) therapy for cardiac repair following myocardial infarction has been demonstrated in clinical studies, albeit with relatively modest structural and functional benefits. In response to the shortcomings of BMC therapy, the use of biomaterials to enhance cell transplantation is being investigated.
   Areas covered: The authors first review what has been learned from BMC therapies for the treatment of myocardial infarction in animal models and in clinical trials. Some issues that may be limiting the efficacy of BMC therapy are then described. Lastly, they summarize several biomaterial approaches that have been reported to improve transplanted cell retention and functional outcome, and then focus on how a material can enhance cell function such as proliferation, viability, endothelial differentiation and angiogenic potential.
   Expert opinion: Improvements are needed if BMC therapy is to become a viable treatment in the clinic. There is optimism that a biomaterial strategy will lead to superior results compared to the cell therapy alone. Through the identification of underlying cell-biomaterial mechanisms, the establishment of comparative standards, and an awareness of the lessons learned from cell therapy trials, biomaterial-enhanced BMC therapy may become an option for the treatment of heart disease patients.
C1 [Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
   Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.
RP Suuronen, EJ (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM esuuronen@ottawaheart.ca
FU Natural Sciences and Engineering Research Council of Canada [342107];
   Ontario Research Excellence Fund (SCORR) [RE07-086]; Ontario Graduate
   Scholarship Award
FX This work was funded by the Natural Sciences and Engineering Research
   Council of Canada (Discovery Grant #342107) and by the Ontario Research
   Excellence Fund (SCORR #RE07-086). B Nadlacki was supported by an
   Ontario Graduate Scholarship Award.
CR Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792
   Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028
   Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9
   Ali-Hasan-Al-Saegh Sadeq, 2015, Asian Cardiovasc Thorac Ann, V23, P363, DOI 10.1177/0218492314553251
   Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4
   Andukuri A, 2013, TISSUE ENG PART C-ME, V19, P375, DOI [10.1089/ten.tec.2012.0312, 10.1089/ten.TEC.2012.0312]
   Antonio N, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-101
   Assmus B, 2014, EUR HEART J, V35, P1275, DOI 10.1093/eurheartj/ehu062
   Atluri P, 2014, J THORAC CARDIOV SUR, V148, P1090, DOI 10.1016/j.jtcvs.2014.06.038
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   Blackburn NJR, 2015, BIOMATERIALS, V39, P182, DOI 10.1016/j.biomaterials.2014.11.004
   Boudoulas KD, 2009, DIS MODEL MECH, V2, P344, DOI 10.1242/dmm.000240
   Brown A, 2011, ACTA BIOMATER, V72, P181
   Carenza E, 2014, NANOMED-NANOTECHNOL, V10, P225, DOI 10.1016/j.nano.2013.06.005
   Ceccaldi C, 2014, ACTA BIOMATER, V10, P901, DOI 10.1016/j.actbio.2013.10.027
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chachques JC, 2007, CELL TRANSPLANT, V16, P927, DOI 10.3727/096368907783338217
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Chang CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153412
   Chen CH, 2014, AM J PHYSIOL-HEART C, V306, pH1078, DOI 10.1152/ajpheart.00801.2013
   Chen CH, 2013, MOL THER, V21, P670, DOI 10.1038/mt.2012.268
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Chen HQ, 2015, APPL SURF SCI, V347, P169, DOI 10.1016/j.apsusc.2015.02.032
   Chen X, 2015, COLLOID SURFACE B, V128, P106, DOI 10.1016/j.colsurfb.2015.02.023
   Chen YL, 2015, INT J CARDIOL, V201, P668, DOI 10.1016/j.ijcard.2015.03.137
   Cheng C, 2016, EUR REV MED PHARMACO, V20, P115
   Cheng Y, 2013, ANN CLIN LAB SCI, V43, P395
   Chi NH, 2012, BIOMATERIALS, V33, P5541, DOI 10.1016/j.biomaterials.2012.04.030
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Dai W, 2010, CARDIOVASC MED, V4, P387
   Daldrup-Link HE, 2004, EUR J NUCL MED MOL I, V31, P1312, DOI 10.1007/s00259-004-1484-2
   Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372
   Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504
   Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943
   Doroudian G, 2014, BIOMED MICRODEVICES, V16, P705, DOI 10.1007/s10544-014-9875-z
   Eleuteri E, 2013, BIOMARKERS, V18, P418, DOI 10.3109/1354750X.2013.805342
   Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386
   Farouz Y, 2015, BIOMATERIALS CARDIAC
   Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019
   Felice F, 2013, EUR J PHARM SCI, V50, P393, DOI 10.1016/j.ejps.2013.08.008
   Fisher SA, 2015, COCHRANE DB SYST REV, V9
   Fortunato O, 2013, CARDIOVASC RES, V100, P192, DOI 10.1093/cvr/cvt153
   Frederick J, 2010, CIRCULATION, V141, P520
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Gaffey AC, 2015, J THORAC CARDIOV SUR, V150, P1268, DOI 10.1016/j.jtcvs.2015.07.035
   Giordano C, 2013, CIRC-CARDIOVASC IMAG, V6, P982, DOI 10.1161/CIRCIMAGING.113.000185
   Giordano C, 2013, EXPERT OPIN BIOL TH, V13, P411, DOI 10.1517/14712598.2013.748739
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Gonzalez-Pecchi V, 2015, MICROVASC RES, V98, P9, DOI 10.1016/j.mvr.2014.11.003
   Gyongyosi M, 2015, CIRC RES, V116, P1346, DOI 10.1161/CIRCRESAHA.116.304346
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hou LQ, 2016, AM J PHYSIOL-HEART C, V310, pH455, DOI 10.1152/ajpheart.00726.2015
   Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451
   Hung HS, 2014, BIOMATERIALS, V35, P6810, DOI 10.1016/j.biomaterials.2014.04.076
   Jakob Philipp, 2013, Curr Heart Fail Rep, V10, P165, DOI 10.1007/s11897-013-0134-z
   Jansen Of Lorkeers SJ, 2015, CIRC RES, V116, P80, DOI DOI 10.1161/CIRCRESAHA.116.304872
   Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kang WJ, 2006, J NUCL MED, V47, P1295
   Karpov RS, 2005, B EXP BIOL MED+, V140, P640, DOI 10.1007/s10517-006-0043-1
   Khan AR, 2016, CIRC RES, V118, P984, DOI 10.1161/CIRCRESAHA.115.308056
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim KA, 2014, BIOL PHARM BULL, V37, P1248, DOI 10.1248/bpb.b14-00172
   Kovacic JC, 2015, CIRC RES, V116, P1287, DOI 10.1161/CIRCRESAHA.115.306323
   Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Lalit PA, 2014, CIRC RES, V114, P1328, DOI 10.1161/CIRCRESAHA.114.300556
   Lee YS, 2015, J CONTROL RELEASE, V205, P128, DOI 10.1016/j.jconrel.2015.01.004
   Lehtonen ST, 2014, J TISSUE ENG REGEN M, V8, P97, DOI 10.1002/term.1502
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li QY, 2013, BIOMATERIALS, V34, P4982, DOI 10.1016/j.biomaterials.2013.03.030
   Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lin X, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0165-3
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu B, 2016, STEM CELLS INT, V2016, DOI DOI 10.1155/2016/1031794
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002
   Lou JY, 2010, THROMB RES, V126, pE175, DOI 10.1016/j.thromres.2009.11.017
   Lovell MJ, 2010, ATHEROSCLEROSIS, V213, P67, DOI 10.1016/j.atherosclerosis.2010.07.045
   MacArthur JW, 2013, CIRCULATION, V128, pS79, DOI 10.1161/CIRCULATIONAHA.112.000343
   Mann DL, 2016, EUR J HEART FAIL, V18, P314, DOI 10.1002/ejhf.449
   McNeill B, 2015, FASEB J, V29, P1198, DOI 10.1096/fj.14-261586
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Nezhad ZM, 2016, INTERACT CARDIOV TH, V22, P839, DOI 10.1093/icvts/ivw020
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Pompilio G, 2015, CIRC RES, V117, P490, DOI 10.1161/CIRCRESAHA.115.307184
   Pozzobon M, 2010, CELL TRANSPLANT, V19, P1247, DOI 10.3727/096368910X505864
   Pozzoli O, 2011, ARTERIOSCL THROM VAS, V31, P1589, DOI 10.1161/ATVBAHA.111.226969
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Qi PK, 2015, COLLOID SURFACE B, V126, P70, DOI 10.1016/j.colsurfb.2014.12.001
   Rao SV, 2016, J AM COLL CARDIOL, V68, P715, DOI 10.1016/j.jacc.2016.05.053
   Ravichandran R, 2015, TISSUE ENG PT A, V21, P1288, DOI [10.1089/ten.tea.2014.0265, 10.1089/ten.TEA.2014.0265]
   Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114
   Rufaihah AJ, 2016, ADV DRUG DELIVER REV, V96, P31, DOI 10.1016/j.addr.2015.07.003
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Sarto P, 2007, J CARD FAIL, V13, P701, DOI 10.1016/j.cardfail.2007.06.722
   Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102
   Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340
   Schussler-Lenz M, 2016, EUR J HEART FAIL, V18, P133, DOI 10.1002/ejhf.422
   Seeto WJ, 2013, ACTA BIOMATER, V9, P8279, DOI 10.1016/j.actbio.2013.05.023
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Sepantafar M, 2016, BIOTECHNOL ADV, V34, P362, DOI 10.1016/j.biotechadv.2016.03.003
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Shevach M, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034106
   Shi M, 2007, HAEMATOL-HEMATOL J, V92, P897, DOI 10.3324/haematol.10669
   Simari RD, 2014, CIRC RES, V114, P1564, DOI 10.1161/CIRCRESAHA.114.303720
   Song M, 2014, BIOMATERIALS, V35, P2436, DOI 10.1016/j.biomaterials.2013.12.011
   Stiles J, 2012, EXP THER MED, V4, P594, DOI 10.3892/etm.2012.654
   Strauer BE, 2011, J AM COLL CARDIOL, V58, P1095, DOI 10.1016/j.jacc.2011.06.016
   Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   Tabuchi M, 2015, MAT SCI ENG C-MATER, V56, P494, DOI 10.1016/j.msec.2015.07.010
   Tarabah F., 2015, REGULATORY AFFAIRS B
   Tardif K, 2011, BIOMATERIALS, V32, P5046, DOI 10.1016/j.biomaterials.2011.04.002
   Thitiwuthikiat P, 2015, TISSUE ENG PT A, V21, P1309, DOI [10.1089/ten.tea.2014.0237, 10.1089/ten.TEA.2014.0237]
   Toeg HD, 2013, ANN THORAC SURG, V96, P1686, DOI 10.1016/j.athoracsur.2013.06.063
   Tongers J, 2014, J MOL CELL CARDIOL, V74, P231, DOI 10.1016/j.yjmcc.2014.05.017
   Turan RG, 2006, MED KLIN, V101, P198
   Ungerleider JL, 2015, METHODS, V84, P53, DOI 10.1016/j.ymeth.2015.03.024
   Ungerleider JL, 2014, STEM CELL TRANSL MED, V3, P1090, DOI 10.5966/sctm.2014-0049
   Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816
   Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wang X, 2014, APPL SURF SCI, V320, P871, DOI 10.1016/j.apsusc.2014.09.004
   Webber Matthew J, 2015, Acta Biomater, V23 Suppl, pS42, DOI 10.1016/j.actbio.2015.07.018
   Wojakowski W, 2012, LEUKEMIA, V26, P23, DOI 10.1038/leu.2011.184
   Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02
   Wollert KC, 2015, HEART, V101, P337, DOI 10.1136/heartjnl-2014-306787
   Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1
   World Health Organization, 2014, 10 LEAD CAUS DEATH W
   Xia Y, 2015, EXP BIOL MED, V240, P593, DOI 10.1177/1535370214560957
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Xu GH, 2015, ACTA BIOMATER, V15, P55, DOI 10.1016/j.actbio.2014.12.016
   Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219
   Yoon YS, 2005, J CLIN INVEST, V115, P326, DOI 10.1172/JC1200522326
   Yuan YF, 2013, BIOMATERIALS, V34, P7292, DOI 10.1016/j.biomaterials.2013.06.003
   Zhang SH, 2012, ARTERIOSCL THROM VAS, V32, P910, DOI 10.1161/ATVBAHA.111.244970
   Zhang SX, 2015, TISSUE ENG PT A, V21, P1173, DOI [10.1089/ten.tea.2014.0352, 10.1089/ten.TEA.2014.0352]
   Zhang SN, 2011, J CELL MOL MED, V15, P2245, DOI 10.1111/j.1582-4934.2010.01217.x
   Zhang XL, 2014, CYTOTHERAPY, V16, P1098, DOI 10.1016/j.jcyt.2014.02.013
   Zhu K, 2015, ARCH MED RES, V46, P286, DOI 10.1016/j.arcmed.2015.06.001
NR 152
TC 3
Z9 3
U1 3
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PY 2016
VL 16
IS 12
BP 1501
EP 1516
DI 10.1080/14712598.2016.1235149
PG 16
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA EB5UI
UT WOS:000387445600006
PM 27611095
DA 2018-10-20
ER

PT J
AU Kanoujia, J
   Singh, M
   Singh, P
   Parashar, P
   Tripathi, CB
   Arya, M
   Saraf, SA
AF Kanoujia, Jovita
   Singh, Mahendra
   Singh, Pooja
   Parashar, Poonam
   Tripathi, Chandra Bhusan
   Arya, Malti
   Saraf, Shubhini A.
TI Genipin crosslinked soy-whey based bioactive material for atorvastatin
   loaded nanoparticles: preparation, characterization and in vivo
   antihyperlipidemic study
SO RSC ADVANCES
LA English
DT Article
ID PROTEIN ISOLATE; SOYBEAN PROTEIN; KAPPA-CARRAGEENAN; DELIVERY-SYSTEMS;
   ENCAPSULATION; CHITOSAN; FILMS; ALLERGENICITY; CARBOHYDRATE; CHOLESTEROL
AB The aim of the present study was to explore the lipid lowering potential of soy protein isolate (SPI) and whey protein concentrate (WPC) for the development of novel bioactive material as a drug delivery system for encapsulation of atorvastatin (ATR) in nanoparticles (NPs) and to enhance the antihyperlipidemic potential. SPI-WPC crosslinks were synthesized through amine-amine crosslinking reaction using genipin and characterized by FTIR, mass analysis and degree of crosslinking. ATR loaded NPs were prepared by desolvation process and the optimized formulation (ATR/ SPI-WPC NPs-10) was selected on the basis of least particle size (158.1 +/- 3.8 nm), zeta potential (-33.5 +/- 2.6 mV), maximum EE (81.23 +/- 1.1%) and DL (31.5 +/- 2.9%). X-ray diffractometry spectra confirmed the encapsulation of ATR into NPs, whereas Transmission electron microscopy revealed that NPs were spherical in shape. Additionally, the ATR/ SPI-WPC NPs significantly reduced cholesterol level as compare to SPI and WPC, individually. The results of internalization and MTT assay revealed efficient cellular uptake and cytocompatibility of the formulation. The results confirmed that SPI and WPC based bioactive material can be considered as promising biomaterial for encapsulation and enhancement of the therapeutic efficiency of ATR.
C1 [Kanoujia, Jovita; Singh, Mahendra; Singh, Pooja; Parashar, Poonam; Tripathi, Chandra Bhusan; Arya, Malti; Saraf, Shubhini A.] Babasaheb Bhimrao Ambedkar Univ, Dept Pharmaceut Sci, Raebareli Rd, Lucknow 226025, Uttar Pradesh, India.
RP Saraf, SA (reprint author), Babasaheb Bhimrao Ambedkar Univ, Dept Pharmaceut Sci, Raebareli Rd, Lucknow 226025, Uttar Pradesh, India.
EM shubhini.saraf@gmail.com
OI Saraf, Shubhini/0000-0002-4180-0931; kanoujia,
   jovita/0000-0002-4766-9890
CR Abbasi A, 2014, FOOD CHEM, V143, P379, DOI 10.1016/j.foodchem.2013.08.018
   Aramwit P, 2010, INT J BIOL MACROMOL, V47, P668, DOI 10.1016/j.ijbiomac.2010.08.015
   Arliss Rebecca M, 2002, Holist Nurs Pract, V16, P40
   Bathool A, 2012, ADV MAT LETT, V3, P466
   BEYNEN AC, 1990, J NUTR, V120, P422
   Biswal PK, 2015, LIFE SCI, V135, P92, DOI 10.1016/j.lfs.2015.05.026
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Chen LY, 2006, TRENDS FOOD SCI TECH, V17, P272, DOI 10.1016/j.tifs.2005.12.011
   Cross ML, 1999, IMMUNOL CELL BIOL, V77, P345, DOI 10.1046/j.1440-1711.1999.00834.x
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Erdman JW, 2000, CIRCULATION, V102, P2555, DOI 10.1161/01.CIR.102.20.2555
   Gulseren I, 2012, FOOD CHEM, V135, P770, DOI 10.1016/j.foodchem.2012.04.146
   Gunasekaran S, 2007, J FOOD ENG, V83, P31, DOI 10.1016/j.jfoodeng.2006.11.001
   Hammann F, 2014, MATERIALS, V7, P7975, DOI 10.3390/ma7127975
   Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019
   Kale RN, 2010, J YOUNG PHARM, V2, P90, DOI 10.4103/0975-1483.62223
   Kanoujia J, 2016, MAT SCI ENG C-MATER, V69, P967, DOI 10.1016/j.msec.2016.08.011
   Kaup S. R., 2011, Genomic Medicine, Biomarkers and Health Sciences, V3, P98
   Kavanagh GM, 2000, INT J BIOL MACROMOL, V28, P41, DOI 10.1016/S0141-8130(00)00144-6
   Kim MS, 2008, EUR J PHARM BIOPHARM, V69, P454, DOI 10.1016/j.ejpb.2008.01.007
   Kumar D, 2012, PHARMACOGN MAG, V8, P314, DOI 10.4103/0973-1296.103663
   Kumar P, 2010, J FOOD ENG, V100, P480, DOI 10.1016/j.jfoodeng.2010.04.035
   Kumar R, 2002, IND CROP PROD, V16, P155, DOI 10.1016/S0926-6690(02)00007-9
   Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423
   Li HJ, 2012, FOOD CHEM, V132, P808, DOI 10.1016/j.foodchem.2011.11.040
   Li Q, 2015, CARBOHYD POLYM, V130, P166, DOI 10.1016/j.carbpol.2015.05.039
   Li XH, 2007, FOOD CHEM, V104, P1410, DOI 10.1016/j.foodchem.2007.02.003
   Marshall Keri, 2004, Altern Med Rev, V9, P136
   Meena R, 2009, FOOD HYDROCOLLOID, V23, P497, DOI 10.1016/j.foodhyd.2008.03.008
   Meena R, 2007, INT J BIOL MACROMOL, V41, P94, DOI 10.1016/j.ijbiomac.2007.01.008
   Mekhail GM, 2012, INT J BIOL MACROMOL, V51, P351, DOI 10.1016/j.ijbiomac.2012.05.026
   Mekhail M, 2014, CARBOHYD POLYM, V108, P91, DOI 10.1016/j.carbpol.2014.03.021
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Nesterenko A, 2013, IND CROP PROD, V42, P469, DOI 10.1016/j.indcrop.2012.06.035
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Pereira FL, 2015, FOOD RES INT, V76, P366, DOI 10.1016/j.foodres.2015.07.034
   RAO AV, 1975, CLIN CHEM, V21, P1523
   Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9
   Shahira M. E., 2014, B FAC PHARM, V52, P1
   Teng Z, 2013, FOOD CHEM, V141, P524, DOI 10.1016/j.foodchem.2013.03.043
   Teng Z, 2012, J AGR FOOD CHEM, V60, P2712, DOI 10.1021/jf205238x
   Torchilin V. P., 2008, NANOTECHNOLOGY DRUGS
   Wacker M, 2011, INT J PHARMACEUT, V414, P225, DOI 10.1016/j.ijpharm.2011.04.046
   WEST CE, 1989, J NUTR, V119, P843
   Winkler H, 2015, EUR POLYM J, V62, P10, DOI 10.1016/j.eurpolymj.2014.10.014
   Won YW, 2008, J CONTROL RELEASE, V127, P154, DOI 10.1016/j.jconrel.2008.01.010
   Wong WW, 1998, AM J CLIN NUTR, V68, p1385S, DOI 10.1093/ajcn/68.6.1385S
   World Health Organization-WHO, 2015, CARD DIS CVDS, P317
   Xiang LX, 2009, CHINESE J POLYM SCI, V27, P843, DOI 10.1142/S0256767909004564
   You RC, 2014, POLYM DEGRAD STABIL, V109, P226, DOI 10.1016/j.polymdegradstab.2014.07.029
   Zhang J, 2012, FOOD CHEM, V133, P390, DOI 10.1016/j.foodchem.2012.01.049
NR 51
TC 1
Z9 1
U1 1
U2 5
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 96
BP 93275
EP 93287
DI 10.1039/c6ra16830b
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA DZ1WI
UT WOS:000385631900007
DA 2018-10-20
ER

PT J
AU Sagar, N
   Singh, AK
   Temgire, MK
   Vijayalakshmi, S
   Dhawan, A
   Kumar, A
   Chattopadhyay, N
   Bellare, JR
AF Sagar, Nitin
   Singh, Atul Kumar
   Temgire, Mayur K.
   Vijayalakshmi, S.
   Dhawan, Alok
   Kumar, Ashutosh
   Chattopadhyay, Naibedya
   Bellare, Jayesh R.
TI 3D scaffold induces efficient bone repair: in vivo studies of
   ultra-structural architecture at the interface
SO RSC ADVANCES
LA English
DT Article
ID SOLID-STATE NMR; SMALL MOLECULES; CORTICAL BONE; RABBIT; REGENERATION;
   IMPLANTS; OSTEOMYELITIS; PERFORMANCE; DEFECTS; PHASE
AB The repair of critical bone loss remains a challenge to orthopaedic surgeons. Various artificial scaffolds have been intensively evaluated to provide an alternative solution for the repair and regeneration of bone defects; however, the inconsistent clinical performances of available materials have prompted the development of reactive 3D scaffolds for bone tissue engineering. We have studied the ability of a functionally designed 3D scaffold to bridge critical size defects and induce new bone formation in a New Zealand white rabbit tibial model, and have evaluated its ultra-structural properties using a combination of techniques, such as solid-state nuclear magnetic resonance (ssNMR), scanning electron microscopy (SEM), energy dispersive X-ray (EDX) and micro-computed tomography (mu-CT) with MIMICS (R) (Materialise's Interactive Medical Image Control System). ssNMR showed the structural similarity of the synthetic biomaterial to naturally occurring human bone. SEM studies showed an increase in Ca/P ratio with time, the progressively uniform distribution of elements in healed bones, and increased new bone formation, finally resembling native (intact) bone mu-CT and MIMICS (R) demonstrated the pattern and morphology of new bone formed, with a noticeable shift in the HU unit towards compact bone, from week 2 to 25. The results suggest that in the critical size bone defect, the scaffold enhanced the formation of new bone having biomaterial composition, ultra-structure and quality resembling that of native bone, thus suggesting significant improvement in guided bone regeneration. This research provides a promising new avenue for orthopaedic implant design that safely biodegrades while promoting new bone growth.
C1 [Sagar, Nitin; Kumar, Ashutosh; Bellare, Jayesh R.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
   [Singh, Atul Kumar; Vijayalakshmi, S.; Bellare, Jayesh R.] Indian Inst Technol, Ctr Res Nanotechnol & Sci, Bombay 400076, Maharashtra, India.
   [Temgire, Mayur K.; Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.
   [Dhawan, Alok] CSIR, Indian Inst Toxicol Res, Nanomat Toxicol Grp, MG Marg, Lucknow 226001, Uttar Pradesh, India.
   [Chattopadhyay, Naibedya] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India.
   [Chattopadhyay, Naibedya] CSIR, Cent Drug Res Inst, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Lucknow 226031, Uttar Pradesh, India.
   [Bellare, Jayesh R.] Indian Inst Technol, Wadhwani Res Ctr Bioengn, Bombay 400076, Maharashtra, India.
RP Bellare, JR (reprint author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.; Bellare, JR (reprint author), Indian Inst Technol, Ctr Res Nanotechnol & Sci, Bombay 400076, Maharashtra, India.; Bellare, JR (reprint author), Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.; Bellare, JR (reprint author), Indian Inst Technol, Wadhwani Res Ctr Bioengn, Bombay 400076, Maharashtra, India.
EM jb@iitb.ac.in
OI Chattopadhyay, Naibedya/0000-0003-2473-0246
FU fellowship DST-INSPIRE from the Department of Science & Technology
   (DST), Government of India; CSIR [BSC0201]; DBT, India
   [BT/PR3138/NNT/28/550/2011]
FX The authors are thankful to Sophisticated Analytical Instrument Facility
   (SAIF) and Centre for Research in Nanotechnology and Science (CRNTS),
   Indian Institute of Technology Bombay, Mumbai for the SEM Facility. We
   thank Dr Rajan Singh and Dr Rohit Teotia for helping in
   characterization. Atul Kumar Singh is supported by a fellowship
   DST-INSPIRE from the Department of Science & Technology (DST),
   Government of India. NC acknowledges funding from CSIR (BSC0201). JRB
   acknowledges funding from DBT, India (BT/PR3138/NNT/28/550/2011).
   Authors are thankful to National facility of High-Field NMR at TIFR,
   Mumbai for the NMR spectrometer time.
CR Alejandro A. G., 2006, BIOMED MATER, V1, P100
   Aravamudhan A, 2013, CURR PHARM DESIGN, V19, P3420, DOI 10.2174/1381612811319190008
   Bayraktar G, 1998, Eur J Prosthodont Restor Dent, V6, P9
   Boyan BD, 1999, CLIN PLAST SURG, V26, P629
   Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679
   Busa B, 2005, CALCIFIED TISSUE INT, V77, P386, DOI 10.1007/s00223-005-0148-y
   CASSELLA JP, 1995, CALCIFIED TISSUE INT, V56, P118, DOI 10.1007/BF00296342
   COBB CM, 1990, J ORAL MAXIL SURG, V48, P268, DOI 10.1016/0278-2391(90)90392-F
   CORSAIR A, 1990, Journal of Oral Implantology, V16, P125
   Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896
   Gong T, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.29
   HjArting-Hansen E., 1970, STUDIES IMPLANTATION
   KRAMER IRH, 1968, ARCH ORAL BIOL, V13, P1263, DOI 10.1016/0003-9969(68)90082-4
   LANDIS WJ, 1978, J ULTRA MOL STRUCT R, V63, P188, DOI 10.1016/S0022-5320(78)80074-4
   Landry PS, 1996, CLIN ORTHOP RELAT R, P260
   LEGROS R, 1987, CALCIFIED TISSUE INT, V41, P137, DOI 10.1007/BF02563793
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   Miller LM, 2007, J BONE MINER RES, V22, P1037, DOI 10.1359/JBMR.070402
   Monjo M, 2010, ACTA BIOMATER, V6, P1405, DOI 10.1016/j.actbio.2009.09.027
   Moucha CS, 2005, BONE REGENERATION AND REPAIR: BIOLOGY AND CLINICAL APPLICATIONS, P169, DOI 10.1385/1-59259-863-3:169
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Sagar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077578
   Sagar N, 2012, J BIOMED MATER RES B, V100B, P624, DOI 10.1002/jbm.b.31983
   Segar CE, 2013, CURR PHARM DESIGN, V19, P3403, DOI 10.2174/1381612811319190007
   Sharma S, 2009, J TISSUE ENG REGEN M, V3, P501, DOI 10.1002/term.186
   Singh AK, 2016, MAT SCI ENG C-MATER, V62, P574, DOI 10.1016/j.msec.2016.02.002
   Thakur RS, 2006, CHEM PHYS LETT, V426, P459, DOI 10.1016/j.cplett.2006.06.007
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   WAGNER J R, 1991, Journal of Oral Implantology, V17, P152
   Wierzchos J, 2008, MICRON, V39, P1363, DOI 10.1016/j.micron.2008.01.022
   Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243
   Xie ZP, 2013, ANTIMICROB AGENTS CH, V57, P3293, DOI 10.1128/AAC.00284-13
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   Zhang JY, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/6/065011
   Zhang X, 2010, BIOMATERIALS, V31, P5865, DOI 10.1016/j.biomaterials.2010.04.005
NR 35
TC 1
Z9 1
U1 0
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 96
BP 93768
EP 93776
DI 10.1039/c6ra20420a
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA DZ1WI
UT WOS:000385631900068
DA 2018-10-20
ER

PT J
AU Erten, E
   Arslan, TS
   Derkus, B
   Arslan, YE
AF Erten, Evren
   Arslan, Tugba Sezgin
   Derkus, Burak
   Arslan, Yavuz Emre
TI Detergent-free decellularization of bovine costal cartilage for
   chondrogenic differentiation of human adipose mesenchymal stem cells in
   vitro
SO RSC ADVANCES
LA English
DT Article
ID ARTICULAR-CARTILAGE; TISSUE; MATRIX; REPAIR; COLLAGEN; SCAFFOLD; BONE;
   REGENERATION; BIOMATERIAL; CONSTRUCTS
AB In this study, we report a novel, detergent-free decellularization protocol for the preparation of intact cartilage ECM-based scaffolds (CEbS) during an effective decalcification process. On treatment with 10 mM Na(2)EDTA, the amount of calcium lost was around 55% +/- 5% (percent +/- S.D.%) (n = 3) and nearly 84% of the nuclear material was removed; however, the most effective removal was observed on treatment with 10 mM Na2EDTA combined with 0.5% Triton X-100 for 48 hours. Notably, our proposed method decreased the GAG content by only 5% compared to untreated CEbS (380.37 +/- 16.02 mu g mg(-1) dry weight). There was no significant difference in hydroxyproline content between the untreated (13.04 +/- 1.51 mg mg(-1) dry weight) sample and our proposed method (12.95 +/- 1.55 mg mg(-1) dry weight). The scaffold morphology and cell attachment were evaluated using SEM micrographs, and the cells that were inoculated with detergent-free decellularized CEbS for 14, 21 and 28 days covered the scaffold area, including the porous cavities. Microscopic observations showed that the cell density increased day by day and there was no cytotoxic evidence for the scaffolds, which is a desirable environment for cells. The histochemical and immunohistochemical assessments are supported by glycosaminoglycan and hydroxyproline assays. The proposed detergent-free decellularization technique could be a promising method for cartilage tissue regeneration.
C1 [Erten, Evren; Arslan, Tugba Sezgin; Arslan, Yavuz Emre] Canakkale Onsekiz Mart Univ, Fac Engn, Dept Bioengn, Regenerat Biomat Lab, TR-17100 Canakkale, Turkey.
   [Derkus, Burak] Ankara Univ, Dept Chem, Bioelectrochem Lab, TR-06100 Ankara, Turkey.
RP Arslan, YE (reprint author), Canakkale Onsekiz Mart Univ, Fac Engn, Dept Bioengn, Regenerat Biomat Lab, TR-17100 Canakkale, Turkey.
EM yavuzea@gmail.com
RI ARSLAN, Yavuz Emre/M-2907-2016
OI ARSLAN, Yavuz Emre/0000-0003-3445-1814; Erten, Evren/0000-0003-2710-5534
FU Scientific and Technological Research Council of Turkey [114S851];
   Canakkale Onsekiz Mart University, Scientific Research Projects
   Coordination Unit [FYL-2015-631]
FX This study was financially supported by the Scientific and Technological
   Research Council of Turkey (Project ID. 114S851) and Canakkale Onsekiz
   Mart University, Scientific Research Projects Coordination Unit (Project
   ID. FYL-2015-631). We would also thank to Canakkale Onsekiz Mart
   University, Science and Technology Application & Research Center for
   collaborating with analyses. The authors would like to thank Dr Selin
   Marangoz, for comments and language proofreading.
CR Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Camarero-Espinosa S, 2016, BIOMATER SCI-UK, V4, P734, DOI 10.1039/c6bm00068a
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   Edelstein Adam I, 2015, Am J Orthop (Belle Mead NJ), V44, pE355
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fitzpatrick LE, 2015, BIOMATER SCI-UK, V3, P12, DOI [10.1039/c4bm00246f, 10.1039/C4BM00246F]
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Griffin M. F., 2016, J MATER SCI-MATER M, V27, P1, DOI DOI 10.1007/S10856-015-5619-8)
   Hoemann CD, 2002, ANAL BIOCHEM, V300, P1, DOI 10.1006/abio.2001.5436
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Luo L, 2016, J MECH BEHAV BIOMED, V55, P21, DOI 10.1016/j.jmbbm.2015.10.002
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Mauck R. L., 2011, TISSUE ENG, V60, P493
   Nair R, 2008, J BIOMAT SCI-POLYM E, V19, P801, DOI 10.1163/156856208784522056
   Naveena N, 2012, J MATER CHEM, V22, P5239, DOI 10.1039/c1jm14401d
   Rowland CR, 2016, BIOMATERIALS, V91, P57, DOI 10.1016/j.biomaterials.2016.03.012
   Schuh E, 2012, J BIOMED MATER RES A, V100A, P38, DOI 10.1002/jbm.a.33226
   Schwarz S., 2012, TISSUE ENG PART A, V18
   Somers P, 2012, ARTIF CELL BLOOD SUB, V40, P151, DOI 10.3109/10731199.2011.637925
   Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966
   Tomo H, 2005, J SHOULDER ELB SURG, V14, P103, DOI 10.1016/j.jse.2004.03.007
   Wang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24779
   Wiles K, 2016, TISSUE ENG PART B-RE, V22, P208, DOI [10.1089/ten.teb.2015.0376, 10.1089/ten.TEB.2015.0376]
   Wu Q, 2015, BIOMED RES INT, DOI 10.1155/2015/785474
   Xu HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086723
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
NR 38
TC 2
Z9 2
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 96
BP 94236
EP 94246
DI 10.1039/c6ra16647d
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA DZ1WI
UT WOS:000385631900121
DA 2018-10-20
ER

PT J
AU Hezarkhani, Z
   Shaabani, A
AF Hezarkhani, Zeinab
   Shaabani, Ahmad
TI Palladium(II) tetrasulfophthalocyanine covalently immobilized on keratin
   protein grafted graphene oxide nanosheets as a new high-performance
   catalyst for C-C coupling reactions
SO RSC ADVANCES
LA English
DT Article
ID HETEROCYCLIC CARBENE-PALLADIUM; SUZUKI-MIYAURA REACTION; AEROBIC
   OXIDATION; IRON PHTHALOCYANINE; ORGANIC-COMPOUNDS; SELECTIVE ADSORPTION;
   RECYCLABLE CATALYST; METAL-COMPLEXES; AQUEOUS-MEDIA; SILK FIBROIN
AB Wool keratin protein, as an amphiphilic biomaterial, was extracted from natural wool and used to modify the surface of graphene oxide nanosheets. An aqua soluble palladium(II) complex with a phthalocyanine ligand possessing the ability to covalently bind on keratin-protein-grafted graphene oxide nanosheets was used to chemically attach palladium(II) complex to modified graphene oxide. The covalently supported palladium(II) tetrasulfophthalocyanine complex revealed efficient catalytic reactivity by controlled temporary release of active species for Heck and Sonogashira coupling reactions in aqueous solution. Heck coupling of styrene and Sonogashira coupling of phenylacetylene with different aryl halides were successfully catalyzed by the synthesized palladium(II) tetrasulfophthalocyanine covalently supported on keratin-protein-grafted graphene oxide nanosheets as a novel catalyst precursor. The controlled release of palladium active species prevents the formation of inactive palladium agglomerates under harsh conditions and consequently this controlled release leads to high catalytic performances.
C1 [Hezarkhani, Zeinab; Shaabani, Ahmad] Shahid Beheshti Univ, Fac Chem, GC, POB 19396-4716, Tehran, Iran.
RP Shaabani, A (reprint author), Shahid Beheshti Univ, Fac Chem, GC, POB 19396-4716, Tehran, Iran.
EM a-shaabani@sbu.ac.ir
FU Iran National Elites Foundation (INEF); Research Council of Shahid
   Beheshti University
FX We gratefully acknowledge financial support from the Iran National
   Elites Foundation (INEF) and the Research Council of Shahid Beheshti
   University.
CR ASQUITH RS, 1977, CHEM NATURAL PROTEIN
   Bai C, 2014, CATAL LETT, V144, P1617, DOI 10.1007/s10562-014-1299-0
   Bang EK, 2012, CHEM SCI, V3, P1752, DOI 10.1039/c2sc20098h
   Beyrhouty M, 2005, NEW J CHEM, V29, P1245, DOI 10.1039/b507211e
   Bonney KJ, 2014, CHEM SOC REV, V43, P6609, DOI [10.1039/C4CS00061G, 10.1039/c4cs00061g]
   Cecil R., 1959, ADV PROTEIN CHEM
   Chinchilla R, 2011, CHEM SOC REV, V40, P5084, DOI 10.1039/c1cs15071e
   Elavarasan S, 2016, RSC ADV, V6, P49376, DOI 10.1039/c6ra04170a
   Fan HL, 2010, BIOMACROMOLECULES, V11, P2345, DOI 10.1021/bm100470q
   Feofanov A, 2002, PHOTOCHEM PHOTOBIOL, V75, P527, DOI 10.1562/0031-8655(2002)075<0527:CWMINE>2.0.CO;2
   Fernandez-Garcia L, 2016, J MOL CATAL A-CHEM, V416, P140, DOI 10.1016/j.molcata.2016.02.023
   Fihri A, 2011, CHEM SOC REV, V40, P5181, DOI 10.1039/c1cs15079k
   FLYNN JH, 1990, J THERM ANAL, V36, P1579, DOI 10.1007/BF01914077
   Garcia AM, 2015, GREEN CHEM, V17, P2146, DOI 10.1039/c5gc00154d
   Hu KS, 2013, ADV MATER, V25, P2301, DOI 10.1002/adma.201300179
   Huang YM, 2016, RSC ADV, V6, P51725, DOI 10.1039/c6ra08618g
   Idris A, 2014, GREEN CHEM, V16, P2857, DOI 10.1039/c4gc00213j
   Jiang YY, 2013, ACS CATAL, V3, P1263, DOI 10.1021/cs4001927
   Kadish K. M., 2002, PORPHYRIN HDB
   Kostas ID, 2007, TETRAHEDRON LETT, V48, P6688, DOI 10.1016/j.tetlet.2007.07.141
   Kovtyukhova NI, 1999, CHEM MATER, V11, P771, DOI 10.1021/cm981085u
   LARSSON R, 1981, J APPL ELECTROCHEM, V11, P489, DOI 10.1007/BF01132437
   Lokesh KS, 2013, DYES PIGMENTS, V96, P269, DOI 10.1016/j.dyepig.2012.08.018
   Ma'mani L, 2014, RSC ADV, V4, P48613, DOI 10.1039/c4ra07130a
   Mahyari M, 2014, CHEM COMMUN, V50, P7855, DOI 10.1039/c4cc01406e
   Mahyari M, 2014, APPL CATAL A-GEN, V469, P524, DOI 10.1016/j.apcata.2013.09.024
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007
   Mofakham H, 2012, J MOL CATAL A-CHEM, V360, P26, DOI 10.1016/j.molcata.2012.04.002
   Movahed SK, 2014, RSC ADV, V4, P14586, DOI 10.1039/c3ra46056h
   Park JH, 2014, TETRAHEDRON LETT, V55, P3426, DOI 10.1016/j.tetlet.2014.04.078
   Perez JM, 2016, RSC ADV, V6, P36932, DOI 10.1039/c6ra01731b
   Poole AJ, 2009, BIOMACROMOLECULES, V10, P1, DOI 10.1021/bm8010648
   RHODES HJ, 1967, MYCOPATH MYCOL APPL, V33, P345, DOI 10.1007/BF02088925
   Rodriguez-Gonzalez C, 2012, IND ENG CHEM RES, V51, P3619, DOI 10.1021/ie200742x
   Rohlich C, 2010, ADV SYNTH CATAL, V352, P2263, DOI 10.1002/adsc.201000458
   Rohlich C, 2010, CHEM-EUR J, V16, P2363, DOI 10.1002/chem.200903331
   Sabater S, 2014, ACS CATAL, V4, P2038, DOI 10.1021/cs5003959
   Schatz A, 2010, ADV FUNCT MATER, V20, P4323, DOI 10.1002/adfm.201000959
   Seyyedhamzeh M, 2012, J PORPHYR PHTHALOCYA, V16, P1110, DOI 10.1142/S1088424612501106
   Shaabani A, 1998, J CHEM RES-S, P672, DOI 10.1039/a708858b
   Shaabani A, 2016, POLYHEDRON, V107, P176, DOI 10.1016/j.poly.2016.01.019
   Shaabani A, 2016, RSC ADV, V6, P30247, DOI 10.1039/c6ra03132c
   Shaabani A, 2015, CELLULOSE, V22, P3027, DOI 10.1007/s10570-015-0708-x
   Shaabani A, 2015, RSC ADV, V5, P61759, DOI 10.1039/c5ra10522f
   Shaabani A, 2014, RSC ADV, V4, P64419, DOI 10.1039/c4ra11101j
   Shang NZ, 2013, RSC ADV, V3, P21863, DOI 10.1039/c3ra44620d
   Sorokin AB, 2013, CHEM REV, V113, P8152, DOI 10.1021/cr4000072
   Wan QX, 2009, CATAL LETT, V128, P487, DOI 10.1007/s10562-008-9780-2
   Wang K, 2016, GREEN CHEM, V18, P476, DOI 10.1039/c5gc01254f
   Wang QJ, 2016, CHEM SOC REV, V45, P1257, DOI 10.1039/c5cs00534e
   Wang S, 2015, RSC ADV, V5, P53935, DOI 10.1039/c5ra10585d
   William J., 1958, J AM CHEM SOC, V80, P1339
   Wojcik P, 2016, RSC ADV, V6, P36491, DOI 10.1039/c6ra02889f
   Wu S, 2011, TETRAHEDRON, V67, P250, DOI 10.1016/j.tet.2010.10.062
   Xu SJ, 2013, ACS APPL MATER INTER, V5, P654, DOI 10.1021/am302076x
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yang JH, 2013, J PHYS CHEM C, V117, P3785, DOI 10.1021/jp311051g
   Yang JH, 2012, J NAT GAS CHEM, V21, P265, DOI 10.1016/S1003-9953(11)60363-0
   Yang T, 2012, J MATER CHEM, V22, P21909, DOI 10.1039/c2jm34712a
   Zhang C, 2015, ACS SUSTAIN CHEM ENG, V3, P396, DOI 10.1021/sc500738k
   Zheng PW, 2013, IND ENG CHEM RES, V52, P14201, DOI 10.1021/ie402220d
   Zhou LN, 2015, RSC ADV, V5, P46017, DOI 10.1039/c5ra03007b
NR 63
TC 4
Z9 4
U1 2
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 101
BP 98956
EP 98967
DI 10.1039/c6ra18814a
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA EB5PF
UT WOS:000387427800049
DA 2018-10-20
ER

PT J
AU Bakopoulou, A
   About, I
AF Bakopoulou, Athina
   About, Imad
TI Stem Cells of Dental Origin: Current Research Trends and Key Milestones
   towards Clinical Application
SO STEM CELLS INTERNATIONAL
LA English
DT Review
ID EXFOLIATED DECIDUOUS TEETH; HUMAN BONE-MARROW; RAT SPINAL-CORD;
   PERIPHERAL-NERVE REGENERATION; MESENCHYMAL STROMAL CELLS; SIDE
   POPULATION CELLS; HUMAN APICAL PAPILLA; NEURON-LIKE CELLS; PULP-LIKE
   TISSUE; IN-VITRO
AB Dental Mesenchymal StemCells (MSCs), includingDental Pulp StemCells (DPSCs), StemCells fromHuman ExfoliatedDeciduous teeth (SHED), and Stem Cells From Apical Papilla (SCAP), have been extensively studied using highly sophisticated in vitro and in vivo systems, yielding substantially improved understanding of their intriguing biological properties. Their capacity to reconstitute various dental and nondental tissues and the inherent angiogenic, neurogenic, and immunomodulatory properties of their secretome have been a subject of meticulous and costly research by various groups over the past decade. Key milestone achievements have exemplified their clinical utility in Regenerative Dentistry, as surrogate therapeutic modules for conventional biomaterial-based approaches, offering regeneration of damaged oral tissues instead of simply "filling the gaps." Thus, the essential next step to validate these immense advances is the implementation of well-designed clinical trials paving the way for exploiting these fascinating research achievements for patient well-being: the ultimate aim of this ground breaking technology. This review paper presents a concise overviewof the major biological properties of the human dental MSCs, critical for the translational pathway "from bench to clinic."
C1 [Bakopoulou, Athina] Aristotle Univ Thessaloniki, Sch Dent, Dept Fixed Prosthesis & Implant Prosthodont, Thessaloniki, Greece.
   [About, Imad] Aix Marseille Univ, CNRS, Inst Movement Sci ISM, Marseille, France.
RP Bakopoulou, A (reprint author), Aristotle Univ Thessaloniki, Sch Dent, Dept Fixed Prosthesis & Implant Prosthodont, Thessaloniki, Greece.
EM abakopoulou@dent.auth.gr
OI Bakopoulou, Athina/0000-0002-2744-6788
CR Abbasalizadeh S, 2013, BIOTECHNOL ADV, V31, P1600, DOI 10.1016/j.biotechadv.2013.08.009
   Abdullah MF, 2014, CELL BIOL INT, V38, P582, DOI 10.1002/cbin.10229
   Abe S, 2012, CELL BIOL INT, V36, P927, DOI 10.1042/CBI20110506
   About I, 2011, Adv Dent Res, V23, P320, DOI 10.1177/0022034511405324
   About I., 2014, DENT PULP BIOL PATHO, P61
   Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027
   Alkaisi A., 2013, J ORAL MAXILLOFACIAL, V71
   Alongi DJ, 2010, REGEN MED, V5, P617, DOI 10.2217/RME.10.30
   Alvarez R, 2015, INT J ORAL SCI, V7, P205, DOI 10.1038/ijos.2015.29
   Lemos CAA, 2016, J PROSTHET DENT, V115, P419, DOI 10.1016/j.prosdent.2015.08.026
   Arnsdorf EJ, 2009, TISSUE ENG PT A, V15, P2637, DOI 10.1089/ten.TEA.2008.0244
   Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979
   Bakopoulou A, 2013, ARCH ORAL BIOL, V58, P1556, DOI 10.1016/j.archoralbio.2013.06.018
   Bakopoulou A, 2011, ARCH ORAL BIOL, V56, P709, DOI 10.1016/j.archoralbio.2010.12.008
   Bakopoulou A, 2015, STEM CELLS DEV, V24, P2496, DOI 10.1089/scd.2015.0197
   Bakopoulou A, 2011, CALCIFIED TISSUE INT, V88, P130, DOI 10.1007/s00223-010-9438-0
   Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208
   Behnia Ali, 2014, World J Stem Cells, V6, P505, DOI 10.4252/wjsc.v6.i4.505
   Bento LW, 2013, J DENT RES, V92, P51, DOI 10.1177/0022034512466263
   Brandenberger R., 2011, BIOPROCESS INT S, P30
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Bronckaers A, 2014, PHARMACOL THERAPEUT, V143, P181, DOI 10.1016/j.pharmthera.2014.02.013
   Bronckaers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071104
   Capelli C, 2015, IMMUNOL LETT, V168, P222, DOI 10.1016/j.imlet.2015.06.006
   Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008
   Casagrande L, 2010, J DENT RES, V89, P603, DOI 10.1177/0022034510364487
   Chang CC, 2014, J FORMOS MED ASSOC, V113, P956, DOI 10.1016/j.jfma.2014.09.003
   Chang HH, 2015, J ENDODONT, V41, P1272, DOI 10.1016/j.joen.2015.03.022
   Chatzistamatiou TK, 2014, TRANSFUSION, V54, P3108, DOI 10.1111/trf.12743
   Chmilewsky F, 2013, J DENT RES, V92, P532, DOI 10.1177/0022034513487377
   Chmilewsky F, 2014, AM J PATHOL, V184, P1991, DOI 10.1016/j.ajpath.2014.04.003
   Conde MCM, 2016, INT ENDOD J, V49, P543, DOI 10.1111/iej.12489
   Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009
   Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54
   d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121
   d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07
   de Almeida JFA, 2014, TISSUE ENG PT A, V20, P3089, DOI [10.1089/ten.tea.2013.0347, 10.1089/ten.TEA.2013.0347]
   De Berdt P, 2015, J DENT RES, V94, P1575, DOI 10.1177/0022034515604612
   De Miguel MP, 2012, CURR MOL MED, V12, P574
   Di Benedetto A, 2015, STEM CELL RES, V15, P618, DOI 10.1016/j.scr.2015.09.011
   Dissanayaka WL, 2015, TISSUE ENG PT A, V21, P550, DOI [10.1089/ten.tea.2014.0154, 10.1089/ten.TEA.2014.0154]
   Dissanayaka WL, 2012, J ENDODONT, V38, P454, DOI 10.1016/j.joen.2011.12.024
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Duailibi SE, 2008, J DENT RES, V87, P745, DOI 10.1177/154405910808700811
   Ducret M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00213
   Duncan HF, 2016, INT ENDOD J, V49, P431, DOI 10.1111/iej.12475
   Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297
   Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001
   El-Sayed KMF, 2015, TISSUE ENG PART B-RE, V21, P451, DOI [10.1089/ten.teb.2014.0675, 10.1089/ten.TEB.2014.0675]
   Eubanks EJ, 2014, J ENDODONT, V40, P652, DOI 10.1016/j.joen.2014.01.005
   Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108
   Feng XM, 2013, CELL MOL NEUROBIOL, V33, P1023, DOI 10.1007/s10571-013-9965-0
   Flores-Torales E, 2010, FOLIA HISTOCHEM CYTO, V48, P682, DOI 10.2478/v10042-010-0063-6
   Fong T., 2010, BIOPROCESS INT, V8, P44
   Fujii H, 2015, BRAIN RES, V1613, P59, DOI 10.1016/j.brainres.2015.04.001
   Gale Z, 2011, J DENT RES, V90, P1240, DOI 10.1177/0022034511417443
   Galler KM, 2016, INT ENDOD J, V49, P581, DOI 10.1111/iej.12492
   Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]
   Gandia C, 2008, STEM CELLS, V26, P638, DOI 10.1634/stemcells.2007-0484
   Gervois P, 2015, STEM CELLS DEV, V24, P296, DOI 10.1089/scd.2014.0117
   Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136
   Gopinathan G, 2013, STEM CELLS DEV, V22, P1763, DOI 10.1089/scd.2012.0711
   Gorin C, 2016, STEM CELL TRANSL MED, V5, P392, DOI 10.5966/sctm.2015-0166
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   He W, 2014, J DENT RES, V93, P496, DOI 10.1177/0022034514525200
   Heng BC, 2016, TISSUE ENG PART B-RE, V22, P220, DOI [10.1089/ten.teb.2015.0488, 10.1089/ten.TEB.2015.0488]
   Hilkens P, 2014, STEM CELL RES, V12, P778, DOI 10.1016/j.scr.2014.03.008
   Hilkens P, 2013, CELL TISSUE RES, V353, P65, DOI 10.1007/s00441-013-1630-x
   Hilkens P, 2015, STEM CELLS DEV, V24, P1610, DOI 10.1089/scd.2014.0510
   Horibe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098553
   Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234
   Huang AHC, 2008, STEM CELLS, V26, P2654, DOI 10.1634/stemcells.2008-0285
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518
   Huang GTJ, 2006, CELL TISSUE RES, V324, P225, DOI 10.1007/s00441-005-0117-9
   Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106
   Inoue T, 2013, TISSUE ENG PT A, V19, P24, DOI [10.1089/ten.tea.2011.0385, 10.1089/ten.TEA.2011.0385]
   Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802
   Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393
   Iohara K, 2014, EXP GERONTOL, V52, P39, DOI 10.1016/j.exger.2014.01.020
   Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.tea.2010.0615, 10.1089/ten.TEA.2010.0615]
   Iohara K, 2013, STEM CELL TRANSL MED, V2, P521, DOI 10.5966/sctm.2012-0132
   Ishizaka R, 2013, BIOMATERIALS, V34, P1888, DOI 10.1016/j.biomaterials.2012.10.045
   Isobe Y, 2016, INT J ORAL MAX SURG, V45, P124, DOI 10.1016/j.ijom.2015.06.022
   Ito K, 2011, INT J ORAL MAX IMPL, V26, P947
   Jakobsen C, 2013, J ORAL REHABIL, V40, P693, DOI 10.1111/joor.12079
   Jamal M, 2015, GENES DIS, V2, P261, DOI 10.1016/j.gendis.2015.05.003
   Janebodin K, 2013, J DENT RES, V92, P524, DOI 10.1177/0022034513485599
   Jarmalaviciute A, 2015, CYTOTHERAPY, V17, P932, DOI 10.1016/j.jcyt.2014.07.013
   Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004
   Jeanneau C, 2015, J DENT RES, V94, P1765, DOI 10.1177/0022034515611074
   Jiao L, 2014, BIOMATERIALS, V35, P4929, DOI 10.1016/j.biomaterials.2014.03.016
   Jin B, 2016, TISSUE ENG PT A, V22, P721, DOI 10.1089/ten.tea.2015.0273
   Kanafi M, 2014, J CELL PHYSIOL, V229, P1369, DOI 10.1002/jcp.24570
   Karbanova J, 2011, CELLS TISSUES ORGANS, V193, P344, DOI 10.1159/000321160
   Kaukua N, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0056-7
   Kawashima N, 2012, ARCH ORAL BIOL, V57, P1439, DOI 10.1016/j.archoralbio.2012.08.010
   Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617
   Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181
   Kim S, 2015, MEDIAT INFLAMM, V2015
   Kiraly M, 2011, NEUROCHEM INT, V59, P371, DOI 10.1016/j.neuint.2011.01.006
   Kodonas K, 2012, J ENDODONT, V38, P913, DOI 10.1016/j.joen.2012.02.005
   La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24
   Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526
   Lee SY, 2012, CELLS TISSUES ORGANS, V196, P23, DOI 10.1159/000331247
   Li J., 2014, BIOMED RES INT, V2014, DOI [DOI 10.1155/2014/319651, 10.1155/2014/319651]
   Li R, 2011, BIOMATERIALS, V32, P4525, DOI 10.1016/j.biomaterials.2011.03.008
   Lin CS, 2012, CYTOTHERAPY, V14, P1159, DOI 10.3109/14653249.2012.729817
   Liu HC, 2011, TISSUE ENG PT A, V17, P2417, DOI [10.1089/ten.tea.2010.0620, 10.1089/ten.TEA.2010.0620]
   Liu JJ, 2015, STEM CELLS, V33, P627, DOI 10.1002/stem.1909
   Lizier NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039885
   Machado CV, 2016, INT ENDOD J, V49, P755, DOI 10.1111/iej.12511
   Malekfar A, 2016, J ENDODONT, V42, P76, DOI 10.1016/j.joen.2015.10.001
   Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127
   Maraldi T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt203
   Marchionni C, 2009, INT J IMMUNOPATH PH, V22, P699, DOI 10.1177/039463200902200315
   Marrelli M, 2013, INT J BIOL SCI, V9, P1070, DOI 10.7150/ijbs.6662
   Martin-Ibanez R., 2009, CURRENT PROTOCOLS ST
   Marynka-Kalmani K, 2010, STEM CELLS, V28, P984, DOI 10.1002/stem.425
   Mathieu S, 2013, J ENDODONT, V39, P228, DOI 10.1016/j.joen.2012.11.007
   Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015
   Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305
   Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045
   Mita T, 2015, BEHAV BRAIN RES, V293, P189, DOI 10.1016/j.bbr.2015.07.043
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Modino SAC, 2005, ARCH ORAL BIOL, V50, P255, DOI 10.1016/j.archoralbio.2005.01.002
   Morad G, 2013, ARCH ORAL BIOL, V58, P1818, DOI 10.1016/j.archoralbio.2013.08.011
   Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004
   Mu C, 2014, BIOMED RES INT, DOI 10.1155/2014/494378
   Nakashima Misako, 2014, J Endod, V40, pS26, DOI 10.1016/j.joen.2014.01.020
   Nourbakhsh N, 2011, INT J DEV BIOL, V55, P189, DOI 10.1387/ijdb.103090nn
   Osathanon T, 2014, ORAL DIS, V20, P352, DOI 10.1111/odi.12119
   Pacini Simone, 2014, Front Cell Dev Biol, V2, P50, DOI 10.3389/fcell.2014.00050
   Padial-Molina M, 2015, BIOMED RES INT, DOI 10.1155/2015/341327
   Petridis X, 2015, J CRANIO MAXILL SURG, V43, P483, DOI 10.1016/j.jcms.2015.02.003
   Pisciotta A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0065-x
   Pivoraite U, 2015, INFLAMMATION, V38, P1933, DOI 10.1007/s10753-015-0173-6
   Prateeptongkum E, 2015, TISSUE CELL, V47, P382, DOI 10.1016/j.tice.2015.05.002
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Ramamoorthi M, 2015, STEM CELLS INT, V2015, DOI DOI 10.1155/2015/37836826106427
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Robey PG, 2015, BONE, V70, P87, DOI 10.1016/j.bone.2014.07.020
   Rosa V, 2013, J DENT RES, V92, P970, DOI 10.1177/0022034513505772
   Saghiri MA, 2015, J ENDODONT, V41, P797, DOI 10.1016/j.joen.2014.12.019
   Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251
   Sakai VT, 2010, J DENT RES, V89, P791, DOI 10.1177/0022034510368647
   Sasaki R, 2008, TISSUE ENG PT A, V14, P1141, DOI 10.1089/ten.tea.2007.0157
   Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387
   Sato A, 2007, CLONING STEM CELLS, V9, P191, DOI 10.1089/clo.2006.0054
   Seo BM, 2008, ORAL DIS, V14, P428, DOI 10.1111/j.1601-0825.2007.01396.x
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094
   Sharma S, 2014, J CLIN DIAGN RES, V8, P309, DOI 10.7860/JCDR/2014/7609.3937
   Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Simon S R J, 2011, Adv Dent Res, V23, P340, DOI 10.1177/0022034511405327
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331
   Sugimura-Wakayama Y, 2015, STEM CELLS DEV, V24, P2687, DOI 10.1089/scd.2015.0104
   Sun F, 2014, J DENT RES, V93, P589, DOI 10.1177/0022034514531146
   Taghipour Z, 2012, STEM CELLS DEV, V21, P1794, DOI 10.1089/scd.2011.0408
   Tarle SA, 2011, J CELL PHYSIOL, V226, P66, DOI 10.1002/jcp.22304
   Tran C, 2015, ADV DRUG DELIVER REV, V82-83, P1, DOI 10.1016/j.addr.2014.10.007
   Urraca N, 2015, STEM CELL RES, V15, P722, DOI 10.1016/j.scr.2015.11.004
   Vanacker J, 2014, J ENDODONT, V40, P1410, DOI 10.1016/j.joen.2014.04.008
   Volponi AA, 2015, J DENT RES, V94, P1568, DOI 10.1177/0022034515599765
   Wang JH, 2014, STEM CELLS DEV, V23, P1405, DOI 10.1089/scd.2013.0580
   Wang JS, 2010, STEM CELLS DEV, V19, P1375, DOI 10.1089/scd.2009.0258
   Wang SN, 2012, STEM CELL RES, V8, P346, DOI 10.1016/j.scr.2011.12.005
   Wang W, 2016, ACTA BIOMATER, V36, P63, DOI 10.1016/j.actbio.2016.03.015
   Wang X, 2012, ARCH ORAL BIOL, V57, P1231, DOI 10.1016/j.archoralbio.2012.02.014
   Xiao LH, 2014, ANNU REV ANAL CHEM, V7, P89, DOI 10.1146/annurev-anchem-071213-020125
   Xiao L, 2013, J CELL BIOCHEM, V114, P2624, DOI 10.1002/jcb.24610
   Yagyuu T, 2010, ARCH ORAL BIOL, V55, P68, DOI 10.1016/j.archoralbio.2009.10.011
   Yalvac ME, 2010, PHARMACOGENOMICS J, V10, P105, DOI 10.1038/tpj.2009.40
   Yamada Y, 2010, TISSUE ENG PT A, V16, P1891, DOI 10.1089/ten.TEA.2009.0732
   Yamamoto T, 2016, CELL TRANSPLANT, V25, P183, DOI 10.3727/096368915X688074
   Yang C, 2014, CELL REPROGRAM, V16, P379, DOI 10.1089/cell.2014.0026
   Yang JW, 2015, BIOMATERIALS, V44, P11, DOI 10.1016/j.biomaterials.2014.12.006
   Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6
   Yu JH, 2006, TISSUE ENG, V12, P3097, DOI 10.1089/ten.2006.12.3097
   Yu S, 2016, STEM CELLS DEV, V25, P499, DOI 10.1089/scd.2015.0298
   Yuan CY, 2015, TISSUE ENG PT A, V21, P1163, DOI [10.1089/ten.tea.2014.0058, 10.1089/ten.TEA.2014.0058]
   Zhang HM, 2015, BIOMATERIALS, V39, P145, DOI 10.1016/j.biomaterials.2014.11.007
   Zhang J, 2015, EXP CELL RES, V332, P259, DOI 10.1016/j.yexcr.2015.01.020
   Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318
   Zhang W, 2016, MOL MED REP, V13, P3747, DOI 10.3892/mmr.2016.4993
   ZHANG WF, 2006, MATER ENG, V10, P10, DOI DOI 10.1016/J.DEVCEL.2006.04.005
   Zheng Y, 2009, J DENT RES, V88, P249, DOI 10.1177/0022034509333804
NR 193
TC 9
Z9 9
U1 4
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2016
AR 4209891
DI 10.1155/2016/4209891
PG 20
WC Cell & Tissue Engineering
SC Cell Biology
GA EB5HZ
UT WOS:000387406200001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wheelton, A
   Mace, J
   Khan, WS
   Anand, S
AF Wheelton, Andrew
   Mace, James
   Khan, Wasim S.
   Anand, Sanjay
TI Biomaterials and Fabrication to Optimise Scaffold Properties for
   Musculoskeletal Tissue Engineering
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Review
DE Biomaterials; bioreactors; fabrication; scaffolds; tissue engineering
ID MESENCHYMAL STEM-CELLS; SMALL-INTESTINAL SUBMUCOSA;
   EXTRACELLULAR-MATRIX; BIOACTIVE GLASS; BONE REPAIR; SOFT-TISSUE;
   COMPOSITE SCAFFOLDS; CARTILAGE FORMATION; POROUS SCAFFOLDS; HARD-TISSUE
AB Tissue engineering has emerged as a promising scientific field potentially yielding in vitro developed tissue to replace degenerative or injured tissues in vivo, thus avoiding the donor site morbidity associated with reconstructive surgery. Integral to the process is the role of scaffolds and the biomaterials used to form them. This review explores the concept of scaffold based tissue engineering and design considerations. The scaffold needs to have certain mechanical and architectural properties, it needs to be biocompatible and biodegradable, and allow combination with bioactive molecules. We also discuss scaffolding techniques, different biomaterial options and fabrication technologies, and future areas of development.
C1 [Wheelton, Andrew; Mace, James; Khan, Wasim S.; Anand, Sanjay] Univ Manchester, Oxford Rd, Manchester M13 9PT, Lancs, England.
RP Khan, WS (reprint author), Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.
EM wasimkhan@doctors.org.uk
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   Blaker JJ, 2003, J BIOMED MATER RES A, P335
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Brodie JC, 2005, J BIOMED MATER RES A, V73A, P409, DOI 10.1002/jbm.a.30279
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   CAO Y, 1994, TRANSPLANT P, V26, P3390
   Castricini R, AM J SPORTS MED, V39, P2
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   Caudwell M, 2015, CURR STEM CELL RES T, V10, P11
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Chimutengwende-Gordon M, 2012, CURR STEM CELL RES T, V7, P122, DOI 10.2174/157488812799219036
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Crowley C, 2013, CURR STEM CELL RES T, V8, P243, DOI 10.2174/1574888X11308030009
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Deloye C, 2004, ACTA ORTHOP BELG, V70, P2004
   Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/1076327042500256
   Dheerendra Sujay K, 2012, Open Orthop J, V6, P281, DOI 10.2174/1874325001206010281
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dunn AS, 2001, J MATER SCI-MATER M, V12, P673, DOI 10.1023/A:1011204106373
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Fisher DM, 2013, CURR STEM CELL RES T, V8, P260
   Gao C, 2007, J BIOMAET SCI POLYM, V18, P799
   GATTI AM, 1994, BIOMATERIALS, V15, P208, DOI 10.1016/0142-9612(94)90069-8
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Gray D, 2001, ANN NY ACAD SCI, V944, P266
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Kanitkar Medha, 2011, Open Orthop J, V5 Suppl 2, P271, DOI 10.2174/1874325001105010271
   Kempen DHR, 2006, J BIOMED MATER RES A, V77A, P103, DOI 10.1002/jbm.a.30336
   Khan Wasim S, 2009, J Perioper Pract, V19, P130
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kosuge D, 2013, CURR STEM CELL RES T, V8, P185, DOI 10.2174/1574888X11308030002
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza RP, 1996, NAT BIOTECHNOL, V14, P1107, DOI 10.1038/nbt0996-1107
   Lee D, 2003, MD TECHNOLOGY WATCH
   Lee KY, 2000, NATURE, V408, P998
   Li JH, 2010, J BIOMED MATER RES A, V95A, P973, DOI 10.1002/jbm.a.32926
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Liu XH, 2009, BIOMATERIALS, V30, P4094, DOI 10.1016/j.biomaterials.2009.04.024
   Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Mabvuure N, 2012, CURR STEM CELL RES T, V7, P287, DOI 10.2174/157488812800793018
   Mafi P, 2012, CURR STEM CELL RES T, V7, P302, DOI 10.2174/157488812800793045
   Mahapatra Anant, 2011, Open Orthop J, V5 Suppl 2, P239, DOI 10.2174/1874325001105010239
   Miko AG, 2000, ELECTRON J BIOTECHN, V13, P114
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   Oragui Emeka, 2011, Open Orthop J, V5 Suppl 2, P267, DOI 10.2174/1874325001105010267
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Punwar Shahid, 2011, Open Orthop J, V5 Suppl 2, P296, DOI 10.2174/1874325001105010296
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Robert L, 2001, PATHOL BIOL, V49, P279, DOI 10.1016/S0369-8114(01)00141-9
   Rodeo SA, 2012, AM J SPORT MED, V40, P1234, DOI 10.1177/0363546512442924
   Roether JA, 2002, J MATER SCI-MATER M, V13, P1207, DOI 10.1023/A:1021166726914
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Shekkeris AS, 2012, CURR STEM CELL RES T, V7, P127
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Taylor PM, 2006, PROG PEDIATR CARDIOL, V21, P219, DOI 10.1016/j.ppedcard.2005.11.010
   Thanabalasundaram G, 2012, CURR STEM CELL RES T, V7, P95, DOI 10.2174/157488812799218974
   Tucker Bethan, 2012, Open Orthop J, V6, P348, DOI 10.2174/1874325001206010348
   UITTO J, 1989, J INVEST DERMATOL, V92, pS61, DOI 10.1111/1523-1747.ep13075039
   USAMI Y, 1994, J VET MED SCI, V56, P761, DOI 10.1292/jvms.56.761
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   van der Pol U, 2010, ACTA BIOMATER, V6, P3755, DOI 10.1016/j.actbio.2010.03.028
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Xynos ID, CALCIF TISSUE INT, V67, P321
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Yates EW, 2012, STEM CELLS INT, DOI 10.1155/2012/438125
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 92
TC 3
Z9 3
U1 1
U2 13
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
EI 2212-3946
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PY 2016
VL 11
IS 7
BP 578
EP 584
DI 10.2174/1574888X11666160614101037
PG 7
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EA7EM
UT WOS:000386792200005
PM 27306403
DA 2018-10-20
ER

PT S
AU Pinheiro, ALB
   Soares, LGP
   Marques, AMC
   Silveira, L
AF Barbosa Pinheiro, Antonio Luiz
   Pinheiro Soares, Luiz Guilherme
   Cordeiro Marques, Aparecida Maria
   Silveira, Landulfo, Jr.
BE Hamblin, MR
   Carroll, JD
   Arany, P
TI Biochemical Changes on the Repair of Surgical Bone Defects Grafted with
   Biphasic Synthetic Micro-Granular HA plus beta-Tricalcium Phosphate
   Induced by Laser and LED Phototherapies Assessed by Raman Spectroscopy
SO MECHANISMS OF PHOTOBIOMODULATION THERAPY XI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms of Photobiomodulation Therapy XI
CY FEB 13-14, 2016
CL San Francisco, CA
SP SPIE
DE Biomaterial; bone repair; laser and LED phototherapy; biochemical assay
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; REGENERATION; LIGHT; PHOTOBIOMODULATION; RABBITS; TISSUE; NM
AB This work aimed the assessment of the biochemical changes during bone mineralization induced by laser and LED irradiation in an animal model of bone repair using a spectral model based on Raman spectroscopy. Six groups were studied: Clot, Laser (lambda 780 nm, 70 mW), LED (lambda 850 nm +/- 10 nm, 150 mW), Biomaterial (biphasic synthetic microgranular hydroxyapatite (HA) + beta-tricalcium phosphate), Laser + Biomaterial and LED + Biomaterial. When indicated, defects were further irradiated at 48 h interval during 2 wks, 20 J/cm(2) per session. At 15th and 30th days, femurs were dissected and spectra of the defects were collected. Raman spectra were submitted to a model to estimate the relative amount of collagen, phosphate HA and carbonate HA, by using spectra of pure collagen, biomaterial and basal bone, respectively. At 15th days, the use of biomaterial associated to phototherapy reduced the collagen formation, whereas the amount of carbonate HA was not different in all groups. The phosphate HA was higher in the groups that received biomaterial grafts. At 30th days, it was observed an increase of collagen for the group Laser + Biomaterial, and a reduction in the carbonate HA for the LED + Biomaterial. The phosphate HA was higher for the groups LED + Biomaterial and Laser + Biomaterial, while decreased for the group Biomaterial. These results indicated that the use of Laser and LED phototherapies improved the repair of bone defects grafted with the biomaterial by increasing the collagen deposition and phosphate HA.
C1 [Barbosa Pinheiro, Antonio Luiz; Pinheiro Soares, Luiz Guilherme; Cordeiro Marques, Aparecida Maria] Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
   [Silveira, Landulfo, Jr.] Univ Camilo Castelo Branco, Parque Tecnol Sao Jose dos Campos, BR-12247016 Sao Jose Dos Campos, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Silveira, Landulfo/I-2474-2012; Pinheiro, Antonio Luiz/A-1962-2008
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321
CR Akkus O, 2003, J BONE MINER RES, V18, P1012, DOI 10.1359/jbmr.2003.18.6.1012
   Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Boivin G, 2003, OSTEOPOROSIS INT, V14, pS19, DOI 10.1007/s00198-002-1347-2
   Brennan JF, 1997, CIRCULATION, V96, P99
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Carvalho FB, 2011, P SOC PHOTO-OPT INS, V7887, DOI DOI 10.1117/12.874288
   Crane NJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.010902
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1
   Krafft C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040801
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Maher JR, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.077001
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   Moler C. B., 2008, NUMERICAL COMPUTING
   Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y
   Okagbare PI, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090502
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Penel G, 2003, DENT MED PROBL, V40, P37
   Pinheiro A.L.B., 2001, LASER THER, V13, P73, DOI DOI 10.5978/ISLSM.13.73
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Soares LGP, 2014, LASER MED SCI, V29, P1575, DOI 10.1007/s10103-014-1563-y
   Silveira L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077003
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Soares Luiz Guilherme P., 2013, Braz. Dent. J., V24, P218, DOI 10.1590/0103-6440201302186
   Stone N, 2007, ANAL BIOANAL CHEM, V387, P1657, DOI 10.1007/s00216-006-0937-9
   TANG XM, 1986, LASER SURG MED, V6, P346, DOI 10.1002/lsm.1900060309
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Yamada K, 1991, J JPN ORTHOP ASSOC, V65, P101
NR 43
TC 0
Z9 0
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-1-62841-929-0
J9 PROC SPIE
PY 2016
VL 9695
AR 969506
DI 10.1117/12.2212571
PG 10
WC Biophysics; Physics, Applied
SC Biophysics; Physics
GA BF6RK
UT WOS:000383612500003
DA 2018-10-20
ER

PT S
AU Soares, LGP
   Silva, ACP
   Silva, APLT
   Neves, BLRC
   Santos, NRS
   Santos, JN
   Pinheiro, ALB
AF Soares, Luiz G. P.
   Silva, Aline C. P.
   Silva, Anna Paula L. T.
   Neves, Bruno L. R. C.
   Santos, Nicole R. S.
   Santos, Jean N.
   Pinheiro, Antonio L. B.
BE Hamblin, MR
   Carroll, JD
   Arany, P
TI Assessment of the influence of Laser phototherapy on the bone repair
   process of complete fractures in tibiae of rabbits stabilized with
   Semi-Rigid Internal fixation treated with or without MTA graft: a
   histological study
SO MECHANISMS OF PHOTOBIOMODULATION THERAPY XI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms of Photobiomodulation Therapy XI
CY FEB 13-14, 2016
CL San Francisco, CA
SP SPIE
DE Biomaterial; Fracture; LLLT; Phototherapy
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; REGENERATION; LIGHT
AB Beside biomaterials, Laser phototherapy has shown positive effects as auxiliary therapy in bone repair process, especially when involving large bone losses. The aim of this histological study was to evaluate, by light microscopy, the influence of laser phototherapy on the repair of complete tibial fractures in rabbits treated or not with semi-rigid internal fixation and Mineral Trioxide Aggregate - MTA graft. Twelve Rabbits were randomly divided into four groups with three animals each. After general anesthesia, complete fractures were created in one tibia with a carborundum disk. All animals (groups I-IV) had the fracture stabilized with semi-rigid fixation (wire osteosynthesis - WO). Group I was routinely fixed with WO; groups II and IV fracture was filled by blood clot and MTA implant. In Groups III and IV fracture was filled by blood clot and further irradiated with laser (lambda 780 nm, 70 mW, CW, Phi = 0.04 cm(2), 20.4 J/cm(2), per session, t = 300s, 142.8 J/cm(2) per treatment). The phototherapy protocol was applied immediately after the surgery and repeated each 48 hours during 15 days. Animal death occurred on the 30th postoperative day. After removal of the specimens, the samples were routinely processed, stained with H&E and evaluated by light microscopy. Histologically, the group treated with MTA graft and irradiated with laser showed the fracture filled by a more organized and mature trabecular bone, when compared with all other groups. From the results of the present study, it may be concluded that the association of Laser phototherapy + MTA graft in fractures treated with WO improved bone repair when compared with fractures treated only with WO.
C1 [Soares, Luiz G. P.; Silva, Aline C. P.; Silva, Anna Paula L. T.; Neves, Bruno L. R. C.; Santos, Nicole R. S.; Pinheiro, Antonio L. B.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
   [Santos, Jean N.] Univ Fed Bahia, Inst Hlth Sci, Av Reitor Miguel Calmon S-N, BR-40110100 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.] Univ Camilo Castelo Branco, Parque Tecnol Sao Jose dos Campos, BR-12247016 Sao Jose Dos Campos, SP, Brazil.
RP Soares, LGP (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170
   Kourkoumelis N, 2010, THESCIENTIFICWORLDJO, V10, P402, DOI 10.1100/tsw.2010.43
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   Pinheiro A. L. B., 2010, APLICACAO LASER ODON, P351
   Pinheiro A. L. B., 2011, IMPLANT NEWS, V8, P29
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Regan JD, 2002, INT ENDOD J, V35, P840, DOI 10.1046/j.1365-2591.2002.00582.x
   Soares Luiz Guilherme P., 2015, Braz. Dent. J., V26, P19, DOI 10.1590/0103-6440201300055
   Soares LGP, 2014, J PHOTOCH PHOTOBIO B, V131, P16, DOI 10.1016/j.jphotobiol.2013.12.015
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P569, DOI 10.1016/S0099-2399(06)80987-8
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
NR 19
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-929-0
J9 PROC SPIE
PY 2016
VL 9695
AR 96950L
DI 10.1117/12.2212534
PG 6
WC Biophysics; Physics, Applied
SC Biophysics; Physics
GA BF6RK
UT WOS:000383612500010
DA 2018-10-20
ER

PT J
AU Riedelova-Reicheltova, Z
   Brynda, E
   Riedel, T
AF Riedelova-Reicheltova, Z.
   Brynda, E.
   Riedel, T.
TI Fibrin Nanostructures for Biomedical Applications
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE Fibrinogen; Fibrin-bound thrombin; Nanostructures; Tissue engineering;
   Biomaterials
ID ENDOTHELIAL-CELLS; STEM-CELLS; THROMBIN; SCAFFOLDS; DIFFERENTIATION;
   POLYMERIZATION; FIBROBLASTS; BIOMATERIAL; INTEGRINS; STRENGTH
AB Fibrin is a versatile biopolymer that has been extensively used in tissue engineering. In this paper fibrin nanostructures prepared using a technique based on the catalytic effect of fibrin-bound thrombin are presented. This technique enables surface-attached thin fibrin networks to form with precisely regulated morphology without the development of fibrin gel in bulk solution. Moreover, the influence of changing the polymerization time, along with the antithrombin III and heparin concentrations on the morphology of fibrin nanostructures was explored. The binding of bioactive molecules (fibronectin, laminin, collagen, VEGF, bFGF, and heparin) to fibrin nanostructures was confirmed. These nanostructures can be used for the surface modification of artificial biomaterials designed for different biomedical applications (e.g. artificial vessels, stents, heart valves, bone and cartilage constructs, skin grafts, etc.) in order to promote the therapeutic outcome.
C1 [Riedelova-Reicheltova, Z.; Brynda, E.; Riedel, T.] Acad Sci Czech Republic, Inst Macromol Chem, Heyrovskeho Nam 2, Prague 16206 6, Czech Republic.
RP Riedelova-Reicheltova, Z (reprint author), Acad Sci Czech Republic, Inst Macromol Chem, Heyrovskeho Nam 2, Prague 16206 6, Czech Republic.
EM riedel@imc.cas.cz
RI Riedel, Tomas/H-6777-2014; Brynda, Eduard/H-6818-2014
OI Riedel, Tomas/0000-0002-2971-6956; 
FU Ministry of Education, Youth and Sports of CR within the National
   Sustainability Program II [BIOCEV-FAR LQ1604]
FX This work was supported by the Ministry of Education, Youth and Sports
   of CR within the National Sustainability Program II, Project BIOCEV-FAR
   LQ1604.
CR Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743
   Averett LE, 2008, LANGMUIR, V24, P4979, DOI 10.1021/la703264x
   Bacakova M, 2016, INT J NANOMED, V11, DOI 10.2147/IJN.S99317
   Blomback B, 2004, BIOPHYS CHEM, V112, P147, DOI 10.1016/j.bpc.2004.07.013
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   de la Puente P, 2014, EXP CELL RES, V322, P1, DOI 10.1016/j.yexcr.2013.12.017
   de la Puente P, 2011, J BIOMED MATER RES A, V99A, P648, DOI 10.1002/jbm.a.33231
   Di Cera E, 2003, CHEST, V124, p11S, DOI 10.1378/chest.124.3_suppl.11S
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Filova E, 2014, J BIOMED MATER RES A, V102, P698, DOI 10.1002/jbm.a.34733
   Filova E, 2009, J BIOMED MATER RES A, V90A, P55, DOI 10.1002/jbm.a.32065
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Koroleva A, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/1/015001
   Kotlin R, 2010, J THROMB THROMBOLYS, V30, P311, DOI 10.1007/s11239-010-0505-1
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Li Yuting, 2015, ScientificWorldJournal, V2015, P685690, DOI 10.1155/2015/685690
   Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039
   Majek P, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-14
   Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x
   Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Mi HY, 2015, J CELL PLAST, V51, P165, DOI 10.1177/0021955X14531002
   MULLER MF, 1989, BIOPOLYMERS, V28, P1011, DOI 10.1002/bip.360280508
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200
   Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301
   Riedel T, 2009, J BIOMED MATER RES A, V88A, P437, DOI 10.1002/jbm.a.31755
   Riedelova-Reicheltova Z, 2014, THROMB HAEMOSTASIS, V111, P79, DOI 10.1160/TH13-04-0267
   ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490
   Sahni A, 2000, BLOOD, V96, P3772
   Schenone M, 2004, CURR OPIN HEMATOL, V11, P272, DOI 10.1097/01.moh.0000130308.37353.d4
   Shats EA, 1997, ATHEROSCLEROSIS, V129, P9, DOI 10.1016/S0021-9150(96)06003-0
   Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780
   Ugarova TP, 2001, ANN NY ACAD SCI, V936, P368
   Verheul H M, 2000, Clin Breast Cancer, V1 Suppl 1, pS80, DOI 10.3816/CBC.2000.s.015
   Weber M, 2014, TISSUE ENG PART C-ME, V20, P265, DOI [10.1089/ten.TEC.2013.0258, 10.1089/ten.tec.2013.0258]
   Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639
   WEISEL JW, 1981, NATURE, V289, P263, DOI 10.1038/289263a0
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Yakovlev S, 2011, J THROMB HAEMOST, V9, P1847, DOI 10.1111/j.1538-7836.2011.04438.x
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
   Yee KO, 1998, CIRC RES, V83, P241, DOI 10.1161/01.RES.83.3.241
   Yermolenko IS, 2011, BIOMACROMOLECULES, V12, P370, DOI 10.1021/bm101122g
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
NR 47
TC 2
Z9 2
U1 0
U2 8
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PY 2016
VL 65
SU 2
BP S263
EP S272
PG 10
WC Physiology
SC Physiology
GA EA5TP
UT WOS:000386686800012
PM 27762592
DA 2018-10-20
ER

PT J
AU Gregurec, D
   Velasco-Lozano, S
   Moya, SE
   Vazquez, L
   Lopez-Gallego, F
AF Gregurec, Danijela
   Velasco-Lozano, Susana
   Moya, Sergio E.
   Vazquez, Luis
   Lopez-Gallego, Fernando
TI Force spectroscopy predicts thermal stability of immobilized proteins by
   measuring microbead mechanics
SO SOFT MATTER
LA English
DT Article
ID FLUORESCENT PROTEIN; HYDROGEL PARTICLES; AGAROSE GELS; MICROSCOPY;
   ENZYMES; SUPPORTS; IMPROVEMENT; SURFACES
AB Optimal immobilization of enzymes on porous microbeads enables the fabrication of highly active and stable heterogeneous biocatalysts to implement biocatalysis in synthetic and analytical chemistry. However, empirical procedures for enzyme immobilization still prevail over rational ones because there is an unmet need for more comprehensive characterization techniques that aid to understand and trace the immobilization process. Here, we present the use of atomic force spectroscopy (AFS) as an innovative solution to indirectly characterize immobilized proteins on porous materials and monitor the immobilization process in real time. We investigate the mechanical properties of porous agarose microbeads immobilizing proteins by indenting a colloidal probe (silica microparticle) into a single bead. AFS demonstrates that the binding of proteins to the solid matrix of an agarose microbead alters its stiffness. Interestingly, we discovered that irreversible and multivalent immobilizations that make microbeads stiffer also stabilize the immobilized proteins against the temperature. Hence, we propose atomic force spectroscopy as a useful technique to indirectly unravel the stability of the immobilized enzymes investigating the mechanics of the heterogenous biocatalysts as a solid biomaterial beyond the intrinsic mechanics of the proteins.
C1 [Gregurec, Danijela; Moya, Sergio E.] CIC BiomaGUNE, Soft Matter Nanotechnol Grp, Paseo Miramon 182, San Sebasitan Donostia, Spain.
   [Gregurec, Danijela] MIT, RLE Bioelect Res Grp, 77 Massachusetts Ave 8-031, Cambridge, MA 02139 USA.
   [Velasco-Lozano, Susana; Lopez-Gallego, Fernando] CIC BiomaGUNE, Heterogeneus Biocatalysis Grp, Paseo Miramon 182, San Sebasitan Donostia 20009, Spain.
   [Vazquez, Luis] CSIC, Inst Ciencia Mat Madrid, Campus Cantoblanco,C Sor Juana Ines de la Cruz 3, Madrid 28049, Spain.
   [Lopez-Gallego, Fernando] Basque Fdn Sci, Ikerbasque, Bilbao, Spain.
RP Lopez-Gallego, F (reprint author), CIC BiomaGUNE, Heterogeneus Biocatalysis Grp, Paseo Miramon 182, San Sebasitan Donostia 20009, Spain.; Lopez-Gallego, F (reprint author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.
EM flopez.ikerbasque@cicbiomagune.es
RI VAZQUEZ, LUIS/A-1272-2009; Moya, Sergio/I-1446-2015; biomaGUNE,
   CIC/J-9136-2014
OI VAZQUEZ, LUIS/0000-0001-6220-2810; biomaGUNE, CIC/0000-0001-7690-0660;
   Moya, Sergio/0000-0002-7174-1960; Lopez Gallego,
   Fernando/0000-0003-0031-1880
FU COST action System biocatalysis [CM103]; IKERBASQUE; Spanish Ministry of
   Economy (MINECO) [MAT2013-48169-R]; CAM (project NANOAVANSENS)
   [S2013/MIT-3029]; MINECO [FIS2012-38866-C05-05]; Marie-Curie actions
   [BIO2014-61838-EXP]
FX We acknowledge COST action CM103-System biocatalysis and IKERBASQUE for
   the funding to FLG. DG and SEM acknowledge the project MAT2013-48169-R
   from the Spanish Ministry of Economy (MINECO) and LV thanks financial
   support from CAM (project NANOAVANSENS, Ref. S2013/MIT-3029) and
   FIS2012-38866-C05-05 from MINECO. FLG also acknowledges the Spanish
   Ministry of Economy and Marie-Curie actions for funding the
   BIO2014-61838-EXP and NANOBIOENER, respectively. We finally acknowledge
   Mr Eneko San Sebastian for his support on image analysis and
   representation.
CR Ahearne M, 2005, J R SOC INTERFACE, V2, P455, DOI 10.1098/rsif.2005.0065
   Aissaoui N, 2014, LANGMUIR, V30, P4066, DOI 10.1021/la404935q
   Aldaye FA, 2010, J AM CHEM SOC, V132, P14727, DOI 10.1021/ja105431h
   Arnal L, 2012, LANGMUIR, V28, P7461, DOI 10.1021/la300811m
   Best JP, 2013, LANGMUIR, V29, P9824, DOI 10.1021/la402146t
   Bolivar JM, 2016, CATAL TODAY, V259, P66, DOI 10.1016/j.cattod.2015.05.004
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chen X, 2014, NAT NANOTECHNOL, V9, P137, DOI [10.1038/NNANO.2013.290, 10.1038/nnano.2013.290]
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   Chou J, 2012, SENSORS-BASEL, V12, P15467, DOI 10.3390/s121115467
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Fernandez-Lorente G., 2015, CURRENT ORGANIC CHEM, V19, P1, DOI DOI 10.2174/1385272819666150429232725
   Godoy CA, 2011, BIOMACROMOLECULES, V12, P1800, DOI 10.1021/bm200161f
   Gregurec D, 2015, COLLOID POLYM SCI, V293, P381, DOI 10.1007/s00396-014-3423-5
   GUISAN JM, 1988, ENZYME MICROB TECH, V10, P375, DOI 10.1016/0141-0229(88)90018-X
   Gustavsson PE, 1997, J CHROMATOGR A, V776, P197, DOI 10.1016/S0021-9673(97)00348-8
   Hartmann M, 2013, CHEM SOC REV, V42, P6277, DOI 10.1039/c3cs60021a
   Hartmann R, 2015, ANGEW CHEM INT EDIT, V54, P1365, DOI 10.1002/anie.201409693
   Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9
   Hertz H, 1882, J REINE ANGEW MATH, V1882, P156, DOI DOI 10.1515/CR11.1882.92.156.(IN
   Hu YH, 2011, J APPL PHYS, V110, DOI 10.1063/1.3647758
   Kiss C, 2009, PROTEIN ENG DES SEL, V22, P313, DOI 10.1093/protein/gzp006
   Kouwer PHJ, 2013, NATURE, V493, P651, DOI 10.1038/nature11839
   Lin D. C., 2006, RECENT RES DEV BIOPH, V5, P333
   Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018
   Mateo C, 2010, BIOMACROMOLECULES, V11, P3112, DOI 10.1021/bm100916r
   McConney ME, 2010, POLYM REV, V50, P235, DOI 10.1080/15583724.2010.493255
   McConney ME, 2009, ADV FUNCT MATER, V19, P2527, DOI 10.1002/adfm.200900606
   Meadows PY, 2003, LANGMUIR, V19, P9566, DOI 10.1021/la035217w
   Medin A. S., 1995, THESIS
   Ngunjiri JN, 2013, ANAL BIOANAL CHEM, V405, P1985, DOI 10.1007/s00216-012-6621-3
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   Orrego AH, 2016, J PHYS CHEM B, V120, P485, DOI 10.1021/acs.jpcb.5b12385
   Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172
   Pedroche J, 2007, ENZYME MICROB TECH, V40, P1160, DOI 10.1016/j.enzmictec.2006.08.023
   Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a
   Secundo F, 2013, CHEM SOC REV, V42, P6250, DOI 10.1039/c3cs35495d
   Tan YH, 2011, NANOSCALE, V3, P3395, DOI 10.1039/c1nr10427f
   Tufvesson P, 2010, FOOD BIOPROD PROCESS, V88, P3, DOI 10.1016/j.fbp.2010.01.003
   Vadillo-Rodriguez V, 2011, SOFT MATTER, V7, P4101, DOI 10.1039/c0sm01054e
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   WEISENHORN AL, 1990, BIOPHYS J, V58, P1251, DOI 10.1016/S0006-3495(90)82465-6
   Wiedemair J, 2007, LANGMUIR, V23, P130, DOI 10.1021/la061288u
NR 45
TC 2
Z9 2
U1 1
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2016
VL 12
IS 42
BP 8718
EP 8725
DI 10.1039/c6sm01435f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA EA9LZ
UT WOS:000386966900009
PM 27714304
OA Bronze
DA 2018-10-20
ER

PT J
AU Cristallini, C
   Rocchietti, EC
   Gagliardi, M
   Mortati, L
   Saviozzi, S
   Bellotti, E
   Turinetto, V
   Sassi, MP
   Barbani, N
   Giachino, C
AF Cristallini, Caterina
   Rocchietti, Elisa Cibrario
   Gagliardi, Mariacristina
   Mortati, Leonardo
   Saviozzi, Silvia
   Bellotti, Elena
   Turinetto, Valentina
   Sassi, Maria Paola
   Barbani, Niccoletta
   Giachino, Claudia
TI Micro- and Macrostructured PLGA/Gelatin Scaffolds Promote Early
   Cardiogenic Commitment of Human Mesenchymal Stem Cells In Vitro
SO STEM CELLS INTERNATIONAL
LA English
DT Article
ID CARDIAC TISSUE CONSTRUCTS; EXTRACELLULAR-MATRIX; CLINICAL-APPLICATIONS;
   POLYGLYCOLIC ACID; HEART FIELD; DIFFERENTIATION; LINEAGE; MUSCLE;
   SPECTROSCOPY; REGENERATION
AB The biomaterial scaffold plays a key role in most tissue engineering strategies. Its surface properties, micropatterning, degradation, and mechanical features affect not only the generation of the tissue construct in vitro, but also its in vivo functionality. The area of myocardial tissue engineering still faces significant difficulties and challenges in the design of bioactive scaffolds, which allow composition variation to accommodate divergence in the evolving myocardial structure. Here we aimed at verifying if a microstructured bioartificial scaffold alone can provoke an effect on stem cell behavior. To this purpose, we fabricated microstructured bioartificial polymeric constructs made of PLGA/gelatin mimicking anisotropic structure and mechanical properties of the myocardium. We found that PLGA/gelatin scaffolds promoted adhesion, elongation, ordered disposition, and early myocardial commitment of human mesenchymal stem cells suggesting that these constructs are able to crosstalk with stem cells in a precise and controlled manner. At the same time, the biomaterial degradation kinetics renders the PLGA/gelatin constructs very attractive for myocardial regeneration approaches.
C1 [Cristallini, Caterina] UOS Pisa, IPCF CNR, Inst Chem Phys Proc, I-56122 Pisa, Italy.
   [Rocchietti, Elisa Cibrario; Saviozzi, Silvia; Turinetto, Valentina; Giachino, Claudia] Univ Turin, Dept Clin & Biol Sci, I-10043 Turin, Italy.
   [Gagliardi, Mariacristina] Ist Italiano Tecnol, Ctr MicrobioRobot SSSA, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
   [Mortati, Leonardo; Sassi, Maria Paola] INRIM, Natl Inst Res Metrol, I-10135 Turin, Italy.
   [Bellotti, Elena; Barbani, Niccoletta] Univ Pisa, Dept Civil & Ind Engn, I-56122 Pisa, Italy.
RP Cristallini, C (reprint author), UOS Pisa, IPCF CNR, Inst Chem Phys Proc, I-56122 Pisa, Italy.; Giachino, C (reprint author), Univ Turin, Dept Clin & Biol Sci, I-10043 Turin, Italy.
EM c.cristallini@diccism.unipi.it; claudia.giachino@unito.it
RI Saviozzi, Silvia/M-4282-2015; Gagliardi, Mariacristina/K-9439-2013
OI Saviozzi, Silvia/0000-0003-3278-9061; Gagliardi,
   Mariacristina/0000-0002-5860-3141; Giachino, Claudia/0000-0001-7957-3925
FU P.O.R. F.E.S.R., of the Regione Piemonte "bando Piattaforme Innovative
   Biotecnologie," [14557]; Mi.S.E.-ICE-CRUI
FX The research leading to these results has received funding from P.O.R.
   F.E.S.R., 2007/2013 of the Regione Piemonte "bando 2008 Piattaforme
   Innovative Biotecnologie," under grant agreement no. 14557, and from
   Mi.S.E.-ICE-CRUI, 2010.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB
   Chang CW, 2013, BIOMATERIALS, V34, P912, DOI 10.1016/j.biomaterials.2012.10.020
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Cheng LY, 2013, J MATER CHEM B, V1, P4428, DOI 10.1039/c3tb20441c
   Cristallini C, 2014, BIOMATERIALS, V35, P92, DOI 10.1016/j.biomaterials.2013.09.058
   Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Faisant N, 2006, INT J PHARMACEUT, V314, P189, DOI 10.1016/j.ijpharm.2005.07.030
   Forte G, 2012, TISSUE ENG PT A, V18, P1837, DOI [10.1089/ten.tea.2011.0707, 10.1089/ten.TEA.2011.0707]
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   Hinits Y, 2012, DEV BIOL, V369, P199, DOI 10.1016/j.ydbio.2012.06.019
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Jana S, 2014, ACTA BIOMATER, V10, P2877, DOI 10.1016/j.actbio.2014.03.014
   Jung S, 2012, BIOTECHNOL APPL BIOC, V59, P106, DOI 10.1002/bab.1006
   Karamboulas Christina, 2006, J Cell Sci, V119, P4315, DOI 10.1242/jcs.03186
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim KI, 2014, BIOMATERIALS, V35, P4792, DOI 10.1016/j.biomaterials.2014.02.048
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lakshmanan R, 2012, EXPERT OPIN BIOL TH, V12, P1623, DOI 10.1517/14712598.2012.721770
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Li B, 2014, MOL PHARMACEUT, V11, P2062, DOI 10.1021/mp5000136
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCain ML, 2014, BIOMATERIALS, V35, P5462, DOI 10.1016/j.biomaterials.2014.03.052
   Meyer F, 2012, J ORTHOP RES, V30, P864, DOI 10.1002/jor.22019
   Minieri V, 2015, J CELL MOL MED, V19, P734, DOI 10.1111/jcmm.12387
   Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046
   Mortati L, 2012, J RAMAN SPECTROSC, V43, P675, DOI 10.1002/jrs.3171
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Navaei A, 2016, ACTA BIOMATER, V41, P133, DOI 10.1016/j.actbio.2016.05.027
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Petibois C, 2006, ANAL BIOANAL CHEM, V386, P1961, DOI 10.1007/s00216-006-0828-0
   Rosellini E, 2010, INT J ARTIF ORGANS, V33, P885
   Sarig U, 2011, EXPERT OPIN BIOL TH, V11, P1055, DOI 10.1517/14712598.2011.578574
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Segtnan VH, 2004, FOOD HYDROCOLLOID, V18, P1, DOI 10.1016/S0268-005X(02)00096-6
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Terrovitis J., 2013, GLOB CARDIOL SCI PRA, V2013, P3
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhou Q., 2010, J THORACIC CARDIOVAS, V140
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 53
TC 1
Z9 1
U1 1
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2016
AR 7176154
DI 10.1155/2016/7176154
PG 16
WC Cell & Tissue Engineering
SC Cell Biology
GA EA7WM
UT WOS:000386843300001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Li, NY
   Song, JQ
   Zhu, GL
   Li, XY
   Liu, L
   Shi, XT
   Wang, YJ
AF Li, Nanying
   Song, Juqing
   Zhu, Guanglin
   Li, Xiaoyu
   Liu, Lei
   Shi, Xuetao
   Wang, Yingjun
TI Periosteum tissue engineering-a review
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; MOLECULAR-BIOLOGY; BONE ALLOGRAFTS; ORIENTATION;
   SCAFFOLD; GRAFTS; MATRIX; GROWTH
AB As always, the clinical therapy of critical size bone defects caused by trauma, tumor removal surgery or congenital malformation is facing great challenges. Currently, various approaches including autograft, allograft and cell-biomaterial composite based tissue-engineering strategies have been implemented to reconstruct injured bone. However, due to damage during the transplantation processes or design negligence of the bionic scaffolds, these methods expose vulnerabilities without the assistance of periosteum, a bilayer membrane on the outer surface of the bone. Periosteum plays a significant role in bone formation and regeneration as a store for progenitor cells, a source of local growth factors and a scaffold to recruit cells and growth factors, and more and more researchers have recognized its great value in tissue engineering application. Besides direct transplantation, periosteum-derived cells can be cultured on various scaffolds for osteogenesis or chondrogenesis application due to their availability. Research studies also provide a biomimetic methodology to synthesize artificial periosteum which mimic native periosteum in structure or function. According to the studies, these tissue-engineered periostea did obviously enhance the therapeutic effects of bone graft and scaffold engineering while they could be directly used as substitutes of native periosteum. Periosteum tissue engineering, whose related research studies have provided new opportunities for the development of bone tissue engineering and therapy, has gradually become a hot spot and there are still lots to consummate. In this review, tissue-engineered periostea were classified into four kinds and discussed, which might help subsequent researchers get a more systematic view of pseudo-periosteum.
C1 [Li, Nanying; Song, Juqing; Zhu, Guanglin; Li, Xiaoyu; Liu, Lei; Wang, Yingjun] South China Univ Technol, Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510641, Guangdong, Peoples R China.
   [Li, Nanying; Song, Juqing; Zhu, Guanglin; Li, Xiaoyu; Liu, Lei; Shi, Xuetao] South China Univ Technol, Dept Biomed Engn, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Wang, YJ (reprint author), South China Univ Technol, Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510641, Guangdong, Peoples R China.; Shi, XT (reprint author), South China Univ Technol, Dept Biomed Engn, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
EM shxt@scut.edu.cn; imwangyj@163.com
FU National Basic Research Program of China [2012CB619100]; National
   Natural Science Foundation of China [51232002, 51502095]; Guangdong
   Natural Science Funds for Distinguished Young Scholar [2016A030306018];
   111 Project [B13039]
FX This study was financially supported by grants from the National Basic
   Research Program of China (2012CB619100), the National Natural Science
   Foundation of China (51232002, 51502095), Guangdong Natural Science
   Funds for Distinguished Young Scholar (2016A030306018), and the 111
   Project (B13039).
CR Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014
   [Anonymous], 2016, OPENSTAX AN PHYS
   Augustin G, 2007, INJURY, V38, P1115, DOI 10.1016/j.injury.2007.05.017
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   BURCHARDT H, 1975, J BONE JOINT SURG BR, V57, P814
   Cuthbert RJ, 2013, BONE, V57, P484, DOI 10.1016/j.bone.2013.08.009
   Davy DT, 1999, ORTHOP CLIN N AM, V30, P553, DOI 10.1016/S0030-5898(05)70108-5
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   DIAZFLORES L, 1992, CLIN ORTHOP RELAT R, P280
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001
   Fan W, 2010, BIOMATERIALS, V31, P3580, DOI 10.1016/j.biomaterials.2010.01.083
   Foolen J, 2008, J ORTHOP RES, V26, P1263, DOI 10.1002/jor.20586
   GOLDBERG VM, 1984, J BONE JOINT SURG AM, V66A, P937, DOI 10.2106/00004623-198466060-00016
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Hoffman MD, 2015, BIOMATERIALS, V52, P426, DOI 10.1016/j.biomaterials.2015.02.064
   Hoffman MD, 2013, BIOMATERIALS, V34, P8887, DOI 10.1016/j.biomaterials.2013.08.005
   Ito Y, 2001, OSTEOARTHR CARTILAGE, V9, P215, DOI 10.1053/joca.2000.0378
   Kang YQ, 2014, ACS APPL MATER INTER, V6, P9622, DOI 10.1021/am502056q
   Masquelet AC, 2003, LANGENBECK ARCH SURG, V388, P344, DOI 10.1007/s00423-003-0379-1
   Ochareon P, 2007, ANAT REC, V290, P1366, DOI 10.1002/ar.20588
   Orwoll ES, 2003, J BONE MINER RES, V18, P949, DOI 10.1359/jbmr.2003.18.6.949
   Parfitt AM, 2002, J BONE MINER RES, V17, P1741, DOI 10.1359/jbmr.2002.17.10.1741
   Rapp SJ, 2012, SURGERY, V152, P595, DOI 10.1016/j.surg.2012.07.019
   Schonmeyr B, 2009, TISSUE ENG PT A, V15, P1833, DOI 10.1089/ten.tea.2008.0446
   Shi XT, 2014, ACS APPL MATER INTER, V6, P11915, DOI 10.1021/am5029236
   Shi XT, 2014, ADV MATER, V26, P3290, DOI 10.1002/adma.201305804
   Shi XT, 2013, ADV HEALTHC MATER, V2, P1229, DOI 10.1002/adhm.201300012
   Shim K. M., 2011, J KOREAN SOC RADIOL, V5, P11
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   STEVENSON S, 1992, J BONE JOINT SURG AM, V74A, P939, DOI 10.2106/00004623-199274060-00017
   Su W. T., 2015, MAT SCI ENG C, P58
   Tang L, 2006, BIOCHEM BIOPH RES CO, V344, P122, DOI 10.1016/j.bbrc.2006.03.123
   Weodarski K. H., 1989, CLIN ORTHOP RELAT R, V241, P265
   Zhang JT, 2011, ADV FUNCT MATER, V21, P4079, DOI 10.1002/adfm.201100739
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
NR 37
TC 6
Z9 6
U1 6
U2 25
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2016
VL 4
IS 11
BP 1554
EP 1561
DI 10.1039/c6bm00481d
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DZ9SO
UT WOS:000386219300002
PM 27722242
DA 2018-10-20
ER

PT J
AU Metineren, H
   Dulgeroglu, TC
   Metineren, MH
   Aydin, E
   Kocak, C
AF Metineren, Hasan
   Dulgeroglu, Turan Cihan
   Metineren, Mehmet Huseyin
   Aydin, Ekrem
   Kocak, Cengiz
TI Effectiveness of platelet-rich fibrin on tendon healing: experimental
   study in a rat model
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Platelet rich fibrin; Achilles tendon; platelet rich plasma; tendon
   injury; experimental model
ID NONOPERATIVE TREATMENT; GROWTH-FACTORS; PLASMA PRP; REPAIR;
   AUGMENTATION; TENDINOPATHY; TRANSMISSION; MEDICINE; RUPTURES; SURGERY
AB Platelet Rich Fibrin (PRF) is a new biological augmentation material which is remarkable with its rich cellular components and growth factors. The aim of this study was to evaluate the effect of PRF on tendon healing in a rat model. PRF and control groups included eight rats. PRF was obtained with centrifuging blood collected from the rats and applied on the tendon repair site in Achilles tendon injury model created in rats. Effectiveness of PRF was evaluated with histological and immuno-histochemical methods. PRF improves formation of regular collagen structures (P<0.01) and also increases vascularity (P<0.05) of the tendon repair site. Cartilage formation occurred both in PRF and control groups. Gap formation was observed only in the control group. PRF is an autogenous biomaterial which enhances and support tendon healing.
C1 [Metineren, Hasan; Dulgeroglu, Turan Cihan; Aydin, Ekrem] Dumlupinar Univ, Fac Med, Dept Orthopaed & Traumatol, Kutahya, Turkey.
   [Metineren, Mehmet Huseyin; Kocak, Cengiz] Dumlupinar Univ, Fac Med, Dept Pathol, Kutahya, Turkey.
RP Metineren, H (reprint author), Dumlupinar Univ, Fac Med, Evliya Celebi Campus, TR-43100 Kutahya, Turkey.
EM drhmetin19@gmail.com
FU Dumlupinar University Scientific Research Project Supporting Fund
FX This project was supported by Dumlupinar University Scientific Research
   Project Supporting Fund.
CR Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1121, DOI 10.2174/138920112800624292
   Choueka J, 2000, J HAND SURG-AM, V25A, P1127, DOI 10.1053/jhsu.2000.20155
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   CONRAD EU, 1995, J BONE JOINT SURG AM, V77A, P214, DOI 10.2106/00004623-199502000-00007
   Dietrich F, 2015, WORLD J PLAST SURG, V4, P101
   Dohan DM, 2006, ORAL SURG ORAL MED O, V101, pe37
   Everts Peter A M, 2006, J Extra Corpor Technol, V38, P174
   George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9
   Ghanaati S, 2014, J ORAL IMPLANTOL, V40, P679, DOI 10.1563/aaid-joi-D-14-00138
   Harry Lorraine E., 2003, Birth Defects Research, V69, P363, DOI 10.1002/bdrc.10024
   Khanna A, 2009, BRIT MED BULL, V90, P85, DOI 10.1093/bmb/ldp013
   Kim TH, 2014, ARCH ORAL BIOL, V59, P550, DOI 10.1016/j.archoralbio.2014.02.004
   Kiran NK, 2011, J DENT SCI RES, V2, P50
   Lemaire R, 2000, J BONE JOINT SURG BR, V82B, P313, DOI 10.1302/0301-620X.82B3.14194
   Lo IKY, 1997, CLIN J SPORT MED, V7, P207, DOI 10.1097/00042752-199707000-00010
   Longo UG, 2011, BRIT MED BULL, V98, P31, DOI 10.1093/bmb/ldq030
   Ma JJ, 2007, J BONE JOINT SURG AM, V89A, P2241, DOI 10.2106/JBJS.D.03054
   Maffulli N, 2010, EXPERT OPIN PHARMACO, V11, P2177, DOI 10.1517/14656566.2010.495715
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Rodeo SA, 2012, AM J SPORT MED, V40, P1234, DOI 10.1177/0363546512442924
   Rosenbaum Andrew J, 2010, HSS J, V6, P164, DOI 10.1007/s11420-009-9152-5
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Sharma P, 2005, SURG-J R COLL SURG E, V3, P309, DOI 10.1016/S1479-666X(05)80109-X
   Sharma Pankaj, 2005, Foot Ankle Clin, V10, P383, DOI 10.1016/j.fcl.2005.01.005
   Shim JW, 2006, BIOMECH MODEL MECHAN, V5, P247, DOI 10.1007/s10237-005-0013-y
   Willits K, 2010, J BONE JOINT SURG AM, V92A, P2767, DOI 10.2106/JBJS.I.01401
   Zumstein MA, 2014, J SHOULDER ELB SURG, V23, P3, DOI 10.1016/j.jse.2013.08.017
   Zumstein MA, 2011, OPER TECHN SPORT MED, V19, P190, DOI 10.1053/j.otsm.2011.01.001
NR 28
TC 0
Z9 0
U1 0
U2 3
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2016
VL 9
IS 7
BP 14260
EP 14265
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EA2MT
UT WOS:000386428400223
DA 2018-10-20
ER

PT J
AU Ritz, U
   Kogler, P
   Hofer, I
   Frank, P
   Klees, S
   Gebhard, S
   Brendel, C
   Kaufmann, K
   Hofmann, A
   Rommens, PM
   Jonas, U
AF Ritz, Ulrike
   Koegler, Peter
   Hoefer, Isabel
   Frank, Petra
   Klees, Sven
   Gebhard, Soeren
   Brendel, Christian
   Kaufmann, Kerstin
   Hofmann, Alexander
   Rommens, Pol Maria
   Jonas, Ulrich
TI Photocrosslinkable polysaccharide hydrogel composites based on dextran
   or pullulan-amylose blends with cytokines for a human co-culture model
   of human osteoblasts and endothelial cells
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID STEM-CELLS; IN-VITRO; OSTEOGENIC DIFFERENTIATION; CONTROLLED-RELEASE;
   DELIVERY; PROLIFERATION; REPAIR; VIVO; SCAFFOLDS; MUSCLE
AB Although a large body of research has been devoted to biomaterial development for bone tissue engineering and related medical disciplines in the last few years, novel and optimized materials especially for bone fractures of critical sizes demand continued development. In this respect, polysaccharide-based hydrogels demonstrate beneficial properties and fulfill the main requirements for a bone tissue scaffold as they are hydrophilic, biocompatible, and biodegradable. The aim of the present study was the development of a natural polysaccharide-based scaffold material that can integrate with the host tissue and support bone regeneration. For this purpose, we prepared and investigated two polymer hydrogel composites of photocrosslinkable derivatives of either pure dextran or a mixture of amylose and pullulan with varying composition. In order to increase their biological activity the swollen hydrogel matrices were compounded with stromal derived growth factor (SDF-1) and bone morphogenic protein (BMP-2). As skeletal development is known to depend on angiogenesis, these hydrogel systems were subjected to mono-and co-culture models of human primary osteoblasts (hOBs) with human endothelial cells (HUVEC - as precursors for blood vessel development). The effect of cytokines on hydrogel-dependent cell behavior was analyzed in the presence and absence of the growth factors SDF-1 and BMP-2. Both the employed cell types grew on all cytokine-modified hydrogel composites, which was assessed by optical microscopy and proliferation assays. Migration assays indicated enhanced HUVEC migration under the influence of SDF-1 and real-time PCR demonstrated an enhanced expression of cell-specific markers for growth factor-modified hydrogels, thus demonstrating their functional bioactivity. Our results demonstrate the fundamental potential of such multi-component polysaccharide hydrogel composites as biomaterials for bone regeneration.
C1 [Ritz, Ulrike; Hofmann, Alexander; Rommens, Pol Maria] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Orthopaed & Traumatol, Biomat Grp Mainz, Mainz, Germany.
   [Koegler, Peter; Hoefer, Isabel; Frank, Petra; Klees, Sven; Gebhard, Soeren; Jonas, Ulrich] Univ Siegen, Macromol Chem, D-57068 Siegen, Germany.
   [Hoefer, Isabel] TU Hamburg Harburg Umwelttech & Energiewirtschaft, Hamburg, Germany.
   [Brendel, Christian] Harvard Med Sch, Childrens Hosp, Boston, MA USA.
   [Kaufmann, Kerstin] Univ Hlth Network, Toronto, ON, Canada.
RP Ritz, U (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Orthopaed & Traumatol, Biomat Grp Mainz, Mainz, Germany.
EM ritz@uni-mainz.de
OI Jonas, Ulrich/0000-0002-2161-4541; Ritz, Ulrike/0000-0001-8936-3227
FU stage I grant (Stufe I-Forderung) from the UNIVERSITATSMEDIZIN of
   Johannes Gutenberg-Universitat Mainz; County Olpe
FX The authors would like to acknowledge financial support through a stage
   I grant (Stufe I-Forderung) from the UNIVERSITATSMEDIZIN of the Johannes
   Gutenberg-Universitat Mainz. Isabel Hofer acknowledges the Student Award
   of the County Olpe 2014. The authors also thank Annette Brunsen for
   providing data from her PhD thesis.
CR Abed A, 2011, J BIOMED MATER RES A, V96A, P535, DOI 10.1002/jbm.a.33007
   Amrita, 2015, CARBOHYD POLYM, V123, P180, DOI 10.1016/j.carbpol.2015.01.038
   Autissier A, 2007, J BIOMED MATER RES A, V82A, P336, DOI 10.1002/jbm.a.30998
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Beines PW, 2007, LANGMUIR, V23, P2231, DOI 10.1021/la063264t
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Brendel C, 2012, GENE THER, V19, P1018, DOI 10.1038/gt.2011.167
   Brunsen A, 2012, J MATER CHEM, V22, P19590, DOI 10.1039/c2jm34006b
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   Cai X, 2010, CARBOHYD RES, V345, P922, DOI 10.1016/j.carres.2010.02.008
   Chatakun P, 2014, CELL MOL LIFE SCI, V71, P113, DOI 10.1007/s00018-013-1326-0
   Chen JP, 2013, COLLOID SURFACE B, V110, P120, DOI 10.1016/j.colsurfb.2013.04.028
   Chen SH, 2013, MACROMOL MATER ENG, V298, P429, DOI 10.1002/mame.201200054
   Chen X., 2013, IEEE ENG MED BIOL SO, V2013, P6228
   Cheng LL, 2011, CHEM RES CHINESE U, V27, P145
   Choritz L, 2013, OPHTHALMOLOGE, V110, P714, DOI 10.1007/s00347-013-2837-7
   Desevaux C, 2002, J BIOMED MATER RES, V63, P772, DOI 10.1002/jbm.10451
   Dhivya S, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0099-z
   Fenn S. L., 2015, J BIOMED MATER RES B, V7, P184
   Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049
   Garg RK, 2014, STEM CELL TRANSL MED, V3, P1079, DOI 10.5966/sctm.2014-0007
   Gonzalez-Meijome JM, 2013, CONTACT LENS ANTERIO, V36, P86, DOI 10.1016/j.clae.2012.10.071
   Hashimoto Y, 2015, BIOMATERIALS, V37, P107, DOI 10.1016/j.biomaterials.2014.10.045
   Hofmann A, 2008, BONE, V42, P894, DOI 10.1016/j.bone.2008.01.013
   Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024
   Holloway JL, 2015, MACROMOL BIOSCI, V15, P1218, DOI 10.1002/mabi.201500178
   Jia JL, 2008, J ORG CHEM, V73, P8867, DOI 10.1021/jo8017445
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kadokawa J, 2013, BIOMOLECULES, V3, P369, DOI 10.3390/biom3030369
   Kadokawa J, 2013, CARBOHYD POLYM, V98, P611, DOI 10.1016/j.carbpol.2013.06.038
   Kamel RA, 2013, J AM COLL SURGEONS, V217, P533, DOI 10.1016/j.jamcollsurg.2013.03.027
   Karikkineth BC, 2013, CURR PHARM BIOTECHNO, V14, P4
   Kim J, 2009, J BIOMED MATER RES A, V88A, P967, DOI 10.1002/jbm.a.31947
   Kimura Y, 2010, J BIOMAT SCI-POLYM E, V21, P37, DOI 10.1163/156856209X410193
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Li HN, 2011, J BIOMED MATER RES A, V98A, P31, DOI 10.1002/jbm.a.33045
   Li SF, 2010, BIORESOURCE TECHNOL, V101, P2197, DOI 10.1016/j.biortech.2009.11.044
   Lisman A, 2014, J BIOMATER APPL, V28, P1386, DOI 10.1177/0885328213509676
   Massai D, 2013, J HEALTHC ENG, V4, P329, DOI 10.1260/2040-2295.4.3.329
   Matricardi P, 2013, ADV DRUG DELIVER REV, V65, P1172, DOI 10.1016/j.addr.2013.04.002
   Minier K, 2014, VET COMP ORTHOPAED, V27, P411, DOI 10.3415/VCOT-14-03-0036
   Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054
   Naderi-Meshkin H, 2016, CELL BIOL INT, V40, P730, DOI 10.1002/cbin.10474
   Park S, 2015, CLIN SCI, V129, P217, DOI 10.1042/CS20140714
   Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/01.BRS.0000020734.34957.6A
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Rath SN, 2011, J MATER SCI-MATER M, V22, P1279, DOI 10.1007/s10856-011-4300-0
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Seelbach RJ, 2015, MACROMOL BIOSCI, V15, P1035, DOI 10.1002/mabi.201500082
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shah AR, 2011, ANN BIOMED ENG, V39, P2501, DOI 10.1007/s10439-011-0344-z
   Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com
   Singh RS, 2008, CARBOHYD POLYM, V73, P515, DOI 10.1016/j.carbpol.2008.01.003
   Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130
   Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108
   Sweeney DF, 2013, EYE CONTACT LENS, V39, P53, DOI 10.1097/ICL.0b013e31827c7899
   Sweeney DF, 2002, INVEST OPHTH VIS SCI, V43, pU214
   Thebaud NB, 2007, J MATER SCI-MATER M, V18, P339, DOI 10.1007/s10856-006-0698-1
   van den Brom CR, 2010, J MATER CHEM, V20, P4827, DOI 10.1039/b927314j
   Varghese S, 2006, ADV POLYM SCI, P95, DOI 10.1007/12_072
   Walters BD, 2014, ACTA BIOMATER, V10, P1488, DOI 10.1016/j.actbio.2013.08.038
   Wong VW, 2011, TISSUE ENG PT A, V17, P631, DOI [10.1089/ten.tea.2010.0298, 10.1089/ten.TEA.2010.0298]
   Wong VW, 2011, MACROMOL BIOSCI, V11, P1458, DOI 10.1002/mabi.201100180
   Xiao P, 2008, POLYM ADVAN TECHNOL, V19, P1305, DOI 10.1002/pat.1132
   Yee A, 2015, BLOOD, V126, P939, DOI 10.1182/blood-2015-04-641696
   Zhang HB, 2014, TISSUE ENG PART B-RE, V20, P492, DOI [10.1089/ten.teb.2013.0452, 10.1089/ten.TEB.2013.0452]
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
   Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200
   zur Nieden NI, 2015, ACS APPL MATER INTER, V7, P10599, DOI 10.1021/acsami.5b02368
NR 69
TC 3
Z9 3
U1 2
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2016
VL 4
IS 40
BP 6552
EP 6564
DI 10.1039/c6tb00654j
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA DZ9YN
UT WOS:000386238900008
OA Other Gold
DA 2018-10-20
ER

PT J
AU Bai, Y
   Li, J
   Li, SJ
   Hao, YL
   Zhang, X
   Yang, R
AF Bai, Yun
   Li, Ji
   Li, Shujun
   Hao, Yulin
   Zhang, Xing
   Yang, Rui
TI Corrosion behaviour and surface modification of the beta-type biomedical
   Ti-24Nb-4Zr-8Sn alloys
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Ti-24Nb-4Zr-8Sn alloy; Corrosion behaviour; Surface nanocrystallisation;
   Micro-arc oxidation
ID MICRO-ARC OXIDATION; APATITE-FORMING ABILITY; TITANIUM-OXIDE FILMS;
   IN-VITRO; ELECTROCHEMICAL-BEHAVIOR; TI-20NB-10ZR-5TA ALLOY;
   MECHANICAL-PROPERTIES; IMPLANT APPLICATIONS; TI-6AL-4V ALLOY; BODY-FLUID
AB The low modulus beta-type Ti-24Nb-4Zr-8Sn alloy is a promising new biomedical alloy due to its excellent mechanical biocompatibility and composition of non-toxic elements. As a biomaterial, to determine its suitability for body implant applications, the important aspect is the evaluation of corrosion behaviour and the establishment of a suitable surface state in terms of a tailored surface topography and chemistry which improves corrosion resistance and enables an optimum osseointegration of bone tissue. The goal of this review is to summary the corrosion properties of Ti-24Nb-4Zr-8Sn alloy in the basic human body environments. Meanwhile, the surface modification technology which is emphasised on surface nanocrystallisation and micro-arc oxidation are systematically discussed, the former has been confirmed to be an effective way to improve the stability and pitting resistance of Ti-24Nb-4Zr-8Sn alloy, especially in the fluoride ions containing environments; whereas the later not only increases the corrosion resistance of Ti-24Nb-4Zr-8Sn alloy, but also induces the formation of apatite on the surface to exhibit good bioactivity.
C1 [Bai, Yun; Li, Shujun; Hao, Yulin; Zhang, Xing; Yang, Rui] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
   [Li, Ji] Xian Thermal Power Res Inst Co Ltd, 136 Xingqing Rd, Xian 710032, Peoples R China.
RP Bai, Y (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM ybai@imr.ac.cn
FU Natural Science Foundation of China [51501200]; National Basic Research
   Program of China [2012CB933901]; Hundred-Talent Program of Chinese
   Academy of Sciences
FX This work was supported by the Natural Science Foundation of China
   [grant number 51501200]; National Basic Research Program of China [grant
   number 2012CB933901]; and the Hundred-Talent Program of Chinese Academy
   of Sciences.
CR Afonso CRM, 2010, ACTA BIOMATER, V6, P1625, DOI 10.1016/j.actbio.2009.11.010
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Bai Y, 2013, MAT SCI ENG C-MATER, V33, P2159, DOI 10.1016/j.msec.2013.01.036
   Bai Y, 2012, APPL SURF SCI, V258, P4035, DOI 10.1016/j.apsusc.2011.12.096
   Bai YJ, 2011, MAT SCI ENG C-MATER, V31, P702, DOI 10.1016/j.msec.2010.12.010
   Bai Y, 2011, APPL SURF SCI, V257, P7010, DOI 10.1016/j.apsusc.2011.03.058
   Balyanov A, 2004, SCRIPTA MATER, V51, P225, DOI 10.1016/j.scriptamat.2004.04.011
   Correa C, 2015, MATER DESIGN, V79, P106, DOI 10.1016/j.matdes.2015.04.048
   Dalmau A, 2015, MAT SCI ENG C-MATER, V48, P55, DOI 10.1016/j.msec.2014.11.036
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Fazel M, 2015, APPL SURF SCI, V324, P751, DOI 10.1016/j.apsusc.2014.11.030
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P7280, DOI 10.1016/j.electacta.2009.07.047
   Figueira N, 2009, ELECTROCHIM ACTA, V54, P921, DOI 10.1016/j.electacta.2008.08.001
   Fojt J, 2015, MAT SCI ENG C-MATER, V56, P532, DOI 10.1016/j.msec.2015.07.029
   Garbacz H, 2007, BIOMOL ENG, V24, P559, DOI 10.1016/j.bioeng.2007.08.007
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Gonzalez M, 2014, MAT SCI ENG C-MATER, V42, P691, DOI 10.1016/j.msec.2014.06.010
   Gostin PF, 2013, J BIOMED MATER RES B, V101B, P269, DOI 10.1002/jbm.b.32836
   Granchi D, 2008, BIOMATERIALS, V29, P1494, DOI 10.1016/j.biomaterials.2007.11.038
   Han X, 2011, J MATER SCI TECHNOL, V27, P317, DOI 10.1016/S1005-0302(11)60068-6
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Huang H. H., 2003, BIOMATERIALS, V24, P8
   Huang R, 2013, MAT SCI ENG C-MATER, V33, P2353, DOI 10.1016/j.msec.2013.01.068
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Jin L, 2014, T NONFERR METAL SOC, V24, P2529, DOI 10.1016/S1003-6326(14)63379-3
   Khan MA, 1999, BIOMATERIALS, V20, P765, DOI 10.1016/S0142-9612(98)00229-4
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032
   Lee TH, 2009, J ALLOY COMPD, V488, P482, DOI 10.1016/j.jallcom.2009.09.015
   Li J, 2014, ACTA BIOMATER, V10, P2866, DOI 10.1016/j.actbio.2014.02.032
   Li J., 2014, THESIS, P95
   Li SJ, 2008, MAT SCI ENG A-STRUCT, V480, P101, DOI 10.1016/j.msea.2007.06.070
   Liu F, 2010, MATER CHEM PHYS, V121, P172, DOI 10.1016/j.matchemphys.2010.01.002
   Majumdar P, 2011, J MECH BEHAV BIOMED, V4, P1132, DOI 10.1016/j.jmbbm.2011.03.023
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Milosev I, 2014, J MATER SCI-MATER M, V25, P1099, DOI 10.1007/s10856-014-5144-1
   Milosev I, 2013, ELECTROCHIM ACTA, V99, P176, DOI 10.1016/j.electacta.2013.03.086
   Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008
   Montazeri M, 2011, APPL SURF SCI, V257, P7268, DOI 10.1016/j.apsusc.2011.03.103
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Oh HJ, 2005, SURF COAT TECH, V198, P247, DOI 10.1016/j.surfcoat.2004.10.029
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Park JW, 2009, ACTA BIOMATER, V5, P3272, DOI 10.1016/j.actbio.2009.04.038
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   Robin A, 2007, MATER CORROS, V58, P173, DOI 10.1002/maco.200604004
   Rodriguez-Mercado JJ, 2011, TOXICOL IN VITRO, V25, P1996, DOI 10.1016/j.tiv.2011.07.009
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   Shukla AK, 2005, INTERMETALLICS, V13, P631, DOI 10.1016/j.intermet.2004.10.001
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Sy Y., 1997, CORROSION, V53, P965
   Tamilselvi S, 2007, MATER CORROS, V58, P113, DOI 10.1002/maco.200603979
   Tao J. X., 2008, THESIS, P76
   Tao XJ, 2009, MAT SCI ENG C-MATER, V29, P1923, DOI 10.1016/j.msec.2009.03.004
   Venugopalan R, 2000, BIOMATERIALS, V21, P1669, DOI 10.1016/S0142-9612(00)00049-1
   Watanabe I, 2003, AM J ORTHOD DENTOFAC, V123, P653, DOI 10.1016/S0889-5406(03)00197-5
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   Wu HH, 2005, MATER LETT, V59, P370, DOI 10.1016/j.matlet.2004.10.019
   Yilmazer H, 2012, J MECH BEHAV BIOMED, V10, P235, DOI 10.1016/j.jmbbm.2012.02.022
   Zheng Y. F., 2006, MAT SCI ENG A-STRUCT, V438-440, P5
NR 65
TC 0
Z9 0
U1 8
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
IS 12
BP 668
EP 680
DI 10.1080/10667857.2016.1212586
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA EA2MP
UT WOS:000386427800002
DA 2018-10-20
ER

PT J
AU Chen, JX
   Tan, LL
   Yang, K
AF Chen, Junxiu
   Tan, Lili
   Yang, Ke
TI Recent advances on the development of biodegradable magnesium alloys: a
   review
SO MATERIALS TECHNOLOGY
LA English
DT Review
DE Biodegradable magnesium; Biodegradation mechanism; Alloying; Surface
   treatment
ID IN-VITRO CORROSION; MG-CA ALLOYS; BIOMEDICAL APPLICATIONS; VIVO
   CORROSION; RARE-EARTH; SUBSTITUTED HYDROXYAPATITE; ORTHOPEDIC
   BIOMATERIALS; MECHANICAL-PROPERTIES; DEGRADATION BEHAVIOR; IMPLANT
   APPLICATION
AB Magnesium alloys have great potential to be used as biodegradable implant materials. In this review, the biodegradation mechanism of magnesium alloys was illustrated and two methods to improve the corrosion resistance of magnesium alloys, namely, alloying and surface treatment were introduced. In each part, the mechanism of improving corrosion resistance was summarised. Finally, the further development of biomaterial magnesium alloys was predicted in this review.
C1 [Chen, Junxiu; Tan, Lili; Yang, Ke] Chinese Acad Sci, Inst Met Res, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
RP Tan, LL (reprint author), Chinese Acad Sci, Inst Met Res, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM lltan@imr.ac.cn
FU National Basic Research Program of China (973 Program) [2012CB619101]
FX This work was supported by the National Basic Research Program of China
   (973 Program) [grant number 2012CB619101].
CR Asl SKF, 2015, MATER CHEM PHYS, V161, P185, DOI 10.1016/j.matchemphys.2015.05.035
   Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094
   Bigi A, 2007, INORG CHIM ACTA, V360, P1009, DOI 10.1016/j.ica.2006.07.074
   Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045
   Cai SH, 2012, MAT SCI ENG C-MATER, V32, P2570, DOI 10.1016/j.msec.2012.07.042
   Chen JH, 2013, MATER DESIGN, V45, P300, DOI 10.1016/j.matdes.2012.09.003
   Chen XB, 2012, CORROS ENG SCI TECHN, V47, P365, DOI 10.1179/1743278212Y.0000000019
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   Chu CL, 2013, APPL SURF SCI, V271, P271, DOI 10.1016/j.apsusc.2013.01.175
   Cui F, 2008, FRONT MAT SCI CHINA, V2, P143
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Gao JH, 2011, APPL SURF SCI, V257, P2231, DOI 10.1016/j.apsusc.2010.09.080
   Geng F, 2009, J MATER SCI-MATER M, V20, P1149, DOI 10.1007/s10856-008-3669-x
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Gu XN, 2009, ACTA BIOMATER, V5, P2790, DOI 10.1016/j.actbio.2009.01.048
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Gu YH, 2013, MATER DESIGN, V46, P66, DOI 10.1016/j.matdes.2012.09.056
   Harandi SE, 2013, MATER RES-IBERO-AM J, V16, P11, DOI [10.1590/S1516-14392012005000151, 10.1590/S1516-14392013000100002]
   Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6
   He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014
   He YH, 2009, CHINESE SCI BULL, V54, P484, DOI 10.1007/s11434-009-0080-z
   Hiromoto S, 2015, ACTA BIOMATER, V11, P520, DOI 10.1016/j.actbio.2014.09.026
   Kim WC, 2011, ELECTROCHEM SOLID ST, V14, pC21, DOI 10.1149/2.021111esl
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Kubasek J, 2013, T NONFERR METAL SOC, V23, P1215, DOI 10.1016/S1003-6326(13)62586-8
   Li H, 2014, MATER DESIGN, V58, P43, DOI 10.1016/j.matdes.2014.01.031
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lin X, 2013, ACTA BIOMATER, V9, P8631, DOI 10.1016/j.actbio.2012.12.016
   Mao L, 2015, ACS APPL MATER INTER, V7, P5320, DOI 10.1021/am5086885
   Marie PJ, 2005, OSTEOPOROSIS INT, V16, pS7, DOI 10.1007/s00198-004-1753.8
   Merolli A, 2003, J MATER SCI-MATER M, V14, P327, DOI 10.1023/A:1022979831639
   Nam ND, 2012, J ALLOY COMPD, V542, P199, DOI 10.1016/j.jallcom.2012.07.083
   Roncevic IS, 2014, INT J ELECTROCHEM SC, V9, P5907
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Singh S, 2015, JOM-US, V67, P702, DOI 10.1007/s11837-015-1364-1
   Song GL, 1999, CORROS SCI, V41, P249
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song YW, 2012, CORROS SCI, V65, P322, DOI 10.1016/j.corsci.2012.08.037
   Song YW, 2012, CORROS SCI, V60, P238, DOI 10.1016/j.corsci.2012.03.030
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sudholz AD, 2011, ELECTROCHEM SOLID ST, V14, pC5, DOI 10.1149/1.3523229
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Willbold E, 2015, ACTA BIOMATER, V11, P554, DOI 10.1016/j.actbio.2014.09.041
   Windhagen H, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-62
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Yamasaki M, 2007, CORROS SCI, V49, P255, DOI 10.1016/j.corsci.2006.05.017
   Yan TT, 2014, J MATER SCI TECHNOL, V30, P666, DOI 10.1016/j.jmst.2013.12.015
   Yan TT, 2010, MAT SCI ENG C-MATER, V30, P740, DOI 10.1016/j.msec.2010.03.007
   Yang MB, 2011, MATER DESIGN, V32, P1967, DOI 10.1016/j.matdes.2010.11.071
   Yun YH, 2009, MATER TODAY, V12, P22, DOI 10.1016/S1369-7021(09)70273-1
   Zeng RC, 2015, CORROS SCI, V96, P23, DOI 10.1016/j.corsci.2015.03.018
   Zhang E, 2005, SCRIPTA MATER, V53, P523, DOI 10.1016/j.scriptamat.2005.05.009
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
   Zhao DW, 2016, BIOMATERIALS, V81, P84, DOI 10.1016/j.biomaterials.2015.11.038
   Zheng Y., 2015, MAGNESIUM ALLOYS DEG
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhou YL, 2011, ADV MATER RES-SWITZ, V197-198, P56, DOI 10.4028/www.scientific.net/AMR.197-198.56
   Zong Y, 2012, MATER SCI ENG B-ADV, V177, P395, DOI 10.1016/j.mseb.2011.09.042
NR 64
TC 4
Z9 4
U1 9
U2 37
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
IS 12
BP 681
EP 688
DI 10.1080/10667857.2016.1212587
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA EA2MP
UT WOS:000386427800003
DA 2018-10-20
ER

PT J
AU Chaturvedi, TP
AF Chaturvedi, T. P.
TI Corrosive behaviour of implant biomaterials in oral environment
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Oral environment; Corrosion; Dental Implant; Titanium; Biocompatibility
ID BACTERIAL ADHESION; IN-VITRO; TITANIUM; MECHANISMS; ALLOYS;
   LIPOPOLYSACCHARIDE; RESISTANCE; ZIRCONIUM; TI6AL4V; SURFACE
AB The major groups of implantable materials in dentistry are metals and alloys, ceramics and polymeric materials. Titanium has developed into a well-accepted metallic biomaterial since many decades, its unique properties like biological, mechanical, physiological and functional phenomenon with living tissue has popularised it with many biomechanical applications including arthroplasty, osteosynthesis, pace-maker cases, oral reconstructive procedures, anchorage of bone conductive hearing aids and jewellery. In clinical situation, some properties of implant biomaterials e.g. elastic modulus, tensile strength and ductility are used to aid in the design and fabrication of the prosthesis. It should be noted, however, that no material including implant can be considered universally biocompatible. Objective of present paper is to provide an overview of various aspects of dental implant materials and its interaction with oral environment with special emphasis on their prognosis and clinical behaviour.
C1 [Chaturvedi, T. P.] Banaras Hindu Univ, Inst Med Sci, Dept Dent, Div Orthodont & Dentofacial Orthopaed,Fac Dent Sc, Varanasi 221005, Uttar Pradesh, India.
RP Chaturvedi, TP (reprint author), Banaras Hindu Univ, Inst Med Sci, Dept Dent, Div Orthodont & Dentofacial Orthopaed,Fac Dent Sc, Varanasi 221005, Uttar Pradesh, India.
EM tpchaturvedi@rediffmail.com
CR Antunes RA, 2012, ACTA BIOMATER, V8, P937, DOI 10.1016/j.actbio.2011.09.012
   Bedi RS, 2009, ACTA BIOMATER, V5, P3265, DOI 10.1016/j.actbio.2009.04.019
   Chan CW, 2016, APPL SURF SCI, V367, P80, DOI 10.1016/j.apsusc.2016.01.091
   Chaturvedi T P, 2010, Indian J Dent Res, V21, P275, DOI 10.4103/0970-9290.66648
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P91
   Chaturvedi T. P., 2013, CLIN COSMET INVESTIG, P51
   Chaturvedi Thakur Prasad, 2012, Indian J Dent Res, V23, P479, DOI 10.4103/0970-9290.104953
   Cui WF, 2015, SURF COAT TECH, V283, P101, DOI 10.1016/j.surfcoat.2015.10.051
   Drugs G. G., 2011, CORROS SCI, V53, P3873
   Faverani LP, 2014, MAT SCI ENG C-MATER, V43, P1, DOI 10.1016/j.msec.2014.06.033
   Huang HL, 2013, THIN SOLID FILMS, V549, P108, DOI 10.1016/j.tsf.2013.07.075
   Kotharu V, 2012, CERAM INT, V38, P731, DOI 10.1016/j.ceramint.2011.07.065
   Lin NM, 2012, APPL SURF SCI, V258, P7047, DOI 10.1016/j.apsusc.2012.03.163
   Mahato N, 2011, MATER LETT, V65, P2241, DOI 10.1016/j.matlet.2011.04.034
   Mareci D, 2013, CORROS SCI, V73, P106, DOI 10.1016/j.corsci.2013.03.030
   Martin-Camean A, 2014, TALANTA, V118, P238, DOI 10.1016/j.talanta.2013.10.035
   Mathew MT, 2012, J MECH BEHAV BIOMED, V8, P71, DOI 10.1016/j.jmbbm.2011.11.004
   Mine Y, 2010, J PROSTHODONT RES, V54, P1, DOI 10.1016/j.jpor.2009.07.003
   Narayanan TSNS, 2014, PROG MATER SCI, V60, P1, DOI 10.1016/j.pmatsci.2013.08.002
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Prasad S, 2015, J ORAL BIOSCI, V57, P192, DOI 10.1016/j.job.2015.08.001
   Barao VAR, 2013, J PROSTHET DENT, V110, P462, DOI 10.1016/j.prosdent.2013.04.004
   Souza JCM, 2015, MAT SCI ENG C-MATER, V47, P384, DOI 10.1016/j.msec.2014.11.055
   Tang XY, 2015, CHEM ENG RES DES, V100, P530, DOI 10.1016/j.cherd.2015.05.003
   Marques IDV, 2016, J MECH BEHAV BIOMED, V60, P8, DOI 10.1016/j.jmbbm.2015.12.030
   Wachi T, 2015, TOXICOLOGY, V327, P1, DOI 10.1016/j.tox.2014.10.016
   Wang JQ, 2014, SURF COAT TECH, V258, P1032, DOI 10.1016/j.surfcoat.2014.07.034
   Ye XX, 2014, SURF COAT TECH, V258, P467, DOI 10.1016/j.surfcoat.2014.08.052
   Yokoyama K, 2002, BIOMATERIALS, V23, P2459, DOI 10.1016/S0142-9612(01)00380-5
   Yokoyama K, 2013, CORROS SCI, V73, P375, DOI 10.1016/j.corsci.2013.04.027
NR 30
TC 2
Z9 2
U1 2
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
IS 12
BP 689
EP 695
DI 10.1080/10667857.2016.1213527
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA EA2MP
UT WOS:000386427800004
DA 2018-10-20
ER

PT J
AU Shaabani, A
   Afaridoun, H
   Shaabani, S
   Nejad, MK
AF Shaabani, Ahmad
   Afaridoun, Hadi
   Shaabani, Shabnam
   Nejad, Mina Keramati
TI Natural hydroxyapatite supported cobalt tetrasulfophthalocyanine: a
   green, renewable and biomaterial-based heterogeneous catalyst for
   selective aerobic oxidation of alkyl arenes and alcohols
SO RSC ADVANCES
LA English
DT Article
ID METALLOPHTHALOCYANINE FUNCTIONALIZED SILICAS; TRANSFER CHAIN
   ISOMERIZATION; HYDROGEN-PEROXIDE OXIDATION; COPPER(II) PHTHALOCYANINE;
   EFFICIENT CATALYST; ASSISTED SYNTHESIS; AROMATIC-COMPOUNDS;
   ROOM-TEMPERATURE; HIGHLY EFFICIENT; NANOPARTICLES
AB Natural hydroxyapatite supported cobalt tetrasulfophthalocyanine (CoTSPc-NHAp) as a green, renewable and biomaterial-based heterogeneous catalyst that mediates oxidation of various secondary benzylic C-H bonds, secondary benzylic and primary and secondary aliphatic alcohols to their corresponding aldehydes and ketones in high yields and selectivity without any additional oxidizing reagent is reported. The structure of the synthesized catalyst was characterized by inductively coupled plasma-optical emission spectrometry (ICP-OES), Fourier transform infrared (FT-IR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), scanning electron microscopy (SEM), and the energy dispersive spectroscopy (EDS) analysis.
C1 [Shaabani, Ahmad; Afaridoun, Hadi; Shaabani, Shabnam; Nejad, Mina Keramati] Shahid Beheshti Univ, Fac Chem, GC, POB 19396-4716, Tehran, Iran.
RP Shaabani, A (reprint author), Shahid Beheshti Univ, Fac Chem, GC, POB 19396-4716, Tehran, Iran.
EM a-shaabani@sbu.ac.ir
FU Iran National Elites Foundation (INEF); Research Council of Shahid
   Beheshti University
FX We gratefully acknowledge financial support of the Iran National Elites
   Foundation (INEF) and the Research Council of Shahid Beheshti
   University.
CR Abidi SSA, 2014, J MATER SCI TECHNOL, V30, P307, DOI 10.1016/j.jmst.2013.10.011
   Agboola B, 2005, J MOL CATAL A-CHEM, V227, P209, DOI 10.1016/j.molcata.2004.10.041
   Alvaro M, 2005, APPL CATAL B-ENVIRON, V57, P37, DOI 10.1016/j.apcatb.2004.10.003
   bin Saiman MI, 2012, ANGEW CHEM INT EDIT, V51, P5981, DOI 10.1002/anie.201201059
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Chen WX, 2007, ENVIRON SCI TECHNOL, V41, P6240, DOI 10.1021/es070002k
   Cornils B., 1996, APPL HOMOGENEOUS CAT
   Dasireddy VDBC, 2012, APPL CATAL A-GEN, V421, P58, DOI 10.1016/j.apcata.2012.01.034
   De Corte S, 2011, ENVIRON SCI TECHNOL, V45, P8506, DOI 10.1021/es2019324
   DELAUNAY J, 1982, J CHEM SOC CHEM COMM, P387, DOI 10.1039/c39820000387
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Galletti AMR, 2013, APPL CATAL A-GEN, V468, P95, DOI 10.1016/j.apcata.2013.08.005
   Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   Hadasch A, 1998, NEW J CHEM, V22, P45, DOI 10.1039/a706741k
   Han Y, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/33/335705
   Hudlicky M., 1990, OXIDATIONS ORGANIC C
   KAGAN J, 1977, TETRAHEDRON LETT, P4289
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   LOPEZ L, 1989, TETRAHEDRON LETT, V30, P3097, DOI 10.1016/S0040-4039(00)99412-7
   Mahyari M, 2014, CHEM COMMUN, V50, P7855, DOI 10.1039/c4cc01406e
   Mahyari M, 2014, APPL CATAL A-GEN, V469, P524, DOI 10.1016/j.apcata.2013.09.024
   McMurray L, 2011, CHEM SOC REV, V40, P1885, DOI 10.1039/c1cs15013h
   Mitsudome T., 2008, ANGEW CHEM, V120, P8056
   MONMA H, 1987, J MATER SCI, V22, P4247, DOI 10.1007/BF01132015
   Mori K, 2004, J AM CHEM SOC, V126, P10657, DOI 10.1021/ja0488683
   MUZART J, 1992, CHEM REV, V92, P113, DOI 10.1021/cr00009a005
   Panwar V, 2015, TETRAHEDRON LETT, V56, P3948, DOI 10.1016/j.tetlet.2015.05.003
   Perollier CP, 2002, CHEM COMMUN, P1548, DOI 10.1039/b204122g
   Pirkanniemi K, 2003, SCI TOTAL ENVIRON, V307, P11, DOI 10.1016/S0048-9697(02)00499-0
   Rakap M, 2012, CATAL TODAY, V183, P17, DOI 10.1016/j.cattod.2011.04.022
   Ratnasamy P, 2009, CATAL TODAY, V141, P3, DOI 10.1016/j.cattod.2008.03.009
   Reddy MP, 2007, WATER RES, V41, P379, DOI 10.1016/j.watres.2006.09.018
   Rezaeifard A, 2012, GREEN CHEM, V14, P3386, DOI 10.1039/c2gc35837a
   Serp P, 2015, RSC CATAL SER, pVII
   Seyedi SM, 2010, CHINESE CHEM LETT, V21, P1303, DOI 10.1016/j.cclet.2010.06.009
   Seyyedhamzeh M, 2012, J PORPHYR PHTHALOCYA, V16, P1110, DOI 10.1142/S1088424612501106
   Shaabani A, 2008, CATAL COMMUN, V10, P129, DOI 10.1016/j.catcom.2008.05.010
   Shaabani A, 2008, CATAL COMMUN, V9, P1692, DOI 10.1016/j.catcom.2007.12.023
   Shaabani A, 2008, APPL CATAL A-GEN, V338, P14, DOI 10.1016/j.apcata.2007.12.014
   Shaabani A, 2016, APPL ORGANOMET CHEM, V30, P772, DOI 10.1002/aoc.3505
   Shaabani A, 2016, RSC ADV, V6, P48396, DOI 10.1039/c6ra04519g
   Shaabani A, 2015, CELLULOSE, V22, P3027, DOI 10.1007/s10570-015-0708-x
   Shaabani A, 2014, J MOL CATAL A-CHEM, V395, P494, DOI 10.1016/j.molcata.2014.09.003
   Shaabani A, 2014, RSC ADV, V4, P64419, DOI 10.1039/c4ra11101j
   Sharma VB, 2003, TETRAHEDRON LETT, V44, P383, DOI 10.1016/S0040-4039(02)02453-X
   Sorokin AB, 2011, CATAL TODAY, V159, P37, DOI 10.1016/j.cattod.2010.06.020
   Sorokin AB, 1999, NEW J CHEM, V23, P473, DOI 10.1039/a901689i
   Sorokin AB, 2000, CATAL TODAY, V57, P45, DOI 10.1016/S0920-5861(99)00312-0
   Sun AH, 2006, J MOL CATAL A-CHEM, V259, P1, DOI 10.1016/j.molcata.2006.04.046
   Thangavel S, 2016, J MOL CATAL A-CHEM, V423, P160, DOI 10.1016/j.molcata.2016.06.017
   Tong XL, 2005, ADV SYNTH CATAL, V347, P1953, DOI 10.1002/adsc.200505183
   Vincenzini P., 1987, HIGH TECH CER P WORL
   Wang WT, 2014, TETRAHEDRON LETT, V55, P124, DOI 10.1016/j.tetlet.2013.10.133
   Wang Y, 2010, ANGEW CHEM INT EDIT, V49, P3356, DOI 10.1002/anie.201000120
   Waser M, 2005, J MOL CATAL A-CHEM, V236, P187, DOI 10.1016/j.molcata.2005.04.017
   Xia W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305610
   Xiong ZG, 2007, CHEM MATER, V19, P1452, DOI 10.1021/cm062437x
   YANG YC, 1985, INORG CHEM, V24, P1765, DOI 10.1021/ic00206a011
   Zahmakiran M, 2010, CHEM COMMUN, V46, P4788, DOI 10.1039/c0cc00494d
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
   Zhou H, 2012, CHEM COMMUN, V48, P6954, DOI 10.1039/c2cc30737e
NR 64
TC 2
Z9 2
U1 3
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 99
BP 97367
EP 97375
DI 10.1039/c6ra24294d
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA DZ9ZN
UT WOS:000386242500113
DA 2018-10-20
ER

PT J
AU Ceylan, S
   Gokturk, D
   Bolgen, N
AF Ceylan, Seda
   Gokturk, Dilek
   Bolgen, Nimet
TI Effect of crosslinking methods on the structure and biocompatibility of
   polyvinyl alcohol/gelatin cryogels
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Cryogel; polyvinyl alcohol; gelatin; scaffold; tissue engineering
ID POLY VINYL ALCOHOL; POLY(VINYL ALCOHOL); GELATIN; GLUTARALDEHYDE;
   HYDROGEL; BLENDS; FILMS; FABRICATION; SCAFFOLDS; DESIGN
AB In this study, polyvinyl alcohol (PVA) and gelatin based cryogels were prepared by crosslinking chemically or physically for tissue engineering applications. Different PVA/Gelatin ratios (100: 0, 90: 10, 70: 30, 50: 50) and crosslinking methods have been used to prepare cryogels; chemical and physical structure of the prepared matrices were analysed by FTIR and SEM; swelling and degradation profiles were followed. Chemical and physical crosslinking was obtained by using glutaraldehyde as crosslinker and by applying freeze thawing cycle, respectively. Gelatin concentration and crosslinking method had significant effect on the pore size, swelling ratio and degradation profiles of the cryogels. Biocompatibility of the cryogels were also investigated by MTT assay. SEM was used to investigate the cell morphology on the scaffolds. The MTT assay findings prove that physically crosslinked PVA/Gelatin scaffolds are more biocompatible and enhance more the adhesion and proliferation of mouse embryonic fibroblast cells (MEF) than chemically crosslinked PVA/Gelatin scaffolds. The overall results demonstrated that, the PVA/Gelatin cyrogels as a suitable biomaterial for tissue engineering applications and crosslinking methods affect the architecture and characteristic properties of the cryogels.
C1 [Ceylan, Seda; Bolgen, Nimet] Mersin Univ, Fac Engn, Dept Chem Engn, Mersin, Turkey.
   [Ceylan, Seda; Gokturk, Dilek] Adana Sci & Technol Univ, Bioengn Dept, Adana, Turkey.
RP Bolgen, N (reprint author), Mersin Univ, Fac Engn, Dept Chem Engn, Mersin, Turkey.
EM nimetbolgen@yahoo.com
FU Scientific Research Projects Unit of Mersin University [BAP-FBE KMB
   2014-1 YL]
FX This work was supported by the Scientific Research Projects Unit of
   Mersin University (BAP-FBE KMB (SC) 2014-1 YL).
CR Alves PMA, 2011, FOOD HYDROCOLLOID, V25, P1751, DOI 10.1016/j.foodhyd.2011.03.018
   Azami M, 2010, POLYM COMPOSITE, V31, P2112, DOI 10.1002/pc.21008
   Bajpai AK, 2005, POLYM INT, V54, P1233, DOI 10.1002/pi.1813
   Choi SM, 2013, INT J POLYM MATER PO, V62, P384, DOI 10.1080/00914037.2012.710862
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Gonzalez JS, 2012, PROC MAT SCI, V1, P483, DOI 10.1016/j.mspro.2012.06.065
   Gualandi C., THESIS
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Imani R, 2013, BIO-MED MATER ENG, V23, P211, DOI 10.3233/BME-130745
   Jiang HJ, 2004, MED ENG PHYS, V26, P269, DOI 10.1016/j.medengphy.2003.10.007
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu YR, 2010, J MECH BEHAV BIOMED, V3, P203, DOI 10.1016/j.jmbbm.2009.07.001
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   Ma R., 2008, J CHINA U MINING TEC, V18, P271, DOI 10.1016/S1006-1266(08)60057-7
   Ma RY, 2009, MAT SCI ENG C-MATER, V29, P1979, DOI 10.1016/j.msec.2009.03.010
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Mendieta-Taboada O, 2008, FOOD HYDROCOLLOID, V22, P1485, DOI 10.1016/j.foodhyd.2007.10.001
   Moraes ICF, 2009, J FOOD ENG, V95, P588, DOI 10.1016/j.jfoodeng.2009.06.023
   Moscato S, 2008, MICRON, V39, P569, DOI 10.1016/j.micron.2007.06.016
   Narbat Mehdi Kazemzadeh, 2006, Iranian Journal of Biotechnology, V4, P54
   Nguyen T.-H., 2010, J BIOMED SCI ENG, V3, P1117, DOI DOI 10.4236/JBISE.2010.312145
   Niu G., 2013, J SCI APPL BIOMED, V1, P1
   Pal K, 2006, J BIOMATER APPL, V21, P75, DOI 10.1177/0885328206056312
   Pazos V, 2009, J MECH BEHAV BIOMED, V2, P542, DOI 10.1016/j.jmbbm.2009.01.003
   Reis E. F., 2006, MAT RES, V9, P185, DOI DOI 10.1590/S1516-14392006000200014
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sinha A, 2007, MAT SCI ENG C-BIO S, V27, P70, DOI 10.1016/j.msec.2006.02.008
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vrana N.E., 2009, THESIS
   Wang W, 2014, CERAM INT, V40, P1789, DOI 10.1016/j.ceramint.2013.07.079
   Wihodo M, 2013, J FOOD ENG, V114, P292, DOI 10.1016/j.jfoodeng.2012.08.021
   Yang JM, 2004, J MEMBRANE SCI, V236, P39, DOI 10.1016/j.memsci.2004.02.005
NR 34
TC 3
Z9 3
U1 3
U2 20
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2016
VL 27
IS 4
BP 327
EP 340
DI 10.3233/BME-161589
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DZ1XH
UT WOS:000385634800002
DA 2018-10-20
ER

PT J
AU Zhang, ZJ
   Jia, HL
   Sun, JY
   Tong, J
AF Zhang, Zhijun
   Jia, Honglei
   Sun, Jiyu
   Tong, Jin
TI Nanoindentation investigation of the stress exponent for the creep of
   dung beetle (Copris ochus Motschulsky) cuticle
SO BIOENGINEERED
LA English
DT Article
DE creep; cuticle; dung beetle; nanoindenter; stress exponent
ID MECHANICAL-PROPERTIES; BIOMIMETIC APPLICATIONS; FOREWING STRUCTURES;
   INDENTATION; SCARABAEIDAE; COLEOPTERA
AB With the rapid development of bionic science, especially the progress that has been made in the fields of biomaterials and biomimetics, there is now great interest in the surface and internal mechanical properties of biological materials at the micro- and nanoscale. The study of micro- and nanoscale biomaterial mechanical properties could enable interdisciplinary applications in materials science, biological science and bionic science. Dung beetle ( Copris ochus Motschulsky) cuticle is a viscoelastic material that is both viscous and flexible via elastic deformation under external forces; where stress sigma, strain epsilon and elastic modulus E are related in the following way: sigma = E epsilon. In addition, as s is related to the rate of strain, time is also a factor. The stress-strain relationships of various parts of dung beetle cuticle were investigated in this paper. As time increased, the stress and strain of the material were found to decrease and increase, respectively, indicating that when the material was indented for a certain period, the interaction force between the indenter and the material gradually achieved a state of dynamic equilibrium. However, strain continued to occur until reaching a point of equilibrium because of the creep phenomenon. The stress-strain curves showed a strong character in each holding time condition: the longer the holding time, the more flattened the stress-strain curve. These findings will be useful in the advanced design of strong, lightweight, and biomimetic composites.
C1 [Zhang, Zhijun] Jilin Univ, Sch Mech Sci & Engn, Dept Mech Design & Automat, Changchun, Peoples R China.
   [Jia, Honglei; Sun, Jiyu; Tong, Jin] Jilin Univ, Minist Educ, Key Lab Bion Engn, 5988 Renmin St,Nanling Campus, Changchun 130022, Peoples R China.
RP Jia, HL; Sun, JY (reprint author), Jilin Univ, Minist Educ, Key Lab Bion Engn, 5988 Renmin St,Nanling Campus, Changchun 130022, Peoples R China.
EM jiahl@vip.163.com; sjy@jlu.edu.cn
CR Arzt E, 2002, Z METALLKD, V93, P345, DOI 10.3139/146.020345
   Barbakadze N, 2006, J EXP BIOL, V209, P722, DOI 10.1242/jeb.02065
   Chen JX, 2015, MAT SCI ENG C-MATER, V55, P620, DOI 10.1016/j.msec.2015.04.045
   Chen JX, 2015, MAT SCI ENG C-MATER, V55, P605, DOI 10.1016/j.msec.2015.05.064
   Cheng Hong, 2003, Acta Entomologica Sinica, V46, P429
   CHIANG DY, 1994, J MATER RES, V9, P903, DOI 10.1557/JMR.1994.0903
   Cseh G, 1997, J MATER SCI, V32, P1733, DOI 10.1023/A:1018524016505
   Enders S, 2004, J MATER RES, V19, P880, DOI 10.1557/jmr.2004.19.3.880
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Gao Y, 2007, RES EXPLOR LAB, V26, P164
   George M, 2002, EXPT MECH, V42, P395
   Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135
   Kim JY, 2000, ARTHROPOD STRUCT DEV, V29, P121, DOI 10.1016/S1467-8039(00)00022-0
   Kohane M, 2003, J BIOMED MATER RES A, V66A, P633, DOI 10.1002/jbm.a.10028
   LI WB, 1991, ACTA METALL MATER, V39, P3099, DOI 10.1016/0956-7151(91)90043-Z
   Lucas BN, 1999, METALL MATER TRANS A, V30, P601, DOI 10.1007/s11661-999-0051-7
   Luo YH, 2015, J MECH MED BIOL, V15, DOI 10.1142/S0219519415300021
   Martinez E, 2003, APPL PHYS A-MATER, V77, P419, DOI 10.1007/s00339-002-1669-0
   Nelson DR, 2003, COMP BIOCHEM PHYS B, V134, P447, DOI 10.1016/S1096-4959(02)00262-2
   Neville A. C., 1975, BIOL ARTHROPOD CUTIC
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108
   POISL WH, 1995, J MATER RES, V10, P2024, DOI 10.1557/JMR.1995.2024
   Scherge M, 2002, APPL MECH REV, V55, pB119
   Scherge M, 2002, BIOL MICRO NANOTRIBO
   Sun JY, 2014, J BIONIC ENG, V11, P144, DOI 10.1016/S1672-6529(14)60029-9
   Sun JY, 2012, ADV MATER RES-SWITZ, V343-344, P1133, DOI 10.4028/www.scientific.net/AMR.343-344.1133
   Tong J, 2005, SOIL TILL RES, V80, P1, DOI 10.1016/j.still.2003.12.012
   Tong J., 2008, INT C BION ENG 2008, P41
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7
   Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935
NR 32
TC 0
Z9 1
U1 1
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2165-5979
EI 2165-5987
J9 BIOENGINEERED
JI Bioengineered
PY 2016
VL 7
IS 5
SI SI
BP 357
EP 364
DI 10.1080/21655979.2016.1226666
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DZ4BM
UT WOS:000385802400011
PM 27710435
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Hanze, J
   Jakubowski, P
   Heers, H
   Hegele, A
   Timmesfeld, N
   Hofmann, R
   Olbert, PJ
AF Haenze, Joerg
   Jakubowski, Peter
   Heers, Hendrik
   Hegele, Axel
   Timmesfeld, Nina
   Hofmann, Rainer
   Olbert, Peter J.
TI Assessing blood platelets as RNA biomarker source for prostate cancer
SO BIOMARKERS
LA English
DT Article
DE Biomaterial; PCA3; thrombocyte
ID GENE; LONG; EXPRESSION; MARKER; TUMORS; PCA3; DD3
AB Context: Blood platelets may offer as RNA biomarker source for cancer as recently described for an oncogenic transcript in glioma patients and for PCA3 in prostate cancer (PCa) patients.
   Objective: Here, we elaborated on this aspect for PCa.
   Materials and methods: PCA3 and other PCa-associated RNA markers were measured in platelets of PCa patients (cases) and healthy subjects (controls) in comparison to PCa cell lines by relative quantitative RT-PCR.
   Results: The RNA markers displayed heterogeneous expression patterns in cell lines and platelets, however, without significant differences between cases and controls.
   Discussion and conclusion: The data do not support platelets as a profitable RNA source for early detection of PCa. Nonetheless, certain PCa-derived RNA markers in platelets may merit further investigation as potential prognostic biomarkers for PCa.
C1 [Haenze, Joerg; Jakubowski, Peter; Heers, Hendrik; Hegele, Axel; Hofmann, Rainer; Olbert, Peter J.] Univ Marburg, Dept Urol & Pediat Urol, Baldingerstr, D-35043 Marburg, Germany.
   [Timmesfeld, Nina] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany.
RP Hanze, J (reprint author), Univ Marburg, Dept Urol & Pediat Urol, Baldingerstr, D-35043 Marburg, Germany.
EM joerg.haenze@med.uni-marburg.de; timmesfn@staff.uni-marburg.de
OI Heers, Hendrik/0000-0002-7157-5077
FU Alfred and Ursula Kulemann Foundation
FX The authors thank Susanne Lingelbach for excellent technical assistance.
   The authors also thank the study participants for their contributions to
   make this study possible. The study was supported by the "Alfred and
   Ursula Kulemann Foundation".
CR Bolton EM, 2014, CLIN CANCER RES, V20, P35, DOI 10.1158/1078-0432.CCR-13-1989
   Bussemakers MJG, 1999, CANCER RES, V59, P5975
   Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995
   de Kok JB, 2002, CANCER RES, V62, P2695
   Erdmann K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-82
   Gandini O, 2003, CANCER RES, V63, P4747
   Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797
   Helo P, 2009, CLIN CHEM, V55, P765, DOI 10.1373/clinchem.2008.117952
   Holmstrom B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3537
   Kaatsch P, 2014, GERMAN CTR CANC REGI
   Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459
   Nilsson RJA, 2011, BLOOD, V118, P3680, DOI 10.1182/blood-2011-03-344408
   Ren SC, 2013, EUR J CANCER, V49, P2949, DOI 10.1016/j.ejca.2013.04.026
   Salameh A, 2015, P NATL ACAD SCI USA, V112, P8403, DOI 10.1073/pnas.1507882112
   Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777
   Sowalsky AG, 2015, MOL CANCER RES, V13, P98, DOI 10.1158/1541-7786.MCR-14-0273
   Verhaegh GW, 2003, CANCER RES, V63, P4248
   Walsh AL, 2014, TRENDS MOL MED, V20, P428, DOI 10.1016/j.molmed.2014.03.005
   Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002
NR 19
TC 2
Z9 2
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1354-750X
EI 1366-5804
J9 BIOMARKERS
JI Biomarkers
PY 2016
VL 21
IS 7
BP 653
EP 659
DI 10.3109/1354750X.2016.1171909
PG 7
WC Biotechnology & Applied Microbiology; Toxicology
SC Biotechnology & Applied Microbiology; Toxicology
GA DY8SA
UT WOS:000385399600012
PM 27121394
DA 2018-10-20
ER

PT S
AU Smetana, M
   Capova, K
   Palcek, P
   Oravcova, M
AF Smetana, Milan
   Capova, Klara
   Palcek, Peter
   Oravcova, Monika
BE Yusa, N
   Uchimoto, T
   Kikuchi, H
TI Identification of Biomaterial Fatigue Cracks by ECT Method
SO ELECTROMAGNETIC NONDESTRUCTIVE EVALUATION (XIX)
SE Studies in Applied Electromagnetics and Mechanics
LA English
DT Proceedings Paper
CT 20th International Workshop on Electromagnetic Non-Destructive
   Evaluation (ENDE)
CY SEP 21-23, 2015
CL Tohoku Univ, Sendai, JAPAN
SP Tohoku Univ, Sch Engn, Tohoku Univ, Inst Fluid Sci, Japan Soc Maintenol, Intelligent Cosmos Res Inst, Sendai Tourism, Convent & Int Assoc, Kajima Fdn
HO Tohoku Univ
DE Non-destructive inspection; eddy current testing; biomaterial fatigue
   cracking; austenitic stainless steel
AB The article deals with the eddy current technique for biomaterial fatigue cracks evaluation. The austenitic steel specimens with the presence of fatigue cracks are inspected under the same conditions. The mechanically induced fatigue cracks are made under the defined conditions, while a micro-plastic deformation is visible. Modular eddy current probe is used for the near-side inspection, while the harmonic signal is used for the driving. The gained results are presented and discussed in the paper.
C1 [Smetana, Milan; Capova, Klara] Univ Zilina, Dept Electromagnet & Biomed Engn, Fac Elect Engn, Univ 1, Zilina 01026, Slovakia.
   [Palcek, Peter; Oravcova, Monika] Univ Zilina, Dept Mat Engn, Fac Mech Engn, Univ 1, Zilina, Slovakia.
RP Smetana, M (reprint author), Univ Zilina, Dept Electromagnet & Biomed Engn, Fac Elect Engn, Univ 1, Zilina 01026, Slovakia.
EM milan.smetana@fel.uniza.sk
CR Boltz E.S., 1998, REV PROG QUANT NONDE, V17, P1033
   Chen Q., 2014, METALLIC IMPLANT BIO
   Dogaru T, 2000, NONDESTRUCT TEST EVA, V16, P31
   LEBRUN B, 1995, MATER EVAL, V53, P1296
   Palcek P., 2015, MAT BIOMEDICINSKEINZ
   WARD WW, 1998, REV PROGR QNDE A, V17, P291
NR 6
TC 2
Z9 2
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1383-7281
BN 978-1-61499-639-2; 978-1-61499-638-5
J9 STUD APPL ELECTROMAG
PY 2016
VL 41
BP 223
EP 229
DI 10.3233/978-1-61499-639-2-223
PG 7
WC Materials Science, Characterization & Testing; Physics, Applied
SC Materials Science; Physics
GA BF9CQ
UT WOS:000385449600029
DA 2018-10-20
ER

PT J
AU Malec, K
   Goralska, J
   Hubalewska-Mazgaj, M
   Glowacz, P
   Jarosz, M
   Brzewski, P
   Sulka, GD
   Jaskula, M
   Wybranska, I
AF Malec, Katarzyna
   Goralska, Joanna
   Hubalewska-Mazgaj, Magdalena
   Glowacz, Paulina
   Jarosz, Magdalena
   Brzewski, Pawel
   Sulka, Grzegorz D.
   Jaskula, Marian
   Wybranska, Iwona
TI Effects of nanoporous anodic titanium oxide on human adipose derived
   stem cells
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE adipose-derived stem cells; anodic titanium oxide; nanotopography;
   osteogenic differentiation; biomaterials
ID GLYCEROL-BASED ELECTROLYTE; POLYMERASE-CHAIN-REACTION; TIO2 NANOTUBE
   SURFACES; OSTEOGENIC DIFFERENTIATION; IN-VITRO; ELECTROCHEMICAL
   ANODIZATION; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; TISSUE;
   IMPLANTS
AB The aim of current bone biomaterials research is to design implants that induce controlled, guided, successful, and rapid healing. Titanium implants are widely used in dental, orthopedic, and reconstructive surgery. A series of studies has indicated that cells can respond not only to the chemical properties of the biomaterial, but also, in particular, to the changes in surface topography. Nanoporous materials remain in focus of scientific queries due to their exclusive properties and broad applications. One such material is nanostructured titanium oxide with highly ordered, mutually perpendicular nanopores. Nanoporous anodic titanium dioxide (TiO2) films were fabricated by a three-step anodization process in propan-1,2,3-triol-based electrolyte containing fluoride ions. Adipose-derived stem cells offer many interesting opportunities for regenerative medicine. The important goal of tissue engineering is to direct stem cell differentiation into a desired cell lineage. The influence of nanoporous TiO2 with pore diameters of 80 and 108 nm on cell response, growth, viability, and ability to differentiate into osteoblastic lineage of human adipose-derived progenitors was explored. Cells were harvested from the subcutaneous abdominal fat tissue by a simple, minimally invasive, and inexpensive method. Our results indicate that anodic nanostructured TiO2 is a safe and nontoxic biomaterial. In vitro studies demonstrated that the nanotopography induced and enhanced osteodifferentiation of human adipose-derived stem cells from the abdominal subcutaneous fat tissue.
C1 [Malec, Katarzyna; Goralska, Joanna; Glowacz, Paulina; Wybranska, Iwona] Jagiellonian Univ, Dept Clin Biochem, Coll Med, Ul Kopernika 15A, PL-31501 Krakow, Poland.
   [Hubalewska-Mazgaj, Magdalena] Jagiellonian Univ, Dept Genet Res & Nutrigen, Malopolska Ctr Biotechnol, Krakow, Poland.
   [Jarosz, Magdalena; Sulka, Grzegorz D.; Jaskula, Marian] Jagiellonian Univ, Dept Phys Chem & Electrochem, Fac Chem, Krakow, Poland.
   [Brzewski, Pawel] Jagiellonian Univ, Dept Dermatol, Coll Med, Krakow, Poland.
RP Malec, K (reprint author), Jagiellonian Univ, Dept Clin Biochem, Coll Med, Ul Kopernika 15A, PL-31501 Krakow, Poland.
EM malec.katarzyna@gmail.com
RI Jaskula, Marian/C-2279-2013
OI Jarosz, Magdalena/0000-0001-5263-9963; Sulka,
   Grzegorz/0000-0001-7431-617X
FU grant Interdisciplinary PhD Studies "Molecular sciences for medicine";
   European Social Fund within the Human Capital Operational Program
FX Katarzyna Malec acknowledges support from the grant Interdisciplinary
   PhD Studies "Molecular sciences for medicine" (co-financed by the
   European Social Fund within the Human Capital Operational Program). The
   authors report no other conflicts of interest in this work.
CR Abrahamsson I, 2001, INT J ORAL MAX IMPL, V16, P323
   Allen M. J., 1994, PROMEGA NOTES, V45, P7
   Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Bialorucki C, 2014, J MECH BEHAV BIOMED, V38, P143, DOI 10.1016/j.jmbbm.2014.06.018
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Carrel A, 1911, J EXP MED, V13, P571, DOI 10.1084/jem.13.5.571
   Chiang CY, 2009, DENT MATER, V25, P1022, DOI 10.1016/j.dental.2009.03.001
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   El-Sadik AO, 2010, CLIN PHARMACOL-ADV A, V2, P9, DOI 10.2147/CPAA.S8931
   Frandsen C. J., 2013, INT J BIOMATER, V2013
   Gao JH, 2009, NANO TODAY, V4, P37, DOI 10.1016/j.nantod.2008.10.009
   Ghafar A, 2011, NANOSCALE RES LETT, V6, P322
   Ghicov A, 2009, CHEM COMMUN, P2791, DOI 10.1039/b822726h
   Girolamo L. de, 2007, J TISSUE ENG REGEN M, V1, P154
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Hackenberg S, 2013, J BIOMED NANOTECHNOL, V9, P86, DOI 10.1166/jbn.2013.1473
   Halvorsen YC, 2000, INT J OBESITY, V24, pS41, DOI 10.1038/sj.ijo.0801503
   Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088
   HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hou YH, 2013, INT J NANOMED, V8, P3619, DOI 10.2147/IJN.S38992
   Huang JY, 2013, INT J PHOTOENERGY, DOI 10.1155/2013/761971
   Indira K, 2012, MATER CHARACT, V71, P58, DOI 10.1016/j.matchar.2012.06.005
   Jarosz M, 2014, ELECTROCHIM ACTA, V136, P412, DOI 10.1016/j.electacta.2014.05.077
   Kapusta-Kolodziej J, 2014, ELECTROCHIM ACTA, V144, P127, DOI 10.1016/j.electacta.2014.08.055
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5
   Lavenus S, 2011, EUR CELLS MATER, V22, P84, DOI 10.22203/eCM.v022a07
   Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI 10.2217/NNM.10.54
   Le Guehennec L, 2008, NANOMEDICINE-UK, V3, P61, DOI 10.2217/17435889.3.1.61
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505
   Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lv LW, 2015, BIOMATERIALS, V39, P193, DOI 10.1016/j.biomaterials.2014.11.002
   Macak JM, 2006, ELECTROCHIM ACTA, V52, P1258, DOI 10.1016/j.electacta.2006.07.021
   MacDougald OA, 2014, METHOD ENZYMOL, V538, P1
   McNamara L. E., 2014, J TISSUE ENG, V5, DOI DOI 10.1177/2041731414536177
   Minagar S, 2013, J BIOMED MATER RES A, V101, P2726, DOI 10.1002/jbm.a.34575
   MULLIS KB, 1990, SCI AM, V262, P56, DOI 10.1038/scientificamerican0490-56
   NACHLAS MM, 1960, ANAL BIOCHEM, V1, P317, DOI 10.1016/0003-2697(60)90029-4
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   PETERSON GL, 1983, METHOD ENZYMOL, V91, P95
   PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4
   Pittrof A, 2012, ACTA BIOMATER, V8, P2639, DOI 10.1016/j.actbio.2012.03.040
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Portan DV, 2012, J BIOMED MATER RES A, V100A, P2546, DOI 10.1002/jbm.a.34188
   Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Sulka GD, 2010, ELECTROCHIM ACTA, V55, P4359, DOI 10.1016/j.electacta.2009.12.053
   Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005
   Vega V, 2007, NANOSCALE RES LETT, V2, P355, DOI 10.1007/s11671-007-9073-5
   von Wilmowsky C, 2009, J BIOMED MATER RES B, V89B, P165, DOI 10.1002/jbm.b.31201
   Wang LN, 2014, INT J NANOMED, V9, P4421, DOI 10.2147/IJN.S65866
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wojnicz R, 2011, KARDIOL POL, V69, P1107
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhu FC, 2012, J CELL PHYSIOL, V227, P2677, DOI 10.1002/jcp.23010
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
NR 76
TC 0
Z9 0
U1 1
U2 8
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2016
VL 11
BP 5349
EP 5360
DI 10.2147/IJN.SI16263
PG 12
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA DY8CT
UT WOS:000385356800001
PM 27789947
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Goyal, P
   Masram, DT
AF Goyal, Pritee
   Masram, Dhanraj T.
TI Azadirachta indica nano biomaterial: A green economical biomaterial for
   removal of Cd (II) and Ni (II) from waste water
SO MATERIALS TODAY-PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Recent Advances in Nano Science and
   Technology (RAINSAT)
CY JUL 08-10, 2015
CL Sathyabama Univ, Int Res Ctr, Chennai, INDIA
HO Sathyabama Univ, Int Res Ctr
DE Waste water; Nano biomaterial; biosorption; regeneration; sorption
   efficiency
ID LEAF POWDER; BIOSORBENT; RECOVERY
AB The study explores the efficacy of NCFS Azadirachta indica leaf powder as an effective adsorbent for the abatement of Cd (II) and Ni (II) from their single metal solution. The resulting novel nano biomaterial was found to enhance the sorption efficiency [2-15%] and stability in terms of regeneration cycles [3 to 5]. Characterization of the designed nano biomaterial was provided on the basis of SEM, FTIR and TGA. Resulting information can be utilized as less expensive, environment friendly method with enhanced sorption efficacy and environmental stability for removal of toxic metal from contaminated water particularly for the rural and remote areas of the Country. The significant sorption properties of the Azadirachta indica nano fiber for various toxic metals have already been established in our laboratory. Resulted nano biomaterial exhibits sorption efficiency of Cd (II): 96.23% and Ni (II): 84.12% and stability in terms of regeneration cycles. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Goyal, Pritee] Sathyabama Univ, Ctr NanoSci & Nano Technol, Chennai 600119, Tamil Nadu, India.
   [Masram, Dhanraj T.] Univ Delhi, Dept Chem, Delhi 110007, India.
RP Masram, DT (reprint author), Univ Delhi, Dept Chem, Delhi 110007, India.
EM dhanraj_masram27@rediffmail.com
CR Ajmal M, 2003, BIORESOURCE TECHNOL, V86, P147, DOI 10.1016/S0960-8524(02)00159-1
   Ejoba R., 2012, J ENV SCI TOXICOL, V1, P14
   Goyal P, 2008, INT J ENVIRON SCI TE, V5, P27, DOI 10.1007/BF03325994
   Goyal P., 2012, INT J ENV ENG MANAG, V3, P330
   Goyal P., 2015, SKY J SOIL SCI ENV M, V4, P10
   Goyal P, 2011, ASIAN J WATER ENVIRO, V8, P77
   Goyal P, 2009, J HAZARD MATER, V172, P1206, DOI 10.1016/j.jhazmat.2009.07.125
   Goyal P, 2008, ARCH ENVIRON PROT, V34, P35
   Iqbal M, 2002, BIORESOURCE TECHNOL, V81, P151, DOI 10.1016/S0960-8524(01)00126-2
   Mandina S., 2013, IOSR J APPL CHEM IOS, V6, P66
   Mudhoo V.K., 2012, ENV CHEM SUSTAIN WOR, V2, P379
   Otto Martha, 2009, ENV HLTH PERSP, V117, P1823
   Paul GT, 2006, NANO TODAY, V1, P44, DOI DOI 10.1016/S1748-0132(06)70048-2
   Perpetuo E.A., 2011, ANAL MODEL TECHNOL A, V28, P605
   Rao RAK, 2011, DESALINATION, V277, P390, DOI 10.1016/j.desal.2011.04.065
   Rickerby DG, 2007, SCI TECHNOL ADV MAT, V8, P19, DOI 10.1016/j.stam.2006.10.002
   Wang B, 2007, COMPOS SCI TECHNOL, V67, P2521, DOI 10.1016/j.compscitech.2006.12.015
   Witek-Krowiak A, 2011, DESALINATION, V265, P126, DOI 10.1016/j.desal.2010.07.042
NR 18
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-7853
J9 MATER TODAY-PROC
JI Mater. Today-Proc.
PY 2016
VL 3
IS 6
BP 1470
EP 1476
DI 10.1016/j.matpr.2016.04.030
PG 7
GA DY9YI
UT WOS:000385492400024
DA 2018-10-20
ER

PT J
AU Bharti, A
   Singh, S
   Meena, VK
   Goyal, N
AF Bharti, Amardeep
   Singh, Suman
   Meena, Vijay Kumar
   Goyal, Navdeep
TI Structural Characterization of Silver-Hydroxyapatite Nanocomposite: A
   Bone Repair Biomaterial
SO MATERIALS TODAY-PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Recent Advances in Nano Science and
   Technology (RAINSAT)
CY JUL 08-10, 2015
CL Sathyabama Univ, Int Res Ctr, Chennai, INDIA
HO Sathyabama Univ, Int Res Ctr
DE Hydroxyapatite; Silver nanoparticles; Biomaterial; Anisotropic
ID NANOPARTICLES
AB Hydroxyapatite (HA) is a form of calcium & phosphate and constitutes large amount of human bone, dental enamel and dentin. HA is widely acceptable as purifier for proteins, drug delivery and body implant material. Structure, density & chemical phase should be specific in order to fit for each application. In this paper, Structural characterization of novel HA incorporated with silver nanoparticles (AgNPs) has been investigated for its application in orthopedic body implants. Silver nanoparticles used in this application are of anisotropic in nature which shows enhanced antibacterial properties in comparison to spherical one. XRD reveals that synthesized nanocomposite has 87% crystallinity with hexagonal geometry as similar to the HA. TEM micrographs shows that the average particle size of nanocomposite is 58.38 nm with polydispersity of 30.73 and is well suitable for orthopaedic body implantation. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Bharti, Amardeep; Goyal, Navdeep] Panjab Univ, Dept Phys, Chandigarh 160014, India.
   [Singh, Suman; Meena, Vijay Kumar] CSIR, Cent Sci Instruments Org, Chandigarh 160030, India.
RP Bharti, A (reprint author), Panjab Univ, Dept Phys, Chandigarh 160014, India.
EM abharti@pu.ac.in
OI Goyal, Navdeep/0000-0002-6993-4085; Bharti, Amardeep/0000-0001-8462-6139
CR Bharti A, 2014, ADV SCI LETT, V20, P1297, DOI 10.1166/asl.2014.5508
   CHEN F, 2012, NANO BIOMED ENG, V4, P41, DOI DOI 10.5101/NBE.V4I1.P41-49
   Chen W., 2006, J BIOMEDICAL MAT R A
   CHUNG FH, 1975, J APPL CRYSTALLOGR, V8, P17, DOI 10.1107/S0021889875009454
   Dasgupta S, 2010, LANGMUIR, V26, P4958, DOI 10.1021/la903617e
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Iconaru SL, 2013, J SPECTROSC, DOI 10.1155/2013/284285
   Ismail E., 2015, J ADV CHEM, V11, P3559
   Kim TI, 2014, J PERIODONTAL IMPLAN, V44, P265, DOI 10.5051/jpis.2014.44.6.265
   Liu G., 2009, ENV SCI TECHNOL
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Rameshbabu N., 2006, J BIOMEDICAL MAT RES, P581
   Shaltout AA, 2011, SPECTROCHIM ACTA A, V83, P56, DOI 10.1016/j.saa.2011.07.036
   Singh S., 2015, J MAT SCI MAT ELECT
   Singh S, 2014, J MATER SCI-MATER EL, V25, P3747, DOI 10.1007/s10854-014-2085-x
NR 16
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2214-7853
J9 MATER TODAY-PROC
JI Mater. Today-Proc.
PY 2016
VL 3
IS 6
BP 2113
EP 2120
DI 10.1016/j.matpr.2016.04.116
PG 8
GA DY9YI
UT WOS:000385492400110
DA 2018-10-20
ER

PT J
AU Zargar, B
   Pourreza, N
   Bayat, E
   Hatamie, A
AF Zargar, Behrooz
   Pourreza, Nahid
   Bayat, Elahe
   Hatamie, Amir
TI Zein bio-nanoparticles: a novel green nanopolymer as a dispersive
   solid-phase extraction adsorbent for separating and determining trace
   amounts of azorubine in different foodstuffs
SO RSC ADVANCES
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; CARBON NANOTUBES; ARRAY DETECTION;
   MICROEXTRACTION; NANOMATERIALS; SAMPLES; WATER; PESTICIDES; PROTEIN;
   DRINKS
AB For the first time, a new, easy, and green method using zein nanoparticles as a dispersive solid-phase extraction (DSPE) adsorbent has been used for the preconcentration of azorubine (a well-known chemical dye additive) as a model compound in foodstuffs. The monitoring of chemical residues in food and the environment is an important function of countless laboratories around the world. SPE and DSPE are more flexible and efficient than liquid-liquid extraction in terms of simplicity, flexibility in choosing the adsorbent and low consumption of organic solvents. To the best of our knowledge, the use of zein nanoparticles as a dispersive solid-phase extraction material has not been reported thus far. The main advantages of this newly discovered research use of zein arise from four aspects: (A) zein biopolymer is a safe biomaterial that has characteristics that include biocompatibility, biodegradability, and low toxicity; (B) its hydrophobic property and unique solubility result in the easy fabrication of zein nanoparticles; (C) it has relatively suitable stability; and (D) composites or conjugates formed between zein and other compounds such as nanomaterials are easy to fabricate. Several experimental parameters, including the amount of sorbent, extraction time, pH and ionic strength of the sample solution, and desorption conditions, were evaluated. Under optimal experimental conditions, the linear correlation coefficient (r(2)) was 0.9978 at a concentration level of 0.005-4.500 mg mL(-1). The limit of detection was 2.8 ng mL(-1) and the relative standard deviations (RSD) for concentrations of 0.5 mg mL(-1) and 3.5 mg mL(-1) were 0.5% and 1.2% (n = 6), respectively. The present method was employed for the analysis of four different food samples (soft drink, pastel gummies, ice cream, and Smarties) and the recoveries of AZ that were obtained were in the range of 94.6% to 103.2%. The results showed that the proposed method was a green, convenient, and fast method for the determination of AZ as a model compound in food samples.
C1 [Zargar, Behrooz; Pourreza, Nahid; Bayat, Elahe; Hatamie, Amir] Shahid Chamran Univ Ahvaz, Fac Sci, Dept Chem, Ahwaz, Iran.
RP Zargar, B (reprint author), Shahid Chamran Univ Ahvaz, Fac Sci, Dept Chem, Ahwaz, Iran.
EM zargar_b@scu.ac.ir
OI Hatamie, Amir/0000-0002-7085-893X
CR Ali I, 2012, CHEM REV, V112, P5073, DOI 10.1021/cr300133d
   Althamneh A.I., 2008, BIOMACROMOLECULES, V9, P3181
   Aragay G, 2012, CHEM REV, V112, P5317, DOI 10.1021/cr300020c
   Aragay G, 2011, CHEM REV, V111, P3433, DOI 10.1021/cr100383r
   ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019
   Asadpour-Zeynali K, 2014, ANAL METHODS-UK, V6, P6110, DOI [10.1039/C4AY00507D, 10.1039/c4ay00507d]
   Asgharinezhad AA, 2014, ANAL CHIM ACTA, V844, P80, DOI 10.1016/j.aca.2014.06.007
   Aufartova J, 2011, ANAL CHIM ACTA, V704, P33, DOI 10.1016/j.aca.2011.07.030
   Aydin F, 2015, RSC ADV, V5, P40422, DOI 10.1039/c4ra17116k
   Bendicho C, 2015, TRAC-TREND ANAL CHEM, V68, P78, DOI 10.1016/j.trac.2015.02.007
   Chanlon S, 2005, J FOOD COMPOS ANAL, V18, P503, DOI 10.1016/j.jfca.2004.05.005
   Ebrahimpour B, 2015, ANAL CHIM ACTA, V885, P98, DOI 10.1016/j.aca.2015.05.025
   Guihen E, 2013, TRAC-TREND ANAL CHEM, V46, P1, DOI 10.1016/j.trac.2013.01.011
   Gupta VK, 2009, J COLLOID INTERF SCI, V335, P24, DOI 10.1016/j.jcis.2009.03.056
   Hatamie A, 2015, LANGMUIR, V31, P10913, DOI 10.1021/acs.langmuir.5b02341
   Hou X, 2014, FOOD CHEM, V153, P121, DOI 10.1016/j.foodchem.2013.12.031
   Hu K, 2014, FOOD RES INT, V64, P329, DOI 10.1016/j.foodres.2014.07.004
   Li JG, 2015, NANOSCALE, V7, P7502, DOI 10.1039/c5nr00857c
   Li KK, 2012, J AGR FOOD CHEM, V60, P11592, DOI 10.1021/jf302752v
   Li XQ, 2015, FOOD CHEM, V182, P316, DOI 10.1016/j.foodchem.2015.03.019
   Mahpishanian S, 2014, TALANTA, V130, P71, DOI 10.1016/j.talanta.2014.06.004
   Matsushima N., 1997, BIOCHIM BIOPHYS ACTA, V1139, P14
   Melchert WR, 2012, ANAL CHIM ACTA, V714, P8, DOI 10.1016/j.aca.2011.11.044
   Miller JN, 2000, STAT CHEMOMETRICS AN
   Nicolas J, 2013, CHEM SOC REV, V42, P1147, DOI 10.1039/c2cs35265f
   ODonnell PB, 1997, EUR J PHARM BIOPHARM, V43, P83, DOI 10.1016/S0939-6411(96)00013-6
   Patel A, 2010, SOFT MATTER, V6, P6192, DOI 10.1039/c0sm00800a
   Patel AR, 2014, CURR OPIN COLLOID IN, V19, P450, DOI 10.1016/j.cocis.2014.08.001
   Pomes A. F., 1971, ENCY POLYM SCI TECHN, V15, P125
   Pourreza N, 2011, TALANTA, V84, P240, DOI 10.1016/j.talanta.2010.12.043
   Rezaee M, 2006, J CHROMATOGR A, V1116, P1, DOI 10.1016/j.chroma.2006.03.007
   Ruso JM, 2004, LANGMUIR, V20, P8988, DOI 10.1021/la049182r
   Saien J, 2010, J TAIWAN INST CHEM E, V41, P295, DOI 10.1016/j.jtice.2009.10.005
   Saithongdee A, 2014, SENSOR ACTUAT B-CHEM, V202, P935, DOI 10.1016/j.snb.2014.06.036
   Sharifi S, 2012, CHEM SOC REV, V41, P2323, DOI 10.1039/c1cs15188f
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Speltini A, 2013, ANAL CHIM ACTA, V783, P1, DOI 10.1016/j.aca.2013.03.041
   Stark Leonard E., 1991, United states patent, Patent No. 5021248
   Subramanian S, 2007, BIOMACROMOLECULES, V8, P2120, DOI 10.1021/bm0701999
   Tapan B., 2010, ADV MATER, V22, P1781
   Turak F, 2014, INT J ANAL CHEM, DOI 10.1155/2014/650465
   Verdolotti L, 2014, ACS SUSTAIN CHEM ENG, V2, P254, DOI 10.1021/sc400295w
   Wang Q., 2014, J APPL POLYM SCI, V131, P2
   Wang Y, 2010, LANGMUIR, V26, P12897, DOI 10.1021/la101688v
   Yah CS, 2011, IRAN J PHARM SCI, V8, P299
   Yang Y, 2014, ANAL METHODS-UK, V6, P5872, DOI [10.1039/c4ay00371c, 10.1039/C4AY00371C]
   Yoshioka N, 2008, TALANTA, V74, P1408, DOI 10.1016/j.talanta.2007.09.015
   Zargar B, 2014, ANAL METHODS-UK, V6, P2506, DOI 10.1039/c3ay41491d
   Zhong QX, 2009, FOOD HYDROCOLLOID, V23, P2380, DOI 10.1016/j.foodhyd.2009.06.015
NR 49
TC 4
Z9 4
U1 1
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 77
BP 73096
EP 73105
DI 10.1039/c6ra09027c
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA DT4ZK
UT WOS:000381490100026
DA 2018-10-20
ER

PT J
AU Alshemary, AZ
   Pazarceviren, AE
   Tezcaner, A
   Evis, Z
AF Alshemary, Ammar Z.
   Pazarceviren, Ahmet Engin
   Tezcaner, Aysen
   Evis, Zafer
TI Mesoporous strontium doped nano sized sulphate hydroxyapatite as a novel
   biomaterial for bone tissue applications (vol 6, pg 68058, 2016)
SO RSC ADVANCES
LA English
DT Correction
C1 [Alshemary, Ammar Z.; Pazarceviren, Ahmet Engin; Tezcaner, Aysen; Evis, Zafer] Middle East Tech Univ, Engn Sci, TR-06800 Ankara, Turkey.
RP Alshemary, AZ (reprint author), Middle East Tech Univ, Engn Sci, TR-06800 Ankara, Turkey.
EM am84ch@gmail.com
RI Pazarceviren, Ahmet Engin/A-9564-2017
OI Pazarceviren, Ahmet Engin/0000-0001-5233-860X
CR Alshemary AZ, 2016, RSC ADV, V6, P68058, DOI 10.1039/c6ra16809d
NR 1
TC 0
Z9 0
U1 0
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 77
BP 73106
EP 73106
DI 10.1039/c6ra90065h
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA DT4ZK
UT WOS:000381490100027
OA Bronze
DA 2018-10-20
ER

PT J
AU Aguayo, S
   Strange, A
   Gadegaard, N
   Dalby, MJ
   Bozec, L
AF Aguayo, S.
   Strange, A.
   Gadegaard, N.
   Dalby, M. J.
   Bozec, L.
TI Influence of biomaterial nanotopography on the adhesive and elastic
   properties of Staphylococcus aureus cells
SO RSC ADVANCES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; CANDIDA-ALBICANS HYPHAE; BACTERIAL ADHESION;
   BIOFILM FORMATION; DENTAL IMPLANTS; SURFACES; MECHANISMS; CAPSULE;
   INFECTIONS; PROTEINS
AB Despite the well-known beneficial effects of biomaterial nanopatterning on host tissue integration, the influence of controlled nanoscale topography on bacterial colonisation and infection remains unknown. Therefore, the aim of the present study was to determine the nanoscale effect of surface nanopatterning on biomaterial colonisation by S. aureus, utilising AFM nanomechanics and single-cell force spectroscopy (SCFS). Nanoindentation of S. aureus bound to planar (PL) and nanopatterned (SQ) polycarbonate (PC) surfaces suggested two distinct areas of mechanical properties, consistent with a central bacterial cell surrounded by a capsullar component. Nevertheless, no differences in elastic moduli were found between bacteria bound to PL and SQ, suggesting a minor role of nanopatterning in bacterial cell elasticity. Furthermore, SCFS demonstrated increased adhesion forces and work between S. aureus and SQ surfaces at 0 s and 1 s contact times. Although WLC modelling showed similarities in contour lengths for attachment to both surfaces, Poisson analysis suggests increased short-range forces for the S. aureus-SQ interactions. In the case of S. aureus-PL, long-range forces were found to not only be dominant but also repulsive in nature, which may help explain the reduced adhesion forces observed during AFM probing. In conclusion, although surface nanopatterning does not significantly influence the elasticity of attached bacterial cells, it was found to promote the early-adhesion of S. aureus cells to the biomaterial surface.
C1 [Aguayo, S.; Strange, A.; Bozec, L.] UCL, Eastman Dent Inst, Dept Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
   [Gadegaard, N.] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8QQ, Lanark, Scotland.
   [Dalby, M. J.] Univ Glasgow, Inst Mol Cell & Syst Biol, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Aguayo, S (reprint author), UCL, Eastman Dent Inst, Dept Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
EM Sebastian.aguayo.13@ucl.ac.uk
OI Gadegaard, Nikolaj/0000-0002-3396-846X; Dalby,
   Matthew/0000-0002-0528-3359; Aguayo, Sebastian/0000-0003-0900-1993
FU Becas-Chile PhD Scholarship Programme
FX This work has been funded by the Becas-Chile PhD Scholarship Programme.
CR Aguayo S, 2015, J DENT RES, V94, P1078, DOI 10.1177/0022034515591485
   Aguayo S, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062001
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   BASELGA R, 1994, VET MICROBIOL, V39, P195, DOI 10.1016/0378-1135(94)90157-0
   Beaussart A, 2013, BIOPHYS J, V104, P1886, DOI 10.1016/j.bpj.2013.03.046
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Chen Y, 2014, APPL ENVIRON MICROB, V80, P637, DOI 10.1128/AEM.02745-13
   Chen Y, 2012, MBIO, V3, DOI 10.1128/mBio.00378-12
   Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11
   Coldren FM, 2009, J BIOMED MATER RES A, V89A, P402, DOI 10.1002/jbm.a.31973
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dufrene YF, 2015, TRENDS MICROBIOL, V23, P376, DOI 10.1016/j.tim.2015.01.011
   Estevez M, 2015, J BIOMED MATER RES A, V103, P1659, DOI 10.1002/jbm.a.35293
   Formosa C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00575
   Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08
   Harris L. G., 2002, European Cells & Materials, V4, P39
   Herman P, 2014, MOL MICROBIOL, V93, P356, DOI 10.1111/mmi.12663
   Holmes MA, 2011, J MAMMARY GLAND BIOL, V16, P373, DOI 10.1007/s10911-011-9237-x
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Huo KF, 2013, BIOMATERIALS, V34, P3467, DOI 10.1016/j.biomaterials.2013.01.071
   Jahed Z, 2014, BIOMATERIALS, V35, P4249, DOI 10.1016/j.biomaterials.2014.01.080
   Kneidinger B, 2003, J BIOL CHEM, V278, P3615, DOI 10.1074/jbc.M203867200
   Lee A, 2010, IMPLANT DENT, V19, P387, DOI 10.1097/ID.0b013e3181effa53
   Logan N., 2013, STEM CELLS INT, V2013
   Loskill P, 2014, BIOPHYS J, V107, P1082, DOI 10.1016/j.bpj.2014.07.029
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   McKendry RA, 2012, BIOCHEM SOC T, V40, P603, DOI 10.1042/BST20120082
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004
   Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023
   Ovchinnikova ES, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-281
   Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rukke HV, 2012, MOL ORAL MICROBIOL, V27, P95, DOI 10.1111/j.2041-1014.2011.00635.x
   Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616
   Sullan RMA, 2015, ACS NANO, V9, P1448, DOI 10.1021/nn5058886
   Svensson S, 2014, INT J NANOMED, V9, P775, DOI 10.2147/IJN.S51465
   Taubenberger AV, 2014, TISSUE ENG PART B-RE, V20, P40, DOI 10.1089/ten.TEB.2013.0125
   Tollersrud T, 2001, APMIS, V109, P541, DOI 10.1111/j.1600-0463.2001.apm090708.x
   Wann ER, 1999, FEMS MICROBIOL LETT, V170, P97
   Webb HK, 2011, J MICROBIOL METH, V86, P131, DOI 10.1016/j.mimet.2011.05.021
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08
NR 46
TC 4
Z9 4
U1 6
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 92
BP 89347
EP 89355
DI 10.1039/c6ra12504b
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA DX5SE
UT WOS:000384441200052
DA 2018-10-20
ER

PT J
AU Zhao, FJ
   Zhang, W
   Fu, XL
   Xie, WH
   Chen, XF
AF Zhao, Fujian
   Zhang, Wen
   Fu, Xiaoling
   Xie, Weihan
   Chen, Xiaofeng
TI Fabrication and characterization of bioactive glass/alginate composite
   scaffolds by a self-crosslinking processing for bone regeneration
SO RSC ADVANCES
LA English
DT Article
ID GLASS SUBMICRON SPHERES; OF-THE-ART; IN-VITRO; MECHANICAL-PROPERTIES;
   CERAMIC SCAFFOLDS; HUMAN OSTEOBLASTS; BIOGLASS(R) 45S5; IONIC PRODUCTS;
   DRUG-DELIVERY; SIZE CONTROL
AB The objective of this study was to synthesize and characterize self-crosslinked bioactive glass/alginate composite scaffolds, as a kind of potential biomaterial for bone regeneration. The scaffolds, fabricated through a self-crosslinking process of alginate by bioactive glass microspheres provided Ca2+ completely without any organic solvent, crosslinking agent, or binder. The microstructure, mechanical properties, apatite-forming ability, ionic release, adhesion, proliferation, and ALP activity of human bone marrow-derived mesenchymal stem cells (hBMSCs) of the scaffolds were evaluated. The results showed that uniform films could be obtained on the surface as well as in abundant crosslinking bridges in the interior of the scaffolds. The rapidly released Ca2+ from bioactive glass could be temporarily stored in alginate, which achieved the controlling release. The scaffolds, with porosities of 75-57%, had a compressive strength in the range of human trabecular bone. At the same time, they presented an excellent apatite formation ability in vitro. In vitro cellular study confirmed that the alginate films temporarily separated cells from bioactive glass which promoted early cell adhesion and all the groups showed good cell proliferation and ALP activity. All these results demonstrate that self-crosslinked scaffolds represent promising candidates for bone regeneration.
C1 [Zhao, Fujian; Zhang, Wen; Fu, Xiaoling; Xie, Weihan; Chen, Xiaofeng] South China Univ Technol, Sch Mat Sci & Engn, Dept Biomed Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Zhao, Fujian; Zhang, Wen; Fu, Xiaoling; Xie, Weihan; Chen, Xiaofeng] Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhao, Fujian; Zhang, Wen; Fu, Xiaoling; Xie, Weihan; Chen, Xiaofeng] South China Univ Technol, Key Lab Biomed Mat & Engn, Minist Educ, Guangzhou 510006, Guangdong, Peoples R China.
RP Chen, XF (reprint author), South China Univ Technol, Sch Mat Sci & Engn, Dept Biomed Engn, Guangzhou 510641, Guangdong, Peoples R China.; Chen, XF (reprint author), Natl Engn Res Ctr Tissue Restorat & Reconstruct, Guangzhou 510006, Guangdong, Peoples R China.; Chen, XF (reprint author), South China Univ Technol, Key Lab Biomed Mat & Engn, Minist Educ, Guangzhou 510006, Guangdong, Peoples R China.
EM chenxf@scut.edu.cn
FU Joint Funds of the National Natural Science Foundation of China
   [U1501245]; Fundamental Research Funds for the Central Universities
   [2015ZP020, 2014ZB0018]; National Natural Science Foundation of China
   [51402108]
FX This study was financially supported by the Joint Funds of the National
   Natural Science Foundation of China (grant no. U1501245), the
   Fundamental Research Funds for the Central Universities (grant no.
   2015ZP020, 2014ZB0018) and the National Natural Science Foundation of
   China (grant no. 51402108).
CR Arcos D, 2009, CHEM MATER, V21, P1000, DOI 10.1021/cm801649z
   Bonino CA, 2011, CARBOHYD POLYM, V85, P111, DOI 10.1016/j.carbpol.2011.02.002
   Erol MM, 2012, ACTA BIOMATER, V8, P792, DOI 10.1016/j.actbio.2011.10.013
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Fu Q, 2010, J BIOMED MATER RES A, V93A, P1380, DOI 10.1002/jbm.a.32637
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Gloria A, 2009, J APPL BIOMATER BIOM, V7, P141
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Guarino V, 2007, EXPERT REV MED DEVIC, V4, P405, DOI 10.1586/17434440.4.3.405
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   HENCH LL, 1995, ANNU REV MATER SCI, V25, P37
   Hu Q, 2014, RSC ADV, V4, P22678, DOI 10.1039/c4ra01276c
   Hu Q, 2013, MATER LETT, V106, P452, DOI 10.1016/j.matlet.2013.04.075
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Labbaf S, 2011, BIOMATERIALS, V32, P1010, DOI 10.1016/j.biomaterials.2010.08.082
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Lin S, 2009, J MATER CHEM, V19, P1276, DOI 10.1039/b814292k
   Luo YX, 2015, ACS APPL MATER INTER, V7, P6541, DOI 10.1021/am508469h
   Luo YX, 2013, J MATER CHEM B, V1, P4088, DOI 10.1039/c3tb20511h
   Luo YX, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015005
   Mishra R, 2009, J MATER SCI-MATER M, V20, P2493, DOI 10.1007/s10856-009-3814-1
   Mohan N., 2005, TRENDS BIOMATERIALS, V18, P219
   Mourino V, 2011, SOFT MATTER, V7, P6705, DOI 10.1039/c1sm05331k
   Mourino V, 2010, ADV ENG MATER, V12, pB283, DOI 10.1002/adem.200980078
   Pamula E, 2011, ANN BIOMED ENG, V39, P2114, DOI 10.1007/s10439-011-0307-4
   Peter M, 2009, CARBOHYD POLYM, V78, P926, DOI 10.1016/j.carbpol.2009.07.016
   Schlossmacher U, 2013, RSC ADV, V3, P11185, DOI 10.1039/c3ra23341c
   Sugiura S, 2005, BIOMATERIALS, V26, P3327, DOI 10.1016/j.biomaterials.2004.08.029
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Venkatesan J, 2015, INT J BIOL MACROMOL, V72, P269, DOI 10.1016/j.ijbiomac.2014.07.008
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   William G., 2007, J BONE JT SURG, V89, P649
   Xia W, 2007, MATER LETT, V61, P3251, DOI 10.1016/j.matlet.2006.11.048
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Zhang JH, 2014, J MATER CHEM B, V2, P7583, DOI 10.1039/c4tb01063a
   Zhang JH, 2014, ACTA BIOMATER, V10, P2269, DOI 10.1016/j.actbio.2014.01.001
   Zhao SC, 2014, J MATER CHEM B, V2, P6106, DOI 10.1039/c4tb00838c
NR 45
TC 4
Z9 4
U1 6
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 94
BP 91201
EP 91208
DI 10.1039/c6ra18309c
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DY8GO
UT WOS:000385367300017
DA 2018-10-20
ER

PT J
AU Meng, FG
   Zhang, ZQ
   Huang, GX
   Chen, WS
   Zhang, ZJ
   He, AS
   Liao, WM
AF Meng, F. G.
   Zhang, Z. Q.
   Huang, G. X.
   Chen, W. S.
   Zhang, Z. J.
   He, A. S.
   Liao, W. M.
TI CHONDROGENESIS OF MESENCHYMAL STEM CELLS IN A NOVEL
   HYALURONATE-COLLAGEN-TRICALCIUM PHOSPHATE SCAFFOLDS FOR KNEE REPAIR
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Cartilage engineering; mesenchymal stem cell; hyaluronic acid; collagen;
   biomaterial; chondrogenesis
ID IN-VITRO CHONDROGENESIS; ARTICULAR-CARTILAGE REPAIR; MARROW STROMAL
   CELLS; OSTEOCHONDRAL DEFECTS; COMPOSITE SCAFFOLD; BONE-FORMATION;
   DIFFERENTIATION; CHONDROCYTES; HYDROGEL; VIVO
AB Scaffolds are expected to play a key role in the induction of chondrogenesis of mesenchymal stem cells (MSCs) for cartilage tissue regeneration. Here, we report the development of a novel tricalcium phosphate-collagen-hyaluronate (TCP-COL-HA) scaffold that can function as a stem cell carrier to induce chondrogenesis and promote cartilage repair, and the investigation of chondroinductive properties of scaffolds containing varying amounts of TCP, COL and HA. TCP-COL-HA scaffolds, as well as TCP-COL scaffolds at two different TCP/COL ratios (50: 50 and 25: 75), were evaluated for their ability to induce cartilage regeneration from rabbit mesenchymal stem cells (rMSCs) in vitro and in vivo. Chondrogenic differentiation was evaluated by sulphated glycosaminoglycan quantification, collagen type II immunohistochemistry, and qRT-PCR. Mechanical strength was evaluated by the compression test. The results showed that the TCP-COL-HA scaffolds enhanced rMSC chondrogenesis to a greater degree than did the TCP-COL scaffolds; for the latter, the scaffold with the lower TCP/COL ratio (25: 75) was superior in terms of promoting rMSC chondrogenesis. Similar results were obtained in an ectopic implantation model in nude mice. In a critical-size rabbit osteochondral defect-repair model, rMSCs seeded on TCP-COL-HA scaffolds showed greater cartilage regeneration and integration into surrounding tissue than the TCP-COL groups, in which cartilage repair was more efficient at the 25: 75 than at the 50: 50 ratio. These results indicate that the addition of HA and different TCP/COL ratios can affect the chondroinductive capacity of scaffolds, and suggest that the TCP-COL-HA scaffold can serve as an effective cell carrier for cartilage regeneration.
C1 [Meng, F. G.; Zhang, Z. Q.; Huang, G. X.; Chen, W. S.; Zhang, Z. J.; He, A. S.; Liao, W. M.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Joint Surg, Guangzhou 510080, Guangdong, Peoples R China.
RP Liao, WM (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
EM liaowmsysu@163.com
FU National Nature Science Foundation of China [81572119, 81472101];
   Guangdong Provincial Natural Science Foundation of China
   [2014A030313064, 2014A030313186]
FX We thank Gang Wu (South China University of Technology, Guangzhou,
   China) for providing scaffold materials and technical assistance. This
   work was supported by the National Nature Science Foundation of China
   (81572119 & 81472101), and the Guangdong Provincial Natural Science
   Foundation of China (2014A030313064 & 2014A030313186). We confirm that
   the authors have no conflicts of interest to declare and there has been
   no significant financial support for this work that could influence its
   outcome.
CR Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI 10.1089/ten.TEA.2008.0511
   Allison DD, 2009, ACTA BIOMATER, V5, P1019, DOI 10.1016/j.actbio.2008.11.013
   Arahira T, 2014, J MECH BEHAV BIOMED, V39, P218, DOI 10.1016/j.jmbbm.2014.07.013
   Bae SE, 2010, J CONTROL RELEASE, V143, P23, DOI 10.1016/j.jconrel.2009.12.024
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Breyner NM, 2010, CELLS TISSUES ORGANS, V191, P119, DOI 10.1159/000231472
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Chen HM, 2009, J ORTHOP RES, V27, P1432, DOI 10.1002/jor.20905
   Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040
   De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Goodstone NJ, 2004, TISSUE ENG, V10, P621, DOI 10.1089/107632704323061979
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Hegewald AA, 2004, TISSUE CELL, V36, P431, DOI 10.1016/j.tice.2004.07.003
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ishida T, 1996, SKELETAL RADIOL, V25, P766, DOI 10.1007/s002560050176
   Jackson D W, 1999, Clin Orthop Relat Res, pS31, DOI 10.1097/00003086-199910001-00005
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jung HH, 2010, J CONTROL RELEASE, V147, P84, DOI 10.1016/j.jconrel.2010.06.020
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Lam J, 2014, OSTEOARTHR CARTILAGE, V22, P1291, DOI 10.1016/j.joca.2014.06.035
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levett PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113216
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Maleski MP, 1996, CONNECT TISSUE RES, V34, P75, DOI 10.3109/03008209609028895
   Marquass B, 2010, J ORTHOP RES, V28, P1586, DOI 10.1002/jor.21173
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Meng FG, 2014, J BIOMED MATER RES A, V102, P2725, DOI 10.1002/jbm.a.34948
   Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Park H, 2014, J BIOMED MATER RES A, V102, P4519, DOI 10.1002/jbm.a.35126
   Park SH, 2011, TISSUE ENG PT A, V17, P1277, DOI [10.1089/ten.tea.2010.0337, 10.1089/ten.TEA.2010.0337]
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189
   Schagemann JC, 2013, J BIOMED MATER RES A, V101, P1620, DOI 10.1002/jbm.a.34457
   Seo J, 2013, RES VET SCI, V95, P1210, DOI 10.1016/j.rvsc.2013.08.016
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Stark Y, 2006, EXP TOXICOL PATHOL, V57, P305, DOI 10.1016/j.etp.2005.10,005
   Steadman J Richard, 2002, J Knee Surg, V15, P170
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Tanaka T, 2005, TISSUE ENG, V11, P331, DOI 10.1089/ten.2005.11.331
   Tigli RS, 2011, J BIOMED MATER RES A, V96A, P21, DOI 10.1002/jbm.a.32949
   van Beuningen HM, 1998, OSTEOARTHR CARTILAGE, V6, P306, DOI 10.1053/joca.1998.0129
   Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3
   Wilson W, 2007, BIOMECH MODEL MECHAN, V6, P43, DOI 10.1007/s10237-006-0044-z
   Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054
   Zhang L, 2012, J BIOMED MATER RES A, V100A, P2717, DOI 10.1002/jbm.a.34194
   Zheng L, 2009, TISSUE ENG PT A, V15, P2145, DOI 10.1089/ten.tea.2008.0268
NR 58
TC 10
Z9 10
U1 2
U2 10
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2016
VL 31
BP 79
EP 94
DI 10.22203/eCM.v031a06
PG 16
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA DY2AI
UT WOS:000384895100006
PM 26728500
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Godoy, RF
   Coathup, MJ
   Blunn, GW
   Alves, ALG
   Robotti, P
   Goodship, AE
AF Godoy, R. F.
   Coathup, M. J.
   Blunn, G. W.
   Alves, A. L. G.
   Robotti, P.
   Goodship, A. E.
TI FAST PLASMA SINTERING DELIVERS FUNCTIONAL GRADED MATERIALS COMPONENTS
   WITH MACROPOROUS STRUCTURES AND OSSEOINTEGRATION PROPERTIES
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Bone colonisation; fast plasma sintering; implant; macroporous; plasma
   spray; sheep; surgery; titanium
ID POROUS TITANIUM IMPLANTS; TOTAL HIP-ARTHROPLASTY; MECHANICAL-PROPERTIES;
   BONE INGROWTH; GROWTH; TISSUE; MICROSTRUCTURE; CONSOLIDATION;
   BIOMATERIAL; INTERFACE
AB We explored the osseointegration potential of two macroporous titanium surfaces obtained using fast plasma sintering (FPS): Ti macroporous structures with 400-600 mu mempty set pores (TiMac400) and 850-1000 mu mempty set pores (TiMac850). They were compared against two surfaces currently in clinical use: Ti-Growth (R) and air plasma spray (Ti-Y367). Each surface was tested, once placed over a Ti-alloy and once onto a CoCr bulk substrate. Implants were placed in medial femoral condyles in 24 sheep. Samples were explanted at four and eight weeks after surgery. Push-out loads were measured using a material-testing system. Bone contact and ingrowth were assessed by histomorphometry and SEM and EDX analyses. Histology showed early osseointegration for all the surfaces tested. At 8 weeks, TiMac400, TiMac850 and Ti-Growth (R) showed deep bone ingrowth and extended colonisation with newly formed bone. The mechanical push-out force was equal in all tested surfaces. Plasma spray surfaces showed greater bone-implant contact and higher level of pores colonisation with new bone than FPS produced surfaces. However, the void pore area in FPS specimens was significantly higher, yet the FPS porous surfaces allowed a deeper osseointegration of bone to implant. FPS manufactured specimens showed similar osseointegration potential to the plasma spray surfaces for orthopaedic implants. FPS is a useful technology for manufacturing macroporous titanium surfaces. Furthermore, its capability to combine two implantable materials, using bulk CoCr with macroporous titanium surfaces, could be of interest as it enables designers to conceive and manufacture innovative components. FPS delivers functional graded materials components with macroporous structures optimised for osseointegration.
C1 [Godoy, R. F.; Coathup, M. J.; Blunn, G. W.; Goodship, A. E.] Univ Coll London, Royal Natl Orthopaed Hosp, Inst Orthopaed & Musculoskeletal Sci, Stanmore, Middx, England.
   [Alves, A. L. G.] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Surg & Anaesthesiol, Botucatu, SP, Brazil.
   [Robotti, P.] Eurocoating Spa, Dept Res & Dev, Trento, Italy.
RP Godoy, RF (reprint author), Inst Orthopaed & Musculoskeletal Sci, Brockley Hill HA7 4LP, Middx, England.
EM r.godoy@ucl.ac.uk
FU Provincia Autonoma Trento, Italy
FX The authors wish to thank Emanuele Magalini and Eleonora Preve
   (Eurocoating spa) for providing the implants for this study. This study
   is part of SpaceCups Project cosponsored by Provincia Autonoma Trento,
   Italy.
CR Baril E, 2011, J MATER SCI-MATER M, V22, P1321, DOI 10.1007/s10856-011-4309-4
   Biemond JE, 2011, J MATER SCI-MATER M, V22, P917, DOI 10.1007/s10856-011-4256-0
   Biemond JE, 2011, ARCH ORTHOP TRAUM SU, V131, P711, DOI 10.1007/s00402-010-1218-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chen D, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-56
   Della Valle CJ, 2009, J BONE JOINT SURG AM, V91A, P1130, DOI 10.2106/JBJS.H.00168
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   Facchini L, 2009, RAPID PROTOTYPING J, V15, P171, DOI 10.1108/13552540910960262
   Frosch KH, 2004, J BIOMED MATER RES A, V68A, P325, DOI 10.1002/jbm.a.20010
   Godoy RF, 2012, EUR CELL MAT S1, V24, P44
   Hollister S J, 2005, Orthod Craniofac Res, V8, P162, DOI 10.1111/j.1601-6343.2005.00329.x
   Johansson C, 1987, Int J Oral Maxillofac Implants, V2, P69
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Lefebvre LP, 2009, J MATER SCI-MATER M, V20, P2223, DOI 10.1007/s10856-009-3798-x
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   MARTIN JH, 1966, AM J CLIN PATHOL, V46, P250
   Matassi F, 2013, CLIN CASES MINER BON, V10, P111, DOI 10.11138/ccmbm/2013.10.2.111
   Menapace C, 2013, POWDER METALL, V56, P102, DOI 10.1179/1743290112Y.0000000003
   Moriyama Y, 2010, ACTA BIOMATER, V6, P1610, DOI 10.1016/j.actbio.2009.10.045
   Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2
   Muth J, 2013, JOM-US, V65, P318, DOI 10.1007/s11837-012-0528-5
   Novaes AB, 2002, INT J ORAL MAX IMPL, V17, P377
   Omori M, 2000, MAT SCI ENG A-STRUCT, V287, P183, DOI 10.1016/S0921-5093(00)00773-5
   Ong JL, 2004, BIOMATERIALS, V25, P4601, DOI 10.1016/j.biomaterials.2003.11.053
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   RADIMSKA.O, 1966, STAIN TECHNOL, V41, P349
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Simmons CA, 2001, J ORTHOPAED RES, V19, P187, DOI 10.1016/S0736-0266(00)90006-8
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Tarala M, 2011, J MATER SCI-MATER M, V22, P2339, DOI 10.1007/s10856-011-4419-z
   Tokita M., 1993, J SOC POWDER TECH JA, V30, P790
   Tsukeoka T, 2005, J BIOMED MATER RES B, V75B, P168, DOI 10.1002/jbm.b.30282
   Vicente N, 2013, POWDER METALL, V56, P143, DOI 10.1179/1743290112Y.0000000040
NR 34
TC 0
Z9 0
U1 0
U2 7
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2016
VL 31
BP 250
EP 263
DI 10.22203/eCM.v031a17
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA DY2AI
UT WOS:000384895100017
PM 27071735
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Hulsart-Billstrom, G
   Dawson, JI
   Hofmann, S
   Muller, R
   Stoddart, MJ
   Alini, M
   Redl, H
   El Haj, A
   Brown, R
   Salih, V
   Hilborn, J
   Larsson, S
   Oreffo, ROC
AF Hulsart-Billstrom, G.
   Dawson, J. I.
   Hofmann, S.
   Muller, R.
   Stoddart, M. J.
   Alini, M.
   Redl, H.
   El Haj, A.
   Brown, R.
   Salih, V.
   Hilborn, J.
   Larsson, S.
   Oreffo, R. O. C.
TI A SURPRISINGLY POOR CORRELATION BETWEEN IN VITRO AND IN VIVO TESTING OF
   BIOMATERIALS FOR BONE REGENERATION: RESULTS OF A MULTICENTRE ANALYSIS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE in vivo; in vitro; correlation; biomaterials; multicentre study
ID MESENCHYMAL STEM-CELLS; COLLAGEN SCAFFOLDS; POLYMER SCAFFOLDS; DIAMOND
   CONCEPT; FIBRIN MATRIX; DIFFERENTIATION; DEFECTS; BMP-2; OSTEOGENESIS;
   STRATEGIES
AB New regenerative materials and approaches need to be assessed through reliable and comparable methods for rapid translation to the clinic. There is a considerable need for proven in vitro assays that are able to reduce the burden on animal testing, by allowing assessment of biomaterial utility predictive of the results currently obtained through in vivo studies. The purpose of this multicentre review was to investigate the correlation between existing in vitro results with in vivo outcomes observed for a range of biomaterials. Members from the European consortium BioDesign, comprising 8 universities in a European multicentre study, provided data from 36 in vivo studies and 47 in vitro assays testing 93 different biomaterials. The outcomes of the in vitro and in vivo experiments were scored according to commonly recognised measures of success relevant to each experiment. The correlation of in vitro with in vivo scores for each assay alone and in combination was assessed. A surprisingly poor correlation between in vitro and in vivo assessments of biomaterials was revealed indicating a clear need for further development of relevant in vitro assays. There was no significant overall correlation between in vitro and in vivo outcome. The mean in vitro scores revealed a trend of covariance to in vivo score with 58 %. The inadequacies of the current in vitro assessments highlighted here further stress the need for the development of novel approaches to in vitro biomaterial testing and validated pre-clinical pipelines.
C1 [Hulsart-Billstrom, G.; Dawson, J. I.; Oreffo, R. O. C.] Univ Southampton, Inst Dev Sci, Ctr Human Dev Stem Cells & Regenerat, Bone & Joint Res Grp, Southampton SO9 5NH, Hants, England.
   [Hulsart-Billstrom, G.; Larsson, S.] Uppsala Univ, Inst Med, Orthoped, Dept Surg Sci, Uppsala, Sweden.
   [Hofmann, S.; Muller, R.] Swiss Fed Inst Technol Zurich ETHZ, Inst Biomech, Vladimir Prelog Weg 3, CH-8093 Zurich, Switzerland.
   [Hofmann, S.] Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.
   [Hofmann, S.] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.
   [Stoddart, M. J.; Alini, M.] AO Res Inst Davos, Davos, Switzerland.
   [Redl, H.] European Inst Excellence Tissue Engn & Regenerat, Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, Austrian Cluster Tissue Regenerat,Vienna Branch, Vienna, Austria.
   [El Haj, A.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.
   [Brown, R.] UCL, Tissue Repair & Engn Ctr, Inst Orthopaed, Stanmore Campus, London, England.
   [Salih, V.] Univ Plymouth, Peninsula Sch Med & Dent, Plymouth, Devon, England.
   [Salih, V.] UCL, Eastman Dent Inst, London, England.
   [Hilborn, J.] Uppsala Univ, Div Polymer Chem, Sci Life Lab A, Dept Chem, Uppsala, Sweden.
RP Oreffo, ROC (reprint author), Univ Southampton, Inst Dev Sci, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat,Human Dev &, Southampton SO16 6YD, Hants, England.
EM roco@soton.ac.uk
RI Muller, Ralph/A-1198-2008; Hofmann, Sandra/F-2832-2010
OI Muller, Ralph/0000-0002-5811-7725; Hofmann, Sandra/0000-0002-2568-8388;
   Oreffo, Richard/0000-0001-5995-6726
FU European Community [262948]
FX This work was supported by a European Community Seventh Framework
   Programme Grant, BioDesign (262948). We acknowledge the provision of
   data from members of the EU BioDesign consortium, without whom this work
   would not have been possible. We thank Wictor Billstrom for valuable
   technical assistance in data sorting as well as Daniel Tang and Stefanie
   Inglis for constructive comments on the manuscript.
CR [Anonymous], F198314 ASTM INT
   [Anonymous], F272109R14 ASTM INT
   Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649
   Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789
   Bering J, 2012, SCI AM, V307, P74, DOI 10.1038/scientificamerican0712-74
   Billstrom GH, 2013, INJURY, V44, pS28, DOI 10.1016/S0020-1383(13)70007-X
   Bolland BJRF, 2008, BONE, V43, P195, DOI 10.1016/j.bone.2008.02.013
   Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19
   Czekanska EM, 2012, EUR CELLS MATER, V24, P1
   Dawson AB, 1926, STAIN TECHNOL, V1, P123, DOI 10.3109/10520292609115636
   Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   FROST HM, 1994, ANGLE ORTHOD, V64, P175
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Georgi N, 2015, STEM CELLS DEV, V24, P1946, DOI 10.1089/scd.2014.0534
   Giannoudis PV, 2008, INJURY, V39, pS5, DOI 10.1016/S0020-1383(08)70010-X
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Gibbs DM, 2014, J TISSUE ENG REGEN M, V10, P187
   GOODWIN CJ, 1995, J IMMUNOL METHODS, V179, P95, DOI 10.1016/0022-1759(94)00277-4
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Holzapfel BM, 2015, BIOMATERIALS, V61, P103, DOI 10.1016/j.biomaterials.2015.04.057
   Kaipel M, 2012, J ORTHOP RES, V30, P1563, DOI 10.1002/jor.22132
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015
   Knight A, 2008, ALTEX-ALTERN TIEREXP, V25, P213
   Ko EK, 2008, TISSUE ENG PT A, V14, P2105, DOI 10.1089/ten.tea.2008.0057
   Langley G, 2007, BIOESSAYS, V29, P918, DOI 10.1002/bies.20628
   Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031
   Marsell R, 2009, INJURY, V40, P4
   McComb RB, 1979, ALKALINE PHOSPHATASE
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8
   Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002
   Muller U, 2007, MED DEVICE TECHNOL, V19, P32
   Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8
   Pound JC, 2006, TISSUE ENG, V12, P2789, DOI 10.1089/ten.2006.12.2789
   RAY RD, 1957, J BONE JOINT SURG AM, V39, P1119, DOI 10.2106/00004623-195739050-00012
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Russell W. M. S., 1959, PRINCIPLES HUMANE EX
   Schutzenberger S, 2012, ARCH ORTHOP TRAUM SU, V132, P1363, DOI 10.1007/s00402-012-1551-2
   Stoddart M J, 2012, Eur Cell Mater, V24, pi
   Ueng SWN, 2007, J ORTHOP RES, V25, P62, DOI 10.1002/jor.20286
   van Griensven M, 2015, ADV DRUG DELIVER REV, V94, P151, DOI 10.1016/j.addr.2015.07.006
   van Wijnen AJ, 2004, ONCOGENE, V23, P4209, DOI 10.1038/sj.onc.1207758
   Ventura M, 2014, J CONTROL RELEASE, V183, P138, DOI 10.1016/j.jconrel.2014.03.044
   Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo
   Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
NR 57
TC 14
Z9 15
U1 0
U2 10
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2016
VL 31
BP 312
EP 322
DI 10.22203/eCM.v031a20
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA DY2AI
UT WOS:000384895100020
PM 27215739
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Capati, MLF
   Nakazono, A
   Yamamoto, K
   Sugimoto, K
   Yanagiguchi, K
   Yamada, S
   Hayashi, Y
AF Capati, Mark Luigi Fabian
   Nakazono, Ayako
   Yamamoto, Kohei
   Sugimoto, Kouji
   Yanagiguchi, Kajiro
   Yamada, Shizuka
   Hayashi, Yoshihiko
TI Fish Collagen Promotes the Expression of Genes Related to Osteoblastic
   Activity
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR BETA-1; DIFFERENTIATION;
   CELLS; PROLIFERATION; OSTEOPONTIN; SUPPRESSION; PHENOTYPE; C2C12; RUNX2
AB Tilapia type I atelocollagen (TAC) is a strong candidate for clinical application as its biological scaffold due to a high degeneration temperature and biologically safe properties. The aim of this study was to confirm the biological effects of TAC in vitro on osteoblastic cells, simulating its clinical application. The proliferation and differentiation of typical preosteoblasts, MC3T3-E1 cells, were investigated using a microarray analysis, staining assay for mineralization, and real-time PCR analysis of the expression of mineralization-related genes. The mRNA expression of 10 genes involved in proliferation and differentiation increased after 3-day culture on an TAC gel, with an average balanced score ratio exceeding 1.5 compared to the control. After two weeks of culture, all three experimental groups showed stronger alkaline phosphatase staining than after one week. The genes expression of alkaline phosphatase, osteocalcin, and bone sialoprotein increased under the experimental conditions. The gene expression of osteopontin did not increase, and no statistical differences were noted among the three experimental groups. The present and previous findings suggest that TAC is not only a suitable alternative to collagen products originating from mammals but also a novel biomaterial with cell differentiation ability for regenerative medicine.
C1 [Capati, Mark Luigi Fabian; Nakazono, Ayako; Yamamoto, Kohei; Sugimoto, Kouji; Yanagiguchi, Kajiro; Yamada, Shizuka; Hayashi, Yoshihiko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
RP Hayashi, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cariol, Nagasaki 8528588, Japan.
EM hayashi@nagasaki-u.ac.jp
FU Funds for Integrated Promotion of Social System Reform and Research and
   Development; Ministry of Education, Science, Sports, and Culture of
   Japan
FX This study was supported in part by Funds for Integrated Promotion of
   Social System Reform and Research and Development, Contract Grant
   Sponsor: Ministry of Education, Science, Sports, and Culture of Japan.
CR AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Capati M. L. F., 2016, BIOL TRACE ELEMENT R
   Cho SW, 2009, BONE, V44, P1069, DOI 10.1016/j.bone.2009.02.012
   Dillow A., 2002, BIOMIMETIC MAT DESIG
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Felber K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144982
   Hayashi Y., 2014, SEAFOOD PROCESSING B, P455
   Hayashi Y, 2012, ADV FOOD NUTR RES, V65, P107, DOI 10.1016/B978-0-12-416003-3.00006-8
   Hesse E, 2010, J BIOMED MATER RES A, V94A, P442, DOI 10.1002/jbm.a.32696
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.0.CO;2-M
   Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Matsumoto R, 2015, J BIOMED MATER RES A, V103, P2531, DOI 10.1002/jbm.a.35387
   Matthews Brya G, 2014, Bonekey Rep, V3, P560, DOI 10.1038/bonekey.2014.55
   Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   Stein GS, 1996, PHYSIOL REV, V76, P593
   Yamamoto K., 2015, INT J POLYM SCI, V2015
   Yamamoto K, 2014, BIOMED RES INT, DOI 10.1155/2014/630757
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156
NR 24
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9422
EI 1687-9430
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2016
AR 5785819
DI 10.1155/2016/5785819
PG 7
WC Polymer Science
SC Polymer Science
GA DY5RI
UT WOS:000385159200001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Nasiri, M
   Tabrizi, SAH
   Almaki, JH
   Nasiri, R
   Idris, A
   Dabagh, S
AF Nasiri, Mahtab
   Tabrizi, Sayed Ali Hassanzadeh
   Almaki, Javad Hamzehalipour
   Nasiri, Rozita
   Idris, Ani
   Dabagh, Shadab
TI Synthesis, functionalization, characterization, and in vitro evaluation
   of robust pH-sensitive CFNs-PA-CaCO3
SO RSC ADVANCES
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; MAGNETIC NANOPARTICLES; DRUG-DELIVERY;
   BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE; ZNO NANOPARTICLES;
   CANCER-THERAPY; PAPAIN ENZYME; APOPTOSIS; CELLS
AB The preparation, characterization, and application of Papain (PA) conjugated CaCO3-coated cobalt ferrite nanoparticles (CFNs-PA-CaCO3) is reported. Papain was covalently attached onto silanized cobalt ferrite nanoparticles (CFNs-APS) and then coated with robust pH sensitive CaCO3. It was characterized by FTIR, XRD, TEM, FESEM, and TGA. The release behaviour of PA from functionalized nanoparticles in acidic and physiological pH was investigated. However, the rate of PA release was slow and enhanced with time at physiological pH; the results illustrate that acidic conditions disassembles the coating, which caused a rapid release of PA. The biocompatibility evaluation of CFNs/CFNs-CaCO3 and the cytotoxicity of free PA/CFNs-PA was carried out in vitro on human breast cancer cells (MDA-MB-231) and human skin fibroblast cells (HSF 1184) by performing an MTT assay. An improved cytotoxic effect was obtained for PA conjugated cobalt ferrites in comparison with free PA. The synthesized delivery system was perfectly tolerable to the blood and cells in concentrations below 200 mu g mL(-1). Investigations were followed out to measure the time and dose dependent cellular uptake of functionalized nanoparticles via the Prussian blue staining method under an inverted microscope, which indicated that functionalized nanoparticles showed internalization properties. The results conveyed that the synthesized system is a promising biomaterial for future biomedical applications, mainly cancer therapy. The present in vitro findings require comparison with those of in vivo studies.
C1 [Nasiri, Mahtab; Tabrizi, Sayed Ali Hassanzadeh; Nasiri, Rozita] Islamic Azad Univ, Adv Mat Res Ctr, Dept Mat Engn, Najafabad Branch, Najafabad, Iran.
   [Almaki, Javad Hamzehalipour; Nasiri, Rozita; Idris, Ani] Univ Teknol Malaysia, Dept Bioproc Engn, Fac Chem Engn, Johor Baharu 81310, Johor, Malaysia.
   [Dabagh, Shadab] Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Johor Baharu 81310, Johor, Malaysia.
RP Nasiri, R (reprint author), Islamic Azad Univ, Adv Mat Res Ctr, Dept Mat Engn, Najafabad Branch, Najafabad, Iran.; Nasiri, R (reprint author), Univ Teknol Malaysia, Dept Bioproc Engn, Fac Chem Engn, Johor Baharu 81310, Johor, Malaysia.
EM roz.sh4524@gmail.com
CR Abdolmohammadi S, 2012, INT J MOL SCI, V13, P4508, DOI 10.3390/ijms13044508
   Abu-Alruz K., 2009, American Journal of Agricultural and Biological Sciences, V4, P173
   Ahmadi M., 2013, ADV MATER PROCESS, V1, P57
   Akila M., 2014, INT J PHARM PHARM SC, V6, P160
   Alexiou C, 2006, EUR BIOPHYS J BIOPHY, V35, P446, DOI 10.1007/s00249-006-0042-1
   Alexiou C, 2000, CANCER RES, V60, P6641
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Almaki JH, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/10/105601
   Amini N, 2016, RSC ADV, V6, P24391, DOI 10.1039/c5ra25654b
   Andreeva DV, 2007, LANGMUIR, V23, P9031, DOI 10.1021/la700958h
   Arsalani N, 2010, EXPRESS POLYM LETT, V4, P329, DOI 10.3144/expresspolymlett.2010.42
   Baldi G, 2007, LANGMUIR, V23, P4026, DOI 10.1021/la063255k
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chittasupho C, 2009, EUR J PHARM SCI, V37, P141, DOI 10.1016/j.ejps.2009.02.008
   Constine L. S., 2008, PRINCETON RAD ONCOLO
   Dabagh S, 2015, MAT SCI SEMICON PROC, V33, P1, DOI 10.1016/j.mssp.2015.01.025
   ENGIN K, 1995, INT J HYPERTHER, V11, P211, DOI 10.3109/02656739509022457
   Fauziya S., 2013, J PHARM SCI, V2, P25
   FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5
   Gani MBA, 2015, INT J PEPT RES THER, V21, P353, DOI 10.1007/s10989-015-9462-z
   Gruttner C, 2007, J MAGN MAGN MATER, V311, P181, DOI 10.1016/j.jmmm.2006.10.1151
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Han DH, 1996, J MAGN MAGN MATER, V161, P376, DOI 10.1016/S0304-8853(96)00263-6
   Herve K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/46/465608
   HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059
   Illes E, 2014, COLLOID SURFACE A, V460, P429, DOI 10.1016/j.colsurfa.2014.01.043
   Islam KN, 2013, POWDER TECHNOL, V235, P70, DOI 10.1016/j.powtec.2012.09.041
   Jayalekshmi AC, 2013, COLLOID SURFACE B, V101, P196, DOI 10.1016/j.colsurfb.2012.06.027
   Juang TY, 2014, MOLECULES, V19, P4997, DOI 10.3390/molecules19044997
   Kainz QM, 2014, FARADAY DISCUSS, V175, P27, DOI 10.1039/c4fd00108g
   Kamba SA, 2013, MOLECULES, V18, P10580, DOI 10.3390/molecules180910580
   Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838
   Kaur M, 2013, J MATER SCI-MATER EL, V24, P4980, DOI 10.1007/s10854-013-1512-8
   Kim DH, 2008, J MAGN MAGN MATER, V320, P2390, DOI 10.1016/j.jmmm.2008.05.023
   Lee ES, 2007, J CONTROL RELEASE, V123, P19, DOI 10.1016/j.jconrel.2007.08.006
   Liang YY, 2007, BIOMACROMOLECULES, V8, P1480, DOI 10.1021/bm061091g
   Liu TY, 2006, LANGMUIR, V22, P5974, DOI 10.1021/la060371e
   Longmire M., 2008, FUTURE MED, P703
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Mahmoud KA, 2013, ACS APPL MATER INTER, V5, P4978, DOI 10.1021/am4007534
   Mansour N, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/03/035701
   Medeiros SF, 2011, INT J PHARMACEUT, V403, P139, DOI 10.1016/j.ijpharm.2010.10.011
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   MENARD R, 1990, BIOCHEMISTRY-US, V29, P6706, DOI 10.1021/bi00480a021
   Mosafa L, 2013, CHINESE J CATAL, V34, P1897, DOI 10.1016/S1872-2067(12)60663-9
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ngadiman NHA, 2015, J MECH BEHAV BIOMED, V49, P90, DOI 10.1016/j.jmbbm.2015.04.029
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Patange SM, 2013, J MOL STRUCT, V1038, P40, DOI 10.1016/j.molstruc.2012.12.053
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   Psimadas D., 2013, NANOTECHNOLOGY, V25, P25101
   Racuciu M, 2006, EUR PHYS J E, V21, P117, DOI 10.1140/epje/i2006-10051-y
   Render D, 2016, J NANOMATER, V2016
   Safaei-Ghomi J, 2013, J MEX CHEM SOC, V57, P1
   Saraswathy A, 2014, CARBOHYD POLYM, V101, P760, DOI 10.1016/j.carbpol.2013.10.015
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Shen YJ, 2015, NANOSCALE, V7, P2941, DOI 10.1039/c4nr06269h
   Singh A, 2014, DRUG DISCOV TODAY, V19, P474, DOI 10.1016/j.drudis.2013.10.005
   Soler MAG, 2004, J MAGN MAGN MATER, V272, P2357, DOI 10.1016/j.jmmm.2003.12.582
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Su BH, 2008, J MATER SCI-MATER M, V19, P745, DOI 10.1007/s10856-007-3006-9
   TSUBAKI M, 1981, P NATL ACAD SCI-BIOL, V78, P3581, DOI 10.1073/pnas.78.6.3581
   Wang CY, 2008, CARBOHYD POLYM, V71, P476, DOI 10.1016/j.carbpol.2007.06.018
   Wang CY, 2006, INT J PHARM, V308, P160, DOI 10.1016/j.ijpharm.2005.11.004
   Wang H, 2004, LANGMUIR, V20, P1877, DOI 10.1021/la035376f
   Wang J, 2010, J PHYS CHEM C, V114, P18940, DOI 10.1021/jp105906p
   Wang ZS, 2006, CHEM MATER, V18, P2912, DOI 10.1021/cm0603102
NR 68
TC 2
Z9 2
U1 1
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 87
BP 84217
EP 84230
DI 10.1039/c6ra14918a
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA DX1LQ
UT WOS:000384129300084
DA 2018-10-20
ER

PT J
AU Skoloudik, L
   Chrobok, V
   Kalfert, D
   Koci, Z
   Sykova, E
   Chumak, T
   Popelar, J
   Syka, J
   Laco, J
   Dedkova, J
   Dayanithi, G
   Filip, S
AF Skoloudik, Lukas
   Chrobok, Viktor
   Kalfert, David
   Koci, Zuzana
   Sykova, Eva
   Chumak, Tetyana
   Popelar, Jiri
   Syka, Josef
   Laco, Jan
   Dedkova, Jana
   Dayanithi, Govindan
   Filip, Stanislav
TI Human Multipotent Mesenchymal Stromal Cells in the Treatment of
   Postoperative Temporal Bone Defect: An Animal Model
SO CELL TRANSPLANTATION
LA English
DT Article
DE Temporal bone; Middle ear surgery; Human bone marrow; Human mesenchymal
   stromal cells (hMSCs); Guinea pig model; Transplantation; Osteogenesis
ID STEM-CELLS; MASTOID OBLITERATION; DIABETIC-PATIENTS; THERAPY;
   CHOLESTEATOMA; REGENERATION; RECONSTRUCTION; ISCHEMIA; INJURY
AB Canal wall down mastoidectomy is one of the most effective treatments for cholesteatoma. However, it results in anatomical changes in the external and middle ear with a negative impact on the patient's quality of life. To provide complete closure of the mastoid cavity and normalize the anatomy of the middle and external ear, we used human multipotent mesenchymal stromal cells (hMSCs), GMP grade, in a guinea pig model. A method for preparing a biomaterial composed of hMSCs, hydroxyapatite, and tissue glue was developed. Animals from the treated group were implanted with biomaterial composed of hydroxyapatite and hMSCs, while animals in the control group received hydroxyapatite alone. When compared to controls, the group implanted with hMSCs showed a significantly higher ratio of new bone formation (p = 0.00174), as well as a significantly higher volume percentage of new immature bone (p = 0.00166). Our results proved a beneficial effect of hMSCs on temporal bone formation and provided a promising tool to improve the quality of life of patients after canal wall down mastoidectomy by hMSC implantation.
C1 [Skoloudik, Lukas; Chrobok, Viktor; Kalfert, David] Charles Univ Prague, Dept Otorhinolaryngol & Head & Neck Surg, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic.
   [Koci, Zuzana; Sykova, Eva; Chumak, Tetyana; Popelar, Jiri; Syka, Josef; Dayanithi, Govindan] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic.
   [Koci, Zuzana; Sykova, Eva] Charles Univ Prague, Dept Neurosci, Fac Med 2, Prague, Czech Republic.
   [Koci, Zuzana] Bioinova Ltd, Prague, Czech Republic.
   [Laco, Jan] Charles Univ Prague, Fingerland Dept Pathol, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic.
   [Dedkova, Jana] Charles Univ Prague, Dept Radiol, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic.
   [Dayanithi, Govindan] Acad Sci Czech Republic, Inst Expt Med, Dept Mol Neurophysiol, Prague, Czech Republic.
   [Dayanithi, Govindan] Univ Montpellier, Inst Natl Sante & Rech Med, Unite Rech, U1198, Montpellier, France.
   [Dayanithi, Govindan] Ecole Prat Hautes Etudes Sorbonne, Paris, France.
   [Filip, Stanislav] Charles Univ Prague, Dept Radiotherapy & Oncol, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic.
RP Filip, S (reprint author), Charles Univ Prague, Dept Radiotherapy & Oncol, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic.
EM filip@fnhk.cz
RI Skoloudik, Lukas/L-5232-2017; Laco, Jan/L-9715-2017
OI Skoloudik, Lukas/0000-0003-4054-8719; Laco, Jan/0000-0002-9602-7501;
   Filip, Stanislav/0000-0002-8567-0745; Chrobok,
   Viktor/0000-0001-7537-139X; Kalfert, David/0000-0003-4369-4113
FU MH CZ-DRO (UHHK) [00179906]; program PRVOUK [P37/06]; NPU of MEYS
   [LO1309]; program PRVOUK (LF UK) [P37/11]
FX This work was supported by MH CZ-DRO (UHHK, 00179906), by the program
   PRVOUK P37/06, P37/11 (LF UK), and NPU of MEYS (LO1309). The authors
   wish to thank Dr. Eva Cermakova for statistical analysis. Govindan
   Dayanithi belongs to the Centre National de la Recherche
   Scientifique-The Ministry of Research and Higher Education-Paris,
   France. We are very grateful to Elisa Brann, IEM AS CR, for her critical
   reading of the manuscript. The authors declare no conflicts of interest.
CR Bortolotti F, 2015, STEM CELL REP, V4, P332, DOI 10.1016/j.stemcr.2015.01.001
   Cheney ML, 1996, AM J OTOL, V17, P137
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dubsky M, 2014, CELL TRANSPLANT, V23, P1517, DOI 10.3727/096368913X674071
   Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227
   Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653
   Franco-Vidal V, 2014, ACTA OTO-LARYNGOL, V134, P358, DOI 10.3109/00016489.2013.859394
   Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002
   He JW, 2010, TISSUE ENG PT A, V16, P127, DOI 10.1089/ten.TEA.2009.0255
   Jang CH, 2008, INT J PEDIATR OTORHI, V72, P1627, DOI 10.1016/j.ijporl.2008.07.017
   Kaplan JM, 2011, CURR STEM CELL RES T, V6, P297
   Koci Z, 2014, CELL BIOCHEM FUNCT, V32, P597, DOI 10.1002/cbf.3056
   Kovach TK, 2015, J IMMUNOL RES, DOI 10.1155/2015/752510
   Kurisaki A, 2010, HUM CELL, V23, P1, DOI 10.1111/j.1749-0774.2010.00080.x
   Leatherman BD, 2002, OTOL NEUROTOL, V23, P657, DOI 10.1097/00129492-200209000-00009
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705
   Murray Brenda, 2001, Angiogenesis, V4, P71, DOI 10.1023/A:1016792319207
   Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6
   Oryan A, 2015, BIOMED ENVIRON SCI, V28, P57, DOI 10.3967/bes2015.006
   Pacini Simone, 2014, Front Cell Dev Biol, V2, P20, DOI 10.3389/fcell.2014.00020
   Pagni G, 2012, ADV DRUG DELIVER REV, V64, P1310, DOI 10.1016/j.addr.2012.03.005
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Potier E, 2010, J BIOMECH, V43, P807, DOI 10.1016/j.jbiomech.2009.11.019
   Raggatt LJ, 2013, AM J PATHOL, V182, P1501, DOI 10.1016/j.ajpath.2013.01.046
   Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937
   Shohet JA, 2002, OTOLARYNG CLIN N AM, V35, P841, DOI 10.1016/S0030-6665(02)00052-X
   Skoloudik L, 2014, MED HYPOTHESES, V82, P769, DOI 10.1016/j.mehy.2014.03.022
   Suzuki H, 2014, ANN OTO RHINOL LARYN, V123, P571, DOI 10.1177/0003489414525335
   Sykova E., 2013, LASER THER, P2287
   Vanecek V, 2013, EUR SPINE J, V22, P2777, DOI 10.1007/s00586-013-2991-2
NR 31
TC 2
Z9 2
U1 0
U2 2
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2016
VL 25
IS 7
BP 1405
EP 1414
DI 10.3727/096368915X689730
PG 10
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA DY0QL
UT WOS:000384801200017
PM 26497735
OA Bronze
DA 2018-10-20
ER

PT J
AU Lin, XY
   Lai, BQ
   Zeng, X
   Che, MT
   Ling, EA
   Wu, WT
   Zeng, YS
AF Lin, Xin-Yi
   Lai, Bi-Qin
   Zeng, Xiang
   Che, Ming-Tian
   Ling, Eng-Ang
   Wu, Wutian
   Zeng, Yuan-Shan
TI Cell Transplantation and Neuroengineering Approach for Spinal Cord
   Injury Treatment: A Summary of Current Laboratory Findings and Review of
   Literature
SO CELL TRANSPLANTATION
LA English
DT Review
DE Neural network; Exogenous neuronal relay; Neurotrophin-3 (NT-3); Nerve
   regeneration; Spinal cord injury (SCI)
ID NEURAL STEM-CELLS; MARROW STROMAL CELLS; PROMOTES AXONAL REGENERATION;
   LONG-DISTANCE GROWTH; SCHWANN-CELLS; ADULT-RAT; NEUROTROPHIC FACTOR;
   FUNCTIONAL RECOVERY; SYNAPTIC-TRANSMISSION; CORTICOSPINAL AXONS
AB Spinal cord injury (SCI) can cause severe traumatic injury to the central nervous system (CNS). Current therapeutic effects achieved for SCI in clinical medicine show that there is still a long way to go to reach the desired goal of full or significant functional recovery. In basic medical research, however, cell transplantation, gene therapy, application of cytokines, and biomaterial scaffolds have been widely used and investigated as treatments for SCI. All of these strategies when used separately would help rebuild, to some extent, the neural circuits in the lesion area of the spinal cord. In light of this, it is generally accepted that a combined treatment may be a more effective strategy. This review focuses primarily on our recent series of work on transplantation of Schwann cells and adult stem cells, and transplantation of stem cell-derived neural network scaffolds with functional synapses. Arising from this, an artificial neural network (an exogenous neuronal relay) has been designed and fabricated by us-a biomaterial scaffold implanted with Schwann cells modified by the neurotrophin-3 (NT-3) gene and adult stem cells modified with the TrkC (receptor of NT-3) gene. More importantly, experimental evidence suggests that the novel artificial network can integrate with the host tissue and serve as an exogenous neuronal relay for signal transfer and functional improvement of SCI.
C1 [Lin, Xin-Yi; Lai, Bi-Qin; Zeng, Xiang; Che, Ming-Tian; Zeng, Yuan-Shan] Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou, Guangdong, Peoples R China.
   [Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore, Singapore.
   [Wu, Wutian] Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.
   [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China.
   [Wu, Wutian] Jinan Univ, Jinan Univ Hong Kong Univ Joint Lab, GHM Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China.
   [Zeng, Yuan-Shan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
   [Zeng, Yuan-Shan] Sun Yat Sen Univ, Inst Spinal Cord Injury, Guangzhou, Guangdong, Peoples R China.
   [Zeng, Yuan-Shan] Coinnovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China.
   [Zeng, Yuan-Shan] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou, Guangdong, Peoples R China.
RP Zeng, YS (reprint author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
EM zengysh@mail.sysu.edu.cn
FU Chinese National Natural Science Foundation [81330028, U1301223];
   National 863 Project [2013AA020106]; Foundation of the Education
   Ministry of China [201300193035]; Foundation of Guangdong Province
   [2011A030300004]; Co-innovation Foundation of Guangzhou [201508020215]
FX This research was supported by grants from the Chinese National Natural
   Science Foundation (Nos. 81330028 and U1301223), National 863 Project
   (No. 2013AA020106), Foundation of the Education Ministry of China (No.
   201300193035), Foundation of Guangdong Province (No. 2011A030300004),
   and Co-innovation Foundation of Guangzhou (No. 201508020215) to Y.-S.
   Zeng. The authors declare no conflicts of interest.
CR Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957
   Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195
   Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
   BIRLING MC, 1995, CURR OPIN CELL BIOL, V7, P878, DOI 10.1016/0955-0674(95)80073-5
   Bonner JF, 2015, BRAIN RES, V1619, P115, DOI 10.1016/j.brainres.2015.01.006
   Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011
   Bradbury EJ, 1998, EUR J NEUROSCI, V10, P3058, DOI 10.1046/j.1460-9568.1998.00307.x
   Bruce JH, 2000, J NEUROTRAUM, V17, P781, DOI 10.1089/neu.2000.17.781
   Bunge MB, 2003, J REHABIL RES DEV, V40, P55, DOI 10.1682/JRRD.2003.08.0055
   BUNGE RP, 1987, J EXP BIOL, V132, P21
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Castellanos DA, 2002, CELL TRANSPLANT, V11, P297
   [陈茜 Chen Qian], 2004, [解剖学报, Acta Anatomica Sinica], V35, P565
   Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251
   Coulson EJ, 2008, J NEUROSCI, V28, P315, DOI 10.1523/JNEUROSCI.2699-07.2008
   Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682
   Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013
   Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001
   Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935
   Di Giovanni S, 2009, EXPERT OPIN THER TAR, V13, P1387, DOI 10.1517/14728220903307517
   [丁英 Ding Ying], 2003, [解剖学报, Acta Anatomica Sinica], V34, P73
   Dobkin BH, 2004, ANNU REV MED, V55, P255, DOI 10.1146/annurev.med.55.091902.104338
   Du BL, 2014, J BIOMED MATER RES A, V102, P1715, DOI 10.1002/jbm.a.34835
   Du BL, 2011, BRAIN RES, V1400, P87, DOI 10.1016/j.brainres.2011.05.019
   Fenrich KK, 2009, J NEUROSCI, V29, P12145, DOI 10.1523/JNEUROSCI.0897-09.2009
   Fortun J, 2009, J NEUROTRAUM, V26, P941, DOI [10.1089/neu.2008.0807, 10.1089/neu.2008-0807]
   Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705
   Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H
   Grill R, 1997, J NEUROSCI, V17, P5560
   GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J
   Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943
   [郭家松 Guo Jiasong], 2003, [解剖学报, Acta Anatomica Sinica], V34, P113
   [郭家松 Guo Jiasong], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P26
   Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970
   Hase T, 2002, EUR J NEUROSCI, V15, P969, DOI 10.1046/j.1460-9568.2002.01932.x
   Hayashi T, 2013, J CLIN INVEST, V123, P272, DOI 10.1172/JCI62516
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014
   Houweling DA, 1998, NEUROSCI LETT, V251, P193, DOI 10.1016/S0304-3940(98)00536-9
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   Klopotowska Dagmara, 2005, Postepy Hig Med Dosw (Online), V59, P517
   Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3
   Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z
   Lai BQ, 2013, BIOMATERIALS, V34, P2888, DOI 10.1016/j.biomaterials.2012.12.046
   LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x
   Lankford KL, 2002, J COMP NEUROL, V443, P259, DOI 10.1002/cne.10117
   Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013
   Lewandowski G, 2014, J NEUROSCI, V34, P9951, DOI 10.1523/JNEUROSCI.1996-14.2014
   Lim MS, 2007, BIOCHEM BIOPH RES CO, V357, P903, DOI 10.1016/j.bbrc.2007.04.045
   Liu Z, 2011, CURR MED CHEM, V18, P5165, DOI 10.2174/092986711797636144
   Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018
   Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Marzella PL, 2002, CLIN EXP PHARMACOL P, V29, P363, DOI 10.1046/j.1440-1681.2002.03684.x
   McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Oudega M, 2005, BRAZ J MED BIOL RES, V38, P825, DOI 10.1590/S0100-879X2005000600003
   PAINO CL, 1991, EXP NEUROL, V114, P254, DOI 10.1016/0014-4886(91)90043-C
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   POLITIS MJ, 1982, J NEUROSCI, V2, P1252
   Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9
   Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7
   SanJose I, 1997, ANAT EMBRYOL, V195, P299
   SanJose I, 1997, INT J DEV BIOL, V41, P509
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Sharp KG, 2014, EXP NEUROL, V257, P186, DOI 10.1016/j.expneurol.2014.04.008
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864
   STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q
   Stewart HJS, 1995, GLIA, V15, P419, DOI 10.1002/glia.440150406
   Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.0.CO;2-Q
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0
   THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593
   Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x
   Tsoulfas P, 1996, J BIOL CHEM, V271, P5691, DOI 10.1074/jbc.271.10.5691
   Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9
   Van Asseldonk JTH, 2003, BRAIN, V126, P186, DOI 10.1093/brain/awg019
   VANEVERCOOREN AB, 1994, ANN NEUROL, V36, pS151
   Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036
   Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001
   WIDMER HR, 1993, J NEUROCHEM, V60, P2111, DOI 10.1111/j.1471-4159.1993.tb03496.x
   Williams RR, 2015, CELL TRANSPLANT, V24, P115, DOI 10.3727/096368913X674657
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   [吴立志 Wu Lizhi], 2004, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical sciences], V25, P10
   [吴立志 Wu Lizhi], 2003, [解剖学报, Acta Anatomica Sinica], V34, P289
   Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113
   Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9
   Zeng X, 2015, BIOMATERIALS, V53, P184, DOI 10.1016/j.biomaterials.2015.02.073
   Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181
   Zeng YS, 2005, DEV NEUROSCI-BASEL, V27, P20, DOI 10.1159/000084529
   Zhang W, 2009, NEUROSCI RES, V64, P170, DOI 10.1016/j.neures.2009.02.010
   Zhang XB, 2007, J NEUROTRAUM, V24, P1863, DOI 10.1089/neu.2007.0334
   Zhang Y, 1998, J NEUROSCI RES, V54, P554
   Zhang YQ, 2012, CELLS TISSUES ORGANS, V195, P313, DOI 10.1159/000327724
   Zhang YQ, 2010, ANAT SCI INT, V85, P61, DOI 10.1007/s12565-009-0056-8
   [张燕青 Zhang Yanqing], 2003, [解剖学报, Acta Anatomica Sinica], V34, P118
   Zhao LX, 2004, EXP NEUROL, V190, P396, DOI 10.1016/j.expneurol.2004.06.025
NR 113
TC 9
Z9 9
U1 2
U2 20
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2016
VL 25
IS 8
BP 1425
EP 1438
DI 10.3727/096368916X690836
PG 14
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA DY0QM
UT WOS:000384801300001
PM 26850705
OA Bronze
DA 2018-10-20
ER

PT J
AU Trimaille, T
   Pertici, V
   Gigmes, D
AF Trimaille, Thomas
   Pertici, Vincent
   Gigmes, Didier
TI Recent advances in synthetic polymer based hydrogels for spinal cord
   repair
SO COMPTES RENDUS CHIMIE
LA English
DT Review
DE Synthetic hydrogel; Spinal cord injury; Bioadhesion; Drug delivery;
   Degradability; Polymers
ID CENTRAL-NERVOUS-SYSTEM; REVERSE THERMAL GEL; FUNCTIONAL RECOVERY;
   DRUG-DELIVERY; AXONAL REGENERATION; BLOCK-COPOLYMERS; CELL-ADHESION;
   INJURY REPAIR; SCAFFOLDS; BIOMATERIALS
AB In spinal cord repair, the challenge consists in combining various therapies that account for multiple deleterious effects in order to induce an efficient recovery. In that context, biomaterial implantation seems to be highly relevant. Indeed, biomaterials not only serve as a growth support to promote sectioned axonal fibers, but are also used for cell transplantation and drug delivery. In this review, we discuss and put into perspective the recent results obtained in the field of spinal cord repair by synthetic hydrogel implantation. The versatility of those biomaterials is presented through the latest chemical strategies developed to enhance their therapeutic effects. (C) 2015 Academie des sciences. Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license.
C1 [Trimaille, Thomas; Pertici, Vincent; Gigmes, Didier] Aix Marseille Univ, CNRS, Inst Chim Radicalaire, UMR 7273, F-13397 Marseille 20, France.
   [Pertici, Vincent] Aix Marseille Univ, CNRS, Inst Sci Mouvement Etienne Jules Morey, UMR 7287,Fac Sci Sport, Marseille 09, France.
RP Trimaille, T; Gigmes, D (reprint author), Aix Marseille Univ, Case 542, Ave Escadrille Normandie Niemen, F-13397 Marseille 20, France.; Trimaille, T; Gigmes, D (reprint author), CNRS, Inst Chim Radicalaire, Equipe,Chim Radicalaire Organ & Polymeres Special, UMR 7273,Case 542, Ave Escadrille Normandie Niemen, F-13397 Marseille 20, France.
EM thomas.trimaille@univ-amu.fr; didier.gigmes@univ-amu.fr
FU Aix-Marseille Universite; Centre National de la Recherche Scientifique
   (CNRS)
FX The authors thank Aix-Marseille Universite and the Centre National de la
   Recherche Scientifique (CNRS) for financial support.
CR Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Chu DS, 2015, BIOMATER SCI-UK, V3, P41, DOI [10.1039/c4bm00259h, 10.1039/C4BM00259H]
   Clement B, 2011, MACROMOL BIOSCI, V11, P1175, DOI 10.1002/mabi.201100067
   Clement B, 2009, BIOMACROMOLECULES, V10, P1436, DOI 10.1021/bm900003f
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Delaittre G, 2012, SOFT MATTER, V8, P7323, DOI 10.1039/c2sm07407a
   Deming TJ, 2005, SOFT MATTER, V1, P28, DOI 10.1039/b500307e
   Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040
   Elli L., 2012, ANN NEUROL, V72, P491
   Estrada V, 2014, NEUROBIOL DIS, V67, P165, DOI 10.1016/j.nbd.2014.03.018
   Fanagan L.A., 2002, NEUROREPORT, V3, P2411
   Gaudin A, 2014, NAT NANOTECHNOL, V9, P1054, DOI [10.1038/nnano.2014.274, 10.1038/NNANO.2014.274]
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020
   Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Hejcl A, 2013, STEM CELLS DEV, V22, P2794, DOI 10.1089/scd.2012.0616
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Jones DR, 2015, ACTA BIOMATER, V13, P52, DOI 10.1016/j.actbio.2014.11.012
   Khaing ZZ, 2014, MATER TODAY, V17, P332, DOI 10.1016/j.mattod.2014.05.011
   Kim M, 2014, HISTOL HISTOPATHOL, V29, P1395, DOI 10.14670/HH-29.1395
   Kubinova S., 2013, J TISSUE ENG REGEN M
   Kubinova S, 2012, REGEN MED, V7, P207, DOI [10.2217/RME.11.121, 10.2217/rme.11.121]
   Kubinova S, 2010, BIOMATERIALS, V31, P5966, DOI 10.1016/j.biomaterials.2010.04.040
   Liu J, 2013, J NEUROL SCI, V325, P127, DOI 10.1016/j.jns.2012.11.022
   Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307
   Macaya D., 2012, BIOMED MATER, V7
   Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890
   McCormick AM, 2013, BIOCONJUGATE CHEM, V24, P1515, DOI 10.1021/bc400058n
   McKinnon DD, 2013, BIOMATER SCI-UK, V1, P460, DOI 10.1039/c3bm00166k
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nicolas J, 2013, PROG POLYM SCI, V38, P63, DOI 10.1016/j.progpolymsci.2012.06.002
   NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Papa S, 2014, J CONTROL RELEASE, V174, P15, DOI 10.1016/j.jconrel.2013.11.001
   Park D, 2011, BIOMATERIALS, V32, P777, DOI 10.1016/j.biomaterials.2010.09.044
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w
   Pertici V., 2013, ASN NEURO, V5, P149
   Pertici V, 2014, BIOMATERIALS, V35, P6248, DOI 10.1016/j.biomaterials.2014.04.020
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Pritchard CD, 2011, BIOMATERIALS, V32, P587, DOI 10.1016/j.biomaterials.2010.08.106
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084
   Rao Shreyas S, 2009, Front Neuroeng, V2, P6, DOI 10.3389/neuro.16.006.2009
   Ritfeld GJ, 2014, BIOMATERIALS, V35, P1924, DOI 10.1016/j.biomaterials.2013.11.062
   Rocha DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088593
   Rossi F, 2013, COLLOID SURFACE B, V108, P169, DOI 10.1016/j.colsurfb.2013.02.046
   Rossi F, 2013, EXPERT OPIN DRUG DEL, V10, P385, DOI 10.1517/17425247.2013.751372
   Ruzicka J, 2013, ACTA NEUROBIOL EXP, V73, P102
   Sacchetti A, 2014, TETRAHEDRON LETT, V55, P6817, DOI 10.1016/j.tetlet.2014.10.069
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sellers DL, 2014, BIOMATERIALS, V35, P8895, DOI 10.1016/j.biomaterials.2014.06.051
   Shah S, 2014, J MATER CHEM B, V2, P7685, DOI 10.1039/c4tb01436g
   Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009
   Shepard JA, 2011, BIOMATERIALS, V32, P5092, DOI 10.1016/j.biomaterials.2011.03.083
   Siraley K.S., 2010, J NEUROTRAUM, V27, P1
   Stanwick J.C., 2012, J CONTROL RELEASE, V160, P666
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   TETZLAFF W, 2011, NEUROTRAUMA, V28, P1611, DOI DOI 10.1089/NEU.2009.1177
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tse Justin R, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1016s47
   Vijayasekaran S, 2000, J BIOMAT SCI-POLYM E, V11, P599, DOI 10.1163/156856200743896
   Woepy S., 2000, NEUROSURG REV, V23, P59
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Wu J, 2014, MOL PHARMACEUT, V11, P3210, DOI 10.1021/mp500393m
   Xia TL, 2013, BRAIN RES, V1538, P41, DOI 10.1016/j.brainres.2013.09.027
   Xing BM, 2014, ACTA BIOMATER, V10, P4127, DOI 10.1016/j.actbio.2014.06.033
   Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhang S, 2014, BIOMATERIALS, V35, P1989, DOI 10.1016/j.biomaterials.2013.11.005
   Zhou WD, 2013, J BIOMAT SCI-POLYM E, V24, P301, DOI 10.1080/09205063.2012.690277
NR 81
TC 1
Z9 1
U1 4
U2 25
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1631-0748
EI 1878-1543
J9 CR CHIM
JI C. R. Chim.
PD JAN-FEB
PY 2016
VL 19
IS 1-2
BP 157
EP 166
DI 10.1016/j.crci.2015.03.016
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA DX6SM
UT WOS:000384513400020
OA Other Gold
DA 2018-10-20
ER

PT J
AU Tezcaner, A
   Baran, ET
   Keskin, D
AF Tezcaner, Aysen
   Baran, Erkan Turker
   Keskin, Dilek
TI Nanoparticles Based on Plasma Proteins for Drug Delivery Applications
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Albumin; Fibrinogen; Lipoprotein; Transferrin. Nanoparticles; Drug
   Delivery
ID HUMAN SERUM-ALBUMIN; PROTAMINE-OLIGONUCLEOTIDE-NANOPARTICLES;
   DENSITY-LIPOPROTEIN NANOPARTICLES; BLOOD-BRAIN-BARRIER; CANCER-THERAPY;
   TRANSFERRIN CONJUGATE; PANCREATIC-CANCER; TARGETED DELIVERY; CONTRAST
   AGENTS; CELLULAR UPTAKE
AB Background: Nanoparticulate delivery systems receive a lot of attention in pharmaceutical research and market due to their in vivo stability, ability to protect entrapped drug, and ease of cellular penetration. The hemo-compatibility and the clearance half-life are important parameters of the nanodelivery systems that will be administered through intravenous route. Natural components, like blood plasma proteins are ideal sources of biomaterial for such systems with their long in vivo half-lives. Methods: The aim of this work is to review in vitro, in vivo and clinical findings of nanocarriers based on blood plasma proteins, namely albumin, lipoproteins, fibrin/fibrinogen, transferrin. Plasma protein based nanocarriers loaded with different bioactive molecules (i.e., anti-cancer, antiviral, anti-epileptic drugs, DNA) have been developed using different preparation methods like desolvation, emulsification, nab-technology, complexation methods. Results: Human serum albumin has attracted the most attention in the last decade as nano-carrier due to its biocompatibility, high binding capacity to various drugs, and easy derivatization by covalent methods. Commercial products of albumin nanoparticles have emerged on the market after its recognition. Low and high density lipoproteins have recently been considered as valuable natural material for preparing hemocompatible small (app 20 nm) lipid-protein vesicles. For other proteins of plasma, however, there are a limited number of studies that explored their potential as nanocarrier formulation. Therefore, there is huge research potential for investigating the proteins like globulins, fibrinogen and transferrin as part of nanocarrier core. Conclusion: Plasma protein based nanoparticulate delivery systems, especially albumin based ones have opened up and also will continue to open new treatment strategy options for treating cancer, AIDS and other complex life threatening diseases with advances in nanotechnology and science.
C1 [Tezcaner, Aysen; Keskin, Dilek] Middle East Tech Univ, Dept Engn Sci, Ankara, Turkey.
   [Tezcaner, Aysen; Keskin, Dilek] Middle East Tech Univ, Dept Biomed Engn, Ankara, Turkey.
   [Tezcaner, Aysen; Baran, Erkan Turker; Keskin, Dilek] Middle East Tech Univ, BIOMATEN Ctr Excellence Biomat & Tissue Engn, Ankara, Turkey.
RP Tezcaner, A (reprint author), Middle East Tech Univ, Dept Engn Sci, Fac Engn, TR-06800 Ankara, Turkey.
EM tezcaner@metu.edu.tr
RI Baran, Erkan/Q-8482-2017
OI Baran, Erkan/0000-0002-0563-6943
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7
   Altintas I, 2013, J CONTROL RELEASE, V165, P110, DOI 10.1016/j.jconrel.2012.11.007
   Brennan FR., 2014, HDB THERAPEUTIC ANTI, V2, P970
   Bunschoten A, 2012, BIOMATERIALS, V33, P867, DOI 10.1016/j.biomaterials.2011.10.005
   Capriotti AL, 2014, CHROMATOGRAPHIA, V77, P755, DOI 10.1007/s10337-014-2677-x
   Capriotti AL, 2013, ANAL BIOANAL CHEM, V405, P635, DOI 10.1007/s00216-011-5691-y
   Caracciolo G, 2014, COLLOID SURFACE B, V123, P673, DOI 10.1016/j.colsurfb.2014.10.008
   Caracciolo G, 2011, LANGMUIR, V27, P15048, DOI 10.1021/la202912f
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Chen YJ, 2015, CELL TISSUE RES, V361, P439, DOI 10.1007/s00441-015-2125-8
   Corbin IR, 2006, NEOPLASIA, V8, P488, DOI 10.1593/neo.05835
   COSTANTINI V, 1992, CANCER METAST REV, V11, P283, DOI 10.1007/BF01307183
   Crisante F, 2009, EUR J PHARM SCI, V36, P555, DOI 10.1016/j.ejps.2008.12.006
   Damascelli B, 2001, CANCER, V92, P2592, DOI 10.1002/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4
   Damiano MG, 2013, ADV DRUG DELIVER REV, V65, P649, DOI 10.1016/j.addr.2012.07.013
   Ding Y, 2014, BIOMATERIALS, V35, P7214, DOI 10.1016/j.biomaterials.2014.05.009
   Dosio F, 2009, INT J PHARMACEUT, V382, P117, DOI 10.1016/j.ijpharm.2009.08.018
   Du CL, 2013, BIOMATERIALS, V34, P3087, DOI 10.1016/j.biomaterials.2013.01.041
   DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
   Eangelis AP, 1999, CLIN IMMUNOL NEWSL, V99, P113
   Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069
   Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031
   Fleischer CC, 2014, ACCOUNTS CHEM RES, V47, P2651, DOI 10.1021/ar500190q
   German JB, 2006, CURR OPIN COLLOID IN, V11, P171, DOI 10.1016/j.cocis.2005.11.006
   Gessner A, 2000, INT J PHARM, V196, P245, DOI 10.1016/S0378-5173(99)00432-9
   Goszczynski T, 2013, BBA-GEN SUBJECTS, V1830, P2526, DOI 10.1016/j.bbagen.2012.11.005
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Hadjidemetriou M, 2015, ACS NANO, V9, P8142, DOI 10.1021/acsnano.5b03300
   Heukers R, 2014, BIOMATERIALS, V35, P601, DOI 10.1016/j.biomaterials.2013.10.001
   Hong MH, 2009, J CONTROL RELEASE, V133, P96, DOI 10.1016/j.jconrel.2008.09.005
   Huntosova V, 2012, INT J PHARMACEUT, V436, P463, DOI 10.1016/j.ijpharm.2012.07.005
   Jiang C, 2015, ACTA BIOMATER, P1461
   Jonas A., 2002, BIOCH LIPIDS LIPOPRO, P483
   Kader A, 1998, J CONTROL RELEASE, V55, P231, DOI 10.1016/S0168-3659(98)00052-2
   Kim TH, 2012, J CONTROL RELEASE, V162, P422, DOI 10.1016/j.jconrel.2012.07.021
   Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028
   Kratzer I, 2007, J CONTROL RELEASE, V117, P301, DOI 10.1016/j.jconrel.2006.11.020
   La Corte ALC, 2011, ADV PROTEIN CHEM STR, V83, P75, DOI 10.1016/B978-0-12-381262-9.00003-3
   Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0
   Li CY, 2013, INT J PHARMACEUT, V448, P79, DOI 10.1016/j.ijpharm.2013.03.019
   Li W, 2008, EXP BIOL MED, V233, P818, DOI 10.3181/0711-RM-320
   Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023
   Lochmann D, 2005, EUR J PHARM BIOPHARM, V59, P419, DOI 10.1016/j.ejpb.2004.04.001
   Lubgan Dorota, 2006, Postepy Biochem, V52, P72
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Mahajan SD, 2010, CURR HIV RES, V8, P396
   Min SY, 2015, INT J PHARMACEUT, V494, P506, DOI 10.1016/j.ijpharm.2015.08.055
   Ming X, 2013, BIOMATERIALS, V34, P7939, DOI 10.1016/j.biomaterials.2013.06.066
   Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h
   Montgomery A, 2015, BIOMATER SCI-UK, V3, P401, DOI 10.1039/c4bm00299g
   Nelson TJ, 2004, United States Patent, Patent No. [US 7682627, 7682627]
   Nikanjarn M, 2007, J CONTROL RELEASE, V124, P163, DOI 10.1016/j.jconrel.2007.09.007
   Patil GV, 2003, DRUG DEVELOP RES, V58, P219, DOI 10.1002/ddr.10157
   Pozzi D, 2014, MOL BIOSYST, V10, P2815, DOI 10.1039/c4mb00292j
   Qi JN, 2010, INT J PHARMACEUT, V393, P176, DOI 10.1016/j.ijpharm.2010.03.063
   Rajangam T, 2013, INT J NANOMED, V8, P3641, DOI 10.2147/IJN.S43945
   Rejinold NS, 2014, COLLOID SURFACE B, V114, P209, DOI 10.1016/j.colsurfb.2013.10.015
   Rejinold NS, 2011, INT J BIOL MACROMOL, V48, P98, DOI 10.1016/j.ijbiomac.2010.10.003
   Rejinold NS, 2010, INT J BIOL MACROMOL, V47, P37, DOI 10.1016/j.ijbiomac.2010.03.023
   Rosenberger I, 2014, J CONTROL RELEASE, V194, P130, DOI 10.1016/j.jconrel.2014.08.017
   Sahoo N, 2015, INT J BIOL MACROMOL, V81, P317, DOI 10.1016/j.ijbiomac.2015.08.006
   Segrest JP, 2001, J LIPID RES, V42, P1346
   Son S, 2013, BIOMATERIALS, V34, P9475, DOI 10.1016/j.biomaterials.2013.08.085
   Szwed M, 2014, TOXICOL IN VITRO, V28, P187, DOI 10.1016/j.tiv.2013.09.013
   Teerlink T, 2004, J LIPID RES, V45, P954, DOI 10.1194/jlr.M300521-JLR200
   Ulbrich K, 2011, INT J PHARMACEUT, V406, P128, DOI 10.1016/j.ijpharm.2010.12.023
   van der Meel R, 2013, ADV DRUG DELIVER REV, V65, P1284, DOI 10.1016/j.addr.2013.08.012
   Vedakumari WS, 2013, BBA-GEN SUBJECTS, V1830, P4244, DOI 10.1016/j.bbagen.2013.04.032
   Wang GJ, 2001, J BONE JOINT SURG AM, V83A, P1503, DOI 10.2106/00004623-200110000-00007
   Watcharin W, 2014, EUR J PHARM BIOPHARM, V87, P132, DOI 10.1016/j.ejpb.2013.12.010
   Weyermann J, 2005, EUR J PHARM BIOPHARM, V59, P431, DOI 10.1016/j.ejpb.2004.07.014
   Wicki A, 2015, J CONTROL RELEASE, V200, P138, DOI 10.1016/j.jconrel.2014.12.030
   Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110
   Wilson B, 2015, INT J BIOL MACROMOL, V81, P763, DOI 10.1016/j.ijbiomac.2015.09.015
   Wilson B, 2014, INT J PHARMACEUT, V473, P73, DOI 10.1016/j.ijpharm.2014.05.056
   Woods A, 2015, J CONTROL RELEASE, V210, P1, DOI 10.1016/j.jconrel.2015.05.269
   Wu L, 2012, INT J PHARMACEUT, V431, P190, DOI 10.1016/j.ijpharm.2012.04.032
   Xu RZ, 2011, BIOCONJUGATE CHEM, V22, P870, DOI 10.1021/bc1002295
   Xu SL, 2011, INT J PHARMACEUT, V404, P205, DOI 10.1016/j.ijpharm.2010.10.053
   Yasunaga M, 2011, CANCER SCI, V102, P1396, DOI 10.1111/j.1349-7006.2011.01954.x
   Zhang N, 2013, CHINESE CHEM LETT, V24, P659, DOI 10.1016/j.cclet.2013.04.029
   Zhang XB, 2010, CANCER LETT, V298, P26, DOI 10.1016/j.canlet.2010.05.023
   Zhao CY, 2014, COLLOID SURFACE B, V123, P787, DOI 10.1016/j.colsurfb.2014.10.024
   Zhao L, 2015, INT J PHARMACEUT, V483, P180, DOI 10.1016/j.ijpharm.2015.02.018
   Zhu QL, 2014, BIOMATERIALS, V35, P5965, DOI 10.1016/j.biomaterials.2014.03.088
NR 86
TC 2
Z9 2
U1 5
U2 22
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PY 2016
VL 22
IS 22
BP 3445
EP 3454
DI 10.2174/1381612822666160209152446
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DX9OB
UT WOS:000384723900011
PM 26861647
DA 2018-10-20
ER

PT J
AU Khawas, P
   Deka, SC
AF Khawas, Prerna
   Deka, Sankar Chandra
TI Comparative Nutritional, Functional, Morphological, and Diffractogram
   Study on Culinary Banana (Musa ABB) Peel at Various Stages of
   Development
SO INTERNATIONAL JOURNAL OF FOOD PROPERTIES
LA English
DT Article
DE Banana peel; GLC; HPLC; FT-IR; SEM; XRD
ID DIETARY FIBER; PLANTAIN PEELS; FRUIT PEELS; STARCH; ANTIOXIDANT;
   VARIETIES; ACID; POLYPHENOLS; COMPONENTS; CELLULOSE
AB The culinary banana peel, which is an agricultural waste available in abundance, has not been able to draw much attention in terms of its utilization. In addition to being an abundant source of functional and nutritional compounds, it also deserves to be utilized in a proper and/or better way. The aim of this study was to explore this agro-waste at different levels of maturity in order to identify the active compounds at particular stage of maturity. Phenolics, flavonoids, and radical scavenging activity were maximum at early developmental stage, whereas compounds like protein, fat, carbohydrates, and starch increased with maturity and declined at over-ripe stage. The starch present in the peel is of C-type as confirmed by x-ray diffractograms and crystalline in nature. The peel, at the edible mature stage 4, yielded a high cellulose content which could be used as a reinforcement material in high-performance biocomposites. The presence of various functional groups indicating the complex nature of the culinary banana peel was confirmed by Fourier transform infrared characterization. Scanning electron microscope micrographs revealed that microstructure of peel changes drastically and degradation of starch and other compounds occurred at the over-ripe stage. Hence, in this context, the culinary banana peel can serve as a potential biomaterial in industrial applications and can add a higher value to this locally important and underutilized crop.
C1 [Khawas, Prerna; Deka, Sankar Chandra] Tezpur Univ, Dept Food Engn & Technol, Napaam 784028, Assam, India.
RP Deka, SC (reprint author), Tezpur Univ, Dept Food Engn & Technol, Napaam 784028, Assam, India.
EM sankar@tezu.ernet.in
FU Ministry of Defense; Ministry of Defense and the Government of India
FX The financial support was received from Ministry of Defense and the
   Government of India, and is duly acknowledged.
CR Adeniji TA, 2008, FRUITS, V63, P65, DOI 10.1051/fruits:2007048
   ADISA VA, 1987, FOOD CHEM, V25, P85, DOI 10.1016/0308-8146(87)90057-4
   Anhwange B.A., 2008, J FOOD TECHNOL, V6, P263
   AOAC, 2010, ASS OFF AN CHEM OFF
   Ashraf A. M., 2011, INT J BIOSCIENCE BIO, V1, P53
   Ashraf MA, 2012, RES J BIOTECHNOL, V7, P81
   BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25
   BRAY HG, 1954, METHOD BIOCHEM ANAL, V1, P27
   Bugaud C, 2009, J SCI FOOD AGR, V89, P407, DOI 10.1002/jsfa.3459
   Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6
   Choi SH, 2012, J AGR FOOD CHEM, V60, P10245, DOI 10.1021/jf302848u
   CORDENUNSI BR, 1995, J AGR FOOD CHEM, V43, P347, DOI 10.1021/jf00050a016
   Cosgrove J. D., 2014, ENCY LIFE SCI, DOI [10.1038/npg.els.0001688, DOI 10.1038/NPG.ELS.0001688]
   del Rio LA, 1998, PLANT PHYSIOL, V116, P1195, DOI 10.1104/pp.116.4.1195
   Delfanian M, 2015, INT J FOOD PROP, V18, P2813, DOI 10.1080/10942912.2015.1013635
   Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Emaga TH, 2008, BIORESOURCE TECHNOL, V99, P4346, DOI 10.1016/j.biortech.2007.08.030
   Emaga TH, 2007, FOOD CHEM, V103, P590, DOI 10.1016/j.foodchem.2006.09.006
   Emaga TH, 2011, TROP ANIM HEALTH PRO, V43, P171, DOI 10.1007/s11250-010-9671-6
   Essien JP, 2005, BIORESOURCE TECHNOL, V96, P1451, DOI 10.1016/j.biortech.2004.12.004
   Fan DM, 2012, STARCH-STARKE, V64, P598, DOI 10.1002/star.201100200
   FERNANDES KM, 1979, J FOOD SCI, V44, P1254, DOI 10.1111/j.1365-2621.1979.tb03493.x
   Gibson L, 2013, ANTIOXIDANTS, V2, P216, DOI 10.3390/antiox2040216
   Goswami B, 1996, FOOD CHEM, V55, P169, DOI 10.1016/0308-8146(95)00072-0
   Gull J, 2012, MOLECULES, V17, P3165, DOI 10.3390/molecules17033165
   Herbert D-H., 1998, AGRON COSTARRIC, V22, P43
   Hodge J. E., 1962, METHODS CARBOHYDRATE, P17
   James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6
   Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667
   JOHN P, 1995, BANANAS PLANTAINS, P434
   KAISER C, 1994, J HORTIC SCI, V69, P437, DOI 10.1080/14620316.1994.11516473
   Khawas P., 2014, International Food Research Journal, V21, P1011
   Khawas P, 2014, AM J FOOD SCI TECHNO, V2, P80
   Khawas P, 2016, CARBOHYD POLYM, V137, P608, DOI 10.1016/j.carbpol.2015.11.020
   Khawas P, 2015, INT J FOOD ENG, V11, P667, DOI 10.1515/ijfe-2015-0094
   Kiyoshi M., 2003, FOOD PRESERVATION SC, V29, P347
   Kumar N, 2008, J SEP SCI, V31, P262, DOI 10.1002/jssc.200700372
   Lohani S, 2004, POSTHARVEST BIOL TEC, V31, P119, DOI 10.1016/j.postharvbio.2003.08.001
   Marschner H., 1995, MINERAL NUTR HIGHER, P278
   Naozuka J, 2011, FOOD CHEM, V124, P1667, DOI 10.1016/j.foodchem.2010.07.051
   Nguyen TBT, 2003, POSTHARVEST BIOL TEC, V30, P187, DOI 10.1016/S0925-5214(03)00103-0
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Pilnik W, 1990, GUMS STABILISERS FOO, V5, P209
   Punna R, 2004, INT J FOOD SCI NUTR, V55, P561, DOI 10.1080/09637480500126418
   Ramadan MF, 2002, EUR FOOD RES TECHNOL, V214, P202, DOI 10.1007/s00217-001-0423-8
   Ranganna S., 2008, HDB ANAL QUALITY CON
   Rop O, 2011, MOLECULES, V16, P74, DOI 10.3390/molecules16010074
   Sadasivam S, 2008, BIOCH METHODS
   Sakyi-Dawson E, 2008, J SCI FOOD AGR, V88, P2724, DOI 10.1002/jsfa.3399
   Sanchez-Rivera MM, 2010, STARCH-STARKE, V62, P155, DOI 10.1002/star.200900209
   Schanderi S.H, 1970, METHOD FOOD ANAL
   Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315
   Siddika A., 2013, J BIOSCIENCE, V21, P35
   Simmonds NW., 1966, BANANAS
   Singh R. R., 2000, POSTHARVEST TECHNOLO, P76
   SOMOGYI M, 1952, J BIOL CHEM, V195, P19
   STAFFORD HA, 1960, PLANT PHYSIOL, V35, P108, DOI 10.1104/pp.35.1.108
   Sultana B, 2008, GRASAS ACEITES, V59, P205
   Sun JX, 2005, POLYM DEGRAD STABIL, V88, P521, DOI 10.1016/j.polymdegradstab.2004.12.013
   Sundaram S, 2011, APPL BIOCHEM BIOTECH, V164, P1192, DOI 10.1007/s12010-011-9205-3
   Thirumavalavan M, 2011, J CHEM ENG DATA, V56, P2249, DOI 10.1021/je101262w
   Wanlapa S, 2015, INT J FOOD PROP, V18, P1306, DOI 10.1080/10942912.2010.535187
   Zeng J, 2011, MOLECULES, V16, P10570, DOI 10.3390/molecules161210570
   Zhang PY, 2005, CARBOHYD POLYM, V59, P443, DOI 10.1016/j.carbpol.2004.10.014
NR 65
TC 1
Z9 1
U1 3
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1094-2912
EI 1532-2386
J9 INT J FOOD PROP
JI Int. J. Food Prop.
PY 2016
VL 19
IS 12
BP 2832
EP 2853
DI 10.1080/10942912.2016.1141296
PG 22
WC Food Science & Technology
SC Food Science & Technology
GA DX3DL
UT WOS:000384253300017
DA 2018-10-20
ER

PT J
AU Asgary, S
   Fazlyab, M
   Nosrat, A
AF Asgary, Saeed
   Fazlyab, Mahta
   Nosrat, Ali
TI Regenerative Endodontic Treatment versus Apical Plug in Immature Teeth:
   Three-Year Follow-Up
SO JOURNAL OF CLINICAL PEDIATRIC DENTISTRY
LA English
DT Article
DE Calcium-Enriched Mixture; Pulp; Revascularization; Regeneration
ID MINERAL TRIOXIDE AGGREGATE; PERMANENT TEETH; PULP REVASCULARIZATION;
   APEXIFICATION; PERIODONTITIS; OUTCOMES; TOOTH; DISCOLORATION; ABSCESS;
   DRAWBACKS
AB This report compares and evaluates the treatment outcomes of regenerative endodontic treatment and apical plug as two accepted treatment protocols in a pair of necrotic immature maxillary central incisors of a 12 year old female. The patient was referred complaining of a dull pain and swelling in her upper lip area. She had a history of trauma to the anterior maxilla two years earlier. Both teeth were clinically diagnosed with pulp necrosis and periapical radiographs revealed that separate periapical radiolucent lesions surrounded the immature apices of both teeth. The left and right incisors were treated with apical plug and regenerative endodontic treatment, respectively, using calcium-enriched mixture (CEM) cement. The patient was followed-up for three years. During this period, both teeth were clinically asymptomatic and showed complete radiographic healing of the periapical lesions. The right central incisor showed root development. No tooth discoloration was evident. Apexcation by apical plug placement and pulp regeneration are both reliable treatments for immature non-vital teeth. In order to choose the right treatment the advantages of either technique should be weighed against its drawbacks. CEM cement can be successfully applied for both purposes. This biomaterial causes less discoloration of the tooth.
C1 [Asgary, Saeed; Fazlyab, Mahta; Nosrat, Ali] Shahid Beheshti Univ Med Sci, Iranian Ctr Endodont Res, Res Inst Dent Sci, Tehran, Iran.
RP Fazlyab, M (reprint author), Shahid Beheshti Univ Med Sci, Res Inst Dent Sci, POB 1983963113, Tehran, Iran.
EM dr.mfazlyab@gmail.com
OI Nosrat, Ali/0000-0003-4768-9717
CR Akcay M, 2014, J ENDODONT, V40, P845, DOI 10.1016/j.joen.2013.09.019
   Alobaid AS, 2014, J ENDODONT, V40, P1063, DOI 10.1016/j.joen.2014.02.016
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026
   Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003
   Chueh LH, 2009, J ENDODONT, V35, P160, DOI 10.1016/j.joen.2008.10.019
   Chueh LH, 2006, J ENDODONT, V32, P1205, DOI 10.1016/j.joen.2006.07.010
   Fouad AF, 2002, ENDOD TOPICS, V3, P52, DOI DOI 10.1034/J.1601-1546.2002.30106.X
   Fouad AF, 2013, ENDODONTIC TOPICS, V28, P24
   Hargreaves KM, 2013, J ENDODONT, V39, pS30, DOI 10.1016/j.joen.2012.11.025
   Huang GTJ, 2009, INT ENDOD J, V42, P855, DOI 10.1111/j.1365-2591.2009.01577.x
   Iwaya S, 2001, DENT TRAUMATOL, V17, P185, DOI 10.1034/j.1600-9657.2001.017004185.x
   Jeeruphan T, 2012, J ENDODONT, V38, P1330, DOI 10.1016/j.joen.2012.06.028
   Johns Dexton Antony, 2014, J Conserv Dent, V17, P487, DOI 10.4103/0972-0707.139850
   Kakoli P, 2009, J ENDODONT, V35, P78, DOI 10.1016/j.joen.2008.10.004
   Kerekes K, 1980, J Endod, V6, P744, DOI 10.1016/S0099-2399(80)80186-5
   Kontakiotis EG, 2014, J ENDODONT, V40, P1045, DOI 10.1016/j.joen.2014.03.013
   Lenherr P, 2012, INT ENDOD J, V45, P942, DOI 10.1111/j.1365-2591.2012.02053.x
   Lenzi R, 2012, J ENDODONT, V38, P411, DOI 10.1016/j.joen.2011.12.003
   Martin G, 2013, J ENDODONT, V39, P138, DOI 10.1016/j.joen.2012.09.015
   Mente J, 2013, J ENDODONT, V39, P20, DOI 10.1016/j.joen.2012.10.007
   Nosrat A, 2013, J ENDODONT, V39, P1291, DOI 10.1016/j.joen.2013.06.019
   Nosrat A, 2012, J ENDODONT, V38, P1428, DOI 10.1016/j.joen.2012.06.025
   Nosrat A, 2011, J ENDODONT, V37, P562, DOI 10.1016/j.joen.2011.01.011
   NYGAARD-OSTBY B, 1971, Scandinavian Journal of Dental Research, V79, P333
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Petrino JA, 2010, J ENDODONT, V36, P536, DOI 10.1016/j.joen.2009.10.006
   Rafter M, 2005, DENT TRAUMATOL, V21, P1, DOI 10.1111/j.1600-9657.2004.00284.x
   Rahimi S, 2012, MED ORAL PATOL ORAL, V17, pE907, DOI 10.4317/medoral.18136
   Reynolds K, 2009, INT ENDOD J, V42, P84, DOI 10.1111/j.1365-2591.2008.01467.x
   Ruparel NB, 2012, J ENDODONT, V38, P1372, DOI 10.1016/j.joen.2012.06.018
   Shah N, 2008, J ENDODONT, V34, P919, DOI 10.1016/j.joen.2008.05.001
   Sheehy EC, 1997, BRIT DENT J, V183, P241, DOI 10.1038/sj.bdj.4809477
   Shimizu E, 2013, J ENDODONT, V39, P1078, DOI 10.1016/j.joen.2013.04.032
   Shin SY, 2009, INT ENDOD J, V42, P1118, DOI 10.1111/j.1365-2591.2009.01633.x
   Siqueira Jr JF, 2004, ENDOD TOP, V7, P93
   Torabinejad M, 2014, J ENDODONT, V40, P515, DOI 10.1016/j.joen.2013.12.025
   Trope Martin, 2010, Dent Clin North Am, V54, P313, DOI 10.1016/j.cden.2009.12.006
   Wigler R, 2013, J ENDODONT, V39, P319, DOI 10.1016/j.joen.2012.11.014
NR 40
TC 5
Z9 5
U1 4
U2 8
PU JOURNAL PEDODONTICS INC
PI BIRMINGHAM
PA 5724 HIGHWAY 280 EAST, BIRMINGHAM, AL 35242 USA
SN 1053-4628
EI 1557-5268
J9 J CLIN PEDIATR DENT
JI J. Clin. Pediatr. Dent.
PY 2016
VL 40
IS 5
BP 356
EP 360
DI 10.17796/1053-4628-40.5.356
PG 5
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA DX8IZ
UT WOS:000384632600004
PM 27617375
DA 2018-10-20
ER

PT J
AU Dar, SU
   Ali, S
   Hameed, MU
   Zuhra, Z
   Wu, ZP
AF Dar, Sami Ullah
   Ali, Shafqat
   Hameed, Muhammad Usman
   Zuhra, Zareen
   Wu, Zhanpeng
TI A facile synthesis, structural morphology and fluorescent properties of
   cross-linked
   poly(cyclotriphosphazene-co-1,3,5-tri(4-hydroxyphenyl)benzene) hybrid
   copolymer microspheres
SO NEW JOURNAL OF CHEMISTRY
LA English
DT Article
ID PRECIPITATION POLYMERIZATION; POLYPHOSPHAZENE MATERIAL; NANOPARTICLES;
   POLYMERS; MONODISPERSE; PARTICLES; STABILITY; CHEMISTRY; LENGTH
AB The ever increasing growth and interest in the field of material science for the production of functionalized polymer microspheres with tunable size is of pivotal importance. This research describes the one pot method for the facile synthesis of fluorescent active poly[cyclotriphosphazene-co-1,3,5-tri(4-hydroxyphenyl)benzene] (PCTHB) microspheres with the desired structural morphology obtained by the reaction of 1,3,5-tri(4-hydroxyphenyl) benzene (HPB) with hexachlorocyclotriphosphazene (HCCP) through the precipitation polymerization. The sizes of the microspheres can be tuned by changing the amount of both the cross linkers in a calculated molar ratio. The mean diameter of the microspheres varies in the range of 0.5-1.1 mu m. The morphology and structure of PCTHB microspheres were characterized by FT-IR, solid state P-31 NMR, SEM, EDX-mapping and TEM analyses. A mechanism for the preparation of PCTHB microspheres has been proposed, in which HPB plays a crucial role, as its presence gives the final desired shape to the microspheres. The concentration of HBP beyond 2 mM has produced irregular morphology of the microspheres. Room-temperature photoluminescence spectra of the PCTHB microspheres reveal a strong emission peak at 372 nm. These fluorescent polymer PCTHB microspheres can be developed with great ease as compared to those with the aid of quantum dots and dyes. Due to these superior properties and novelty of our synthesized material, it can be used as a potential biomaterial for several applications such as diagnostics, photocatalysis, biological imaging, organic or inorganic analysis, and light emitting diodes.
C1 [Dar, Sami Ullah; Ali, Shafqat; Hameed, Muhammad Usman; Wu, Zhanpeng] Beijing Univ Chem Technol, Key Lab Carbon Fibre & Funct Polymers, Minist Educ, Beijing 100029, Peoples R China.
   [Zuhra, Zareen] Beijing Univ Chem Technol, Inst Sci, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
RP Wu, ZP (reprint author), Beijing Univ Chem Technol, Key Lab Carbon Fibre & Funct Polymers, Minist Educ, Beijing 100029, Peoples R China.
EM wuzp@mail.buct.edu.cn
RI Zuhra, Zareen/G-5119-2018
OI Zuhra, Zareen/0000-0003-4751-7149
FU National Natural Science Foundation of China [51273018]
FX This research was financially supported by the National Natural Science
   Foundation of China (Project 51273018). Shafqat Ali is thanked for
   making an equal contribution as performed by the first author. Minijie
   Cui is thanked for her technical assistance.
CR Ainscough E. W., 2007, INORG CHEM, V46, P7
   Allcock HR, 2004, PHOSPHORUS SULFUR, V179, P661, DOI 10.1080/10426500490426386
   Allcock HR, 2001, MACROMOLECULES, V34, P5140, DOI 10.1021/ma010084b
   Allcock HR, 2000, CHEM MATER, V12, P2530, DOI 10.1021/cm990381j
   Barner L, 2009, ADV MATER, V21, P2547, DOI 10.1002/adma.200900373
   Bolink HJ, 2008, ORG ELECTRON, V9, P155, DOI 10.1016/j.orgel.2007.10.005
   Chang YK, 2005, CHEM MATER, V17, P4449, DOI 10.1021/cm050122w
   Chaplin AB, 2005, INORG CHEM, V44, P8407, DOI 10.1021/ic0511266
   Chen JA, 2011, J PHYS CHEM B, V115, P3354, DOI 10.1021/jp111443x
   Chu LY, 2007, ANGEW CHEM INT EDIT, V46, P8970, DOI 10.1002/anie.200701358
   DEWAR MJS, 1960, J CHEM SOC, P2423, DOI 10.1039/jr9600002423
   Duque JG, 2011, J PHYS CHEM C, V115, P15147, DOI 10.1021/jp2012107
   Fu JW, 2015, CHEM ENG J, V281, P42, DOI 10.1016/j.cej.2015.06.088
   Guang X. G., 2011, J PHYS CHEM C, V115, P2332
   Hu Y, 2014, LANGMUIR, V30, P4458, DOI 10.1021/la500270t
   Jiang JS, 2011, MACROMOLECULES, V44, P5893, DOI 10.1021/ma201038e
   Kawaguchi H, 2000, PROG POLYM SCI, V25, P1171, DOI 10.1016/S0079-6700(00)00024-1
   Kim DH, 2005, SMALL, V1, P99, DOI 10.1002/smll.200400024
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   Li GL, 2013, CHEM SOC REV, V42, P3628, DOI 10.1039/c3cs35517a
   Liu SZ, 2011, LANGMUIR, V27, P3982, DOI 10.1021/la104547z
   Liu W, 2011, CHEM COMMUN, V47, P11447, DOI 10.1039/c1cc14224k
   Mark J. E., 2005, INORG POLYM
   Medina-Castillo AL, 2010, MACROMOLECULES, V43, P5804, DOI 10.1021/ma100841c
   Osborne MA, 2011, ACS NANO, V5, P8295, DOI 10.1021/nn202994w
   Pai RK, 2011, J PHYS CHEM C, V115, P1674, DOI 10.1021/jp109589h
   Pan TJ, 2012, MACROMOL CHEM PHYS, V213, P1590, DOI 10.1002/macp.201200099
   RABENSTEIN DL, 1988, ANAL CHEM, V60, pR1
   Samori P, 2011, ADV FUNCT MATER, V21, P1210, DOI 10.1002/adfm.201100462
   Shim SE, 2004, J POLYM SCI POL CHEM, V42, P835, DOI 10.1002/pola.11028
   Stone DA, 2006, J POLYM SCI POL CHEM, V44, P69, DOI 10.1002/pola.21140
   Sudhakar S, 2006, MACROMOL RAPID COMM, V27, P247, DOI 10.1002/marc.200500771
   Sun H, 1997, J AM CHEM SOC, V119, P3611, DOI 10.1021/ja963077p
   Tissandier C, 2012, LANGMUIR, V28, P209, DOI 10.1021/la203580q
   Wang C, 2014, MATER HORIZ, V1, P535, DOI 10.1039/c4mh00082j
   Wei W, 2010, CHEM COMMUN, V46, P487, DOI 10.1039/b917137a
   Wu WB, 2015, CHEM SOC REV, V44, P3997, DOI 10.1039/c4cs00224e
   Zhang P, 2009, MACROMOL CHEM PHYSIC, V210, P792, DOI 10.1002/macp.200800597
   Zhang ZL, 2010, J MATER CHEM, V20, P1179, DOI 10.1039/b919955a
NR 39
TC 1
Z9 1
U1 7
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1144-0546
EI 1369-9261
J9 NEW J CHEM
JI New J. Chem.
PY 2016
VL 40
IS 10
BP 8418
EP 8423
DI 10.1039/c6nj01578f
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA DX9YW
UT WOS:000384754300030
DA 2018-10-20
ER

PT J
AU Soni, SK
   Kabir, KMM
   Babarao, R
   Coyle, VE
   Sarkar, S
   Sabri, YM
   Bhargava, SK
AF Soni, Sarvesh Kumar
   Kabir, K. M. Mohibul
   Babarao, Ravichandar
   Coyle, Victoria E.
   Sarkar, Sampa
   Sabri, Ylias M.
   Bhargava, Suresh K.
TI A QCM-based 'on-off' mechanistic study of gas adsorption by plasmid DNA
   and DNA-[Bmim][PF6] construct
SO RSC ADVANCES
LA English
DT Article
ID VOLATILE ORGANIC-COMPOUNDS; QUARTZ-CRYSTAL MICROBALANCE; IONIC LIQUIDS;
   METAL IONS; AMMONIA; IR; ACETALDEHYDE; GOLD; SPECTROSCOPY; BIOMARKERS
AB The study of the adsorption behavior of disease markers such as ammonia (NH3) and acetaldehyde (CH3CHO) with biomaterials is important, as it will improve our understanding of their interaction behavior and enable the development of self-diagnosis technologies, among others. In this study, three types of DNA-based biomaterials were synthesized (pGFP plasmid DNA isolated from E. coli DH5 alpha, a DNA-ionic liquid construct (DNA-IL) and DNA-ionic liquid-gold chloride (DNA-IL-Au)) and their adsorption capacities for NH3 and CH3CHO were tested by utilizing a gravimetric transducer, namely, a quartz crystal microbalance (QCM). Pristine DNA itself displayed high sensitivity towards both gases, with a pristine DNA-based QCM displaying magnitudes of response of similar to 3.74 and 2.62 ng cm(-2) mu g(-1) following 10 minutes of exposure to 600 ppm NH3 and CH3CHO, respectively. Interestingly, no response was observed when these gases were exposed to the DNA-IL complex, which comprised DNA modified with the hydrophobic IL [Bmim][PF6]. However, when the DNA-IL complex was further treated with HAuCl4, the biomaterial (DNA-IL-Au) regained its adsorption capacity, exhibiting magnitudes of adsorption/response up to 140% and 36% higher than its DNA counterpart toward NH3 and CH3CHO, respectively. It was also observed that the utilization of DNA-IL-Au significantly reduced the sensitivity of the QCM device to humidity content, which indicates that the developed biomaterial can be readily employed to detect NH3 and CH3CHO in humid environments. Further study showed that the magnitudes of the QCM response of the DNA and DNA-IL-Au materials toward the different concentrations of NH3 and CH3CHO that were tested follow the loading ratio correlation (LRC), which thus indicates that the developed materials can potentially be utilized as sensitive layers for the detection of biomarker gases that are produced in the body as a result of biomedical disorders. In addition, a plausible sorption mechanism has also been proposed on the basis of the interaction of DNA with the ionic liquid and HAuCl4 (experimentally proved by XPS and FTIR), which strongly indicates the role of the phosphates and nucleobases of DNA for the electrostatic binding of NH3 and CH3CHO, respectively.
C1 [Soni, Sarvesh Kumar; Kabir, K. M. Mohibul; Coyle, Victoria E.; Sabri, Ylias M.; Bhargava, Suresh K.] RMIT Univ, Sch Sci, Ctr Adv Mat & Ind Chem, Melbourne, Vic 3001, Australia.
   [Babarao, Ravichandar] CSIRO Mfg Flagship, Clayton South MDC, Private Bag 10, Clayton, Vic 3169, Australia.
   [Babarao, Ravichandar; Sarkar, Sampa] RMIT Univ, Sch Sci, Melbourne, Vic 3001, Australia.
RP Soni, SK; Sabri, YM; Bhargava, SK (reprint author), RMIT Univ, Sch Sci, Ctr Adv Mat & Ind Chem, Melbourne, Vic 3001, Australia.
EM sarveshkumar.soni@rmit.edu.au; ylias.sabri@rmit.edu.au;
   suresh.bhargava@rmit.edu.au
OI Kabir, K M Mohibul/0000-0003-3742-5742; Sabri,
   Ylias/0000-0001-9422-5670; Babarao, Ravichandar/0000-0003-3556-495X
FU Department of Education, Govt. of Australia; Australian Research Council
   Endeavour research award; DECRA fellowship; Research Publications Grant
   (HDRPG) from RMIT's College of Science, Engineering and Health (SEH)
FX Department of Education, Govt. of Australia and Australian Research
   Council Endeavour research award to SKS and SS, and DECRA fellowship to
   RB, respectively. Higher Degree by Research Publications Grant (HDRPG)
   from RMIT's College of Science, Engineering and Health (SEH) to KMMK.
CR Abu-Salah KM, 2015, SENSORS-BASEL, V15, P14539, DOI 10.3390/s150614539
   Amann A, 2011, EXPERT REV MOL DIAGN, V11, P207, DOI [10.1586/ERM.10.112, 10.1586/erm.10.112]
   Andreeva N, 2012, SENSOR ACTUAT B-CHEM, V164, P15, DOI 10.1016/j.snb.2012.01.051
   Andrushchenko VV, 1997, J MOL STRUCT, V408, P225, DOI 10.1016/S0022-2860(96)09672-X
   [Anonymous], 1987, PHYS TECHNOL, V18, P170, DOI 10.1088/0305-4624/18/4/I04
   [Anonymous], 2010, ALCOHOL CONSUMPTION, V96
   Balbo S., 2014, CANC PREVENTION DIET, P237
   Berg RW, 2005, J PHYS CHEM B, V109, P19018, DOI 10.1021/jp050691r
   Bogdanffy MS, 2003, TOXICOL LETT, V140, P83, DOI 10.1016/S0378-4274(02)00504-0
   Braun CS, 2003, BIOPHYS J, V84, P1114, DOI 10.1016/S0006-3495(03)74927-3
   Brubach JB, 2001, J PHYS CHEM B, V105, P430, DOI 10.1021/jp002983s
   Bruni P, 2001, J MOL STRUCT, V565, P237, DOI 10.1016/S0022-2860(01)00526-9
   Cha S, 2014, PHYS CHEM CHEM PHYS, V16, P9591, DOI 10.1039/c4cp00589a
   Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x
   Cheng TF, 2008, J BIOL CHEM, V283, P27820, DOI 10.1074/jbc.M804086200
   Cho YM, 2012, AM J EMERG MED, V30, P1395, DOI 10.1016/j.ajem.2011.10.009
   Dharaskar SA, 2013, SCI WORLD J, DOI 10.1155/2013/395274
   GARDINER DJ, 1981, ADV MOL RELAX INT PR, V20, P131, DOI 10.1016/0378-4487(81)80009-X
   Gouma P, 2010, IEEE SENS J, V10, P49, DOI 10.1109/JSEN.2009.2036050
   Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u
   Hackl EV, 1997, J MOL STRUCT, V408, P229, DOI 10.1016/S0022-2860(96)09534-8
   Hasan M, 1999, INORG CHEM, V38, P5637, DOI 10.1021/ic990657p
   He YX, 2013, CHINESE SCI BULL, V58, P2950, DOI 10.1007/s11434-013-5845-8
   HEMMINKI K, 1984, ARCH TOXICOL, V55, P186, DOI 10.1007/BF00316126
   Ji XB, 2007, ELECTROANAL, V19, P2194, DOI 10.1002/elan.200703997
   Kabir K. M. M., 2015, J SENSORS, V2015, P7
   Kabir KMM, 2015, LANGMUIR, V31, P8519, DOI 10.1021/acs.langmuir.5b01858
   Kalyanasundaram K., 2007, THESIS
   Li B, 2006, NANO LETT, V6, P1598, DOI 10.1021/nl060498o
   Li ZJ, 2015, RSC ADV, V5, P81362, DOI 10.1039/c5ra13730f
   [Liu Guiqiang 刘桂强], 2004, Chinese Optics Letters, V2, P154
   Long F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02308
   Lourenco C, 2014, METABOLITES, V4, P465, DOI 10.3390/metabo4020465
   Mahshid SS, 2015, J AM CHEM SOC, V137, P15596, DOI 10.1021/jacs.5b04942
   Maroni M., 1995, INDOOR AIR QUALITY C
   Millonig G, 2011, INT J CANCER, V128, P533, DOI 10.1002/ijc.25604
   Mochalski P, 2015, CELL BIOCHEM BIOPHYS, V71, P323, DOI 10.1007/s12013-014-0201-4
   Moeller BC, 2013, TOXICOL SCI, V133, P1, DOI 10.1093/toxsci/kft029
   Molhave L., 1991, INDOOR AIR, V4, P357, DOI DOI 10.1111/J.1600-0668.1991.00001.X
   Rieder J, 2001, WIEN KLIN WOCHENSCHR, V113, P181
   Sabri YM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06741
   Soni SK, 2015, LANGMUIR, V31, P4722, DOI 10.1021/acs.langmuir.5b00402
   Wang JH, 2007, ANAL CHEM, V79, P620, DOI 10.1021/ac061145c
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Yokozeki A, 2007, IND ENG CHEM RES, V46, P1605, DOI 10.1021/ie061260d
   Zhang H, 2011, J NANOSCI NANOTECHNO, V11, P5939, DOI 10.1166/jnn.2011.4408
NR 46
TC 0
Z9 0
U1 3
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 84
BP 81318
EP 81329
DI 10.1039/c6ra14759c
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA DW8KF
UT WOS:000383903500109
DA 2018-10-20
ER

PT J
AU Pospisil, T
   Hamzic, LF
   Ahmed, LB
   Lovric, M
   Gajovic, S
   Frkanec, L
AF Pospisil, Tihomir
   Hamzic, Lejla Ferhatovic
   Ahmed, Lada Brkic
   Lovric, Marija
   Gajovic, Srecko
   Frkanec, Leo
TI Synthesis, characterization and in vitro biocompatibility assessment of
   a novel tripeptide hydrogelator, as a promising scaffold for tissue
   engineering applications
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID PEPTIDE HYDROGEL; 3D CULTURE; GELATION; CELL; BIOMATERIALS;
   DIFFERENTIATION; REGENERATION; DERIVATIVES; ASSEMBLIES; NANOFIBERS
AB We have synthesized and characterized a self-assembling tripeptide hydrogelator Ac-L-Phe-L-Phe-L-Ala-NH2. A series of experiments showed that the hydrogel material could serve as a stabile and biocompatible physical support as it improves the survival of HEK293T cells in vitro, thus being a promising biomaterial for use in tissue engineering applications.
C1 [Pospisil, Tihomir; Frkanec, Leo] Rudjer Boskovic Inst, Lab Supramol Chem, Div Organ Chem & Biochem, Bijenicka 54, Zagreb 10000, Croatia.
   [Hamzic, Lejla Ferhatovic; Ahmed, Lada Brkic; Lovric, Marija; Gajovic, Srecko] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Salata 12, Zagreb 10000, Croatia.
RP Frkanec, L (reprint author), Rudjer Boskovic Inst, Lab Supramol Chem, Div Organ Chem & Biochem, Bijenicka 54, Zagreb 10000, Croatia.; Gajovic, S (reprint author), Univ Zagreb, Sch Med, Croatian Inst Brain Res, Salata 12, Zagreb 10000, Croatia.
EM srecko.gajovic@hiim.hr; frkanec@irb.hr
OI Frkanec, Leo/0000-0001-9065-7003; Gajovic, Srecko/0000-0001-8668-5239
FU Ministry of Science, Education and Sports of the Republic of Croatia;
   Croatian Science Foundation (HRZZ project) [IP-11-2013-7387]; EU FP7
   Glow-Brain project [REGPOT-2012-CT2012-316120]; European Regional
   Development Fund (ERDF) - EU FP7 grant
FX This work was supported by the Ministry of Science, Education and Sports
   of the Republic of Croatia, the Croatian Science Foundation (HRZZ
   project IP-11-2013-7387), and EU FP7 Glow-Brain project
   (REGPOT-2012-CT2012-316120). The authors thank Dr Hrvoje Banfic
   (Croatian Institute for Brain Research, University of Zagreb, School of
   Medicine, Zagreb) for providing HEK293T cells. We greatly acknowledge
   the access to the equipment in possession of the University of Rijeka
   within the project RISK "Development of University of Rijeka campus
   laboratory research infrastructure", financed by the European Regional
   Development Fund (ERDF) supported by a EU FP7 grant, and particularly Dr
   Karlo Wittine and Dr Uros Andelkovic for providing HRMS spectra.
CR Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Caplar V, 2010, CHEM-EUR J, V16, P3066, DOI 10.1002/chem.200902342
   Deechongkit S, 2005, J AM CHEM SOC, V127, P8562, DOI 10.1021/ja050558c
   Dong RJ, 2015, BIOMATER SCI-UK, V3, P937, DOI 10.1039/c4bm00448e
   Du XW, 2015, CHEM REV, V115, P13165, DOI 10.1021/acs.chemrev.5b00299
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Frkanec L, 2002, J AM CHEM SOC, V124, P9716, DOI 10.1021/ja027189u
   Frkanec L, 2010, CHEM COMMUN, V46, P522, DOI 10.1039/b920353m
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Gelain F., 2009, BIOTECHNOL BIOENG, V103, P655
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a
   Hynd MR, 2007, J BIOMAT SCI-POLYM E, V18, P1223, DOI 10.1163/156856207782177909
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Liebmann T, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-88
   Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767
   Liu NN, 2014, TETRAHEDRON, V70, P6630, DOI 10.1016/j.tet.2014.06.108
   Ma ML, 2010, J AM CHEM SOC, V132, P2719, DOI 10.1021/ja9088764
   Makarevic J, 2002, CHEM COMMUN, P2238, DOI 10.1039/b206690d
   Makarevic J, 2010, BEILSTEIN J ORG CHEM, V6, P945, DOI 10.3762/bjoc.6.106
   Marchesan S., 2013, J BIONANOSCI, V3, P21, DOI 10.1007/s12668-012-0074-1
   Miljanic S, 2006, EUR J ORG CHEM, P1323, DOI 10.1002/ejoc.200500535
   Motamed S, 2016, SOFT MATTER, V12, P2243, DOI 10.1039/c5sm02902c
   Nagai Y, 2012, BIOMATERIALS, V33, P1044, DOI 10.1016/j.biomaterials.2011.10.049
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   NITECKI DE, 1968, J ORG CHEM, V33, P864, DOI 10.1021/jo01266a091
   Nune M, 2013, CURR PROTEIN PEPT SC, V14, P70, DOI 10.2174/1389203711314010010
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Ouyang L., 2015, BIOFABRICATION, P7
   Panda J. J., 2012, ACS APPL MATER INTER, V2, P2839
   Pospisil T., 2016, C CZECH CHEM SOC S S, V14, P126
   Raeburn J, 2013, CHEM SOC REV, V42, P5143, DOI 10.1039/c3cs60030k
   Ramezani MR, 2014, BIOCELL, V38, P11
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Ryan DM, 2012, POLYM CHEM-UK, V3, P18, DOI 10.1039/c1py00335f
   Seow WY, 2014, MATER TODAY, V17, P381, DOI 10.1016/j.mattod.2014.04.028
   Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tatman PD, 2016, BIOMATER SCI-UK, V4, P543, DOI 10.1039/c5bm00550g
   Truong WT, 2011, CHEM-ASIAN J, V6, P30, DOI 10.1002/asia.201000592
   Wang HM, 2012, NANOSCALE, V4, P5259, DOI 10.1039/c2nr31149f
   Wang HM, 2011, SOFT MATTER, V7, P3897, DOI 10.1039/c0sm01405b
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yan XH, 2010, CHEM SOC REV, V39, P1877, DOI 10.1039/b915765b
   Ying L., 2014, SCI CHINA PHYS MECH, V57, P849
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu ZQ, 2016, BIOMATER SCI-UK, V4, P365, DOI 10.1039/c5bm00472a
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 53
TC 1
Z9 1
U1 0
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2016
VL 4
IS 10
BP 1412
EP 1416
DI 10.1039/c6bm00287k
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA DX5FA
UT WOS:000384404000001
PM 27508285
OA Green Published
DA 2018-10-20
ER

PT J
AU Zhang, H
   Guo, YY
   Yao, JF
   He, M
AF Zhang, Huan
   Guo, Yingying
   Yao, Jianfeng
   He, Ming
TI Epoxidised soybean oil polymer composites reinforced with modified
   microcrystalline cellulose
SO JOURNAL OF EXPERIMENTAL NANOSCIENCE
LA English
DT Article
DE composite; epoxidised polymer; microcrystalline cellulose; biomaterial
ID LINSEED OIL; UNSATURATED POLYESTER; NANOCRYSTALS; THERMOSETS; ACID;
   BIODEGRADATION; POLYURETHANES
AB Microcrystalline cellulose (MCC) grafted with n-octadecyl isocyanate (18C-g-MCC) was introduced as the reinforcing filler in epoxidised soybean oil (ESO) polymer. The wetting characteristics of 18C-g-MCC were evaluated by static contact angle and the results show that the hydrophobicity of MCC was improved by the introduction of nonpolar alkyl groups. The ESO composites were synthesised with different contents of 18C-g-MCC (from 0 to 25 wt%) by a thermally cured method. The reinforcing effects of 18C-g-MCC were evaluated by scanning electron microscopy, mechanical test, dynamic mechanical analysis and thermal stability test. The results show that the tensile strength, the impact strength, Young's modulus, the flexural strength and glass transition temperature of the composites increase gradually with the increase of 18C-g-MCC content, while the elongation at break begins to decrease with 18C-g-MCC content of more than 20 wt%. Contact angle and water absorption analysis of the composites indicate the addition of 18C-g-MCC increases the water absorption of the ESO polymer.
C1 [Zhang, Huan; Guo, Yingying; He, Ming] Nanjing Forestry Univ, Dept Chem & Mat Sci, Coll Sci, Nanjing, Jiangsu, Peoples R China.
   [Yao, Jianfeng] Nanjing Forestry Univ, Dept Chem Engn, Coll Chem Engn, Nanjing, Jiangsu, Peoples R China.
RP He, M (reprint author), Nanjing Forestry Univ, Dept Chem & Mat Sci, Coll Sci, Nanjing, Jiangsu, Peoples R China.
EM heming@njfu.edu.cn
RI Yao, Jianfeng/C-1010-2011
OI Yao, Jianfeng/0000-0002-3619-6741
FU Natural Science Foundation of Jiangsu Province, China [BK 20141469]
FX Natural Science Foundation of Jiangsu Province, China [grant number BK
   20141469].
CR Bai W, 2009, COMPOS PART A-APPL S, V40, P1597, DOI 10.1016/j.compositesa.2009.07.006
   Boquillon N, 2000, POLYMER, V41, P8603, DOI 10.1016/S0032-3861(00)00256-1
   Cakmakli B, 2007, J APPL POLYM SCI, V105, P3448, DOI 10.1002/app.26397
   Cateto CA, 2009, IND ENG CHEM RES, V48, P2583, DOI 10.1021/ie801251r
   de Espinosa LM, 2008, J POLYM SCI POL CHEM, V46, P6843, DOI 10.1002/pola.22992
   Dogan E, 2008, J APPL POLYM SCI, V110, P1129, DOI 10.1002/app.28708
   Dwan'isa JPL, 2004, J MATER SCI, V39, P2081
   Haafiz MKM, 2013, CARBOHYD POLYM, V98, P139, DOI 10.1016/j.carbpol.2013.05.069
   He M, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42488
   Keles E, 2009, J POLYM ENVIRON, V17, P153, DOI 10.1007/s10924-009-0132-0
   Kim JR, 2012, IND CROP PROD, V36, P485, DOI 10.1016/j.indcrop.2011.10.036
   Lin N, 2011, CARBOHYD POLYM, V83, P1834, DOI 10.1016/j.carbpol.2010.10.047
   Liu HY, 2010, BIORESOURCE TECHNOL, V101, P5685, DOI 10.1016/j.biortech.2010.02.045
   Liu ZS, 2010, J AM OIL CHEM SOC, V87, P437, DOI 10.1007/s11746-009-1514-0
   Luo XG, 2013, MACROMOL MATER ENG, V298, P412, DOI 10.1002/mame.201200030
   Ma XF, 2008, CARBOHYD POLYM, V72, P369, DOI 10.1016/j.carbpol.2007.09.002
   Missoum K, 2012, CELLULOSE, V19, P1957, DOI 10.1007/s10570-012-9780-7
   Miyagawa H, 2006, IND ENG CHEM RES, V45, P1014, DOI 10.1021/ie050902e
   Miyagawa H, 2007, J POLYM SCI POL PHYS, V45, P698, DOI 10.1002/polb.21059
   Petrovic ZS, 2010, J POLYM ENVIRON, V18, P94, DOI 10.1007/s10924-010-0194-z
   Qiu WL, 2004, J APPL POLYM SCI, V94, P1326, DOI 10.1002/app.21123
   Quirino RL, 2012, GREEN CHEM, V14, P1398, DOI 10.1039/c2gc35204d
   Shogren RL, 2004, J POLYM ENVIRON, V12, P173, DOI 10.1023/B:JOOE.0000038549.73769.7d
   Siqueira G, 2010, LANGMUIR, V26, P402, DOI 10.1021/la9028595
   Sun XW, 2014, CARBOHYD POLYM, V101, P642, DOI 10.1016/j.carbpol.2013.09.088
   Supanchaiyamat N, 2012, GREEN CHEM, V14, P1759, DOI 10.1039/c2gc35154d
   Tan SG, 2014, POLYM INT, V63, P273, DOI 10.1002/pi.4501
   Watanabe A, 2006, J MOL STRUCT, V799, P102, DOI 10.1016/j.molstruc.2006.03.018
   Wik VM, 2011, POLYM ENG SCI, V51, P1389, DOI 10.1002/pen.21939
   Xia Y, 2009, MACROMOL MATER ENG, V294, P590, DOI 10.1002/mame.200900060
   Xu XZ, 2013, ACS APPL MATER INTER, V5, P2999, DOI 10.1021/am302624t
   Yew GH, 2005, POLYM DEGRAD STABIL, V90, P488, DOI 10.1016/j.polydegradstab.2005.04.006
   Zhang J, 2013, PROG ORG COAT, V76, P1683, DOI 10.1016/j.porgcoat.2013.07.017
   Zhang Z, 2015, ACS SUSTAIN CHEM ENG, V3, P574, DOI 10.1021/sc5000792c
NR 34
TC 1
Z9 1
U1 2
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1745-8080
EI 1745-8099
J9 J EXP NANOSCI
JI J. Exp. Nanosci.
PY 2016
VL 11
IS 15
BP 1213
EP 1226
DI 10.1080/17458080.2016.1209584
PG 14
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DX3ZJ
UT WOS:000384316100004
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Bacelar, AH
   Silva-Correia, J
   Oliveira, JM
   Reis, RL
AF Bacelar, Ana H.
   Silva-Correia, Joana
   Oliveira, Joaquim M.
   Reis, Rui L.
TI Recent progress in gellan gum hydrogels provided by functionalization
   strategies
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Review
ID TISSUE-ENGINEERING APPLICATIONS; IN-VITRO; MECHANICAL-PROPERTIES;
   CONTROLLED-RELEASE; CELLS; REGENERATION; DELIVERY; GELS;
   DIFFERENTIATION; FORMULATIONS
AB Gellan gum, a microbial exopolysaccharide fermentation product of Pseudomonas elodea, is a natural biomaterial that has shown promise for tissue engineering and regenerative medicine applications. Although this exopolysaccharide possesses many advantages, such as interesting physicochemical properties and non-cytotoxicity, the mechanical properties and processability of gellan gum are not totally satisfactory in different tissue engineering contexts, i.e. gellan gum hydrogels are mechanically weak and the high gelling temperature is also unfavourable. An additional critical limitation is the lack of specific attachment sites for anchorage-dependent cells. However, the multiple hydroxyl groups and the free carboxyl per repeating unit of gellan gum can be used for chemical modification and functionalization in order to optimize its physicochemical and biological properties. A number of physical modification approaches have also been employed. This review outlines the recent progress in gellan gum hydrogels and their derivatives, and identifies the new challenges in tissue engineering, provided by blending and/or chemical modification.
C1 [Bacelar, Ana H.; Silva-Correia, Joana; Oliveira, Joaquim M.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk,Parque Ciencia & Tecnol,Zona Ind Gandra, P-4805017 Barco Gmr, Portugal.
   [Bacelar, Ana H.; Silva-Correia, Joana; Oliveira, Joaquim M.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
RP Oliveira, JM (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk,Parque Ciencia & Tecnol,Zona Ind Gandra, P-4805017 Barco Gmr, Portugal.; Oliveira, JM (reprint author), ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Oliveira, Joaquim Miguel/H-8636-2012; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012; Silva-Correia, Joana/D-4980-2012
OI Oliveira, Joaquim Miguel/0000-0001-7052-8837; Reis, Rui
   L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Silva-Correia,
   Joana/0000-0003-1312-3109
FU Portuguese Foundation for Science and Technology (FCT) through the
   project EPIDisc [UTAP-EXPL/BBBECT/0050/2014]; FCT [SFRH/BPD/100590/2014,
   IF/00423/2012]
FX The authors would like to acknowledge the financial support provided by
   the Portuguese Foundation for Science and Technology (FCT) through the
   project EPIDisc (UTAP-EXPL/BBBECT/0050/2014), funded in the Framework of
   the "International Collaboratory for Emerging Technologies, CoLab'', UT
   Austin Portugal Program. The authors also thank FCT for the fellowship
   grant of J. Silva-Correia (SFRH/BPD/100590/2014) and the distinction
   attributed to J. M. Oliveira under the Investigator FCT program
   (IF/00423/2012).
CR Agnihotri SA, 2005, DRUG DEV IND PHARM, V31, P491, DOI 10.1080/03639040500215875
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Babu R. Jayachandra, 2010, Current Drug Delivery, V7, P36
   Barbani N, 2012, J MATER SCI-MATER M, V23, P51, DOI 10.1007/s10856-011-4505-2
   Bellini D, 2015, EUR POLYM J, V72, P642, DOI 10.1016/j.eurpolymj.2015.02.043
   BeMiller J. N., 1996, Journal of Applied Glycoscience, V43, P377
   Canadas R, 2012, J TISSUE ENG REGEN M, V6, P16
   Cencetti C, 2011, J MATER SCI-MATER M, V22, P263, DOI 10.1007/s10856-010-4217-z
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   CRESCENZI V, 1990, NATO ADV SCI I E-APP, V186, P277
   D'Arrigo G, 2012, SOFT MATTER, V8, P11557, DOI 10.1039/c2sm26178b
   da Silva LP, 2014, ACTA BIOMATER, V10, P4787, DOI 10.1016/j.actbio.2014.07.009
   Dentini M, 2001, MACROMOLECULES, V34, P1449, DOI 10.1021/ma001185x
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Douglas TEL, 2014, J TISSUE ENG REGEN M, V8, P906, DOI 10.1002/term.1616
   Douglas TEL, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045014
   Douglas TEL, 2016, J TISSUE ENG REGEN M, V10, P938, DOI 10.1002/term.1875
   Du HW, 2012, MACROMOL BIOSCI, V12, P952, DOI 10.1002/mabi.201100422
   Ferris CJ, 2015, J MATER CHEM B, V3, P1106, DOI 10.1039/c4tb01727g
   Ferris CJ, 2013, BIOMATER SCI-UK, V1, P224, DOI 10.1039/c2bm00114d
   Fialho AM, 2008, APPL MICROBIOL BIOT, V79, P889, DOI 10.1007/s00253-008-1496-0
   Gantar A, 2014, MAT SCI ENG C-MATER, V43, P27, DOI 10.1016/j.msec.2014.06.045
   Giavasis I, 2000, CRIT REV BIOTECHNOL, V20, P177, DOI 10.1080/07388550008984169
   Gibson W., 1997, THICKENING GELLING A, P119
   Gong YH, 2009, J MATER CHEM, V19, P1968, DOI 10.1039/b818090c
   GRASDALEN H, 1987, CARBOHYD POLYM, V7, P371, DOI 10.1016/0144-8617(87)90004-X
   Hamcerencu M, 2008, CARBOHYD POLYM, V71, P92, DOI 10.1016/j.carbpol.2007.05.021
   Hamcerencu M, 2012, CARBOHYD POLYM, V89, P438, DOI 10.1016/j.carbpol.2012.03.026
   JANSSON PE, 1983, CARBOHYD RES, V124, P135, DOI 10.1016/0008-6215(83)88361-X
   Kang D., 2015, POLYSACCHARIDES BIOA, P1627
   Khang G, 2015, J TISSUE ENG REGEN M, V9, P265, DOI 10.1002/term.1625
   Krauland AH, 2003, J PHARM SCI, V92, P1234, DOI 10.1002/jps.10371
   Lee H, 2011, J BIOMED MATER RES B, V98B, P238, DOI 10.1002/jbm.b.31845
   Lee MW, 2012, CARBOHYD POLYM, V90, P1132, DOI 10.1016/j.carbpol.2012.06.064
   Lee MW, 2010, CARBOHYD POLYM, V82, P920, DOI 10.1016/j.carbpol.2010.06.019
   Lozano R, 2015, BIOMATERIALS, V67, P264, DOI 10.1016/j.biomaterials.2015.07.022
   Manda-Guiba MG, 2012, J TISSUE ENG REGEN M, V6, P15
   Matricardi P, 2009, MOLECULES, V14, P3376, DOI 10.3390/molecules14093376
   Miyamoto K, 1996, CARBOHYD POLYM, V30, P161, DOI 10.1016/S0144-8617(96)00087-2
   Miyazaki S, 1999, J CONTROL RELEASE, V60, P287, DOI 10.1016/S0168-3659(99)00084-X
   MOORHOUSE R, 1981, SOLUTION PROPERTIES, P111
   Morris ER, 2012, FOOD HYDROCOLLOID, V28, P373, DOI 10.1016/j.foodhyd.2012.01.004
   Ogawa E, 2002, FOOD HYDROCOLLOID, V16, P1, DOI 10.1016/S0268-005X(01)00024-8
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Oliveira JT, 2009, J TISSUE ENG REGEN M, V3, P493, DOI 10.1002/term.184
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Oliveira MB, 2016, ACTA BIOMATER, V41, P119, DOI 10.1016/j.actbio.2016.05.033
   Osmalek T, 2014, INT J PHARMACEUT, V466, P328, DOI 10.1016/j.ijpharm.2014.03.038
   Pacelli S, 2015, INT J BIOL MACROMOL, V72, P1335, DOI 10.1016/j.ijbiomac.2014.10.046
   Pereira DR, 2014, KEY ENG MATER, V587, P255, DOI 10.4028/www.scientific.net/KEM.587.255
   Pereira DR, 2011, TISSUE ENG PART C-ME, V17, P961, DOI [10.1089/ten.tec.2011.0115, 10.1089/ten.TEC.2011.0115]
   Prajapati VD, 2013, CARBOHYD POLYM, V93, P670, DOI 10.1016/j.carbpol.2013.01.030
   Quinn F. X., 1993, Polymer Gels and Networks, V1, P93, DOI 10.1016/0966-7822(93)90014-9
   Recuenco FC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04723
   Reis R. L., 2010, [No title captured], Patent No. [WO2011/119059, 2011119059]
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   Silva D. A., 2013, J APPL POLYM SCI, V130, P3374
   Silva NA, 2013, BIOCHIMIE, V95, P2314, DOI 10.1016/j.biochi.2013.08.016
   Silva NA, 2012, BIOMATERIALS, V33, P6345, DOI 10.1016/j.biomaterials.2012.05.050
   Silva-Correia J, 2011, J TISSUE ENG REGEN M, V5, pE97, DOI 10.1002/term.363
   Silva-Correia J, 2013, J BIOMED MATER RES A, V101, P3438, DOI 10.1002/jbm.a.34650
   Silva-Correia J, 2013, ADV HEALTHC MATER, V2, P568, DOI 10.1002/adhm.201200256
   Silva-Correia J, 2012, TISSUE ENG PT A, V18, P1203, DOI [10.1089/ten.tea.2011.0632, 10.1089/ten.TEA.2011.0632]
   Singh BN, 2004, PHARM DEV TECHNOL, V9, P399, DOI 10.1081/PDT-200035793
   Smith AM, 2007, J BIOMATER APPL, V22, P241, DOI 10.1177/0885328207076522
   Soto AM, 2016, LANGMUIR, V32, P5173, DOI 10.1021/acs.langmuir.6b00554
   Suri S, 2006, J BIOMED MATER RES A, V79A, P650, DOI 10.1002/jbm.a.30917
   Tang YJ, 2012, CARBOHYD POLYM, V88, P46, DOI 10.1016/j.carbpol.2011.11.058
   Wang CM, 2008, ACTA BIOMATER, V4, P1226, DOI 10.1016/j.actbio.2008.03.008
   Wen C, 2014, POLYM INT, V63, P1643, DOI 10.1002/pi.4683
   Yadav S, 2014, CARBOHYD POLYM, V99, P601, DOI 10.1016/j.carbpol.2013.08.068
NR 74
TC 10
Z9 10
U1 2
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2016
VL 4
IS 37
BP 6164
EP 6174
DI 10.1039/c6tb01488g
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DX5TK
UT WOS:000384444800001
DA 2018-10-20
ER

PT J
AU Zhao, YF
   Yan, HJ
   Qiao, SP
   Zhang, L
   Wang, TR
   Meng, QY
   Chen, XB
   Lin, FH
   Guo, K
   Li, CF
   Tian, WM
AF Zhao, Yufang
   Yan, Hongji
   Qiao, Shupei
   Zhang, Long
   Wang, Tianran
   Meng, Qingyuan
   Chen, Xiongbiao
   Lin, Feng-Huei
   Guo, Kai
   Li, Chunfeng
   Tian, Weiming
TI Hydrogels bearing bioengineered mimetic embryonic microenvironments for
   tumor reversion
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID HUMAN BREAST-CANCER; MELANOMA-CELLS; IN-VIVO; STEM-CELLS; SELF-RENEWAL;
   GROWTH; HYALURONAN; PROGRESSION; SUPPRESSES; PHENOTYPE
AB Embryonic microenvironments can reverse the metastatic phenotype of aggressive tumors by inhibiting the Nodal signaling pathway. Here, we hypothesize that embryonic microenvironments can be transplanted for the purpose of oncotherapy. We report the development of an injectable bioactive hydrogel system containing the key antagonists of Nodal signaling-Cripto-1 receptor antibodies (2B11)-for the creation of embryonic microenvironments and the examination of their effect on tumor reversion treatment using a mouse model. Our in vitro results show that the hydrogel system can reduce the mitochondrial membrane potential of MDA-MB-231 and MCF-7, promote cell apoptosis, and reduce the invasive ability of cells. Our in vivo results illustrate that the hydrogel system can significantly inhibit tumor growth in both breast cancer and melanoma tumor-bearing mouse models, as well as transform the cell morphology of melanoma B16 cells to melanin-like cells. Furthermore, the results of the up-regulation of tumor suppressor genes and the down-regulation of oncogenes by high-throughput sequencing confirm that the developed system can also selectively turn on some tumor suppressor genes and turn off certain oncogenes so as to prompt the benign reversion of the tumor phenotype. Taken together, our results demonstrate the injectable biomaterial system is able to create an effective microenvironment for melanoma and breast tumor therapy.
C1 [Zhao, Yufang; Yan, Hongji; Qiao, Shupei; Zhang, Long; Wang, Tianran; Guo, Kai; Li, Chunfeng; Tian, Weiming] Harbin Inst Technol, Bio X Ctr, Sch Life Sci & Technol, Harbin 150080, Peoples R China.
   [Yan, Hongji] Uppsala Univ, Div Polymer Chem, Dept Chem, Angstrom Lab, Box 538, S-75121 Uppsala, Sweden.
   [Meng, Qingyuan] Chinese Acad Sci, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100190, Peoples R China.
   [Chen, Xiongbiao] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK, Canada.
   [Lin, Feng-Huei] Natl Hlth Res Inst, Div Biomed Engn & Nanomed Res, Miaoli, Taiwan.
   [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei, Taiwan.
   [Lin, Feng-Huei] Natl Taiwan Univ, Coll Engn, Taipei, Taiwan.
   [Tian, Weiming] Harbin Inst Technol, Room 302,Bldg 2E,Sci Pk,2 Yikuang St, Harbin 150080, Heilongjiang, Peoples R China.
RP Tian, WM (reprint author), Harbin Inst Technol, Bio X Ctr, Sch Life Sci & Technol, Harbin 150080, Peoples R China.; Tian, WM (reprint author), Harbin Inst Technol, Room 302,Bldg 2E,Sci Pk,2 Yikuang St, Harbin 150080, Heilongjiang, Peoples R China.
EM tianweiming@hit.edu.cn
OI Tian, Weiming/0000-0003-4958-4118
FU National Natural Science Foundation of China [81361128005, 50903024]
FX This research was supported by the National Natural Science Foundation
   of China (grants 81361128005 and 50903024). We thank Professor Lingyun
   Zhao at the School of Materials Science and Engineering, Tsinghua
   University for the preparation of the BT474 tumor-bearing mice.
   English-language editing of this manuscript was performed by Journal
   Prep.
CR Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788
   Alaniz L, 2009, CANCER LETT, V278, P9, DOI 10.1016/j.canlet.2008.12.029
   Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328
   Busch C, 2011, EXP DERMATOL, V20, P200
   Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/NMAT4009, 10.1038/nmat4009]
   Chen IF, 2006, MOL CANCER THER, V5, P1, DOI 10.1158/1535-7163.MCT-05-0310
   Cucina A, 2006, APOPTOSIS, V11, P1617, DOI 10.1007/s10495-006-8895-4
   de Castro NP, 2010, FUTURE ONCOL, V6, P1127, DOI [10.2217/fon.10.68, 10.2217/FON.10.68]
   Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398
   DVORAK HF, 1987, LAB INVEST, V57, P673
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gvozdenovic A, 2013, J BONE MINER RES, V28, P838, DOI 10.1002/jbmr.1817
   Hamaguchi T, 2005, BRIT J CANCER, V92, P1240, DOI 10.1038/sj.bjc.6602479
   Hamano Y, 2005, BIOCHEM BIOPH RES CO, V333, P292, DOI 10.1016/j.bbrc.2005.05.130
   Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108
   Jeon O, 2013, ADV FUNCT MATER, V23, P4765, DOI 10.1002/adfm.201300529
   Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103
   Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335
   Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55
   Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471
   Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001
   Lowney JK, 1999, ANN SURG ONCOL, V6, P604, DOI 10.1007/s10434-999-0604-4
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mattei F, 2012, NEOPLASIA, V14, P1223, DOI 10.1593/neo.121444
   Mikhail AS, 2009, J CONTROL RELEASE, V138, P214, DOI 10.1016/j.jconrel.2009.04.010
   Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818
   Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122
   Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105
   Postovit LM, 2006, STEM CELLS, V24, P501, DOI 10.1634/stemcells.2005-0459
   Postovit LM, 2006, CANCER RES, V66, P7833, DOI 10.1158/0008-5472.CAN-06-0731
   Qu JT, 2011, J NEURO-ONCOL, V104, P729, DOI 10.1007/s11060-011-0558-9
   Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394
   Quail DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048237
   Quail DF, 2012, CURR STEM CELL RES T, V7, P197
   Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918
   Strizzi L, 2012, CANCER RES, V72, P1915, DOI 10.1158/0008-5472.CAN-11-3419
   Su WY, 2010, ACTA BIOMATER, V6, P3044, DOI 10.1016/j.actbio.2010.02.037
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448
   VANSLOOTEN HJ, 1995, BRIT J CANCER, V72, P22, DOI 10.1038/bjc.1995.271
   Yeo TK, 1996, AM J PATHOL, V148, P1733
NR 46
TC 2
Z9 2
U1 3
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2016
VL 4
IS 37
BP 6183
EP 6191
DI 10.1039/c6tb00927a
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DX5TK
UT WOS:000384444800003
DA 2018-10-20
ER

PT S
AU Liu, HJ
   Simmons, CA
   Sun, Y
AF Liu, Haijiao
   Simmons, Craig A.
   Sun, Yu
GP IEEE
TI A MICROFABRICATED PLATFORM WITH ON-CHIP STRAIN SENSING AND HYDROGEL
   ARRAYS FOR 3D MECHANICAL STIMULATION OF CELLS
SO 2016 IEEE 29TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL
   SYSTEMS (MEMS)
SE Proceedings IEEE Micro Electro Mechanical Systems
LA English
DT Proceedings Paper
CT 29th IEEE International Conference on Micro Electro Mechanical Systems
   (MEMS)
CY JAN 24-28, 2016
CL Shanghai, PEOPLES R CHINA
SP IEEE, IEEE Robot & Automat Soc
ID DIFFERENTIATION; MICROARRAY; TISSUE
AB Current high-throughput biomaterial screening approaches fail to consider the effects of dynamic mechanical stimulation, despite its importance in regenerative medicine applications. This paper reports a deformable membrane array that enables both 3D dynamic stretch and real-time stiffness sensing of cell-hydrogel constructs. The device membranes were fabricated with off-stoichiometry thiol-ene based polydimethylsiloxane (OSTE-PDMS) that is effective to covalently bond cell seeded polyethylene glycol norbornene (PEG-NB) 3D hydrogels. We show that human mesenchymal stromal cells embedded in hydrogels and subjected to dynamic mechanical stimulation undergo myofibroblast differentiation and synthesize collagen, leading to gel stiffening. This system can be scaled up to larger arrays to enable systematic screening of 3D microenvironmental cues on cell function and tissue formation in vitro.
C1 [Liu, Haijiao; Simmons, Craig A.; Sun, Yu] Univ Toronto, Toronto, ON, Canada.
RP Simmons, CA; Sun, Y (reprint author), Univ Toronto, Toronto, ON, Canada.
EM simmons@mie.utoronto.ca; sun@mie.utoronto.ca
OI Sun, Yu/0000-0001-7895-0741
CR Carlborg CF, 2011, LAB CHIP, V11, P3136, DOI 10.1039/c1lc20388f
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111
   Lau K, 2015, NAT CELL BIOL, V17, P569, DOI 10.1038/ncb3156
   Liu HJ, 2014, ACS NANO, V8, P3821, DOI 10.1021/nn500553z
   Liu HJ, 2013, J BIOMECH, V46, P1967, DOI 10.1016/j.jbiomech.2013.05.001
   Mabry KM, 2016, BIOMATERIALS, V74, P31, DOI 10.1016/j.biomaterials.2015.09.035
   MacQueen L, 2012, LAB CHIP, V12, P4178, DOI [10.1039/c21c40670e, 10.1039/c2lc40670e]
   Mihic A, 2014, BIOMATERIALS, V35, P2798, DOI 10.1016/j.biomaterials.2013.12.052
   Moraes C., 2013, INTEGR BIOL, V5, P673
   Nguyen EH, 2014, BIOMATERIALS, V35, P2149, DOI 10.1016/j.biomaterials.2013.11.054
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037
NR 15
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1084-6999
BN 978-1-5090-1973-1
J9 PROC IEEE MICR ELECT
PY 2016
BP 267
EP 270
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Physics, Applied
SC Engineering; Science & Technology - Other Topics; Physics
GA BF4ZH
UT WOS:000381797300071
DA 2018-10-20
ER

PT S
AU Cigasova, J
   Stevulova, N
   Schwarzova, I
AF Cigasova, Julia
   Stevulova, Nadezda
   Schwarzova, Ivana
BE KohseHoinghaus, K
   Ranzi, E
TI Innovative Use of Plant Wastes-Hemp Hurds Slices
SO 2ND INTERNATIONAL CONFERENCE ON BIOMASS (ICONBM 2016)
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT 2nd International Conference on Biomass (IConBM)
CY JUN 19-22, 2016
CL Taormina, ITALY
ID COMPOSITES; CONCRETE; BEHAVIOR
AB Green materials and structures have gained the worldwide attention over the past few years. Interest in the utilization of lignocellulosic biomass in the form of natural fibres (biofibres usually derived from plant) as organic filler into lightweight fibre reinforced composites for sustainable building constructions is steadily increasing.
   Excellent physical and mechanical properties of hemp as fast growth predetermine its use in building materials (biocomposites) prepared with inorganic matrix.
   With a world production of 214,000 ton, hemp is one of the 10 major primary plants grown as source of bast fibres (i.e. fibres obtained from the exterior part of the stem) and hurds (i.e. inner woody part of the stem, also called shives), used for various industrial purposes, such as: textiles, cordage, panelling, biofuel, paper, plastic composites and building materials.
   In particular, the hemp hurds, which in the past was discarded (only fibres and seeds were used), is now of great interest for the unique properties that confers to building materials. Key problem for successful application of hemp hurds is heterogeneity and hydrophility resulting in high moisture sorption sensitivity of biomaterial. Chemical and/or physical treatment of the fibres surface is applied to decrease the hydrophility and modify lignocellulosic material composition.
   In this paper presented results of capillary absorption of biocomposites based on hemp hurds slices (untreated and chemically treated) as a filler and two various type of binders (conventional Portland cement and alternative MgO-cement). Capillary absorption demonstrates the ability of building materials containing open pores the absorbing moisture. Effect of various types of binder and influence of modified hemp hurds on properties of composites were observed.
C1 [Cigasova, Julia; Stevulova, Nadezda; Schwarzova, Ivana] Tech Univ Kosice, Inst Environm Engn, Fac Civil Engn, Vysokoskolska 4, Kosice 04200, Slovakia.
RP Schwarzova, I (reprint author), Tech Univ Kosice, Inst Environm Engn, Fac Civil Engn, Vysokoskolska 4, Kosice 04200, Slovakia.
EM ivana.schwarzova@tuke.sk
OI Stevulova, Nadezda/0000-0003-1093-044X
CR Arizzi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125520
   Cigasova Julia, 2013, International Journal of Modern Manufacturing Technologies, V5, P27
   Cigasova J., 2014, POLLACK PERIODICA, V9, P51
   Cigasova J, 2014, CHEM ENGINEER TRANS, V37, P685, DOI 10.3303/CET1437115
   Cigasova J, 2013, CHEM ENGINEER TRANS, V32, P1615, DOI 10.3303/CET1332270
   Gonen T, 2007, CONSTR BUILD MATER, V21, P1040, DOI 10.1016/j.conbuildmat.2006.02.010
   Kidalova L., 2011, CEST 2011 12 INT C E
   Newman G., 2014, EUROPEAN DECORTICATI
   Nicos S, 1997, CEMENT CONCRETE RES, V27, P747
   Nozahic V, 2012, CEMENT CONCRETE COMP, V34, P231, DOI 10.1016/j.cemconcomp.2011.09.002
   Pejic BM, 2008, BIORESOURCE TECHNOL, V99, P7152, DOI 10.1016/j.biortech.2007.12.073
   Stevulova N, 2015, MATERIALS, V8, P2243, DOI 10.3390/ma8052243
   Stevulova N, 2014, MATERIALS, V7, P8131, DOI 10.3390/ma7128131
NR 13
TC 1
Z9 1
U1 3
U2 8
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-41-9
J9 CHEM ENGINEER TRANS
PY 2016
VL 50
BP 373
EP 378
DI 10.3303/CET1650063
PG 6
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA BF6LR
UT WOS:000383266200063
DA 2018-10-20
ER

PT S
AU Zaludin, MAF
   Jamal, ZAZ
   Jamaludin, SB
   Derman, MN
AF Zaludin, Mohd Amin Farhan
   Jamal, Zul Azhar Zahid
   Jamaludin, Shamsul Baharin
   Derman, Mohd Nazree
BE Nazeri, MFB
   Ying, LB
   BinIdris, MS
TI A Brief Review of Calcium Phosphate Conversion Coating on Magnesium and
   its Alloys
SO 2ND INTERNATIONAL CONFERENCE ON FUNCTIONAL MATERIALS AND METALLURGY
   (ICOFM 2016)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 2nd International Conference on Functional Materials and Metallurgy
   (ICoFM)
CY MAY 28, 2016
CL MALAYSIA
SP Univ Malaysia Perlis, Sch Mat Engn, Ctr Frontier Mat Res
ID BIOMEDICAL APPLICATIONS; DEGRADATION BEHAVIOR; CORROSION BEHAVIOR;
   IN-VITRO; HYDROXYAPATITE; CYTOCOMPATIBILITY
AB Recent developments have shown that magnesium is a promising candidate to be used as a biomaterial. Owing to its light weight, biocompatibility and compressive strength comparable with natural bones makes magnesium as an excellent choice for biomaterial. However, high reactivity and low corrosion resistance properties have restricted the application of magnesium as biomaterials. At the moment, several strategies have been developed to solve this problem. Surface modification of magnesium is one of the popular solutions to solve the problem. Among many techniques developed in the surface modification, conversion coating method is one of the simple and effective techniques. From various types of conversion coating, calcium phosphate-based conversion coating is the most suitable for biomedical fields. This paper reviews some studies on calcium phosphate coating on Mg and its alloys via chemical conversion method and discusses some factors determining the coating performance.
C1 [Zaludin, Mohd Amin Farhan; Jamal, Zul Azhar Zahid; Jamaludin, Shamsul Baharin; Derman, Mohd Nazree] UniMAP, Ctr Frontier Mat Res, Sch Mat Engn, Blok B, Kangar 01000, Perlis, Malaysia.
   [Jamaludin, Shamsul Baharin; Derman, Mohd Nazree] UniMAP, Sch Mat Engn, Arau 02600, Perlis, Malaysia.
RP Zaludin, MAF (reprint author), UniMAP, Ctr Frontier Mat Res, Sch Mat Engn, Blok B, Kangar 01000, Perlis, Malaysia.
EM aminzaludin90@yahoo.com; zulazhar@unimap.edu.my; sbaharin@unimap.edu.my;
   nazree@unimap.edu.my
OI Zaludin, Mohd Amin Farhan/0000-0002-9170-4526; Derman, Mohd
   Nazree/0000-0002-8564-7326
CR Barbosa M., 2010, CIENC TECNOL MATER, V22, P48
   Brundavanam S., 2014, AM J BIOMEDICAL ENG, V4, P79
   Chen XB, 2011, CORROS SCI, V53, P2263, DOI 10.1016/j.corsci.2011.03.008
   Chen X.-B., 2011, CORR, V67
   De-Bao Liu, 2010, Frontiers of Materials Science in China, V4, P139, DOI 10.1007/s11706-010-0034-z
   Dorozhkin SV, 2014, ACTA BIOMATER, V10, P2919, DOI 10.1016/j.actbio.2014.02.026
   Dorozhkin SV, 2012, PROG BIOMATER, V1, DOI 10.1186/2194-0517-1-1
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Eddy G., 2012, AM J BIOMED ENG, V2, P218, DOI DOI 10.5923/J.AJBE.20120206.02
   Gonzalez S, 2012, J MECH BEHAV BIOMED, V6, P53, DOI 10.1016/j.jmbbm.2011.09.014
   Heness G., 2004, MATER FORUM, V27, P104
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Hu H., 2014, MAGNESIUM ALLOYS PRO, P67
   Kalpakjian S., 2009, MANUFACTURING ENG TE, P973
   Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005
   Liu B, 2015, MAT SCI ENG C-MATER, V47, P97, DOI 10.1016/j.msec.2014.11.038
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   Ma J, 2014, J ORTHOP TRANSL, V2, P118, DOI 10.1016/j.jot.2014.03.004
   Noorakma ACW, 2013, J MATER ENG PERFORM, V22, P2997, DOI 10.1007/s11665-013-0589-9
   Razavi M, 2010, MATER CHARACT, V61, P1363, DOI 10.1016/j.matchar.2010.09.008
   Seyedraoufi ZS, 2013, J MECH BEHAV BIOMED, V21, P1, DOI 10.1016/j.jmbbm.2013.01.023
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Su YC, 2013, J ELECTROCHEM SOC, V160, pC536, DOI 10.1149/2.036311jes
   Su YC, 2012, INT J ELECTROCHEM SC, V7, P11497
   Wang B, 2013, INT J MOL SCI, V14, P23614, DOI 10.3390/ijms141223614
   Wang HX, 2011, COLLOID SURFACE B, V88, P254, DOI 10.1016/j.colsurfb.2011.06.040
   Wang Q, 2011, MATER SCI ENG B-ADV, V176, P1718, DOI 10.1016/j.mseb.2011.06.005
   Waterman J, 2011, MATER SCI ENG B-ADV, V176, P1756, DOI 10.1016/j.mseb.2011.06.021
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Zhao Y, 2012, CORROS SCI, V59, P360, DOI 10.1016/j.corsci.2012.03.020
NR 30
TC 0
Z9 0
U1 2
U2 8
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1414-3
J9 AIP CONF PROC
PY 2016
VL 1756
AR UNSP 080001
DI 10.1063/1.4958780
PG 5
WC Metallurgy & Metallurgical Engineering; Physics, Applied
SC Metallurgy & Metallurgical Engineering; Physics
GA BF6EZ
UT WOS:000383024900037
DA 2018-10-20
ER

PT B
AU Avdonkina, N
   Slavyanskaya, T
   Baldueva, I
   Salnikova, S
AF Avdonkina, Natalia
   Slavyanskaya Tatiana
   Baldueva, Irina
   Salnikova, Svetlana
BE Sepiashvili, R
TI Features of cultivation of cells of urothelial carcinoma
SO ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: INNOVATIVE TECHNOLOGIES
LA English
DT Proceedings Paper
CT 9th World Asthma, Allergy and COPD Forum
CY JUL 01-04, 2016
CL St Petersburg, RUSSIA
SP World Immunopathol Org
DE bladder cancer; primary culture; anti-tumor vaccines; immunotherapy;
   urothelial carcinoma; cell viability
AB Steady growth of bladder cancer (BC) incidence rate and large quantity of its mutations presumes considerably high immunogenicity of tumor cells, and, correspondingly, its sensitivity to immunotherapy. Development of personalized dendritic cell antitumor vaccines (PDATV) against BC is the actual problem, which covers many aspects, necessary for its standardization. The article presents own experimental findings related to development of optimal conditions of transportation of biomaterials; temperature and time modes of storage of samples were defined; comparative analysis of different methods of tumor disaggregation was performed, based on evaluation of vitality of autologous cells of urothelial carcinoma (CUC) in the process of their cultivation for the purpose of creation of PDATV against BC. Thus, we have worked out optimal parameters for preservation of viability of autologous CUC in the process of transportation and storage of biomaterial from BC patients, requiring performance of PDATV immunotherapy from remote health facilities.
C1 [Avdonkina, Natalia; Slavyanskaya Tatiana] Peoples Friendship Univ Russia, Moscow, Russia.
   [Slavyanskaya Tatiana; Salnikova, Svetlana] Inst Immunophysiol, Moscow, Russia.
   [Baldueva, Irina] Minist Healthcare Russian Federat, FSBI Petrov Res Inst Oncol, St Petersburg, Russia.
RP Slavyanskaya, T (reprint author), Peoples Friendship Univ Russia, Moscow, Russia.; Slavyanskaya, T (reprint author), Inst Immunophysiol, Moscow, Russia.
EM tslavyanskaya@gmail.com
RI Sepiashvili, Revaz/J-9866-2018; Avdonkina, Natalia/P-3886-2015
OI Avdonkina, Natalia/0000-0002-3533-2721
CR Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477
   Avdonkina N.A., 2015, ALLERGOLOGY IMMUNOLO, V16, P358
   Avdonkina N. A., 2015, INT J IMMUNOREH, V17, P88
   Baldueva I.A., 2015, ALLERGOLOGY IMMUNOLO, V16, P354
   Cheryl D. H., 2013, METHOD MOL BIOL, V946, P363
   Freshney R. I., 2013, CULTURE ANIMAL CELLS, P463
   Ragai R. M., 2012, METHOD MOL BIOL, V7651, P31
   Salnikova S.V., 2016, ALLERGOLOGY IMMUNOLO, V17, P21
   Salnikova S.V., 2015, INT J IMMUNOREH, V17, P87
   Sepiashvili R.I., 1997, INT J IMMUNOREH, V6, P5
   Sepiashvili R.I., 2015, ALLERGOLOGY IMMUNOLO, V16, P101
   Slavyanskaya T.A., 2009, INT J IMMUNOREH, V11, P24
NR 12
TC 0
Z9 0
U1 0
U2 0
PU FILODIRITTO PUBLISHER
PI BOLOGNA
PA INFOROMATICA SRL, VIA CASTIGLIONE, 81, BOLOGNA, 40124, ITALY
BN 978-88-95922-70-6
PY 2016
BP 297
EP 301
PG 5
WC Allergy; Immunology; Respiratory System
SC Allergy; Immunology; Respiratory System
GA BF7AF
UT WOS:000383882000039
DA 2018-10-20
ER

PT J
AU Choudhury, M
   Talukdar, B
   Devi, D
AF Choudhury, Manasee
   Talukdar, Bijit
   Devi, Dipali
TI Surface smoothening and characterization of silk fibers of Antheraea
   assamensis Helfer (muga) using some natural agents
SO JOURNAL OF THE TEXTILE INSTITUTE
LA English
DT Article
DE muga silk fiber; bio-degumming; citric acid; Musa balbisiana; Dillenia
   indica
ID INFRARED-SPECTROSCOPY; PHYSICAL-PROPERTIES; BOMBYX-MORI; PROTEINS;
   FIBROIN; ACID; CONFORMATION; FILMS; POLYPEPTIDES; INTERFACE
AB Cocoons of Antheraea assamensis (muga) silkworm were treated with different classes of natural-acidic (Citrus limon and Dillenia indica) and alkaline (Musa balbisiana) materials with the aim to elucidate their effectiveness as degumming agents. The tensile strength of silk fibers increased significantly after bio-degumming compared to industrial degumming using sodium carbonate. Scanning electron microscopy of bio-degummed fibers appeared clean and even with clear individual fibroin filaments. FTIR studies confirmed that bio-degumming resulted in holding the innate nature of muga silk. Under the implemented experimental conditions, M. balbisiana and C. limon functioned as most efficient degumming agents, followed by D. indica. The findings of this study propose the use of such eco-friendly degumming practices over the usual harsh industrial treatments for obtaining applaudable quality of silk with robust strength necessary for both textile and biomaterial purpose, besides reducing the impact of chemical toxicity on the environment.
C1 [Choudhury, Manasee; Talukdar, Bijit; Devi, Dipali] IASST, Div Life Sci, Seri Biotech Unit, Gauhati, India.
RP Devi, D (reprint author), IASST, Div Life Sci, Seri Biotech Unit, Gauhati, India.
EM dipali.devi@gmail.com
FU Department of Science and Technology (DST) [IASST/PF/2012-13/2145-2153]
FX This work was supported by the Department of Science and Technology
   (DST) [grant number IASST/PF/2012-13/2145-2153].
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6
   Choudhury M, 2016, J TEXT I, V107, P346, DOI 10.1080/00405000.2015.1034926
   Deka DC, 2007, INDIAN J TRADIT KNOW, V6, P72
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Freddi G, 1996, J SOC DYERS COLOUR, V112, P191
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Gulrajani ML, 1996, INDIAN J FIBRE TEXT, V21, P270
   GULRAJANI ML, 1992, INDIAN J FIBRE TEXT, V17, P39
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Higa M, 1998, J MEMBRANE SCI, V140, P213, DOI 10.1016/S0376-7388(97)00284-6
   HITCHCOCK DI, 1954, J GEN PHYSIOL, V37, P717, DOI 10.1085/jgp.37.6.717
   Ho M, 2012, COMPOS B, V43, P2801, DOI DOI 10.1016/J.COMPOSITESB.2012.04.042
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Khan MMR, 2010, BIORESOURCE TECHNOL, V101, P8439, DOI 10.1016/j.biortech.2010.05.100
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mahmoodi NM, 2010, J CLEAN PROD, V18, P146, DOI 10.1016/j.jclepro.2009.10.003
   MILNERWHITE EJ, 1987, TRENDS BIOCHEM SCI, V12, P189
   Reddy N, 2010, INT J BIOL MACROMOL, V46, P419, DOI 10.1016/j.ijbiomac.2010.02.013
   SANGER F, 1952, ADV PROTEIN CHEM, V7, P1, DOI 10.1016/S0065-3233(08)60017-0
   Saravanan D., 2014, COMP DEGUMMING TECHN, P1
   Sarma MB, 2012, J SCI IND RES INDIA, V71, P270
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   TSUKADA M, 1988, J POLYM SCI POL PHYS, V26, P949, DOI 10.1002/polb.1988.090260418
   TSUKADA M, 1992, J APPL POLYM SCI, V44, P2203, DOI 10.1002/app.1992.070441217
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   Vyas SK, 2016, J TEXT I, V107, P191, DOI 10.1080/00405000.2015.1020670
   Zahn H., 1993, ULLMANNS ENCY IND CH, VA 24, P95
   Zhou W, 2006, PROG CHEM, V18, P1514
NR 38
TC 0
Z9 0
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0040-5000
EI 1754-2340
J9 J TEXT I
JI J. Text. Inst.
PY 2016
VL 107
IS 11
BP 1347
EP 1356
DI 10.1080/00405000.2015.1108688
PG 10
WC Materials Science, Textiles
SC Materials Science
GA DV5HO
UT WOS:000382958100001
DA 2018-10-20
ER

PT S
AU Benatti, ACB
   Xavier, MV
   Macedo, MF
   Rodrigues, AA
   Jardini, AL
   Filho, RM
   Kharmandayan, P
AF Benatti, Ana Carolina B.
   Xavier, Mariana V.
   Macedo, Milton F.
   Rodrigues, Ana Amelia
   Jardini, Andre L.
   Filho, Rubens M.
   Kharmandayan, Paulo
BE Bardone, E
   Bravi, M
   Keshavarz, T
TI Comparative Analysis of Biocompatibility between Poly (L-lactic Acid)
   (PLLA) and PLDL Purac (R) Nanofibers for use in Tissue Engineering
SO 5TH INTERNATIONAL SYMPOSIUM ON INDUSTRIAL BIOTECHNOLOGY (IBIC 2016)
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT 5th International Conference on Industrial Biotechnology (IBIC)
CY APR 10-11, 2016
CL Bologna, ITALY
ID IN-VITRO; PROLIFERATION
AB The absorbable polyacid, poly (L-Lactide) (PLLA) is one of the most commonly used and studied materials in tissue engineering, for its biocompatibility and biodegradability. This work will show that the PLLA synthesized at our laboratory has the same biocompatibility as the PLDL Purac (R). The PLLA was synthesized through ringopening polymerization and manufactured into nanofibers through the electrospinning process. The cytotoxicity of the material was evaluated by the calorimetric MTT assay (Sigma), Live/Dead (Molecular Probes), Direct Contact, Elution and Agar Diffusion. The assays were performed using nanofibers membranes made with PLLA and with PLDL Purac (R), where the biomaterials were in contact with the fibroblast cell culture, in the sense to compare the results between them. For the MTT, Live/Dead and Elution assays the nanofiber membranes were incubated with the fibroblast cell culture for 24h, 48h and 72h. For the Direct Contact and Agar Diffusion the nanofiber membranes were maintained in contact with the cells for 24h. For the assay controls we used DMEM-LG containing 0.5% phenol as the positive control of toxicity CT(+) and for negative control of toxicity CT(-) DMEM-LG containing 10% FBS. The ANOVA test was used to measure the MTT assay results, and within 24h of exposure, the cells in contact with the PLLA showed a higher proliferation rate than CT(-) and PLDL Purac (R), being significantly different (p< 0,05). Whatsoever, there were no statistically significant differences between the PLLA, the PLDL Purac (R), and the CT(-) after 48h and 72h of culture (p>0.05). The morphology of the cells in contact with both biomaterials was also considered normal, showing no signal of cytotoxicity. The high rates of proliferation and viability of the cells in contact with the PLLA, shown by the biocompatibility assays, demonstrate that the PLLA is a biocompatible material. The PLDL Purac (R) exhibited similar results, as expected. Those findings show that the PLLA synthesized has the same biocompatibility as the PLDL Purac (R). Thus, the PLLA synthesized in our laboratory is a high quality biomaterial that can assist in the manufacturing of nanofibers that can be adapted for different biomedical applications.
C1 [Benatti, Ana Carolina B.; Xavier, Mariana V.; Macedo, Milton F.; Rodrigues, Ana Amelia; Jardini, Andre L.; Filho, Rubens M.; Kharmandayan, Paulo] Univ Estadual Campinas, Sch Chem Engn, Inst Biofabricat, BR-13081970 Campinas, SP, Brazil.
   [Benatti, Ana Carolina B.; Kharmandayan, Paulo] Univ Estadual Campinas, Dept Surg, Sch Med Sci, BR-13083970 Campinas, SP, Brazil.
RP Benatti, ACB (reprint author), Univ Estadual Campinas, Sch Chem Engn, Inst Biofabricat, BR-13081970 Campinas, SP, Brazil.; Benatti, ACB (reprint author), Univ Estadual Campinas, Dept Surg, Sch Med Sci, BR-13083970 Campinas, SP, Brazil.
EM carol_benatti@hotmail.com
RI Jardini, Andre Luiz/N-9963-2016
OI Jardini, Andre Luiz/0000-0002-9381-9335
CR Bernstein A, 2012, ARCH ORTHOP TRAUM SU, V132, P1637, DOI 10.1007/s00402-012-1592-6
   Dong YX, 2009, TISSUE ENG PART B-RE, V15, P333, DOI [10.1089/ten.teb.2008.0619, 10.1089/ten.TEB.2008.0619]
   Fukushima K, 2008, J POLYM SCI POL CHEM, V46, P3714, DOI 10.1002/pola.22712
   Leiggener CS, 2006, BIOMATERIALS, V27, P202, DOI 10.1016/j.biomaterials.2005.05.068
   Lopes M. S., 2014, MICROREACTOR DEV SYN
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Sarasua JR, 2011, J MATER SCI-MATER M, V22, P2513, DOI 10.1007/s10856-011-4425-1
   Wu G, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-97
NR 8
TC 0
Z9 0
U1 0
U2 6
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-40-2
J9 CHEM ENGINEER TRANS
PY 2016
VL 49
BP 199
EP 204
DI 10.3303/CET1649034
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA BF6LQ
UT WOS:000383265300034
DA 2018-10-20
ER

PT S
AU Gabriel, LP
   Benatti, ACB
   Jardini, AL
   Bastos, GNT
   Kharmandayan, P
   Dias, CGBT
   Maciel, R
AF Gabriel, Lais P.
   Benatti, Ana Carolina B.
   Jardini, Andre L.
   Bastos, Gilmara N. T.
   Kharmandayan, Paulo
   Dias, Carmen G. B. T.
   Maciel Filho, Rubens
BE Bardone, E
   Bravi, M
   Keshavarz, T
TI Synthesis and Characterization of Bio-Based Polyurethane for Tissue
   Engineering Applications
SO 5TH INTERNATIONAL SYMPOSIUM ON INDUSTRIAL BIOTECHNOLOGY (IBIC 2016)
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT 5th International Conference on Industrial Biotechnology (IBIC)
CY APR 10-11, 2016
CL Bologna, ITALY
ID EUTERPE-OLERACEA MART.; DRUG-DELIVERY; SEEDS; OIL
AB Tissue Engineering offers a new route for the reconstruction of new organs and tissues that have suffered trauma or injury. With this respect, the production of tridimensional scaffolds to allow cells to attach, migrate and proliferate is the base of Tissue Engineering. In this study, a polyurethane scaffold was synthesized in a batch reactor by the reaction of bio-based polyol extracted from Euterpe oleracea Mart. seeds (acai berry), a renewable raw material present in Amazon Region of Brazil, and a polyisocyanate derived from hexamethylene diisocyanate. The chemical structure of the scaffold was characterized by using proton nuclear magnetic resonance spectroscopy, the distribution of average porosity and pore size was characterized by Xray microtomography, the thermal properties were determined by thermogravimetric analysis and the biocompatibility was studied by in vitro assays. The results showed that the scaffold presents excellent morphological, chemical and thermal properties, with an appropriate porosity for cell attachment, cell growth proliferation, it also shows no inflammatory response, a good biocompatibility making it applicable as a new biomaterial for future applications in Tissue Engineering.
C1 [Gabriel, Lais P.; Jardini, Andre L.; Maciel Filho, Rubens] Univ Estadual Campinas, Sch Chem Engn, Campinas, SP, Brazil.
   [Benatti, Ana Carolina B.; Kharmandayan, Paulo] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil.
   [Bastos, Gilmara N. T.] Fed Univ Para, Lab Neuroinflammat, BR-66059 Belem, Para, Brazil.
   [Dias, Carmen G. B. T.] Fed Univ Para, Sch Mech Engn, BR-66059 Belem, Para, Brazil.
RP Gabriel, LP (reprint author), Univ Estadual Campinas, Sch Chem Engn, Campinas, SP, Brazil.
EM lagabriel@gmail.com
RI Pellizzer Gabriel, Lais/M-3124-2015; Jardini, Andre Luiz/N-9963-2016
OI Pellizzer Gabriel, Lais/0000-0003-4035-5626; Jardini, Andre
   Luiz/0000-0002-9381-9335; Bueno Benatti, Ana
   Carolina/0000-0002-3510-8439
CR Alishiri M, 2014, MAT SCI ENG C-MATER, V42, P763, DOI 10.1016/j.msec.2014.05.056
   Barreira R.M., 2009, CARACTERIZACAO FISIC
   Barros L, 2015, IND CROP PROD, V76, P318, DOI 10.1016/j.indcrop.2015.05.086
   Blit PH, 2010, J BIOMED MATER RES A, V94A, P1226, DOI 10.1002/jbm.a.32804
   Bonomo LDF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089933
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Dube MA, 2014, MACROMOL REACT ENG, V8, P7, DOI 10.1002/mren.201300103
   El-Sayed AA, 2010, J MATER SCI-MATER M, V21, P507, DOI 10.1007/s10856-009-3900-4
   Garrison TF, 2014, POLYMER, V55, P1004, DOI 10.1016/j.polymer.2014.01.014
   Heinen M, 2014, POLYM DEGRAD STABIL, V108, P76, DOI 10.1016/j.polymdegradstab.2014.05.024
   Hu J, 2014, FITOTERAPIA, V99, P178, DOI 10.1016/j.fitote.2014.09.020
   Kalita H, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39579
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li JJ, 2014, J MATER CHEM B, V2, P7272, DOI 10.1039/c4tb01073f
   Mishra A, 2014, ACTA BIOMATER, V10, P2133, DOI 10.1016/j.actbio.2013.12.035
   Wycoff W, 2015, J FOOD COMPOS ANAL, V41, P181, DOI 10.1016/j.jfca.2015.01.021
NR 16
TC 0
Z9 0
U1 0
U2 6
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-40-2
J9 CHEM ENGINEER TRANS
PY 2016
VL 49
BP 349
EP 354
DI 10.3303/CET1649059
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA BF6LQ
UT WOS:000383265300059
DA 2018-10-20
ER

PT J
AU Hussain, T
   Schneider, M
   Summer, B
   Strieth, S
AF Hussain, Timon
   Schneider, Manuela
   Summer, Burkhard
   Strieth, Sebastian
TI Pre-operative in vitro fibroblast coating of porous polyethylene
   compound grafts - Cell survival in vivo and effects on biocompatibility
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Tissue engineering; porous polyethylene; Medpor; dermal fibroblasts;
   angiogenesis; in vivo fluorescence microscopy
ID TISSUE ENGINEERED CARTILAGE; EAR RECONSTRUCTION; HOST TISSUE;
   ANGIOGENESIS; IMPLANTS; SCAFFOLDS; GROWTH; BIOMATERIALS; RHINOPLASTY;
   EXPRESSION
AB BACKGROUND: Key factors for successful porous polyethylene (PPE) implantation are rapid vascularization and low inflammatory response. Dermal fibroblasts produce a variety of pro-angiogenic and immunmodulatory factors.
   OBJECTIVE: The aim of this tissue engineering study was to investigate whether coating PPE implants with dermal fibroblasts in vitro is sustainable in vivo and whether the kinetics of blood vessel ingrowth and immunological responses are hereby affected.
   METHODS: PPE implants were cultured with syngeneic GFP-transfected dermal fibroblasts. Cells on the biomaterial were quantified before implantation into dorsal skinfold chamber preparations of C57Bl/6 mice. Uncoated implants served as controls. Angiogenic activity and leukocyte-endothelial cell interactions were repeatedly analyzed. After 10 days, mechanical integration was measured and surviving fluorescently labeled fibroblasts were quantified. Expression of inflammatory cytokines was assessed by quantitative real time-reverse transcription PCR.
   RESULTS: PPE implants were successfully coated with dermal fibroblasts in vitro and 69% of the cells were still detectable at the end of observation. Angiogenic parameters increased during the observation period in both groups. IL-2, IL17A and IL-10 tended to be increased in coated implants, but did not affect leukocyte-endothelial cell interactions.
   CONCLUSIONS: Dermal fibroblast-coating of porous polyethylene implants is feasible and sustainable in vivo. Alone it does not improve biocompatibility but may be beneficial in combination with specific growth factor supplements.
C1 [Hussain, Timon; Schneider, Manuela; Strieth, Sebastian] Univ Munich LMU, Walter Brendel Ctr Expt Med WBex, Marchioninistr 27, D-81377 Munich, Germany.
   [Hussain, Timon] Univ Essen Gesamthsch, Dept Otorhinolaryngol Head & Neck Surg, Hufelandstr 55, D-45147 Essen, Germany.
   [Summer, Burkhard] Univ Munich LMU, Dept Dermatol, Frauenlobstr 9-11, D-80337 Munich, Germany.
   [Strieth, Sebastian] Univ Med Ctr Mainz, Dept Otorhinolaryngol, Langenbeckstr 1, D-55131 Mainz, Germany.
RP Strieth, S (reprint author), Univ Med Ctr Mainz, Dept Otorhinolaryngol, BiomaTICS Lab, Langenbeckstr 1, D-55131 Mainz, Germany.
EM sebastian.strieth@unimedizin-mainz.de
FU Friedrich-Baur-Stiftung (Munich, Germany); Porex Surgical Inc. (Newnan,
   GA); BiomaTICS (Biomaterials, Tissues and Cells in Science) Consortium
   at the University Medical Center Mainz (Germany)
FX This study was supported by Friedrich-Baur-Stiftung (Munich, Germany),
   Porex Surgical Inc. (Newnan, GA) and the BiomaTICS (Biomaterials,
   Tissues and Cells in Science) Consortium at the University Medical
   Center Mainz (Germany).
CR Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   Berghaus Alexander, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P270, DOI 10.1097/01.moo.0000233599.14671.4a
   Berghaus A, 2010, ADV OTO-RHINO-LARYNG, V68, P53, DOI 10.1159/000314562
   CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Edwards SL, 2011, TISSUE ENG PART C-ME, V17, P123, DOI [10.1089/ten.tec.2010.0182, 10.1089/ten.TEC.2010.0182]
   Ehrmantraut S, 2012, TISSUE ENG PT A, V18, P1562, DOI [10.1089/ten.TEA.2011.0340, 10.1089/ten.tea.2011.0340]
   Eichhorn ME, 2007, CANCER BIOL THER, V6, P920, DOI 10.4161/cbt.6.6.4207
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Han SK, 2006, PLAST RECONSTR SURG, V117, P829, DOI 10.1097/01.prs.000201458.80364.31
   Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595
   Hurley JR, 2010, AM J PHYSIOL-CELL PH, V299, pC444, DOI 10.1152/ajpcell.00572.2009
   Klyscz T, 1997, BIOMED TECH, V42, P168, DOI 10.1515/bmte.1997.42.6.168
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   LEUNIG M, 1992, CANCER RES, V52, P6553
   Martin T A, 1999, Angiogenesis, V3, P69, DOI 10.1023/A:1009004212357
   Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025
   O'Sullivan NA, 2015, J BIOMED MATER RES B, V103, P983, DOI 10.1002/jbm.b.33269
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Peled ZM, 2008, PLAST RECONSTR SURG, V121, p85E, DOI 10.1097/01.prs.0000299386.73127.a7
   Pu FR, 2010, BIOMATERIALS, V31, P4330, DOI 10.1016/j.biomaterials.2010.02.010
   Reichel CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116883
   Ribatti D, 2001, ANAT RECORD, V264, P317, DOI 10.1002/ar.10021
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Sclafani AP, 1997, ARCH OTOLARYNGOL, V123, P328
   SHIMABUKURO Y, 1992, IMMUNOLOGY, V76, P344
   Stelter K, 2007, RHINOLOGY, V45, P325
   Strieth S, 2005, TRANSPLANTATION, V79, P392, DOI 10.1097/01.TP.0000151633.92173.75
   Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670
   Trompezinski S, 2004, EXP DERMATOL, V13, P98, DOI 10.1111/j.0906-6705.2004.00137.x
   Vollmar B, 2001, AM J PATHOL, V159, P1661, DOI 10.1016/S0002-9440(10)63013-1
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
NR 39
TC 0
Z9 0
U1 1
U2 8
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2016
VL 27
IS 2-3
BP 237
EP 249
DI 10.3233/BME-161579
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DV8LD
UT WOS:000383187600010
PM 27567778
DA 2018-10-20
ER

PT J
AU Song, JE
   Lee, SE
   Cha, SR
   Jang, NK
   Tripathy, N
   Reis, RL
   Khang, G
AF Song, Jeong Eun
   Lee, Seon Eui
   Cha, Se Rom
   Jang, Na Keum
   Tripathy, Nirmalya
   Reis, Rui L.
   Khang, Gilson
TI Inflammatory response study of gellan gum impregnated duck's feet
   derived collagen sponges
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Gellan gum; collagen; sponge; inflammatory responses; tissue
   regeneration
ID BIOLOGICAL EVALUATION; SCAFFOLDS; HYDROGELS; SKIN; REGENERATION;
   FORMULATIONS; BIOMATERIAL; MATRIX
AB Tissue engineered biomaterials have biodegradable and biocompatible properties. In this study, we have fabricated sponges using duck's feet derived collagen (DC) and gellan gum (GG), and further studied its inflammatory responses. The as-prepared duck's feet DC/GG sponges showed the possibility of application as a tissue engineering material through in vitro and in vivo experiments. The physical and chemical properties of sponges were characterized by compression strength, porosity, and scanning electron microscopy, etc. In vitro cell viability were investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide (MTT) assay. An inflammatory response was studied after seeding RAW264.7 cells on as-fabricated sponges using reverse transcriptase-polymerase chain reaction. In vivo studies were carried out by implanting in subcutaneous nude mouse followed by extraction, histological staining. Collectively, superior results were showed by DC/GG sponges than GG sponge in terms of physical property and cell proliferation and thus can be considered as a potential candidate for future tissue engineering applications.
C1 [Song, Jeong Eun; Lee, Seon Eui; Cha, Se Rom; Jang, Na Keum; Tripathy, Nirmalya; Khang, Gilson] Chonbuk Natl Univ, Dept Polymer Nano Sci & Technol, Dept BIN Fus Technol, Jeonju, South Korea.
   [Song, Jeong Eun; Lee, Seon Eui; Cha, Se Rom; Jang, Na Keum; Tripathy, Nirmalya; Khang, Gilson] Chonbuk Natl Univ, Polymer Fus Res Ctr, Jeonju, South Korea.
   [Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, Guimaraes, Portugal.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept Polymer Nano Sci & Technol, Dept BIN Fus Technol, Jeonju, South Korea.; Khang, G (reprint author), Chonbuk Natl Univ, Polymer Fus Res Ctr, Jeonju, South Korea.
EM gskhang@jbnu.ac.kr
RI song, jeong eun/P-9106-2015; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012
OI song, jeong eun/0000-0001-6879-7616; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456
FU Technology Commercialization Support Program, Ministry for Food,
   Agriculture, Forestry and Fisheries (MIFAFF) [814005-03-2-HD020]; Korea
   Health Technology R&D Project through the KHIDI, Ministry of Health and
   Welfare (MOHW), Republic of Korea [HI15C2996]
FX This work was supported by Technology Commercialization Support Program
   [grant number 814005-03-2-HD020], Ministry for Food, Agriculture,
   Forestry and Fisheries (MIFAFF) and grant of the Korea Health Technology
   R&D Project through the KHIDI [grant number HI15C2996], Ministry of
   Health and Welfare (MOHW), Republic of Korea.
CR Aamodt JM, 2016, BIOMATERIALS, V86, P68, DOI 10.1016/j.biomaterials.2016.02.003
   Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Cha SR, 2015, POLYM-KOREA, V39, P493, DOI 10.7317/pk.2015.39.3.493
   Chandika P, 2015, INT J BIOL MACROMOL, V81, P504, DOI 10.1016/j.ijbiomac.2015.08.038
   Chen FM, 2016, PROG POLYM SCI, V53, P86, DOI 10.1016/j.progpolymsci.2015.02.004
   Chen JD, 2016, LWT-FOOD SCI TECHNOL, V66, P453, DOI 10.1016/j.lwt.2015.10.070
   Cholas R, 2016, MAT SCI ENG C-MATER, V63, P499, DOI 10.1016/j.msec.2016.03.022
   Fauzi MB, 2016, MAT SCI ENG C-MATER, V68, P163, DOI 10.1016/j.msec.2016.05.109
   Gantar A, 2014, MAT SCI ENG C-MATER, V43, P27, DOI 10.1016/j.msec.2014.06.045
   Garcia Eugenio José, 2012, Braz. Dent. J., V23, P22, DOI 10.1590/S0103-64402012000100004
   Ghazanfari S, 2016, BIOMATERIALS, V97, P74, DOI 10.1016/j.biomaterials.2016.04.028
   Ju HW, 2016, INT J BIOL MACROMOL, V85, P29, DOI 10.1016/j.ijbiomac.2015.12.055
   Kanimozhi K, 2016, MAT SCI ENG C-MATER, V61, P484, DOI 10.1016/j.msec.2015.12.084
   Khang G, 2015, J TISSUE ENG REGEN M, V9, P265, DOI 10.1002/term.1625
   Kim SH, 2016, INT J BIOL MACROMOL, V85, P442, DOI 10.1016/j.ijbiomac.2015.12.086
   Kim SM, 2015, POLYM-KOREA, V39, P837, DOI 10.7317/pk.2015.39.6.837
   Kuk H, 2015, POLYM-KOREA, V39, P846, DOI 10.7317/pk.2015.39.6.846
   Lozano R, 2015, BIOMATERIALS, V67, P264, DOI 10.1016/j.biomaterials.2015.07.022
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lupascu FG, 2015, EUR J PHARM SCI, V77, P122, DOI 10.1016/j.ejps.2015.06.008
   Mahmoud AA, 2016, EUR J PHARM SCI, V83, P155, DOI 10.1016/j.ejps.2015.12.026
   Moxon SR, 2016, INT J BIOL MACROMOL, V84, P79, DOI 10.1016/j.ijbiomac.2015.12.007
   Osmalek T, 2014, INT J PHARMACEUT, V466, P328, DOI 10.1016/j.ijpharm.2014.03.038
   Przekora A, 2016, MAT SCI ENG C-MATER, V61, P355, DOI 10.1016/j.msec.2015.12.066
   Salunke SR, 2016, INT J BIOL MACROMOL, V87, P41, DOI 10.1016/j.ijbiomac.2016.02.044
   Wang JH, 2016, MAT SCI ENG C-MATER, V61, P705, DOI 10.1016/j.msec.2015.12.097
NR 26
TC 3
Z9 3
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2016
VL 27
IS 15
BP 1495
EP 1506
DI 10.1080/09205063.2016.1213218
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA DV8AO
UT WOS:000383160100002
PM 27416732
DA 2018-10-20
ER

PT S
AU Meng, ZK
   Jaiswal, MK
   Chitrakar, C
   Thakur, T
   Gaharwar, AK
   Yakovlev, VV
AF Meng, Zhaokai
   Jaiswal, Manish K.
   Chitrakar, Chandani
   Thakur, Teena
   Gaharwar, Akhilesh K.
   Yakovlev, Vladislav V.
BE Kabashin, AV
   Geohegan, DB
   Dubowski, JJ
TI Brillouin microspectroscopy of nanostructured biomaterials: Photonics
   assisted tailoring of mechanical properties
SO SYNTHESIS AND PHOTONICS OF NANOSCALE MATERIALS XIII
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Synthesis and Photonics of Nanoscale Materials XIII
CY FEB 15-17, 2016
CL San Francisco, CA
SP SPIE
DE Brillouin spectroscopy; tissue engineering; gelatin methacrylate
   (GelMA); nanoparticle
ID ACOUSTOOPTICS TUNABLE FILTER; NANOCOMPOSITE HYDROGELS; RESPONSIVE
   HYDROGELS; OPTICAL MICROSCOPY; SPECTROSCOPY; CELL; MECHANOTRANSDUCTION;
   NANOMATERIALS
AB Developing new biomaterials is essential for the next-generation of materials for bioenergy, bioelectronics, basic biology, medical diagnostics, cancer research, and regenerative medicine. Specifically, recent progress in nanotechnology has stimulated the development of multifunctional biomaterials for tissue engineering applications. The physical properties of nanocomposite biomaterials, including elasticity and viscosity, play key roles in controlling cell fate, which underlines therapeutic success. Conventional mechanical tests, including uniaxial compression and tension, dynamic mechanical analysis and shear rheology, require mechanical forces to be directly exerted onto the sample and therefore may not be suitable for in situ measurements or continuous monitoring of mechanical stiffness. In this study, we employ spontaneous Brillouin spectroscopy as a viscoelasticity-specific probing technique. We utilized a Brillouin spectrometer to characterize biomaterial's microscopic elasticity and correlated those with conventional mechanical tests (e.g., rheology).
C1 [Meng, Zhaokai; Jaiswal, Manish K.; Chitrakar, Chandani; Thakur, Teena; Gaharwar, Akhilesh K.; Yakovlev, Vladislav V.] Texas A&M Univ, College Stn, TX 77843 USA.
RP Meng, ZK (reprint author), Texas A&M Univ, College Stn, TX 77843 USA.
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Antonacci G, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0843
   Antonacci G, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4927400
   Ballmann CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep18139
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Berghaus KV, 2015, JOVE-J VIS EXP, DOI 10.3791/53468
   Burdick JA, 2003, BIOMACROMOLECULES, V4, P149, DOI 10.1021/bm025677o
   Daoudi K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120552
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Huwart L, 2008, GASTROENTEROLOGY, V135, P32, DOI 10.1053/j.gastro.2008.03.076
   Hytch MJ, 1998, ULTRAMICROSCOPY, V74, P131, DOI 10.1016/S0304-3991(98)00035-7
   Jaiswal MK, 2016, ACS NANO, V10, P246, DOI 10.1021/acsnano.5b03918
   Kerativitayanan P, 2015, ADV HEALTHC MATER, V4, P1600, DOI 10.1002/adhm.201500272
   Khanlari A, 2013, MACROMOLECULES, V46, P9609, DOI 10.1021/ma401838h
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Koetting MC, 2015, MAT SCI ENG R, V93, P1, DOI 10.1016/j.mser.2015.04.001
   Meng ZK, 2016, J BIOPHOTONICS, V9, P201, DOI 10.1002/jbio.201500163
   Meng ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20017
   Meng ZK, 2015, ANALYST, V140, P7160, DOI 10.1039/c5an01700a
   Meng ZK, 2015, P NATL ACAD SCI USA, V112, P12315, DOI 10.1073/pnas.1516249112
   Meng ZK, 2014, OPT EXPRESS, V22, P5410, DOI 10.1364/OE.22.005410
   Meng ZK, 2013, APPL PHYS B-LASERS O, V112, P99, DOI 10.1007/s00340-013-5405-6
   Meng ZK, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/6/065701
   Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Petrov GI, 2015, OPT EXPRESS, V23, P24669, DOI 10.1364/OE.23.024669
   SANDERCOCK JR, 1982, TOP APPL PHYS, V51, P173
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Scarcelli G, 2008, NAT PHOTONICS, V2, P39, DOI 10.1038/nphoton.2007.250
   Scarcelli G, 2012, INVEST OPHTH VIS SCI, V53, P185, DOI 10.1167/iovs.11-8281
   Scarcelli G, 2011, BIOPHYS J, V101, P1539, DOI 10.1016/j.bpj.2011.08.008
   Scarcelli G, 2011, OPT EXPRESS, V19, P10913, DOI 10.1364/OE.19.010913
   Steelman Z, 2015, J BIOPHOTONICS, V8, P408, DOI 10.1002/jbio.201400047
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Thakur T., 2016, J BIOMEDICAL MAT R A
   Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033
   Traverso AJ, 2015, ANAL CHEM, V87, P7519, DOI 10.1021/acs.analchem.5b02104
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xia Y., 2008, NAT MATER, V7, P759
   Yakovlev V. V., 2015, APPL SPECTR IN PRESS
   Yakovlev V. V., 2014, J INNOV OPT HEAL SCI, V8
   Yang H, 2007, ADV MATER, V19, P3085, DOI 10.1002/adma.200702050
NR 46
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-1-62841-972-6
J9 PROC SPIE
PY 2016
VL 9737
AR 97370G
DI 10.1117/12.2222816
PG 8
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA BF4JJ
UT WOS:000381079300012
DA 2018-10-20
ER

PT S
AU Jamal, FI
   Guha, S
   Eissa, MH
   Kissinger, D
   Wessel, J
AF Jamal, F. I.
   Guha, S.
   Eissa, M. H.
   Kissinger, D.
   Wessel, J.
GP IEEE
TI A 24 GHz Dielectric Sensor Based on Distributed Architecture
SO 2016 GERMAN MICROWAVE CONFERENCE (GEMIC)
SE German Microwave Conference
LA English
DT Proceedings Paper
CT German Microwave Conference (GeMiC)
CY MAR 14-16, 2016
CL Bochum, GERMANY
SP RUHR Univ Bochum, AIRBUS Defence & Space, Anritsu, ANSYS, AR Europe, BSW TestSystems & Consulting, Carl Cranz Gesellschaft, CST, EMCO, Fraunhofer, GLOBES Elektronik GMBH & Co KG, IMST, Ind Elect, Intel, Keysight Technologies, KROHNE, MiCIAN, Microwave Journal, REMCOM, ROHDE & SCHWARZ, Rosenberger, TACTRON Electronik, TELEDYNE LECROY, Telemeter Elect, IMA e V, European Microwave Assoc, VDE, ITG, IEEE, IEEE MTT S, Albatross Projects
DE distributed amplifier; microwave sensor; bio-sensor; dielectric;
   permittivity
AB In this paper, a dielectric sensor based on distributed architecture topology is presented. The measured sensor delivers the dielectric information as a notch frequency between 21 GHz to 25 GHz. The proposed sensor is intended to perform as a microwave dielectric sensor to identify biomaterials but can be used for other applications as well. It is fabricated in a standard 0.25 mu m SiGe BiCMOS process with HBTs (f(T)/f(max) = 120/140 GHz) and it consumes 13.4 mW DC power. The sensor has been simulated and measured with different dielectric materials. For proof of concept, first experiments have been conducted for air, epoxy resin and honey. Owing to the distributed concept and the destructive interference, a sensitivity of 0.32 GHz per unit permittivity (1.35% of the center frequency) was achieved. Based on these permittivity measurements, the presented results illustrate that this technique is a promising solution for biomaterial sensing and characterization.
C1 [Jamal, F. I.; Guha, S.; Eissa, M. H.; Kissinger, D.; Wessel, J.] IHP, Technol Pk 25, D-15236 Frankfurt, Oder, Germany.
   [Kissinger, D.] Tech Univ Berlin, Einsteinufer 17, D-10587 Berlin, Germany.
RP Jamal, FI (reprint author), IHP, Technol Pk 25, D-15236 Frankfurt, Oder, Germany.
CR Agarwal B, 1998, IEEE T MICROW THEORY, V46, P2553, DOI 10.1109/22.739247
   Asami K, 2002, J NON-CRYST SOLIDS, V305, P268, DOI 10.1016/S0022-3093(02)01110-9
   Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001
   GINZTON EL, 1948, P IRE, V36, P956, DOI 10.1109/JRPROC.1948.231624
   Grenier K, 2009, IEEE T MICROW THEORY, V57, P3246, DOI 10.1109/TMTT.2009.2034226
   Helmy AA, 2012, IEEE T MICROW THEORY, V60, P4157, DOI 10.1109/TMTT.2012.2224363
   Helmy AA, 2012, IEEE J SOLID-ST CIRC, V47, P2467, DOI 10.1109/JSSC.2012.2203458
   Hofmann M, 2013, IEEE T MICROW THEORY, V61, P2195, DOI 10.1109/TMTT.2013.2250516
   Jamal F. I., 2014, 44 EUR MICR C EUMC D, P1032
   Laemmle B, 2013, IEEE T MICROW THEORY, V61, P2185, DOI 10.1109/TMTT.2013.2253792
   Song CR, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3072806
   WEIR WB, 1974, P IEEE, V62, P33, DOI 10.1109/PROC.1974.9382
   Wu H, 2001, IEEE J SOLID-ST CIRC, V36, P493, DOI 10.1109/4.910488
NR 13
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2167-8022
BN 978-3-9812-6687-0
J9 GER MICROW CONF
PY 2016
BP 173
EP 176
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA BF5WI
UT WOS:000382696600044
DA 2018-10-20
ER

PT J
AU Gaetani, R
   Yin, C
   Srikumar, N
   Braden, R
   Doevendans, PA
   Sluijter, JPG
   Christman, KL
AF Gaetani, Roberto
   Yin, Christopher
   Srikumar, Neha
   Braden, Rebecca
   Doevendans, Pieter A.
   Sluijter, Joost P. G.
   Christman, Karen L.
TI Cardiac-Derived Extracellular Matrix Enhances Cardiogenic Properties of
   Human Cardiac Progenitor Cells
SO CELL TRANSPLANTATION
LA English
DT Article
DE Cardiac tissue engineering; Cardiac progenitor cells (CPCs); Cardiac
   extracellular matrix; Cardiac regeneration
ID RANDOMIZED PHASE-1 TRIAL; MESENCHYMAL STEM-CELLS; MYOCARDIAL-INFARCTION;
   ISCHEMIC CARDIOMYOPATHY; HEART-FAILURE; POSTMYOCARDIAL INFARCTION;
   IN-VITRO; REGENERATION; THERAPY; TRANSPLANTATION
AB The use of biomaterials has been demonstrated as a viable strategy to promote cell survival and cardiac repair. However, limitations on combinational cell biomaterial therapies exist, as cellular behavior is influenced by the microenvironment and physical characteristics of the material. Among the different scaffolds employed for cardiac tissue engineering, a myocardial matrix hydrogel has been shown to promote cardiogenesis in murine cardiac progenitor cells (mCPCs) in vitro. In this study, we investigated the influence of the hydrogel on Sca-1-like human fetal and adult CPCs (fCPCs and aCPCs) when encapsulated in three-dimensional (3D) material in vitro. fCPCs encapsulated in the myocardial matrix showed an increase in the gene expression level of cardiac markers GATA-4 and MLC2v and the vascular marker vascular endothelial growth factor receptor 2 (VEGFR2) after 4 days in culture, and a significant increase in GATA-4 up to 1 week. Increased gene expression levels of Nkx2.5, MEF2c, VEGFR2, and CD31 were also observed when aCPCs were cultured in the matrix compared to collagen. Cell survival was sustained in both hydrogels up to 1 week in culture with the myocardial matrix capable of enhancing the expression of the proliferation marker Ki-67 after 4 days in culture. When encapsulated CPCs were treated with H2O2, an improved survival of the cells cultured in the myocardial matrix was observed. Finally, we evaluated the use of the myocardial matrix as hydrogel for in vivo cell transplantation and demonstrated that the gelation properties of the hydrogel are not influenced by the cells. In summary, we showed that the myocardial matrix hydrogel promotes human CPC cardiogenic potential, proliferation, and survival and is a favorable hydrogel for 3D in vitro culture. Furthermore, we demonstrated the in vivo applicability of the matrix as a potential vehicle for cell transplantation.
C1 [Gaetani, Roberto; Yin, Christopher; Srikumar, Neha; Braden, Rebecca; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA.
   [Doevendans, Pieter A.; Sluijter, Joost P. G.] Univ Med Ctr Utrecht, DH&L, Dept Cardiol, Utrecht, Netherlands.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
OI Sluijter, Joost/0000-0003-2088-9102
FU National Institutes of Health (NHLBI) [R01HL113468]; Netherlands Cardio
   Vascular Research Initiative (CVON); Dutch Heart Foundation; Dutch
   Federation of University Medical Centers; Netherlands Organization for
   Health Research and Development; Royal Netherlands Academy of Sciences;
   Leduq Foundation through a transatlantic career development young
   investigator award
FX This research was supported in part by the National Institutes of Health
   (NHLBI) through R01HL113468 (to K.L.C.), the Netherlands Cardio Vascular
   Research Initiative (CVON), the Dutch Heart Foundation, the Dutch
   Federation of University Medical Centers, the Netherlands Organization
   for Health Research and Development, the Royal Netherlands Academy of
   Sciences (to J.P.G.S.), and the Leduq Foundation through a transatlantic
   career development young investigator award (to R.G.). The authors would
   like to thank Dr. Mary Nguyen and Jessica Ungerleider for their
   thoughtful revisions on this article. Dr. Christman is a cofounder,
   board member; consultant, and holds equity interest in Ventrix Inc.
CR Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Behfar A, 2014, NAT REV CARDIOL, V11, P232, DOI 10.1038/nrcardio.2014.9
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Chimenti I, 2011, BIOMATERIALS, V32, P9271, DOI 10.1016/j.biomaterials.2011.08.049
   Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feyen D, 2013, CARDIOVASC RES, V99, P83, DOI 10.1093/cvr/cvt078
   Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Gaetani R, 2015, BIOMATERIALS, V61, P339, DOI 10.1016/j.biomaterials.2015.05.005
   Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003
   Gaetani R, 2010, J CELL MOL MED, V14, P1071, DOI 10.1111/j.1582-4934.2010.01078.x
   Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Gyongyosi M, 2015, CIRC RES, V116, P1346, DOI 10.1161/CIRCRESAHA.116.304346
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297
   Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724
   Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mehta A, 2013, CELL TRANSPLANT, V22, P1, DOI 10.3727/096368912X653282
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Nakayama KH, 2014, ADV HEALTHC MATER, V3, P628, DOI 10.1002/adhm.201300620
   Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0
   Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003
   Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114
   Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229
   Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146
   Taylor DA, 2014, AM J TRANSPLANT, V14, P2448, DOI 10.1111/ajt.12939
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991
   Ungerleider JL, 2015, METHODS, V84, P53, DOI 10.1016/j.ymeth.2015.03.024
   van Marion MH, 2015, J MOL CELL CARDIOL, V87, P79, DOI 10.1016/j.yjmcc.2015.08.010
   Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110
   Wu KH, 2011, ANN THORAC SURG, V92, P1917, DOI 10.1016/j.athoracsur.2011.07.012
   Ye KY, 2011, J CARDIOVASC TRANSL, V4, P575, DOI 10.1007/s12265-011-9303-1
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
NR 57
TC 11
Z9 11
U1 2
U2 6
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2016
VL 25
IS 9
SI SI
BP 1653
EP 1663
DI 10.3727/096368915X689794
PG 11
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA DV3DD
UT WOS:000382800300007
PM 26572770
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Rani, S
   Malik, AK
   Kaur, R
   Kaur, R
AF Rani, Susheela
   Malik, Ashok Kumar
   Kaur, Ramandeep
   Kaur, Ripneel
CA Heena
TI A Review for the Analysis of Antidepressant, Antiepileptic and Quinolone
   Type Drugs in Pharmaceuticals and Environmental Samples
SO CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE Antidepressants; antiepileptics; gas chromatography; high performance
   liquid chromatography; quinolones
ID PERFORMANCE-LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; SOLID-PHASE
   EXTRACTION; THIN-LAYER-CHROMATOGRAPHY; NONSTEROIDAL ANTIINFLAMMATORY
   DRUGS; CAPILLARY-ZONE-ELECTROPHORESIS; BAR-SORPTIVE EXTRACTION;
   MOLECULARLY IMPRINTED POLYMERS; UNION DECISION 2002/657/EC; HPLC-UV
   METHOD
AB The analysis of drugs in various biological fluids is an important criterion for the determination of the physiological performance of a drug. After sampling of the biological fluid, the next step in the analytical process is sample preparation. Sample preparation is essential for isolation of desired components from complex biological matrices and greatly influences their reliable and accurate determination. The complexity of biological fluids adds to the challenge of direct determination of the drug by chromatographic analysis, therefore demanding a sample preparation step that is often time consuming, tedious and frequently overlooked. However, direct online injection methods offer the advantage of reducing sample preparation steps and enabling effective pre-concentration and clean-up of biological fluids. These procedures can be automated and therefore reduce the requirements for handling potentially infectious biomaterial, improve reproducibility, and minimize sample manipulations and potential contamination.This review is focused on the discovery and development of high-performance liquid chromatography (HPLC) and gas chromatography (GC) with different detectors. The drugs covered in this review are antiepileptics, antidepressant (AD), and quinolones. The application of these methods for determination of these drugs in biological, environmental and pharmaceutical samples has also been discussed.
C1 [Rani, Susheela; Malik, Ashok Kumar; Kaur, Ramandeep; Kaur, Ripneel; Heena] Punjabi Univ, Dept Chem, Patiala 147002, Punjab, India.
RP Malik, AK (reprint author), Punjabi Univ, Dept Chem, Patiala 147002, Punjab, India.
EM malik_chem2002@yahoo.co.uk
FU UGC, New Delhi
FX The authors are thankful to UGC, New Delhi for providing the financial
   support.
CR Abdellatef HE, 2006, SPECTROCHIM ACTA A, V65, P997, DOI 10.1016/j.saa.2006.01.001
   Adamowicz P, 2010, FORENSIC SCI INT, V198, P39, DOI 10.1016/j.forsciint.2010.02.012
   Ansermot N, 2008, CLIN BIOCHEM, V41, P728, DOI 10.1016/j.clinbiochem.2008.02.014
   Antonilli L, 2011, J PHARMACEUT BIOMED, V56, P763, DOI 10.1016/j.jpba.2011.07.018
   Aranas AT, 2011, TALANTA, V85, P86, DOI 10.1016/j.talanta.2011.03.032
   Ayad MM, 2007, SPECTROCHIM ACTA A, V66, P106, DOI 10.1016/j.saa.2006.02.031
   Babu MKM, 2004, J PHARMACEUT BIOMED, V34, P315, DOI 10.1016/S0731-7085(03)00525-9
   Bahrami G, 2006, J CHROMATOGR B, V835, P123, DOI 10.1016/j.jchromb.2006.03.011
   Bailac S, 2006, ANAL CHIM ACTA, V580, P163, DOI 10.1016/j.aca.2006.07.064
   Benito-Pena E, 2008, J CHROMATOGR A, V1208, P62, DOI 10.1016/j.chroma.2008.08.109
   Bisceglia KJ, 2010, J CHROMATOGR A, V1217, P558, DOI 10.1016/j.chroma.2009.11.062
   Bogusz MJ, 2007, J CHROMATOGR B, V850, P471, DOI 10.1016/j.jchromb.2006.12.048
   Bolderman RW, 2009, J CHROMATOGR B, V877, P1727, DOI 10.1016/j.jchromb.2009.04.029
   Boudesocque L, 2012, J CHROMATOGR A, V1236, P115, DOI 10.1016/j.chroma.2012.03.010
   Breaud AR, 2010, CLIN CHIM ACTA, V411, P825, DOI 10.1016/j.cca.2010.02.067
   Breaud AR, 2009, CLIN BIOCHEM, V42, P1300, DOI 10.1016/j.clinbiochem.2009.05.006
   Breton H, 2005, J CHROMATOGR B, V828, P80, DOI 10.1016/j.jchromb.2005.09.019
   Brondz I, 2009, J CHROMATOGR A, V1216, P824, DOI 10.1016/j.chroma.2008.11.043
   Bugamelli F, 2002, ANAL CHIM ACTA, V472, P1, DOI 10.1016/S0003-2670(02)00980-7
   Caban M, 2014, J CHROMATOGR A, V1346, P107, DOI 10.1016/j.chroma.2014.04.054
   Sampedro MC, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2012.01.002
   CASTRO A, 2007, J CHROMATOGR A, V1160, P3
   Chambers EE, 2014, J PHARMACEUT BIOMED, V88, P660, DOI 10.1016/j.jpba.2013.09.001
   Chaves AR, 2010, J CHROMATOGR B, V878, P2123, DOI 10.1016/j.jchromb.2010.06.023
   Cheng C, 2010, J CHROMATOGR A, V1217, P6413, DOI 10.1016/j.chroma.2010.08.016
   Chou CC, 2005, ANAL CHIM ACTA, V538, P49, DOI 10.1016/j.aca.2005.02.018
   Christodoulou EA, 2007, J SEP SCI, V30, P2421, DOI 10.1002/jssc.200700129
   Clemente M, 2006, J CHROMATOGR A, V1135, P170, DOI 10.1016/j.chroma.2006.09.041
   Contin M, 2005, J CHROMATOGR B, V828, P113, DOI 10.1016/j.jchromb.2005.09.009
   Contin M, 2008, J CHROMATOGR B, V873, P129, DOI 10.1016/j.jchromb.2008.08.007
   Contin M, 2010, J CHROMATOGR B, V878, P461, DOI 10.1016/j.jchromb.2009.11.039
   Corciaa D. D., 2013, J CHROMATOGR B, V927, P133
   Queiroza RHC, 2008, J PHARMACEUT BIOMED, V48, P428, DOI 10.1016/j.jpba.2008.03.020
   Cruces-Blanco C, 2012, TRAC-TREND ANAL CHEM, V31, P85, DOI 10.1016/j.trac.2011.06.019
   Dandan G., 2013, J CHROMATOGR A, V1317, P217
   Dawson AH, 2004, MED TOXICOL, P834
   Diaz-Alvarez M, 2009, ANAL BIOANAL CHEM, V393, P899, DOI 10.1007/s00216-008-2300-9
   Dobor J, 2010, MICROCHEM J, V94, P36, DOI 10.1016/j.microc.2009.08.007
   Dowling G, 2011, J PHARMACEUT BIOMED, V56, P359, DOI 10.1016/j.jpba.2011.05.029
   Duran-Alvarez JC, 2009, TALANTA, V78, P1159, DOI 10.1016/j.talanta.2009.01.035
   Emidio ES, 2010, ANAL CHIM ACTA, V670, P63, DOI 10.1016/j.aca.2010.04.023
   Es'haghi Z, 2009, ANAL CHIM ACTA, V641, P83, DOI 10.1016/j.aca.2009.03.043
   Ferranti V, 1998, J CHROMATOGR B, V718, P199, DOI 10.1016/S0378-4347(98)00356-9
   Ferreira A, 2014, J CHROMATOGR B, V971, P20, DOI 10.1016/j.jchromb.2014.09.010
   Frahnert C, 2003, J CHROMATOGR B, V794, P35, DOI 10.1016/S01570-0232(03)00393-3
   Furukori N. Y., 2005, J PHARM BIOMED ANAL, V37, P121
   Gadkariem E A, 2009, Saudi Pharm J, V17, P289, DOI 10.1016/j.jsps.2009.10.005
   Silva BJG, 2008, J CHROMATOGR B, V862, P181, DOI 10.1016/j.jchromb.2007.12.006
   Gondova T, 2010, J AOAC INT, V93, P778
   Gonzalez-Marino I, 2010, J CHROMATOGR A, V1217, P1748, DOI 10.1016/j.chroma.2010.01.046
   Gottardo R, 2007, J CHROMATOGR A, V1159, P185, DOI 10.1016/j.chroma.2007.01.011
   Gottardo R, 2012, FORENSIC SCI INT, V216, P101, DOI 10.1016/j.forsciint.2011.09.004
   Guthery B, 2010, J CHROMATOGR A, V1217, P4402, DOI 10.1016/j.chroma.2010.04.020
   Hassouan MK, 2007, J CHROMATOGR B, V852, P625, DOI 10.1016/j.jchromb.2006.12.039
   Helenkar A, 2010, TALANTA, V82, P600, DOI 10.1016/j.talanta.2010.05.014
   Hernandez SR, 2003, TALANTA, V61, P743, DOI 10.1016/S0039-9140(03)00335-7
   Herranz S, 2007, J CHROMATOGR A, V1140, P63, DOI 10.1016/j.chroma.2006.11.058
   Hilali A, 2005, J PHARMACEUT BIOMED, V38, P768, DOI 10.1016/j.jpba.2005.02.011
   Hiroyuki K., 2003, TRENDS ANAL CHEM, V22, P232
   Holtzapple CK, 2001, J CHROMATOGR B, V754, P1, DOI 10.1016/S0378-4347(00)00575-2
   Hoshina K, 2009, J CHROMATOGR A, V1216, P4957, DOI 10.1016/j.chroma.2009.04.071
   Hu T, 2012, J CHROMATOGR A, V1219, P104, DOI 10.1016/j.chroma.2011.11.009
   Iammarino M, 2010, ANAL CHIM ACTA, V672, P61, DOI 10.1016/j.aca.2010.04.002
   Issa YM, 2011, J ADV RES, V2, P25, DOI 10.1016/j.jare.2010.08.007
   Ivandini TA, 2002, J ELECTROANAL CHEM, V521, P117, DOI 10.1016/S0022-0728(02)00666-6
   Jain DS, 2007, TALANTA, V72, P80, DOI 10.1016/j.talanta.2006.09.033
   Joya X, 2010, FORENSIC SCI INT, V196, P38, DOI 10.1016/j.forsciint.2009.12.044
   Juan-Garcia A, 2006, ELECTROPHORESIS, V27, P2240, DOI 10.1002/elps.200500868
   Juan-Garcia A, 2007, ELECTROPHORESIS, V28, P4180, DOI 10.1002/elps.200700383
   Karpinska J, 2002, J PHARMACEUT BIOMED, V29, P519, DOI 10.1016/S0731-7085(02)00097-3
   Kaufmann A, 2007, ANAL CHIM ACTA, V586, P13, DOI 10.1016/j.aca.2006.10.026
   Kaur H, 2010, THERAPY, V7, P49, DOI DOI 10.2217/THY.09.84
   Kim KB, 2011, J PHARMACEUT BIOMED, V56, P771, DOI 10.1016/j.jpba.2011.07.019
   Kirschbaum KM, 2005, CLIN CHEM, V51, P1718, DOI 10.1373/clinchem.2005.049809
   Kostic N, 2013, TALANTA, V116, P91, DOI 10.1016/j.talanta.2013.04.082
   Kuhn J, 2013, TALANTA, V110, P71, DOI 10.1016/j.talanta.2013.02.010
   Kumar A, 2008, J SEP SCI, V31, P294, DOI 10.1002/jssc.200700373
   Kumar MN, 2011, J PHARMACEUT BIOMED, V54, P596, DOI 10.1016/j.jpba.2010.09.026
   Langel K, 2011, J CHROMATOGR B, V879, P859, DOI 10.1016/j.jchromb.2011.02.027
   Lattanzio G, 2008, J PHARMACEUT BIOMED, V46, P381, DOI 10.1016/j.jpba.2007.09.027
   Laverdiere I, 2012, J CHROMATOGR B, V885, P131, DOI 10.1016/j.jchromb.2011.12.029
   Liu H, 2007, J CHROMATOGR B, V858, P42, DOI 10.1016/j.jchromb.2007.08.004
   Liu XM, 2009, J CHROMATOGR B, V877, P3144, DOI 10.1016/j.jchromb.2009.08.002
   Luo YB, 2010, J CHROMATOGR A, V1217, P3583, DOI 10.1016/j.chroma.2010.03.036
   Lynch KL, 2010, CLIN CHIM ACTA, V411, P1474, DOI 10.1016/j.cca.2010.05.046
   Maeda S, 2013, J CHROMATOGR B, V921, P43, DOI 10.1016/j.jchromb.2013.01.014
   Mandrioli R, 2003, J CHROMATOGR B, V783, P253, DOI 10.1016/S1570-0232(02)00664-5
   Maurer HH, 2002, J MASS SPECTROM, V37, P687, DOI 10.1002/jms.325
   Meinitzer A, 2010, THER DRUG MONIT, V32, P61, DOI 10.1097/FTD.0b013e3181c49a00
   Meisen I, 2011, BBA-MOL CELL BIOL L, V1811, P875, DOI 10.1016/j.bbalip.2011.04.006
   Meloun M, 2007, ANAL CHIM ACTA, V584, P419, DOI 10.1016/j.aca.2006.11.049
   Meng JR, 2012, ANAL CHIM ACTA, V710, P125, DOI 10.1016/j.aca.2011.09.033
   Meng Z, 2015, FOOD CHEM, V174, P597, DOI 10.1016/j.foodchem.2014.11.067
   Mercolini L, 2010, J PHARMACEUT BIOMED, V53, P62, DOI 10.1016/j.jpba.2010.02.036
   Miao XS, 2003, ANAL CHEM, V75, P3731, DOI 10.1021/ac030082k
   Miova K, 2010, CLIN CHIM ACTA, V411, P1957
   Mohamed NA, 2011, TALANTA, V85, P2121, DOI 10.1016/j.talanta.2011.07.053
   Moller M, 2010, FORENSIC SCI INT, V196, P64, DOI 10.1016/j.forsciint.2009.12.046
   Mowafy HA, 2012, SAUDI PHARM J, V20, P29, DOI 10.1016/j.jsps.2011.04.003
   Mullett WM, 2007, J BIOCHEM BIOPH METH, V70, P263, DOI 10.1016/j.jbbm.2006.10.001
   Mullett WM, 2002, J CHROMATOGR A, V963, P325, DOI 10.1016/S0021-9673(02)00216-9
   Musuamba FT, 2009, THER DRUG MONIT, V31, P110, DOI 10.1097/FTD.0b013e318191897d
   Nemeth K, 2011, J PHARMACEUT BIOMED, V54, P475, DOI 10.1016/j.jpba.2010.09.020
   Nemutlu E, 2007, CHROMATOGRAPHIA, V66, pS15
   Nevado JJB, 2005, J PHARMACEUT BIOMED, V38, P52, DOI 10.1016/j.jpba.2004.11.062
   Nikolaou P, 2015, J PHARMACEUT BIOMED, V102, P25, DOI 10.1016/j.jpba.2014.08.034
   Notari S, 2006, J CHROMATOGR B, V831, P258, DOI 10.1016/j.jchromb.2005.12.016
   Omara HA, 2011, ARAB J CHEM, V4, P287, DOI 10.1016/j.arabjc.2010.06.048
   Omara HA, 2012, J SAUDI CHEM SOC, V16, P75, DOI 10.1016/j.jscs.2010.11.001
   Paglia G, 2007, J CHROMATOGR B, V860, P153, DOI 10.1016/j.jchromb.2007.10.025
   Patil KM, 2005, J PHARMACEUT BIOMED, V39, P181, DOI 10.1016/j.jpba.2005.02.045
   Piest'ansky J, 2014, J CHROMATOGR A, V1358, P285, DOI 10.1016/j.chroma.2014.06.083
   Pikkemaat MG, 2007, FOOD ADDIT CONTAM, V24, P842, DOI 10.1080/02652030701295275
   Pinto PCAG, 2006, TALANTA, V68, P857, DOI 10.1016/j.talanta.2005.06.008
   Prieto A, 2011, ANAL CHIM ACTA, V685, P146, DOI 10.1016/j.aca.2010.11.038
   Reddersen K, 2003, J SEP SCI, V26, P1443, DOI 10.1002/jssc.200301533
   Roy SMN, 2008, E-J CHEM, V5, P169, DOI 10.1155/2008/362512
   Sachse J, 2006, J CHROMATOGR B, V830, P342, DOI 10.1016/j.jchromb.2005.11.032
   Salm P, 2008, THER DRUG MONIT, V30, P292, DOI 10.1097/FTD.0b013e3181771feb
   Samanidou VF, 2007, J SEP SCI, V30, P2430, DOI 10.1002/jssc.200700057
   Santos-Neto AJ, 2006, J CHROMATOGR A, V1105, P71, DOI 10.1016/j.chroma.2005.12.001
   Saracino MA, 2010, ANAL CHIM ACTA, V661, P222, DOI 10.1016/j.aca.2009.12.030
   Seger C, 2009, NAT PROTOC, V4, P526, DOI 10.1038/nprot.2009.25
   Seidi S, 2013, J CHROMATOGR B, V913, P138, DOI 10.1016/j.jchromb.2012.12.008
   Shen JY, 2004, ANAL CHIM ACTA, V513, P451, DOI 10.1016/j.aca.2004.02.065
   Shinozuka T, 2006, FORENSIC SCI INT, V162, P108, DOI 10.1016/j.forsciint.2006.03.038
   Singh AK, 2009, TALANTA, V78, P1310, DOI 10.1016/j.talanta.2009.01.058
   Sorensen LK, 2011, FORENSIC SCI INT, V206, P119, DOI 10.1016/j.forsciint.2010.07.016
   Starek M, 2013, J PHARMACEUT BIOMED, V85, P132, DOI 10.1016/j.jpba.2013.07.017
   Storey JM, 2014, J CHROMATOGR B, V972, P38, DOI 10.1016/j.jchromb.2014.09.009
   Sturini M, 2009, J SEP SCI, V32, P3020, DOI 10.1002/jssc.200900135
   Sun XL, 2014, J CHROMATOGR A, V1359, P1, DOI 10.1016/j.chroma.2014.07.007
   Szoko E, 2010, J PHARMACEUT BIOMED, V53, P1180, DOI 10.1016/j.jpba.2010.07.045
   Tanaka E, 1997, J CHROMATOGR B, V692, P405, DOI 10.1016/S0378-4347(96)00510-5
   Taylor PJ, 2007, J CHROMATOGR B, V848, P208, DOI 10.1016/j.jchromb.2006.10.029
   Thomas S, 2012, J PHARMACEUT BIOMED, V61, P165, DOI 10.1016/j.jpba.2011.11.024
   Thormann W, 2001, J CHROMATOGR A, V924, P429, DOI 10.1016/S0021-9673(01)00854-8
   Tienpont B, 2003, J PHARMACEUT BIOMED, V32, P569, DOI 10.1016/S0731-7085(03)00164-X
   Tienpont B, 2002, ANAL BIOANAL CHEM, V373, P46, DOI 10.1007/s00216-002-1260-8
   Tuerk J, 2006, J CHROMATOGR B, V831, P72, DOI 10.1016/j.jchromb.2005.11.030
   Turiel E, 2006, ANAL CHIM ACTA, V562, P30, DOI 10.1016/j.aca.2006.01.054
   Vermeij TAC, 2007, J CHROMATOGR B, V857, P40, DOI 10.1016/j.jchromb.2007.06.023
   Waldschmitt C, 2007, THER DRUG MONIT, V29, P767, DOI 10.1097/FTD.0b013e31815d0dfa
   Waldschmitt C, 2009, CHROMATOGRAPHIA, V69, P821, DOI 10.1365/s10337-009-1003-5
   Wang IT, 2010, J CHROMATOGR B, V878, P3095, DOI 10.1016/j.jchromb.2010.09.014
   Wu H, 2010, SPECTROCHIM ACTA A, V75, P1624, DOI 10.1016/j.saa.2010.02.031
   Xiaofang F., 2005, ANAL BIOANAL CHEM, V381, P75
   Yan H, 2008, B KOREAN CHEM SOC, V29, P1173
   Yan HY, 2007, ANAL CHEM, V79, P8242, DOI 10.1021/ac070644q
   Yan HY, 2011, J PHARMACEUT BIOMED, V54, P53, DOI 10.1016/j.jpba.2010.08.007
   Zarzycki PK, 2011, J CHROMATOGR A, V1218, P5694, DOI 10.1016/j.chroma.2011.06.065
   Zhang ZX, 2009, ANAL BIOCHEM, V387, P171, DOI 10.1016/j.ab.2009.01.026
   Zheng MM, 2010, J CHROMATOGR A, V1217, P7493, DOI 10.1016/j.chroma.2010.10.002
   Zhong ZX, 2012, FOOD CHEM, V131, P1044, DOI 10.1016/j.foodchem.2011.09.086
   Zydek G, 2011, J CHROMATOGR B, V879, P1764, DOI 10.1016/j.jchromb.2011.04.025
NR 155
TC 4
Z9 4
U1 4
U2 24
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8347
EI 1547-6510
J9 CRIT REV ANAL CHEM
JI Crit. Rev. Anal. Chem.
PY 2016
VL 46
IS 5
BP 424
EP 442
DI 10.1080/10408347.2016.1141670
PG 19
WC Chemistry, Analytical
SC Chemistry
GA DV0OY
UT WOS:000382619600006
PM 26939618
DA 2018-10-20
ER

PT S
AU Smetana, M
   Chudacik, V
   Capova, K
   Oravcova, M
AF Smetana, Milan
   Chudacik, Vladimir
   Capova, Klara
   Oravcova, Monika
BE Pietka, E
   Badura, P
   Kawa, J
   Wieclawek, W
TI Non-destructive Evaluation of Biomaterial's Magnetic Field After Plastic
   Deformation
SO INFORMATION TECHNOLOGIES IN MEDICINE (ITIB 2016), VOL 2
SE Advances in Intelligent Systems and Computing
LA English
DT Proceedings Paper
CT 5th International Conference on Information Technologies in Biomedicine
   (ITIB)
CY JUN 20-22, 2016
CL Kamien Slaski, POLAND
DE Non-destructive evaluation; Fluxgate sensor; Conductive biomaterials;
   Austenitic stainless steel
AB The article deals with the non-destructive evaluation of conductive biomaterials. Various austenitic steel specimens are inspected under the same conditions. Residual weak magnetic field of the biomaterials is investigated. Commercial fluxgate sensor is used for the inspection. The gained results are presented and discussed in the paper. Biomaterials applied in the form of implants are under long-term mechanical stresses.
C1 [Smetana, Milan; Chudacik, Vladimir; Capova, Klara] Univ Zilina, Dept Electromagnet & Biomed Engn, Fac Elect Engn, Univ 1, Zilina 01026, Slovakia.
   [Oravcova, Monika] Univ Zilina, Dept Mat Engn, Fac Mech Engn, Univ 1, Zilina 01026, Slovakia.
RP Chudacik, V (reprint author), Univ Zilina, Dept Electromagnet & Biomed Engn, Fac Elect Engn, Univ 1, Zilina 01026, Slovakia.
EM vladimir.chudacik@fel.uniza.sk
CR Boltz E.S., 1998, REV PROG QUANT NONDE, V17, P1033
   Chen Q., 2014, METALLIC IMPLANT BIO
   Dogaru T, 2000, NONDESTRUCT TEST EVA, V16, P31
   Gruger H., ARRAY MINIATURIZED F
   Kreutzbruck M., FLUXGATE MAGNETOMETE
   LEBRUN B, 1995, MATER EVAL, V53, P1296
   Li Y, 2008, NDT&E INT, V41, P477, DOI 10.1016/j.ndteint.2008.02.001
   Palcek P., 2015, MAT BIOMEDICAL ENG
   Smetana M., 2015, ELECTROMAGNETIC NOND, V40, P35
   Smetana M., 2015, P 20 INT WORKSH EL N
   WARD WW, 1998, REV PROGR QNDE A, V17, P291
NR 11
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2194-5357
BN 978-3-319-39904-1; 978-3-319-39903-4
J9 ADV INTELL SYST
PY 2016
VL 472
BP 399
EP 407
DI 10.1007/978-3-319-39904-1_35
PG 9
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Health Care Sciences & Services; Medical
   Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA BF5UJ
UT WOS:000382647800035
DA 2018-10-20
ER

PT J
AU Zhang, J
   Guo, R
   Liu, J
AF Zhang, Jie
   Guo, Rui
   Liu, Jing
TI Self-propelled liquid metal motors steered by a magnetic or electrical
   field for drug delivery
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID CATALYTIC NANOMOTORS; OIL DROPLETS; MOTION; ELECTRONICS; MOVEMENT;
   OBJECTS; WATER; PUMP
AB Self-propelled motors have inspired enormous potential in accomplishing various tasks when navigating in an aqueous environment due to their virtues of requiring no external energy source and autonomous locomotion. However, without reliable controllability, their potential value would be heavily reduced. Here, we demonstrate an innovative millimeter-scale self-propelled motor steered by an external magnetic or electric field, which successfully enables the motor to avoid out-of-control motion behavior encountered previously. A nickel cap is electroplated on a liquid metal droplet. The on-board fuel aluminum foil not only triggers the autonomous movement, but also enhances the adhesion between the nickel cap and the droplet. The current motor, composed of a nickel cap, aluminum and liquid metal, is capable of running with a velocity of 3 cm s(-1) for hours without the use of an external energy source. In addition, the integration of the nickel cap renders a magnetic field exploitable to easily alter the performance of the motor remotely. Furthermore, an external electrical field offers a feasible way to accelerate the motor directionally in a reliable manner. More importantly, as a conceptual experiment, when loaded with soft alginate-based biomaterial containing aluminium nanoparticles as drugs, such a motor is still able to be self-propelled, exhibiting steerable motion for drug delivery. The remarkable features of the liquid metal motor, such as softness, controllable self-propelled movement and drug-delivery application, represent a critical step toward functional intelligent soft robots or machines.
C1 [Zhang, Jie; Guo, Rui; Liu, Jing] Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China.
   [Liu, Jing] Chinese Acad Sci, Tech Inst Phys & Chem, Beijing Key Lab Cryobiomed Engn, Beijing 100190, Peoples R China.
   [Liu, Jing] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Cryogen, Beijing 100190, Peoples R China.
RP Liu, J (reprint author), Tsinghua Univ, Dept Biomed Engn, Sch Med, Beijing 100084, Peoples R China.; Liu, J (reprint author), Chinese Acad Sci, Tech Inst Phys & Chem, Beijing Key Lab Cryobiomed Engn, Beijing 100190, Peoples R China.; Liu, J (reprint author), Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Cryogen, Beijing 100190, Peoples R China.
EM jliubme@tsinghua.edu.cn
FU Beijing Municipal Science and Technology Funding [Z151100003715002];
   NSFC [51376102]; Dean's Research Funding of the Chinese Academy of
   Sciences
FX This work was partially supported by Beijing Municipal Science and
   Technology Funding under Grant No. Z151100003715002, NSFC under Grant #
   51376102 and Dean's Research Funding of the Chinese Academy of Sciences.
CR Balasubramanian S, 2009, SMALL, V5, P1569, DOI 10.1002/smll.200900023
   Boley JW, 2014, ADV FUNCT MATER, V24, P3501, DOI 10.1002/adfm.201303220
   Burdick J, 2008, J AM CHEM SOC, V130, P8164, DOI 10.1021/ja803529u
   Calvo-Marzal P, 2009, CHEM COMMUN, P4509, DOI 10.1039/b909227g
   Chen YJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016303
   Cheng S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114381
   Fang WQ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4897309
   Fosdick SE, 2013, ANGEW CHEM INT EDIT, V52, P10438, DOI 10.1002/anie.201300947
   Gao M, 2014, LAB CHIP, V14, P1866, DOI 10.1039/c4lc00111g
   Gibbs JG, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3122346
   Gozen BA, 2014, ADV MATER, V26, P5211, DOI 10.1002/adma.201400502
   Hanczyc MM, 2007, J AM CHEM SOC, V129, P9386, DOI 10.1021/ja0706955
   Huttenloch P, 2003, ENVIRON SCI TECHNOL, V37, P4269, DOI 10.1021/es020237q
   Jin C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03442
   Kagan D, 2009, J AM CHEM SOC, V131, P12082, DOI 10.1021/ja905142q
   Kline TR, 2005, ANGEW CHEM INT EDIT, V44, P744, DOI 10.1002/anie.200461890
   Koo HJ, 2011, ADV MATER, V23, P3559, DOI 10.1002/adma.201101257
   Lammert PE, 1996, J THEOR BIOL, V178, P387, DOI 10.1006/jtbi.1996.0035
   Liu TY, 2012, J MICROELECTROMECH S, V21, P443, DOI 10.1109/JMEMS.2011.2174421
   Ma X, 2015, CHEM COMMUN, V51, P5467, DOI 10.1039/c4cc08285k
   Palacci J, 2013, SCIENCE, V339, P936, DOI 10.1126/science.1230020
   Sheng L, 2014, ADV MATER, V26, P6036, DOI 10.1002/adma.201400843
   Sivan V, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896629
   So JH, 2011, LAB CHIP, V11, P905, DOI 10.1039/c0lc00501k
   Solovev AA, 2011, ANGEW CHEM INT EDIT, V50, P10875, DOI 10.1002/anie.201102096
   Solovev AA, 2010, ADV FUNCT MATER, V20, P2430, DOI 10.1002/adfm.200902376
   Srinivasan A, 2015, SOFT MATTER, V11, P3958, DOI 10.1039/c5sm00273g
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Tang SY, 2014, ADV FUNCT MATER, V24, P5851, DOI 10.1002/adfm.201400689
   Tang SY, 2014, P NATL ACAD SCI USA, V111, P3304, DOI 10.1073/pnas.1319878111
   Tang SY, 2013, NANOSCALE, V5, P5949, DOI 10.1039/c3nr00185g
   Tang XK, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826923
   Toyota T, 2009, J AM CHEM SOC, V131, P5012, DOI 10.1021/ja806689p
   Wang J, 2010, SMALL, V6, P338, DOI 10.1002/smll.200901746
   Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058771
   Zhang J, 2015, SCI BULL, V60, P943, DOI 10.1007/s11434-015-0786-z
   Zhang J, 2015, ADV MATER, V27, P2648, DOI 10.1002/adma.201405438
   Zhang J, 2014, SCI REP-UK, V4, DOI 10.1038/srep07116
   Zhao GJ, 2012, CHEM COMMUN, V48, P10090, DOI 10.1039/c2cc35671f
   Zhao GJ, 2011, CHEM-EUR J, V17, P12020, DOI 10.1002/chem.201101450
   Zheng Y, 2013, AIP ADV, V3, DOI 10.1063/1.4832220
NR 41
TC 20
Z9 20
U1 7
U2 60
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2016
VL 4
IS 32
BP 5349
EP 5357
DI 10.1039/c6tb00996d
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DU3MP
UT WOS:000382115500002
DA 2018-10-20
ER

PT J
AU Popescu, S
   Mindroiu, M
   Cabuzu, D
   Pirvu, C
AF Popescu, Simona
   Mindroiu, Mihaela
   Cabuzu, Daniela
   Pirvu, Cristian
TI The Roll of NaPSS Surfactant on the Ceria Nanoparticles Embedding in
   Polypyrrole Films
SO JOURNAL OF NANOMATERIALS
LA English
DT Article
ID METAL-OXIDE NANOPARTICLES; COMPOSITE COATINGS; TITANIUM SURFACE;
   ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; TI6AL7NB ALLOY;
   IN-VITRO; BIOCOMPATIBILITY; POLYMER; BIOMATERIAL
AB Ceriumoxide nanoparticles (CeO2 NPs) in crystalline form have been synthesized by a coprecipitation method. CeO2 nanoparticles were then embedded in polypyrrole (PPy) films during the electropolymerization of pyrrole (Py) on titanium substrate. The influence of poly(sodium 4-styrenesulfonate) (NaPSS) surfactant used during polymerization on the embedding of CeO2 NPs in polypyrrole films was investigated. The new films were characterized in terms of surface analysis, wettability, electrochemical behaviour, and antibacterial effect. The surface and electrochemical characterization revealed the role of surfactant on PPy doping process cerium oxide incorporation. In the presence of surfactant, CeO2 NPs are preferentially embedded in the polymeric film while, without surfactant, the ceria nanoparticles are quasiuniformly spread as agglomerates onto polymeric films. The antibacterial effect of studied PPy films was substantially improved in the presence of cerium oxide and depends by the polymerization conditions.
C1 [Popescu, Simona; Mindroiu, Mihaela; Cabuzu, Daniela; Pirvu, Cristian] Univ Politehn Bucuresti, 313 Splaiul Independentei,Sect 6, Bucharest 060042, Romania.
RP Pirvu, C (reprint author), Univ Politehn Bucuresti, 313 Splaiul Independentei,Sect 6, Bucharest 060042, Romania.
EM c_pirvu@chim.upb.ro
FU project of CNCS-UEFISCDI [PN2-253/2014-NANOCOAT]
FX This work was supported by a project of CNCS-UEFISCDI,
   PN2-253/2014-NANOCOAT. The authors wish to thank Ms. Cristina Nicolescu
   for XRD analysis and Ms. Camelia Ungureanu for antibacterial activity
   analysis.
CR Ateh DD, 2006, TISSUE ENG, V12, P645, DOI 10.1089/ten.2006.12.645
   Baker CH, 2013, TRANSL CANCER RES, V2, P343, DOI 10.3978/j.issn.2218-676X.2013.08.15
   Benmouhoub C, 2014, ELECTROCHIM ACTA, V145, P270, DOI 10.1016/j.electacta.2014.07.151
   Bouldin R, 2011, SYNTHETIC MET, V161, P1611, DOI 10.1016/j.synthmet.2011.05.026
   Cabuk M, 2014, APPL SURF SCI, V318, P168, DOI 10.1016/j.apsusc.2014.02.180
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chen JL, 2010, J BIOMED MATER RES A, V95A, P341, DOI 10.1002/jbm.a.32847
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   De Leon A, 2015, INTELLIGENT COATINGS, P409
   Dizaj SM, 2014, MAT SCI ENG C-MATER, V44, P278, DOI 10.1016/j.msec.2014.08.031
   Earley ST, 2005, SYNTHETIC MET, V148, P111, DOI 10.1016/j.synthmet.2004.09.020
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gokulakrishnan R, 2012, ASIAN PAC J TROP DIS, V2, P411, DOI DOI 10.1016/S2222-1808(12)60089-9
   Gonzalez MB, 2013, ELECTROCHIM ACTA, V102, P66, DOI 10.1016/j.electacta.2013.03.116
   Gulati K, 2012, ACTA BIOMATER, V8, P449, DOI 10.1016/j.actbio.2011.09.004
   Helary G, 2009, ACTA BIOMATER, V5, P124, DOI 10.1016/j.actbio.2008.07.037
   Idla K, 2000, ELECTROCHIM ACTA, V45, P2121, DOI 10.1016/S0013-4686(99)00433-8
   Ishihara K, 2010, WOODHEAD PUBL MATER, P283, DOI 10.1533/9781845699246.3.283
   Jorgensen J.H., 2015, SUSCEPTIBILITY TEST
   Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8
   Kuang YS, 2011, J NANOSCI NANOTECHNO, V11, P4103, DOI 10.1166/jnn.2011.3858
   Lee YH, 2010, APPL SURF SCI, V256, P5882, DOI 10.1016/j.apsusc.2010.03.069
   Li YL, 2005, LANGMUIR, V21, P10702, DOI 10.1021/la0514314
   Liu F., 2014, COMPOSITES B, V69, P232
   Liu KQ, 2013, OPT MATER, V35, P2710, DOI 10.1016/j.optmat.2013.08.012
   Ma W, 2010, SURF COAT TECH, V205, P1736, DOI 10.1016/j.surfcoat.2010.07.113
   Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005
   Mindroiu M, 2013, APPL SURF SCI, V276, P401, DOI 10.1016/j.apsusc.2013.03.107
   Mindroiu M, 2013, MAT SCI ENG C-MATER, V33, P3353, DOI 10.1016/j.msec.2013.04.016
   Mishra SK, 2015, CARBOHYD POLYM, V121, P37, DOI 10.1016/j.carbpol.2014.12.027
   Mishra SK, 2014, J MECH BEHAV BIOMED, V40, P314, DOI 10.1016/j.jmbbm.2014.08.014
   Moritz M, 2013, CHEM ENG J, V228, P596, DOI 10.1016/j.cej.2013.05.046
   Pirvu C, 2011, ELECTROCHIM ACTA, V56, P9893, DOI 10.1016/j.electacta.2011.08.061
   Pirvu C, 2010, MOL CRYST LIQ CRYST, V521, P126, DOI 10.1080/15421401003715884
   Sehgal A, 2005, LANGMUIR, V21, P9359, DOI 10.1021/la0513757
   Shah V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047827
   Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366
   Tan GX, 2013, APPL SURF SCI, V279, P293, DOI 10.1016/j.apsusc.2013.04.088
   Ungureanu C, 2014, MAT SCI ENG C-MATER, V42, P726, DOI 10.1016/j.msec.2014.06.020
   Ungureanu C, 2012, PROG ORG COAT, V75, P349, DOI 10.1016/j.porgcoat.2012.07.015
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Weiss Z, 2004, J POLYM SCI POL CHEM, V42, P1658, DOI 10.1002/pola.11097
   Zare EN, 2014, SYNTHETIC MET, V187, P9, DOI 10.1016/j.synthmet.2013.09.045
   Zarras P, 2014, WOODH PUBL SER METAL, P328, DOI 10.1533/9780857096883.2.328
NR 44
TC 1
Z9 1
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-4110
EI 1687-4129
J9 J NANOMATER
JI J. Nanomater.
PY 2016
AR 9747931
DI 10.1155/2016/9747931
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DT4OG
UT WOS:000381459900001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Thomas, A
   Bera, J
AF Thomas, Ashley
   Bera, J.
TI Crystallization and sintering behavior of Glass-ceramic powder
   synthesized by Sol-Gel Process
SO JOURNAL OF THE AUSTRALIAN CERAMIC SOCIETY
LA English
DT Article
DE Glass-Ceramics; Sol-Gel synthesis; Sintering; Crystallization behavior
ID BIOACTIVE GLASS; BONE; SCAFFOLDS; 45S5
AB The glass-ceramics in the system SiO2-CaO-Na2O-P2O5, well known as an excellent biomaterial for bone tissue engineering was synthesized by aqueous sol-gel method. The thermal decomposition behavior of the gel was studied using thermo-gravimetric analysis and differential scanning calorimetry. The crystallization behavior of glass was characterized by X-ray diffraction phase analysis, Fourier Transform Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM). The results revealed that the crystallization occurred at a temperature of 700 degrees C and the glass-ceramics was composed of primary phases; combeite (Na2Ca2Si3O9) and devitrite (Na2Ca3Si6O16). Microstructural analysis revealed that there were simultaneous sintering and crystallization processes occurring during heat treatment. Sintering kinetics of the glass-ceramics powder was also investigated.
C1 [Thomas, Ashley; Bera, J.] Natl Inst Technol, Dept Ceram Engn, Rourkela, India.
RP Bera, J (reprint author), Natl Inst Technol, Dept Ceram Engn, Rourkela, India.
EM jbera@nitrkl.ac.in
FU National Institute of Technology, Rourkela, India
FX This research was financially supported by the National Institute of
   Technology, Rourkela, India.
CR Bretcanu O, 2009, J EUR CERAM SOC, V29, P3299, DOI 10.1016/j.jeurceramsoc.2009.06.035
   Cacciotti I, 2012, J MATER SCI-MATER M, V23, P1849, DOI 10.1007/s10856-012-4667-6
   Chen QZ, 2010, ACTA BIOMATER, V6, P4143, DOI 10.1016/j.actbio.2010.04.022
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   flench L.L., 1971, J BIOMED MATER RES, V5, P117
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   Hench L.L., 1999, INTRO BIOCERAMICS
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Kim HW, 2005, J MATER SCI-MATER M, V16, P189, DOI 10.1007/s10856-005-6679-y
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Lefebvre L, 2008, ACTA BIOMATER, V4, P1894, DOI 10.1016/j.actbio.2008.05.019
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Peitl O, 2012, ACTA BIOMATER, V8, P321, DOI 10.1016/j.actbio.2011.10.014
   Pirayesh H, 2013, J AM CERAM SOC, V96, P1643, DOI 10.1111/jace.12190
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Siqueira RL, 2011, MAT SCI ENG C-MATER, V31, P983, DOI 10.1016/j.msec.2011.02.018
NR 19
TC 2
Z9 2
U1 0
U2 3
PU AUSTRALIAN CERAMIC SOCIETY
PI PERTH
PA C/O CURTIN UNIV TECHNOLOGY, GPO BOX U1987, PERTH, 6845 W A, AUSTRALIA
SN 2510-1560
EI 2510-1579
J9 J AUST CERAM SOC
JI J. Aust. Ceram. Soc.
PY 2016
VL 52
IS 2
BP 87
EP 91
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA DV1VE
UT WOS:000382709400011
DA 2018-10-20
ER

PT J
AU Wang, L
   Xu, H
   Gu, L
   Han, TT
   Wang, S
   Meng, FB
AF Wang, L.
   Xu, H.
   Gu, L.
   Han, T. T.
   Wang, S.
   Meng, F. B.
TI Bioinspired synthesis, characterization and antibacterial activity of
   plant-mediated silver nanoparticles using purple sweet potato root
   extract
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Purple sweet potato; Biosynthesis; Silver nanoparticles; TEM; XRD;
   Antibacterial activity
ID FERRITE COMPOSITE NANOPARTICLES; ANTIMICROBIAL ACTIVITY; BIOMATERIAL
   SYSTEM; AU NANOPARTICLES; LEAF; ANTHOCYANINS; BIOSYNTHESIS; TEMPERATURE;
   AG
AB Biosynthesis of silver nanoparticles (AgNPs) has become a promising synthetic strategy in nanotechnology in recent years. In this study, the purple sweet potato (Ipomoea batatas L.) root extract was found to have a new application for the synthesis of AgNPs. It is a natural, eco-friendly and low-cost procedure that uses purple sweet potato extract as reducing and stabilizing agent. The as-prepared AgNPs were characterized by UV-visible spectroscopy, transmission electron microscopy, atomic force microscopy, X-ray diffraction and Fourier transform infrared spectroscopy. In addition, the biosynthesized AgNPs showed remarkable broad-spectrum antimicrobial activity against eight typical pathogens, including four clinic pathogens and four aquatic pathogens. Thus, the AgNPs synthesized with the help of purple sweet potato extract can be used as a powerful antibacterial agent and have great potential in different applications.
C1 [Wang, L.; Wang, S.] Ludong Univ, Coll Life Sci, Yantai 264025, Peoples R China.
   [Xu, H.; Han, T. T.; Meng, F. B.] Ludong Univ, Coll Chem & Mat Sci, Yantai 264025, Peoples R China.
   [Gu, L.] Yantai Acad Agr Sci, Fruit Inst, Yantai 265500, Peoples R China.
RP Xu, H (reprint author), Ludong Univ, Coll Chem & Mat Sci, Yantai 264025, Peoples R China.
EM xuhui235@163.com
FU National Natural Science Foundation of China [31570649, 21104030];
   Natural Science Foundation of Shandong Province [ZR2013CM018];
   Scientific Research Projects of Shandong University [J15LE03]
FX This work was supported by the National Natural Science Foundation of
   China [No. 31570649], [No. 21104030]; Natural Science Foundation of
   Shandong Province [No. ZR2013CM018]; Scientific Research Projects of
   Shandong University [No. J15LE03].
CR Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7
   Depan D, 2015, J BIOMED NANOTECHNOL, V11, P306, DOI 10.1166/jbn.2015.1908
   Galvano F, 2004, J NUTR BIOCHEM, V15, P2, DOI 10.1016/j.jnutbio.2003.07.004
   Gardea-Torresdey JL, 2003, LANGMUIR, V19, P1357, DOI 10.1021/la020835i
   Gardea-Torresdey JL, 2002, NANO LETT, V2, P397, DOI 10.1021/nl015673+
   Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200
   Girase B, 2011, MAT SCI ENG C-MATER, V31, P1759, DOI 10.1016/j.msec.2011.08.007
   Girase B., 2012, ADV BIOMATER, V14, pB93
   Jiao YuZhi, 2012, African Journal of Biotechnology, V11, P7046
   Kasthuri J, 2009, COLLOID SURFACE B, V68, P55, DOI 10.1016/j.colsurfb.2008.09.021
   Kaviya S, 2011, J NANOTECHNOL, DOI 10.1155/2011/152970
   Kokura S, 2010, NANOMED-NANOTECHNOL, V6, P570, DOI 10.1016/j.nano.2009.12.002
   Konwarh R, 2011, COLLOID SURFACE B, V84, P338, DOI 10.1016/j.colsurfb.2011.01.024
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Krutyakov Yu. A., 2008, RUSS CHEM REV, V77, P233, DOI DOI 10.1070/RC2008V077N03ABEH003751
   Kumar S, 2014, MATER TECHNOL, V29, pB59, DOI 10.1179/1753555713Y.0000000117
   Lin LQ, 2010, CHEM ENG J, V162, P852, DOI 10.1016/j.cej.2010.06.023
   Lukman AI, 2011, J COLLOID INTERF SCI, V353, P433, DOI 10.1016/j.jcis.2010.09.088
   Miri A, 2015, SPECTROCHIM ACTA A, V141, P287, DOI 10.1016/j.saa.2015.01.024
   Mojtaba D., 2013, MIDDLE E J SCI RES, V13, P710
   Nabikhan A, 2010, COLLOID SURFACE B, V79, P488, DOI 10.1016/j.colsurfb.2010.05.018
   Njagi EC, 2011, LANGMUIR, V27, P264, DOI 10.1021/la103190n
   Patil RS, 2012, SPECTROCHIM ACTA A, V91, P234, DOI 10.1016/j.saa.2012.02.009
   Prashanth S., 2001, INT J ENG SCI TECHNO, V3, P6235
   Rajendran A, 2014, MATER TECHNOL, V29, pB26, DOI 10.1179/1753555713Y.0000000113
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sadeghi B, 2015, SPECTROCHIM ACTA A, V134, P310, DOI 10.1016/j.saa.2014.06.046
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Song H. Y., 2006, EUR CELLS MATER, V11, P58
   Song J, 2012, ACS APPL MATER INTER, V4, P460, DOI 10.1021/am201563t
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Vahabi K., 2011, INSCIENCES J, V1, P65, DOI [10.5640/insc.010165, DOI 10.5640/INSC.010165]
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020
   Zhang YW, 2008, J COLLOID INTERF SCI, V325, P371, DOI 10.1016/j.jcis.2008.05.063
   Zhao JG, 2013, NUTR RES PRACT, V7, P359, DOI 10.4162/nrp.2013.7.5.359
NR 38
TC 2
Z9 2
U1 4
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
IS 8
BP 437
EP 442
DI 10.1080/10667857.2015.1105575
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA DU4NM
UT WOS:000382189800002
DA 2018-10-20
ER

PT J
AU Cui, CX
   Xu, LJ
   Xie, TP
   Peng, TF
AF Cui, Caixi
   Xu, Longjun
   Xie, Taiping
   Peng, Tiefeng
TI Synthesis and photocatalytic activity of magnetic heterostructure
   ZnFe2O4-SrFe12O19
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Heterostructure; Magnetic; Photocatalytic
ID NANOCRYSTALLINE NICKEL FERRITE; REVERSE MICELLE TECHNIQUE; COMPOSITE
   NANOPARTICLES; VISIBLE-LIGHT; MICROEMULSION TECHNIQUE; ANTIMICROBIAL
   ACTIVITY; BIOMATERIAL SYSTEM; ZINC FERRITES; BEHAVIOR; SHELL
AB Here, we prepare a n-n-type heterojunction with excellent magnetic properties synthesized via a simple chemical coprecipitation method. The magnetic heterojunction is composed of a soft-magnetic component, ZnFe2O4 and a hard-magnetic component, SrFe12O19. The photocatalytic activity of magnetic heterostructure is shown to be better than that of pure semiconductor under visible light irradiation. The enhancement of photocatalytic activity is interpreted in detail in this work. In fact, the prepared ZnFe2O4-SrFe12O19 magnetic composite has potential application in antimicrobial activity under ultraviolet light irradiation and in magnetic carrier system for magnetic drug-targeting delivery.
C1 [Cui, Caixi; Xu, Longjun; Xie, Taiping; Peng, Tiefeng] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China.
   [Xie, Taiping] Dianjiang Minist Land Resources & Housing Author, Chongqing 408300, Peoples R China.
RP Cui, CX; Xu, LJ (reprint author), Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China.
EM cuicaixi@163.com; xulj@cqu.edu.cn
FU National Natural Science Foundation of China [NSFC.51374259]; Scientific
   Research Foundation of State Key Lab of Coal Mine Disaster Dynamics and
   Control [2011DA105287-KF201309]; Fundamental and advanced research
   projects of Chongqing Science and Technology Commission [2013jjB20001]
FX The authors are thankful to the National Natural Science Foundation of
   China [grant number NSFC.51374259], Scientific Research Foundation of
   State Key Lab of Coal Mine Disaster Dynamics and Control [grant number
   2011DA105287-KF201309] and the Fundamental and advanced research
   projects of Chongqing Science and Technology Commission [grant number
   2013jjB20001], for their fund support.
CR Chinnasamy CN, 2001, SCRIPTA MATER, V44, P1407, DOI 10.1016/S1359-6462(01)00844-2
   DEHAART LGJ, 1985, J ELECTROCHEM SOC, V132, P2933, DOI 10.1149/1.2113696
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Gaya U. I., 2014, HETEROGENEOUS PHOTOC, V1
   Ghods P, 2011, APPL SURF SCI, V257, P4669, DOI 10.1016/j.apsusc.2010.12.120
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   Guo FY, 2012, J MAGN MAGN MATER, V324, P1209, DOI 10.1016/j.jmmm.2011.11.011
   Hankare PP, 2011, J ALLOY COMPD, V509, P2160, DOI 10.1016/j.jallcom.2010.10.173
   Iqbal MJ, 2008, CHEM ENG J, V136, P383, DOI 10.1016/j.cej.2007.05.046
   Jiang TF, 2013, NANOSCALE, V5, P2938, DOI 10.1039/c3nr34219k
   Kale A, 2004, J MAGN MAGN MATER, V277, P350, DOI 10.1016/j.jmmm.2003.11.015
   Li XY, 2011, J COLLOID INTERF SCI, V358, P102, DOI 10.1016/j.jcis.2011.02.052
   Li YB, 2009, SOLID STATE SCI, V11, P1319, DOI 10.1016/j.solidstatesciences.2009.04.014
   Liu FF, 2009, ACTA MATER, V57, P2684, DOI 10.1016/j.actamat.2009.02.022
   Liu SL, 2012, POWDER TECHNOL, V217, P502, DOI 10.1016/j.powtec.2011.11.010
   Lv KZ, 2011, J HAZARD MATER, V189, P329, DOI 10.1016/j.jhazmat.2011.02.038
   Meena RS, 2010, MATER SCI ENG B-ADV, V171, P133, DOI 10.1016/j.mseb.2010.03.086
   Misra RDK, 2003, MATER SCI TECH-LOND, V19, P1617, DOI 10.1179/026708303225008040
   Misra RDK, 2003, MATER SCI TECH-LOND, V19, P826, DOI 10.1179/026708303225003018
   Mohanta O, 2013, J ALLOY COMPD, V564, P78, DOI 10.1016/j.jallcom.2013.02.074
   Nathani H, 2005, MAT SCI ENG B-SOLID, V121, P126, DOI 10.1016/j.mseb.2005.03.016
   Nathani H, 2004, MAT SCI ENG B-SOLID, V113, P228, DOI 10.1016/j.mseb.2004.08.010
   Nathani H, 2004, MAT SCI ENG B-SOLID, V111, P95, DOI 10.1016/j.mseb.2004.03.002
   Nerlov J, 1998, SURF SCI, V401, P56, DOI 10.1016/S0039-6028(97)00911-4
   Norman C, 2011, J MEMBRANE SCI, V382, P158, DOI 10.1016/j.memsci.2011.08.006
   Pullar RC, 2012, PROG MATER SCI, V57, P1191, DOI 10.1016/j.pmatsci.2012.04.001
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Shahraki RR, 2012, J MAGN MAGN MATER, V324, P3762, DOI 10.1016/j.jmmm.2012.06.020
   Shamaila S, 2011, J COLLOID INTERF SCI, V356, P465, DOI 10.1016/j.jcis.2011.01.015
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Su J, 2011, J PHYS CHEM C, V115, P8064, DOI 10.1021/jp200274k
   Su MH, 2012, J HAZARD MATER, V211, P95, DOI 10.1016/j.jhazmat.2011.10.006
   Wang WZ, 2013, APPL CATAL B-ENVIRON, V134, P293, DOI 10.1016/j.apcatb.2013.01.013
   Wang YF, 2009, J ALLOY COMPD, V467, P284, DOI 10.1016/j.jallcom.2007.12.037
   Xie JS, 2012, CARBON, V50, P800, DOI 10.1016/j.carbon.2011.09.036
   Xie TP, 2014, DALTON T, V43, P2211, DOI 10.1039/c3dt52219a
   Xie TP, 2013, J PHYS CHEM C, V117, P24601, DOI 10.1021/jp408627e
   Xie TP, 2012, POWDER TECHNOL, V232, P87, DOI 10.1016/j.powtec.2012.08.015
   Xu XX, 2013, CATAL TODAY, V199, P22, DOI 10.1016/j.cattod.2012.03.013
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhang WQ, 2013, DALTON T, V42, P15464, DOI 10.1039/c3dt52068d
NR 46
TC 3
Z9 4
U1 3
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
IS 8
BP 454
EP 462
DI 10.1080/10667857.2015.1105578
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA DU4NM
UT WOS:000382189800005
DA 2018-10-20
ER

PT J
AU Wang, B
   Di, J
   Xia, JX
   Xu, L
   Xu, H
   Zhang, Q
   Chen, ZG
   Li, HM
AF Wang, Bin
   Di, Jun
   Xia, Jiexiang
   Xu, Li
   Xu, Hui
   Zhang, Qi
   Chen, Zhigang
   Li, Huaming
TI Graphene-like BN/BiOBr composite: synthesis via a reactable ionic liquid
   and enhanced visible light photocatalytic performance
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Graphene-like BN; BiOBr; Photocatalysis; Ionic liquid
ID HEXAGONAL BORON-NITRIDE; CARBON QUANTUM DOTS; MILLED H-BN; MECHANISM
   INSIGHT; SOLVOTHERMAL SYNTHESIS; ANTIMICROBIAL ACTIVITY; ULTRATHIN
   NANOSHEETS; FACILE FABRICATION; BIOBR MICROSPHERES; BIOMATERIAL SYSTEM
AB Herein, novel graphene-like BN/BiOBr composite was prepared through a facile solvothermal method in the presence of reactable ionic liquid [C(16)mim]Br. The structure and morphology of the as-prepared samples were investigated by X-ray diffraction (XRD), Transmission electron microscopy, field-emission scanning electron microscope, energy dispersive X-ray spectrometry, UV-vis diffuse reflectance spectroscopy, Fourier transform infrared spectra and photoluminescence (PL). The photocatalytic activity was evaluated by the degradation of Rhodamine B (RhB) aqueous solution under visible light irradiation. Results showed that the 0.05 wt% BN/BiOBr composite catalysts exhibit higher photoactivity than pure BiOBr. The enhanced photocatalytic activity was attributed to the efficient separation of the photogenerated electron-hole pairs of the composites which was confirmed by the electrochemical impedance spectroscopy, photocurrent and PL analysis. Meanwhile, the main active species of BN/BiOBr during the photocatalysis process were determined to be holes (h(+)).
C1 [Wang, Bin; Di, Jun; Xia, Jiexiang; Xu, Li; Xu, Hui; Zhang, Qi; Li, Huaming] Jiangsu Univ, Sch Chem & Chem Engn, Inst Energy Res, 301 Xuefu Rd, Zhenjiang 212013, Peoples R China.
   [Chen, Zhigang] Jiangsu Univ, Sch Environm, Zhenjiang 212013, Peoples R China.
RP Xia, JX; Li, HM (reprint author), Jiangsu Univ, Sch Chem & Chem Engn, Inst Energy Res, 301 Xuefu Rd, Zhenjiang 212013, Peoples R China.
EM xjx@ujs.edu.cn; lhm@ujs.edu.cn
RI huaming, li/S-1885-2016
CR Ai LH, 2014, APPL CATAL B-ENVIRON, V148, P191, DOI 10.1016/j.apcatb.2013.10.056
   An CH, 2014, RSC ADV, V4, P2409, DOI 10.1039/c3ra46527f
   CATELLANI A, 1987, PHYS REV B, V36, P6105, DOI 10.1103/PhysRevB.36.6105
   Chen JJ, 2014, APPL SURF SCI, V313, P1, DOI 10.1016/j.apsusc.2014.04.109
   Cheng HF, 2014, NANOSCALE, V6, P2009, DOI 10.1039/c3nr05529a
   Cheng HF, 2011, CHEM COMMUN, V47, P7054, DOI 10.1039/c1cc11525a
   Depan D, 2014, MAT SCI ENG C-MATER, V34, P221, DOI 10.1016/j.msec.2013.09.025
   Di J, 2015, MATER TECHNOL, V30, P113, DOI 10.1179/1753555714Y.0000000226
   Di J, 2015, ACS APPL MATER INTER, V7, P20111, DOI 10.1021/acsami.5b05268
   Di J, 2015, J MATER CHEM A, V3, P15108, DOI 10.1039/c5ta02388b
   Di J, 2015, NANOSCALE, V7, P11433, DOI 10.1039/c5nr01350j
   Di J, 2015, APPL CATAL B-ENVIRON, V168, P51, DOI 10.1016/j.apcatb.2014.11.057
   Di J, 2014, J MATER CHEM A, V2, P15864, DOI 10.1039/c4ta02400a
   Di J, 2014, DALTON T, V43, P15429, DOI 10.1039/c4dt01652a
   Di J, 2014, J MATER CHEM A, V2, P5340, DOI 10.1039/c3ta14617k
   Di J, 2014, RSC ADV, V4, P14281, DOI 10.1039/c3ra45670f
   Di J, 2013, RSC ADV, V3, P19624, DOI 10.1039/c3ra42269k
   Fu XL, 2013, APPL SURF SCI, V280, P828, DOI 10.1016/j.apsusc.2013.05.069
   Fu XL, 2013, J HAZARD MATER, V244, P102, DOI 10.1016/j.jhazmat.2012.11.033
   GEICK R, 1966, PHYS REV, V146, P543, DOI 10.1103/PhysRev.146.543
   Guan ML, 2013, J AM CHEM SOC, V135, P10411, DOI 10.1021/ja402956f
   Huo YN, 2014, APPL CATAL B-ENVIRON, V148, P550, DOI 10.1016/j.apcatb.2013.11.040
   Huo YN, 2012, APPL CATAL B-ENVIRON, V111, P334, DOI 10.1016/j.apcatb.2011.10.016
   Jiang Z, 2010, J PHOTOCH PHOTOBIO A, V212, P8, DOI 10.1016/j.jphotochem.2010.03.004
   Kong L, 2011, CHEM COMMUN, V47, P5512, DOI 10.1039/c1cc10446b
   Lightcap IV, 2010, NANO LETT, V10, P577, DOI 10.1021/nl9035109
   Nag A, 2010, ACS NANO, V4, P1539, DOI 10.1021/nn9018762
   Nakamoto K., 1986, INFRARED RAMAN SPECT
   Obregon S, 2013, J MOL CATAL A-CHEM, V376, P40, DOI 10.1016/j.molcata.2013.04.012
   Perret PG, 2012, J ELECTROCHEM SOC, V159, pA1554, DOI 10.1149/2.064208jes
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Shah JS, 2011, ADV ENG MATER, V13, pB41, DOI 10.1002/adem.201080051
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tian HT, 2012, CATAL SCI TECHNOL, V2, P2351, DOI 10.1039/c2cy20303k
   Tu XM, 2012, CHEM-EUR J, V18, P14359, DOI 10.1002/chem.201200892
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang XC, 2012, ACS CATAL, V2, P1596, DOI 10.1021/cs300240x
   Wang YJ, 2011, ENERG ENVIRON SCI, V4, P2922, DOI 10.1039/c0ee00825g
   Wei XX, 2013, J HAZARD MATER, V263, P650, DOI 10.1016/j.jhazmat.2013.10.027
   Xia JX, 2016, APPL CATAL B-ENVIRON, V181, P260, DOI 10.1016/j.apcatb.2015.07.035
   Xia JX, 2014, RSC ADV, V4, P82, DOI 10.1039/c3ra44191a
   Xia JX, 2011, DALTON T, V40, P5249, DOI 10.1039/c0dt01511c
   Xie J, 2011, ACS NANO, V5, P9225, DOI 10.1021/nn203480h
   Xiong J, 2015, J MATER CHEM A, V3, P12738, DOI 10.1039/c5ta01346a
   Xiong J, 2015, GREEN CHEM, V17, P1647, DOI 10.1039/c4gc02053g
   Xu X, 2013, APPL CATAL A-GEN, V455, P183, DOI 10.1016/j.apcata.2013.01.035
   Xu Y, 2014, ACS APPL MATER INTER, V6, P20408, DOI 10.1021/am505975n
   Zhang J, 2008, ACTA BIOMATER, V4, P40, DOI 10.1016/j.actbio.2007.06.006
   Zhang XM, 2012, APPL SURF SCI, V258, P7826, DOI 10.1016/j.apsusc.2012.04.049
NR 53
TC 1
Z9 1
U1 13
U2 58
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PY 2016
VL 31
IS 8
BP 463
EP 470
DI 10.1080/10667857.2015.1105579
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA DU4NM
UT WOS:000382189800006
DA 2018-10-20
ER

PT J
AU Zhang, XJ
   Cheng, J
   Zhuo, RX
AF Zhang, Xiaojin
   Cheng, Juan
   Zhuo, Renxi
TI Amphiphilic hyperbranched polymers with a biodegradable hyperbranched
   poly(epsilon-caprolactone) core prepared from homologous AB(2)
   macromonomer
SO RSC ADVANCES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; BLOCK-COPOLYMERS; DRUG-DELIVERY;
   GRAFT-COPOLYMERS; MICELLES; POLYGLYCEROL; CRYSTALLIZATION; NANOCARRIERS;
   BACKBONE; VESICLES
AB Amphiphilic hyperbranched polymers with a biodegradable hyperbranched poly(epsilon-caprolactone) core were synthesized by one-pot polyesterification of AB(2) macromonomer (including two carboxyl groups and one hydroxyl group) and poly(ethylene glycol) methyl ether, as a very promising biodegradable and biocompatible biomaterial for drug controlled release.
C1 [Zhang, Xiaojin; Zhuo, Renxi] Wuhan Univ, Dept Chem, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
   [Cheng, Juan] South Cent Univ Nationalities, Key Lab Catalysis & Mat Sci, State Ethn Affairs Commiss, Wuhan 430074, Peoples R China.
   [Cheng, Juan] South Cent Univ Nationalities, Minist Educ, Wuhan 430074, Peoples R China.
RP Zhang, XJ (reprint author), Wuhan Univ, Dept Chem, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
EM zhangxj@whu.edu.cn
RI Zhang, Xiaojin/O-3556-2017
OI Zhang, Xiaojin/0000-0001-6624-2377
FU National Basic Research Program of China [2011CB606202]; National
   Natural Science Foundation of China [51403241]
FX This work was financially supported by the National Basic Research
   Program of China (2011CB606202) and the National Natural Science
   Foundation of China (51403241).
CR Blanazs A, 2009, MACROMOL RAPID COMM, V30, P267, DOI 10.1002/marc.200800713
   Cai GQ, 2011, ACTA BIOMATER, V7, P3729, DOI 10.1016/j.actbio.2011.06.027
   Choi I, 2013, MACROMOLECULES, V46, P1425, DOI 10.1021/ma302483j
   Choi J, 2003, MACROMOLECULES, V36, P8630, DOI 10.1021/ma034170i
   Engelhardt N, 2013, MACROMOL CHEM PHYS, V214, P2783, DOI 10.1002/macp.201300573
   Ernenwein D, 2015, MACROMOL CHEM PHYS, V216, P1729, DOI 10.1002/macp.201500159
   Fan X., 2015, RSC ADV, V5
   Finnegan JR, 2014, J AM CHEM SOC, V136, P13835, DOI 10.1021/ja507121h
   Ghasdian N, 2015, MACROMOL RAPID COMM, V36, P528, DOI 10.1002/marc.201400621
   Gottschalk C, 2006, MACROMOLECULES, V39, P1719, DOI 10.1021/ma0513259
   Hu HQ, 2014, SOFT MATTER, V10, P3867, DOI 10.1039/c3sm52607k
   Hu M, 2012, BIOMACROMOLECULES, V13, P3552, DOI 10.1021/bm300966d
   Huang Y, 2015, POLYM CHEM-UK, V6, P2794, DOI 10.1039/c5py00144g
   Kim KH, 2008, MACROMOL BIOSCI, V8, P339, DOI 10.1002/mabi.200700161
   Kowalczuk A, 2014, PROG POLYM SCI, V39, P43, DOI 10.1016/j.progpolymsci.2013.10.004
   Licciardi M, 2014, J MATER CHEM B, V2, P4262, DOI 10.1039/c4tb00235k
   Lin RH, 1998, J ORG CHEM, V63, P4069, DOI 10.1021/jo980153t
   Liu MJ, 1999, MACROMOLECULES, V32, P6881, DOI 10.1021/ma990785x
   McKenzie BE, 2010, J AM CHEM SOC, V132, P10256, DOI 10.1021/ja102040u
   Palanisamy A, 2014, RSC ADV, V4, P54752, DOI 10.1039/c4ra09061f
   Parzuchowski PG, 2008, MACROMOLECULES, V41, P3859, DOI 10.1021/ma8000912
   Parzuchowski PG, 2006, MACROMOLECULES, V39, P7181, DOI 10.1021/ma061488c
   Rizis G, 2014, ANGEW CHEM INT EDIT, V53, P9000, DOI 10.1002/anie.201404089
   Rudolph T, 2015, ACS NANO, V9, P10085, DOI 10.1021/acsnano.5b03660
   Tirino P, 2014, MACROMOL CHEM PHYS, V215, P1218, DOI 10.1002/macp.201400043
   Trollsas M, 1998, MACROMOLECULES, V31, P4390, DOI 10.1021/ma980151a
   Trollsas M, 1998, MACROMOLECULES, V31, P3439, DOI 10.1021/ma980241f
   Tryznowski M, 2012, MACROMOLECULES, V45, P6819, DOI 10.1021/ma3011153
   Tsai HC, 2011, MACROMOL RAPID COMM, V32, P1442, DOI 10.1002/marc.201100157
   Tyrrell ZL, 2010, PROG POLYM SCI, V35, P1128, DOI 10.1016/j.progpolymsci.2010.06.003
   Venkataraman S, 2013, MACROMOL RAPID COMM, V34, P652, DOI 10.1002/marc.201200751
   Wan XJ, 2011, BIOMACROMOLECULES, V12, P1146, DOI 10.1021/bm101463d
   Wang Y, 2012, ADV DRUG DELIVER REV, V64, P852, DOI 10.1016/j.addr.2012.03.011
   Wiradharma N, 2009, NANO TODAY, V4, P302, DOI 10.1016/j.nantod.2009.06.001
   Yan LT, 2013, PROG POLYM SCI, V38, P369, DOI 10.1016/j.progpolymsci.2012.05.001
   Yoon K, 2015, POLYM CHEM-UK, V6, P531, DOI 10.1039/c4py01380h
   Yu XH, 2005, MACROMOLECULES, V38, P6244, DOI 10.1021/ma048839c
   Zhang WW, 2016, RSC ADV, V6, P20761, DOI 10.1039/c6ra00699j
   Zhang WL, 2010, BIOMACROMOLECULES, V11, P1331, DOI 10.1021/bm100116g
   Zhang XJ, 2015, MACROMOL CHEM PHYS, V216, P1712, DOI 10.1002/macp.201500161
   Zhang XJ, 2012, J POLYM SCI POL CHEM, V50, P2687, DOI 10.1002/pola.26051
   Zhang XJ, 2010, MACROMOL RAPID COMM, V31, P2155, DOI 10.1002/marc.201000392
   Zhang XJ, 2010, MACROMOLECULES, V43, P6671, DOI 10.1021/ma100653u
NR 43
TC 2
Z9 2
U1 2
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 57
BP 52334
EP 52338
DI 10.1039/c6ra08531h
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA DU2ZI
UT WOS:000382079800104
DA 2018-10-20
ER

PT J
AU Chen, QS
   Qian, MQ
   Jia, CY
   Lin, JM
   Jiang, GM
   Guan, BH
AF Chen, Qiaoshan
   Qian, Mengqian
   Jia, Caiyun
   Lin, Junming
   Jiang, Guangming
   Guan, Baohong
TI Formation of mesoporous calcium sulfate microspheres through phase
   conversion in controlled calcination
SO RSC ADVANCES
LA English
DT Article
ID PHOTOCATALYTIC ACTIVITY; CRYSTAL-STRUCTURE; DRUG-DELIVERY; HEMIHYDRATE;
   MORPHOLOGY; OXIDE; MICROSTRUCTURE; HYDROXYAPATITE; TEMPERATURE; CEMENTS
AB Calcium sulfate has been used as a biomedical material for over a century thanks to its biocompatible, biodegradable and cementitious properties. However the dense structure and low surface area of existing materials exclude its adsorption properties and restrict the applications. In this work, mesoporous calcium sulfate microspheres are prepared through topological conversion of monodisperse alpha-calcium sulfate hemihydrate (alpha-HH) microspheres under controlled calcination. The calcination process contributes to the phase conversion from alpha-HH to calcium sulfate anhydrite (AH) along with the elimination of structural water and the reduction of crystallite size, resulting in the formation of mesopores. The microspheres composed of 29.56 wt% alpha-HH and 70.44 wt% AH demonstrate a maximum surface area of 30.62 m(2) g(-1) and an ibuprofen (IBU) loading capacity of 22.44 mg g(-1), which shows a one hundred times improvement in surface area compared with traditional calcium sulfate materials. This is the first time drugs have been loaded directly to calcium sulfate particles, showing that the mesoporous calcium sulfate microspheres with uniform particle size and ordered pore structure could be a promising carrier as a biomaterial.
C1 [Chen, Qiaoshan; Qian, Mengqian; Jia, Caiyun; Lin, Junming; Guan, Baohong] Zhejiang Univ, Dept Environm Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Jiang, Guangming] Chongqing Technol & Business Univ, Engn Res Ctr Waste Oil Recovery Technol & Equipme, Chongqing 400067, Peoples R China.
RP Guan, BH (reprint author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310058, Zhejiang, Peoples R China.
EM guanbaohong@zju.edu.cn
FU National Science Foundation of China [21176219]
FX We thank the National Science Foundation of China (Project 21176219) for
   support of this research.
CR Vu AT, 2014, IND ENG CHEM RES, V53, P13228, DOI 10.1021/ie5018546
   Bao QL, 2008, J PHYS CHEM B, V112, P12270, DOI 10.1021/jp804988h
   Cabanas MV, 2002, CHEM MATER, V14, P3550, DOI 10.1021/cm021121w
   Chen QS, 2015, CRYSTENGCOMM, V17, P8549, DOI 10.1039/c5ce01923k
   Cho JY, 2012, RSC ADV, V2, P2449, DOI 10.1039/c2ra00022a
   Christensen AN, 2008, CHEM MATER, V20, P2124, DOI 10.1021/cm7027542
   Doadrio JC, 2004, BIOMATERIALS, V25, P2629, DOI 10.1016/j.biomaterials.2003.09.037
   Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7
   Guan BH, 2009, FUEL, V88, P1286, DOI 10.1016/j.fuel.2009.01.004
   Guo LM, 2013, ACS APPL MATER INTER, V5, P11080, DOI 10.1021/am4032778
   Hou HL, 2014, J AM CHEM SOC, V136, P16716, DOI 10.1021/ja508840c
   Jung HM, 2010, BIOMATERIALS, V31, P29, DOI 10.1016/j.biomaterials.2009.09.019
   Kimling MC, 2012, J MATER CHEM, V22, P4073, DOI 10.1039/c2jm15720a
   Kong B, 2012, LANGMUIR, V28, P14137, DOI 10.1021/la302459z
   Lee B, 2001, CHEM COMMUN, P2118, DOI 10.1039/b104516b
   Mokkelbost T, 2004, CHEM MATER, V16, P5489, DOI 10.1021/cm048583p
   Nandi M, 2011, CHEM COMMUN, V47, P6677, DOI 10.1039/c1cc11007a
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Sato S, 1998, BIOMATERIALS, V19, P1895, DOI 10.1016/S0142-9612(98)00102-1
   Song SW, 2005, LANGMUIR, V21, P9568, DOI 10.1021/la051167e
   Song XY, 2003, J MATER CHEM, V13, P1817, DOI 10.1039/b212735k
   Tang ML, 2010, MAT SCI ENG C-MATER, V30, P1107, DOI 10.1016/j.msec.2010.06.006
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Tuysuz H, 2012, INORG CHEM, V51, P11745, DOI 10.1021/ic301671a
   Tuzuner T, 2006, J CHEMOTHERAPY, V18, P628, DOI 10.1179/joc.2006.18.6.628
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Wang WQ, 2009, J COLLOID INTERF SCI, V331, P156, DOI 10.1016/j.jcis.2008.11.024
   Wang YW, 2012, J MATER CHEM, V22, P22055, DOI 10.1039/c2jm34087a
   Wang YW, 2012, CHEM COMMUN, V48, P504, DOI 10.1039/c1cc14210k
   WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6
   Wu KCW, 2011, CHEM COMMUN, V47, P5232, DOI 10.1039/c1cc10659g
   Yamauchi Y, 2009, CHEM REC, V9, P321, DOI 10.1002/tcr.200900022
   Yu JG, 2003, J PHYS CHEM B, V107, P13871, DOI 10.1021/jp036158y
   Zhan SH, 2015, RSC ADV, V5, P29353, DOI 10.1039/c4ra17300g
   Zhang X, 2016, RSC ADV, V6, P58925, DOI 10.1039/c6ra11085a
NR 35
TC 0
Z9 0
U1 3
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 83
BP 79578
EP 79583
DI 10.1039/c6ra17425f
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA DU9LU
UT WOS:000382539600035
DA 2018-10-20
ER

PT J
AU Shrestha, LK
   Adhikari, L
   Shrestha, RG
   Adhikari, MP
   Adhikari, R
   Hill, JP
   Pradhananga, RR
   Ariga, K
AF Shrestha, Lok Kumar
   Adhikari, Laxmi
   Shrestha, Rekha Goswami
   Adhikari, Mandira Pradhananga
   Adhikari, Rina
   Hill, Jonathan P.
   Pradhananga, Raja Ram
   Ariga, Katsuhiko
TI Nanoporous carbon materials with enhanced supercapacitance performance
   and non-aromatic chemical sensing with C-1/C-2 alcohol discrimination
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Article
DE Nanoporous carbon materials; electrochemical properties; vapor sensing;
   non-aromatic chemical sensing; alcohol discrimination
ID BY-LAYER FILMS; ACTIVATED CARBON; PHOSPHORIC-ACID; DIRECT CARBONIZATION;
   FULLERENE CRYSTALS; NANOARCHITECTONICS; ADSORPTION; SURFACE; COMPOSITE;
   GRAPHENE
AB We have investigated the textural properties, electrochemical supercapacitances and vapor sensing performances of bamboo-derived nanoporous carbon materials (NCM). Bamboo, an abundant natural biomaterial, was chemically activated with phosphoric acid at 400 degrees C and the effect of impregnation ratio of phosphoric acid on the textural properties and electrochemical performances was systematically investigated. Fourier transform-infrared (FTIR) spectroscopy confirmed the presence of various oxygen-containing surface functional groups (i.e. carboxyl, carboxylate, carbonyl and phenolic groups) in NCM. The prepared NCM are amorphous in nature and contain hierarchical micropores and mesopores. Surface areas and pore volumes were found in the range 218-1431 m(2) g(-1) and 0.26-1.26 cm(3) g(-1), respectively, and could be controlled by adjusting the impregnation ratio of phosphoric acid and bamboo cane powder. NCM exhibited electrical double-layer supercapacitor behavior giving a high specific capacitance of c. 256 F g(-1) at a scan rate of 5 mV s(-1) together with high cyclic stability with capacitance retention of about 92.6% after 1000 cycles. Furthermore, NCM exhibited excellent vapor sensing performance with high sensitivity for non-aromatic chemicals such as acetic acid. The system would be useful to discriminate C-1 and C-2 alcohol (methanol and ethanol).
   [GRAPHICS]
C1 [Shrestha, Lok Kumar; Shrestha, Rekha Goswami; Hill, Jonathan P.; Ariga, Katsuhiko] NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki, Japan.
   [Adhikari, Laxmi; Adhikari, Mandira Pradhananga; Adhikari, Rina; Pradhananga, Raja Ram] Tribhuvan Univ, Cent Dept Chem, Kathmandu, Nepal.
RP Shrestha, LK; Ariga, K (reprint author), NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki, Japan.
EM SHRESTHA.Lokkumar@nims.go.jp; ARIGA.Katsuhiko@nims.go.jp
RI Hill, Jonathan/B-9332-2011; ARIGA, Katsuhiko/H-2695-2011; Shrestha, Lok
   Kumar/B-9537-2013
OI Hill, Jonathan/0000-0002-4229-5842; Shrestha, Lok
   Kumar/0000-0003-2680-6291
FU World Premier International Research Initiative (WPI Initiative), MEXT,
   Japan
FX This work was funded by the World Premier International Research
   Initiative (WPI Initiative), MEXT, Japan.
CR Adhikari MP, 2015, B CHEM SOC JPN, V88, P1108, DOI 10.1246/bcsj.20150092
   Aguila SA, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/5/055004
   Altenor S, 2009, J HAZARD MATER, V165, P1029, DOI 10.1016/j.jhazmat.2008.10.133
   Ariga K, 2008, ANGEW CHEM INT EDIT, V47, P7254, DOI 10.1002/anie.200802820
   Ariga K, 2016, ANALYST, V141, P2629, DOI 10.1039/c6an00057f
   Ariga K, 2014, APL MATER, V2, DOI 10.1063/1.4868177
   Ariga K, 2012, B CHEM SOC JPN, V85, P1, DOI 10.1246/bcsj.20110162
   Chaikittisilp W, 2012, CHEM COMMUN, V48, P7259, DOI 10.1039/c2cc33433j
   Fang JH, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/5/055009
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Ferrari AC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075414
   Foo KY, 2012, BIORESOURCE TECHNOL, V112, P143, DOI 10.1016/j.biortech.2012.01.178
   Fujigaya T, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/2/024802
   Hu M, 2012, J AM CHEM SOC, V134, P2864, DOI 10.1021/ja208940u
   Ishihara S, 2013, ACS APPL MATER INTER, V5, P5927, DOI 10.1021/am401956s
   Jagtoyen M, 1998, CARBON, V36, P1085, DOI 10.1016/S0008-6223(98)00082-7
   Ji QM, 2010, ANGEW CHEM INT EDIT, V49, P9737, DOI 10.1002/anie.201004929
   Ji QM, 2009, J AM CHEM SOC, V131, P4220, DOI 10.1021/ja9010354
   Jin SB, 2016, J MATER CHEM A, V4, P5737, DOI 10.1039/c6ta00516k
   Joshi S, 2015, ADV POWDER TECHNOL, V26, P894, DOI 10.1016/j.apt.2015.03.004
   Kosaki Y, 2013, ACS APPL MATER INTER, V5, P2930, DOI 10.1021/am400940q
   Li K, J MAT CHEM A
   Liou TH, 2010, CHEM ENG J, V158, P129, DOI 10.1016/j.cej.2009.12.016
   Lu FN, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/1/014805
   Malgras V, 2015, B CHEM SOC JPN, V88, P1171, DOI 10.1246/bcsj.20150143
   Minami K, 2015, ADV MATER, V27, P4020, DOI 10.1002/adma.201501690
   Nakanishi W, 2014, NANO TODAY, V9, P378, DOI 10.1016/j.nantod.2014.05.002
   Njoku VO, 2013, CHEM ENG J, V215, P383, DOI 10.1016/j.cej.2012.10.068
   Okman I, 2014, APPL SURF SCI, V293, P138, DOI 10.1016/j.apsusc.2013.12.117
   Rajendran R, 2015, J INORG ORGANOMET P, V25, P267, DOI 10.1007/s10904-014-0102-4
   Rajendran R, 2014, J MATER CHEM A, V2, P18480, DOI 10.1039/c4ta03996c
   Rana M, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/1/014803
   Raposo F, 2009, J HAZARD MATER, V165, P291, DOI 10.1016/j.jhazmat.2008.09.106
   Shimodaira N, 2002, J APPL PHYS, V92, P902, DOI 10.1063/1.1487434
   Shrestha LK, 2015, ANGEW CHEM INT EDIT, V54, P951, DOI 10.1002/anie.201408856
   Shrestha LK, 2013, CHEM-ASIAN J, V8, P1662, DOI 10.1002/asia.201300247
   Sych NV, 2012, APPL SURF SCI, V261, P75, DOI 10.1016/j.apsusc.2012.07.084
   Terzyk AP, 2001, COLLOID SURFACE A, V177, P23, DOI 10.1016/S0927-7757(00)00594-X
   Tian WQ, 2015, J MATER CHEM A, V3, P5656, DOI 10.1039/c4ta06620k
   Timur S, 2006, ENERG FUEL, V20, P2636, DOI 10.1021/ef060219k
   Torad NL, 2014, SMALL, V10, P2096, DOI 10.1002/smll.201302910
   Nabais JMV, 2013, APPL SURF SCI, V265, P919, DOI 10.1016/j.apsusc.2012.11.164
   Yang SY, 2011, J MATER CHEM, V21, P2374, DOI 10.1039/c0jm03199b
   Yu HR, 2013, MICROPOR MESOPOR MAT, V172, P131, DOI 10.1016/j.micromeso.2013.01.018
   Zhang ST, 2014, J MATER CHEM A, V2, P15889, DOI 10.1039/c4ta03503h
   Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770
   Zhu ZL, 2007, J COLLOID INTERF SCI, V316, P628, DOI 10.1016/j.jcis.2007.09.016
NR 47
TC 9
Z9 9
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1468-6996
EI 1878-5514
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PY 2016
VL 17
IS 1
BP 483
EP 492
DI 10.1080/14686996.2016.1219971
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA DU9GY
UT WOS:000382525800014
PM 27877898
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhou, X
   Zhang, JM
   Feng, GW
   Shen, J
   Kong, DL
   Zhao, Q
AF Zhou, Xin
   Zhang, Jimin
   Feng, Guowei
   Shen, Jie
   Kong, Deling
   Zhao, Qiang
TI Nitric Oxide-Releasing Biomaterials for Biomedical Applications
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE Nitric oxide; Biomaterials; Controlled delivery; Biomedical
   applications; Cardiovascular diseases; Cancer
ID MODIFIED POLY(AMIDOAMINE) DENDRIMERS; SITU CATALYTIC GENERATION;
   ANTI-BIOFILM EFFICACY; IN-STENT RESTENOSIS; COLON-CANCER CELLS; CHITOSAN
   OLIGOSACCHARIDES; STAPHYLOCOCCUS-AUREUS; SILICA NANOPARTICLES;
   ANTIBACTERIAL AGENTS; POLYMERIC COATINGS
AB Nitric oxide (NO), as an essential signaling molecule, participates in various physiological processes such as cardiovascular homeostasis, neuronal transmission, immunomodulation, and tumor growth. The multiple role of NO in physiology and pathophysiology has triggered a massive interest in the strategies of delivering exogenous NO for biomedical applications. Hence, different kinds of NO prodrugs have been developed up to date, including diazeniumdiolates, S-nitrosothiol, metal-nitrosyl, nitrobenzene, and so on. However, the clinical application of these low molecular weight NO donors has been restricted due to the problems of burst release, low payloads, and untargeted delivery. The delivery of NO by biomaterial-based carrier offers a beneficial strategy to realize the controlled and sustained delivery of NO to the targeted tissues or organs. In detail, NO-donor prodrugs have been attached and loaded to diverse biomaterials to fabricate nanoparticles, hydrogels, and coating platforms by means of physical, chemical, or supramolecular techniques. These NO-releasing biomaterials hold promise for a number of biomedical applications ranging from therapy of the ischemic disease and several types of cancer to cardiovascular devices and wound dressing. First, surface coating with NO-releasing biomaterials could mimic the physiological function of vascular endothelium, therefore promoting vascularization and improving the patency of cardiovascular implants. Next, because NO also mediates many important processes that take place after cutaneous injury, NO-releasing biomaterials could serve as ideal wound dressing to accelerate tissue regeneration. Finally, biomaterials enable localized delivery of high dose of NO to tumors in a sustained manner, thus generating potent tumoricidal effect. In this review, we will summarize the progress of different NO-releasing biomaterials, and highlight their biomedical applications with a hope to inspire new perspectives in the area of biomaterial-based NO-delivery systems.
C1 [Zhou, Xin; Zhang, Jimin; Kong, Deling; Zhao, Qiang] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ, Tianjin 300071, Peoples R China.
   [Feng, Guowei] Tianjin Med Univ Canc Inst & Hosp, Dept Genitourinary Oncol, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China.
   [Shen, Jie] Nankai Univ, Sch Pharm, Tianjin 300071, Peoples R China.
RP Zhao, Q (reprint author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.; Kong, DL (reprint author), Nankai Univ, Inst Mol Biol, Tianjin 300071, Peoples R China.
EM kongdeling@nankai.edu.cn; qiangzhao@nankai.edu.cn
FU NSFC [81522023, 81530059, 81371699]; Program for Changjiang Scholars and
   Innovative Research Team in University [IRT13023]
FX The work was financially supported by NSFC projects (No. 81522023,
   81530059, and 81371699) and Program for Changjiang Scholars and
   Innovative Research Team in University (No. IRT13023).
CR Abbasi K, 2011, CARDIOLOGY, V118, P8, DOI 10.1159/000324316
   Adamian A.A., 2004, KHIRURG IM PIROGOVA, V12, P10
   Adams DJ, 2001, LEUKEMIA, V15, P1852, DOI 10.1038/sj.leu.2402291
   Ahern TP, 2014, LANCET ONCOL, V15, pE461, DOI 10.1016/S1470-2045(14)70119-6
   Alagem-Shafir M, 2014, ACTA BIOMATER, V10, P2304, DOI 10.1016/j.actbio.2013.12.043
   Amadeu TP, 2007, J EUR ACAD DERMATOL, V21, P629, DOI 10.1111/j.1468-3083.2006.02032.x
   An J, 2015, SCI CHINA LIFE SCI, V58, P765, DOI 10.1007/s11427-015-4870-z
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Backlund CJ, 2016, ACTA BIOMATER, V29, P198, DOI 10.1016/j.actbio.2015.10.021
   Bahnson ESM, 2016, ANTIOXID REDOX SIGN, V24, P401, DOI 10.1089/ars.2015.6363
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Bian K, 2014, NITRIC OXIDE-BIOL CH, V43, P3, DOI 10.1016/j.niox.2014.08.006
   Bice JS, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0540-y
   Blecher K, 2012, NANOMED-NANOTECHNOL, V8, P1364, DOI 10.1016/j.nano.2012.02.014
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Brisbois EJ, 2014, ACTA BIOMATER, V10, P4136, DOI 10.1016/j.actbio.2014.06.032
   Brisbois EJ, 2013, BIOMATERIALS, V34, P6957, DOI 10.1016/j.biomaterials.2013.05.063
   Burgaud JL, 2002, ANN NY ACAD SCI, V962, P360, DOI 10.1111/j.1749-6632.2002.tb04080.x
   Burke AJ, 2013, CARCINOGENESIS, V34, P503, DOI 10.1093/carcin/bgt034
   Burks PT, 2013, J AM CHEM SOC, V135, P18145, DOI 10.1021/ja408516w
   Cai WY, 2012, BIOMATERIALS, V33, P7933, DOI 10.1016/j.biomaterials.2012.07.027
   Carpenter AW, 2012, BIOMACROMOLECULES, V13, P3334, DOI 10.1021/bm301108x
   Carpenter AW, 2012, CHEM SOC REV, V41, P3742, DOI 10.1039/c2cs15273h
   Carpenter AW, 2011, ACS NANO, V5, P7235, DOI 10.1021/nn202054f
   Chang WL, 2015, POLYMER, V57, P70, DOI 10.1016/j.polymer.2014.12.020
   Chen SY, 2014, MAT SCI ENG C-MATER, V45, P491, DOI 10.1016/j.msec.2014.09.040
   Cheng HW, 2012, TOXICOL APPL PHARM, V264, P161, DOI 10.1016/j.taap.2012.07.029
   Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x
   Coneski PN, 2011, POLYM CHEM-UK, V2, P906, DOI 10.1039/c0py00269k
   Coneski PN, 2011, ACS APPL MATER INTER, V3, P426, DOI 10.1021/am101010e
   Cortivo R, 2010, NANOMEDICINE-UK, V5, P641, DOI 10.2217/NNM.10.32
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   Das DS, 2016, LEUKEMIA
   Simoes MMDG, 2010, J BIOMED MATER RES B, V93B, P416, DOI 10.1002/jbm.b.31598
   DeRosa F, 2007, J AM CHEM SOC, V129, P3786, DOI 10.1021/ja0686864
   Diring S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3684
   Do YS, 2004, RADIOLOGY, V230, P377, DOI 10.1148/radiol.2302020417
   Duan SF, 2012, BIOMATERIALS, V33, P3243, DOI 10.1016/j.biomaterials.2012.01.026
   Duan XB, 2002, BIOMATERIALS, V23, P1197, DOI 10.1016/S0142-9612(01)00234-4
   Duong HTT, 2015, SMALL, V11, P2291, DOI 10.1002/smll.201402870
   Duong HTT, 2014, BIOMACROMOLECULES, V15, P2583, DOI 10.1021/bm500422v
   Duong HTT, 2013, CHEM COMMUN, V49, P4190, DOI 10.1039/c2cc37181b
   Fleser PS, 2004, J VASC SURG, V40, P803, DOI 10.1016/j.jvs.2004.07.007
   Ford PC, 2013, NITRIC OXIDE-BIOL CH, V34, P56, DOI 10.1016/j.niox.2013.02.001
   Friedman A, 2011, VIRULENCE, V2, P217, DOI 10.4161/viru.2.3.16161
   Friedman AJ, 2008, NITRIC OXIDE-BIOL CH, V19, P12, DOI 10.1016/j.niox.2008.04.003
   Frost MC, 2003, MICROCHEM J, V74, P277, DOI 10.1016/S0026-265X(03)00033-X
   Frost MC, 2002, ANAL CHEM, V74, P5942, DOI 10.1021/ac025944g
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Fuseler JW, 2012, BIOMATERIALS, V33, P1032, DOI 10.1016/j.biomaterials.2011.10.029
   Gallo A, 2013, APPL SURF SCI, V279, P216, DOI 10.1016/j.apsusc.2013.04.072
   Gao J, 2013, CHEM COMMUN, V49, P9173, DOI 10.1039/c3cc45666h
   Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102
   Gappa-Fahlenkamp H, 2005, BIOMATERIALS, V26, P3479, DOI 10.1016/j.biomaterials.2004.09.028
   Garcia JV, 2012, SMALL, V8, P3800, DOI 10.1002/smll.201201213
   Georgii JL, 2011, J TISSUE ENG REGEN M, V5, P612, DOI 10.1002/term.353
   Ghanbari H, 2009, TRENDS BIOTECHNOL, V27, P359, DOI 10.1016/j.tibtech.2009.03.002
   Gifford R, 2005, J BIOMED MATER RES A, V75A, P755, DOI 10.1002/jbm.a.30359
   Grisham MB, 1999, AM J PHYSIOL-GASTR L, V276, pG315, DOI 10.1152/ajpgi.1999.276.2.G315
   Han G, 2012, AM J PATHOL, V180, P1465, DOI 10.1016/j.ajpath.2011.12.013
   Han G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007804
   Handa H, 2014, J MATER CHEM B, V2, P1059, DOI 10.1039/c3tb21771j
   He NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep10902
   Hetrick EM, 2007, BIOMATERIALS, V28, P1948, DOI 10.1016/j.biomaterials.2007.01.006
   Hetrick EM, 2009, BIOMATERIALS, V30, P2782, DOI 10.1016/j.biomaterials.2009.01.052
   Huang SL, 2009, J AM COLL CARDIOL, V54, P652, DOI 10.1016/j.jacc.2009.04.039
   Hwang S, 2008, BIOMATERIALS, V29, P2443, DOI 10.1016/j.biomaterials.2008.02.004
   IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6
   Jiang JM, 2002, CHINESE MED J-PEKING, V115, P968
   Jo YS, 2009, J AM CHEM SOC, V131, P14413, DOI 10.1021/ja905123t
   Johnson TA, 2010, NITRIC OXIDE-BIOL CH, V22, P30, DOI 10.1016/j.niox.2009.11.002
   Jones ML, 2010, APPL MICROBIOL BIOT, V88, P401, DOI 10.1007/s00253-010-2733-x
   Joslin JM, 2013, ACS APPL MATER INTER, V5, P9285, DOI 10.1021/am402112y
   Jun HW, 2005, BIOMACROMOLECULES, V6, P838, DOI 10.1021/bm049419y
   Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406
   Kang Y, 2015, J CONTROL RELEASE, V220, P624, DOI 10.1016/j.jconrel.2015.08.057
   Kanugula AK, 2014, FEBS J, V281, P3719, DOI 10.1111/febs.12893
   Kapadia MR, 2008, J VASC SURG, V47, P173, DOI 10.1016/j.jvs.2007.09.005
   Kashfi K, 2002, J PHARMACOL EXP THER, V303, P1273, DOI 10.1124/jpet.102.042754
   KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23
   Kaul S, 2000, J AM COLL CARDIOL, V35, P493, DOI 10.1016/S0735-1097(99)00543-4
   Kaur I, 2013, J PHARM PHARMACOL, V65, P1329, DOI 10.1111/jphp.12100
   Kim J, 2014, J MATER CHEM B, V2, P341, DOI 10.1039/c3tb21259a
   Kim JO, 2015, INT J BIOL MACROMOL, V79, P217, DOI 10.1016/j.ijbiomac.2015.04.073
   Kiziltepe T, 2007, BLOOD, V110, P709, DOI 10.1182/blood-2006-10-052845
   Koh A, 2013, ACS APPL MATER INTER, V5, P7956, DOI 10.1021/am402044s
   Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Kutner A., 2013, EXPERT REV DERMATOL, V8, P451
   Lala PK, 1998, CANCER METAST REV, V17, P91, DOI 10.1023/A:1005960822365
   Lam CF, 2003, TOXICOL APPL PHARM, V190, P65, DOI 10.1016/S0041-008X(03)00193-5
   Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036
   Li ZJ, 2009, J CELL BIOCHEM, V106, P194, DOI 10.1002/jcb.22003
   Lim DJ, 2014, INT J NANOMED, V9, P13, DOI 10.2147/IJN.S50873
   Lim SJ, 2002, INT J CANCER, V101, P243, DOI 10.1002/ijc.10596
   Lin CE, 2004, J MED CHEM, V47, P2276, DOI 10.1021/jm0304111
   Lipke EA, 2005, ACTA BIOMATER, V1, P597, DOI 10.1016/j.actbio.2005.07.010
   Liu TW, 2015, POLYM CHEM-UK, V6, P3305, DOI 10.1039/c5py00001g
   Liu VWT, 2008, CARDIOVASC RES, V77, P19, DOI 10.1016/j.cardiores.2007.06.024
   Lowe A, 2015, ACTA BIOMATER, V13, P121, DOI 10.1016/j.actbio.2014.11.032
   Lowe A, 2014, MATER LETT, V125, P221, DOI 10.1016/j.matlet.2014.03.174
   Lowe A, 2012, MACROMOLECULES, V45, P5894, DOI 10.1021/ma300913w
   Lu Y, 2015, ACTA BIOMATER, V12, P62, DOI 10.1016/j.actbio.2014.10.028
   Lu Y, 2014, BIOMATERIALS, V35, P1716, DOI 10.1016/j.biomaterials.2013.11.015
   Lu Y, 2013, BIOMACROMOLECULES, V14, P3589, DOI 10.1021/bm400961r
   Macherla C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00193
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   Major TC, 2010, BIOMATERIALS, V31, P2736, DOI 10.1016/j.biomaterials.2009.12.028
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   Marcilli RHM, 2014, COLLOID SURFACE B, V116, P643, DOI 10.1016/j.colsurfb.2013.10.036
   Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95
   Mascharak PK, 2012, INDIAN J CHEM A, V51, P99
   Michl TD, 2015, CHEM COMMUN, V51, P7058, DOI 10.1039/c5cc01722j
   Mihu MR, 2010, VIRULENCE, V1, P62, DOI 10.4161/viru.1.2.10038
   Miller MR, 2007, BRIT J PHARMACOL, V151, P305, DOI 10.1038/sj.bjb.0707224
   Mitchell-Koch JT, 2006, J POLYM SCI POL CHEM, V44, P2282, DOI 10.1002/pola.21314
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Munaweera I, 2015, J INORG BIOCHEM, V153, P23, DOI 10.1016/j.jinorgbio.2015.09.002
   Nablo BJ, 2005, BIOMATERIALS, V26, P4405, DOI 10.1016/j.biomaterials.2004.11.015
   Nablo BJ, 2005, BIOMATERIALS, V26, P6984, DOI 10.1016/j.biomaterials.2005.05.017
   Nablo BJ, 2005, BIOMATERIALS, V26, P917, DOI 10.1016/j.biomaterials.2004.03.031
   Nablo BJ, 2004, BIOMACROMOLECULES, V5, P2034, DOI 10.1021/bm049727w
   Nablo BJ, 2003, J BIOMED MATER RES A, V67A, P1276, DOI 10.1002/jbm.a.20030
   Naghavi N, 2013, SMALL, V9, P22, DOI 10.1002/smll.201200458
   Nichols SP, 2012, ADV DRUG DELIVER REV, V64, P1177, DOI 10.1016/j.addr.2012.03.002
   Nie Y, 2016, TURK J BIOL, V40, P316, DOI 10.3906/biy-1507-143
   Ning SC, 2012, CANCER RES, V72, P2600, DOI 10.1158/0008-5472.CAN-11-2303
   Nurhasni H, 2015, INT J NANOMED, V10, P3065, DOI 10.2147/IJN.S82199
   Ostrowski AD, 2009, DALTON T, P10660, DOI 10.1039/b912898k
   Pai RM, 2016, TOXICOL SCI, V151, P245, DOI 10.1093/toxsci/kfw037
   Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868
   Park J, 2013, BIOMATERIALS, V34, P8766, DOI 10.1016/j.biomaterials.2013.07.064
   Pearce CG, 2008, FREE RADICAL BIO MED, V44, P73, DOI 10.1016/j.frecradbiomed.2007.09.010
   Pegalajar-Jurado A, 2015, J CONTROL RELEASE, V217, P228, DOI 10.1016/j.jconrel.2015.09.015
   PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699
   Puiu SC, 2009, J BIOMED MATER RES B, V91B, P203, DOI 10.1002/jbm.b.31391
   Reid T, 2015, LANCET ONCOL, V16, P1133, DOI 10.1016/S1470-2045(15)00089-3
   Reighard KP, 2015, BIOFOULING, V31, P775, DOI 10.1080/08927014.2015.1107548
   Reighard KP, 2015, ANTIMICROB AGENTS CH, V59, P6506, DOI 10.1128/AAC.01208-15
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Ridnour LA, 2006, ANTIOXID REDOX SIGN, V8, P1329, DOI 10.1089/ars.2006.8.1329
   Riganti C, 2005, CANCER RES, V65, P516
   Rigas B, 2007, BIOCHEM SOC T, V35, P1364, DOI 10.1042/BST0351364
   Rizk M, 2004, WORLD J SURG, V28, P301, DOI 10.1007/s00268-003-7396-7
   Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s
   Schairer D, 2012, VIRULENCE, V3, P62, DOI 10.4161/viru.3.1.18816
   Schanuel FS, 2015, COLLOID SURFACE B, V130, P182, DOI 10.1016/j.colsurfb.2015.04.007
   Scharn DM, 2012, EUR J VASC ENDOVASC, V43, P66, DOI 10.1016/j.ejvs.2011.09.009
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   Seabra AB, 2007, BRIT J DERMATOL, V156, P814, DOI 10.1111/j.1365-2133.2006.07718.x
   Seabra AB, 2004, BRIT J DERMATOL, V151, P977, DOI 10.1111/j.1365-2133.2004.06213.x
   Seabra AB, 2008, ARTIF ORGANS, V32, P262, DOI 10.1111/j.1525-1594.2008.00540.x
   Seabra AB, 2015, BIOTECHNOL ADV, V33, P1370, DOI 10.1016/j.biotechadv.2015.01.005
   Serrano MC, 2011, MACROMOL BIOSCI, V11, P700, DOI 10.1002/mabi.201000509
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Sharma K, 2014, NITRIC OXIDE-BIOL CH, V43, P8, DOI 10.1016/j.niox.2014.07.005
   Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   SNYDER SH, 1992, SCIENCE, V257, P494, DOI 10.1126/science.1353273
   Sortino S, 2002, ANGEW CHEM INT EDIT, V41, P1914, DOI 10.1002/1521-3773(20020603)41:11<1914::AID-ANIE1914>3.0.CO;2-J
   Stasko NA, 2006, J AM CHEM SOC, V128, P8265, DOI 10.1021/ja060875z
   Stevens EV, 2010, MOL PHARMACEUT, V7, P775, DOI 10.1021/mp9002865
   Suzuki T, 2005, J AM CHEM SOC, V127, P11720, DOI 10.1021/ja0512024
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Taite LJ, 2011, CARDIOVASC ENG TECHN, V2, P113, DOI DOI 10.1007/S13239-011-0040-Z
   Taladriz-Blanco P, 2014, J PHOTOCH PHOTOBIO A, V293, P65, DOI 10.1016/j.jphotochem.2014.07.022
   Tan LJ, 2014, CHEM COMMUN, V50, P5725, DOI 10.1039/c4cc01126k
   Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020
   Tong JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080186
   Varu VN, 2009, VASC ENDOVASC SURG, V43, P121, DOI 10.1177/1538574408322752
   Vercelino R, 2013, J MATER SCI-MATER M, V24, P2157, DOI 10.1007/s10856-013-4973-7
   Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l
   Wang ZH, 2015, J CONTROL RELEASE, V210, P179, DOI 10.1016/j.jconrel.2015.05.283
   Weng YJ, 2011, BIOMATERIALS, V32, P1253, DOI 10.1016/j.biomaterials.2010.10.039
   Williams JL, 2001, CANCER RES, V61, P3285
   Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6
   Wink DA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P802
   Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711
   WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003
   Wink DA, 1997, J BIOL CHEM, V272, P11147
   WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007
   Wink DA, 2008, NITRIC OXIDE-BIOL CH, V19, P65, DOI 10.1016/j.niox.2008.05.003
   Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2
   Worley BV, 2015, MOL PHARMACEUT, V12, P1573, DOI 10.1021/acs.molpharmaceut.5b00006
   Wu B, 2007, BIOMATERIALS, V28, P4047, DOI 10.1016/j.biomaterials.2007.06.002
   Xu H, 2008, ORG LETT, V10, P4593, DOI 10.1021/ol801883f
   Xu ZQ, 2015, MATER CHEM PHYS, V162, P286, DOI 10.1016/j.matchemphys.2015.05.069
   Yang J, 2008, LANGMUIR, V24, P10265, DOI 10.1021/la801466e
   Yang Y, 2015, BIOSURF BIOTRIBOL, V1, P177
   Yang ZL, 2015, BIOMATERIALS, V63, P80, DOI 10.1016/j.biomaterials.2015.06.016
   Yao XP, 2015, BIOMATERIALS, V60, P130, DOI 10.1016/j.biomaterials.2015.04.046
   Yu SH, 2015, ACS MACRO LETT, V4, P1278, DOI 10.1021/acsmacrolett.5b00733
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhang QY, 2015, J BIOMED MATER RES A, V103, P929, DOI 10.1002/jbm.a.35239
   Zhang X, 2015, ADV FUNCT MATER, V25, P3049, DOI 10.1002/adfm.201404402
   Zhao HC, 2010, J BIOMED MATER RES A, V93A, P356, DOI 10.1002/jbm.a.32536
   Zhao Q, 2013, BIOMATERIALS, V34, P8450, DOI 10.1016/j.biomaterials.2013.07.045
   Zhou YJ, 2011, APPL SURF SCI, V258, P1776, DOI 10.1016/j.apsusc.2011.10.043
   Zhou ZR, 2005, BIOMATERIALS, V26, P6506, DOI 10.1016/j.biomaterials.2005.04.046
   Zhu HF, 2007, WORLD J SURG, V31, P624, DOI 10.1007/s00268-007-0727-3
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 208
TC 5
Z9 6
U1 25
U2 93
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2016
VL 23
IS 24
BP 2579
EP 2601
DI 10.2174/0929867323666160729104647
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA DU5QC
UT WOS:000382265400003
PM 27480214
DA 2018-10-20
ER

PT J
AU Lopes, HB
   Ferraz, EP
   Almeida, ALG
   Florio, P
   Gimenes, R
   Rosa, AL
   Beloti, MM
AF Lopes, Helena B.
   Ferraz, Emanuela P.
   Almeida, Adriana L. G.
   Florio, Pedro
   Gimenes, Rossano
   Rosa, Adalberto L.
   Beloti, Marcio M.
TI Participation of MicroRNA-34a and RANKL on bone repair induced by
   poly(vinylidene-trifluoroethylene)/barium titanate membrane
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Bone; biomaterial; microRNA; osteoclast; RANKL
ID IN-VITRO BIOCOMPATIBILITY; MESENCHYMAL STEM-CELLS; OSTEOCLAST
   DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; BARRIER MEMBRANES;
   REGENERATION; COMPOSITE; AUGMENTATION; DEFECTS; MOUSE
AB The poly(vinylidene-trifluoroethylene)/barium titanate (PVDF) membrane enhances in vitro osteoblast differentiation and in vivo bone repair. Here, we hypothesized that this higher bone repair could be also due to bone resorption inhibition mediated by a microRNA (miR)/RANKL circuit. To test our hypothesis, the large-scale miR expression of bone tissue grown on PVDF and polytetrafluoroethylene (PTFE) membranes was evaluated to identify potential RANKL-targeted miRs modulated by PVDF. The animal model used was rat calvarial defects implanted with either PVDF or PTFE. At 4 and 8weeks, the bone tissue grown on membranes was submitted to a large-scale analysis of miRs by microarray. The expression of miR-34a and some of its targets, including RANKL, were evaluated by real-time polimerase chain reaction and osteoclast activity was detected by tartrate-resistant acid phosphatase (TRAP) staining. Among more than 250 miRs, twelve, including miR-34a, were simultaneously higher expressed (2 fold) at 4 and 8weeks on PVDF. The higher expression of miR-34a was concomitant with a reduced expression of all its evaluated targets, including RANKL. Additionally, more TRAP-positive cells were observed in bone tissue grown on PTFE compared with PVDF in both time points. In conclusion, our results suggest that the higher bone formation induced by PVDF could be, at least in part, triggered by a miR-34a increase and RANKL decrease, which may inhibit osteoclast differentiation and activity, and bone resorption.
C1 [Lopes, Helena B.; Ferraz, Emanuela P.; Almeida, Adriana L. G.; Florio, Pedro; Rosa, Adalberto L.; Beloti, Marcio M.] Univ Sao Paulo, Sch Dent Ribeirao Preto, Cell Culture Lab, Ribeirao Preto, Brazil.
   [Gimenes, Rossano] Univ Fed Itajuba, Inst Chem & Phys, Itajuba, Brazil.
RP Beloti, MM (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Cell Culture Lab, Ribeirao Preto, Brazil.
EM mmbeloti@usp.br
RI Rosa, Adalberto/A-6314-2008; Ferraz, Emanuela/J-9441-2012
OI Rosa, Adalberto/0000-0002-6495-2778; Ferraz,
   Emanuela/0000-0001-6833-4865; Bacha Lopes, Helena/0000-0002-6998-5296
FU State of Sao Paulo Research Foundation (FAPESP, Brazil) [2011/10658-8,
   2011/13623-0, 2013/01622-5]; Minas Gerais State Research Foundation
   (FAPEMIG, Brazil) [TEC - APQ-03013-15]
FX This work was supported by State of Sao Paulo Research Foundation
   (FAPESP, Brazil) [grant number 2011/10658-8], [grant number
   2011/13623-0], [grant number 2013/01622-5] and Minas Gerais State
   Research Foundation (FAPEMIG, Brazil) [grant number TEC - APQ-03013-15].
CR Avtanski DB, 2015, ONCOTARGET, V6, P16396, DOI 10.18632/oncotarget.3844
   Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801
   Cheng P, 2013, J BONE MINER RES, V28, P1180, DOI 10.1002/jbmr.1845
   Dimitriou R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-81
   Dp B, 2004, CELL, V116, P281, DOI DOI 10.1016/S0092-8674(04)00045-5
   Gimenes R, 2004, P SOC PHOTO-OPT INS, V5385, P539, DOI 10.1117/12.548647
   Hammerle CHF, 2003, PERIODONTOL 2000, V33, P36, DOI 10.1046/j.0906-6713.2003.03304.x
   Hassan MQ, 2015, BONE, V81, P746, DOI 10.1016/j.bone.2015.05.026
   Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001
   JOVANOVIC SA, 1995, INT J PERIODONT REST, V15, P57
   Jung RE, 2009, CLIN ORAL IMPLAN RES, V20, P162, DOI 10.1111/j.1600-0501.2008.01634.x
   Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375
   Lee Y, 2013, BONE, V56, P383, DOI 10.1016/j.bone.2013.07.007
   Li JD, 2011, J BIOMAT SCI-POLYM E, V22, P263, DOI [10.1163/092050609X12602753096279, 10.1163/0920506O9XI2602753O96279]
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Lopes HB, 2014, J BIOMATER APPL, V29, P104, DOI 10.1177/0885328213515735
   Matsumoto G, 2012, INT J ORAL MAX IMPL, V27, P587
   Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006
   Qadir AS, 2015, J CELL BIOCHEM, V116, P730, DOI 10.1002/jcb.25026
   Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306
   Rowe MJ, 2016, J BIOMED MATER RES B, V104, P594, DOI 10.1002/jbm.b.33430
   Santos TD, 2015, J APPL ORAL SCI, V23, P623, DOI 10.1590/1678-775720150374
   Sanz-Sanchez I, 2015, J DENT RES, V94, p128S, DOI 10.1177/0022034515594780
   Sun F, 2014, J DENT RES, V93, P589, DOI 10.1177/0022034514531146
   Teixeira LN, 2011, J MATER SCI-MATER M, V22, P151, DOI 10.1007/s10856-010-4189-z
   Teixeira LN, 2010, ACTA BIOMATER, V6, P979, DOI 10.1016/j.actbio.2009.08.024
   Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0
   Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057
   Xie Q, 2016, BIOMATERIALS, V75, P279, DOI 10.1016/j.biomaterials.2015.10.042
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   Zhang J, 2012, FEBS LETT, V586, P3255, DOI 10.1016/j.febslet.2012.06.047
NR 31
TC 2
Z9 2
U1 3
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2016
VL 27
IS 13
BP 1369
EP 1379
DI 10.1080/09205063.2016.1203217
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA DS8TG
UT WOS:000381055300007
PM 27312544
DA 2018-10-20
ER

PT J
AU Bojarova, P
   Kren, V
AF Bojarova, P.
   Kren, V.
TI Sugared biomaterial binding lectins: achievements and perspectives
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID C-TYPE LECTINS; AMPHIPHILIC JANUS GLYCODENDRIMERS; BIOMEDICALLY RELEVANT
   LECTINS; PROTEIN-GLYCAN INTERACTIONS; HIGH-THROUGHPUT DETECTION;
   HIGH-AFFINITY; QUANTUM DOTS; GOLD NANOPARTICLES;
   CARBOHYDRATE-RECOGNITION; CHEMOENZYMATIC SYNTHESIS
AB Lectins, a distinct group of glycan-binding proteins, play a prominent role in the immune system ranging from pathogen recognition and tuning of inflammation to cell adhesion or cellular signalling. The possibilities of their detailed study expanded along with the rapid development of biomaterials in the last decade. The immense knowledge of all aspects of glycan-lectin interactions both in vitro and in vivo may be efficiently used in bioimaging, targeted drug delivery, diagnostic and analytic biological methods. Practically applicable examples comprise photoluminescence and optical biosensors, ingenious three-dimensional carbohydrate microarrays for high-throughput screening, matrices for magnetic resonance imaging, targeted hyperthermal treatment of cancer tissues, selective inhibitors of bacterial toxins and pathogen-recognising lectin receptors, and many others. This review aims to present an up-to-date systematic overview of glycan-decorated biomaterials promising for interactions with lectins, especially those applicable in biology, biotechnology or medicine. The lectins of interest include galectin-1, -3 and -7 participating in tumour progression, bacterial lectins from Pseudomonas aeruginosa (PA-IL), E. coli (Fim-H) and Clostridium botulinum (HA33) or DC-SIGN, receptors of macrophages and dendritic cells. The spectrum of lectin-binding biomaterials covered herein ranges from glycosylated organic structures, calixarene and fullerene cores over glycopeptides and glycoproteins, functionalised carbohydrate scaffolds of cyclodextrin or chitin to self-assembling glycopolymer clusters, gels, micelles and liposomes. Glyconanoparticles, glycan arrays, and other biomaterials with a solid core are described in detail, including inorganic matrices like hydroxyapatite or stainless steel for bioimplants.
C1 [Bojarova, P.; Kren, V.] Acad Sci Czech Republic, Inst Microbiol, Lab Biotransformat, Videnska 1083, CZ-14220 Prague 4, Czech Republic.
RP Bojarova, P (reprint author), Acad Sci Czech Republic, Inst Microbiol, Lab Biotransformat, Videnska 1083, CZ-14220 Prague 4, Czech Republic.
EM bojarova@biomed.cas.cz
RI Bojarova, Pavla/R-4742-2017; Kren, Vladimir/H-8461-2014
OI Bojarova, Pavla/0000-0001-7069-0973; 
FU Czech Science Foundation [15-02578J]; COST Action Chemistry
   "MultiGlycoNano" [CM1102]
FX This study was supported by the project no. 15-02578J of the Czech
   Science Foundation and by COST Action Chemistry CM1102 "MultiGlycoNano".
   We would like to thank Dr Christopher S. Chambers, Inst. Microbiol.,
   Prague, for language revision.
CR Adamiak K, 2012, J MOL CATAL B-ENZYM, V84, P108, DOI 10.1016/j.molcatb.2012.02.002
   Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200
   Andre S, 2008, CHEMBIOCHEM, V9, P1649, DOI 10.1002/cbic.200800035
   Andre S, 2015, ORG BIOMOL CHEM, V13, P4190, DOI 10.1039/c5ob00048c
   Andre S, 2015, BIOORG MED CHEM LETT, V25, P931, DOI 10.1016/j.bmcl.2014.12.049
   Arigi E, 2012, GLYCOCONJUGATE J, V29, P1, DOI 10.1007/s10719-011-9359-9
   Arosio D, 2005, J AM CHEM SOC, V127, P3660, DOI 10.1021/jp0444029
   Astorgues-Xerri L, 2014, CANCER TREAT REV, V40, P307, DOI 10.1016/j.ctrv.2013.07.007
   Aykac A, 2014, LANGMUIR, V30, P234, DOI 10.1021/la403454p
   Baradel N, 2013, ANGEW CHEM INT EDIT, V52, P2335, DOI 10.1002/anie.201209052
   BARONDES SH, 1988, TRENDS BIOCHEM SCI, V13, P480, DOI 10.1016/0968-0004(88)90235-6
   Becer CR, 2010, J AM CHEM SOC, V132, P15130, DOI 10.1021/ja1056714
   Beckmann HSG, 2012, CHEM-EUR J, V18, P6548, DOI 10.1002/chem.201200382
   Bernardi S, 2014, BEILSTEIN J ORG CHEM, V10, P1672, DOI 10.3762/bjoc.10.175
   Biswas S, 2015, CARBOHYD RES, V405, P93, DOI 10.1016/j.carres.2014.11.002
   Blanchard H, 2014, AUST J CHEM, V67, P1763, DOI 10.1071/CH14362
   Blixt O, 2008, J AM CHEM SOC, V130, P6680, DOI [10.1021/ja801052g, 10.1021/ja80l052g]
   Blomqvist L., 2009, Can. Pat, Patent No. [2731642A1, 2731642]
   Bojarova P, 2013, CHEM SOC REV, V42, P4774, DOI 10.1039/c2cs35395d
   Bonduelle C, 2013, FARADAY DISCUSS, V166, P137, DOI 10.1039/c3fd00082f
   Bouffard E, 2015, CURR MED CHEM, V22, P3014, DOI 10.2174/0929867322666150805103104
   BOYD WC, 1954, PROTEINS, V2, P756
   Branderhorst HM, 2008, CHEMBIOCHEM, V9, P1836, DOI 10.1002/cbic.200800195
   Cagnoni AJ, 2014, J ORG CHEM, V79, P6456, DOI 10.1021/jo500883v
   Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x
   Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025
   Cecioni S., 2012, World Pat, Patent No. [2012076934A1, 2012076934]
   Cecioni S, 2015, CHEM REV, V115, P525, DOI 10.1021/cr500303t
   Cecioni S, 2009, CHEM-EUR J, V15, P13232, DOI 10.1002/chem.200901799
   Celik E, 2015, BIOTECHNOL J, V10, P199, DOI 10.1002/biot.201400354
   Chabre YM, 2013, CHEM SOC REV, V42, P4657, DOI 10.1039/c3cs35483k
   Chmielewski MJ, 2014, CHEM-EUR J, V20, P6960, DOI 10.1002/chem.201304511
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Cholleti SR, 2012, OMICS, V16, P497, DOI 10.1089/omi.2012.0013
   Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004
   Conolly S., 2005, US Pat, Patent No. [20050261575A1, 20050261575]
   Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056
   Dal Bo AG, 2014, CARBOHYD RES, V397, P31, DOI 10.1016/j.carres.2014.07.021
   Dal Bo AG, 2012, LANGMUIR, V28, P1418, DOI 10.1021/la204388h
   Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002
   Das S, 2012, BIOMACROMOLECULES, V13, P3695, DOI 10.1021/bm301170u
   Daskhan GC, 2015, CARBOHYD RES, V405, P13, DOI 10.1016/j.carres.2014.07.017
   Deniaud D, 2011, ORG BIOMOL CHEM, V9, P966, DOI 10.1039/c0ob00389a
   Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003
   Drozdova A, 2011, CARBOHYD RES, V346, P1599, DOI 10.1016/j.carres.2011.04.043
   Eissa AM, 2013, J POLYM SCI POL CHEM, V51, P5184, DOI 10.1002/pola.26959
   Eissa AM, 2013, ADV POLYM SCI, V253, P71, DOI 10.1007/12_2012_177
   El-Boubbou K, 2010, J AM CHEM SOC, V132, P4490, DOI 10.1021/ja100455c
   Engering A, 2002, TRENDS IMMUNOL, V23, P480, DOI 10.1016/S1471-4906(02)02296-2
   Francois-Heude M, 2015, CHEM-EUR J, V21, P1978, DOI 10.1002/chem.201405481
   Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735
   Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005
   Garcia-Hartjes J, 2013, ORG BIOMOL CHEM, V11, P4340, DOI 10.1039/c3ob40515j
   Garcia-Vallejo JJ, 2013, MOL IMMUNOL, V53, P387, DOI 10.1016/j.molimm.2012.09.012
   Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   Geng J, 2011, MACROMOLECULES, V44, P4276, DOI 10.1021/ma200343q
   Gening ML, 2013, CHEM-EUR J, V19, P9272, DOI 10.1002/chem.201300135
   Godula K, 2010, J AM CHEM SOC, V132, P9963, DOI 10.1021/ja103009d
   Gomez-Garcia M, 2012, J ORG CHEM, V77, P1273, DOI 10.1021/jo201797b
   Gorityala BK, 2012, J AM CHEM SOC, V134, P15229, DOI 10.1021/ja306288p
   Gorityala BK, 2010, CHEM SOC REV, V39, P2925, DOI 10.1039/b919525b
   Groman E. V., 2013, US Pat, Patent No. [8501158B2, 8501158]
   Grunstein D, 2011, J AM CHEM SOC, V133, P13957, DOI 10.1021/ja2036767
   Hao NJ, 2016, BIOSENS BIOELECTRON, V76, P113, DOI 10.1016/j.bios.2015.07.031
   Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103
   HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297
   Hu J, 2011, BIOMATERIALS, V32, P1177, DOI 10.1016/j.biomaterials.2010.10.015
   Huang GL, 2014, CURR MED CHEM, V21, P288
   Huang KT, 2011, CHEMBIOCHEM, V12, P56, DOI 10.1002/cbic.201000567
   Ishii T, 2016, CHEM COMMUN, V52, P1517, DOI 10.1039/c5cc06661a
   Jacobs J, 2014, MACROMOLECULES, V47, P7303, DOI 10.1021/ma5020462
   Jiang XZ, 2009, BIOCONJUGATE CHEM, V20, P994, DOI 10.1021/bc800566f
   Jin Y, 2016, J COLLOID INTERF SCI, V462, P19, DOI 10.1016/j.jcis.2015.09.047
   Kato T, 2010, BIOCHEM BIOPH RES CO, V394, P200, DOI 10.1016/j.bbrc.2010.02.155
   Kauscher U, 2012, BEILSTEIN J ORG CHEM, V8, P1543, DOI 10.3762/bjoc.8.175
   Kawakami S, 2014, J CONTROL RELEASE, V190, P542, DOI 10.1016/j.jconrel.2014.06.001
   Kletter D., 2013, CURR PROTOCOLS CHEM, V5, P1, DOI DOI 10.1002/9780470559277.CH130028
   Kohri M, 2011, EUR POLYM J, V47, P2351, DOI 10.1016/j.eurpolymj.2011.09.016
   Kolusheva S, 2000, NAT BIOTECHNOL, V18, P225, DOI 10.1038/72697
   Kumar J, 2011, MACROMOL RAPID COMM, V32, P1620, DOI 10.1002/marc.201100331
   Lartigue L, 2011, J AM CHEM SOC, V133, P10459, DOI 10.1021/ja111448t
   Liang K, 2012, BIOCONJUGATE CHEM, V23, P1300, DOI 10.1021/bc300142s
   Liao JF, 2012, CURR PHARM DESIGN, V18, P3432, DOI 10.2174/138161212801227050
   Liau WT, 2015, BIOMACROMOLECULES, V16, P284, DOI 10.1021/bm501482q
   Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x
   Liu XO, 2007, COLLOID SURFACE B, V58, P3, DOI 10.1016/j.colsurfb.2006.08.005
   Liu Y, 2009, BIOL CHEM, V390, P647, DOI 10.1515/BC.2009.071
   Lowe AB, 2003, POLYMER, V44, P6761, DOI 10.1016/j.polymer.2003.08.039
   Luczkowiak J, 2013, BIOMACROMOLECULES, V14, P431, DOI 10.1021/bm3016658
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823
   Maeda H, 2012, J CONTROL RELEASE, V164, P138, DOI 10.1016/j.jconrel.2012.04.038
   Maglinao M, 2014, J CONTROL RELEASE, V175, P36, DOI 10.1016/j.jconrel.2013.12.011
   Magnani J. L., 2010, U. S. Pat, Patent No. [20100041626A1, 20100041626]
   Maljaars CEP, 2008, BIOSENS BIOELECTRON, V24, P60, DOI 10.1016/j.bios.2008.03.014
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Maupin KA, 2012, GLYCOBIOLOGY, V22, P160, DOI 10.1093/glycob/cwr128
   Michel AK, 2014, CHEMBIOCHEM, V15, P2106, DOI 10.1002/cbic.201402134
   Mrazek H, 2013, BIOTECHNOL ADV, V31, P17, DOI 10.1016/j.biotechadv.2012.03.008
   Munoz A, 2016, NAT CHEM, V8, P50, DOI [10.1038/nchem.2387, 10.1038/NCHEM.2387]
   Munoz-Bonilla A, 2012, J POLYM SCI POL CHEM, V50, P5087, DOI 10.1002/pola.26367
   Nagae M, 2014, INT J MOL SCI, V15, P3768, DOI 10.3390/ijms15033768
   Napoletano C, 2012, EUR J IMMUNOL, V42, P936, DOI 10.1002/eji.201142086
   Ng S, 2015, J AM CHEM SOC, V137, P5248, DOI 10.1021/ja511237n
   Nierengarten I, 2014, CHEM-ASIAN J, V9, P1436, DOI 10.1002/asia.201400133
   Novoa A, 2014, CHEMBIOCHEM, V15, P2058, DOI 10.1002/cbic.201402280
   Nycholat CM, 2013, J AM CHEM SOC, V135, P18280, DOI 10.1021/ja409781c
   Ohno K, 1998, J POLYM SCI POL CHEM, V36, P2473, DOI 10.1002/(SICI)1099-0518(199810)36:14<2473::AID-POLA5>3.0.CO;2-U
   Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041
   Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021
   Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b
   Pati D, 2012, J AM CHEM SOC, V134, P7796, DOI 10.1021/ja300065f
   Paulson J., 2007, World Pat, Patent No. [2007056525A2, 2007056525]
   Pei DF, 2015, COLLOID SURFACE B, V127, P130, DOI 10.1016/j.colsurfb.2015.01.032
   Pei DF, 2015, COLLOID SURFACE B, V126, P367, DOI 10.1016/j.colsurfb.2014.11.046
   Percec V, 2013, J AM CHEM SOC, V135, P9055, DOI 10.1021/ja403323y
   Leal MP, 2011, CHEM-EUR J, V17, P1828, DOI 10.1002/chem.201002236
   Pfaff A, 2011, BIOMACROMOLECULES, V12, P3805, DOI 10.1021/bm201051p
   Plante OJ, 2003, CURR OPIN DRUG DI DE, V6, P521
   Ponader D, 2014, J AM CHEM SOC, V136, P2008, DOI 10.1021/ja411582t
   Ponader D, 2012, BIOMACROMOLECULES, V13, P1845, DOI 10.1021/bm300331z
   Pugliese G, 2015, GLYCOBIOLOGY, V25, P136, DOI 10.1093/glycob/cwu111
   Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536
   Ramaswamy S, 2015, FEBS J, V282, P372, DOI 10.1111/febs.13140
   Rangin M, 2004, J AM CHEM SOC, V126, P5038, DOI 10.1021/ja039822x
   Rech C, 2011, ADV SYNTH CATAL, V353, P2492, DOI 10.1002/adsc.201100375
   REED MA, 1988, PHYS REV LETT, V60, P535, DOI 10.1103/PhysRevLett.60.535
   Reymond JL, 2012, ORG BIOMOL CHEM, V10, P1483, DOI 10.1039/c2ob06938e
   Reynolds M, 2012, CHEM-EUR J, V18, P4264, DOI 10.1002/chem.201102034
   Ribeiro-Viana R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2302
   Richards SJ, 2012, ANGEW CHEM INT EDIT, V51, P7812, DOI 10.1002/anie.201202945
   Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236
   Russo L, 2014, CARBOHYD RES, V389, P12, DOI 10.1016/j.carres.2013.11.008
   Russo L, 2011, CARBOHYD RES, V346, P1564, DOI 10.1016/j.carres.2011.04.044
   Sansone F, 2013, CHEM SOC REV, V42, P4623, DOI 10.1039/c2cs35437c
   Sattin S, 2010, ACS CHEM BIOL, V5, P301, DOI 10.1021/cb900216e
   Sauerzapfe B, 2009, GLYCOCONJUGATE J, V26, P141, DOI 10.1007/s10719-008-9172-2
   Saussez S, 2006, CELL MOL LIFE SCI, V63, P686, DOI 10.1007/s00018-005-5458-8
   Schellenberger E., 2009, Eur. Pat, Patent No. [2022508A1, 2022508]
   Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899
   Selvaprakash K, 2014, BIOSENS BIOELECTRON, V61, P88, DOI 10.1016/j.bios.2014.04.055
   Simonova A, 2014, J MOL CATAL B-ENZYM, V101, P47, DOI 10.1016/j.molcatb.2013.12.018
   Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y
   Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3
   Song L, 2014, CLIN CHIM ACTA, V431, P185, DOI 10.1016/j.cca.2014.01.019
   Song XZ, 2014, CURR OPIN CHEM BIOL, V18, P70, DOI 10.1016/j.cbpa.2014.01.001
   Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540
   Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119
   Song XZ, 2009, ACS CHEM BIOL, V4, P741, DOI 10.1021/cb900067h
   Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004
   Soomro ZH, 2011, ORG BIOMOL CHEM, V9, P6587, DOI 10.1039/c1ob05676j
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Tan YH, 2013, NEW J CHEM, V37, P2150, DOI 10.1039/c3nj00253e
   Tong Q, 2012, ANAL CHEM, V84, P3049, DOI 10.1021/ac203455b
   Tsutsumi H, 2012, BIOORG MED CHEM LETT, V22, P6825, DOI 10.1016/j.bmcl.2012.09.051
   Valtola L, 2014, EUR POLYM J, V59, P282, DOI 10.1016/j.eurpolymj.2014.07.031
   van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203
   Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008
   Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146
   Vazquez-Dorbatt V, 2012, CHEMBIOCHEM, V13, P2478, DOI 10.1002/cbic.201200480
   Vincent SP, 2016, CHEM-EUR J, V22, P88, DOI 10.1002/chem.201504110
   Voskuhl J, 2010, CHEM-EUR J, V16, P2790, DOI 10.1002/chem.200902423
   Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106
   Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275
   Wang H, 2013, BIOORGAN MED CHEM, V21, P2037, DOI 10.1016/j.bmc.2013.01.028
   Wang JX, 2011, ORG BIOMOL CHEM, V9, P2219, DOI 10.1039/c0ob00680g
   Wang Z, 2013, SCIENCE, V341, P379, DOI 10.1126/science.1236231
   Watanabe S, 2010, COLLOID SURFACE B, V81, P570, DOI 10.1016/j.colsurfb.2010.07.061
   Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x
   Weng CI, 2015, BIOSENS BIOELECTRON, V68, P1, DOI 10.1016/j.bios.2014.12.028
   Wittmann V, 2013, CHEM SOC REV, V42, P4492, DOI 10.1039/c3cs60089k
   Xuan PF, 2012, GLYCOBIOLOGY, V22, P552, DOI 10.1093/glycob/cwr163
   Yang Q, 2011, MACROMOLECULES, V44, P1303, DOI 10.1021/ma1025972
   Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719
   Yang Y, 2012, TETRAHEDRON, V68, P7148, DOI 10.1016/j.tet.2012.06.035
   Yau T, 2015, MOLECULES, V20, P3791, DOI 10.3390/molecules20033791
   Yilmaz G, 2013, EUR POLYM J, V49, P3046, DOI 10.1016/j.eurpolymj.2013.06.001
   Zamfir L., 2012, NAT COMMUN, V3, P1138
   Zhang Q, 2013, ANGEW CHEM INT EDIT, V52, P4435, DOI 10.1002/anie.201300068
   Zhang SD, 2015, J AM CHEM SOC, V137, P13334, DOI 10.1021/jacs.5b08844
   Zhang SD, 2015, ANGEW CHEM INT EDIT, V54, P4036, DOI 10.1002/anie.201410882
   Zhang SD, 2014, ANGEW CHEM INT EDIT, V53, P10899, DOI 10.1002/anie.201403186
   Zhou J, 2014, BIOCONJUGATE CHEM, V25, P640, DOI 10.1021/bc500004c
NR 184
TC 14
Z9 14
U1 18
U2 82
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2016
VL 4
IS 8
BP 1142
EP 1160
DI 10.1039/c6bm00088f
PG 19
WC Materials Science, Biomaterials
SC Materials Science
GA DS6MH
UT WOS:000380895500001
PM 27075026
OA Bronze
DA 2018-10-20
ER

PT J
AU Huang, SS
   Liang, NY
   Hu, Y
   Zhou, X
   Abidi, N
AF Huang, Shishu
   Liang, Nuanyi
   Hu, Yang
   Zhou, Xin
   Abidi, Noureddine
TI Polydopamine-Assisted Surface Modification for Bone Biosubstitutes
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID GLY-ASP PEPTIDES; IN-VITRO; HYDROXYAPATITE NANOPARTICLES; INSPIRED
   COATINGS; MUSSEL ADHESIVE; TITANIUM-ALLOY; MYTILUS-EDULIS;
   CELL-ADHESION; CROSS-LINKING; SOLID-STATE
AB Polydopamine (PDA) prepared in the form of a layer of polymerized dopamine (DA) in a weak alkaline solution has been used as a versatile biomimetic surface modifier as well as a broadly used immobilizing macromolecule. This review mainly discusses the progress of biomaterial surface modification inspired by the participation of PDA in bone tissue engineering. A comparison between PDA-assisted coating techniques and traditional surface modification applied to bone tissue engineering is first presented. Secondly, the chemical composition and the underlying formation mechanism of PDA coating layer as a unique surface modifier are interpreted and discussed. Furthermore, several typical examples are provided to evidence the importance of PDA-assisted coating techniques in the construction of bone biosubstitutes and the improvement of material biocompatibility. Nowadays, the application of PDA as a superior surface modifier in multifunctional biomaterials is drawing tremendous interests in bone tissue scaffolds to promote the osteointegration for bone regeneration.
C1 [Huang, Shishu] Sichuan Univ, West China Hosp, Dept Orthoped Surg, Chengdu 610041, Sichuan, Peoples R China.
   [Liang, Nuanyi; Hu, Yang; Zhou, Xin] Chinese Acad Sci, Ctr Human Tissues & Organs Degenerat, Shenzhen 518055, Guangdong, Peoples R China.
   [Liang, Nuanyi; Hu, Yang; Zhou, Xin] Chinese Acad Sci, Shenzhen Key Lab Marine Biomed Mat, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.
   [Hu, Yang; Abidi, Noureddine] Texas Tech Univ, Dept Plant & Soil Sci, Fiber & Biopolymer Res Inst, Lubbock, TX 79409 USA.
RP Hu, Y (reprint author), Chinese Acad Sci, Ctr Human Tissues & Organs Degenerat, Shenzhen 518055, Guangdong, Peoples R China.; Hu, Y (reprint author), Chinese Acad Sci, Shenzhen Key Lab Marine Biomed Mat, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.; Hu, Y (reprint author), Texas Tech Univ, Dept Plant & Soil Sci, Fiber & Biopolymer Res Inst, Lubbock, TX 79409 USA.
EM yang.hu@ttu.edu
OI Zuo, Wangda/0000-0003-2102-5592
FU Natural Science Foundation of China [31570967, 31370978, 81472078];
   Shenzhen Science and Technology Program [JCYJ20140610152828698];
   Shenzhen Key Laboratory of Marine Biomedical Materials
   [ZDSY20130401165820356]
FX This work was supported by the Natural Science Foundation of China
   (31570967, 31370978, and 81472078), the Shenzhen Science and Technology
   Program (JCYJ20140610152828698), and the Shenzhen Key Laboratory of
   Marine Biomedical Materials (ZDSY20130401165820356).
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Burchill LJ, 2012, FUTUR CARDIOL, V8, P329, DOI [10.2217/fca.12.11, 10.2217/FCA.12.11]
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Cai YL, 2014, COLLOID SURFACE B, V116, P681, DOI 10.1016/j.colsurfb.2013.11.004
   Chen SG, 2009, ELECTROCHEM COMMUN, V11, P1675, DOI 10.1016/j.elecom.2009.06.021
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Chien CY, 2013, J BIOMED MATER RES A, V101, P740, DOI 10.1002/jbm.a.34376
   Chien HW, 2012, ACTA BIOMATER, V8, P3678, DOI 10.1016/j.actbio.2012.06.033
   Cho HJ, 2014, ACS APPL MATER INTER, V6, P11225, DOI 10.1021/am501391z
   CLARK MB, 1990, ANAL CHEM, V62, P949, DOI 10.1021/ac00208a011
   d'Ischia M, 2014, ACCOUNTS CHEM RES, V47, P3541, DOI 10.1021/ar500273y
   d'Ischia M, 2011, EUR J ORG CHEM, P5501, DOI 10.1002/ejoc.201100796
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001
   DIEHL DJ, 1992, COMPR PSYCHIAT, V33, P115, DOI 10.1016/0010-440X(92)90007-D
   Dreyer DR, 2013, CHEM SCI, V4, P3796, DOI 10.1039/c3sc51501j
   Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b
   Gao X, 2016, ACS APPL MATER INTER, V8, P3499, DOI 10.1021/acsami.5b12413
   Ge LP, 2016, J BIOMATER APPL, V30, P1385, DOI 10.1177/0885328216628469
   Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044
   He JA, 2011, MACROMOLECULES, V44, P2245, DOI 10.1021/ma1029532
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012
   Hong S, 2011, NANOMEDICINE-UK, V6, P793, DOI [10.2217/nnm.11.76, 10.2217/NNM.11.76]
   Hu Y, 2016, J MATER CHEM B, V4, P1235, DOI 10.1039/c5tb02091c
   Jaganathan SK, 2014, BIOMED RES INT, DOI 10.1155/2014/459465
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Judeinstein P, 1996, J MATER CHEM, V6, P511, DOI 10.1039/jm9960600511
   Jun DR, 2014, COLLOID SURFACE B, V121, P395, DOI 10.1016/j.colsurfb.2014.06.027
   Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028
   Kang SM, 2009, J AM CHEM SOC, V131, P13224, DOI 10.1021/ja905183k
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kim E, 2014, ACS APPL MATER INTER, V6, P8288, DOI 10.1021/am5011095
   Kim TH, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025008
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Li WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150294
   Liebscher J, 2013, LANGMUIR, V29, P10539, DOI 10.1021/la4020288
   Liu HR, 2015, MAT SCI ENG C-MATER, V49, P14, DOI 10.1016/j.msec.2014.12.064
   Liu QZ, 2012, LANGMUIR, V28, P5845, DOI 10.1021/la300187q
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Luo RF, 2013, ACS APPL MATER INTER, V5, P1704, DOI 10.1021/am3027635
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x
   Molzahn Anita E, 2003, Nephrol Nurs J, V30, P17
   Mrowczynski R, 2013, MATER CHEM PHYS, V138, P295, DOI 10.1016/j.matchemphys.2012.11.059
   Nijhuis AWG, 2013, TISSUE ENG PART C-ME, V19, P610, DOI [10.1089/ten.tec.2012.0313, 10.1089/ten.TEC.2012.0313]
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pan HT, 2014, J BIOMED MATER RES A, V102, P4526, DOI 10.1002/jbm.a.35129
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   PATIL AO, 1986, MOL CRYST LIQ CRYST, V134, P279, DOI 10.1080/00268948608079591
   Perikamana SKM, 2015, ACS APPL MATER INTER, V7, P8798, DOI 10.1021/acsami.5b01340
   Peterson MB, 2014, MACROMOL RAPID COMM, V35, P291, DOI 10.1002/marc.201300746
   Pezzella A, 2009, J AM CHEM SOC, V131, P15270, DOI 10.1021/ja905162s
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259
   Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949
   Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347
   SCHEFFER JR, 1985, J AM CHEM SOC, V107, P4898, DOI 10.1021/ja00303a014
   Schmitt L, 2000, BIOPHYS J, V78, P3275, DOI 10.1016/S0006-3495(00)76863-9
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   Shalev T, 2012, J MATER CHEM, V22, P2026, DOI 10.1039/c1jm13994k
   Shen WX, 2012, COLLOID SURFACE B, V94, P347, DOI 10.1016/j.colsurfb.2012.02.009
   SUGUMARAN M, 1989, ARCH INSECT BIOCHEM, V11, P127, DOI 10.1002/arch.940110206
   Sun K, 2012, LANGMUIR, V28, P2131, DOI 10.1021/la2041967
   Sun K, 2011, LANGMUIR, V27, P5709, DOI 10.1021/la2012099
   Terrill H. C., 2015, OPTIMIZATION POLYDOP
   Tsai WB, 2011, ACTA BIOMATER, V7, P2518, DOI 10.1016/j.actbio.2011.03.010
   Vanderleyden E, 2014, MAT SCI ENG C-MATER, V42, P396, DOI 10.1016/j.msec.2014.05.048
   Velard F, 2010, BIOMATERIALS, V31, P2001, DOI 10.1016/j.biomaterials.2009.11.066
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wei Q, 2011, J BIOMED MATER RES A, V96A, P38, DOI 10.1002/jbm.a.32956
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
   Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j
   Yu F, 2010, J MOL STRUCT, V982, P152, DOI 10.1016/j.molstruc.2010.08.021
   Yu XH, 2014, RSC ADV, V4, P7185, DOI 10.1039/c3ra44137g
   Zhang AJ, 2012, SCI CHINA CHEM, V55, P830, DOI 10.1007/s11426-012-4504-2
   Zhang ZS, 1996, INORG CHEM, V35, P1571, DOI 10.1021/ic941303v
   Zhou P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113087
   Zhou WH, 2010, BIOSENS BIOELECTRON, V26, P585, DOI 10.1016/j.bios.2010.07.024
NR 100
TC 13
Z9 13
U1 7
U2 72
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 2389895
DI 10.1155/2016/2389895
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA DU2MN
UT WOS:000382045300001
PM 27595097
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Gantar, A
   Drnovsek, N
   Casuso, P
   Perez-San Vicente, A
   Rodriguez, J
   Dupin, D
   Novak, S
   Loinaz, I
AF Gantar, Ana
   Drnovsek, Natasa
   Casuso, Pablo
   Perez-San Vicente, Adrian
   Rodriguez, Javier
   Dupin, Damien
   Novak, Sasa
   Loinaz, Iraida
TI Injectable and self-healing dynamic hydrogel containing bioactive glass
   nanoparticles as a potential biomaterial for bone regeneration
SO RSC ADVANCES
LA English
DT Article
ID IN-VITRO CHARACTERIZATION; MECHANICAL-PROPERTIES; POLYMER NETWORKS;
   TISSUE; COMPOSITES; PARTICLES; DEFECTS; SYSTEMS; ABILITY
AB Combination of an Au-based 4-arms thiol terminated poly(ethylene glycol) [Au-(PEGSH)(4)] dynamic hydrogel exhibiting self-healing ability with 100 nm bioactive glass (BAG) nanoparticles agglomerated in 10 mm clusters, produced via a particulate sol-gel method, resulted in the formation of hydrogel nanocomposites [Au-(PEGSH)(4)-BAG] with enhanced properties. Au-(PEGSH)(4)-BAG hydrogel nanocomposites were prepared by injecting simultaneously an aqueous solution of a (PEGSH)(4) homopolymer containing different amounts of BAG nanoparticles with an aqueous solution of HAuCl4 using a double barrel syringe. Electron microscopy studies suggested that the clusters of inorganic particles were homogeneously distributed into the polymeric matrix. Rheology studies demonstrated that stiffer hydrogels were obtained after the addition of BAG nanoparticles. The presence of the inorganic colloids appeared to affect slightly the dynamic character of the pristine hydrogel by slowing down the exchange reaction between gold-thiolate (Au-S) and disulfides (SS). Despite slower Au-S/SS exchange, the resulting hydrogel nanocomposites were still exhibiting pH-dependent properties and self-healing abilities, as judged by frequency sweep experiments. In addition, compression tests demonstrated the major drawbacks of each individual material, i.e. brittleness for BAG nanoparticles and weak consistency for Au-(PEGSH)(4), were suppressed to result in a material composite with high resistance to stress and relatively large deformation ability. Moreover, the slow diffusion inside the 3D matrix allowed the degradation of the BAG nanoparticles to be delayed as well as the pH to be maintained around physiological values. For the same reason, the incorporation of those BAG nanoparticles into the dynamic hydrogel proved to reduce the cytotoxicity of the organic particles. Finally, in vitro degradation of BAG nanoparticles embedded in the dynamic hydrogel led to the formation of hydroxyapatite. As a result, osteoinductive properties could be anticipated for the Au-(PEGSH)(4)-BAG hydrogel nanocomposite which allows this new injectable and self-healing dynamic biomaterial to be considered as a scaffold to induce and promote bone self-repair.
C1 [Gantar, Ana; Drnovsek, Natasa; Novak, Sasa] Jozef Stefan Inst, Dept Nanostruct Mat, Ljubljana, Slovenia.
   [Gantar, Ana; Novak, Sasa] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia.
   [Casuso, Pablo; Perez-San Vicente, Adrian; Rodriguez, Javier; Dupin, Damien; Loinaz, Iraida] IK4 CIDETEC Res Ctr, Div Mat, Paseo Miramon 196, Donostia San Sebastian 20009, Spain.
RP Dupin, D (reprint author), IK4 CIDETEC Res Ctr, Div Mat, Paseo Miramon 196, Donostia San Sebastian 20009, Spain.
EM ddupin@cidetec.es
FU Slovenian Research Agency
FX The Slovenian Research Agency is acknowledged for financially supporting
   the Ph.D. study of the first author, Ms. Ana Gantar. This work was
   performed within the short-term scientific mission (STSM Reference
   number: COST-STSM-MP1005-15698) of Ms. Gantar at the CIDETEC, Spain,
   under the COST Action MP1005 "From nano to macro biomaterials (design,
   processing, characterization, modelling) and applications to stem cells
   regenerative orthopaedic and dental medicine (NAMABIO)".
CR Amamoto Y, 2011, ANGEW CHEM INT EDIT, V50, P1660, DOI 10.1002/anie.201003888
   Bae KH, 2013, J MATER CHEM B, V1, P5371, DOI 10.1039/c3tb20940g
   Barcan GA, 2015, J AM CHEM SOC, V137, P5650, DOI 10.1021/jacs.5b02161
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Boccaccini AR, 2010, COMPOS SCI TECHNOL, V70, P1764, DOI 10.1016/j.compscitech.2010.06.002
   Casuso P, 2015, BIOMACROMOLECULES, V16, P3552, DOI 10.1021/acs.biomac.5b00980
   Casuso P, 2014, CHEM COMMUN, V50, P15199, DOI 10.1039/c4cc05735j
   Chen XH, 2015, INT J NANOMED, V10, P839, DOI 10.2147/IJN.S69001
   Couto DS, 2009, ACTA BIOMATER, V5, P115, DOI 10.1016/j.actbio.2008.08.006
   Cromwell OR, 2015, J AM CHEM SOC, V137, P6492, DOI 10.1021/jacs.5b03551
   Deng GH, 2012, ACS MACRO LETT, V1, P275, DOI 10.1021/mz200195n
   Douglas TEL, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045014
   Drnovsek N, 2012, THESIS
   Drnovsek N, 2012, INT ORTHOP, V36, P1739, DOI 10.1007/s00264-012-1520-y
   Fairbanks BD, 2011, MACROMOLECULES, V44, P2444, DOI 10.1021/ma200202w
   Gabbai-Armelin PR, 2014, RSC ADV, V4, P45778, DOI 10.1039/c4ra07522f
   Gantar A, 2014, MAT SCI ENG C-MATER, V43, P27, DOI 10.1016/j.msec.2014.06.045
   Garner E, 2000, J BIOMECH ENG-T ASME, V122, P166, DOI 10.1115/1.429638
   Gibbs DM, 2014, J TISSUE ENG REGEN M, V10, P187
   Guarino V, 2013, ADV HEALTHC MATER, V2, P218, DOI 10.1002/adhm.201200152
   He LH, 2011, CHEM COMMUN, V47, P7497, DOI 10.1039/c1cc11928a
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jones Julian R, 2015, Acta Biomater, V23 Suppl, pS53, DOI 10.1016/j.actbio.2015.07.019
   Khaing ZZ, 2014, MATER TODAY, V17, P332, DOI 10.1016/j.mattod.2014.05.011
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Loh X. J., 2015, IN SITU GELLING POLY, P5
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Madaghiele M, 2014, BURNS TRAUMA, V2, DOI 10.4103/2321-3868.143616
   McGann CL, 2013, MACROMOL CHEM PHYS, V214, P203, DOI 10.1002/macp.201200412
   Misra SK, 2010, J R SOC INTERFACE, V7, P453, DOI 10.1098/rsif.2009.0255
   Pan HB, 2010, ACTA BIOMATER, V6, P4181, DOI 10.1016/j.actbio.2010.05.013
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Roberts MC, 2007, ADV MATER, V19, P2503, DOI 10.1002/adma.200602649
   Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
   Skardal A, 2010, ADV MATER, V22, P4736, DOI 10.1002/adma.201001436
   Sohrabi M, 2013, MAT SCI ENG C-MATER, V33, P3730, DOI 10.1016/j.msec.2013.05.005
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
   Yang B, 2012, POLYM CHEM-UK, V3, P3235, DOI 10.1039/c2py20627g
   Yount WC, 2005, J AM CHEM SOC, V127, P14488, DOI 10.1021/ja054298a
NR 43
TC 7
Z9 7
U1 8
U2 76
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 73
BP 69156
EP 69166
DI 10.1039/c6ra17327f
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA DT5HJ
UT WOS:000381512600067
DA 2018-10-20
ER

PT S
AU Robinson, D
   Karnik, S
   Mills, D
AF Robinson, Darrell
   Karnik, Sonali
   Mills, David
GP IEEE
TI Stem Cell Proliferation and Differentiation through Capped Clay
   Nanotubes
SO 2016 32ND SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE (SBEC)
SE Proceedings of the Southern Biomedical Engineering Conference
LA English
DT Proceedings Paper
CT 32nd Southern Biomedical Engineering Conference (SBEC)
CY MAR 11-13, 2016
CL Shreveport, LA
SP Ctr Biomed Engn Rehabilitat Sci, Louisiana Tech Univ, LSU Hlth, Biomed Res Fdn
DE Hydrogels; Stem Cells; Halloysite; Regenerative medicine; Bone tissue
   engineering
AB Stem cells can be coaxed to grow into new bone or new cartilage better and faster when given the right molecular cues [1, 2]. Depending on the target tissue, control over the physical, chemical and mechanical influences is key to directing cell behavior in three-dimensions, and, ultimately, as a method to grow tissues for regenerative medicine applications. We designed a hydrogel that provides control over local biomaterial properties and that permits guidance over the process of development leading to extracellular matrix and tissue development. Our hydrogel nanocomposite consisting of alginate or chitosan, and growth factors doped Halloysite Nanotubes (HNTs). Results demonstrate that HNT addition improved nanocomposite material properties and created a cell supportive environment. While the focus in this study was on osteoblast differentiation this approach may permit local control over the behavior of varied cell types and allow the engineering of complex tissues using a single stem cell source.
C1 [Robinson, Darrell; Karnik, Sonali] Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71270 USA.
   [Mills, David] Louisiana Tech Univ, Sch Biol Sci, Ruston, LA 71270 USA.
RP Mills, D (reprint author), Louisiana Tech Univ, Sch Biol Sci, Ruston, LA 71270 USA.
EM dkmills@latech.edu
CR Chen JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt318
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
NR 3
TC 1
Z9 1
U1 0
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1086-4105
BN 978-1-5090-2133-8
J9 PR SOUTH BIOMED ENG
PY 2016
BP 25
EP 26
DI 10.1109/SBEC.2016.79
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BF4WY
UT WOS:000381754100010
DA 2018-10-20
ER

PT S
AU Turner, E
   Burnett, L
   Yazdani, SK
AF Turner, Emily
   Burnett, Luke
   Yazdani, Saami K.
GP IEEE
TI Keratose as a Novel Drug Carrier for Drug Coated Balloons
SO 2016 32ND SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE (SBEC)
SE Proceedings of the Southern Biomedical Engineering Conference
LA English
DT Proceedings Paper
CT 32nd Southern Biomedical Engineering Conference (SBEC)
CY MAR 11-13, 2016
CL Shreveport, LA
SP Ctr Biomed Engn Rehabilitat Sci, Louisiana Tech Univ, LSU Hlth, Biomed Res Fdn
AB Drug coated balloons (DCB) represent a novel approach to develop a superior intervention for the treatment of peripheral artery disease (PAD). DCB are coated with anti-proliferative drugs, typically paclitaxel, which combat neointimal hyperplasia reducing the occurrence of restenosis. Success of DCB is limited by poor retention within the artery following deployment. Excipients have marginally improved paclitaxel retention however retention rates are still less than 10% 24-hours post-treatment1-5. There exists a need for an improved drug carrier which can support long-term drug retention. Keratose, an extracted form of keratin derived from human hair, is a potential option for an excipient due to its intrinsic scaffolding characteristics, biocompatibility, and ability to support tunable release of various drugs and factors6-9. Briefly, various paclitaxel-containing keratose hydrogels were formed. Keratose degradation and paclitaxel release were quantified up to 45 days by spectrophotometry and HPLC-MS/MS respectively. To confirm the ability of keratose to form a DCB, keratose hydrogels were coated on angioplasty balloons using a dipping technique. The keratose DCB was sectioned and coating thickness was quantified by light microscopy. Results demonstrated that paclitaxel-keratose hydrogels degraded and released paclitaxel as a function of keratose concentration. The keratose DCB displayed uniform coating circumferentially with coating thicknesses ranging from 5-20 microns. These studies highlight the potential of a new biomaterial that can provide a safe and controllable drug release profile for treatment of PAD.
C1 [Turner, Emily; Yazdani, Saami K.] Univ S Alabama, Mech Engn, Mobile, AL 36688 USA.
   [Burnett, Luke] KeraNetics, Winston Salem, NC USA.
RP Turner, E (reprint author), Univ S Alabama, Mech Engn, Mobile, AL 36688 USA.
EM eat1322@jagmail.southalabama.edu
OI Turner, Emily/0000-0002-2161-7144
CR Burnett L, SPATIOTEMPORALLY CON
   Burnett LR, 2013, BIOMATERIALS, V34, P2632, DOI 10.1016/j.biomaterials.2012.12.022
   Cortese B, 2010, HEART, V96, P1291, DOI 10.1136/hrt.2010.195057
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Kelsch B, 2011, INVEST RADIOL, V46, P255, DOI 10.1097/RLI.0b013e31820577df
   Posa A, 2010, CATHETER CARDIO INTE, V76, P395, DOI 10.1002/ccd.22468
   Saul JM, 2011, J BIOMEDICAL MAT R A, V4, P544
   Scheinert D, 2014, JACC-CARDIOVASC INTE, V7, P11, DOI 10.1016/j.jcin.2013.05.022
   Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0
   Scheller B, 2003, J AM COLL CARDIOLOGY, V42, P1450
NR 11
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1086-4105
BN 978-1-5090-2133-8
J9 PR SOUTH BIOMED ENG
PY 2016
BP 68
EP 69
DI 10.1109/SBEC.2016.33
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BF4WY
UT WOS:000381754100028
DA 2018-10-20
ER

PT S
AU Nguyen, NH
   Kansakar, U
   Delahoussaye, M
   Minullina, R
   Lvov, Y
   DeCoster, MA
AF Nguyen, Nam H.
   Kansakar, Urna
   Delahoussaye, Miles
   Minullina, Renata
   Lvov, Yuri
   DeCoster, Mark A.
GP IEEE
TI Interaction of degradable and non-degradable biomaterial with brain
   cells for tissue engineering and cancer treatment
SO 2016 32ND SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE (SBEC)
SE Proceedings of the Southern Biomedical Engineering Conference
LA English
DT Proceedings Paper
CT 32nd Southern Biomedical Engineering Conference (SBEC)
CY MAR 11-13, 2016
CL Shreveport, LA
SP Ctr Biomed Engn Rehabilitat Sci, Louisiana Tech Univ, LSU Hlth, Biomed Res Fdn
DE Tissue engineering; Cell culture; Biomaterial; Brain cells; Microscopy
AB This research compares interaction of two non-degradable materials: 2 mu m fluorescent beads and halloysite nanotubes (HNTs) and one degradable biomaterial - High Aspect Ratio Structure (HARS) biocomposites, with microglial brain cells. White light and fluorescence microscopy were used to capture images and were analyzed using Image Pro Plus 7.0 software. Results show interactions between microglial cells and biomaterials which can be carried out for applications in tissue engineering as well as for testing anti-cancer effects.
C1 [Nguyen, Nam H.; Kansakar, Urna; Delahoussaye, Miles; DeCoster, Mark A.] Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.
   [Minullina, Renata; Lvov, Yuri; DeCoster, Mark A.] Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA.
   [Lvov, Yuri; DeCoster, Mark A.] Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA.
RP DeCoster, MA (reprint author), Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.; DeCoster, MA (reprint author), Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA.; DeCoster, MA (reprint author), Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA.
EM decoster@latech.edu
CR CARLSSON J, 1989, EUR J CANCER CLIN ON, V25, P1127, DOI 10.1016/0277-5379(89)90404-5
   Deodhar Sneha, 2014, IOP C SERIES MAT SCI, V64
   Kelly Kinsey Cotton, 2015, J VISUALIZED EXPT, V101
   Parekh G, 2014, INT J PHARMACEUT, V465, P218, DOI 10.1016/j.ijpharm.2014.01.041
   Vergaro V, 2010, BIOMACROMOLECULES, V11, P820, DOI 10.1021/bm9014446
   Xing Q, 2010, ACTA BIOMATER, V6, P2132, DOI 10.1016/j.actbio.2009.12.036
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1086-4105
BN 978-1-5090-2133-8
J9 PR SOUTH BIOMED ENG
PY 2016
BP 81
EP 82
DI 10.1109/SBEC.2016.81
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BF4WY
UT WOS:000381754100032
DA 2018-10-20
ER

PT J
AU Suryavanshi, A
   Srivastava, R
AF Suryavanshi, Ajay
   Srivastava, Rohit
TI Preparation and Characterization of Mg-PCL Nanocomposites
SO ADVANCED SCIENCE LETTERS
LA English
DT Proceedings Paper
CT 1st International Conference on Emerging Materials - Characterization
   and Application (EMCA)
CY DEC 04-06, 2014
CL CSIR, Cent Glass & Ceram Res Inst Campus, Kolkata, INDIA
SP CSIR, Cent Glass & Ceram Res Inst, Adv Mech & Mat Characterizat Div, Natl Inst Technol Durgapur, MHRD Ctr Excellence Adv Mat, CSIR, Cent Glass & Ceram Res Inst, Mat Characterizat & Instrumentat Div
HO CSIR, Cent Glass & Ceram Res Inst Campus
DE PCL Nanocomposite; Magnesium Nanoparticles; Polymer Matrix; Mechanical
   Properties; Interfacial Adhesion
ID SOLUTION INTERCALATION; MECHANICAL-PROPERTIES; MELT INTERCALATION;
   NANOPARTICLES; MAGNESIUM; POLYCAPROLACTONE; BIOMATERIALS; DEGRADATION;
   ALLOYS
AB Polymer composites have been researched in depth for plethora of biomedical applications. We prepared Magnesium-Polycaprolactone (Mg-PCL) composites incorporating Mg nanofillers (0.5%-10% w/w) into PCL polymer matrix by twin-screw extrusion mixing. Magnesium nanoparticles were synthesized by Lithium reduction method and characterized by UV-Vis spectroscopy, XRD analysis, FEG-SEM/EDX, FEG-TEM, DLS, Zeta analysis, etc. Specimens for mechanical (tensile testing) and physical characterization were prepared by injection molding and compression molding, respectively. Characterization studies of magnesium nanoparticles using UV-Vis spectroscopy and XRD analysis revealed characteristic absorbance peak (lambda(max)) at 263 nm and diffraction peaks indexed to various crystalline planes of Mg nanoparticles, respectively. FEG-SEM/EDX, FEG-TEM data showed hexagonal-shaped monocrystalline Mg nanoparticles with Mg and 0 as main constituents. DLS and zeta analysis demonstrated size range of 100-300 nm (monodispersity) with PDI 0.24 and zeta potential +48.19 mV indicating stability of dispersion and positive surface charge. Physical characterization of as-prepared Mg-PCL nanocomposites by SEM revealed distribution of Mg particles proportional to filler loading. Mechanical studies showed no significant change in tensile properties of neat PCL on filler addition. This could be attributed to preservation of crystallization behavior of PCL in XRD and DSC data even at highest filler concentration tested. Also, chemical functionalities of polymer matrix remained unaffected by Magnesium nanoparticles addition as seen in FTIR. Thus, Mg-PCL nanocomposites were successfully synthesized and characterized and could be further tested biologically to explore its biomaterial potential.
C1 [Suryavanshi, Ajay; Srivastava, Rohit] Indian Inst Technol, NanoBios Lab, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
RP Srivastava, R (reprint author), Indian Inst Technol, NanoBios Lab, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
CR Chieng BW, 2012, INT J MOL SCI, V13, P10920, DOI 10.3390/ijms130910920
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Cifuentes SC, 2012, MATER LETT, V74, P239, DOI 10.1016/j.matlet.2012.01.134
   Di YW, 2003, J POLYM SCI POL PHYS, V41, P670, DOI 10.1002/polb.10420
   Du LC, 2006, COMPOS SCI TECHNOL, V66, P913, DOI 10.1016/j.compscitech.2005.08.012
   Fukushima K, 2009, MAT SCI ENG C-BIO S, V29, P1433, DOI 10.1016/j.msec.2008.11.005
   Haas I, 2008, CHEM COMMUN, P1795, DOI 10.1039/b717670h
   Hench L., 1995, ANNU REV MATER SCI, V25, P279
   Hong ZK, 2008, ACTA BIOMATER, V4, P1297, DOI 10.1016/j.actbio.2008.03.007
   Lepoittevin B, 2002, POLYMER, V43, P4017, DOI 10.1016/S0032-3861(02)00229-X
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Ljungberg N, 2006, POLYMER, V47, P6285, DOI 10.1016/j.polymer.2006.07.013
   Ma FQ, 2011, J PHYS CHEM SOLIDS, V72, P111, DOI 10.1016/j.jpcs.2010.11.008
   Marras SI, 2008, ACTA BIOMATER, V4, P756, DOI 10.1016/j.actbio.2007.12.005
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mukherjee DP, 2011, J CRANIOFAC SURG, V22, P679, DOI 10.1097/SCS.0b013e318207432f
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Peng HD, 2010, THERMOCHIM ACTA, V502, P1, DOI 10.1016/j.tca.2010.01.009
   Song MR, 2008, MATER CHARACT, V59, P514, DOI 10.1016/j.matchar.2007.03.008
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wang G., 2011, CHIN J POLYM SCI, V31, P1
   Weng L, 2013, INT J NANOMED, V8, P1773, DOI 10.2147/IJN.S39031
   Weng L, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485105
   Zhang FZ, 2007, APPL SURF SCI, V253, P7393, DOI 10.1016/j.apsusc.2007.03.022
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 25
TC 0
Z9 0
U1 1
U2 6
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1936-6612
EI 1936-7317
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD JAN
PY 2016
VL 22
IS 1
SI SI
BP 13
EP 20
DI 10.1166/asl.2016.6815
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS4EQ
UT WOS:000380734600004
DA 2018-10-20
ER

PT J
AU Gaudin, R
   Knipfer, C
   Henningsen, A
   Smeets, R
   Heiland, M
   Hadlock, T
AF Gaudin, Robert
   Knipfer, Christian
   Henningsen, Anders
   Smeets, Ralf
   Heiland, Max
   Hadlock, Tessa
TI Approaches to Peripheral Nerve Repair: Generations of Biomaterial
   Conduits Yielding to Replacing Autologous Nerve Grafts in
   Craniomaxillofacial Surgery
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Review
ID RAT SCIATIC-NERVE; CILIARY NEUROTROPHIC FACTOR; NEURAL STEM-CELLS;
   MOTONEURONS IN-VIVO; ELECTRICAL-STIMULATION PROMOTES; DYING-BACK
   PROCESS; AXONAL REGENERATION; GROWTH-FACTOR; SCHWANN-CELL; FUNCTIONAL
   RECOVERY
AB Peripheral nerve injury is a common clinical entity, which may arise due to traumatic, tumorous, or even iatrogenic injury in craniomaxillofacial surgery. Despite advances in biomaterials and techniques over the past several decades, reconstruction of nerve gaps remains a challenge. Autografts are the gold standard for nerve reconstruction. Using autografts, there is donor site morbidity, subsequent sensory deficit, and potential for neuroma development and infection. Moreover, the need for a second surgical site and limited availability of donor nerves remain a challenge. Thus, increasing efforts have been directed to develop artificial nerve guidance conduits (ANCs) as new methods to replace autografts in the future. Various synthetic conduit materials have been tested in vitro and in vivo, and several first- and second-generation conduits are FDA approved and available for purchase, while third-generation conduits still remain in experimental stages. This paper reviews the current treatment options, summarizes the published literature, and assesses future prospects for the repair of peripheral nerve injury in craniomaxillofacial surgery with a particular focus on facial nerve regeneration.
C1 [Gaudin, Robert; Hadlock, Tessa] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol Head & Neck Surg, Div Facial Plast & Reconstruct Surg, 243 Charles St, Boston, MA 02114 USA.
   [Knipfer, Christian; Smeets, Ralf; Heiland, Max] Univ Med Ctr Hamburg Eppendorf, Dept Oral & Maxillofacial Surg, Martinistr 52, D-20246 Hamburg, Germany.
   [Henningsen, Anders] Bundeswehrkrankenhaus Hamburg, Dept Oral & Maxillofacial Surg, Lesserstr 180, D-22049 Hamburg, Germany.
RP Gaudin, R (reprint author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol Head & Neck Surg, Div Facial Plast & Reconstruct Surg, 243 Charles St, Boston, MA 02114 USA.
EM robert-a-gaudin@t-online.de
OI Heiland, Max/0000-0002-4987-2913
CR AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Ahmed MR, 2005, J PERIPHER NERV SYST, V10, P17, DOI 10.1111/j.1085-9489.2005.10105.x
   Al-Majed AA, 2000, J NEUROSCI, V20, P2602
   Allen C, 2000, DRUG DELIV, V7, P139
   Arai T, 2000, SCAND J PLAST RECONS, V34, P101
   Araki T, 2001, J BIOL CHEM, V276, P34131, DOI 10.1074/jbc.M104271200
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Arslantunali D, 2014, MED DEVICES-EVID RES, V7, P405, DOI 10.2147/MDER.S59124
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Ballance C, 1924, BRIT MED J, V1924, P349, DOI 10.1136/bmj.2.3322.349
   Bannasch H, 2005, PANMINERVA MED, V47, P53
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Baumgartner BJ, 1998, J NEUROSCI RES, V54, P766, DOI 10.1002/(SICI)1097-4547(19981215)54:6<766::AID-JNR4>3.0.CO;2-A
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Bekler HI, 2010, ACTA ORTHOP TRAUMATO, V44, P157, DOI 10.3944/AOTT.2010.2298
   BOULDIN TW, 1979, AM J PATHOL, V94, P241
   Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x
   Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277
   Bozkurt A, 2012, BIOMATERIALS, V33, P1363, DOI 10.1016/j.biomaterials.2011.10.069
   Brant JA, 2016, J NEUROL SURG PART B, V77, pP111
   Braun S, 1996, J NEUROL SCI, V136, P17, DOI 10.1016/0022-510X(95)00315-S
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Brown RQ, 2005, J BIOMED MATER RES A, V74A, P32, DOI 10.1002/jbm.a.30250
   BRUNELLI GA, 1994, MICROSURG, V15, P176, DOI 10.1002/micr.1920150307
   Brushart TM, 2002, J NEUROSCI, V22, P6631
   Bunger O, 1891, BEITR PATHOL ANAL, V10, P312
   Bushnell BD, 2008, J HAND SURG-AM, V33A, P1081, DOI 10.1016/j.jhsa.2008.03.015
   Carriel V, 2014, EXPERT REV NEUROTHER, V14, P301, DOI 10.1586/14737175.2014.887444
   CAVANAGH JB, 1979, ARCH PATHOL LAB MED, V103, P659
   Chai H, 1999, NEUROSCI LETT, V274, P147, DOI 10.1016/S0304-3940(99)00671-0
   Chang LW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-84
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chhabra Avneesh, 2014, Indian J Radiol Imaging, V24, P217, DOI 10.4103/0971-3026.137025
   Chiriac S, 2012, J HAND SURG-EUR VOL, V37E, P342, DOI 10.1177/1753193411422685
   Cho MS, 2012, J HAND SURG-AM, V37A, P2340, DOI 10.1016/j.jhsa.2012.08.028
   Clavijo-Alvarez JA, 2007, PLAST RECONSTR SURG, V119, P1839, DOI 10.1097/01.prs.0000260232.43019.a0
   Cobianchi S, 2013, EXP NEUROL, V240, P157, DOI 10.1016/j.expneurol.2012.11.023
   Cohen-Karni T, 2012, NANO LETT, V12, P5403, DOI 10.1021/nl302810c
   Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788
   CRAWLEY WA, 1992, PLAST RECONSTR SURG, V90, P300, DOI 10.1097/00006534-199290020-00022
   Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155
   Cui Y, 2014, BIOMATERIALS, V35, P7819, DOI 10.1016/j.biomaterials.2014.05.065
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Das S, 2015, BIOMATERIALS, V62, P66, DOI 10.1016/j.biomaterials.2015.04.047
   Lucena EED, 2014, J ORAL MAXIL SURG, V72, P1001, DOI 10.1016/j.joms.2013.11.006
   Deal DN, 2012, J AM ACAD ORTHOP SUR, V20, P63, DOI 10.5435/JAAOS-20-02-063
   Dellon AL, 2006, J HAND SURG-AM, V31A, P1495, DOI 10.1016/j.jhsa.2006.07.003
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   Den Dunnen WFA, 1998, J MATER SCI-MATER M, V9, P811, DOI 10.1023/A:1008987910224
   den Dunnen WFA, 2001, BIOMATERIALS, V22, P1171, DOI 10.1016/S0142-9612(00)00339-2
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dezawa Mari, 2002, Anatomical Science International, V77, P12, DOI 10.1046/j.0022-7722.2002.00012.x
   di Summa PG, 2014, NEUROSCI LETT, V572, P26, DOI 10.1016/j.neulet.2014.04.029
   Dinis TM, 2015, J MECH BEHAV BIOMED, V41, P43, DOI 10.1016/j.jmbbm.2014.09.029
   Dinis TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109770
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011
   Duda S, 2014, BIOMED RES INT, DOI 10.1155/2014/835269
   Duncan SFM, 2015, OCHSNER J, V15, P191
   Dwivedi N., 2006, P AM ASS NEUR SURG A
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fansa H, 2002, MUSCLE NERVE, V26, P87, DOI 10.1002/mus.10165
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   Foehn A., 2007, V140, P167
   Frerichs O, 2002, MICROSURG, V22, P311, DOI 10.1002/micr.10056
   Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011
   Gambarotta G, 2013, INT REV NEUROBIOL, V108, P223, DOI 10.1016/B978-0-12-410499-0.00009-5
   Georgiou M, 2015, BIOMATERIALS, V37, P242, DOI 10.1016/j.biomaterials.2014.10.009
   Gerth DJ, 2015, WORLD J CLIN CASES, V3, P141, DOI 10.12998/wjcc.v3.i2.141
   GLUCK T, 1880, ARCH KLIN CHIR, V25, P606
   Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488
   Gottlieb DI, 2002, ANNU REV NEUROSCI, V25, P381, DOI 10.1146/annurev.neuro.25.112701.142904
   Griffin JW, 2013, J BONE JOINT SURG AM, V95A, P2144, DOI 10.2106/JBJS.L.00704
   Gu XS, 2014, BIOMATERIALS, V35, P6143, DOI 10.1016/j.biomaterials.2014.04.064
   GULATI AK, 1988, J NEUROSURG, V68, P117, DOI 10.3171/jns.1988.68.1.0117
   Gunn S, 2010, LARYNGOSCOPE, V120, pS206, DOI 10.1002/lary.21674
   Guo BF, 2009, OTOLARYNG HEAD NECK, V140, P159, DOI 10.1016/j.otohns.2008.10.039
   Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hadlock T A, 1998, Facial Plast Surg, V14, P179, DOI 10.1055/s-2008-1064343
   Han SSW, 2000, JAMA-J AM MED ASSOC, V283, P2300, DOI 10.1001/jama.283.17.2300
   Hardy JG, 2013, CURR OPIN BIOTECH, V24, P847, DOI 10.1016/j.copbio.2013.03.011
   He B, 2014, NEURAL REGEN RES, V9, P661, DOI 10.4103/1673-5374.130094
   HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9
   HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho PR, 1998, ARCH OTOLARYNGOL, V124, P761, DOI 10.1001/archotol.124.7.761
   Hohman MH, 2014, JAMA FACIAL PLAST SU, V16, P20, DOI 10.1001/jamafacial.2013.1431
   Hua J, 1996, Plast Reconstr Surg, V98, P851, DOI 10.1097/00006534-199610000-00016
   Huang JH, 2009, J NEUROTRAUM, V26, P1805, DOI [10.1089/neu.2008.0732, 10.1089/neu.2008-0732]
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607
   Ichihara S, 2008, INJURY, V39, pS29, DOI 10.1016/j.injury.2008.08.029
   Inada Yuji, 2007, Neurosurgery, V61, pE1105
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Johnson EO, 2008, INJURY, V39, pS37, DOI 10.1016/j.injury.2008.06.015
   Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012
   Jones MG, 1999, PAIN, V79, P21, DOI 10.1016/S0304-3959(98)00142-0
   Jowett N, 2015, JAMA FACIAL PLAST SU, V17, P293, DOI 10.1001/jamafacial.2015.0399
   Kadler KE, 1996, BIOCHEM J, V316, P1
   KANJE M, 1988, BRAIN RES, V439, P116, DOI 10.1016/0006-8993(88)91467-9
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Keller-Peck CR, 2001, J NEUROSCI, V21, P6136
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Kim J., 2015, ACTA OTO-LARYNGOL, V36, P100
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Kitahara AK, 1999, SCAND J PLAST RECONS, V33, P187
   Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025
   KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M
   Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316
   Korte W., 1903, DEUT MED WOCHENSCHR, V17, P293
   KOVACS GTA, 1992, IEEE T BIO-MED ENG, V39, P893, DOI 10.1109/10.256422
   Kraus H., 1940, ARCH KLIN CHIRURGIE, V199, P318
   LAIRD JMA, 1995, NEUROSCIENCE, V65, P209, DOI 10.1016/0306-4522(94)00465-H
   Lal D, 2008, OTOLARYNG HEAD NECK, V139, P68, DOI 10.1016/j.otohns.2008.04.030
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621
   Lee JY, 2012, J BONE JOINT SURG AM, V94A, P2084, DOI 10.2106/JBJS.K.00658
   Lichtenfels M, 2013, MICROSURG, V33, P383, DOI 10.1002/micr.22105
   Lin MY, 2013, HAND CLIN, V29, P331, DOI 10.1016/j.hcl.2013.04.003
   Lin Qiang, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P167
   Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346
   Liodaki E, 2013, J RECONSTR MICROSURG, V29, DOI 10.1055/s-0033-1348033
   Liu HW, 2013, NEURAL REGEN RES, V8, P3139, DOI 10.3969/j.issn.1673-5374.2013.33.008
   Lobsiger CS, 2002, BIOL CHEM, V383, P245, DOI 10.1515/BC.2002.026
   Lohmeyer JA, 2009, J RECONSTR MICROSURG, V25, P55, DOI 10.1055/s-0028-1103505
   Lu Yan, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P603
   LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927
   LUNDBORG G, 1982, J NEUROPATH EXP NEUR, V41, P412, DOI 10.1097/00005072-198207000-00004
   Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P100, DOI 10.1016/j.jhsb.2003.09.018
   MACKINNON S, 1982, NEUROSURGERY, V10, P61, DOI 10.1227/00006123-198201000-00011
   MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024
   Mackinnon SE, 2001, PLAST RECONSTR SURG, V107, P1419, DOI 10.1097/00006534-200105000-00016
   Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030
   Marquardt LM, 2013, CURR OPIN BIOTECH, V24, P887, DOI 10.1016/j.copbio.2013.05.006
   Matsumine H, 2014, J TISSUE ENG REGEN M, V8, P454, DOI 10.1002/term.1540
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Meek MF, 2007, BIO-MED MATER ENG, V17, P329
   Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642
   Meek MF, 1996, MICROSURG, V17, P555, DOI 10.1002/(SICI)1098-2752(1996)17:10<555::AID-MICR5>3.0.CO;2-P
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Meek MF, 1999, MICROSURG, V19, P381, DOI 10.1002/(SICI)1098-2752(1999)19:8<381::AID-MICR6>3.0.CO;2-7
   Meek MF, 2001, MUSCLE NERVE, V24, P753, DOI 10.1002/mus.1066
   Meek MF, 2001, BIOMATERIALS, V22, P1177, DOI 10.1016/S0142-9612(00)00340-9
   Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862
   Moir MS, 2000, ARCH OTOLARYNGOL, V126, P501, DOI 10.1001/archotol.126.4.501
   Montgomery A, 2015, BIOMATER SCI-UK, V3, P401, DOI 10.1039/c4bm00299g
   Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8
   MORRISSEY TK, 1991, J NEUROSCI, V11, P2433
   Mottaghitalab F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074417
   Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Newman JP, 1996, ARCH OTOLARYNGOL, V122, P399
   Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725
   Nicolino S, 2003, NEUROREPORT, V14, P1541, DOI 10.1097/01.wnr.0000085691.46774.cc
   Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3
   OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0
   Orbay H, 2012, J PLAST RECONSTR AES, V65, P657, DOI 10.1016/j.bjps.2011.11.035
   Park KI, 1999, J NEUROTRAUM, V16, P675, DOI 10.1089/neu.1999.16.675
   Park SY, 2015, J TISSUE ENG REGEN M, V9, P66, DOI 10.1002/term.1615
   Peng GL, 2015, FACIAL PLAST SURG, V31, P128, DOI 10.1055/s-0035-1549046
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Quigley AF, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016008
   Rafiuddin M, 2003, BRAIN RES, V993, P208, DOI 10.1016/j.brainres.2003.08.057
   Ramburrun P, 2014, BIOMED RES INT, DOI 10.1155/2014/132350
   Rao MS, 1997, J NEUROBIOL, V32, P722, DOI 10.1002/(SICI)1097-4695(19970620)32:7<722::AID-NEU7>3.0.CO;2-6
   Rappa G, 2004, NEUROSCIENCE, V124, P823, DOI 10.1016/j.neuroscience.2003.11.030
   Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031
   Reid AJ, 2013, NEUROSCI LETT, V544, P125, DOI 10.1016/j.neulet.2013.04.001
   ROSEN J M, 1989, Journal of Rehabilitation Research and Development, V26, P1
   ROSENWASSER RH, 1991, NEUROSURGERY, V29, P568, DOI 10.1227/00006123-199110000-00014
   Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580
   SAHENK Z, 1994, BRAIN RES, V655, P246, DOI 10.1016/0006-8993(94)91621-7
   Santos X, 1998, J NEUROSCI METH, V85, P119, DOI 10.1016/S0165-0270(98)00130-7
   Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387
   Scaramella L F, 1996, Ear Nose Throat J, V75, P347
   Schmauss D, 2014, J RECONSTR MICROSURG, V30, P561, DOI 10.1055/s-0034-1375237
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Secer HI, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-11
   SENDTNER M, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90187-2
   Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307
   Sharma N, 2009, RESTOR NEUROL NEUROS, V27, P633, DOI 10.3233/RNN-2009-0489
   Shi Y, 2012, TRANSPLANTING NEURAL, V26, P1040
   Shi Y, 2009, ACTA OTO-LARYNGOL, V129, P906, DOI 10.1080/00016480802468153
   Shin RH, 2009, J BONE JOINT SURG AM, V91A, P2194, DOI 10.2106/JBJS.H.01301
   Siegel SG, 2000, EXP NEUROL, V166, P205, DOI 10.1006/exnr.2000.7528
   Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799
   Simon CM, 2010, HUM MOL GENET, V19, P973, DOI 10.1093/hmg/ddp562
   Sinis N, 2009, ANN ANAT, V191, P356, DOI 10.1016/j.aanat.2009.03.004
   SISKEN BF, 1993, J CELL BIOCHEM, V51, P404, DOI 10.1002/jcb.2400510404
   Sivak W. N., 2014, J TISSUE ENG REGENER
   Skouras E, 2009, RESTOR NEUROL NEUROS, V27, P237, DOI 10.3233/RNN-2009-0474
   Smith RM, 2004, J INVEST SURG, V17, P339, DOI 10.1080/08941930490524417
   SPENCER PS, 1977, J NEUROPATH EXP NEUR, V36, P276, DOI 10.1097/00005072-197703000-00005
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   Stassart RM, 2013, NAT NEUROSCI, V16, P48, DOI 10.1038/nn.3281
   Strauch RJ, 2013, J HAND SURG-AM, V38A, P1252, DOI 10.1016/j.jhsa.2013.02.034
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491
   Syed Neeraja, 2010, Mol Cell Pharmacol, V2, P161
   Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010
   Tan X.-x., 2009, J CHINA MED U, V4
   Taras JS, 2011, J HAND SURG-AM, V36A, P1441, DOI 10.1016/j.jhsa.2011.06.009
   Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017
   Terzis JK, 2008, FACIAL PLAST SURG, V24, P177, DOI 10.1055/s-2008-1075833
   Thomsen L, 2010, CHIR MAIN, V29, P255, DOI 10.1016/j.main.2010.07.004
   Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077
   Tomassoni D., 2013, BIOMED RES INT, V2013
   Tyner Tim R, 2007, Am J Surg, V193, pe1, DOI 10.1016/j.amjsurg.2006.08.026
   Utley DS, 1996, ARCH OTOLARYNGOL, V122, P407
   VALENTINI RF, 1989, BRAIN RES, V480, P300, DOI 10.1016/0006-8993(89)90196-0
   Varejao ASP, 2003, MICROSURG, V23, P338, DOI 10.1002/micr.10147
   VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x
   Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011
   Volk GF, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-25
   Wang H, 2015, ACS APPL MATER INTER, V7, P9589, DOI 10.1021/acsami.5b01149
   Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056
   Wangensteen Kirk J, 2010, Hand (N Y), V5, P273, DOI 10.1007/s11552-009-9245-0
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436
   Wrede, 1909, DEUT MED WOCHENSCHR, V35, P1125
   Wu P, 2013, J NEUROSCI METH, V214, P37, DOI 10.1016/j.jneumeth.2013.01.003
   Xie HJ, 2015, ADV HEALTHC MATER, V4, P2195, DOI 10.1002/adhm.201500355
   YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202
   Yang F, 2005, BIOMATERIALS, V26, P15
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yi JS, 2013, J KOREAN NEUROSURG S, V53, P65, DOI 10.3340/jkns.2013.53.2.65
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Costa HJZR, 2013, BRAIN RES, V1510, P10, DOI 10.1016/j.brainres.2013.03.025
   ZANAKIS MF, 1988, ACUPUNCTURE ELECTRO, V13, P47, DOI 10.3727/036012988816358741
   Zhang BGX, 2014, INT J ARTIF ORGANS, V37, P277, DOI 10.5301/ijao.5000317
   Zhang H, 2015, MAT SCI ENG C-MATER, V56, P564, DOI 10.1016/j.msec.2015.06.024
   Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1111/j.1460-9568.2000.01312.x
NR 248
TC 13
Z9 14
U1 2
U2 14
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 3856262
DI 10.1155/2016/3856262
PG 18
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA DT3WK
UT WOS:000381411700001
PM 27556032
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhu, HY
   Wu, HX
   Wu, M
   Gong, QY
AF Zhu, Hongyan
   Wu, Haoxing
   Wu, Min
   Gong, Qiyong
TI Tetrazine Bioorthogonal Reaction: A Novel Scheme for Polymer and
   Biomaterials
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
DE Bioorthogonal chemistry; tetrazine; polymer; biomaterials; nanoparticles
ID FREE CLICK CHEMISTRY; LIVE MAMMALIAN-CELLS; SITU-FORMING HYDROGELS;
   DIELS-ALDER REACTIONS; IN-VIVO CHEMISTRY; TURN-ON PROBES; NORBORNENE
   CHEMISTRY; TRANS-CYCLOOCTENE; BIOMEDICAL APPLICATIONS;
   PHOTOCLICK-CHEMISTRY
AB Bioorthogonal reactions have been widely used on live-cell labeling, animal tissue imaging, drug delivery, and biomaterials in the recent ten years. Tetrazine bioorthogonal chemistry is not only orthogonal with biological system, other click chemistry and traditional polymer chemistry, but also has superb kinetics, generates biocompatibility products, and proceeds under mild reaction condition. All these features enable tetrazine bioorthogonal chemistry to be widely applied to polymer and biomaterial science. Recently there are many exciting accomplishments. This chemistry can act as an ideal method for polymer and nanoparticle modification, a desired vehicle for nanoparticles in vivo delivery, new polymerization strategy, and novel hydrogel formation platform. In this review, we introduce recent advancements in biomaterials based on tetrazine bioorthogonal chemistry.
C1 [Zhu, Hongyan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Stem Cell Biol, Chengdu, Peoples R China.
   [Wu, Min; Gong, Qiyong] Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu 610041, Sichuan, Peoples R China.
   [Wu, Haoxing] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.
RP Wu, HX (reprint author), Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu 610041, Sichuan, Peoples R China.; Gong, QY (reprint author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM haoxing1021@gmail.com; qiyonggong@hmrrc.org.cn
FU National Natural Science Foundation of China [81371536]
FX The authors would like to acknowledge the support from National Natural
   Science Foundation of China (Grant No. 81371536) awarded to Hongyan Zhu
   and Min Wu.
CR Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228
   Agarwal P, 2015, ANGEW CHEM INT EDIT, V54, P11504, DOI 10.1002/anie.201504249
   Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI [10.1021/ac5004982, 10.1021/bc5004982]
   Alge DL, 2013, BIOMACROMOLECULES, V14, P949, DOI 10.1021/bm4000508
   Aucagne V, 2006, ORG LETT, V8, P4505, DOI 10.1021/ol061657d
   Barker IA, 2011, MACROMOL RAPID COMM, V32, P1362, DOI 10.1002/marc.201100324
   Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104
   Baumgartner R, 2015, POLYM CHEM-UK, V6, P3586, DOI 10.1039/c5py00119f
   Binder WH, 2007, MACROMOL RAPID COMM, V28, P15, DOI 10.1002/marc.200600625
   Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805
   Blizzard RJ, 2015, J AM CHEM SOC, V137, P10044, DOI 10.1021/jacs.5b03275
   Budin G, 2011, ANGEW CHEM INT EDIT, V50, P9378, DOI 10.1002/anie.201103273
   Carlson JCT, 2013, ANGEW CHEM INT EDIT, V52, P6917, DOI 10.1002/anie.201301100
   Clavier G, 2010, CHEM REV, V110, P3299, DOI 10.1021/cr900357e
   Codelli JA, 2008, J AM CHEM SOC, V130, P11486, DOI 10.1021/ja803086r
   Cok AM, 2013, MACROMOL SYMP, V329, P108, DOI 10.1002/masy.201300008
   Cole CM, 2013, CHEMBIOCHEM, V14, P205, DOI 10.1002/cbic.201200719
   Curtius T, 1930, J PRAKTISCHE CHEMIE, V125, P40, DOI 10.1002/prac.19301250103
   Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009
   Darko A, 2014, CHEM SCI, V5, P3770, DOI 10.1039/c4sc01348d
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Delaittre G, 2015, ACCOUNTS CHEM RES, V48, P1296, DOI 10.1021/acs.accounts.5b00075
   Denk C, 2014, ANGEW CHEM INT EDIT, V53, P9655, DOI 10.1002/anie.201404277
   Desai RM, 2015, BIOMATERIALS, V50, P30, DOI 10.1016/j.biomaterials.2015.01.048
   Devaraj NK, 2012, P NATL ACAD SCI USA, V109, P4762, DOI 10.1073/pnas.1113466109
   Devaraj NK, 2011, ACCOUNTS CHEM RES, V44, P816, DOI 10.1021/ar200037t
   Devaraj NK, 2010, ANGEW CHEM INT EDIT, V49, P2869, DOI 10.1002/anie.200906120
   Devaraj NK, 2008, BIOCONJUGATE CHEM, V19, P2297, DOI 10.1021/bc8004446
   Ehret F, 2015, J AM CHEM SOC, V137, P8876, DOI 10.1021/jacs.5b03371
   Elliott TS, 2014, NAT BIOTECHNOL, V32, P465, DOI 10.1038/nbt.2860
   Emmetiere F, 2013, BIOCONJUGATE CHEM, V24, P1784, DOI 10.1021/bc400322h
   Erdmann RS, 2014, ANGEW CHEM INT EDIT, V53, P10242, DOI 10.1002/anie.201403349
   Espeel P, 2015, MACROMOLECULES, V48, P2, DOI 10.1021/ma501386v
   Evans HL, 2014, CHEM COMMUN, V50, P9557, DOI 10.1039/c4cc03903c
   Fan YP, 2013, BIOMACROMOLECULES, V14, P2814, DOI 10.1021/bm400637s
   Gergely B. C., 2015, METHODS APPL FLUORES, V3
   Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Gramlich WM, 2013, BIOMATERIALS, V34, P9803, DOI 10.1016/j.biomaterials.2013.08.089
   Grieshaber SE, 2012, BIOMACROMOLECULES, V13, P1774, DOI 10.1021/bm3002705
   Grover GN, 2012, BIOMACROMOLECULES, V13, P3013, DOI 10.1021/bm301346e
   Han HS, 2015, P NATL ACAD SCI USA, V112, P1350, DOI 10.1073/pnas.1421632111
   Han HS, 2010, J AM CHEM SOC, V132, P7838, DOI 10.1021/ja101677r
   Hansell CF, 2014, NANOSCALE, V6, P4102, DOI 10.1039/c3nr06706h
   Hansell CF, 2012, ACS MACRO LETT, V1, P896, DOI 10.1021/mz300230c
   Hansell CF, 2011, J AM CHEM SOC, V133, P13828, DOI 10.1021/ja203957h
   Hapuarachchige S, 2014, BIOMATERIALS, V35, P2346, DOI 10.1016/j.biomaterials.2013.11.075
   Haun JB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002048
   Haun JB, 2010, NAT NANOTECHNOL, V5, P660, DOI [10.1038/nnano.2010.148, 10.1038/NNANO.2010.148]
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hofmann KA, 1912, BER DTSCH CHEM GES, V45, P2731, DOI 10.1002/cber.191204502185
   Howes PD, 2014, SCIENCE, V346, P53, DOI 10.1126/science.1247390
   Ingale SA, 2013, J ORG CHEM, V78, P3394, DOI 10.1021/jo400059b
   Issadore D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003747
   Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q
   Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g
   Johnson JA, 2008, CHEM COMMUN, P3064, DOI 10.1039/b803043j
   Johnson LM, 2010, ACS APPL MATER INTER, V2, P1963, DOI 10.1021/am100275n
   Karver MR, 2011, BIOCONJUGATE CHEM, V22, P2263, DOI 10.1021/bc200295y
   Kawamoto K, 2015, ACS MACRO LETT, V4, P458, DOI 10.1021/acsmacrolett.5b00221
   Knall AC, 2013, CHEM COMMUN, V49, P7325, DOI 10.1039/c3cc42925c
   Knall AC, 2013, CHEM SOC REV, V42, P5131, DOI 10.1039/c3cs60049a
   Kohn M, 2004, ANGEW CHEM INT EDIT, V43, P3106, DOI 10.1002/anie.200401744
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Koo H, 2012, ANGEW CHEM INT EDIT, V51, P11836, DOI 10.1002/anie.201206703
   Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w
   Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g
   Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250
   Li J, 2014, NAT CHEM BIOL, V10, P1003, DOI 10.1038/nchembio.1656
   Lim RKV, 2011, ACCOUNTS CHEM RES, V44, P828, DOI 10.1021/ar200021p
   Liu HX, 2013, TETRAHEDRON LETT, V54, P4645, DOI 10.1016/j.tetlet.2013.06.053
   Liu S, 2015, ADV MATER, V27, P2783, DOI 10.1002/adma.201500360
   Liu S, 2015, CHEM COMMUN, V51, P5218, DOI 10.1039/c4cc09568e
   Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/nchem.1546, 10.1038/NCHEM.1546]
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutz JF, 2008, ANGEW CHEM INT EDIT, V47, P2182, DOI 10.1002/anie.200705365
   Lyon LA, 2009, CHEM SOC REV, V38, P865, DOI 10.1039/b715522k
   Maha R.K., 2013, NANOTECHNOL REV, V2, P215
   Matikonda SS, 2015, CHEM SCI, V6, P1212, DOI 10.1039/c4sc02574a
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Meimetis LG, 2014, ANGEW CHEM INT EDIT, V53, P7531, DOI 10.1002/anie.201403890
   Meng XT, 2016, PROG POLYM SCI, V53, P52, DOI 10.1016/j.progpolymsci.2015.07.006
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]
   Patterson DM, 2015, CURR OPIN CHEM BIOL, V28, P141, DOI 10.1016/j.cbpa.2015.07.006
   Patterson DM, 2014, ACS CHEM BIOL, V9, P592, DOI 10.1021/cb400828a
   Patterson DM, 2012, J AM CHEM SOC, V134, P18638, DOI 10.1021/ja3060436
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13
   Pujari SS, 2013, J ORG CHEM, V78, P8545, DOI 10.1021/jo4012706
   Ramadoss NS, 2015, J AM CHEM SOC, V137, P5288, DOI 10.1021/jacs.5b01876
   Ramil CP, 2013, CHEM COMMUN, V49, P11007, DOI 10.1039/c3cc44272a
   Rashidian M, 2015, ACS CENTRAL SCI, V1, P142, DOI 10.1021/acscentsci.5b00121
   Rieder U, 2014, ANGEW CHEM INT EDIT, V53, P9168, DOI 10.1002/anie.201403580
   Rossin R, 2013, BIOCONJUGATE CHEM, V24, P1210, DOI 10.1021/bc400153y
   Rossin R, 2010, ANGEW CHEM INT EDIT, V49, P3375, DOI 10.1002/anie.200906294
   Royzen M, 2008, J AM CHEM SOC, V130, P3760, DOI 10.1021/ja8001919
   Ruzette AV, 2005, NAT MATER, V4, P19, DOI 10.1038/nmat1295
   Sachdeva A, 2014, J AM CHEM SOC, V136, P7785, DOI 10.1021/ja4129789
   Salata O.V., 2004, J NANOBIOTECHNOL, V2, P3, DOI DOI 10.1186/1477-3155-2-3
   Saracoglu N, 2007, TETRAHEDRON, V63, P4199, DOI 10.1016/j.tet.2007.02.051
   Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007
   Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v
   Seckute J, 2013, CURR OPIN CHEM BIOL, V17, P761, DOI 10.1016/j.cbpa.2013.08.004
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Selvaraj R, 2013, CURR OPIN CHEM BIOL, V17, P753, DOI 10.1016/j.cbpa.2013.07.031
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Spicer CD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5740
   Takahashi A, 2013, BIOMACROMOLECULES, V14, P3581, DOI 10.1021/bm4009606
   Taylor MT, 2011, J AM CHEM SOC, V133, P9646, DOI 10.1021/ja201844c
   Thomas JD, 2012, BIOCONJUGATE CHEM, V23, P2007, DOI 10.1021/bc300052u
   Truong VX, 2015, J AM CHEM SOC, V137, P1618, DOI 10.1021/ja511681s
   Tsai YH, 2015, NAT CHEM, V7, P554, DOI [10.1038/nchem.2253, 10.1038/NCHEM.2253]
   Tsarevsky NV, 2005, MACROMOLECULES, V38, P3558, DOI 10.1021/ma050370d
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Versteegen RM, 2013, ANGEW CHEM INT EDIT, V52, P14112, DOI 10.1002/anie.201305969
   Walker CN, 2014, ACS MACRO LETT, V3, P453, DOI 10.1021/mz5001288
   Wang C, 2015, POLYM CHEM-UK, V6, P3758, DOI 10.1039/c5py00326a
   Wang DZ, 2013, HETEROCYCL COMMUN, V19, P171, DOI 10.1515/hc-2013-0072
   Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]
   Wang YZ, 2008, ORG LETT, V10, P3725, DOI 10.1021/ol801350r
   Wang YZ, 2009, ANGEW CHEM INT EDIT, V48, P5330, DOI 10.1002/anie.200901220
   Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917
   Williams RJ, 2012, ACS MACRO LETT, V1, P1285, DOI 10.1021/mz300496q
   Wu HX, 2014, J AM CHEM SOC, V136, P17942, DOI 10.1021/ja510839r
   Wu HX, 2014, ANGEW CHEM INT EDIT, V53, P5805, DOI 10.1002/anie.201400135
   Xi WX, 2014, ADV FUNCT MATER, V24, P2572, DOI 10.1002/adfm.201302847
   Yang J, 2014, CHEM-EUR J, V20, P3365, DOI 10.1002/chem.201304225
   Yang J, 2012, ANGEW CHEM INT EDIT, V51, P7476, DOI 10.1002/anie.201202122
   Yang J, 2012, ANGEW CHEM INT EDIT, V51, P5222, DOI 10.1002/anie.201201117
   Yang KS, 2012, ANGEW CHEM INT EDIT, V51, P6598, DOI 10.1002/anie.201200994
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu ZP, 2013, J AM CHEM SOC, V135, P16766, DOI 10.1021/ja407867a
   Yu ZP, 2012, ANGEW CHEM INT EDIT, V51, P10600, DOI 10.1002/anie.201205352
   Yuan Z, 2012, ORG LETT, V14, P2590, DOI 10.1021/ol300899n
   Zhang H, 2014, ACS MACRO LETT, V3, P727, DOI 10.1021/mz5002993
   Zheng JK, 2012, ACS MACRO LETT, V1, P1071, DOI 10.1021/mz3003775
   Zhou HX, 2014, J AM CHEM SOC, V136, P9464, DOI 10.1021/ja5042385
   Zhou HX, 2013, ANGEW CHEM INT EDIT, V52, P2235, DOI 10.1002/anie.201207966
   Zhou HX, 2012, P NATL ACAD SCI USA, V109, P19119, DOI 10.1073/pnas.1213169109
NR 142
TC 1
Z9 1
U1 10
U2 53
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1385-2728
EI 1875-5348
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PY 2016
VL 20
IS 17
BP 1756
EP 1767
DI 10.2174/1385272820666151102212821
PG 12
WC Chemistry, Organic
SC Chemistry
GA DS5PF
UT WOS:000380833700002
OA Bronze
DA 2018-10-20
ER

PT J
AU Li, WQ
   Lu, L
   Jiao, YP
   Zhang, CW
   Zhou, CR
AF Li, Wenqiang
   Lu, Lu
   Jiao, Yanpeng
   Zhang, Chaowen
   Zhou, Changren
TI Poly(L-lactide) crystallization topography directs MC3T3-E1 cells
   response
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Poly(L-lactide); crystallization morphology; cell culture; contact
   guidance; MC3T3-E1
ID RING-BANDED SPHERULITES; GROWTH-FACTORS; ACID); FILMS; SCAFFOLDS;
   POLYMERS; SURFACES; GUIDANCE; PLGA
AB Biomaterial surface topography significantly influences cellular form and function. Using poly(L-lactic acid) films with normal spherulites, banded spherulites, and amorphous surfaces as model substrates, we conducted a systematic assessment of the role for polymer crystallization induced surface morphologies on cell growth and contact guidance. Microscopy and image analysis showed that the MC3T3-E1 cells spread out in a random fashion on the amorphous substrate. At 24h post-seeding, MC3T3-E1 cells on both types of spherulite surfaces were elongated and aligned along the spherulite radius direction. For the banded spherulite surface with radial stripes and coupling annular grooves, the cell orientation and cell nuclear localization were related to the grooves structure. With increasing time, this orientation preference was weaker. These results demonstrate that the patterning of polymer crystallization structure provide important signals for guiding cells to exhibit characteristic orientation and morphology especially in the early stages of regeneration.
C1 [Li, Wenqiang; Lu, Lu; Jiao, Yanpeng; Zhang, Chaowen; Zhou, Changren] Jinan Univ, Dept Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China.
RP Lu, L; Zhou, CR (reprint author), Jinan Univ, Dept Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China.
EM tlulu@jnu.edu.cn; tcrz9@jnu.edu.cn
FU Natural Science Foundation of Guangdong Province [2014A030313379];
   National Natural Science Foundation of China [31571030]
FX This work was supported by the Natural Science Foundation of Guangdong
   Province [grant number 2014A030313379]; the National Natural Science
   Foundation of China [grant number 31571030].
CR Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067
   Bernardo V, 2012, MATER LETT, V87, P105, DOI 10.1016/j.matlet.2012.07.088
   Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001
   Chelli B, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0041
   Martinez EC, 2007, J MATER SCI-MATER M, V18, P1627, DOI 10.1007/s10856-007-3038-1
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Degirmenbasi N, 2009, J BIOMED MATER RES A, V88A, P94, DOI 10.1002/jbm.a.31874
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074
   Izal I, 2013, KNEE SURG SPORT TR A, V21, P1737, DOI 10.1007/s00167-012-2148-6
   Jang TS, 2012, J BIOMED MATER RES B, V100B, P321, DOI 10.1002/jbm.b.31952
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Kusumoto Y, 2016, CLIN IMPLANT DENT R, V18, P261, DOI 10.1111/cid.12293
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Lee JB, 2013, J BIOMED NANOTECHNOL, V9, P424, DOI 10.1166/jbn.2013.1514
   Li J, 2011, MACROMOLECULES, V44, P2918, DOI 10.1021/ma1025434
   Li X, 2015, BIOMATERIALS, V49, P135, DOI 10.1016/j.biomaterials.2015.01.060
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Nishio S, 2012, CIRCULATION, V125, P2343, DOI 10.1161/CIRCULATIONAHA.110.000901
   Ribeiro C, 2015, J BIOMED MATER RES A, V103, P2260, DOI 10.1002/jbm.a.35367
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Run M, 2009, FRONT CHEM ENG CHIN, V3, P255, DOI [10.1007/s11705-009-0008-9, DOI 10.1007/S11705-009-0008-9]
   Saeidlou S, 2012, PROG POLYM SCI, V37, P1657, DOI 10.1016/j.progpolymsci.2012.07.005
   Su CC, 2013, PHYS CHEM CHEM PHYS, V15, P2495, DOI 10.1039/c2cp43523c
   Sun JR, 2010, BIOMACROMOLECULES, V11, P3067, DOI 10.1021/bm100883m
   TSUJI H, 1995, POLYMER, V36, P2709, DOI 10.1016/0032-3861(95)93647-5
   VASANTHAKUMARI R, 1983, POLYMER, V24, P175, DOI 10.1016/0032-3861(83)90129-5
   Wang K, 2012, LANGMUIR, V28, P4382, DOI 10.1021/la205162d
   Wang YM, 2007, J APPL POLYM SCI, V105, P3500, DOI 10.1002/app.26494
   Woo EM, 2015, EUR POLYM J, V71, P27, DOI 10.1016/j.eurpolymj.2015.07.045
   Xie Y, 2012, THE NANOBIOTECHNOLOG
   Xu J, 2005, POLYMER, V46, P9176, DOI 10.1016/j.polymer.2005.07.010
   Zhang TP, 2011, J PHYS CHEM B, V115, P13835, DOI 10.1021/jp2087863
   Zhang YQ, 2014, CRYSTENGCOMM, V16, P1026, DOI 10.1039/c3ce42083c
NR 35
TC 2
Z9 2
U1 6
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2016
VL 27
IS 13
BP 1317
EP 1330
DI 10.1080/09205063.2016.1196530
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA DS8TG
UT WOS:000381055300003
PM 27376548
DA 2018-10-20
ER

PT J
AU Dorrepaal, R
   Malegori, C
   Gowen, A
AF Dorrepaal, Ronan
   Malegori, Cristina
   Gowen, Aoife
TI Tutorial: Time series hyperspectral image analysis
SO JOURNAL OF NEAR INFRARED SPECTROSCOPY
LA English
DT Article
DE hyperspectral; chemometrics; Matlab; R; spike-detection; pre-treatment;
   masking; training; calibration; validation
ID QUALITY
AB A hyperspectral image is a large dataset in which each pixel corresponds to a spectrum, thus providing high-quality detail of a sample surface. Hyperspectral images are thus characterised by dual information, spectral and spatial, which allows for the acquisition of both qualitative and quantitative information from a sample. A hyperspectral image, commonly known as a "hypercube", comprises two spatial dimensions and one spectral dimension. The data of such a file contain both chemical and physical information. Such files need to be analysed with a computational "chemometric" approach in order to reduce the dimensionality of the data, while retaining the most useful spectral information. Time series hyperspectral imaging data comprise multiple hypercubes, each presenting the sample at a different time point, requiring additional considerations in the data analysis. This paper provides a step-by-step tutorial for time series hyperspectral data analysis, with detailed command line scripts in the Matlab and R computing languages presented in the supplementary data. The example time series data, available for download, are a set of time series hyperspectral images following the setting of a cement-based biomaterial. Starting from spectral pre-processing (image acquisition, background removal, dead pixels and spikes, masking) and pre-treatments, the typical steps encountered in time series hyperspectral image processing are then presented, including unsupervised and supervised chemometric methods. At the end of the tutorial paper, some general guidelines on hyperspectral image processing are proposed.
C1 [Dorrepaal, Ronan; Gowen, Aoife] UCD Coll Engn & Architecture, UCD Sch Biosyst & Food Engn, Dublin, Ireland.
   [Malegori, Cristina] Univ Milan, DeFENS Dept Food Environm & Nutr Sci, Milan, Italy.
RP Gowen, A (reprint author), UCD Coll Engn & Architecture, UCD Sch Biosyst & Food Engn, Dublin, Ireland.
EM aoife.gowen@ucd.ie
OI Malegori, Cristina/0000-0002-1760-8915; Dorrepaal,
   Ronan/0000-0002-1429-5570
FU EU FP7 under the European Research Council Starting Grant programme
FX The first and last authors acknowledge funding from the EU FP7 under the
   European Research Council Starting Grant programme.
CR Amigo JM, 2015, ANAL CHIM ACTA, V896, P34, DOI 10.1016/j.aca.2015.09.030
   Burger J, 2011, CHEMOMETR INTELL LAB, V108, P13, DOI 10.1016/j.chemolab.2011.04.001
   Dardenne P., 2009, SOME CONSIDERATIONS
   Esquerre C, 2012, CHEMOMETR INTELL LAB, V117, P129, DOI 10.1016/j.chemolab.2012.02.006
   Firtha F, 2008, SENSORS-BASEL, V8, P3287, DOI 10.3390/s8053287
   Gowen AA, 2011, ANAL CHIM ACTA, V705, P272, DOI 10.1016/j.aca.2011.06.031
   Gowen A, 2014, J NEAR INFRARED SPEC, V22, P261, DOI 10.1255/jnirs.1114
   Huang H, 2014, SENSORS-BASEL, V14, P7248, DOI 10.3390/s140407248
   Li ZJ, 2007, CEMENT CONCRETE RES, V37, P866, DOI 10.1016/j.cemconres.2007.03.015
   Tan Y., 2014, J BIOMED MATER RES A, V103, P194
   Zhang L, 2007, APPL SPECTROSC, V61, P1015, DOI 10.1366/000370207781745847
NR 11
TC 8
Z9 8
U1 2
U2 7
PU N I R PUBLICATIONS
PI CHICHESTER
PA 6 CHARLTON MILL, CHARLTON, CHICHESTER PO18 0HY, WEST SUSSEX, ENGLAND
SN 0967-0335
EI 1751-6552
J9 J NEAR INFRARED SPEC
JI J. Near Infrared Spectrosc.
PY 2016
VL 24
IS 2
BP 89
EP 107
DI 10.1255/jnirs.1208
PG 19
WC Chemistry, Applied; Spectroscopy
SC Chemistry; Spectroscopy
GA DT7PB
UT WOS:000381677600002
OA Green Published
DA 2018-10-20
ER

PT J
AU Lerdchai, K
   Kitsongsermthon, J
   Ratanavaraporn, J
   Kanokpanont, S
   Damrongsakkul, S
AF Lerdchai, Kantarat
   Kitsongsermthon, Jutarat
   Ratanavaraporn, Juthamas
   Kanokpanont, Sorada
   Damrongsakkul, Siriporn
TI Thai Silk Fibroin/Gelatin Sponges for the Dual Controlled Release of
   Curcumin and Docosahexaenoic Acid for Anticancer Treatment
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE silk fibroin; gelatin; curcumin; DHA; cervical cancer cells; controlled
   release; cell culture; biodegradable polymers; proteins; toxicology
ID OSTEOGENIC DIFFERENTIATION; CERVICAL-CANCER; STEM-CELLS; FIBROIN;
   GELATIN; SCAFFOLDS; DELIVERY; CHITOOLIGOSACCHARIDE; CHEMOTHERAPY;
   BIOMATERIAL
AB In this study, curcumin and/or docosahexaenoic acid (DHA) were encapsulated in Thai silk fibroin/gelatin (SF/G) sponges, prepared at different blending ratios, aimed to be applied as a controlled release system for localized cancer therapy. The SF/G sponges were fabricated by freeze-drying and glutaraldehyde cross-linking techniques. Physicochemical properties of the SF/G sponges were characterized. Then, curcumin and/or DHA were loaded in the sponges by physical adsorption. The encapsulation efficiency and the in vitro release of curcumin and/or DHA from the sponges were evaluated. SF/G sponges could encapsulate curcumin and/or DHA at high encapsulation efficiency. The highly cross-linked and slowly degrading SF/G (50/50) sponge released curcumin and/or DHA at the slowest rate. The in vitro cytotoxicity of the sponges against noncancer cells (L929 mouse fibroblast) and anticancer of curcumin and/or DHA released from the sponges against cervical cancer cells (CaSki) were tested. All sponges were not toxic to L929 mouse fibroblast. The mixed curcumin-DHA at the ratio of 1:4 had the highest inhibiting effect on the growth of CaSki, comparing with the release of curcumin or DHA alone. SF/G sponges could be a potential carrier for dual release of curcumin and DHA for anticancer effect. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
C1 [Lerdchai, Kantarat; Kanokpanont, Sorada; Damrongsakkul, Siriporn] Chulalongkorn Univ, Fac Engn, Dept Chem Engn, PhayaThai Rd, Bangkok 10330, Thailand.
   [Kitsongsermthon, Jutarat] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmaceut & Ind Pharm, PhayaThai Rd, Bangkok 10330, Thailand.
   [Ratanavaraporn, Juthamas] Chulalongkorn Univ, Fac Engn, Biomed Engn Program, PhayaThai Rd, Bangkok 10330, Thailand.
RP Damrongsakkul, S (reprint author), Chulalongkorn Univ, Fac Engn, Dept Chem Engn, PhayaThai Rd, Bangkok 10330, Thailand.
EM siriporn.d@chula.ac.th
FU Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University
   [CU-57-006-HR]
FX This work has been supported by the Ratchadaphiseksomphot Endowment Fund
   of Chulalongkorn University (CU-57-006-HR). We thank Assoc. Prof.
   Parvapan Bhattarakosol, Department of Microbiology, Faculty of Medicine,
   Chulalongkorn University for her kind supply of CaSki cells.
CR Altenburg JD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-149
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Dash S, 2010, ACTA POL PHARM, V67, P217
   Gupta V, 2009, INT J NANOMED, V4, P115
   Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4
   Jetbumpenkul P, 2012, INT J BIOL MACROMOL, V50, P7, DOI 10.1016/j.ijbiomac.2011.08.028
   Kasoju N, 2012, J BIOMED MATER RES B, V100B, P1854, DOI 10.1002/jbm.b.32753
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kulkarni AR, 1999, PHARM ACTA HELV, V74, P29, DOI DOI 10.1016/S0031-6865(99)00015-1
   Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10
   LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Manju S, 2011, COLLOID SURFACE B, V82, P588, DOI 10.1016/j.colsurfb.2010.10.021
   Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Okhawilai M, 2010, INT J BIOL MACROMOL, V46, P544, DOI 10.1016/j.ijbiomac.2010.02.008
   Ratanavaraporn J, 2014, J MATER SCI-MATER M, V25, P401, DOI 10.1007/s10856-013-5082-3
   Ratanavaraporn J, 2011, J BIOMAT SCI-POLYM E, V22, P1083, DOI 10.1163/092050610X499050
   Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x
   Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502
   RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J
   Rujisomnapa J, 2007, THESIS
   Saw CLL, 2010, BIOCHEM PHARMACOL, V79, P421, DOI 10.1016/j.bcp.2009.08.030
   Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954
   Siddiqui RA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-418
   Siddiqui RA, 2011, BIOFACTORS, V37, P399, DOI 10.1002/biof.181
   Somvipart S, 2013, INT J BIOL MACROMOL, V55, P176, DOI 10.1016/j.ijbiomac.2013.01.006
   Swamy MV, 2008, NUTR CANCER, V60, P81, DOI 10.1080/01635580802416703
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Thangapazham RL, 2006, AAPS J, V8, pE443, DOI 10.1208/aapsj080352
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6
   Wongputtaraksa T, 2012, J BIOMED MATER RES B, V100B, P2307, DOI 10.1002/jbm.b.32802
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 36
TC 9
Z9 10
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD JAN
PY 2016
VL 105
IS 1
BP 221
EP 230
DI 10.1002/jps.24701
PG 10
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DT8TN
UT WOS:000381768000028
PM 26579620
DA 2018-10-20
ER

PT J
AU Chen, Y
   Song, GL
   Qiu, YH
   Tan, HM
   Ye, YC
   Guo, YW
AF Chen, Yu
   Song, Ganlin
   Qiu, Yihui
   Tan, Huimin
   Ye, Yanchun
   Guo, Yanwen
TI The Recent Progress in the Preparation of Chitosan 6-OH Immobilized
   Cyclodextrin and its Application
SO MINI-REVIEWS IN ORGANIC CHEMISTRY
LA English
DT Article
DE Application; chitosan; cyclodextrin; immobilization; locating;
   preparation
ID BEARING BETA-CYCLODEXTRIN; DRUG-DELIVERY; ADSORPTION PROPERTY; CLICK
   CHEMISTRY; COMPLEXES; NANOPARTICLES; NANOCARRIERS; LIPOSOMES; AGENTS;
   BEADS
AB Chitosan is an ideal biomaterial due to its excellent comprehensive properties. Cyclodextrins bearing the cavity structure and amphiphilic properties have become the focus of supramolecular chemistry. The chemical immobilization of cyclodextrin on the chitosan skeleton can be a feasible means to generate supramolecular host material. However, cyclodextrin is usually immobilized on the 2-NH2 group of chitosan, which suppresses the activities of the amino group such as physiological activities, functionalization, modification, and so on. Therefore, efforts have been made to immobilize cyclodextrin at the 6-OH position of chitosan to maintain the functions of the 2-NH2 group, and thus to achieve materials with the excellent supramolecular inclusion properties of cyclodextrin and the remarkable advantages of chitosan in membrane formation, immobilization, functionalization and biochemical properties, especially the prominent bioactivity derived from its 2-NH2. In the present paper, various recently reported synthesis routes for chitosan 6-OH immobilized cyclodextrin derivatives (CTS-6-CD) were introduced in detail. The applications of CTS-6-CD in drug delivery, absorbents, the corrosion inhibition of metal and biosensor due to the unique properties of CTS-6-CD was reviewed. The perspectives on the developing of particular derivatives were also discussed.
C1 [Chen, Yu; Song, Ganlin; Qiu, Yihui; Tan, Huimin] Beijing Inst Technol, Sch Mat Sci & Engn, Beijing, Peoples R China.
   [Ye, Yanchun; Guo, Yanwen] Beijing Inst Technol, Sch Chem, Beijing, Peoples R China.
RP Chen, Y (reprint author), Beijing Inst Technol, Sch Mat Sci & Engn, Beijing, Peoples R China.
EM cylsy@163.com
FU Natural Science Foundation of China [50903008]; Youth Talent Plan of
   Beijing City [YETP1163]; Combination Project of Guangdong Province
   [2013A090100005]; "Yangfan" Innovative Research Team Project of
   Guangdong Province
FX The authors gratefully acknowledge the financial support of the Natural
   Science Foundation of China (No. 50903008), the Youth Talent Plan of
   Beijing City (YETP1163), the Combination Project of Guangdong Province
   (2013A090100005) and the "Yangfan" Innovative Research Team Project of
   Guangdong Province.
CR Alamdarnejad G, 2013, J MATER SCI-MATER M, V24, P1939, DOI 10.1007/s10856-013-4947-9
   Billiet L, 2009, POLYMER, V50, P3877, DOI 10.1016/j.polymer.2009.06.034
   Chen CY, 2007, BIORESOURCE TECHNOL, V98, P2578, DOI 10.1016/j.biortech.2006.09.009
   Chen WT, 2015, MOL CRYST LIQ CRYST, V612, P220, DOI 10.1080/15421406.2015.1031583
   Chen Y, 2015, INT J POLYM SCI, DOI 10.1155/2015/419506
   Chen Y, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41499
   Chen Y, 2013, FIBER POLYM, V14, P1058, DOI 10.1007/s12221-013-1058-7
   Chen Y, 2012, J APPL POLYM SCI, V125, pE378, DOI 10.1002/app.36836
   Chen Y, 2009, ACTA POLYM SIN, P712
   Chiu SH, 2004, FOOD RES INT, V37, P217, DOI 10.1016/j.foodres.2003.12.001
   Cho E, 2015, MOLECULES, V20, P19620, DOI 10.3390/molecules201019620
   Fan LL, 2012, COLLOID SURFACE B, V95, P42, DOI 10.1016/j.colsurfb.2012.02.007
   Gaffar MA, 2004, CARBOHYD POLYM, V56, P387, DOI 10.1016/j.carbpol.2004.01.007
   [葛亚芳 GE Yafang], 2010, [化工进展, Chemical Industry and Engineering Progress], V29, P233
   Gharib R, 2015, CARBOHYD POLYM, V129, P175, DOI 10.1016/j.carbpol.2015.04.048
   Gidwani B, 2014, COLLOID SURFACE B, V114, P130, DOI 10.1016/j.colsurfb.2013.09.035
   Hong SS, 2015, INT J PHARMACEUT, V483, P142, DOI 10.1016/j.ijpharm.2015.02.013
   Krajewska B, 2005, SEP PURIF TECHNOL, V41, P305, DOI 10.1016/j.seppur.2004.03.019
   [李海丰 LI Hai-feng], 2009, [环境科学与技术, Enuivonmental Science and Technology], V32, P1
   Li WH, 2012, APPL MECH MATER, V152-154, P244, DOI 10.4028/www.scientific.net/AMM.152-154.244
   Li W, 2012, ADV MATER RES-SWITZ, V461, P393, DOI 10.4028/www.scientific.net/AMR.461.393
   Liu Y, 2015, IND ENG CHEM RES, V54, P5664, DOI 10.1021/acs.iecr.5b00930
   [马志伟 MA Zhiwei], 2007, [合成化学, Chinese Journal of Synthetic Chemistry], V15, P605
   Mavridis IM, 2015, INT J PHARMACEUT, V492, P275, DOI 10.1016/j.ijpharm.2015.06.004
   Natarajan JV, 2014, J CONTROL RELEASE, V193, P122, DOI 10.1016/j.jconrel.2014.05.029
   Ojijo V, 2013, PROG POLYM SCI, V38, P1543, DOI 10.1016/j.progpolymsci.2013.05.011
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   Prochowicz D, 2016, COORDIN CHEM REV, V306, P331, DOI 10.1016/j.ccr.2015.07.016
   Qian YY, 2015, INT J ELECTROCHEM SC, V10, P10756
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Sreenivasan K, 1998, J APPL POLYM SCI, V69, P1051, DOI 10.1002/(SICI)1097-4628(19980808)69:6<1051::AID-APP1>3.0.CO;2-F
   Valente AJM, 2014, ADV COLLOID INTERFAC, V205, P156, DOI 10.1016/j.cis.2013.08.001
   VPPalayam S. P., 2013, NAT PROD COMMUN, V8, P221
   Wade L. G., 1999, ORGANIC CHEM, P822
   Wang GH, 2010, FRESEN ENVIRON BULL, V19, P811
   [王晓明 Wang Xiaoming], 2015, [环境工程学报, Chinese Journal of Environmental Engineering], V9, P2237
   Yang S, 2016, SMALL, V12, P360, DOI 10.1002/smll.201503121
   Yukiko E. R., 2012, CARBOHYD POLYM, V87, P2237
   Zha F, 2008, CARBOHYD POLYM, V72, P456, DOI 10.1016/j.carbpol.2007.09.013
   Zha F, 2007, J MACROMOL SCI A, V44, P413, DOI 10.1080/10601320601188232
   Zhang JX, 2013, ADV DRUG DELIVER REV, V65, P1215, DOI 10.1016/j.addr.2013.05.001
   Zhang XY, 2004, J APPL POLYM SCI, V94, P860, DOI 10.1002/app.20759
   Zheng W, 2014, BIO-MED MATER ENG, V24, P229, DOI 10.3233/BME-130803
   Zhou LC, 2012, ACTA PHYS-CHIM SIN, V28, P1615, DOI 10.3866/PKU.WHXB201204282
NR 44
TC 0
Z9 0
U1 1
U2 20
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-193X
EI 1875-6298
J9 MINI-REV ORG CHEM
JI Mini-Rev. Org. Chem.
PY 2016
VL 13
IS 2
BP 154
EP 163
DI 10.2174/1570193X13666160225000901
PG 10
WC Chemistry, Organic
SC Chemistry
GA DS5QL
UT WOS:000380837100007
DA 2018-10-20
ER

PT J
AU Ge, F
   Yu, MF
   Lin, J
   Yu, CX
   Weng, WJ
   Cheng, K
   Wang, HM
AF Ge, Fei
   Yu, Mengfei
   Lin, Jun
   Yu, Cuixia
   Weng, Wenjian
   Cheng, Kui
   Wang, Huiming
TI Mesenchymal stem cells in response to exposed rod-heights of TiO2
   nanorod films
SO RSC ADVANCES
LA English
DT Article
ID DIFFERENTIATION; NANOTUBES; SURFACE; MORPHOLOGY; SCAFFOLDS; CELLULOSE;
   NANOWIRE; GROWTH
AB Cellular responses are strongly sensitive to surface structure, so the optimization of the structures is essential in biomaterial research. In this work, the exposed nanorod-heights in TiO2 nanorod films were adjusted for enhancing cellular responses. The adjustment was realized by incorporating mesoporous bioactive glass (MBG) into the nanorod films via a sol-gel method. The exposed nanorod-heights in the films could be changed from the original similar to 300 nm to similar to 200 nm and similar to 100 nm. The cellular responses on the nanostructured surfaces were evaluated through culturing mesenchymal stem cells (MSCs). The results showed that the films with shortened nanorod-heights had better cellular responses and could accelerate osteogenic differentiation and mineralization, and the films with 100 nm nanorod-height provided the best surface for cell growth. This is attributed to the nanostructure with the shortened nanorod-heights being well recognized by the cells, consequently the cells grew with a faster osteogenic differentiation through a strengthened BMP-smads signal pathway.
C1 [Ge, Fei; Yu, Cuixia; Weng, Wenjian; Cheng, Kui] Zhejiang Univ, State Key Lab Silicon Mat, Sch Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
   [Yu, Mengfei; Lin, Jun; Wang, Huiming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.
   [Weng, Wenjian] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Weng, WJ (reprint author), Zhejiang Univ, State Key Lab Silicon Mat, Sch Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.; Wang, HM (reprint author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.; Weng, WJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
EM wengwj@zju.edu; wangmysm@yahoo.com.cn
FU National Natural Science Foundation of China [51272228, 81271955,
   51472216, 51372217]; National Basic Research Program of China (973
   Program) [2012CB933600]; Fundamental Research Funds for the Central
   Universities [2013QNA4010, 2014XZZX005]
FX This work is financially supported by the National Natural Science
   Foundation of China (51272228, 81271955, 51472216, 51372217), National
   Basic Research Program of China (973 Program, 2012CB933600). The Key
   Science Technology Innovation Team of Zhejiang Province (2013TD02),
   Natural Science Foundation of Zhejiang (LY15E020004) and Fundamental
   Research Funds for the Central Universities (2013QNA4010, 2014XZZX005).
CR Azadmanjiri J, 2016, RSC ADV, V6, P55825, DOI 10.1039/c6ra10289a
   Bagherifard S, 2014, ACS APPL MATER INTER, V6, P7963, DOI 10.1021/am501119k
   Cheng K, 2015, COLLOID SURFACE B, V126, P387, DOI 10.1016/j.colsurfb.2014.12.002
   Chung TH, 2016, RSC ADV, V6, P45553, DOI 10.1039/c6ra03453e
   Collart-Dutilleul PY, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-564
   Dai XH, 2016, RSC ADV, V6, P43685, DOI 10.1039/c6ra04772f
   El-Said WA, 2010, ULTRAMICROSCOPY, V110, P676, DOI 10.1016/j.ultramic.2010.02.031
   Feng J, 2014, RSC ADV, V4, P28683, DOI 10.1039/c4ra03122a
   Khandare JJ, 2012, NANOSCALE, V4, P837, DOI 10.1039/c1nr11540e
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Li GL, 2016, ACS APPL MATER INTER, V8, P3840, DOI 10.1021/acsami.5b10633
   Li M, 2016, RSC ADV, V6, P36910, DOI 10.1039/c6ra00398b
   Li Z, 2016, RSC ADV, V6, P42229, DOI 10.1039/c6ra07685h
   Liu DD, 2015, RSC ADV, V5, P42233, DOI 10.1039/c5ra02311d
   Liu XW, 2015, ACS APPL MATER INTER, V7, P18540, DOI 10.1021/acsami.5b04868
   Luo M, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215605
   Luu TU, 2015, ACS APPL MATER INTER, V7, P28665, DOI 10.1021/acsami.5b10589
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Seo JH, 2016, RSC ADV, V6, P35668, DOI 10.1039/c6ra03967g
   Song JL, 2014, IND ENG CHEM RES, V53, P708, DOI 10.1021/ie4036803
   Tang D, 2011, THIN SOLID FILMS, V519, P7644, DOI 10.1016/j.tsf.2011.05.011
   Vida Y, 2016, RSC ADV, V6, P49839, DOI 10.1039/c6ra06177j
   Xia LG, 2016, J MATER CHEM B, V4, P3313, DOI 10.1039/c6tb00187d
   Zhao D, 2015, J MATER CHEM B, V3, P4272, DOI 10.1039/c5tb00324e
   Zhao HX, 2011, BIOMATERIALS, V32, P5837, DOI 10.1016/j.biomaterials.2011.04.083
   Zheng HJ, 2007, J GERONTOL A-BIOL, V62, P136, DOI 10.1093/gerona/62.2.136
   Zhou JH, 2013, ACS APPL MATER INTER, V5, P5358, DOI 10.1021/am401339n
NR 27
TC 4
Z9 4
U1 8
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 72
BP 67778
EP 67784
DI 10.1039/c6ra13081j
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA DS1NM
UT WOS:000380362700039
DA 2018-10-20
ER

PT J
AU Cheng, Y
   Zhou, FF
   Li, SB
   Chen, ZL
AF Cheng, Ying
   Zhou, Fengfei
   Li, Shibin
   Chen, Zuliang
TI Removal of mixed contaminants, crystal violet, and heavy metal ions by
   using immobilized stains as the functional biomaterial
SO RSC ADVANCES
LA English
DT Article
ID BURKHOLDERIA-VIETNAMIENSIS C09V; AQUEOUS-SOLUTION; GEL BEADS;
   BIOSORPTION; KAOLIN; COPPER; DYE; BIODEGRADATION; EQUILIBRIUM;
   DECOLORIZATION
AB A new functional biomaterial based on Burkholderia vietnamiensis C09V (C09V) was immobilized on beads and used for simultaneous removal of both heavy metals and crystal violet (CV). The results showed that removal of CV and metal ions using immobilized cell bead (biomaterial) was more efficient than that of free cells, wherein 89.4% of CV and 64.1% of Cu(II) were removed after 42 h of using the biomaterial, whilst only 27.1% of CV and 23.9% of Cu(II) were removed by free cells. Similar results were also observed in the CV and Cr(VI) removal. Fourier transform infrared spectroscopy (FTIR) revealed the change of functional groups in the presence of heavy metals. Scanning electron microscopy (SEM) showed that the existence of Cu( II) and Cr(VI) affected the cellular morphology of the strain. X-ray energy-dispersive spectrometer (EDS) indicated that Cu(II) and Cr(VI) adsorbed. Further Cr(VI) reduced to Cr(III) was observed by X-ray photoelectron spectroscopy analysis (XPS). Finally, reusability and wastewater application were carried out, which shows that this functional material has a potential for co-removal of CV and heavy metals.
C1 [Cheng, Ying; Zhou, Fengfei; Chen, Zuliang] Fujian Normal Univ, Sch Environm Sci & Engn, Fuzhou 350007, Fujian Province, Peoples R China.
   [Li, Shibin] Texas Tech Univ, Inst Environm & Human Hlth TIEHH, Dept Environm Toxicol, Lubbock, TX 79409 USA.
   [Cheng, Ying; Chen, Zuliang] Univ Newcastle, Global Ctr Environm Remediat, Callaghan, NSW 2308, Australia.
RP Chen, ZL (reprint author), Fujian Normal Univ, Sch Environm Sci & Engn, Fuzhou 350007, Fujian Province, Peoples R China.; Chen, ZL (reprint author), Univ Newcastle, Global Ctr Environm Remediat, Callaghan, NSW 2308, Australia.
EM zuliang.chen@newcastle.edu.au
FU Department of Science and Technology, Fujian Province, China [2014Y0055]
FX The financial support of key project (2014Y0055), Department of Science
   and Technology, Fujian Province, China is gratefully acknowledged.
CR Aksu Z, 2009, J HAZARD MATER, V168, P310, DOI 10.1016/j.jhazmat.2009.02.027
   Bajguz A, 2011, ARCH ENVIRON CON TOX, V60, P406, DOI 10.1007/s00244-010-9551-0
   Chen CY, 2009, J HAZARD MATER, V172, P1439, DOI 10.1016/j.jhazmat.2009.08.009
   Cheng Y, 2012, ECOTOX ENVIRON SAFE, V83, P108, DOI 10.1016/j.ecoenv.2012.06.017
   dos Santos AB, 2007, BIORESOURCE TECHNOL, V98, P2369, DOI 10.1016/j.biortech.2006.11.013
   Gao JF, 2010, BIORESOURCE TECHNOL, V101, P5793, DOI 10.1016/j.biortech.2010.02.091
   Ha J, 2009, BIORESOURCE TECHNOL, V100, P1138, DOI 10.1016/j.biortech.2008.08.022
   Jadhav JP, 2010, BIORESOURCE TECHNOL, V101, P165, DOI 10.1016/j.biortech.2009.08.027
   Colin VL, 2012, INT BIODETER BIODEGR, V69, P28, DOI 10.1016/j.ibiod.2011.12.001
   Li YH, 2011, J ENVIRON SCI-CHINA, V23, P404, DOI 10.1016/S1001-0742(10)60442-1
   Liu YJ, 2009, BIOCHEM ENG J, V44, P187, DOI 10.1016/j.bej.2008.12.001
   Maznah WOW, 2012, J ENVIRON SCI-CHINA, V24, P1386, DOI 10.1016/S1001-0742(11)60931-5
   Nandi BK, 2009, APPL CLAY SCI, V42, P583, DOI 10.1016/j.clay.2008.03.015
   Nandi BK, 2009, J HAZARD MATER, V161, P387, DOI 10.1016/j.jhazmat.2008.03.110
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   Pour ZS, 2015, RSC ADV, V5, P64106, DOI 10.1039/c5ra08025h
   Quintelas C, 2009, CHEM ENG J, V149, P319, DOI 10.1016/j.cej.2008.11.025
   Rosales E, 2012, DESALINATION, V284, P150, DOI 10.1016/j.desal.2011.08.049
   Saeed A, 2009, J HAZARD MATER, V168, P406, DOI 10.1016/j.jhazmat.2009.02.058
   Song HX, 2009, BIORESOURCE TECHNOL, V100, P5079, DOI 10.1016/j.biortech.2009.05.060
   Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003
   Srivastava S, 2015, ENVIRON SCI POLLUT R, V22, P15386, DOI 10.1007/s11356-015-5278-9
   Tan CY, 2011, DESALINATION, V266, P56, DOI 10.1016/j.desal.2010.08.002
   Wang BE, 2008, J HAZARD MATER, V157, P1, DOI 10.1016/j.jhazmat.2007.12.069
   Wang SL, 2009, DESALINATION, V249, P991, DOI 10.1016/j.desal.2009.09.017
   Wu L, 2009, J ENVIRON SCI-CHINA, V21, P237, DOI 10.1016/S1001-0742(08)62257-3
   Yahaya YA, 2009, J HAZARD MATER, V161, P189, DOI 10.1016/j.jhazmat.2008.03.104
   Zhou FF, 2014, ECOTOX ENVIRON SAFE, V105, P1, DOI 10.1016/j.ecoenv.2014.03.028
   Zhou LC, 2009, J HAZARD MATER, V167, P1106, DOI 10.1016/j.jhazmat.2009.01.118
NR 29
TC 1
Z9 1
U1 1
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 72
BP 67858
EP 67865
DI 10.1039/c6ra13337a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DS1NM
UT WOS:000380362700048
DA 2018-10-20
ER

PT J
AU Alshemary, AZ
   Pazarceviren, AE
   Tezcaner, A
   Evis, Z
AF Alshemary, Ammar Z.
   Pazarceviren, Ahmet Engin
   Tezcaner, Aysen
   Evis, Zafer
TI Mesoporous strontium doped nano sized sulphate hydroxyapatite as a novel
   biomaterial for bone tissue applications
SO RSC ADVANCES
LA English
DT Article
ID IN-VITRO BIOACTIVITY; SUBSTITUTED HYDROXYAPATITE; BIOMEDICAL
   APPLICATIONS; CALCIUM PHOSPHATES; CELL-PROLIFERATION; PROTEIN
   ADSORPTION; DRUG-RELEASE; OSTEOBLAST; SURFACE; NANOPARTICLES
AB In this study a novel nano-structured hydroxyapatite (HA) incorporated with different fractions of Sr2+ and SO42- ions has been synthesized using the wet precipitation method and characterized. This study explored the potential benefits of dual doping of Sr2+ and SO42- ions for the first time, which would contribute to bone prosthetics' clinical success. The substitution of Sr2+ and SO42- ions into the HA crystal structure was confirmed using XRD, FTIR, Raman spectroscopy, FESEM, BET and XPS techniques. Fetal Bovine Serum (FBS) was used as a model protein for adsorption assay. FBS revealed higher affinity towards Sr-SHA materials rather than pure HA. In vitro bioactivity studies showed that the HA dissolution rate increased with incorporation of Sr2+ and SO42- ions in the HA structure. The highest dissolution rate was recorded on the 1st day of immersion in Simulated Body Fluid (SBF) for SHA and Sr-SHA groups. Intense growth of apatite grains on the surface of Sr-SHA with Ca/P ratio of (1.41-1.64) was observed after 14 days of incubation in SBF. In vitro cytotoxicity studies conducted with Sarcoma Osteogenic (Saos-2) cells showed that Sr-SHA was cytocompatible. It was observed that Sr-SHA promoted cell adhesion, spreading and proliferation of Saos-2 cells compared to pure HA. Saos-2 cells seeded on Sr-SHA had statistically higher alkaline phosphatase (ALP) activity and intracellular calcium deposition compared to HA. Collectively, our results showed that Sr-SHA materials with enhanced bioactivity, cytocompatibility and osteogenic activity hold great potential to be used as materials for bone tissue regeneration.
C1 [Alshemary, Ammar Z.; Pazarceviren, Ahmet Engin; Tezcaner, Aysen; Evis, Zafer] Middle East Tech Univ, Engn Sci, TR-06800 Ankara, Turkey.
RP Alshemary, AZ (reprint author), Middle East Tech Univ, Engn Sci, TR-06800 Ankara, Turkey.
EM am84ch@gmail.com
RI Pazarceviren, Ahmet Engin/A-9564-2017
OI Pazarceviren, Ahmet Engin/0000-0001-5233-860X
FU TUBITAK via 2221 Visiting Scientists Fellowship Programme
FX The authors would like to thank TUBITAK for providing financial support
   via 2221 Visiting Scientists Fellowship Programme.
CR Abe Y, 2013, BIOMED RES INT, DOI 10.1155/2013/626452
   Alshemary AZ, 2015, CERAM INT, V41, P11886, DOI 10.1016/j.ceramint.2015.06.003
   Alshemary AZ, 2015, J ALLOY COMPD, V645, P478, DOI 10.1016/j.jallcom.2015.05.064
   Alshemary AZ, 2015, SCI ADV MATER, V7, P249, DOI 10.1166/sam.2015.2103
   Alshemary AZ, 2013, MATER RES BULL, V48, P2106, DOI 10.1016/j.materresbull.2013.02.015
   Anjaneyulu U, 2016, RSC ADV, V6, P10997, DOI 10.1039/c5ra21479c
   Bakker AD, 2013, BONE, V53, P112, DOI 10.1016/j.bone.2012.11.044
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Bhat Sumrita, 2013, Biomatter, V3, DOI 10.4161/biom.24717
   Bigi A, 2007, INORG CHIM ACTA, V360, P1009, DOI 10.1016/j.ica.2006.07.074
   Boyd AR, 2015, MAT SCI ENG C-MATER, V46, P290, DOI 10.1016/j.msec.2014.10.046
   Boyd A. R., 2015, J MATER SCI-MATER M, V26, P1
   Cai YL, 2009, THIN SOLID FILMS, V517, P5347, DOI 10.1016/j.tsf.2009.03.071
   Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Caverzasio J, 2008, BONE, V42, P1131, DOI 10.1016/j.bone.2008.02.010
   Chandra VS, 2015, CERAM INT, V41, P13153, DOI 10.1016/j.ceramint.2015.07.088
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   de Araujo TS, 2007, J MATER SCI, V42, P2236, DOI 10.1007/s10853-006-0536-3
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Fan X, 2009, T NONFERR METAL SOC, V19, P347, DOI 10.1016/S1003-6326(08)60276-9
   Fang C, 2014, J MATER CHEM B, V2, P1264, DOI 10.1039/c3tb21544j
   Filippousi M, 2015, J MATER CHEM B, V3, P5991, DOI 10.1039/c5tb00827a
   FOWLER BO, 1974, INORG CHEM, V13, P207, DOI 10.1021/ic50131a040
   Fraga AF, 2011, APPL SURF SCI, V257, P3888, DOI 10.1016/j.apsusc.2010.11.104
   Fromigue O, 2006, OSTEOPOROSIS INT, V17, pS351
   Ocampo JIG, 2016, J ADV RES, V7, P297, DOI 10.1016/j.jare.2015.06.006
   Gu J., 2016, J MATER SCI-MATER M, V27, P1
   Hapanowicz RP, 1996, J SOLID STATE CHEM, V123, P183, DOI 10.1006/jssc.1996.0166
   Hemalatha T, 2014, ACTA METALL SIN-ENGL, V27, P1152, DOI 10.1007/s40195-014-0153-0
   Holland TJB, 1997, MINERAL MAG, V61, P65, DOI 10.1180/minmag.1997.061.404.07
   Johal KK, 2002, J MATER SCI-MATER M, V13, P375, DOI 10.1023/A:1014336517741
   Ke DX, 2015, J BIOMED MATER RES B, V103, P1549, DOI 10.1002/jbm.b.33321
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kolmas J, 2007, SOLID STATE NUCL MAG, V32, P53, DOI 10.1016/j.ssnmr.2007.08.001
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Lee WH, 2013, RSC ADV, V3, P4040, DOI 10.1039/c3ra22966a
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Li K, 2012, ADV ENG MATER, V14, pB155, DOI 10.1002/adem.201080145
   Liu JL, 2005, J MATER SCI, V40, P6145, DOI 10.1007/s10853-005-3165-3
   Liu P, 2014, MED PRIN PRACT, V23, P264, DOI 10.1159/000359951
   Liyana M. R. N., 2014, Advanced Materials Research, V980, P13, DOI 10.4028/www.scientific.net/AMR.980.13
   Manimekalai R., 2012, OPT PHOTONICS J, V2, P1
   Mostafa NY, 2011, J AM CERAM SOC, V94, P1584, DOI 10.1111/j.1551-2916.2010.04282.x
   Mukherjee S, 2008, J AM CHEM SOC, V130, P1264, DOI 10.1021/ja0759949
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Orellana BR, 2015, J BIOMED MATER RES B, V103, P135, DOI 10.1002/jbm.b.33181
   PELTIER LF, 1978, J BONE JOINT SURG AM, V60, P820, DOI 10.2106/00004623-197860060-00017
   Ramesh K, 2012, J PHYS CHEM C, V116, P18736, DOI 10.1021/jp304187v
   Raucci MG, 2016, REGEN BIOMATER, V3, P13, DOI 10.1093/rb/rbv026
   Raucci M.G., 2015, J MATER SCI-MATER M, V26, P1
   Rodriguez J., 2011, ACTA ODONTOL LATINOA, V25, P208
   Romer P, 2012, ANN ANAT, V194, P208, DOI 10.1016/j.aanat.2011.09.008
   Shiba K, 2016, CRYST GROWTH DES, V16, P1463, DOI 10.1021/acs.cgd.5b01599
   Smith IO, 2004, J BIOMED MATER RES A, V70A, P436, DOI 10.1002/jbm.a.30098
   Steinfurth D, 2012, J PLANT PHYSIOL, V169, P72, DOI 10.1016/j.jplph.2011.08.012
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Supova M, 2015, CERAM INT, V41, P9203, DOI 10.1016/j.ceramint.2015.03.316
   Surmeneva MA, 2013, RSC ADV, V3, P11240, DOI 10.1039/c3ra40446c
   Tarafder S, 2010, LANGMUIR, V26, P16625, DOI 10.1021/la101851f
   Vandiver J, 2006, J BIOMED MATER RES A, V78A, P352, DOI 10.1002/jbm.a.30737
   Wang P, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.17
   Wang YH, 2016, COLLOID SURFACE B, V140, P297, DOI 10.1016/j.colsurfb.2015.12.056
   Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yan TT, 2013, ADV MATER RES-SWITZ, V738, P38, DOI 10.4028/www.scientific.net/AMR.738.38
   Yang F, 2011, STEM CELLS, V29, P981, DOI 10.1002/stem.646
   Yang YH, 2013, J MATER CHEM B, V1, P2447, DOI 10.1039/c3tb20365d
   Zhao HY, 2010, J CATAL, V272, P176, DOI 10.1016/j.jcat.2010.02.028
   Zhao YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069339
   Zhou JH, 2013, ACS APPL MATER INTER, V5, P5358, DOI 10.1021/am401339n
NR 73
TC 4
Z9 4
U1 8
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 72
BP 68058
EP 68071
DI 10.1039/c6ra16809d
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA DS1NM
UT WOS:000380362700070
DA 2018-10-20
ER

PT J
AU Wang, Y
   Zhang, BM
   Zhai, GX
AF Wang, Yang
   Zhang, Baomei
   Zhai, Guangxi
TI The effect of incubation conditions on the hemolytic properties of
   unmodified graphene oxide with various concentrations
SO RSC ADVANCES
LA English
DT Article
ID THROMBO-PROTECTIVE SAFER; BIOMEDICAL APPLICATIONS; RABBIT ERYTHROCYTES;
   IN-VITRO; DIABETES-MELLITUS; OSMOTIC FRAGILITY; AQUEOUS-SOLUTIONS;
   OXIDATIVE STRESS; SURFACE-AREA; SIALIC-ACID
AB The hemolysis assay is a common method used to evaluate the in vitro biocompatibility of biomaterials, but presently there is inadequate understanding of the interactions between RBCs and biomaterials, especially from the view of the incubation conditions and sample concentration. In this report, we used unmodified graphene oxide (GO) as a biomaterial model and measured the hemolytic properties of GO at a series of concentrations under multiple conditions, including medium type, red blood cell (RBC) species, RBC concentration, storage duration of the RBCs, animal health status, centrifugal speed, exposure time and incubation temperature. Additionally, a calculation method for the hemolytic index was proposed so as to objectively evaluate the hemolysis properties, distinct from frequently used methods. Compared to the hemolytic results under these conditions, we found that the hemolytic properties of GO had huge differences, and false-negative or false-positive errors might be produced by inappropriate incubation conditions. In our opinion, the feasible conditions for unmodified GO are: isotonic glucose solution as the medium type, fresh and healthy rabbit RBCs as the test object, 1% hematocrit as the RBC concentration, 3000 rpm for 5 min as the centrifugation conditions, 6 h as the exposure time and physiological temperature (37 degrees C) as the incubation temperature.
C1 [Wang, Yang; Zhang, Baomei; Zhai, Guangxi] Shandong Univ, Dept Pharmaceut, Coll Pharmaceut Sci, Jinan 250012, Peoples R China.
RP Zhai, GX (reprint author), Shandong Univ, Dept Pharmaceut, Coll Pharmaceut Sci, Jinan 250012, Peoples R China.
EM professorgxzhai@126.com
FU Natural Science Foundation of Shandong Province, China [ZR2015HM032]
FX This work was supported by the Natural Science Foundation of Shandong
   Province, China (No. ZR2015HM032).
CR ALARCONSEGOVIA D, 1979, J IMMUNOL, V122, P1855
   ALONI B, 1977, BIOCHIM BIOPHYS ACTA, V465, P46, DOI 10.1016/0005-2736(77)90354-6
   American Society for Testing and Materials, 2000, F75600 ASTM, pF756
   Arosio D, 2002, BIOPOLYMERS, V63, P1, DOI 10.1002/bip.1057
   BALDUINI CL, 1977, H-S Z PHYSIOL CHEM, V358, P1143, DOI 10.1515/bchm2.1977.358.2.1143
   Balkan J, 2002, BIOSCI BIOTECH BIOCH, V66, P2701, DOI 10.1271/bbb.66.2701
   BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   Bersenyi A, 2003, ACTA VET HUNG, V51, P297, DOI 10.1556/AVet.51.2003.3.5
   Buhler I, 2001, EUR J CLIN INVEST, V31, P79, DOI 10.1046/j.1365-2362.2001.00769.x
   Cai B, 2015, APPL SURF SCI, V356, P844, DOI 10.1016/j.apsusc.2015.08.178
   CHALFIN D, 1956, J CELL COMPAR PHYSL, V47, P215, DOI 10.1002/jcp.1030470204
   Chan KC, 2007, FOOD CHEM TOXICOL, V45, P502, DOI 10.1016/j.fct.2006.10.005
   Cheng C, 2012, BIOMACROMOLECULES, V13, P4236, DOI 10.1021/bm3014999
   CONDREA E, 1964, BIOCHIM BIOPHYS ACTA, V84, P365, DOI 10.1016/0926-6542(64)90001-0
   Coppola L, 1997, DIABETIC MED, V14, P959
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DEGIER J, 1961, BIOCHIM BIOPHYS ACTA, V49, P286, DOI 10.1016/0006-3002(61)90128-7
   DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V266, P26, DOI 10.1016/0005-2736(72)90116-2
   Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615
   Dong X. U., 2010, CHEM J CHINESE U, V31, P2354
   Lemos GSD, 2011, CELL BIOCHEM BIOPHYS, V61, P531, DOI 10.1007/s12013-011-9235-z
   DUROCHER JR, 1975, BLOOD, V45, P11
   Feng R, 2015, J BIOMED MATER RES A, V103, P2006, DOI 10.1002/jbm.a.35341
   Forsyth AM, 2012, MICROVASC RES, V83, P347, DOI 10.1016/j.mvr.2012.02.004
   Guo CL, 2011, CHEM COMMUN, V47, P12658, DOI 10.1039/c1cc15052a
   Guo MX, 2013, CARBON, V61, P321, DOI 10.1016/j.carbon.2013.05.011
   He A, 2013, RSC ADV, V3, P22120, DOI 10.1039/c3ra44775h
   Henkelman S, 2009, MAT SCI ENG C-BIO S, V29, P1650, DOI 10.1016/j.msec.2009.01.002
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   JAFFE ER, 1958, J CLIN INVEST, V37, P1293, DOI 10.1172/JCI103717
   JONES RL, 1981, AM J MED, V70, P339, DOI 10.1016/0002-9343(81)90771-3
   Kiew SF, 2016, J CONTROL RELEASE, V226, P217, DOI 10.1016/j.jconrel.2016.02.015
   Kiriukhin MY, 2002, BIOPHYS CHEM, V99, P155, DOI 10.1016/S0301-4622(02)00153-9
   Koenig SP, 2011, NAT NANOTECHNOL, V6, P543, DOI [10.1038/nnano.2011.123, 10.1038/NNANO.2011.123]
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Lee SC, 2015, SCI REP-UK, V5, DOI 10.1038/srep12306
   LEVERETT LB, 1972, BIOPHYS J, V12, P257, DOI 10.1016/S0006-3495(72)86085-5
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   MAGINNISS LA, 1987, ENVIRON HEALTH PERSP, V72, P35
   MALMBERG CG, 1950, J RES NAT BUR STAND, V45, P299, DOI 10.6028/jres.045.030
   Meng N, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/18/185101
   Montes-Navajas P, 2013, LANGMUIR, V29, P13443, DOI 10.1021/la4029904
   NELSON GJ, 1967, BIOCHIM BIOPHYS ACTA, V144, P221, DOI 10.1016/0005-2760(67)90152-X
   Papi M, 2015, RSC ADV, V5, P81638, DOI 10.1039/c5ra15083c
   PATEL VP, 1985, P NATL ACAD SCI USA, V82, P440, DOI 10.1073/pnas.82.2.440
   Pei XB, 2014, ACS NANO, V8, P1966, DOI 10.1021/nn5000578
   Pinto AM, 2016, CARBON, V99, P318, DOI 10.1016/j.carbon.2015.11.076
   Pinto AM, 2013, COLLOID SURFACE B, V111, P188, DOI 10.1016/j.colsurfb.2013.05.022
   Ren HL, 2010, ACS NANO, V4, P7169, DOI 10.1021/nn101696r
   Resmi H, 2005, CELL BIOCHEM FUNCT, V23, P163, DOI 10.1027/cbf.1129
   RICHIERI GV, 1985, BIOCHIM BIOPHYS ACTA, V813, P41, DOI 10.1016/0005-2736(85)90343-8
   SARDET C, 1972, J LIPID RES, V13, P705
   Seabra AB, 2014, CHEM RES TOXICOL, V27, P159, DOI 10.1021/tx400385x
   SEEMAN P, 1969, BIOCHIM BIOPHYS ACTA, V183, P476, DOI 10.1016/0005-2736(69)90162-X
   Shamsipur M, 2015, MICROCHIM ACTA, V182, P1131, DOI 10.1007/s00604-014-1428-x
   Shang JZ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00792
   Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t
   SMITH EKM, 1972, CAN J PHYSIOL PHARM, V50, P791, DOI 10.1139/y72-115
   SMITH GN, 1973, SCAND J HAEMATOL, V11, P188
   SNYDER LM, 1985, BRIT J HAEMATOL, V59, P513, DOI 10.1111/j.1365-2141.1985.tb07338.x
   Some S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06314
   Tan JT, 2016, MAT SCI ENG C-MATER, V61, P681, DOI 10.1016/j.msec.2015.12.098
   Thampi S, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41809
   Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]
   Wan H, 2014, NANOSCALE, V6, P8743, DOI 10.1039/c4nr01044b
   Wang TT, 2015, TOXICOL RES-UK, V4, P885, DOI 10.1039/c4tx00138a
   Wang YL, 2015, ACS NANO, V9, P10142, DOI 10.1021/acsnano.5b03763
   WAUGH RE, 1992, BLOOD, V79, P1351
   Whitby RLD, 2012, ACS NANO, V6, P3967, DOI 10.1021/nn3002278
   Widmaier E. P., 2011, VANDERS HUMAN PHYSL, P359
   Wu HX, 2014, CARBON, V69, P379, DOI 10.1016/j.carbon.2013.12.039
   Xiao YH, 2014, DRUG DELIV, V21, P362, DOI 10.3109/10717544.2013.846997
   Xie XY, 2015, NANOSCALE, V7, P7992, DOI 10.1039/c5nr01107h
   Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005
   Zhou NL, 2013, J MATER SCI, V48, P7097, DOI 10.1007/s10853-013-7523-2
   Zhou XF, 2014, CURR MED CHEM, V21, P855, DOI 10.2174/0929867320666131119124325
NR 76
TC 3
Z9 3
U1 3
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 72
BP 68322
EP 68334
DI 10.1039/c6ra13607a
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA DS1NM
UT WOS:000380362700099
DA 2018-10-20
ER

PT J
AU Ma, C
   Wang, Z
   Lu, X
   Lu, JX
   Bai, F
   Wang, CF
   Li, L
   Hou, SX
   Wang, HD
AF Ma, Chao
   Wang, Zhen
   Lu, Xiao
   Lu, Jian-Xi
   Bai, Feng
   Wang, Chao-Feng
   Li, Li
   Hou, Shu-Xun
   Wang, Hua-Dong
TI In vivo angiogenesis in tissues penetrating into porous beta-tricalcium
   phosphate scaffolds
SO RSC ADVANCES
LA English
DT Article
ID VIABLE ENGINEERED TISSUES; ENHANCED VASCULARIZATION; COMPOSITE SCAFFOLD;
   BONE REGENERATION; OSTEOGENESIS; BIOCERAMICS; CERAMICS; VESSELS; DESIGN;
   BLOOD
AB In order to understand in vivo angiogenesis in a three-dimensional bone graft and the surrounding tissue penetration into the scaffolds, we implanted spherical porous beta-tricalcium phosphate (beta-TCP) scaffolding materials into the lumbodorsal fascia of New Zealand rabbits. At different times postoperatively, non-decalcified tissue sections were prepared and analyzed. Results showed that obvious angiogenesis accompanied the surrounding tissue penetration towards the center of implanted porous sphere. Quantitative analysis revealed that during the angiogenetic process there was a rapid increase in vessel numbers in the first 4 weeks but a significant drop afterwards, and there was a steady growth for vessel remolding (diameter expanding) after implantation. Further analysis on the distribution of vessels with different calibers indicated that small capillaries (50 mu m or less in diameter) and arterioles (50-100 mu m in diameter) accounted for the most part (>93.3%) while the proportion of large vessels (>100 mu m in diameter) increased to 6.66% on the 12th week after implantation. In addition, we adopted a stereological method to compare angiogenesis and tissue penetration in the biomaterial implants quantitatively. With the scaffolds grafted, material biodegradation became evident in the outermost zone and was in close correlation with the increased blood vessel volume. To sum up, angiogenesis was a prerequisite for tissue penetration into the scaffolds, a process influenced by blood vessel formation and material biodegradation.
C1 [Ma, Chao; Li, Li; Hou, Shu-Xun; Wang, Hua-Dong] Gen Hosp Chinese Peoples Liberat Army PLAGH, Affiliated Hosp 1, Dept Orthoped, Beijing 100048, Peoples R China.
   [Wang, Zhen] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China.
   [Lu, Xiao] South China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
   [Lu, Jian-Xi] Shanghai Biolu Biomat Co Ltd, Shanghai 200018, Peoples R China.
   [Bai, Feng] 451 PLA Hosp, Dept Orthoped, Xian 710054, Peoples R China.
   [Wang, Chao-Feng] Navy Gen Hosp, Dept Orthoped, Beijing 100048, Peoples R China.
RP Hou, SX (reprint author), Gen Hosp Chinese Peoples Liberat Army PLAGH, Affiliated Hosp 1, Dept Orthoped, Beijing 100048, Peoples R China.
EM houshx_304@126.com
CR Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Baiguera S, 2013, ANGIOGENESIS, V16, P1, DOI 10.1007/s10456-012-9307-8
   Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Cruz-Orive LM, 2005, J MICROSC-OXFORD, V219, P18, DOI 10.1111/j.1365-2818.2005.01489.x
   Davison N, 2012, ACTA BIOMATER, V8, P2759, DOI 10.1016/j.actbio.2012.04.007
   Ding YT, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0779
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   Dorozhkin SV, 2015, J FUNCT BIOMATER, V6, P708, DOI 10.3390/jfb6030708
   Duan RQ, 2016, J ORTHOP RES, V34, P1865, DOI 10.1002/jor.23201
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   Garcia Y, 2007, BIOMATERIALS, V28, P175, DOI 10.1016/j.biomaterials.2006.08.037
   Ghanaati S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015005
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Griffin KS, 2015, CLIN REV BONE MINER, V13, P232, DOI 10.1007/s12018-015-9194-9
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kim J, 2015, GEOMECH ENERGY ENVIR, V2, P1, DOI 10.1016/j.gete.2015.03.001
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lei B, 2014, J BIOMED MATER RES B, V102, P1528, DOI 10.1002/jbm.b.33133
   Li HY, 2014, BIOMATERIALS, V35, P3803, DOI 10.1016/j.biomaterials.2014.01.039
   Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056
   Liu ZL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0507
   Lokmic Z, 2011, HISTOL HISTOPATHOL, V26, P781, DOI 10.14670/HH-26.781
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320
   Priya SK, 2016, INT J CANCER, V139, P729, DOI 10.1002/ijc.30067
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948
   Spiller KL, 2015, ANN BIOMED ENG, V43, P616, DOI 10.1007/s10439-014-1156-8
   Stegen S, 2015, BONE, V70, P19, DOI 10.1016/j.bone.2014.09.017
   Thottappillil N, 2015, VASC HEALTH RISK MAN, V11, P79, DOI 10.2147/VHRM.S50536
   Tian L, 2011, J CARDIOVASC TRANSL, V4, P685, DOI 10.1007/s12265-011-9301-3
   Tschanz S, 2014, ANN ANAT, V196, P3, DOI 10.1016/j.aanat.2013.04.011
   Wang C, 2013, BIOMATERIALS, V34, P64, DOI 10.1016/j.biomaterials.2012.09.021
   Wang C, 2012, ACTA BIOMATER, V8, P350, DOI 10.1016/j.actbio.2011.08.019
   Xie YZ, 2006, BIOMATERIALS, V27, P2761, DOI 10.1016/j.biomaterials.2005.12.011
   Yang K, 2015, MAT SCI ENG C-MATER, V56, P37, DOI 10.1016/j.msec.2015.05.083
   Yang L, 2015, MOL MED REP, V12, P2343, DOI 10.3892/mmr.2015.3653
   Zhang JW, 2014, ACTA BIOMATER, V10, P3254, DOI 10.1016/j.actbio.2014.03.021
   Zhao MD, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/6/065016
NR 44
TC 1
Z9 1
U1 3
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 72
BP 68363
EP 68370
DI 10.1039/c6ra09633f
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DS1NM
UT WOS:000380362700104
DA 2018-10-20
ER

PT J
AU Scarano, A
   Ceccarelli, M
   Marchetti, M
   Piattelli, A
   Mortellaro, C
AF Scarano, Antonio
   Ceccarelli, Maurizio
   Marchetti, Massimiliano
   Piattelli, Adriano
   Mortellaro, Carmen
TI Soft Tissue Augmentation with Autologous Platelet Gel and beta-TCP: A
   Histologic and Histometric Study in Mice
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID MUSCLE STRAIN INJURIES; ENRICHED PLASMA; SURGERY
AB Background. Facial aging is a dynamic process involving both soft tissue and bony structures. Skin atrophy, with loss of tone, elasticity, and distribution of facial fat, coupled with gravity and muscle activity, leads to wrinkling and folds. Purpose. The aim of the study was to evaluate microporous tricalcium phosphate (beta-TCP) and autologous platelet gel (APG) mix in mice for oral and maxillofacial soft tissue augmentation. The hypothesis was that beta-TCP added with APG was able to increase the biostimulating effect on fibroblasts and quicken resorption. Materials and Methods. Ten female, 6-8-week-old black-haired mice were selected beta-TCP/APG gel was injected into one cheek; the other was used as control. The animals were sacrificed at 8 weeks and histologically evaluated. Results. The new fibroblast was intensively stained with acid fuchsin and presented in contact with beta-TCP. At higher magnification, actively secreting fibroblasts were observed at the periphery of beta-TCP with a well differentiated fibroblast cell line and blood vessels. Acid fuchsin stained cutaneous structures in pink: no epidermal/dermal alterations or pathological inflammatory infiltrates were detected. The margins of beta-TCP granules were clear and not diffused near tissues. Conclusion. APG with beta-TCP preserves skin morphology, without immune response, with an excellent tolerability and is a promising scaffold for cells and biomaterial for soft tissue augmentation.
C1 [Scarano, Antonio; Ceccarelli, Maurizio; Piattelli, Adriano] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66100 Chieti, Italy.
   [Scarano, Antonio] Univ G dAnnunzio, CeSI MeT, Via Vestini 31, I-66100 Chieti, Italy.
   [Marchetti, Massimiliano] Univ Roma La Sapienza, Dept Surg Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Mortellaro, Carmen] Regina Margherita Pediat Hosp, Oral Surg Unit, Viale Piazza Armi 1, I-28100 Novara, Italy.
   [Mortellaro, Carmen] Univ Piemonte Orientale, Viale Piazza Armi 1, I-28100 Novara, Italy.
RP Scarano, A (reprint author), Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66100 Chieti, Italy.; Scarano, A (reprint author), Univ G dAnnunzio, CeSI MeT, Via Vestini 31, I-66100 Chieti, Italy.
EM ascarano@unich.it
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146
CR Andre P, 2004, J EUR ACAD DERMATOL, V18, P422, DOI 10.1111/j.1468-3083.2004.00934.x
   Baeyens W, 2010, Rev Med Brux, V31, P521
   Ceccarelli M., 2010, PHYSL MED LETT, V1
   Evian Cyril I, 2003, Compend Contin Educ Dent, V24, P195
   Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3
   Hamilton B, 2010, ACTA ORTHOP BELG, V76, P443
   Hamilton BH, 2011, CLIN J SPORT MED, V21, P31, DOI 10.1097/JSM.0b013e318205a658
   Hammond JW, 2009, AM J SPORT MED, V37, P1135, DOI 10.1177/0363546508330974
   Hom DB, 2008, ARCH FACIAL PLAST S, V10, P402, DOI 10.1001/archfaci.10.6.402
   Levine RA, 2003, AESTHET PLAST SURG, V27, P265, DOI 10.1007/s00266-003-2112-4
   Mendelson B, 2012, AESTHET PLAST SURG, V36, P753, DOI 10.1007/s00266-012-9904-3
   Richard MJ, 2009, OPHTHAL PLAST RECONS, V25, P382, DOI 10.1097/IOP.0b013e3181b2f766
   Rutkowski James L, 2008, J Oral Implantol, V34, P25, DOI 10.1563/1548-1336(2008)34[25:AAOARS]2.0.CO;2
   Scarano A, 2012, EUR J INFLAMM, V10, P31
   Scarano A., 2016, J CRANIOFACIAL SURG
   Scimeca Christy L, 2010, J Diabetes Sci Technol, V4, P1121
   Shaw RB, 2010, PLAST RECONSTR SURG, V125, P332, DOI 10.1097/PRS.0b013e3181c2a685
   Sjerobabski-Masnec I, 2010, ACTA CLIN CROAT, V49, P515
   Soares DJ, 2015, FACIAL PLAST SURG CL, V23, P185, DOI 10.1016/j.fsc.2015.01.004
   Vashi Neelam A, 2016, J Clin Aesthet Dermatol, V9, P31
NR 20
TC 1
Z9 1
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2016
AR 2078104
DI 10.1155/2016/2078104
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA DS0TG
UT WOS:000380309000001
PM 27478828
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Aiyelabegan, HT
   Zaidi, SSZ
   Fanuel, S
   Eatemadi, A
   Ebadi, MTK
   Sadroddiny, E
AF Aiyelabegan, Hammed T.
   Zaidi, Sadaf S. Z.
   Fanuel, Songwe
   Eatemadi, Ali
   Ebadi, Malihe T. K.
   Sadroddiny, Esmaeil
TI Albumin-based biomaterial for lung tissue engineering applications
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Albumin; lungs and biomaterial; regenerative medicine; scaffold; tissue
   engineering
ID HUMAN-SERUM-ALBUMIN; SURFACTANT-ASSOCIATED PROTEIN; MESENCHYMAL
   STEM-CELLS; AMINO-ACID-SEQUENCES; PULMONARY SURFACTANT; SPINAL-CORD;
   ENDOTHELIAL-CELLS; BONE REGENERATION; COLLAGEN SPONGES; BINDING PROTEIN
AB The role of albumin-based biomaterials in tissue engineering (TE) cannot be overemphasized. The authors review the role of albumin in lungs scaffold grafting, which promotes cell seeding. Albumin grafted on decellularized lungs scaffold is presented as a great support material for cell-tissue interaction as well as for ease in attachment, growth, and differentiation when seeded with different types of cells. Albumin scaffold fabrication from different sources is a promising approach that may facilitate medical treatments from bench-to-bed, although the role of this scaffold in lungs surfactant proteins regeneration and binding needs to be fully elucidated.
   [GRAPHICS]
   .
C1 [Aiyelabegan, Hammed T.; Zaidi, Sadaf S. Z.; Fanuel, Songwe; Eatemadi, Ali; Ebadi, Malihe T. K.; Sadroddiny, Esmaeil] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, 88 Italia St,POB 1417755469, Tehran, Iran.
   [Aiyelabegan, Hammed T.; Zaidi, Sadaf S. Z.; Fanuel, Songwe] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Int Campus, Tehran, Iran.
RP Sadroddiny, E (reprint author), Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, 88 Italia St,POB 1417755469, Tehran, Iran.
EM sadroddiny@sina.tums.ac.ir
CR BERNARD A, 1992, CLIN CHIM ACTA, V207, P239, DOI 10.1016/0009-8981(92)90122-7
   Bosse D, 2005, J CLIN PHARMACOL, V45, P57, DOI 10.1177/0091270004269646
   BREEZE RG, 1977, AM REV RESPIR DIS, V116, P705, DOI 10.1164/arrd.1977.116.4.705
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen TA, 2009, SCAND J GASTROENTERO, V44, P619, DOI 10.1080/00365520902719273
   DRICKAMER K, 1986, J BIOL CHEM, V261, P6878
   Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069
   Evans TW, 2002, ALIMENT PHARM THERAP, V16, P6, DOI 10.1046/j.1365-2036.2002.00190.x
   Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002
   Ferrero-Gutierrez A, 2013, HISTOL HISTOPATHOL, V28, P89, DOI 10.14670/HH-28.89
   FISHER JH, 1989, BIOCHIM BIOPHYS ACTA, V995, P225, DOI 10.1016/0167-4838(89)90040-X
   Fleischer S, 2014, BIOTECHNOL BIOENG, V111, P1246, DOI 10.1002/bit.25185
   FLOROS J, 1987, J BIOL CHEM, V262, P13592
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Gallego L., 2009, INT J ORAL MAXILLOF, V25, P699
   Gallego L, 2010, TISSUE ENG PT A, V16, P1179, DOI [10.1089/ten.tea.2009.0517, 10.1089/ten.TEA.2009.0517]
   Gallego L, 2010, J BIOMATER APPL, V25, P367, DOI 10.1177/0885328209353643
   Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338
   Gauvin R, 2011, ACS NANO, V5, P4258, DOI 10.1021/nn201826d
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030
   GLASSER SW, 1987, P NATL ACAD SCI USA, V84, P4007, DOI 10.1073/pnas.84.12.4007
   GRATHWOHL C, 1979, BIOCHIM BIOPHYS ACTA, V552, P509, DOI 10.1016/0005-2736(79)90195-0
   HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877
   HAURUM JS, 1993, BIOCHEM J, V293, P873, DOI 10.1042/bj2930873
   HAWGOOD S, 1987, P NATL ACAD SCI USA, V84, P66, DOI 10.1073/pnas.84.1.66
   Hawgood S, 1996, LUNG SCI FDN, P557
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0
   Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Imen EH, 2009, J BIOTECHNOL, V139, P19, DOI 10.1016/j.jbiotec.2008.09.011
   Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x
   Kang BJ, 2013, J BIOMAT SCI-POLYM E, V24, P1233, DOI 10.1080/09205063.2012.745717
   Kang ET, 2000, ADV MATER, V12, P1481, DOI 10.1002/1521-4095(200010)12:20<1481::AID-ADMA1481>3.0.CO;2-Z
   Kim C., 2009, BIOMED MATER, V3
   KING RJ, 1973, AM J PHYSIOL, V224, P788
   Kolska Z, 2014, POLYM DEGRAD STABIL, V101, P1, DOI 10.1016/j.polymdegradstab.2014.01.024
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li PS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05600
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Liu CZ, 2008, J BIOMED MATER RES B, V85B, P519, DOI 10.1002/jbm.b.30975
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Lu JH, 1997, BIOESSAYS, V19, P509, DOI 10.1002/bies.950190610
   LU JH, 1992, BIOCHEM J, V284, P795, DOI 10.1042/bj2840795
   Lubman R. L., 1996, LUNG SCI FDN, P585
   Maltais A, 2009, FOOD HYDROCOLLOID, V23, P1647, DOI 10.1016/j.foodhyd.2008.12.006
   Sarrasague MM, 2011, RESP PHYSIOL NEUROBI, V175, P316, DOI 10.1016/j.resp.2010.12.009
   McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203
   MCREYNOLDS L, 1978, NATURE, V273, P723, DOI 10.1038/273723a0
   Meyer U., 2009, FUNDAMENTALS TISSUE
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599
   NORDLUNDMOLLER L, 1990, J BIOL CHEM, V265, P12690
   Nseir N, 2013, TISSUE ENG PART C-ME, V19, P257, DOI [10.1089/ten.tec.2012.0118, 10.1089/ten.TEC.2012.0118]
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Orlando G, 2012, ANN SURG, V256, P363, DOI 10.1097/SLA.0b013e31825a02ab
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   PERSSON A, 1989, BIOCHEMISTRY-US, V28, P6361, DOI 10.1021/bi00441a031
   PERSSON A, 1988, BIOCHEMISTRY-US, V27, P8576, DOI 10.1021/bi00423a011
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Quaglia F, 2008, INT J PHARMACEUT, V364, P281, DOI 10.1016/j.ijpharm.2008.04.030
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Richardson J. B., 1980, LUNG BIOL HLTH DIS P, P1
   Robbins A., 1996, LUNG SCI FDN, P445
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   Rohanizadeh R, 2009, J MATER SCI-MATER M, V20, P2413, DOI 10.1007/s10856-009-3819-9
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shak S, 1996, LUNG SCI FDN, P479
   Shen QX, 2013, MAT SCI ENG C-MATER, V33, P1860, DOI 10.1016/j.msec.2013.01.064
   Slepi N., 2014, NANOSCALE RES LETT, V9, P161
   Song JJ, 2011, ANN THORAC SURG, V92, P998, DOI 10.1016/j.athoracsur.2011.05.018
   Staub K. H., 1988, TXB RESP MED, P12
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Svorcik V, 2001, RADIAT PHYS CHEM, V60, P89, DOI 10.1016/S0969-806X(00)00320-0
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   THIEL S, 1989, FEBS LETT, V250, P78, DOI 10.1016/0014-5793(89)80689-1
   THUNG SN, 1989, HEPATOLOGY, V9, P726, DOI 10.1002/hep.1840090512
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wagner DE, 2014, BIOMATERIALS, V35, P3281, DOI 10.1016/j.biomaterials.2013.12.103
   Wang HJ, 2009, MATERIALS, V2, P613, DOI 10.3390/ma2020613
   Wang XY, 2006, MATER TODAY, V9, P44, DOI 10.1016/S1369-7021(06)71742-4
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   WARR RG, 1987, P NATL ACAD SCI USA, V84, P7915, DOI 10.1073/pnas.84.22.7915
   Weibel ER, 2013, AM J RESP CRIT CARE, V187, P342, DOI 10.1164/rccm.201212-2260OE
   Weszl M, 2012, J ORTHOP RES, V30, P489, DOI 10.1002/jor.21527
   WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yamazoe H, 2008, LANGMUIR, V24, P8402, DOI 10.1021/la801221r
   Yamazoe H, 2008, J BIOMED MATER RES A, V86A, P228, DOI 10.1002/jbm.a.31654
   Yoon D, 2015, J VET SCI, V16, P397, DOI 10.4142/jvs.2015.16.4.397
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 102
TC 4
Z9 4
U1 2
U2 7
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PY 2016
VL 65
IS 16
BP 853
EP 861
DI 10.1080/00914037.2016.1180610
PG 9
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA DR8FT
UT WOS:000380134500006
DA 2018-10-20
ER

PT S
AU Nugraha, FKA
   Tontowi, AE
AF Nugraha, Felix Krisna Aji
   Tontowi, Alva Edi
BE Kusuma, DY
TI Shrinkage of [HA/Bioplastic/Sericin] Composite Part Printed by
   Bioprinter
SO 2016 CONFERENCE ON FUNDAMENTAL AND APPLIED SCIENCE FOR ADVANCED
   TECHNOLOGY (CONFAST 2016)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT Conference on Fundamental and Applied Science for Advanced Technology
   (ConFAST)
CY JAN 25-26, 2016
CL Yogyakarta, INDONESIA
SP Univ Ahmad Dahlan, Pusat Sains Teknologi Akselerator BATAN, Univ Teknologi Sumbawa, Nano Ctr Indonesia
DE Shrinkage; Biocomposite; 3D printer extrution machine/bioprinter;
   Response Surface Method; Taguchi
AB Biomaterial have been widely used in tissue engineering. However, shrinkage is still major issue in the application due to its major impact on the accuracy. In this works, the shrinkage of the printed composite material was studied. The composite material ut in this utilized orks were hydoxyapatite HA (Sigma Aldrich), cassava starch based bioplastic, and sericin extracted from Bombyx morii. The printed biocomposite with the size 100 mm x 25 mm x 3 mm was prepared composed of HA and bP with mass ratio of 40/60, 50/50, and 60/40. The HA suspension was added with 0.3% (w/w) sericin. The shrinkage evaluation, was conducted by measuring the size of the dry printed spesimen as compared against the CAD model. Surface Respon analysis reveals the optimum iocomposite paste composition of suspension HA: bP at 50: 50, with the addition of 0.3% sericin on hydroxyapatite suspension. The smallest shrinkage obtained by the Respon Surface Method with the lenght response, width response, and thickness respon of 1%, 4%, 28% respectively.
C1 [Nugraha, Felix Krisna Aji; Tontowi, Alva Edi] Univ Gadjah Mada, Dept Mech & Ind Engn, Yogyakarta, Indonesia.
RP Nugraha, FKA (reprint author), Univ Gadjah Mada, Dept Mech & Ind Engn, Yogyakarta, Indonesia.
EM aji.atmickr@gmail.com; alvaedytontowi@ugm.ac.id
CR Bagsik A., 2011, MECH PROPERTIES FUSE
   Davis H.E., 2013, MULTIFUNCTIONAL BIOM, P1
   Gapsari F., 2010, JURNAL REKAYASA MESI, V1, P59
   Heynick M., 2006, LAPA DIG TECHN SEM
   Mason MS, 2007, P SOL FREEF FABR S A, P124
   Pujiyanto E, 2012, ADV MATER RES-SWITZ, V445, P463, DOI 10.4028/www.scientific.net/AMR.445.463
   Tontowi A.E., 2014, C NANOCON PUN IND
   Tontowi A.E., 2015, INT J APPL ENG RES, V10, P32951
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
NR 9
TC 0
Z9 0
U1 2
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1403-7
J9 AIP CONF PROC
PY 2016
VL 1746
AR 020037
DI 10.1063/1.4953962
PG 6
WC Physics, Applied
SC Physics
GA BF1CQ
UT WOS:000380371100037
DA 2018-10-20
ER

PT S
AU Agrawal, NK
   Sharma, TK
   Chauhan, M
   Agarwal, R
   Vijay, YK
   Swami, KC
AF Agrawal, Narendra Kumar
   Sharma, Tamanna Kumari
   Chauhan, Manish
   Agarwal, Ravi
   Vijay, Y. K.
   Swami, K. C.
BE Chitra, R
   Bhattacharya, S
   Sahoo, NK
TI Enhancement in Biological Response of Ag-Nano Composite Polymer
   Membranes Using Plasma Treatment for Fabrication of Efficient Bio
   Materials
SO DAE SOLID STATE PHYSICS SYMPOSIUM 2015
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT DAE Solid State Physics Symposium
CY DEC 21-25, 2015
CL Amity Univ, Noida, INDIA
SP Board Res Nucl Sci, Dept Atom Energy, Dept Atom Energy
HO Amity Univ
DE Ag nanoparticle; Plasma Treatment; High adhesion; Wettability; Surface
   modification; Nano-Bio Material
AB Biomaterials are nonviable material used in medical devices, intended to interact with biological systems, which are becoming necessary for the development of artificial material for biological systems such as artificial skin diaphragm, valves for heart and kidney, lenses for eye etc. Polymers having novel properties like antibacterial, antimicrobial, high adhesion, blood compatibility and wettability are most suitable for synthesis of biomaterial, but all of these properties does not exist in any natural or artificial polymeric material. Nano particles and plasma treatment can offer these properties to the polymers. Hence a new nano-biomaterial has been developed by modifying the surface and chemical properties of Ag nanocomposite polymer membranes (NCPM) by Argon ion plasma treatment. These membranes were characterized using different techniques for surface and chemical modifications occurred. Bacterial adhesion and wettability were also tested for these membranes, to show direct use of this new class of nano-biomaterial for biomedical applications.
C1 [Agrawal, Narendra Kumar; Swami, K. C.] Malaviya Natl Inst Technol, Dept Phys, Jaipur, Rajasthan, India.
   [Agrawal, Narendra Kumar; Sharma, Tamanna Kumari] Poddar Grp Inst, Poddar Int Coll, Jaipur, Rajasthan, India.
   [Chauhan, Manish; Agarwal, Ravi] Univ Rajasthan, Ctr Converging Technol, Jaipur, Rajasthan, India.
   [Vijay, Y. K.] Univ Rajasthan, Dept Phys, Jaipur, Rajasthan, India.
RP Chauhan, M (reprint author), Univ Rajasthan, Ctr Converging Technol, Jaipur, Rajasthan, India.
EM nka.isro@gmail.com
OI Vijay, Yogesh/0000-0003-3299-7944
CR Agarwal P, 2013, ADV SCI ENG MED, V5, P709
   Agrawal N. K., 2014, ADV SCI ENG MED, V6
   Agrawal N. K., 2014, J BIONANOSCI, V8, P108
   Agrawal N.K., 2013, J MAT SCI SURF ENG, V1, P4
   Kedawat G, 2014, ACS APPL MATER INTER, V6, P8407, DOI 10.1021/am501307h
   Kulkarni S. K., 2009, HDB NANOTECHNOLOGY P, V50
   Mehrdad F., 2010, J ENG ENV SCI, V34, P281
   Ravi Agarwal, 2014, Advanced Science, Engineering and Medicine (ASEM), V6, P203, DOI 10.1166/asem.2014.1474
NR 8
TC 0
Z9 0
U1 0
U2 11
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-1378-8
J9 AIP CONF PROC
PY 2016
VL 1731
AR 040002
DI 10.1063/1.4947638
PG 3
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA BF1CR
UT WOS:000380371600034
DA 2018-10-20
ER

PT J
AU Cierech, M
   Wojnarowicz, J
   Szmigiel, D
   Baczkowski, B
   Grudniak, AM
   Wolska, KI
   Lojkowski, W
   Mierzwinska-Nastalska, E
AF Cierech, Mariusz
   Wojnarowicz, Jacek
   Szmigiel, Dariusz
   Baczkowski, Bohdan
   Grudniak, Anna Maria
   Wolska, Krystyna Izabela
   Lojkowski, Witold
   Mierzwinska-Nastalska, Elzbieta
TI Preparation and characterization of ZnO-PMMA resin nanocomposites for
   denture bases
SO ACTA OF BIOENGINEERING AND BIOMECHANICS
LA English
DT Article
DE ZnO nanoparticles; Candida albicans; acrylic resins
ID ACRYLIC RESIN; ZINC-OXIDE; SILVER NANOPARTICLES; CANDIDA-ALBICANS;
   ADHESION; ANTIBACTERIAL; MECHANISM
AB Purpose: The aim of the paper was to investigate the antifungal activity of zinc oxide nanoparticles (ZnONPs) against Candida albicans. Some attempts have been made to find out the best way to introduce ZnONPs into polymethyl methacrylate (PMMA) resin material and to determine some parameters of a newly formed composite. Material and methods: Zinc oxide nanoparticles were manufactured and their basic physical parameters were determined (average particle size, density, specific surface area). Minimal inhibitory concentration (MIC) of ZnONPs was determined for the Candida albicans standard strain. The average size of ZnO conglomerates in the monomer solution of PMMA resin was measured using a dynamic light scattering instrument. PMMA resin samples with incorporated ZnONPs were produced. The morphology of nanopowder and the newly formed composite was examined under a scanning electron microscope (SEM). In addition, the roughness parameter of PMMA resin material was investigated before and after ZnONPs modification. Results: Nanopowder with the average particle size of 30 nm, density of 5.24 g/cm(3) and surface area of 39 m(2)/g was obtained. MIC was determined at the level of 0.75 mg/mL. The average size of ZnO conglomerates in the monomer solution of acrylic resin dropped by 11 times after ultrasound activation. SEM examination of a newly formed composite showed a successful introduction of ZnONPs confirmed by the energy dispersive X-ray spectroscopy (EDS) analysis. There were no statistically significant differences in the biomaterial roughness before and after the modification of ZnONPs. Conclusion: Zinc oxide nanoparticles were successfully incorporated into acrylic resin used for the production of denture bases. The presence of nanoparticles with sizes below 100 nm was confirmed. Nevertheless a newly created composite needs to be further investigated to improve its homogeneity, and to check its microbiological properties, strength and biocompatibility prior to its possible clinical use.
C1 [Cierech, Mariusz; Baczkowski, Bohdan; Mierzwinska-Nastalska, Elzbieta] Med Univ Warsaw, Dept Prosthet Dent, Nowogrodzka 59, PL-02006 Warsaw, Poland.
   [Wojnarowicz, Jacek; Lojkowski, Witold] Polish Acad Sci, Inst High Pressure Phys, Warsaw, Poland.
   [Szmigiel, Dariusz] Inst Electr Mat Technol, Div Silicon Microsyst & Nanostruct Technol, Warsaw, Poland.
   [Grudniak, Anna Maria; Wolska, Krystyna Izabela] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, PL-00325 Warsaw, Poland.
   [Lojkowski, Witold] Bialystok Tech Univ, Fac Management, Bialystok, Poland.
RP Cierech, M (reprint author), Med Univ Warsaw, Dept Prosthet Dent, Nowogrodzka 59, PL-02006 Warsaw, Poland.
EM mariusz.cierech@wp.pl
RI Wojnarowicz, Jacek/O-4096-2016
OI Wojnarowicz, Jacek/0000-0002-6106-5188
FU Faculty of Medicine and Dentistry, Medical University of Warsaw; EU
   [FP7-NMP4-LA-2012-280983]
FX The work was supported by a research project carried out in the years
   2014-2015, funded by a statutory grant obtained by the Faculty of
   Medicine and Dentistry, Medical University of Warsaw.; This work was
   partially funded under the EU FP7 SHYMAN project (grant agreement no.
   FP7-NMP4-LA-2012-280983), coordinated by E. Lester (The University of
   Nottingham, United Kingdom; www.shyman.eu).
CR Abbeele AV, 2008, GERODONTOLOGY, V25, P222, DOI 10.1111/j.1741-2358.2007.00247.x
   Agren MS, 1999, ARCH DERMATOL, V135, P1273, DOI 10.1001/archderm.135.10.1273-a
   [Anonymous], 2000, CLIN MICROBIOL INFEC, V6, P509
   Arai T, 2009, J ORAL REHABIL, V36, P902, DOI 10.1111/j.1365-2842.2009.02012.x
   Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347
   Birnboim A, 1998, J AM CERAM SOC, V81, P1493
   Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780
   ERICSSON HM, 1971, ACTA PATHOLOG MICROB, P1
   Gendreau L, 2011, J PROSTHODONT, V20, P251, DOI 10.1111/j.1532-849X.2011.00698.x
   Gondal MA, 2012, J ENVIRON SCI HEAL A, V47, P1413, DOI 10.1080/10934529.2012.672384
   Khan MF, 2014, INT J NANOMED, V9, P853, DOI 10.2147/IJN.S47351
   Lazarin AA, 2013, ARCH ORAL BIOL, V58, P1, DOI 10.1016/j.archoralbio.2012.10.005
   Li Z, 2016, GERODONTOLOGY, V33, P209, DOI 10.1111/ger.12142
   Lojkowski W, 2014, INORGANICS, V2, P606, DOI 10.3390/inorganics2040606
   Majcher A, 2013, INT J CHEM REACT ENG, V11, P361, DOI 10.1515/ijcre-2012-0009
   Moriarty P, 2001, REP PROG PHYS, V64, P297, DOI 10.1088/0034-4885/64/3/201
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nam KY, 2014, J ADV PROSTHODONT, V6, P207, DOI 10.4047/jap.2014.6.3.207
   Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Sato M, 2013, DENT MATER J, V32, P355, DOI 10.4012/dmj.2012-295
   Spiechowicz E., 1998, ORAL CAVITY CANDIDOS
   Wejrzanowski T, 2006, APPL SURF SCI, V253, P204, DOI 10.1016/j.apsusc.2006.05.089
   Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k
NR 26
TC 8
Z9 8
U1 0
U2 11
PU WROCLAW UNIV TECHNOLOGY
PI WROCLAW
PA WROCLAW UNIV TECHNOLOGY, MECHANICAL DEPT, WYBRZEZE WYSPIANSKIEGO 27,
   WROCLAW, 50-370, POLAND
SN 1509-409X
J9 ACTA BIOENG BIOMECH
JI Acta Bioeng. Biomech.
PY 2016
VL 18
IS 2
BP 31
EP 41
DI 10.5277/ABB-00232-2014-04
PG 11
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA DR5AQ
UT WOS:000379915800004
PM 27406971
DA 2018-10-20
ER

PT J
AU Velnar, T
   Bunc, G
   Klobucar, R
   Gradisnik, L
AF Velnar, Tomaz
   Bunc, Gorazd
   Klobucar, Robert
   Gradisnik, Lidija
TI Biomaterials and host versus graft response: A short review
SO BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Review
DE Host versus graft disease; biomaterial; wound healing; transplant;
   tissue
ID FOREIGN-BODY REACTION; MEMBRANE MICROARCHITECTURE; DELIVERY SYSTEMS;
   VASCULAR GRAFTS; CHRONIC WOUNDS; DRUG-DELIVERY; DISEASE; ANGIOGENESIS;
   COMPLEMENT; NEOVASCULARIZATION
AB Biomaterials and biotechnology are increasing becoming an important area in modern medicine. The main aim in this area is the development of materials, which are biocompatible to normal tissue. Tissue-implant interactions with molecular, biological and cellular characteristics at the implant-tissue interface are important for the use and development of implants. Implantation may cause an inflammatory and immune response in tissue, foreign body reaction, systemic toxicity and imminent infection. Tissue-implant interactions determine the implant life-period. The aims of the study are to consider the biological response to implants. Biomaterials and host reactions to implants and their mechanisms are also briefly discussed.
C1 [Velnar, Tomaz; Bunc, Gorazd] Univ Med Ctr Maribor, Dept Neurosurg, Ljubljanska 5, Maribor 2000, Slovenia.
   [Velnar, Tomaz] Univ Med Ctr Ljubljana, Dept Neurosurg, Ljubljana, Slovenia.
   [Klobucar, Robert] Royal Berkshire Hosp, Dept Gen Surg, Reading, Berks, England.
   [Gradisnik, Lidija] Med Fac Maribor, Inst Biomed Sci, Maribor, Slovenia.
RP Velnar, T (reprint author), Univ Med Ctr Maribor, Dept Neurosurg, Ljubljanska 5, Maribor 2000, Slovenia.
EM tvelnar@hotmail.com
CR Adams DH, 2005, SEMIN LIVER DIS, V25, P281, DOI 10.1055/s-2005-916320
   Albrektsson T, 2008, AUST DENT J, V53, pS34, DOI 10.1111/j.1834-7819.2008.00039.x
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson James M., 1996, P165
   Ashammakhi N, 2007, J CRANIOFAC SURG, V18, P3, DOI 10.1097/01.scs.0000236444.05345.53
   Attinger CE, 2006, PLAST RECONSTR SURG, V117, p72S, DOI 10.1097/01.prs.0000225470.42514.8f
   Baum CL, 2005, DERMATOL SURG, V31, P674
   Biedermann BC, 2008, BEST PRACT RES CL HA, V21, P129, DOI 10.1016/j.beha.2008.02.003
   Binyamin Gary, 2006, Semin Pediatr Surg, V15, P276, DOI 10.1053/j.sempedsurg.2006.07.007
   Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Broughton G. II., 2006, PLAST RECONSTR SURG, V117, P1, DOI DOI 10.1097/01.PRS.0000222562.60260.F9
   Christensen L, 2007, DERMATOL SURG, V33, pS168, DOI 10.1111/j.1524-4725.2007.33357.x
   CLARK RAF, 1993, AM J MED SCI, V306, P42, DOI 10.1097/00000441-199307000-00011
   COURTNEY JM, 1993, INT J ARTIF ORGANS, V16, P164
   Degreef HJ, 1998, DERMATOL CLIN, V16, P365, DOI 10.1016/S0733-8635(05)70019-X
   Dhir S, 2014, ARCH DIS CHILD, V99, P1150, DOI 10.1136/archdischild-2013-304832
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Edwards Sharon L, 2006, Nurs Stand, V21, P48
   Edwards SL, 2006, NURS STAND, V21, P58
   Ennis W J, 2000, Ostomy Wound Manage, V46, p39S
   ENNIS WJ, 2000, OSTOMY WOUND MANAG, V46, pS49
   Esposito M, 2013, COCHRANE DATABASE SY, V7
   Falanga V, 1998, J Cutan Med Surg, V3 Suppl 1, pS1
   Flanagan M, 2000, J Wound Care, V9, P299
   Glat PM, 1997, GRABB SMITHS PLASTIC, P3
   Gouverneur M, 2006, J INTERN MED, V259, P393, DOI 10.1111/j.1365-2796.2006.01625.x
   Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2
   Greisler H P, 1991, ASAIO Trans, V37, pM472
   GREISLER HP, 1993, J BIOMED MATER RES, V27, P955, DOI 10.1002/jbm.820270715
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1992, J BIOMED MATER RES, V26, P1449, DOI 10.1002/jbm.820261105
   Guenther DA, 2005, PEDIATR TRANSPLANT, V9, P277, DOI 10.1111/j.1399-3046.2005.00308.x
   Hart J, 2002, J Wound Care, V11, P205
   Hess C T, 2000, Adv Skin Wound Care, V13, P127
   Holtan SG, 2014, BLOOD, V124, P363, DOI 10.1182/blood-2014-01-514786
   Hunt T K, 2000, Adv Skin Wound Care, V13, P6
   Jaglowski SM, 2014, CURR OPIN HEMATOL, V21, P141, DOI 10.1097/MOH.0000000000000026
   JESPERSEN J, 1988, DAN MED BULL, V35, P1
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Labler L, 2006, ZBL CHIR, V131, pS62
   Latour R A Jr, 1995, Clin Podiatr Med Surg, V12, P519
   Lawrence WT, 1998, CLIN PLAST SURG, V25, P321
   LIM HW, 1990, DERMATOL CLIN, V8, P609
   LINDENAUER SM, 1984, J CARDIOVASC SURG, V25, P36
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220
   Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173
   Mulder GD, 2002, J AM PODIAT MED ASSN, V92, P34, DOI 10.7547/87507315-92-1-34
   MULLEREBERHARD HJ, 1985, J INVEST DERMATOL, V85, pS47
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Natarajan S, 2000, Am J Clin Dermatol, V1, P269, DOI 10.2165/00128071-200001050-00002
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Okada F, 2007, INT J CANCER, V121, P2364, DOI 10.1002/ijc.23125
   Okan Denis, 2007, Adv Skin Wound Care, V20, P39, DOI 10.1097/00129334-200701000-00013
   Orenstein SB, 2010, HERNIA, V14, P511, DOI 10.1007/s10029-010-0680-1
   Padera RF, 1996, BIOMATERIALS, V17, P277, DOI 10.1016/0142-9612(96)85565-7
   Panuncialman J, 2009, SURG CLIN N AM, V89, P611, DOI 10.1016/j.suc.2009.03.009
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   PODACK ER, 1984, MOL IMMUNOL, V21, P589, DOI 10.1016/0161-5890(84)90044-0
   POOL JG, 1977, AM J MED TECHNOL, V43, P776
   Ramasastry SS, 2005, CLIN PLAST SURG, V32, P195, DOI 10.1016/j.cps.2004.12.001
   Rice J, 2000, Collegian, V7, P40, DOI 10.1016/S1322-7696(08)60377-7
   Richardson Marion, 2004, Nurs Times, V100, P50
   Robson MC, 2001, CURR PROB SURG, V38, P65
   Rossomando Edward F, 2007, Compend Contin Educ Dent, V28, P418
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Servold S A, 1991, Clin Podiatr Med Surg, V8, P937
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   SIEGGREEN MY, 1987, NURS CLIN N AM, V22, P439
   Sigler M, 2005, Z KARDIOL, V94, P383, DOI 10.1007/s00392-005-0231-4
   Steed DL, 2003, SURG CLIN N AM, V83, P547, DOI 10.1016/S0039-6109(02)00208-6
   Strecker-McGraw MK, 2007, EMERG MED CLIN N AM, V25, P1, DOI 10.1016/j.emc.2006.12.002
   Szycher M, 1992, J Biomater Appl, V7, P142, DOI 10.1177/088532829200700204
   Tardito E, 1993, Minerva Cardioangiol, V41, P59
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Vanwijck R, 2001, Bull Mem Acad R Med Belg, V156, P175
   Walmsley GG, 2015, PLAST RECONSTR SURG, V135, P907, DOI 10.1097/PRS.0000000000000972
   Warren SM, 2002, ORTHOPEDICS, V25, pS1201
   Whitney JD, 2005, NURS CLIN N AM, V40, P191, DOI 10.1016/j.cnur.2004.09.002
   Wilkinson C D W, 2004, Eur Cell Mater, V8, P21
   Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yates CC, 2012, BIRTH DEFECTS RES C, V96, P325, DOI 10.1002/bdrc.21024
   Zhou H, 2009, MED HYPOTHESES, V72, P567, DOI 10.1016/j.mehy.2008.12.028
   Zim Shane, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P349, DOI 10.1097/01.moo.0000130576.04818.55
NR 90
TC 3
Z9 3
U1 1
U2 16
PU ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO
PI CEKALUSA
PA UNIV SARAJEVO, MEDICAL FAC, CEKALUSA, SARAJEVO 90, BOSNIA & HERCEG
SN 1512-8601
EI 1840-4812
J9 BOSNIAN J BASIC MED
JI Bosnian J. Basic Med. Sci.
PY 2016
VL 16
IS 2
BP 82
EP 90
DI 10.17305/bjbms.2016.525
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DR6UZ
UT WOS:000380038100001
PM 26894284
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Balikov, DA
   Fang, B
   Chun, YW
   Crowder, SW
   Prasai, D
   Lee, JB
   Bolotin, KI
   Sung, HJ
AF Balikov, Daniel A.
   Fang, Brian
   Chun, Young Wook
   Crowder, Spencer W.
   Prasai, Dhiraj
   Lee, Jung Bok
   Bolotin, Kiril I.
   Sung, Hak-Joon
TI Directing lineage specification of human mesenchymal stem cells by
   decoupling electrical stimulation and physical patterning on unmodified
   graphene
SO NANOSCALE
LA English
DT Article
ID MICROTUBULE-ASSOCIATED PROTEINS; EXTRACELLULAR-MATRIX; STROMAL CELLS;
   EXPRESSION; DIFFERENTIATION; REGENERATION; BONE; OSTEOPONTIN;
   OSTEOGENESIS; NEUROGENESIS
AB The organization and composition of the extracellular matrix (ECM) have been shown to impact the propagation of electrical signals in multiple tissue types. To date, many studies with electroactive biomaterial substrates have relied upon passive electrical stimulation of the ionic media to affect cell behavior. However, development of cell culture systems in which stimulation can be directly applied to the material - thereby isolating the signal to the cell-material interface and cell-cell contracts - would provide a more physiologically-relevant paradigm for investigating how electrical cues modulate lineage-specific stem cell differentiation. In the present study, we have employed unmodified, directly-stimulated, (un)patterned graphene as a cell culture substrate to investigate how extrinsic electrical cycling influences the differentiation of naive human mesenchymal stem cells (hMSCs) without the bias of exogenous biochemicals. We first demonstrated that cyclic stimulation does not deteriorate the cell culture media or result in cytotoxic pH, which are critical experiments for correct interpretation of changes in cell behavior. We then measured how the expression of osteogenic and neurogenic lineage-specific markers were altered simply by exposure to electrical stimulation and/or physical patterns. Expression of the early osteogenic transcription factor RUNX2 was increased by electrical stimulation on all graphene substrates, but the mature marker osteopontin was only modulated when stimulation was combined with physical patterns. In contrast, the expression of the neurogenic markers MAP2 and beta(3)-tubulin were enhanced in all electrical stimulation conditions, and were less responsive to the presence of patterns. These data indicate that specific combinations of non-biological inputs - material type, electrical stimulation, physical patterns - can regulate hMSC lineage specification. This study represents a substantial step in understanding how the interplay of electrophysical stimuli regulate stem cell behavior and helps to clarify the potential for graphene substrates in tissue engineering applications.
C1 [Balikov, Daniel A.; Fang, Brian; Chun, Young Wook; Crowder, Spencer W.; Lee, Jung Bok; Sung, Hak-Joon] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
   [Fang, Brian; Prasai, Dhiraj; Bolotin, Kiril I.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.
   [Chun, Young Wook; Sung, Hak-Joon] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA.
   [Sung, Hak-Joon] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea.
   [Chun, Young Wook] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA.
   [Crowder, Spencer W.] Imperial Coll London, Dept Mat & Bioengn, London, England.
RP Sung, HJ (reprint author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.; Bolotin, KI (reprint author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.; Sung, HJ (reprint author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA.; Sung, HJ (reprint author), Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea.
EM kirill.bolotin@vanderbilt.edu; hak-joon.sung@vanderbilt.edu
RI Bolotin, Kirill/O-5101-2016
OI Balikov, Daniel/0000-0003-0392-5087
FU NSF CBET BME [1056046]; NSF DMR BMAT [1506717]; NIH EB [019509]; AHA
   [GRNT25890018]; Yonsei University College of Medicine [6-2016-0031];
   Vanderbilt Medical Scientist Training Program T32 training grant
   [GM007347]
FX This research was funded and supported by NSF CBET BME 1056046, NSF DMR
   BMAT 1506717, NIH EB 019509 and AHA GRNT25890018. This study was also
   financially supported by the Faculty Research Assistance Program of
   Yonsei University College of Medicine for 2016 (6-2016-0031). DAB was
   partially supported by the Vanderbilt Medical Scientist Training Program
   T32 training grant GM007347. This study also used resources provided by
   the Vanderbilt Institute of Nanoscale Sciences and Engineering (VINSE),
   a facility renovated under NSF ARI-R2 DMR-0963361.
CR Aaron RK, 1996, J ORTHOPAED RES, V14, P582, DOI 10.1002/jor.1100140412
   Abbasnia Keramatollah, 2015, Anat Cell Biol, V48, P104, DOI 10.5115/acb.2015.48.2.104
   Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832
   ARMSTRONG FA, 1984, J AM CHEM SOC, V106, P921, DOI 10.1021/ja00316a015
   Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108
   Bowers SLK, 2010, J MOL CELL CARDIOL, V48, P474, DOI 10.1016/j.yjmcc.2009.08.024
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Chen Q, 2014, STEM CELLS, V32, P327, DOI 10.1002/stem.1567
   Cho MR, 2002, IEEE T PLASMA SCI, V30, P1504, DOI 10.1109/TPS.2002.804200
   Creecy CM, 2013, TISSUE ENG PT A, V19, P467, DOI [10.1089/ten.tea.2012.0091, 10.1089/ten.TEA.2012.0091]
   Crowder SW, 2013, NANOSCALE, V5, P4171, DOI 10.1039/c3nr00803g
   Dehmelt L, 2005, GENOME BIOL, V6
   DENHARDT DT, 1993, FASEB J, V7, P1475
   DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   GEISERT EE, 1990, P NATL ACAD SCI USA, V87, P3967, DOI 10.1073/pnas.87.10.3967
   GOODMAN SL, 1987, J CELL BIOL, V105, P589, DOI 10.1083/jcb.105.1.589
   Hammerick KE, 2010, TISSUE ENG PT A, V16, P917, DOI [10.1089/ten.tea.2009.0267, 10.1089/ten.TEA.2009.0267]
   Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995
   HUBER G, 1984, J NEUROSCI, V4, P151
   Hunter GK, 2010, LANGMUIR, V26, P18639, DOI 10.1021/la100401r
   IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741
   Kim TH, 2015, ACS NANO, V9, P3780, DOI 10.1021/nn5066028
   Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003
   Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974
   Lee J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05188
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   LEWIS SA, 1985, J CELL BIOL, V101, P852, DOI 10.1083/jcb.101.3.852
   Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245
   Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17817
   MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882
   Matos MA, 2010, BIOTECHNOL PROGR, V26, P664, DOI 10.1002/btpr.389
   McKee MD, 2005, CELLS TISSUES ORGANS, V181, P176, DOI 10.1159/000091379
   MEMBERG SP, 1995, J NEUROBIOL, V27, P26, DOI 10.1002/neu.480270104
   Nguyen HT, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046011
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236
   Park JS, 2012, BIOMATERIALS, V33, P7300, DOI 10.1016/j.biomaterials.2012.06.069
   Paulson AF, 2014, CELL ADHES MIGR, V8, P19, DOI 10.4161/cam.27839
   Rey J. A. Cubillos, 2012, REV MED, V20, P14
   Rinkevich Y, 2014, P NATL ACAD SCI USA, V111, P9846, DOI 10.1073/pnas.1410097111
   Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8
   Ross CL, 2015, STEM CELL RES, V15, P96, DOI 10.1016/j.scr.2015.04.009
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4
   Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001
   Wang Q, 1998, CLIN ORTHOP RELAT R, P259
   Wechsler ME, 2016, TISSUE ENG PART C-ME, V22, P155, DOI 10.1089/ten.tec.2015.0324
NR 51
TC 8
Z9 8
U1 6
U2 48
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2016
VL 8
IS 28
BP 13730
EP 13739
DI 10.1039/c6nr04400j
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DR6OL
UT WOS:000380021100027
PM 27411950
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yao, DY
   Liu, HF
   Fan, YB
AF Yao, Danyu
   Liu, Haifeng
   Fan, Yubo
TI Fabrication of water-stable silk fibroin scaffolds through self-assembly
   of proteins
SO RSC ADVANCES
LA English
DT Article
ID TISSUE; BIOMATERIALS; MODEL; FILMS
AB Silk fibroin (SF) is a promising biomaterial and has been widely used in tissue engineering. However, most of the currently used fabrication techniques require the use of organic solvents that cannot be removed thoroughly. The residual organic solvents reduce the proliferation capacity of cells. In this study, we developed water-insoluble SF scaffolds by a simple temperature induced method without the addition of organic or inorganic substances. Temperature was used to tune the self-assembly of SF during the freezing process, which resulted in water stable porous scaffolds directly. Compared with the traditional methanol treated scaffolds, the current scaffolds presented a less crystalline structure, lower elasticity modulus and faster degradation rate. In addition, human umbilical vein endothelial cells (HUVECs) showed an enhanced adhesion capacity, better spreading morphology and a faster proliferation rate on the scaffold. Investigation of the scaffold formation mechanism revealed that the performance of the current scaffold was dominated by the storage time and temperature, which tuned the self-assembly process of SF by controlling the molecular activity and contributed to the low crystallinity of the structure and water-insolubility. The results indicated that this low crystallinity scaffold holds great promise as a candidate for soft tissue repair materials.
C1 [Yao, Danyu; Liu, Haifeng; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Xue Yuan Rd 37, Beijing 100191, Peoples R China.
   [Fan, Yubo] Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China.
RP Liu, HF; Fan, YB (reprint author), Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Xue Yuan Rd 37, Beijing 100191, Peoples R China.; Fan, YB (reprint author), Natl Res Ctr Rehabil Tech Aids, Beijing 100176, Peoples R China.
EM haifengliu@buaa.edu.cn; yubofan@buaa.edu.cn
FU National Key Technology RD Program [2012BAI18B06, 2014BAI11B02,
   2014BAI11B03]; National Natural Science Foundation of China [31470938,
   11421202, 61227902, 11120101001]; International Joint Research Center of
   Aerospace Biotechnology and Medical Engineering of the Ministry of
   Science and Technology of China; 111 Project [B13003]; Research Fund for
   the Doctoral Program of Higher Education of China [20131102130004];
   transformation project for major achievements for the Central
   Universities in Beijing [ZDZH20141000601]; Fundamental Research Funds
   for the Central Universities
FX This work was supported by the National Key Technology R&D Program
   (2012BAI18B06, 2014BAI11B02, 2014BAI11B03), National Natural Science
   Foundation of China (31470938, 11421202, 61227902, and 11120101001),
   International Joint Research Center of Aerospace Biotechnology and
   Medical Engineering of the Ministry of Science and Technology of China,
   111 Project (B13003), Research Fund for the Doctoral Program of Higher
   Education of China (20131102130004), The transformation project for
   major achievements for the Central Universities in Beijing
   (ZDZH20141000601), and Fundamental Research Funds for the Central
   Universities.
CR Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   Chwalek K, 2015, NAT PROTOC, V10, P1362, DOI 10.1038/nprot.2015.091
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Han HY, 2016, ADV FUNCT MATER, V26, P421, DOI 10.1002/adfm.201504160
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Liu HF, 2011, BIOMACROMOLECULES, V12, P2914, DOI 10.1021/bm200479f
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Pei YZ, 2015, ACTA BIOMATER, V13, P168, DOI 10.1016/j.actbio.2014.11.016
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Wang XX, 2006, BIOMATERIALS, V27, P1924, DOI 10.1016/j.biomaterials.2005.09.029
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Ye JH, 2011, BIOMATERIALS, V32, P5065, DOI 10.1016/j.biomaterials.2011.03.053
NR 21
TC 7
Z9 7
U1 11
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 66
BP 61402
EP 61409
DI 10.1039/c6ra10670f
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DQ8TY
UT WOS:000379485200051
DA 2018-10-20
ER

PT J
AU Stewart, NA
   Molina, GF
   Issa, JPM
   Yates, NA
   Sosovicka, M
   Vieira, AR
   Line, SRP
   Montgomery, J
   Gerlach, RF
AF Stewart, Nicolas Andre
   Molina, Gabriela Ferian
   Issa, Joao Paulo Mardegan
   Yates, Nathan Andrew
   Sosovicka, Mark
   Vieira, Alexandre Rezende
   Peres Line, Sergio Roberto
   Montgomery, Janet
   Gerlach, Raquel Fernanda
TI The identification of peptides by nanoLC-MS/MS from human surface tooth
   enamel following a simple acid etch extraction
SO RSC ADVANCES
LA English
DT Article
ID MASS-SPECTROMETRY; DENTAL ENAMEL; AMELOGENIN; PROTEINS; EVOLUTION;
   SEQUENCES; CHILDREN; RECOVERY; REVEALS; TEETH
AB Tooth enamel is the hardest, densest and most mineralized tissue in vertebrates. This is due to the high crystallinity of enamel. During enamel formation, proteins responsible for mineralization are degraded by proteases, which results in mature enamel having less than 1% proteinaceous material, mostly as peptides. Many toxicological studies have taken advantage of the stability of tooth enamel to study heavy metal exposure, however few studies have been successful in identifying peptides from the enamel, especially from a single tooth. Furthermore, amelogenin, the most abundant protein involved in tooth development, is expressed from both the X and Y chromosomes and is dimorphic. Sequencing of the gender dimorphic peptide regions may be useful in determining gender, especially when no other biomaterial is available nor intact DNA remains. In light of this, a method employing nanoflow liquid chromatography (nanoLC) electrospray ionization tandem mass spectrometry (MS/MS) was used to analyse peptides released through an acid etch of the enamel from individual teeth. Two approaches were investigated, one with trypsin digest following acid etch and one without. Peptide identification was accomplished using typical proteomics methodology by searching against the human proteome. Peptides from the major enamel structural proteins were identified including amelogenin isoforms, ameloblastin, and enamelin. Furthermore, Y-chromosome-specific amelogenin peptides were also detected in mature enamel. Peptides were identified from the enamel of single teeth on present-day and archaeological samples in a non-destructive and minimally invasive method by nanoLC-MS/MS. The identification of tooth enamel specific peptides with this approach allows for its potential applications in forensic analysis and archaeological studies.
C1 [Stewart, Nicolas Andre] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.
   [Molina, Gabriela Ferian; Issa, Joao Paulo Mardegan; Gerlach, Raquel Fernanda] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, FORP, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Yates, Nathan Andrew] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA 15261 USA.
   [Yates, Nathan Andrew] Univ Pittsburgh, Sch Hlth Sci, Biomed Mass Spectrometry Ctr, Pittsburgh, PA 15213 USA.
   [Sosovicka, Mark] Univ Pittsburgh, Sch Dent Med, Dept Oral & Maxillofacial Surg, 3501 Terrace St, Pittsburgh, PA 15261 USA.
   [Vieira, Alexandre Rezende] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, 3501 Terrace St, Pittsburgh, PA 15261 USA.
   [Peres Line, Sergio Roberto] Univ Estadual Campinas, UNICAMP, FOP, Dept Morphol,Dent Sch Piracicaba, Campinas, SP, Brazil.
   [Montgomery, Janet] Univ Durham, Dept Archaeol, Dawson Bldg,South Rd, Durham DH1 3LE, England.
RP Gerlach, RF (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Basic Pathol, FORP, Ave Cafe S-N, BR-14040904 Ribeirao Preto, SP, Brazil.
EM rfgerlach@forp.usp.br
RI Issa, Joao Paulo/A-2505-2011
OI Issa, Joao Paulo/0000-0002-1056-0795; Stewart,
   Nicolas/0000-0002-8969-4242
FU State of Sao Paulo Research Foundation (FAPESP, Sao Paulo, SP, Brazil)
   [2011/23963-3]; (Brazilian) National Research Council (CNPq, Brasilia,
   DF, Brazil);  [P30CA047904]
FX We would like to thank Dr Steve M. Sweet at the Genome Damage and
   Stability Center, Sussex University for access to the nanoLC-Orbitrap MS
   instrument. This study was supported by the State of Sao Paulo Research
   Foundation (FAPESP, Sao Paulo, SP, Brazil, Grant 2011/23963-3) and the
   (Brazilian) National Research Council (CNPq, Brasilia, DF, Brazil). Some
   of this work used the University of Pittsburgh Cancer Institute shared
   resources that are supported in part by award P30CA047904. We thank the
   Laboratorio Nacional de Biociencias (LNBio) at LNLS, in Campinas,
   Brazil, for the use of Mass Spectrometers. We are grateful to Niall
   Hammond (Archaeo-Environment Ltd) and Northern Archaeological Associates
   for access to the Seaham skeletal collection excavated in 1999 and to
   Tessi Loeffelmann for sexing the individuals in the course of her MSc
   dissertation in 2014 'Of doomed and transient men: the Anglo-Saxon
   skeletons of Seaham in their context' at Durham University.
CR Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614
   Bartlett John D, 2013, ISRN Dent, V2013, P684607, DOI 10.1155/2013/684607
   Bonde JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033269
   BROOKES SJ, 1995, ARCH ORAL BIOL, V40, P1, DOI 10.1016/0003-9969(94)00135-X
   Buckley M, 2013, RAPID COMMUN MASS SP, V27, P531, DOI 10.1002/rcm.6481
   Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316
   Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u
   Castiblanco GA, 2015, EUR J ORAL SCI, V123, P390, DOI 10.1111/eos.12214
   de Almeida GRC, 2008, ENVIRON RES, V107, P264, DOI 10.1016/j.envres.2008.01.002
   de Almeida GRC, 2011, SCI TOTAL ENVIRON, V409, P1799, DOI 10.1016/j.scitotenv.2011.01.004
   Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465
   Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100
   LIMEBACK H, 1990, ARCH ORAL BIOL, V35, P459, DOI 10.1016/0003-9969(90)90209-S
   Line Sergio Roberto Peres, 2005, Brazilian Journal of Morphological Sciences, V22, P67
   Line SRP, 2005, J VERTEBR PALEONTOL, V25, P924, DOI 10.1671/0272-4634(2005)025[0924:ESOPMO]2.0.CO;2
   Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034
   Nagano T, 2009, J DENT RES, V88, P823, DOI 10.1177/0022034509342694
   Nanci A, 2008, 10 CATES ORAL HISTOL
   Porto IM, 2011, EUR J ORAL SCI, V119, P83, DOI 10.1111/j.1600-0722.2011.00885.x
   Porto IM, 2011, J ARCHAEOL SCI, V38, P3596, DOI 10.1016/j.jas.2011.08.030
   Ramenzoni LL, 2006, P R SOC B, V273, P1155, DOI 10.1098/rspb.2005.3409
   SALIDO EC, 1992, AM J HUM GENET, V50, P303
   SANANTONIO JD, 2011, PLOS ONE, V0006
   Schweitzer MH, 2014, ANAL CHEM, V86, P6731, DOI 10.1021/ac500803w
   Sire JY, 2005, ARCH ORAL BIOL, V50, P205, DOI 10.1016/j.archoralbio.2004.09.004
   Zhang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024952
NR 26
TC 4
Z9 4
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 66
BP 61673
EP 61679
DI 10.1039/c6ra05120k
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA DQ8TY
UT WOS:000379485200081
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Gao, Y
   Xu, CJ
   Wang, LH
AF Gao, Yu
   Xu, Chenjie
   Wang, Lianhui
TI Non-invasive monitoring of the osteogenic differentiation of human
   mesenchymal stem cells on a polycaprolactone scaffold using Raman
   imaging
SO RSC ADVANCES
LA English
DT Article
ID TISSUE ENGINEERING SCAFFOLDS; MESSENGER-RNA; BONE; NANOPARTICLES;
   NANOSENSORS
AB Scaffold-based bone tissue engineering often involves the use of human mesenchymal stem cells (hMSCs) that are seeded into three-dimensional (3D) scaffolds and induced to generate new bone by osteoinductive cues. In order to obtain an efficacious reconstruction of bone tissue, hMSCs must grow and differentiate in osteogenic conditions on biomaterial scaffolds to be subsequently implanted in vivo. Traditional evaluation of the osteogenic differentiation of hMSCs on scaffolds depends on time-consuming and cell-destroying end-point assays. This work explores the use of Raman spectroscopy as a non-invasive and real-time imaging method for continuous monitoring of the osteogenic differentiation of hMSCs on a polycaprolactone scaffold. In a period of 28 days, Raman spectroscopic imaging with a single cell resolution provided fingerprint chemical information and structural information on the differentiating hMSCs. Delayed mineralization was observed for hMSC osteogenic differentiation on PCL scaffolds in comparison to that on tissue culture plates.
C1 [Gao, Yu; Wang, Lianhui] Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, 9 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.
   [Gao, Yu; Wang, Lianhui] Nanjing Univ Posts & Telecommun, Jiangsu Natl Synergist Innovat Ctr Adv Mat SICAM, Inst Adv Mat, 9 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.
   [Xu, Chenjie] Nanyang Technol Univ, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 637457, Singapore.
   [Xu, Chenjie] Nanyang Technol Univ, NTU Northwestern Inst Nanomed, 50 Nanyang Ave, Singapore 639798, Singapore.
RP Wang, LH (reprint author), Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, 9 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.; Wang, LH (reprint author), Nanjing Univ Posts & Telecommun, Jiangsu Natl Synergist Innovat Ctr Adv Mat SICAM, Inst Adv Mat, 9 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.; Xu, CJ (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 637457, Singapore.; Xu, CJ (reprint author), Nanyang Technol Univ, NTU Northwestern Inst Nanomed, 50 Nanyang Ave, Singapore 639798, Singapore.
EM cjxu@ntu.edu.sg; iamlhwang@njupt.edu.cn
RI Gao, Yu/I-4883-2015; xu, chenjie/E-4075-2012
OI Gao, Yu/0000-0002-8724-7748; 
FU Ministry of Education Tier 1 Academic Research Fund [RG131/15];
   NTU-Northwestern Institute for Nanomedicine [M4081502.F40]; National
   Basic Research Program of China [2012CB933301]; Jiangsu National
   Synergistic Innovation Center for Advanced Materials (SICAM); Program
   for Changjiang Scholars and Innovative Research Team in University
   [IRT_15R37]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD) [YX03001]
FX The work was supported by Ministry of Education Tier 1 Academic Research
   Fund (RG131/15) and NTU-Northwestern Institute for Nanomedicine
   (M4081502.F40 to C. J. X). L. H. Wang acknowledges the National Basic
   Research Program of China (2012CB933301), the Jiangsu National
   Synergistic Innovation Center for Advanced Materials (SICAM), the
   Program for Changjiang Scholars and Innovative Research Team in
   University (IRT_15R37), and the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD, YX03001) for support.
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Chiang HK, 2009, J RAMAN SPECTROSC, V40, P546, DOI 10.1002/jrs.2161
   Gao Y, 2016, ACS APPL MATER INTER, V8, P6336, DOI 10.1021/acsami.5b12409
   Gao Y, 2016, NANOSCALE, V8, P2568, DOI 10.1039/c5nr07287e
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Ghita A, 2014, ANALYST, V139, P55, DOI 10.1039/c3an01716h
   Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017
   Hung PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065438
   Kalpakcioglu BB, 2011, BONE, V48, P1221, DOI 10.1016/j.bone.2011.02.005
   Kazanci M, 2007, BONE, V41, P456, DOI 10.1016/j.bone.2007.04.200
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Lim J, 2014, SMALL, V10, P2495, DOI 10.1002/smll.201302389
   Liu YC, 2013, BIOTECHNOL ADV, V31, P688, DOI 10.1016/j.biotechadv.2012.10.003
   Liu YC, 2015, J TISSUE ENG REGEN M, V9, P85, DOI 10.1002/term.1617
   McManus LL, 2011, ANALYST, V136, P2471, DOI 10.1039/c1an15167c
   Pully VV, 2010, ANAL CHEM, V82, P1844, DOI 10.1021/ac902515c
   Stewart S, 2012, ANNU REV ANAL CHEM, V5, P337, DOI 10.1146/annurev-anchem-062011-143152
   Wang M, 2016, ACS APPL MATER INTER, V8, P5877, DOI 10.1021/acsami.5b12234
   Wiraja C, 2016, SMALL, V12, P1342, DOI 10.1002/smll.201502047
   Wiraja C, 2015, J MATER CHEM B, V3, P6148, DOI 10.1039/c5tb00876j
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n
   Zhang ZY, 2012, BIOMATERIALS, V33, P2656, DOI 10.1016/j.biomaterials.2011.12.025
   Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078
   Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028
NR 26
TC 2
Z9 2
U1 2
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 66
BP 61771
EP 61776
DI 10.1039/c6ra11636a
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA DQ8TY
UT WOS:000379485200093
OA Bronze
DA 2018-10-20
ER

EF